PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Baer, CE; Iavarone, AT; Alber, T; Sassetti, CM				Baer, Christina E.; Iavarone, Anthony T.; Alber, Tom; Sassetti, Christopher M.			Biochemical and Spatial Coincidence in the Provisional Ser/Thr Protein Kinase Interaction Network of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL SYNTHESIS; SERINE/THREONINE KINASE; ACTIVATION MECHANISM; ALLOSTERIC ACTIVATION; MASS-SPECTROMETRY; PKNB KINASE; PHOSPHORYLATION; GROWTH; DIVISION; IDENTIFICATION	Many Gram-positive bacteria coordinate cellular processes by signaling through Ser/Thr protein kinases (STPKs), but the architecture of these phosphosignaling cascades is unknown. To investigate the network structure of a prokaryotic STPK system, we comprehensively explored the pattern of signal transduction in the Mycobacterium tuberculosis Ser/Thr kinome. Autophosphorylation is the dominant mode of STPK activation, but the 11 M. tuberculosis STPKs also show a specific pattern of efficient cross-phosphorylation in vitro. The biochemical specificity intrinsic to each kinase domain was used to map the provisional signaling network, revealing a three-layer architecture that includes master regulators, signal transducers, and terminal substrates. Fluorescence microscopy revealed that the STPKs are specifically localized in the cell. Master STPKs are concentrated at the same subcellular sites as their substrates, providing additional support for the biochemically defined network. Together, these studies imply a branched functional architecture of the M. tuberculosis Ser/Thr kinome that could enable horizontal signal spreading. This systems-level approach provides a biochemical and spatial framework for understanding Ser/Thr phospho-signaling in M. tuberculosis, which differs fundamentally from previously defined linear histidine kinase cascades.	[Baer, Christina E.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Inst QB3, Chem Mass Spectrometry Facil QB3, Berkeley, CA 94720 USA; [Alber, Tom] Univ Calif Berkeley, Inst QB3, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Baer, Christina E.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Sassetti, CM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Sherman Ctr ASC8-2051,368 Plantat St, Worcester, MA 01605 USA.	christopher.sassetti@umassmed.edu		Baer, Christina/0000-0002-8909-2583	National Institutes of Health [AI095208, GM070962]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064282, P01AI095208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Although the cellular roles of these individual STPKs are begin Grants AI095208 (to C. S.) and GM070962 (to T. A.).	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bell C, 2012, J PROTEOME RES, V11, P119, DOI 10.1021/pr2007939; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; England P, 2009, FEBS LETT, V583, P301, DOI 10.1016/j.febslet.2008.12.036; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; Hatzios SK, 2013, P NATL ACAD SCI USA, V110, pE5069, DOI 10.1073/pnas.1321205110; Jones G, 2006, J BACTERIOL, V188, P7470, DOI 10.1128/JB.00800-06; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Lombana TN, 2010, STRUCTURE, V18, P1667, DOI 10.1016/j.str.2010.09.019; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, PROTEOMICS, V6, P3754, DOI 10.1002/pmic.200500900; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Muoz-Dorado J., 1991, CELL, V67, P995, DOI DOI 10.1016/0092-8674(91)90372-6; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roumestand C, 2011, STRUCTURE, V19, P1525, DOI 10.1016/j.str.2011.07.011; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Schultz C, 2009, MOL MICROBIOL, V74, P724, DOI 10.1111/j.1365-2958.2009.06897.x; Sharma K, 2004, FEMS MICROBIOL LETT, V233, P107, DOI 10.1016/j.femsle.2004.01.045; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	49	46	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20422	20433		10.1074/jbc.M114.559054	http://dx.doi.org/10.1074/jbc.M114.559054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928517	hybrid, Green Published			2022-12-28	WOS:000339396600002
J	Fraser, PE				Fraser, Paul E.			Prions and Prion-like Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NEURODEGENERATIVE DISEASES; PATHOGENIC PROTEINS; SCRAPIE AGENT; SPREAD	Prions are self-replicating protein aggregates and are the primary causative factor in a number of neurological diseases in mammals. The prion protein (PrP) undergoes a conformational transformation leading to aggregation into an infectious cellular pathogen. Prion-like protein spreading and transmission of aggregates between cells have also been demonstrated for other proteins associated with Alzheimer disease and Parkinson disease. This protein-only phenomenon may therefore have broader implications in neurodegenerative disorders. The minireviews in this thematic series highlight the recent advances in prion biology and the roles these unique proteins play in disease.	[Fraser, Paul E.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5T 2S8, Canada	University of Toronto; University of Toronto	Fraser, PE (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada.	pfraser@asbmb.org						ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ashe KH, 2013, PRION, V7, P55, DOI 10.4161/pri.23061; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Halliday M, 2014, J BIOL CHEM, V289, P19862, DOI 10.1074/jbc.R114.568477; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; KIMBERLIN RH, 1982, NATURE, V297, P107, DOI 10.1038/297107a0; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Supattapone S, 2014, J BIOL CHEM, V289, P19850, DOI 10.1074/jbc.R113.511329; Walker LC, 2012, J BIOL CHEM, V287, P33109, DOI 10.1074/jbc.R112.399378; Watts JC, 2014, J BIOL CHEM, V289, P19841, DOI 10.1074/jbc.R114.550707; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	16	26	29	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19839	19840		10.1074/jbc.R114.583492	http://dx.doi.org/10.1074/jbc.R114.583492			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24860092	Green Published, hybrid			2022-12-28	WOS:000339395200001
J	Sommers, JA; Banerjee, T; Hinds, T; Wan, BB; Wold, MS; Lei, M; Brosh, RM				Sommers, Joshua A.; Banerjee, Taraswi; Hinds, Twila; Wan, Bingbing; Wold, Marc S.; Lei, Ming; Brosh, Robert M., Jr.			Novel Function of the Fanconi Anemia Group J or RECQ1 Helicase to Disrupt Protein-DNA Complexes in a Replication Protein A-stimulated Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-QUADRUPLEX DNA; WERNER-SYNDROME HELICASE; BLOOMS-SYNDROME HELICASE; ESCHERICHIA-COLI; BINDING PROTEIN; HOMOLOGOUS RECOMBINATION; MAMMALIAN TELOMERES; GENOMIC STABILITY; NUCLEOPROTEIN FILAMENTS; SUBSTRATE-SPECIFICITY	Understanding how cellular machinery deals with chromosomal genome complexity is an important question because protein bound to DNA may affect various cellular processes of nucleic acid metabolism. DNA helicases are at the forefront of such processes, yet there is only limited knowledge how they remodel protein-DNA complexes and how these mechanisms are regulated. We have determined that representative human RecQ and Fe-S cluster DNA helicases are potently blocked by a protein-DNA interaction. The Fanconi anemia group J (FANCJ) helicase partners with the single-stranded DNA-binding protein replication protein A (RPA) to displace BamHI-E111A bound to duplex DNA in a specific manner. Protein displacement was dependent on the ATPase-driven function of the helicase and unique properties of RPA. Further biochemical studies demonstrated that the shelterin proteins TRF1 and TRF2, which preferentially bind the telomeric repeat found at chromosome ends, effectively block FANCJ from unwinding the forked duplex telomeric substrate. RPA, but not the Escherichia coli single-stranded DNA-binding protein or shelterin factor Pot1, stimulated FANCJ ejection of TRF1 from the telomeric DNA substrate. FANCJ was also able to displace TRF2 from the telomeric substrate in an RPA-dependent manner. The stimulation of helicase-catalyzed protein displacement is also observed with the DNA helicase RECQ1, suggesting a conserved functional interaction of RPA-interacting helicases. These findings suggest that partnerships between RPA and interacting human DNA helicases may greatly enhance their ability to dislodge proteins bound to duplex DNA, an activity that is likely to be highly relevant to their biological roles in DNA metabolism.	[Sommers, Joshua A.; Banerjee, Taraswi; Hinds, Twila; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Wan, Bingbing; Lei, Ming] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan; University of Iowa	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020; Banerjee, Taraswi/AAC-6093-2020	Wold, Marc/0000-0002-4580-1624; Wan, Bingbing/0000-0001-8629-0616	National Institutes of Health Intramural Research Program of the NIA; Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741, ZIAAG000753] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIA. This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.).	Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P949, DOI 10.1093/nar/gkq889; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Baharoglu Z, 2010, MOL MICROBIOL, V77, P324, DOI 10.1111/j.1365-2958.2010.07208.x; BEDINGER P, 1983, CELL, V34, P115, DOI 10.1016/0092-8674(83)90141-1; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bidnenko V, 2006, MOL MICROBIOL, V62, P382, DOI 10.1111/j.1365-2958.2006.05382.x; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bosco N, 2012, CHROMOSOMA, V121, P465, DOI 10.1007/s00412-012-0377-6; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chavez A, 2009, BBA-MOL BASIS DIS, V1792, P329, DOI 10.1016/j.bbadis.2009.02.008; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; De Septenville AL, 2012, PLOS GENET, V8, P116, DOI 10.1371/journal.pgen.1002622; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Engler LE, 2001, J MOL BIOL, V307, P619, DOI 10.1006/jmbi.2000.4428; Finkelstein IJ, 2010, NATURE, V468, P983, DOI 10.1038/nature09561; Fujimoto S, 2009, BIOCHEM CELL BIOL, V87, P875, DOI [10.1139/O09-051, 10.1139/o09-051]; Gupta MK, 2013, P NATL ACAD SCI USA, V110, P7252, DOI 10.1073/pnas.1303890110; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Hanaoka S, 2005, PROTEIN SCI, V14, P119, DOI 10.1110/ps.04983705; Hass CS, 2012, J BIOL CHEM, V287, P3908, DOI 10.1074/jbc.M111.287441; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Le Breton C, 2008, NUCLEIC ACIDS RES, V36, P4964, DOI 10.1093/nar/gkn441; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; McGlynn P, 2008, J MOL BIOL, V381, P249, DOI 10.1016/j.jmb.2008.05.053; McGlynn P, 2011, BIOCHEM SOC T, V39, P606, DOI 10.1042/BST0390606; Nora GJ, 2010, NUCLEIC ACIDS RES, V38, P3984, DOI 10.1093/nar/gkq144; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Popuri V, 2014, NUCLEIC ACIDS RES, V42, P5671, DOI 10.1093/nar/gku200; Qiu YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3281; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Schwendener S, 2010, J BIOL CHEM, V285, P15739, DOI 10.1074/jbc.M110.110478; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Simandlova J, 2013, J BIOL CHEM, V288, P34168, DOI 10.1074/jbc.M113.484493; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Symington LS, 2006, GENE DEV, V20, P2479, DOI 10.1101/gad.1477106; Uringa EJ, 2011, NUCLEIC ACIDS RES, V39, P1647, DOI 10.1093/nar/gkq1045; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang F, 2011, METHODS MOL BIOL, V735, P173, DOI 10.1007/978-1-61779-092-8_17; Ward JD, 2010, MOL CELL, V37, P259, DOI 10.1016/j.molcel.2009.12.026; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2010, BLOOD, V116, P3780, DOI 10.1182/blood-2009-11-256016; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; YANCEYWRONA JE, 1992, NUCLEIC ACIDS RES, V20, P6713, DOI 10.1093/nar/20.24.6713; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	80	25	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19928	19941		10.1074/jbc.M113.542456	http://dx.doi.org/10.1074/jbc.M113.542456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895130	Green Published, hybrid			2022-12-28	WOS:000339395200011
J	Wu, J; Kim, S; Kwak, MS; Jeong, JB; Min, HJ; Yoon, HG; Ahn, JH; Shin, JS				Wu, Jie; Kim, Sol; Kwak, Man Sup; Jeong, Jang Bin; Min, Hyun Jin; Yoon, Ho-Geun; Ahn, Jin-Hyun; Shin, Jeon-Soo			High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) SUMOylation by the SUMO E3 Ligase PIAS1 Decreases the Binding Affinity to Nucleosome Core Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL-PROTEINS HMG-14; LIVING CELLS; POSTTRANSLATIONAL MODIFICATIONS; MITOTIC PHOSPHORYLATION; CHROMATIN; DYNAMICS; HMGB1; REGULATOR; SECRETION; DISTINCT	High mobility group nucleosomal binding domain 2 (HMGN2) is a small and unique non-histone protein that has many functions in a variety of cellular processes, including regulation of chromatin structure, transcription, and DNA repair. In addition, it may have other roles in antimicrobial activity, cell homing, and regulating cytokine release. Although the biochemical properties of HMGN2 protein are regulated by acetylation and phosphorylation, it is not yet known whether HMGN2 activity can also be regulated by SUMOylation. In this study, we demonstrated for the first time that HMGN2 is modified by covalent attachment of small ubiquitin-related modifier 1 (SUMO1) by pro-inflammatory signal and identified the major SUMOylated lysine residues that localize to the HMGN2 nucleosome-binding domain at Lys-17 and Lys-35. SENP1 can deSUMOylate SUMOylated HMGN2, and PIAS1 is the E3 ligase responsible for SUMOylation of HMGN2. Finally, using SUMO1-conjugated HMGN2 purified from a basal SUMOylation system in Escherichia coli, we demonstrated that SUMOylated HMGN2 has decreased the binding affinity to nucleosome core particles in comparison to unSUMOylated HMGN2. These observations potentially provide new perspectives for understanding the functions of HMGN2 in inflammatory reaction.	[Wu, Jie; Kim, Sol; Kwak, Man Sup; Jeong, Jang Bin; Min, Hyun Jin; Shin, Jeon-Soo] Yonsei Univ, Dept Microbiol, Coll Med, Seoul 120752, South Korea; [Wu, Jie; Jeong, Jang Bin; Min, Hyun Jin; Yoon, Ho-Geun; Shin, Jeon-Soo] Yonsei Univ, Brain Korea Plus Project Med Sci 21, Coll Med, Seoul 120752, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul 120752, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul 120752, South Korea; [Yoon, Ho-Geun] Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, Seoul 120752, South Korea; [Wu, Jie] Harbin Med Univ, Med Genet Lab, Harbin 150086, Peoples R China; [Ahn, Jin-Hyun] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon 440746, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Harbin Medical University; Sungkyunkwan University (SKKU)	Shin, JS (corresponding author), Yonsei Univ, Dept Microbiol, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea.	jsshin6203@yuhs.ac	kim, sol/I-2198-2019; Chung-ang, HyunJin/AAO-9395-2020	, Man Sup Kwak/0000-0002-3989-3016; Yoon, Ho-Geun Yoon/0000-0003-2718-3372; Shin, Jeon-Soo/0000-0002-8294-3234	National Research Foundation of Korea (NRF) - Korean government (MEST) [2011-0017611, 2014R1A4A1008625]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (MEST) (2011-0017611 and 2014R1A4A1008625).	Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Cao XF, 2008, MOL CANCER THER, V7, P923, DOI 10.1158/1535-7163.MCT-07-0540; Catez F, 2003, BIOCHEM CELL BIOL, V81, P113, DOI 10.1139/o03-040; Deng LX, 2011, FEBS J, V278, P2152, DOI 10.1111/j.1742-4658.2011.08132.x; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Feng Y, 2005, J LEUKOCYTE BIOL, V78, P1136, DOI 10.1189/jlb.0505280; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerlitz G, 2010, BBA-GENE REGUL MECH, V1799, P80, DOI 10.1016/j.bbagrm.2009.10.007; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Herrera JE, 1999, MOL CELL BIOL, V19, P3466; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; MARDIAN JKW, 1980, SCIENCE, V209, P1534, DOI 10.1126/science.7433974; Messner S, 2009, FASEB J, V23, P3978, DOI 10.1096/fj.09-137695; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pogna EA, 2010, BBA-GENE REGUL MECH, V1799, P93, DOI 10.1016/j.bbagrm.2009.11.018; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Prymakowska-Bosak M, 2002, MOL CELL BIOL, V22, P6809, DOI 10.1128/MCB.22.19.6809-6819.2002; Prymakowska-Bosak M, 2001, MOL CELL BIOL, V21, P5169, DOI 10.1128/MCB.21.15.5169-5178.2001; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Terada K, 2010, DEV BIOL, V347, P180, DOI 10.1016/j.ydbio.2010.08.023; TRIESCHMANN L, 1995, MOL CELL BIOL, V15, P6663; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; Ueda T, 2008, MOL CELL BIOL, V28, P2872, DOI 10.1128/MCB.02181-07; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Witty J, 2010, BIOCHEM J, V428, P247, DOI 10.1042/BJ20091948; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang QC, 2008, BBA-PROTEINS PROTEOM, V1784, P1159, DOI 10.1016/j.bbapap.2008.04.028	42	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20000	20011		10.1074/jbc.M114.555425	http://dx.doi.org/10.1074/jbc.M114.555425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24872413	Green Published, hybrid			2022-12-28	WOS:000339395200016
J	Vartak-Sharma, N; Gelman, BB; Joshi, C; Borgamann, K; Ghorpade, A				Vartak-Sharma, Neha; Gelman, Benjamin B.; Joshi, Chaitanya; Borgamann, Kathleen; Ghorpade, Anuja			Astrocyte Elevated Gene-1 Is a Novel Modulator of HIV-1-associated Neuroinflammation via Regulation of Nuclear Factor-kappa B Signaling and Excitatory Amino Acid Transporter-2 Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-ASSOCIATED DEMENTIA; BLOOD-BRAIN-BARRIER; VIRUS TYPE-1 TAT; CHEMOTACTIC CYTOKINES; NEURONAL INJURY; HUMAN MONOCYTES; MESSENGER-RNA; PROTEIN; EXPRESSION; ACTIVATION	Astrocyte elevated gene-1 (AEG-1), a novel human immunodeficiency virus (HIV)-1 and tumor necrosis factor (TNF)-alpha inducible oncogene, has generated significant interest in the field of cancer research as a therapeutic target for many metastatic aggressive tumors. However, little is known about its role in astrocyte responses during HIV-1 central nervous system (CNS) infection and whether it contributes toward the development of HIV-associated neurocognitive disorders (HAND). Therefore, in this study, we investigated changes in AEG-1 CNS expression in HIV-1-infected brain tissues and elucidated a potential mechanism of AEG-1-mediated regulation of HAND. Immunoblotting and immunohistochemical analyses of HIV-1 seropositive and HIV-1 encephalitic human brain tissues revealed significantly elevated levels of AEG-1 protein. Immunohistochemical analyses of HIV-1 Tat transgenic mouse brain tissues also showed a marked increase in AEG-1 staining. Similar to in vivo observations, cultured astrocytes expressing HIV-1 Tat also revealed AEG-1 and cytokine up-regulation. Astrocytes treated with HAND-relevant stimuli, TNF-alpha, interleukin (IL)1 beta, and HIV-1, also significantly induced AEG-1 expression and nuclear translocation via activation of the nuclear factor (NF)-kappa B pathway. Co-immunoprecipitation studies demonstrated IL-1 beta -or TNF-alpha-induced AEG-1 interaction with NF-kappa B p65 subunit. AEG-1 knockdown decreased NF-kappa B activation, nuclear translocation, and transcriptional output in TNF-alpha -treated astrocytes. Moreover, IL-1 beta treatment of AEG1-overexpressing astrocytes significantly lowered expression of excitatory amino acid transporter 2, increased expression of excitatory amino acid transporter 2 repressor ying yang 1, and reduced glutamate clearance, a major transducer of excitotoxic neuronal damage. Findings from this study identify a novel transcriptional co-factor function of AEG-1 and further implicate AEG-1 in HAND-associated neuroinflammation.	[Vartak-Sharma, Neha; Joshi, Chaitanya; Borgamann, Kathleen; Ghorpade, Anuja] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA; [Gelman, Benjamin B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Gelman, Benjamin B.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	University of North Texas System; University of North Texas Health Science Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Ghorpade, A (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	Anuja.Ghorpade@unthsc.edu	Borgmann, Kathleen/ABU-3329-2022; Joshi, Chaitanya G/AAK-1842-2020	Borgmann, Kathleen/0000-0003-0897-390X; Joshi, Chaitanya G/0000-0003-4680-2861	National Institutes of Health [R01MH087345]; National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [5R24HD0008836];  [U01 MH083507];  [R24NS045091];  [U01MH083506];  [R24 MH059745];  [U01MH083501];  [R24MH059724];  [U01MH083500];  [R24NS038841];  [U01MH083545];  [R01NS072005];  [R01MH79886]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH059724, U01MH083500, U24MH100928, U01MH083545, U01MH083506, U01MH083507, R01MH079886, U24MH100930, R24MH059745, U01MH083501, R01MH087345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS038841, R01NS045091, R01NS072005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01MH087345 (to A. G. and the JES Edwards Foundation); U01 MH083507, R24NS045091, U01MH083506, R24 MH059745, U01MH083501, R24MH059724, U01MH083500, R24NS038841, and U01MH083545 (to the National NeuroAIDS Tissue Consortium); R01NS072005; and R01MH79886. This work was also supported by National Institutes of Health Award Number 5R24HD0008836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.	Aschner M, 1998, NEUROTOXICOLOGY, V19, P269; Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Atlante A, 2001, FEBS LETT, V497, P1, DOI 10.1016/S0014-5793(01)02437-1; BACKUS KH, 1989, J NEUROSCI RES, V22, P274, DOI 10.1002/jnr.490220307; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Benediktsson AM, 2012, GLIA, V60, P175, DOI 10.1002/glia.21249; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Borjabad A, 2010, J NEUROIMMUNE PHARM, V5, P44, DOI 10.1007/s11481-009-9167-1; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chadderton T, 1997, CELL MOL BIOL, V43, P1227; Chang JR, 2011, J BIOL CHEM, V286, P41125, DOI 10.1074/jbc.M111.268466; Chen W, 2010, NEOPLASMA, V57, P522, DOI 10.4149/neo_2010_06_522; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Gardner J, 2006, J NEUROSCI RES, V83, P1281, DOI 10.1002/jnr.20823; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Ghorpade A, 1998, J VIROL, V72, P3340, DOI 10.1128/JVI.72.4.3340-3350.1998; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Karki P, 2014, MOL CELL BIOL, V34, P1280, DOI 10.1128/MCB.01176-13; KASAHARA T, 1990, BIOCHEM BIOPH RES CO, V167, P1242, DOI 10.1016/0006-291X(90)90657-9; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Kutsch O, 2000, J VIROL, V74, P9214, DOI 10.1128/JVI.74.19.9214-9221.2000; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Liao WT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-205; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Lopez-Bayghen E, 2011, IUBMB LIFE, V63, P816, DOI 10.1002/iub.536; LopezVillegas D, 1997, P NATL ACAD SCI USA, V94, P9854, DOI 10.1073/pnas.94.18.9854; Manthrope M., 1986, BRAIN RES, V25, P191; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2002, J INFECT DIS, V186, pS193, DOI 10.1086/344528; Navia B. A., 2005, The neurology of AIDS, P339; Nguyen TP, 2010, AM J PATHOL, V176, P893, DOI 10.2353/ajpath.2010.090390; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Persidsky Y, 1997, J NEUROVIROL, V3, P401, DOI 10.3109/13550289709031186; Sabri F, 2003, BRAIN PATHOL, V13, P84, DOI 10.1111/j.1750-3639.2003.tb00009.x; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sun W, 2011, ONCOL REP, V26, P1133, DOI 10.3892/or.2011.1387; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; Thirkettle HJ, 2009, CLIN CANCER RES, V15, P3003, DOI 10.1158/1078-0432.CCR-08-2046; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Trujillo JR, 2005, CELL RES, V15, P962, DOI 10.1038/sj.cr.7290374; UGUCCIONI M, 1995, EUR J IMMUNOL, V25, P64, DOI 10.1002/eji.1830250113; UNAIDS, 2008, 17 INT AIDS C JOINT; Vartak-Sharma N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-195; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Weiss JM, 1999, J IMMUNOL, V163, P2953; Wesselingh SL, 1997, J NEUROIMMUNOL, V74, P1, DOI 10.1016/S0165-5728(96)00160-9; Xing HQ, 2009, J NEUROPATH EXP NEUR, V68, P199, DOI 10.1097/NEN.0b013e31819715df; Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008; Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015	69	41	43	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19599	19612		10.1074/jbc.M114.567644	http://dx.doi.org/10.1074/jbc.M114.567644			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855648	hybrid, Green Published			2022-12-28	WOS:000339326800033
J	Weber, M; Hartmann, AM; Beyer, T; Ripperger, A; Nothwang, HG				Weber, Maren; Hartmann, Anna-Maria; Beyer, Timo; Ripperger, Anne; Nothwang, Hans Gerd			A Novel Regulatory Locus of Phosphorylation in the C Terminus of the Potassium Chloride Cotransporter KCC2 That Interferes with N-Ethylmaleimide or Staurosporine-mediated Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPORAL-LOBE EPILEPSY; ALANINE-RICH KINASE; AUDITORY BRAIN-STEM; K-CL; HIPPOCAMPAL-NEURONS; ION-TRANSPORT; INHIBITORY NEUROTRANSMISSION; SEQUENCE ALIGNMENT; PROTEIN-KINASES; DOWN-REGULATION	The neuron-specific cation chloride cotransporter KCC2 plays a crucial role in hyperpolarizing synaptic inhibition. Transporter dysfunction is associated with various neurological disorders, raising interest in regulatory mechanisms. Phosphorylation has been identified as a key regulatory process. Here, we retrieved experimentally observed phosphorylation sites of KCC2 from public databases and report on the systematic analysis of six phosphorylated serines, Ser(25), Ser(26), Ser(937), Ser(1022), Ser(1025), and Ser(1026). Alanine or aspartate substitutions of these residues were analyzed in HEK-293 cells. All mutants were expressed in a pattern similar to wild-type KCC2 (KCC2(WT)). Tl+ flux measurements demonstrated unchanged transport activity for Ser(25), Ser(26), Ser(1022), Ser(1025), and Ser(1026) mutants. In contrast, KCC2(S937D), mimicking phosphorylation, resulted in a significant up-regulation of transport activity. Aspartate substitution of Thr(934), a neighboring putative phosphorylation site, resulted in a comparable increase in KCC2 transport activity. Both KCC2(T934D) and KCC2(S937D) mutants were inhibited by the kinase inhibitor staurosporine and by N-ethylmaleimide, whereas KCC2(WT), KCC2(T934A), and KCC2(S937A) were activated. The inverse staurosporine effect on aspartate versus alanine substitutions reveals a cross-talk between different phosphorylation sites of KCC2. Immunoblot and cell surface labeling experiments detected no alterations in total abundance or surface expression of KCC2(T934D) and KCC2(S937D) compared with KCC2(WT). These data reveal kinetic regulation of transport activity by these residues. In summary, our data identify a novel key regulatory phosphorylation site of KCC2 and a functional interaction between different conformation-changing post-translational modifications. The action of pharmacological agents aimed to modulate KCC2 activity for therapeutic benefit might therefore be highly context-specific.	[Weber, Maren; Hartmann, Anna-Maria; Beyer, Timo; Ripperger, Anne; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Ctr Excellence Hearing4All, D-26111 Oldenburg, Germany; [Hartmann, Anna-Maria] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Systemat & Evolutionary Biol Grp, D-26111 Oldenburg, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, D-26111 Oldenburg, Germany.	hans.g.nothwang@uni-oldenburg.de		Nothwang, Hans Gerd/0000-0001-7695-6437	Deutsche Forschungsgemeinschaft [428/3-1, 428/4-2];  [Ha6338/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by Deutsche Forschungsgemeinschaft Grants No428/3-1 and No428/4-2 (to H. G. N.) and Ha6338/2-1 (to A.-M. H).	Acton BA, 2012, J NEUROSCI, V32, P8746, DOI 10.1523/JNEUROSCI.6089-11.2012; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Becker M, 2003, CELL TISSUE RES, V312, P155, DOI 10.1007/s00441-003-0713-5; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Chamma I, 2013, J NEUROSCI, V33, P15488, DOI 10.1523/JNEUROSCI.5889-12.2013; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Coull JAM, 2009, CURR OPIN INVEST DR, V10, P56; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; DeFranceschi L, 1997, J CLIN INVEST, V99, P220, DOI 10.1172/JCI119150; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Di Fulvio M, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P169; Doding A, 2012, BIOCHEM BIOPH RES CO, V420, P492, DOI 10.1016/j.bbrc.2012.02.147; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flatman PW, 1996, AM J PHYSIOL-CELL PH, V271, pC255, DOI 10.1152/ajpcell.1996.271.1.C255; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GEORGE JN, 1989, J MEMBRANE BIOL, V112, P51, DOI 10.1007/BF01871163; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hartmann AM, 2014, MOL BIOL EVOL, V31, P434, DOI 10.1093/molbev/mst225; Hartmann Anna-Maria, 2011, BMC Res Notes, V4, P526, DOI 10.1186/1756-0500-4-526; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Holtzman EJ, 1998, AM J PHYSIOL-RENAL, V275, pF550, DOI 10.1152/ajprenal.1998.275.4.F550; Horn Z, 2010, EUR J NEUROSCI, V31, P2142, DOI 10.1111/j.1460-9568.2010.07258.x; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2012, J BIOL CHEM, V287, P20839, DOI 10.1074/jbc.M111.319418; Ivakine EA, 2013, P NATL ACAD SCI USA, V110, P3561, DOI 10.1073/pnas.1212907110; Janssen SP, 2011, NEUROSCIENCE, V184, P183, DOI 10.1016/j.neuroscience.2011.03.060; JENNINGS ML, 1990, J GEN PHYSIOL, V95, P1021, DOI 10.1085/jgp.95.6.1021; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; LAUF PK, 1995, AM J PHYSIOL-CELL PH, V269, pC1167, DOI 10.1152/ajpcell.1995.269.5.C1167; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Lytle C, 2002, AM J PHYSIOL-CELL PH, V283, pC1422, DOI 10.1152/ajpcell.00130.2002; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; Melo Z, 2013, J BIOL CHEM, V288, P31468, DOI 10.1074/jbc.M113.475574; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Monette MY, 2014, J BIOL CHEM, V289, P7569, DOI 10.1074/jbc.M113.542258; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Schindler J, 2013, J NEUROSCI METH, V213, P153, DOI 10.1016/j.jneumeth.2012.10.003; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Wenz M, 2009, BIOCHEM BIOPH RES CO, V381, P388, DOI 10.1016/j.bbrc.2009.02.057; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Zhao BB, 2008, CELL SIGNAL, V20, P1769, DOI 10.1016/j.cellsig.2008.06.011	79	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18668	18679		10.1074/jbc.M114.567834	http://dx.doi.org/10.1074/jbc.M114.567834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849604	Green Published, hybrid			2022-12-28	WOS:000339062900006
J	Woo, AYH; Jozwiak, K; Toll, L; Tanga, MJ; Kozocas, JA; Jimenez, L; Huang, Y; Song, Y; Plazinska, A; Pajak, K; Paul, RK; Bernier, M; Wainer, IW; Xiao, RP				Woo, Anthony Yiu-Ho; Jozwiak, Krzysztof; Toll, Lawrence; Tanga, Mary J.; Kozocas, Joseph A.; Jimenez, Lucita; Huang, Ying; Song, Ying; Plazinska, Anita; Pajak, Karolina; Paul, Rajib K.; Bernier, Michel; Wainer, Irving W.; Xiao, Rui-Ping			Tyrosine 308 Is Necessary for Ligand-directed G(s) Protein-biased Signaling of beta(2)-Adrenoceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-FIELD ANALYSIS; FUNCTIONAL SELECTIVITY; COUPLED RECEPTOR; CARDIAC MYOCYTES; KINASE-A; FENOTEROL DERIVATIVES; DRUG DISCOVERY; PHOSPHORYLATION; BINDING; G(I)	Interaction of a given G protein-coupled receptor to multiple different G proteins is a widespread phenomenon. For instance, beta(2)-adrenoceptor (beta(2)-AR) couples dually to G(s) and G(i) proteins. Previous studies have shown that cAMP-dependent protein kinase (PKA)-mediated phosphorylation of beta(2)-AR causes a switch in receptor coupling from G(s) to G(i). More recent studies have demonstrated that phosphorylation of beta(2)-AR byGproteincoupled receptor kinases, particularly GRK2, markedly enhances the G(i) coupling. Wehave previously shown that although most beta(2)-AR agonists cause both G(s) and G(i) activation, (R,R')fenoterol preferentially activates beta(2)-AR-G(s) signaling. However, the structural basis for this functional selectivity remains elusive. Here, using docking simulation and site-directed mutagenesis, we defined Tyr-308 as the key amino acid residue on beta(2)-AR essential for G(s)-biased signaling. Following stimulation with a beta(2)-AR-G(s)-biased agonist (R,R')-4'-aminofenoterol, the G(i) disruptor pertussis toxin produced no effects on the receptor-mediated ERK phosphorylation in HEK293 cells nor on the contractile response in cardiomyocytes expressing the wild-type beta(2)-AR. Interestingly, Y308F substitution on beta(2)-AR enabled (R,R')-4'-aminofenoterol to activate G(i) and to produce these responses in a pertussis toxin-sensitive manner without altering beta(2)-AR phosphorylation by PKA or G protein-coupled receptor kinases. These results indicate that, in addition to the phosphorylation status, the intrinsic structural feature of beta(2)-AR plays a crucial role in the receptor coupling selectivity to G proteins. We conclude that specific interactions between the ligand and the Tyr-308 residue of beta(2)-AR stabilize receptor conformations favoring the receptor-G(s) protein coupling and subsequently result in G(s)-biased agonism.	[Woo, Anthony Yiu-Ho; Huang, Ying; Song, Ying] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China; [Woo, Anthony Yiu-Ho; Huang, Ying; Song, Ying; Xiao, Rui-Ping] Peking Univ, Inst Mol Med, Ctr Life Sci, Beijing 100871, Peoples R China; [Woo, Anthony Yiu-Ho] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA; [Paul, Rajib K.; Bernier, Michel; Wainer, Irving W.] NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA; [Jozwiak, Krzysztof; Plazinska, Anita; Pajak, Karolina] Med Univ Lublin, Dept Chem, Lublin, Poland; [Toll, Lawrence] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Tanga, Mary J.; Kozocas, Joseph A.; Jimenez, Lucita] SRI Int, Menlo Pk, CA 94025 USA	Peking University; University Town of Shenzhen; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Medical University of Lublin; Torrey Pines Institute for Molecular Studies, Florida; SRI International	Woo, AYH (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Peoples R China.	yiuhowoo@pkusz.edu.cn; xiaor@pku.edu.cn	Woo, Anthony/D-4305-2014; Bernier, Michel/AAO-3983-2021; Xiao, Rui-Ping/AAE-2629-2019; Yimei, Wang/AAE-4083-2019; Bernier, Michel/Y-7139-2019	Woo, Anthony/0000-0003-0662-698X; Bernier, Michel/0000-0002-5948-368X; Jozwiak, Krzysztof/0000-0001-6018-5092; Plazinska, Anita/0000-0002-3698-2574	National Institutes of Health Intramural Research Program from NIA; National Institutes of Health from NIA [N01-AG31009]; National Basic Research Program of China [2012CB518000]; National Science Foundation of China [31221002]; National Major Scientific Research Program of China [2012CB910402]; National Scientific Technology Major Project of China [2013ZX09507001]; Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University; Foundation for Polish Science [TEAM 2009-4/5]	National Institutes of Health Intramural Research Program from NIA; National Institutes of Health from NIA; National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific Research Program of China; National Scientific Technology Major Project of China; Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program from NIA (to A. Y. H. W., R. K. P., M. B., and I. W. W.) and by National Institutes of Health Grant N01-AG31009 from NIA. This work was also supported by National Basic Research Program of China Grant 2012CB518000 and National Science Foundation of China Project 31221002 (to R. P. X.), National Major Scientific Research Program of China Grant 2012CB910402, National Scientific Technology Major Project of China Grant 2013ZX09507001 (to A. Y. H. W.), Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, and Foundation for Polish Science Grant TEAM 2009-4/5 Programs (to K. J.).	Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Beigi F, 2006, CHIRALITY, V18, P822, DOI 10.1002/chir.20317; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Chakir K, 2011, J MOL CELL CARDIOL, V50, P1000, DOI 10.1016/j.yjmcc.2011.01.015; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Fowler JC, 2012, MOL PHARMACOL, V81, P820, DOI 10.1124/mol.111.075457; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; HAUSDORFF WP, 1990, SYM SOC EXP BIOL, V44, P225; Isogaya M, 1999, MOL PHARMACOL, V56, P875, DOI 10.1124/mol.56.5.875; Iyer V, 2006, BRIT J PHARMACOL, V147, P249, DOI 10.1038/sj.bjp.0706551; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; Jozwiak K, 2007, J MED CHEM, V50, P2903, DOI 10.1021/jm070030d; Jozwiak K, 2010, BIOORGAN MED CHEM, V18, P728, DOI 10.1016/j.bmc.2009.11.062; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu RJ, 2009, J BIOL CHEM, V284, P32279, DOI 10.1074/jbc.M109.021428; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Neubig RR, 2007, MOL PHARMACOL, V71, P1200, DOI 10.1124/mol.107.034926; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Plazinska A, 2013, J MOL MODEL, V19, P4919, DOI 10.1007/s00894-013-1981-y; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Seifert R, 2009, MOL PHARMACOL, V75, P13, DOI 10.1124/mol.108.052944; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; Woo AYH, 2009, MOL PHARMACOL, V75, P158, DOI 10.1124/mol.108.051078; Xiao RP, 2003, CIRCULATION, V108, P1633, DOI 10.1161/01.CIR.0000087595.17277.73; Xiao RP, 1999, CIRC RES, V84, P43; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zhang SJ, 2000, J BIOL CHEM, V275, P21773, DOI 10.1074/jbc.M909484199; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429; Zhu WZ, 2012, CIRC RES, V110, P265, DOI 10.1161/CIRCRESAHA.111.253260	48	35	38	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19351	19363		10.1074/jbc.M114.558882	http://dx.doi.org/10.1074/jbc.M114.558882			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24831005	Green Published, hybrid			2022-12-28	WOS:000339326800012
J	Zhang, JS; Gao, FD; Zhao, JH; Ogawa, T; Wang, QX; Ma, WM				Zhang, Jingsong; Gao, Fudan; Zhao, Jiaohong; Ogawa, Teruo; Wang, Quanxi; Ma, Weimin			NdhP Is an Exclusive Subunit of Large Complex of NADPH Dehydrogenase Essential to Stabilize the Complex in Synechocystis sp Strain PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLASTIC NAD(P)H DEHYDROGENASE; CYCLIC ELECTRON-TRANSPORT; PYRIDINE-NUCLEOTIDE DEHYDROGENASE; RESPIRATORY COMPLEX; PHOTOSYSTEM-I; THERMOSYNECHOCOCCUS-ELONGATUS; EFFICIENT OPERATION; PROTEIN COMPLEXES; CYANOBACTERIUM; IDENTIFICATION	Two major complexes of NADPH dehydrogenase (NDH-1) have been identified in cyanobacteria. A large complex (NDH-1L) contains NdhD1 and NdhF1, which are absent in a medium size complex (NDH-1M). They play important roles in respiration, cyclic electron transport around photosystem I, and CO2 acquisition. Two mutants sensitive to high light for growth and impaired in NDH-1-mediated cyclic electron transfer were isolated from Synechocystis sp. strain PCC 6803 transformed with a transposon-bearing library. Both mutants had a tag in sml0013 encoding NdhP, a single transmembrane small subunit of the NDH-1 complex. During prolonged incubation of the wild type thylakoid membrane with n-dodecyl beta-D-maltoside (DM), about half of the NDH-1L was disassembled to NDH-1M and the rest decomposed completely without forming NDH-1M. In the ndhP deletion mutant (Delta ndhP), disassembling of NDH-1L to NDH-1M occurred even on ice, and decomposition to a small piece occurred at room temperature much faster than in the wild type. Deletion of the C-terminal tail of NdhP gave the same result. The C terminus of NdhP was tagged by YFP-His(6). Blue native gel electrophoresis of the DM-treated thylakoid membrane of this strain and Western analysis using the antibody against GFP revealed that NdhP-YFP-His(6) was exclusively confined to NDH-1L. During prolonged incubation of the thylakoid membrane of the tagged strain with DM at room temperature, NDH-1L was partially disassembled to NDH-1M and the 160-kDa band containing NdhP-YFP-His6 and possibly NdhD1 and NdhF1. We therefore conclude that NdhP, especially its C-terminal tail, is essential to assemble NdhD1 and NdhF1 and stabilize the NDH-1L complex.	[Zhang, Jingsong; Gao, Fudan; Zhao, Jiaohong; Wang, Quanxi; Ma, Weimin] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China; [Ogawa, Teruo] Nagoya Univ, Biosci Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Shanghai Normal University; Nagoya University	Ma, WM (corresponding author), Shanghai Normal Univ, Coll Life & Environm Sci, 100 Guilin Rd, Shanghai 200234, Peoples R China.	wma@shnu.edu.cn	Ma, Weimin/A-8158-2015	Ma, Weimin/0000-0003-4964-415X; Zhang, Jingsong/0000-0002-8044-7608	National Natural Science Foundation of China [31370270]; National Basic Research Program of China Grant [2009CB118500]; Shanghai Education Committee [12ZZ132]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China Grant(National Basic Research Program of China); Shanghai Education Committee	This work was supported in part by National Natural Science Foundation of China Grant 31370270, National Basic Research Program of China Grant 2009CB118500, and Project of Shanghai Education Committee Grant 12ZZ132.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Armbruster U, 2013, PLANT CELL, V25, P3926, DOI 10.1105/tpc.113.114785; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Battchikova N, 2005, J BIOL CHEM, V280, P2587, DOI 10.1074/jbc.M410914200; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2011, J BIOL CHEM, V286, P36992, DOI 10.1074/jbc.M111.263780; Bernat G, 2011, J BACTERIOL, V193, P292, DOI 10.1128/JB.00984-10; Birungi M, 2010, BBA-BIOENERGETICS, V1797, P1681, DOI 10.1016/j.bbabio.2010.06.004; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Dai HL, 2013, PLANT J, V75, P858, DOI 10.1111/tpj.12251; Deng Y, 2003, PLANT CELL PHYSIOL, V44, P534, DOI 10.1093/pcp/pcg067; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GOMBOS Z, 1994, P NATL ACAD SCI USA, V91, P8787, DOI 10.1073/pnas.91.19.8787; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Ishikawa N, 2008, PLANT CELL PHYSIOL, V49, P1066, DOI 10.1093/pcp/pcn083; Jansen T, 2002, J PLANT PHYSIOL, V159, P1205, DOI 10.1078/0176-1617-00829; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Long ZJ, 2011, AFR J MICROBIOL RES, V5, P3603; Ma W., 2009, FRONT BIOL CHINA, V4, P137, DOI [10.1007/s11515-009-0005-x, DOI 10.1007/S11515-009-0005-X]; Ma WM, 2005, PHYSIOL PLANTARUM, V125, P135, DOI 10.1111/j.1399-3054.2005.00555.x; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; MI HL, 1992, PLANT CELL PHYSIOL, V33, P1233; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Ogawa T, 2007, PHOTOSYNTH RES, V93, P69, DOI 10.1007/s11120-006-9128-y; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Ohkawa H, 2002, FUNCT PLANT BIOL, V29, P195, DOI 10.1071/PP01180; Ohkawa H, 2001, J BACTERIOL, V183, P4938, DOI 10.1128/JB.183.16.4938-4939.2001; Peng LW, 2012, PLANT CELL, V24, P202, DOI 10.1105/tpc.111.090597; Peng LW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001040; Peng LW, 2011, BBA-BIOENERGETICS, V1807, P945, DOI 10.1016/j.bbabio.2010.10.015; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Schwarz D, 2013, PLANT PHYSIOL, V163, P1191, DOI 10.1104/pp.113.224287; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Sirpio S, 2009, J BIOL CHEM, V284, P905, DOI 10.1074/jbc.M805404200; Suorsa M, 2009, MOL PLANT, V2, P1127, DOI 10.1093/mp/ssp052; Torres-Bacete J, 2011, J BIOL CHEM, V286, P34007, DOI 10.1074/jbc.M111.260968; Wang P, 2006, PLANT PHYSIOL, V141, P465, DOI 10.1104/pp.105.070490; WILLIAMS JGK, 1983, GENE, V24, P37, DOI 10.1016/0378-1119(83)90129-4; Xu M, 2008, PLANT CELL PHYSIOL, V49, P994, DOI 10.1093/pcp/pcn074; Yabuta S, 2010, PLANT CELL PHYSIOL, V51, P866, DOI 10.1093/pcp/pcq060; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Zhang PP, 2012, PLANT CELL, V24, P1952, DOI 10.1105/tpc.111.094417; Zhang PP, 2005, BIOCHEM J, V390, P513, DOI 10.1042/BJ20050390; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	58	31	36	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18770	18781		10.1074/jbc.M114.553404	http://dx.doi.org/10.1074/jbc.M114.553404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847053	hybrid, Green Published			2022-12-28	WOS:000339062900013
J	Hisatomi, O; Nakatani, Y; Takeuchi, K; Takahashi, F; Kataoka, H				Hisatomi, Osamu; Nakatani, Yoichi; Takeuchi, Ken; Takahashi, Fumio; Kataoka, Hironao			Blue Light-induced Dimerization of Monomeric Aureochrome-1 Enhances Its Affinity for the Target Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; BINDING DOMAINS; PHOTORECEPTOR; LOV; DNA; ARABIDOPSIS; EXPRESSION; OXYGEN; GENE; DITHIOTHREITOL	Aureochrome-1 (AUREO1) is a blue light (BL) receptor that mediates the branching response in stramenopile alga, Vaucheria frigida. AUREO1 contains a basic leucine zipper (bZIP) domain in the central region and a light-oxygen-voltage sensing (LOV) domain at the C terminus, and has been suggested to function as a light-regulated transcription factor. We have previously reported that preparations of recombinant AUREO1 contained the complete coding sequence (full-length, FL) and N-terminal truncated protein (ZL) containing bZIP and LOV domains, and suggested that wild-type ZL (ZLwt(2)) was in a dimer form with intermolecular disulfide linkages at Cys(162) and Cys(182) (Hisatomi, O., Takeuchi, K., Zikihara, K., Ookubo, Y., Nakatani, Y., Takahashi, F., Tokutomi, S., and Kataoka, H. (2013) Plant Cell Physiol. 54, 93-106). In the present study, we report the photoreactions, oligomeric structures, and DNA binding of monomeric cysteine to serine-mutated ZL (ZLC(2)S), DTT-treated ZL (DTT-ZL), and FL (DTT-FL). Recombinant AUREO1 showed similar spectral properties and dark regeneration kinetics to those of dimeric ZLwt2. Dynamic light scattering and size exclusion chromatography revealed that ZLC2S and DTT-ZL were monomeric in the dark state. Dissociation of intermolecular disulfide bonds of ZLwt2 was in equilibrium with a midpoint oxidation-redox potential of approximately -245 +/- 15 mV. BL induced the dimerization of monomeric ZL, which subsequently increased its affinity for the target sequence. Also, DTT-FL was monomeric in the dark state and underwent BL-induced dimerization, which led to formation of the FL2.DNA complex. Taken together, our results suggest that monomeric AUREO1 is present in vivo, with dimerization playing a key role in its role as a BL-regulated transcription factor.	[Hisatomi, Osamu; Nakatani, Yoichi; Takeuchi, Ken] Osaka Univ, Dept Earth & Space Sci, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Takahashi, Fumio] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Kusatsu, Shiga 5258577, Japan; [Takahashi, Fumio] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kataoka, Hironao] Tohoku Univ, Bot Gardens, Aoba Ku, Sendai, Miyagi 9800862, Japan	Osaka University; Ritsumeikan University; Japan Science & Technology Agency (JST); Tohoku University	Hisatomi, O (corresponding author), Osaka Univ, Dept Earth & Space Sci, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan.	hisatomi@ess.sci.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23120517]; Japan Society for the Promotion of Science [22570162]; Grants-in-Aid for Scientific Research [24657025] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (number 23120517) (to O. H.) from The Ministry of Education, Culture, Sports, Science and Technology and by a Grant-in-Aid for Scientific Research (C) (number 22570162) (O. H.) from the Japan Society for the Promotion of Science.	Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Costa BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074451; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Danciu TE, 2010, J CELL BIOCHEM, V109, P417, DOI 10.1002/jcb.22415; Deng YY, 2014, MAR BIOTECHNOL, V16, P135, DOI 10.1007/s10126-013-9539-7; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; HALLIWELL B, 1972, BIOCHEM J, V129, P1157, DOI 10.1042/bj1291157; Herman E, 2013, BIOCHEMISTRY-US, V52, P3094, DOI 10.1021/bi400197u; Hisatomi O, 2013, PLANT CELL PHYSIOL, V54, P93, DOI 10.1093/pcp/pcs160; Huang YJ, 2014, BIOTECHNOL LETT, V36, P575, DOI 10.1007/s10529-013-1386-0; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Iwata T, 2002, J AM CHEM SOC, V124, P11840, DOI 10.1021/ja020834c; IYER KS, 1973, J BIOL CHEM, V248, P707; JOELSON T, 1990, J BIOL CHEM, V265, P3183; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kozuka T, 2011, PLANT CELL, V23, P3684, DOI 10.1105/tpc.111.085852; Lechner R, 2010, PHOTOCH PHOTOBIO SCI, V9, P1367, DOI 10.1039/c0pp00202j; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Mitre D, 2012, STRUCTURE, V20, P698, DOI 10.1016/j.str.2012.02.016; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Seo A, 2013, ANAL BIOANAL CHEM, V405, P6379, DOI 10.1007/s00216-013-7063-2; Shaikhali J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-48; Shaikhali J, 2012, J BIOL CHEM, V287, P27510, DOI 10.1074/jbc.M112.361394; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Toyooka T, 2011, BIOPHYS J, V100, P2801, DOI 10.1016/j.bpj.2011.02.043; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; Zikihara K, 2006, BIOCHEMISTRY-US, V45, P10828, DOI 10.1021/bi0607857; Zoltowski BD, 2008, BIOCHEMISTRY-US, V47, P7012, DOI 10.1021/bi8007017; Zoltowski BD, 2013, BIOCHEMISTRY-US, V52, P6653, DOI 10.1021/bi401040m	39	34	36	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17379	17391		10.1074/jbc.M114.554618	http://dx.doi.org/10.1074/jbc.M114.554618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24790107	hybrid, Green Published			2022-12-28	WOS:000338018100008
J	Dhar, N; Rana, S; Razdan, S; Bhat, WW; Hussain, A; Dhar, RS; Vaishnavi, S; Hamid, A; Vishwakarma, R; Lattoo, SK				Dhar, Niha; Rana, Satiander; Razdan, Sumeer; Bhat, Wajid Waheed; Hussain, Aashiq; Dhar, Rekha S.; Vaishnavi, Samantha; Hamid, Abid; Vishwakarma, Ram; Lattoo, Surrinder K.			Cloning and Functional Characterization of Three Branch Point Oxidosqualene Cyclases from Withania somnifera (L.) Dunal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; GENE-EXPRESSION; TRITERPENE SYNTHASES; PROMOTER ANALYSIS; METHYL JASMONATE; MESSENGER-RNA; WITHAFERIN-A; PLANT; SQUALENE; PROTEIN	Oxidosqualene cyclases (OSCs) positioned at a key metabolic subdividing junction execute indispensable enzymatic cyclization of 2,3-oxidosqualene for varied triterpenoid biosynthesis. Such branch points present favorable gene targets for redirecting metabolic flux toward specific secondary metabolites. However, detailed information regarding the candidate OSCs covering different branches and their regulation is necessary for the desired genetic manipulation. The aim of the present study, therefore, was to characterize members of OSC superfamily from Withania somnifera (Ws), a medicinal plant of immense repute known to synthesize a large array of biologically active steroidal lactone triterpenoids called withanolides. Three full-length OSC cDNAs, beta-amyrin synthase (WsOSC/BS), lupeol synthase (WsOSC/LS), and cycloartenol synthase (WsOSC/CS), having open reading frames of 2289, 2268, and 2277 bp, were isolated. Heterologous expression in Schizosaccharomyces pombe, LC-MS analyses, and kinetic studies confirmed their monofunctionality. The three WsOSCs were found to be spatially regulated at transcriptional level with WsOSC/CS being maximally expressed in leaf tissue. Promoter analysis of three WsOSCs genes resulted in identification of distinct cis-regulatory elements. Further, transcript profiling under methyl jasmonate, gibberellic acid, and yeast extract elicitations displayed differential transcriptional regulation of each of the OSCs. Changes were also observed in mRNA levels under elicitations and further substantiated with protein expression levels by Western blotting. Negative regulation by yeast extract resulted in significant increase in withanolide content. Empirical evidence suggests that repression of competitive branch OSCs like WsOSC/BS and WsOSC/LS possibly leads to diversion of substrate pool toward WsOSC/CS for increased withanolide production.	[Dhar, Niha; Rana, Satiander; Razdan, Sumeer; Bhat, Wajid Waheed; Dhar, Rekha S.; Lattoo, Surrinder K.] CSIR Indian Inst Integrat Med, Plant Biotechnol Div, Jammu 180001, India; [Hussain, Aashiq; Hamid, Abid] CSIR Indian Inst Integrat Med, Div Canc Pharmacol, Jammu 180001, India; [Vishwakarma, Ram] CSIR Indian Inst Integrat Med, Div Med Chem, Jammu 180001, India; [Vaishnavi, Samantha] Shri Mata Vaishno Devi Univ, Sch Biotechnol, Katra 182320, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Shri Mata Vaishno Devi University	Lattoo, SK (corresponding author), CSIR Indian Inst Integrat Med, Plant Biotechnol Div, Canal Rd, Jammu 180001, India.	sklattoo@iiim.ac.in	Rana, Satiander/G-3696-2012; Bhat, Wajid Waheed/E-6645-2012	Rana, Satiander/0000-0001-9197-8378; Bhat, Wajid Waheed/0000-0002-7049-8671; DHAR, NIHA/0000-0002-3295-8016	Council of Scientific and Industrial Research, Government of India, New Delhi [BSC-0108]; Council of Scientific and Industrial Research, Government of India, New Delhi	Council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Council of Scientific and Industrial Research, Government of India, New Delhi, under Network Project BSC-0108 and by a Senior Research Fellowship from the Council of Scientific and Industrial Research, Government of India, New Delhi (to N. D., S. R., S. R., A. H., and W. W. B.).	ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; Aoyagi H, 2001, APPL MICROBIOL BIOT, V57, P482, DOI 10.1007/s002530100819; Bais HP, 2001, IN VITRO CELL DEV-PL, V37, P293, DOI 10.1007/s11627-001-0052-8; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Brendolise C, 2011, FEBS J, V278, P2485, DOI 10.1111/j.1742-4658.2011.08175.x; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Byun S. Y., 1989, THESIS STATE U NEW J; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Dhar RS, 2006, PHYTOCHEMISTRY, V67, P2269, DOI 10.1016/j.phytochem.2006.07.014; ELSAKKA M, 1990, Revista Medico-Chirurgicala Societatii di Medici si Naturalisti din Iasi, V94, P385; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Fu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000216; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hayashi H, 2004, BIOL PHARM BULL, V27, P1086, DOI 10.1248/bpb.27.1086; Hayashi H, 2003, PLANT CELL PHYSIOL, V44, P404, DOI 10.1093/pcp/pcg054; Husselstein-Muller T, 2001, PLANT MOL BIOL, V45, P75, DOI 10.1023/A:1006476123930; Iturbe-Ormaetxe I, 2003, PLANT MOL BIOL, V51, P731, DOI 10.1023/A:1022519709298; Jacobs DI, 2000, PHYTOCHEM ANALYSIS, V11, P277, DOI 10.1002/1099-1565(200009/10)11:5&lt;277::AID-PCA535&gt;3.0.CO;2-S; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kawano N, 2002, BIOL PHARM BULL, V25, P477, DOI 10.1248/bpb.25.477; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069; Kushiro T, 2000, J AM CHEM SOC, V122, P6816, DOI 10.1021/ja0010709; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lattoo SK, 2007, CURR SCI INDIA, V92, P1390; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MB, 2001, PLANT CELL REP, V20, P674; MAHATO SB, 1992, PHYTOCHEMISTRY, V31, P2199, DOI 10.1016/0031-9422(92)83257-Y; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; McCloud TG, 2010, MOLECULES, V15, P4526, DOI 10.3390/molecules15074526; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Morita M, 2000, EUR J BIOCHEM, V267, P3453, DOI 10.1046/j.1432-1327.2000.01357.x; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Pal S, 2011, J HORTIC SCI BIOTECH, V86, P391, DOI 10.1080/14620316.2011.11512779; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P621, DOI 10.1093/nar/20.3.621; Radman R, 2003, BIOTECHNOL APPL BIOC, V37, P91, DOI 10.1042/BA20020118; Rana S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057068; Rana S, 2012, IN VITRO CELL DEV-PL, V48, P546, DOI 10.1007/s11627-012-9458-8; Razdan S, 2013, MOL BIOL REP, V40, P905, DOI 10.1007/s11033-012-2131-9; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sharaf-Eldin MA, 2007, SCI HORTIC-AMSTERDAM, V111, P326, DOI 10.1016/j.scienta.2006.12.002; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Walther D, 2007, PLOS GENET, V3, P216, DOI 10.1371/journal.pgen.0030011; Wang ZH, 2010, J BIOL CHEM, V285, P29703, DOI 10.1074/jbc.M109.098871; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Xu R, 2004, PHYTOCHEMISTRY, V65, P261, DOI 10.1016/j.phytochem.2003.11.014; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	56	50	54	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17249	17267		10.1074/jbc.M114.571919	http://dx.doi.org/10.1074/jbc.M114.571919			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24770414	Green Published, hybrid			2022-12-28	WOS:000338016200057
J	Nam, Y; Kim, JH; Seo, M; Kim, JH; Jin, M; Jeon, S; Seo, JS; Lee, WH; Bing, SJ; Jee, Y; Lee, WK; Park, DH; Kook, H; Suk, K				Nam, Youngpyo; Kim, Jong-Heon; Seo, Minchul; Kim, Jae-Hong; Jin, Myungwon; Jeon, Sangmin; Seo, Jung-san; Lee, Won-Ha; Bing, So Jin; Jee, Youngheun; Lee, Won Kee; Park, Dong Ho; Kook, Hyun; Suk, Kyoungho			Lipocalin-2 Protein Deficiency Ameliorates Experimental Autoimmune Encephalomyelitis THE PATHOGENIC ROLE OF LIPOCALIN-2 IN THE CENTRAL NERVOUS SYSTEM AND PERIPHERAL LYMPHOID TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; GELATINASE-ASSOCIATED LIPOCALIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CD8(+) T-CELLS; MULTIPLE-SCLEROSIS; CHEMOKINE RECEPTORS; REACTIVE ASTROCYTES; NEURON DEATH; EXPRESSION; PATHOGENESIS	Lipocalin-2 (LCN2) plays an important role in cellular processes as diverse as cell growth, migration/invasion, differentiation, and death/survival. Furthermore, recent studies indicate that LCN2 expression and secretion by glial cells are induced by inflammatory stimuli in the central nervous system. The present study was undertaken to examine the regulation of LCN2 expression in experimental autoimmune encephalomyelitis (EAE) and to determine the role of LCN2 in the disease process. LCN2 expression was found to be strongly increased in spinal cord and secondary lymphoid tissues after EAE induction. In spinal cords astrocytes and microglia were the major cell types expressing LCN2 and its receptor 24p3R, respectively, whereas in spleens, LCN2 and 24p3R were highly expressed in neutrophils and dendritic cells, respectively. Furthermore, disease severity, inflammatory infiltration, demyelination, glial activation, the expression of inflammatory mediators, and the proliferation of MOG-specific T cells were significantly attenuated in Lcn2-deficient mice as compared with wild-type animals. Myelin oligodendrocyte glycoprotein-specific T cells in culture exhibited an increased expression of Il17a, Ifng, Rorc, and Tbet after treatment with recombinant LCN2 protein. Moreover, LCN2-treated glial cells expressed higher levels of proinflammatory cytokines, chemokines, and MMP-9. Adoptive transfer and recombinant LCN2 protein injection experiments suggested that LCN2 expression in spinal cord and peripheral immune organs contributes to EAE development. Taken together, these results imply LCN2 is a critical mediator of autoimmune inflammation and disease development in EAE and suggest that LCN2 be regarded a potential therapeutic target in multiple sclerosis.	[Nam, Youngpyo; Kim, Jong-Heon; Seo, Minchul; Kim, Jae-Hong; Jin, Myungwon; Jeon, Sangmin; Seo, Jung-san; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Brain Sci & Engn Inst, Taegu 700422, South Korea; [Nam, Youngpyo; Kim, Jong-Heon; Seo, Minchul; Kim, Jae-Hong; Jin, Myungwon; Jeon, Sangmin; Seo, Jung-san; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Taegu 700422, South Korea; [Lee, Won-Ha] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Bing, So Jin; Jee, Youngheun] Jeju Natl Univ, Coll Vet Med, Cheju 690756, South Korea; [Bing, So Jin; Jee, Youngheun] Jeju Natl Univ, Appl Radiol Inst, Cheju 690756, South Korea; [Lee, Won Kee] Kyungpook Natl Univ, Sch Med, Ctr Biostat, Taegu 700422, South Korea; [Park, Dong Ho] Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, Taegu 700422, South Korea; [Kook, Hyun] Chonnam Natl Univ, Sch Med, Dept Pharmacol, Kwangju 501746, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Jeju National University; Jeju National University; Kyungpook National University; Kyungpook National University; Chonnam National University	Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, 101 Dong In, Taegu 700422, South Korea.	ksuk@knu.ac.kr	Kook, Hyun/AAR-5405-2021	Kook, Hyun/0000-0002-0740-1806	National Research Foundation of Korea - Korean government (MSIP) [2008-0062282]; Korean Health Technology R&D Project, Korean Ministry of Health and Welfare Grant [A111345]	National Research Foundation of Korea - Korean government (MSIP); Korean Health Technology R&D Project, Korean Ministry of Health and Welfare Grant	This work was supported by National Research Foundation of Korea Grant 2008-0062282 funded by the Korean government (MSIP) and by Korean Health Technology R&D Project, Korean Ministry of Health and Welfare Grant A111345.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Archelos JJ, 2000, ANN NEUROL, V47, P694, DOI 10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Bullard DC, 2007, J IMMUNOL, V178, P851, DOI 10.4049/jimmunol.178.2.851; Chia WJ, 2011, NEUROCHEM INT, V59, P591, DOI 10.1016/j.neuint.2011.04.007; Choi J, 2011, J NEUROL SCI, V305, P28, DOI 10.1016/j.jns.2011.03.023; Cornet A, 2000, J NEUROIMMUNOL, V106, P69, DOI 10.1016/S0165-5728(99)00215-5; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Crocker SJ, 2006, AM J PATHOL, V169, P2104, DOI 10.2353/ajpath.2006.060626; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; DIJKSTRA CD, 1992, J NEUROIMMUNOL, V40, P183, DOI 10.1016/0165-5728(92)90132-5; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; ESIRI MM, 1977, LANCET, V2, P478; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Flower DR, 1996, BIOCHEM J, V318, P1; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; GIJBELS K, 1992, J NEUROIMMUNOL, V41, P29, DOI 10.1016/0165-5728(92)90192-N; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hawlisch H, 2004, MOL IMMUNOL, V41, P123, DOI 10.1016/j.molimm.2004.03.019; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HRABARENEVEY S, 1989, ONCOGENE, V4, P601; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Ip JPK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-124; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jeon S, 2013, J BIOL CHEM, V288, P24116, DOI 10.1074/jbc.M113.454140; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Katano M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2587; Kohl J, 2006, ADV EXP MED BIOL, V586, P71; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2012, J NEUROSCI RES, V90, P540, DOI 10.1002/jnr.22779; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lin YL, 2003, EUR J IMMUNOL, V33, P2736, DOI 10.1002/eji.200324087; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Luchtefeld M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019427; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Marques F, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00033; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Mucha M, 2011, P NATL ACAD SCI USA, V108, P18436, DOI 10.1073/pnas.1107936108; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nataf S, 2000, J IMMUNOL, V165, P5867, DOI 10.4049/jimmunol.165.10.5867; Naude PJW, 2012, FASEB J, V26, P2811, DOI 10.1096/fj.11-202457; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; PANEK RB, 1994, J IMMUNOL, V153, P4555; PETTINELLI CB, 1981, J IMMUNOL, V127, P1420; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; Rathore KI, 2011, J NEUROSCI, V31, P13412, DOI 10.1523/JNEUROSCI.0116-11.2011; Sayed BA, 2011, J IMMUNOL, V186, P3294, DOI 10.4049/jimmunol.1003574; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Simpson J, 2000, J NEUROIMMUNOL, V108, P192, DOI 10.1016/S0165-5728(00)00274-5; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P511, DOI 10.1016/j.it.2009.07.002; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Szalai AJ, 2007, MOL IMMUNOL, V44, P3132, DOI 10.1016/j.molimm.2007.02.002; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Wang YN, 2007, BIOCHEM BIOPH RES CO, V353, P857, DOI 10.1016/j.bbrc.2006.12.104; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zappulla JP, 2002, J NEUROIMMUNOL, V131, P5, DOI 10.1016/S0165-5728(02)00250-3; Zhang GX, 2000, MULT SCLER J, V6, P3, DOI 10.1191/135245800678827446	81	78	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16773	16789		10.1074/jbc.M113.542282	http://dx.doi.org/10.1074/jbc.M113.542282			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24808182	Green Published, hybrid			2022-12-28	WOS:000338016200016
J	Edwards, W; Fung-Leung, WP; Huang, CC; Chi, E; Wu, N; Liu, Y; Maher, MP; Bonesteel, R; Connor, J; Fellows, R; Garcia, E; Lee, J; Lu, L; Ngo, K; Scott, B; Zhou, H; Swanson, RV; Wickenden, AD				Edwards, Wilson; Fung-Leung, Wai-Ping; Huang, Chichi; Chi, Ellen; Wu, Nancy; Liu, Yi; Maher, Michael P.; Bonesteel, Rachelle; Connor, Judith; Fellows, Ross; Garcia, Elena; Lee, Jerry; Lu, Lu; Ngo, Karen; Scott, Brian; Zhou, Hong; Swanson, Ronald V.; Wickenden, Alan D.			Targeting the Ion Channel Kv1.3 with Scorpion Venom Peptides Engineered for Potency, Selectivity, and Half-life	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; POTASSIUM CHANNEL; ESCHERICHIA-COLI; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; MINIATURE SWINE; DISEASES; TOXIN; BLOCKADE	Ion channels are an attractive class of drug targets, but progress in developing inhibitors for therapeutic use has been limited largely due to challenges in identifying subtype selective small molecules. Animal venoms provide an alternative source of ion channel modulators, and the venoms of several species, such as scorpions, spiders and snails, are known to be rich sources of ion channel modulating peptides. Importantly, these peptides often bind to hyper-variable extracellular loops, creating the potential for subtype selectivity rarely achieved with small molecules. We have engineered scorpion venom peptides and incorporated them in fusion proteins to generate highly potent and selective Kv1.3 inhibitors with long in vivo half-lives. Kv1.3 has been reported to play a role in human T cell activation, and therefore, these Kv1.3 inhibitor fusion proteins may have potential for the treatment of autoimmune diseases. Our results support an emerging approach to generating subtype selective therapeutic ion channel inhibitors.	[Edwards, Wilson; Fung-Leung, Wai-Ping; Huang, Chichi; Chi, Ellen; Wu, Nancy; Liu, Yi; Maher, Michael P.; Bonesteel, Rachelle; Connor, Judith; Fellows, Ross; Garcia, Elena; Lee, Jerry; Lu, Lu; Ngo, Karen; Scott, Brian; Zhou, Hong; Swanson, Ronald V.; Wickenden, Alan D.] Janssen Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Edwards, W (corresponding author), Janssen Res & Dev LLC, 3210 Merryfield Row, San Diego, CA 92121 USA.	wedward3@its.jnj.com	Maher, Michael/R-9773-2019	Maher, Michael/0000-0001-9138-0448; Fung-Leung, Wai-Ping/0000-0001-7013-8855; Swanson, Ronald/0000-0002-6486-2676				Abdel-Mottaleb Y, 2008, TOXICON, V51, P1424, DOI 10.1016/j.toxicon.2008.03.027; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BHANDARI DG, 1986, EUR J BIOCHEM, V160, P349, DOI 10.1111/j.1432-1033.1986.tb09978.x; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Desir GV, 2005, EXPERT OPIN THER TAR, V9, P571, DOI 10.1517/14728222.9.3.571; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P875, DOI 10.1517/13543784.13.7.875; Evans G., 2003, Method for assembly of a polynucleotide encoding a target polypeptide, Patent No. [US 6670127, 6670127]; Evans GA, 2003, US Patent, Patent No. [6,521,427, 6521427]; EVANS JS, 1986, FEBS LETT, V208, P211, DOI 10.1016/0014-5793(86)81020-1; Ge XY, 2006, BRIT J ORAL MAX SURG, V44, P146, DOI 10.1016/j.bjoms.2005.04.004; Gilhar A, 2011, J INVEST DERMATOL, V131, P118, DOI 10.1038/jid.2010.245; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Koo GC, 1997, J IMMUNOL, V158, P5120; LIN CS, 1993, J EXP MED, V177, P637, DOI 10.1084/jem.177.3.637; MacLeod H, 2010, CELL IMMUNOL, V266, P14, DOI 10.1016/j.cellimm.2010.08.005; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; McCormick AL, 2001, J INFECT DIS, V184, P1423, DOI 10.1086/324371; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PACKMAN LC, 1984, EMBO J, V3, P1315, DOI 10.1002/j.1460-2075.1984.tb01969.x; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Tarcha EJ, 2012, J PHARMACOL EXP THER, V342, P642, DOI 10.1124/jpet.112.191890; Triggle D. J., 2006, VOLTAGE GATED ION CH, P219; TURNER SL, 1993, PROTEIN ENG, V6, P101, DOI 10.1093/protein/6.1.101; Vetter I, 2012, CURR TOP MED CHEM, V12, P1546, DOI 10.2174/156802612802652457; Warnecke G, 2005, EUR J CARDIO-THORAC, V28, P454, DOI 10.1016/j.ejcts.2005.05.023	34	21	22	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22704	22714		10.1074/jbc.M114.568642	http://dx.doi.org/10.1074/jbc.M114.568642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24939846	hybrid, Green Published			2022-12-28	WOS:000341017200016
J	Edagawa, M; Kawauchi, J; Hirata, M; Goshima, H; Inoue, M; Okamoto, T; Murakami, A; Maehara, Y; Kitajima, S				Edagawa, Makoto; Kawauchi, Junya; Hirata, Manabu; Goshima, Hiroto; Inoue, Makoto; Okamoto, Tatsuro; Murakami, Akira; Maehara, Yoshihiko; Kitajima, Shigetaka			Role of Activating Transcription Factor 3 (ATF3) in Endoplasmic Reticulum (ER) Stress-induced Sensitization of p53-deficient Human Colon Cancer Cells to Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis through Up-regulation of Death Receptor 5 (DR5) by Zerumbone and Celecoxib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; TRAIL-INDUCED APOPTOSIS; GENE-EXPRESSION; ENDOTHELIAL-CELLS; DOWN-REGULATION; DNA-DAMAGE; INDUCTION; PROMOTER; KINASE	Death receptor 5 (DR5) is a death domain-containing transmembrane receptor that triggers cell death upon binding to its ligand, TNF-related apoptosis-inducing ligand (TRAIL), and a combination of TRAIL and agents that increase the expression of DR5 is expected to be a novel anticancer therapy. In this report, we demonstrate that the stress response gene ATF3 is required for endoplasmic reticulum stress-mediated DR5 induction upon zerumbone (ZER) and celecoxib (CCB) in human p53-deficient colorectal cancer cells. Both agents activated PERK-eIF2 alpha kinases and induced the expression of activating transcription factor 4 (ATF4)-CCAAT enhancer-binding protein (C/EBP) homologous protein, which were remarkably suppressed by reactive oxygen species scavengers. In the absence of ATF3, the induction of DR5 mRNA and protein was abrogated significantly, and this was associated with reduced cell death by cotreatment of TRAIL with ZER or CCB. By contrast, exogenous expression of ATF3 caused a more rapid and elevated expression of DR5, resulting in enhanced sensitivity to apoptotic cell death by TRAIL/ZER or TRAIL/CCB. A reporter assay demonstrated that at least two ATF/cAMP response element motifs as well as C/EBP homologous protein motif at the proximal region of the human DR5 gene promoter were required for ZER-induced DR5 gene transcription. Taken together, our results provide novel insights into the role of ATF3 as an essential transcription factor for p53-independent DR5 induction upon both ZER and CCB treatment, and this may be a useful biomarker for TRAIL-based anticancer therapy.	[Edagawa, Makoto; Kawauchi, Junya; Hirata, Manabu; Goshima, Hiroto; Inoue, Makoto; Kitajima, Shigetaka] Tokyo Med & Dent Univ, Dept Biochem Genet, Med Res Inst, Tokyo 1138510, Japan; [Edagawa, Makoto; Okamoto, Tatsuro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Murakami, Akira] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan	Tokyo Medical & Dental University (TMDU); Kyushu University; Kyoto University	Kitajima, S (corresponding author), Tokyo Med & Dent Univ, Dept Biochem Genet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kita.bgen@mri.tmd.ac.jp			JSPS KAKENHI [24590373, 25134708, 24118002]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grants 24590373 and 25134708 (to S. K.) and 24118002 (to J. K.).	Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Farczadi E, 1999, NEOPLASMA, V46, P219; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gjymishka A, 2009, BIOCHEM J, V417, P695, DOI 10.1042/BJ20081706; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Grosch S, 2001, FASEB J, V15, P2742, DOI 10.1096/fj.01-0299fje; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hai T, 1999, GENE EXPRESSION, V7, P321; Hamdulay SS, 2010, FREE RADICAL BIO MED, V48, P1013, DOI 10.1016/j.freeradbiomed.2010.01.017; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He Q, 2008, ONCOGENE, V27, P2656, DOI 10.1038/sj.onc.1210894; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Kardosh A, 2008, CANCER RES, V68, P843, DOI 10.1158/0008-5472.CAN-07-5555; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kim M, 2009, INT J CANCER, V124, P264, DOI 10.1002/ijc.23923; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; Kojima Y, 2011, J BIOL CHEM, V286, P43383, DOI 10.1074/jbc.M111.309377; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Ohnishi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058641; Ohnishi K, 2013, BIOCHEM BIOPH RES CO, V430, P616, DOI 10.1016/j.bbrc.2012.11.104; Ohnishi K, 2009, BIOSCI BIOTECH BIOCH, V73, P1905, DOI 10.1271/bbb.90265; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Prasannan R, 2012, BIOCHEM PHARMACOL, V84, P1268, DOI 10.1016/j.bcp.2012.07.015; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scott N, 1998, EUR J SURG ONCOL, V24, P169, DOI 10.1016/S0748-7983(98)92861-X; Sheikh MS, 1998, CANCER RES, V58, P1593; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Shin JW, 2011, CANCER PREV RES, V4, P860, DOI 10.1158/1940-6207.CAPR-10-0354; Sobhan PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059350; Takada Y, 2005, ONCOGENE, V24, P6957, DOI 10.1038/sj.onc.1208845; Taketani K, 2012, ONCOGENE, V31, P2210, DOI 10.1038/onc.2011.397; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xiang H, 2002, ONCOGENE, V21, P3611, DOI 10.1038/sj.onc.1205449; Xu LY, 2012, MOL CANCER THER, V11, P2174, DOI 10.1158/1535-7163.MCT-12-0602; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhang C, 2001, BIOCHEM BIOPH RES CO, V289, P718, DOI 10.1006/bbrc.2001.6044	62	73	74	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21544	21561		10.1074/jbc.M114.558890	http://dx.doi.org/10.1074/jbc.M114.558890			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939851	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000340558300030
J	Hirose, Y; Johnson, ZI; Schoepflin, ZR; Markova, DZ; Chiba, K; Toyama, Y; Shapiro, IM; Risbud, MV				Hirose, Yuichiro; Johnson, Zariel I.; Schoepflin, Zachary R.; Markova, Dessislava Z.; Chiba, Kazuhiro; Toyama, Yoshiaki; Shapiro, Irving M.; Risbud, Makarand V.			FIH-1-Mint3 Axis Does Not Control HIF-1 alpha Transcriptional Activity in Nucleus Pulposus Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; AMYLOID PRECURSOR PROTEIN; INTERVERTEBRAL DISC; ASPARAGINYL HYDROXYLASE; GENE-EXPRESSION; PROLYL 4-HYDROXYLASES; FIH; DEGENERATION; DEGRADATION; PATHWAY	The objective of this study was to determine the role of FIH-1 in regulating HIF-1 activity in the nucleus pulposus (NP) cells and the control of this regulation by binding and sequestration of FIH-1 by Mint3. FIH-1 and Mint3 were both expressed in the NP and were shown to strongly co-localize within the cell nucleus. Although both mRNA and protein expression of FIH-1 decreased in hypoxia, only Mint3 protein levels were hypoxia-sensitive. Overexpression of FIH-1 was able to reduce HIF-1 function, as seen by changes in activities of hypoxia response element-luciferase reporter and HIF-1 alpha-C-TAD and HIF-2 alpha-TAD. Moreover, co-transfection of either full-length Mint3 or the N terminus of Mint3 abrogated FIH-1-dependent reduction in HIF-1 activity under both normoxia and hypoxia. Nuclear levels of FIH-1 and Mint3 decreased in hypoxia, and the use of specific nuclear import and export inhibitors clearly showed that cellular compartmentalization of overexpressed FIH-1 was critical for its regulation of HIF-1 activity in NP cells. Interestingly, microarray results after stable silencing of FIH-1 showed no significant changes in transcripts of classical HIF-1 target genes. However, expression of several other transcripts, including those of the Notch pathway, changed in FIH-1-silenced cells. Moreover, co-transfection of Notch-ICD could restore suppression of HIF-1-TAD activity by exogenous FIH-1. Taken together, these results suggest that, possibly due to low endogenous levels and/or preferential association with substrates such as Notch, FIH-1 activity does not represent a major mechanism by which NP cells control HIF-1-dependent transcription, a testament to their adaptation to a unique hypoxic niche.	[Hirose, Yuichiro; Johnson, Zariel I.; Schoepflin, Zachary R.; Markova, Dessislava Z.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Hirose, Yuichiro; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1088345, Japan; [Chiba, Kazuhiro] Kitasato Univ, Kitasato Inst Hosp, Dept Orthopaed Surg, Tokyo 1088641, Japan	Jefferson University; Keio University; Kitasato University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Suite 511 Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [AR055655, AR064733, AR050087, T32 AR052273]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064733, R01AR055655, T32AR052273, R01AR050087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055655, AR064733, and AR050087 (to M. R.).; Supported by National Institutes of Health Grant T32 AR052273.	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Couvelard A, 2008, CLIN CANCER RES, V14, P6634, DOI 10.1158/1078-0432.CCR-07-5258; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Deng AH, 2010, AM J PHYSIOL-RENAL, V299, pF1365, DOI 10.1152/ajprenal.00153.2010; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Gogate SS, 2012, J BONE MINER RES, V27, P1106, DOI 10.1002/jbmr.1571; Gogate SS, 2011, ARTHRITIS RHEUM-US, V63, P1950, DOI 10.1002/art.30342; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hiyama A, 2011, ARTHRITIS RHEUM-US, V63, P1355, DOI 10.1002/art.30246; Hyseni A, 2011, CELL ONCOL, V34, P565, DOI 10.1007/s13402-011-0053-5; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; KAUPPILA LI, 1995, J BONE JOINT SURG AM, V77A, P26, DOI 10.2106/00004623-199501000-00004; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kroeze SGC, 2010, EUR J CANCER, V46, P3375, DOI 10.1016/j.ejca.2010.07.018; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Li JP, 2007, MOL CELL BIOL, V27, P7345, DOI 10.1128/MCB.02201-06; Lu H, 2012, INT J NEPHROL RENOV, V5, P101, DOI 10.2147/IJNRD.S27332; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Schodel J, 2010, KIDNEY INT, V78, P857, DOI 10.1038/ki.2010.284; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Short MD, 2006, MOL BIOL CELL, V17, P1995, DOI 10.1091/mbc.E05-09-0869; Singleton RS, 2011, J BIOL CHEM, V286, P33784, DOI 10.1074/jbc.M111.262808; Skubutyte R, 2010, ARTHRITIS RHEUM-US, V62, P2707, DOI 10.1002/art.27558; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Wang EF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086102; Weidemann A, 2008, J AM SOC NEPHROL, V19, P486, DOI 10.1681/ASN.2007040419; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Yan B, 2011, MOL CELL BIOCHEM, V348, P1, DOI 10.1007/s11010-010-0631-2; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001	46	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20594	20605		10.1074/jbc.M114.565101	http://dx.doi.org/10.1074/jbc.M114.565101			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24867948	Green Published, hybrid			2022-12-28	WOS:000339396600019
J	Meng, XW; Koh, BD; Zhang, JS; Flatten, KS; Schneider, PA; Billadeau, DD; Hess, AD; Smith, BD; Karp, JE; Kaufmann, SH				Meng, X. Wei; Koh, Brian D.; Zhang, Jin-San; Flatten, Karen S.; Schneider, Paula A.; Billadeau, Daniel D.; Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.; Kaufmann, Scott H.			Poly(ADP-ribose) Polymerase Inhibitors Sensitize Cancer Cells to Death Receptor-mediated Apoptosis by Enhancing Death Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; NUCLEAR-MATRIX; PANCREATIC-CANCER; GENOTOXIC STRESS; TOPOISOMERASE-I; CHICKEN OVIDUCT; LEUKEMIA-CELLS; PARP; TRAIL; GENE	Recombinant human tumor necrosis factor-alpha-related apoptosis inducing ligand (TRAIL), agonistic monoclonal antibodies to TRAIL receptors, and small molecule TRAIL receptor agonists are in various stages of preclinical and early phase clinical testing as potential anticancer drugs. Accordingly, there is substantial interest in understanding factors that affect sensitivity to these agents. In the present study we observed that the poly(ADP-ribose) polymerase (PARP) inhibitors olaparib and veliparib sensitize the myeloid leukemia cell lines ML-1 and K562, the ovarian cancer line PEO1, non-small cell lung cancer line A549, and a majority of clinical AML isolates, but not normal marrow, to TRAIL. Further analysis demonstrated that PARP inhibitor treatment results in activation of the FAS and TNFRSF10B (death receptor 5 (DR5)) promoters, increased Fas and DR5 mRNA, and elevated cell surface expression of these receptors in sensitized cells. Chromatin immunoprecipitation demonstrated enhanced binding of the transcription factor Sp1 to the TNFRSF10B promoter in the presence of PARP inhibitor. Knockdown of PARP1 or PARP2 (but not PARP3 and PARP4) not only increased expression of Fas and DR5 at the mRNA and protein level, but also recapitulated the sensitizing effects of the PARP inhibition. Conversely, Sp1 knockdown diminished the PARP inhibitor effects. In view of the fact that TRAIL is part of the armamentarium of natural killer cells, these observations identify a new facet of PARP inhibitor action while simultaneously providing the mechanistic underpinnings of a novel therapeutic combination that warrants further investigation.	[Meng, X. Wei; Koh, Brian D.; Zhang, Jin-San; Flatten, Karen S.; Schneider, Paula A.; Billadeau, Daniel D.; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Meng, X. Wei; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD 21205 USA	Mayo Clinic; Mayo Clinic; Johns Hopkins University	Meng, XW (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	Meng.Xue@Mayo.edu; Kaufmann.scott@mayo.edu		Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [P50 CA136393, P30 CA15083]; Ovarian Cancer Research Fund; Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE [P50CA136393, P30CA006973, P30CA015083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA136393 and P30 CA15083. This work was also supported by the Ovarian Cancer Research Fund and the Mayo Foundation for Education and Research.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Bajaj M, 2011, EXPERT OPIN BIOL TH, V11, P1519, DOI 10.1517/14712598.2011.610788; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; BI SC, 1992, LEUKEMIA, V6, P839; Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chan H, 1999, MOL CELL BIOL, V19, P2098, DOI 10.1128/mcb.19.3.2098; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Creagh EM, 2001, BIOCHEM SOC T, V29, P696, DOI 10.1042/0300-5127:0290696; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Davie JR, 2008, ADV ENZYME REGUL, V48, P189, DOI 10.1016/j.advenzreg.2007.11.016; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eaves C, 1995, ATLAS HUMAN HEMATOPO; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Falschlehner C, 2009, ADV EXP MED BIOL, V647, P195, DOI 10.1007/978-0-387-89520-8_14; FEINSTEIN E, 1992, ONCOGENE, V7, P1853; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gagne JP, 2012, NUCLEIC ACIDS RES, V40, P7788, DOI 10.1093/nar/gks486; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Higuchi H, 2004, J BIOL CHEM, V279, P51, DOI 10.1074/jbc.M309476200; Hilton JF, 2013, FRONT BIOSCI-LANDMRK, V18, P1393, DOI 10.2741/4188; Huehls AM, 2011, CANCER RES, V71, P4944, DOI 10.1158/0008-5472.CAN-11-0814; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; KASTAN MB, 1991, CANCER RES, V51, P6304; KAUFMANN SH, 1986, J BIOL CHEM, V261, P1962; Kaufmann SH, 2001, ANAL BIOCHEM, V296, P283, DOI 10.1006/abio.2001.5313; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kummar S, 2011, CANCER RES, V71, P5626, DOI 10.1158/0008-5472.CAN-11-1227; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Liu XS, 2009, MOL CANCER RES, V7, P1686, DOI 10.1158/1541-7786.MCR-09-0299; Matthews DE, 1988, USING UNDERSTANDING, P178; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meng XW, 2011, J BIOL CHEM, V286, P35823, DOI 10.1074/jbc.M111.240432; Meng XW, 2010, J BIOL CHEM, V285, P888, DOI 10.1074/jbc.M109.057638; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Mesa RA, 2005, BLOOD, V106, P318, DOI 10.1182/blood-2004-09-3523; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Naka T, 2002, CANCER RES, V62, P5800; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Patel AG, 2012, J BIOL CHEM, V287, P4198, DOI 10.1074/jbc.M111.296475; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Plummer Ruth, 2012, Clin Adv Hematol Oncol, V10, P322; Ravi R, 2004, CANCER RES, V64, P9105, DOI 10.1158/0008-5472.CAN-04-2488; ROBINSON SI, 1983, NUCLEIC ACIDS RES, V11, P5113, DOI 10.1093/nar/11.15.5113; ROBINSON SI, 1982, CELL, V28, P99, DOI 10.1016/0092-8674(82)90379-8; Rosato RR, 2007, CANCER RES, V67, P9490, DOI 10.1158/0008-5472.CAN-07-0598; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Smith MA, 2013, CLIN CANCER RES, V19, P2828, DOI 10.1158/1078-0432.CCR-13-0043; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUN JM, 1993, FEBS LETT, V331, P141, DOI 10.1016/0014-5793(93)80313-J; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang GL, 2013, NAT CHEM BIOL, V9, P84, DOI [10.1038/NCHEMBIO.1153, 10.1038/nchembio.1153]; Wang S, 2010, CURR MED CHEM, V17, P3309, DOI 10.2174/092986710793176285; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; Wilson NS, 2012, CANCER CELL, V22, P80, DOI 10.1016/j.ccr.2012.05.014; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yelamos J, 2008, TRENDS MOL MED, V14, P169, DOI 10.1016/j.molmed.2008.02.003; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7; Yuan KY, 2013, CLIN CANCER RES, V19, P4750, DOI 10.1158/1078-0432.CCR-13-0516; Zhang JS, 2011, ONCOGENE, V30, P3705, DOI 10.1038/onc.2011.90	79	41	41	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20543	20558		10.1074/jbc.M114.549220	http://dx.doi.org/10.1074/jbc.M114.549220			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895135	Green Published, hybrid			2022-12-28	WOS:000339396600015
J	Nigam, A; Almabruk, KH; Saxena, A; Yang, JT; Mukherjee, U; Kaur, H; Kohli, P; Kumari, R; Singh, P; Zakharov, LN; Singh, Y; Mahmud, T; Lal, R				Nigam, Aeshna; Almabruk, Khaled H.; Saxena, Anjali; Yang, Jongtae; Mukherjee, Udita; Kaur, Hardeep; Kohli, Puneet; Kumari, Rashmi; Singh, Priya; Zakharov, Lev N.; Singh, Yogendra; Mahmud, Taifo; Lal, Rup			Modification of Rifamycin Polyketide Backbone Leads to Improved Drug Activity against Rifampicin-resistant Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYCOLATOPSIS-MEDITERRANEI S699; BIOSYNTHETIC GENE-CLUSTER; RNA-POLYMERASE; ERYTHROMYCIN DERIVATIVES; SYNTHASE; CLONING; DOMAIN; SYNTHETASE; MECHANISM; SUBSTRATE	Rifamycin B, a product of Amycolatopsis mediterranei S699, is the precursor of clinically used antibiotics that are effective against tuberculosis, leprosy, and AIDS-related mycobacterial infections. However, prolonged usage of these antibiotics has resulted in the emergence of rifamycin-resistant strains of Mycobacterium tuberculosis. As part of our effort to generate better analogs of rifamycin, we substituted the acyltransferase domain of module 6 of rifamycin polyketide synthase with that of module 2 of rapamycin polyketide synthase. The resulting mutants (rifAT6::rapAT2) of A. mediterranei S699 produced new rifamycin analogs, 24-desmethylrifamycin B and 24-desmethylrifamycin SV, which contained modification in the polyketide backbone. 24-Desmethylrifamycin B was then converted to 24-desmethylrifamycin S, whose structure was confirmed by MS, NMR, and X-ray crystallography. Subsequently, 24-desmethylrifamycin S was converted to 24-desmethylrifampicin, which showed excellent antibacterial activity against several rifampicin-resistant M. tuberculosis strains.	[Nigam, Aeshna; Saxena, Anjali; Mukherjee, Udita; Kaur, Hardeep; Kohli, Puneet; Kumari, Rashmi; Singh, Priya; Lal, Rup] Univ Delhi, Dept Zool, Delhi 110007, India; [Almabruk, Khaled H.; Yang, Jongtae; Mahmud, Taifo] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Zakharov, Lev N.; Mahmud, Taifo] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA; [Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India	University of Delhi; Oregon State University; Oregon State University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Mahmud, T (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	taifo.mahmud@oregonstate.edu; ruplal@gmail.com	Lal, Rup/AFP-1009-2022; Mahmud, Taifo/A-1492-2015	Mahmud, Taifo/0000-0001-9639-526X	Department of Biotechnology of the Government of India; University of Delhi; M.J. Murdock Charitable Trust; Medical Research Foundation of Oregon; Council of Scientific and Industrial Research; University Grants Commission; Government of Libya	Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India); University of Delhi(University of Delhi); M.J. Murdock Charitable Trust; Medical Research Foundation of Oregon; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Government of Libya	The work at Delhi University was supported by grants from the Department of Biotechnology of the Government of India and Grants from the University of Delhi. Work at Oregon State University was supported by an Exceptional Opportunity Grant from the M.J. Murdock Charitable Trust and the Medical Research Foundation of Oregon. This work was also supported by research fellowships from the Council of Scientific and Industrial Research and University Grants Commission (to A. N., A. S., U. M., P. K., R. K., and P. S.) and a scholarship from the Government of Libya (to K. H. A.).	Admiraal SJ, 2003, J AM CHEM SOC, V125, P13664, DOI 10.1021/ja0379060; Admiraal SJ, 2001, BIOCHEMISTRY-US, V40, P6116, DOI 10.1021/bi010080z; [Anonymous], SHELXTL 6 10 PROGR S; Aristoff PA, 2010, TUBERCULOSIS, V90, P94, DOI 10.1016/j.tube.2010.02.001; Artsimovitch I, 2005, CELL, V122, P351, DOI 10.1016/j.cell.2005.07.014; August PR, 1998, CHEM BIOL, V5, P69, DOI 10.1016/S1074-5521(98)90141-7; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Crump JA, 2011, J CLIN MICROBIOL, V49, P3054, DOI 10.1128/JCM.01035-11; Floss HG, 2006, J BIOTECHNOL, V124, P242, DOI 10.1016/j.jbiotec.2005.12.001; Gaisser S, 1997, MOL GEN GENET, V256, P239, DOI 10.1007/s004380050566; HARTMANN GR, 1985, ANGEW CHEM INT EDIT, V24, P1009, DOI 10.1002/anie.198510093; Jacobsen JR, 1998, BIOORGAN MED CHEM, V6, P1171, DOI 10.1016/S0968-0896(98)00081-9; Kaur H, 2001, MICROBIOL RES, V156, P239, DOI 10.1078/0944-5013-00108; Khanna M, 1998, MICROBIOL RES, V153, P205; Khosla C, 2009, CURR OPIN CHEM BIOL, V13, P135, DOI 10.1016/j.cbpa.2008.12.018; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim CG, 1998, J BIOL CHEM, V273, P6030, DOI 10.1074/jbc.273.11.6030; LAL R, 1995, CRIT REV MICROBIOL, V21, P19, DOI 10.3109/10408419509113532; Lal R, 1998, J ANTIBIOT, V51, P161, DOI 10.7164/antibiotics.51.161; LAL R, 1994, BIOESSAYS, V16, P211, DOI 10.1002/bies.950160313; Lal R, 2000, TRENDS BIOTECHNOL, V18, P264, DOI 10.1016/S0167-7799(00)01443-8; LAL R, 1991, APPL ENVIRON MICROB, V57, P665, DOI 10.1128/AEM.57.3.665-671.1991; Lal R, 1996, CRIT REV MICROBIOL, V22, P201, DOI 10.3109/10408419609105481; Lal R., 1999, U. S. Patent, Patent No. [US 00598560A, 00598560]; Lau J, 1999, BIOCHEMISTRY-US, V38, P1643, DOI 10.1021/bi9820311; Marsili L., 1984, U. S. Patent, Patent No. [3,963,705, 3963705]; Molodtsov V, 2013, J MED CHEM, V56, P4758, DOI 10.1021/jm4004889; Oliynyk M, 1996, CHEM BIOL, V3, P833, DOI 10.1016/S1074-5521(96)90069-1; Prasad B, 2009, J PHARMACEUT BIOMED, V50, P475, DOI 10.1016/j.jpba.2009.05.009; Ranganathan A, 1999, CHEM BIOL, V6, P731, DOI 10.1016/S1074-5521(00)80020-4; Ruan X, 1997, J BACTERIOL, V179, P6416, DOI 10.1128/jb.179.20.6416-6425.1997; Schupp T, 1998, FEMS MICROBIOL LETT, V159, P201, DOI 10.1111/j.1574-6968.1998.tb12861.x; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; Sheldrick G. M., 1998, BRUKER SIEMENS AREA; Stassi DL, 1998, P NATL ACAD SCI USA, V95, P7305, DOI 10.1073/pnas.95.13.7305; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stratmann A, 1999, MICROBIOL-SGM, V145, P3365, DOI 10.1099/00221287-145-12-3365; Tuteja D, 2000, PLASMID, V43, P1, DOI 10.1006/plas.1999.1426; Verma M, 2011, J BACTERIOL, V193, P5562, DOI 10.1128/JB.05819-11; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Wilson MC, 2010, J AM CHEM SOC, V132, P12757, DOI 10.1021/ja105891a; Xu J, 2005, MICROBIOL-SGM, V151, P2515, DOI 10.1099/mic.0.28138-0; Xu J, 2003, ARCH BIOCHEM BIOPHYS, V411, P277, DOI 10.1016/S0003-9861(03)00004-3; Xue Q, 1999, P NATL ACAD SCI USA, V96, P11740, DOI 10.1073/pnas.96.21.11740; Yu TW, 1999, P NATL ACAD SCI USA, V96, P9051, DOI 10.1073/pnas.96.16.9051	45	30	31	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21142	21152		10.1074/jbc.M114.572636	http://dx.doi.org/10.1074/jbc.M114.572636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923585	Green Published, hybrid			2022-12-28	WOS:000339396600064
J	Ul-Hussain, M; Olk, S; Schoenebeck, B; Wasielewski, B; Meier, C; Prochnow, N; May, C; Galozzi, S; Marcus, K; Zoidl, G; Dermietzel, R				Ul-Hussain, Mahboob; Olk, Stephan; Schoenebeck, Bodo; Wasielewski, Bianca; Meier, Carola; Prochnow, Nora; May, Caroline; Galozzi, Sara; Marcus, Katrin; Zoidl, Georg; Dermietzel, Rolf			Internal Ribosomal Entry Site (IRES) Activity Generates Endogenous Carboxyl-terminal Domains of Cx43 and Is Responsive to Hypoxic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE-INDEPENDENT INITIATION; GAP-JUNCTION FORMATION; CELL-GROWTH; MESSENGER-RNA; MEDIATED TRANSLATION; POSSIBLE MECHANISM; GLIOMA-CELLS; CONNEXIN43; PROTEIN; ASTROCYTES	Connexin43 (Cx43) is the most abundant gap junction protein in higher vertebrate organisms and has been shown to be involved in junctional and non-junctional functions. In addition to the expression of full-length Cx43, endogenously produced carboxyl-terminal segments of Cx43 have been described and have been suggested to be involved in manifold biological functions, such as hypoxic preconditioning and neuronal migration. Molecular aspects, however, behind the separate generation of carboxyl-terminal segments of Cx43 have remained elusive. Here we report on a mechanism that may play a key role in the separate production of these domains. First, stringent evidence derived from siRNA treatment and specific knockouts revealed significant loss of the low molecular weight fragments of Cx43. By applying a dicistronic vector strategy on transfected cell lines, we were able to identify putative IRES activity (nucleotides 442-637) in the coding region of Cx43, which resides upstream from the nucleotide sequence encoding the carboxyl terminus (nucleotides 637-1149). Functional responsiveness of the endogenous expression of Cx43 fragments to hypoxic/ischemic treatment was evaluated in in vitro and in vivo models, which led to a significant increase of the fastest migrating form (20 kDa) under conditions of metabolic deprivation. By nano-MS spectrometry, we achieved stringent evidence of the identity of the 20-kDa segment as part of the carboxyl-terminal domain of full-length Cx43. Our data prove the existence of endogenously expressed carboxyl-terminal domains, which may serve as valuable tools for further translational application in ischemic disorders.	[Ul-Hussain, Mahboob; Olk, Stephan; Schoenebeck, Bodo; Wasielewski, Bianca; Prochnow, Nora; May, Caroline; Galozzi, Sara; Marcus, Katrin; Dermietzel, Rolf] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Med Proteome Ctr, D-44081 Bochum, Germany; [Ul-Hussain, Mahboob; Olk, Stephan; Schoenebeck, Bodo; Wasielewski, Bianca; Prochnow, Nora; May, Caroline; Galozzi, Sara; Marcus, Katrin; Dermietzel, Rolf] Ruhr Univ Bochum, Int Grad Sch Neurosci, D-44081 Bochum, Germany; [Ul-Hussain, Mahboob] Univ Kashmir, Dept Biotechnol, Srinaga, India; [Meier, Carola] Univ Saarland, Fac Med, Dept Anat & Cell Biol, D-66424 Saarland, Germany; [Zoidl, Georg] York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada	Ruhr University Bochum; Ruhr University Bochum; University of Kashmir; Saarland University; York University - Canada	Dermietzel, R (corresponding author), Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Univ St 150, D-44081 Bochum, Germany.	rolf.dermietzel@rub.de			International Graduate School of Neuroscience of NRW/Germany; German Research Council (Deutsche Forschungsgemeinschaft (DFG); DFG [SFB 509]; Graduate College 736, Development and Plasticity of the Nervous System)	International Graduate School of Neuroscience of NRW/Germany; German Research Council (Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Graduate College 736, Development and Plasticity of the Nervous System)	This work was supported by the International Graduate School of Neuroscience of NRW/Germany (to M. H. and S. O.), German Research Council (Deutsche Forschungsgemeinschaft (DFG), Graduate College 736, Development and Plasticity of the Nervous System) (to B. W.), and DFG Grant SFB 509 (to R. D. and G. Z.).	Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Crespin S, 2010, J CELL BIOCHEM, V110, P589, DOI 10.1002/jcb.22554; Cusato K, 2003, J NEUROSCI, V23, P6413; Dang XT, 2003, MOL CELL BIOCHEM, V242, P35, DOI 10.1023/A:1021152709313; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Gellhaus A, 2004, J BIOL CHEM, V279, P36931, DOI 10.1074/jbc.M404073200; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Hudder A, 2000, J BIOL CHEM, V275, P34586, DOI 10.1074/jbc.M005199200; Joshi-Mukherjee R, 2007, CELL COMMUN ADHES, V14, P75, DOI 10.1080/15419060701402320; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; King TJ, 2005, BBA-BIOMEMBRANES, V1719, P146, DOI 10.1016/j.bbamem.2005.08.012; Kozoriz MG, 2010, J NEUROPATH EXP NEUR, V69, P196, DOI 10.1097/NEN.0b013e3181cd44df; Lahlou H, 2005, MOL CELL BIOL, V25, P4034, DOI 10.1128/MCB.25.10.4034-4045.2005; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lauring AS, 2000, MOL CELL, V6, P939, DOI 10.1016/S1097-2765(05)00084-5; LEVINE S, 1960, ARCH PATHOL, V69, P544; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; Moorby C, 2001, EXP CELL RES, V271, P238, DOI 10.1006/excr.2001.5357; Olbina G, 2003, MOL CANCER RES, V1, P690; Omori Y, 1998, INT J CANCER, V78, P446, DOI 10.1002/(SICI)1097-0215(19981109)78:4<446::AID-IJC10>3.3.CO;2-4; RajBhandary UL, 2000, P NATL ACAD SCI USA, V97, P1325, DOI 10.1073/pnas.040579197; Santiago MF, 2010, J BIOL CHEM, V285, P11836, DOI 10.1074/jbc.M109.058750; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Schiavi A, 1999, FEBS LETT, V464, P118, DOI 10.1016/S0014-5793(99)01699-3; Smyth JW, 2013, CELL REP, V5, P611, DOI 10.1016/j.celrep.2013.10.009; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Theis M, 2003, J NEUROSCI, V23, P766; Ul-Hussain M, 2012, BRAIN RES, V1487, P99, DOI 10.1016/j.brainres.2012.05.065; Ul-Hussain M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-92; Ul-Hussain M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-52; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Zhang YW, 2003, J BIOL CHEM, V278, P44852, DOI 10.1074/jbc.M305072200	46	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20979	20990		10.1074/jbc.M113.540187	http://dx.doi.org/10.1074/jbc.M113.540187			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24872408	hybrid, Green Published			2022-12-28	WOS:000339396600051
J	Birukawa, NK; Murase, K; Sato, Y; Kosaka, A; Yoneda, A; Nishita, H; Fujita, R; Nishimura, M; Ninomiya, T; Kajiwara, K; Miyazaki, M; Nakashima, Y; Ota, S; Murakami, Y; Tanaka, Y; Minomi, K; Tamura, Y; Niitsu, Y				Birukawa, Naoko Kubo; Murase, Kazuyuki; Sato, Yasushi; Kosaka, Akemi; Yoneda, Akihiro; Nishita, Hiroki; Fujita, Ryosuke; Nishimura, Miyuki; Ninomiya, Takafumi; Kajiwara, Keiko; Miyazaki, Miyono; Nakashima, Yusuke; Ota, Sigenori; Murakami, Yuya; Tanaka, Yasunobu; Minomi, Kenjiro; Tamura, Yasuaki; Niitsu, Yoshiro			Activated Hepatic Stellate Cells Are Dependent on Self-collagen, Cleaved by Membrane Type 1 Matrix Metalloproteinase for Their Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER FIBROSIS RESOLUTION; A-COUPLED LIPOSOMES; TISSUE INHIBITOR; APOPTOSIS; FIBRONECTIN; EXPRESSION; PROLIFERATION; MECHANISMS; STRATEGIES; CHAPERONE	Stellate cells are distributed throughout organs, where, upon chronic damage, they become activated and proliferate to secrete collagen, which results in organ fibrosis. An intriguing property of hepatic stellate cells (HSCs) is that they undergo apoptosis when collagen is resolved by stopping tissue damage or by treatment, even though the mechanisms are unknown. Here we disclose the fact that HSCs, normal diploid cells, acquired dependence on collagen for their growth during the transition from quiescent to active states. The intramolecular RGD motifs of collagen were exposed by cleavage with their own membrane type 1 matrix metalloproteinase (MT1-MMP). The following evidence supports this conclusion. When rat activated HSCs (aHSCs) were transduced with siRNA against the collagen-specific chaperone gp46 to inhibit collagen secretion, the cells underwent autophagy followed by apoptosis. Concomitantly, the growth of aHSCs was suppressed, whereas that of quiescent HSCs was not. These in vitro results are compatible with the in vivo observation that apoptosis of aHSCs was induced in cirrhotic livers of rats treated with siRNAgp46. siRNA against MT1-MMP and addition of tissue inhibitor of metalloproteinase 2 (TIMP-2), which mainly inhibits MT1-MMP, also significantly suppressed the growth of aHSCs in vitro. The RGD inhibitors echistatin and GRGDS peptide and siRNA against the RGD receptor alpha V beta 1 resulted in the inhibition of aHSCs growth. Transduction of siRNAs against gp46, alpha V beta 1, and MT1-MMP to aHSCs inhibited the survival signal of PI3K/AKT/I kappa B. These results could provide novel antifibrosis strategies.	[Birukawa, Naoko Kubo; Kosaka, Akemi; Yoneda, Akihiro; Nishita, Hiroki; Fujita, Ryosuke; Nishimura, Miyuki; Kajiwara, Keiko; Miyazaki, Miyono; Nakashima, Yusuke; Ota, Sigenori; Murakami, Yuya; Tanaka, Yasunobu; Minomi, Kenjiro; Niitsu, Yoshiro] Sapporo Med Univ, Sch Med, Dept Mol Target Explorat, Sapporo, Hokkaido 0608556, Japan; [Murase, Kazuyuki; Sato, Yasushi] Sapporo Med Univ, Sch Med, Dept Internal Med 4, Sapporo, Hokkaido 0608556, Japan; [Ninomiya, Takafumi] Sapporo Med Univ, Sch Med, Dept Basic Med Sci, Dept Anat 1, Sapporo, Hokkaido 0608556, Japan; [Kajiwara, Keiko; Miyazaki, Miyono; Tanaka, Yasunobu; Minomi, Kenjiro] Nitto Denko Corp, Translat Res Grp, Hokkaido Lab, Mol Therapeut Dept,Corp Business Dev Div, Sapporo, Hokkaido 0010021, Japan; [Tamura, Yasuaki] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0010021, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Nitto Denko Corporation; Hokkaido University	Niitsu, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Mol Target Explorat, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	niitsu@sapmed.ac.jp		Sato, Yasushi/0000-0002-6776-4609				Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Chiba H, 2006, J CELL BIOL, V175, P971, DOI 10.1083/jcb.200608012; Fowell AJ, 2011, BIOCHEM BIOPH RES CO, V407, P277, DOI 10.1016/j.bbrc.2011.02.009; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Hartland SN, 2009, LIVER INT, V29, P966, DOI 10.1111/j.1478-3231.2009.02070.x; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Issa R, 2002, FASEB J, V16, P47, DOI 10.1096/fj.02-0494fje; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jiang QA, 2011, MOL BIOL CELL, V22, P1167, DOI 10.1091/mbc.E10-10-0860; Katoh D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.27; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Rodriguez-Juan C, 2009, CELL PHYSIOL BIOCHEM, V24, P271, DOI 10.1159/000233252; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Sheu JR, 1997, J PHARM PHARMACOL, V49, P78, DOI 10.1111/j.2042-7158.1997.tb06756.x; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Xu GX, 1997, J PATHOL, V183, P90, DOI 10.1002/(SICI)1096-9896(199709)183:1<90::AID-PATH1105>3.0.CO;2-J; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625; Zhao LN, 2007, J MOL HISTOL, V38, P53, DOI 10.1007/s10735-007-9078-5; Zhou XY, 2006, J BIOL CHEM, V281, P39757, DOI 10.1074/jbc.M605621200; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200	29	21	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20209	20221		10.1074/jbc.M113.544494	http://dx.doi.org/10.1074/jbc.M113.544494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24867951	Green Published, hybrid			2022-12-28	WOS:000339395200034
J	Lee, GH; Chhangawala, Z; von Daake, S; Savas, JN; Yates, JR; Comoletti, D; D'Arcangelo, G				Lee, Gum Hwa; Chhangawala, Zinal; von Daake, Sventja; Savas, Jeffrey N.; Yates, John R., III; Comoletti, Davide; D'Arcangelo, Gabriella			Reelin Induces Erk1/2 Signaling in Cortical Neurons Through a Non-canonical Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; ACTIVATED PROTEIN-KINASE; CAJAL-RETZIUS CELLS; SYNAPTIC PLASTICITY; TYROSINE KINASE; HIPPOCAMPAL CONNECTIONS; DENDRITE DEVELOPMENT; DISABLED-1; PHOSPHORYLATION; MIGRATION	Reelin is an extracellular protein that controls many aspects of pre- and postnatal brain development and function. The molecular mechanisms that mediate postnatal activities of Reelin are not well understood. Here, we first set out to express and purify the full length Reelin protein and a biologically active central fragment. Second, we investigated in detail the signal transduction mechanisms elicited by these purified Reelin proteins in cortical neurons. Unexpectedly, we discovered that the full-length Reelin moiety, but not the central fragment, is capable of activating Erk1/2 signaling, leading to increased p90RSK phosphorylation and the induction of immediate-early gene expression. Remarkably, Erk1/2 activation is not mediated by the canonical signal transduction pathway, involving ApoER2/VLDLR and Dab1, that mediates other functions of Reelin in early brain development. The activation of Erk1/2 signaling likely contributes to the modulation of neuronal maturation and synaptic plasticity by Reelin in the postnatal and adult brain.	[Lee, Gum Hwa; D'Arcangelo, Gabriella] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Chhangawala, Zinal; von Daake, Sventja; Comoletti, Davide] Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol & Mol & Cellular Neurobiol, La Jolla, CA 92037 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Scripps Research Institute	D'Arcangelo, G (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	darcangelo@biology.rutgers.edu		D'Arcangelo, Gabriella/0000-0003-1575-1010	National Institutes of Health [R01-MH092906]; New Jersey Governor's Council for Medical Research and Treatment of Autism [10-409-SCH-E-O]; NIH [K99DC013805-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC013805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Governor's Council for Medical Research and Treatment of Autism; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported in part by National Institutes of Health Grant R01-MH092906 (to D. C.) and by Research Grant 10-409-SCH-E-O from the New Jersey Governor's Council for Medical Research and Treatment of Autism (to G. D.).; Supported by NIH Pathway to Independence Award K99DC013805-01.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Ballif BA, 2003, MOL BRAIN RES, V117, P152, DOI 10.1016/S0169-328X(03)00295-X; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Borrell V, 1999, J NEUROSCI, V19, P1345; Bouche E, 2013, CELL RES, V23, P473, DOI 10.1038/cr.2013.7; Catchpole T, 2011, J NEUROSCI, V31, P11472, DOI 10.1523/JNEUROSCI.6349-10.2011; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Comoletti D, 2010, STRUCTURE, V18, P1044, DOI 10.1016/j.str.2010.06.005; Curtis J, 1999, J NEUROSCI RES, V58, P88, DOI 10.1002/(SICI)1097-4547(19991001)58:1<88::AID-JNR9>3.3.CO;2-I; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; D'Arcangelo G., 2014, ADV NEUROSCI; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Gil-Sanz C, 2013, NEURON, V79, P461, DOI 10.1016/j.neuron.2013.06.040; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iafrati J, 2014, MOL PSYCHIATR, V19, P417, DOI 10.1038/mp.2013.66; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Koie M, 2014, J BIOL CHEM, V289, P12922, DOI 10.1074/jbc.M113.536326; Krueger DD, 2006, PSYCHOPHARMACOLOGY, V189, P95, DOI 10.1007/s00213-006-0530-0; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; Larson J, 2003, BRAIN RES, V971, P40, DOI 10.1016/S0006-8993(03)02353-9; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Qiu SF, 2007, J NEUROPHYSIOL, V97, P2312, DOI 10.1152/jn.00869.2006; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Senturk A, 2011, NATURE, V472, P356, DOI 10.1038/nature09874; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Simo S, 2007, CEREB CORTEX, V17, P294, DOI 10.1093/cercor/bhj147; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Trotter J, 2013, J NEUROSCI, V33, P15652, DOI 10.1523/JNEUROSCI.2010-13.2013; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104	66	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20307	20317		10.1074/jbc.M114.576249	http://dx.doi.org/10.1074/jbc.M114.576249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24876378	Green Published, hybrid			2022-12-28	WOS:000339395200042
J	Saraf, A; Luo, J; Morris, DR; Storm, DR				Saraf, Amit; Luo, Jie; Morris, David R.; Storm, Daniel R.			Phosphorylation of Eukaryotic Translation Initiation Factor 4E and Eukaryotic Translation Initiation Factor 4E-binding Protein (4EBP) and Their Upstream Signaling Components Undergo Diurnal Oscillation in the Mouse Hippocampus IMPLICATIONS FOR MEMORY PERSISTENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; LONG-TERM-MEMORY; MESSENGER-RNA; SUPRACHIASMATIC NUCLEUS; SYNAPTIC PLASTICITY; CIRCADIAN-RHYTHMS; MNK1; FEAR; CONSOLIDATION; CLOCK	Translation of mRNA plays a critical role in consolidation of long-term memory. Here, we report that markers of initiation of mRNA translation are activated during training for contextual memory and that they undergo diurnal oscillation in the mouse hippocampus with maximal activity observed during the daytime (zeitgeber time 4-8 h). Phosphorylation and activation of eukaryotic translation initiation factor 4E (eIF4E), eIF4E-binding protein 1 (4EBP1), ribosomal protein S6, and eIF4F cap-complex formation, all of which are markers for translation initiation, were higher in the hippocampus during the daytime compared with night. The circadian oscillation in markers of mRNA translation was lost in memory-deficient transgenic mice lacking calmodulin-stimulated adenylyl cyclases. Moreover, disruption of the circadian rhythm blocked diurnal oscillations in eIF4E, 4EBP1, rpS6, Akt, and ERK1/2 phosphorylation and impaired memory consolidation. Furthermore, repeated inhibition of translation in the hippocampus 48 h after contextual training with the protein synthesis inhibitor anisomycin impaired memory persistence. We conclude that repeated activation of markers of translation initiation in hippocampus during the circadian cycle might be critical for memory persistence.	[Saraf, Amit; Luo, Jie; Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Morris, David R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Mail Box 357750,Hlth Sci Bldg, Seattle, WA 98195 USA.	dstorm@u.washington.edu	Saraf, amit/GZL-0533-2022	Saraf, amit/0000-0002-0823-2266; Luo, Jie/0000-0003-1899-3111	National Institutes of Health [NS 20498, MH 073601]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 20498 and MH 073601 (to D. R. S.).	Akashi M, 2000, GENE DEV, V14, P645; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Blum S, 1999, J NEUROSCI, V19, P3535; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cao R, 2013, NEURON, V79, P712, DOI 10.1016/j.neuron.2013.06.026; Coogan AN, 2003, J NEUROSCI, V23, P3085; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; de Paula RM, 2008, CELL CYCLE, V7, P2630, DOI 10.4161/cc.7.17.6516; Devan BD, 2001, NEUROBIOL LEARN MEM, V75, P51, DOI 10.1006/nlme.1999.3957; Duncan RF, 2003, BIOCHEM J, V369, P213, DOI 10.1042/BJ20020435; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gal-Ben-Ari S, 2012, LEARN MEMORY, V19, P410, DOI 10.1101/lm.026849.112; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Ho AK, 2003, MOL CELL ENDOCRINOL, V208, P23, DOI 10.1016/S0303-7207(03)00260-0; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Luo J, 2013, J NEUROSCI, V33, P6460, DOI 10.1523/JNEUROSCI.5018-12.2013; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Senthil D, 2002, AM J PHYSIOL-RENAL, V283, pF1226, DOI 10.1152/ajprenal.00109.2002; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Sudo M, 2003, NEUROSCIENCE, V121, P493, DOI 10.1016/S0306-4522(03)00457-3; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wanisch K, 2008, NEUROBIOL LEARN MEM, V90, P485, DOI 10.1016/j.nlm.2008.02.007; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2	54	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20129	20138		10.1074/jbc.M114.552638	http://dx.doi.org/10.1074/jbc.M114.552638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895127	Green Published, hybrid			2022-12-28	WOS:000339395200026
J	Ananieva, EA; Patel, CH; Drake, CH; Powell, JD; Hutson, SM				Ananieva, Elitsa A.; Patel, Chirag H.; Drake, Charles H.; Powell, Jonathan D.; Hutson, Susan M.			Cytosolic Branched Chain Aminotransferase (BCATc) Regulates mTORC1 Signaling and Glycolytic Metabolism in CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID CATABOLISM; NEUROTRANSMITTER METABOLISM; ARGININE METABOLISM; LEUCINE METABOLISM; PROTEIN-SYNTHESIS; IMMUNE-RESPONSES; EXPRESSION; ACTIVATION; PATHWAY; TRANSAMINATION	Here we show that expression of the cytosolic branched chain aminotransferase (BCATc) is triggered by the T cell receptor (TCR) of CD4(+) T cells. Induction of BCATc correlates with increased Leu transamination, whereas T cells from the BCATc(-/-) mouse exhibit lower Leu transamination and higher intracellular Leu concentrations than the cells from wild type (WT) mice. Induction of BCATc by TCR in WT cells is prevented by the calcineurin-nuclear factor of activated T cells (NFAT) inhibitor, cyclosporin A (CsA), suggesting that NFAT controls BCATc expression. Leu is a known activator of the mammalian target of rapamycin complex 1 (mTORC1). mTOR is emerging as a critical regulator of T cell activation, differentiation, and metabolism. Activated T cells from BCATc(-/-) mice show increased phosphorylation of mTORC1 downstream targets, S6 and 4EBP-1, indicating higher mTORC1 activation than in T cells from WT mice. Furthermore, T cells from BCATc(-/-) mice display higher rates of glycolysis, glycolytic capacity, and glycolytic reserve when compared with activated WT cells. These findings reveal BCATc as a novel regulator of T cell activation and metabolism and highlight the important role of Leu metabolism in T cells.	[Ananieva, Elitsa A.; Hutson, Susan M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Patel, Chirag H.; Drake, Charles H.; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA	Virginia Polytechnic Institute & State University; Johns Hopkins University	Ananieva, EA (corresponding author), Virginia Tech, Dept Human Nutr Foods & Exercise, ILSB Bldg,1981 Kraft Dr, Blacksburg, VA 24061 USA.	eanani75@vt.edu			National Institutes of Health Grants [DK34738, R01CA098109]; Virginia Tech; NATIONAL CANCER INSTITUTE [R01CA098109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034738, R56DK034738] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tech; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK34738 (to S. M. H.) and R01CA098109 (to J. D. P.) and a grant from Virginia Tech (to S. M. H.).	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Broos S, 2011, NUCLEIC ACIDS RES, V39, pW74, DOI 10.1093/nar/gkr355; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Cole JT, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00018; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; GARBER AJ, 1976, J BIOL CHEM, V251, P826; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; GOTO M, 1977, GANN, V68, P663; HALL TR, 1993, J BIOL CHEM, V268, P3092; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; HARRIS RA, 1995, ADV ENZYME REGUL, V35, P147, DOI 10.1016/0065-2571(94)00020-4; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; HARRIS RA, 1990, ADV ENZYME REGUL, V30, P245; Hidayat S, 2003, BIOCHEM BIOPH RES CO, V301, P417, DOI 10.1016/S0006-291X(02)03052-8; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; HUTSON SM, 1988, J BIOL CHEM, V263, P3618; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; Hutson SM, 1998, J NEUROCHEM, V71, P863; ICHIHARA A, 1966, J BIOCHEM-TOKYO, V59, P160, DOI 10.1093/oxfordjournals.jbchem.a128277; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kaesler S, 2012, EUR J IMMUNOL, V42, P831, DOI 10.1002/eji.201141690; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE824, DOI 10.1152/ajpendo.00085.2002; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Mittal D, 2013, J INVEST DERMATOL, V133, P2686, DOI 10.1038/jid.2013.222; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Powell JD, 2013, COLD SH Q B, V78, P125, DOI 10.1101/sqb.2013.78.020214; Powell JD, 2013, NAT IMMUNOL, V14, P422, DOI 10.1038/ni.2594; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Sweatt AJ, 2004, J COMP NEUROL, V477, P360, DOI 10.1002/cne.20200; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; WALLIN R, 1990, J BIOL CHEM, V265, P6019; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; Yudkoff M, 1996, J NEUROCHEM, V66, P378; Zha XJ, 2011, CELL CYCLE, V10, P1015, DOI 10.4161/cc.10.7.15063; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510; Zhou W, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-53; Zhou YS, 2010, J BIOL CHEM, V285, P33718, DOI 10.1074/jbc.M110.136846	67	53	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18793	18804		10.1074/jbc.M114.554113	http://dx.doi.org/10.1074/jbc.M114.554113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847056	Green Published, hybrid			2022-12-28	WOS:000339062900015
J	Barcena-Uribarri, I; Thein, M; Barbot, M; Sans-Serramitjana, E; Bonde, M; Mentele, R; Lottspeich, F; Bergstrom, S; Benz, R				Barcena-Uribarri, Ivan; Thein, Marcus; Barbot, Mariam; Sans-Serramitjana, Eulalia; Bonde, Mari; Mentele, Reinhard; Lottspeich, Friedrich; Bergstrom, Sven; Benz, Roland			Study of the Protein Complex, Pore Diameter, and Pore-forming Activity of the Borrelia burgdorferi P13 Porin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID BILAYER-MEMBRANES; LYME-DISEASE SPIROCHETE; COLI OUTER-MEMBRANE; ESCHERICHIA-COLI; BINDING-SITE; INSERTIONAL INACTIVATION; MOLECULAR-BASIS; ION CHANNELS; PERMEABILITY; ELIMINATION	P13 is one of the major outer membrane proteins of Borrelia burgdorferi. Previous studies described P13 as a porin. In the present study some structure and function aspects of P13 were studied. P13 showed according to lipid bilayer studies a channel-forming activity of 0.6 nanosiemens in 1 M KCl. Single channel and selectivity measurements demonstrated that P13 had no preference for either cations or anions and showed no voltage-gating up to +/-100 mV. Blue native polyacrylamide gel electrophoresis was used to isolate and characterize the P13 protein complex in its native state. The complex had a high molecular mass of about 300 kDa and was only composed of P13 monomers. The channel size was investigated using non-electrolytes revealing an apparent diameter of about 1.4 nm with a 400-Da molecular mass cut-off. Multichannel titrations with different substrates reinforced the idea that P13 forms a general diffusion channel. The identity of P13 within the complex was confirmed by second dimension SDS-PAGE, Western blotting, mass spectrometry, and the use of a p13 deletion mutant strain. The results suggested that P13 is the protein responsible for the 0.6-nanosiemens pore-forming activity in the outer membrane of B. burgdorferi.	[Barcena-Uribarri, Ivan; Thein, Marcus; Barbot, Mariam; Sans-Serramitjana, Eulalia; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Barcena-Uribarri, Ivan; Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; [Bonde, Mari; Bergstrom, Sven] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Mentele, Reinhard; Lottspeich, Friedrich] Max Planck Inst Biochem, Prot Anal Dept, D-82152 Martinsried, Germany	University of Wurzburg; Jacobs University; Umea University; Max Planck Society	Barcena-Uribarri, I (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Campusring 1, D-28759 Bremen, Germany.	i.barcenauribarri@jacobs-university.de		Benz, Roland/0000-0002-9510-9265	Stint (Sweden); Deutscher Akademischer Austauschdienst (DAAD) (Germany); Deutsche Forschungsgemeinschaft [Be 864/15-1, Wi 933]; Swedish Medical Research Council Grant [07922]; Alfonso Martin Escudero Foundation	Stint (Sweden); Deutscher Akademischer Austauschdienst (DAAD) (Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Medical Research Council Grant; Alfonso Martin Escudero Foundation	This work was supported by a joint project between Stint (Sweden) and Deutscher Akademischer Austauschdienst (DAAD) (Germany) (to S. B. and R. B.), the Deutsche Forschungsgemeinschaft (Be 864/15-1; to R. B.), Wi 933 (to Mathias Winterhalter), and Swedish Medical Research Council Grant 07922 (to S. B.).; Supported by the Alfonso Martin Escudero Foundation.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; Barcena-Uribarri I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078272; Barcena-Uribarri I, 2010, BBA-BIOMEMBRANES, V1798, P1197, DOI 10.1016/j.bbamem.2010.02.011; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BENZ R, 1988, EUR J BIOCHEM, V176, P699, DOI 10.1111/j.1432-1033.1988.tb14333.x; Benz R., 2001, PORINS STRUCTURE FUN; Benz R., 1994, BACTERIAL CELL WALL, P397; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BURGDORFER W, 1984, YALE J BIOL MED, V57, P515; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Cluss RG, 2004, INFECT IMMUN, V72, P6279, DOI 10.1128/IAI.72.11.6279-6286.2004; Coburn J, 2003, P NATL ACAD SCI USA, V100, P7301, DOI 10.1073/pnas.1131117100; Coburn J, 1999, MOL MICROBIOL, V34, P926, DOI 10.1046/j.1365-2958.1999.01654.x; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; HANCOCK REW, 1986, BIOCHIM BIOPHYS ACTA, V860, P699, DOI 10.1016/0005-2736(86)90569-9; HANCOCK REW, 1988, EUR J CLIN MICROBIOL, V7, P713, DOI 10.1007/BF01975036; Hasle G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00048; Kim BH, 2001, MOL MICROBIOL, V41, P665, DOI 10.1046/j.1365-2958.2001.02544.x; Krasilnikov OV, 1998, J MEMBRANE BIOL, V161, P83; KRASILNIKOV OV, 1992, FEMS MICROBIOL IMMUN, V105, P93; Kumru OS, 2011, J BACTERIOL, V193, P5759, DOI 10.1128/JB.05622-11; Lide D.R., 1998, CRC HDB CHEM PHYS, P99; LUDWIG O, 1986, BIOCHIM BIOPHYS ACTA, V860, P268, DOI 10.1016/0005-2736(86)90523-7; MAGNARELLI LA, 1989, J INFECT DIS, V159, P43, DOI 10.1093/infdis/159.1.43; Mahendran KR, 2010, J PHYS CHEM B, V114, P5170, DOI 10.1021/jp911485k; MAIER C, 1988, J BIOL CHEM, V263, P2493; Mannelli A, 2012, FEMS MICROBIOL REV, V36, P837, DOI 10.1111/j.1574-6976.2011.00312.x; MARK JE, 1965, J AM CHEM SOC, V87, P1415, DOI 10.1021/ja01085a001; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Mulay V, 2007, J BACTERIOL, V189, P2063, DOI 10.1128/JB.01239-06; Nablo BJ, 2008, BIOPHYS J, V95, P1157, DOI 10.1529/biophysj.107.121715; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noppa L, 2001, INFECT IMMUN, V69, P3323, DOI 10.1128/IAI.69.5.3323-3334.2001; Obermeier O. H. F., 1873, ENTDECKUNG FADENFORM; Ostberg Y, 2002, J BACTERIOL, V184, P6811, DOI 10.1128/JB.184.24.6811-6819.2002; Pinne M, 2004, MICROBIOL-SGM, V150, P549, DOI 10.1099/mic.0.26728-0; Pinne M, 2006, J BACTERIOL, V188, P4207, DOI 10.1128/JB.00302-06; Pinne M, 2007, FEMS MICROBIOL LETT, V266, P241, DOI 10.1111/j.1574-6968.2006.00529.x; Rempp P., 1957, J CHIM PHYS PCB, V54, P432; SABIROV RZ, 1993, GEN PHYSIOL BIOPHYS, V12, P95; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Sicklinger M, 2003, J CLIN MICROBIOL, V41, P1791, DOI 10.1128/JCM.41.4.1791-1793.2003; Skare JT, 1996, J BACTERIOL, V178, P4909, DOI 10.1128/jb.178.16.4909-4918.1996; SKARE JT, 1995, J CLIN INVEST, V96, P2380, DOI 10.1172/JCI118295; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Steere AC, 2006, WIEN KLIN WOCHENSCHR, V118, P625, DOI 10.1007/s00508-006-0687-x; Thein M, 2008, J BACTERIOL, V190, P7035, DOI 10.1128/JB.00818-08; Thein M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036523; Tristram-Nagle S, 2010, CHEM PHYS LIPIDS, V163, P630, DOI 10.1016/j.chemphyslip.2010.04.011; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	59	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18614	18624		10.1074/jbc.M113.539528	http://dx.doi.org/10.1074/jbc.M113.539528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24825899	Green Published, hybrid			2022-12-28	WOS:000339062900001
J	Borthakur, S; Lee, H; Kim, S; Wang, BC; Buck, M				Borthakur, Susmita; Lee, HyeongJu; Kim, SoonJeung; Wang, Bing-Cheng; Buck, Matthias			Binding and Function of Phosphotyrosines of the Ephrin A2 (EphA2) Receptor Using Synthetic Sterile alpha Motif (SAM) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION SITES; CELL-MIGRATION; SH2 DOMAIN; SIGNAL-TRANSDUCTION; LIPID PHOSPHATASE; CRYSTAL-STRUCTURE; PEPTIDE COMPLEX; BREAST-CANCER; PROTEIN; GRB7	The sterile alpha motif (SAM) domain of the ephrin receptor tyrosine kinase, EphA2, undergoes tyrosine phosphorylation, but the effect of phosphorylation on the structure and interactions of the receptor is unknown. Studies to address these questions have been hindered by the difficulty of obtaining site-specifically phosphorylated proteins in adequate amounts. Here, we describe the use of chemically synthesized and specifically modified domain-length peptides to study the behavior of phosphorylated EphA2 SAM domains. We show that tyrosine phosphorylation of any of the three tyrosines, Tyr(921), Tyr(930), and Tyr(960), has a surprisingly small effect on the EphA2 SAM structure and stability. However, phosphorylation at Tyr(921) and Ty(r)9(30) enables differential binding to the Src homology 2 domain of the adaptor protein Grb7, which we propose will lead to distinct functional outcomes. Setting up different signaling platforms defined by selective interactions with adaptor proteins thus adds another level of regulation to EphA2 signaling.	[Borthakur, Susmita; Lee, HyeongJu; Kim, SoonJeung; Wang, Bing-Cheng; Buck, Matthias] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Wang, Bing-Cheng] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Wang, Bing-Cheng; Buck, Matthias] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wang, Bing-Cheng] MetroHlth Med Ctr, Rammelkamp Ctr Res, Cleveland, OH 44109 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; MetroHealth System	Buck, M (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	matthias.buck@case.edu	Buck, Matthias/B-2106-2017	Buck, Matthias/0000-0002-2958-0403	National Institutes of Health [R01GM092851, R01CA152371, R01CA155676, R01DK077876]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA152371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM092851 and R01CA152371 (to M. B.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to S. B.).; Supported by National Institutes of Health Grants R01CA155676 and R01DK077876.	Armstrong CT, 2011, BIOINFORMATICS, V27, P1908, DOI 10.1093/bioinformatics/btr299; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balasubramaniam D, 2011, PROTEIN SCI, V20, P1172, DOI 10.1002/pro.646; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Edimo WE, 2012, BIOESSAYS, V34, P634, DOI 10.1002/bies.201100195; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Himanen JP, 2003, INT J BIOCHEM CELL B, V35, P130, DOI 10.1016/S1357-2725(02)00096-1; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Ivancic M, 2005, PROTEIN SCI, V14, P1556, DOI 10.1110/ps.041102305; Ivancic M, 2003, J BIOMOL NMR, V27, P205, DOI 10.1023/A:1025498409113; Janes PW, 1997, J BIOL CHEM, V272, P8490, DOI 10.1074/jbc.272.13.8490; Jehle J, 2012, BRIT J PHARMACOL, V167, P1563, DOI 10.1111/j.1476-5381.2012.02117.x; Kalo MS, 1999, BIOCHEMISTRY-US, V38, P14396, DOI 10.1021/bi991628t; Kalo MS, 2001, J BIOL CHEM, V276, P38940, DOI 10.1074/jbc.M105815200; Kalo MS, 1999, CELL TISSUE RES, V298, P1, DOI 10.1007/PL00008807; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Lee H, 2013, MOL CELL BIOL, V33, P1430, DOI 10.1128/MCB.01708-12; Lee HJ, 2012, STRUCTURE, V20, P41, DOI 10.1016/j.str.2011.11.013; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leone M, 2008, BIOCHEMISTRY-US, V47, P12721, DOI 10.1021/bi801713f; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Nag A, 2009, BIOPHYS J, V96, P2604, DOI 10.1016/j.bpj.2009.01.019; Paavilainen S, 2013, PROTEIN EXPRES PURIF, V92, P112, DOI 10.1016/j.pep.2013.08.016; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Peterson TA, 2012, J MOL RECOGNIT, V25, P427, DOI 10.1002/jmr.2205; Pias SC, 2010, CRIT REV IMMUNOL, V30, P299, DOI 10.1615/CritRevImmunol.v30.i3.70; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Ramachander R, 2004, J MOL BIOL, V342, P1353, DOI 10.1016/j.jmb.2004.08.011; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Schultz J, 1997, PROTEIN SCI, V6, P249; Singla N, 2011, CHEM BIOL, V18, P361, DOI 10.1016/j.chembiol.2011.01.011; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Timsah Z, 2014, NAT STRUCT MOL BIOL, V21, P180, DOI 10.1038/nsmb.2752; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315; Zhang LQ, 2013, BIOPHYS J, V105, P2412, DOI 10.1016/j.bpj.2013.09.052; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	53	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19694	19703		10.1074/jbc.M114.567602	http://dx.doi.org/10.1074/jbc.M114.567602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24825902	Green Published, hybrid			2022-12-28	WOS:000339326800041
J	Choi, WI; Kim, MY; Jeon, BN; Koh, DI; Yun, CO; Li, Y; Lee, CE; Oh, J; Kim, K; Hur, MW				Choi, Won-Il; Kim, Min-Young; Jeon, Bu-Nam; Koh, Dong-In; Yun, Chae-Ok; Li, Yan; Lee, Choong-Eun; Oh, Jiyoung; Kim, Kunhong; Hur, Man-Wook			Role of Promyelocytic Leukemia Zinc Finger (PLZF) in Cell Proliferation and Cyclin-dependent Kinase Inhibitor 1A (p21WAF/CDKN1A) Gene Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; HISTONE DEACETYLASE; P21(WAF1/CIP1) GENE; TUMOR SUPPRESSION; PROTEIN PLZF; EXPRESSION; RECEPTOR; P53; APOPTOSIS; INTERACTS	Promyelocytic leukemia zinc finger (PLZF) is a transcription repressor that was initially isolated as a fusion protein with retinoic acid receptor alpha. PLZF is aberrantly overexpressed in various human solid tumors, such as clear cell renal carcinoma, glioblastoma, and seminoma. PLZF causes cellular transformation of NIH3T3 cells and increases cell proliferation in several cell types. PLZF also increases tumor growth in the mouse xenograft tumor model. PLZF may stimulate cell proliferation by controlling expression of the genes of the p53 pathway (ARF, TP53, and CDKN1A). We found that PLZF can directly repress transcription of CDKN1A encoding p21, a negative regulator of cell cycle progression. PLZF binds to the proximal Sp1-binding GC-box 5/6 and the distal p53-responsive elements of the CDKN1A promoter to represstranscription. Interestingly, PLZF interacts with Sp1 or p53 and competes with Sp1 or p53. PLZF interacts with corepressors, such as mSin3A, NCoR, and SMRT, thereby deacetylates Ac-H3 and Ac-H4 histones at the CDKN1A promoter, which indicated the involvement of the corepressor.HDACs complex in transcription repression by PLZF. Also, PLZF represses transcription of TP53 and also decreases p53 protein stability by ubiquitination. PLZF may act as a potential proto-oncoprotein in various cell types.	[Choi, Won-Il; Kim, Min-Young; Jeon, Bu-Nam; Koh, Dong-In; Kim, Kunhong; Hur, Man-Wook] Yonsei Univ, Sch Med, Severance Biomed Res Inst, Dept Biochem & Mol Biol,Brain Korea Plus Project, Seoul 120752, South Korea; [Yun, Chae-Ok; Li, Yan] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea; [Lee, Choong-Eun; Oh, Jiyoung] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Yonsei University; Hanyang University; Sungkyunkwan University (SKKU)	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Severance Biomed Res Inst, Dept Biochem & Mol Biol,Brain Korea Plus Project, 50 Yonsei Ro, Seoul 120752, South Korea.	mwhur2@yuhs.ac	Yun, Chae-Ok/P-3698-2015	CHOI, WONIL/0000-0002-4837-0436; Hur, Man-Wook/0000-0002-3416-1334; Kim, Kunhong/0000-0001-5639-6372; Yun, Chae-Ok/0000-0002-9466-4531	National R&D Program for Cancer Control, Korean Ministry for Health, Welfare and Family affairs [00001561]; DOYAK Research Grant from the Korea Research Foundation of the Korea Ministry of Education, Science and Technology [2011-0028817]	National R&D Program for Cancer Control, Korean Ministry for Health, Welfare and Family affairs; DOYAK Research Grant from the Korea Research Foundation of the Korea Ministry of Education, Science and Technology	This work was supported by Grant 00001561 (to M.-W. H.) from the National R&D Program for Cancer Control, Korean Ministry for Health, Welfare and Family affairs and DOYAK Research Grant 2011-0028817 from the Korea Research Foundation of the Korea Ministry of Education, Science and Technology.	Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Bernardo MV, 2007, BIOCHEM BIOPH RES CO, V359, P317, DOI 10.1016/j.bbrc.2007.05.085; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Cheung M, 2010, ONCOGENE, V29, P1633, DOI 10.1038/onc.2009.455; Choi WI, 2013, NUCLEIC ACIDS RES, V41, P6403, DOI 10.1093/nar/gkt359; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Costoya JA, 2008, ONCOGENE, V27, P3789, DOI 10.1038/onc.2008.7; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Felicetti F, 2004, ONCOGENE, V23, P4567, DOI 10.1038/sj.onc.1207597; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; HARPER JW, 1993, CELL, V75, P805; Hobbs RM, 2010, ONCOTARGET, V1, P3, DOI 10.18632/oncotarget.102; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Parrado A, 2004, P NATL ACAD SCI USA, V101, P1898, DOI 10.1073/pnas.0308358100; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; REID A, 1995, BLOOD, V86, P4544, DOI 10.1182/blood.V86.12.4544.bloodjournal86124544; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Ward JO, 2001, BLOOD, V98, P3290, DOI 10.1182/blood.V98.12.3290; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375	36	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18625	18640		10.1074/jbc.M113.538751	http://dx.doi.org/10.1074/jbc.M113.538751			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24821727	hybrid, Green Published			2022-12-28	WOS:000339062900002
J	Coultrap, SJ; Bayer, KU				Coultrap, Steven J.; Bayer, K. Ulrich			Nitric Oxide Induces Ca2+-independent Activity of the Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE PHOSPHORYLATION; ALPHA-CAMKII; AUTOPHOSPHORYLATION; CALMODULIN; ACTIVATION; MECHANISM; INFORMATION; MODULATION; PLASTICITY; AUTONOMY	Both signaling by nitric oxide (NO) and by the Ca2+/calmodulin (CaM)-dependent protein kinase II alpha isoform (CaMKII alpha) are implicated in two opposing forms of synaptic plasticity underlying learning and memory, as well as in excitotoxic/ischemic neuronal cell death. For CaMKII alpha, these functions specifically involve also Ca2+-independent autonomous activity, traditionally generated by Thr-286 autophosphorylation. Here, we demonstrate that NO-induced S-nitrosylation of CaMKII alpha also directly generated autonomous activity, and that CaMKII inhibition protected from NO-induced neuronal cell death. NO induced S-nitrosylation at Cys-280/289, and mutation of either site abolished autonomy, indicating that simultaneous nitrosylation at both sites was required. Additionally, autonomy was generated only when Ca2+/CaM was present during NO exposure. Thus, generation of this form of CaMKII alpha autonomy requires simultaneous signaling by NO and Ca2+. Nitrosylation also significantly reduced subsequent CaMKII alpha autophosphorylation specifically at Thr-286, but not at Thr-305. A previously described reduction of CaMKII activity by S-nitrosylation at Cys-6 was also observed here, but only after prolonged (>5 min) exposure to NO donors. These results demonstrate a novel regulation of CaMKII by another second messenger system and indicate its involvement in excitotoxic neuronal cell death.	[Coultrap, Steven J.; Bayer, K. Ulrich] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Coultrap, SJ (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Anschutz Med Campus,Mail Stop 8303,RC1 North, Aurora, CO 80045 USA.	steve.coultrap@ucdenver.edu; ulli.bayer@ucdenver.edu			National Institutes of Health [NS081248, NS080851]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154, R01NS080851, R01NS081248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported, in whole or in part, by National Institutes of Health Grants NS081248 and NS080851 (to K. U. B.). The University of Colorado is currently seeking patent protection for a CaMKII inhibitor used in this study.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Aarts MM, 2004, CURR MOL MED, V4, P137, DOI 10.2174/1566524043479202; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Coultrap S.J., 2012, NEUROMETHODS PROTEIN, P49; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Coultrap SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037176; Coultrap SJ, 2011, ACTA PHARMACOL SIN, V32, P861, DOI 10.1038/aps.2011.68; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fujii H, 2013, CELL REP, V3, P978, DOI 10.1016/j.celrep.2013.03.033; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gutierrez DA, 2013, CARDIOVASC RES, V100, P392, DOI 10.1093/cvr/cvt201; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jones RJ, 2007, AM J PHYSIOL-HEART C, V292, pH2634, DOI 10.1152/ajpheart.01247.2006; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Sen N, 2010, TRENDS NEUROSCI, V33, P493, DOI 10.1016/j.tins.2010.07.004; Song T, 2008, BIOCHEM J, V412, P223, DOI 10.1042/BJ20071195; Stanton PK, 2003, J NEUROSCI, V23, P5936; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Watanabe Y, 2003, BIOCHEM J, V372, P465, DOI 10.1042/BJ20030380; Zhang DM, 2014, J PHYSIOL-LONDON, V592, P971, DOI 10.1113/jphysiol.2013.264697	45	54	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19458	19465		10.1074/jbc.M114.558254	http://dx.doi.org/10.1074/jbc.M114.558254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855644	Green Published, hybrid			2022-12-28	WOS:000339326800021
J	Kiontke, S; Gnau, P; Haselsberger, R; Batschauer, A; Essen, LO				Kiontke, Stephan; Gnau, Petra; Haselsberger, Reinhard; Batschauer, Alfred; Essen, Lars-Oliver			Structural and Evolutionary Aspects of Antenna Chromophore Usage by Class II Photolyases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT PHOTORECEPTORS; DNA PHOTOLYASE; ANACYSTIS-NIDULANS; CRYSTAL-STRUCTURE; PHOTOLYASE/CRYPTOCHROME FAMILY; THERMUS-THERMOPHILUS; 2ND CHROMOPHORE; CRYPTOCHROMES; IDENTIFICATION; REPAIR	Light-harvesting and resonance energy transfer to the catalytic FAD cofactor are key roles for the antenna chromophores of light-driven DNA photolyases, which remove UV-induced DNA lesions. So far, five chemically diverse chromophores have been described for several photolyases and related cryptochromes, but no correlation between phylogeny and used antenna has been found. Despite a common protein topology, structural analysis of the distantly related class II photolyase from the archaeon Methanosarcina mazei (MmCPDII) as well as plantal orthologues indicated several differences in terms of DNA and FAD binding and electron transfer pathways. For MmCPDII we identify 8-hydroxydeazaflavin (8-HDF) as cognate antenna by in vitro and in vivo reconstitution, whereas the higher plant class II photolyase from Arabidopsis thaliana fails to bind any of the known chromophores. According to the 1.9 structure of theMmCPDII.8-HDF complex, its antenna binding site differs from other members of the photolyase-cryptochrome superfamily by an antenna loop that changes its conformation by 12 angstrom upon 8-HDF binding. Additionally, so-called N-and C-motifs contribute as conserved elements to the binding of deprotonated 8-HDF and allow predicting 8-HDF binding for most of the class II photolyases in the whole phylome. The 8-HDF antenna is used throughout the viridiplantae ranging from green microalgae to bryophyta and pteridophyta, i.e. mosses and ferns, but interestingly not in higher plants. Overall, we suggest that 8-hydroxydeazaflavin is a crucial factor for the survival of most higher eukaryotes which depend on class II photolyases to struggle with the genotoxic effects of solar UV exposure.	[Kiontke, Stephan; Gnau, Petra; Essen, Lars-Oliver] Univ Marburg, Biomed Res Ctr FB15, Unit Struct Biochem, D-35032 Marburg, Germany; [Haselsberger, Reinhard] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore 637371, Singapore; [Batschauer, Alfred] Univ Marburg, Fac Biol, Dept Plant Physiol & Photobiol, D-35032 Marburg, Germany	Philipps University Marburg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Philipps University Marburg	Essen, LO (corresponding author), Univ Marburg, Biomed Res Ctr FB15, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026	LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz) Center for Synthetic Microbiology (Marburg); Deutsche Forschungsgemeinschaft [BA985/12-1]	LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz) Center for Synthetic Microbiology (Marburg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz) Center for Synthetic Microbiology (Marburg) and Deutsche Forschungsgemeinschaft Grant BA985/12-1.	Chakrabarti P, 2007, PROG BIOPHYS MOL BIO, V95, P83, DOI 10.1016/j.pbiomolbio.2007.03.016; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; DeLano W.L, PYMOL MOL GRAPHICS S; EKER APM, 1990, J BIOL CHEM, V265, P8009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; Fujihashi M, 2007, J MOL BIOL, V365, P903, DOI 10.1016/j.jmb.2006.10.012; Geisselbrecht Y, 2012, EMBO REP, V13, P223, DOI 10.1038/embor.2012.2; Glas AF, 2009, P NATL ACAD SCI USA, V106, P11540, DOI 10.1073/pnas.0812665106; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; Hitomi K, 2012, J BIOL CHEM, V287, P12060, DOI 10.1074/jbc.M111.244020; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiontke S, 2011, EMBO J, V30, P4437, DOI 10.1038/emboj.2011.313; Klar T, 2007, J MOL BIOL, V366, P954, DOI 10.1016/j.jmb.2006.11.066; Klar T, 2006, CHEMBIOCHEM, V7, P1798, DOI 10.1002/cbic.200600206; Kort R, 2004, ACTA CRYSTALLOGR D, V60, P1205, DOI 10.1107/S0907444904009321; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu ZY, 2011, P NATL ACAD SCI USA, V108, P14831, DOI 10.1073/pnas.1110927108; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; MALHOTRA K, 1992, J BIOL CHEM, V267, P15406; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okafuji A, 2010, DNA REPAIR, V9, P495, DOI 10.1016/j.dnarep.2010.01.014; Petersen JL, 2001, NUCLEIC ACIDS RES, V29, P4472, DOI 10.1093/nar/29.21.4472; Rausher MD., 2006, SCI FLAVONOIDS, P175, DOI [10.1007/978-0-387-28822-2_7, DOI 10.1007/978-0-387-28822-2_7]; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2012, BIOCHEMISTRY-US, V51, P167, DOI 10.1021/bi201536w; Thiagarajan V, 2011, P NATL ACAD SCI USA, V108, P9402, DOI 10.1073/pnas.1101026108; Ueda T, 2005, J BIOL CHEM, V280, P36237, DOI 10.1074/jbc.M507972200; WALSH C, 1986, ACCOUNTS CHEM RES, V19, P216, DOI 10.1021/ar00127a004	35	32	33	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19659	19669		10.1074/jbc.M113.542431	http://dx.doi.org/10.1074/jbc.M113.542431			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24849603	hybrid, Green Published			2022-12-28	WOS:000339326800038
J	Su, WM; Han, GS; Carman, GM				Su, Wen-Min; Han, Gil-Soo; Carman, George M.			Cross-talk Phosphorylations by Protein Kinase C and Pho85p-Pho80p Protein Kinase Regulate Pah1p Phosphatidate Phosphatase Abundance in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MEMBRANE GROWTH; PHOSPHOLIPID-SYNTHESIS; CTP SYNTHETASE; LIPID-METABOLISM; PHOSPHATIDYLCHOLINE SYNTHESIS; MULTISITE PHOSPHORYLATION; MEDIATED REGULATION; ORTHOLOGUE PAH1P; MAJOR SITES; CELL-CYCLE	Yeast Pah1p is the phosphatidate phosphatase that catalyzes the penultimate step in triacylglycerol synthesis and plays a role in the transcriptional regulation of phospholipid synthesis genes. The enzyme is multiply phosphorylated, some of which is mediated by Pho85p-Pho80p, Cdc28p-cyclin B, and protein kinase A. Here, we showed that Pah1p is a bona fide substrate of protein kinase C; the phosphorylation reaction was time-and dose-dependent and dependent on the concentrations of ATP (K-m = 4.5 mu M) and Pah1p (K-m = 0.75 mu M). The stoichiometry of the reaction was 0.8 mol of phosphate/mol of Pah1p. By combining mass spectrometry, truncation analysis, site-directed mutagenesis, and phosphopeptide mapping, we identified Ser-677, Ser-769, Ser-773, and Ser-788 as major sites of phosphorylation. Analysis of Pah1p phosphorylations by different protein kinases showed that prephosphorylation with protein kinase C reduces its subsequent phosphorylation with protein kinase A and vice versa. Prephosphorylation with Pho85p-Pho80p had an inhibitory effect on its subsequent phosphorylation with protein kinase C; however, prephosphorylation with protein kinase C had no effect on the subsequent phosphorylation with Pho85p-Pho80p. Unlike its phosphorylations by Pho85p-Pho80p and protein kinase A, which cause a significant reduction in phosphatidate phosphatase activity, the phosphorylation of Pah1p by protein kinase C had a small stimulatory effect on the enzyme activity. Analysis of phosphorylation-deficient forms of Pah1p indicated that protein kinase C does not have a major effect on its location or its function in triacylglycerol synthesis, but instead, the phosphorylation favors loss of Pah1p abundance when it is not phosphorylated with Pho85p-Pho80p.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health Grant [NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Symeon Siniossoglou for supplying the pah1 Delta and pah1 Delta nem1 Delta mutants and Erin O'Shea for the plasmids to express Pho85p-Pho80p. Mass spectrometry data were obtained from an Orbitrap instrument funded in part by National Institutes of Health Grant NS046593 for the support of the Rutgers Biomedical and Health Sciences-New Jersey Medical School Neuroproteomics Core Facility.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman George M, 2011, Front Biol (Beijing), V6, P172; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 2004, BIOCHEM CELL BIOL, V82, P62, DOI 10.1139/o03-064; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Choi MG, 2005, J BIOL CHEM, V280, P26105, DOI 10.1074/jbc.M503551200; Choi MG, 2003, J BIOL CHEM, V278, P23610, DOI 10.1074/jbc.M303337200; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; KENNEDY EP, 1961, FED PROC, V20, P934; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; OGITA K, 1990, P NATL ACAD SCI USA, V87, P5011, DOI 10.1073/pnas.87.13.5011; Park TS, 2003, J BIOL CHEM, V278, P20785, DOI 10.1074/jbc.M301394200; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Rose MD., 1990, METHODS YEAST GENETI; Saleem RA, 2010, MOL CELL PROTEOMICS, V9, P2076, DOI 10.1074/mcp.M000116-MCP201; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON AJ, 1991, P ROY SOC B-BIOL SCI, V243, P165, DOI 10.1098/rspb.1991.0027; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WATANABE M, 1994, J BIOL CHEM, V269, P16829; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Yang WL, 1996, J BIOL CHEM, V271, P11113, DOI 10.1074/jbc.271.19.11113; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002	100	32	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18818	18830		10.1074/jbc.M114.581462	http://dx.doi.org/10.1074/jbc.M114.581462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24876385	Green Published, hybrid			2022-12-28	WOS:000339062900017
J	Jokela, TA; Karna, R; Makkonen, KM; Laitinen, JT; Tammi, RH; Tammi, MI				Jokela, Tiina A.; Karna, Riikka; Makkonen, Katri M.; Laitinen, Jarmo T.; Tammi, Raija H.; Tammi, Markku I.			Extracellular UDP-Glucose Activates P2Y(14) Receptor and Induces Signal Transducer and Activator of Transcription 3 (STAT3) Tyr(705) Phosphorylation and Binding to Hyaluronan Synthase 2 (HAS2) Promoter, Stimulating Hyaluronan Synthesis of Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURINERGIC RECEPTORS; RETINOIC ACID; SERINE PHOSPHORYLATION; DIFFERENTIATION; ACCUMULATION; EPIDERMIS; CULTURES; RELEASE; CELLS; PROLIFERATION	Hyaluronan, a major matrix molecule in epidermis, is often increased by stimuli that enhance keratinocyte proliferation and migration. We found that small amounts of UDP-sugars were released from keratinocytes and that UDP-glucose (UDP-Glc) added into keratinocyte cultures induced a specific, rapid induction of hyaluronan synthase 2 (HAS2), and an increase of hyaluronan synthesis. The up-regulation of HAS2 was associated with JAK2 and ERK1/2 activation, and specific Tyr(705) phosphorylation of transcription factor STAT3. Inhibition of JAK2, STAT3, or G(i)-coupled receptors blocked the induction of HAS2 expression by UDP-Glc, the latter inhibitor suggesting that the signaling was triggered by the UDP-sugar receptor P2Y(14). Chromatin immunoprecipitations demonstrated increased promoter binding of Tyr(P)(705)-STAT3 at the time of HAS2 induction. Interestingly, at the same time Ser(P)(727)-STAT3 binding to its response element regions in the HAS2 promoter was unchanged or decreased. UDP-Glc also stimulated keratinocyte migration, proliferation, and IL-8 expression, supporting a notion that UDP-Glc signals for epidermal inflammation, enhanced hyaluronan synthesis as an integral part of it.	[Jokela, Tiina A.; Karna, Riikka; Makkonen, Katri M.; Laitinen, Jarmo T.; Tammi, Raija H.; Tammi, Markku I.] Univ Eastern Finland, Sch Med, Inst Biomed, FIN-70210 Kuopio, Finland; [Makkonen, Katri M.] Univ Eastern Finland, Sch Med, Inst Dent, FIN-70210 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Jokela, TA (corresponding author), Univ Eastern Finland, Sch Med, Inst Biomed, POB 1627, FIN-70210 Kuopio, Finland.	tiina.jokela@gmail.com	Tammi, Markku/AAQ-7878-2021; Jokela, Tiina/O-9206-2015	Jokela, Tiina/0000-0002-7521-3866; Laitinen, Jarmo T/0000-0002-9490-3686	Academy of Finland; The Sigrid Juselius Foundation; EVO Funds of the Kuopio University Hospital; The Mizutani Foundation; Cancer Center of the University of Eastern Finland; Glycoscience Graduate School; Paavo Koistinen Foundation; Kuopio University foundation	Academy of Finland(Academy of Finland); The Sigrid Juselius Foundation(Sigrid Juselius Foundation); EVO Funds of the Kuopio University Hospital; The Mizutani Foundation; Cancer Center of the University of Eastern Finland; Glycoscience Graduate School; Paavo Koistinen Foundation; Kuopio University foundation	This work was supported by grants from the Academy of Finland (to M. I. T.), The Sigrid Juselius Foundation (to M. I. T. and R. H. T.), the EVO Funds of the Kuopio University Hospital (to M. I. T.), The Mizutani Foundation (to M. I. T.), the Cancer Center of the University of Eastern Finland (to M. I. T. and R. H. T.), Glycoscience Graduate School (to T. A. J. and M. I. T.), Paavo Koistinen Foundation (to T. A. J.), and Kuopio University foundation (to T. A. J.).	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg J, 2001, METHOD ENZYMOL, V333, P138; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Burrell HE, 2003, J INVEST DERMATOL, V120, P440, DOI 10.1046/j.1523-1747.2003.12050.x; Ceresa BP, 1997, ENDOCRINOLOGY, V138, P4131, DOI 10.1210/en.138.10.4131; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Fricks IP, 2009, J PHARMACOL EXP THER, V330, P162, DOI 10.1124/jpet.109.150730; Gao ZG, 2010, BIOCHEM PHARMACOL, V79, P873, DOI 10.1016/j.bcp.2009.10.024; Greig AVH, 2003, J INVEST DERMATOL, V121, P1145, DOI 10.1046/j.1523-1747.2003.12567.x; Hall CL, 1995, J NEURO-ONCOL, V26, P221, DOI 10.1007/BF01052625; Harden TK, 2010, ACTA PHYSIOL, V199, P149, DOI 10.1111/j.1748-1716.2010.02116.x; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Ipata PL, 2011, INT J BIOCHEM CELL B, V43, P140, DOI 10.1016/j.biocel.2010.10.007; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; KOPF GS, 1991, METHOD ENZYMOL, V195, P257; Kreda SM, 2008, BRIT J PHARMACOL, V153, P1528, DOI 10.1038/sj.bjp.0707692; Lee BC, 2003, GENE DEV, V17, P1592, DOI 10.1101/gad.1071503; Lee HK, 2009, KOREAN J PHYSIOL PHA, V13, P161, DOI 10.4196/kjpp.2009.13.3.161; Maytin EV, 2004, AM J PATHOL, V165, P1331, DOI 10.1016/S0002-9440(10)63391-3; Monslow J, 2009, J INVEST DERMATOL, V129, P2046, DOI 10.1038/jid.2009.9; Moore DJ, 2003, MOL BRAIN RES, V118, P10, DOI 10.1016/S0169-328X(03)00330-9; Muller T, 2005, AM J RESP CELL MOL, V33, P601, DOI 10.1165/rcmb.2005-0181OC; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Passi A, 2004, EXP CELL RES, V296, P123, DOI 10.1016/j.yexer.2004.01.031; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Ripple MO, 2013, J BIOL CHEM, V288, P2933, DOI 10.1074/jbc.M112.430082; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; SAMPSON PM, 1992, J CLIN INVEST, V90, P1492, DOI 10.1172/JCI116017; Sandjeu Y, 2009, J PHYSIOL PHARMACOL, V60, P23; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Sesma JI, 2009, J BIOL CHEM, V284, P12572, DOI 10.1074/jbc.M806759200; Shirakata Y, 2010, J DERMATOL SCI, V59, P73, DOI 10.1016/j.jdermsci.2010.05.002; Siiskonen H, 2011, J HISTOCHEM CYTOCHEM, V59, P908, DOI 10.1369/0022155411417874; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91; Tsukimoto M, 2010, RADIAT RES, V173, P298, DOI 10.1667/RR1732.1; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Wakahara R, 2012, GENES CELLS, V17, P132, DOI 10.1111/j.1365-2443.2011.01575.x; Washburn KB, 2006, NEUROSCIENCE, V142, P411, DOI 10.1016/j.neuroscience.2006.06.034; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zippel N, 2012, STEM CELLS DEV, V21, P884, DOI 10.1089/scd.2010.0576	59	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18569	18581		10.1074/jbc.M114.551804	http://dx.doi.org/10.1074/jbc.M114.551804			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24847057	Green Published, hybrid			2022-12-28	WOS:000338042000053
J	Lu, ZK; Ma, XN; Zhang, HM; Ji, HH; Ding, H; Zhang, J; Luo, D; Sun, YJ; Li, XD				Lu, Zekuan; Ma, Xiao-Nan; Zhang, Hai-Man; Ji, Huan-Hong; Ding, Hao; Zhang, Jie; Luo, Dan; Sun, Yujie; Li, Xiang-dong			Mouse Myosin-19 Is a Plus-end-directed, High-duty Ratio Molecular Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; REGULATORY LIGHT-CHAIN; GLOBULAR TAIL DOMAIN; MEDIATED DIMERIZATION; UNCONVENTIONAL MYOSIN; DEPENDENT REGULATION; KINETIC MECHANISM; PROCESSIVE MOTOR; VI MOTOR; 2 HEADS	Class XIX myosin (Myo19) is a vertebrate-specific unconventional myosin, responsible for the transport of mitochondria. To characterize biochemical properties of Myo19, we prepared recombinant mouse Myo19-truncated constructs containing the motor domain and the IQ motifs using the baculovirus/Sf9 expression system. We identified regulatory light chain (RLC) of smooth muscle/non-muscle myosin-2 as the light chain of Myo19. The actin-activated ATPase activity and the actin-gliding velocity of Myo19-truncated constructs were about onethird and one-sixth as those of myosin-5a, respectively. The apparent affinity of Myo19 to actin was about the same as that of myosin-5a. The RLCs bound to Myo19 could be phosphorylated by myosin light chain kinase, but this phosphorylation had little effect on the actin-activated ATPase activity and the actin-gliding activity of Myo19-truncated constructs. Using dual fluorescence-labeled actin filaments, we determined that Myo19 is a plus-end-directed molecular motor. We found that, similar to that of the high-duty ratio myosin, such as myosin-5a, ADP release rate was comparable with the maximal actin-activated ATPase activity of Myo19, indicating that ADP release is a ratelimiting step for the ATPase cycle of acto-Myo19. ADP strongly inhibited the actin-activated ATPase activity and actin-gliding activity of Myo19-truncated constructs. Based on the above results, we concluded that Myo19 is a high-duty ratio molecular motor moving to the plus-end of the actin filament.	[Lu, Zekuan; Ma, Xiao-Nan; Zhang, Hai-Man; Ji, Huan-Hong; Ding, Hao; Zhang, Jie; Luo, Dan; Li, Xiang-dong] Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, Natl Lab Integrated Management Insect Pests & Rod, Beijing 100101, Peoples R China; [Sun, Yujie] Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Sch Life Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University	Li, XD (corresponding author), Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, Natl Lab Integrated Management Insect Pests & Rod, Beijing 100101, Peoples R China.	lixd@ioz.ac.cn			National Basic Research Program of China [2013CB932802]; National Natural Science Foundation of China [31201071, 31171367]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2013CB932802 and National Natural Science Foundation of China Grants 31201071 and 31171367.	Adikes RC, 2013, CYTOSKELETON, V70, P281, DOI 10.1002/cm.21110; Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Cremo C. R., 2008, PROTEINS CELL REGULA, p[125, 169]; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; Cull MG, 2000, METHOD ENZYMOL, V326, P430; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; IKEBE M, 1987, J BIOL CHEM, V262, P9569; IKEBE M, 1994, J BIOL CHEM, V269, P28165; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Li XD, 2000, BIOCHEMISTRY-US, V39, P2254, DOI 10.1021/bi9924617; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Lu ZK, 2012, J BIOL CHEM, V287, P16530, DOI 10.1074/jbc.M112.343079; Ma RN, 2013, BIOCHEMISTRY-US, V52, P6240, DOI 10.1021/bi400554s; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Nitzsche B, 2008, NAT NANOTECHNOL, V3, P552, DOI 10.1038/nnano.2008.216; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Park I, 2011, BIOCHEM J, V434, P171, DOI 10.1042/BJ20101473; POLLARD TD, 1982, METHOD CELL BIOL, V24, P333; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	50	29	31	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18535	18548		10.1074/jbc.M114.569087	http://dx.doi.org/10.1074/jbc.M114.569087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825904	Green Published, hybrid			2022-12-28	WOS:000338042000050
J	Ross, LS; Gamo, FJ; Lafuente-Monasterio, MJ; Singh, OMP; Rowland, P; Wiegand, RC; Wirth, DF				Ross, Leila S.; Gamo, Francisco Javier; Lafuente-Monasterio, Maria Jose; Singh, Onkar M. P.; Rowland, Paul; Wiegand, Roger C.; Wirth, Dyann F.			In Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTEMETHER-LUMEFANTRINE; ANTIMALARIAL ACTIVITY; VIVO SELECTION; MALARIA; DISCOVERY; ATOVAQUONE; EVOLUTION; FITNESS	Malaria is a preventable and treatable disease; yet half of the world's population lives at risk of infection, and an estimated 660,000 people die of malaria-related causes every year. Rising drug resistance threatens to make malaria untreatable, necessitating both the discovery of new antimalarial agents and the development of strategies to identify and suppress the emergence and spread of drug resistance. We focused on in-development dihydroorotate dehydrogenase (DHODH) inhibitors. Characterizing resistance pathways for antimalarial agents not yet in clinical use will increase our understanding of the potential for resistance. We identified resistance mechanisms of Plasmodium falciparum (Pf) DHODH inhibitors via in vitro resistance selections. We found 11 point mutations in the PfDHODH target. Target gene amplification and unknown mechanisms also contributed to resistance, albeit to a lesser extent. These mutant parasites were often hypersensitive to other PfDHODH inhibitors, which immediately suggested a novel combination therapy approach to preventing resistance. Indeed, a combination of wild-type and mutant-type selective inhibitors led to resistance far less often than either drug alone. The effects of point mutations in PfDHODH were corroborated with purified recombinant wild-type and mutant-type PfDHODH proteins, which showed the same trends in drug response as the cognate cell lines. Comparative growth assays demonstrated that two mutant parasites grew less robustly than their wild-type parent, and the purified protein of those mutants showed a decrease in catalytic efficiency, thereby suggesting a reason for the diminished growth rate. Co-crystallography of PfDHODH with three inhibitors suggested that hydrophobic interactions are important for drug binding and selectivity.	[Ross, Leila S.; Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Gamo, Francisco Javier; Lafuente-Monasterio, Maria Jose] GlaxoSmithKline, Madrid 28760, Spain; [Singh, Onkar M. P.; Rowland, Paul] GlaxoSmithKline, Computat & Struct Chem, Stevenage SG1 2NY, Herts, England; [Wiegand, Roger C.; Wirth, Dyann F.] Broad Inst, Infect Dis Initiat, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; GlaxoSmithKline; GlaxoSmithKline; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Wirth, DF (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave,SPH1 Rm 705, Boston, MA 02115 USA.	dfwirth@hsph.harvard.edu		Ross, Leila/0000-0003-4360-5213	National Institutes of Health [R01 AI093716-01A1]; Medicines for Malaria Venture; Bill and Melinda Gates Foundation; Broad Institute SPARC program; Genzyme Humanitarian Assistance for Neglected Diseases Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicines for Malaria Venture; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Broad Institute SPARC program; Genzyme Humanitarian Assistance for Neglected Diseases Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI093716-01A1 (to R. C. W.). This work was also supported by Medicines for Malaria Venture, the Bill and Melinda Gates Foundation, the Broad Institute SPARC program, and the Genzyme Humanitarian Assistance for Neglected Diseases Program.	Anderson T, 2011, PHARMACOGENOMICS, V12, P59, DOI [10.2217/pgs.10.165, 10.2217/PGS.10.165]; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bedingfield PTP, 2012, J MED CHEM, V55, P5841, DOI 10.1021/jm300157n; Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081; Brown KM, 2010, MOL BIOL EVOL, V27, P2682, DOI 10.1093/molbev/msq160; Costanzo MS, 2011, J GENET, V90, P187, DOI 10.1007/s12041-011-0072-z; Deng XY, 2009, J BIOL CHEM, V284, P26999, DOI 10.1074/jbc.M109.028589; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; Ekland EH, 2008, INT J PARASITOL, V38, P743, DOI 10.1016/j.ijpara.2008.03.004; Ekland EH, 2007, CURR OPIN MICROBIOL, V10, P363, DOI 10.1016/j.mib.2007.07.007; Fisher N, 2012, J BIOL CHEM, V287, P9731, DOI 10.1074/jbc.M111.324319; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Flannery EL, 2013, NAT REV MICROBIOL, V11, P849, DOI 10.1038/nrmicro3138; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375; Hurt DE, 2006, ACTA CRYSTALLOGR D, V62, P312, DOI 10.1107/S0907444905042642; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lukens AK, 2014, P NATL ACAD SCI USA, V111, P799, DOI 10.1073/pnas.1320886110; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Nzila A, 2010, J ANTIMICROB CHEMOTH, V65, P390, DOI 10.1093/jac/dkp449; Peixoto L, 2004, PARASITOLOGY, V128, P245, DOI 10.1017/S0031182003004517; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Witkowski B, 2009, DRUG RESIST UPDATE, V12, P42, DOI 10.1016/j.drup.2009.01.001; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109	36	45	46	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					17980	17995		10.1074/jbc.M114.558353	http://dx.doi.org/10.1074/jbc.M114.558353			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24782313	Green Published, hybrid			2022-12-28	WOS:000338042000003
J	Pedersen, NB; Wang, SJ; Narimatsu, Y; Yang, Z; Halim, A; Schjoldager, KTBG; Madsen, TD; Seidah, NG; Bennett, EP; Levery, SB; Clausen, H				Pedersen, Nis Borbye; Wang, Shengjun; Narimatsu, Yoshiki; Yang, Zhang; Halim, Adnan; Schjoldager, Katrine Ter-Borch Gram; Madsen, Thomas Daugbjerg; Seidah, Nabil G.; Bennett, Eric Paul; Levery, Steven B.; Clausen, Henrik			Low Density Lipoprotein Receptor Class A Repeats Are O-Glycosylated in Linker Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; MONENSIN-RESISTANT MUTANT; LDL RECEPTOR; HYDRAZIDE CHEMISTRY; HEPATIC LIPASE; RAP COMPLEX; PROTEIN; GLYCOPROTEOME; CONSERVATION; DROSOPHILA	The low density lipoprotein receptor (LDLR) is crucial for cholesterol homeostasis and deficiency in LDLR functions cause hypercholesterolemia. LDLR is a type I transmembrane protein that requires O-glycosylation for stable expression at the cell surface. It has previously been suggested that LDLR O-glycosylation is found N-terminal to the juxtamembrane region. Recently we identified O-glycosylation sites in the linker regions between the characteristic LDLR class A repeats in several LDLR-related receptors using the "SimpleCell" O-glycoproteome shotgun strategy. Herein, we have systematically characterized O-glycosylation sites on recombinant LDLR shed from HEK293 SimpleCells and CHO wild-typecells. We find that the short linker regions between LDLR class A repeats contain an evolutionarily conserved O-glycosylation site at position-1 of the first cysteine residue of most repeats, which in wild-type CHO cells is glycosylated with the typical sialylated core 1 structure. The glycosites in linker regions of LDLR class A repeats are conserved in LDLR from man to Xenopus and found in other homologous receptors. O-Glycosylation is controlled by a large family of polypeptide GalNAc transferases. Probing into which isoform(s) contributed to glycosylation of the linker regions of the LDLR class A repeats by in vitro enzyme assays suggested a major role of GalNAc-T11. This was supported by expression of LDLR in HEK293 cells, where knock-out of the GalNAc-T11 isoform resulted in the loss of glycosylation of three of four linker regions.	[Pedersen, Nis Borbye; Wang, Shengjun; Narimatsu, Yoshiki; Yang, Zhang; Halim, Adnan; Schjoldager, Katrine Ter-Borch Gram; Madsen, Thomas Daugbjerg; Bennett, Eric Paul; Levery, Steven B.; Clausen, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Ctr Glyc, Dept Cellular Med, DK-2200 Copenhagen N, Denmark; [Pedersen, Nis Borbye; Wang, Shengjun; Narimatsu, Yoshiki; Yang, Zhang; Halim, Adnan; Schjoldager, Katrine Ter-Borch Gram; Madsen, Thomas Daugbjerg; Bennett, Eric Paul; Levery, Steven B.; Clausen, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Ctr Glyc, Dept Mol Med, DK-2200 Copenhagen N, Denmark; [Pedersen, Nis Borbye; Wang, Shengjun; Narimatsu, Yoshiki; Yang, Zhang; Halim, Adnan; Schjoldager, Katrine Ter-Borch Gram; Madsen, Thomas Daugbjerg; Bennett, Eric Paul; Levery, Steven B.; Clausen, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Sch Dent, DK-2200 Copenhagen N, Denmark; [Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada	University of Copenhagen; University of Copenhagen; University of Copenhagen; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Clausen, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Ctr Glyc, Dept Cellular Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	hclau@sund.ku.dk	Seidah, Nabil/I-3596-2013; Borbye-Lorenzen, Nis/J-6369-2014; Bennett, Eric/AAG-6120-2020; clausen, henrik/AAD-8016-2021; Yang, Zhang/I-8934-2016; Narimatsu, Yoshiki/G-8388-2019	Seidah, Nabil/0000-0001-6503-9342; Borbye-Lorenzen, Nis/0000-0003-3725-4533; Bennett, Eric/0000-0002-4976-0647; Yang, Zhang/0000-0002-4756-5813; Madsen, Thomas Daugbjerg/0000-0002-7598-4636; Narimatsu, Yoshiki/0000-0003-1428-5695; Halim, Adnan/0000-0003-1629-187X; Clausen, Henrik/0000-0002-0915-5055	Kirsten og Freddy Johansen Fonden; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Carlsberg Foundation; Novo Nordisk Foundation; Danish Research Councils, a program of excellence from the University of Copenhagen; Danish National Research Foundation [DNRF107]; Canada Chair Grants [216684]; CIHR [102741]	Kirsten og Freddy Johansen Fonden; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Councils, a program of excellence from the University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Canada Chair Grants; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Kirsten og Freddy Johansen Fonden, A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal, The Carlsberg Foundation, The Novo Nordisk Foundation, The Danish Research Councils, a program of excellence from the University of Copenhagen, The Danish National Research Foundation (DNRF107), and Canada Chair Grants 216684 and CIHR Grant 102741 (to N. G. S.).	Andersen OM, 2000, BIOCHEMISTRY-US, V39, P10627, DOI 10.1021/bi000498h; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bennett EP, 2010, GLYCOCONJUGATE J, V27, P435, DOI 10.1007/s10719-010-9290-5; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Bu GJ, 2001, INT REV CYTOL, V209, P79; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; Darula Z, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016774; Davignon J, 2010, CURR ATHEROSCLER REP, V12, P308, DOI 10.1007/s11883-010-0123-6; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Iijima H, 1998, J BIOCHEM-TOKYO, V124, P747, DOI 10.1093/oxfordjournals.jbchem.a022175; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P9307, DOI 10.1074/jbc.270.16.9307; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; NYKJAER A, 1993, J BIOL CHEM, V268, P15048; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Parra-Peralbo E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001297; Rodenburg KW, 2006, INSECT BIOCHEM MOLEC, V36, P250, DOI 10.1016/j.ibmb.2006.01.003; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; SEGUCHI T, 1991, ARCH BIOCHEM BIOPHYS, V284, P245, DOI 10.1016/0003-9861(91)90292-Q; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Takeuchi H, 2010, SEMIN CELL DEV BIOL, V21, P638, DOI 10.1016/j.semcdb.2010.03.003; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; TOMITA K, 1987, J BIOL CHEM, V262, P1398; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Vakhrushev SY, 2013, MOL CELL PROTEOMICS, V12, P932, DOI 10.1074/mcp.O112.021972; Verges M, 2004, J BIOL CHEM, V279, P9030, DOI 10.1074/jbc.M312908200; YOSHIMURA A, 1987, J BIOL CHEM, V262, P13299; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200	59	34	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17312	17324		10.1074/jbc.M113.545053	http://dx.doi.org/10.1074/jbc.M113.545053			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24798328	Green Published, hybrid			2022-12-28	WOS:000338018100003
J	Raina, M; Moghal, A; Kano, A; Jerums, M; Schnier, PD; Luo, S; Deshpande, R; Bondarenko, PV; Lin, H; Ibba, M				Raina, Medha; Moghal, Adil; Kano, Amanda; Jerums, Mathew; Schnier, Paul D.; Luo, Shun; Deshpande, Rohini; Bondarenko, Pavel V.; Lin, Henry; Ibba, Michael			Reduced Amino Acid Specificity of Mammalian Tyrosyl-tRNA Synthetase Is Associated with Elevated Mistranslation of Tyr Codons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; TRANSLATIONAL FIDELITY; GENETIC-CODE; CELL-LINES; IN-VITRO; SEQUENCE; ERRORS; MECHANISMS; INHIBITORS; SB-219383	Quality control operates at different steps in translation to limit errors to approximately one mistranslated codon per 10,000 codons during mRNA-directed protein synthesis. Recent studies have suggested that error rates may actually vary considerably during translation under different growth conditions. Here we examined the misincorporation of Phe at Tyr codons during synthesis of a recombinant antibody produced in tyrosine-limited Chinese hamster ovary (CHO) cells. Tyr to Phe replacements were previously found to occur throughout the antibody at a rate of up to 0.7% irrespective of the identity or context of the Tyr codon translated. Despite this comparatively high mistranslation rate, no significant change in cellular viability was observed. Monitoring of Phe and Tyr levels revealed that changes in error rates correlated with changes in amino acid pools, suggesting that mischarging of tRNA(Tyr) with noncognate Phe by tyrosyl-tRNA synthetase was responsible for mistranslation. Steady-state kinetic analyses of CHO cytoplasmic tyrosyl-tRNA synthetase revealed a 25-fold lower specificity for Tyr over Phe as compared with previously characterized bacterial enzymes, consistent with the observed increase in translation error rates during tyrosine limitation. Functional comparisons of mammalian and bacterial tyrosyl-tRNA synthetase revealed key differences at residues responsible for amino acid recognition, highlighting differences in evolutionary constraints for translation quality control.	[Raina, Medha; Moghal, Adil; Ibba, Michael] Ohio State Univ, Dept Microbiol, Ohio State Biochem Program, Columbus, OH 43210 USA; [Raina, Medha; Moghal, Adil; Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Kano, Amanda; Jerums, Mathew; Schnier, Paul D.; Luo, Shun; Deshpande, Rohini; Bondarenko, Pavel V.; Lin, Henry] Amgen Inc, Thousand Oaks, CA 91320 USA	Ohio State University; Ohio State University; Amgen	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu	Raina, Medha/J-5154-2019	Raina, Medha/0000-0001-9690-6576; Moghal, Adil/0000-0003-4097-331X	National Science Foundation (NSF) [MCB-1052344]; NSF-Grant Opportunities for Academic Liaison with Industry (NSF-GOALI) fellowship; NIH [GM008512, GM086252]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM086252, T32GM008512] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF-Grant Opportunities for Academic Liaison with Industry (NSF-GOALI) fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (NSF) Grant MCB-1052344 (to M. I.) an NSF-Grant Opportunities for Academic Liaison with Industry (NSF-GOALI) fellowship (to M. R) and NIH training grant fellowships (GM008512 and GM086252 to A.M.).	Austin J, 2002, J BIOL CHEM, V277, P20243, DOI 10.1074/jbc.M201923200; Berge JM, 2000, J ANTIBIOT, V53, P1282, DOI 10.7164/antibiotics.53.1282; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Feeney L, 2013, BIOTECHNOL BIOENG, V110, P1087, DOI 10.1002/bit.24759; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; FERSHT AR, 1981, PROC R SOC SER B-BIO, V212, P351, DOI 10.1098/rspb.1981.0044; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; HARRIS RJ, 1993, BIO-TECHNOL, V11, P1293; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jarvest RL, 2001, BIOORG MED CHEM LETT, V11, P715, DOI 10.1016/S0960-894X(01)00040-3; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Oue S, 1999, J BIOL CHEM, V274, P2344, DOI 10.1074/jbc.274.4.2344; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Polycarpo C, 2003, MOL CELL, V12, P287, DOI 10.1016/S1097-2765(03)00280-6; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wen DY, 2009, J BIOL CHEM, V284, P32686, DOI 10.1074/jbc.M109.059360; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h; Zhang Y, 2005, PROTEIN SCI, V14, P1340, DOI 10.1110/ps.041239305; Zhang ZQ, 2013, BIOCHEMISTRY-US, V52, P8165, DOI 10.1021/bi401002c	39	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17780	17790		10.1074/jbc.M114.564609	http://dx.doi.org/10.1074/jbc.M114.564609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24828507	Green Published, hybrid			2022-12-28	WOS:000338018100041
J	Sondersorg, AC; Busse, D; Kyereme, J; Rothermel, M; Neufang, G; Gisselmann, G; Hatt, H; Conrad, H				Sondersorg, Anna Christina; Busse, Daniela; Kyereme, Jessica; Rothermel, Markus; Neufang, Gitta; Gisselmann, Guenter; Hatt, Hanns; Conrad, Heike			Chemosensory Information Processing between Keratinocytes and Trigeminal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SENSORY NEURONS; ATP RELEASE; INTRACELLULAR CALCIUM; MESSENGER-RNA; HISTAMINE H-4; NERVE-FIBERS; CELLS; RAT; RESPONSES	Trigeminal fibers terminate within the facial mucosa and skin and transmit tactile, proprioceptive, chemical, and nociceptive sensations. Trigeminal sensations can arise from the direct stimulation of intraepithelial free nerve endings or indirectly through information transmission from adjacent cells at the peripheral innervation area. For mechanical and thermal cues, communication processes between skin cells and somatosensory neurons have already been suggested. High concentrations of most odors typically provoke trigeminal sensations in vivo but surprisingly fail to activate trigeminal neuron monocultures. This fact favors the hypothesis that epithelial cells may participate in chemodetection and subsequently transmit signals to neighboring trigeminal fibers. Keratinocytes, the major cell type of the epidermis, express various receptors that enable reactions to multiple environmental stimuli. Here, using a co-culture approach, we show for the first time that exposure to the odorant chemicals induces a chemical communication between human HaCaT keratinocytes and mouse trigeminal neurons. Moreover, a supernatant analysis of stimulated keratinocytes and subsequent blocking experiments with pyrodoxalphosphate-6-azophenyl-2',4'-disulfonate revealed that ATP serves as the mediating transmitter molecule released from skin cells after odor stimulation. We show that the ATP release resulting from Javanol (R) stimulation of keratinocytes was mediated by pannexins. Consequently, keratinocytes act as chemosensors linking the environment and the trigeminal system via ATP signaling.	[Sondersorg, Anna Christina; Busse, Daniela; Kyereme, Jessica; Rothermel, Markus; Gisselmann, Guenter; Hatt, Hanns; Conrad, Heike] Ruhr Univ Bochum, Dept Cell Physiol, D-44780 Bochum, Germany; [Neufang, Gitta] Beiersdorf AG, Dermatol Skin Care, D-20245 Hamburg, Germany	Ruhr University Bochum; Beiersdorf AG	Hatt, H (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150,Gebaude ND4, D-44780 Bochum, Germany.	Hanns.Hatt@ruhr-uni-bochum.de	Rothermel, Markus/T-6848-2018	Rothermel, Markus/0000-0002-0929-993X	Max-Planck-Research School for Chemical Biology; Ruhr-University Research School; Ruhr-University Bochum Grant [SFB642]	Max-Planck-Research School for Chemical Biology; Ruhr-University Research School; Ruhr-University Bochum Grant	Supported by the Max-Planck-Research School for Chemical Biology and the Ruhr-University Research School.; Supported by Ruhr-University Bochum Grant SFB642. To whom correspondence should be addressed. Tel.: 49-234-32-24586; Fax: 49-234-14129; E-mail: Hanns.Hatt@ruhr-uni-bochum.de.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Alimohammadi H, 2000, CHEM SENSES, V25, P61, DOI 10.1093/chemse/25.1.61; Bell JK, 2004, BRIT J PHARMACOL, V142, P374, DOI 10.1038/sj.bjp.0705754; Bonaventure P, 1998, NEUROREPORT, V9, P641, DOI 10.1097/00001756-199803090-00015; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Braet K, 2003, J CELL PHYSIOL, V197, P205, DOI 10.1002/jcp.10365; Braunstein GM, 2001, J BIOL CHEM, V276, P6621, DOI 10.1074/jbc.M005893200; Burrell HE, 2003, J INVEST DERMATOL, V120, P440, DOI 10.1046/j.1523-1747.2003.12050.x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHURCH MK, 1987, BRIT J PHARMACOL, V90, P421, DOI 10.1111/j.1476-5381.1987.tb08972.x; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cometto-Muniz JE, 2004, EXP BRAIN RES, V158, P196, DOI 10.1007/s00221-004-1890-5; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; Denda M, 2001, BIOCHEM BIOPH RES CO, V285, P1250, DOI 10.1006/bbrc.2001.5299; Denda M, 2007, SKIN RES TECHNOL, V13, P195, DOI 10.1111/j.1600-0846.2007.00210.x; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Durkin MM, 1999, MOL BRAIN RES, V71, P185, DOI 10.1016/S0169-328X(99)00182-5; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; FINGER TE, 1990, J COMP NEUROL, V302, P884, DOI 10.1002/cne.903020415; Fulbright RK, 1998, AM J NEURORADIOL, V19, P1721; Gendaszewska-Darmach E, 2011, PURINERG SIGNAL, V7, P193, DOI 10.1007/s11302-011-9233-z; Giustizieri ML, 2004, J ALLERGY CLIN IMMUN, V114, P1176, DOI 10.1016/j.jaci.2004.07.054; GU YP, 1994, J NEUROSCI, V14, P4561; HILLIGES M, 1995, J INVEST DERMATOL, V104, P134, DOI 10.1111/1523-1747.ep12613631; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Inoue T, 2005, PAIN, V117, P193, DOI 10.1016/j.pain.2005.06.012; Jacob TJC, 2006, CHEM SENSES, V31, P3, DOI 10.1093/chemse/bji073; Kalmes M, 2006, BIOL CHEM, V387, P1201, DOI 10.1515/BC.2006.148; Koganezawa T, 2006, BRIT J PHARMACOL, V148, P579, DOI 10.1038/sj.bjp.0706765; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Lang PM, 2003, J NEUROPHYSIOL, V90, P3295, DOI 10.1152/jn.00512.2003; Lichte K, 2008, J INVEST DERMATOL, V128, P1487, DOI 10.1038/sj.jid.5701207; Lin WH, 2008, J NEUROPHYSIOL, V99, P1451, DOI 10.1152/jn.01195.2007; Liu L, 1998, BRAIN RES, V809, P238, DOI 10.1016/S0006-8993(98)00862-2; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; LUZARDOBAPTISTA M, 1973, ORAL SURG ORAL MED O, V35, P372, DOI 10.1016/0030-4220(73)90075-3; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacGlashan Donald Jr., 2003, Journal of Allergy and Clinical Immunology, V112, pS53, DOI 10.1016/S0091-6749(03)01877-3; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; MASON JR, 1983, BRAIN RES, V269, P196; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mobarakeh JI, 2000, EUR J PHARMACOL, V391, P81, DOI 10.1016/S0014-2999(00)00060-1; Ohkawara S, 2010, BIOL PHARM BULL, V33, P1434, DOI 10.1248/bpb.33.1434; PILLAI S, 1992, J CLIN INVEST, V90, P42, DOI 10.1172/JCI115854; Ralevic V, 1998, PHARMACOL REV, V50, P413; REIMER WJ, 1992, AM J PHYSIOL, V263, pC1040, DOI 10.1152/ajpcell.1992.263.5.C1040; Roggenkamp D, 2012, J INVEST DERMATOL, V132, P1892, DOI 10.1038/jid.2012.44; Rossbach K, 2009, EXP DERMATOL, V18, P57, DOI 10.1111/j.1600-0625.2008.00762.x; ROYSTER M, 1995, ENDOCRINOLOGY, V136, P3892, DOI 10.1210/en.136.9.3892; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; SILVER WL, 1991, BRAIN RES, V561, P212, DOI 10.1016/0006-8993(91)91597-T; SILVER WL, 1992, ANN NY ACAD SCI, V641, P152, DOI 10.1111/j.1749-6632.1992.tb16540.x; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Spehr J, 2004, EUR J NEUROSCI, V19, P2497, DOI 10.1111/j.0953-816X.2004.03329.x; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stotz SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002082; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Tucker D., 1971, NONOLFACTORY RESPONS, P164; Ulmann L, 2007, EUR J NEUROSCI, V26, P113, DOI 10.1111/j.1460-9568.2007.05649.x; von Kugelgen I., 2008, PHARM MAMMALIAN P2X; Weltman JK, 2000, ALLERGY ASTHMA PROC, V21, P125, DOI 10.2500/108854100778148954; ZAHM DS, 1985, BRAIN RES REV, V9, P147, DOI 10.1016/0165-0173(85)90011-6; Zhu JJ, 1998, NEUROSCIENCE, V87, P767, DOI 10.1016/S0306-4522(98)00209-7	66	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17529	17540		10.1074/jbc.M113.499699	http://dx.doi.org/10.1074/jbc.M113.499699			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24790106	Green Published, hybrid			2022-12-28	WOS:000338018100019
J	Zhao, CC; Gillette, DD; Li, XH; Zhang, ZB; Wen, HT				Zhao, Changcheng; Gillette, Devyn D.; Li, Xinghui; Zhang, Zhibin; Wen, Haitao			Nuclear Factor E2-related Factor-2 (Nrf2) Is Required for NLRP3 and AIM2 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; OXIDATIVE STRESS; ENHANCES SUSCEPTIBILITY; CASPASE-1 ACTIVATION; INSULIN-RESISTANCE; PATHWAY; MICE; ANTIOXIDANT; INNATE; ATHEROSCLEROSIS	Despite the number of extensive studies on the immune function and signaling of inflammasomes in various diseases, the activating mechanism of inflammasome, especially the NLRP3 inflammasome, is not fully understood. Nuclear factor E2-related Factor-2 (Nrf2), a key transcription factor that regulates cellular redox homeostasis, has been reported to play both protective and pathogenic roles depending on the disease conditions through undefined mechanism. This study reveals an essential role of Nrf2 in inflammasome activation. LPS stimulation increased Nrf2 protein levels in a Myd88-dependent manner. When compared with wild-type controls, Nrf2-deficient (Nrf2(-/-)) macrophages showed decreased maturation and secretion of caspase-1 and IL-1 beta and reduced apoptosis-associated speck-like protein containing CARD (ASC) speck formation in response to various NLRP3 and AIM2 inflammasome stimuli. In contrast, NLRC4 inflammasome activation was not controlled by Nrf2. Biochemical analysis revealed that Nrf2 appeared in the ASC-enriched cytosolic compartment after NLRP3 inflammasome activation. Furthermore, mitochondrial reactive oxygen species-induced NLRP3 activation also required Nrf2. Nrf2(-/-) mice showed a dramatic decrease in immune cell recruitment and IL-1 beta generation in alum-induced peritonitis, which is a typical IL-1 signaling-dependent inflammation animal model. This work discovered a critical proinflammatory effect of Nrf2 by mediating inflammasome activation.	[Zhao, Changcheng; Gillette, Devyn D.; Li, Xinghui; Zhang, Zhibin; Wen, Haitao] Univ N Carolina, Dept Surg, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Wen, HT (corresponding author), 8001B Burnett Womack Bldg,160 Dent Circle,CB 7292, Chapel Hill, NC 27599 USA.	haiwen@med.unc.edu	Wen, Haitao/AAJ-7621-2020	Zhang, Zhibin/0000-0003-1349-2713	National Institutes of Health [K01DK098307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant K01DK098307 (to H. W.).	Barajas B, 2011, ARTERIOSCL THROM VAS, V31, P58, DOI 10.1161/ATVBAHA.110.210906; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Cho HY, 2009, AM J RESP CRIT CARE, V179, P138, DOI 10.1164/rccm.200804-535OC; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Reddy NM, 2009, J IMMUNOL, V183, P4601, DOI 10.4049/jimmunol.0901754; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sussan TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003791; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	50	113	117	4	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17020	17029		10.1074/jbc.M114.563114	http://dx.doi.org/10.1074/jbc.M114.563114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24798340	Green Published, hybrid			2022-12-28	WOS:000338016200036
J	Dusterhoft, S; Hobel, K; Oldefest, M; Lokau, J; Waetzig, GH; Chalaris, A; Garbers, C; Scheller, J; Rose-John, S; Lorenzen, I; Grotzinger, J				Duesterhoeft, Stefan; Hoebel, Katharina; Oldefest, Mirja; Lokau, Juliane; Waetzig, Georg H.; Chalaris, Athena; Garbers, Christoph; Scheller, Juergen; Rose-John, Stefan; Lorenzen, Inken; Groetzinger, Joachim			A Disintegrin and Metalloprotease 17 Dynamic Interaction Sequence, the Sweet Tooth for the Human Interleukin 6 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA-CONVERTING-ENZYME; PROTEIN-DISULFIDE-ISOMERASE; MEMBRANE-PROXIMAL DOMAIN; TNF-ALPHA; MOLECULAR SWITCH; L-SELECTIN; THROMBUS FORMATION; SHEDDING ACTIVITY; EGF RECEPTOR	A disintegrin and metalloprotease 17 (ADAM17) is a major sheddase involved in the regulation of a wide range of biological processes. Key substrates of ADAM17 are the IL-6 receptor (IL-6R) and TNF-alpha. The extracellular region of ADAM17 consists of a prodomain, a catalytic domain, a disintegrin domain, and a membrane-proximal domain as well as a small stalk region. This study demonstrates that this juxtamembrane segment is highly conserved, alpha-helical, and involved in IL-6R binding. This process is regulated by the structure of the preceding membrane-proximal domain, which acts as molecular switch of ADAM17 activity operated by a protein-disulfide isomerase. Hence, we have termed the conserved stalk region "Conserved ADAM seventeen dynamic interaction sequence" (CANDIS). Finally, we identified the region in IL-6R that binds to CANDIS. In contrast to the type I transmembrane proteins, the IL-6R, and IL-1RII, CANDIS does not bind the type II transmembrane protein TNF-alpha, demonstrating fundamental differences in the respective shedding by ADAM17.	[Duesterhoeft, Stefan; Hoebel, Katharina; Oldefest, Mirja; Lokau, Juliane; Chalaris, Athena; Garbers, Christoph; Rose-John, Stefan; Lorenzen, Inken; Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, D-24118 Kiel, Germany; [Garbers, Christoph; Scheller, Juergen] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany	University of Kiel; Heinrich Heine University Dusseldorf	Grotzinger, J (corresponding author), Univ Kiel, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany.	jgroetzinger@biochem.uni-kiel.de	Düsterhöft, Stefan/AAW-9604-2020; Rose-John, Stefan/A-7998-2010; Garbers, Christoph/D-9932-2015; Scheller, Jürgen/K-5290-2015; Waetzig, Georg/AAV-7486-2021	Düsterhöft, Stefan/0000-0002-6926-136X; Rose-John, Stefan/0000-0002-7519-3279; Garbers, Christoph/0000-0003-4939-6950; Lokau, Juliane/0000-0002-2573-7282	Deutsche Forschungsgemeinschaft [SFB 877, GA 2048/1-1]; Excellence Cluster 306 "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster 306 "Inflammation at Interfaces"	This study was supported by Deutsche Forschungsgemeinschaft Grants SFB 877, A6, Z2, and Z3 and GA 2048/1-1(to C. G.) and by the Excellence Cluster 306 "Inflammation at Interfaces."	Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Arndt PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019938; Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Bax DV, 2004, J BIOL CHEM, V279, P22377, DOI 10.1074/jbc.M400180200; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chanthaphavong RS, 2012, J BIOL CHEM, V287, P35887, DOI 10.1074/jbc.M112.365171; Cho J, 2012, BLOOD, V120, P647, DOI 10.1182/blood-2011-08-372532; Delano D.W., 2002, PYMOL MOL GRAPHICS S; Dusterhoft S, 2013, J AM CHEM SOC, V135, P5776, DOI 10.1021/ja400340u; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gooz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033350; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Itai T, 2001, EUR J BIOCHEM, V268, P2074, DOI 10.1046/j.1432-1327.2001.02085.x; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Kim K, 2013, BLOOD, V122, P1052, DOI 10.1182/blood-2013-03-492504; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li XJ, 2004, J BIOL CHEM, V279, P27365, DOI 10.1074/jbc.M401690200; Lorenzen I, 2012, FEBS LETT, V586, P1093, DOI 10.1016/j.febslet.2012.03.012; Lorenzen I, 2011, BIOCHEM BIOPH RES CO, V415, P330, DOI 10.1016/j.bbrc.2011.10.056; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MULLBERG J, 1993, FEBS LETT, V332, P174, DOI 10.1016/0014-5793(93)80507-Q; Oldefest M, 2013, BIOCHEM BIOPH RES CO, V436, P66, DOI 10.1016/j.bbrc.2013.04.107; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Richards FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040597; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Santos D O, 1999, Nihon Hansenbyo Gakkai Zasshi, V68, P185; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soderberg A, 2013, ANTIOXID REDOX SIGN, V18, P363, DOI 10.1089/ars.2012.4789; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; Takeda S, 2009, SEMIN CELL DEV BIOL, V20, P146, DOI 10.1016/j.semcdb.2008.07.009; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Trad A, 2013, INT J ONCOL, V42, P1793, DOI 10.3892/ijo.2013.1864; Van Hauwermeiren F, 2011, CYTOKINE GROWTH F R, V22, P311, DOI 10.1016/j.cytogfr.2011.09.004; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179	57	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16336	16348		10.1074/jbc.M114.557322	http://dx.doi.org/10.1074/jbc.M114.557322			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24790088	hybrid, Green Published			2022-12-28	WOS:000337965700037
J	Zhang, SY; Shen, GZ; Li, ZK; Golbeck, JH; Bryant, DA				Zhang, Shuyi; Shen, Gaozhong; Li, Zhongkui; Golbeck, John H.; Bryant, Donald A.			Vipp1 Is Essential for the Biogenesis of Photosystem I but Not Thylakoid Membranes in Synechococcus sp PCC 7002	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE-SHOCK; PLASMA-MEMBRANE; SP PCC-7002; SYNECHOCYSTIS; PROTEIN; GENE; INACTIVATION; MUTANT; PHOSPHATIDYLGLYCEROL; IDENTIFICATION	The biogenesis of thylakoid membranes in cyanobacteria is presently not well understood, but the vipp1 gene product has been suggested to play an important role in this process. Previous studies in Synechocystis sp. PCC 6803 reported that vipp1 (sll0617) was essential. By constructing a fully segregated null mutant in vipp1 (SynPCC7002_A0294) in Synechococcus sp. PCC 7002, we show that Vipp1 is not essential. Spectroscopic studies revealed that Photosystem I (PS I) was below detection limits in the vipp1 mutant, but Photosystem II (PS II) was still assembled and was active. Thylakoid membranes were still observed in vipp1 mutant cells and resembled those in a psaAB mutant that completely lacks PS I. When the vipp1 mutation was complemented with the orthologous vipp1 gene from Synechocystis sp. PCC 6803 that was expressed from the strong P-cpcBA promoter, PS I content and activities were restored to normal levels, and cells again produced thylakoids that were indistinguishable from those of wild type. Transcription profiling showed that psaAB transcripts were lower in abundance in the vipp1 mutant. However, when the yfp gene was expressed from the P-psaAB promoter in the presence and the absence of Vipp1, no difference in YFP expression was observed, which shows that Vipp1 is not a transcription factor for the psaAB genes. This study shows that thylakoids are still produced in the absence of Vipp1 and that normal thylakoid biogenesis in Synechococcus sp. PCC 7002 requires expression and biogenesis of PS I, which in turn requires Vipp1.	[Zhang, Shuyi; Shen, Gaozhong; Li, Zhongkui; Golbeck, John H.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Golbeck, John H.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA.	dab14@psu.edu		Zhang, Shuyi/0000-0001-8500-5836	National Science Foundation [MCB-1021725]; Air Force Office of Scientific Research [FA9550-11-1-0148]; Direct For Biological Sciences [1021725] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-1021725 (to D. A. B. and J. H. G.) and by Air Force Office of Scientific Research Grant FA9550-11-1-0148 (to D. A. B.).	Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; Des Marais DJ, 2000, SCIENCE, V289, P1703; Domonkos I, 2004, PLANT PHYSIOL, V134, P1471, DOI 10.1104/pp.103.037754; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Frigaard NU, 2004, METH MOL B, V274, P325; Fuhrmann E, 2009, MOL BIOL CELL, V20, P4620, DOI 10.1091/mbc.E09-04-0319; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; Gao H, 2009, FEMS MICROBIOL LETT, V292, P63, DOI 10.1111/j.1574-6968.2008.01470.x; Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hagio M, 2002, PLANT CELL PHYSIOL, V43, P1456, DOI 10.1093/pcp/pcf185; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; Im CS, 2002, PLANT J, V30, P301, DOI 10.1046/j.1365-313X.2001.01287.x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI HM, 1994, PLANT MOL BIOL, V25, P619, DOI 10.1007/BF00029601; Lo SM, 2012, PLANT J, V71, P656, DOI 10.1111/j.1365-313X.2012.05020.x; Ludwig M, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00354, 10.3389/fmicb.2012.00145]; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; NILSSON F, 1992, ARCH BIOCHEM BIOPHYS, V295, P340, DOI 10.1016/0003-9861(92)90526-3; Nomura CT, 2006, PHOTOSYNTH RES, V87, P215, DOI 10.1007/s11120-005-8533-y; Nordhues A, 2012, PLANT CELL, V24, P637, DOI 10.1105/tpc.111.092692; Reinbothe S, 1996, PLANT CELL, V8, P763, DOI 10.1105/tpc.8.5.763; Sakamoto T, 1998, ARCH MICROBIOL, V169, P10; SHEN GZ, 1995, PHOTOSYNTH RES, V44, P41, DOI 10.1007/BF00018295; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Spence E, 2004, J BIOL CHEM, V279, P55792, DOI 10.1074/jbc.M411041200; Srivastava R, 2006, ARCH MICROBIOL, V185, P238, DOI 10.1007/s00203-006-0086-8; Stanley DN, 2013, PLANT PHYSIOL, V161, P824, DOI 10.1104/pp.112.210542; SUZUKI JY, 1992, PLANT CELL, V4, P929, DOI 10.1105/tpc.4.8.929; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; van de Meene AMT, 2012, BBA-BIOMEMBRANES, V1818, P1427, DOI 10.1016/j.bbamem.2012.01.019; Vothknecht UC, 2001, BBA-MOL CELL RES, V1541, P91, DOI 10.1016/S0167-4889(01)00153-7; Vothknecht UC, 2012, J EXP BOT, V63, P1699, DOI 10.1093/jxb/err357; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Xu Y, 2011, METHODS MOL BIOL, V684, P273, DOI [10.1007/978.1.60761.925.3_21, 10.1007/978-1-60761-925-3_21]	43	42	43	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15904	15914		10.1074/jbc.M114.555631	http://dx.doi.org/10.1074/jbc.M114.555631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764304	Green Published, hybrid			2022-12-28	WOS:000337965700002
J	Nifoussi, SK; Ratcliffe, NR; Ornstein, DL; Kasof, G; Strack, S; Craig, RW				Nifoussi, Shanna K.; Ratcliffe, Nora R.; Ornstein, Deborah L.; Kasof, Gary; Strack, Stefan; Craig, Ruth W.			Inhibition of Protein Phosphatase 2A (PP2A) Prevents Mcl-1 Protein Dephosphorylation at the Thr-163/Ser-159 Phosphodegron, Dramatically Reducing Expression in Mcl-1-amplified Lymphoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE; BCL-XL; C-MYC; SIGNALING PATHWAYS; CATALYTIC SUBUNIT; INDUCED APOPTOSIS; TARGETING MCL-1; ALPHA-SUBUNIT; BREAST-CANCER; OKADAIC ACID	Abundant, sustained expression of prosurvival Mcl-1 is an important determinant of viability and drug resistance in cancer cells. The Mcl-1 protein contains PEST sequences (enriched in proline, glutamic acid, serine, and threonine) and is normally subject to rapid turnover via multiple different pathways. One of these pathways involves a phosphodegron in the PEST region, where Thr-163 phosphorylation primes for Ser-159 phosphorylation by glycogen synthase kinase-3. Turnover via this phosphodegron-targeted pathway is reduced in Mcl-1-overexpressing BL41-3 Burkitt lymphoma and other cancer cells; turnover is further slowed in the presence of phorbol ester-induced ERK activation, resulting in Mcl-1 stabilization and an exacerbation of chemoresistance. The present studies focused on Mcl-1 dephosphorylation, which was also found to profoundly influence turnover. Exposure of BL41-3 cells to an inhibitor of protein phosphatase 2A (PP2A), okadaic acid, resulted in a rapid increase in phosphorylation at Thr-163 and Ser-159, along with a precipitous decrease in Mcl-1 expression. The decline in Mcl-1 expression preceded the appearance of cell death markers and was not slowed in the presence of phorbol ester. Upon exposure to calyculin A, which also potently inhibits PP2A, versus tautomycin, which does not, only the former increased Thr163/Ser-159 phosphorylation and decreased Mcl-1 expression. Mcl-1 co-immunoprecipitated with PP2A upon transfection into CHO cells, and PP2A/A alpha knockdown recapitulated the increase in Mcl-1 phosphorylation and decrease in expression. In sum, inhibition of PP2A prevents Mcl-1 dephosphorylation and results in rapid loss of this prosurvival protein in chemoresistant cancer cells.	[Nifoussi, Shanna K.; Craig, Ruth W.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Ratcliffe, Nora R.; Ornstein, Deborah L.] Geisel Sch Med Dartmouth, Dept Pathol, Hanover, NH 03755 USA; [Nifoussi, Shanna K.; Craig, Ruth W.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA; [Ratcliffe, Nora R.] Vet Affairs Med Ctr, White River Jct, VT 05001 USA; [Kasof, Gary] Cell Signaling Technol, Danvers, MA 01923 USA; [Strack, Stefan] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa	Craig, RW (corresponding author), Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, 1 Rope Ferry Rd, Hanover, NH 03755 USA.	Ruth.W.Craig@Dartmouth.edu		Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [R01CA057359]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA057359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA057359 (to R. W. C.).	Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; Bononi A, 2011, ENZYME RES, V2011, DOI [10.4061/2011/329098, DOI 10.4061/2011/329098]; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Cao XB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-42; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Cohen NA, 2012, CHEM BIOL, V19, P1175, DOI 10.1016/j.chembiol.2012.07.018; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Deng XM, 2009, BLOOD, V113, P422, DOI 10.1182/blood-2008-06-165134; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Doi K, 2012, J BIOL CHEM, V287, P10224, DOI 10.1074/jbc.M111.334532; Domina AM, 2000, J BIOL CHEM, V275, P21688, DOI 10.1074/jbc.M000915200; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Einarson Margret B, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4738; Ertel F, 2013, EMBO REP, V14, P328, DOI 10.1038/embor.2013.20; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Foley TD, 2005, BIOCHEM BIOPH RES CO, V330, P1224, DOI 10.1016/j.bbrc.2005.03.108; Foley TD, 2007, NEUROCHEM RES, V32, P1957, DOI 10.1007/s11064-007-9394-x; Foley TD, 2011, NEUROCHEM RES, V36, P232, DOI 10.1007/s11064-010-0310-4; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Huang XA, 2006, CYTOM PART A, V69A, P222, DOI 10.1002/cyto.a.20257; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Lewy DS, 2002, CURR MED CHEM, V9, P2005, DOI 10.2174/0929867023368809; Magiera MM, 2013, CELL DEATH DIFFER, V20, P281, DOI 10.1038/cdd.2012.124; Marriott HM, 2005, J CLIN INVEST, V115, P359, DOI 10.1172/JCI200521766; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Meric-Bernstam F, 2014, MOL CANCER THER, V13, P1382, DOI 10.1158/1535-7163.MCT-13-0482; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Okamoto T, 2014, P NATL ACAD SCI USA, V111, P261, DOI 10.1073/pnas.1321259110; Peddaboina C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-541; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Ren H, 2013, CANCER LETT, V338, P229, DOI 10.1016/j.canlet.2013.03.032; Reynolds JE, 1996, EXP CELL RES, V225, P430, DOI 10.1006/excr.1996.0194; Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470; Ruvolo PP, 2011, LEUKEMIA, V25, P1711, DOI 10.1038/leu.2011.146; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Sio TT, 2014, J HUM GENET, V59, P124, DOI 10.1038/jhg.2013.132; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Swingle Mark, 2007, V365, P23; Thomas S, 2013, EXPERT OPIN THER TAR, V17, P61, DOI 10.1517/14728222.2013.733001; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Vrana JA, 2002, CANCER RES, V62, P892; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; WURM FM, 1986, P NATL ACAD SCI USA, V83, P5414, DOI 10.1073/pnas.83.15.5414; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	70	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21950	21959		10.1074/jbc.M114.587873	http://dx.doi.org/10.1074/jbc.M114.587873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24939844	Green Published, hybrid			2022-12-28	WOS:000340593500012
J	Albareda, M; Pacios, LF; Manyani, H; Rey, L; Brito, B; Imperial, J; Ruiz-Argueso, T; Palacios, JM				Albareda, Marta; Pacios, Luis F.; Manyani, Hamid; Rey, Luis; Brito, Belen; Imperial, Juan; Ruiz-Argueeso, Tomas; Palacios, Jose M.			Maturation of Rhizobium leguminosarum Hydrogenase in the Presence of Oxygen Requires the Interaction of the Chaperone HypC and the Scaffolding Protein HupK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NIFE-HYDROGENASE; BV VICIAE; LARGE SUBUNIT; ACTIVE-SITE; I-TASSER; IRON; BIOSYNTHESIS; COFACTOR; GENES	[NiFe] hydrogenases are key enzymes for the energy and redox metabolisms of different microorganisms. Synthesis of these metalloenzymes involves a complex series of biochemical reactions catalyzed by a plethora of accessory proteins, many of them required to synthesize and insert the unique NiFe(CN)(2)CO cofactor. HypC is an accessory protein conserved in all [NiFe] hydrogenase systems and involved in the synthesis and transfer of the Fe(CN)(2)CO cofactor precursor. Hydrogenase accessory proteins from bacteria-synthesizing hydrogenase in the presence of oxygen include HupK, a scaffolding protein with a moderate sequence similarity to the hydrogenase large subunit and proposed to participate as an intermediate chaperone in the synthesis of the NiFe cofactor. The endosymbiotic bacterium Rhizobium leguminosarum contains a single hydrogenase system that can be expressed under two different physiological conditions: free-living microaerobic cells (similar to 12 mu M O-2) and bacteroids from legume nodules (similar to 10-100 nM O-2). We have used bioinformatic tools to model HupK structure and interaction of this protein with HypC. Site-directed mutagenesis at positions predicted as critical by the structural analysis have allowed the identification of HupK and HypC residues relevant for the maturation of hydrogenase. Mutant proteins altered in some of these residues show a different phenotype depending on the physiological condition tested. Modeling of HypC also predicts the existence of a stable HypC dimer whose presence was also demonstrated by immunoblot analysis. This study widens our understanding on the mechanisms for metalloenzyme biosynthesis in the presence of oxygen.	[Albareda, Marta; Manyani, Hamid; Rey, Luis; Brito, Belen; Imperial, Juan; Ruiz-Argueeso, Tomas; Palacios, Jose M.] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid 28223, Spain; [Albareda, Marta; Manyani, Hamid; Rey, Luis; Brito, Belen; Imperial, Juan; Ruiz-Argueeso, Tomas; Palacios, Jose M.] Univ Politecn Madrid, Dept Biotecnol, Escuela Tecn Super Ingn Agronomos, Madrid 28223, Spain; [Pacios, Luis F.] Univ Politecn Madrid, Dept Biotecnol, Escuela Tecn Super Ingn Montes, E-28040 Madrid, Spain; [Imperial, Juan] Univ Politecn Madrid, Consejo Super Invest Cient, Ctr Biotecnol Genom Plantas, Madrid 28223, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Politecnica de Madrid	Palacios, JM (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Campus Montegancedo, Madrid 28223, Spain.	jose.palacios@upm.es	Manyani, Hamid/AFE-8060-2022; Rey, Luis/A-3389-2014; Albareda, Marta/A-6549-2017; Ruiz-Argueso, TOMAS-ANDRES/I-1803-2015; imperial, Juan/G-3925-2015; Pacios, Luis F./AAL-6124-2021; Manyani, Hamid/AAE-9636-2022; Palacios, Jose/K-1435-2017; Pacios, Luis F/I-5164-2015	Rey, Luis/0000-0003-3477-6942; Albareda, Marta/0000-0002-4343-4445; Ruiz-Argueso, TOMAS-ANDRES/0000-0001-9118-3065; imperial, Juan/0000-0002-5002-6458; Pacios, Luis F./0000-0002-0585-4289; Pacios, Luis F/0000-0002-0585-4289; PALACIOS ALBERTI, JOSE MANUEL/0000-0002-2541-8812; Manyani Charroudi, Hamid/0000-0001-6129-2092	Spain's MINECO [BIO2010-15301]; Comunidad Autonoma de Madrid; Fundacion Ramon Areces	Spain's MINECO; Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	This work was supported by projects from Spain's MINECO (BIO2010-15301; to J. M. P.), Comunidad Autonoma de Madrid (Project Microambiente-CM; to T. R.-A.), and Fundacion Ramon Areces (to J. I.).	Albareda M, 2013, J PHYS CHEM B, V117, P13523, DOI 10.1021/jp407574n; Albareda M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-256; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baginsky C, 2005, APPL ENVIRON MICROB, V71, P7536, DOI 10.1128/AEM.71.11.7536-7538.2005; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BATUT J, 1994, ANTON LEEUW INT J G, V66, P129, DOI 10.1007/BF00871636; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Brito B, 1997, P NATL ACAD SCI USA, V94, P6019, DOI 10.1073/pnas.94.12.6019; BRITO B, 1995, MOL PLANT MICROBE IN, V8, P235, DOI 10.1094/MPMI-8-0235; BRITO B, 1994, J BACTERIOL, V176, P5297, DOI 10.1128/JB.176.17.5297-5303.1994; Brito B, 2002, APPL ENVIRON MICROB, V68, P2461, DOI 10.1128/AEM.68.5.2461-2467.2002; Burstel I, 2012, J BIOL CHEM, V287, P38845, DOI 10.1074/jbc.M112.376947; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano W. L, 2013, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Drapal N, 1998, BIOCHEMISTRY-US, V37, P2941, DOI 10.1021/bi9720078; Evans H., 1988, WORLD CROPS COOL SEA, P777; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Fritsch J, 2013, NAT REV MICROBIOL, V11, P106, DOI 10.1038/nrmicro2940; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; IMPERIAL J, 1993, MOL MICROBIOL, V9, P1305, DOI 10.1111/j.1365-2958.1993.tb01260.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Leach MR, 2007, J BIOL CHEM, V282, P16177, DOI 10.1074/jbc.M610834200; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; LEYVA A, 1987, J BACTERIOL, V169, P4929, DOI 10.1128/jb.169.11.4929-4934.1987; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Magalon A, 2000, J BIOL CHEM, V275, P21114, DOI 10.1074/jbc.M000987200; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; Maroti G, 2010, INT J HYDROGEN ENERG, V35, P3358, DOI 10.1016/j.ijhydene.2009.10.059; Nyilasi A, 2014, INT J HYDROGEN ENERG, V39, P18556, DOI 10.1016/j.ijhydene.2013.12.173; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Parkin A, 2012, CURR OPIN CHEM BIOL, V16, P26, DOI 10.1016/j.cbpa.2012.01.012; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; REY L, 1992, J MOL BIOL, V228, P998, DOI 10.1016/0022-2836(92)90886-O; ROSSMANN R, 1995, EUR J BIOCHEM, V227, P545, DOI 10.1111/j.1432-1033.1995.tb20422.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Ruiz-Argueso T, 2000, PROKARYOTIC NITROGEN FIXATION, P489; RUIZARGUESO T, 1978, ARCH MICROBIOL, V116, P113, DOI 10.1007/BF00406025; Sambrook J., 2001, MOL CLONING LAB MANU; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soboh B, 2013, FEBS LETT, V587, P2512, DOI 10.1016/j.febslet.2013.06.055; Soboh B, 2012, BIOCHEM BIOPH RES CO, V424, P158, DOI 10.1016/j.bbrc.2012.06.096; Stiebritz MT, 2012, CHEM SCI, V3, P1739, DOI 10.1039/c2sc01112c; Stripp ST, 2013, BIOCHEMISTRY-US, V52, P3289, DOI 10.1021/bi400302v; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	69	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21217	21229		10.1074/jbc.M114.577403	http://dx.doi.org/10.1074/jbc.M114.577403			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942742	Green Published, hybrid			2022-12-28	WOS:000340558300002
J	Matta-Camacho, E; Banerjee, S; Hughes, TS; Solt, LA; Wang, YJ; Burris, TP; Kojetin, DJ				Matta-Camacho, Edna; Banerjee, Subhashis; Hughes, Travis S.; Solt, Laura A.; Wang, Yongjun; Burris, Thomas P.; Kojetin, Douglas J.			Structure of REV-ERB beta Ligand-binding Domain Bound to a Porphyrin Antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COBALT-PROTOPORPHYRIN; TRANSCRIPTION FACTOR; ZINC-PROTOPORPHYRIN; SYNTHASE ACTIVITY; HEME OXYGENASE; CO-BINDING; ALPHA; DYNAMICS; MODULATION; EXPRESSION	REV-ERB alpha and REV-ERB beta are members of the nuclear receptor (NR) superfamily of ligand-regulated transcription factors that play important roles in the regulation of circadian physiology, metabolism, and immune function. Although the REV-ERBs were originally characterized as orphan receptors, recent studies have demonstrated that they function as receptors for heme. Here, we demonstrate that cobalt protoporphyrin IX (CoPP) and zinc protoporphyrin IX (ZnPP) are ligands that bind directly to the REV-ERBs. However, instead of mimicking the agonist action of heme, CoPP and ZnPP function as antagonists of REV-ERB function. This was unexpected because the only distinction between these ligands is the metal ion that is coordinated. To understand the structural basis by which REV-ERB beta can differentiate between a porphyrin agonist and antagonist, we characterized the interaction between REV-ERB beta with heme, CoPP, and ZnPP using biochemical and structural approaches, including x-ray crystallography and NMR. The crystal structure of CoPP-bound REV-ERB beta indicates only minor conformational changes induced byCoPPcompared with heme, including the porphyrin ring of CoPP, which adopts a planar conformation as opposed to the puckered conformation observed in the heme-bound REV-ERB beta crystal structure. Thus, subtle changes in the porphyrin metal center and ring conformation may influence the agonist versus antagonist action of porphyrins and when considered with other studies suggest that gas binding to the iron metal center heme may drive alterations in REV-ERB activity.	[Matta-Camacho, Edna; Banerjee, Subhashis; Hughes, Travis S.; Solt, Laura A.; Wang, Yongjun; Burris, Thomas P.; Kojetin, Douglas J.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33418 USA; [Wang, Yongjun; Burris, Thomas P.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63103 USA	Scripps Research Institute; Saint Louis University	Burris, TP (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 South Grand Blvd, St Louis, MO 63104 USA.	burristp@slu.edu; dkojetin@scripps.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449; Hughes, Travis/0000-0002-5764-5884	National Institutes of Health [DK080201, DK101871]; James and Esther King Biomedical Research Program from the Florida Department of Health Grant [1KN-09]; Scripps Research Institute; National Institutes of Health National Research Service Award [DK097890, DK088499]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101871, F32DK097890, R01DK080201, F32DK088499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Program from the Florida Department of Health Grant; Scripps Research Institute; National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080201 (to T. P. B.) and DK101871 (to D. J. K.). This work was also supported by the James and Esther King Biomedical Research Program from the Florida Department of Health Grant 1KN-09 (to D. J. K.) and start-up funds provided by The Scripps Research Institute (to D. J. K.).; Recipient of National Institutes of Health National Research Service Award DK097890.; Recipient of National Institutes of Health National Research Service Award DK088499.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BLOUGH NV, 1980, J AM CHEM SOC, V102, P5683, DOI 10.1021/ja00537a050; Brucker EA, 1996, J BIOL CHEM, V271, P25419, DOI 10.1074/jbc.271.41.25419; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Csongradi E, 2012, INT J OBESITY, V36, P244, DOI 10.1038/ijo.2011.78; Degtyarenko I, 2006, BIOPHYS J, V91, P2024, DOI 10.1529/biophysj.106.083048; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; DUMAS B, 1994, MOL ENDOCRINOL, V8, P996, DOI 10.1210/me.8.8.996; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALBRAITH RA, 1990, PHARMACOLOGY, V41, P292, DOI 10.1159/000138738; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; HOFFMAN BM, 1970, COBOGLOBINS OXYGEN C; Hughes TS, 2012, STRUCTURE, V20, P139, DOI 10.1016/j.str.2011.10.018; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Labbe RF, 1999, CLIN CHEM, V45, P2060; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Lu JY, 2006, BIOCHEMISTRY-US, V45, P1629, DOI 10.1021/bi051474j; MAINES MD, 1981, BIOCHIM BIOPHYS ACTA, V673, P339, DOI 10.1016/0304-4165(81)90465-7; Marden MC, 2000, FEBS LETT, V472, P221, DOI 10.1016/S0014-5793(00)01423-X; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Olea C, 2008, ACS CHEM BIOL, V3, P703, DOI 10.1021/cb800185h; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phelan CA, 2010, NAT STRUCT MOL BIOL, V17, P808, DOI 10.1038/nsmb.1860; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Renaud JP, 2000, MOL ENDOCRINOL, V14, P700, DOI 10.1210/me.14.5.700; Rodgers KR, 2005, J INORG BIOCHEM, V99, P963, DOI 10.1016/j.jinorgbio.2005.02.016; Savkur RS, 2004, VITAM HORM, V68, P145; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; SMITH A, 1993, J BIOL CHEM, V268, P7365; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Tsai AL, 2011, J BIOL CHEM, V286, P43182, DOI 10.1074/jbc.M111.290304; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Weeks CL, 2009, J AM CHEM SOC, V131, P12809, DOI 10.1021/ja904468w; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001; YONETANI T, 1972, J BIOL CHEM, V247, P2447; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	52	19	20	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20054	20066		10.1074/jbc.M113.545111	http://dx.doi.org/10.1074/jbc.M113.545111			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24872411	Green Published, hybrid			2022-12-28	WOS:000339395200020
J	Tang, QY; Zhang, Z; Meng, XY; Cui, M; Logothetis, DE				Tang, Qiong-Yao; Zhang, Zhe; Meng, Xuan-Yu; Cui, Meng; Logothetis, Diomedes E.			Structural Determinants of Phosphatidylinositol 4,5-Bisphosphate (PIP2) Regulation of BK Channel Activity through the RCK1 Ca2+ Coordination Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; RECTIFYING K+ CHANNELS; DIASTOLIC HYPERTENSION; SENSITIVITY; VOLTAGE; DOMAIN; SUBUNIT; POLYMORPHISM; EPILEPSY; MUTATION	Big or high conductance potassium (BK) channels are activated by voltage and intracellular calcium (Ca2+). Phosphatidylinositol 4,5-bisphosphate (PIP2), a ubiquitous modulator of ion channel activity, has been reported to enhance Ca2+-driven gating of BK channels, but a molecular understanding of this interplay or even of the PIP2 regulation of this channel's activity remains elusive. Here, we identify structural determinants in the KDRDD loop (which follows the alpha A helix in the RCK1 domain) to be responsible for the coupling between Ca2+ and PIP2 in regulating BK channel activity. In the absence of Ca2+, RCK1 structural elements limit channel activation through a decrease in the channel's PIP2 apparent affinity. This inhibitory influence of BK channel activation can be relieved by mutation of residues that (a) connect either the RCK1 Ca2+ coordination site (Asp(367) or its flanking basic residues in the KDRDD loop) to the PIP2-interacting residues (Lys(392) and Arg(393)) found in the alpha B helix or (b) are involved in hydrophobic interactions between the alpha A and alpha B helix of the RCK1 domain. In the presence of Ca2+, the RCK1-inhibitory influence of channel-PIP2 interactions and channel activity is relieved by Ca2+ engaging Asp367. Our results demonstrate that, along with Ca2+ and voltage, PIP2 is a third factor critical to the integral control of BK channel activity.	[Tang, Qiong-Yao; Zhang, Zhe; Meng, Xuan-Yu; Cui, Meng; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA; [Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Peoples R China; [Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou 221004, Peoples R China	Virginia Commonwealth University; Xuzhou Medical University; Xuzhou Medical University	Tang, QY (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	qtang@vcu.edu; delogothetis@vcu.edu			National Institutes of Health (NIH) Grants [R01-HL059949, R01-HL090882]; NIH, NCRR [S10RR027411]; American Heart Association Grant [09SDG2290002]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, R01HL090882] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association Grant(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R01-HL059949 and R01-HL090882 (to D. E. L.) and by NIH, NCRR, Grant S10RR027411 (to M. C.). This work was also supported by American Heart Association Grant 09SDG2290002 (to Z. Z.).	Abderemane-Ali F, 2012, J BIOL CHEM, V287, P36158, DOI 10.1074/jbc.M112.382085; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hou PP, 2013, SCI REP-UK, V3, DOI 10.1038/srep01666; Kelley-Hedgepeth A, 2009, J HYPERTENS, V27, P55, DOI 10.1097/HJH.0b013e328317c8ae; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Kohler R, 2000, CIRC RES, V87, P496; Kruse M, 2013, CHANNELS, V7, P530, DOI 10.4161/chan.25816; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Lingle CJ, 2002, J GEN PHYSIOL, V120, P261, DOI 10.1085/jgp.20028689; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lorenz S, 2007, AM J MED GENET B, V144B, P10, DOI 10.1002/ajmg.b.30369; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nielsen T, 2008, J HYPERTENS, V26, P2142, DOI 10.1097/HJH.0b013e32830b894a; Riazi MA, 1999, GENOMICS, V62, P90, DOI 10.1006/geno.1999.5975; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Seibold MA, 2008, HUM MOL GENET, V17, P2681, DOI 10.1093/hmg/ddn168; Senti M, 2005, CIRC RES, V97, P1360, DOI 10.1161/01.RES.0000196557.93717.95; Shelley C, 2010, J GEN PHYSIOL, V135, P461, DOI 10.1085/jgp.200910331; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tang QY, 2010, J BIOL CHEM, V285, P19259, DOI 10.1074/jbc.M109.100156; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; Tomas M, 2008, J HYPERTENS, V26, P2147, DOI 10.1097/HJH.0b013e32831103d8; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zhang GH, 2010, P NATL ACAD SCI USA, V107, P18700, DOI 10.1073/pnas.1010124107; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607; Zhang Z, 2006, J NEUROSCI, V26, P11833, DOI 10.1523/JNEUROSCI.3812-06.2006; Zhang Z, 2013, CHANNELS, V7, P194, DOI 10.4161/chan.24492; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010; Zhou Y, 2010, J GEN PHYSIOL, V135, P481, DOI 10.1085/jgp.201010403	56	25	26	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18860	18872		10.1074/jbc.M113.538033	http://dx.doi.org/10.1074/jbc.M113.538033			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24778177	Green Published, hybrid			2022-12-28	WOS:000339062900020
J	Wang, HB; Gutierrez-Uzquiza, A; Garg, R; Barrio-Real, L; Abera, MB; Lopez-Haber, C; Rosemblit, C; Lu, HS; Abba, M; Kazanietz, MG				Wang, HongBin; Gutierrez-Uzquiza, Alvaro; Garg, Rachana; Barrio-Real, Laura; Abera, Mahlet B.; Lopez-Haber, Cynthia; Rosemblit, Cinthia; Lu, Huaisheng; Abba, Martin; Kazanietz, Marcelo G.			Transcriptional Regulation of Oncogenic Protein Kinase C epsilon (PKC epsilon) by STAT1 and Sp1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; CYCLIN D1; ESTROGEN-RECEPTOR; OXIDATIVE-STRESS; PROSTATE-CANCER; EPIGENETIC REPRESSION; INSULIN-RESISTANCE; DRUG ACTIVITY; GROWTH-FACTOR	Overexpression of PKC epsilon, a kinase associated with tumor aggressiveness and widely implicated in malignant transformation and metastasis, is a hallmark of multiple cancers, including mammary, prostate, and lung cancer. To characterize the mechanisms that control PKC epsilon expression and its up-regulation in cancer, we cloned an similar to 1.6-kb promoter segment of the human PKC epsilon gene (PRKCE) that displays elevated transcriptional activity in cancer cells. A comprehensive deletional analysis established two regions rich in Sp1 and STAT1 sites located between -777 and -105 bp (region A) and -921 and -796 bp (region B), respectively, as responsible for the high transcriptional activity observed in cancer cells. A more detailed mutagenesis analysis followed by EMSA and ChIP identified Sp1 sites in positions -668/-659 and -269/-247 as well as STAT1 sites in positions -880/-869 and -793/-782 as the elements responsible for elevated promoter activity in breast cancer cells relative to normal mammary epithelial cells. RNAi silencing of Sp1 and STAT1 in breast cancer cells reduced PKC epsilon mRNA and protein expression, as well as PRKCE promoter activity. Moreover, a strong correlation was found between PKC epsilon and phospho-Ser-727 (active) STAT1 levels in breast cancer cells. Our results may have significant implications for the development of approaches to target PKC epsilon and its effectors in cancer therapeutics.	[Wang, HongBin; Gutierrez-Uzquiza, Alvaro; Garg, Rachana; Barrio-Real, Laura; Abera, Mahlet B.; Lopez-Haber, Cynthia; Rosemblit, Cinthia; Lu, Huaisheng; Kazanietz, Marcelo G.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Abba, Martin] Univ Nacl La Plata, Ctr Invest Inmunol Basicas & Aplicadas, RA-1900 La Plata, Argentina	University of Pennsylvania; Pennsylvania Medicine; National University of La Plata	Kazanietz, MG (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Uzquiza, Alvaro Gutierrez/E-4073-2012; Garg, Rachana/AAQ-9518-2020	Uzquiza, Alvaro Gutierrez/0000-0002-0446-4131; Abba, Martin/0000-0002-9206-2369; Lopez Haber, Cynthia/0000-0001-9106-543X; Garg, Rachana/0000-0002-7808-1053	National Institutes of Health [R01-CA89202]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA89202 (to M. G. K.).	Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; CACACE AM, 1993, ONCOGENE, V8, P2095; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Cao YX, 2000, BIOCHEM J, V350, P883, DOI 10.1042/0264-6021:3500883; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; CHEN YY, 1994, ONCOGENE, V9, P2269; Cheng MB, 2010, CELL SIGNAL, V22, P1206, DOI 10.1016/j.cellsig.2010.03.012; Churchill EN, 2010, CARDIOVASC RES, V85, P385, DOI 10.1093/cvr/cvp334; Dann S. G., 2013, ONCOGENE; Finkenzeller Gunter, 2004, Angiogenesis, V7, P59, DOI 10.1023/B:AGEN.0000037332.66411.f0; Franci C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058183; Fryknas M, 2007, INT J CANCER, V120, P189, DOI 10.1002/ijc.22291; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Garg R, 2012, J BIOL CHEM, V287, P37570, DOI 10.1074/jbc.M112.398925; Glait C, 2006, EXP CELL RES, V312, P3899, DOI 10.1016/j.yexcr.2006.08.016; Greenwood C, 2012, J PROTEOMICS, V75, P3031, DOI 10.1016/j.jprot.2011.11.033; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Hagiwara K, 2012, GENE CHROMOSOME CANC, V51, P1024, DOI 10.1002/gcc.21985; Han W, 2013, MOL CARCINOGEN, V52, P959, DOI 10.1002/mc.21936; Hix LM, 2013, J BIOL CHEM, V288, P11676, DOI 10.1074/jbc.M112.441402; Ivaska J, 2003, NAT CELL BIOL, V5, P363, DOI 10.1038/ncb957; Jin HJ, 2011, J BIOL CHEM, V286, P19840, DOI 10.1074/jbc.M110.203687; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kampfer S, 2001, J BIOL CHEM, V276, P42834, DOI 10.1074/jbc.M102047200; Khodarev NN, 2012, CLIN CANCER RES, V18, P3015, DOI 10.1158/1078-0432.CCR-11-3225; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Lee AM, 2011, P NATL ACAD SCI USA, V108, P16080, DOI 10.1073/pnas.1106277108; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lopez-Haber C, 2013, MOL PHARMACOL, V83, P1141, DOI 10.1124/mol.112.084293; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Magkou C, 2012, HISTOPATHOLOGY, V60, P1125, DOI 10.1111/j.1365-2559.2011.04143.x; Maor S, 2006, J ENDOCRINOL, V191, P605, DOI 10.1677/joe.1.07016; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Mesquita RFDS, 2014, MOL CELL BIOL, V34, P574, DOI 10.1128/MCB.01098-13; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632; Perletti GP, 1996, ONCOGENE, V12, P847; Quann EJ, 2011, NAT IMMUNOL, V12, P647, DOI 10.1038/ni.2033; Rajski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029743; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Rickardson L, 2005, BRIT J CANCER, V93, P483, DOI 10.1038/sj.bjc.6602699; Rickardson L, 2006, CANCER CHEMOTH PHARM, V58, P749, DOI 10.1007/s00280-006-0216-7; Salvatori L, 2011, BIOMED PHARMACOTHER, V65, P307, DOI 10.1016/j.biopha.2011.03.007; SASTRY M, 1993, BIOCHEMISTRY-US, V32, P6588, DOI 10.1021/bi00077a012; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schultz J, 2010, CLIN EXP METASTAS, V27, P133, DOI 10.1007/s10585-010-9310-7; Shankar E, 2008, ONCOGENE, V27, P3957, DOI 10.1038/onc.2008.39; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Su T., 2013, ISRN ONCOL, V2013; Taminau J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-335; Verma AK, 2006, MOL CARCINOGEN, V45, P381, DOI 10.1002/mc.20230; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Wang Xiao-Bing, 2007, Ai Zheng, V26, P996; Wu DF, 2012, J CLIN INVEST, V122, P1306, DOI 10.1172/JCI61934; Wu DQ, 2002, CANCER RES, V62, P2423; Xiong FX, 2012, FASEB J, V26, P2753, DOI 10.1096/fj.11-199422; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Zannetti A, 2000, CANCER RES, V60, P1546; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	68	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19823	19838		10.1074/jbc.M114.548446	http://dx.doi.org/10.1074/jbc.M114.548446			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24825907	hybrid, Green Published			2022-12-28	WOS:000339326800053
J	Xie, R; Xu, JY; Wen, GR; Jin, H; Liu, XM; Yang, Y; Ji, B; Jiang, YX; Song, PH; Dong, H; Tuo, BG				Xie, Rui; Xu, Jingyu; Wen, Guorong; Jin, Hai; Liu, Xuemei; Yang, Yuan; Ji, Bei; Jiang, Yixia; Song, Penghong; Dong, Hui; Tuo, Biguang			The P2Y(2) Nucleotide Receptor Mediates the Proliferation and Migration of Human Hepatocellular Carcinoma Cells Induced by ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ATP; PURINERGIC RECEPTORS; CANCER CELLS; LIVER-CANCER; P2 RECEPTORS; INFLAMMATION; EXPRESSION; CALCIUM; HEPATOCYTES; ROLES	ATP is an abundant biochemical component of the tumor microenvironment and a physiologic ligand for the P2Y(2) nucleotide receptor (P2Y(2)R). In this study, we investigated the effect of ATP on the cellular behavior of human hepatocellular carcinoma (HCC) cells and the role of P2Y(2)R in ATP action and aimed to find a new therapeutic target against HCC. The experiments were performed in native isolated human HCC cells, normal hepatocytes, human HCC cell lines, and nude mice. We found that the mRNA and protein expression levels of P2Y(2)R in native human HCC cells and the human HCC cell lines HepG2 and BEL-7404 were enhanced markedly compared with human normal hepatocytes and the normal hepatocyte line LO2, respectively. ATP induced intracellular Ca2+ increases in HCC cells and promoted the proliferation and migration of HCC cells and the growth of HCC in nude mice. The P2Y receptor antagonist suramin, P2Y(2)R-specific shRNA, the store-operated calcium channel inhibitors 2-aminoethoxydiphenyl borate (2-APB) and 1-(beta-3-(4-methoxyphenyl) propoxyl-4-methoxyphenethyl) 1H-imidazolehydrochloride (SKF96365), and stromal interaction molecule (STIM1)-specific shRNA inhibited the action of ATP on HCC cells. In conclusion, P2Y(2)R mediated the action of ATP on the cellular behavior of HCC cells through store-operated calcium channel-mediated Ca2+ signaling, and targeting P2Y(2)R may be a promising therapeutic strategy against human HCC.	[Xie, Rui; Xu, Jingyu; Wen, Guorong; Jin, Hai; Liu, Xuemei; Yang, Yuan; Ji, Bei; Jiang, Yixia; Dong, Hui; Tuo, Biguang] Zunyi Med Coll, Affiliated Hosp, Dept Gastroenterol, Zunyi 563003, Peoples R China; [Xie, Rui; Xu, Jingyu; Wen, Guorong; Jin, Hai; Liu, Xuemei; Yang, Yuan; Ji, Bei; Jiang, Yixia; Dong, Hui; Tuo, Biguang] Digest Dis Inst Guizhou Prov, Zunyi 563003, Peoples R China; [Xu, Jingyu; Wen, Guorong; Jin, Hai; Tuo, Biguang] Zunyi Med Coll, Res Ctr Med & Biol, Zunyi 563003, Peoples R China; [Song, Penghong] Zhejiang Univ, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth, Affiliated Hosp 1,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zunyi Medical University; Zunyi Medical University; Zhejiang University	Dong, H (corresponding author), Zunyi Med Coll, Affiliated Hosp, Dept Gastroenterol, 149 Dalian Rd, Zunyi 563003, Peoples R China.	h2dong@ucsd.edu; tuobiguang@aliyun.com			National Natural Science Foundation of China [91129719, 81160265, 81272675]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Research Program of National Natural Science Foundation of China Grant 91129719 (to B. T.), by National Natural Science Foundation of China Grant 81160265 (to J. X.), and by National Natural Science Foundation of China Grant 81272675 (to P. S.).	Birrer RB, 2003, ANN CLIN LAB SCI, V33, P39; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Geschwind JFH, 2002, CANCER RES, V62, P3909; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Kolachala VL, 2008, AM J PHYSIOL-GASTR L, V294, pG401, DOI 10.1152/ajpgi.00454.2007; Kunzli BM, 2007, AM J PHYSIOL-GASTR L, V292, pG223, DOI 10.1152/ajpgi.00259.2006; Lewis RS, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003970; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Madsen CP, 2012, AM J PHYSIOL-CELL PH, V303, pC625, DOI 10.1152/ajpcell.00287.2011; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Minguez B, 2009, CURR OPIN GASTROEN, V25, P186, DOI 10.1097/MOG.0b013e32832962a1; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Nylund G., 2007, Autonomic & Autacoid Pharmacology, V27, P79, DOI 10.1111/j.1474-8673.2007.00389.x; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Roman RM, 1999, GASTROENTEROLOGY, V116, P964, DOI 10.1016/S0016-5085(99)70081-8; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Schafer R, 2003, AM J PHYSIOL-LUNG C, V285, pL376, DOI 10.1152/ajplung.00447.2002; Schofl C, 1999, AM J PHYSIOL-GASTR L, V276, pG164, DOI 10.1152/ajpgi.1999.276.1.G164; Sun XF, 2013, HEPATOLOGY, V57, P205, DOI 10.1002/hep.25989; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Thevananther S, 2004, HEPATOLOGY, V39, P393, DOI 10.1002/hep.20075; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; von Kugelgen I, 2011, ADV PHARMACOL, V61, P373, DOI 10.1016/B978-0-12-385526-8.00012-6; Wagstaff SC, 2000, CARCINOGENESIS, V21, P2175, DOI 10.1093/carcin/21.12.2175; Xu JY, 2012, CARCINOGENESIS, V33, P2432, DOI 10.1093/carcin/bgs277; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	31	58	63	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19137	19149		10.1074/jbc.M113.540047	http://dx.doi.org/10.1074/jbc.M113.540047			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847054	Green Published, hybrid			2022-12-28	WOS:000339062900043
J	MacDonald, LC; Berger, BW				MacDonald, Logan C.; Berger, Bryan W.			Insight into the Role of Substrate-binding Residues in Conferring Substrate Specificity for the Multifunctional Polysaccharide Lyase Smlt1473	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMONIAE HYALURONATE LYASE; SWISS-MODEL WORKSPACE; CHONDROITIN AC LYASE; ALGINATE LYASE; CRYSTAL-STRUCTURE; PK(A) VALUES; ANGSTROM RESOLUTION; CATALYTIC MECHANISM; URONIC ACID; ION-PAIRS	Anionic polysaccharides are of growing interest in the biotechnology industry due to their potential pharmaceutical applications in drug delivery and wound treatment. Chemical composition and polymer length strongly influence the physical and biological properties of the polysaccharide and thus its potential industrial and medical applications. One promising approach to determining monomer composition and controlling the degree of polymerization involves the use of polysaccharide lyases, which catalyze the depolymerization of anionic polysaccharides via a beta-elimination mechanism. Utilization of these enzymes for the production of custom-made oligosaccharides requires a high degree of control over substrate specificity. Previously, we characterized a polysaccharide lyase (Smlt1473) from Stenotrophomonas maltophilia k279a, which exhibited significant activity against hyaluronan (HA), poly-beta-D-glucuronic acid (poly-GlcUA), and poly-beta-D-mannuronic acid (poly-ManA) in a pH-regulated manner. Here, we utilize a sequence structure guided approach based on a homology model of Smlt1473 to identify nine putative substrate-binding residues and examine their effect on substrate specificity via site-directed mutagenesis. Interestingly, single point mutations H221F and R312L resulted in increased activity and specificity toward poly-ManA and poly-GlcUA, respectively. Furthermore, a W171A mutant nearly eliminated HA activity, while increasing poly-ManA and poly-GlcUA activity by at least 35%. The effect of these mutations was analyzed by comparison with the high resolution structure of Sphingomonas sp. A1-III alginate lyase in complex with poly-ManA tetrasaccharide and by taking into account the structural differences between HA, poly-GlcUA, and poly-ManA. Overall, our results demonstrate that even minor changes in active site architecture have a significant effect on the substrate specificity of Smlt1473, whose structural plasticity could be applied to the design of highly active and specific polysaccharide lyases.	[MacDonald, Logan C.; Berger, Bryan W.] Lehigh Univ, Program Bioengn, Bethlehem, PA 18015 USA; [Berger, Bryan W.] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University	Berger, BW (corresponding author), Lehigh Univ, Dept Chem Engn, B320 Iacocca Hall,111 Res Dr, Bethlehem, PA 18015 USA.	bwb209@lehigh.edu	Berger, Bryan/D-7985-2014	Berger, Bryan/0000-0002-6135-8677	Directorate For Engineering [1227924] Funding Source: National Science Foundation	Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATKINS EDT, 1973, BIOPOLYMERS, V12, P1865, DOI 10.1002/bip.1973.360120813; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Braccini I, 1999, CARBOHYD RES, V317, P119, DOI 10.1016/S0008-6215(99)00062-2; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Elboutachfaiti R, 2011, CARBOHYD POLYM, V84, P1, DOI 10.1016/j.carbpol.2010.10.063; Elmabrouk ZH, 2011, PROTEINS, V79, P965, DOI 10.1002/prot.22938; Farrell EK, 2012, BIOCHEMISTRY-US, V51, P10259, DOI 10.1021/bi301425r; Fylstra D, 1998, INTERFACES, V28, P29, DOI 10.1287/inte.28.5.29; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Hamza A, 2011, BBA-PROTEINS PROTEOM, V1814, P1739, DOI 10.1016/j.bbapap.2011.08.018; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Kelly SJ, 2001, GLYCOBIOLOGY, V11, P297, DOI 10.1093/glycob/11.4.297; Lee SI, 2012, APPL MICROBIOL BIOT, V95, P1643, DOI 10.1007/s00253-012-4266-y; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; MacDonald LC, 2014, J BIOL CHEM, V289, P312, DOI 10.1074/jbc.M113.489195; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Nukui M, 2003, J BIOL CHEM, V278, P3079, DOI 10.1074/jbc.M204999200; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PREISS J, 1962, J BIOL CHEM, V237, P309; Rigden DJ, 2003, J BIOL CHEM, V278, P50596, DOI 10.1074/jbc.M307596200; Rye CS, 2006, CHEMBIOCHEM, V7, P631, DOI 10.1002/cbic.200500428; Sambrook J, 2001, MOL CLONING; Shaya D, 2010, J BIOL CHEM, V285, P20051, DOI 10.1074/jbc.M110.101071; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; WIGLEY DB, 1987, BIOCHEM BIOPH RES CO, V149, P927, DOI 10.1016/0006-291X(87)90497-9; Wilkins MR, 1999, METH MOL B, V112, P531; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509	43	16	17	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18022	18032		10.1074/jbc.M114.571299	http://dx.doi.org/10.1074/jbc.M114.571299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24808176	Green Published, hybrid			2022-12-28	WOS:000338042000006
J	Wisniewska, M; Happonen, L; Kahn, F; Varjosalo, M; Malmstrom, L; Rosenberger, G; Karlsson, C; Cazzamali, G; Pozdnyakova, I; Frick, IM; Bjorck, L; Streicher, W; Malmstrom, J; Wikstrom, M				Wisniewska, Magdalena; Happonen, Lotta; Kahn, Fredrik; Varjosalo, Markku; Malmstroem, Lars; Rosenberger, George; Karlsson, Christofer; Cazzamali, Giuseppe; Pozdnyakova, Irina; Frick, Inga-Maria; Bjorck, Lars; Streicher, Werner; Malmstrom, Johan; Wikstrom, Mats			Functional and Structural Properties of a Novel Protein and Virulence Factor (Protein sHIP) in Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; GROUP-A STREPTOCOCCUS; SERUM OPACITY FACTOR; GENOME SEQUENCE; SURFACE; STRAIN; IDENTIFICATION; BACTERIA; SYSTEM; SERVER	Streptococcus pyogenes is a significant bacterial pathogen in the human population. The importance of virulence factors for the survival and colonization of S. pyogenes is well established, and many of these factors are exposed to the extracellular environment, enabling bacterial interactions with the host. In the present study, we quantitatively analyzed and compared S. pyogenes proteins in the growth medium of a strain that is virulent to mice with a non-virulent strain. Particularly, one of these proteins was present at significantly higher levels in stationary growth medium from the virulent strain. We determined the three-dimensional structure of the protein that showed a unique tetrameric organization composed of four helix-loop-helix motifs. Affinity pull-down mass spectrometry analysis in human plasma demonstrated that the protein interacts with histidine-rich glycoprotein (HRG), and the name sHIP (streptococcal histidine-rich glycoprotein-interacting protein) is therefore proposed. HRG has antibacterial activity, and when challenged by HRG, sHIP was found to rescue S. pyogenes bacteria. This and the finding that patients with invasive S. pyogenes infection respond with antibody production against sHIP suggest a role for the protein in S. pyogenes pathogenesis.	[Wisniewska, Magdalena; Cazzamali, Giuseppe; Pozdnyakova, Irina; Streicher, Werner; Wikstrom, Mats] Univ Copenhagen, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark; [Happonen, Lotta; Kahn, Fredrik; Karlsson, Christofer; Frick, Inga-Maria; Bjorck, Lars; Malmstrom, Johan] Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden; [Varjosalo, Markku] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Malmstroem, Lars; Rosenberger, George] ETH, Dept Biol, CH-8093 Zurich, Switzerland	Novo Nordisk Foundation; University of Copenhagen; Lund University; University of Helsinki; Swiss Federal Institutes of Technology Domain; ETH Zurich	Malmstrom, J (corresponding author), Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden.	mats.wikstrom@cpr.ku.dk	Malmström, Lars/R-4991-2019; Happonen, Lotta J./AAI-2032-2021; Rosenberger, George/S-7458-2019; Malmström, Johan A/B-7660-2009; Kahn, Fredrik/X-5338-2018; Rosenberger, George/C-1412-2017; Varjosalo, Markku/K-6424-2015	Malmström, Lars/0000-0001-9885-9312; Happonen, Lotta J./0000-0002-5922-4549; Malmström, Johan A/0000-0002-2889-7169; Kahn, Fredrik/0000-0001-5566-6350; Rosenberger, George/0000-0002-1655-6789; Varjosalo, Markku/0000-0002-1340-9732; Streicher, Werner/0000-0002-2425-5839	Swedish Research Council [7480, 2008, 3356, 621-2012-3559]; Swedish Foundation for Strategic Research [FFL4]; Crafoord Foundation [20100892]; Wallenberg Academy [KAW 2012.0178]; European Research Council [ERC-2012-StG-309831]; Swedish Government Funds for Clinical Research; Knut and Alice Wallenberg Foundation; Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Crafoord Foundation; Wallenberg Academy; European Research Council(European Research Council (ERC)European Commission); Swedish Government Funds for Clinical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umea University	This work was supported by Swedish Research Council Projects 7480, 2008: 3356, and 621-2012-3559); Swedish Foundation for Strategic Research Grant FFL4; Crafoord Foundation Grant 20100892; Wallenberg Academy Fellowship KAW 2012.0178; European Research Council Starting Grant ERC-2012-StG-309831; Swedish Government Funds for Clinical Research (ALF); and the Knut and Alice Wallenberg Foundation.; Recipient of a MIMS Clinical Research Fellowship from the Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umea University.	ABE J, 1991, J IMMUNOL, V146, P3747; AKERSTROM B, 1985, J IMMUNOL, V135, P2589; AKESSON P, 1990, MOL IMMUNOL, V27, P523, DOI 10.1016/0161-5890(90)90071-7; Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Akesson P, 2004, J INFECT DIS, V189, P797, DOI 10.1086/381982; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; BJORCK L, 1989, NATURE, V337, P385, DOI 10.1038/337385a0; Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Choi Hyungwon, 2012, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0815s39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Courtney HS, 1999, MOL MICROBIOL, V32, P89, DOI 10.1046/j.1365-2958.1999.01328.x; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernie-King BA, 2002, INFECT IMMUN, V70, P4908, DOI 10.1128/IAI.70.9.4908-4916.2002; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaffe J, 1996, MOL MICROBIOL, V21, P373, DOI 10.1046/j.1365-2958.1996.6331356.x; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamezawa Y, 1997, INFECT IMMUN, V65, P3828, DOI 10.1128/IAI.65.9.3828-3833.1997; Karlsson C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2297; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KREIKEMEYER B, 1995, MOL MICROBIOL, V17, P137, DOI 10.1111/j.1365-2958.1995.mmi_17010137.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2012, J BIOMOL STRUCT DYN, V30, P773, DOI 10.1080/07391102.2012.689705; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; Le Breton Y, 2013, INFECT IMMUN, V81, P862, DOI 10.1128/IAI.00837-12; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Malmstrom L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-158; MOLLICK JA, 1993, J CLIN INVEST, V92, P710, DOI 10.1172/JCI116641; Niclasen LM, 2011, BIOCHEM J, V434, P123, DOI 10.1042/BJ20100984; Nithianantham S, 2009, J BIOL CHEM, V284, P3865, DOI 10.1074/jbc.M805503200; Nordenfelt P, 2012, J EXP MED, V209, P2367, DOI 10.1084/jem.20120325; NORRBYTEGLUND A, 1994, INFECT IMMUN, V62, P5227, DOI 10.1128/IAI.62.12.5227-5233.1994; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; RAJU R, 1976, AM J SURG, V132, P64, DOI 10.1016/0002-9610(76)90292-0; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Reuter M, 2010, J BIOL CHEM, V285, P38473, DOI 10.1074/jbc.M110.143727; Rocha CL, 1999, INFECT IMMUN, V67, P2720, DOI 10.1128/IAI.67.6.2720-2728.1999; Rosales C, 2009, BIOCHEMISTRY-US, V48, P8070, DOI 10.1021/bi901087z; Rydengard V, 2007, FEBS J, V274, P377, DOI 10.1111/j.1742-4658.2006.05586.x; SCHMIDT KH, 1990, ZBL BAKT-INT J MED M, V273, P216; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shannon O, 2010, BLOOD, V116, P2365, DOI 10.1182/blood-2010-02-271858; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Sjoholm K, 2014, MOL BIOSYST, V10, P1698, DOI 10.1039/c3mb70555b; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; SWANSON J, 1969, J EXP MED, V130, P1063, DOI 10.1084/jem.130.5.1063; TALAY SR, 1994, MOL MICROBIOL, V13, P531, DOI 10.1111/j.1365-2958.1994.tb00448.x; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; TOMAI MA, 1992, INFECT IMMUN, V60, P701, DOI 10.1128/IAI.60.2.701-705.1992; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waldetoft KW, 2014, MICROBIOL-SGM, V160, P279, DOI 10.1099/mic.0.071332-0; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Weisser H, 2013, J PROTEOME RES, V12, P1628, DOI 10.1021/pr300992u; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	72	5	5	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18175	18188		10.1074/jbc.M114.565978	http://dx.doi.org/10.1074/jbc.M114.565978			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825900	hybrid, Green Published			2022-12-28	WOS:000338042000020
J	Yin, MM; Wang, XR; Yao, GD; Lu, MR; Liang, M; Sun, YP; Sun, F				Yin, Mianmian; Wang, Xiaorong; Yao, Guidong; Lu, Mingrong; Liang, Meng; Sun, Yingpu; Sun, Fei			Transactivation of MicroRNA-320 by MicroRNA-383 Regulates Granulosa Cell Functions by Targeting E2F1 and SF-1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; TRANSCRIPTION FACTOR E2F-1; PROSTATE-CANCER CELLS; GROWTH-FACTOR-BETA; FACTOR-I; TUMOR-SUPPRESSOR; GENE-EXPRESSION; PROLIFERATION; APOPTOSIS; OVARY	Our previous studies have shown that microRNA-320 (miR-320) is one of the most down-regulated microRNAs (miRNA) in mouse ovarian granulosa cells (GCs) after TGF-beta 1 treatment. However, the underlying mechanisms of miR-320 involved in GC function during follicular development remain unknown. In this study, we found that pregnant mare serum gonadotropin treatment resulted in the suppression of miR-320 expression in a time-dependent manner. miR-320 was mainly expressed in GCs and oocytes of mouse ovarian follicles in follicular development. Over-expression of miR-320 inhibited estradiol synthesis and proliferation of GCs through targeting E2F1 and SF-1. E2F1/SF-1 mediated miR-320-induced suppression of GC proliferation and of GC steroidogenesis. FSH down-regulated the expression of miR-320 and regulated the function of miR-320 in mouse GCs. miR-383 promoted the expression of miR-320 and enhanced miR-320-mediated suppression of GC proliferation. Injection of miR-320 into the ovaries of mice partially promoted the production of testosterone and progesterone but inhibited estradiol release in vivo. Moreover, the expression of miR-320 and miR-383 was up-regulated in the follicular fluid of polycystic ovarian syndrome patients, although the expression of E2F1 and SF-1 was down-regulated in GCs. These data demonstrated that miR-320 regulates the proliferation and steroid production by targeting E2F1 and SF-1 in the follicular development. Understanding the regulation of miRNA biogenesis and function in the follicular development will potentiate the usefulness of miRNA in the treatment of reproduction and some steroid-related disorders.	[Yin, Mianmian; Wang, Xiaorong; Lu, Mingrong; Liang, Meng; Sun, Fei] Univ Sci & Technol China, Inst Immunol, Hefei 230026, Anhui, Peoples R China; [Yin, Mianmian; Wang, Xiaorong; Lu, Mingrong; Liang, Meng; Sun, Fei] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Innate Immun & Chron Dis, Innovat Ctr Cell Biol,Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Yin, Mianmian; Wang, Xiaorong; Lu, Mingrong; Liang, Meng; Sun, Fei] Univ Sci & Technol China, Med Ctr, Hefei 230026, Anhui, Peoples R China; [Yin, Mianmian; Wang, Xiaorong; Lu, Mingrong; Liang, Meng; Sun, Fei] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Yao, Guidong; Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Henan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Zhengzhou University	Sun, YP (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	syp2008@vip.sina.com; feisun@ustc.edu.cn	Yin, Mianmian/AAG-4192-2019; Sun, Fei/N-2850-2013; wang, xiao/HGB-7081-2022	Yin, Mianmian/0000-0001-5573-8991; wang, xiao/0000-0002-4088-3341	National Natural Science Foundation of China [31171379, 81125005, 31271605]; National Basic Research Program of China [2014CB943100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 31171379 and 81125005 (to F. S.), 31271605 (to Y. S.), and National Basic Research Program of China Grant 2014CB943100.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Amsterdam A, 1997, ENDOCR REV, V18, P435, DOI 10.1210/er.18.4.435; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; Cutolo M, 2005, ARTHRITIS RES THER, V7, pR1124, DOI 10.1186/ar1791; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Emmrich S, 2010, CELL CYCLE, V9, P2555, DOI 10.4161/cc.9.13.12061; Feng Biao, 2012, ISRN Endocrinol, V2012, P549875, DOI 10.5402/2012/549875; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GALLO RV, 1981, BIOL REPROD, V24, P100, DOI 10.1095/biolreprod24.1.100; GillingSmith C, 1997, CLIN ENDOCRINOL, V47, P93, DOI 10.1046/j.1365-2265.1997.2321049.x; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; Hillier SG, 2001, MOL CELL ENDOCRINOL, V179, P39, DOI 10.1016/S0303-7207(01)00469-5; Holmberg C, 1998, ONCOGENE, V17, P143, DOI 10.1038/sj.onc.1201915; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Jamnongjit M, 2006, CELL CYCLE, V5, P1178, DOI 10.4161/cc.5.11.2803; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jongen V H W M, 2006, Minerva Endocrinol, V31, P47; Kim BM, 2012, BIOCHEM BIOPH RES CO, V426, P183, DOI 10.1016/j.bbrc.2012.08.058; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Lee KH, 1996, BIOTECHNOL BIOENG, V50, P273, DOI 10.1002/(SICI)1097-0290(19960505)50:3<273::AID-BIT6>3.0.CO;2-D; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Macklon NS, 2001, ARCH MED RES, V32, P595, DOI 10.1016/S0188-4409(01)00327-7; Majors BS, 2008, J BIOTECHNOL, V138, P103, DOI 10.1016/j.jbiotec.2008.08.003; MICHAEL MD, 1995, J BIOL CHEM, V270, P13561, DOI 10.1074/jbc.270.22.13561; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; MONDSCHEIN JS, 1988, ENDOCRINOLOGY, V123, P1970, DOI 10.1210/endo-123-4-1970; Moore RK, 2005, MOL CELL ENDOCRINOL, V234, P67, DOI 10.1016/j.mce.2004.10.012; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Nielsen ME, 2011, MOL HUM REPROD, V17, P63, DOI 10.1093/molehr/gaq073; Noel JC, 2010, APPL IMMUNOHISTO M M, V18, P258, DOI 10.1097/PAI.0b013e3181c06948; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; ROBINSON S, 1993, CLIN ENDOCRINOL, V39, P351, DOI 10.1111/j.1365-2265.1993.tb02376.x; Shao RJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE604, DOI 10.1152/ajpendo.00350.2006; Shen LC, 2013, J CLIN ENDOCR METAB, V98, P1575, DOI 10.1210/jc.2012-3010; Shimasaki S, 1999, P NATL ACAD SCI USA, V96, P7282, DOI 10.1073/pnas.96.13.7282; Stefani G, 2006, COLD SPRING HARB SYM, V71, P129, DOI 10.1101/sqb.2006.71.032; Stouffer RL, 2007, FRONT BIOSCI, V12, P297, DOI 10.2741/2065; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; THOMPSON EA, 1974, J BIOL CHEM, V249, P5373; VANDERHYDEN BC, 1993, ENDOCRINOLOGY, V133, P423, DOI 10.1210/en.133.1.423; Vitt UA, 1998, BIOL REPROD, V59, P854, DOI 10.1095/biolreprod59.4.854; Wang W, 2011, REPRODUCTION, V141, P643, DOI 10.1530/REP-10-0098; Webber LJ, 2003, LANCET, V362, P1017, DOI 10.1016/S0140-6736(03)14410-8; White RE, 2012, NEUROREPORT, V23, P590, DOI 10.1097/WNR.0b013e3283540394; Willis DS, 1998, J CLIN ENDOCR METAB, V83, P3984, DOI 10.1210/jc.83.11.3984; Xu SY, 2011, ENDOCRINOLOGY, V152, P3941, DOI 10.1210/en.2011-1147; Yang G, 2011, J MOL MED, V89, P1037, DOI 10.1007/s00109-011-0775-x; Yang M, 2008, PHARMACOL THERAPEUT, V117, P94, DOI 10.1016/j.pharmthera.2007.08.004; Yang XK, 2012, REPRODUCTION, V144, P235, DOI 10.1530/REP-11-0371; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Yao N, 2010, ENDOCRINE, V38, P158, DOI 10.1007/s12020-010-9345-1; Yin MM, 2012, MOL ENDOCRINOL, V26, P1129, DOI 10.1210/me.2011-1341	80	100	112	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18239	18257		10.1074/jbc.M113.546044	http://dx.doi.org/10.1074/jbc.M113.546044			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828505	Green Published, hybrid			2022-12-28	WOS:000338042000025
J	Ly, K; Saavedra, YGL; Canuel, M; Routhier, S; Desjardins, R; Hamelin, J; Mayne, J; Lazure, C; Seidah, NG; Day, R				Ly, Kevin; Saavedra, Yascara Grisel Luna; Canuel, Maryssa; Routhier, Sophie; Desjardins, Roxane; Hamelin, Josee; Mayne, Janice; Lazure, Claude; Seidah, Nabil G.; Day, Robert			Annexin A2 Reduces PCSK9 Protein Levels via a Translational Mechanism and Interacts with the M1 and M2 Domains of PCSK9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; C-TERMINAL DOMAIN; LDL-RECEPTOR; MESSENGER-RNA; POSTTRANSLATIONAL MODIFICATIONS; POSTTRANSCRIPTIONAL REGULATION; LIVER-REGENERATION; MOUSE-LIVER; IN-VIVO; DEGRADATION	Annexin A2 (AnxA2) was reported to be an extracellular endogenous inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) activity on cell-surface LDL receptor degradation. In this study, we investigated the effect of silencing the expression of AnxA2 and PCSK9 in HepG2 and Huh7 cells to better define the role of AnxA2 in PCSK9 regulation. AnxA2 knockdown in Huh7 cells significantly increased PCSK9 protein levels as opposed to AnxA2 knockdown in HepG2 cells. However, HepG2 cells overexpressing AnxA2 had lower levels of PCSK9 protein. Overall, our data revealed a plausible new role of AnxA2 in the reduction of PCSK9 protein levels via a translational mechanism. Moreover, the C-terminal Cys/His-rich domain of PCSK9 is crucial in the regulation of PCSK9 activity, and we demonstrated by far-Western blot assay that the M1 and M2 domains are necessary for the specific interaction of PCSK9's C-terminal Cys/His-rich domain and AnxA2. Finally, we produced and purified recombinant PCSK9 from humans and mice, which was characterized and used to perform 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate LDL cell-based assays on the stable knockdown HepG2 and Huh7 cells. We also demonstrated for the first time the equipotency of human and mouse PCSK9 R218S on human cells.	[Ly, Kevin; Routhier, Sophie; Desjardins, Roxane; Day, Robert] Univ Sherbrooke, Fac Med & Sci Sante, Inst Pharmacol Sherbrooke, Dept Surg,Urol Div, Sherbrooke, PQ J1H 5N4, Canada; [Saavedra, Yascara Grisel Luna; Canuel, Maryssa; Hamelin, Josee; Seidah, Nabil G.] Univ Montreal, Lab Biochem Neuroendocrinol, Montreal, PQ H2W 1R7, Canada; [Lazure, Claude] Univ Montreal, Lab Neuropeptides Struct & Metab, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Mayne, Janice] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada	University of Sherbrooke; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa	Day, R (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Inst Pharmacol Sherbrooke, 3001 12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Robert.day@usherbrooke.ca			Fondation Leducq [13 CVD 03]; Canadian Institutes of Health Research Team [2496]; Strauss Foundation; Canadian Institutes of Health Research [MOP-102741]; Canada Chair Grant [216684]; Fonds de Recherche du Quebec-Sante	Fondation Leducq(Leducq Foundation); Canadian Institutes of Health Research Team(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Chair Grant; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Fondation Leducq Grant 13 CVD 03, Canadian Institutes of Health Research Team Grant 2496, a Strauss Foundation grant, Canadian Institutes of Health Research Grant MOP-102741, and Canada Chair Grant 216684 (to N. G. S. and R. D.).; Recipient of studentship support from the Fonds de Recherche du Quebec-Sante and Canadian Institutes of Health Research.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Bharadwaj A, 2013, INT J MOL SCI, V14, P6259, DOI 10.3390/ijms14036259; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Couture Frederic, 2011, Biomol Concepts, V2, P421; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Denault JB, 2000, PROTEIN EXPRES PURIF, V19, P113, DOI 10.1006/prep.2000.1215; Dewpura T, 2008, FEBS J, V275, P3480, DOI 10.1111/j.1742-4658.2008.06495.x; Dewpura T, 2011, METHODS MOL BIOL, V768, P167, DOI 10.1007/978-1-61779-204-5_8; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Hollas H, 2006, BBA-MOL CELL RES, V1763, P1325, DOI 10.1016/j.bbamcr.2006.08.043; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Konrad RJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-38; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Madureira PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050591; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mickleburgh I, 2005, FEBS J, V272, P413, DOI 10.1111/j.1742-4658.2004.04481.x; Morel E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001118; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Schiele F, 2014, J MOL BIOL, V426, P843, DOI 10.1016/j.jmb.2013.11.011; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sharathchandra A, 2012, RNA BIOL, V9, P1429, DOI 10.4161/rna.22707; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Vedeler A, 2000, BIOCHEM J, V348, P565, DOI 10.1042/0264-6021:3480565; Vedeler A, 2012, CURR PROTEIN PEPT SC, V13, P401, DOI 10.2174/138920312801619402; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	52	30	33	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17732	17746		10.1074/jbc.M113.541094	http://dx.doi.org/10.1074/jbc.M113.541094			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24808179	Green Published, hybrid			2022-12-28	WOS:000338018100037
J	Park, Y; Vennekate, W; Yavuz, H; Preobraschenski, J; Hernandez, JM; Riedel, D; Walla, PJ; Jahn, R				Park, Yongsoo; Vennekate, Wensi; Yavuz, Halenur; Preobraschenski, Julia; Hernandez, Javier M.; Riedel, Dietmar; Walla, Peter Jomo; Jahn, Reinhard			alpha-SNAP Interferes with the Zippering of the SNARE Protein Membrane Fusion Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; COMPLEX; DOCKING; YEAST; NSF; PARTICLES; VACUOLES; SYNTAXIN	Neuronal exocytosis is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. Before fusion, SNARE proteins form complexes bridging the membrane followed by assembly toward the C-terminal membrane anchors, thus initiating membrane fusion. After fusion, the SNARE complex is disassembled by the AAA-ATPase N-ethylmaleimide-sensitive factor that requires the cofactor alpha-SNAP to first bind to the assembled SNARE complex. Using chromaffin granules and liposomes we now show that alpha-SNAP on its own interferes with the zippering of membrane-anchored SNARE complexes midway through the zippering reaction, arresting SNAREs in a partially assembled trans-complex and preventing fusion. Intriguingly, the interference does not result in an inhibitory effect on synaptic vesicles, suggesting that membrane properties also influence the final outcome of alpha-SNAP interference with SNARE zippering. We suggest that binding of alpha-SNAP to the SNARE complex affects the ability of the SNARE complex to harness energy or transmit force to the membrane.	[Park, Yongsoo; Vennekate, Wensi; Yavuz, Halenur; Preobraschenski, Julia; Hernandez, Javier M.; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Vennekate, Wensi; Walla, Peter Jomo] Max Planck Inst Biophys Chem, AG Biomol Spect & Single Mol Detect, D-37077 Gottingen, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Facil Electron Microscopy, D-37077 Gottingen, Germany; [Walla, Peter Jomo] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Braunschweig University of Technology	Jahn, R (corresponding author), Fassberg 11, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Park, Yongsoo/G-9285-2014	Park, Yongsoo/0000-0001-8336-8051; Jahn, Reinhard/0000-0003-1542-3498	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM072694] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Burgalossi A, 2010, NEURON, V68, P473, DOI 10.1016/j.neuron.2010.09.019; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; CLARY DO, 1990, J BIOL CHEM, V265, P10109; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Cypionka A, 2009, P NATL ACAD SCI USA, V106, P18575, DOI 10.1073/pnas.0906677106; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Muller CB, 2008, J PHYS CHEM B, V112, P8236, DOI 10.1021/jp802280u; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286	33	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16326	16335		10.1074/jbc.M114.556803	http://dx.doi.org/10.1074/jbc.M114.556803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778182	Green Published, hybrid			2022-12-28	WOS:000337965700036
J	Pang, A; Frank, S; Brown, I; Warren, MJ; Pickersgill, RW				Pang, Allan; Frank, Stefanie; Brown, Ian; Warren, Martin J.; Pickersgill, Richard W.			Structural Insights into Higher Order Assembly and Function of the Bacterial Microcompartment Protein PduA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-ENTERICA; 1,2-PROPANEDIOL; ORGANELLES; TYPHIMURIUM; CARBOXYSOMES; ETHANOLAMINE; SEQUENCE; OPERON; SHELL; FORM	Bacterial microcompartments are large proteinaceous assemblies that are found in the cytoplasm of some bacteria. These structures consist of proteins constituting a shell that houses a number of enzymes involved in specific metabolic processes. The 1,2-propanediol-utilizing microcompartment is assembled from seven different types of shell proteins, one of which is PduA. It is one of the more abundant components of the shell and intriguingly can form nanotubule-like structures when expressed on its own in the cytoplasm of Escherichia coli. We propose a model that accounts for the size and appearance of these PduA structures and underpin our model using a combinatorial approach. Making strategic mutations at Lys-26, Val51, and Arg-79, we targeted residues predicted to be important for PduA assembly. We present the effect of the amino acid residue substitution on the phenotype of the PduA higher order assemblies (transmission electron microscopy) and the crystal structure of the K26D mutant with one glycerol molecule bound to the central pore. Our results support the view that the hexamer-hexamer interactions seen in PduA crystals persist in the cytoplasmic structures and reveal the profound influence of the two key amino acids, Lys-26 and Arg-79, on tiling, not only in the crystal lattice but also in the bacterial cytoplasm. Understanding and controlling PduA assemblies is valuable in order to inform manipulation for synthetic biology and biotechnological applications.	[Pang, Allan; Pickersgill, Richard W.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Frank, Stefanie; Brown, Ian; Warren, Martin J.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	University of London; Queen Mary University London; University of Kent	Warren, MJ (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.	m.j.warren@kent.ac.uk; r.w.pickersgill@qmul.ac.uk	Pang, Allan/AAU-3701-2021	Warren, Martin/0000-0002-6028-6456; Frank, Stefanie/0000-0003-3153-6417	Biotechnology and Biological Sciences Research Council [BB/H013180/1, BB/I013334/1]; Higher Education Council of England; Queen Mary University of London; BBSRC [BB/I013334/1, BB/H013180/1, BB/M002969/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M002969/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Higher Education Council of England; Queen Mary University of London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/H013180/1 and BB/I013334/1 and the Higher Education Council of England.; Recipient of studentship funding from Queen Mary University of London.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; BOCK E, 1974, ARCH MICROBIOL, V97, P115, DOI 10.1007/BF00403051; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank S, 2013, J BIOTECHNOL, V163, P273, DOI 10.1016/j.jbiotec.2012.09.002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pang A, 2012, ACTA CRYSTALLOGR D, V68, P1642, DOI 10.1107/S0907444912039315; Pang A, 2011, ACTA CRYSTALLOGR D, V67, P91, DOI 10.1107/S0907444910050201; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walter D, 1997, J BACTERIOL, V179, P1013, DOI 10.1128/jb.179.4.1013-1022.1997; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	32	47	49	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22377	22384		10.1074/jbc.M114.569285	http://dx.doi.org/10.1074/jbc.M114.569285			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24873823	Green Published, hybrid			2022-12-28	WOS:000340593500048
J	Hall, MD; Marshall, TS; Kwit, ADT; Jenkins, LMM; Dulcey, AE; Madigan, JP; Pluchino, KM; Goldsborough, AS; Brimacombe, KR; Griffiths, GL; Gottesman, MM				Hall, Matthew D.; Marshall, Travis S.; Kwit, Alexandra D. T.; Jenkins, Lisa M. Miller; Dulcey, Andres E.; Madigan, James P.; Pluchino, Kristen M.; Goldsborough, Andrew S.; Brimacombe, Kyle R.; Griffiths, Gary L.; Gottesman, Michael M.			Inhibition of Glutathione Peroxidase Mediates the Collateral Sensitivity of Multidrug-resistant Cells to Tiopronin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISATIN-BETA-THIOSEMICARBAZONES; HYDROGEN-PEROXIDE; SELECTIVE ACTIVITY; CANCER; DRUG; DETOXIFICATION; MECHANISMS; APOPTOSIS; CATALASE; IDENTIFICATION	Multidrug resistance (MDR) is a major obstacle to the successful chemotherapy of cancer. MDR is often the result of overexpression of ATP-binding cassette transporters following chemotherapy. A common ATP-binding cassette transporter that is overexpressed in MDR cancer cells is P-glycoprotein, which actively effluxes drugs against a concentration gradient, producing an MDR phenotype. Collateral sensitivity (CS), a phenomenon of drug hypersensitivity, is defined as the ability of certain compounds to selectively target MDR cells, but not the drug-sensitive parent cells from which they were derived. The drug tiopronin has been previously shown to elicit CS. However, unlike other CS agents, the mechanism of action was not dependent on the expression of P-glycoprotein in MDR cells. We have determined that the CS activity of tiopronin is mediated by the generation of reactive oxygen species (ROS) and that CS can be reversed by a variety of ROS-scavenging compounds. Specifically, selective toxicity of tiopronin toward MDR cells is achieved by inhibition of glutathione peroxidase (GPx), and the mode of inhibition of GPx1 by tiopronin is shown in this report. Why MDR cells are particularly sensitive to ROS is discussed, as is the difficulty in exploiting this hypersensitivity to tiopronin in the clinic.	[Hall, Matthew D.; Marshall, Travis S.; Kwit, Alexandra D. T.; Jenkins, Lisa M. Miller; Madigan, James P.; Pluchino, Kristen M.; Goldsborough, Andrew S.; Brimacombe, Kyle R.; Gottesman, Michael M.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dulcey, Andres E.; Griffiths, Gary L.] NHLBI, Imaging Probe Dev Ctr, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gottesman, MM (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mgottesman@nih.gov	Jenkins, Lisa/AAI-2490-2021		National Institutes of Health Intramural Research Program; NATIONAL CANCER INSTITUTE [ZICBC011430, ZIABC010830] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005090] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program.	Andreadis C, 2007, BLOOD, V109, P3409, DOI 10.1182/blood-2006-09-047621; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; BARTON DHR, 1991, TETRAHEDRON, V47, P6127, DOI 10.1016/S0040-4020(01)86546-7; BATIST G, 1986, J BIOL CHEM, V261, P5544; Brimacombe KR, 2009, ASSAY DRUG DEV TECHN, V7, P233, DOI 10.1089/adt.2008.165; Cabello CM, 2007, CURR OPIN INVEST DR, V8, P1022; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; CHAUDIERE J, 1984, J BIOL CHEM, V259, P1043; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Danieli B, 2006, J ORG CHEM, V71, P2848, DOI 10.1021/jo052677g; DEANGELIS L, 1978, DRUG TODAY, V14, P37; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; DOROSHOW JH, 1990, PHARMACOL THERAPEUT, V47, P359, DOI 10.1016/0163-7258(90)90062-7; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; Flohe L, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P167, DOI 10.1007/978-1-4614-1025-6_13; Fojo T, 2008, ONCOLOGIST, V13, P277, DOI 10.1634/theoncologist.2007-0090; GAETANI GF, 1989, BLOOD, V73, P334; Gillet JP, 2012, CLIN CANCER RES, V18, P3197, DOI 10.1158/1078-0432.CCR-12-0056; Gladyshev VN, 1999, J BIOMED SCI, V6, P151, DOI 10.1007/BF02255899; Goldsborough AS, 2011, J MED CHEM, V54, P4987, DOI 10.1021/jm2001663; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gupte A, 2007, FREE RADICAL BIO MED, V43, P1271, DOI 10.1016/j.freeradbiomed.2007.07.003; Hall MD, 2011, J MED CHEM, V54, P5878, DOI 10.1021/jm2006047; Hall MD, 2009, TRENDS PHARMACOL SCI, V30, P546, DOI 10.1016/j.tips.2009.07.003; Hall MD, 2009, J MED CHEM, V52, P3191, DOI 10.1021/jm800861c; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Huff LM, 2006, J BIOL CHEM, V281, P36501, DOI 10.1074/jbc.M602998200; Jeitner TM, 2001, TOXICOL SCI, V63, P57, DOI 10.1093/toxsci/63.1.57; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Laberge RM, 2007, BIOCHEM PHARMACOL, V73, P1727, DOI 10.1016/j.bcp.2007.02.005; LOCK RB, 1988, INT J CANCER, V42, P373, DOI 10.1002/ijc.2910420312; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Ludwig JA, 2006, CANCER RES, V66, P4808, DOI 10.1158/0008-5472.CAN-05-3322; Marks KM, 2011, J NAT PROD, V74, P567, DOI 10.1021/np100429s; Minagawa Y, 2001, Hum Cell, V14, P237; Mix H, 2007, NUCLEIC ACIDS RES, V35, P414, DOI 10.1093/nar/gkl1060; MULLER C, 1994, INT J CANCER, V56, P749, DOI 10.1002/ijc.2910560523; Nicholls P, 2012, ARCH BIOCHEM BIOPHYS, V525, P95, DOI 10.1016/j.abb.2012.01.015; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Park YS, 2003, FREE RADICAL RES, V37, P205, DOI 10.1080/1071576021000041005; PATRICK TB, 1993, J ORG CHEM, V58, P705, DOI 10.1021/jo00055a026; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Saga Y, 2008, ONCOL REP, V20, P1299, DOI 10.3892/or_00000144; SAMUELS BL, 1991, CANCER RES, V51, P521; Sawada T, 1997, IMMUNOPHARMACOLOGY, V35, P195, DOI 10.1016/S0162-3109(96)00145-2; Schulz R, 2012, BIOORG MED CHEM LETT, V22, P6712, DOI 10.1016/j.bmcl.2012.08.091; SHEN DW, 1986, J BIOL CHEM, V261, P7762; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; UDUPI V, 1992, FREE RADICAL RES COM, V16, P315, DOI 10.3109/10715769209049184; Vitai M, 1997, CLIN CHIM ACTA, V261, P35, DOI 10.1016/S0009-8981(97)06514-5; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010	58	35	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21473	21489		10.1074/jbc.M114.581702	http://dx.doi.org/10.1074/jbc.M114.581702			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24930045	Green Published, hybrid			2022-12-28	WOS:000340558300025
J	Adams, EJ; Chen, XW; O'Shea, KS; Ginsburg, D				Adams, Elizabeth J.; Chen, Xiao-Wei; O'Shea, K. Sue; Ginsburg, David			Mammalian COPII Coat Component SEC24C Is Required for Embryonic Development in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN TRANSPORTER; MEMBRANE-PROTEINS; CARGO SELECTION; EXPRESSION; MUTATIONS; MECHANISMS; DATABASE; HOMEOSTASIS; DISRUPTION; VESICLES	COPII-coated vesicles mediate the transport of newly synthesized proteins from the endoplasmic reticulum to the Golgi. SEC24 is the COPII component primarily responsible for recruitment of protein cargoes into nascent vesicles. There are four Sec24 paralogs in mammals, with mice deficient in SEC24A, -B, and -D exhibiting a wide range of phenotypes. We now report the characterization of mice with deficiency in the fourth Sec24 paralog, SEC24C. Although mice haploinsufficient for Sec24c exhibit no apparent abnormalities, homozygous deficiency results in embryonic lethality at approximately embryonic day 7. Tissue-specific deletion of Sec24c in hepatocytes, pancreatic cells, smooth muscle cells, and intestinal epithelial cells results in phenotypically normal mice. Thus, SEC24C is required in early mammalian development but is dispensable in a number of tissues, likely as a result of compensation by other Sec24 paralogs. The embryonic lethality resulting from loss of SEC24C occurs considerably later than the lethality previously observed in SEC24D deficiency; it is clearly distinct from the restricted neural tube phenotype of Sec24b null embryos and the mild hypocholesterolemic phenotype of adult Sec24a null mice. Taken together, these results demonstrate that the four Sec24 paralogs have developed unique functions over the course of vertebrate evolution.	[Adams, Elizabeth J.; Chen, Xiao-Wei; Ginsburg, David] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Adams, Elizabeth J.; Ginsburg, David] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [O'Shea, K. Sue] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med Human Genet & Pediat, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Ginsburg, D (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu		Chen, Xiao-Wei/0000-0001-6466-6248; Ginsburg, David/0000-0002-6436-8942	University of Michigan Multipurpose Arthritis Center; National Institutes of Health [AR20557, CA46592]; University of Michigan Cancer Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039693, P01HL057346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	University of Michigan Multipurpose Arthritis Center(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Jonathan Goldberg for helpful discussions regarding the Sec24c splice forms, Marta Dzaman for help with E7.5 histology, and Anya Kiseleva and Gengeng Yu for their technical support. We acknowledge Elizabeth Hughes, Keith Childs, Galina Gavrilina, and Debora VanHeyningen for preparation of ES cell mouse chimeras from gene-trapped ES clone EPD0241-2-A11 and the Transgenic Animal Model Core of the University of Michigan's Biomedical Research Core Facilities (core support was provided by the University of Michigan Multipurpose Arthritis Center, National Institutes of Health Grant AR20557, University of Michigan Cancer Center, and National Institutes of Health Grant CA46592). All histology work was performed in the Microscopy and Image Analysis Laboratory at the University of Michigan, Biomedical Research Core Facilities, with the assistance of Judy Poore. The Microscopy and Image Analysis Laboratory is a multiuser imaging facility supported by NCI, National Institutes of Health, O'Brien Renal Center, University of Michigan Medical School, and Endowment for the Basic Sciences, Department of Cell and Developmental Biology, and the University of Michigan.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; BAHOU WF, 1988, BLOOD, V72, P308; Baines AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061114; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Driever W, 1996, DEVELOPMENT, V123, P37; Fahim AT, 2009, THROMB RES, V123, P785, DOI 10.1016/j.thromres.2008.07.004; Frutkin AD, 2006, J MOL CELL CARDIOL, V41, P724, DOI 10.1016/j.yjmcc.2006.06.067; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Nagy A., 2003, MANIPULATING MOUSE E, P237; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Richardson L, 2010, NUCLEIC ACIDS RES, V38, pD703, DOI 10.1093/nar/gkp763; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tang BL, 1999, BIOCHEM BIOPH RES CO, V258, P679, DOI 10.1006/bbrc.1999.0574; Tao JY, 2012, P NATL ACAD SCI USA, V109, pE2001, DOI 10.1073/pnas.1209207109; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Westrick RJ, 2010, P NATL ACAD SCI USA, V107, P16904, DOI 10.1073/pnas.1012050107; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yang XW., 2005, CURR PROTOC NEUROSCI, V20; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153	54	19	19	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20858	20870		10.1074/jbc.M114.566687	http://dx.doi.org/10.1074/jbc.M114.566687			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24876386	Green Published, hybrid			2022-12-28	WOS:000339396600040
J	Ahrman, E; Lorenzo, P; Holmgren, K; Grodzinsky, AJ; Dahlberg, LE; Saxne, T; Heinegard, D; Onnerfjord, P				Ahrman, Emma; Lorenzo, Pilar; Holmgren, Kristin; Grodzinsky, Alan J.; Dahlberg, Leif E.; Saxne, Tore; Heinegard, Dick; Onnerfjord, Patrik			Novel Cartilage Oligomeric Matrix Protein (COMP) Neoepitopes Identified in Synovial Fluids from Patients with Joint Diseases Using Affinity Chromatography and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODIES; ARTICULAR-CARTILAGE; SERUM; OSTEOARTHRITIS; METALLOPROTEINASE; PROGRESSION; BIOMARKERS; FRAGMENTS; CLEAVAGE	To identify patients at risk for progressive joint damage, there is a need for early diagnostic tools to detect molecular events leading to cartilage destruction. Isolation and characterization of distinct cartilage oligomeric matrix protein (COMP) fragments derived from cartilage and released into synovial fluid will allow discrimination between different pathological conditions and monitoring of disease progression. Early detection of disease and processes in the tissue as well as an understanding of the pathologic mechanisms will also open the way for novel treatment strategies. Disease-specific COMP fragments were isolated by affinity chromatography of synovial fluids from patients with rheumatoid arthritis, osteoarthritis, or acute trauma. Enriched COMP fragments were separated by SDS-PAGE followed by in-gel digestion and mass spectrometric identification and characterization. Using the enzymes trypsin, chymotrypsin, and Asp-N for the digestions, an extensive analysis of the enriched fragments could be accomplished. Twelve different neoepitopes were identified and characterized within the enriched COMP fragments. For one of the neoepitopes, Ser(77), an inhibition ELISA was developed. This ELISA quantifies COMP fragments clearly distinguishable from total COMP. Furthermore, fragments containing the neoepitope Ser(77) were released into the culture medium of cytokine (TNF-alpha and IL-6/soluble IL-6 receptor)-stimulated human cartilage explants. The identified neoepitopes provide a complement to the currently available commercial assays for cartilage markers. Through neoepitope assays, tools to pinpoint disease progression, evaluation methods for therapy, and means to elucidate disease mechanisms will be provided.	[Ahrman, Emma; Lorenzo, Pilar; Holmgren, Kristin; Saxne, Tore; Heinegard, Dick; Onnerfjord, Patrik] Lund Univ, Rheumatol Sect, Dept Clin Sci Lund, Biomed Ctr C12, SE-22184 Lund, Sweden; [Grodzinsky, Alan J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Grodzinsky, Alan J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Grodzinsky, Alan J.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Dahlberg, Leif E.] Lund Univ, Skane Univ Hosp, Dept Orthoped, SE-22185 Lund, Sweden	Lund University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Lund University; Skane University Hospital	Ahrman, E (corresponding author), Lund Univ, Rheumatol Sect, Dept Clin Sci Lund, Biomed Ctr C12, SE-22184 Lund, Sweden.	emma.ahrman@med.lu.se	Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937	Inga-Britt and Arne Lundberg Foundation; Crafoord foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045779] Funding Source: NIH RePORTER	Inga-Britt and Arne Lundberg Foundation; Crafoord foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Tobias Gustavsson (The Novo Nordisk Foundation, Center for Protein Research, University of Copenhagen, Copenhagen, Denmark) for the generous gift of the protein used in the inhibition ELISA. Yang Li and Yang Wang (Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA) harvested, prepared, and cultured the human cartilage explant samples. We thank Dr. Susan Chubinskaya of Rush University Medical Center for providing human tissue, Gift of Hope and the donor's family for human cartilage, and Dr. Arkady Margulis for tissue procurement. We thank the Inga-Britt and Arne Lundberg Foundation as well as the Crafoord foundation for funding the mass spectrometers used in this study.	Andersson MLE, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-229; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; DiCesare PE, 1997, FEBS LETT, V412, P249, DOI 10.1016/S0014-5793(97)00789-8; Dickinson SC, 2003, MATRIX BIOL, V22, P267, DOI 10.1016/S0945-053X(03)00034-9; Ganu V, 1998, ARTHRITIS RHEUM, V41, P2143, DOI 10.1002/1529-0131(199812)41:12<2143::AID-ART9>3.0.CO;2-P; Geng H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4022; Geng H, 2013, ARTHRITIS RHEUM-US, V65, P2301, DOI 10.1002/art.38046; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Heinegard D., 2012, U. S. Patent, Patent No. [8,110,663, 8110663]; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Heinegard D, 2009, INT J EXP PATHOL, V90, P575, DOI 10.1111/j.1365-2613.2009.00695.x; Hesselstrand R, 2008, ANN RHEUM DIS, V67, P1242, DOI 10.1136/ard.2007.082099; Kraus VB, 2011, OSTEOARTHR CARTILAGE, V19, P515, DOI 10.1016/j.joca.2010.08.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai Y, 2012, OSTEOARTHR CARTILAGE, V20, P854, DOI 10.1016/j.joca.2012.05.003; Lindqvist E, 2005, ANN RHEUM DIS, V64, P196, DOI 10.1136/ard.2003.019992; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Liu CJ, 2006, J BIOL CHEM, V281, P15800, DOI 10.1074/jbc.M513433200; Lotz M, 2013, ANN RHEUM DIS, V72, P1756, DOI 10.1136/annrheumdis-2013-203726; MANSSON B, 1995, J CLIN INVEST, V95, P1071, DOI 10.1172/JCI117753; Muehleman C, 1997, OSTEOARTHR CARTILAGE, V5, P23, DOI 10.1016/S1063-4584(97)80029-5; Neidhart M, 1997, BRIT J RHEUMATOL, V36, P1151; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; SAXNE T, 1992, BRIT J RHEUMATOL, V31, P583; SAXNE T, 2006, RHEUMATOID ARTHRITIS, P301; SHARIF M, 1995, BRIT J RHEUMATOL, V34, P306; Sui YH, 2009, ARTHRITIS RHEUM-US, V60, P2985, DOI 10.1002/art.24857; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tseng S, 2009, BIOMARK INSIGHTS, V4, P33; Vilim V, 2003, CLIN CHIM ACTA, V328, P59, DOI 10.1016/S0009-8981(02)00375-3; Vilim V, 1997, ARCH BIOCHEM BIOPHYS, V341, P8, DOI 10.1006/abbi.1997.9941; Williams FMK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2344	38	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20908	20916		10.1074/jbc.M114.554683	http://dx.doi.org/10.1074/jbc.M114.554683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917676	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000339396600044
J	Cao, J; Meng, SM; Chang, E; Beckwith-Fickas, K; Xiong, LS; Cole, RN; Radovick, S; Wondisford, FE; He, L				Cao, Jia; Meng, Shumei; Chang, Evan; Beckwith-Fickas, Katherine; Xiong, Lishou; Cole, Robert N.; Radovick, Sally; Wondisford, Fredric E.; He, Ling			Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC GLUCONEOGENESIS; RESPIRATORY-CHAIN; CANCER; PHOSPHORYLATION; RISK; MICE; PHARMACOKINETICS; PHARMACODYNAMICS; INHIBITION; MECHANISM	Metformin is a first-line antidiabetic agent taken by 150 million people across the world every year, yet its mechanism remains only partially understood and controversial. It was proposed that suppression of glucose production in hepatocytes by metformin is AMPK-independent; however, unachievably high concentrations of metformin were employed in these studies. In the current study, we find that metformin, via an AMP-activated protein kinase (AMPK)-dependent mechanism, suppresses glucose production and gluconeogenic gene expression in primary hepatocytes at concentrations found in the portal vein of animals (60-80 mu M). Metformin also inhibits gluconeogenic gene expression in the liver of mice administered orally with metformin. Furthermore, the cAMP-PKA pathway negatively regulates AMPK activity through phosphorylation at Ser-485/497 on the alpha subunit, which in turn reduces net phosphorylation at Thr-172. Because diabetic patients often have hyperglucagonemia, AMPK alpha phosphorylation at Ser-485/497 is a therapeutic target to improve metformin efficacy.	[Cao, Jia; Meng, Shumei; Chang, Evan; Xiong, Lishou; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA; [Cao, Jia; Meng, Shumei; Chang, Evan; Xiong, Lishou; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Metab, Baltimore, MD 21287 USA; [Cao, Jia; Meng, Shumei; Chang, Evan; Xiong, Lishou; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Div Metab, Baltimore, MD 21287 USA; [Cao, Jia; Meng, Shumei; Chang, Evan; Xiong, Lishou; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Med, Div Metab, Baltimore, MD 21287 USA; [Beckwith-Fickas, Katherine; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Endocrinol, Baltimore, MD 21287 USA; [Beckwith-Fickas, Katherine; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Endocrinol, Baltimore, MD 21287 USA; [Beckwith-Fickas, Katherine; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Div Endocrinol, Baltimore, MD 21287 USA; [Beckwith-Fickas, Katherine; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21287 USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Pediat, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Physiol, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Med, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	He, L (corresponding author), Div Metab, 600 N Wolfe St, Baltimore, MD 21287 USA.	heling@jhmi.edu			National Institutes of Health through the NIDDK [R00DK085142]; Johns Hopkins University-University of Maryland Diabetes Research Center, National Institutes of Health from NIDDK [P60DK079637]; Johns Hopkins Institute for Clinical and Translational Research - National Center for Advancing Translational Sciences [UL1TR000424-06]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK063349, P30DK089502, R00DK085142, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; Johns Hopkins University-University of Maryland Diabetes Research Center, National Institutes of Health from NIDDK; Johns Hopkins Institute for Clinical and Translational Research - National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part National Institutes of Health Grant R00DK085142 through the NIDDK (to L. H.), The Johns Hopkins University-University of Maryland Diabetes Research Center, National Institutes of Health Grant P60DK079637 from NIDDK, and an award from the Johns Hopkins Institute for Clinical and Translational Research funded by the National Center for Advancing Translational Sciences Grant UL1TR000424-06 (to L. H.).	BROVKO LY, 1994, ANAL BIOCHEM, V220, P410, DOI 10.1006/abio.1994.1358; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Garcia-Haro L, 2012, FEBS LETT, V586, P4241, DOI 10.1016/j.febslet.2012.10.032; Gorman MW, 2003, LUMINESCENCE, V18, P173, DOI 10.1002/bio.721; He L, 2014, J ENDOCRINOL, V221, P363, DOI 10.1530/JOE-14-0084; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Higgins JW, 2012, DRUG METAB DISPOS, V40, P1170, DOI 10.1124/dmd.112.044875; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Jang EH, 2010, DRUG METAB PHARMACOK, V25, P392, DOI 10.2133/dmpk.DMPK-10-NT-010; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pulinilkunnil T, 2011, J BIOL CHEM, V286, P8798, DOI 10.1074/jbc.M111.218719; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Soraya H, 2012, INT IMMUNOPHARMACOL, V14, P785, DOI 10.1016/j.intimp.2012.10.014; Stocker SL, 2013, CLIN PHARMACOL THER, V93, P186, DOI 10.1038/clpt.2012.210; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Tsuchiya Y, 2012, BIOSCIENCE REP, V32, P197, DOI 10.1042/BSR20110076; TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	39	124	128	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20435	20446		10.1074/jbc.M114.567271	http://dx.doi.org/10.1074/jbc.M114.567271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928508	hybrid, Green Published			2022-12-28	WOS:000339396600003
J	Lee, YH; Morrison, BL; Bottaro, DP				Lee, Young H.; Morrison, Bethanie L.; Bottaro, Donald P.			Synergistic Signaling of Tumor Cell Invasiveness by Hepatocyte Growth Factor and Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CARCINOMA CELLS; BETA-CATENIN; MESENCHYMAL TRANSITION; CANCER CELLS; E-CADHERIN; IN-VITRO; C-JUN; AUTOPHAGY; ACTIVATION; MET	Hepatocyte growth factor (HGF) signaling promotes tumor invasiveness in renal cell carcinoma (RCC) and other cancers. In clear cell RCC, VHL loss generates pseudohypoxia that exacerbates HGF-driven invasion through beta-catenin deregulation. Hypoxia also enhances HGF-driven invasiveness by papillary RCC cells, but in the absence of VHL, loss signaling integration involves three parallel routes: 1) hypoxia-induced reactive oxygen species production and decreased DUSP2 expression, leading to enhanced mitogen-activated protein kinase (MAPK) cascade activation; 2) reactive oxygen species-induced diacylglycerol production by phospholipase C gamma, leading to protein kinase C activation and increased protein phosphatase-2A activity, thereby suppressing HGF-induced Akt activation; and 3) a profound shift from HGF-enhanced, proliferation-oriented metabolism to autophagy-dependent invasion and suppression of proliferation. This tripartite signaling integration was not unique to RCC or HGF; in RCC cells, invasive synergy induced by the combination of hypoxia and epidermal growth factor occurred through the same mechanism, and in estrogen receptor-positive breast cancer cells, this mechanism was suppressed in the absence of estrogen. These results define the molecular basis of growth factor and hypoxia invasive synergy in VHL-competent papillary RCC cells, illustrate the plasticity of invasive and proliferative tumor cell states, and provide signaling profiles by which they may be predicted.	[Lee, Young H.; Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Morrison, Bethanie L.] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bottaro, DP (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bldg 10 CRC Rm 2-3952,10 Ctr Dr MSC 1107, Bethesda, MD 20892 USA.	dbottaro@helix.nih.gov	Bottaro, Donald P/F-8550-2010; Bottaro, Donald P/AAF-3853-2020	Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334	National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011124] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Asnaghi L., 2013, AM ASS CANC RES ANN; Athauda G, 2006, CLIN CANCER RES, V12, P4154, DOI 10.1158/1078-0432.CCR-06-0250; Ben-Ami I, 2011, J BIOL CHEM, V286, P31022, DOI 10.1074/jbc.M111.247726; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Chaudary N, 2013, RADIOTHER ONCOL, V108, P506, DOI 10.1016/j.radonc.2013.06.019; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Gopalakrishna R, 1999, CANCER LETT, V136, P143, DOI 10.1016/S0304-3835(98)00315-2; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Ide T, 2006, INT J CANCER, V119, P2750, DOI 10.1002/ijc.22178; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Liao Y, 2010, AM J TRANSL RES, V2, P19; Linehan WM, 2010, ANNU REV MED, V61, P329, DOI 10.1146/annurev.med.042808.171650; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069485; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Peruzzi B, 2006, CELL CYCLE, V5, P2839, DOI 10.4161/cc.5.24.3581; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pursiheimo JP, 2009, ONCOGENE, V28, P334, DOI 10.1038/onc.2008.392; Rubin J. S., 2011, UCSD MOL PAGES, DOI [10.6072/H0.MP.A004032.01, DOI 10.6072/H0.MP.A004032.01]; Tai CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-95; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanimura S, 1998, ONCOGENE, V17, P57, DOI 10.1038/sj.onc.1201905; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Ueda K, 2013, ARTERIOSCL THROM VAS, V33, P1837, DOI 10.1161/ATVBAHA.112.300752; van Adelsberg J, 2001, J BIOL CHEM, V276, P15099, DOI 10.1074/jbc.M006634200; Wong VCL, 2012, INT J CANCER, V130, P83, DOI 10.1002/ijc.25970; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	49	18	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20448	20461		10.1074/jbc.M114.580597	http://dx.doi.org/10.1074/jbc.M114.580597			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24914205	Green Published, hybrid			2022-12-28	WOS:000339396600004
J	Zhuo, Y; Vishnivetskiy, SA; Zhan, XZ; Gurevich, VV; Klug, CS				Zhuo, Ya; Vishnivetskiy, Sergey A.; Zhan, Xuanzhi; Gurevich, Vsevolod V.; Klug, Candice S.			Identification of Receptor Binding-induced Conformational Changes in Non-visual Arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CLATHRIN ADAPTER AP-2; BETA-ARRESTIN; CRYSTAL-STRUCTURE; RHODOPSIN PHOSPHORYLATION; VISUAL ARRESTIN; SPECIFICITY; ACTIVATION; EXPRESSION; ELEMENTS	The non-visual arrestins, arrestin-2 and arrestin-3, belong to a small family of multifunctional cytosolic proteins. Non-visual arrestins interact with hundreds of G protein-coupled receptors (GPCRs) and regulate GPCR desensitization by binding active phosphorylated GPCRs and uncoupling them from heterotrimeric G proteins. Recently, non-visual arrestins have been shown to mediate G protein-independent signaling by serving as adaptors and scaffolds that assemble multiprotein complexes. By recruiting various partners, including trafficking and signaling proteins, directly to GPCRs, non-visual arrestins connect activated receptors to diverse signaling pathways. To investigate arrestin-mediated signaling, a structural understanding of arrestin activation and interaction with GPCRs is essential. Here we identified global and local conformational changes in the non-visual arrestins upon binding to the model GPCR rhodopsin. To detect conformational changes, pairs of spin labels were introduced into arrestin-2 and arrestin-3, and the interspin distances in the absence and presence of the receptor were measured by double electron electron resonance spectroscopy. Our data indicate that both non-visual arrestins undergo several conformational changes similar to arrestin-1, including the finger loop moving toward the predicted location of the receptor in the complex as well as the C-tail release upon receptor binding. The arrestin-2 results also suggest that there is no clam shell-like closure of the N- and C-domains and that the loop containing residue 136 (homolog of 139 in arrestin-1) has high flexibility in both free and receptor-bound states.	[Zhuo, Ya; Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Vishnivetskiy, Sergey A.; Zhan, Xuanzhi; Gurevich, Vsevolod V.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Medical College of Wisconsin; Vanderbilt University	Klug, CS (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	candice@mcw.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health (NIH) [GM077561, EY011500, GM081756]; NIH [S10RR022422, S10OD011937, P41EB001980]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022422] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD011937] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants GM077561, EY011500, and GM081756 (to V. V. G.). The DEER instrumentation was supported by NIH Grants S10RR022422 and S10OD011937, and data were collected at the National Biomedical EPR Center (supported by NIH Grant P41EB001980).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Feuerstein SE, 2009, BIOCHEMISTRY-US, V48, P10733, DOI 10.1021/bi900544p; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hatmal MM, 2012, BIOPOLYMERS, V97, P35, DOI 10.1002/bip.21699; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Moaven H, 2013, P NATL ACAD SCI USA, V110, P9463, DOI 10.1073/pnas.1301126110; Modzelewska A, 2006, CELL BIOCHEM BIOPHYS, V46, P1, DOI 10.1385/CBB:46:1:1; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; PALCZEWSKI K, 1992, BIOCHEMISTRY-US, V31, P3902, DOI 10.1021/bi00131a003; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rapp CS, 2005, PROTEINS, V60, P103, DOI 10.1002/prot.20492; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Skegro D, 2007, PHOTOCHEM PHOTOBIOL, V83, P385, DOI 10.1562/2006-08-25-RA-1014; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P11741, DOI 10.1074/jbc.M113.450031; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Warshaviak DT, 2013, J MAGN RESON, V232, P53, DOI 10.1016/j.jmr.2013.04.013; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	68	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20991	21002		10.1074/jbc.M114.560680	http://dx.doi.org/10.1074/jbc.M114.560680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24867953	hybrid, Green Published			2022-12-28	WOS:000339396600052
J	McMillan, SJ; Sharma, RS; Richards, HE; Hegde, V; Crocker, PR				McMillan, Sarah J.; Sharma, Ritu S.; Richards, Hannah E.; Hegde, Vikas; Crocker, Paul R.			Siglec-E Promotes beta 2-Integrin-dependent NADPH Oxidase Activation to Suppress Neutrophil Recruitment to the Lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; MICE; INFLAMMATION; P47(PHOX); RESPONSES; INJURY	Siglec-E is a sialic acid-binding Ig-like lectin expressed on murine myeloid cells. It has recently been shown to function as a negative regulator of beta 2-integrin-dependent neutrophil recruitment to the lung following exposure to lipopolysaccharide (LPS). Here, we demonstrate that siglec-E promoted neutrophil production of reactive oxygen species (ROS) following CD11b beta 2-integrin ligation with fibrinogen in a sialic acid-dependent manner, but it had no effect on ROS triggered by a variety of other stimulants. Siglec-E promotion of ROS was likely mediated via Akt activation, because siglec-E-deficient neutrophils plated on fibrinogen exhibited reduced phosphorylation of Akt, and the Akt inhibitor, MK2206, blocked fibrinogen-induced ROS. In vivo imaging showed that siglec-E also promoted ROS in acutely inflamed lungs following exposure of mice to LPS. Importantly, siglec-E-promoted ROS were required for its inhibitory function, as the NADPH oxidase inhibitor, apocynin, reversed the siglec-E-mediated suppression of neutrophil recruitment and blocked neutrophil ROS production in vitro. Taken together, these results demonstrate that siglec-E functions as an inhibitory receptor of neutrophils via positive regulation of NADPH oxidase activation and ROS production. Our findings have implications for the inhibitory role of siglec-9 on human neutrophils in sepsis and acute lung injury.	[McMillan, Sarah J.; Sharma, Ritu S.; Richards, Hannah E.; Crocker, Paul R.] Univ Dundee, Dept Cell Signalling & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Hegde, Vikas] Univ Dundee, Ctr Dermatol & Genet Med, Div Mol Med, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	Crocker, PR (corresponding author), Univ Dundee, Dept Cell Signalling & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland.	p.r.crocker@dundee.ac.uk			Medical Research Council [G0700314, G0801742]; MRC [G0700314, G0801742] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr. Angelika Grundling, Imperial College London, for the generous gift of S. aureus and Alena Shmakova for initial observations with MK2206. We also thank Prof. W. H. Irwin McLean, supported by the Medical Research Council (Grants G0700314 and G0801742) for use of the IVIS imaging system.	Anderson KE, 2008, BLOOD, V112, P5202, DOI 10.1182/blood-2008-04-149450; Boyle KB, 2012, ANN NY ACAD SCI, V1273, P68, DOI 10.1111/j.1749-6632.2012.06821.x; Boyle KB, 2011, J IMMUNOL, V186, P2978, DOI 10.4049/jimmunol.1002268; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; DOERSCHUK CM, 1987, J APPL PHYSIOL, V63, P1806, DOI 10.1152/jappl.1987.63.5.1806; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Kielland A, 2009, FREE RADICAL BIO MED, V47, P760, DOI 10.1016/j.freeradbiomed.2009.06.013; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; McMillan SJ, 2013, BLOOD, V121, P2084, DOI 10.1182/blood-2012-08-449983; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Segal BH, 2007, AM J PHYSIOL-LUNG C, V292, pL760, DOI 10.1152/ajplung.00281.2006; Segal BH, 2011, BIOL BLOOD MARROW TR, V17, pS123, DOI 10.1016/j.bbmt.2010.09.008; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang WJ, 2009, FREE RADICAL BIO MED, V46, P791, DOI 10.1016/j.freeradbiomed.2008.12.003	23	38	41	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20370	20376		10.1074/jbc.M114.574624	http://dx.doi.org/10.1074/jbc.M114.574624			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895121	Green Published, hybrid			2022-12-28	WOS:000339395200047
J	Zhuang, XL; Stahl, SJ; Watts, NR; DiMattia, MA; Steven, AC; Wingfield, PT				Zhuang, Xiaolei; Stahl, Stephen J.; Watts, Norman R.; DiMattia, Michael A.; Steven, Alasdair C.; Wingfield, Paul T.			A Cell-penetrating Antibody Fragment against HIV-1 Rev Has High Antiviral Activity CHARACTERIZATION OF THE PARATOPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-CD4 MONOCLONAL-ANTIBODY; NUCLEAR-LOCALIZATION; PEPTIDE; BINDING; TAT; RRE; MINIANTIBODY; REPLICATION; ANTAGONISM; CORECEPTOR	The HIV-1 protein Rev oligomerizes on viral transcripts and directs their nuclear export. Previously, a Fab against Rev generated by phage display was used to crystallize and solve the structure of the Rev oligomerization domain. Here we have investigated the capability of this Fab to block Rev oligomerization and inhibit HIV-1 replication. The Fab itself did not have antiviral activity, but when a Tat-derived cell-penetrating peptide was appended, the resulting molecule (FabRev1-Tat) was strongly inhibitory of three different CCR5-tropic HIV-1 isolates (IC50 = 0.09-0.44 mu g/ml), as assessed by suppression of reverse transcriptase activity in infected peripheral blood mononuclear cells, and had low cell toxicity (TC50 > 100 mu g/ml). FabRev1-Tat was taken up by both peripheral blood mononuclear and HEK293T cells, appearing in both the cytoplasm and nucleus, as shown by immunofluorescence confocal laser scanning microscopy. Computational alanine scanning was used to identify key residues in the complementarity-determining regions to guide mutagenesis experiments. Residues in the light chain CDR3 (LCDR3) were assessed to be important. Residues in LCDR3 were mutated, and LCDR3-Tyr(92) was found to be critical for binding to Rev, as judged by surface plasmon resonance and electron microscopy. Peptides corresponding to all six CDR regions were synthesized and tested for Rev binding. None of the linear peptides had significant affinity for Rev, but four of the amide-cyclic forms did. Especially cyclic-LCDR3 (LGGYPAASYRTA) had high affinity for Rev and was able to effectively depolymerize Rev filaments, as shown by both surface plasmon resonance and electron microscopy.	NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA; [DiMattia, Michael A.; Steven, Alasdair C.] NIAMSD, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Wingfield, PT (corresponding author), NIH, Bldg 6B,Rm 1B130, Bethesda, MD 20892 USA.	pelpw@helix.nih.gov		Wingfield, Paul/0000-0002-9515-4752	Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN272200700041C]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041115, ZIAAR041166] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs. Marc Nicklaus and Megan Peach (NCI/National Institutes of Health) for performing the computational alanine scanning, and Drs. Steven Turk (NIAID/National Institutes of Health) and Christoph Rader (Scripps) for much appreciated discussions. Drs. Evelyn Ralston and Kristina Zaal (NIAMS/National Institutes of Health) provided advice on the immunofluorescence microscopy. We also thank Joshua Kaufman and Ira Palmer (NIAMS/National Institutes of Health) for expert technical assistance. The anti-HIV testing was conducted by the Southern Research Institute using federal funds from the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, under contract HHSN272200700041C entitled "Confirmatory In Vitro Evaluations of HIV Therapeutics."	Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Bes C, 2001, FEBS LETT, V508, P67, DOI 10.1016/S0014-5793(01)03036-8; Casset F, 2003, BIOCHEM BIOPH RES CO, V307, P198, DOI 10.1016/S0006-291X(03)01131-8; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Dupont E, 2011, METHODS MOL BIOL, V683, P21, DOI 10.1007/978-1-60761-919-2_2; Fang XY, 2013, CELL, V155, P594, DOI 10.1016/j.cell.2013.10.008; Fleta-Soriano E, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-17; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Guo QG, 2012, CHEM BIOL DRUG DES, V79, P683, DOI 10.1111/j.1747-0285.2011.01315.x; Heap CJ, 2005, J GEN VIROL, V86, P1791, DOI 10.1099/vir.0.80812-0; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jain C, 2001, MOL CELL, V7, P603, DOI 10.1016/S1097-2765(01)00207-6; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kruger DM, 2010, NUCLEIC ACIDS RES, V38, pW480, DOI 10.1093/nar/gkq471; Laune D, 2002, J IMMUNOL METHODS, V267, P53, DOI 10.1016/S0022-1759(02)00140-0; LEVI M, 1993, P NATL ACAD SCI USA, V90, P4374, DOI 10.1073/pnas.90.10.4374; Levi M, 2000, AIDS RES HUM RETROV, V16, P59, DOI 10.1089/088922200309601; Lewis HD, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-79; Lo SL, 2008, BIOMATERIALS, V29, P2408, DOI 10.1016/j.biomaterials.2008.01.031; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Monnet C, 1999, J BIOL CHEM, V274, P3789, DOI 10.1074/jbc.274.6.3789; Mora JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012352; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; Shimane K, 2010, INT J BIOCHEM CELL B, V42, P1482, DOI 10.1016/j.biocel.2010.05.005; Sloan EA, 2013, J VIROL, V87, P11173, DOI 10.1128/JVI.01392-13; Stahl SJ, 2010, J MOL BIOL, V397, P697, DOI 10.1016/j.jmb.2010.01.061; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Vercruysse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060259; Watts NR, 1998, J STRUCT BIOL, V121, P41, DOI 10.1006/jsbi.1998.3964; WINGFIELD PT, 1991, BIOCHEMISTRY-US, V30, P7527, DOI 10.1021/bi00244a023; Wong RW, 2013, NUCLEIC ACIDS RES, V41, P9471, DOI 10.1093/nar/gkt727; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Zaro JL, 2009, MOL PHARMACEUT, V6, P337, DOI 10.1021/mp800239p; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094	41	17	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20222	20233		10.1074/jbc.M114.581090	http://dx.doi.org/10.1074/jbc.M114.581090			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24878961	Green Published, hybrid			2022-12-28	WOS:000339395200035
J	King, DT; Lameignere, E; Strynadka, NCJ				King, Dustin T.; Lameignere, Emilie; Strynadka, Natalie C. J.			Structural Insights into the Lipoprotein Outer Membrane Regulator of Penicillin-binding Protein 1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; WALL SYNTHESIS; PREDICTION; PBP1B; MECHANISM; DISORDER; SHAPE	In bacteria, the synthesis of the protective peptidoglycan sacculus is a dynamic process that is tightly regulated at multiple levels. Recently, the lipoprotein co-factor LpoB has been found essential for the in vivo function of the major peptidoglycan synthase PBP1b in Enterobacteriaceae. Here, we reveal the crystal structures of Salmonella enterica and Escherichia coli LpoB. The LpoB protein can be modeled as a ball and tether, consisting of a disordered N-terminal region followed by a compact globular C-terminal domain. Taken together, our structural data allow us to propose new insights into LpoB-mediated regulation of peptidoglycan synthesis.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca		King, Dustin/0000-0003-1775-2885	Canadian Institutes of Health Research; Howard Hughes Medical Institute International Scholar Program; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; Canada Research Chair Programs	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute International Scholar Program(Howard Hughes Medical Institute); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Canada Research Chair Programs(Canada Research Chairs)	This work was supported by the Canadian Institutes of Health Research, Howard Hughes Medical Institute International Scholar Program, Canadian Foundation for Innovation, British Columbia Knowledge Development Fund, and the Canada Research Chair Programs (to N. C. J. S.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alam MM, 2013, CLIN VACCINE IMMUNOL, V20, P712, DOI 10.1128/CVI.00054-13; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bardaweel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020897; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Cai XY, 2013, ACTA CRYSTALLOGR F, V69, P362, DOI 10.1107/S1744309113004417; DeLano W.L, PYMOL MOL GRAPHICS S; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson A. M., 2009, PROTEIN CRYSTALLIZAT, P137; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lupoli TJ, 2014, J AM CHEM SOC, V136, P52, DOI 10.1021/ja410813j; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Page MGP, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P79, DOI 10.1007/978-1-4614-1400-1_3; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Park JT, 1996, MICROB DRUG RESIST, V2, P105, DOI 10.1089/mdr.1996.2.105; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ranjit DK, 2013, J BACTERIOL, V195, P2452, DOI 10.1128/JB.00160-13; Sobhanifar S, 2013, CURR OPIN STRUC BIOL, V23, P695, DOI 10.1016/j.sbi.2013.07.008; Sun JM, 2012, NUCLEIC ACIDS RES, V40, pW298, DOI 10.1093/nar/gks361; Sung MT, 2009, P NATL ACAD SCI USA, V106, P8824, DOI 10.1073/pnas.0904030106; Terashima H, 2013, P NATL ACAD SCI USA, V110, P6133, DOI 10.1073/pnas.1222655110; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Turner RD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2503; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Van Valen D, 2009, BIOPHYS J, V96, P1275, DOI 10.1016/j.bpj.2008.10.052; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Windisch B, 2006, BIOPHYS J, V91, P2383, DOI 10.1529/biophysj.105.078543; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woody R. W., 2011, INSTRUMENTAL ANAL IN, P303; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang JC, 2004, MOL MICROBIOL, V52, P651, DOI 10.1111/j.1365-2958.2004.03991.x	50	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19245	19253		10.1074/jbc.M114.565879	http://dx.doi.org/10.1074/jbc.M114.565879			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24808177	hybrid, Green Published			2022-12-28	WOS:000339062900051
J	Mattijssen, F; Georgiadi, A; Andasarie, T; Szalowska, E; Zota, A; Krones-Herzig, A; Heier, C; Ratman, D; De Bosscher, K; Qi, L; Zechner, R; Herzig, S; Kersten, S				Mattijssen, Frits; Georgiadi, Anastasia; Andasarie, Tresty; Szalowska, Ewa; Zota, Annika; Krones-Herzig, Anja; Heier, Christoph; Ratman, Dariusz; De Bosscher, Karolien; Qi, Ling; Zechner, Rudolf; Herzig, Stephan; Kersten, Sander			Hypoxia-inducible Lipid Droplet-associated (HILPDA) Is a Novel Peroxisome Proliferator-activated Receptor (PPAR) Target Involved in Hepatic Triglyceride Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; LOW-DENSITY LIPOPROTEINS; FATTY-ACID OXIDATION; NUCLEAR RECEPTORS; GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; ADIPOSE LIPOLYSIS; MICE LACKING; ALPHA; STEATOHEPATITIS	Peroxisome proliferator-activated receptors (PPARs) play major roles in the regulation of hepatic lipid metabolism through the control of numerous genes involved in processes such as lipid uptake and fatty acid oxidation. Here we identify hypoxia-inducible lipid droplet-associated (Hilpda/Hig2) as a novel PPAR target gene and demonstrate its involvement in hepatic lipid metabolism. Microarray analysis revealed that Hilpda is one of the most highly induced genes by the PPAR alpha agonist Wy14643 in mouse precision cut liver slices. Induction of Hilpda mRNA by Wy14643 was confirmed in mouse and human hepatocytes. Oral dosing with Wy14643 similarly induced Hilpda mRNA levels in livers of wild-type mice but not Ppara(-/-) mice. Transactivation studies and chromatin immunoprecipitation showed that Hilpda is a direct PPAR alpha target gene via a conserved PPAR response element located 1200 base pairs upstream of the transcription start site. Hepatic overexpression of HILPDA in mice via adeno-associated virus led to a 4-fold increase in liver triglyceride storage, without any changes in key genes involved in de novo lipogenesis, beta-oxidation, or lipolysis. Moreover, intracellular lipase activity was not affected by HILPDA overexpression. Strikingly, HILPDA overexpression significantly impaired hepatic triglyceride secretion. Taken together, our data uncover HILPDA as a novel PPAR target that raises hepatic triglyceride storage via regulation of triglyceride secretion.	[Mattijssen, Frits; Georgiadi, Anastasia; Andasarie, Tresty; Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr, NL-6700 EV Wageningen, Netherlands; [Szalowska, Ewa] Univ Wageningen & Res Ctr, RIKILT Inst Food Safety, NL-6700 AE Wageningen, Netherlands; [Zota, Annika; Krones-Herzig, Anja; Herzig, Stephan] Heidelberg Univ, Joint Div Mol Metab Control, DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ Heidelberg,Ctr Mol Biol, D-69120 Heidelberg, Germany; [Zota, Annika; Krones-Herzig, Anja; Herzig, Stephan] Heidelberg Univ, Univ Hosp, D-69120 Heidelberg, Germany; [Heier, Christoph; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, Graz, Austria; [Ratman, Dariusz; De Bosscher, Karolien] Univ Ghent, Flanders Inst Biotechnol, Dept Med Prot Res, Nucl Receptor Signaling Unit,Cytokine Receptor La, B-9000 Ghent, Belgium; [Qi, Ling; Kersten, Sander] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Wageningen University & Research; Wageningen University & Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Graz; Flanders Institute for Biotechnology (VIB); Ghent University; Cornell University	Kersten, S (corresponding author), Wageningen Univ, Nutr Metab & Genom Grp, Bomenweg 2, NL-6703 HD Wageningen, Netherlands.	sander.kersten@wur.nl	Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734; Heier, Christoph/0000-0001-6858-408X; Qi, Ling/0000-0001-8229-0184; Herzig, Stephan/0000-0003-3950-3652; Zechner, Rudolf/0000-0001-5483-1182; De Bosscher, Karolien/0000-0001-5059-9718	Fondation Leducq Grant [12CVD04]; Netherlands Organization for Health Research and Development Grant, NWO ZonMW [40-00812-98-08030]; Austrian Science Fund (FWF) [Z 136, F 3002] Funding Source: researchfish	Fondation Leducq Grant(Leducq Foundation); Netherlands Organization for Health Research and Development Grant, NWO ZonMW; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Fondation Leducq Grant 12CVD04 and by Netherlands Organization for Health Research and Development Grant 40-00812-98-08030, NWO ZonMW.	Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; GORDON GB, 1977, AM J PATHOL, V88, P663; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Kashireddy PV, 2004, HEPATOL RES, V30, P104, DOI 10.1016/j.hepres.2004.06.004; Kenny PA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-3; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Kong LB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-246; Lalloyer F, 2010, ARTERIOSCL THROM VAS, V30, P894, DOI 10.1161/ATVBAHA.108.179689; Li XH, 2012, J LIPID RES, V53, P1877, DOI 10.1194/jlr.M026591; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Linden D, 2002, J BIOL CHEM, V277, P23044, DOI 10.1074/jbc.M110416200; Linden D, 2001, J LIPID RES, V42, P1831; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pawlak M, 2012, CURR TOP MED CHEM, V12, P486, DOI 10.2174/156802612799436641; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Roberts LD, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r75; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Schupp M, 2010, J BIOL CHEM, V285, P40409, DOI 10.1074/jbc.R110.182451; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Shah A, 2010, ATHEROSCLEROSIS, V210, P35, DOI 10.1016/j.atherosclerosis.2009.11.010; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Wang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072315; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422	55	47	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19279	19293		10.1074/jbc.M114.570044	http://dx.doi.org/10.1074/jbc.M114.570044			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24876382	Green Published, hybrid			2022-12-28	WOS:000339326800006
J	Spyridaki, K; Matsoukas, MT; Cordomi, A; Gkountelias, K; Papadokostaki, M; Mavromoustakos, T; Logothetis, DE; Margioris, AN; Pardo, L; Liapakis, G				Spyridaki, Katerina; Matsoukas, Minos-Timotheos; Cordomi, Arnau; Gkountelias, Kostas; Papadokostaki, Maria; Mavromoustakos, Thomas; Logothetis, Diomedes E.; Margioris, Andrew N.; Pardo, Leonardo; Liapakis, George			Structural-Functional Analysis of the Third Transmembrane Domain of the Corticotropin-releasing Factor Type 1 Receptor ROLE IN ACTIVATION AND ALLOSTERIC ANTAGONISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; SCANNING MUTAGENESIS; BINDING; FAMILY; ASTRESSIN; ALIGNMENT; UROCORTIN; RESIDUES; PEPTIDE	The corticotropin-releasing factor (CRF) type 1 receptor (CRF1R) for the 41-amino acid peptide CRF is a class B G protein-coupledreceptor, which plays a key role in the response of our body to stressful stimuli and the maintenance of homeostasis by regulating neural and endocrine functions. CRF and related peptides, such as sauvagine, bind to the extracellular regions of CRF1R and activate the receptor. In contrast, small nonpeptide antagonists, which are effective against stress-related disorders, such as depression and anxiety, have been proposed to interact with the helical transmembrane domains (TMs) of CRF1R and allosterically antagonize peptide binding and receptor activation. Here, we aimed to elucidate the role of the third TM(TM3) in the molecular mechanisms underlying activation of CRF1R. TM3 was selected because its tilted orientation, relative to the membrane, allows its residues to establish key interactions with ligands, other TM helices, and the G protein. Using a combination of pharmacological, biochemical, and computational approaches, we found that Phe-203(3.40) and Gly-210(3.47) in TM3 play an important role in receptor activation. Our experimental findings also suggest that Phe-203(3.40) interacts with nonpeptide antagonists.	[Spyridaki, Katerina; Gkountelias, Kostas; Papadokostaki, Maria; Liapakis, George] Univ Crete, Dept Pharmacol, Sch Med, Iraklion 71003, Greece; [Margioris, Andrew N.] Univ Crete, Dept Clin Chem, Sch Med, Iraklion 71003, Greece; [Matsoukas, Minos-Timotheos; Cordomi, Arnau; Pardo, Leonardo] Univ Autonoma Barcelona, Lab Med Computac, Fac Med, Bellaterra 08193, Spain; [Mavromoustakos, Thomas] Univ Athens, Dept Chem, Organ Chem Lab, Athens 11571, Greece; [Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	University of Crete; University of Crete; Autonomous University of Barcelona; National & Kapodistrian University of Athens; Virginia Commonwealth University	Liapakis, G (corresponding author), Univ Crete, Dept Pharmacol, Sch Med, Voutes 71003, Crete, Greece.	liapakis@med.uoc.gr	Mavromoustakos, Thomas/C-4696-2017; Matsoukas, Minos-Timotheos/B-8746-2012; Cordomí, Arnau/A-1686-2009	Mavromoustakos, Thomas/0000-0001-5309-992X; Matsoukas, Minos-Timotheos/0000-0002-4642-8163; Cordomí, Arnau/0000-0002-3848-2928; Pardo, Leonardo/0000-0003-1778-7420	National Alliance for Research on Schizophrenia and Depression; Greek Ministry of Health; Ministerio de Ciencia e Innovacion [SAF2013-48271-C2-2-R]; ISCIII	National Alliance for Research on Schizophrenia and Depression(NARSAD); Greek Ministry of Health(Greek Ministry of Development-GSRT); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ISCIII(Instituto de Salud Carlos III)	This work was supported in part by a National Alliance for Research on Schizophrenia and Depression grant (to G. L.), a grant from the Greek Ministry of Health (to G. L.), and Grant SAF2013-48271-C2-2-R from Ministerio de Ciencia e Innovacion (to L. P.).; Recipient of a contract grant from ISCIII.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Ersoy BA, 2012, NAT CHEM BIOL, V8, P725, DOI [10.1038/nchembio.1008, 10.1038/NCHEMBIO.1008]; George L, 2012, CURR PHARM DESIGN, V18, P175, DOI 10.2174/138161212799040529; Gkountelias K, 2010, MOL PHARMACOL, V78, P785, DOI 10.1124/mol.110.065474; Gkountelias K, 2009, MOL PHARMACOL, V75, P793, DOI 10.1124/mol.108.052423; Grigoriadis Dimitri E., 2001, Current Medicinal Chemistry - Central Nervous System Agents, V1, P63, DOI 10.2174/1568015013358734; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Liapakis G, 2011, CURR MED CHEM, V18, P2583, DOI 10.2174/092986711795933704; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Perlman JH, 1996, BIOCHEMISTRY-US, V35, P7643, DOI 10.1021/bi952202r; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WINSLOW JT, 1989, PHARMACOL BIOCHEM BE, V32, P919, DOI 10.1016/0091-3057(89)90059-2; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	31	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18966	18977		10.1074/jbc.M113.544460	http://dx.doi.org/10.1074/jbc.M113.544460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24838244	Green Published, hybrid			2022-12-28	WOS:000339062900029
J	Urvalek, AM; Gudas, LJ				Urvalek, Alison M.; Gudas, Lorraine J.			Retinoic Acid and Histone Deacetylases Regulate Epigenetic Changes in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO-REPRESSOR; RESPONSE ELEMENTS; GENE-EXPRESSION; COMPLEX; ROLES; DIFFERENTIATION; CHROMATIN; HDAC2; DEMETHYLATION; RECRUITMENT	All-trans-retinoic acid (RA) is a vitamin A metabolite that plays major roles in regulating stem cell differentiation and development. RA is the ligand of the retinoic acid receptor (RAR) family of transcription factors, which interact with retinoic acid response elements (RAREs) within target gene proximal promoters and enhancers. Although RA-mediated gene activation is well understood, less is known about the mechanisms for repression at RA-regulated genes. Using chromatin immunoprecipitation experiments, we show that in embryonic stem cells in the absence of RA, histone deacetylases (HDACs) differentially bind to various RAREs in proximal promoters or enhancer regions of RA-regulated genes; HDAC1, HDAC2, and HDAC3 bind at RAREs in the Hoxa1 and Cyp26a1 gene regulatory regions, whereas only HDAC1 binds at the RAR beta 2 RARE. shRNA knockdown of HDAC1, HDAC2, or HDAC3 differentially increases the deposition of the histone 3 lysine 27 acetylation (H3K27ac) epigenetic mark associated with increases in these three transcripts. Importantly, RA treatment differentially mediates the removal of HDACs from the Hoxa1, Cyp26a1, and RAR beta 2 genes and promotes the deposition of the H3K27ac mark at these genes. Overall, we show that HDACs differentially bind to RA-regulated genes to control key epigenetic marks involved in stem cell differentiation.	[Urvalek, Alison M.; Gudas, Lorraine J.] Cornell Univ, Dept Pharmacol, Weill Cornell Med Coll, New York, NY 10065 USA; [Urvalek, Alison M.; Gudas, Lorraine J.] Cornell Univ, Meyer Canc Ctr, Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University; Cornell University	Gudas, LJ (corresponding author), Cornell Univ, Dept Pharmacol, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA.	ljgudas@med.cornell.edu			National Institutes of Health [F32-AA021045, T32CA062948, RO1CA43778]; NATIONAL CANCER INSTITUTE [R01CA043796, T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA021045, R01AA018332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants F32-AA021045 (to A. U.) and T32CA062948 and RO1CA43778 (to L. J. G.).	Amat R, 2011, J CELL PHYSIOL, V226, P293, DOI 10.1002/jcp.22420; Arts J, 2009, CLIN CANCER RES, V15, P6841, DOI 10.1158/1078-0432.CCR-09-0547; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Forneris F, 2009, FEBS J, V276, P4304, DOI 10.1111/j.1742-4658.2009.07142.x; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu F, 2009, BIOORG MED CHEM LETT, V19, P3928, DOI 10.1016/j.bmcl.2009.03.085; Jung JE, 2012, STEM CELLS DEV, V21, P554, DOI 10.1089/scd.2011.0110; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kashyap V, 2010, J BIOL CHEM, V285, P14534, DOI 10.1074/jbc.M110.115345; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Maroni P, 2012, BIOCHEM BIOPH RES CO, V428, P271, DOI 10.1016/j.bbrc.2012.10.044; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Morey L, 2008, MOL CELL BIOL, V28, P5912, DOI 10.1128/MCB.00467-08; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Shahhoseini M, 2013, BIOCHEM CELL BIOL, V91, P116, DOI 10.1139/bcb-2012-0049; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stiehl DP, 2007, CANCER RES, V67, P2256, DOI 10.1158/0008-5472.CAN-06-3985; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Toffolo E, 2014, J NEUROCHEM, V128, P603, DOI 10.1111/jnc.12457; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Winter M, 2013, EMBO J, V32, P3176, DOI 10.1038/emboj.2013.243; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zimmermann S, 2007, CANCER RES, V67, P9047, DOI 10.1158/0008-5472.CAN-07-0312	62	54	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19519	19530		10.1074/jbc.M114.556555	http://dx.doi.org/10.1074/jbc.M114.556555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24821725	Green Published, hybrid			2022-12-28	WOS:000339326800027
J	Aghajanian, H; Choi, C; Ho, VC; Gupta, M; Singh, MK; Epstein, JA				Aghajanian, Haig; Choi, Connie; Ho, Vivienne C.; Gupta, Mudit; Singh, Manvendra K.; Epstein, Jonathan A.			Semaphorin 3d and Semaphorin 3e Direct Endothelial Motility through Distinct Molecular Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE COLLAPSE; VASCULAR DEVELOPMENT; CANCER CELLS; ANGIOGENESIS; NEUROPILIN-1; BRAIN; ATTRACTION; INHIBITION; EXPRESSION; RECEPTORS	Class 3 semaphorins were initially described as axonal growth cone guidance molecules that signal through plexin and neuropilin coreceptors and since then have been established to be regulators of vascular development. Semaphorin 3e (Sema3e) has been shown previously to repel endothelial cells and is the only class 3 semaphorin known to be capable of signaling via a plexin receptor without a neuropilin coreceptor. Sema3e signals through plexin D1 (Plxnd1) to regulate vascular patterning by modulating the cytoskeleton and focal adhesion structures. We showed recently that semaphorin 3d (Sema3d) mediates endothelial cell repulsion and pulmonary vein patterning during embryogenesis. Here we show that Sema3d and Sema3e affect human umbilical vein endothelial cells similarly but through distinct molecular signaling pathways. Time-lapse imaging studies show that both Sema3d and Sema3e can inhibit cell motility and migration, and tube formation assays indicate that both can impede tubulogenesis. Endothelial cells incubated with either Sema3d or Sema3e demonstrate a loss of actin stress fibers and focal adhesions. However, the addition of neuropilin 1 (Nrp1)-blocking antibody or siRNA knockdown of Nrp1 inhibits Sema3d-mediated, but not Sema3e-mediated, cytoskeletal reorganization, and siRNA knockdown of Nrp1 abrogates Sema3d-mediated, but not Sema3e-mediated, inhibition of tubulogenesis. On the other hand, endothelial cells deficient in Plxnd1 are resistant to endothelial repulsion mediated by Sema3e but not Sema3d. Unlike Sema3e, Sema3d incubation results in phosphorylation of Akt in human umbilical vein endothelial cells, and inhibition of the PI3K/Akt pathway blocks the endothelial guidance and cytoskeletal reorganization functions of Sema3d but not Sema3e.	Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Epstein, JA (corresponding author), Smilow Translat Res Ctr 9-105,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	epsteinj@upenn.edu		Aghajanian, Haig/0000-0002-8317-0157; Epstein, Jonathan/0000-0001-8637-4465; Singh, Manvendra K./0000-0002-2884-0074	National Institutes of Health [R01HL118768]; American Heart Association [13PRE16940111]; Spain Fund for Cardiovascular Research; W. W. Smith endowed chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Spain Fund for Cardiovascular Research; W. W. Smith endowed chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL118768 (to J. A. E.). This work was also supported by American Heart Association Grant 13PRE16940111 (to H. A.), by the Spain Fund for Cardiovascular Research (to J. A. E.), and by the W. W. Smith endowed chair (to J. A. E.).	Atwal JK, 2003, J NEUROSCI, V23, P7602; Auerbach R, 1997, AM J PATHOL, V151, P1183; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006; BOUGERET C, 1992, J IMMUNOL, V148, P318; Casazza A, 2010, J CLIN INVEST, V120, P2684, DOI 10.1172/JCI42118; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Degenhardt K, 2013, NAT MED, V19, P760, DOI 10.1038/nm.3185; Feiner L, 2001, DEVELOPMENT, V128, P3061; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Gu CH, 2013, EXP CELL RES, V319, P1306, DOI 10.1016/j.yexcr.2013.02.003; Guan F, 2006, KIDNEY INT, V69, P1564, DOI 10.1038/sj.ki.5000313; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Meadows SM, 2012, CIRC RES, V110, P34, DOI 10.1161/CIRCRESAHA.111.249847; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Parker MW, 2013, J MOL BIOL, V425, P4405, DOI 10.1016/j.jmb.2013.07.017; Potiron VA, 2007, CANCER RES, V67, P8708, DOI 10.1158/0008-5472.CAN-06-3612; Riccomagno MM, 2012, CELL, V149, P1594, DOI 10.1016/j.cell.2012.05.018; Sabag AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042912; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00028; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Yamamizu K, 2011, CIRC J, V75, P253, DOI 10.1253/circj.CJ-10-0915; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	34	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					17971	17979		10.1074/jbc.M113.544833	http://dx.doi.org/10.1074/jbc.M113.544833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825896	hybrid, Green Published			2022-12-28	WOS:000338042000002
J	Burns, LT; Wente, SR				Burns, Laura T.; Wente, Susan R.			Casein Kinase II Regulation of the Hot1 Transcription Factor Promotes Stochastic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; NUCLEAR-LOCALIZATION; OSMOTIC SHOCK; MAP KINASE; HOG1; STRESS; ACTIVATION; INDUCTION; DISRUPTION	In Saccharomyces cerevisiae, Hog1 MAPK is activated and induces a transcriptional program in response to hyperosmotic stress. Several Hog1-responsive genes exhibit stochastic transcription, resulting in cell-to-cell variability in mRNA and protein levels. However, the mechanisms governing stochastic gene activity are not fully defined. Here we uncover a novel role for casein kinase II (CK2) in the cellular response to hyperosmotic stress. CK2 interacts with and phosphorylates the Hot1 transcription factor; however, Hot1 phosphorylation is not sufficient for controlling the stochastic response. The CK2 protein itself is required to negatively regulate mRNA expression of Hot1-responsive genes and Hot1 enrichment at target promoters. Single-cell gene expression analysis reveals altered activation of Hot1-targeted STL1 in ck2 mutants, resulting in a bimodal to unimodal shift in expression. Together, this work reveals a novel CK2 function during the hyperosmotic stress response that promotes cell-to-cell variability in gene expression.	[Burns, Laura T.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 465 21st Ave S, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu			National Institutes of Health [R37GM051219];  [T32CA009582];  [1S10RR027714]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051219, R37GM051219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37GM051219 (to S. R. W.), a training position on Grant T32CA009582 (to L. T. B.), and Grant 1S10RR027714 (to the Mass Spectrometry Research Center Proteomic Core).	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; Brachmann CB, 1998, YEAST, V14, P115; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Cook KE, 2012, G3-GENES GENOM GENET, V2, P1129, DOI 10.1534/g3.112.003251; de Nadal E, 1999, J BACTERIOL, V181, P6456, DOI 10.1128/JB.181.20.6456-6462.1999; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gomar-Alba M, 2013, BBA-GENE REGUL MECH, V1829, P1111, DOI 10.1016/j.bbagrm.2013.07.009; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Ji HT, 2013, CLIN CANCER RES, V19, P6335, DOI 10.1158/1078-0432.CCR-13-2478; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Neuert G, 2013, SCIENCE, V339, P584, DOI 10.1126/science.1231456; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Pascual-Ahuir A, 2001, J BIOL CHEM, V276, P37373, DOI 10.1074/jbc.M105755200; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Pickin KA, 2010, FEMS YEAST RES, V10, P839, DOI 10.1111/j.1567-1364.2010.00677.x; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Ruiz-Roig C, 2012, MOL BIOL CELL, V23, P4286, DOI 10.1091/mbc.E12-04-0289; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; SAMBROOK J, 1989, MOL CLONING LAB MANU, V6, P1; Sherman F., 1986, LAB COURSE MANUAL ME, p[39, 79, 103]; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tenney KA, 1999, MOL CELL BIOCHEM, V191, P161, DOI 10.1023/A:1006893824947; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07	48	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17668	17679		10.1074/jbc.M114.561217	http://dx.doi.org/10.1074/jbc.M114.561217			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24817120	Green Published, hybrid			2022-12-28	WOS:000338018100031
J	Gurram, RK; Kujur, W; Maurya, SK; Agrewala, JN				Gurram, Rama Krishna; Kujur, Weshely; Maurya, Sudeep K.; Agrewala, Javed N.			Caerulomycin A Enhances Transforming Growth Factor-beta (TGF-beta)-Smad3 Protein Signaling by Suppressing Interferon-gamma (IFN-gamma)-Signal Transducer and Activator of Transcription 1 (STAT1) Protein Signaling to Expand Regulatory T Cells (Tregs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; IFN-GAMMA; IMMUNOSUPPRESSIVE DRUGS; RHEUMATOID-ARTHRITIS; FOXP3 EXPRESSION; TH17 CELLS; IN-VITRO; INHIBITOR; TOLERANCE; DIFFERENTIATION	Cytokines play a very important role in the regulation of immune homeostasis. Regulatory T cells (Tregs) responsible for the generation of peripheral tolerance are under the tight regulation of the cytokine milieu. In this study, we report a novel role of a bipyridyl compound, Caerulomycin A (CaeA), in inducing the generation of Tregs. It was observed that CaeA substantially up-regulated the pool of Tregs, as evidenced by an increased frequency of CD4(+) Foxp3(+) cells. In addition, CaeA significantly suppressed the number of Th1 and Th17 cells, as supported by a decreased percentage of CD4(+) /IFN-gamma(+) and CD4(+)/IL-17(+) cells, respectively. Furthermore, we established the mechanism and observed that CaeA interfered with IFN-gamma-induced STAT1 signaling by augmenting SOCS1 expression. An increase in the TGF-beta-mediated Smad3 activity was also noted. Furthermore, CaeA rescued Tregs from IFN-gamma-induced inhibition. These results were corroborated by blocking Smad3 activity, which abolished the CaeA-facilitated generation of Tregs. In essence, our results indicate a novel role of CaeA in inducing the generation of Tregs. This finding suggests that CaeA has enough potential to be considered as a potent future drug for the treatment of autoimmunity.	[Gurram, Rama Krishna; Kujur, Weshely; Maurya, Sudeep K.; Agrewala, Javed N.] CSIR, Immunol Lab, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Agrewala, JN (corresponding author), CSIR, Immunol Lab, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	javed@imtech.res.in	Gurram, Rama/AAO-4940-2020; Maurya, Sudeep Kumar Kumar/AAB-8744-2022; Agrewala, Javed Naim/AAS-8449-2021	Gurram, Rama/0000-0002-1956-0249; Maurya, Sudeep Kumar Kumar/0000-0002-9983-5598; 	Council of Scientific and Industrial Research; Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research.; Recipient of fellowships of the Council of Scientific and Industrial Research, New Delhi, India.	Bagavant H, 2005, J IMMUNOL, V175, P944, DOI 10.4049/jimmunol.175.2.944; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101; Borel JF, 2002, WIEN KLIN WOCHENSCHR, V114, P433; Cao YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074955; Chang JH, 2009, EUR J IMMUNOL, V39, P1241, DOI 10.1002/eji.200838913; CHATTERJEE DK, 1984, Z PARASITENKD, V70, P569, DOI 10.1007/BF00926587; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Collison LW, 2011, METHODS MOL BIOL, V707, P21, DOI 10.1007/978-1-61737-979-6_2; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9; De Rose V, 2004, J LEUKOCYTE BIOL, V76, P423, DOI 10.1189/jlb.0503247; Doncarli A, 1997, EUR J IMMUNOL, V27, P1451, DOI 10.1002/eji.1830270623; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; FUNK A, 1959, CAN J MICROBIOL, V5, P317, DOI 10.1139/m59-039; Garber K, 2013, NAT BIOTECHNOL, V31, P3, DOI 10.1038/nbt0113-3; Garber K, 2011, NAT BIOTECHNOL, V29, P467, DOI 10.1038/nbt0611-467; Glimcher LH, 2000, GENE DEV, V14, P1693; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Issa F, 2010, CURR OPIN ORGAN TRAN, V15, P757, DOI 10.1097/MOT.0b013e32834017ae; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Martins GA, 1999, INFECT IMMUN, V67, P3864, DOI 10.1128/IAI.67.8.3864-3871.1999; Masunaga Y, 2007, ANN PHARMACOTHER, V41, P21, DOI 10.1345/aph.1H219; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mizobucbi T, 2003, J IMMUNOL, V171, P1140, DOI 10.4049/jimmunol.171.3.1140; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Osaki M, 2003, BIOCHEM J, V369, P103, DOI 10.1042/BJ20020928; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Payne R, 2000, J PAIN, V1, P14, DOI 10.1054/jpai.2000.16611; Rook GAW, 2012, CLIN REV ALLERG IMMU, V42, P5, DOI 10.1007/s12016-011-8285-8; Rosato E, 2010, J BIOL REG HOMEOS AG, V24, P251; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; Shevach EM, 2004, ARTHRITIS RHEUM, V50, P2721, DOI 10.1002/art.20500; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Weng HL, 2007, J HEPATOL, V46, P295, DOI 10.1016/j.jhep.2006.09.014; Williams Richard O, 2004, Methods Mol Med, V98, P207; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Wu CJ, 2013, INT ARCH ALLERGY IMM, V160, P356, DOI 10.1159/000343030; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598	64	22	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17515	17528		10.1074/jbc.M113.545871	http://dx.doi.org/10.1074/jbc.M113.545871			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24811173	Green Published, hybrid			2022-12-28	WOS:000338018100018
J	Petropoulos, AD; McDonald, ME; Green, R; Zaher, HS				Petropoulos, Alexandros D.; McDonald, Megan E.; Green, Rachel; Zaher, Hani S.			Distinct Roles for Release Factor 1 and Release Factor 2 in Translational Quality Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-TRANSFER-RNA; CODON RECOGNITION; CHAIN TERMINATION; FACTORS RF1; CRYSTAL-STRUCTURES; DECODING CENTER; STOP CODON; RIBOSOME; DISSOCIATION; HYDROLYSIS	In bacteria, stop codons are recognized by two similar class 1 release factors, release factor 1 (RF1) and release factor 2 (RF2). Normally, during termination, the class 2 release factor 3 (RF3), a GTPase, functions downstream of peptide release where it accelerates the dissociation of RF1/RF2 prior to ribosome recycling. In addition to their canonical function in termination, both classes of release factor are also involved in a post peptidyl transfer quality control (post PT QC) mechanism where the termination factors recognize mismatched (i.e. error-containing) ribosome complexes and promote premature termination. Here, using a well defined in vitro system, we explored the role of release factors in canonical termination and post PT QC. As reported previously, during canonical termination, RF1 and RF2 recognize stop codons in a similar manner, and RF3 accelerates their rate of dissociation. During post PT QC, only RF2 (and not RF1) effectively binds to mismatched ribosome complexes; and whereas the addition of RF3 to RF2 increased its rate of release on mismatched complexes, the addition of RF3 to RF1 inhibited its rate of release but increased the rate of peptidyl-tRNA dissociation. Our data strongly suggest that RF2, in addition to its primary role in peptide release, functions as the principle factor for post PT QC.	[Petropoulos, Alexandros D.; McDonald, Megan E.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Zaher, Hani S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Howard Hughes Medical Institute; Johns Hopkins University; Washington University (WUSTL)	Zaher, HS (corresponding author), Washington Univ, Dept Biol, Campus Box 1137,One Brookings Dr, St Louis, MO 63130 USA.	hzaher@wustl.edu			National Institutes of Health [R00GM094210, R01GM059425-06A1]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM094210, R01GM059425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00GM094210 (to H. S. Z.) and R01GM059425-06A1 (to R. G.). This work was also supported by the Howard Hughes Medical Institute (to R. G.).	Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; CAPECCHI MR, 1969, COLD SPRING HARB SYM, V34, P469, DOI 10.1101/SQB.1969.034.01.053; CASKEY T, 1969, COLD SPRING HARB SYM, V34, P479, DOI 10.1101/SQB.1969.034.01.054; Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Eyler DE, 2013, J BIOL CHEM, V288, P29530, DOI 10.1074/jbc.M113.487090; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; He SL, 2010, NAT STRUCT MOL BIOL, V17, P465, DOI 10.1038/nsmb.1766; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Jin H, 2010, P NATL ACAD SCI USA, V107, P8593, DOI 10.1073/pnas.1003995107; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Koutmou KS, 2014, RNA, V20, P609, DOI 10.1261/rna.042523.113; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; MILMAN G, 1969, P NATL ACAD SCI USA, V63, P183, DOI 10.1073/pnas.63.1.183; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Ortiz-Meoz RF, 2011, J BIOL CHEM, V286, P25604, DOI 10.1074/jbc.M111.256255; Peske F, 2014, NUCLEIC ACIDS RES, V42, P1812, DOI 10.1093/nar/gkt1095; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; TATE W, 1990, NUCLEIC ACIDS RES, V18, P6537, DOI 10.1093/nar/18.22.6537; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Youngman EM, 2006, COLD SPRING HARB SYM, V71, P545, DOI 10.1101/sqb.2006.71.036; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Zaher HS, 2011, CELL, V147, P396, DOI 10.1016/j.cell.2011.08.045; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zaher HS, 2004, BIOCHEMISTRY-US, V43, P7873, DOI 10.1021/bi0497300; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zhou J, 2012, CURR OPIN STRUC BIOL, V22, P733, DOI 10.1016/j.sbi.2012.08.004	36	20	20	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17589	17596		10.1074/jbc.M114.564989	http://dx.doi.org/10.1074/jbc.M114.564989			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24798339	Green Published, hybrid			2022-12-28	WOS:000338018100024
J	El Khoury, N; Mathieu, S; Fiset, C				El Khoury, Nabil; Mathieu, Sophie; Fiset, Celine			Interleukin-1 beta Reduces L-type Ca2+ Current through Protein Kinase C epsilon Activation in Mouse Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; CARDIAC MYOCYTES; NITRIC-OXIDE; OXIDATIVE STRESS; CULTURED CARDIOMYOCYTES; DILATED CARDIOMYOPATHY; CIRCULATING LEVELS; TRANSGENIC MICE; ANGIOTENSIN-II	Inflammation is now widely recognized as a key component of heart disease. Patients suffering from arrhythmias and heart failure have increased levels of tumor necrosis factor-alpha (TNF alpha) and interleukin-1 beta (IL-1 beta). Evidence suggests that these cytokines are important mediators of cardiac remodeling; however, their effects on ion channels and arrhythmogenesis remain incompletely understood. The L-type Ca2+ current (I-CaL) is a major determinant of the plateau phase of cardiac action potential and has a critical excitation-contraction coupling role. Thus, altering its properties could have detrimental effects on cardiac electrical and contractile functions. Accordingly, the objective of this study was to elucidate the effect of TNF alpha and IL-1 beta on I-CaL, while exploring the underlying regulatory mechanisms. Neonatal mouse ventricular myocytes were treated with a pathophysiological concentration (30 pg/ml) of TNF alpha and IL-1 beta for 24 h. Voltage-clamp recordings showed that TNF alpha had no effect on I-CaL, whereas IL-1 beta decreased the current density by 36%. Although both IL-1 beta -and TNF alpha-treated myocytes showed significant increase in reactive oxidative species (ROS), Western blot experiments revealed that only IL-1 beta increased PKC epsilon membrane translocation. The antioxidant N-acetyl-L-cysteine normalized ROS levels and restored I-CaL density. Furthermore, the PKC epsilon translocation inhibitor epsilon-V1-2 blocked the effect of IL-1 beta on I-CaL. The reduction of I-CaL by IL-1 beta was also seen in cultured adult ventricular myocytes. Overall, chronic IL-1 beta treatment decreased I-CaL density in cardiomyocytes. These effects implicated ROS signaling and PKC epsilon activation. These findings could contribute to explain the role of IL-1 beta in the development of arrhythmia and heart failure.	[El Khoury, Nabil; Mathieu, Sophie; Fiset, Celine] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Mathieu, Sophie; Fiset, Celine] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [El Khoury, Nabil] Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Fiset, C (corresponding author), Montreal Heart Inst, 5000 Belanger, Montreal, PQ H1T 1C8, Canada.	celine.fiset@icm-mhi.org		Fiset, Celine/0000-0003-2309-4823	Canadian Institutes of Health Research [CIHR-MOP-89934]; Fonds de Recherche du Quebec en Sante Ph.D. scholarship; Montreal Heart Institute Foundation scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec en Sante Ph.D. scholarship; Montreal Heart Institute Foundation scholarship	This work was supported in part by Canadian Institutes of Health Research Operating Grant CIHR-MOP-89934 (to C. F.).; Recipient of the Fonds de Recherche du Quebec en Sante Ph.D. scholarship and a Montreal Heart Institute Foundation scholarship.	Aukrust P, 2004, AUTOIMMUN REV, V3, P221, DOI 10.1016/S1568-9972(03)00103-4; Balafanova Z, 2002, J BIOL CHEM, V277, P15021, DOI 10.1074/jbc.M112451200; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Brouillette J, 2007, J MOL CELL CARDIOL, V43, P159, DOI 10.1016/j.yjmcc.2007.05.007; Chahine M, 2008, PFLUG ARCH EUR J PHY, V455, P913, DOI 10.1007/s00424-007-0342-z; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Combes A, 2002, PFLUG ARCH EUR J PHY, V445, P246, DOI 10.1007/s00424-002-0921-y; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Fernandez-Velasco M, 2007, AM J PHYSIOL-HEART C, V293, pH238, DOI 10.1152/ajpheart.01122.2006; Ferreira JCB, 2011, J MOL CELL CARDIOL, V51, P980, DOI 10.1016/j.yjmcc.2011.08.025; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Francis SE, 1998, J MOL CELL CARDIOL, V30, P215, DOI 10.1006/jmcc.1997.0592; Giorgi C, 2010, ANTIOXID REDOX SIGN, V13, P1051, DOI 10.1089/ars.2009.2825; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Grandy SA, 2007, AM J PHYSIOL-HEART C, V293, pH2168, DOI 10.1152/ajpheart.00521.2007; Grandy SA, 2010, J CARDIOVASC ELECTR, V21, P916, DOI 10.1111/j.1540-8167.2009.01713.x; Grandy SA, 2009, J MOL CELL CARDIOL, V47, P238, DOI 10.1016/j.yjmcc.2009.02.025; GUILLEN I, 1995, AM J PHYSIOL-REG I, V269, pR229, DOI 10.1152/ajpregu.1995.269.2.R229; GULICK T, 1989, P NATL ACAD SCI USA, V86, P6753, DOI 10.1073/pnas.86.17.6753; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Hu KL, 2000, AM J PHYSIOL-HEART C, V279, pH2658, DOI 10.1152/ajpheart.2000.279.6.H2658; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kawada H, 2006, CIRC J, V70, P605, DOI 10.1253/circj.70.605; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Lizotte E, 2005, ANAL BIOCHEM, V345, P47, DOI 10.1016/j.ab.2005.07.001; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Makary S, 2011, CIRC RES, V109, P1031, DOI 10.1161/CIRCRESAHA.111.253120; McTiernan CF, 1997, CIRC RES, V81, P493, DOI 10.1161/01.RES.81.4.493; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Murray DR, 1996, CIRC RES, V78, P154, DOI 10.1161/01.RES.78.1.154; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; NUSS HB, 1994, J PHYSIOL-LONDON, V479, P265, DOI 10.1113/jphysiol.1994.sp020294; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Orus J, 2000, J HEART LUNG TRANSPL, V19, P419, DOI 10.1016/S1053-2498(00)00083-8; Petkova-Kirova PS, 2006, AM J PHYSIOL-HEART C, V290, pH2098, DOI 10.1152/ajpheart.00097.2005; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; Rivard K, 2011, AM J PHYSIOL-HEART C, V301, pH2018, DOI 10.1152/ajpheart.01092.2010; Roig E, 1998, AM J CARDIOL, V82, P688, DOI 10.1016/S0002-9149(98)00388-9; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Saba S, 2005, AM J PHYSIOL-HEART C, V289, pH1456, DOI 10.1152/ajpheart.00733.2004; SCHULZ R, 1995, BRIT J PHARMACOL, V114, P27, DOI 10.1111/j.1476-5381.1995.tb14901.x; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Tanaka H, 1998, COMP BIOCHEM PHYS A, V120, P431, DOI 10.1016/S1095-6433(98)10043-0; Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9; THAIK CM, 1995, J CLIN INVEST, V96, P1093, DOI 10.1172/JCI118095; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Yue YK, 2004, BIOCHEM BIOPH RES CO, V314, P749, DOI 10.1016/j.bbrc.2003.12.155	53	39	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21896	21908		10.1074/jbc.M114.549642	http://dx.doi.org/10.1074/jbc.M114.549642			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24936064	Green Published, hybrid			2022-12-28	WOS:000340593500008
J	Moreno, E; Andradas, C; Medrano, M; Caffarel, MM; Perez-Gomez, E; Blasco-Benito, S; Gomez-Canas, M; Pazos, MR; Irving, AJ; Lluis, C; Canela, EI; Fernandez-Ruiz, J; Guzman, M; McCormick, PJ; Sanchez, C				Moreno, Estefania; Andradas, Clara; Medrano, Mireia; Caffarel, Maria M.; Perez-Gomez, Eduardo; Blasco-Benito, Sandra; Gomez-Canas, Maria; Ruth Pazos, M.; Irving, Andrew J.; Lluis, Carme; Canela, Enric I.; Fernandez-Ruiz, Javier; Guzman, Manuel; McCormick, Peter J.; Sanchez, Cristina			Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; PROXIMITY LIGATION ASSAY; CANNABINOID RECEPTORS; LYSOPHOSPHATIDYLINOSITOL RECEPTOR; FUNCTIONAL HETEROMERS; GPR55; CB1; PROLIFERATION; ANTAGONISTS; INHIBITION	The G protein-coupled receptors CB2 (CB2R) and GPR55 are overexpressed in cancer cells and human tumors. Because a modulation of GPR55 activity by cannabinoids has been suggested, we analyzed whether this receptor participates in cannabinoid effects on cancer cells. Here we show that CB2R and GPR55 form heteromers in cancer cells, that these structures possess unique signaling properties, and that modulation of these heteromers can modify the antitumoral activity of cannabinoids in vivo. These findings unveil the existence of previously unknown signaling platforms that help explain the complex behavior of cannabinoids and may constitute new targets for therapeutic intervention in oncology.	[Moreno, Estefania; Medrano, Mireia; Lluis, Carme; Canela, Enric I.; McCormick, Peter J.] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Moreno, Estefania; Medrano, Mireia; Gomez-Canas, Maria; Ruth Pazos, M.; Lluis, Carme; Canela, Enric I.; Fernandez-Ruiz, Javier; Guzman, Manuel; McCormick, Peter J.] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain; [Moreno, Estefania; Medrano, Mireia; Lluis, Carme; Canela, Enric I.; McCormick, Peter J.] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain; [Andradas, Clara; Caffarel, Maria M.; Perez-Gomez, Eduardo; Blasco-Benito, Sandra; Guzman, Manuel; Sanchez, Cristina] Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Gomez-Canas, Maria; Ruth Pazos, M.; Fernandez-Ruiz, Javier] Univ Complutense, Sch Med, Dept Biochem & Mol Biol 3, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; [Perez-Gomez, Eduardo; Blasco-Benito, Sandra; Sanchez, Cristina] Hosp 12 Octubre, Inst Invest, E-28041 Madrid, Spain; [Gomez-Canas, Maria; Fernandez-Ruiz, Javier; Guzman, Manuel] IRYCIS, Madrid 28034, Spain; [Irving, Andrew J.] Univ Dundee, Ninewells Hosp, Div Neurosci, Dundee DD1 9SY, Scotland; [McCormick, Peter J.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England	University of Barcelona; CIBERNED; University of Barcelona; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre; University of Dundee; University of East Anglia	McCormick, PJ (corresponding author), Univ E Anglia, Sch Pharm, CP 1-44,Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	p.mccormick@uea.ac.uk; cristina.sanchez@quim.ucm.es	Sanchez, Cristina/AFQ-4745-2022; Medrano, Mireia/AFP-3427-2022; Canela, Enric I./M-8726-2013; Pérez-Gómez, Eduardo/GYA-5856-2022; Sanchez, Cristina/H-4980-2017; Pazos, Ruth/D-6797-2019; Medrano, Mireia/GVS-3226-2022; Guillén, Estefanía Moreno/ABE-4371-2020; Perez-gomez, Eduardo/F-5906-2015; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018; McCormick, Peter/E-7387-2012	Medrano, Mireia/0000-0002-8707-5501; Canela, Enric I./0000-0003-4992-7440; Pérez-Gómez, Eduardo/0000-0003-0160-5565; Sanchez, Cristina/0000-0002-1428-3078; Pazos, Ruth/0000-0001-7613-795X; Perez-gomez, Eduardo/0000-0003-0160-5565; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604; Gomez Canas, Maria/0000-0002-2520-948X; Moreno, Estefania/0000-0002-2491-5753; Caffarel, Maria/0000-0002-7442-6827; Blasco Benito, Sandra/0000-0002-6714-2340; McCormick, Peter/0000-0002-2225-5181; Guzman, Manuel/0000-0001-7475-118X	Spanish Ministry of Economy and Competitiveness [PI11/00295]; Ramon y Cajal fellowship; Madrid Regional Government [S2010/BMD-2308]; TV3 Marato Project [308/C/2013]; Fundacion Cientifica Asociacion Espanola Contra el Cancer	Spanish Ministry of Economy and Competitiveness(Spanish Government); Ramon y Cajal fellowship(Spanish Government); Madrid Regional Government; TV3 Marato Project; Fundacion Cientifica Asociacion Espanola Contra el Cancer	This work was supported by Spanish Ministry of Economy and Competitiveness Grant PI11/00295 (to C. S.), by a Ramon y Cajal fellowship (to P. J. M.), by Madrid Regional Government Grant S2010/BMD-2308 (to M. G.), and by funds from TV3 Marato Project 308/C/2013 (to P. J. M.).; Recipient of a postdoctoral research contract from the Fundacion Cientifica Asociacion Espanola Contra el Cancer.	Anavi-Goffer S, 2012, J BIOL CHEM, V287, P91, DOI 10.1074/jbc.M111.296020; Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Callen L, 2012, J BIOL CHEM, V287, P20851, DOI 10.1074/jbc.M111.335273; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Gonzalez S, 2012, MOL PSYCHIATR, V17, P650, DOI 10.1038/mp.2011.93; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Kargl J, 2012, J BIOL CHEM, V287, P44234, DOI 10.1074/jbc.M112.364109; Lorente M, 2011, CELL DEATH DIFFER, V18, P959, DOI 10.1038/cdd.2010.170; Marcellino S, 2008, ANAL CHIM ACTA, V629, P73, DOI 10.1016/j.aca.2008.09.031; Mato S, 2010, MOL PHARMACOL, V77, P424, DOI 10.1124/mol.109.060079; Moreira FA, 2010, CURR TOP BEHAV NEURO, V2, P429, DOI 10.1007/7854_2009_16; Navarro G, 2010, J BIOL CHEM, V285, P27346, DOI 10.1074/jbc.M110.115634; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Perez-Gomez E, 2013, ONCOGENE, V32, P2534, DOI 10.1038/onc.2012.278; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Rempel V, 2013, J MED CHEM, V56, P4798, DOI 10.1021/jm4005175; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Sanudo-Pena MC, 2000, EUR J PHARMACOL, V391, P269, DOI 10.1016/S0014-2999(00)00044-3; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sulcova E, 1998, PHARMACOL BIOCHEM BE, V59, P347, DOI 10.1016/S0091-3057(97)00422-X; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106	38	71	76	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21960	21972		10.1074/jbc.M114.561761	http://dx.doi.org/10.1074/jbc.M114.561761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942731	Green Published, hybrid			2022-12-28	WOS:000340593500013
J	Adijanto, J; Du, JH; Moffat, C; Seifert, EL; Hurley, JB; Philp, NJ				Adijanto, Jeffrey; Du, Jianhai; Moffat, Cynthia; Seifert, Erin L.; Hurley, James B.; Philp, Nancy J.			The Retinal Pigment Epithelium Utilizes Fatty Acids for Ketogenesis IMPLICATIONS FOR METABOLIC COUPLING WITH THE OUTER RETINA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR PHAGOCYTOSIS; ARACHIDONIC ACIDS; BETA-OXIDATION; KETONE-BODIES; GLIAL-CELLS; EXPRESSION; TRANSCRIPTOME; TRANSPORTERS; ASTROCYTES; INHIBITOR	Every day, shortly after light onset, photoreceptor cells shed approximately a tenth of their outer segment. The adjacent retinal pigment epithelial (RPE) cells phagocytize and digest shed photoreceptor outer segment, which provides a rich source of fatty acids that could be utilized as an energy substrate. From a microarray analysis, we found that RPE cells express particularly high levels of the mitochondrial HMG-CoA synthase 2 (Hmgcs2) compared with all other tissues (except the liver and colon), leading to the hypothesis that RPE cells, like hepatocytes, can produce beta-hydroxybutyrate (beta-HB) from fatty acids. Using primary human fetal RPE (hfRPE) cells cultured on Transwell filters with separate apical and basal chambers, we demonstrate that hfRPE cells can metabolize palmitate, a saturated fatty acid that constitutes approximate to 15% of all lipids in the photoreceptor outer segment, to produce beta-HB. Importantly, we found that hfRPE cells preferentially release beta-HB into the apical chamber and that this process is mediated primarily by monocarboxylate transporter isoform 1 (MCT1). Using a GC-MS analysis of C-13-labeled metabolites, we showed that retinal cells can take up and metabolize 13C-labeled beta-HB into various TCA cycle intermediates and amino acids. Collectively, our data support a novel mechanism of RPE-retina metabolic coupling in which RPE cells metabolize fatty acids to produce beta-HB, which is transported to the retina for use as a metabolic substrate.	[Adijanto, Jeffrey; Moffat, Cynthia; Seifert, Erin L.; Philp, Nancy J.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Du, Jianhai; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Du, Jianhai; Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	Jefferson University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Adijanto, J (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	jadijan1@gmail.com; nancy.philp@jefferson.edu	Du, Jianhai/J-6197-2014	Du, Jianhai/0000-0002-5612-4091; Philp, Nancy/0000-0001-7028-0448	National Institutes of Health [EY012042, EY017863, EY006641]; NATIONAL EYE INSTITUTE [R56EY012042, R01EY017863, R01EY006641, F32EY006641, R01EY012042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012042 (to N. J. P.) and EY017863 and EY006641 (to J. B. H.).	Blazquez C, 1998, J NEUROCHEM, V71, P1597; Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; CHEN HM, 1993, EXP EYE RES, V57, P369, DOI 10.1006/exer.1993.1136; CHEN HM, 1993, J LIPID RES, V34, P1943; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; Ershov AV, 2000, J NEUROSCI RES, V60, P328, DOI 10.1002/(SICI)1097-4547(20000501)60:3<328::AID-JNR7>3.0.CO;2-5; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gallagher-Colombo S, 2010, INVEST OPHTH VIS SCI, V51, P5343, DOI 10.1167/iovs.09-5028; Guzman M, 2001, TRENDS ENDOCRIN MET, V12, P169, DOI 10.1016/S1043-2760(00)00370-2; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Hugo SE, 2012, GENE DEV, V26, P282, DOI 10.1101/gad.180968.111; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Koso H, 2009, INVEST OPHTH VIS SCI, V50, P5411, DOI 10.1167/iovs.08-3246; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Li R, 2009, AM J PHYSIOL-CELL PH, V297, pC1452, DOI 10.1152/ajpcell.00255.2009; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mustafi D, 2013, FASEB J, V27, P4585, DOI 10.1096/fj.13-237537; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Oyster C. W., 1999, HUMAN EYE STRUCTURE, P714; PANDAJONAS S, 1994, OPHTHALMOLOGY, V101, P519; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Price NT, 1998, BIOCHEM J, V329, P321; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; Tyni T, 2002, PEDIATR RES, V52, P595, DOI 10.1203/01.PDR.0000030874.20888.2D; Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	40	78	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20570	20582		10.1074/jbc.M114.565457	http://dx.doi.org/10.1074/jbc.M114.565457			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898254	Green Published, hybrid			2022-12-28	WOS:000339396600017
J	Bakele, M; Lotz-Havla, AS; Jakowetz, A; Carevic, M; Marcos, V; Muntau, AC; Gersting, SW; Hartl, D				Bakele, Martina; Lotz-Havla, Amelie S.; Jakowetz, Anja; Carevic, Melanie; Marcos, Veronica; Muntau, Ania C.; Gersting, Soeren W.; Hartl, Dominik			An Interactive Network of Elastase, Secretases, and PAR-2 Protein Regulates CXCR1 Receptor Surface Expression on Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROSIS LUNG-DISEASE; RESONANCE ENERGY-TRANSFER; GAMMA-SECRETASE; CYSTIC-FIBROSIS; PRESENILIN/GAMMA-SECRETASE; INTRAMEMBRANE PROTEOLYSIS; CHEMOKINE RECEPTORS; ALZHEIMERS-DISEASE; LOCALIZATION; MECHANISMS	CXCL8 (IL-8) recruits and activates neutrophils through the G protein-coupled chemokine receptor CXCR1. We showed previously that elastase cleaves CXCR1 and thereby impairs antibacterial host defense. However, the molecular intracellular machinery involved in this process remained undefined. Here we demonstrate by using flow cytometry, confocal microscopy, subcellular fractionation, co-immunoprecipitation, and bioluminescence resonance energy transfer that combined alpha- and gamma-secretase activities are functionally involved in elastase-mediated regulation of CXCR1 surface expression on human neutrophils, whereas matrix metalloproteases are dispensable. We further demonstrate that PAR-2 is stored in mobilizable compartments in neutrophils. Bioluminescence resonance energy transfer and co-immunoprecipitation studies showed that secretases, PAR-2, and CXCR1 colocalize and physically interact in a novel protease/secretase-chemokine receptor network. PAR-2 blocking experiments provided evidence that elastase increased intracellular presenilin-1 expression through PAR-2 signaling. When viewed in combination, these studies establish a novel functional network of elastase, secretases, and PAR-2 that regulate CXCR1 expression on neutrophils. Interfering with this network could lead to novel therapeutic approaches in neutrophilic diseases, such as cystic fibrosis or rheumatoid arthritis.	[Bakele, Martina; Jakowetz, Anja; Carevic, Melanie; Hartl, Dominik] Univ Tubingen, Childrens Hosp, Emmy Noether Grp, D-72076 Tubingen, Germany; [Lotz-Havla, Amelie S.; Marcos, Veronica; Muntau, Ania C.; Gersting, Soeren W.] Univ Munich, Dr von Hauner Childrens Hosp, D-80337 Munich, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Munich	Hartl, D (corresponding author), Univ Tubingen, Childrens Hosp, D-72076 Tubingen, Germany.	dominik.hartl@med.uni-tuebingen.de	Gersting, Soeren/D-4612-2011	Gersting, Soeren/0000-0001-7482-4748	German Research Foundation (DFG) [HA 5274/3-1]; Novartis Foundation; Bavarian Genome Research Network; LMUexcellent [42595-6];  [CRC/SFB685]	German Research Foundation (DFG)(German Research Foundation (DFG)); Novartis Foundation(Novartis); Bavarian Genome Research Network; LMUexcellent; 	This work was supported by the German Research Foundation (DFG, Emmy Noether Programme HA 5274/3-1; to D. H.), the Novartis Foundation (to D. H.), the CRC/SFB685 (to D. H.), the Bavarian Genome Research Network (BayGene; to A. C. M. and S. W. G.), and by LMUexcellent (Grant 42595-6; to A. C. M. and S. W. G.).	Bakele M, 2014, J BIOL CHEM, V289, P5320, DOI 10.1074/jbc.M113.505636; Berger M, 2012, J BIOL CHEM, V287, P19409, DOI 10.1074/jbc.M112.353557; Carey BW, 2007, BIOCHEM J, V401, P121, DOI 10.1042/BJ20060847; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Elzinga BM, 2009, J BIOL CHEM, V284, P1394, DOI 10.1074/jbc.M803108200; Gaggar A, 2011, EUR RESPIR J, V38, P721, DOI 10.1183/09031936.00173210; Gersting SW, 2012, METHODS MOL BIOL, V815, P253, DOI 10.1007/978-1-61779-424-7_19; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Hager M, 2010, J INTERN MED, V268, P25, DOI 10.1111/j.1365-2796.2010.02237.x; Hanafusa H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1161; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jeon AHW, 2013, J BIOL CHEM, V288, P15352, DOI 10.1074/jbc.M112.441840; Kanke T, 2005, J PHARMACOL SCI, V97, P38, DOI 10.1254/jphs.FMJ04005X7; Kormann MSD, 2012, EUR RESPIR J, V39, P1385, DOI 10.1183/09031936.00130011; Mambole AS, 2008, J BIOL CHEM, V283, P23627, DOI 10.1074/jbc.M710286200; Owen C, 2001, PULM PHARMACOL THER, V14, P193, DOI 10.1006/pupt.2001.0281; Owen CA, 2008, INT J BIOCHEM CELL B, V40, P1246, DOI 10.1016/j.biocel.2008.01.020; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Reutershan J, 2006, DRUG NEWS PERSPECT, V19, P615, DOI 10.1358/dnp.2006.19.10.1068009; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; Sabroe I, 2002, EUR RESPIR J, V19, P350, DOI 10.1183/09031936.02.00253602; Sagel SD, 2002, J PEDIATR-US, V141, P811, DOI 10.1067/mpd.2002.129847; Singh JK, 2013, CLIN CANCER RES, V19, P643, DOI 10.1158/1078-0432.CCR-12-1063; Sly PD, 2013, NEW ENGL J MED, V368, P1963, DOI 10.1056/NEJMoa1301725; Stockley RA, 1999, AM J RESP CRIT CARE, V160, pS49, DOI 10.1164/ajrccm.160.supplement_1.13; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P8534, DOI 10.1073/pnas.1202691109; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	36	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20516	20525		10.1074/jbc.M114.575803	http://dx.doi.org/10.1074/jbc.M114.575803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24914212	Green Published, hybrid			2022-12-28	WOS:000339396600013
J	Zhao, X; Kuja-Panula, J; Sundvik, M; Chen, YC; Aho, V; Peltola, MA; Porkka-Heiskanen, T; Panula, P; Rauvala, H				Zhao, Xiang; Kuja-Panula, Juha; Sundvik, Maria; Chen, Yu-Chia; Aho, Vilma; Peltola, Marjaana A.; Porkka-Heiskanen, Tarja; Panula, Pertti; Rauvala, Heikki			Amigo Adhesion Protein Regulates Development of Neural Circuits in Zebrafish Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARVAL ZEBRAFISH; EMBRYONIC-DEVELOPMENT; POTASSIUM CHANNEL; ROBO RECEPTORS; MESSENGER-RNA; AXON TRACT; NEURONS; CELL; SLIT; CARBOHYDRATE	The Amigo protein family consists of three transmembrane proteins characterized by six leucine-rich repeat domains and one immunoglobulin-like domain in their extracellular moieties. Previous in vitro studies have suggested a role as homophilic adhesion molecules in brain neurons, but the in vivo functions remain unknown. Here we have cloned all three zebrafish amigos and show that amigo1 is the predominant family member expressed during nervous system development in zebrafish. Knockdown of amigo1 expression using morpholino oligonucleotides impairs the formation of fasciculated tracts in early fiber scaffolds of brain. A similar defect in fiber tract development is caused by mRNA-mediated expression of the Amigo1 ectodomain that inhibits adhesion mediated by the full-length protein. Analysis of differentiated neural circuits reveals defects in the catecholaminergic system. At the behavioral level, the disturbed formation of neural circuitry is reflected in enhanced locomotor activity and in the inability of the larvae to perform normal escape responses. We suggest that Amigo1 is essential for the development of neural circuits of zebrafish, where its mechanism involves homophilic interactions within the developing fiber tracts and regulation of the Kv2.1 potassium channel to form functional neural circuitry that controls locomotion.	[Zhao, Xiang; Kuja-Panula, Juha; Sundvik, Maria; Chen, Yu-Chia; Peltola, Marjaana A.; Panula, Pertti; Rauvala, Heikki] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; [Sundvik, Maria; Chen, Yu-Chia; Panula, Pertti] Univ Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland; [Aho, Vilma; Porkka-Heiskanen, Tarja] Univ Helsinki, Inst Biomed Physiol, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Rauvala, H (corresponding author), Univ Helsinki, Ctr Neurosci, POB 56 Viikinkaari 4, FIN-00014 Helsinki, Finland.	heikki.rauvala@helsinki.fi	Zhao, Xiang/AAK-9641-2020	Zhao, Xiang/0000-0002-3339-4806; Lammi, Vilma/0000-0002-3256-5239; Rauvala, Heikki/0000-0001-7809-9811; Stenberg, Tarja/0000-0003-1843-7625; Panula, Pertti/0000-0002-1189-5132	Academy of Finland; Sigrid Juselius Foundation; Doctoral Program in Brain and Mind of the Doctoral School in Health Sciences	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Doctoral Program in Brain and Mind of the Doctoral School in Health Sciences	This work was supported by the Academy of Finland and the Sigrid Juselius Foundation.; Supported by the Doctoral Program in Brain and Mind of the Doctoral School in Health Sciences.	Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Chen YA, 2012, J CELL PHYSIOL, V227, P2217, DOI 10.1002/jcp.22958; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fink M, 2006, DEV DYNAM, V235, P3370, DOI 10.1002/dvdy.20995; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Kajander T, 2011, J MOL BIOL, V413, P1001, DOI 10.1016/j.jmb.2011.09.032; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Kastenhuber E, 2009, J NEUROSCI, V29, P8914, DOI 10.1523/JNEUROSCI.0568-09.2009; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KIMMEL CB, 1980, J COMP PHYSIOL, V140, P343, DOI 10.1007/BF00606274; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Laeremans A, 2013, BRAIN STRUCT FUNCT, V218, P123, DOI 10.1007/s00429-012-0387-4; Liu YC, 2012, J COMP PHYSIOL A, V198, P11, DOI 10.1007/s00359-011-0682-1; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; METCALFE WK, 1990, DEVELOPMENT, V110, P491; Mueller T., 2005, ATLAS EARLY ZEBRAFIS, P29; Mueller T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00064; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; Ono T, 2003, J NEUROSCI, V23, P5887; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; Peltola MA, 2011, EMBO REP, V12, P1293, DOI 10.1038/embor.2011.204; PETERS A, 1967, J CELL BIOL, V32, P113, DOI 10.1083/jcb.32.1.113; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rivera J, 2007, EUR J NEUROSCI, V25, P136, DOI 10.1111/j.1460-9568.2006.05277.x; ROSS LS, 1992, J NEUROSCI, V12, P467; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sallinen V, 2009, J NEUROCHEM, V109, P403, DOI 10.1111/j.1471-4159.2009.05986.x; Schweitzer J, 2012, DEV NEUROBIOL, V72, P256, DOI 10.1002/dneu.20911; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Thisse C., 2005, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; WILSON SW, 1990, DEVELOPMENT, V108, P121; Wullimann Mario F, 2002, Brain Res Gene Expr Patterns, V1, P187; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232; Zhao X, 2011, J BIOL CHEM, V286, P23200, DOI 10.1074/jbc.M111.223834	50	10	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19958	19975		10.1074/jbc.M113.545582	http://dx.doi.org/10.1074/jbc.M113.545582			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24904058	Green Published, hybrid			2022-12-28	WOS:000339395200013
J	Gifford, SM; Liu, WZ; Mader, CC; Halo, TL; Machida, K; Boggon, TJ; Koleske, AJ				Gifford, Stacey M.; Liu, Weizhi; Mader, Christopher C.; Halo, Tiffany L.; Machida, Kazuya; Boggon, Titus J.; Koleske, Anthony J.			Two Amino Acid Residues Confer Different Binding Affinities of Abelson Family Kinase Src Homology 2 Domains for Phosphorylated Cortactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABL TYROSINE KINASE; 3-DIMENSIONAL SOLUTION STRUCTURE; SH2 DOMAIN; C-ABL; ACTIN POLYMERIZATION; MOLECULAR-GRAPHICS; CELL-MIGRATION; F-ACTIN; ADHESION; PEPTIDE	The closely related Abl family kinases, Arg and Abl, play important non-redundant roles in the regulation of cell morphogenesis and motility. Despite similar N-terminal sequences, Arg and Abl interact with different substrates and binding partners with varying affinities. This selectivity may be due to slight differences in amino acid sequence leading to differential interactions with target proteins. We report that the Arg Src homology (SH) 2 domain binds two specific phosphotyrosines on cortactin, a known Abl/Arg substrate, with over 10-fold higher affinity than the Abl SH2 domain. We show that this significant affinity difference is due to the substitution of arginine 161 and serine 187 in Abl to leucine 207 and threonine 233 in Arg, respectively. We constructed Abl SH2 domains with R161L and S187T mutations alone and in combination and find that these substitutions are sufficient to convert the low affinity Abl SH2 domain to a higher affinity "Arg-like" SH2 domain in binding to a phospho-cortactin peptide. We crystallized the Arg SH2 domain for structural comparison to existing crystal structures of the Abl SH2 domain. We show that these two residues are important determinants of Arg and Abl SH2 domain binding specificity. Finally, we expressed Arg containing an "Abl-like" low affinity mutant Arg SH2 domain (L207R/T233S) and find that this mutant, although properly localized to the cell periphery, does not support wild type levels of cell edge protrusion. Together, these observations indicate that these two amino acid positions confer different binding affinities and cellular functions on the distinct Abl family kinases.	[Gifford, Stacey M.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Liu, Weizhi; Boggon, Titus J.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Mader, Christopher C.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Halo, Tiffany L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Boggon, Titus J.; Koleske, Anthony J.] Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; [Machida, Kazuya] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Raymond & Beverly Sackler Lab Genet & Mol Med, Farmington, CT 06030 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; University of Connecticut	Boggon, TJ (corresponding author), Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu; anthony.koleske@yale.edu			National Institutes of Health [GM100411, AI075133, NS39475, CA133346, R01 CA82258]; Connecticut Breast Health Initiative; American Heart Association [11PRE7450039]; Women's Health Research at Yale; NATIONAL CANCER INSTITUTE [R01CA082258, R01CA133346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Breast Health Initiative; American Heart Association(American Heart Association); Women's Health Research at Yale; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM100411 and AI075133 (to T. J. B.), NS39475, GM100411, and CA133346 (to A. J. K.), and pilot grants from the Connecticut Breast Health Initiative and Women's Health Research at Yale (to T. J. B. and A. J. K.).; Supported by American Heart Association Founders Affiliate Predoctoral Fellowship 11PRE7450039.; Supported by National Institutes of Health Grant R01 CA82258.	Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILMER T, 1994, J BIOL CHEM, V269, P31711; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Liu WZ, 2012, ACTA CRYSTALLOGR F, V68, P154, DOI 10.1107/S1744309111056132; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Metzler WJ, 1996, BIOCHEMISTRY-US, V35, P6201, DOI 10.1021/bi960157x; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Miller MM, 2010, BIOCHEMISTRY-US, V49, P2227, DOI 10.1021/bi901721u; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nam HJ, 1996, STRUCTURE, V4, P1105, DOI 10.1016/S0969-2126(96)00116-5; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; Peacock JG, 2010, CYTOSKELETON, V67, P666, DOI 10.1002/cm.20479; Pellicena P, 1998, J BIOL CHEM, V273, P15325, DOI 10.1074/jbc.273.25.15325; PEREGO R, 1991, ONCOGENE, V6, P1899; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RENSHAW MW, 1988, MOL CELL BIOL, V8, P4547, DOI 10.1128/MCB.8.10.4547; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Tong L, 1996, J MOL BIOL, V256, P601, DOI 10.1006/jmbi.1996.0112; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	45	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19704	19713		10.1074/jbc.M114.556480	http://dx.doi.org/10.1074/jbc.M114.556480			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891505	hybrid, Green Published			2022-12-28	WOS:000339326800042
J	Rahman, SU; Arenas, J; Ozturk, H; Dekker, N; van Ulsen, P				Rahman, Sadeeq Ur; Arenas, Jesus; Ozturk, Hulya; Dekker, Nicole; van Ulsen, Peter			The Polypeptide Transport-associated (POTRA) Domains of TpsB Transporters Determine the System Specificity of Two-partner Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS; PROTEIN SECRETION; ARCHITECTURE; SIGNAL; OMP85; HRPA	The two-partner secretion (TPS) systems of Gram-negative bacteria secrete large TpsA exoproteins by a dedicated TpsB transporter in the outer membrane. TpsBs contain an N-terminal module located in the periplasm that includes two polypeptide transport-associated (POTRA) domains. These are thought to initiate secretion of a TpsA by binding its N-terminal secretion signal, called the TPS domain. Neisseria meningitidis encodes up to five TpsA proteins that are secreted via only two TpsB transporters: TpsB1 and TpsB2. Of these two, the TpsB2 recognizes the TPS domains of all TpsAs, despite their sequence diversity. By contrast, the TpsB1 shows a limited recognition of a TPS domain that is shared by two TpsAs. The difference in substrate specificity of the TpsBs enabled us to investigate the role of the POTRA domains in the selection of TPS domains. We tested secretion of TPS domains or full-length TpsAs by TpsB mutants with deleted, duplicated, and exchanged POTRA domains. Exchanging the two POTRA domains of a TpsB resulted in a switch in specificity. Furthermore, exchanging a single POTRA domain showed that each of the two domains contributed to the cargo selection. Remarkably, the order of the POTRA domains could be reversed without affecting substrate selection, but this aberrant order did result in an alternatively processed secretion product. Our results suggest that secretion of a TpsA is initiated by engaging both POTRA domains of a TpsB transporter and that these select the cognate TpsAs for secretion.	[Rahman, Sadeeq Ur; Ozturk, Hulya; Dekker, Nicole; van Ulsen, Peter] Vrije Univ Amsterdam, Dept Mol Cell Biol, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Arenas, Jesus] Univ Utrecht, Dept Biol, Sect Mol Microbiol, NL-3584 CH Utrecht, Netherlands	Vrije Universiteit Amsterdam; Utrecht University	van Ulsen, P (corresponding author), Vrije Univ Amsterdam, Dept Mol Cell Biol, Sect Mol Microbiol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	j.p.van.ulsen@vu.nl	Arenas, Jesús/A-5420-2017; Rahman, Sadeeq ur/F-6107-2010	Arenas, Jesús/0000-0002-8134-0693; Rahman, Sadeeq ur/0000-0002-9314-6257; van Ulsen, Peter/0000-0002-2164-1611	Higher Education Commission of Pakistan; Netherlands Organization for Health Research and Development (ZonMw)	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Supported by the Higher Education Commission of Pakistan.; Supported by the Netherlands Organization for Health Research and Development (ZonMw).	Arenas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-622; Arnold T, 2010, J BIOL CHEM, V285, P18003, DOI 10.1074/jbc.M110.112516; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Delattre AS, 2011, MOL MICROBIOL, V81, P99, DOI 10.1111/j.1365-2958.2011.07680.x; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Grass S, 2000, MOL MICROBIOL, V36, P55, DOI 10.1046/j.1365-2958.2000.01812.x; Hodak H, 2006, MOL MICROBIOL, V61, P368, DOI 10.1111/j.1365-2958.2006.05242.x; Jacob-Dubuisson F, 2013, RES MICROBIOL, V164, P583, DOI 10.1016/j.resmic.2013.03.009; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Koenig P, 2010, J BIOL CHEM, V285, P18016, DOI 10.1074/jbc.M110.112649; NAKAMURA K, 1976, J BIOCHEM, V80, P1411, DOI 10.1093/oxfordjournals.jbchem.a131414; Neil RB, 2009, INFECT IMMUN, V77, P2285, DOI 10.1128/IAI.01502-08; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rahman SU, 2013, J BACTERIOL, V195, P788, DOI 10.1128/JB.01355-12; Robson SA, 2006, P NATL ACAD SCI USA, V103, P6700, DOI 10.1073/pnas.0601397103; Ruer S, 2008, EMBO J, V27, P2669, DOI 10.1038/emboj.2008.197; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Sauri A, 2011, J MOL BIOL, V412, P553, DOI 10.1016/j.jmb.2011.07.035; Schmitt C, 2007, J BACTERIOL, V189, P7968, DOI 10.1128/JB.00851-07; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Surana NK, 2004, P NATL ACAD SCI USA, V101, P14497, DOI 10.1073/pnas.0404679101; Tala A, 2008, CELL MICROBIOL, V10, P2461, DOI 10.1111/j.1462-5822.2008.01222.x; van Ulsen P, 2006, FEMS MICROBIOL REV, V30, P292, DOI 10.1111/j.1574-6976.2006.00013.x; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; van Ulsen P, 2001, FEMS IMMUNOL MED MIC, V32, P53, DOI 10.1016/S0928-8244(01)00271-1; van Ulsen P, 2008, INFECT IMMUN, V76, P4649, DOI 10.1128/IAI.00393-08; van Ulsen P, 2006, MICROBES INFECT, V8, P2088, DOI 10.1016/j.micinf.2006.03.007; van Ulsen P, 2014, BBA-MOL CELL RES, V1843, P1592, DOI 10.1016/j.bbamcr.2013.11.006; Walker G, 2004, INFECT IMMUN, V72, P611, DOI 10.1128/IAI.72.1.611-614.2004	37	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19799	19809		10.1074/jbc.M113.544627	http://dx.doi.org/10.1074/jbc.M113.544627			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872418	Green Published, hybrid			2022-12-28	WOS:000339326800051
J	Zhou, JJ; Wang, F; Xu, ZW; Lo, WS; Lau, CF; Chiang, KP; Nangle, LA; Ashlock, MA; Mendlein, JD; Yang, XL; Zhang, MJ; Schimmel, P				Zhou, Jie J.; Wang, Feng; Xu, Zhiwen; Lo, Wing-Sze; Lau, Ching-Fun; Chiang, Kyle P.; Nangle, Leslie A.; Ashlock, Melissa A.; Mendlein, John D.; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul			Secreted Histidyl-tRNA Synthetase Splice Variants Elaborate Major Epitopes for Autoantibodies in Inflammatory Myositis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CYTOKINE; COMPLEX; NOISE; AUTOANTIGENS; FRAGMENT; MODEL; AIMP2	Inflammatory and debilitating myositis and interstitial lung disease are commonly associated with autoantibodies (anti-Jo-1 antibodies) to cytoplasmic histidyl-tRNA synthetase (HisRS). Anti-Jo-1 antibodies from different disease-afflicted patients react mostly with spatially separated epitopes in the three-dimensional structure of human HisRS. We noted that two HisRS splice variants (SVs) include these spatially separated regions, but each SV lacks the HisRS catalytic domain. Despite the large deletions, the two SVs cross-react with a substantial population of anti-Jo-1 antibodies from myositis patients. Moreover, expression of at least one of the SVs is up-regulated in dermatomyositis patients, and cell-based experiments show that both SVs and HisRS can be secreted. We suggest that, in patients with inflammatory myositis, anti-Jo-1 antibodies may have extracellular activity.	[Zhou, Jie J.; Wang, Feng; Xu, Zhiwen; Lo, Wing-Sze; Lau, Ching-Fun; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul] Hong Kong Univ Sci & Technol, IAS HKUST Scripps R&D Lab, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Zhou, Jie J.; Wang, Feng; Xu, Zhiwen; Lo, Wing-Sze; Lau, Ching-Fun] Pangu BioPharma, Hong Kong, Hong Kong, Peoples R China; [Chiang, Kyle P.; Nangle, Leslie A.; Ashlock, Melissa A.; Mendlein, John D.] aTyr Pharma, San Diego, CA 92121 USA; [Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, La Jolla, CA 92037 USA; [Schimmel, Paul] Scripps Florida, Jupiter, FL 33458 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Scripps Research Institute; State University System of Florida; University of Florida	Schimmel, P (corresponding author), Hong Kong Univ Sci & Technol, IAS HKUST Scripps R&D Lab, Inst Adv Study, Kowloon, Hong Kong, Peoples R China.	schimmel@scripps.edu	Lo, Cario Wing Sze/DGZ-8810-2022; Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X; Zhang, Mingjie/0000-0001-9404-0190	National Institutes of Health from NCI [CA92577]; Innovation and Technology Fund of Hong Kong [UIM181, UIM192, UIM199]; aTyr Pharma; NFCR Fellowship from the National Foundation for Cancer Research;  [GM88278]; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Innovation and Technology Fund of Hong Kong; aTyr Pharma; NFCR Fellowship from the National Foundation for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA92577 from NCI and Grant GM88278. This work was also supported by Innovation and Technology Fund of Hong Kong Grants UIM181, UIM192, and UIM199; aTyr Pharma; and an NFCR Fellowship (to the Scripps Laboratory for tRNA synthetase research) from the National Foundation for Cancer Research. Professors Mingjie Zhang, Xiang-Lei Yang, and Paul Schimmel are financially benefited by aTyr Pharma in the form of compensation, stock ownership, or both.	Banin E, 2006, INVEST OPHTH VIS SCI, V47, P2125, DOI 10.1167/iovs.05-1096; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Choi JW, 2012, J MOL CELL BIOL, V4, P164, DOI 10.1093/jmcb/mjs018; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; Choi JW, 2009, J CELL SCI, V122, P2710, DOI 10.1242/jcs.049767; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Greenberg Y, 2008, FASEB J, V22, P1597, DOI 10.1096/fj.07-9973com; Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105; Harlow E., 1999, USING ANTIBODIES LAB, P449; He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jura M, 2007, CRIT REV IMMUNOL, V27, P559, DOI 10.1615/CritRevImmunol.v27.i6.60; Kapoor M, 2008, J BIOL CHEM, V283, P2070, DOI 10.1074/jbc.M706028200; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; Kim HO, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-113; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Kron MA, 2013, CLIN VACCINE IMMUNOL, V20, P276, DOI 10.1128/CVI.00594-12; Kron MA, 2012, MOL BIOCHEM PARASIT, V185, P66, DOI 10.1016/j.molbiopara.2012.06.003; Kuznetsov VA, 2002, GENETICS, V161, P1321; Kwon HS, 2012, J CELL SCI, V125, P4620, DOI 10.1242/jcs.108209; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Mammen AL, 2011, NAT REV NEUROL, V7, P343, DOI 10.1038/nrneurol.2011.63; MARTIN A, 1995, FASEB J, V9, P1226, DOI 10.1096/fasebj.9.12.7672516; MATHEWS MB, 1983, NATURE, V304, P177, DOI 10.1038/304177a0; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; NISHIKAI M, 1980, ARTHRITIS RHEUM, V23, P881, DOI 10.1002/art.1780230802; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; RABEN N, 1994, J BIOL CHEM, V269, P24277; Rouabhia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071660; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Soejima M, 2011, ARTHRITIS RHEUM-US, V63, P479, DOI 10.1002/art.30113; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Targoff IN, 2000, CURR OPIN RHEUMATOL, V12, P475, DOI 10.1097/00002281-200011000-00001; Tzima E, 2003, P NATL ACAD SCI USA, V100, P14903, DOI 10.1073/pnas.2436330100; Vo MN, 2011, J BIOL CHEM, V286, P11563, DOI 10.1074/jbc.C110.213876; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang F, 2013, J BIOL CHEM, V288, P29223, DOI 10.1074/jbc.C113.490599; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Wu PC, 1999, CANCER RES, V59, P205; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	49	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19269	19275		10.1074/jbc.C114.571026	http://dx.doi.org/10.1074/jbc.C114.571026			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24898250	Green Published, hybrid			2022-12-28	WOS:000339326800002
J	Hauck, AFE; Hardman, SJO; Kutta, RJ; Greetham, GM; Heyes, DJ; Scrutton, NS				Hauck, Anna F. E.; Hardman, Samantha J. O.; Kutta, Roger J.; Greetham, Gregory M.; Heyes, Derren J.; Scrutton, Nigel S.			The Photoinitiated Reaction Pathway of Full-length Cyanobacteriochrome Tlr0924 Monitored Over 12 Orders of Magnitude	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAFAST DYNAMICS; PHYTOCHROME AGP1; LUMI-R; FEMTOSECOND; PHOTOCONVERSION; PHYCOVIOLOBILIN; PHOTORECEPTOR; PHOTODYNAMICS; SPECTROSCOPY; KINETICS	The coupling of photochemistry to protein chemical and structural change is crucial to biological light-activated signaling mechanisms. This is typified by cyanobacteriochromes (CBCRs), members of the phytochrome superfamily of photoreceptors that exhibit a high degree of spectral diversity, collectively spanning the entire visible spectrum. CBCRs utilize a basic E/Z isomerization of the bilin chromophore as the primary step in their photocycle, which consists of reversible photoconversion between two photostates. Despite intense interest in these photoreceptors as signal transduction modules a complete description of light-activated chemical and structural changes has not been reported. The CBCR Tlr0924 contains both phycocyanobilin and phycoviolobilin chromophores, and these two species photoisomerize in parallel via spectrally and kinetically equivalent intermediates before the second step of the photoreaction where the reaction pathways diverge, the loss of a thioether linkage to a conserved cysteine residue occurs, and the phycocyanobilin reaction terminates in a red-absorbing state, whereas the phycoviolobilin reaction proceeds more rapidly to a final green-absorbing state. Here time-resolved visible transient absorption spectroscopy (femtosecond to second) has been used, in conjunction with time-resolved IR spectroscopy (femtosecond to nanosecond) and cryotrapping techniques, to follow the entire photoconversion of the blue-absorbing states to the green-and red-absorbing states of the full-length form of Tlr0924 CBCR. Our analysis shows that Tlr0924 undergoes an unprecedented long photoreaction that spans from picoseconds to seconds. We show that the thermally driven, long timescale changes are less complex than those reported for the red/far-red photocycles of the related phytochrome photoreceptors.	[Hauck, Anna F. E.; Hardman, Samantha J. O.; Kutta, Roger J.; Heyes, Derren J.; Scrutton, Nigel S.] Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Hauck, Anna F. E.; Hardman, Samantha J. O.; Kutta, Roger J.; Heyes, Derren J.; Scrutton, Nigel S.] Univ Manchester, Fac Life Sci, Photon Sci Inst, Manchester M13 9PL, Lancs, England; [Greetham, Gregory M.] Harwell Oxford, Sci & Technol Facil Council, Res Complex Harwell, Cent Laser Facil, Didcot OX11 0QX, Oxon, England	University of Manchester; University of Manchester; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Scrutton, NS (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester M13 9PL, Lancs, England.	nigel.scrutton@manchester.ac.uk	Scrutton, Nigel/B-7352-2017	Scrutton, Nigel/0000-0002-4182-3500; Heyes, Derren/0000-0002-7453-1571; Hardman, Samantha/0000-0002-8310-4758	Engineering and Physical Sciences Research Council (EPSRC) [EP/I01974X/1, EP/J020192/1]; Biotechnology and Biological Sciences Research Council Collaborative Award in Science and Engineering (BBSRC CASE) award; TgK Scientific Ltd. (Bradford-on-Avon, United Kingdom); Biotechnology and Biological Sciences Research Council [955916] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I01974X/1, EP/J020192/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/H001840/1] Funding Source: researchfish; EPSRC [EP/I01974X/1, EP/J020192/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council Collaborative Award in Science and Engineering (BBSRC CASE) award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); TgK Scientific Ltd. (Bradford-on-Avon, United Kingdom); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work work was supported by the Engineering and Physical Sciences Research Council (EPSRC) Grants EP/I01974X/1, and EP/J020192/1. The time-resolved infrared measurements were carried out through program access support of the United Kingdom Science and Technology Facilities Council (STFC).; Supported by a Biotechnology and Biological Sciences Research Council Collaborative Award in Science and Engineering (BBSRC CASE) award and by TgK Scientific Ltd. (Bradford-on-Avon, United Kingdom).	Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Bischoff M, 2001, BIOCHEMISTRY-US, V40, P181, DOI 10.1021/bi0011734; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; Chizhov I, 2013, BIOPHYS J, V105, P2210, DOI 10.1016/j.bpj.2013.09.033; Cornilescu CC, 2014, J BIOL CHEM, V289, P3055, DOI 10.1074/jbc.M113.531053; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Durin G, 2009, BIOPHYS J, V96, P1902, DOI [10.1016/j.bpj.2008.10.065, 10.1016/j.bpj.200X.10.065]; Foerstendorf H, 1996, BIOCHEMISTRY-US, V35, P10793, DOI 10.1021/bi960960r; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Freer LH, 2012, J PHYS CHEM B, V116, P10571, DOI 10.1021/jp302637u; Fukushima Y, 2011, BIOCHEMISTRY-US, V50, P6328, DOI 10.1021/bi101799w; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Gottlieb SM, 2014, BIOCHEMISTRY-US, V53, P1029, DOI 10.1021/bi4015538; Gottlieb SM, 2013, BIOCHEMISTRY-US, V52, P8198, DOI 10.1021/bi400946q; Greetham GM, 2010, APPL SPECTROSC, V64, P1311, DOI 10.1366/000370210793561673; Heyes DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052418; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Heyne K, 2002, BIOPHYS J, V82, P1004, DOI 10.1016/S0006-3495(02)75460-X; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Jones AR, 2012, J PHYS CHEM A, V116, P5586, DOI 10.1021/jp304594d; Kim PW, 2013, J PHYS CHEM LETT, V4, P2605, DOI 10.1021/jz401443q; Kim PW, 2012, CHEM PHYS LETT, V549, P86, DOI 10.1016/j.cplett.2012.08.044; Kim PW, 2012, BIOCHEMISTRY-US, V51, P608, DOI 10.1021/bi201507k; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lorenc M, 2002, APPL PHYS B-LASERS O, V74, P19, DOI 10.1007/s003400100750; Mroginski MA, 2011, J PHYS CHEM B, V115, P1220, DOI 10.1021/jp108265h; Muller MG, 2008, BIOPHYS J, V94, P4370, DOI 10.1529/biophysj.106.091652; Piwowarski P, 2010, CHEMPHYSCHEM, V11, P1207, DOI 10.1002/cphc.200901008; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Schumann C, 2007, CHEMPHYSCHEM, V8, P1657, DOI 10.1002/cphc.200700210; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Toh KC, 2011, J PHYS CHEM A, V115, P3778, DOI 10.1021/jp106891x; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; van Thor JJ, 2007, J AM CHEM SOC, V129, P126, DOI 10.1021/ja0660709; van Wilderen LJGW, 2009, J PHYS CHEM B, V113, P16354, DOI 10.1021/jp9038539; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Yoshihara S, 2006, BIOCHEMISTRY-US, V45, P3775, DOI 10.1021/bi051983l	44	13	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17747	17757		10.1074/jbc.M114.566133	http://dx.doi.org/10.1074/jbc.M114.566133			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24817121	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000338018100038
J	England, H; Summersgill, HR; Edye, ME; Rothwell, NJ; Brough, D				England, Hazel; Summersgill, Holly R.; Edye, Michelle E.; Rothwell, Nancy J.; Brough, David			Release of Interleukin-1 alpha or Interleukin-1 beta Depends on Mechanism of Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED NECROSIS; INDUCED INFLAMMATION; RECEPTOR ANTAGONIST; BRAIN-INJURY; APOPTOSIS; CASPASE-8; INFLAMMASOMES; MACROPHAGES; IL-1-ALPHA; IL-1-BETA	The cytokine interleukin-1 (IL-1) has two main pro-inflammatory forms, IL-1 alpha and IL-1 beta, which are central to host responses to infection and to damaging sterile inflammation. Processing of IL-1 precursor proteins to active cytokines commonly occurs through activation of proteases, notably caspases and calpains. These proteases are instrumental in cell death, and inflammation and cell death are closely associated, hence we sought to determine the impact of cell death pathways on IL-1 processing and release. Wediscovered that apoptotic regulation of caspase-8 specifically induced the processing and release of IL-1 beta. Conversely, necroptosis caused the processing and release of IL-1 alpha, and this was independent of IL-1 beta processing and release. These data suggest that the mechanism through which an IL-1-expressing cell dies dictates the nature of the inflammatory mechanism that follows. These insights may allow modification of inflammation through the selective targeting of cell death mechanisms during disease.	[England, Hazel; Summersgill, Holly R.; Edye, Michelle E.; Rothwell, Nancy J.; Brough, David] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Brough, D (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.brough@manchester.ac.uk		Edye, Michelle/0000-0003-0727-8366; England, Hazel/0000-0002-8324-614X; Brough, David/0000-0002-2250-2381	Wellcome Trust; Engineering and Physical Sciences Research Council (EPSRC); Biotechnology and Biological Sciences Research Council (BBSRC)	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust fellowship and Engineering and Physical Sciences Research Council (EPSRC) and Biotechnology and Biological Sciences Research Council (BBSRC) studentships.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Angell SY, 2012, SCIENCE, V337, P1456, DOI 10.1126/science.1228293; Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Clarke MCH, 2010, CIRC RES, V106, P363, DOI 10.1161/CIRCRESAHA.109.208389; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P389, DOI 10.1016/j.smim.2013.10.001; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Greenhalgh AD, 2012, DIS MODEL MECH, V5, P823, DOI 10.1242/dmm.008557; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Laird MD, 2008, FREE RADICAL BIO MED, V45, P1103, DOI 10.1016/j.freeradbiomed.2008.07.003; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Reardon S, 2011, SCIENCE, V333, P558, DOI 10.1126/science.333.6042.558; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Toldo S, 2012, CARDIOVASC DRUG THER, V26, P273, DOI 10.1007/s10557-012-6389-x; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	39	94	95	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15942	15950		10.1074/jbc.M114.557561	http://dx.doi.org/10.1074/jbc.M114.557561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24790078	Green Published, hybrid			2022-12-28	WOS:000337965700005
J	Kasabova, M; Joulin-Giet, A; Lecaille, F; Gilmore, BF; Marchand-Adam, S; Saidi, A; Lalmanach, G				Kasabova, Mariana; Joulin-Giet, Alix; Lecaille, Fabien; Gilmore, Brendan F.; Marchand-Adam, Sylvain; Saidi, Ahlame; Lalmanach, Gilles			Regulation of TGF-beta 1-driven Differentiation of Human Lung Fibroblasts EMERGING ROLES OF CATHEPSIN B AND CYSTATIN C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CYSTEINE CATHEPSINS; TGF-BETA; METHYL-ESTER; EXPRESSION; OVEREXPRESSION; PROTEASES; FIBROSIS; LATENT; ACTIVATION	Lung matrix homeostasis partly depends on the fine regulation of proteolytic activities. We examined the expression of human cysteine cathepsins (Cats) and their relative contribution to TGF-beta 1-induced fibroblast differentiation into myofibroblasts. Assays were conducted using both primary fibroblasts obtained from patients with idiopathic pulmonary fibrosis and human lung CCD-19Lu fibroblasts. Pharmacological inhibition and genetic silencing of Cat B diminished alpha-smooth muscle actin expression, delayed fibroblast differentiation, and led to an accumulation of intracellular 50-kDa TGF-beta 1. Moreover, the addition of Cat B generated a 25-kDa mature form of TGF-beta 1 in Cat B siRNA-pretreated lysates. Inhibition of Cat B decreased Smad 2/3 phosphorylation but had no effect on p38 MAPK and JNK phosphorylation, indicating that Cat B mostly disturbs TGF-beta 1-driven canonical Smad signaling pathway. Although mRNA expression of cystatin C was stable, its secretion, which was inhibited by brefeldin A, increased during TGF-beta 1-induced differentiation of idiopathic pulmonary fibrosis and CCD-19Lu fibroblasts. In addition, cystatin C participated in the control of extracellular Cats, because its gene silencing restored their proteolytic activities. These data support the notion that Cat B participates in lung myofibrogenesis as suggested for stellate cells during liver fibrosis. Moreover, we propose that TGF-beta 1 promotes fibrosis by driving the effective cystatin C-dependent inhibition of extracellular matrix-degrading Cats.	[Saidi, Ahlame; Lalmanach, Gilles] Univ Tours, Equipe Mecanismes Proteolyt Inflammat 2, Ctr Etud Pathol Resp, INSERM,U1100,Fac Med, F-37032 Tours, France; [Gilmore, Brendan F.] Queens Univ Belfast, Sch Pharm, McClay Res Ctr, Belfast BT9 7BL, Antrim, North Ireland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Queens University Belfast	Lalmanach, G (corresponding author), Univ Tours, INSERM, UMR 1100, CEPR,Fac Med, 10Blvd Tonnelle, F-37032 Tours, France.	gilles.lalmanach@univ-tours.fr	Lecaille, Fabien/GRY-5313-2022	marchand-adam, sylvain/0000-0002-9522-3738; Saidi, Ahlame/0000-0002-0282-2476; Lecaille, Fabien/0000-0003-1060-4222; Lalmanach, Gilles/0000-0001-8562-4821	la Region Centre (FibroCat Project) [201000049823]; Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de l'Education Nationale de la Recherche et de la Technologie, France	la Region Centre (FibroCat Project)(Region Centre-Val de Loire); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Education Nationale de la Recherche et de la Technologie, France	This work was supported by la Region Centre (FibroCat Project 201000049823). We acknowledge the Institut National de la Sante et de la Recherche Medicale (INSERM) for institutional funding.; Recipient of a doctoral fellowship from the Ministere de l'Education Nationale de la Recherche et de la Technologie, France.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Adamali HI, 2012, DRUG DES DEV THER, V6, P261, DOI 10.2147/DDDT.S29928; AKAMINE A, 1992, AM J RESP CELL MOL, V6, P382, DOI 10.1165/ajrcmb/6.4.382; Andl CD, 2010, NEOPLASIA, V12, P485, DOI 10.1593/neo.10216; Assfalg-Machleidt I, 1992, Agents Actions Suppl, V38 ( Pt 1), P312; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; BRUNNER AM, 1988, MOL CELL BIOL, V8, P2229, DOI 10.1128/MCB.8.5.2229; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Buhling F, 1999, AM J RESP CELL MOL, V20, P612; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Canbay A, 2003, J CLIN INVEST, V112, P152, DOI 10.1172/JCI200317740; Chen H, 2013, CARDIOVASC RES, V100, P84, DOI 10.1093/cvr/cvt158; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Florent I, 2005, BIOL CHEM, V386, P401, DOI 10.1515/BC.2005.048; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gauldie Jack, 2006, Proc Am Thorac Soc, V3, P696, DOI 10.1513/pats.200605-125SF; Gerber A, 2001, J INTERF CYTOK RES, V21, P11, DOI 10.1089/107999001459114; Gogineni VR, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.170; Gressner AM, 2006, WORLD J GASTROENTERO, V12, P731, DOI 10.3748/wjg.v12.i5.731; Guo M, 2002, J BIOL CHEM, V277, P14829, DOI 10.1074/jbc.M108180200; HEIDTMANN HH, 1993, ONCOL RES, V5, P441; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Kasabova M, 2014, PROTEOM CLIN APPL, V8, P447, DOI 10.1002/prca.201300047; Kasabova M, 2011, CLIN REV BONE MINER, V9, P148, DOI 10.1007/s12018-011-9094-6; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; Koslowski R, 2003, EUR RESPIR J, V22, P427, DOI 10.1183/09031936.03.00112903; Lalmanach G, 2006, BIOL CHEM, V387, P863, DOI 10.1515/BC.2006.109; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Moles A, 2012, J BIOL CHEM, V287, P1178, DOI 10.1074/jbc.M111.272393; Moles A, 2009, HEPATOLOGY, V49, P1297, DOI 10.1002/hep.22753; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Naudin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025577; Novinec M, 2013, BIOL CHEM, V394, P1163, DOI 10.1515/hsz-2013-0134; Perdereau C, 2006, BBA-MOL BASIS DIS, V1762, P351, DOI 10.1016/j.bbadis.2005.10.005; PURCHIO AF, 1988, J BIOL CHEM, V263, P14211; Quinn Derek J, 2010, Open Respir Med J, V4, P20, DOI 10.2174/1874306401004020020; Raghu G, 2006, EUR RESPIR J, V27, P136, DOI 10.1183/09031936.06.00037005; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Serveau-Avesque C, 2006, BIOL CELL, V98, P15, DOI 10.1042/BC20040512; Shi GP, 1999, J CLIN INVEST, V104, P1191, DOI 10.1172/JCI7709; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Srivastava M, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-54; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Takeyabu K, 1998, EUR RESPIR J, V12, P1033, DOI 10.1183/09031936.98.12051033; Tsai CH, 2007, ORAL ONCOL, V43, P680, DOI 10.1016/j.oraloncology.2006.08.009; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; van den Brule S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-84; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138; Yin M, 2012, AM J PATHOL, V181, P2202, DOI 10.1016/j.ajpath.2012.08.027; Zhang DW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-154; Zhang DW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-72; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22	64	53	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16239	16251		10.1074/jbc.M113.542407	http://dx.doi.org/10.1074/jbc.M113.542407			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24790080	Green Published, hybrid			2022-12-28	WOS:000337965700028
J	Dorfmueller, HC; Ferenbach, AT; Borodkin, VS; van Aalten, DMF				Dorfmueller, Helge C.; Ferenbach, Andrew T.; Borodkin, Vladimir S.; van Aalten, Daan M. F.			A Structural and Biochemical Model of Processive Chitin Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOSACCHARIDE CHAIN-LENGTH; SACCHAROMYCES-CEREVISIAE; INNER-MEMBRANE; SYNTHASE 2; SEQUENCE ALIGNMENT; RHIZOBIUM; NODC; INHIBITOR; CLASSIFICATION; IDENTIFICATION	Chitin synthases (CHS) produce chitin, an essential component of the fungal cell wall. The molecular mechanism of processive chitin synthesis is not understood, limiting the discovery of new inhibitors of this enzyme class. We identified the bacterial glycosyltransferase NodC as an appropriate model system to study the general structure and reaction mechanism of CHS. A high throughput screening-compatible novel assay demonstrates that a known inhibitor of fungal CHS also inhibit NodC. A structural model of NodC, on the basis of the recently published BcsA cellulose synthase structure, enabled probing of the catalytic mechanism by mutagenesis, demonstrating the essential roles of the DD and QXXRW catalytic motifs. The NodC membrane topology was mapped, validating the structural model. Together, these approaches give insight into the CHS structure and mechanism and provide a platform for the discovery of inhibitors for this antifungal target.	[Dorfmueller, Helge C.; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Borodkin, Vladimir S.; van Aalten, Daan M. F.] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	Dorfmueller, HC (corresponding author), Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland.	hczdorfmueller@dundee.ac.uk; dmfvanaalten@dundee.ac.uk		Dorfmueller, Helge/0000-0003-1288-044X; Ferenbach, Andrew/0000-0002-1562-7987; van Aalten, Daan/0000-0002-1499-6908	Wellcome Trust [092193]; Medical Research Council [G0900138/90614]; Medical Research Council [MR/M004139/1, G0900138] Funding Source: researchfish; MRC [G0900138, MR/M004139/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust Sir Henry Wellcome Postdoctoral Fellowship 092193 and Medical Research Council Program Grant G0900138/90614.	ATKINSON EM, 1992, MOL PLANT MICROBE IN, V5, P439, DOI 10.1094/MPMI-5-439; Barny MA, 1996, MOL MICROBIOL, V19, P443, DOI 10.1046/j.1365-2958.1996.382911.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; BOWEN AR, 1992, P NATL ACAD SCI USA, V89, P519, DOI 10.1073/pnas.89.2.519; CABIB E, 1991, ANTIMICROB AGENTS CH, V35, P170, DOI 10.1128/AAC.35.1.170; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; DEBELLE F, 1992, MOL PLANT MICROBE IN, V5, P443, DOI 10.1094/MPMI-5-443; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Imai T, 2003, BIOCHEM J, V374, P755, DOI 10.1042/BJ20030145; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kamst E, 1997, J BACTERIOL, V179, P2103, DOI 10.1128/jb.179.7.2103-2108.1997; Kamst E, 2000, MOL GEN GENET, V264, P75, DOI 10.1007/s004380000281; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; Karnezis T, 2003, GLYCOBIOLOGY, V13, P693, DOI 10.1093/glycob/cwg093; Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Martinez-Rucobo FW, 2009, BIOCHEM J, V417, P547, DOI 10.1042/BJ20081475; Masubuchi K, 2000, BIOORG MED CHEM LETT, V10, P1459, DOI 10.1016/S0960-894X(00)00257-2; Mavingui P, 1998, J BACTERIOL, V180, P2866, DOI 10.1128/JB.180.11.2866-2874.1998; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; ORLEAN P, 1987, J BIOL CHEM, V262, P5732; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Ruiz-Herrera J., 2003, Current Drug Targets - Infectious Disorders, V3, P77, DOI 10.2174/1568005033342064; SEMINO CE, 1995, P NATL ACAD SCI USA, V92, P3498, DOI 10.1073/pnas.92.8.3498; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Streng A, 2011, PLANT SIGNAL BEHAV, V6, P1510, DOI 10.4161/psb.6.10.17444; Sudoh M, 2000, J BIOL CHEM, V275, P32901, DOI 10.1074/jbc.M003634200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchida Y, 1996, J BIOCHEM, V119, P659; Xie J, 2001, CARBOHYD RES, V334, P177, DOI 10.1016/S0008-6215(01)00191-4; Yabe T, 1998, EUR J BIOCHEM, V258, P941, DOI 10.1046/j.1432-1327.1998.2580941.x	35	35	35	2	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23020	23028		10.1074/jbc.M114.563353	http://dx.doi.org/10.1074/jbc.M114.563353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24942743	Green Published, hybrid			2022-12-28	WOS:000341017200040
J	Shanmugam, I; Abbas, M; Ayoub, F; Mirabal, S; Bsaili, M; Caulder, EK; Weinstock, DM; Tomkinson, AE; Hromas, R; Shaheen, M				Shanmugam, Ilanchezhian; Abbas, Mohammad; Ayoub, Farhan; Mirabal, Susan; Bsaili, Manal; Caulder, Erin K.; Weinstock, David M.; Tomkinson, Alan E.; Hromas, Robert; Shaheen, Monte			Ubiquitin-specific Peptidase 20 Regulates Rad17 Stability, Checkpoint Kinase 1 Phosphorylation and DNA Repair by Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; MAMMALIAN-CELLS; DAMAGE RESPONSE; ATR; ENDONUCLEASE; COMPLEXES; RECOVERY; REVEALS; FORK	Rad17 is a subunit of the Rad9-Hus1-Rad1 clamp loader complex, which is required for Chk1 activation after DNA damage. Rad17 has been shown to be regulated by the ubiquitin-proteasome system. We have identified a deubiquitylase, USP20 that is required for Rad17 protein stability in the steady-state and post DNA damage. We demonstrate that USP20 and Rad17 interact, and that this interaction is enhanced by UV exposure. We show that USP20 regulation of Rad17 is at the protein level in a proteasome-dependent manner. USP20 depletion results in poor activation of Chk1 protein by phosphorylation, consistent with Rad17 role in ATR-mediated phosphorylation of Chk1. Similar to other DNA repair proteins, USP20 is phosphorylated post DNA damage, and its depletion sensitizes cancer cells to damaging agents that form blocks ahead of the replication forks. Similar to Chk1 and Rad17, which enhance recombinational repair of collapsed replication forks, we demonstrate that USP20 depletion impairs DNA double strand break repair by homologous recombination. Together, our data establish a new function of USP20 in genome maintenance and DNA repair.	[Shanmugam, Ilanchezhian; Abbas, Mohammad; Ayoub, Farhan; Mirabal, Susan; Bsaili, Manal; Caulder, Erin K.; Tomkinson, Alan E.; Shaheen, Monte] Univ New Mexico, Dept Internal Med, Div Hematol Oncol, Albuquerque, NM 87131 USA; [Shanmugam, Ilanchezhian; Abbas, Mohammad; Ayoub, Farhan; Mirabal, Susan; Bsaili, Manal; Caulder, Erin K.; Tomkinson, Alan E.; Shaheen, Monte] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Hromas, Robert] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Weinstock, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	University of New Mexico; University of New Mexico; State University System of Florida; University of Florida; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Shaheen, M (corresponding author), Univ New Mexico, Ctr Canc, 1201 Camino de Salud NE, Albuquerque, NM 87131 USA.	moshaheen@salud.unm.edu			NIH [5K01HL103182-03]; UNM Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNM Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIH Grant 5K01HL103182-03 (to M. S.) and start-up funds from the UNM Cancer Center.	Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Budzowska M, 2004, EMBO J, V23, P3548, DOI 10.1038/sj.emboj.7600353; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nishino K, 2008, GENES GENET SYST, V83, P427, DOI 10.1266/ggs.83.427; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Yata K, 2012, MOL CELL, V45, P371, DOI 10.1016/j.molcel.2011.12.028; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	21	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22739	22748		10.1074/jbc.M114.550459	http://dx.doi.org/10.1074/jbc.M114.550459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24923443	hybrid, Green Published			2022-12-28	WOS:000341017200019
J	Ahn, BJ; Le, H; Shin, MW; Bae, SJ; Lee, EJ; Lee, SY; Yang, JH; Wee, HJ; Cha, JH; Seo, JH; Lee, HS; Lee, HJ; Arai, K; Lo, EH; Jeon, S; Oh, GT; Kim, WJ; Ryu, JK; Suh, JK; Kim, KW				Ahn, Bum Ju; Le, Hoang; Shin, Min Wook; Bae, Sung-Jin; Lee, Eun Ji; Lee, Sung Yi; Yang, Ju Hee; Wee, Hee-Jun; Cha, Jong-Ho; Seo, Ji Hae; Lee, Hye Shin; Lee, Hyo-Jong; Arai, Ken; Lo, Eng H.; Jeon, Sejin; Oh, Goo Taeg; Kim, Woo Jean; Ryu, Ji-Kan; Suh, Jun-Kyu; Kim, Kyu-Won			Ninjurin1 Enhances the Basal Motility and Transendothelial Migration of Immune Cells by Inducing Protrusive Membrane Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; LEUKOCYTE MIGRATION; ADHESION MOLECULE; ENDOTHELIAL-CELLS; MYELOID CELLS; RHO GTPASES; FILOPODIA; EXTRAVASATION; INFLAMMATION; DIAPEDESIS	Ninjurin1 is involved in the pathogenesis of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, by mediating leukocyte extravasation, a process that depends on homotypic binding. However, the precise regulatory mechanisms of Ninjurin1 during inflammation are largely undefined. We therefore examined the pro-migratory function of Ninjurin1 and its regulatory mechanisms in macrophages. Interestingly, Ninjurin1-deficient bone marrow-derived macrophages exhibited reduced membrane protrusion formation and dynamics, resulting in the impairment of cell motility. Furthermore, exogenous Ninjurin1 was distributed at the membrane of filopodial structures in Raw264.7 macrophage cells. In Raw264.7 cells, RNA interference of Ninjurin1 reduced the number of filopodial projections, whereas overexpression of Ninjurin1 facilitated their formation and thus promoted cell motility. Ninjurin1-induced filopodial protrusion formation required the activation of Rac1. In Raw264.7 cells penetrating an MBEC4 endothelial cell monolayer, Ninjurin1 was localized to the membrane of protrusions and promoted their formation, suggesting that Ninjurin1-induced protrusive activity contributed to transendothelial migration. Taking these data together, we conclude that Ninjurin1 enhances macrophage motility and consequent extravasation of immune cells through the regulation of protrusive membrane dynamics. We expect these findings to provide insight into the understanding of immune responses mediated by Ninjurin1.	[Ahn, Bum Ju; Le, Hoang; Shin, Min Wook; Bae, Sung-Jin; Lee, Eun Ji; Lee, Sung Yi; Yang, Ju Hee; Wee, Hee-Jun; Cha, Jong-Ho; Seo, Ji Hae; Lee, Hye Shin; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul 151742, South Korea; [Ahn, Bum Ju; Le, Hoang; Shin, Min Wook; Bae, Sung-Jin; Lee, Eun Ji; Lee, Sung Yi; Yang, Ju Hee; Wee, Hee-Jun; Cha, Jong-Ho; Seo, Ji Hae; Lee, Hye Shin; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul 151742, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, Coll Med, Seoul 151742, South Korea; [Lee, Hyo-Jong] Inje Univ, Coll Pharm, Gimhae 621749, South Korea; [Arai, Ken; Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Boston, MA 02114 USA; [Arai, Ken; Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Boston, MA 02114 USA; [Arai, Ken; Lo, Eng H.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Jeon, Sejin; Oh, Goo Taeg] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Jeon, Sejin; Oh, Goo Taeg] Ewha Womans Univ, Program GT5, Seoul 120750, South Korea; [Kim, Woo Jean; Ryu, Ji-Kan; Suh, Jun-Kyu] Inha Univ, Natl Res Ctr Sexual Med, Sch Med, Inchon 402751, South Korea; [Kim, Woo Jean; Ryu, Ji-Kan; Suh, Jun-Kyu] Inha Univ, Dept Urol, Sch Med, Inchon 402751, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inje University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Ewha Womans University; Ewha Womans University; Inha University; Inha University	Kim, KW (corresponding author), Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul 151742, South Korea.	qwonkim@snu.ac.kr	shin, minwook/HGA-4297-2022; Kim, Kyu Won/AAJ-7213-2020; Bae, Sung-Jin/AAX-9144-2021; Jeon, Sejin/GWU-7864-2022; Jeon, Sejin/GRJ-6826-2022; Oh, Goo Taeg/AAQ-9995-2021	Bae, Sung-Jin/0000-0001-8975-0876; Lee, Hyo-Jong/0000-0003-4826-7954; Le, Hoang/0000-0001-8427-3230	National Research Foundation of Korea; Ministry of Education, Science and Technology through the Global Research Laboratory Program [2011-0021874]; Brain Korea 21 Program; Global Core Research Center Program [2012-0001187]; Basic Science Research Program through the National Research Foundation - Ministry of Education, Science and Technology [2013R1A1A2058956]; National Institutes of Health [R37-NS37074, R01-76694, P01-NS55104]; National Research Foundation - Korean Government (Ministry of Education, Science and Technology) [2013003407]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [A110076]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037074, P01NS055104] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology through the Global Research Laboratory Program; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Global Core Research Center Program; Basic Science Research Program through the National Research Foundation - Ministry of Education, Science and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation - Korean Government (Ministry of Education, Science and Technology); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from a National Research Foundation of Korea, a grant funded by the Ministry of Education, Science and Technology through the Global Research Laboratory Program (2011-0021874), Brain Korea 21 Program, and the Global Core Research Center Program Grant 2012-0001187.; Supported by Basic Science Research Program through the National Research Foundation funded by Ministry of Education, Science and Technology Grant 2013R1A1A2058956.; Supported by National Institutes of Health Grants R37-NS37074, R01-76694, and P01-NS55104 (to E. H. L.).; Supported by National Research Foundation Grant 2013003407 funded by the Korean Government (Ministry of Education, Science and Technology).; Supported by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs Grant A110076.	Ahn BJ, 2014, J BIOL CHEM, V289, P3328, DOI 10.1074/jbc.M113.498212; Ahn BJ, 2012, BIOCHEM BIOPH RES CO, V428, P438, DOI 10.1016/j.bbrc.2012.10.099; Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Dodelet-Devillers A, 2009, J MOL MED, V87, P765, DOI 10.1007/s00109-009-0488-6; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lee HJ, 2009, CELL DEATH DIFFER, V16, P1395, DOI 10.1038/cdd.2009.78; Ley K, 2008, J CELL BIOL, V183, P375, DOI 10.1083/jcb.200809173; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020	35	19	20	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21926	21936		10.1074/jbc.M113.532358	http://dx.doi.org/10.1074/jbc.M113.532358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24917672	hybrid, Green Published			2022-12-28	WOS:000340593500010
J	Purushotham, S; Deivanayagam, C				Purushotham, Sangeetha; Deivanayagam, Champion			The Calcium-induced Conformation and Glycosylation of Scavenger-rich Cysteine Repeat (SRCR) Domains of Glycoprotein 340 Influence the High Affinity Interaction with Antigen I/II Homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-GORDONII SSPB; HUMAN SALIVARY AGGLUTININ; SURFACE-PLASMON RESONANCE; CRYSTAL-STRUCTURE; BACTERIA-BINDING; MEDIATED ADHERENCE; FAMILY ADHESINS; PROTEIN GP-340; DENTAL-CARIES; GENITAL-TRACT	Oral streptococci adhere to tooth-immobilized glycoprotein 340 (GP340) via the surface protein antigen I/II (AgI/II) and its homologs as the first step in pathogenesis. Studying this interaction using recombinant proteins, we observed that calcium increases the conformational stability of the scavenger-rich cysteine repeat (SRCRs) domains of GP340. Our results also show that AgI/II adheres specifically with nanomolar affinity to the calcium-induced SRCR conformation in an immobilized state and not in solution. This interaction is significantly dependent on the O-linked carbohydrates present on the SRCRs. This study also establishes that a single SRCR domain of GP340 contains the two surfaces to which the apical and C-terminal regions of AgI/II non-competitively adhere. Compared with the single SRCR domain, the three tandem SRCR domains displayed a collective/cooperative increase in their bacterial adherence and aggregation. The previously described SRCRP2 peptide that was shown to aggregate several oral streptococci displayed limited aggregation and also nonspecific adherence compared to SRCR domains. Finally, we show distinct species-specific adherence/aggregation between Streptococcus mutans AgI/II and Streptococcus gordonii SspB in their interaction with the SRCRs. This study concludes that identification of the metal ion and carbohydrate adherence motifs on both SRCRs and AgI/II homologs could lead to the development of anti-adhesive inhibitors that could deter the adherence of pathogenic oral streptococci and thereby prevent the onset of infections.	[Purushotham, Sangeetha; Deivanayagam, Champion] Univ Alabama Birmingham, Struct Biol Ctr, Dept Vis Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Deivanayagam, C (corresponding author), Univ Alabama Birmingham, Struct Biol Ctr, Dept Vis Sci, 1025 18th St South,CBSE 100, Birmingham, AL 35294 USA.	champy@uab.edu		Deivanayagam, Champion/0000-0003-2972-1824	National Institutes of Health [R01DE017737]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE017737.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; BRADY LJ, 1992, INFECT IMMUN, V60, P1008, DOI 10.1128/IAI.60.3.1008-1017.1992; Christopeit T, 2009, ANAL BIOCHEM, V391, P39, DOI 10.1016/j.ab.2009.04.037; Chung WO, 2000, INFECT IMMUN, V68, P6758, DOI 10.1128/IAI.68.12.6758-6762.2000; Claudianos C, 2002, MOL MICROBIOL, V45, P1473, DOI 10.1046/j.1365-2958.2002.03118.x; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Demuth DR, 1996, MOL MICROBIOL, V20, P403, DOI 10.1111/j.1365-2958.1996.tb02627.x; DEMUTH DR, 1990, MICROB PATHOGENESIS, V9, P199, DOI 10.1016/0882-4010(90)90022-I; El-Sabaeny A, 2001, INFECT IMMUN, V69, P6520, DOI 10.1128/IAI.69.10.6520-6522.2001; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; Esberg A, 2012, INFECT IMMUN, V80, P3869, DOI 10.1128/IAI.00435-12; Hobb RI, 2010, MICROBES INFECT, V12, P476, DOI 10.1016/j.micinf.2010.02.009; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; LAMONT RJ, 1991, INFECT IMMUN, V59, P3446, DOI 10.1128/IAI.59.10.3446-3450.1991; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LEHNER T, 1980, LANCET, V1, P995; Leito JTD, 2011, MOL IMMUNOL, V49, P185, DOI 10.1016/j.molimm.2011.08.010; Ligtenberg AJM, 2007, BIOL CHEM, V388, P1275, DOI 10.1515/BC.2007.158; Ligtenberg AJM, 2010, INT J MOL SCI, V11, P5213, DOI 10.3390/ijms1112521; Ligtenberg TJM, 2001, BIOCHEM J, V359, P243, DOI 10.1042/0264-6021:3590243; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Malamud D, 2011, Adv Dent Res, V23, P34, DOI 10.1177/0022034511399282; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Oli MW, 2006, J MICROBIOL METH, V65, P503, DOI 10.1016/j.mimet.2005.09.011; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; Purushotham S, 2013, PROTEIN EXPRES PURIF, V90, P67, DOI 10.1016/j.pep.2013.05.003; Robinette RA, 2011, VACCINE, V29, P6292, DOI 10.1016/j.vaccine.2011.06.027; Rodamilans B, 2007, J BIOL CHEM, V282, P12669, DOI 10.1074/jbc.M611699200; Russell MW, 2004, CARIES RES, V38, P230, DOI 10.1159/000077759; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Stoddard E, 2009, J VIROL, V83, P8596, DOI 10.1128/JVI.00744-09; Wu ZW, 2006, AIDS RES HUM RETROV, V22, P508, DOI 10.1089/aid.2006.22.508; Wu ZW, 2004, AIDS RES HUM RETROV, V20, P600, DOI 10.1089/0889222041217400; Yang ZRW, 2004, PROTEIN SCI, V13, P830, DOI 10.1110/ps.03330104; Young A, 1997, EUR J ORAL SCI, V105, P485, DOI 10.1111/j.1600-0722.1997.tb00235.x	52	24	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21877	21887		10.1074/jbc.M114.565507	http://dx.doi.org/10.1074/jbc.M114.565507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24923446	Green Published, hybrid			2022-12-28	WOS:000340593500006
J	Kamath-Loeb, AS; Balakrishna, S; Whittington, D; Shen, JC; Emond, MJ; Okabe, T; Masutani, C; Hanaoka, F; Nishimura, S; Loeb, LA				Kamath-Loeb, Ashwini S.; Balakrishna, Sharath; Whittington, Dale; Shen, Jiang-Cheng; Emond, Mary J.; Okabe, Takayoshi; Masutani, Chikahide; Hanaoka, Fumio; Nishimura, Susumu; Loeb, Lawrence A.			Sphingosine, a Modulator of Human Translesion DNA Polymerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XERODERMA-PIGMENTOSUM VARIANT; HIGH-FIDELITY; CANCER-CELLS; LUNG-CANCER; POL-KAPPA; ETA; EXPRESSION; CERAMIDE; CHEMOTHERAPY; REPLICATION	Translesion (TLS) DNA polymerases are specialized, error-prone enzymes that synthesize DNA across bulky, replication-stalling DNA adducts. In so doing, they facilitate the progression of DNA synthesis and promote cell proliferation. To potentiate the effect of cancer chemotherapeutic regimens, we sought to identify inhibitors of TLS DNA polymerases. We screened five libraries of similar to 3000 small molecules, including one comprising similar to 600 nucleoside analogs, for their effect on primer extension activity of DNA polymerase eta(Pol eta). We serendipitously identified sphingosine, a lipid-signaling molecule that robustly stimulates the activity of Pol eta by similar to 100-fold at low micromolar concentrations but inhibits it at higher concentrations. This effect is specific to the Y-family DNA polymerases, Pols eta, kappa, and iota. The addition of a single phosphate group on sphingosine completely abrogates this effect. Likewise, the inclusion of other sphingolipids, including ceramide and sphingomyelin to extension reactions does not elicit this response. Sphingosine increases the rate of correct and incorrect nucleotide incorporation while having no effect on polymerase processivity. Endogenous Pol eta activity is modulated similarly as the recombinant enzyme. Importantly, sphingosine-treated cells exhibit increased lesion bypass activity, and sphingosine tethered to membrane lipids mimics the effects of free sphingosine. Our studies have uncovered sphingosine as a modulator of TLS DNA polymerase activity; this property of sphingosine may be associated with its known role as a signaling molecule in regulating cell proliferation in response to cellular stress.	[Kamath-Loeb, Ashwini S.; Balakrishna, Sharath; Shen, Jiang-Cheng; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA; [Kamath-Loeb, Ashwini S.; Balakrishna, Sharath; Shen, Jiang-Cheng; Loeb, Lawrence A.] Univ Washington, Dept Biochem, Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA; [Whittington, Dale] Univ Washington, Mass Spectrometry Ctr, Dept Med Chem, Seattle, WA 98195 USA; [Emond, Mary J.] Univ Washington, Seattle, WA 98195 USA; [Emond, Mary J.] Univ Washington, Ctr Biomed Stat, Seattle, WA 98195 USA; [Okabe, Takayoshi] Univ Tokyo, Open Innovat Ctr Drug Discovery, Tokyo 1130033, Japan; [Masutani, Chikahide] Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Nagoya, Aichi 4648601, Japan; [Hanaoka, Fumio] Gakushuin Univ, Inst Biomol Sci, Fac Sci, Tokyo 1718588, Japan; [Nishimura, Susumu] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058575, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo; Nagoya University; Gakushuin University; University of Tsukuba	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA.	laloeb@uw.edu	Masutani, Chikahide/I-6160-2014; Balakrishna, Sharath/AAA-4755-2022; Balakrishna, Sharath/AAC-6450-2020	Balakrishna, Sharath/0000-0002-9734-711X; Masutani, Chikahide/0000-0002-8600-8227	National Institutes of Health [P01-CA 077852, P01-AG 001751]; Grants-in-Aid for Scientific Research [22131008] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-CA 077852 and P01-AG 001751 (to L. A. L.).	Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Brauze D, 2012, ENVIRON TOXICOL PHAR, V34, P819, DOI 10.1016/j.etap.2012.09.004; Ceppi P, 2009, CLIN CANCER RES, V15, P1039, DOI 10.1158/1078-0432.CCR-08-1227; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Cleaver JE, 1999, CANCER RES, V59, P1102; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Goodman MF, 2000, CURR OPIN GENET DEV, V10, P162, DOI 10.1016/S0959-437X(00)00057-5; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Kamath-Loeb AS, 2012, J BIOL CHEM, V287, P12480, DOI 10.1074/jbc.M111.332577; KamathLoeb AS, 1997, J BIOL CHEM, V272, P5892, DOI 10.1074/jbc.272.9.5892; Kino K., 2004, NUCL ACIDS S SER, V48, P171, DOI [10.1093/nass/48.1.171, DOI 10.1093/NASS/48.1.171]; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lemee F, 2007, ONCOGENE, V26, P3387, DOI 10.1038/sj.onc.1210116; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; O-Wang J, 2001, CANCER RES, V61, P5366; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Salehan MR, 2013, BRIT J BIOMED SCI, V70, P31, DOI 10.1080/09674845.2013.11669927; Sasaki H, 2009, BIOPHYS J, V96, P2727, DOI 10.1016/j.bpj.2008.12.3926; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Seber G., 2003, LINEAR REGRESSION AN; Shen JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04894; SIMBULAN CMG, 1994, BIOCHEMISTRY-US, V33, P9007, DOI 10.1021/bi00196a019; Singer WD, 2013, DNA REPAIR, V12, P817, DOI 10.1016/j.dnarep.2013.07.010; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Teng KY, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-126; Urs AN, 2006, ENDOCRINOLOGY, V147, P5249, DOI 10.1210/en.2006-0355; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; Velasco-Miguel S, 2003, DNA REPAIR, V2, P91, DOI 10.1016/S1568-7864(02)00189-1; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Yang J, 2004, CANCER RES, V64, P5597, DOI 10.1158/0008-5472.CAN-04-0603; ZHANG H, 1990, J BIOL CHEM, V265, P76; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	46	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21663	21672		10.1074/jbc.M114.570242	http://dx.doi.org/10.1074/jbc.M114.570242			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24928506	Green Published, hybrid			2022-12-28	WOS:000340558300040
J	Saito, F; Suyama, A; Oka, T; Yoko-o, T; Matsuoka, K; Jigami, Y; Shimma, Y				Saito, Fumie; Suyama, Akiko; Oka, Takuji; Yoko-o, Takehiko; Matsuoka, Ken; Jigami, Yoshifumi; Shimma, Yoh-ichi			Identification of Novel Peptidyl Serine alpha-Galactosyltransferase Gene Family in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL PROTEINS; CONTIGUOUS HYDROXYPROLINE RESIDUES; ARABINOGALACTAN-PROTEINS; ENDOPLASMIC-RETICULUM; PROLYL 4-HYDROXYLASE; ARABIDOPSIS-THALIANA; FUNCTIONAL IDENTIFICATION; DISC ELECTROPHORESIS; VACUOLAR PROTEIN; O-GLYCOSYLATION	In plants, serine residues in extensin, a cell wall protein, are glycosylated with O-linked galactose. However, the enzyme that is involved in the galactosylation of serine had not yet been identified. To identify the peptidyl serine O-alpha-galactosyltransferase (SGT), we chose Chlamydomonas reinhardtii as a model. We established an assay system for SGT activity using C. reinhardtii and Arabidopsis thaliana cell extracts. SGT protein was partially purified from cell extracts of C. reinhardtii and analyzed by tandem mass spectrometry to determine its amino acid sequence. The sequence matched the open reading frame XP_001696927 in the C. reinhardtii proteome database, and a corresponding DNA fragment encoding 748 amino acids (BAL63043) was cloned from a C. reinhardtii cDNA library. The 748-amino acid protein (CrSGT1) was produced using a yeast expression system, and the SGT activity was examined. Hydroxylation of proline residues adjacent to a serine in acceptor peptides was required for SGT activity. Genes for proteins containing conserved domains were found in various plant genomes, including A. thaliana and Nicotiana tabacum. The AtSGT1 and NtSGT1 proteins also showed SGT activity when expressed in yeast. In addition, knock-out lines of AtSGT1 and knockdown lines of NtSGT1 showed no or reduced SGT activity. The SGT1 sequence, which contains a conserved DXD motif and a C-terminal membrane spanning region, is the first example of a glycosyltransferase with type I membrane protein topology, and it showed no homology with known glycosyltransferases, indicat-ing that SGT1 belongs to a novel glycosyltransferase gene family existing only in the plant kingdom.	[Saito, Fumie; Yoko-o, Takehiko; Jigami, Yoshifumi; Shimma, Yoh-ichi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058566, Japan; [Saito, Fumie; Yoko-o, Takehiko] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Suyama, Akiko; Matsuoka, Ken] Kyushu Univ, Fac Agr, Lab Plant Nutr, Higashi Ku, Fukuoka 8128581, Japan; [Oka, Takuji] Sojo Univ, Fac Biotechnol & Life Sci, Dept Appl Microbial Technol, Kumamoto 8600082, Japan; [Matsuoka, Ken] Kyushu Univ, Biotron Applicat Ctr, Higashi Ku, Fukuoka 8128581, Japan; [Matsuoka, Ken] Kyushu Univ, Organelle Homeostasis Res Ctr, Higashi Ku, Fukuoka 8128581, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Kyushu University; Sojo University; Kyushu University; Kyushu University	Shimma, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	yohichi-shimma@aist.go.jp	Matsuoka, Ken/E-3215-2010; Yoko-o, Takehiko/L-7093-2018	Yoko-o, Takehiko/0000-0003-0291-8299; Oka, Takuji/0000-0002-5691-654X; Matsuoka, Ken/0000-0001-7229-7294	Ministry of Economy, Trade and Industry, Japan	Ministry of Economy, Trade and Industry, Japan	This work was supported by grants from the Ministry of Economy, Trade and Industry, Japan.	Adair W.S., 1990, P15; AKASHI T, 1990, PLANTA, V182, P363, DOI 10.1007/BF02411386; ALLEN AK, 1978, BIOCHEM J, V171, P665, DOI 10.1042/bj1710665; ASHFORD D, 1982, BIOCHEM J, V201, P199, DOI 10.1042/bj2010199; Bassham DC, 2000, MOL BIOL CELL, V11, P2251, DOI 10.1091/mbc.11.7.2251; Basu D, 2013, J BIOL CHEM, V288, P10132, DOI 10.1074/jbc.M112.432609; Bertioli D, 1997, Methods Mol Biol, V67, P233; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Du H, 1996, TRENDS CELL BIOL, V6, P411, DOI 10.1016/S0962-8924(96)20036-4; Farid A, 2011, PLANT J, V68, P314, DOI 10.1111/j.1365-313X.2011.04688.x; FINCHER GB, 1983, ANNU REV PLANT PHYS, V34, P47, DOI 10.1146/annurev.pp.34.060183.000403; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Goodrum LJ, 2000, PHYTOCHEMISTRY, V54, P99, DOI 10.1016/S0031-9422(00)00043-1; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; HASE S, 1992, BIOSCI BIOTECH BIOCH, V56, P1676, DOI 10.1271/bbb.56.1676; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; Ishimizu T, 2007, J BIOCHEM, V141, P593, DOI 10.1093/jb/mvm064; KIELISZEWSKI MJ, 1995, J BIOL CHEM, V270, P2541, DOI 10.1074/jbc.270.6.2541; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kieliszewski MJ, 2001, CELL MOL LIFE SCI, V58, P1386, DOI 10.1007/PL00000783; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; Ko MK, 2001, EXP CELL RES, V264, P363, DOI 10.1006/excr.2000.5155; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; LAMPORT DTA, 1973, BIOCHEM J, V133, P125, DOI 10.1042/bj1330125; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Mahendran T, 2008, J AGR FOOD CHEM, V56, P9269, DOI 10.1021/jf800849a; Matsuoka K, 1995, PLANT J, V8, P877, DOI 10.1046/j.1365-313X.1995.8060877.x; MATSUOKA K, 1991, P NATL ACAD SCI USA, V88, P834, DOI 10.1073/pnas.88.3.834; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02613; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Natsuka S, 2011, BIOSCI BIOTECH BIOCH, V75, P1405, DOI 10.1271/bbb.110233; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Obayashi T, 2010, J PLANT RES, V123, P311, DOI 10.1007/s10265-010-0333-6; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Ogawa-Ohnishi M, 2013, NAT CHEM BIOL, V9, P726, DOI [10.1038/nchembio.1351, 10.1038/NCHEMBIO.1351]; Ohshima Y, 2001, PLANT CELL PHYSIOL, V42, P1119, DOI 10.1093/pcp/pce141; Oka T, 2010, PLANT PHYSIOL, V152, P332, DOI 10.1104/pp.109.146266; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; Pattison RJ, 2009, TRENDS PLANT SCI, V14, P92, DOI 10.1016/j.tplants.2008.11.008; Schoberer J, 2011, MOL PLANT, V4, P220, DOI 10.1093/mp/ssq082; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Shimizu M, 2005, PLANT J, V42, P877, DOI 10.1111/j.1365-313X.2005.02419.x; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; SUZUKI M, 1994, PLANT MOL BIOL, V25, P507, DOI 10.1007/BF00043878; Tan L, 2003, PLANT PHYSIOL, V132, P1362, DOI 10.1104/pp.103.021766; Tan L, 2010, J BIOL CHEM, V285, P24575, DOI 10.1074/jbc.M109.100149; TANAKA A, 1990, NUCLEIC ACIDS RES, V18, P6767, DOI 10.1093/nar/18.23.6767; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; van Hengel AJ, 2001, PLANT PHYSIOL, V125, P1880, DOI 10.1104/pp.125.4.1880; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; WAFFENSCHMIDT S, 1993, PLANT CELL, V5, P809, DOI 10.1105/tpc.5.7.809; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Yoshiba Y, 2001, DNA RES, V8, P115, DOI 10.1093/dnares/8.3.115; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x	67	45	50	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20405	20420		10.1074/jbc.M114.553933	http://dx.doi.org/10.1074/jbc.M114.553933			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24914209	hybrid, Green Published			2022-12-28	WOS:000339396600001
J	Holmes, BB; Diamond, MI				Holmes, Brandon B.; Diamond, Marc I.			Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEPARAN-SULFATE PROTEOGLYCANS; ALPHA-SYNUCLEIN FIBRILS; BETA IMMUNIZATION AN1792; TO-NEURON TRANSMISSION; MOUSE MODEL; PASSIVE-IMMUNIZATION; PENTOSAN POLYSULFATE; ENDOGENOUS TAU; LONG-TERM; IN-VIVO	Work over the past 4 years indicates that multiple proteins associated with neurodegenerative diseases, especially Tau and alpha-synuclein, can propagate aggregates between cells in a prion-like manner. This means that once an aggregate is formed it can escape the cell of origin, contact a connected cell, enter the cell, and induce further aggregation via templated conformational change. The prion model predicts a key role for extracellular protein aggregates in mediating progression of disease. This suggests new therapeutic approaches based on blocking neuronal uptake of protein aggregates and promoting their clearance. This will likely include therapeutic antibodies or small molecules, both of which can be developed and optimized in vitro prior to preclinical studies.	[Holmes, Brandon B.; Diamond, Marc I.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL)	Diamond, MI (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63110 USA.	diamondm@neuro.wustl.edu		Holmes, Brandon/0000-0002-1153-840X	National Institutes of Health [1R01NS071835-01, 5 F31 NS079039-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS079039, R01NS071835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01NS071835-01 (to M. I. D.) and Grant 5 F31 NS079039-03 (to B. B. H).	Angot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039465; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Conrad EH, 1998, HEPARIN BINDING PROT; Dawson HN, 2001, J CELL SCI, V114, P1179; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Dujardin S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-14; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOUDSMIT J, 1980, NEUROLOGY, V30, P945, DOI 10.1212/WNL.30.9.945; Gout E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541939; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Larramendy-Gozalo C, 2007, J GEN VIROL, V88, P1062, DOI 10.1099/vir.0.82286-0; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee Sangmook, 2012, Int J Alzheimers Dis, V2012, P172837, DOI 10.1155/2012/172837; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li JL, 2011, EMBO REP, V12, P1243, DOI 10.1038/embor.2011.191; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Perez M, 1996, J NEUROCHEM, V67, P1183; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Plouffe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036873; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; PRUSINER SB, 1993, ARCH NEUROL-CHICAGO, V50, P1129, DOI 10.1001/archneur.1993.00540110011002; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Rasool S, 2013, J NEUROCHEM, V126, P473, DOI 10.1111/jnc.12305; Ravits J, 2007, NEUROLOGY, V68, P1571, DOI 10.1212/01.wnl.0000260965.20021.47; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Safar J, 2000, ARCH VIROL, P227; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schonberger O, 2003, BIOCHEM BIOPH RES CO, V312, P473, DOI 10.1016/j.bbrc.2003.10.150; SCOTT JR, 1992, J GEN VIROL, V73, P1637, DOI 10.1099/0022-1317-73-7-1637; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; SNOW AD, 1988, AM J PATHOL, V133, P456; SPEAR PG, 1992, ADV EXP MED BIOL, V313, P341; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	101	138	142	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19855	19861		10.1074/jbc.R114.549295	http://dx.doi.org/10.1074/jbc.R114.549295			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24860099	Green Published, hybrid			2022-12-28	WOS:000339395200004
J	Thompson, MD; Mei, Y; Weisbrod, RM; Silver, M; Shukla, PC; Bolotina, VM; Cohen, RA; Tong, XY				Thompson, Melissa D.; Mei, Yu; Weisbrod, Robert M.; Silver, Marcy; Shukla, Praphulla C.; Bolotina, Victoria M.; Cohen, Richard A.; Tong, Xiaoyong			Glutathione Adducts on Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase Cys-674 Regulate Endothelial Cell Calcium Stores and Angiogenic Function as Well as Promote Ischemic Blood Flow Recovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ENDOPLASMIC-RETICULUM; MIGRATION; HINDLIMB; SERCA2; MODEL	The sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) is key to Ca2+ homeostasis and is redox-regulated by reversible glutathione (GSH) adducts on the cysteine (C) 674 thiol that stimulate Ca2+ uptake activity and endothelial cell angiogenic responses in vitro. We found that mouse hind limb muscle ischemia induced S-glutathione adducts on SERCA in both whole muscle tissue and endothelial cells. To determine the role of S-glutathiolation, we used a SERCA 2 C674S heterozygote knock-in (SKI) mouse lacking half the key thiol. Following hind limb ischemia, SKI animals had decreased SERCA S-glutathione adducts and impaired blood flow recovery. We studied SKI microvascular endothelial cells in which total SERCA 2 expression was unchanged. Cultured SKI microvascular endothelial cells showed impaired migration and network formation compared with wild type (WT). Ca2+ studies showed decreased nitric oxide (center dot NO)-induced 45Ca(2+) uptake into the endoplasmic reticulum (ER) of SKI cells, while Fura-2 studies revealed lower Ca2+ stores and decreased vascular endothelial growth factor (VEGF)-and center dot NO-induced Ca2+ influx. Adenoviral overexpression of calreticulin, an ER Ca2+ binding protein, increased ionomycin-releasable stores, VEGF-induced Ca2+ influx and endo-thelial cell migration. Taken together, these data indicate that the redox-sensitive Cys-674 thiol on SERCA 2 is required for normal endothelial cell Ca2+ homeostasis and ischemia-induced angiogenic responses, revealing a novel redox control of angiogenesis via Ca2+ stores.	[Thompson, Melissa D.; Mei, Yu; Weisbrod, Robert M.; Silver, Marcy; Shukla, Praphulla C.; Cohen, Richard A.; Tong, Xiaoyong] Boston Univ, Sch Med, Dept Med, Vasc Biol Sect,Whitaker Cardiovasc Inst, 650 Albany St,X720, Boston, MA 02118 USA; [Bolotina, Victoria M.] Boston Univ, Sch Med, Ion Channel & Calcium Signaling Unit, Boston, MA 02118 USA; [Tong, Xiaoyong] Chongqing Univ, Innovat Drug Res Ctr, Chongqing 401331, Peoples R China	Boston University; Boston University; Chongqing University	Tong, XY (corresponding author), Boston Univ, Sch Med, Dept Med, Vasc Biol Sect,Whitaker Cardiovasc Inst, 650 Albany St,X720, Boston, MA 02118 USA.	racohen@bu.edu; xy_tong@yahoo.com	Tong, Xiaoyong/L-5791-2019; Shukla, Praphulla Chandra/GSO-1633-2022	Shukla, Praphulla Chandra/0000-0001-9031-1547; /0000-0002-1070-6408	National Institute of Health [HL031607-30, R37 HL104017, R01-HL071793]; NHLBI [HL07969, N01-HV-28178]; American Diabetes Association [7-09-JF-69]; Boston University; Calcium Affinity Research Collaborative of the Evans Center, Department of Medicine, Boston University Medical Center; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031607, R01HL028178, R37HL104017, T32HL007969, R01HL071793] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association(American Diabetes Association); Boston University; Calcium Affinity Research Collaborative of the Evans Center, Department of Medicine, Boston University Medical Center; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grants HL031607-30 (to R. A. C., X. T.), R37 HL104017 (to R. A. C.), and R01-HL071793 (to V. B.), NHLBI T32 Training Grant HL07969 (to M. D. T.) American Diabetes Association Award 7-09-JF-69 (to X. T.), and a Martin Luther King, Jr. Fellowship from Boston University (to M. D. T.), and the NHLBI-sponsored Boston University Cardiovascular Proteomics Center (Contract No. N01-HV-28178, to R. A. C.). These studies were also supported by the Calcium Affinity Research Collaborative of the Evans Center, Department of Medicine, Boston University Medical Center.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Adachi T, 2001, CIRCULATION, V104, P1040, DOI 10.1161/hc3501.093798; Adachi T, 2010, ADV PHARMACOL, V59, P165, DOI 10.1016/S1054-3589(10)59006-9; Carmeliet P, 1998, CARDIOVASC RES, V39, P8, DOI 10.1016/S0008-6363(98)00108-4; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; CORDA S, 1995, CIRC RES, V77, P927, DOI 10.1161/01.RES.77.5.927; Evangelista AM, 2012, ANTIOXID REDOX SIGN, V17, P1099, DOI 10.1089/ars.2011.4022; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Haeussler DJ, 2013, J BIOL CHEM, V288, P15380, DOI 10.1074/jbc.M112.427765; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Lotfi S, 2013, ATHEROSCLEROSIS, V227, P1, DOI 10.1016/j.atherosclerosis.2012.10.060; Maulik N, 2002, ANTIOXID REDOX SIGN, V4, P805, DOI 10.1089/152308602760598963; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Neufeld Gera, 1994, Progress in Growth Factor Research, V5, P89, DOI 10.1016/0955-2235(94)90019-1; Tamarat R, 2002, HYPERTENSION, V39, P830, DOI 10.1161/hy0302.104671; Urano T, 2008, ARTERIOSCL THROM VAS, V28, P827, DOI 10.1161/ATVBAHA.107.149674; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006; Ziegelstein RC, 2006, BIOCHEM BIOPH RES CO, V342, P153, DOI 10.1016/j.bbrc.2006.01.135	23	41	42	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19907	19916		10.1074/jbc.M114.554451	http://dx.doi.org/10.1074/jbc.M114.554451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24920669	Green Published, hybrid			2022-12-28	WOS:000339395200009
J	Alvarado, DM; Coulombe, PA				Alvarado, David M.; Coulombe, Pierre A.			Directed Expression of a Chimeric Type II Keratin Partially Rescues Keratin 5-null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; CORNIFIED CELL-ENVELOPE; TRANSGENIC MOUSE SKIN; HUMAN EPIDERMAL-CELLS; INTERMEDIATE-FILAMENTS; MECHANICAL-PROPERTIES; SELF-ORGANIZATION; EPITHELIAL-CELLS; GENE; NETWORKS	The crucial role of structural support fulfilled by keratin intermediate filaments (IFs) in surface epithelia likely requires that they be organized into cross-linked networks. For IFs comprised of keratins 5 and 14 (K5 and K14), which occur in basal keratinocytes of the epidermis, formation of cross-linked bundles is, in part, self-driven through cis-acting determinants. Here, we targeted the expression of a bundling-competent KRT5/KRT8 chimeric cDNA (KRT8bc) or bundling-deficient wild type KRT8 as a control to the epidermal basal layer of Krt5-null mice to assess the functional importance of keratin IF self-organization in vivo. Such targeted expression of K8bc rescued Krt5-null mice with a 47% frequency, whereas K8 completely failed to do so. This outcome correlated with lower than expected levels of K8bc and especially K8 mRNA and protein in the epidermis of E18.5 replacement embryos. Ex vivo culture of embryonic skin keratinocytes confirmed the ability of K8bc to form IFs in the absence of K5. Additionally, electron microscopy analysis of E18.5 embryonic skin revealed that the striking defects observed in keratin IF bundling, cytoarchitecture, and mitochondria are partially restored by K8bc expression. As young adults, viable KRT8bc replacement mice develop alopecia and chronic skin lesions, indicating that the skin epithelia are not completely normal. These findings are consistent with a contribution of self-mediated organization of keratin IFs to structural support and cytoarchitecture in basal layer keratinocytes of the epidermis and underscore the importance of context-dependent regulation for keratin genes and proteins in vivo.	[Alvarado, David M.; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Training Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Alvarado, David M.; Coulombe, Pierre A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Coulombe, PA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	coulombe@jhu.edu		Alvarado, David/0000-0001-8748-0761	National Institutes of Health [AR042047]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR042047, R01AR042047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR042047.	Bernot KM, 2005, J CELL BIOL, V168, P965, DOI 10.1083/jcb.200408116; Betz RC, 2006, AM J HUM GENET, V78, P510, DOI 10.1086/500850; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Casanova ML, 2004, FASEB J, V18, P1556, DOI 10.1096/fj.04-1683fje; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; Feng X, 2013, J INVEST DERMATOL, V133, P850, DOI 10.1038/jid.2012.397; FRANKE WW, 1981, J MOL BIOL, V153, P933, DOI 10.1016/0022-2836(81)90460-5; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Green KJ, 2005, ADV PROTEIN CHEM, V70, P143, DOI 10.1016/S0065-3233(04)70006-6; HANUKOGLU I, 1983, CELL, V33, P915, DOI 10.1016/0092-8674(83)90034-X; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Jang SI, 2005, J CELL SCI, V118, P781, DOI 10.1242/jcs.01647; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kerns ML, 2007, P NATL ACAD SCI USA, V104, P14460, DOI 10.1073/pnas.0706486104; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kirfel J, 2002, DIFFERENTIATION, V70, P56, DOI 10.1046/j.1432-0436.2002.700106.x; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; KULESH DA, 1989, MOL CELL BIOL, V9, P1553, DOI 10.1128/MCB.9.4.1553; Kumemura H, 2008, BIOCHEM BIOPH RES CO, V367, P33, DOI 10.1016/j.bbrc.2007.12.116; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; LEE SC, 1993, J BIOL CHEM, V268, P12164; LERSCH R, 1988, MOL CELL BIOL, V8, P486, DOI 10.1128/MCB.8.1.486; LERSCH R, 1989, MOL CELL BIOL, V9, P3685, DOI 10.1128/MCB.9.9.3685; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; LEUBE RE, 1986, DIFFERENTIATION, V33, P69, DOI 10.1111/j.1432-0436.1986.tb00412.x; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; Liovic M, 2009, EXP CELL RES, V315, P2995, DOI 10.1016/j.yexcr.2009.07.013; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Lu H, 2007, J INVEST DERMATOL, V127, P2781, DOI 10.1038/sj.jid.5700918; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; McGowan K, 1998, Subcell Biochem, V31, P173; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McLean WHI, 2011, HUM MOL GENET, V20, pR189, DOI 10.1093/hmg/ddr379; MOLL R, 1984, DIFFERENTIATION, V28, P136, DOI 10.1111/j.1432-0436.1984.tb00277.x; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Reichelt J, 2010, METHODS MOL BIOL, V585, P59, DOI 10.1007/978-1-60761-380-0_5; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roth W, 2009, HUM MUTAT, V30, P832, DOI 10.1002/humu.20981; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; Seltmann K, 2013, P NATL ACAD SCI USA, V110, P18507, DOI 10.1073/pnas.1310493110; Seltmann K, 2013, J INVEST DERMATOL, V133, P181, DOI 10.1038/jid.2012.256; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; SUN TT, 1978, J BIOL CHEM, V253, P2053; Suozzi KC, 2012, J CELL BIOL, V197, P465, DOI 10.1083/jcb.201112034; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; TAKAHASHI K, 1994, J CELL BIOL, V127, P505, DOI 10.1083/jcb.127.2.505; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; WILSON AK, 1992, J CELL BIOL, V119, P401, DOI 10.1083/jcb.119.2.401; Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522	64	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19435	19447		10.1074/jbc.M114.553867	http://dx.doi.org/10.1074/jbc.M114.553867			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867950	Green Published, hybrid			2022-12-28	WOS:000339326800019
J	Brady, OA; Zhou, XL; Hu, FH				Brady, Owen A.; Zhou, Xiaolai; Hu, Fenghua			Regulated Intramembrane Proteolysis of the Frontotemporal Lobar Degeneration Risk Factor, TMEM106B, by Signal Peptide Peptidase-like 2a (SPPL2a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; B-CELL; ASPARTIC PROTEASE; INVARIANT CHAIN; DENDRITIC CELLS; TNF-ALPHA; CLEAVAGE; MEMBRANE; PRESENILIN	The sequential processing of single pass transmembrane proteins via ectodomain shedding followed by intramembrane proteolysis is involved in a wide variety of signaling processes, as well as maintenance of membrane protein homeostasis. Here we report that the recently identified frontotemporal lobar degeneration risk factor TMEM106B undergoes regulated intramembrane proteolysis. We demonstrate that TMEM106B is readily processed to an N-terminal fragment containing the transmembrane and intracellular domains, and this processing is dependent on the activities of lysosomal proteases. The N-terminal fragment is further processed into a small, rapidly degraded intracellular domain. The GxGD aspartyl proteases SPPL2a and, to a lesser extent, SPPL2b are responsible for this intramembrane cleavage event. Additionally, the TMEM106B paralog TMEM106A is also lysosomally localized; however, it is not a specific substrate of SPPL2a or SPPL2b. Our data add to the growing list of proteins that undergo intramembrane proteolysis and may shed light on the regulation of the frontotemporal lobar degeneration risk factor TMEM106B.	[Brady, Owen A.; Zhou, Xiaolai; Hu, Fenghua] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Hu, FH (corresponding author), 345 Weill Hall, Ithaca, NY 14853 USA.	fh87@cornell.edu	Zhou, Xiaolai/AAF-7227-2020		National Institutes of Health [R21 NS081357-01]; Weill Institute for Cell and Molecular Biology; Association of Frontotemporal Dementia, Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081357, R01NS088448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Institute for Cell and Molecular Biology; Association of Frontotemporal Dementia, Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 NS081357-01 (to F. H.). This work was also supported by funding from the Weill Institute for Cell and Molecular Biology and from the Association of Frontotemporal Dementia, Alzheimer's Association (to F. H.).	Behnke J, 2011, FEBS LETT, V585, P2951, DOI 10.1016/j.febslet.2011.08.043; Beisner DR, 2013, J EXP MED, V210, P23, DOI 10.1084/jem.20121072; Bergmann H, 2013, J EXP MED, V210, P31, DOI 10.1084/jem.20121076; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fluhrer R, 2012, J BIOL CHEM, V287, P5156, DOI 10.1074/jbc.M111.328104; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Gallagher MD, 2014, ACTA NEUROPATHOL, V127, P407, DOI 10.1007/s00401-013-1239-x; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Lemberg MK, 2011, TRAFFIC, V12, P1109, DOI 10.1111/j.1600-0854.2011.01219.x; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lu RC, 2014, J NEURAL TRANSM, V121, P283, DOI 10.1007/s00702-013-1106-x; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Rutherford NJ, 2012, NEUROLOGY, V79, P717, DOI 10.1212/WNL.0b013e318264e3ac; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schneppenheim J, 2014, MOL CELL BIOL, V34, P1398, DOI 10.1128/MCB.00038-14; Schneppenheim J, 2013, J EXP MED, V210, P41, DOI 10.1084/jem.20121069; Schwenk BM, 2014, EMBO J, V33, P450, DOI 10.1002/embj.201385857; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; TANAKA RD, 1986, J LIPID RES, V27, P261; van Blitterswijk M, 2014, ACTA NEUROPATHOL, V127, P397, DOI 10.1007/s00401-013-1240-4; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yu Q, 2000, GENE DEV, V14, P163; Zahn C, 2013, FEBS J, V280, P1653, DOI 10.1111/febs.12176	52	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19670	19680		10.1074/jbc.M113.515700	http://dx.doi.org/10.1074/jbc.M113.515700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872421	Green Published, hybrid			2022-12-28	WOS:000339326800039
J	Kuhle, K; Krausze, J; Curth, U; Rossle, M; Heuner, K; Lang, C; Flieger, A				Kuhle, Katja; Krausze, Joern; Curth, Ute; Roessle, Manfred; Heuner, Klaus; Lang, Christina; Flieger, Antje			Oligomerization Inhibits Legionella pneumophila PlaB Phospholipase A Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE PHOSPHOLIPASE; LIPOLYTIC ENZYMES; ERYTHROCYTE CA-2+-ATPASE; ALLOSTERIC REGULATION; ENZYMATIC-ACTIVITY; OUTER-MEMBRANE; PROTEIN; A(2); ACTIVATION; INFECTION	The intracellularly replicating lung pathogen Legionella pneumophila consists of an extraordinary variety of phospholipases, including at least 15 different phospholipases A (PLA). Among them, PlaB, the first characterized member of a novel lipase family, is a hemolytic virulence factor that exhibits the most prominent PLA activity in L. pneumophila. We analyzed here protein oligomerization, the importance of oligomerization for activity, addressed further essential regions for activity within the PlaB C terminus, and the significance of PlaB-derived lipolytic activity for L. pneumophila intracellular replication. We determined by means of analytical ultracentrifugation and small angle x-ray scattering analysis that PlaB forms homodimers and homotetramers. The C-terminal 5, 10, or 15 amino acids, although the individual regions contributed to PLA activity, were not essential for protein tetramerization. Infection of mouse macrophages with L. pneumophila wild type, plaB knock-out mutant, and plaB complementing or various mutated plaB-harboring strains showed that catalytic activity of PlaB promotes intracellular replication. We observed that PlaB was most active in the lower nanomolar concentration range but not at or only at a low level at concentration above 0.1 mu M where it exists in a dimer/tetramer equilibrium. We therefore conclude that PlaB is a virulence factor that, on the one hand, assembles in inactive tetramers at micromolar concentrations. On the other hand, oligomer dissociation at nanomolar concentrations activates PLA activity. Our data highlight the first example of concentration-dependent phospholipase inactivation by tetramerization, which may protect the bacterium from internal PLA activity, but enzyme dissociation may allow its activation after export.	[Kuhle, Katja; Heuner, Klaus; Lang, Christina; Flieger, Antje] Robert Koch Inst, D-38855 Wernigerode, Germany; [Krausze, Joern] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Curth, Ute] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Roessle, Manfred] DESY, Hamburg Branch 22603, European Mol Biol Lab, Hamburg, Germany; [Roessle, Manfred] Lubeck Univ Appl Sci, D-23562 Lubeck, Germany	Robert Koch Institute; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Luebeck University of Applied Sciences	Flieger, A (corresponding author), Robert Koch Inst, Div Enteropathogen Bacteria & Legionella, Burgstr 37, D-38855 Wernigerode, Germany.	fliegera@rki.de		Flieger, Antje/0000-0003-3819-2979; Rossle, Manfred/0000-0003-4196-0430	Robert Koch-Institute; German Research Foundation [DFG FL359/4-2]	Robert Koch-Institute; German Research Foundation(German Research Foundation (DFG))	This work was supported by the Robert Koch-Institute (to A. F.) and by Grant DFG FL359/4-2 from the German Research Foundation.	Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Aurass P, 2013, J BIOL CHEM, V288, P11080, DOI 10.1074/jbc.M112.426049; Banerji S, 2005, INFECT IMMUN, V73, P2899, DOI 10.1128/IAI.73.5.2899-2909.2005; Banerji S, 2004, MICROBIOL-SGM, V150, P522, DOI 10.1099/mic.0.26957-0; Beernink PT, 1996, P NATL ACAD SCI USA, V93, P5374, DOI 10.1073/pnas.93.11.5374; Bender J, 2009, J BIOL CHEM, V284, P27185, DOI 10.1074/jbc.M109.026021; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blanc G, 2005, ANN NY ACAD SCI, V1063, P83, DOI 10.1196/annals.1355.012; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Cheng JJ, 2012, J BIOL CHEM, V287, P40317, DOI 10.1074/jbc.M112.395277; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; de Oliveira AHC, 2001, BIOCHEMISTRY-US, V40, P6912, DOI 10.1021/bi0026728; Dekker N, 1997, J BIOL CHEM, V272, P3179, DOI 10.1074/jbc.272.6.3179; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; FANG GD, 1989, MEDICINE, V68, P116, DOI 10.1097/00005792-198903000-00005; Faulkner Gary, 2013, Methods Mol Biol, V954, P279, DOI 10.1007/978-1-62703-161-5_17; Flieger A, 2004, INFECT IMMUN, V72, P2648, DOI 10.1128/IAI.72.5.2648-2658.2004; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; Griffon N, 2009, J BIOL CHEM, V284, P23322, DOI 10.1074/jbc.M109.037002; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; Kozak NA, 2010, J BACTERIOL, V192, P1030, DOI 10.1128/JB.01272-09; Kuhle K, 2014, CURR TOP MICROBIOL, V376, P175, DOI 10.1007/82_2013_348; Lang C, 2012, J BIOL CHEM, V287, P23464, DOI 10.1074/jbc.M112.346387; Lang C, 2011, EUR J CELL BIOL, V90, P903, DOI 10.1016/j.ejcb.2010.12.003; Laue M. T., 1992, BIOCH POLYM SCI, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Magro AJ, 2003, BIOCHEM BIOPH RES CO, V311, P713, DOI 10.1016/j.bbrc.2003.10.047; Marchi-Salvador DP, 2008, PROTEINS, V72, P883, DOI 10.1002/prot.21980; Merzbacher M, 2004, EUR J BIOCHEM, V271, P367, DOI 10.1046/j.1432-1033.2003.03935.x; Muder RR, 2002, CLIN INFECT DIS, V35, P990, DOI 10.1086/342884; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Qin T, 2012, J BACTERIOL, V194, P1251, DOI 10.1128/JB.06352-11; ROPP PA, 1991, J BIOL CHEM, V266, P7682; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Sanchez SA, 2001, BIOCHEMISTRY-US, V40, P6903, DOI 10.1021/bi001599i; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schunder E, 2010, INT J MED MICROBIOL, V300, P313, DOI 10.1016/j.ijmm.2010.01.002; SHINODA S, 1991, J GEN MICROBIOL, V137, P2705, DOI 10.1099/00221287-137-12-2705; Snijder HJ, 2000, BBA-MOL CELL BIOL L, V1488, P91, DOI 10.1016/S1388-1981(00)00113-X; Snijder HJ, 1999, NATURE, V401, P717, DOI 10.1038/44890; St-Denis A, 1999, J IMMUNOL, V163, P5505; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; TRAUT TW, 1994, CRIT REV BIOCHEM MOL, V29, P125, DOI 10.3109/10409239409086799; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Viner R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002988; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Wilhelm S, 1999, J BACTERIOL, V181, P6977, DOI 10.1128/JB.181.22.6977-6986.1999; Wyszomirski KH, 2012, NUCLEIC ACIDS RES, V40, P3610, DOI 10.1093/nar/gkr1239; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou YL, 2006, INT J BIOCHEM CELL B, V38, P1986, DOI 10.1016/j.biocel.2006.05.012	56	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18657	18666		10.1074/jbc.M114.573196	http://dx.doi.org/10.1074/jbc.M114.573196			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24811180	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000339062900004
J	Kwa, MQ; Nguyen, T; Huynh, J; Ramnath, D; De Nardo, D; Lam, PY; Reynolds, EC; Hamilton, JA; Sweet, MJ; Scholz, GM				Kwa, Mei Qi; Thao Nguyen; Jennifer Huynh; Ramnath, Divya; De Nardo, Dominic; Lam, Pui Yeng; Reynolds, Eric C.; Hamilton, John A.; Sweet, Matthew J.; Scholz, Glen M.			Interferon Regulatory Factor 6 Differentially Regulates Toll-like Receptor 2-dependent Chemokine Gene Expression in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; RESPIRATORY SYNCYTIAL VIRUS; TRANSCRIPTION FACTORS; NUCLEAR TRANSLOCATION; DENDRITIC CELLS; DNA-BINDING; IRF FAMILY; IN-VIVO; ACTIVATION	Epidermal and mucosal epithelial cells are integral to host defense. They not only act as a physical barrier but also utilize pattern recognition receptors, such as the Toll-like receptors (TLRs), to detect and respond to pathogens. Members of the interferon regulatory factor (IRF) family of transcription factors are key components of TLR signaling as they impart specificity to downstream responses. Although IRF6 is a critical regulator of epithelial cell proliferation and differentiation, its role in TLR signaling has not previously been addressed. We show here that IRF6 is activated by IRAK1 as well as by MyD88 but not by TRIF or TBK1. Co-immunoprecipitation experiments further demonstrated that IRF6 can interact with IRAK1. Gene silencing in epithelial cells along with gene promoter reporter assays showed that IRAK1 mediates TLR2-inducible CCL5 gene expression at least in part by promoting IRF6 activation. Conversely, IRAK1 regulated CXCL8 gene expression independently of IRF6, thus identifying a molecular mechanism by which TLR2 signaling differentially regulates the expression of specific chemokines in epithelial cells. Bioinformatics analysis and mutagenesis-based experiments identified Ser-413 and Ser-424 as key regulatory sites in IRF6. Phosphomimetic mutation of these residues resulted in greatly enhanced IRF6 dimerization and trans-activator function. Collectively, our findings suggest that, in addition to its importance for epithelial barrier function, IRF6 also contributes to host defense by providing specificity to the regulation of inflammatory chemokine expression by TLR2 in epithelial cells.	[Kwa, Mei Qi; Jennifer Huynh; Reynolds, Eric C.; Scholz, Glen M.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia; [Kwa, Mei Qi; Jennifer Huynh; Reynolds, Eric C.; Scholz, Glen M.] Univ Melbourne, Royal Melbourne Hosp, Inst Bio21, Melbourne, Vic 3010, Australia; [Kwa, Mei Qi; Thao Nguyen; Jennifer Huynh; De Nardo, Dominic; Lam, Pui Yeng; Hamilton, John A.; Scholz, Glen M.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Ramnath, Divya; Sweet, Matthew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Ramnath, Divya; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Queensland; University of Queensland	Scholz, GM (corresponding author), Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic 3010, Australia.	glenms@unimelb.edu.au	Ramnath, Divya/C-2735-2015; Sweet, Matthew J/F-2229-2011; Kwa, Mei/I-6802-2018; Nguyen, Thao/GWN-0419-2022	Ramnath, Divya/0000-0002-1935-9043; Sweet, Matthew J/0000-0002-0406-8139; Kwa, Mei/0000-0001-8890-3391; Scholz, Glen/0000-0003-2722-6344; Reynolds, Eric/0000-0002-6618-4856; De Nardo, Dominic/0000-0002-7045-4695; Hamilton, John A/0000-0002-9493-9224; Lam, Pui Yeng/0000-0003-4031-367X	National Health and Medical Research Council [628769]; Oral Health CRC	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Oral Health CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by National Health and Medical Research Council Project Grant 628769 and the Oral Health CRC.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; Casola A, 2001, J VIROL, V75, P6428, DOI 10.1128/JVI.75.14.6428-6439.2001; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; De Nardo D, 2005, J BIOL CHEM, V280, P9813, DOI 10.1074/jbc.M409745200; De Nardo D, 2009, CELL SIGNAL, V21, P246, DOI 10.1016/j.cellsig.2008.10.009; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fukata M, 2009, CURR OPIN PHARMACOL, V9, P680, DOI 10.1016/j.coph.2009.09.006; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krausgruber T, 2010, BLOOD, V115, P4421, DOI 10.1182/blood-2010-01-263020; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Miller Lloyd S, 2008, Adv Dermatol, V24, P71; Nguyen T, 2009, CELL SIGNAL, V21, P719, DOI 10.1016/j.cellsig.2009.01.010; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Way KJ, 2009, J LEUKOCYTE BIOL, V85, P766, DOI 10.1189/jlb.1108689	59	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19758	19768		10.1074/jbc.M114.584540	http://dx.doi.org/10.1074/jbc.M114.584540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872416	Green Published, hybrid			2022-12-28	WOS:000339326800047
J	Ong, ST; Freeley, M; Skubis-Zegadlo, J; Fazil, MHUT; Kelleher, D; Fresser, F; Baier, G; Verma, NK; Long, A				Ong, Seow Theng; Freeley, Michael; Skubis-Zegadlo, Joanna; Fazil, Mobashar Hussain Urf Turabe; Kelleher, Dermot; Fresser, Friedrich; Baier, Gottfried; Verma, Navin Kumar; Long, Aideen			Phosphorylation of Rab5a Protein by Protein Kinase C epsilon Is Crucial for T-cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; PKC-EPSILON; MEDIATED PHOSPHORYLATION; MEMBRANE TRAFFICKING; GROWTH-FACTOR; RHO-GTPASES; INTEGRIN; LFA-1; ADHESION; ACTIVATION	Rab GTPases control membrane traffic and receptor-mediated endocytosis. Within this context, Rab5a plays an important role in the spatial regulation of intracellular transport and signal transduction processes. Here, we report a previously uncharacterized role for Rab5a in the regulation of T-cell motility. We show that Rab5a physically associates with protein kinase C epsilon (PKC epsilon) in migrating T-cells. After stimulation of T-cells through the integrin LFA-1 or the chemokine receptor CXCR4, Rab5a is phosphorylated on an N-terminal Thr-7 site by PKC epsilon. Both Rab5a and PKC epsilon dynamically interact at the centrosomal region of migrating cells, and PKC epsilon-mediated phosphorylation on Thr-7 regulates Rab5a trafficking to the cell leading edge. Furthermore, we demonstrate that Rab5a Thr-7 phosphorylation is functionally necessary for Rac1 activation, actin rearrangement, and T-cell motility. We present a novel mechanism by which a PKC epsilon-Rab5a-Rac1 axis regulates cytoskeleton remodeling and T-cell migration, both of which are central for the adaptive immune response.	[Ong, Seow Theng; Freeley, Michael; Skubis-Zegadlo, Joanna; Long, Aideen] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin 8, Ireland; [Skubis-Zegadlo, Joanna] Med Univ Warsaw, Dept Appl Pharm & Bioengn, PL-02091 Warsaw, Poland; [Fazil, Mobashar Hussain Urf Turabe; Kelleher, Dermot; Verma, Navin Kumar] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637553, Singapore; [Kelleher, Dermot] Univ London Imperial Coll Sci Technol & Med, Fac Med, London SW7 2AZ, England; [Fresser, Friedrich; Baier, Gottfried] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria	Trinity College Dublin; Medical University of Warsaw; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Medical University of Innsbruck	Verma, NK (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637553, Singapore.	nkverma@ntu.edu.sg; longai@tcd.ie	Verma, Navin Kumar/B-7641-2008; Fazil, M H U Turabe/C-9373-2016; Long, Aideen/HGB-4149-2022; Fazil, M H U Turabe/AAA-1329-2020	Verma, Navin Kumar/0000-0002-5940-6633; Fazil, M H U Turabe/0000-0002-4621-8625; Fazil, M H U Turabe/0000-0002-4621-8625; Freeley, Michael/0000-0002-5763-6582	Science Foundation Ireland; Higher Education Authority of Ireland under PRTLI cycle 3; Health Research Board of Ireland; Marie Curie [MTKDCT-2005-029798]; NTU-MOE start-up grant; FWF Austrian Science Fund [P19505-B05]; European Community Program SYBILLA [HEALTH-F4-2008-201106]; Austrian Science Fund (FWF) [P 25044] Funding Source: researchfish	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Higher Education Authority of Ireland under PRTLI cycle 3; Health Research Board of Ireland; Marie Curie(European Commission); NTU-MOE start-up grant; FWF Austrian Science Fund(Austrian Science Fund (FWF)); European Community Program SYBILLA; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from Science Foundation Ireland (to A. L.), Higher Education Authority of Ireland under PRTLI cycle 3 (to D. K.), Health Research Board of Ireland (to A. L.), Marie Curie MTKDCT-2005-029798 (to J. S.-Z.), NTU-MOE start-up grant (to N. K. V.), FWF Austrian Science Fund (P19505-B05) (to F. F. and G. B.), and the European Community Program SYBILLA under Grant HEALTH-F4-2008-201106 (to F. F. and G. B.).	Akita Y, 2008, FEBS J, V275, P3995, DOI 10.1111/j.1742-4658.2008.06557.x; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; Besson A, 2001, ONCOGENE, V20, P7398, DOI 10.1038/sj.onc.1204899; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chae YC, 2010, MOL CELL BIOL, V30, P5086, DOI 10.1128/MCB.00443-10; Chun JS, 1996, J BIOL CHEM, V271, P13008, DOI 10.1074/jbc.271.22.13008; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; Freeley M, 2012, J IMMUNOL, V188, P6357, DOI 10.4049/jimmunol.1103242; Freeley M, 2010, J BIOMOL SCREEN, V15, P541, DOI 10.1177/1087057110369703; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hernandez RM, 2001, J CELL BIOCHEM, V83, P532, DOI 10.1002/jcb.1246; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LI GP, 1993, J BIOL CHEM, V268, P24475; Long A, 2004, ANN NY ACAD SCI, V1028, P313, DOI 10.1193/annals.1322.035; Magee Tony, 1992, Trends in Cell Biology, V2, P318, DOI 10.1016/0962-8924(92)90172-J; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; Radhakrishna H, 1999, J CELL SCI, V112, P855; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; SANFORD JC, 1995, MOL BIOL CELL, V6, P71, DOI 10.1091/mbc.6.1.71; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Serio G, 2011, P NATL ACAD SCI USA, V108, P17337, DOI 10.1073/pnas.1103516108; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Stanley P, 2012, BIOL OPEN, V1, P1161, DOI 10.1242/bio.20122824; Stawowy P, 2005, CARDIOVASC RES, V67, P50, DOI 10.1016/j.cardiores.2005.03.002; STEELEMORTIMER O, 1994, EMBO J, V13, P34, DOI 10.1002/j.1460-2075.1994.tb06232.x; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Stenmark H, 2001, GENOME BIOL, V2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Svensson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038517; Tachado SD, 2002, J CELL BIOCHEM, V85, P785, DOI 10.1002/jcb.10164; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Verma NK, 2008, J MOL MED-JMM, V86, P457, DOI 10.1007/s00109-008-0312-8; Verma NK, 2012, J BIOL CHEM, V287, P27204, DOI 10.1074/jbc.M112.376616; Verma NK, 2011, J CELL PHYSIOL, V226, P1489, DOI 10.1002/jcp.22478; Verma NK, 2010, CELL MOL BIOL LETT, V15, P342, DOI 10.2478/s11658-010-0008-2; Verma NK, 2004, BRIT J PHARMACOL, V143, P1006, DOI 10.1038/sj.bjp.0706002; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1; Zeng LL, 2012, ADV EXP MED BIOL, V740, P639, DOI 10.1007/978-94-007-2888-2_28; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200	76	41	42	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19420	19434		10.1074/jbc.M113.545863	http://dx.doi.org/10.1074/jbc.M113.545863			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872409	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000339326800018
J	Plengpanich, W; Young, SG; Khovidhunkit, W; Bensadoun, A; Karnman, H; Ploug, M; Gardsvoll, H; Leung, CS; Adeyo, O; Larsson, M; Muanpetch, S; Charoen, S; Fong, LG; Niramitmahapanya, S; Beigneux, AP				Plengpanich, Wanee; Young, Stephen G.; Khovidhunkit, Weerapan; Bensadoun, Andre; Karnman, Hirankorn; Ploug, Michael; Gardsvoll, Henrik; Leung, Calvin S.; Adeyo, Oludotun; Larsson, Mikael; Muanpetch, Suwanna; Charoen, Supannika; Fong, Loren G.; Niramitmahapanya, Sathit; Beigneux, Anne P.			Multimerization of Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1) and Familial Chylomicronemia from a Serine-to-Cysteine Substitution in GPIHBP1 Ly6 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE RECEPTOR; MONOCLONAL-ANTIBODIES; GPIHBP1-DEFICIENT MICE; PLASMINOGEN-ACTIVATOR; LIPASE; MUTATIONS; CELLS; HYPERTRIGLYCERIDEMIA; DEFICIENCY; EPITOPE	GPIHBP1, a glycosylphosphatidylinositol-anchored glycoprotein of microvascular endothelial cells, binds lipoprotein lipase (LPL) within the interstitial spaces and transports it across endothelial cells to the capillary lumen. The ability of GPIHBP1 to bind LPL depends on the Ly6 domain, a three-fingered structure containing 10 cysteines and a conserved pattern of disulfide bond formation. Here, we report a patient with severe hypertriglyceridemia who was homozygous for a GPIHBP1 point mutation that converted a serine in the GPIHBP1 Ly6 domain (Ser-107) to a cysteine. Two hypertriglyceridemic siblings were homozygous for the same mutation. All three homozygotes had very low levels of LPL in the preheparin plasma. We suspected that the extra cysteine in GPIHBP1-S107C might prevent the trafficking of the protein to the cell surface, but this was not the case. However, nearly all of the GPIHBP1-S107C on the cell surface was in the form of disulfide-linked dimers and multimers, whereas wild-type GPIHBP1 was predominantly monomeric. An insect cell GPIHBP1 expression system confirmed the propensity of GPIHBP1-S107C to form disulfide-linked dimers and to form multimers. Functional studies showed that only GPIHBP1 monomers bind LPL. In keeping with that finding, there was no binding of LPL to GPIHBP1-S107C in either cell-based or cell-free binding assays. We conclude that an extra cysteine in the GPIHBP1 Ly6 motif results in multimerization of GPIHBP1, defective LPL binding, and severe hypertriglyceridemia.	[Plengpanich, Wanee; Khovidhunkit, Weerapan; Karnman, Hirankorn; Muanpetch, Suwanna; Charoen, Supannika] Chulalongkorn Univ, Dept Med, Fac Med, Bangkok 10330, Thailand; [Plengpanich, Wanee; Khovidhunkit, Weerapan; Karnman, Hirankorn; Muanpetch, Suwanna; Charoen, Supannika] Thai Red Cross Soc, Bangkok 10330, Thailand; [Young, Stephen G.; Leung, Calvin S.; Adeyo, Oludotun; Fong, Loren G.; Beigneux, Anne P.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Ploug, Michael; Gardsvoll, Henrik] Rigshosp, Finsen Lab, DK-2200 Copenhagen, Denmark; [Ploug, Michael; Gardsvoll, Henrik] Rigshosp, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Larsson, Mikael] Umea Univ, Dept Med Biosci & Physiol Chem, SE-90187 Umea, Sweden; [Niramitmahapanya, Sathit] Rangsit Univ, Rajavithi Hosp, Dept Med, Coll Med, Bangkok 10400, Thailand	Chulalongkorn University; Thai Red Cross Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cornell University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Umea University; Rajavithi Hospital; Rangsit University	Khovidhunkit, W (corresponding author), Chulalongkorn Univ, Hormonal & Metab Disorders Res Unit, King Chulalongkorn Mem Hosp, Fac Med,Dept Med, Samakkee Payabarn Bldg,2nd Floor,Rama 4 Rd, Bangkok 10330, Thailand.	wkhovid@gmail.com; abeigneux@mednet.ucla.edu		Ploug, Michael/0000-0003-2215-4265; Young, Stephen/0000-0001-7270-3176; Leung, Calvin/0000-0003-4973-3646	National Institutes of Health [HL094732, HL090553, HL087228]; Asahi Glass Foundation; Thailand Government Research Budget [2556, 2557]; Ratchadapiseksompotch Research Fund; Chulalongkorn University grants; Leducq Transatlantic Network Grant [12CVD04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, R01HL087228, R01HL094732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asahi Glass Foundation; Thailand Government Research Budget; Ratchadapiseksompotch Research Fund; Chulalongkorn University grants; Leducq Transatlantic Network Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094732, HL090553, and HL087228. This work was also supported by the Asahi Glass Foundation, the Thailand Government Research Budget (Years 2556 and 2557), the Ratchadapiseksompotch Research Fund, Chulalongkorn University grants, and by Leducq Transatlantic Network Grant 12CVD04.	Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2011, J BIOL CHEM, V286, P19735, DOI 10.1074/jbc.M111.242024; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; Charriere S, 2011, J CLIN ENDOCR METAB, V96, pE1675, DOI 10.1210/jc.2011-1444; Coca-Prieto I, 2011, J INTERN MED, V270, P224, DOI 10.1111/j.1365-2796.2011.02361.x; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; FLETCHER A, 1992, IMMUNOLOGY, V75, P507; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2007, PROTEIN EXPRES PURIF, V52, P384, DOI 10.1016/j.pep.2006.11.013; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2013, J HISTOCHEM CYTOCHEM, V61, P802, DOI 10.1369/0022155413501879; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Gin P, 2007, BBA-MOL CELL BIOL L, V1771, P1464, DOI 10.1016/j.bbalip.2007.10.005; Gin P, 2011, ARTERIOSCL THROM VAS, V31, P176, DOI 10.1161/ATVBAHA.110.214718; Ginzinger DG, 1999, EUR J CLIN INVEST, V29, P17, DOI 10.1046/j.1365-2362.1999.00435.x; Haritunians T, 2002, CIRC RES, V90, P506, DOI 10.1161/01.RES.0000013796.73742.C8; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; Mertens HDT, 2012, J BIOL CHEM, V287, P34304, DOI 10.1074/jbc.M112.398404; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; PETERSON J, 1992, J LIPID RES, V33, P1165; Ploug M, 2002, BIOCHEM SOC T, V30, P177, DOI 10.1042/BST0300177; Rios JJ, 2012, J INHERIT METAB DIS, V35, P531, DOI 10.1007/s10545-011-9406-5; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; Tybjaerg-Hansen A, 2005, ARTERIOSCL THROM VAS, V25, P211, DOI 10.1161/01.ATV.0000149380.94980.f0; Voss CV, 2011, P NATL ACAD SCI USA, V108, P7980, DOI 10.1073/pnas.1100992108; Wang J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-23; Weinstein MM, 2012, ARTERIOSCL THROM VAS, V32, P230, DOI 10.1161/ATVBAHA.111.241406; Weinstein MM, 2008, J BIOL CHEM, V283, P34511, DOI 10.1074/jbc.M806067200; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058; Yamamoto H, 2013, J ATHEROSCLER THROMB, V20, P777	37	37	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19491	19499		10.1074/jbc.M114.558528	http://dx.doi.org/10.1074/jbc.M114.558528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24847059	Green Published, hybrid			2022-12-28	WOS:000339326800024
J	Bielopolski, N; Lam, AD; Bar-On, D; Sauer, M; Stuenkel, EL; Ashery, U				Bielopolski, Noa; Lam, Alice D.; Bar-On, Dana; Sauer, Markus; Stuenkel, Edward L.; Ashery, Uri			Differential Interaction of Tomosyn with Syntaxin and SNAP25 Depends on Domains in the WD40 beta-Propeller Core and Determines Its Inhibitory Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX-FORMATION; NEUROTRANSMITTER RELEASE; PLASMA-MEMBRANE; FLUORESCENT-PROBES; CHROMAFFIN CELLS; IMAGING REVEALS; LIVING CELLS; LIVE CELLS; PROTEIN; EXOCYTOSIS	Neuronal exocytosis depends on efficient formation of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes and is regulated by tomosyn, a SNARE-binding protein. To gain new information about tomosyn's activity, we characterized its mobility and organization on the plasma membrane (PM) in relation to other SNARE proteins and inhibition of exocytosis. By using direct stochastic optical reconstruction microscopy (dSTORM), we found tomosyn to be organized in small clusters adjacent to syntaxin clusters. In addition, we show that tomosyn is present in both syntaxin-tomosyn complexes and syntaxin-SNAP25-tomosyn complexes. Tomosyn mutants that lack residues 537-578 or 897-917 from its beta-propeller core diffused faster on the PM and exhibited reduced binding to SNAP25, suggesting that these mutants shift the equilibrium between tomosyn-syntaxin-SNAP25 complexes on the PM to tomosyn-syntaxin complexes. As these deletion mutants impose less inhibition on exocytosis, we suggest that tomosyn inhibition is mediated via tomosyn-syntaxin-SNAP25 complexes and not tomosyn-syntaxin complexes. These findings characterize, for the first time, tomosyn's dynamics at the PM and its relation to its inhibition of exocytosis.	[Bielopolski, Noa; Bar-On, Dana; Ashery, Uri] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Bar-On, Dana; Ashery, Uri] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Lam, Alice D.; Stuenkel, Edward L.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sauer, Markus] Univ Wurzburg, Dept Biotechnol & Biophys, D-97074 Wurzburg, Germany	Tel Aviv University; Tel Aviv University; University of Michigan System; University of Michigan; University of Wurzburg	Ashery, U (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	uria@post.tau.ac.il	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Ashery, Uri/0000-0001-6338-7888; Stuenkel, Edward/0000-0001-8225-5725	National Institutes of Health [RO1 NS053978]; Israel Science Foundation [730/11]; United States-Israel Binational Science Foundation [2009279]; German-Israeli Foundation [1125-145.1/2010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS053978 (to E. S. and U. A.). This work was also supported by Israel Science Foundation Grant 730/11 (to U. A.), United States-Israel Binational Science Foundation Grant 2009279 (to U. A.), and German-Israeli Foundation Grant 1125-145.1/2010 (to U. A. and M. S.).	Aikawa Y, 2006, MOL BIOL CELL, V17, P2113, DOI 10.1091/mbc.E06-01-0074; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; Bar-On D, 2008, FEBS LETT, V582, P3563, DOI 10.1016/j.febslet.2008.08.040; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Bar-On D, 2009, J NEUROSCI, V29, P12292, DOI 10.1523/JNEUROSCI.0710-09.2009; Berkovich R, 2011, TRAFFIC, V12, P1648, DOI 10.1111/j.1600-0854.2011.01264.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burdina AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026185; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gladycheva SE, 2004, J PHYSIOL-LONDON, V558, P857, DOI 10.1113/jphysiol.2004.067249; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Halemani ND, 2010, TRAFFIC, V11, P394, DOI 10.1111/j.1600-0854.2009.01020.x; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Knowles MK, 2010, P NATL ACAD SCI USA, V107, P20810, DOI 10.1073/pnas.1014840107; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Li YL, 2007, BIOPHYS J, V93, P2178, DOI 10.1529/biophysj.106.101220; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; Neer EJ, 2000, P NATL ACAD SCI USA, V97, P960, DOI 10.1073/pnas.97.3.960; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; Ribrault C, 2011, J NEUROSCI, V31, P17590, DOI 10.1523/JNEUROSCI.4065-11.2011; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; SCHIAVO G, 1995, J BIOL CHEM, V270, P10566, DOI 10.1074/jbc.270.18.10566; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Smyth AM, 2013, J BIOL CHEM, V288, P5102, DOI 10.1074/jbc.M112.407585; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; XIA ZX, 1992, J BIOL CHEM, V267, P22289; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53	52	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17087	17099		10.1074/jbc.M113.515296	http://dx.doi.org/10.1074/jbc.M113.515296			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782308	Green Published, hybrid			2022-12-28	WOS:000338016200042
J	Ridley, C; Kouvatsos, N; Raynal, BD; Howard, M; Collins, RF; Desseyn, JL; Jowitt, TA; Baldock, C; Davis, CW; Hardingham, TE; Thornton, DJ				Ridley, Caroline; Kouvatsos, Nikos; Raynal, Bertrand D.; Howard, Marj; Collins, Richard F.; Desseyn, Jean-Luc; Jowitt, Thomas A.; Baldock, Clair; Davis, C. William; Hardingham, Timothy E.; Thornton, David J.			Assembly of the Respiratory Mucin MUC5B A NEW MODEL FOR A GEL-FORMING MUCIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; CYSTIC-FIBROSIS; HYDRODYNAMIC PROPERTIES; MOLECULAR-MECHANISM; ELECTRON-MICROSCOPY; TERMINAL DOMAINS; INTESTINAL MUCIN; MUCUS; SECRETION; CALCIUM	Mucins are essential components in mucus gels that form protective barriers at all epithelial surfaces, but much remains unknown about their assembly, intragranular organization, and post-secretion unfurling to form mucus. MUC5B is a major polymeric mucin expressed by respiratory epithelia, and we investigated the molecular mechanisms involved during its assembly. Studies of intact polymeric MUC5B revealed a single high affinity calcium-binding site, distinct from multiple low affinity sites on each MUC5B monomer. Self-diffusion studies with intact MUC5B showed that calcium binding at the protein site catalyzed reversible cross-links between MUC5B chains to form networks. The site of cross-linking was identified in the MUC5B D3-domain as it was specifically blocked by D3 peptide antibodies. Biophysical analysis and single particle EM of recombinant MUC5B N terminus (D1D2D'D3; NT5B) and subdomains (D1, D1-D2, D2-D'-D3, and D3) generated structural models of monomers and disulfide-linked dimers and suggested that MUC5B multimerizes by disulfide linkage between D3-domains to form linear polymer chains. Moreover, these analyses revealed reversible homotypic interactions of NT5B at low pH and in high calcium, between disulfide-linked NT5B dimers, but not monomers. These results enable a model of MUC5B to be derived, which predicts mechanisms of mucin intracellular assembly and storage, which may be common to the other major gel-forming polymeric mucins.	[Ridley, Caroline; Kouvatsos, Nikos; Raynal, Bertrand D.; Howard, Marj; Jowitt, Thomas A.; Baldock, Clair; Hardingham, Timothy E.; Thornton, David J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Ridley, Caroline; Kouvatsos, Nikos; Raynal, Bertrand D.; Howard, Marj; Collins, Richard F.; Jowitt, Thomas A.; Baldock, Clair; Hardingham, Timothy E.; Thornton, David J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Desseyn, Jean-Luc] Univ Lille, INSERM, U995, F-59045 Lille, France; [Davis, C. William] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27517 USA	University of Manchester; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of North Carolina; University of North Carolina Chapel Hill	Thornton, DJ (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	dave.thornton@manchester.ac.uk	Desseyn, Jean-Luc/M-5070-2018	Desseyn, Jean-Luc/0000-0001-6876-8049; Baldock, Clair/0000-0003-3497-1959; Hardingham, Timothy/0000-0001-8271-6763; Jowitt, Thomas/0000-0002-4045-0933; raynal, Bertrand/0000-0001-5634-0408; Ridley, Caroline/0000-0002-5483-0320; Thornton, David/0000-0001-7148-1970; Kouvatsos, Nikolaos/0000-0003-0425-1141	Cystic Fibrosis Foundation Therapeutics [THORNT07XXX0]; Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust [088785/Z/09/Z]; Biotechnology and Biological Sciences Research Council [BB/D522389/1] Funding Source: researchfish; BBSRC [BB/D522389/1] Funding Source: UKRI	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from Cystic Fibrosis Foundation Therapeutics (THORNT07XXX0) and Biotechnology and Biological Sciences Research Council (BBSRC). The Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, is supported by core funding from the Wellcome Trust (088785/Z/09/Z).	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Asker N, 1998, BIOCHEM J, V335, P381, DOI 10.1042/bj3350381; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Collins RF, 2013, BIOCHEM J, V450, P417, DOI 10.1042/BJ20121599; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; de la Torre JG, 2001, EUR BIOPHYS J BIOPHY, V30, P457, DOI 10.1007/s002490100176; Desseyn JL, 1998, J BIOL CHEM, V273, P30157, DOI 10.1074/jbc.273.46.30157; FORSTNER JF, 1976, PEDIATR RES, V10, P609, DOI 10.1203/00006450-197606000-00009; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; GUM JR, 1994, J BIOL CHEM, V269, P2440; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Kuver R, 2004, BIOCHEM BIOPH RES CO, V314, P330, DOI 10.1016/j.bbrc.2003.12.088; Kuver R, 2000, GLYCOBIOLOGY, V10, P149, DOI 10.1093/glycob/10.2.149; Perez-Vilar J, 2006, J BIOL CHEM, V281, P4844, DOI 10.1074/jbc.M510520200; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; PerezVilar J, 1996, J BIOL CHEM, V271, P9845, DOI 10.1074/jbc.271.16.9845; Quinton PM, 2010, AM J PHYSIOL-LUNG C, V298, pL13, DOI 10.1152/ajplung.00358.2009; Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200; Raynal BDE, 2002, BIOCHEM J, V362, P289, DOI 10.1042/0264-6021:3620289; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Rogers DF, 2004, CURR OPIN PHARMACOL, V4, P241, DOI 10.1016/j.coph.2004.01.011; Round AN, 2004, J STRUCT BIOL, V145, P246, DOI 10.1016/j.jsb.2003.10.029; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; SHEEHAN JK, 1995, AM J RESP CELL MOL, V13, P748, DOI 10.1165/ajrcmb.13.6.7576713; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Thornton DJ, 1997, J BIOL CHEM, V272, P9561; Thornton DJ, 2000, AM J PHYSIOL-LUNG C, V278, pL1118, DOI 10.1152/ajplung.2000.278.6.L1118; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; VERDUGO P, 1987, BIORHEOLOGY, V24, P625; VERDUGO P, 1987, J DENT RES, V66, P506, DOI 10.1177/00220345870660022001; Verdugo P, 2012, P NATL ACAD SCI USA, V109, pE2956, DOI 10.1073/pnas.1211117109; VISCHER UM, 1994, BLOOD, V83, P3536; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	45	65	66	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16409	16420		10.1074/jbc.M114.566679	http://dx.doi.org/10.1074/jbc.M114.566679			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778189	Green Published, hybrid			2022-12-28	WOS:000337965700043
J	Soares, RJ; Cagnin, S; Chemello, F; Silvestrin, M; Musaro, A; De Pitta, C; Lanfranchi, G; Sandri, M				Soares, Ricardo Jose; Cagnin, Stefano; Chemello, Francesco; Silvestrin, Matteo; Musaro, Antonio; De Pitta, Cristiano; Lanfranchi, Gerolamo; Sandri, Marco			Involvement of MicroRNAs in the Regulation of Muscle Wasting during Catabolic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YIN YANG 1; SKELETAL-MUSCLE; IN-VIVO; UBIQUITIN-PROTEASOME; ATROPHY INVOLVE; GENE-EXPRESSION; AUTOPHAGY; TRANSCRIPTION; DENERVATION; MICE	Loss of muscle proteins and the consequent weakness has important clinical consequences in diseases such as cancer, diabetes, chronic heart failure, and in aging. In fact, excessive proteolysis causes cachexia, accelerates disease progression, and worsens life expectancy. Muscle atrophy involves a common pattern of transcriptional changes in a small subset of genes named atrophy-related genes or atrogenes. Whether microRNAs play a role in the atrophy program and muscle loss is debated. To understand the involvement of miRNAs in atrophy we performed miRNA expression profiling of mouse muscles under wasting conditions such as fasting, denervation, diabetes, and cancer cachexia. We found that the miRNA signature is peculiar of each catabolic condition. We then focused on denervation and we revealed that changes in transcripts and microRNAs expression did not occur simultaneously but were shifted. Indeed, whereas transcriptional control of the atrophy-related genes peaks at 3 days, changes of miRNA expression maximized at 7 days after denervation. Among the different miRNAs, microRNA-206 and -21 were the most induced in denervated muscles. We characterized their pattern of expression and defined their role in muscle homeostasis. Indeed, in vivo gain and loss of function experiments revealed that miRNA-206 and miRNA-21 were sufficient and required for atrophy program. In silico and in vivo approaches identified transcription factor YY1 and the translational initiator factor eIF4E3 as downstream targets of these miRNAs. Thus miRNAs are important for finetuning the atrophy program and their modulation can be a novel potential therapeutic approach to counteract muscle loss and weakness in catabolic conditions.	[Soares, Ricardo Jose; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Sandri, Marco] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Cagnin, Stefano; Chemello, Francesco; Silvestrin, Matteo; De Pitta, Cristiano; Lanfranchi, Gerolamo] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Cagnin, Stefano; Chemello, Francesco; Silvestrin, Matteo; De Pitta, Cristiano; Lanfranchi, Gerolamo] Univ Padua, CRIBI Biotechnol Ctr, I-35121 Padua, Italy; [Soares, Ricardo Jose] Univ Coimbra, PhD Programme Expt Biol & Biomedicine, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Sandri, Marco] CNR, Inst Neurosci, I-35121 Padua, Italy; [Musaro, Antonio] Univ Roma La Sapienza, DAHFMO Unit Histol & Med Embryol, I-00161 Rome, Italy; [Sandri, Marco] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Padua; University of Padua; University of Padua; Universidade de Coimbra; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	De Pitta, C (corresponding author), Univ Padua, Dept Biol, Via Trieste 75, I-35121 Padua, Italy.	cristiano.depitta@unipd.it; gerolamo.lanfranchi@unipd.it; marco.sandri@unipd.it	Musarò, Antonio/K-9598-2016; cagnin, stefano/E-9095-2011; Chemello, Francesco/ABB-3801-2020; De Pitta, Cristiano/AAY-7302-2020; Ribeiro Soares, Ricardo Jose/M-9706-2015; Musaro, Antonio/P-2953-2019	Musarò, Antonio/0000-0002-2944-9739; cagnin, stefano/0000-0001-7271-4625; De Pitta, Cristiano/0000-0001-8013-8162; Ribeiro Soares, Ricardo Jose/0000-0002-0457-6862; Musaro, Antonio/0000-0002-2944-9739; Chemello, Francesco/0000-0002-3877-527X	Telethon-Italy [TCP04009]; European Research Council (ERC) [282310-MyoPHAGY]; Progetti di Ricerca di Ateneo of University of Padova; Foundation Leducq; CARIPARO; "Bolsa de Doutoramento" of the "Fundacao para a Ciencia e Tecnologia" [SFRH/BD/15890/2005]; Association Francaise contre les Myopathies [14724]	Telethon-Italy(Fondazione Telethon); European Research Council (ERC)(European Research Council (ERC)); Progetti di Ricerca di Ateneo of University of Padova; Foundation Leducq(Leducq Foundation); CARIPARO(Fondazione Cariparo); "Bolsa de Doutoramento" of the "Fundacao para a Ciencia e Tecnologia"; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported in part by Telethon-Italy Grant TCP04009, European Research Council (ERC) Grant 282310-MyoPHAGY, Progetti di Ricerca di Ateneo of University of Padova, Foundation Leducq, and CARIPARO (to M. S.).; Recipient of a "Bolsa de Doutoramento" of the "Fundacao para a Ciencia e Tecnologia" Grant SFRH/BD/15890/2005 and a fellow from the Association Francaise contre les Myopathies (Grant 14724).	Adams GR, 2007, J APPL PHYSIOL, V103, P1644, DOI 10.1152/japplphysiol.00669.2007; Agarwal P, 2013, BBA-MOL BASIS DIS, V1832, P1294, DOI 10.1016/j.bbadis.2013.03.021; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blattler SM, 2012, MOL CELL BIOL, V32, P3333, DOI 10.1128/MCB.00337-12; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chemello F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016807; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hsieh CH, 2011, J TRAUMA, V70, P472, DOI 10.1097/TA.0b013e3181e634ce; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeng SF, 2009, J NEUROTRAUM, V26, P2345, DOI 10.1089/neu.2009.0960; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Koning M, 2012, DIFFERENTIATION, V84, P314, DOI 10.1016/j.diff.2012.08.002; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Luo W, 2013, J GENET GENOMICS, V40, P107, DOI 10.1016/j.jgg.2013.02.002; Lynch GS, 2007, PHARMACOL THERAPEUT, V113, P461, DOI 10.1016/j.pharmthera.2006.11.004; Magnusson C, 2005, EUR J NEUROSCI, V21, P577, DOI 10.1111/j.1460-9568.2005.03855.x; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Raffaello A, 2006, PHYSIOL GENOMICS, V25, P60, DOI 10.1152/physiolgenomics.00051.2005; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Romualdi C, 2005, NUCLEIC ACIDS RES, V33, pW644, DOI 10.1093/nar/gki497; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; SCHIAFFINO S, 1972, J ULTRA MOL STRUCT R, V39, P1, DOI 10.1016/S0022-5320(72)80002-9; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen H, 2013, MOL CELL BIOCHEM, V381, P105, DOI 10.1007/s11010-013-1692-9; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaccaro MI, 2008, AUTOPHAGY, V4, P388, DOI 10.4161/auto.5656; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Winbanks CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073589; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Zacharewicz E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00266	64	107	112	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21909	21925		10.1074/jbc.M114.561845	http://dx.doi.org/10.1074/jbc.M114.561845			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24891504	hybrid, Green Published			2022-12-28	WOS:000340593500009
J	Mamais, A; Chia, R; Beilina, A; Hauser, DN; Hall, C; Lewis, PA; Cookson, MR; Bandopadhyay, R				Mamais, Adamantios; Chia, Ruth; Beilina, Alexandra; Hauser, David N.; Hall, Christine; Lewis, Patrick A.; Cookson, Mark R.; Bandopadhyay, Rina			Arsenite Stress Down-regulates Phosphorylation and 14-3-3 Binding of Leucine-rich Repeat Kinase 2 (LRRK2), Promoting Self-association and Cellular Redistribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE PATHOLOGY; G2019S MUTATION; GTP-BINDING; ROC DOMAIN; INHIBITION; PROTEINS; LEUCINE-RICH-REPEAT-KINASE-2; LOCALIZATION; DEGRADATION; ACTIVATION	Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are a common genetic cause of Parkinson disease, but the mechanisms whereby LRRK2 is regulated are unknown. Phosphorylation of LRRK2 at Ser(910)/Ser(935) mediates interaction with 14-3-3. Pharmacological inhibition of its kinase activity abolishes Ser(910)/Ser(935) phosphorylation and 14-3-3 binding, and this effect is also mimicked by pathogenic mutations. However, physiological situations where dephosphorylation occurs have not been defined. Here, we show that arsenite or H2O2-induced stresses promote loss of Ser(910)/Ser(935) phosphorylation, which is reversed by phosphatase inhibition. Arsenite-induced dephosphorylation is accompanied by loss of 14-3-3 binding and is observed in wild type, G2019S, and kinase-dead D2017A LRRK2. Arsenite stress stimulates LRRK2 self-association and association with protein phosphatase 1 alpha, decreases kinase activity and GTP binding in vitro, and induces translocation of LRRK2 to centrosomes. Our data indicate that signaling events induced by arsenite and oxidative stress may regulate LRRK2 function.	[Mamais, Adamantios; Bandopadhyay, Rina] UCL, Inst Neurol, Reta Lila Weston Inst Neurol Studies, London WC1N 1PJ, England; [Mamais, Adamantios; Hall, Christine; Lewis, Patrick A.; Bandopadhyay, Rina] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BJ, England; [Mamais, Adamantios; Chia, Ruth; Beilina, Alexandra; Hauser, David N.; Cookson, Mark R.] NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Chia, Ruth] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Hauser, David N.] Brown Univ, Dept Neurosci, Natl Inst Hlth Grad Partnership Program, Providence, RI 02912 USA; [Lewis, Patrick A.] Univ Reading, Sch Pharm, Reading RG6 6AP, Berks, England	University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Georgetown University; Brown University; National Institutes of Health (NIH) - USA; University of Reading	Mamais, A (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	adamantios.mamais@nih.gov; rina.bandopadhyay@ucl.ac.uk	Chia, Ruth/AAF-4900-2021; Hauser, David/I-4933-2012; Hauser, David/AAJ-1536-2020; Cookson, Mark/AAW-2516-2021; Bandopadhyay, Rina/C-7926-2009	Chia, Ruth/0000-0002-4709-7423; Hauser, David/0000-0002-9500-5255; Cookson, Mark/0000-0002-1058-3831; Mamais, Adamantios/0000-0002-5546-7084; Lewis, Patrick/0000-0003-4537-0489	National Institutes of Health, NIA, Intramural Research Program; Michael J. Fox Foundation; Reta Lila Weston Institute of Neurological Studies; Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award [WT089698]; Medical Research Council [MR/L010933/1, MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [F-1002] Funding Source: researchfish; MRC [MR/L010933/1, MC_G1000735] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [ZIAAG000948] Funding Source: NIH RePORTER	National Institutes of Health, NIA, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Michael J. Fox Foundation; Reta Lila Weston Institute of Neurological Studies; Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health, NIA, Intramural Research Program. This work was also supported by grants from the Michael J. Fox Foundation (to R. B. and P. A. L.), funding from the Reta Lila Weston Institute of Neurological Studies, and the Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award (Grant WT089698) to the UK Parkinson's Disease Consortium whose members are from the University College London Institute of Neurology, the University of Sheffield, and the MRC Protein Phosphorylation Unit at the University of Dundee.	Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Biosa A, 2013, HUM MOL GENET, V22, P1140, DOI 10.1093/hmg/dds522; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; BOND U, 1988, J BIOL CHEM, V263, P2384; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Caesar M, 2013, NEUROBIOL DIS, V54, P280, DOI 10.1016/j.nbd.2012.12.019; Civiero L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043472; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Dzamko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039132; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Halliday G, 2011, MOVEMENT DISORD, V26, P1015, DOI 10.1002/mds.23669; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Ito G, 2012, BIOCHEM J, V441, P987, DOI 10.1042/BJ20111215; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; James NG, 2012, BIOPHYS J, V102, pA41, DOI 10.1016/j.bpj.2012.04.046; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Jung DK, 2003, EXP CELL RES, V290, P144, DOI 10.1016/S0014-4827(03)00320-3; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; KENNEY LJ, 1988, J BIOL CHEM, V263, P7954; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Korecka JA, 2013, RESTOR NEUROL NEUROS, V31, P155, DOI 10.3233/RNN-110222; Li XJ, 2010, J BIOL CHEM, V285, P29569, DOI 10.1074/jbc.M110.127639; Lobbestael E, 2013, BIOCHEM J, V456, P119, DOI 10.1042/BJ20121772; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Papkovskaia TD, 2012, HUM MOL GENET, V21, P4201, DOI 10.1093/hmg/dds244; Pungaliya PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013672; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Roussel RR, 2000, ARCH BIOCHEM BIOPHYS, V377, P204, DOI 10.1006/abbi.2000.1770; Rudenko IN, 2012, BIOCHEM J, V446, P99, DOI 10.1042/BJ20120637; Samikkannu T, 2003, CHEM RES TOXICOL, V16, P409, DOI 10.1021/tx025615j; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Taymans JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023207; Waxman EA, 2009, J NEUROPATH EXP NEUR, V68, P785, DOI 10.1097/NEN.0b013e3181aaf4fd; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Wigley WC, 1999, J CELL BIOL, V145, P481; Yuan SS, 2003, TOXICOL IN VITRO, V17, P139, DOI 10.1016/S0887-2333(02)00129-7; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	66	29	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21386	21400		10.1074/jbc.M113.528463	http://dx.doi.org/10.1074/jbc.M113.528463			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942733	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000340558300018
J	Eisenstein, A; Carroll, SH; Johnston-Cox, H; Farb, M; Gokce, N; Ravid, K				Eisenstein, Anna; Carroll, Shannon H.; Johnston-Cox, Hillary; Farb, Melissa; Gokce, Noyan; Ravid, Katya			An Adenosine Receptor-Kruppel-like Factor 4 Protein Axis Inhibits Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; BINDING PROTEIN; GENE-EXPRESSION; ALPHA-SUBUNIT; 3T3-L1 CELLS; INSULIN-RESISTANCE; BONE MARROW; STEM-CELLS	Adipogenesis represents a key process in adipose tissue development and remodeling, including during obesity. Exploring the regulation of adipogenesis by extracellular ligands is fundamental to our understanding of this process. Adenosine, an extracellular nucleoside signaling molecule found in adipose tissue depots, acts on adenosine receptors. Here we report that, among these receptors, the A2b adenosine receptor (A2bAR) is highly expressed in adipocyte progenitors. Activation of the A2bAR potently inhibits differentiation of mouse stromal vascular cells into adipocytes, whereas A2bAR knockdown stimulates adipogenesis. The A2bAR inhibits differentiation through a novel signaling cascade involving sustained expression of Kruppel-like factor 4 (KLF4), a regulator of stem cell maintenance. Knockdown of KLF4 ablates the ability of the A2bAR to inhibit differentiation. A2bAR activation also inhibits adipogenesis in a human primary preadipocyte culture system. We analyzed the A2bAR-KLF4 axis in adipose tissue of obese subjects and, intriguingly, found a strong correlation between A2bAR and KLF4 expression in both subcutaneous and visceral human fat. Hence, our study implicates the A2bAR as a regulator of adipocyte differentiation and the A2bAR-KLF4 axis as a potentially significant modulator of adipose biology.	[Eisenstein, Anna; Johnston-Cox, Hillary; Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Carroll, Shannon H.; Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Eisenstein, Anna; Johnston-Cox, Hillary; Farb, Melissa; Gokce, Noyan; Ravid, Katya] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Ravid, Katya] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Ravid, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med,CVI, 700 Albany St,W-601, Boston, MA 02118 USA.	kravid@bu.edu			NHLBI, National Institutes of Health [HL93149]; National Institutes of Health [R01HL114675-02]; Boston Nutrition Obesity Research Center Pilot [DK046200]; NIDDK, National Institutes of Health NRSA F30 [DK098834]; National Institutes of Health Cardiovascular Training Grant [HL007969]; American Heart Association [12POST11780028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114675, R01HL093149, T32HL007969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK098834, P30DK046200] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Nutrition Obesity Research Center Pilot; NIDDK, National Institutes of Health NRSA F30; National Institutes of Health Cardiovascular Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant HL93149 (to K. R.) and National Institutes of Health Grant R01HL114675-02) (to N. G.). This work was also supported by Boston Nutrition Obesity Research Center Pilot Grant DK046200 (to K. R.).; Supported by NIDDK, National Institutes of Health NRSA F30 award DK098834.; Supported by National Institutes of Health Cardiovascular Training Grant HL007969.; Supported by American Heart Association Postdoctoral Fellowship Grant 12POST11780028.	Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Borglum JD, 1996, MOL CELL ENDOCRINOL, V117, P17, DOI 10.1016/0303-7207(95)03728-4; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carroll SH, 2012, J BIOL CHEM, V287, P15718, DOI 10.1074/jbc.M112.344994; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Denis-Henriot D, 1998, ENDOCRINOLOGY, V139, P2892, DOI 10.1210/en.139.6.2892; DIGIROLAMO M, 1971, AM J PHYSIOL, V221, P850, DOI 10.1152/ajplegacy.1971.221.3.850; Eisenstein A, 2014, J CELL PHYSIOL, V229, P414, DOI 10.1002/jcp.24473; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Farb MG, 2011, J AM COLL CARDIOL, V58, P232, DOI 10.1016/j.jacc.2011.01.051; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fox KE, 2008, J BIOL CHEM, V283, P35096, DOI 10.1074/jbc.M806423200; Fox KE, 2006, J BIOL CHEM, V281, P40341, DOI 10.1074/jbc.M605077200; Fredholm B B, 1976, Acta Physiol Scand, V96, P122; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; FREDHOLM BB, 1981, J PHYSIOL-LONDON, V313, P351, DOI 10.1113/jphysiol.1981.sp013670; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Gao ZG, 2011, EXPERT OPIN EMERG DR, V16, P597, DOI 10.1517/14728214.2011.644786; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Graham SJL, 2009, DIFFERENTIATION, V77, P239, DOI 10.1016/j.diff.2008.10.013; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hausman Dorothy B., 2008, V456, P201, DOI 10.1007/978-1-59745-245-8_15; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Johnston-Cox H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040584; Kawai M, 2009, NAT REV RHEUMATOL, V5, P365, DOI 10.1038/nrrheum.2009.102; Kim Y, 2013, LIPIDS, V48, P787, DOI 10.1007/s11745-013-3803-5; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Koupenova M, 2012, CIRCULATION, V125, P354, DOI 10.1161/CIRCULATIONAHA.111.057596; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEBARON FN, 1956, J NEUROCHEM, V1, P101, DOI 10.1111/j.1471-4159.1956.tb12060.x; Lee MJ, 2012, OBESITY, V20, P2334, DOI 10.1038/oby.2012.116; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Linden J, 1999, MOL PHARMACOL, V56, P705; Liu XX, 1998, J BIOL CHEM, V273, P11685, DOI 10.1074/jbc.273.19.11685; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Ntambi JM, 1996, DIFFERENTIATION, V60, P151, DOI 10.1007/s002580050145; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROZMAN C, 1989, EXP HEMATOL, V17, P34; Saulnier N, 2011, CYTOTHERAPY, V13, P329, DOI 10.3109/14653249.2010.515576; SCHWABE U, 1973, N-S ARCH PHARMACOL, V276, P133, DOI 10.1007/BF00501186; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Tang Y, 1999, DIABETES, V48, P1830, DOI 10.2337/diabetes.48.9.1830; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tuominen JT, 1999, DIABETES CARE, V22, P1196, DOI 10.2337/diacare.22.7.1196; VASSAUX G, 1993, BIOCHEM BIOPH RES CO, V193, P1123, DOI 10.1006/bbrc.1993.1742; Vroegrijk IOCM, 2013, OBESITY, V21, P2037, DOI 10.1002/oby.20354; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; Wang HY, 1999, J BIOL CHEM, V274, P32159, DOI 10.1074/jbc.274.45.32159; Wang HY, 1996, J BIOL CHEM, V271, P22022, DOI 10.1074/jbc.271.36.22022; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yu G, 2011, METHODS MOL BIOL, V702, P193, DOI 10.1007/978-1-61737-960-4_14; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhang L, 2009, J ENDOCRINOL, V202, P207, DOI 10.1677/JOE-09-0099; Zhang Y, 2002, J CELL BIOCHEM, V85, P523, DOI 10.1002/jcb.10141	69	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21071	21081		10.1074/jbc.M114.566406	http://dx.doi.org/10.1074/jbc.M114.566406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928509	Green Published, hybrid			2022-12-28	WOS:000339396600058
J	Morales, JF; Morin, TJ; Yu, B; Tatsuno, GP; O'Rourke, SM; Theolis, R; Mesa, KA; Berman, PW				Morales, Javier F.; Morin, Trevor J.; Yu, Bin; Tatsuno, Gwen P.; O'Rourke, Sara M.; Theolis, Richard, Jr.; Mesa, Kathryn A.; Berman, Phillip W.			HIV-1 Envelope Proteins and V1/V2 Domain Scaffolds with Mannose-5 to Improve the Magnitude and Quality of Protective Antibody Responses to HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BROADLY NEUTRALIZING ANTIBODIES; VACCINE EFFICACY TRIAL; MONOCLONAL-ANTIBODIES; RECOMBINANT GLYCOPROTEIN-120; POTENT NEUTRALIZATION; SYNTHETIC GLYCOPEPTIDES; TYPE-1 INFECTION; CD4-BINDING SITE; STRUCTURAL BASIS	Two lines of investigation have highlighted the importance of antibodies to the V1/V2 domain of gp120 in providing protection from HIV-1 infection. First, the recent RV144 HIV-1 vaccine trial documented a correlation between non-neutralizing antibodies to the V2 domain and protection. Second, multiple broadly neutralizing monoclonal antibodies to the V1/V2 domain (e. g. PG9) have been isolated from rare infected individuals, termed elite neutralizers. Interestingly, the binding of both types of antibodies appears to depend on the same cluster of amino acids (positions 167-171) adjacent to the junction of the B and C strands of the four-stranded V1/V2 domain beta-sheet structure. However, the broadly neutralizing mAb, PG9, additionally depends on mannose-5 glycans at positions 156 and 160 for binding. Because the gp120 vaccine immunogens used in previous HIV-1 vaccine trials were enriched for complex sialic acid-containing glycans, and lacked the high mannose structures required for the binding of PG9-like mAbs, we wondered if these immunogens could be improved by limiting glycosylation to mannose-5 glycans. Here, we describe the PG9 binding activity of monomeric gp120s from multiple strains of HIV-1 produced with mannose-5 glycans. We also describe the properties of glycopeptide scaffolds from the V1/V2 domain also expressed with mannose-5 glycans. The V1/V2 scaffold from the A244 isolate was able to bind the PG9, CH01, and CH03 mAbs with high affinity provided that the proper glycans were present. We further show that immunization with A244 V1/V2 fragments alone, or in a prime/boost regimen with gp120, enhanced the antibody response to sequences in the V1/V2 domain associated with protection in the RV144 trial.	[Morales, Javier F.; Morin, Trevor J.; Yu, Bin; Tatsuno, Gwen P.; O'Rourke, Sara M.; Theolis, Richard, Jr.; Mesa, Kathryn A.; Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Berman, PW (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, 1156 High St,MS SOE2, Santa Cruz, CA 95064 USA.	pwb@soe.ucsc.edu			National Institutes of Health from NIAID [R01 AI 089378-01]; National Institute on Drug Abuse [R01 DA 26801-01A1]; Henry Jackson Foundation [683948]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026801] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Henry Jackson Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI 089378-01 from NIAID and R01 DA 26801-01A1 from National Institute on Drug Abuse. This work was also supported by Grant 683948 from the Henry Jackson Foundation.	Alam SM, 2013, P NATL ACAD SCI USA, V110, P18214, DOI 10.1073/pnas.1317855110; Alam SM, 2013, J VIROL, V87, P1554, DOI 10.1128/JVI.00718-12; Amin MN, 2013, NAT CHEM BIOL, V9, P521, DOI 10.1038/nchembio.1288; ANDERSON KP, 1989, J INFECT DIS, V160, P960, DOI 10.1093/infdis/160.6.960; Andersson KM, 2011, VACCINE, V29, P6092, DOI 10.1016/j.vaccine.2011.06.060; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Aussedat B, 2013, J AM CHEM SOC, V135, P13113, DOI 10.1021/ja405990z; Beddows S, 1998, J GEN VIROL, V79, P77, DOI 10.1099/0022-1317-79-1-77; Beddows S, 2005, VIROLOGY, V337, P136, DOI 10.1016/j.virol.2005.03.033; BELSHE RB, 1994, JAMA-J AM MED ASSOC, V272, P475, DOI 10.1001/jama.272.6.475; Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; Berman PW, 1997, J INFECT DIS, V176, P384, DOI 10.1086/514055; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Euler Z, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00215; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Excler JL, 2013, CURR OPIN HIV AIDS, V8, P421, DOI 10.1097/COH.0b013e3283632c26; FISCHINGER PJ, 1985, CANCER RES, V45, P4694; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; FRANCIS DP, 1985, NEW ENGL J MED, V313, P1586, DOI 10.1056/NEJM198512193132506; Gilbert PB, 1998, BIOMETRICS, V54, P799, DOI 10.2307/2533835; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Go EP, 2011, INT J MASS SPECTROM, V305, P209, DOI 10.1016/j.ijms.2010.11.009; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Haynes BF, 2013, CURR OPIN HIV AIDS, V8, P326, DOI 10.1097/COH.0b013e328361d178; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Koff WC, 2012, VACCINE, V30, P4310, DOI 10.1016/j.vaccine.2011.11.014; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Long EF, 2011, VACCINE, V29, P6113, DOI 10.1016/j.vaccine.2011.04.013; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; Migasena S, 2000, AIDS RES HUM RETROV, V16, P655, DOI 10.1089/088922200308882; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; MORIKAWA Y, 1990, AIDS RES HUM RETROV, V6, P765, DOI 10.1089/aid.1990.6.765; Nakamura GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039045; NAKAMURA GR, 1993, J VIROL, V67, P6179, DOI 10.1128/JVI.67.10.6179-6191.1993; Nature Publishing Group, 1985, NATURE, V313, P254; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; O'Rourke SM, 2009, J VIROL, V83, P7728, DOI 10.1128/JVI.00688-09; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WANG YH, 1995, VIROLOGY, V208, P142, DOI 10.1006/viro.1995.1137; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903; Yu B, 2010, J VIROL, V84, P1513, DOI 10.1128/JVI.01765-09; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629	98	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20526	20542		10.1074/jbc.M114.554089	http://dx.doi.org/10.1074/jbc.M114.554089			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24872420	hybrid, Green Published			2022-12-28	WOS:000339396600014
J	Barucker, C; Harmeier, A; Weiske, J; Fauler, B; Albring, KF; Prokop, S; Hildebrand, P; Lurz, R; Heppner, FL; Huber, O; Multhaup, G				Barucker, Christian; Harmeier, Anja; Weiske, Joerg; Fauler, Beatrix; Albring, Kai Frederik; Prokop, Stefan; Hildebrand, Peter; Lurz, Rudi; Heppner, Frank L.; Huber, Otmar; Multhaup, Gerhard			Nuclear Translocation Uncovers the Amyloid Peptide A beta 42 as a Regulator of Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; APOLIPOPROTEIN-E; DIFFERENTIAL REGULATION; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; TRANSGENIC MICE; HUMAN BRAIN; CELL-DEATH	Although soluble species of the amyloid-beta peptide A beta 42 correlate with disease symptoms in Alzheimer disease, little is known about the biological activities of amyloid-beta (A beta). Here, we show that A beta peptides varying in lengths from 38 to 43 amino acids are internalized by cultured neuroblastoma cells and can be found in the nucleus. By three independent methods, we demonstrate direct detection of nuclear A beta 42 as follows: (i) biochemical analysis of nuclear fractions; (ii) detection of biotin-labeled A beta in living cells by confocal laser scanning microscopy; and (iii) transmission electron microscopy of A beta in cultured cells, as well as brain tissue of wild-type and transgenic APPPS1 mice (overexpression of amyloid precursor protein and presenilin 1 with Swedish and L166P mutations, respectively). Also, this study details a novel role for A beta 42 in nuclear signaling, distinct from the amyloid precursor protein intracellular domain. Chromatin immunoprecipitation showed that A beta 42 specifically interacts as a repressor of gene transcription with LRP1 and KAI1 promoters. By quantitative RT-PCR, we confirmed that mRNA levels of the examined candidate genes were exclusively decreased by the potentially neurotoxic A beta 42 wild-type peptide. Shorter peptides (A beta 38 or A beta 40) and other longer peptides (nontoxic A beta 42 G33A substitution or A beta 43) did not affect mRNA levels. Overall, our data indicate that the nuclear translocation of A beta 42 impacts gene regulation, and deleterious effects of A beta 42 in Alzheimer disease pathogenesis may be influenced by altering the expression profiles of disease-modifying genes.	[Barucker, Christian; Harmeier, Anja; Multhaup, Gerhard] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Barucker, Christian; Multhaup, Gerhard] McGill Univ, Dept Pharmacol & Therapeut, Fac Med, Montreal, PQ H3G 0B1, Canada; [Weiske, Joerg; Albring, Kai Frederik; Huber, Otmar] Charite Campus Benjamin Franklin, Inst Clin Chem & Pathobiochem, D-12203 Berlin, Germany; [Fauler, Beatrix; Lurz, Rudi] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Albring, Kai Frederik; Huber, Otmar] Univ Jena, Inst Biochem 2, Jena Univ Hosp, D-07743 Jena, Germany; [Prokop, Stefan; Heppner, Frank L.] Charite, Dept Neuropathol, D-10117 Berlin, Germany; [Hildebrand, Peter] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	Free University of Berlin; McGill University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Multhaup, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Fac Med, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	gerhard.multhaup@mcgill.ca	Heppner, Frank/ABH-8393-2020; Huber, Otmar/AAA-4548-2021; Prokop, Stefan/Y-1257-2019	Heppner, Frank/0000-0001-9816-8917; Huber, Otmar/0000-0003-4359-1747; Prokop, Stefan/0000-0002-5633-2149; Albring, Kai Frederik/0000-0003-3761-7533	Deutsche Forschungsgemeinschaft [SFB740, GRK1123, SFBTRR 43, NeuroCure Exc 257]; Kompetenznetz Degenerative Demenzen Forderkennzeichen Grant [01 GI 0723]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kompetenznetz Degenerative Demenzen Forderkennzeichen Grant	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB740 and GRK1123 (to G. M.), Kompetenznetz Degenerative Demenzen Forderkennzeichen Grant 01 GI 0723 (to G. M.), Deutsche Forschungsgemeinschaft grants (to F. L. H. and S. P.), and Deutsche Forschungsgemeinschaft Grant SFBTRR 43 and NeuroCure Exc 257 (to F. L. H.).	Aho L, 2010, J ALZHEIMERS DIS, V20, P1015, DOI 10.3233/JAD-2010-091681; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bailey JA, 2011, GENE, V488, P13, DOI 10.1016/j.gene.2011.06.017; Barrantes A, 2007, J ALZHEIMERS DIS, V12, P345; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; FRASER PE, 1991, J NEUROSCI RES, V28, P474, DOI 10.1002/jnr.490280404; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Ida N, 1996, FEBS LETT, V394, P174, DOI 10.1016/0014-5793(96)00948-9; Kaden D, 2012, EMBO MOL MED, V4, P647, DOI 10.1002/emmm.201200239; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maloney B, 2011, GENE, V488, P1, DOI 10.1016/j.gene.2011.06.004; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Riese F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076094; Rowe A, 2008, NEOPLASIA, V10, P1421, DOI 10.1593/neo.08850; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Uchida Y, 2007, J BIOL CHEM, V282, P19700, DOI 10.1074/jbc.M703099200; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wegiel J, 2007, ACTA NEUROPATHOL, V113, P389, DOI 10.1007/s00401-006-0191-4; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	64	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20182	20191		10.1074/jbc.M114.564690	http://dx.doi.org/10.1074/jbc.M114.564690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24878959	Green Published, hybrid			2022-12-28	WOS:000339395200031
J	Kumar, P; Tripathi, A; Ranjan, R; Halbert, J; Gilberger, T; Doerig, C; Sharma, P				Kumar, Praveen; Tripathi, Anuj; Ranjan, Ravikant; Halbert, Jean; Gilberger, Tim; Doerig, Christian; Sharma, Pushkar			Regulation of Plasmodium falciparum Development by Calcium-dependent Protein Kinase 7 (PfCDPK7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE INVASION; MALARIA PARASITES; FOOD VACUOLE; HOST-CELL; LOCALIZATION; PATHWAY; EVENTS	Second messengers such as phosphoinositides and calcium are known to control diverse processes involved in the development of malaria parasites. However, the underlying molecular mechanisms and pathways need to be unraveled, which may be achieved by understanding the regulation of effectors of these second messengers. Calcium-dependent protein kinase (CDPK) family members regulate diverse parasitic processes. Because CDPKs are absent from the host, these kinases are considered as potential drug targets. We have dissected the function of an atypical CDPK from Plasmodium falciparum, PfCDPK7. The domain architecture of PfCDPK7 is very different from that of other CDPKs; it has a pleckstrin homology domain adjacent to the kinase domain and two calcium-binding EF-hands at its N terminus. We demonstrate that PfCDPK7 interacts with PI(4,5)P-2 via its pleckstrin homology domain, which may guide its subcellular localization. Disruption of PfCDPK7 caused a marked reduction in the growth of the blood stage parasites, as maturation of rings to trophozoites was markedly stalled. In addition, parasite proliferation was significantly attenuated. These findings shed light on an important role for PfCDPK7 in the erythrocytic asexual cycle of malaria parasites.	[Kumar, Praveen; Tripathi, Anuj; Ranjan, Ravikant; Sharma, Pushkar] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Halbert, Jean; Doerig, Christian] Ecole Polytech Fed Lausanne, Global Hlth Inst, Inserm EPFL Joint Lab, CH-1015 Lausanne, Switzerland; [Gilberger, Tim] McMaster Univ, Dept Pathol & Mol Med, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4L8, Canada; [Gilberger, Tim] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Doerig, Christian] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; McMaster University; Bernhard Nocht Institut fur Tropenmedizin; Monash University	Sharma, P (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	pushkar@nii.ac.in	Kumar, Praveen/S-8449-2019; Ranjan, Ravikant/AAT-1000-2021; Doerig, Christian/Q-9900-2019	Ranjan, Ravikant/0000-0002-3997-4879; Gilberger, Tim-Wolf/0000-0002-7965-8272; Kumar, Praveen/0000-0002-9438-0731; Doerig, Christian/0000-0002-3188-094X	Department of Science and Technology (DST), India; MALSIG project - European Union; Department of Biotechnology (DBT), India; IR-BMBF (Federal Ministry of Education and Research), Germany [IND 09/024]; Council for Scientific and Industrial Research, India	Department of Science and Technology (DST), India(Department of Science & Technology (India)); MALSIG project - European Union; Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); IR-BMBF (Federal Ministry of Education and Research), Germany; Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a Swarnajayanti Fellowship Grant from Department of Science and Technology (DST), India (to P. S.), the MALSIG project funded by the European Union under FP7, and a Indo-German collaborative grant by Department of Biotechnology (DBT), India, and IR-BMBF (Federal Ministry of Education and Research) Grant IND 09/024, Germany (to P. S. and T. G.).; Supported by the Junior Research Fellowship by the Council for Scientific and Industrial Research, India.; Supported by the Senior Research Fellowship by the Council for Scientific and Industrial Research, India.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Baker DA, 2011, CELL MICROBIOL, V13, P331, DOI 10.1111/j.1462-5822.2010.01561.x; Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Dorin- Semblat D., 2013, KINOME, V1, P4, DOI DOI 10.2478/KIN0ME-2013-0001; Dorin-Semblat D, 2008, EUKARYOT CELL, V7, P279, DOI 10.1128/EC.00245-07; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leber W, 2009, INT J PARASITOL, V39, P645, DOI 10.1016/j.ijpara.2008.11.015; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; McIntosh MT, 2007, J BIOL CHEM, V282, P11499, DOI 10.1074/jbc.M610974200; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Morlon-Guyot J, 2014, CELL MICROBIOL, V16, P95, DOI 10.1111/cmi.12186; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sharma P, 2013, CURR OPIN MICROBIOL, V16, P432, DOI 10.1016/j.mib.2013.07.004; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657	27	32	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20386	20395		10.1074/jbc.M114.561670	http://dx.doi.org/10.1074/jbc.M114.561670			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895132	hybrid, Green Published			2022-12-28	WOS:000339395200049
J	Mnpotra, JS; Qiao, ZH; Cai, J; Lynch, DL; Grossfield, A; Leioatts, N; Hurst, DP; Pitman, MC; Song, ZH; Reggio, PH				Mnpotra, Jagjeet S.; Qiao, Zhuanhong; Cai, Jian; Lynch, Diane L.; Grossfield, Alan; Leioatts, Nicholas; Hurst, Dow P.; Pitman, Michael C.; Song, Zhao-Hui; Reggio, Patricia H.			Structural Basis of G Protein-coupled Receptor-G(i) Protein Interaction FORMATION OF THE CANNABINOID CB2 RECEPTOR-G(i) PROTEIN COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM CRYSTAL-STRUCTURE; LIGHT-ACTIVATED RHODOPSIN; BETA-GAMMA-SUBUNITS; ALPHA-SUBUNIT; CROSS-LINKING; MOLECULAR RECOGNITION; OPIOID RECEPTOR; LIGAND-BINDING; FORCE-FIELD; DYNAMICS	In this study, we applied a comprehensive G protein-coupled receptor-G alpha(i) protein chemical cross-linking strategy to map the cannabinoid receptor subtype 2 (CB2)-G alpha(i) interface and then used molecular dynamics simulations to explore the dynamics of complex formation. Three cross-link sites were identified using LC-MS/MS and electrospray ionization-MS/MS as follows: 1) a sulfhydryl cross-link between C3.53(134) in TMH3 and the G alpha(i) C-terminal i-3 residue Cys-351; 2) a lysine cross-link between K6.35(245) in TMH6 and the G alpha(i) C-terminal i-5 residue, Lys-349; and 3) a lysine cross-link between K5.64(215) in TMH5 and the G alpha(i) alpha(4)beta(6) loop residue, Lys-317. To investigate the dynamics and nature of the conformational changes involved in CB2 center dot G(i) complex formation, we carried out microsecond-time scale molecular dynamics simulations of the CB2 R*center dot G alpha(i1)beta(1)gamma(2) complex embedded in a 1-palmitoyl-2-oleoyl-phosphatidylcholine bilayer, using cross-linking information as validation. Our results show that although molecular dynamics simulations started with the G protein orientation in the beta 2-AR*center dot G alpha(s)beta(1)gamma(2) complex crystal structure, the G alpha(i1)beta(1)gamma(2) protein reoriented itself within 300 ns. Two major changes occurred as follows. 1) The G alpha(i1) alpha 5 helix tilt changed due to the outward movement of TMH5 in CB2 R*. 2) A 25 degrees clockwise rotation of G alpha(i1)beta(1)gamma(2) underneath CB2 R* occurred, with rotation ceasing when Pro-139 (IC-2 loop) anchors in a hydrophobic pocket on G alpha(i1) (Val-34, Leu-194, Phe-196, Phe-336, Thr-340, Ile-343, and Ile-344). In this complex, all three experimentally identified cross-links can occur. These findings should be relevant for other class A G protein-coupled receptors that couple to G(i) proteins.	[Hurst, Dow P.; Pitman, Michael C.; Reggio, Patricia H.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27402 USA; [Qiao, Zhuanhong; Cai, Jian; Song, Zhao-Hui] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Grossfield, Alan; Leioatts, Nicholas] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Pitman, Michael C.] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA	University of North Carolina; University of North Carolina Greensboro; University of Louisville; University of Rochester; International Business Machines (IBM)	Song, ZH (corresponding author), Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.	zhsong@louisville.edu; phreggio@uncg.edu		Grossfield, Alan/0000-0002-5877-2789; Leioatts, Nicholas/0000-0001-8847-8305	National Institutes of Health [DA011551, GM095496, DA003934, DA021358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003934, K05DA021358, R29DA011551, R01DA011551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA011551 (to Z. H. S.), GM095496 (to A. M. G.), and DA003934 and DA021358 (to P. H. R.).	Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bouaboula M, 1999, MOL PHARMACOL, V55, P473; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Feng WK, 2003, BIOCHEM PHARMACOL, V65, P1077, DOI 10.1016/S0006-2952(03)00005-4; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gara A, 2005, IBM J RES DEV, V49, P195, DOI 10.1147/rd.492.0195; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MORO O, 1993, J BIOL CHEM, V268, P22273; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Romo T., 2009, 31 ANN INT C IEEE EM, P2332, DOI DOI 10.1109/IEMBS.2009.5335065; SANFORD J, 1991, J BIOL CHEM, V266, P9570; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Slessareva JE, 2003, J BIOL CHEM, V278, P50530, DOI 10.1074/jbc.M304417200; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Storr M, 2002, CAN J PHYSIOL PHARM, V80, P67, DOI 10.1139/Y02-005; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Ulloa-Aguirre A, 2007, MOL CELL ENDOCRINOL, V260, P153, DOI 10.1016/j.mce.2005.11.050; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wright KL, 2008, BRIT J PHARMACOL, V153, P263, DOI 10.1038/sj.bjp.0707486; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yu ET, 2008, J PROTEOME RES, V7, P4848, DOI 10.1021/pr800443f; Zhang RD, 2007, PROTEIN EXPRES PURIF, V55, P225, DOI 10.1016/j.pep.2007.03.018; Zheng CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063262	67	25	25	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20259	20272		10.1074/jbc.M113.539916	http://dx.doi.org/10.1074/jbc.M113.539916			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24855641	Green Published, hybrid			2022-12-28	WOS:000339395200038
J	Yang, J; Singh, V; Chen, TE; Sarker, R; Xiong, L; Cha, B; Jin, S; Li, X; Tse, CM; Zachos, NC; Donowitz, M				Yang, Jianbo; Singh, Varsha; Chen, Tian-E; Sarker, Rafiquel; Xiong, Lishou; Cha, Boyoung; Jin, Shi; Li, Xuhang; Tse, C. Ming; Zachos, Nicholas C.; Donowitz, Mark			NHERF2/NHERF3 Protein Heterodimerization and Macrocomplex Formation Are Required for the Inhibition of NHE3 Activity by Carbachol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; NA+/H+ EXCHANGER NHE3; ILEAL BRUSH-BORDER; PDZ DOMAINS; SCAFFOLDING PROTEINS; CLASS-B; STIMULATION; TRAFFICKING; ASSOCIATION; COMPLEX	NHERF1, NHERF2, and NHERF3 belong to the NHERF (Na+/H+ exchanger regulatory factor) family of PSD-95/Discs-large/ZO-1 (PDZ) scaffolding proteins. Individually, each NHERF protein has been shown to be involved in the regulation of multiple receptors or transporters including Na+/H+ exchanger 3 (NHE3). Although NHERF dimerizations have been reported, results have been inconsistent, and the physiological function of NHERF dimerizations is still unknown. The current study semiquantitatively compared the interaction strength among all possible homodimerizations and heterodimerizations of these three NHERF proteins by pulldown and co-immunoprecipitation assays. Both methods showed that NHERF2 and NHERF3 heterodimerize as the strongest interaction among all NHERF dimerizations. In vivo NHERF2/NHERF3 heterodimerization was confirmed by FRET and FRAP (fluorescence recovery after photobleach). NHERF2/NHERF3 heterodimerization is mediated by PDZ domains of NHERF2 and the C-terminal PDZ domain recognition motif of NHERF3. The NHERF3-4A mutant is defective in heterodimerization with NHERF2 and does not support the inhibition of NHE3 by carbachol. This suggests a role for NHERF2/NHERF3 heterodimerization in the regulation of NHE3 activity. In addition, both PDZ domains of NHERF2 could be simultaneously occupied by NHERF3 and another ligand such as NHE3, alpha-actinin-4, and PKC alpha, promoting formation of NHE3 macrocomplexes. This study suggests that NHERF2/NHERF3 heterodimerization mediates the formation of NHE3 macrocomplexes, which are required for the inhibition of NHE3 activity by carbachol.	[Yang, Jianbo; Singh, Varsha; Chen, Tian-E; Sarker, Rafiquel; Xiong, Lishou; Cha, Boyoung; Jin, Shi; Li, Xuhang; Tse, C. Ming; Zachos, Nicholas C.; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Yang, Jianbo/G-1254-2013; Zachos, Nicholas/GWC-7914-2022	Jin, Shi/0000-0003-0177-5716	National Institutes of Health [P30DK089502]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084, R01DK061765, R01DK026523, K08DK088950, P30DK089502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mr. John Gibas (Johns Hopkins University) for technical assistance in performance of the FRET and FRAP studies. We thank Dr. Chris Yun (Emory University) for providing rabbit polyclonal antibody against NHERF2. We acknowledge use of the Kudsi Imaging Core Facility (National Institutes of Health Grant P30DK089502).	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Blaine J, 2011, ADV CHRONIC KIDNEY D, V18, P77, DOI 10.1053/j.ackd.2011.01.005; Cha BY, 2010, J CELL SCI, V123, P2434, DOI 10.1242/jcs.056713; Chang BH, 2011, CHEM BIOL, V18, P1143, DOI 10.1016/j.chembiol.2011.06.013; Chen MM, 2010, J PHYSIOL-LONDON, V588, P5049, DOI 10.1113/jphysiol.2010.198721; CHOUGH SP, 1993, YALE J BIOL MED, V66, P525; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; Cotton LM, 2010, MOL REPROD DEV, V77, P114, DOI 10.1002/mrd.21122; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; DONOWITZ M, 1989, J CLIN INVEST, V83, P1953, DOI 10.1172/JCI114104; DONOWITZ M, 1982, LIFE SCI, V31, P1929, DOI 10.1016/0024-3205(82)90031-5; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Lamprecht G, 2002, BIOCHEMISTRY-US, V41, P12336, DOI 10.1021/bi0259103; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Singh V, 2014, CLIN GASTROENTEROL H, V12, P27, DOI 10.1016/j.cgh.2013.10.020; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tsukamoto K, 2013, J BIOL CHEM, V288, P19845, DOI 10.1074/jbc.M113.460170; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yang JB, 2013, J BIOL CHEM, V288, P16960, DOI 10.1074/jbc.M113.470799; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641	50	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20039	20053		10.1074/jbc.M114.562413	http://dx.doi.org/10.1074/jbc.M114.562413			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24867958	hybrid, Green Published			2022-12-28	WOS:000339395200019
J	Chen, YY; Chen, JY; Yu, JJ; Yang, GZ; Temple, E; Harbinski, F; Gao, H; Wilson, C; Pagliarini, R; Zhou, WL				Chen, Yaoyu; Chen, Jinyun; Yu, Jianjun; Yang, Guizhi; Temple, Emilia; Harbinski, Fred; Gao, Hui; Wilson, Christopher; Pagliarini, Raymond; Zhou, Wenlai			Identification of Mixed Lineage Leukemia 1(MLL1) Protein as a Coactivator of Heat Shock Factor 1(HSF1) Protein in Response to Heat Shock Protein 90 (HSP90) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3K4 METHYLTRANSFERASE ACTIVITY; MLL; GENE; COMPLEX; MENIN; EXPRESSION; HSF1; PHOSPHORYLATION; DEGRADATION; EXECUTION	Heat shock protein 90 (HSP90) inhibition inhibits cancer cell proliferation through depleting client oncoproteins and shutting down multiple oncogenic pathways. Therefore, it is an attractive strategy for targeting human cancers. Several HSP90 inhibitors, including AUY922 and STA9090, show promising effects in clinical trials. However, the efficacy of HSP90 inhibitors may be limited by heat shock factor 1 (HSF1)-mediated feedback mechanisms. Here, we identify, through an siRNA screen, that the histone H3 lysine 4 methyltransferase MLL1 functions as a coactivator of HSF1 in response to HSP90 inhibition. MLL1 is recruited to the promoters of HSF1 target genes and regulates their expression in response to HSP90 inhibition. In addition, a striking combination effect is observed when MLL1 depletion is combined with HSP90 inhibition in various human cancer cell lines and tumor models. Thus, targeting MLL1 may block a HSF1-mediated feedback mechanism induced by HSP90 inhibition and provide a new avenue to enhance HSP90 inhibitor activity in human cancers.	[Chen, Yaoyu; Chen, Jinyun; Yang, Guizhi; Gao, Hui; Pagliarini, Raymond; Zhou, Wenlai] Novartis Inst Biomed Res, Dept Oncol, Cambridge, MA 02139 USA; [Temple, Emilia; Harbinski, Fred] Novartis Inst Biomed Res, Dept Dev & Mol Pathways, Cambridge, MA 02139 USA; [Wilson, Christopher] Novartis Inst Biomed Res, Dept Neurosci, Cambridge, MA 02139 USA; [Yu, Jianjun] Novartis Inst Biomed Res, Dept Oncol, Emeryville, CA 94608 USA	Novartis; Novartis; Novartis; Novartis	Zhou, WL (corresponding author), Novartis Inst Biomed Res, Dept Oncol, 250 Mass Ave, Cambridge, MA 02139 USA.	wenlai.zhou@novartis.com			Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This work was supported by a presidential postdoctoral fellowship from Novartis Institutes for Biomedical Research (to Y. C.).	Ansari KI, 2013, ONCOGENE, V32, P3359, DOI 10.1038/onc.2012.352; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Beliakoff J, 2003, CLIN CANCER RES, V9, P4961; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Chen YY, 2013, ONCOTARGET, V4, P816, DOI 10.18632/oncotarget.991; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Daniel JA, 2012, BBA-GENE REGUL MECH, V1819, P733, DOI 10.1016/j.bbagrm.2012.01.019; de Billy E, 2009, CELL CYCLE, V8, P3806, DOI 10.4161/cc.8.23.10423; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; GENUA MI, 1980, J PHARM SCI, V69, P1282, DOI 10.1002/jps.2600691113; Gomez AV, 2008, MOL CELL, V31, P222, DOI 10.1016/j.molcel.2008.06.015; Grembecka J, 2012, NAT CHEM BIOL, V8, P277, DOI [10.1038/NCHEMBIO.773, 10.1038/nchembio.773]; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Heddleston JM, 2012, CELL DEATH DIFFER, V19, P428, DOI 10.1038/cdd.2011.109; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Liu H, 2008, CELL CYCLE, V7, P428, DOI 10.4161/cc.7.4.5426; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Liu H, 2010, NATURE, V467, P343, DOI 10.1038/nature09350; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Menezes DL, 2012, MOL CANCER THER, V11, P730, DOI 10.1158/1535-7163.MCT-11-0667; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munster PN, 2002, CANCER RES, V62, P3132; Naylor TL, 2011, CANCER RES, V71, P2643, DOI 10.1158/0008-5472.CAN-10-2525; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ozdemir Oner, 2003, Cytometry, V56A, P53, DOI 10.1002/cyto.a.10081; Piper PW, 2011, PHARMACEUTICALS, V4, P1400, DOI 10.3390/ph4111400; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shi AB, 2012, BLOOD, V120, P4461, DOI 10.1182/blood-2012-05-429274; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Timothy D., 2013, RSC DRUG DISCOVERY; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	50	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18914	18927		10.1074/jbc.M114.574053	http://dx.doi.org/10.1074/jbc.M114.574053			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831003	Green Published, hybrid			2022-12-28	WOS:000339062900025
J	Gotzke, H; Palombo, I; Muheim, C; Perrody, E; Genevaux, P; Kudva, R; Muller, M; Daley, DO				Gotzke, Hansjorg; Palombo, Isolde; Muheim, Claudio; Perrody, Elsa; Genevaux, Pierre; Kudva, Renuka; Mueller, Matthias; Daley, Daniel O.			YfgM Is an Ancillary Subunit of the SecYEG Translocon in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; GRAM-NEGATIVE BACTERIA; CHAPERONE; STRESS; GENE; YIDC; MECHANISMS; SECRETION; COMPONENT; INSERTION	Protein secretion in Gram-negative bacteria is essential for both cell viability and pathogenesis. The vast majority of secreted proteins exit the cytoplasm through a transmembrane conduit called the Sec translocon in a process that is facilitated by ancillary modules, such as SecA, SecDF-YajC, YidC, and PpiD. In this study we have characterized YfgM, a protein with no annotated function. We found it to be a novel ancillary subunit of the Sec translocon as it co-purifies with both PpiD and the SecYEG translocon after immunoprecipitation and blue native/SDS-PAGE. Phenotypic analyses of strains lacking yfgM suggest that its physiological role in the cell overlaps with the periplasmic chaperones SurA and Skp. We, therefore, propose a role for YfgM in mediating the trafficking of proteins from the Sec translocon to the periplasmic chaperone network that contains SurA, Skp, DegP, PpiD, and FkpA.	[Gotzke, Hansjorg; Palombo, Isolde; Muheim, Claudio; Daley, Daniel O.] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Perrody, Elsa; Genevaux, Pierre] CNRS, Lab Microbiol & Genet Mol, F-31062 Toulouse, France; [Perrody, Elsa; Genevaux, Pierre] Univ Toulouse 3, F-31062 Toulouse, France; [Kudva, Renuka; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol, D-79104 Freiburg, Germany; [Kudva, Renuka; Mueller, Matthias] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany	Stockholm University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Freiburg; University of Freiburg	Daley, DO (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, Svante Arrhenius Vag 16c, SE-10691 Stockholm, Sweden.	ddaley@dbb.su.se	Genevaux, Pierre/A-4851-2015	Daley, Daniel/0000-0002-6425-5059; GENEVAUX, Pierre/0000-0001-7539-3126; Kudva, Renuka/0000-0003-0426-3716	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Swedish Research Council (to D. O. D.).	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bordes P, 2011, P NATL ACAD SCI USA, V108, P8438, DOI 10.1073/pnas.1101189108; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12; Dalbey RE, 2012, FEMS MICROBIOL REV, V36, P1023, DOI 10.1111/j.1574-6976.2012.00327.x; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Economou A, 2000, FEBS LETT, V476, P18, DOI 10.1016/S0014-5793(00)01662-8; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Fang J, 2011, PROTEIN PEPTIDE LETT, V18, P601, DOI 10.2174/092986611795222713; GARDEL C, 1987, J BACTERIOL, V169, P1286, DOI 10.1128/jb.169.3.1286-1290.1987; GARDEL C, 1990, EMBO J, V9, P4205, DOI 10.1002/j.1460-2075.1990.tb07645.x; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Kato Y, 2003, FEBS LETT, V550, P114, DOI 10.1016/S0014-5793(03)00847-0; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Perrody E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003037; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rapp M, 2004, PROTEIN SCI, V13, P937, DOI 10.1110/ps.03553804; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schwalm J, 2013, J BACTERIOL, V195, P3734, DOI 10.1128/JB.00431-13; Schweiger R, 2012, J CELL SCI, V125, P5196, DOI 10.1242/jcs.111054; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Toddo S, 2012, PROTEIN SCI, V21, P1571, DOI 10.1002/pro.2131; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Westphal K, 2012, J BIOL CHEM, V287, P42962, DOI 10.1074/jbc.M112.388470; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	57	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19089	19097		10.1074/jbc.M113.541672	http://dx.doi.org/10.1074/jbc.M113.541672			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855643	Green Published, hybrid			2022-12-28	WOS:000339062900039
J	Lengyel, P				Lengyel, Peter			Wanderings in Biochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; PEPTIDE-CHAIN ELONGATION; ASCITES TUMOR-CELLS; EMBRYONAL CARCINOMA-CELLS; INTERFERON-ACTIVATABLE GENES; ACID POLYMERIZATION FACTORS; BEATING CARDIAC MYOCYTES; INDUCIBLE P202 PROTEIN; AMINOACYL-TRANSFER RNA; NF-KAPPA-B	My Ph.D. thesis in the laboratory of Severo Ochoa at New York University School of Medicine in 1962 included the determination of the nucleotide compositions of codons specifying amino acids. The experiments were based on the use of random copolyribonucleotides (synthesized by polynucleotide phosphorylase) as messenger RNA in a cell-free protein-synthesizing system. At Yale University, where I joined the faculty, my co-workers and I first studied the mechanisms of protein synthesis. Thereafter, we explored the interferons (IFNs), which were discovered as antiviral defense agents but were revealed to be components of a highly complex multifunctional system. We isolated pure IFNs and characterized IFN-activated genes, the proteins they encode, and their functions. We concentrated on a cluster of IFN-activated genes, the p200 cluster, which arose by repeated gene duplications and which encodes a large family of highly multifunctional proteins. For example, the murine protein p204 can be activated in numerous tissues by distinct transcription factors. It modulates cell proliferation and the differentiation of a variety of tissues by binding to many proteins. p204 also inhibits the activities of wild-type Ras proteins and Ras oncoproteins.	Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Lengyel, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA.	peter.lengyel@yale.edu						ADAMS JM, 1966, P NATL ACAD SCI USA, V55, P147, DOI 10.1073/pnas.55.1.147; ALGRANAT.ID, 1966, J BIOL CHEM, V241, P1778; ARCA M, 1964, BIOCHIM BIOPHYS ACTA, V87, P440, DOI 10.1016/0926-6550(64)90116-1; BAGLIONI C, 1978, NATURE, V273, P684, DOI 10.1038/273684a0; BALL LA, 1979, VIROLOGY, V94, P282, DOI 10.1016/0042-6822(79)90462-8; BARKER HA, 1958, P NATL ACAD SCI USA, V44, P1093, DOI 10.1073/pnas.44.11.1093; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BROWN GE, 1976, BIOCHEM BIOPH RES CO, V69, P114, DOI 10.1016/S0006-291X(76)80280-X; CABRER B, 1979, J BIOL CHEM, V254, P3681; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CHOUBEY D, 1992, J CELL BIOL, V116, P1333, DOI 10.1083/jcb.116.6.1333; Choubey D, 1996, EMBO J, V15, P5668, DOI 10.1002/j.1460-2075.1996.tb00951.x; CHOUBEY D, 1989, J BIOL CHEM, V264, P17182; CHOUBEY D, 1993, J INTERFERON RES, V13, P43, DOI 10.1089/jir.1993.13.43; CHOUBEY D, 1995, J BIOL CHEM, V270, P6134, DOI 10.1074/jbc.270.11.6134; Choubey D, 1996, BIOCHEM BIOPH RES CO, V221, P396, DOI 10.1006/bbrc.1996.0607; Choubey D, 2010, J INTERF CYTOK RES, V30, P371, DOI 10.1089/jir.2009.0096; CLARK BFC, 1966, J MOL BIOL, V17, P394, DOI 10.1016/S0022-2836(66)80150-X; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; Datta B, 1996, J BIOL CHEM, V271, P27544, DOI 10.1074/jbc.271.44.27544; Deschamps S, 2003, GENOMICS, V82, P34, DOI 10.1016/S0888-7543(03)00092-2; Ding B, 2008, J BIOL CHEM, V283, P5831, DOI 10.1074/jbc.M709680200; Ding B, 2006, J BIOL CHEM, V281, P14882, DOI 10.1074/jbc.M511747200; Ding B, 2006, J BIOL CHEM, V281, P14893, DOI 10.1074/jbc.M511748200; EISENSTADT J, 1966, SCIENCE, V154, P524; ENGEL DA, 1988, VIROLOGY, V166, P24, DOI 10.1016/0042-6822(88)90142-0; ERDOS T, 1959, NATURE, V183, P618, DOI 10.1038/183618a0; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; FARRELL PJ, 1978, P NATL ACAD SCI USA, V75, P5893, DOI 10.1073/pnas.75.12.5893; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; GARCIABLANCO MA, 1985, J VIROL, V53, P893; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GRIBAUDO G, 1991, J VIROL, V65, P1748, DOI 10.1128/JVI.65.4.1748-1757.1991; GRUNBERGMANAGO M, 1955, J AM CHEM SOC, V77, P3165, DOI 10.1021/ja01616a093; Gupta S L, 1969, Cold Spring Harb Symp Quant Biol, V34, P630; GUPTA SL, 1971, BIOCHEMISTRY-US, V10, P4410, DOI 10.1021/bi00800a010; Hertel L, 2000, ONCOGENE, V19, P3598, DOI 10.1038/sj.onc.1203697; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; KERR IM, 1977, NATURE, V268, P540, DOI 10.1038/268540a0; KONDO M, 1968, NATURE, V220, P368, DOI 10.1038/220368a0; Kong L, 2008, CELL MOL LIFE SCI, V65, P3494, DOI 10.1007/s00018-008-8342-5; KUMAR R, 1988, J VIROL, V62, P3175, DOI 10.1128/JVI.62.9.3175-3181.1988; LENGYEL P, 1969, BACTERIOL REV, V33, P264, DOI 10.1128/MMBR.33.2.264-301.1969; LENGYEL P, 1969, COLD SPRING HARB SYM, V34, P828, DOI 10.1101/SQB.1969.034.01.094; LENGYEL P, 1960, J AM CHEM SOC, V82, P752, DOI 10.1021/ja01488a070; LENGYEL P, 1961, P NATL ACAD SCI USA, V47, P1936, DOI 10.1073/pnas.47.12.1936; LENGYEL P, 1966, J GEN PHYSIOL, V49, P305, DOI 10.1085/jgp.49.6.305; LENGYEL P, 1960, P NATL ACAD SCI USA, V46, P1312, DOI 10.1073/pnas.46.10.1312; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; Lengyel P, 2012, ANNU REV MICROBIOL, V66, P27, DOI 10.1146/annurev-micro-010312-100615; Lengyel P, 2010, CELL MOL LIFE SCI, V67, P335, DOI 10.1007/s00018-009-0195-z; Liu CJ, 2000, MOL CELL BIOL, V20, P7024, DOI 10.1128/MCB.20.18.7024-7036.2000; Liu CJ, 1999, EMBO J, V18, P2845, DOI 10.1093/emboj/18.10.2845; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Luan Y, 2007, J BIOL CHEM, V282, P16860, DOI 10.1074/jbc.M610943200; Luan Y, 2008, CYTOKINE GROWTH F R, V19, P357, DOI 10.1016/j.cytogfr.2008.11.002; LUCASLEN.J, 1966, P NATL ACAD SCI USA, V55, P1562, DOI 10.1073/pnas.55.6.1562; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Ma XY, 2003, J BIOL CHEM, V278, P23008, DOI 10.1074/jbc.M302105200; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARCUS PI, 1966, VIROLOGY, V30, P502, DOI 10.1016/0042-6822(66)90126-7; MCMAHON SB, 1995, J EXP MED, V181, P417, DOI 10.1084/jem.181.1.417; Min W, 1996, MOL CELL BIOL, V16, P359; Nirenberg M, 2004, TRENDS BIOCHEM SCI, V29, P46, DOI 10.1016/j.tibs.2003.11.009; NOMURA M, 1967, P NATL ACAD SCI USA, V58, P946, DOI 10.1073/pnas.58.3.946; OCHOA S, 1980, ANNU REV BIOCHEM, V49, P1, DOI 10.1146/annurev.bi.49.070180.000245; ONO Y, 1968, NATURE, V220, P1304, DOI 10.1038/2201304a0; ONO Y, 1969, NATURE, V222, P645, DOI 10.1038/222645a0; ONO Y, 1969, NATURE, V223, P697, DOI 10.1038/223697a0; OPDENAKKER G, 1989, VIROLOGY, V171, P568, DOI 10.1016/0042-6822(89)90626-0; Pitha-Rowe IF, 2007, CYTOKINE GROWTH F R, V18, P409, DOI 10.1016/j.cytogfr.2007.06.017; RATNER L, 1978, BIOCHEM BIOPH RES CO, V81, P947, DOI 10.1016/0006-291X(78)91443-2; REYNOLDS FH, 1975, P NATL ACAD SCI USA, V72, P4881, DOI 10.1073/pnas.72.12.4881; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; RUDNICKI MA, 1990, DEV BIOL, V138, P348, DOI 10.1016/0012-1606(90)90202-T; SAMANTA H, 1982, UCLA SYMP MOL CELL B, V25, P59; SANGER F, 1951, BIOCHEM J, V49, P481, DOI 10.1042/bj0490481; SEN GC, 1976, NATURE, V264, P370, DOI 10.1038/264370a0; SHAW GD, 1983, NUCLEIC ACIDS RES, V11, P555, DOI 10.1093/nar/11.3.555; SKOULTCHI A, 1968, P NATL ACAD SCI USA, V60, P675, DOI 10.1073/pnas.60.2.675; SKOULTCHI A, 1970, BIOCHEMISTRY-US, V9, P508, DOI 10.1021/bi00805a009; SKOULTCHI A, 1969, COLD SPRING HARB SYM, V34, P437, DOI 10.1101/SQB.1969.034.01.050; SLATTERY E, 1979, P NATL ACAD SCI USA, V76, P4778, DOI 10.1073/pnas.76.10.4778; SOLL D, 1967, J MOL BIOL, V29, P97, DOI 10.1016/0022-2836(67)90183-0; SPEYER JF, 1962, P NATL ACAD SCI USA, V48, P684, DOI 10.1073/pnas.48.4.684; SPOTTS CR, 1961, NATURE, V192, P633, DOI 10.1038/192633a0; STEITZ JA, 1969, COLD SPRING HARB SYM, V34, P621, DOI 10.1101/SQB.1969.034.01.072; STLAURENT G, 1983, CELL, V33, P95; Straub F.B., 1942, STUDIES I MED CHEM U, P3; SUNDHARA.G, 1968, P NATL ACAD SCI USA, V61, P693, DOI 10.1073/pnas.61.2.693; TAIRA H, 1980, SCIENCE, V207, P528, DOI 10.1126/science.7352261; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; TRAPANI JA, 1992, IMMUNOGENETICS, V36, P369; Ullmann A, 2011, GENOME BIOL EVOL, V3, P1025, DOI 10.1093/gbe/evr024; VASSEF A, 1974, BIOCHIM BIOPHYS ACTA, V353, P115, DOI 10.1016/0005-2787(74)90102-6; VAZQUEZ D, 1979, INHIBITORS PROTEIN S; Wang H, 2000, J BIOL CHEM, V275, P27377; Wang H, 1999, GENOMICS, V60, P281, DOI 10.1006/geno.1999.5923; Wang H, 2002, J INTERF CYTOK RES, V22, P729, DOI 10.1089/10799900260100231; Weinberg RA, 2006, BIOL CANC; Weissmann C, 1981, INTERFERON, V3, P101; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0; Xin H, 2003, J CELL BIOCHEM, V88, P191, DOI 10.1002/jcb.10372; Xin H, 2001, ONCOGENE, V20, P6828, DOI 10.1038/sj.onc.1204844; Xin H, 2006, J IMMUNOL, V176, P5863, DOI 10.4049/jimmunol.176.10.5863; Yin Q, 2013, CELL REP, V4, P327, DOI 10.1016/j.celrep.2013.06.024; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	113	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19254	19268		10.1074/jbc.X114.554121	http://dx.doi.org/10.1074/jbc.X114.554121			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867946	Green Published, hybrid			2022-12-28	WOS:000339326800001
J	Madonna, R; Geng, YJ; Bolli, R; Rokosh, G; Ferdinandy, P; Patterson, C; De Caterina, R				Madonna, Rosalinda; Geng, Yong-Jian; Bolli, Roberto; Rokosh, Gregg; Ferdinandy, Peter; Patterson, Cam; De Caterina, Raffaele			Co-Activation of Nuclear Factor-kappa B and Myocardin/Serum Response Factor Conveys the Hypertrophy Signal of High Insulin Levels in Cardiac Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; DIABETIC CARDIOMYOPATHY; VCAM-1 EXPRESSION; MESENCHYMAL CELLS; MESSENGER-RNA; GENE; ACTIVATION; PROTEIN; OBESE; IDENTIFICATION	Hyperinsulinemia contributes to cardiac hypertrophy and heart failure in patients with the metabolic syndrome and type 2 diabetes. Here, high circulating levels of tumor necrosis factor (TNF)-alpha may synergize with insulin in signaling inflammation and cardiac hypertrophy. Wetested whether high insulin affects activation of TNF-alpha -induced NF-kappa B and myocardin/serum response factor (SRF) to convey hypertrophy signaling in cardiac myoblasts. In canine cardiac myoblasts, treatment with high insulin (10(-8) to 10(-7) M) for 0-24 h increased insulin receptor substrate (IRS)-1 phosphorylation at Ser-307, decreased protein levels of chaperone-associated ubiquitin (Ub) E3 ligase Cterminus of heat shock protein 70-interacting protein (CHIP), increased SRF activity, as well as beta-myosin heavy chain (MHC) and myocardin expressions. Here siRNAs to myocardin or NF-kappa B, as well as CHIP overexpression prevented (while siRNA-mediated CHIP disruption potentiated) high insulin-induced SR element (SRE) activation and beta-MHC expression. Insulin markedly potentiated TNF-alpha -induced NF-kappa B activation. Compared with insulin alone, insulin+TNF-alpha increased SRF/SRE binding and beta-MHC expression, which was reversed by the NF-kappa B inhibitor pyrrolidine dithiocarbamate (PDTC) and by NF-kappa B silencing. In the hearts of db/db diabetic mice, in which Akt phosphorylation was decreased, p38MAPK, Akt1, and IRS-1 phosphorylation at Ser-307 were increased, together with myocardin expression as well as SRE and NF-kappa B activities. In response to high insulin, cardiac myoblasts increase the expression or the promyogenic transcription factors myocardin/ SRF in a CHIP-dependent manner. Insulin potentiates TNF-alpha in inducing NF-kappa B and SRF/SRE activities. In hyperin-sulinemic states, myocardin may act as a nuclear effector of insulin, promoting cardiac hypertrophy.	[Madonna, Rosalinda; Geng, Yong-Jian] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Madonna, Rosalinda; Geng, Yong-Jian] Univ Texas Med Sch Houston, Houston, TX 77030 USA; [Madonna, Rosalinda; De Caterina, Raffaele] Univ G DAnnunzio, Inst Cardiol, I-66100 Chieti, Italy; [Madonna, Rosalinda; De Caterina, Raffaele] Univ G DAnnunzio, Ctr Excellence Aging, I-66100 Chieti, Italy; [Bolli, Roberto; Rokosh, Gregg] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40202 USA; [Ferdinandy, Peter] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1085 Budapest, Hungary; [Patterson, Cam] Univ Texas Med Branch, Ctr Mol Cardiol, Galveston, TX 77555 USA	Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Louisville; Semmelweis University; University of Texas System; University of Texas Medical Branch Galveston	De Caterina, R (corresponding author), Univ G DAnnunzio, Osped SS Annunziata, Inst Cardiol, Via Vestini, I-66013 Chieti, Italy.	rdecater@unich.it	De Caterina, Raffaele/K-3857-2016; Ferdinandy, Péter/H-9181-2019	De Caterina, Raffaele/0000-0003-1637-574X; Rokosh, Gregg/0000-0002-9214-2254; Madonna, Rosalinda/0000-0001-6455-2777	National Institutes of Health [R01HL59249, R01HL69509]; Italian Istituto Nazionale Ricerche Cardiovascolari (I.N.R.C.); CARIPLO; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078825, R01HL059249, R01HL069509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Istituto Nazionale Ricerche Cardiovascolari (I.N.R.C.); CARIPLO(Fondazione Cariplo); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Grants R01HL59249 and R01HL69509 from the National Institutes of Health (to Y.-J. G.) and the Italian Istituto Nazionale Ricerche Cardiovascolari (I.N.R.C.) and CARIPLO (to R. M. and R. D. C.).	Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Burke JR, 2003, CURR OPIN DRUG DI DE, V6, P720; Chen CY, 1996, MOL CELL BIOL, V16, P6372; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Fonarow GC, 2006, ENDOCRIN METAB CLIN, V35, P575, DOI 10.1016/j.ecl.2006.05.003; Franzoso G, 1996, EMBO J, V15, P3403, DOI 10.1002/j.1460-2075.1996.tb00706.x; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; HITTINGER L, 1995, CIRCULATION, V92, P978, DOI 10.1161/01.CIR.92.4.978; Jersmann HPA, 2001, INFECT IMMUN, V69, P1273, DOI 10.1128/IAI.69.3.1273-1279.2001; Karnik AA, 2007, CURR HYPERTENS REP, V9, P467, DOI 10.1007/s11906-007-0086-3; Kim YB, 2000, DIABETES, V49, P847, DOI 10.2337/diabetes.49.5.847; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Li Y.P., 2001, FASEB J, V15, P1413; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Madonna R, 2007, INT J IMMUNOPATH PH, V20, P539, DOI 10.1177/039463200702000312; Madonna R, 2005, J BIOL CHEM, V280, P13503, DOI 10.1074/jbc.M411859200; Madonna R, 2013, INT J IMMUNOPATH PH, V26, P59, DOI 10.1177/039463201302600106; Madonna R, 2009, THROMB HAEMOSTASIS, V101, P345, DOI 10.1160/TH08-07-0484; Madonna R, 2008, BBA-MOL BASIS DIS, V1782, P511, DOI 10.1016/j.bbadis.2008.05.006; Madonna R, 2008, STEM CELLS, V26, P202, DOI 10.1634/stemcells.2007-0490; Madonna R, 2013, CIRC RES, V113, P902, DOI 10.1161/CIRCRESAHA.113.301690; Madonna R, 2013, INT J CARDIOL, V167, P2912, DOI 10.1016/j.ijcard.2012.07.017; Madonna R, 2011, THROMB HAEMOSTASIS, V106, P500, DOI 10.1160/TH10-09-0574; Madonna R, 2009, EXP CELL RES, V315, P2921, DOI 10.1016/j.yexcr.2009.07.016; Maisch B, 2011, HERZ, V36, P102, DOI 10.1007/s00059-011-3429-4; MCMILLAN DE, 1989, METABOLISM, V38, P1042, DOI 10.1016/0026-0495(89)90038-3; Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3; Morisco C, 2005, CIRC RES, V96, P180, DOI 10.1161/01.RES.0000152968.71868.c3; Moylan JS, 2008, AM J PHYSIOL-CELL PH, V295, pC986, DOI 10.1152/ajpcell.00041.2008; Navab M, 2008, CURR OPIN CLIN NUTR, V11, P459, DOI 10.1097/MCO.0b013e32830460c2; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; O'Neill BT, 2005, J CLIN INVEST, V115, P2059, DOI 10.1172/JCI25900; PAOLISSO G, 1995, EUR J CLIN INVEST, V25, P529, DOI 10.1111/j.1365-2362.1995.tb01740.x; Park CW, 2009, DIABETES, V58, P2666, DOI 10.2337/db09-0136; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; SAAD MF, 1989, LANCET, V1, P1356; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shimizu I, 2010, J CLIN INVEST, V120, P1506, DOI 10.1172/JCI40096; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zelarayan L, 2009, CARDIOVASC RES, V84, P416, DOI 10.1093/cvr/cvp237; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	66	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19585	19598		10.1074/jbc.M113.540559	http://dx.doi.org/10.1074/jbc.M113.540559			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855642	Green Published, hybrid			2022-12-28	WOS:000339326800032
J	Morris, LL; Hartman, IZ; Jun, DJ; Seemann, J; DeBose-Boyd, RA				Morris, Lindsey L.; Hartman, Isamu Z.; Jun, Dong-Jae; Seemann, Joachim; DeBose-Boyd, Russell A.			Sequential Actions of the AAA-ATPase Valosin-containing Protein (VCP)/p97 and the Proteasome 19 S Regulatory Particle in Sterol-accelerated, Endoplasmic Reticulum (ER)associated Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; HMG-COA REDUCTASE; CLEAVAGE-ACTIVATING PROTEIN; ER-ASSOCIATED DEGRADATION; LOW-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; MEMBRANE-PROTEIN; INDUCED DISLOCATION; UBIQUITIN LIGASE; SENSING DOMAIN	Accelerated endoplasmic reticulum (ER)-associated degradation (ERAD) of the cholesterol biosynthetic enzyme 3-hydroxy3-methylglutaryl-coenzyme A reductase results from its sterol-induced binding to ER membrane proteins called Insig-1 and Insig-2. This binding allows for subsequent ubiquitination of reductase by Insig-associated ubiquitin ligases. Once ubiquitinated, reductase becomes dislocated from ER membranes into the cytosol for degradation by 26 S proteasomes through poorly defined reactions mediated by the AAA-ATPase valosin-containing protein (VCP)/p97 and augmented by the nonsterol isoprenoid geranylgeraniol. Here, we report that the oxysterol 25-hydroxycholesterol and geranylgeraniol combine to trigger extraction of reductase across ER membranes prior to its cytosolic release. This conclusion was drawn from studies utilizing a novel assay that measures membrane extraction of reductase by determining susceptibility of a lumenal epitope in the enzyme to in vitro protease digestion. Susceptibility of the lumenal epitope to protease digestion and thus membrane extraction of reductase were tightly regulated by 25-hydroxycholesterol and geranylgeraniol. The reaction was inhibited by RNA interference-mediated knockdown of either Insigs or VCP/p97. In contrast, reductase continued to become membrane-extracted, but not cytosolically dislocated, in cells deficient for AAA-ATPases of the proteasome 19 S regulatory particle. These findings establish sequential roles for VCP/p97 and the 19 S regulatory particle in the sterol-accelerated ERAD of reductase that may be applicable to the ERAD of other substrates.	[Morris, Lindsey L.; Hartman, Isamu Z.; Jun, Dong-Jae; DeBose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Seemann, Joachim] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [DeBose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBose-Boyd, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu		Morris, Lindsey/0000-0001-8512-1562	National Institutes of Health, a Division of Cell and Molecular Biology Training Program [HL20948, GM090216, T32GM008203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090216, R01GM096070, T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health, a Division of Cell and Molecular Biology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL20948, GM090216, and T32GM008203, a Division of Cell and Molecular Biology Training Program grant (to L. L. M.).	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; BROWN MS, 1980, J LIPID RES, V21, P505; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Ehlinger A, 2013, BIOCHEMISTRY-US, V52, P3618, DOI 10.1021/bi400417a; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Elsabrouty R, 2013, MOL BIOL CELL, V24, P3300, DOI 10.1091/mbc.E13-03-0157; Faulkner RA, 2013, J LIPID RES, V54, P1011, DOI 10.1194/jlr.M033639; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; LISCUM L, 1985, J BIOL CHEM, V260, P522; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MOSLEY ST, 1983, J BIOL CHEM, V258, P3875; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nguyen AD, 2009, J BIOL CHEM, V284, P26778, DOI 10.1074/jbc.M109.032342; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pietroni P, 2013, BIOCHEM J, V453, P435, DOI 10.1042/BJ20130133; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Roitelman J, 2004, J BIOL CHEM, V279, P6465, DOI 10.1074/jbc.M308094200; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616	47	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19053	19066		10.1074/jbc.M114.576652	http://dx.doi.org/10.1074/jbc.M114.576652			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24860107	hybrid, Green Published			2022-12-28	WOS:000339062900036
J	Penas, C; Ramachandran, V; Simanski, S; Lee, C; Madoux, F; Rahaim, RJ; Chauhan, R; Barnaby, O; Schurer, S; Hodder, P; Steen, J; Roush, WR; Ayad, NG				Penas, Clara; Ramachandran, Vimal; Simanski, Scott; Lee, Choogon; Madoux, Franck; Rahaim, Ronald J.; Chauhan, Ruchi; Barnaby, Omar; Schurer, Stephan; Hodder, Peter; Steen, Judith; Roush, William R.; Ayad, Nagi G.			Casein Kinase 1 delta-dependent Wee1 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; SCF-BETA-TRCP; SOMATIC WEE1; CELL-CYCLE; UBIQUITIN LIGASE; MITOTIC ENTRY; S PHASE; PHOSPHORYLATION; INHIBITORS; CK1-DELTA/EPSILON	Eukaryotic mitotic entry is controlled by Cdk1, which is activated by the Cdc25 phosphatase and inhibited by Wee1 tyrosine kinase, a target of the ubiquitin proteasome pathway. Here we use a reporter of Wee1 degradation, K328M-Wee1-luciferase, to screen a kinase-directed chemical library. Hit profiling identified CK1 delta-dependent Wee1 degradation. Small-molecule CK1 delta inhibitors specifically disrupted Wee1 destruction and arrested HeLa cell proliferation. Pharmacological inhibition, siRNA knockdown, or conditional deletion of CK1 delta also reduced Wee1 turnover. Thus, these studies define a previously unappreciated role for CK1 delta in controlling the cell cycle.	[Ayad, Nagi G.] Univ Miami, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat, Miami, FL 33136 USA; [Schurer, Stephan] Univ Miami, Dept Pharmacol, Miami, FL 33136 USA; [Simanski, Scott] Scripps Florida, Dept Canc Biol, Jupiter, FL 33458 USA; [Madoux, Franck; Hodder, Peter] Scripps Florida, Lead Identificat Div, Translat Res Inst, Jupiter, FL 33458 USA; [Rahaim, Ronald J.; Roush, William R.] Scripps Florida, Dept Chem, Jupiter, FL 33458 USA; [Lee, Choogon] Florida State Univ, Coll Med, Dept Biol Sci, Tallahassee, FL 32306 USA; [Chauhan, Ruchi; Barnaby, Omar; Steen, Judith] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA	University of Miami; University of Miami; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; Florida State University; Harvard University; Boston Children's Hospital	Ayad, NG (corresponding author), Univ Miami, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat, 1095 NW 14th Ter,LPLC,R48, Miami, FL 33136 USA.	nayad@med.miami.edu		Simanski, Scott/0000-0002-7594-5952	National Institutes of Health Grants [R21 NS056991, 1R01NS067289, R01NS-053616, MH084512];  [U54MH074404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512, U54MH074404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053616, R01NS067289, R21NS056991] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS056991 (to N. G. A.), 1R01NS067289 (to N. G. A.), R01NS-053616 (to C. L.), MH084512 (to F. M. and P. H.). This work was also supported by Grant U54MH074404 to W. R. R. (Dr. Hugh Rosen, PI).	Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Bibian M, 2013, BIOORG MED CHEM LETT, V23, P4374, DOI 10.1016/j.bmcl.2013.05.075; Chen SC, 2004, J BIOL CHEM, V279, P13755, DOI 10.1074/jbc.M310064200; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Li CQ, 2010, MOL CELL BIOL, V30, P116, DOI 10.1128/MCB.01876-08; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Madoux F, 2010, J BIOMOL SCREEN, V15, P907, DOI 10.1177/1087057110375848; Mahajan K, 2012, NAT STRUCT MOL BIOL, V19, P930, DOI 10.1038/nsmb.2356; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Oumata N, 2008, J MED CHEM, V51, P5229, DOI 10.1021/jm800109e; Owens L, 2010, J BIOL CHEM, V285, P6761, DOI 10.1074/jbc.M109.093237; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Smith A, 2007, CELL CYCLE, V6, P2795, DOI 10.4161/cc.6.22.4919; Tominaga Y, 2006, INT J BIOL SCI, V2, P161; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Verkaar F, 2011, CHEM BIOL, V18, P485, DOI 10.1016/j.chembiol.2011.01.015; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Wu CL, 2001, CANCER RES, V61, P7325	31	18	18	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18893	18903		10.1074/jbc.M114.547661	http://dx.doi.org/10.1074/jbc.M114.547661			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24817118	Green Published, hybrid			2022-12-28	WOS:000339062900023
J	MacDonald, BT; Hien, A; Zhang, XJ; Iranloye, O; Virshup, DM; Waterman, ML; He, X				MacDonald, Bryan T.; Hien, Annie; Zhang, Xinjun; Iranloye, Oladoyin; Virshup, David M.; Waterman, Marian L.; He, Xi			Disulfide Bond Requirements for Active Wnt Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; MUTATIONS; PROTEIN; WINGLESS; EXPRESSION; SECRETION; OLIGODONTIA; COMPONENTS; INHIBITOR; DYSPLASIA	Secreted Wnt lipoproteins are cysteine-rich and lipid-modified morphogens that bind to the Frizzled (FZD) receptor and LDL receptor-related protein 6 (LRP6). Wnt engages FZD through protruding thumb and index finger domains, which are each assembled from paired beta strands secured by disulfide bonds and grasp two sides of the FZD ectodomain. The importance of Wnt disulfide bonds has been assumed but uncharacterized. We systematically analyzed cysteines and associated disulfide bonds in the prototypic Wnt3a. Our data show that mutation of any individual cysteine of Wnt3a results in covalent Wnt oligomers through ectopic intermolecular disulfide bond formation and diminishes/abolishes Wnt signaling. Although individual cysteine mutations in the amino part of the saposin-like domain and in the base of the index finger are better tolerated and permit residual Wnt3a secretion/activity, those in the amino terminus, the thumb, and at the tip of the index finger are incompatible with secretion and/or activity. A few select double cysteine mutants based on the disulfide bond pattern restore Wnt secretion/activity. Further, a double cysteine mutation at the index finger tip results in a Wnt3a with normal secretion but minimal FZD binding and dominant negative properties. Our results experimentally validate predictions from the Wnt crystal structure and highlight critical but different roles of the saposin-like and cytokine-like domains, including the thumb and the index finger in Wnt folding/secretion and FZD binding. Finally, we modified existing expression vectors for 19 epitope-tagged human WNT proteins by removal of a tag-supplied ectopic cysteine, thereby generating tagged WNT ligands active in canonical and non-canonical signaling.	[He, Xi] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Virshup, David M.] Duke Natl Univ Singapore, Grad Sch Med, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Waterman, Marian L.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National University of Singapore; University of California System; University of California Irvine	He, X (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X	National Institutes of Health [RO1 GM074241, RO1 AR060359]; BCH Intellectual and Developmental Disabilities Research Center [P30 HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA108697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCH Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM074241 and RO1 AR060359 (to X. H.).; Holder of an endowed research chair of Boston Children's Hospital (BCH) and supported by BCH Intellectual and Developmental Disabilities Research Center Grant P30 HD-18655. To whom correspondence should be addressed. Tel.: 617-919-2257; Fax: 617-919-2771; E-mail: xi. he@childrens.harvard.edu.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arzoo PS, 2014, AM J MED GENET A, V164, P353, DOI 10.1002/ajmg.a.36243; Bazan JF, 2012, DEV CELL, V23, P227, DOI 10.1016/j.devcel.2012.07.011; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Castori M, 2011, CLIN GENET, V79, P92, DOI 10.1111/j.1399-0004.2010.01513.x; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Chu MLH, 2013, STRUCTURE, V21, P1235, DOI 10.1016/j.str.2013.05.006; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dierick HA, 1998, DEVELOPMENT, V125, P4729; Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567; Faqeih E, 2013, J MED GENET, V50, P491, DOI 10.1136/jmedgenet-2013-101750; Ganguly A, 2005, DEVELOPMENT, V132, P3419, DOI 10.1242/dev.01903; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Green JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058395; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kantaputra P, 2014, AM J MED GENET A, V164, P1041, DOI 10.1002/ajmg.a.36388; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458; Lapebie P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005823; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MASON JO, 1992, MOL BIOL CELL, V3, P521, DOI 10.1091/mbc.3.5.521; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Mostowska A, 2013, CLIN GENET, V84, P429, DOI 10.1111/cge.12061; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Plaisancie J, 2013, AM J MED GENET A, V161A, P671, DOI 10.1002/ajmg.a.35747; Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009; Rios-Esteves J., 2014, J BIOL CHEM, V114; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; ROBINOW M, 1969, AM J DIS CHILD, V117, P645, DOI 10.1001/archpedi.1969.02100030647005; Roifman M, 2015, CLIN GENET, V87, P34, DOI 10.1111/cge.12401; Shibamoto S, 1998, GENES CELLS, V3, P659; Song SJ, 2014, HUM GENET, V133, P117, DOI 10.1007/s00439-013-1360-x; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Woods CG, 2006, AM J HUM GENET, V79, P402, DOI 10.1086/506332; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	62	57	58	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18122	18136		10.1074/jbc.M114.575027	http://dx.doi.org/10.1074/jbc.M114.575027			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24841207	hybrid, Green Published			2022-12-28	WOS:000338042000016
J	Miazzi, C; Ferraro, P; Pontarin, G; Rampazzo, C; Reichard, P; Bianchi, V				Miazzi, Cristina; Ferraro, Paola; Pontarin, Giovanna; Rampazzo, Chiara; Reichard, Peter; Bianchi, Vera			Allosteric Regulation of the Human and Mouse Deoxyribonucleotide Triphosphohydrolase Sterile alpha-Motif/Histidine-Aspartate Domain-containing Protein 1 (SAMHD1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR SAMHD1; DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE; HIV-1 RESTRICTION; ENTEROCOCCUS-FAECALIS; DNA-REPLICATION; CELLS; MITOCHONDRIAL; INHIBITION; ACTIVATION	The deoxyribonucleotide triphosphohydrolase SAMHD1 restricts lentiviral infection by depleting the dNTPs required for viral DNA synthesis. In cultured human fibroblasts SAMHD1 is expressed maximally during quiescence preventing accumulation of dNTPs outside S phase. siRNA silencing of SAMHD1 increases dNTP pools, stops cycling human cells in G(1), and blocks DNA replication. Surprisingly, knock-out of the mouse gene does not affect the well being of the animals. dNTPs are both substrates and allosteric effectors for SAMHD1. In the crystal structure each subunit of the homotetrameric protein contains one substrate-binding site and two nonidentical effector-binding sites, site 1 binding dGTP, site 2 dGTP or dATP. Here we compare allosteric properties of pure recombinant human and mouse SAMHD1. Both enzymes are activated 3-4-fold by allosteric effectors. We propose that in quiescent cells where SAMHD1 is maximally expressed GTP binds to site 1 with very high affinity, stabilizing site 2 of the tetrameric structure. Any canonical dNTP can bind to site 2 and activate SAMHD1, but in cells only dATP or dTTP are present at sufficient concentrations. The apparent K-m for dATP at site 2 is similar to 10 mu M for mouse and 1 mu M for human SAMHD1, for dTTP the corresponding values are 50 and 2 mu M. Tetrameric SAMHD1 is activated for the hydrolysis of any dNTP only after binding of a dNTP to site 2. The lower K-m constants for human SAMHD1 induce activation at lower cellular concentrations of dNTPs thereby limiting the size of dNTP pools more efficiently in quiescent human cells.	[Miazzi, Cristina; Ferraro, Paola; Pontarin, Giovanna; Rampazzo, Chiara; Reichard, Peter; Bianchi, Vera] Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Bianchi, V (corresponding author), Dept Biol, Via Ugo Bassi 58B, I-35131 Padua, Italy.	vbianchi@bio.unipd.it			University of Padova; Italian Telethon Grant [GGP09019]	University of Padova; Italian Telethon Grant(Fondazione Telethon)	This work was supported by the University of Padova, Strategic Project 2008 "Models of Mitochondrial Diseases" and Italian Telethon Grant GGP09019.	Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gandhi VV, 2011, NUCLEOS NUCLEOT NUCL, V30, P317, DOI 10.1080/15257770.2011.586955; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Mega R, 2009, FEBS J, V276, P3211, DOI 10.1111/j.1742-4658.2009.07035.x; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Vorontsov II, 2014, J BIOL CHEM, V289, P2815, DOI 10.1074/jbc.M113.524207; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	28	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18339	18346		10.1074/jbc.M114.571091	http://dx.doi.org/10.1074/jbc.M114.571091			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828500	hybrid, Green Published			2022-12-28	WOS:000338042000033
J	Muta, H; Lee, YH; Kardos, J; Lin, YX; Yagi, H; Goto, Y				Muta, Hiroya; Lee, Young-Ho; Kardos, Jozsef; Lin, Yuxi; Yagi, Hisashi; Goto, Yuji			Supersaturation-limited Amyloid Fibrillation of Insulin Revealed by Ultrasonication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CRYSTALLIZATION; NEURODEGENERATIVE DISEASES; FIBRILS; OLIGOMERS; SCRAPIE; BETA(2)-MICROGLOBULIN; AGGREGATION; MECHANISM; ACCELERATION; MICROSCOPY	Amyloid fibrils form in supersaturated solutions via a nucleation and growth mechanism. We proposed that ultrasonication may be an effective agitation to trigger nucleation that would otherwise not occur under the persistent metastability of supersaturation. However, the roles of supersaturation and effects of ultrasonication have not been elucidated in detail except for limited cases. Insulin is an amyloidogenic protein that is useful for investigating the mechanisms underlying amyloid fibrillation with biological relevance. We studied the alcohol-induced amyloid fibrillation of insulin using various concentrations of 2,2,2-trifluoroethanol and 1,1,1,3,3,3-hexafluoro-2-propanol at pH 2.0 and 4.8. Ultrasonic irradiation effectively triggered fibrillation under conditions in which insulin retained persistent supersaturation. Structural analyses by circular dichroism, Fourier transform infrared spectroscopy, transmission electron microscopy, and atomic force microscopy revealed that the dominant structures of fibrils varied between parallel and antiparallel beta-sheets depending on the solvent conditions. pH and alcohol concentration-dependent phase diagrams showed a marked difference before and after the ultrasonic treatment, which indicated that the persistent metastability of supersaturation determined the conformations of insulin. These results indicate the importance of an alternative view of amyloid fibrils as supersaturation-limited crystal-like aggregates formed above the solubility limit.	[Muta, Hiroya; Lee, Young-Ho; Lin, Yuxi; Yagi, Hisashi; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kardos, Jozsef] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	Osaka University; Eotvos Lorand University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Kardos, József/J-1035-2017	Kardos, József/0000-0002-2135-2932	Ministry of Education, Science, Sports, and Culture for Scientific Research, Japan; Takeda Science Foundation; Hungarian Academy of Sciences; Hungarian Scientific Research Fund [81950]; Grants-in-Aid for Scientific Research [25870407] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture for Scientific Research, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Ministry of Education, Science, Sports, and Culture for Scientific Research, Japan, and the Takeda Science Foundation.; Supported by Bolyai Janos fellowship of the Hungarian Academy of Sciences and Hungarian Scientific Research Fund Grant 81950.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Asherie N, 2004, METHODS, V34, P266, DOI 10.1016/j.ymeth.2004.03.028; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Bystrom R, 2008, CELL BIOCHEM BIOPHYS, V52, P175, DOI 10.1007/s12013-008-9033-4; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Crespo R, 2010, J APPL CRYSTALLOGR, V43, P1419, DOI 10.1107/S0021889810040951; Durbin SD, 1996, ANNU REV PHYS CHEM, V47, P171, DOI 10.1146/annurev.physchem.47.1.171; Dzwolak W, 2005, BIOCHEMISTRY-US, V44, P8948, DOI 10.1021/bi050281t; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; KAM Z, 1978, J MOL BIOL, V123, P539, DOI 10.1016/0022-2836(78)90206-1; Kardos J, 2005, BBA-PROTEINS PROTEOM, V1753, P108, DOI 10.1016/j.bbapap.2005.08.013; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Lin YX, 2014, LANGMUIR, V30, P1845, DOI 10.1021/la403100h; Loksztejn A, 2010, J MOL BIOL, V395, P643, DOI 10.1016/j.jmb.2009.10.065; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Roeder AM, 2013, J BIOL CHEM, V288, P27638, DOI 10.1074/jbc.M113.463273; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sekhar A, 2011, BIOCHEMISTRY-US, V50, P805, DOI 10.1021/bi101312h; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Whitmore L, 2011, NUCLEIC ACIDS RES, V39, pD480, DOI 10.1093/nar/gkq1026; Yagi H, 2013, BBA-PROTEINS PROTEOM, V1834, P2480, DOI 10.1016/j.bbapap.2013.08.013; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	47	39	39	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18228	18238		10.1074/jbc.M114.566950	http://dx.doi.org/10.1074/jbc.M114.566950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24847058	Green Published, hybrid			2022-12-28	WOS:000338042000024
J	No, YR; He, PJ; Yoo, BK; Yun, CC				No, Yi Ran; He, Peijian; Yoo, Byong Kwon; Yun, C. Chris			Unique Regulation of Human Na+/H+ Exchanger 3 (NHE3) by Nedd4-2 Ligase That Differs from Non-primate NHE3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; UBIQUITIN LIGASES; PROXIMAL TUBULE; BLOOD-PRESSURE; ISOFORM NHE3; WW DOMAINS; ACTIVATION; PHOSPHORYLATION; HYPERTENSION; DEGRADATION	Na+/H+ exchanger NHE3 expressed in the intestine and kidney plays a major role in NaCl and HCO3- absorption that is closely linked to fluid absorption and blood pressure regulation. The Nedd4 family of E3 ubiquitin ligases interacts with a number of transporters and channels via PY motifs. A comparison of NHE3 sequences revealed the presence of PY motifs in NHE3s from human and several non-human primates but not in non-primate NHE3s. In this study we evaluated the differences between human and non-primate NHE3s in ubiquitination and interaction with Nedd4-2. We found that Nedd4-2 ubiquitinated human NHE3 (hNHE3) and altered its expression and activity. Surprisingly, rat NHE3 coimmunoprecipitated Nedd4-2, but its expression and activity were not altered by silencing of Nedd4-2. Ubiquitination by Nedd4-2 rendered hNHE3 to undergo internalization at a significantly greater rate than non-primate NHE3s without altering protein stability. Insertion of a PY motif in rabbit NHE3 recapitulated the interaction with Nedd4-2 and enhanced internalization. Thus, we propose a new model where disruption of Nedd4-2 interaction elevates hNHE3 expression and activity.	[No, Yi Ran; He, Peijian; Yoo, Byong Kwon; Yun, C. Chris] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Yun, C. Chris] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Yun, CC (corresponding author), Emory Univ, Sch Med, Div Digest Dis, Whitehead Bldg Rm 201,615 Michael St, Atlanta, GA 30322 USA.	ccyun@emory.edu		He, Peijian/0000-0002-9526-8004; Yoo, Brian/0000-0003-0683-1887	National Institutes of Health [R24DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK061418, T32DK007771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The microscopy core was supported by National Institutes of Health Grant R24DK064399.	Alexander RT, 2009, J EXP BIOL, V212, P1630, DOI 10.1242/jeb.027375; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; Armando I, 2014, FASEB J, V28, P1422, DOI 10.1096/fj.13-243840; Biemesderfer D, 1999, J BIOL CHEM, V274, P17518, DOI 10.1074/jbc.274.25.17518; Bobulescu IA, 2009, PFLUG ARCH EUR J PHY, V458, P5, DOI 10.1007/s00424-008-0595-1; Bobulescu IA, 2005, CURR OPIN NEPHROL HY, V14, P485, DOI 10.1097/01.mnh.0000174146.52915.5d; Cabado AG, 1996, J BIOL CHEM, V271, P3590; Chandran S, 2011, J BIOL CHEM, V286, P37830, DOI 10.1074/jbc.M111.293233; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Fouladkou F, 2004, AM J PHYSIOL-RENAL, V287, pF550, DOI 10.1152/ajprenal.00353.2003; Fuster DG, 2007, AM J PHYSIOL-RENAL, V292, pF577, DOI 10.1152/ajprenal.00240.2006; Gill RK, 2005, GASTROENTEROLOGY, V128, P962, DOI 10.1053/j.gastro.2005.02.011; Girardi ACC, 2012, AM J PHYSIOL-CELL PH, V302, pC1569, DOI 10.1152/ajpcell.00017.2012; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; He PJ, 2011, MOL BIOL CELL, V22, P3812, DOI 10.1091/mbc.E11-04-0328; He PJ, 2010, J BIOL CHEM, V285, P27869, DOI 10.1074/jbc.M110.133066; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kanelis V, 1998, BIOCHEM CELL BIOL, V76, P341, DOI 10.1139/bcb-76-2-3-341; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; LaPointe MS, 2002, KIDNEY INT, V62, P157, DOI 10.1046/j.1523-1755.2002.00406.x; LIFTON RP, 1991, HYPERTENSION, V17, P8, DOI 10.1161/01.HYP.17.1.8; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Noonan WT, 2005, AM J PHYSIOL-REG I, V288, pR685, DOI 10.1152/ajpregu.00209.2004; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Pankow JS, 2005, AM J HYPERTENS, V18, P672, DOI 10.1016/j.amjhyper.2004.12.004; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Riquier ADM, 2009, AM J PHYSIOL-CELL PH, V296, pC900, DOI 10.1152/ajpcell.00526.2008; Rotin D, 2011, PFLUG ARCH EUR J PHY, V461, P1, DOI 10.1007/s00424-010-0893-2; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Simonin A, 2010, J BIOL CHEM, V285, P38293, DOI 10.1074/jbc.M110.115089; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yewdell JW, 2011, CELL BIOL INT, V35, P457, DOI 10.1042/CBI20110055; Yip KP, 1998, AM J PHYSIOL-RENAL, V275, pF565, DOI 10.1152/ajprenal.1998.275.4.F565; Yoo BK, 2012, AM J PHYSIOL-GASTR L, V303, pG180, DOI 10.1152/ajpgi.00069.2012; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	53	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18360	18372		10.1074/jbc.M113.541706	http://dx.doi.org/10.1074/jbc.M113.541706			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831004	Green Published, hybrid			2022-12-28	WOS:000338042000035
J	Choi, BH; Pagano, M; Huang, CS; Dai, W				Choi, Byeong Hyeok; Pagano, Michele; Huang, Chaunshu; Dai, Wei			Cdh1, a Substrate-recruiting Component of Anaphase-promoting Complex/Cyclosome (APC/C) Ubiquitin E3 Ligase, Specifically Interacts with Phosphatase and Tensin Homolog (PTEN) and Promotes Its Removal from Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; NUCLEAR PTEN; STABILITY; PHOSPHORYLATION; NEDD4-1	A pool of PTEN localizes to the nucleus. However, the exact mechanism by which nuclear PTEN is regulated remains unclear. We have recently reported that Plk1 specifically phosphorylates PTEN on Ser-380 during mitosis. Here we report that PTEN also localized to chromatin and that chromatin PTEN was removed by a proteasome-dependent process during mitotic exit. Pulldown analysis revealed that Cdh1, but not Cdc20, was significantly associated with PTEN. Cdh1 interacted with PTEN via two separate domains, and their interaction was enhanced by MG132, a proteasome inhibitor. Cdh1 negatively controlled the stability of chromatin PTEN by polyubiquitination. Phosphorylation of PTEN on Ser-380 impaired its interaction with Cdh1, thus positively regulating PTEN stability on chromatin. Significantly, the PTEN interaction with Cdh1 was phosphatase-independent, and Cdh1 knockdown via RNAi led to significant accumulation of chromatin PTEN, delaying mitotic exit. Combined, our studies identify Cdh1 as an important regulator of nuclear/chromatin PTEN during mitosis.	[Choi, Byeong Hyeok; Huang, Chaunshu; Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Choi, Byeong Hyeok; Huang, Chaunshu; Dai, Wei] NYU, Sch Med, Dept Biochem, Tuxedo Pk, NY 10987 USA; [Choi, Byeong Hyeok; Huang, Chaunshu; Dai, Wei] NYU, Sch Med, Dept Mol Pharmacol, Tuxedo Pk, NY 10987 USA; [Pagano, Michele] NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; New York University; New York University; Howard Hughes Medical Institute; New York University	Dai, W (corresponding author), Dept Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@nyumc.org		pagano, michele/0000-0003-3210-2442; Choi, Byeong Hyeok/0000-0002-8866-1131; Huang, Chuanshu/0000-0003-4133-5096; Dai, Wei/0000-0003-0169-8327	United States Public Service Awards [CA090658, CA150512]; National Institutes of Health Center Grant, NIEHS [ES000260]; National Institutes of Health [R01-GM057587, R21-AG032560]; NATIONAL CANCER INSTITUTE [R01CA150512, R37CA076584, P30CA016087, R01CA090658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032560] Funding Source: NIH RePORTER	United States Public Service Awards; National Institutes of Health Center Grant, NIEHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by United States Public Service Awards CA090658 and CA150512 (to W. D.), National Institutes of Health Center Grant ES000260 from the NIEHS, and National Institutes of Health Grants R01-GM057587 and R21-AG032560 (to M. P.).	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Choi BH, 2014, J BIOL CHEM, V289, P14066, DOI 10.1074/jbc.M114.558155; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Hu LY, 2011, CELL CYCLE, V10, P2373, DOI 10.4161/cc.10.14.16310; Lee JT, 2013, CELL RES, V23, P552, DOI 10.1038/cr.2013.27; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241	24	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17951	17959		10.1074/jbc.M114.559005	http://dx.doi.org/10.1074/jbc.M114.559005			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24811168	hybrid, Green Published			2022-12-28	WOS:000338018100055
J	Nelson, DW; Gao, Y; Yen, MI; Yen, CLE				Nelson, David W.; Gao, Yu; Yen, Mei-I; Yen, Chi-Liang Eric			Intestine-specific Deletion of Acyl-CoA: Monoacylglycerol Acyltransferase (MGAT) 2 Protects Mice from Diet-induced Obesity and Glucose Intolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; ENERGY-BALANCE; FATTY-ACIDS; 1 DGAT1; METABOLISM; SECRETION; TRIGLYCERIDE; DEFICIENCY; ABSORPTION; MECHANISMS	The absorption of dietary fat involves the re-esterification of digested triacylglycerol in the enterocytes, a process catalyzed by acyl-CoA: monoacylglycerol acyltransferase (MGAT) 2. Mice without a functional gene encoding MGAT2 (Mogat2(-/-)) are protected from diet-induced obesity. Surprisingly, these mice absorb normal amounts of dietary fat but increase their energy expenditure. MGAT2 is expressed in tissues besides intestine, including adipose tissue in both mice and humans. To test the hypothesis that intestinal MGAT2 regulates systemic energy balance, we generated and characterized mice deficient in MGAT2 specifically in the small intestine (Mogat2(IKO)). We found that, like Mogat2(-/-) mice, Mogat2(IKO) mice also showed a delay in fat absorption, a decrease in food intake, and a propensity to use fatty acids as fuel when first exposed to a high fat diet. Mogat2(IKO) mice increased energy expenditure although to a lesser degree than Mogat2(-/-) mice and were protected against diet-induced weight gain and associated comorbidities, including hepatic steatosis, hypercholesterolemia, and glucose intolerance. These findings illustrate that intestinal lipid metabolism plays a crucial role in the regulation of systemic energy balance and may be a feasible intervention target. In addition, they suggest that MGAT activity in extraintestinal tissues may also modulate energy metabolism.	[Nelson, David W.; Gao, Yu; Yen, Mei-I; Yen, Chi-Liang Eric] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yen, CLE (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	yen@nutrisci.wisc.edu	Gao, Yu/AAU-9530-2021	Gao, Yu/0000-0002-4210-7338	National Institutes of Health [R01DK088210, T32DK007665]; United States Department of Agriculture [WIS01442]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088210, T32DK007665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK088210 (to E. Y.) and T32DK007665 (to D. N.). This work was also supported by United States Department of Agriculture Grant WIS01442.	Ables GP, 2012, J LIPID RES, V53, P2364, DOI 10.1194/jlr.M029041; Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chambers AP, 2013, CURR BIOL, V23, pR379, DOI 10.1016/j.cub.2013.03.020; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Chon SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043962; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Denison H, 2014, DIABETES OBES METAB, V16, P334, DOI 10.1111/dom.12221; Doi R, 2010, J BIOL CHEM, V285, P22114, DOI 10.1074/jbc.M110.110361; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao Y, 2013, J LIPID RES, V54, P1644, DOI 10.1194/jlr.M035493; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hiramine Y, 2010, J LIPID RES, V51, P1424, DOI 10.1194/jlr.M002584; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; Kindel T, 2010, ATHEROSCLEROSIS SUPP, V11, P11, DOI 10.1016/j.atherosclerosissup.2010.03.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; Mansbach CM, 2007, AM J PHYSIOL-GASTR L, V293, pG645, DOI 10.1152/ajpgi.00299.2007; Mitra MS, 2013, P NATL ACAD SCI USA, V110, P642, DOI 10.1073/pnas.1213493110; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Quarta C, 2011, TRENDS MOL MED, V17, P518, DOI 10.1016/j.molmed.2011.05.002; Ryan KK, 2012, CELL METAB, V15, P137, DOI 10.1016/j.cmet.2011.12.013; Storch J, 2008, J LIPID RES, V49, P1762, DOI 10.1194/jlr.M800116-JLR200; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899	43	49	50	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17338	17349		10.1074/jbc.M114.555961	http://dx.doi.org/10.1074/jbc.M114.555961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24784138	hybrid, Green Published			2022-12-28	WOS:000338018100005
J	Ou, CY; Chen, TC; Lee, JV; Wang, JC; Stallcup, MR				Ou, Chen-Yin; Chen, Tzu-Chieh; Lee, Joyce V.; Wang, Jen-Chywan; Stallcup, Michael R.			Coregulator Cell Cycle and Apoptosis Regulator 1 (CCAR1) Positively Regulates Adipocyte Differentiation through the Glucocorticoid Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN RECEPTOR; KEY REGULATOR; TARGET GENES; BETA-CATENIN; PPAR-GAMMA; ADIPOGENESIS; COACTIVATOR; EXPRESSION; ACTIVATION; DYSREGULATION	Glucocorticoids contribute to adipocyte differentiation by cooperating with transcription factors, such as CCAAT/enhancer-binding protein beta (C/EBP beta), to stimulate transcription of the gene encoding peroxisome proliferator-activated receptor (PPAR gamma), a master regulator of adipogenesis. However, the mechanism of PPAR gamma gene regulation by glucocorticoids, the glucocorticoid receptor (GR), and its coregulators is poorly understood. Here we show that two GR binding regions (GBRs) in the mouse PPAR gamma gene were responsive to glucocorticoid, and treatment of 3T3-L1 preadipocytes with glucocorticoid alone induced GR occupancy and chromatin remodeling at PPAR gamma GBRs, which also contain binding sites for C/EBP and PPAR gamma proteins. GR recruited cell cycle and apoptosis regulator 1 (CCAR1), a transcription coregulator, to the PPAR gamma gene GBRs. Notably, CCAR1 was required for GR occupancy and chromatin remodeling at one of the PPAR gamma gene GBRs. Moreover, depletion of CCAR1 markedly suppressed differentiation of mouse mesenchymal stem cells and 3T3-L1 preadipocytes to mature adipocytes and decreased induction of PPAR gamma, C/EBP alpha, and C/EBP delta. Although CCAR1 was required for stimulation of several GR-regulated adipogenic genes in 3T3-L1 preadipocytes by glucocorticoid, it was not required for GR-activated transcription of certain anti-inflammatory genes in human A549 lung epithelial cells. Overall, our results highlighted the novel and specific roles of GR and CCAR1 in adipogenesis.	[Ou, Chen-Yin; Stallcup, Michael R.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Chen, Tzu-Chieh; Lee, Joyce V.; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of Southern California; University of California System; University of California Berkeley	Wang, JC (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Morgan Hall,Rm 231, Berkeley, CA 94720 USA.	walwang@berkeley.edu; stallcup@usc.edu	Ou, Chenyin/AAM-7473-2020; Wang, Jen-Chywan/AAX-4445-2020	Ou, Chenyin/0000-0002-8036-7317; Wang, Jen-Chywan/0000-0001-6030-6886	National Institutes of Health [DK043093, DK083591, P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093, R01DK083591, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK043093 (to M. R. S.), DK083591 (to J.-C. W.), and P30 CA014089 (a Cancer Center Support Grant to the University of Southern California).	Ali A, 2004, J MED CHEM, V47, P2441, DOI 10.1021/jm030585i; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Bungard CJ, 2011, BIOORGAN MED CHEM, V19, P7374, DOI 10.1016/j.bmc.2011.10.054; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Kim YR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-197; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Nishizuka M, 2001, J BIOL CHEM, V276, P29625, DOI 10.1074/jbc.C100272200; Ou CY, 2011, MOL CANCER RES, V9, P660, DOI 10.1158/1541-7786.MCR-10-0223; Ou CY, 2009, J BIOL CHEM, V284, P20629, DOI 10.1074/jbc.M109.014332; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Roberge C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1465, DOI 10.1152/ajpendo.00516.2007; Roohk DJ, 2010, J PHARMACOL EXP THER, V333, P281, DOI 10.1124/jpet.109.162487; Saladin R, 1999, CELL GROWTH DIFFER, V10, P43; Seo WY, 2013, NUCLEIC ACIDS RES, V41, P8526, DOI 10.1093/nar/gkt644; Shah N, 2004, BIOORG MED CHEM LETT, V14, P5199, DOI 10.1016/j.bmcl.2004.07.052; Shimba S, 2004, J BIOL CHEM, V279, P40946, DOI 10.1074/jbc.M400840200; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Siersbaek R, 2011, COLD SH Q B, V76, P247, DOI 10.1101/sqb.2011.76.010512; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Teyssier C, 2006, MOL ENDOCRINOL, V20, P1276, DOI 10.1210/me.2005-0393; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang LF, 2013, EMBO J, V32, P45, DOI 10.1038/emboj.2012.306; Yu EJ, 2013, ONCOGENE, V32, P4160, DOI 10.1038/onc.2012.420; Yu EJ, 2011, NUCLEIC ACIDS RES, V39, P6932, DOI 10.1093/nar/gkr347	35	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17078	17086		10.1074/jbc.M114.548081	http://dx.doi.org/10.1074/jbc.M114.548081			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24811171	Green Published, hybrid			2022-12-28	WOS:000338016200041
J	Schlessinger, A; Sun, NN; Colas, C; Pajor, AM				Schlessinger, Avner; Sun, Nina N.; Colas, Claire; Pajor, Ana M.			Determinants of Substrate and Cation Transport in the Human Na+/Dicarboxylate Cotransporter NaDC3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DICARBOXYLATE TRANSPORTER; STRUCTURE PREDICTION; INSULIN-RESISTANCE; PROTEIN; SODIUM; AFFINITY; CLASSIFICATION; SPECIFICITY; RECOGNITION; EXPRESSION	Metabolic intermediates, such as succinate and citrate, regulate important processes ranging from energy metabolism to fatty acid synthesis. Cytosolic concentrations of these metabolites are controlled, in part, by members of the SLC13 gene family. The molecular mechanism underlying Na+-coupled di- and tricarboxylate transport by this family is understood poorly. The human Na+/dicarboxylate cotransporter NaDC3 (SLC13A3) is found in various tissues, including the kidney, liver, and brain. In addition to citric acid cycle intermediates such as alpha-ketoglutarate and succinate, NaDC3 transports other compounds into cells, including N-acetyl aspartate, mercaptosuccinate, and glutathione, in keeping with its dual roles in cell nutrition and detoxification. In this study, we construct a homology structural model of NaDC3 on the basis of the structure of the Vibrio cholerae homolog vcINDY. Our computations are followed by experimental testing of the predicted NaDC3 structure and mode of interaction with various substrates. The results of this study show that the substrate and cation binding domains of NaDC3 are composed of residues in the opposing hairpin loops and unwound portions of adjacent helices. Furthermore, these results provide a possible explanation for the differential substrate specificity among dicarboxylate transporters that underpin their diverse biological roles in metabolism and detoxification. The structural model of NaDC3 provides a framework for understanding substrate selectivity and the Na+-coupled anion transport mechanism by the human SLC13 family and other key solute carrier transporters.	[Schlessinger, Avner; Colas, Claire] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Sun, Nina N.; Pajor, Ana M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92130 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego	Schlessinger, A (corresponding author), 1 Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.	avner.schlessinger@mssm.edu; apajor@ucsd.edu		Colas, Claire/0000-0001-6703-9186	National Institutes of Health [R01 GM108911]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project supported, in whole or in part, by National Institutes of Health Grant R01 GM108911 (to A. S. and C. C.).	Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Burckhardt BC, 2005, AM J PHYSIOL-RENAL, V288, pF792, DOI 10.1152/ajprenal.00360.2004; Burckhardt BC, 2002, J AM SOC NEPHROL, V13, P2628, DOI 10.1097/01.ASN.0000033463.58641.F9; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coleman RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075992; Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; GULLANS SR, 1988, AM J PHYSIOL, V255, pF1170, DOI 10.1152/ajprenal.1988.255.6.F1170; Huang W, 2000, J PHARMACOL EXP THER, V295, P392; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaufhold M, 2011, AM J PHYSIOL-RENAL, V301, pF1026, DOI 10.1152/ajprenal.00169.2011; King Steven C., 2004, BMC Biochemistry, V5, P16, DOI 10.1186/1471-2091-5-16; Knauf F, 2002, P NATL ACAD SCI USA, V99, P14315, DOI 10.1073/pnas.222531899; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; Oshiro N, 2006, BIOCHEMISTRY-US, V45, P2302, DOI 10.1021/bi052328g; Oshiro N, 2006, BBA-BIOMEMBRANES, V1758, P781, DOI 10.1016/j.bbamem.2006.05.005; Pajor AM, 2005, J BIOL CHEM, V280, P18728, DOI 10.1074/jbc.M501265200; Pajor AM, 1998, J BIOL CHEM, V273, P18923, DOI 10.1074/jbc.273.30.18923; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Pajor AM, 2010, AM J PHYSIOL-RENAL, V299, pF704, DOI 10.1152/ajprenal.00213.2010; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Prakash S, 2003, BBA-BIOMEMBRANES, V1618, P79, DOI 10.1016/j.bbamem.2003.10.010; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger A, 2013, CLIN PHARMACOL THER, V94, P19, DOI 10.1038/clpt.2013.73; Schlessinger A, 2013, CURR TOP MED CHEM, V13, P843, DOI 10.2174/1568026611313070007; Schlessinger A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388157; Schorbach L, 2013, NEPHRON PHYSIOL, V124, P1, DOI 10.1159/000356419; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shuprisha A, 1999, AM J PHYSIOL-RENAL, V277, pF513, DOI 10.1152/ajprenal.1999.277.4.F513; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stoppa GR, 2008, J ENDOCRINOL, V198, P157, DOI 10.1677/JOE-07-0428; Wang HP, 2000, AM J PHYSIOL-CELL PH, V278, pC1019, DOI 10.1152/ajpcell.2000.278.5.C1019; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	41	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16998	17008		10.1074/jbc.M114.554790	http://dx.doi.org/10.1074/jbc.M114.554790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24808185	Green Published, hybrid			2022-12-28	WOS:000338016200034
J	Kumari, G; Ulrich, T; Krause, M; Finkernagel, F; Gaubatz, S				Kumari, Geeta; Ulrich, Tanja; Krause, Michael; Finkernagel, Florian; Gaubatz, Stefan			Induction of p21CIP1 Protein and Cell Cycle Arrest after Inhibition of Aurora B Kinase Is Attributed to Aneuploidy and Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CHROMOSOMAL PASSENGER COMPLEX; MAMMALIAN-CELLS; DNA-DAMAGE; TETRAPLOIDY CHECKPOINT; P53; PHOSPHORYLATION; MITOSIS; ELONGATION; P21(CIP1)	Cell cycle progression requires a series of highly coordinated events that ultimately lead to faithful segregation of chromosomes. Aurora B is an essential mitotic kinase, which is involved in regulation of microtubule-kinetochore attachments and cytokinesis. Inhibition of Aurora B results in stabilization of p53 and induction of p53-target genes such as p21 to inhibit proliferation. We have previously demonstrated that induction of p21 by p53 after inhibition of Aurora B is dependent on the p38 MAPK, which promotes transcriptional elongation of p21 by RNA Pol II. In this study, we show that a subset of p53-target genes are induced in a p38-dependent manner upon inhibition of Aurora B. We also demonstrate that inhibition of Aurora B results in down-regulation of E2F-mediated transcription and that the cell cycle arrest after Aurora B inhibition depends on p53 and pRB tumor suppressor pathways. In addition, we report that activation of p21 after inhibition of Aurora B is correlated with increased chromosome missegregation and aneuploidy but not with binucleation or tetraploidy. We provide evidence that p21 is activated in aneuploid cells by reactive oxygen species (ROS) and p38 MAPK. Finally, we demonstrate that certain drugs that act on aneuploid cells synergize with inhibitors of Aurora B to inhibit colony formation and oncogenic transformation. These findings provide an important link between aneuploidy and the stress pathways activated by Aurora B inhibition and also support the use of Aurora B inhibitors in combination therapy for treatment of cancer.	[Kumari, Geeta; Ulrich, Tanja; Gaubatz, Stefan] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97080 Wurzburg, Germany; [Kumari, Geeta; Ulrich, Tanja; Gaubatz, Stefan] Comprehens Canc Ctr Mainfranken, D-97080 Wurzburg, Germany; [Krause, Michael; Finkernagel, Florian] Univ Marburg, Inst Mol Biol & Tumor Res IMT, D-35033 Marburg, Germany	University of Wurzburg; University of Wurzburg; Philipps University Marburg	Gaubatz, S (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Dept Physiol Chem, Bioctr, D-97074 Wurzburg, Germany.	stefan.gaubatz@biozentrum.uni-wuerzburg.de		Gaubatz, Stefan/0000-0001-8751-4191	DFG [575/6-1, TR17-B1]; priority research program LOEWE Tumor and Inflammation; German Excellence Initiative	DFG(German Research Foundation (DFG)); priority research program LOEWE Tumor and Inflammation; German Excellence Initiative	This work was supported by grants from the DFG (575/6-1 and TR17-B1) (to S. G.) and the priority research program LOEWE Tumor and Inflammation (to F. F.).; Supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg.	Al-Romaih K, 2003, CANCER GENET CYTOGEN, V144, P91, DOI 10.1016/S0165-4608(02)00929-9; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132; Blagosklonny MV, 2006, CELL CYCLE, V5, P971, DOI 10.4161/cc.5.9.2711; Boss DS, 2009, ONCOLOGIST, V14, P780, DOI 10.1634/theoncologist.2009-0019; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dreier MR, 2009, EXP CELL RES, V315, P1085, DOI 10.1016/j.yexcr.2009.02.008; EARNSHAW WC, 1991, J CELL SCI, V98, P443; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gully CP, 2012, P NATL ACAD SCI USA, V109, pE1513, DOI 10.1073/pnas.1110287109; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Katayama H, 2010, BBA-GENE REGUL MECH, V1799, P829, DOI 10.1016/j.bbagrm.2010.09.004; Kawauchi J, 2013, J BIOL CHEM, V288, P24302, DOI 10.1074/jbc.M113.496703; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; KIERSTEAD TD, 1993, J VIROL, V67, P1817, DOI 10.1128/JVI.67.4.1817-1829.1993; Kumari G, 2013, CELL CYCLE, V12, P2051, DOI 10.4161/cc.25100; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411; Marxer M, 2014, ONCOGENE, V33, P3550, DOI 10.1038/onc.2013.325; Nair JS, 2009, MOL BIOL CELL, V20, P2218, DOI 10.1091/mbc.E08-08-0885; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Trakala M, 2013, CELL CYCLE, V12, P1030, DOI 10.4161/cc.24004; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Valin A, 2013, MOL CELL BIOL, V33, P1582, DOI 10.1128/MCB.00323-12; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Wu LM, 2011, J BIOL CHEM, V286, P2236, DOI 10.1074/jbc.M110.174755; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800	47	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16072	16084		10.1074/jbc.M114.555060	http://dx.doi.org/10.1074/jbc.M114.555060			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24782314	hybrid, Green Published			2022-12-28	WOS:000337965700016
J	Guo, J; Carrington, Y; Alber, A; Ehlting, J				Guo, Jia; Carrington, Yuriko; Alber, Annette; Ehlting, Juergen			Molecular Characterization of Quinate and Shikimate Metabolism in Populus trichocarpa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Gene Expression; Plant Biochemistry; Plant Defense; Secondary Metabolism; Primary Metabolism; Quinate Biosynthesis; Shikimate Pathway	TRANSGENIC TOBACCO PLANTS; ALICYCLIC ACID METABOLISM; CHLOROGENIC ACID; QUINIC ACID; AROMATIC BIOSYNTHESIS; 5-DEHYDROSHIKIMIC REDUCTASE; PHENYLALANINE BIOSYNTHESIS; PARTIAL-PURIFICATION; GENE FAMILY; PATHWAY	Background: Shikimate is essential for protein biosynthesis. Quinate and its derivatives are protective secondary metabolites. Results: Members of the same gene family encode enzymes with either shikimate or quinate dehydrogenase activity. Conclusion: The molecular genetic basis of plant quinate metabolism has been unraveled in vitro. Significance: Identifying quinate metabolic enzymes will allow testing its ecological function and may enable biotechnological applications. The shikimate pathway leads to the biosynthesis of aromatic amino acids essential for protein biosynthesis and the production of a wide array of plant secondary metabolites. Among them, quinate is an astringent feeding deterrent that can be formed in a single step reaction from 3-dehydroquinate catalyzed by quinate dehydrogenase (QDH). 3-Dehydroquinate is also the substrate for shikimate biosynthesis through the sequential actions of dehydroquinate dehydratase (DQD) and shikimate dehydrogenase (SDH) contained in a single protein in plants. The reaction mechanism of QDH resembles that of SDH. The poplar genome encodes five DQD/SDH-like genes (Poptr1 to Poptr5), which have diverged into two distinct groups based on sequence analysis and protein structure prediction. In vitro biochemical assays proved that Poptr1 and -5 are true DQD/SDHs, whereas Poptr2 and -3 instead have QDH activity with only residual DQD/SDH activity. Poplar DQD/SDHs have distinct expression profiles suggesting separate roles in protein and lignin biosynthesis. Also, the QDH genes are differentially expressed. In summary, quinate (secondary metabolism) and shikimate (primary metabolism) metabolic activities are encoded by distinct members of the same gene family, each having different physiological functions.	[Ehlting, Juergen] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Ehlting, Juergen] Univ Victoria, Ctr Forest Biol, Victoria, BC V8W 2Y2, Canada	University of Victoria; University of Victoria	Ehlting, J (corresponding author), Univ Victoria, Dept Biol, POB 1700 Stn CSC, Victoria, BC V8W 2Y2, Canada.	je@uvic.ca		Ehlting, Jurgen/0000-0003-2302-696X	Canadian Foundation for Innovation	Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank Johannes Moquenco for technical assistance and Dr. C. Peter Constabel for critical reading of the manuscript. We appreciate the help from Dr. Martin Boulanger with protein structure modeling and interpretation. We are thankful to Dr. Osao Adachi for providing 3-dehydroshikimate prior to it becoming commercially available. Laboratory infrastructure was supported by a Leaders Opportunity Fund from the Canadian Foundation for Innovation (to J.E.).	BALINSKY D, 1971, BIOCHEMISTRY-US, V10, P1947; BALINSKY D, 1961, BIOCHEM J, V80, P292, DOI 10.1042/bj0800292; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Bischoff M, 2001, PLANT PHYSIOL, V125, P1891, DOI 10.1104/pp.125.4.1891; BONNER CA, 1994, BIOCHEM J, V302, P11, DOI 10.1042/bj3020011; BOUDET AM, 1980, PLANT CELL PHYSIOL, V21, P785, DOI 10.1093/oxfordjournals.pcp.a076053; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buschiazzo E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-8; COLE RA, 1984, ANN APPL BIOL, V105, P129, DOI 10.1111/j.1744-7348.1984.tb02809.x; COLE RA, 1985, ANN APPL BIOL, V106, P211, DOI 10.1111/j.1744-7348.1985.tb03110.x; DAVIES DD, 1972, BIOCHEM J, V127, P335, DOI 10.1042/bj1270335; De Sotillo DR, 1998, J FOOD SCI, V63, P907, DOI 10.1111/j.1365-2621.1998.tb17924.x; DEWICK PM, 1995, NAT PROD REP, V12, P579, DOI 10.1039/np9951200579; Diaz J, 1997, PHYSIOL PLANTARUM, V100, P147, DOI 10.1034/j.1399-3054.1997.1000116.x; Ding L, 2007, J EXP BOT, V58, P2053, DOI 10.1093/jxb/erm059; DOWSETT JR, 1971, BIOCHEM J, V123, pP23; EDWARDS PJ, 1983, OECOLOGIA, V59, P88, DOI 10.1007/BF00388079; Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Floss H. G., 1979, RECENT ADV PHYTOCHEM, V12, P59; FRIEND J, 1973, PHYSIOL PLANT PATHOL, V3, P495, DOI 10.1016/0048-4059(73)90060-X; GAMBORG OL, 1967, PHYTOCHEMISTRY, V6, P1067, DOI 10.1016/S0031-9422(00)86063-X; GAMBORG OL, 1966, BIOCHIM BIOPHYS ACTA, V128, P483, DOI 10.1016/0926-6593(66)90009-9; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Givry S, 2007, CARBOHYD RES, V342, P859, DOI 10.1016/j.carres.2006.12.013; Goldschmidt O., 1964, TAPPI, V47, P528; GRAZIANA A, 1980, PLANT CELL PHYSIOL, V21, P1163, DOI 10.1093/oxfordjournals.pcp.a076115; Graziana A., 1983, GROUP POL JOURN INT, P120; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hamberger Bjoern, 2006, V40, P85; Haruta M, 2001, PLANT MOL BIOL, V46, P347, DOI 10.1023/A:1010654711619; HERRMANN KM, 1995, PLANT CELL, V7, P907; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; JOHNSON G, 1952, SCIENCE, V115, P627, DOI 10.1126/science.115.2997.627; KANG XB, 1993, PHYTOCHEMISTRY, V33, P769, DOI 10.1016/0031-9422(93)85272-S; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131; LEUSCHNER C, 1995, PLANT PHYSIOL, V108, P319, DOI 10.1104/pp.108.1.319; LEUSCHNER C, 1991, PHYTOCHEMISTRY, V30, P2203, DOI 10.1016/0031-9422(91)83615-R; Lindner HA, 2005, J BIOL CHEM, V280, P7162, DOI 10.1074/jbc.M412028200; Lou ZX, 2011, J FOOD SCI, V76, pM398, DOI 10.1111/j.1750-3841.2011.02213.x; Ma CM, 2007, BIOORGAN MED CHEM, V15, P6830, DOI 10.1016/j.bmc.2007.07.038; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; MAHER EA, 1994, P NATL ACAD SCI USA, V91, P7802, DOI 10.1073/pnas.91.16.7802; Marsh KB, 2009, FUNCT PLANT BIOL, V36, P463, DOI 10.1071/FP08240; MARUTA Y, 1995, J AGR FOOD CHEM, V43, P2592, DOI 10.1021/jf00058a007; MCCLURE TT, 1960, AM J BOT, V47, P277, DOI 10.2307/2439607; MINAMIKA.T, 1969, PLANT CELL PHYSIOL, V10, P283; MINAMIKAWA T, 1977, PLANT CELL PHYSIOL, V18, P743; Morton LW, 2000, CLIN EXP PHARMACOL P, V27, P152, DOI 10.1046/j.1440-1681.2000.03214.x; MOUSDALE DM, 1985, J CHROMATOGR, V329, P268, DOI 10.1016/S0021-9673(01)81929-4; Muir RM, 2011, PLANT MOL BIOL, V75, P555, DOI 10.1007/s11103-011-9739-3; NANDY M, 1961, ARCH BIOCHEM BIOPHYS, V92, P399, DOI 10.1016/0003-9861(61)90378-2; Nie LD, 2009, TETRAHEDRON-ASYMMETR, V20, P124, DOI 10.1016/j.tetasy.2008.11.027; OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988; OSSIPOV V, 1995, TREES-STRUCT FUNCT, V10, P46, DOI 10.1007/BF00197779; Ossipov V, 2000, PLANT PHYSIOL BIOCH, V38, P923, DOI 10.1016/S0981-9428(00)01203-1; Ossipov V., 1986, BIOKHIMIYA, V51, P230; Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323; PILET PE, 1964, PHYTOCHEMISTRY, V3, P617, DOI 10.1016/S0031-9422(00)82937-4; REFENO G, 1982, PLANTA, V154, P193, DOI 10.1007/BF00387863; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Rogiers SY, 1997, CAN J BOT, V75, P1215, DOI 10.1139/b97-835; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; SCHMID J, 1995, PHYTOCHEMISTRY, V39, P737, DOI 10.1016/0031-9422(94)00962-S; SCHMIDT CL, 1991, J PLANT PHYSIOL, V138, P51, DOI 10.1016/S0176-1617(11)80729-7; Singh SA, 2007, CRYST GROWTH DES, V7, P2153, DOI 10.1021/cg7007107; Singh SA, 2006, BIOCHEMISTRY-US, V45, P7787, DOI 10.1021/bi060366+; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08; Tohge T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00062; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Weaver LM, 1997, TRENDS PLANT SCI, V2, P346, DOI 10.1016/S1360-1385(97)84622-5; WEINSTEIN L, 1961, CONTRIB BOYCE THOMPS, V21, P201; YANIV H, 1955, J BIOL CHEM, V213, P787; YOSHIDA S, 1969, ANN REV PLANT PHYSIO, V20, P41, DOI 10.1146/annurev.pp.20.060169.000353; Zhang XL, 2005, J BIOCHEM MOL BIOL, V38, P624	79	30	30	2	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23846	23858		10.1074/jbc.M114.558536	http://dx.doi.org/10.1074/jbc.M114.558536			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24942735	Green Published, hybrid			2022-12-28	WOS:000341505000051
J	Zhang, G; Chen, X; Qiu, FH; Zhu, FX; Lei, WJ; Nie, J				Zhang, Guo; Chen, Xia; Qiu, Fanghua; Zhu, Fengxin; Lei, Wenjing; Nie, Jing			RETRACTED: A Novel Interaction between the SH2 Domain of Signaling Adaptor Protein Nck-1 and the Upstream Regulator of the Rho Family GTPase Rac1 Engulfment and Cell Motility 1 (ELMO1) Promotes Rac1 Activation and Cell Motility (Retracted article. See vol. 294, pg. 20262, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ACTIN-BASED MOTILITY; EXCHANGE FACTOR; IDENTIFICATION; BINDING; PHOSPHORYLATION; WASP; ORGANIZATION; CYTOSKELETON; COMPLEXES; MECHANISM	Nck family proteins function as adaptors to couple tyrosine phosphorylation signals to actin cytoskeleton reorganization. Several lines of evidence indicate that Nck family proteins involve in regulating the activity of Rho family GTPases. In the present study, we characterized a novel interaction between Nck-1 with engulfment and cell motility 1 (ELMO1). GST pull-down and co-immunoprecipitation assay demonstrated that the Nck-1-ELMO1 interaction is mediated by the SH2 domain of Nck-1 and the phosphotyrosine residues at position 18, 216, 395, and 511 of ELMO1. A R308K mutant of Nck-1 (in which the SH2 domain was inactive), or a 4YF mutant of ELMO1 lacking these four phosphotyrosine residues, diminished Nck-1-ELMO1 interaction. Conversely, tyrosine phosphatase inhibitor treatment and overexpression of Src family kinase Hck significantly enhanced Nck-1-ELMO1 interaction. Moreover, wild type Nck-1, but not R308K mutant, significantly augmented the interaction between ELMO1 and constitutively active RhoG (RhoG(V12A)), thus promoted Rac1 activation and cell motility. Taken together, the present study characterized a novel Nck-1-ELMO1 interaction and defined a new role for Nck-1 in regulating Rac1 activity.	[Zhang, Guo; Chen, Xia; Zhu, Fengxin; Lei, Wenjing; Nie, Jing] Southern Med Univ, Div Nephrol, State Key Lab Organ Failure Res, Guangdong Prov Inst Nephrol,Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China; [Qiu, Fanghua] Guangzhou Hosp Tradit Chinese Med, Dept Clin Lab, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou University of Chinese Medicine	Nie, J (corresponding author), Southern Med Univ, Div Nephrol, State Key Lab Organ Failure Res, Guangdong Prov Inst Nephrol,Nanfang Hosp, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.	niejing@smu.edu.cn			National Science Foundation of China [81288001, 81200503]; Guangdong Provincial Department of Education, Science, and Technology Innovation Fund [2012KJCX0027]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Department of Education, Science, and Technology Innovation Fund	This work was supported by Grant 81288001 from the National Science Foundation of China, Grant 2012KJCX0027 from the Guangdong Provincial Department of Education, Science, and Technology Innovation Fund (to J. N.), and Grant 81200503 from the National Science Foundation of China (to F. Z.).	Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Braun P, 2012, PROTEOMICS, V12, P1478, DOI 10.1002/pmic.201100563; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Chaki Sankar P, 2013, Bioarchitecture, V3, P57, DOI 10.4161/bioa.25744; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Dodding MP, 2009, CELL HOST MICROBE, V6, P536, DOI 10.1016/j.chom.2009.10.011; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Hwang PM, 2002, EMBO J, V21, P314, DOI 10.1093/emboj/21.3.314; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Kiyono M, 2000, J BIOL CHEM, V275, P5441, DOI 10.1074/jbc.275.8.5441; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Li W, 2001, ONCOGENE, V20, P6403, DOI 10.1038/sj.onc.1204782; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; McCarty JH, 1998, BIOESSAYS, V20, P913, DOI 10.1002/(SICI)1521-1878(199811)20:11<913::AID-BIES6>3.0.CO;2-T; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Patel Manishha, 2011, Small GTPases, V2, P268; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Pawson T, 2000, GENE DEV, V14, P1027; Rao Y, 1998, P NATL ACAD SCI USA, V95, P2077, DOI 10.1073/pnas.95.5.2077; Rao Y, 2005, INT J BIOL SCI, V1, P80; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Scott MP, 2002, J BIOL CHEM, V277, P28238, DOI 10.1074/jbc.M202783200; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Shen SL, 2011, BBA-MOL BASIS DIS, V1812, P703, DOI 10.1016/j.bbadis.2011.03.004; Takenawa T, 2001, J CELL SCI, V114, P1801; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tu YZ, 2001, FEBS LETT, V491, P193, DOI 10.1016/S0014-5793(01)02195-0; Yokoyama N, 2005, BIOCHEMISTRY-US, V44, P8841, DOI 10.1021/bi0500832; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936	43	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23112	23122		10.1074/jbc.M114.549550	http://dx.doi.org/10.1074/jbc.M114.549550			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24928514	Green Published, hybrid			2022-12-28	WOS:000341017200048
J	Akimoto, M; Zhang, ZY; Boulton, S; Selvaratnam, R; VanSchouwen, B; Gloyd, M; Accili, EA; Lange, OF; Melacini, G				Akimoto, Madoka; Zhang, Zaiyong; Boulton, Stephen; Selvaratnam, Rajeevan; VanSchouwen, Bryan; Gloyd, Melanie; Accili, Eric A.; Lange, Oliver F.; Melacini, Giuseppe			A Mechanism for the Auto-inhibition of Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) Channel Opening and Its Relief by cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; NMR CHEMICAL-SHIFTS; STRUCTURAL BASIS; BINDING DOMAIN; CONFORMATIONAL-CHANGES; DEPENDENT ALLOSTERY; STRUCTURE REVEALS; TERMINAL REGION; CS-ROSETTA; DYNAMICS	Hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channels control neuronal and cardiac electrical rhythmicity. There are four homologous isoforms (HCN1-4) sharing a common multidomain architecture that includes an N-terminal transmembrane tetrameric ion channel followed by a cytoplasmic "C-linker," which connects a more distal cAMP-binding domain (CBD) to the inner pore. Channel opening is primarily stimulated by transmembrane elements that sense membrane hyperpolarization, although cAMP reduces the voltage required for HCN activation by promoting tetramerization of the intracellular C-linker, which in turn relieves auto-inhibition of the inner pore gate. Although binding of cAMP has been proposed to relieve auto-inhibition by affecting the structure of the C-linker and CBD, the nature and extent of these cAMP-dependent changes remain limitedly explored. Here, we used NMR to probe the changes caused by the binding of cAMP and of cCMP, a partial agonist, to the apo-CBD of HCN4. Our data indicate that the CBD exists in a dynamic two-state equilibrium, whose position as gauged by NMR chemical shifts correlates with the V-1/2 voltage measured through electrophysiology. In the absence of cAMP, the most populated CBD state leads to steric clashes with the activated or "tetrameric" C-linker, which becomes energetically unfavored. The steric clashes of the apo tetramer are eliminated either by cAMP binding, which selects for a CBD state devoid of steric clashes with the tetrameric C-linker and facilitates channel opening, or by a transition of apo-HCN to monomers or dimer of dimers, in which the C-linker becomes less structured, and channel opening is not facilitated.	[Akimoto, Madoka; Selvaratnam, Rajeevan; VanSchouwen, Bryan; Gloyd, Melanie; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Boulton, Stephen; Gloyd, Melanie; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Zhang, Zaiyong; Lange, Oliver F.] Tech Univ Munich, Biomol NMR, D-85747 Garching, Germany; [Zhang, Zaiyong; Lange, Oliver F.] Tech Univ Munich, Munich Ctr Integrated Prot Sci, Dept Chem, D-85747 Garching, Germany; [Accili, Eric A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Lange, Oliver F.] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany	McMaster University; McMaster University; Technical University of Munich; Technical University of Munich; University of British Columbia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Boulton, Stephen/AAM-3440-2021	Boulton, Stephen/0000-0002-2521-2240; Selvaratnam, Rajeevan/0000-0003-4457-616X	Canadian Institutes of Health Research [MOP-68897]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-68897 (to G. M.) from the Canadian Institutes of Health Research.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Anand GS, 2010, MOL CELL PROTEOMICS, V9, P2225, DOI 10.1074/mcp.M900388-MCP200; Badireddy Suguna, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M110.004390; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Boulton S, 2014, BIOCHEM SOC T, V42, P302, DOI 10.1042/BST20130282; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Bruystens JGH, 2014, STRUCTURE, V22, P59, DOI 10.1016/j.str.2013.10.012; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P219, DOI 10.1007/s10858-005-7944-6; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Gavina JMA, 2009, BIOCHEMISTRY-US, V48, P223, DOI 10.1021/bi802121g; Goddard TD., SPARKY VERSION 3; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hegle AP, 2010, AM J PHYSIOL-CELL PH, V298, pC1066, DOI 10.1152/ajpcell.00389.2009; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Ilouz R, 2012, P NATL ACAD SCI USA, V109, P12443, DOI 10.1073/pnas.1209538109; Jackson HA, 2007, PHYSIOL GENOMICS, V29, P231, DOI 10.1152/physiolgenomics.00142.2006; Jackson HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047590; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Kusch J, 2012, NAT CHEM BIOL, V8, P162, DOI 10.1038/nchembio.747; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Macri V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00894; Macri V, 2009, J BIOL CHEM, V284, P15659, DOI 10.1074/jbc.M809164200; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; McNicholl ET, 2010, J BIOL CHEM, V285, P15523, DOI 10.1074/jbc.M110.105783; Ming DM, 2004, J BIOMOL NMR, V29, P363, DOI 10.1023/B:JNMR.0000032612.70767.35; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Nussinov R, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045004; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; Nussinov R, 2011, TRENDS PHARMACOL SCI, V32, P686, DOI 10.1016/j.tips.2011.08.004; Pawley NH, 2002, J MOL BIOL, V324, P991, DOI 10.1016/S0022-2836(02)01146-4; Qu Y, 2008, J PHYSIOL-LONDON, V586, P701, DOI 10.1113/jphysiol.2007.144329; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2012, BIOCHEM SOC T, V40, P219, DOI 10.1042/BST20110628; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Sgourakis NG, 2011, J AM CHEM SOC, V133, P6288, DOI 10.1021/ja111318m; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi L, 2011, J AM CHEM SOC, V133, P2232, DOI 10.1021/ja109080t; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Thompson J, 2011, PROTEINS, V79, P2380, DOI 10.1002/prot.23046; Thompson JM, 2012, P NATL ACAD SCI USA, V109, P9875, DOI 10.1073/pnas.1202485109; Tonelli M, 2009, J AM CHEM SOC, V131, P14138, DOI 10.1021/ja904766g; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; van der Schot G, 2013, J BIOMOL NMR, V57, P27, DOI 10.1007/s10858-013-9762-6; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Vernon R, 2013, J BIOMOL NMR, V57, P117, DOI 10.1007/s10858-013-9772-4; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Warner LR, 2011, J MOL BIOL, V411, P83, DOI 10.1016/j.jmb.2011.05.022; Whitaker GM, 2007, J BIOL CHEM, V282, P22900, DOI 10.1074/jbc.M610978200; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129	82	57	59	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22205	22220		10.1074/jbc.M114.572164	http://dx.doi.org/10.1074/jbc.M114.572164			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24878962	Green Published, hybrid			2022-12-28	WOS:000340593500035
J	Duan, L; Ying, GG; Danzer, B; Perez, RE; Shariat-Madar, Z; Levenson, VV; Maki, CG				Duan, Lei; Ying, Guoguang; Danzer, Brian; Perez, Ricardo E.; Shariat-Madar, Zia; Levenson, Victor V.; Maki, Carl G.			The Prolyl Peptidases PRCP/PREP Regulate IRS-1 Stability Critical for Rapamycin-induced Feedback Activation of PI3K and AKT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; MOLECULAR TARGETED THERAPIES; PANCREATIC-CANCER; PHOSPHOINOSITIDE 3-KINASE; PLASMA PREKALLIKREIN; MTOR; PHOSPHORYLATION; INHIBITION; MECHANISM; OVEREXPRESSION	The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/AKT)/mammalian target of rapamycin (mTOR) pathway conveys signals from receptor tyrosine kinases (RTKs) to regulate cell metabolism, proliferation, survival, and motility. Previously we found that prolylcarboxypeptidase (PRCP) regulate proliferation and survival in breast cancer cells. In this study, we found that PRCP and the related family member prolylendopeptidase (PREP) are essential for proliferation and survival of pancreatic cancer cells. Depletion/inhibition of PRCP and PREP-induced serine phosphorylation and degradation of IRS-1, leading to inactivation of the cellular PI3K and AKT. Notably, depletion/inhibition of PRCP/PREP destabilized IRS-1 in the cells treated with rapamycin, blocking the feedback activation PI3K/AKT. Consequently, inhibition of PRCP/PREP enhanced rapamycin-induced cytotoxicity. Thus, we have identified PRCP and PREP as a stabilizer of IRS-1 which is critical for PI3K/AKT/mTOR signaling in pancreatic cancer cells.	[Duan, Lei; Danzer, Brian; Perez, Ricardo E.; Maki, Carl G.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Ying, Guoguang] Tianjin Med Univ, Canc Inst & Hosp, Canc Cell Biol Lab, Tianjin 300060, Peoples R China; [Shariat-Madar, Zia] Univ Mississippi, Dept Pharmacol, University, MS 38677 USA; [Levenson, Victor V.] US Biomarkers Inc, Buffalo Grove, IL 60089 USA	Rush University; Tianjin Medical University; University of Mississippi	Duan, L (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	lduan@rush.edu; victor@usbiomarkers.com; Carl_Maki@rush.edu			National Institutes of Health from the National Cancer Institute (NCI) [1R01CA137598-01A1]; NATIONAL CANCER INSTITUTE [R01CA137598] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA137598-01A1 from the National Cancer Institute (NCI) (to C. G. M.).	Adams GN, 2013, BLOOD, V122, P1522, DOI 10.1182/blood-2012-10-460360; AKT pathway in human cancer, NAT REV CANC, V2, P489; Bao B, 2011, BBA-REV CANCER, V1815, P135, DOI 10.1016/j.bbcan.2010.11.003; Bayraktar S, 2010, MT SINAI J MED, V77, P606, DOI 10.1002/msj.20217; Bergmann U, 1996, BIOCHEM BIOPH RES CO, V220, P886, DOI 10.1006/bbrc.1996.0500; Borja-Cacho D, 2008, AM J SURG, V196, P430, DOI 10.1016/j.amjsurg.2008.04.009; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Darzynkiewicz Z, 2010, ADV EXP MED BIOL, V676, P137; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Duan L, 2011, J BIOL CHEM, V286, P2864, DOI 10.1074/jbc.M110.143271; Easton JB, 2006, CANCER CELL, V9, P153, DOI 10.1016/j.ccr.2006.02.027; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Evers BM, 2005, AM J SURG, V190, P279, DOI 10.1016/j.amjsurg.2005.05.027; Falasca M, 2011, ANTI-CANCER AGENT ME, V11, P455, DOI 10.2174/187152011795677382; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; HADARI YR, 1992, J BIOL CHEM, V267, P17483; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Metz HE, 2011, CLIN CANCER RES, V17, P206, DOI 10.1158/1078-0432.CCR-10-0434; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Philip PA, 2011, LANCET ONCOL, V12, P206, DOI 10.1016/S1470-2045(11)70029-8; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Rieder S, 2011, ANTI-CANCER AGENT ME, V11, P427, DOI 10.2174/187152011795677454; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Schulz I, 2005, J NEUROCHEM, V94, P970, DOI 10.1111/j.1471-4159.2005.03237.x; Shariat-Madar Z, 2005, AM J PHYSIOL-HEART C, V289, pH2697, DOI 10.1152/ajpheart.00715.2005; Shariat-Madar Z, 2004, BLOOD, V103, P4554, DOI 10.1182/blood-2003-07-2510; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Wallingford N, 2009, J CLIN INVEST, V119, P2291, DOI 10.1172/JCI37209; Wilkowski R., 2008, V177, P79; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	44	15	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21694	21705		10.1074/jbc.M114.550038	http://dx.doi.org/10.1074/jbc.M114.550038			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936056	Green Published, hybrid			2022-12-28	WOS:000340558300043
J	Lin, SX; Zhang, Q; Cao, ZG; Lu, YB; Zhang, H; Yan, K; Liu, Y; McKee, MD; Qin, CL; Chen, Z; Feng, JQ				Lin, Shuxian; Zhang, Qi; Cao, Zhengguo; Lu, Yongbo; Zhang, Hua; Yan, Kevin; Liu, Ying; McKee, Marc D.; Qin, Chunlin; Chen, Zhi; Feng, Jian Q.			Constitutive Nuclear Expression of Dentin Matrix Protein 1 Fails to Rescue the Dmp1-null Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIA; IN-VITRO; SIBLING PROTEINS; ACIDIC PHOSPHOPROTEIN; DMP1-DEFICIENT MICE; DMP1; GENE; BONE; OSTEOCYTES; VIVO	Dentin matrix protein 1 (DMP1) plays multiple roles in bone, tooth, phosphate homeostasis, kidney, salivary gland, reproductive cycles, and the development of cancer. In vitro studies have indicated two different biological mechanisms: 1) as a matrix protein, DMP1 interacts with alpha v beta 3 integrin and activates MAP kinase signaling; and 2) DMP1 serves as a transcription co-factor. In vivo studies have demonstrated its key role in osteocytes. This study attempted to determine whether DMP1 functions as a transcription co-factor and regulates osteoblast functions. For gene expression comparisons using adenovirus constructs, we targeted the expression of DMP1 either to the nucleus only by replacing the endogenous signal peptide with a nuclear localization signal (NLS) sequence (referred to as (NLS)DMP1) or to the extracellular matrix as the WT type (referred to as (SP)DMP1) in MC3T3 osteoblasts. High levels of DMP1 in either form greatly increased osteogenic gene expression in an identical manner. However, the targeted (NLS)DMP1 transgene driven by a 3.6-kb rat Col 1 alpha 1 promoter in the nucleus of osteoblasts and osteocytes failed to rescue the phenotyope of Dmp1-null mice, whereas the (SP)DMP1 transgene rescued the rickets defect. These studies support the notion that DMP1 functions as an extracellular matrix protein, rather than as a transcription cofactor in vivo. We also show that DMP1 continues its expression in osteoblasts during postnatal development and that the deletion of Dmp1 leads to an increase in osteoblast proliferation. However, poor mineralization in the metaphysis indicates a critical role for DMP1 in both osteoblasts and osteocytes.	[Lin, Shuxian; Lu, Yongbo; Zhang, Hua; Liu, Ying; Qin, Chunlin; Feng, Jian Q.] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Lin, Shuxian; Cao, Zhengguo; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Hubei, Peoples R China; [Lin, Shuxian; Cao, Zhengguo; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Hubei, Peoples R China; [Zhang, Qi] Tongji Univ, Sch Stomatol, Dept Endodont, Lab Oral Biomed Sci & Translat Med, Shanghai 200092, Peoples R China; [Yan, Kevin] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [McKee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ H3A 0G4, Canada; [McKee, Marc D.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0G4, Canada	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wuhan University; Wuhan University; Tongji University; Columbia University; McGill University; McGill University	Chen, Z (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.	zhichen@whu.edu.cn; jfeng@bcd.tamhsc.edu	Chen, Zhi/V-2214-2017; McKee, Marc D/E-2187-2011	Chen, Zhi/0000-0003-2095-1324; McKee, Marc D/0000-0001-8349-965X; Lu, Yongbo/0000-0003-3692-1736; Cao, Zhengguo/0000-0002-4261-9034; Zhang, Hua/0000-0002-6789-9343	National Institutes of Health [DE018486, R56DE022789]; NSF under the State Scholarship Fund of China [2010627108]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE022789, R01DE018486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF under the State Scholarship Fund of China; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants DE018486 and R56DE022789 (to J. Q. F.) and Scholarship NSF 2010627108 under the State Scholarship Fund of China (to S. L.).	Barron MJ, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001162; Braut A, 2002, CONNECT TISSUE RES, V43, P216, DOI 10.1080/03008200290001078; Bucciarelli E, 2007, BREAST CANCER RES TR, V105, P95, DOI 10.1007/s10549-006-9436-0; Burra S, 2010, P NATL ACAD SCI USA, V107, P13648, DOI 10.1073/pnas.1009382107; Chaplet M, 2003, J BONE MINER RES, V18, P1506, DOI 10.1359/jbmr.2003.18.8.1506; Corsi A, 2001, ARCH PATHOL LAB MED, V125, P1375; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Eapen A, 2011, CELLS TISSUES ORGANS, V194, P255, DOI 10.1159/000324258; Farrow EG, 2009, BONE, V44, P287, DOI 10.1016/j.bone.2008.10.040; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GEORGE A, 1993, J BIOL CHEM, V268, P12624; He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726; Hirst KL, 1997, J DENT RES, V76, P754, DOI 10.1177/00220345970760030701; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Jiang BC, 2010, J BONE MINER RES, V25, P2155, DOI 10.1002/jbmr.117; Kaartinen MT, 2005, J DENT RES, V84, P607, DOI 10.1177/154405910508400705; Koshida R, 2010, J BONE MINER METAB, V28, P585, DOI 10.1007/s00774-010-0169-0; Kucka M, 2013, MOL ENDOCRINOL, V27, P1840, DOI 10.1210/me.2013-1068; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Lu YB, 2009, CELLS TISSUES ORGANS, V189, P175, DOI 10.1159/000151727; Lv K, 2010, INT J BIOL SCI, V6, P537; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; Makitie O, 2010, J BONE MINER RES, V25, P2165, DOI 10.1002/jbmr.105; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Rangiani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042329; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Sato S, 2008, ARTHRITIS RHEUM, V58, P2764, DOI 10.1002/art.23805; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Siyam A, 2012, BIOCHEM BIOPH RES CO, V424, P641, DOI 10.1016/j.bbrc.2012.07.037; Sun Y, 2011, J DENT RES, V90, P619, DOI 10.1177/0022034510397839; Sun Y, 2011, CELLS TISSUES ORGANS, V194, P199, DOI 10.1159/000324672; Sun Y, 2010, J BIOL CHEM, V285, P31713, DOI 10.1074/jbc.M110.137059; Sun Y, 2010, J HISTOCHEM CYTOCHEM, V58, P1033, DOI 10.1369/jhc.2010.956771; Tartaix PH, 2004, J BIOL CHEM, V279, P18115, DOI 10.1074/jbc.M314114200; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Turan S, 2010, BONE, V46, P402, DOI 10.1016/j.bone.2009.09.016; Wu H, 2011, J BIOL CHEM, V286, P29462, DOI 10.1074/jbc.M110.194746; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294	49	13	13	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21533	21543		10.1074/jbc.M113.543330	http://dx.doi.org/10.1074/jbc.M113.543330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24917674	hybrid, Green Published			2022-12-28	WOS:000340558300029
J	Skilandat, M; Sigel, RKO				Skilandat, Miriam; Sigel, Roland K. O.			The Role of Mg(II) in DNA Cleavage Site Recognition in Group II Intron Ribozymes SOLUTION STRUCTURE AND METAL ION BINDING SITES OF THE RNA.DNA COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA HYBRID DUPLEX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; NUCLEIC-ACIDS; NMR STRUCTURE; EXON-BINDING; XPLOR-NIH; MG2+ IONS; IN-VIVO; MAGNESIUM	Group II intron ribozymes catalyze the cleavage of (and their reinsertion into) DNA and RNA targets using a Mg2+-dependent reaction. The target is cleaved 3' to the last nucleotide of intron binding site 1 (IBS1), one of three regions that form base pairs with the intron's exon binding sites (EBS1 to -3). We solved the NMR solution structure of the d3' hairpin of the Sc.ai5 gamma intron containing EBS1 in its 11-nucleotide loop in complex with the dIBS1 DNA 7-mer and compare it with the analogous RNA.RNA contact. The EBS1.dIBS1 helix is slightly flexible and non-symmetric. NMR data reveal two major groove binding sites for divalent metal ions at the EBS1.dIBS1 helix, and surface plasmon resonance experiments show that low concentrations of Mg2+ considerably enhance the affinity of dIBS1 for EBS1. Our results indicate that identification of both RNA and DNA IBS1 targets, presentation of the scissile bond, and stabilization of the structure by metal ions are governed by the overall structure of EBS1.dIBS1 and the surrounding loop nucleotides but are irrespective of different EBS1.(d)IBS1 geometries and interstrand affinities.	[Skilandat, Miriam; Sigel, Roland K. O.] Univ Zurich, Dept Chem, CH-8057 Zurich, Switzerland	University of Zurich	Sigel, RKO (corresponding author), Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	roland.sigel@chem.uzh.ch	Sigel, Roland/O-9883-2016	Sigel, Roland/0000-0002-1307-7993	Swiss National Science Foundation [200021-124834]; University of Zurich; European Research Commission Starting Grant MIRNA	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; European Research Commission Starting Grant MIRNA	This work was supported by Swiss National Science Foundation Grant 200021-124834 (to R. K. O. S.), the University of Zurich, and European Research Commission Starting Grant MIRNA (to R. K. O. S.).	ALLAIN FHT, 1995, NUCLEIC ACIDS RES, V23, P341, DOI 10.1093/nar/23.3.341; AUGUSTIN S, 1990, NATURE, V343, P383, DOI 10.1038/343383a0; Bai Y, 2007, J AM CHEM SOC, V129, P14981, DOI 10.1021/ja075020g; Barrientos-Duran A, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-24; Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Bradshaw Patrick C, 2006, BMC Biochem, V7, P4, DOI 10.1186/1471-2091-7-4; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; Chan RT, 2012, NAT STRUCT MOL BIOL, V19, P555, DOI 10.1038/nsmb.2270; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Costa M, 1999, EMBO J, V18, P1025, DOI 10.1093/emboj/18.4.1025; Costa M, 2000, EMBO J, V19, P5007, DOI 10.1093/emboj/19.18.5007; Costa M, 1998, RNA, V4, P1055, DOI 10.1017/S1355838298980670; Cross CW, 1997, BIOCHEMISTRY-US, V36, P4096, DOI 10.1021/bi962382k; Curcio MJ, 1996, CELL, V84, P9, DOI 10.1016/S0092-8674(00)80987-3; de Lencastre A, 2005, NAT STRUCT MOL BIOL, V12, P626, DOI 10.1038/nsmb957; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donghi D, 2013, NUCLEIC ACIDS RES, V41, P2489, DOI 10.1093/nar/gks1179; Donghi D, 2011, METAL IONS LIFE SCI, V9, P197, DOI 10.1039/978184973251200197; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Erat MC, 2008, J BIOL INORG CHEM, V13, P1025, DOI 10.1007/s00775-008-0390-7; Erat MC, 2007, INORG CHEM, V46, P11224, DOI 10.1021/ic701627t; Erat MC, 2007, CHEMBIOCHEM, V8, P306, DOI 10.1002/cbic.200600459; Erat MC, 2011, METAL IONS LIFE SCI, V9, P37, DOI 10.1039/978184973251200037; Fedor MJ, 2002, CURR OPIN STRUC BIOL, V12, P289, DOI 10.1016/S0959-440X(02)00324-X; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Freisinger E, 2007, COORDIN CHEM REV, V251, P1834, DOI 10.1016/j.ccr.2007.03.008; Gallo S, 2005, CHIMIA, V59, P812, DOI 10.2533/000942905777675589; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Gordon PM, 2007, CHEM BIOL, V14, P607, DOI 10.1016/j.chembiol.2007.05.008; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; HALL KB, 1991, BIOCHEMISTRY-US, V30, P10606, DOI 10.1021/bi00108a002; Hampel KJ, 1998, BIOCHEMISTRY-US, V37, P14672, DOI 10.1021/bi981083n; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; HUNG SH, 1994, NUCLEIC ACIDS RES, V22, P4326, DOI 10.1093/nar/22.20.4326; HURD RE, 1979, BIOCHEMISTRY-US, V18, P4012, DOI 10.1021/bi00585a026; JACQUIER A, 1987, CELL, V50, P17, DOI 10.1016/0092-8674(87)90658-1; Kieft JS, 1997, STRUCTURE, V5, P713, DOI 10.1016/S0969-2126(97)00225-6; KOCH JL, 1992, MOL CELL BIOL, V12, P1950, DOI 10.1128/MCB.12.5.1950; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruschel D, 2014, RNA, V20, P295, DOI 10.1261/rna.041137.113; Kruschel D, 2008, J INORG BIOCHEM, V102, P2147, DOI 10.1016/j.jinorgbio.2008.08.006; Kurz JC, 2002, BIOCHEMISTRY-US, V41, P9545, DOI 10.1021/bi025553w; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Mastroianni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003121; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Mills DA, 1996, J BACTERIOL, V178, P3531, DOI 10.1128/jb.178.12.3531-3538.1996; Mohr G, 2000, GENE DEV, V14, P559; MORL M, 1992, CELL, V70, P803, DOI 10.1016/0092-8674(92)90313-2; Pechlaner M, 2012, METAL IONS LIFE SCI, V10, P1, DOI 10.1007/978-94-007-2172-2_1; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Pyle AM, 2007, TRENDS BIOCHEM SCI, V32, P138, DOI 10.1016/j.tibs.2007.01.005; Qin PZ, 1999, J MOL BIOL, V291, P15, DOI 10.1006/jmbi.1999.2922; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Qin PZF, 1997, BIOCHEMISTRY-US, V36, P4718, DOI 10.1021/bi962665c; RATMEYER L, 1994, BIOCHEMISTRY-US, V33, P5298, DOI 10.1021/bi00183a037; ROBERTS RW, 1992, SCIENCE, V258, P1463, DOI 10.1126/science.1279808; Robinson H, 1996, NUCLEIC ACIDS RES, V24, P676, DOI 10.1093/nar/24.4.676; Rowinska-Zyrek M, 2013, Z ANORG ALLG CHEM, V639, P1313, DOI 10.1002/zaac.201300123; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; SCHMELZER C, 1986, CELL, V46, P557, DOI 10.1016/0092-8674(86)90881-0; Schnabl J, 2012, NUCLEIC ACIDS RES, V40, pD434, DOI 10.1093/nar/gkr920; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SERAPHIN B, 1992, GENE, V113, P1, DOI 10.1016/0378-1119(92)90663-A; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SIGEL H, 1990, COORDIN CHEM REV, V100, P453, DOI 10.1016/0010-8545(90)85018-N; Sigel RKO, 2000, NAT STRUCT BIOL, V7, P1111; Sigel RKO, 2005, EUR J INORG CHEM, P2281, DOI 10.1002/ejic.200401007; Sigel RKO, 2007, CHEM REV, V107, P97, DOI 10.1021/cr0502605; Steiner M, 2008, P NATL ACAD SCI USA, V105, P13853, DOI 10.1073/pnas.0804034105; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Su LHJ, 2001, J MOL BIOL, V306, P655, DOI 10.1006/jmbi.2000.4323; Su LJ, 2005, NUCLEIC ACIDS RES, V33, P6674, DOI 10.1093/nar/gki973; Swisher JF, 2002, J MOL BIOL, V315, P297, DOI 10.1006/jmbi.2001.5233; Tjandra N, 1997, J MAGN RESON, V124, P512, DOI 10.1006/jmre.1996.1088; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Truong DM, 2013, P NATL ACAD SCI USA, V110, pE3800, DOI 10.1073/pnas.1315742110; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Varani G, 1996, PROG NUCL MAG RES SP, V29, P51, DOI 10.1016/0079-6565(96)01028-X; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang JM, 2010, ACTA CRYSTALLOGR D, V66, P988, DOI 10.1107/S0907444910029938; WIESENBERGER G, 1992, J BIOL CHEM, V267, P6963; Xiang Q, 1998, BIOCHEMISTRY-US, V37, P3839, DOI 10.1021/bi972661n; Xiong Y, 2000, NUCLEIC ACIDS RES, V28, P2171, DOI 10.1093/nar/28.10.2171; Yang J, 1996, NATURE, V381, P332, DOI 10.1038/381332a0; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358; Zhuang FL, 2009, RNA, V15, P432, DOI 10.1261/rna.1378909; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	107	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20650	20663		10.1074/jbc.M113.542381	http://dx.doi.org/10.1074/jbc.M113.542381			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895129	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000339396600024
J	Gromek, KA; Suchy, FP; Meddaugh, HR; Wrobel, RL; LaPointe, LM; Chu, UB; Primm, JG; Ruoho, AE; Senes, A; Fox, BG				Gromek, Katarzyna A.; Suchy, Fabian P.; Meddaugh, Hannah R.; Wrobel, Russell L.; LaPointe, Loren M.; Chu, Uyen B.; Primm, John G.; Ruoho, Arnold E.; Senes, Alessandro; Fox, Brian G.			The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; DOMAIN-LIKE-I; BINDING-SITE; STEROID-BINDING; GXXXG MOTIF; TRANSMEMBRANE DOMAIN; CHANNEL MODULATION; HELIX ASSOCIATION; MEMBRANE-PROTEINS; OXIDATIVE STRESS	Sigma-1 receptor (S1R) is a mammalian member of the ERG2 and sigma-1 receptor-like protein family (pfam04622). It has been implicated in drug addiction and many human neurological disorders, including Alzheimer and Parkinson diseases and amyotrophic lateral sclerosis. A broad range of synthetic small molecules, including cocaine, (+)-pentazocine, haloperidol, and small endogenous molecules such as N,N-dimethyltryptamine, sphingosine, and steroids, have been identified as regulators of S1R. However, the mechanism of activation of S1R remains obscure. Here, we provide evidence in vitro that S1R has ligand binding activity only in an oligomeric state. The oligomeric state is prone to decay into an apparent monomeric form when exposed to elevated temperature, with loss of ligand binding activity. This decay is suppressed in the presence of the known S1R ligands such as haloperidol, BD-1047, and sphingosine. S1R has a GXXXG motif in its second transmembrane region, and these motifs are often involved in oligomerization of membrane proteins. Disrupting mutations within the GXXXG motif shifted the fraction of the higher oligomeric states toward smaller states and resulted in a significant decrease in specific (+)-[H-3]pentazocine binding. Results presented here support the proposal that S1R function may be regulated by its oligomeric state. Possible mechanisms of molecular regulation of interacting protein partners by S1R in the presence of small molecule ligands are discussed.	[Gromek, Katarzyna A.; Suchy, Fabian P.; Meddaugh, Hannah R.; Wrobel, Russell L.; Primm, John G.; Fox, Brian G.] Univ Wisconsin, Transmembrane Prot Ctr, Madison, WI 53706 USA; [LaPointe, Loren M.; Senes, Alessandro; Fox, Brian G.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Chu, Uyen B.; Ruoho, Arnold E.] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ruoho, AE (corresponding author), Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA.	aeruoho@wisc.edu; bgfox@biochem.wisc.edu		SENES, ALESSANDRO/0000-0002-3807-2275	National Institutes of Health [1S10RR023748-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094584, R01GM099752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Emily T. Beebe, Ronnie O. Frederick, and Shin-ichi Makino for helpful comments on experimental procedures and analysis of results. Light scattering experiments performed at the Yale University W. M. Keck Foundation were supported by National Institutes of Health Grant 1S10RR023748-01.	Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Brune S, 2012, ASSAY DRUG DEV TECHN, V10, P365, DOI 10.1089/adt.2011.0376; Bucolo C, 2006, NEUROREPORT, V17, P287, DOI 10.1097/01.wnr.0000199469.21734.e1; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; Chu UB, 2013, BIOCHEMISTRY-US, V52, P859, DOI 10.1021/bi301517u; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Colabufo Nicola Antonio, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P161; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P1, DOI 10.1016/j.coph.2009.11.002; Fontanilla D, 2008, BIOCHEMISTRY-US, V47, P7205, DOI 10.1021/bi800564j; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Gromek KA, 2013, PROTEIN EXPRES PURIF, V89, P203, DOI 10.1016/j.pep.2013.03.013; GUNDLACH AL, 1986, J NEUROSCI, V6, P1757; Ha YJ, 2011, INVEST OPHTH VIS SCI, V52, P527, DOI 10.1167/iovs.10-5731; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Hayashi T, 2010, J PHARMACOL EXP THER, V332, P1054, DOI 10.1124/jpet.109.159244; Herrmann JR, 2009, J MOL BIOL, V385, P912, DOI 10.1016/j.jmb.2008.10.058; Hiranita T, 2010, J PHARMACOL EXP THER, V332, P515, DOI 10.1124/jpet.109.159236; ITZHAK Y, 1987, EUR J PHARMACOL, V136, P231, DOI 10.1016/0014-2999(87)90715-1; Jbilo O, 1997, J BIOL CHEM, V272, P27107, DOI 10.1074/jbc.272.43.27107; Johannessen M, 2009, AM J PHYSIOL-CELL PH, V296, pC1049, DOI 10.1152/ajpcell.00431.2008; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; LARGENT BL, 1986, EUR J PHARMACOL, V124, P183, DOI 10.1016/0014-2999(86)90142-1; Low C, 2013, BBA-GEN SUBJECTS, V1830, P3497, DOI 10.1016/j.bbagen.2013.02.001; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; MATSUMOTO RR, 1995, EUR J PHARMACOL, V280, P301, DOI 10.1016/0014-2999(95)00208-3; Mavlyutov TA, 2012, NEUROSCIENCE, V206, P60, DOI 10.1016/j.neuroscience.2011.12.040; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Mishina M, 2005, ACTA NEUROL SCAND, V112, P103, DOI 10.1111/j.1600-0404.2005.00432.x; Mishina M, 2008, ANN NUCL MED, V22, P151, DOI 10.1007/s12149-007-0094-z; Moebius FF, 1996, BIOCHEMISTRY-US, V35, P16871, DOI 10.1021/bi961996m; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; Na JH, 2013, PROTEIN EXPRES PURIF, V88, P190, DOI 10.1016/j.pep.2013.01.001; Narayanan S, 2011, FUTURE MED CHEM, V3, P79, DOI 10.4155/FMC.10.279; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Ortega-Roldan JL, 2013, J BIOL CHEM, V288, P21448, DOI 10.1074/jbc.M113.450379; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Pal A, 2012, EUR J PHARMACOL, V682, P12, DOI 10.1016/j.ejphar.2012.01.030; Pal A, 2008, J BIOL CHEM, V283, P19646, DOI 10.1074/jbc.M802192200; Ramachandran S, 2007, PROTEIN EXPRES PURIF, V51, P283, DOI 10.1016/j.pep.2006.07.019; Ramachandran S, 2009, EUR J PHARMACOL, V609, P19, DOI 10.1016/j.ejphar.2009.03.003; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SCHUSTER DI, 1995, BRAIN RES, V670, P14, DOI 10.1016/0006-8993(94)01123-Y; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Seth P, 1997, BIOCHEM BIOPH RES CO, V241, P535, DOI 10.1006/bbrc.1997.7840; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Shaw W V, 1975, Methods Enzymol, V43, P737; Smith SB, 2008, INVEST OPHTH VIS SCI, V49, P4154, DOI 10.1167/iovs.08-1824; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Ujike H, 1996, EUR J PHARMACOL, V296, P123, DOI 10.1016/0014-2999(95)00693-1; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Villard V, 2011, J PSYCHOPHARMACOL, V25, P1101, DOI 10.1177/0269881110379286; Vukoti K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046290; Wang LX, 2012, MECH AGEING DEV, V133, P665, DOI 10.1016/j.mad.2012.09.005; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8; Zhang MR, 2002, NUCL MED BIOL, V29, P469, DOI 10.1016/S0969-8051(02)00293-7	74	72	75	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20333	20344		10.1074/jbc.M113.537993	http://dx.doi.org/10.1074/jbc.M113.537993			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24847081	Green Published, hybrid			2022-12-28	WOS:000339395200044
J	Lee, SC; Lin, CC; Wang, CH; Wu, PL; Huang, HW; Chang, CI; Wu, WG				Lee, Shao-Chen; Lin, Chien-Chu; Wang, Chia-Hui; Wu, Po-Long; Huang, Hsuan-Wei; Chang, Chung-I; Wu, Wen-guey			Endocytotic Routes of Cobra Cardiotoxins Depend on Spatial Distribution of Positively Charged and Hydrophobic Domains to Target Distinct Types of Sulfated Glycoconjugates on Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; PENETRATING PEPTIDES; LIPID RAFTS; CATHEPSIN-D; X-RAY; MEMBRANE; BINDING; VENOM; PATHWAY; DYNAMIN	Cobra cardiotoxins (CTX) are a family of three-fingered basic polypeptides known to interact with diverse targets such as heparan sulfates, sulfatides, and integrins on cell surfaces. After CTX bind to the membrane surface, they are internalized to intracellular space and exert their cytotoxicity via an unknown mechanism. By the combined in vitro kinetic binding, three-dimensional x-ray structure determination, and cell biology studies on the naturally abundant CTX homologues from the Taiwanese cobra, we showed that slight variations on the spatial distribution of positively charged or hydrophobic domains among CTX A2, A3, and A4 could lead to significant changes in their endocytotic pathways and action mechanisms via distinct sulfated glycoconjugate-mediated processes. The intracellular locations of these structurally similar CTX after internalization are shown to vary between the mitochondria and lysosomes via either dynamin2-dependent or -independent processes with distinct membrane cholesterol sensitivity. Evidence is presented to suggest that the shifting between the sulfated glycoconjugates as distinct targets of CTX A2, A3, and A4 might play roles in the co-evolutionary arms race between venomous snake toxins to cope with different membrane repair mechanisms at the cellular levels. The sensitivity of endocytotic routes to the spatial distribution of positively charged or hydrophobic domains may provide an explanation for the diverse endocytosis pathways of other cell-penetrating basic polypeptides.	[Lee, Shao-Chen] FuJen Catholic Univ, Sch Med, New Taipei City 24205, Taiwan; [Lin, Chien-Chu; Wang, Chia-Hui; Wu, Po-Long; Huang, Hsuan-Wei; Wu, Wen-guey] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Lin, Chien-Chu; Wang, Chia-Hui; Wu, Po-Long; Huang, Hsuan-Wei; Wu, Wen-guey] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Lin, Chien-Chu; Chang, Chung-I] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan	Fu Jen Catholic University; National Tsing Hua University; National Tsing Hua University; Academia Sinica - Taiwan	Wu, WG (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan.	lswwg@life.nthu.edu.tw		Huang, Hsuan-wei/0000-0003-2924-1118	National Science Council, Taiwan [NSC94-2311-B007-023, NSC98-2311-B007-009-MY3, NSC97-2311-B030-001, NSC101-2311-B-030-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grants NSC94-2311-B007-023 and NSC98-2311-B007-009-MY3 (to W.-G. W.) and NSC97-2311-B030-001 and NSC101-2311-B-030-002 (to S-C. L.) from the National Science Council, Taiwan.	BJORNSSON TD, 1988, J PHARMACOL EXP THER, V245, P804; Chen TS, 2005, BIOCHEMISTRY-US, V44, P7414, DOI 10.1021/bi050172e; CHIEN KY, 1994, J BIOL CHEM, V269, P14473; Cleal K, 2013, CURR PHARM DESIGN, V19, P2878; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057318; Feofanov AV, 2005, BIOCHEM J, V390, P11, DOI 10.1042/BJ20041892; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Gonzalez-Jamett Arlek M, 2013, Front Endocrinol (Lausanne), V4, P126, DOI 10.3389/fendo.2013.00126; Gupta A, 2011, EUR BIOPHYS J BIOPHY, V40, P727, DOI 10.1007/s00249-011-0685-4; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kliemt S, 2013, J PROTEOME RES, V12, P378, DOI 10.1021/pr300640h; Kuo JH, 2013, J BIOL CHEM, V288, P13522, DOI 10.1074/jbc.M113.455329; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SC, 2005, J BIOL CHEM, V280, P9567, DOI 10.1074/jbc.M412398200; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minarowska A, 2007, FOLIA HISTOCHEM CYTO, V45, P159; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Nugent MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P726, DOI 10.1134/S0006297913070055; Ohara K, 2013, PEPTIDES, V50, P28, DOI 10.1016/j.peptides.2013.09.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OWNBY CL, 1993, TOXICON, V31, P697, DOI 10.1016/0041-0101(93)90376-T; Patel HV, 1997, J BIOL CHEM, V272, P1484, DOI 10.1074/jbc.272.32.20185; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; Stringer SE, 2002, BLOOD, V100, P1543, DOI 10.1182/blood.V100.5.1543.h81702001543_1543_1550; Su SH, 2003, TOXICOL APPL PHARM, V193, P97, DOI 10.1016/S0041-008X(03)00327-2; Tang Q, 2012, LANGMUIR, V28, P16126, DOI 10.1021/la303299s; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Vanhollebeke B, 2010, EUKARYOT CELL, V9, P1272, DOI 10.1128/EC.00076-10; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; Wang CH, 2006, J BIOL CHEM, V281, P656, DOI 10.1074/jbc.M507880200; Wang CH, 2005, TOXICON, V46, P430, DOI 10.1016/j.toxicon.2005.06.012; Wang CH, 2005, FEBS LETT, V579, P3169, DOI 10.1016/j.febslet.2005.05.006; Wu MY, 2013, AM J CHINESE MED, V41, P643, DOI 10.1142/S0192415X13500456; Yamano S, 2011, J CONTROL RELEASE, V152, P278, DOI 10.1016/j.jconrel.2011.02.004; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	56	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20170	20181		10.1074/jbc.M114.557157	http://dx.doi.org/10.1074/jbc.M114.557157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898246	hybrid, Green Published			2022-12-28	WOS:000339395200030
J	Wang, Q; Wang, YQ; Fritz, D; Rajshankar, D; Downey, GP; McCulloch, CA				Wang, Qin; Wang, Yongqiang; Fritz, Dominik; Rajshankar, Dhaarmini; Downey, Gregory P.; McCulloch, Christopher A.			Interactions of the Protein-tyrosine Phosphatase-alpha with the Focal Adhesion Targeting Domain of Focal Adhesion Kinase Are Involved in Interleukin-1 Signaling in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; INTEGRIN; FAK; ACTIVATION; RECEPTOR; EXPRESSION; BINDING; RAS; MATRIX-METALLOPROTEINASE-9; AUTOPHOSPHORYLATION	Interleukin-1 (IL-1) signaling in fibroblasts is mediated through focal adhesions, organelles that are enriched with adaptor and cytoskeletal proteins that regulate signal transduction. We examined interactions of the focal adhesion kinase (FAK) with protein-tyrosine phosphatase-alpha (PTP-alpha) in IL-1 signaling. In wild type and FAK knock-out mouse embryonic fibroblasts, we found by immunoblotting, immunoprecipitation, immuno-staining, and gene silencing that FAK is required for IL-1-mediated sequestration of PTP alpha to focal adhesions. Immunoprecipitation and pulldown assays of purified proteins demonstrated a direct interaction between FAK and PTP alpha, which was dependent on the FAT domain of FAK and by an intact membraneproximal phosphatase domain of PTP alpha. Recruitment of PTP alpha to focal adhesions, IL-1-induced Ca2+ release from the endoplasmic reticulum, ERK activation, and IL-6, MMP-3, and MMP-9 expression were all blocked in FAK knock-out fibroblasts. These processes were restored in FAK knock-out cells transfected with wild type FAK, FAT domain, and FRNK. Our data indicate that IL-1-induced signaling through focal adhesions involves interactions between the FAT domain of FAK and PTP alpha.	[Wang, Qin; Wang, Yongqiang; Fritz, Dominik; Rajshankar, Dhaarmini; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada; [Downey, Gregory P.] Natl Jewish Hlth, Div Pulm Sleep & Crit Care Med, Dept Med, Denver, CO 80206 USA; [Downey, Gregory P.] Univ Colorado, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO 80045 USA; [Downey, Gregory P.] Univ Colorado, Div Pulm Sci & Crit Care Med, Dept Integrated Dept Immunol, Aurora, CO 80045 USA	University of Toronto; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McCulloch, CA (corresponding author), Univ Toronto, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca		Downey, Gregory P/0000-0003-3253-5862	National Institutes of Health from NHLBI [HL090669]; Canadian Institute of Health Research [MOP-384254]; National Institutes of Health/NHLBI; Canada Research Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090669] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL090669 from NHLBI (to G. P. D.). This work was also supported by Canadian Institute of Health Research Operating Grant MOP-384254 (to C. A. M.) and by an operating grant from the National Institutes of Health/NHLBI.; Supported by a Canada Research Chair (Tier 1). To whom correspondence should be addressed: Rm. 244, Fitzgerald Bldg., University of Toronto, 150 College St., Toronto, ON M5S 3E2, Canada. Tel.: 416-978-1258; Fax: 416-978-5956; E-mail: christopher.mcculloch@utoronto.ca.	Abreu MTH, 2008, AM J PHYSIOL-CELL PH, V294, pC931, DOI 10.1152/ajpcell.00359.2007; Abreu MTH, 2006, J CELL PHYSIOL, V207, P132, DOI 10.1002/jcp.20544; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Amin ARMR, 2003, GENES CELLS, V8, P515, DOI 10.1046/j.1365-2443.2003.00652.x; Aplin AE, 1999, J CELL SCI, V112, P695; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chen M., 2006, J BIOL CHEM, V281; Cullen PJ, 2006, CURR OPIN CELL BIOL, V18, P157, DOI 10.1016/j.ceb.2006.02.012; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Dinarello CA, 2003, NAT MED, V9, P20, DOI 10.1038/nm0103-20; Goldring SR, 2003, RHEUMATOLOGY, V42, P11, DOI 10.1093/rheumatology/keg327; Golubovskaya VM, 2007, INT REV CYTOL, V263, P103, DOI 10.1016/S0074-7696(07)63003-4; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; ILLC D, 1995, NATURE, V377, P539; ISSHIKI H, 1990, MOL CELL BIOL, V10, P2757, DOI 10.1128/MCB.10.6.2757; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Panetti TS, 2002, FRONT BIOSCI-LANDMRK, V7, pD143, DOI 10.2741/panetti; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Shibata K, 1998, CANCER RES, V58, P900; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang Qin, 2003, FASEB Journal, V17, P1898; Wang Q, 2010, J BIOL CHEM, V285, P22308, DOI 10.1074/jbc.M110.102426; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	49	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18427	18441		10.1074/jbc.M113.540294	http://dx.doi.org/10.1074/jbc.M113.540294			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24821720	hybrid, Green Published			2022-12-28	WOS:000338042000040
J	Canas, C; Suzuki, Y; Marchisone, C; Carrasco, B; Freire-Beneitez, V; Takeyasu, K; Alonso, JC; Ayora, S				Canas, Cristina; Suzuki, Yuki; Marchisone, Chiara; Carrasco, Begona; Freire-Beneitez, Veronica; Takeyasu, Kunio; Alonso, Juan C.; Ayora, Silvia			Interaction of Branch Migration Translocases with the Holliday Junction-resolving Enzyme and Their Implications in Holliday Junction Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; ESCHERICHIA-COLI RUVA; BACILLUS-SUBTILIS; DNA-REPLICATION; HOMOLOGOUS RECOMBINATION; IN-VITRO; MYCOPLASMA-PNEUMONIAE; GENETIC-RECOMBINATION; ATPASE ACTIVITY; RECG HELICASE	Double-strand break repair involves the formation of Holliday junction (HJ) structures that need to be resolved to promote correct replication and chromosomal segregation. The molecular mechanisms of HJ branch migration and/or resolution are poorly characterized in Firmicutes. Genetic evidence suggested that the absence of the RuvAB branch migration translocase and the RecU HJ resolvase is synthetically lethal in Bacillus subtilis, whereas a recU recG mutant was viable. In vitro RecU, which is restricted to bacteria of the Firmicutes phylum, binds HJs with high affinity. In this work we found that RecU does not bind simultaneously with RecG to a HJ. RuvB by interacting with RecU bound to the central region of HJ DNA, loses its nonspecific association with DNA, and re-localizes with RecU to form a ternary complex. RecU cannot stimulate the ATPase or branch migration activity of RuvB. The presence of RuvB.ATP gamma S greatly stimulates RecU-mediated HJ resolution, but the addition of ATP or RuvA abolishes this stimulatory effect. A RecU.HJ.RuvAB complex might be formed. RecU does not increase the RuvAB activities but slightly inhibits them.	[Canas, Cristina; Marchisone, Chiara; Carrasco, Begona; Freire-Beneitez, Veronica; Alonso, Juan C.; Ayora, Silvia] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain; [Suzuki, Yuki; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Kyoto University	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain.	jcalonso@cnb.cisc.es; sayora@cnb.cisc.es	Suzuki, Yuki/H-9950-2015; Ayora, Silvia/D-2552-2009; Alonso, Juan Carlos/D-2595-2009	Suzuki, Yuki/0000-0003-1848-0105; Ayora, Silvia/0000-0003-3121-1786; Alonso, Juan Carlos/0000-0002-5178-7179; Carrasco, Begona/0000-0002-5671-1296; Freire Beneitez, Veronica/0000-0003-1485-8596	Ministerio de Economia y Competividad (MINECO) [BFU2012-39879-C02-01, CSD2007-00010, BFU2012-39879-C02-02]; Comunidad de Madrid [S2009MAT-1507]; Japan-Spain Bilateral Joint Project [2010JP0017];  [BFU2006-01062]	Ministerio de Economia y Competividad (MINECO); Comunidad de Madrid(Comunidad de Madrid); Japan-Spain Bilateral Joint Project; 	This work was supported by Ministerio de Economia y Competividad (MINECO) Grants BFU2012-39879-C02-01, CSD2007-00010 (to J. C. A.) and BFU2012-39879-C02-02 (to S. A.), by Comunidad de Madrid Grant S2009MAT-1507 (to J. C. A.), and Japan-Spain Bilateral Joint Project Award 2010JP0017 (to J. C. A. and K. T.).; Recipient of a Fellowship (BFU2006-01062 to J. C. A.).	Abd Wahab S, 2013, J BIOL CHEM, V288, P26397, DOI 10.1074/jbc.M113.500223; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Ayora S, 2004, P NATL ACAD SCI USA, V101, P452, DOI 10.1073/pnas.2533829100; Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Bradley AS, 2011, J BIOL CHEM, V286, P22372, DOI 10.1074/jbc.M111.233908; Canas C, 2008, NUCLEIC ACIDS RES, V36, P5242, DOI 10.1093/nar/gkn500; Canas C, 2011, J MOL BIOL, V410, P39, DOI 10.1016/j.jmb.2011.05.008; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carrasco B, 2004, J BACTERIOL, V186, P5557, DOI 10.1128/JB.186.17.5557-5566.2004; Carrasco B, 2009, J MOL BIOL, V390, P1, DOI 10.1016/j.jmb.2009.04.065; Davies AA, 1998, CURR BIOL, V8, P725, DOI 10.1016/S0960-9822(98)70282-9; Dawid A, 2004, P NATL ACAD SCI USA, V101, P11611, DOI 10.1073/pnas.0404369101; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Estevao S, 2011, J BACTERIOL, V193, P6425, DOI 10.1128/JB.06003-11; Fogg JM, 2000, BIOCHEMISTRY-US, V39, P4082, DOI 10.1021/bi992785v; Garcia-Gonzalez A, 2013, GENE, V528, P295, DOI 10.1016/j.gene.2013.05.082; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HOLLIDAY R, 1964, GENETICS, V50, P323; Kang J, 2008, J BACTERIOL, V190, P4218, DOI 10.1128/JB.01848-07; Khanduja JS, 2012, J BIOL CHEM, V287, P1345, DOI 10.1074/jbc.M111.304741; Kosa JL, 2004, MUTAT RES-FUND MOL M, V554, P149, DOI 10.1016/j.mrfmmm.2004.04.011; Lee YC, 2003, J MOL BIOL, V333, P677, DOI 10.1016/j.jmb.2003.08.047; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; Lo Piano A, 2011, VIRUS RES, V160, P1, DOI 10.1016/j.virusres.2011.06.009; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; MCCULLOCH R, 1994, EMBO J, V13, P1844, DOI 10.1002/j.1460-2075.1994.tb06453.x; McGlynn P, 2002, TRENDS GENET, V18, P413, DOI 10.1016/S0168-9525(02)02720-8; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McGregor N, 2005, STRUCTURE, V13, P1341, DOI 10.1016/j.str.2005.05.011; MITCHELL AH, 1994, J MOL BIOL, V243, P208, DOI 10.1006/jmbi.1994.1648; Nettikadan S, 1996, BIOCHEM BIOPH RES CO, V226, P645, DOI 10.1006/bbrc.1996.1409; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Pratto F, 2009, J BIOL CHEM, V284, P30298, DOI 10.1074/jbc.M109.035410; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Sanchez H, 2005, GENETICS, V171, P873, DOI 10.1534/genetics.105.045906; Sanchez H, 2007, MOL MICROBIOL, V65, P920, DOI 10.1111/j.1365-2958.2007.05835.x; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Sechman EV, 2006, MOL MICROBIOL, V61, P185, DOI 10.1111/j.1365-2958.2006.05213.x; SHARPLES GJ, 1994, EMBO J, V13, P6133, DOI 10.1002/j.1460-2075.1994.tb06960.x; Sluijter M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038301; Sluijter M, 2010, MOL MICROBIOL, V77, P1261, DOI 10.1111/j.1365-2958.2010.07288.x; Suzuki Y., 2014, NUCL ACIDS IN PRESS; Thakur RS, 2013, FEBS J, V280, P1841, DOI 10.1111/febs.12208; Tong J, 1996, J BACTERIOL, V178, P2695, DOI 10.1128/jb.178.9.2695-2700.1996; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; van Gool AJ, 1999, GENE DEV, V13, P1861, DOI 10.1101/gad.13.14.1861; Wen Q, 2005, DNA REPAIR, V4, P23, DOI 10.1016/j.dnarep.2004.07.008; West SC, 2009, BIOCHEM SOC T, V37, P519, DOI 10.1042/BST0370519; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; White MF, 2011, BIOCHEM SOC T, V39, P15, DOI 10.1042/BST0390015; Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326; Zecchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048440; Zegeye ED, 2012, MICROBIOL-SGM, V158, P1982, DOI 10.1099/mic.0.058693-0; Zerbib D, 1997, J MOL BIOL, V270, P663, DOI 10.1006/jmbi.1997.1157	60	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17634	17646		10.1074/jbc.M114.552794	http://dx.doi.org/10.1074/jbc.M114.552794			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24770420	hybrid, Green Published			2022-12-28	WOS:000338018100028
J	Stechschulte, LA; Wuescher, L; Marino, JS; Hill, JW; Eng, C; Hinds, TD				Stechschulte, Lance A.; Wuescher, Leah; Marino, Joseph S.; Hill, Jennifer W.; Eng, Charis; Hinds, Terry D., Jr.			Glucocorticoid Receptor beta Stimulates Akt1 Growth Pathway by Attenuation of PTEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER CELL-PROLIFERATION; GR-BETA; HEPATOCARCINOMA HEPG2; SPLICE VARIANT; CYCLE ARREST; IN-VITRO; EXPRESSION; ISOFORM; RESISTANCE	Glucocorticoids (GCs) are known inhibitors of proliferation and are commonly prescribed to cancer patients to inhibit tumor growth and induce apoptosis via the glucocorticoid receptor (GR). Because of alternative splicing, the GR exists as two isoforms, GR alpha and GR beta. The growth inhibitory actions of GCs are mediated via GR alpha, a hormone-induced transcription factor. The GR beta isoform, however, lacks helix 12 of the ligand-binding domain and cannot bind GCs. While we have previously shown that GR beta mRNA is responsive to insulin, the role of GR beta in insulin signaling and growth pathways is unknown. In the present study, we show that GR beta suppresses PTEN expression, leading to enhanced insulin-stimulated growth. These characteristics were independent of the inhibitory qualities that have been reported for GR beta on GR alpha. Additionally, we found that GR beta increased phosphorylation of Akt basally, which was further amplified following insulin treatment. In particular, GR beta specifically targets Akt1 in growth pathways. Our results demonstrate that the GR beta/Akt1 axis is a major player in insulin-stimulated growth.	[Stechschulte, Lance A.; Hill, Jennifer W.; Hinds, Terry D., Jr.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Hypertens & Personalized Med, Toledo, OH 43614 USA; [Wuescher, Leah] Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, Toledo, OH 43614 USA; [Marino, Joseph S.] Univ N Carolina, Dept Kinesiol, Charlotte, NC 28223 USA; [Eng, Charis] Cleveland Clin, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of North Carolina; University of North Carolina Charlotte; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Hinds, TD (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 3000 Arlington Ave,Mailstop 1008, Toledo, OH 43614 USA.	Terry.Hinds@utoledo.edu	Wuescher, Leah/ABC-8822-2020; Hill, Jennifer/AAD-8415-2019; Hinds, Terry/B-8495-2015	Wuescher, Leah/0000-0002-9708-7709; Hill, Jennifer/0000-0001-7482-9215; Hinds, Terry/0000-0002-7599-1529; Marino, Joseph/0000-0002-6207-5986; Stechschulte, Lance/0000-0001-9783-6194	National Institutes of Health PRIDE [HL106365]; University of Toledo deArce-Memorial Endowment Fund; NATIONAL CANCER INSTITUTE [P01CA124570] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL106365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health PRIDE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toledo deArce-Memorial Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part by National Institutes of Health PRIDE Grant HL106365 (to T. D. H.) and the University of Toledo deArce-Memorial Endowment Fund (to J. W. H.).	Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DuBois DC, 2013, STEROIDS, V78, P312, DOI 10.1016/j.steroids.2012.11.014; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fischer-Posovszky P, 2012, MOL CELL ENDOCRINOL, V358, P135, DOI 10.1016/j.mce.2012.03.018; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Goswami A, 2006, CANCER RES, V66, P2889, DOI 10.1158/0008-5472.CAN-05-4458; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Kelly A, 2008, J ALLERGY CLIN IMMUN, V121, P203, DOI 10.1016/j.jaci.2007.09.010; Kino T, 2001, J ENDOCRINOL, V169, P437, DOI 10.1677/joe.0.1690437; Kino T, 2009, BIOCHEM BIOPH RES CO, V381, P671, DOI 10.1016/j.bbrc.2009.02.110; Leung DYM, 1997, J EXP MED, V186, P1567, DOI 10.1084/jem.186.9.1567; Ligr M, 2012, J UROLOGY, V188, P981, DOI 10.1016/j.juro.2012.04.102; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; Longui CA, 2000, HORM METAB RES, V32, P401, DOI 10.1055/s-2007-978661; Luo CX, 2010, BIOCHEM BIOPH RES CO, V397, P486, DOI 10.1016/j.bbrc.2010.05.140; Ni ZH, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-47; Nuutinen U, 2006, EXP CELL RES, V312, P322, DOI 10.1016/j.yexcr.2005.10.023; Oakley RH, 1996, J BIOL CHEM, V271, P9550, DOI 10.1074/jbc.271.16.9550; Oakley RH, 1999, J BIOL CHEM, V274, P27857, DOI 10.1074/jbc.274.39.27857; Oakley RH, 1997, ENDOCRINOLOGY, V138, P5028, DOI 10.1210/en.138.11.5028; Periyasamy S, 2010, ONCOGENE, V29, P1691, DOI 10.1038/onc.2009.458; Piotrowska H, 2007, BIOMED PHARMACOTHER, V61, P451, DOI 10.1016/j.biopha.2007.03.007; Piotrowska H, 2009, ARCH MED RES, V40, P156, DOI 10.1016/j.arcmed.2009.02.004; Piotrowski P, 2007, FOLIA HISTOCHEM CYTO, V45, P339; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Psarra AMG, 2005, INT J BIOCHEM CELL B, V37, P2544, DOI 10.1016/j.biocel.2005.06.015; Ray DW, 1996, CANCER RES, V56, P3276; Rivers C, 1999, J CLIN ENDOCR METAB, V84, P4283, DOI 10.1210/jc.84.11.4283; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Solakidi S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P240; Strickland I, 2001, J EXP MED, V193, P585, DOI 10.1084/jem.193.5.585; TRAPP T, 1994, NEURON, V13, P1457, DOI 10.1016/0896-6273(94)90431-6; Varricchio L, 2011, BLOOD, V118, P425, DOI 10.1182/blood-2010-07-296921; Vazquez-Tello A, 2013, J CLIN IMMUNOL, V33, P466, DOI 10.1007/s10875-012-9828-3; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Wang Y, 2011, ONCOGENE, V30, P4327, DOI 10.1038/onc.2011.144; Wang Z, 2003, J BIOL CHEM, V278, P50897, DOI 10.1074/jbc.M310297200; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098; Xia C, 2006, J CELL PHYSIOL, V209, P56, DOI 10.1002/jcp.20707; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; Zhang C, 2012, LEUKEMIA RES, V36, P342, DOI 10.1016/j.leukres.2011.10.022; Zheng YC, 2012, MOL CANCER THER, V11, P2621, DOI 10.1158/1535-7163.MCT-12-0621; Zhu J, 2007, BBA-MOL CELL RES, V1773, P1087, DOI 10.1016/j.bbamcr.2007.04.016; Zhu XY, 2004, J STEROID BIOCHEM, V92, P375, DOI 10.1016/j.jsbmb.2004.07.010	50	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17885	17894		10.1074/jbc.M113.544072	http://dx.doi.org/10.1074/jbc.M113.544072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24817119	Green Published, hybrid			2022-12-28	WOS:000338018100049
J	Kanagawa, M; Liu, Y; Hanashima, S; Ikeda, A; Chai, WG; Nakano, Y; Kojima-Aikawa, K; Feizi, T; Yamaguchi, Y				Kanagawa, Mayumi; Liu, Yan; Hanashima, Shinya; Ikeda, Akemi; Chai, Wengang; Nakano, Yukiko; Kojima-Aikawa, Kyoko; Feizi, Ten; Yamaguchi, Yoshiki			Structural Basis for Multiple Sugar Recognition of Jacalin-related Human ZG16p Lectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ZYMOGEN GRANULES; PROTEIN O-MANNOSYLATION; CARBOHYDRATE-BINDING; CRYSTAL-STRUCTURES; MESSENGER-RNA; ACINAR-CELLS; RAT PANCREAS; X-RAY; MANNOSE; MEMBRANE	ZG16p is a soluble mammalian lectin, the first to be described with a Jacalin-related beta-prism-fold. ZG16p has been reported to bind both to glycosaminoglycans and mannose. To determine the structural basis of the multiple sugar-binding properties, we conducted glycan microarray analyses of human ZG16p. We observed that ZG16p preferentially binds to alpha-mannose-terminating short glycans such as Ser/Thr-linked O-mannose, but not to high mannose-type N-glycans. Among sulfated glycosaminoglycan oligomers examined, chondroitin sulfate B and heparin oligosaccharides showed significant binding. Crystallographic studies of human ZG16p lectin in the presence of selected ligands revealed the mechanism of multiple sugar recognition. Man alpha 1-3Man and Glc beta 1-3Glc bound in different orientations: the nonreducing end of the former and the reducing end of the latter fitted in the canonical shallow mannose binding pocket. Solution NMR analysis using N-15-labeled ZG16p defined the heparin-binding region, which is on an adjacent flat surface of the protein. On-array competitive binding assays suggest that it is possible for ZG16p to bind simultaneously to both types of ligands. Recognition of a broad spectrum of ligands by ZG16p may account for the multiple functions of this lectin in the formation of zymogen granules via glycosaminoglycan binding, and in the recognition of pathogens in the digestive system through alpha-mannose-related recognition.	[Kanagawa, Mayumi; Hanashima, Shinya; Ikeda, Akemi; Yamaguchi, Yoshiki] RIKEN Global Res Cluster, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr, Struct Glycobiol Team, Wako, Saitama 3510198, Japan; [Liu, Yan; Chai, Wengang; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England; [Nakano, Yukiko; Kojima-Aikawa, Kyoko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Nakano, Yukiko; Kojima-Aikawa, Kyoko] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan	RIKEN; Imperial College London; Ochanomizu University; Ochanomizu University	Liu, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	yan.liu2@imperial.ac.uk; yyoshiki@riken.jp	Yamaguchi, Yoshiki/N-5246-2015; Liu, Yan/D-9117-2013; Hanashima, Shinya/AGN-0921-2022	Yamaguchi, Yoshiki/0000-0003-0100-5439; Hanashima, Shinya/0000-0003-3102-7890; Feizi, Ten/0000-0001-6495-0329; Liu, Yan/0000-0002-2566-6867	United Kingdom Research Council Basic Technology Initiative [GRS/79268, EP/G037604/1]; Wellcome Trust [WT093378MA, WT099197MA];  [25460054]; Grants-in-Aid for Scientific Research [25460054] Funding Source: KAKEN; EPSRC [EP/G037604/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S79268/02, EP/G037604/1] Funding Source: researchfish	United Kingdom Research Council Basic Technology Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Grant-in-aid for Scientific Research (C) 25460054 (to Y. Y.) and by United Kingdom Research Council Basic Technology Initiative Glycoarrays Grant GRS/79268 and Translational Grant EP/G037604/1 and Wellcome Trust Grants WT093378MA and WT099197MA (to T. F.).	Borta H, 2010, J PROTEOME RES, V9, P4927, DOI 10.1021/pr100052q; Bourne Y, 1999, STRUCTURE, V7, P1473, DOI 10.1016/S0969-2126(00)88338-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai H, 2011, EUR J ORG CHEM, V2011, P3685, DOI 10.1002/ejoc.201100304; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; Chai WG, 2001, INFECT IMMUN, V69, P420, DOI 10.1128/IAI.69.1.420-425.2001; Chai WG, 1998, ANAL CHEM, V70, P2060, DOI 10.1021/ac9712761; CRONSHAGEN U, 1994, EUR J CELL BIOL, V65, P366; del Sol FG, 2005, J MOL BIOL, V353, P574, DOI 10.1016/j.jmb.2005.08.055; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; HELANDER A, 1992, CARBOHYD RES, V230, P299; Kalus I, 2002, BIOCHEM J, V362, P433, DOI 10.1042/0264-6021:3620433; Kanagawa M, 2011, BIOCHEM BIOPH RES CO, V404, P201, DOI 10.1016/j.bbrc.2010.11.093; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; KETTERER B, 1988, MUTAT RES, V202, P343, DOI 10.1016/0027-5107(88)90197-2; Kleene R, 1999, EUR J CELL BIOL, V78, P79, DOI 10.1016/S0171-9335(99)80009-0; Kumazawa-Inoue K, 2012, GLYCOBIOLOGY, V22, P258, DOI 10.1093/glycob/cwr145; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Lengeler KB, 2008, CELL MOL LIFE SCI, V65, P528, DOI 10.1007/s00018-007-7409-z; Liu Y, 2012, METHODS MOL BIOL, V808, P117, DOI 10.1007/978-1-61779-373-8_8; LOGSDON CD, 1985, J CELL BIOL, V100, P1200, DOI 10.1083/jcb.100.4.1200; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuschwander-Tetri BA, 2004, PANCREAS, V28, pE104, DOI 10.1097/00006676-200405000-00022; Oka T, 2005, MICROBIOL-SGM, V151, P3657, DOI 10.1099/mic.0.28088-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Pratap JV, 2002, J MOL BIOL, V317, P237, DOI 10.1006/jmbi.2001.5432; Rabijns A, 2005, FEBS J, V272, P3725, DOI 10.1111/j.1742-4658.2005.04801.x; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Schmidt K, 2001, J BIOL CHEM, V276, P14315, DOI 10.1074/jbc.M006221200; Schmidt K, 2000, J CELL SCI, V113, P2233; Sharma A, 2011, GLYCOBIOLOGY, V21, P23, DOI 10.1093/glycob/cwq128; Stoll MS, 2009, P BEILST S GLYC BIOI, P123; Subedi GP, 2012, PROTEIN EXPRES PURIF, V82, P197, DOI 10.1016/j.pep.2011.12.010; SWAROVSKY B, 1988, EUR J CELL BIOL, V47, P101; Tateno H, 2012, GLYCOBIOLOGY, V22, P210, DOI 10.1093/glycob/cwr130; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; WANG CS, 1983, BIOCHIM BIOPHYS ACTA, V754, P142, DOI 10.1016/0005-2760(83)90155-8; WANG CS, 1983, ANAL BIOCHEM, V133, P457, DOI 10.1016/0003-2697(83)90108-2; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhou YB, 2007, BIOCHEM BIOPH RES CO, V355, P679, DOI 10.1016/j.bbrc.2007.02.020; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	52	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16954	16965		10.1074/jbc.M113.539114	http://dx.doi.org/10.1074/jbc.M113.539114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24790092	hybrid, Green Published			2022-12-28	WOS:000338016200030
J	Ludwig, M; Pandelia, ME; Chew, CY; Zhang, B; Golbeck, JH; Krebs, C; Bryant, DA				Ludwig, Marcus; Pandelia, Maria-Eirini; Chew, Chyue Yie; Zhang, Bo; Golbeck, John H.; Krebs, Carsten; Bryant, Donald A.			ChlR Protein of Synechococcus sp PCC 7002 Is a Transcription Activator That Uses an Oxygen-sensitive [4Fe-4S] Cluster to Control Genes involved in Pigment Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPROPORPHYRINOGEN-III OXIDASE; ESCHERICHIA-COLI; CHLOROBIUM-TEPIDUM; CRYSTAL-STRUCTURE; HEME OXYGENASE; SUFBCDS OPERON; 2FE-2S; BIOGENESIS; CLONING; FNR	Synechococcus sp. PCC 7002 and many other cyanobacteria have two genes that encode key enzymes involved in chlorophyll a, biliverdin, and heme biosynthesis: acsF(I)/acsF(II), ho1/ho2, and hemF/hemN. Under atmospheric O-2 levels, AcsF(I) synthesizes 3,8-divinyl protochlorophyllide from Mg-protoporphyrin IX monomethyl ester, Ho1 oxidatively cleaves heme to form biliverdin, and HemF oxidizes coproporphyrinogen III to protoporphyrinogen IX. Under microoxic conditions, another set of genes directs the synthesis of alternative enzymes AcsF(II), Ho2, and HemN. In Synechococcus sp. PCC 7002, open reading frame SynPCC7002_ A1993 encodes a MarR family transcriptional regulator, which is located immediately upstream from the operon comprising acsF(II), ho2, hemN, and desF (the latter encodes a putative fatty acid desaturase). Deletion and complementation analyses showed that this gene, denoted chlR, is a transcriptional activator that is essential for transcription of the acsF(II)-ho2-hemN-desF operon under microoxic conditions. Global transcriptome analyses showed that ChlR controls the expression of only these four genes. Co-expression of chlR with a yfp reporter gene under the control of the acsF(II) promoter from Synechocystis sp. PCC 6803 in Escherichia coli demonstrated that no other cyanobacterium-specific components are required for proper functioning of this regulatory circuit. A combination of analytical methods and Mossbauer and EPR spectroscopies showed that reconstituted, recombinant ChlR forms homodimers that harbor one oxygen-sensitive [4Fe-4S] cluster. We conclude that ChlR is a transcriptional activator that uses a [4Fe-4S] cluster to sense O-2 levels and thereby control the expression of the acsF(II)-ho2-hemN-desF operon.	[Ludwig, Marcus; Chew, Chyue Yie; Golbeck, John H.; Krebs, Carsten; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Pandelia, Maria-Eirini; Zhang, Bo; Golbeck, John H.; Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA.	dab14@psu.edu	Zhang, Bo/O-9996-2014; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	Air Force Office of Scientific Research Multidisciplinary University Research Initiative Grant [FA9550-11-1-0148]; National Science Foundation [MCB-1021725]; Direct For Biological Sciences [1021725] Funding Source: National Science Foundation	Air Force Office of Scientific Research Multidisciplinary University Research Initiative Grant; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Air Force Office of Scientific Research Multidisciplinary University Research Initiative Grant FA9550-11-1-0148 (to D. A. B.) and National Science Foundation Grant MCB-1021725 (to D. A. B. and J. H. G.).	Alvey RM, 2011, J BACTERIOL, V193, P1663, DOI 10.1128/JB.01392-10; Aoki R, 2012, J BIOL CHEM, V287, P13500, DOI 10.1074/jbc.M112.346205; Aoki R, 2011, PLANT CELL PHYSIOL, V52, P1744, DOI 10.1093/pcp/pcr108; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Beinert H, 1978, Methods Enzymol, V54, P435; Bennette NB, 2011, ANAL CHEM, V83, P3808, DOI 10.1021/ac200108a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryant D.A., 1994, MOL BIOL CYANOBACTER; Bryant DA, 2013, ADV BOT RES, V66, P99, DOI 10.1016/B978-0-12-397923-0.00004-7; Cannon WR, 2011, J PROTEOME RES, V10, P2306, DOI 10.1021/pr101130b; Cicchillo RM, 2004, J BIOL CHEM, V279, P32418, DOI 10.1074/jbc.M404381200; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; Flores E, 2005, PHOTOSYNTH RES, V83, P117, DOI 10.1007/s11120-004-5830-9; Frigaard NU, 2004, METH MOL B, V274, P325; Frigaard NU, 2004, J BACTERIOL, V186, P646, DOI 10.1128/JB.186.3.646-653.2004; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; Grove TL, 2013, BIOCHEMISTRY-US, V52, P2874, DOI 10.1021/bi400136u; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ludwig M, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00354, 10.3389/fmicb.2012.00145]; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Phillips JD, 2004, J BIOL CHEM, V279, P38960, DOI 10.1074/jbc.M406050200; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; Roche B, 2013, BBA-BIOENERGETICS, V1827, P923, DOI 10.1016/j.bbabio.2013.05.001; SAKAMOTO T, 1994, J BIOL CHEM, V269, P25576; Sakamoto T, 1997, MOL MICROBIOL, V23, P1281, DOI 10.1046/j.1365-2958.1997.3071676.x; Saunders AH, 2008, BIOCHEMISTRY-US, V47, P10999, DOI 10.1021/bi801268f; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; STEVENS SE, 1980, P NATL ACAD SCI-BIOL, V77, P6052, DOI 10.1073/pnas.77.10.6052; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; SWEENEY WV, 1980, ANNU REV BIOCHEM, V49, P139, DOI 10.1146/annurev.bi.49.070180.001035; TRAUTWEIN AX, 1991, STRUCT BOND, V78, P1; TROUP B, 1994, J BACTERIOL, V176, P673, DOI 10.1128/jb.176.3.673-680.1994; TROUP B, 1995, J BACTERIOL, V177, P3326, DOI 10.1128/jb.177.11.3326-3331.1995; Wang T, 2004, J BACTERIOL, V186, P956, DOI 10.1128/JB.186.4.956-967.2004; Xu Y., 2010, THESIS PENNSYLVANIA; Xu Y, 2011, METHODS MOL BIOL, V684, P273, DOI [10.1007/978.1.60761.925.3_21, 10.1007/978-1-60761-925-3_21]; Yilmaz M, 2010, PHOTOSYNTH RES, V103, P47, DOI 10.1007/s11120-009-9506-3; Yu JP, 2003, J BACTERIOL, V185, P3878, DOI 10.1128/JB.185.13.3878-3887.2003; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; Zhang XH, 2005, FEBS J, V272, P1012, DOI 10.1111/j.1742-4658.2004.04535.x	57	18	19	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16624	16639		10.1074/jbc.M114.561233	http://dx.doi.org/10.1074/jbc.M114.561233			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782315	hybrid, Green Published			2022-12-28	WOS:000338016200002
J	Eklund, G; Lang, S; Glindre, J; Ehlen, A; Alvarado-Kristensson, M				Eklund, Greta; Lang, Stefan; Glindre, Johan; Ehlen, Asa; Alvarado-Kristensson, Maria			The Nuclear Localization of gamma-Tubulin Is Regulated by SadB-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MICROTUBULE NUCLEATION; GENE-EXPRESSION; RING COMPLEX; PROTEIN; CENTROSOME; TRANSCRIPTION; DUPLICATION; KINASES; PHASE	gamma-Tubulin is an important cell division regulator that arranges microtubule assembly and mitotic spindle formation. Cytosolic gamma-tubulin nucleates alpha- and beta-tubulin in a growing microtubule by forming the ring-shaped protein complex gamma TuRC. Nuclear gamma-tubulin also regulates S-phase progression by moderating the activities of E2 promoter-binding factors. The mechanism that regulates localization of gamma-tubulin is currently unknown. Here, we demonstrate that the human Ser/Thr kinase SadB short localizes to chromatin and centrosomes. We found that SadB-mediated phosphorylation of gamma-tubulin on Ser385 formed chromatin-associated gamma-tubulin complexes that moderate gene expression. In this way, the C-terminal region of gamma-tubulin regulates S-phase progression. In addition, chromatin levels of gamma-tubulin were decreased by the reduction of SadB levels or expression of a non-phosphorylatable Ala(385)-gamma-tubulin but were enhanced by expression of SadB, wild-type gamma-tubulin, or a phosphomimetic Asp(385)-gamma-tubulin mutant. Our results demonstrate that SadB kinases regulate the cellular localization of gamma-tubulin and thereby control S-phase progression.	[Eklund, Greta; Lang, Stefan; Glindre, Johan; Ehlen, Asa; Alvarado-Kristensson, Maria] Lund Univ, Div Mol Pathol, Dept Lab Med, Skane Univ Hosp, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Alvarado-Kristensson, M (corresponding author), Lund Univ, SUS Malmo, 59 Jan Waldenstroms St,Floor 2, SE-20502 Malmo, Sweden.	maria.alvarado-kristensson@med.lu.se	Alvarado-Kristensson, Maria T./C-4543-2014	Eklund, Greta/0000-0002-2498-7765; Alvarado Kristensson, Maria Teresa/0000-0003-0598-7986	Swedish Research Council; Swedish Cancer Society; Swedish childhood cancer foundation; Royal Physiographic Society in Lund; Gradfoordska Foundation; Gunnar Nilsson Foundation; Gyllenstiernska Krapperupsstiftelsen; Skane University Hospital in Malmo Cancer Research Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish childhood cancer foundation(European Commission); Royal Physiographic Society in Lund; Gradfoordska Foundation; Gunnar Nilsson Foundation; Gyllenstiernska Krapperupsstiftelsen; Skane University Hospital in Malmo Cancer Research Fund	This work was supported by the Swedish Research Council, the Swedish Cancer Society, the Swedish childhood cancer foundation, the Royal Physiographic Society in Lund, the Gradfoordska and Gunnar Nilsson Foundations, Gyllenstiernska Krapperupsstiftelsen, and the Skane University Hospital in Malmo Cancer Research Fund.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Carrera AC, 2009, CELL CYCLE, V8, P4005, DOI 10.4161/cc.8.24.10178; Coppola G, 2011, METHODS MOL BIOL, V793, P417, DOI 10.1007/978-1-61779-328-8_28; Edgerton-Morgan H, 2012, J CELL BIOL, V198, P785, DOI 10.1083/jcb.201203115; Ehlen A, 2012, J BIOL CHEM, V287, P17241, DOI 10.1074/jbc.M112.357038; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gonsior SM, 1999, J CELL SCI, V112, P797; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hegemann B, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001993; Hoog G, 2011, FASEB J, V25, P3815, DOI 10.1096/fj.11-187484; Horejsi B, 2012, J CELL PHYSIOL, V227, P367, DOI 10.1002/jcp.22772; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lesca C, 2005, ONCOGENE, V24, P5165, DOI 10.1038/sj.onc.1208723; Lin TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019700; Lu R, 2004, J BIOL CHEM, V279, P31164, DOI 10.1074/jbc.M404728200; Marques M, 2008, MOL CELL BIOL, V28, P2803, DOI 10.1128/MCB.01786-07; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Yuba-Kubo A, 2005, DEV BIOL, V282, P361, DOI 10.1016/j.ydbio.2005.03.031; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	31	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21360	21373		10.1074/jbc.M114.562389	http://dx.doi.org/10.1074/jbc.M114.562389			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942739	Green Published, hybrid			2022-12-28	WOS:000340558300016
J	Zheng, QQ; Jiang, DQ; Zhang, W; Zhang, QQ; Zhao, Q; Jin, J; Li, X; Yang, HT; Bartlam, M; Shaw, N; Zhou, WH; Rao, ZH				Zheng, Qianqian; Jiang, Dunquan; Zhang, Wei; Zhang, Qingqing; Zhao, Qi; Jin, Jin; Li, Xin; Yang, Haitao; Bartlam, Mark; Shaw, Neil; Zhou, Weihong; Rao, Zihe			Mechanism of Dephosphorylation of Glucosyl-3-phosphoglycerate by a Histidine Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; METHYLGLUCOSE LIPOPOLYSACCHARIDE; MYCOBACTERIAL POLYSACCHARIDES; BACILLUS-STEAROTHERMOPHILUS; COMPLEX-FORMATION; BIOSYNTHESIS; BACTERIAL; PATHWAY; GLUCOSYLGLYCERATE; THERMOPHILUS	Mycobacterium tuberculosis (Mtb) synthesizes polymethylated polysaccharides that form complexes with long chain fatty acids. These complexes, referred to as methylglucose lipopolysaccharides (MGLPs), regulate fatty acid biosynthesis in vivo, including biosynthesis of mycolic acids that are essential for building the cell wall. Glucosyl-3-phosphoglycerate phosphatase (GpgP, EC 5.4.2.1), encoded by Rv2419c gene, catalyzes the second step of the pathway for the biosynthesis of MGLPs. The molecular basis for this dephosphorylation is currently not understood. Here, we describe the crystal structures of apo-, vanadate-bound, and phosphate-bound MtbGpgP, depicting unliganded, reaction intermediate mimic, and product-bound views of MtbGpgP, respectively. The enzyme consists of a single domain made up of a central beta-sheet flanked by alpha-helices on either side. The active site is located in a positively charged cleft situated above the central beta-sheet. Unambiguous electron density for vanadate covalently bound to His(11), mimicking the phosphohistidine intermediate, was observed. The role of residues interacting with the ligands in catalysis was probed by site-directed mutagenesis. Arg(10), His(11), Asn(17), Gln(23), Arg(60), Glu(84), His(159), and Leu(209) are important for enzymatic activity. Comparison of the structures of MtbGpgP revealed conformational changes in a key loop region connecting beta 1 with alpha 1. This loop regulates access to the active site. MtbGpgP functions as dimer. L209E mutation resulted in monomeric GpgP, rendering the enzyme incapable of dephosphorylation. The structures of GpgP reported here are the first crystal structures for histidine-phosphatase-type GpgPs. These structures shed light on a key step in biosynthesis of MGLPs that could be targeted for development of anti-tuberculosis therapeutics.	[Zheng, Qianqian; Jiang, Dunquan; Zhang, Wei; Zhang, Qingqing; Zhao, Qi; Li, Xin; Yang, Haitao; Shaw, Neil; Zhou, Weihong; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Yang, Haitao] Tianjin Univ, Coll Life Sci, Tianjin 300073, Peoples R China; [Shaw, Neil; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China; [Rao, Zihe] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Zhao, Qi] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Nankai University; Tianjin University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; Yale University	Zhou, WH (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	zhouwh@nankai.edu.cn; raozh@xtal.tsinghua.edu.cn	Yang, Haitao/G-9116-2012; li, xin/HHS-9461-2022; Rao, Zihe/HCH-6944-2022; Li, Lambert LL/F-7146-2015; zhang, qingqing/GXF-2381-2022; Jiang, Quan/GQA-6586-2022	Zhang, Wei/0000-0001-8693-6747; Bartlam, Mark/0000-0001-5173-5080; Zheng, Qianqian/0000-0002-1760-4906; Shaw, Neil/0000-0003-2722-9967	Ministry of Science and Technology of China Project 973 [2013CB733904, 2014CB542800]; National Science Foundation of China [813300237]	Ministry of Science and Technology of China Project 973; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 2013CB733904 and 2014CB542800 from the Ministry of Science and Technology of China Project 973 and by National Science Foundation of China Grant 813300237.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BERGERON R, 1975, J BIOL CHEM, V250, P1223; Bond CS, 2001, J BIOL CHEM, V276, P3247, DOI 10.1074/jbc.M007318200; Bond CS, 2002, J MOL BIOL, V316, P1071, DOI 10.1006/jmbi.2002.5418; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiba Y, 2013, J BIOL CHEM, V288, P11448, DOI 10.1074/jbc.M112.449561; Costa J, 2006, J BACTERIOL, V188, P1022, DOI 10.1128/JB.188.3.1022-1030.2006; Costa J, 2007, J BACTERIOL, V189, P1648, DOI 10.1128/JB.00841-06; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Davies DR, 2011, ACTA CRYSTALLOGR F, V67, P1044, DOI 10.1107/S1744309111030405; Empadinhas N, 2003, APPL ENVIRON MICROB, V69, P3272, DOI 10.1128/AEM.69.6.3272-3279.2003; Empadinhas N, 2001, J BIOL CHEM, V276, P43580, DOI 10.1074/jbc.M108054200; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fothergill-Gilmore L. A., 1989, ADV ENZYMOLOGY RELAT, V62, P227; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; ILTON M, 1971, P NATL ACAD SCI USA, V68, P87, DOI 10.1073/pnas.68.1.87; KAMISANGO K, 1987, J BIOL CHEM, V262, P4580; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee YH, 1996, BIOCHEMISTRY-US, V35, P6010, DOI 10.1021/bi9600613; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MACHIDA Y, 1973, P NATL ACAD SCI USA, V70, P1146, DOI 10.1073/pnas.70.4.1146; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendes V, 2012, NAT PROD REP, V29, P834, DOI 10.1039/c2np20014g; Mendes V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00177; Mendes V, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-21; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2002, J MOL BIOL, V315, P1129, DOI 10.1006/jmbi.2001.5290; Rigden DJ, 2003, J MOL BIOL, V325, P411, DOI 10.1016/S0022-2836(02)01229-9; Riley LW, 2006, J CLIN INVEST, V116, P1475, DOI 10.1172/JCI28734; SAIER MH, 1968, J BIOL CHEM, V243, P4332; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Some Daniel, 2013, Biophys Rev, V5, P147, DOI 10.1007/s12551-013-0107-1; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; Syson K, 2011, J BIOL CHEM, V286, P38298, DOI 10.1074/jbc.M111.279315; TAKAI A, 1991, BIOCHEM J, V275, P233, DOI 10.1042/bj2750233; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Tuffal G, 1998, GLYCOBIOLOGY, V8, P675, DOI 10.1093/glycob/8.7.675; TUFFAL G, 1995, EUR J BIOCHEM, V233, P377, DOI 10.1111/j.1432-1033.1995.377_1.x; Yuen MH, 1999, J BIOL CHEM, V274, P2176, DOI 10.1074/jbc.274.4.2176	47	8	9	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21242	21251		10.1074/jbc.M114.569913	http://dx.doi.org/10.1074/jbc.M114.569913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24914210	hybrid, Green Published			2022-12-28	WOS:000340558300004
J	Jones, CL; Bhatla, T; Blum, R; Wang, JH; Paugh, SW; Wen, X; Bourgeois, W; Bitterman, DS; Raetz, EA; Morrison, DJ; Teachey, DT; Evans, WE; Garabedian, MJ; Carroll, WL				Jones, Courtney L.; Bhatla, Teena; Blum, Roy; Wang, Jinhua; Paugh, Steven W.; Wen, Xin; Bourgeois, Wallace; Bitterman, Danielle S.; Raetz, Elizabeth A.; Morrison, Debra J.; Teachey, David T.; Evans, William E.; Garabedian, Michael J.; Carroll, William L.			Loss of TBL1XR1 Disrupts Glucocorticoid Receptor Recruitment to Chromatin and Results in Glucocorticoid Resistance in a B-Lymphoblastic Leukemia Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED TRANSCRIPTION; MEDIATED APOPTOSIS; GENOMIC ANALYSIS; DRUG-RESISTANCE; GENE NETWORKS; CELL-LINES; EXPRESSION; MECHANISMS; ACTIVATION; MUTATIONS	Although great advances have been made in the treatment of pediatric acute lymphoblastic leukemia, up to one of five patients will relapse, and their prognosis thereafter is dismal. We have previously identified recurrent deletions in TBL1XR1, which encodes for an F-box like protein responsible for regulating the nuclear hormone repressor complex stability. Here we model TBL1XR1 deletions in B-precursor ALL cell lines and show that TBL1XR1 knockdown results in reduced glucocorticoid receptor recruitment to glucocorticoid responsive genes and ultimately decreased glucocorticoid signaling caused by increased levels of nuclear hormone repressor 1 and HDAC3. Reduction in glucocorticoid signaling in TBL1XR1-depleted lines resulted in resistance to glucocorticoid agonists, but not to other chemotherapeutic agents. Importantly, we show that treatment with the HDAC inhibitor SAHA restores sensitivity to prednisolone in TBL1XR1-depleted cells. Altogether, our data indicate that loss of TBL1XR1 is a novel driver of glucocorticoid resistance in ALL and that epigenetic therapy may have future application in restoring drug sensitivity at relapse.	[Jones, Courtney L.; Blum, Roy; Wang, Jinhua; Wen, Xin; Bourgeois, Wallace; Bitterman, Danielle S.; Morrison, Debra J.; Carroll, William L.] NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Bhatla, Teena; Carroll, William L.] NYU, Langone Med Ctr, Div Pediat Hematol & Oncol, New York, NY 10016 USA; [Wang, Jinhua; Wen, Xin] NYU, Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Garabedian, Michael J.] NYU, Langone Med Ctr, Dept Microbiol, New York, NY 10016 USA; [Paugh, Steven W.; Evans, William E.] St Jude Childrens Res Hosp, Hematol Malignancies Program, Memphis, TN 38105 USA; [Paugh, Steven W.; Evans, William E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Raetz, Elizabeth A.] Univ Utah, Div Pediat Hematol & Oncol, Salt Lake City, UT 84102 USA; [Teachey, David T.] Childrens Hosp Philadelphia, Dept Pediat, Div Oncol, Philadelphia, PA 19104 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Carroll, WL (corresponding author), NYU, Inst Canc, Smilow 1201,522 First Ave, New York, NY 10016 USA.	william.carroll@nyumc.org	Evans, William E./C-2069-2012; Paugh, Steven/A-7739-2008	Evans, William E./0000-0002-9333-5322; Paugh, Steven/0000-0001-5697-9228; Teachey, David/0000-0001-7373-8987; Bourgeois, Wallace/0000-0002-6935-8890; Morrison, Debra/0000-0002-8265-5910; Blum, Roy/0000-0002-3987-7198	National Institutes of Health [R01 CA140729, 2P30CA016087-33, T32 GM066704, F32 CA141762, R37 CA36401]; Ira Sohn Conference Foundation; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [R01CA140729, R37CA036401, F32CA141762, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ira Sohn Conference Foundation; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA140729 and 2P30CA016087-33 (to W. L. C.), T32 GM066704 (to C. L. J.), F32 CA141762 (to S. W. P.), and R37 CA36401 (to W. E. E.). This work was also supported by funds from the Ira Sohn Conference Foundation (to T. B.) and St. Baldrick's Foundation (to D. S. B.).	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Bachmann PS, 2007, CANCER RES, V67, P4482, DOI 10.1158/0008-5472.CAN-06-4244; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; Beesley AH, 2009, LEUKEMIA RES, V33, P321, DOI 10.1016/j.leukres.2008.08.007; Bhatla T, 2012, BLOOD, V119, P5201, DOI 10.1182/blood-2012-01-401687; CADEPOND F, 1991, J BIOL CHEM, V266, P5834; Carroll WL, 2012, J PEDIATR-US, V160, P10, DOI 10.1016/j.jpeds.2011.08.006; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Dandekar S. C., 2013, BLOOD; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Gonzalez-Aguilar A, 2012, CLIN CANCER RES, V18, P5203, DOI 10.1158/1078-0432.CCR-12-0845; Greenstein S, 2002, CLIN CANCER RES, V8, P1681; Gruhn B, 2013, LEUKEMIA RES, V37, P1200, DOI 10.1016/j.leukres.2013.07.016; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; KASPERS GJL, 1994, LEUKEMIA LYMPHOMA, V13, P187, DOI 10.3109/10428199409056282; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Moreno DA, 2010, BRIT J HAEMATOL, V150, P665, DOI 10.1111/j.1365-2141.2010.08301.x; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Olsson L, 2014, LEUKEMIA, V28, P302, DOI 10.1038/leu.2013.206; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Pieters R, 1998, LEUKEMIA, V12, P1344, DOI 10.1038/sj.leu.2401129; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Schmiegelow K, 2001, LEUKEMIA, V15, P1066, DOI 10.1038/sj.leu.2402144; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Tijchon E, 2013, LEUKEMIA, V27, P541, DOI 10.1038/leu.2012.293; Tissing WJE, 2007, BLOOD, V109, P3929, DOI 10.1182/blood-2006-11-056366; Tissing WJE, 2003, LEUKEMIA, V17, P17, DOI 10.1038/sj.leu.2402733; van Galen JC, 2010, BLOOD, V115, P4810, DOI 10.1182/blood-2009-05-223081; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; ZHANG LQ, 1993, LEUKEMIA, V7, P1865; Zhang XM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-31; Zhao YN, 2011, MED ONCOL, V28, P1609, DOI 10.1007/s12032-010-9641-x	43	43	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20502	20515		10.1074/jbc.M114.569889	http://dx.doi.org/10.1074/jbc.M114.569889			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895125	Green Published, hybrid			2022-12-28	WOS:000339396600012
J	Makinoshima, H; Takita, M; Matsumoto, S; Yagishita, A; Owada, S; Esumi, H; Tsuchihara, K				Makinoshima, Hideki; Takita, Masahiro; Matsumoto, Shingo; Yagishita, Atsushi; Owada, Satoshi; Esumi, Hiroyasu; Tsuchihara, Katsuya			Epidermal Growth Factor Receptor ( EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IONIZATION MASS-SPECTROMETRY; TYROSINE KINASE INHIBITORS; CANCER-CELL METABOLISM; C-MYC; MUTATIONS; GEFITINIB; PROLIFERATION; TRANSLOCATION; TUMORS	Genetic mutations in tumor cells cause several unique metabolic phenotypes that are critical for cancer cell proliferation. Mutations in the tyrosine kinase epidermal growth factor receptor (EGFR) induce oncogenic addiction in lung adenocarcinoma (LAD). However, the linkage between oncogenic mutated EGFR and cancer cell metabolism has not yet been clearly elucidated. Here we show that EGFR signaling plays an important role in aerobic glycolysis in EGFR-mutated LAD cells. EGFR-tyrosine kinase inhibitors (TKIs) decreased lactate production, glucose consumption, and the glucose-induced extracellular acidification rate (ECAR), indicating that EGFR signaling maintained aerobic glycolysis in LAD cells. Metabolomic analysis revealed that metabolites in the glycolysis, pentose phosphate pathway (PPP), pyrimidine biosynthesis, and redox metabolism were significantly decreased after treatment of LAD cells with EGFR-TKI. On a molecular basis, the glucose transport carried out by glucose transporter 3 (GLUT3) was downregulated in TKI-sensitive LAD cells. Moreover, EGFR signaling activated carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD), which catalyzes the first step in de novo pyrimidine synthesis. We conclude that EGFR signaling regulates the global metabolic pathway in EGFR-mutated LAD cells. Our data provide evidence that may link therapeutic response to the regulation of metabolism, which is an attractive target for the development of more effective targeted therapies to treat patients with EGFR-mutated LAD.	[Makinoshima, Hideki; Takita, Masahiro; Matsumoto, Shingo; Yagishita, Atsushi; Tsuchihara, Katsuya] Natl Canc Ctr, Div Translat Res, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan; [Takita, Masahiro; Tsuchihara, Katsuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778561, Japan; [Matsumoto, Shingo] Natl Canc Ctr Hosp East, Thorac Oncol Div, Kashiwa, Chiba 2778577, Japan; [Owada, Satoshi; Esumi, Hiroyasu] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 2780022, Japan	National Cancer Center - Japan; University of Tokyo; National Cancer Center - Japan; Tokyo University of Science	Makinoshima, H (corresponding author), Natl Canc Ctr, Div Translat Res, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan.	hmakinos@east.ncc.go.jp			National Cancer Center Research and Development Fund [25-A-6]; JSPS KAKENHI [24300345]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Cancer Center Research and Development Fund (25-A-6) and JSPS KAKENHI Grant Number 24300345 (to K. T.).	Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Donev IS, 2011, CLIN CANCER RES, V17, P2260, DOI 10.1158/1078-0432.CCR-10-1993; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2014, ONCOGENE, V33, P4279, DOI 10.1038/onc.2013.406; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Irmer D, 2007, ONCOGENE, V26, P5693, DOI 10.1038/sj.onc.1210383; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Kim SM, 2013, MOL CANCER THER, V12, P2145, DOI 10.1158/1535-7163.MCT-12-1188; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Levitzki A, 2013, ANNU REV PHARMACOL, V53, P161, DOI 10.1146/annurev-pharmtox-011112-140341; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mellinghoff I, 2007, PLOS MED, V4, P1620, DOI 10.1371/journal.pmed.0040321; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Okamoto K, 2010, CANCER RES, V70, P10402, DOI 10.1158/0008-5472.CAN-10-2438; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Sudo M, 2013, CANCER CHEMOTH PHARM, V71, P1325, DOI 10.1007/s00280-013-2132-y; Suzuki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073484; Takahashi R, 2012, CLIN CANCER RES, V18, P220, DOI 10.1158/1078-0432.CCR-11-0868; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wong N, 2015, CANCER LETT, V356, P184, DOI 10.1016/j.canlet.2014.01.031; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	44	121	126	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20813	20823		10.1074/jbc.M114.575464	http://dx.doi.org/10.1074/jbc.M114.575464			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928511	Green Published, hybrid			2022-12-28	WOS:000339396600036
J	Mellergaard, M; Skovbakke, SL; Schneider, CL; Lauridsen, F; Andresen, L; Jensen, H; Skov, S				Mellergaard, Maiken; Skovbakke, Sarah Line; Schneider, Christine L.; Lauridsen, Felicia; Andresen, Lars; Jensen, Helle; Skov, Soren			N-Glycosylation of Asparagine 8 Regulates Surface Expression of Major Histocompatibility Complex Class I Chain-related Protein A (MICA) Alleles Dependent on Threonine 24	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NKG2D LIGAND EXPRESSION; ACTIVATED T-LYMPHOCYTES; INTRACELLULAR RETENTION; LINKED OLIGOSACCHARIDES; GLYCOPROTEIN UL16; DOWN-REGULATION; MOLECULES; CELLS; HUMAN-HERPESVIRUS-7; SEQUESTRATION	NKG2Dis an activating receptor expressed on several types of human lymphocytes. NKG2D ligands can be induced upon cell stress and are frequently targeted post-translationally in infected or transformed cells to avoid immune recognition. Virus infection and inflammation alter protein N-glycosylation, and we have previously shown that changes in cellular N-glycosylation are involved in regulation of NKG2D ligand surface expression. The specific mode of regulation through N-glycosylation is, however, unknown. Here we investigated whether direct N-glycosylation of the NKG2D ligand MICA itself is critical for cell surface expression and sought to identify the essential residues. We found that a single N-glycosylation site (Asn(8)) was important for MICA018 surface expression. The frequently expressed MICA allele 008, with an altered transmembrane and intracellular domain, was not affected by mutation of this N-glycosylation site. Mutational analysis revealed that a single amino acid (Thr(24)) in the extracellular domain of MICA018 was essential for the N-glycosylation dependence, whereas the intracellular domain was not involved. The HHV7 immunoevasin, U21, was found to inhibit MICA018 surface expression by affecting N-glycosylation, and the retention was rescued by T24A substitution. Our study reveals N-glycosylation as an allele-specific regulatory mechanism important for regulation of surface expression of MICA018, and we pinpoint the residues essential for this N-glycosylation dependence. In addition, we show that this regulatory mechanism of MICA surface expression is likely targeted during different pathological conditions.	[Mellergaard, Maiken; Skovbakke, Sarah Line; Lauridsen, Felicia; Andresen, Lars; Jensen, Helle; Skov, Soren] Univ Copenhagen, Immunol Lab, Fac Hlth & Med Sci, Sect Expt Anim Models, DK-1870 Frederiksberg, Denmark; [Schneider, Christine L.] Carroll Univ, Dept Biol, Waukesha, WI 53186 USA	University of Copenhagen	Skov, S (corresponding author), Univ Copenhagen, Immunol Lab, Stigbojlen 7, DK-1870 Frederiksberg, Denmark.	sosk@sund.ku.dk	Andresen, Lars/O-2271-2019; Andresen, Lars/K-1287-2012	Andresen, Lars/0000-0002-6362-7973; Skovbakke, Sarah Line/0000-0002-4673-4419; Mellergaard, Maiken/0000-0001-5854-1086; Skov, Soren/0000-0003-0732-0026	Danish Council for Independent Research/Medical Sciences [DFF-1331-00169]	Danish Council for Independent Research/Medical Sciences(Det Frie Forskningsrad (DFF))	This work was supported by Project DFF-1331-00169 from the Danish Council for Independent Research/Medical Sciences.	Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Andresen L, 2012, J IMMUNOL, V188, P1847, DOI 10.4049/jimmunol.1004085; Andresen L, 2009, J IMMUNOL, V183, P897, DOI 10.4049/jimmunol.0803014; Ashiru O, 2009, J VIROL, V83, P12345, DOI 10.1128/JVI.01175-09; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Benjamin L., 2007, CELLS, P120; Blauvelt A, 2001, J INVEST DERM SYMP P, V6, P197, DOI 10.1046/j.0022-202x.2001.00040.x; Chalupny NJ, 2006, BIOCHEM BIOPH RES CO, V346, P175, DOI 10.1016/j.bbrc.2006.05.092; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; ELBEIN AD, 1991, TRENDS BIOTECHNOL, V9, P346, DOI 10.1016/0167-7799(91)90117-Z; Fares F, 2006, BBA-GEN SUBJECTS, V1760, P560, DOI 10.1016/j.bbagen.2005.12.022; FERNANDES B, 1991, CANCER RES, V51, P718; Fuertes MB, 2008, J IMMUNOL, V180, P4606, DOI 10.4049/jimmunol.180.7.4606; Glosson NL, 2010, J BIOL CHEM, V285, P37016, DOI 10.1074/jbc.M110.125849; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hudson AW, 2001, J VIROL, V75, P12347, DOI 10.1128/JVI.75.24.12347-12358.2001; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Kroemer G, 2007, IMMUNOL REV, V220, P5; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Lopez-Larrea C, 2008, TRENDS MOL MED, V14, P179, DOI 10.1016/j.molmed.2008.02.004; Marcos NT, 2008, J CLIN INVEST, V118, P2325, DOI [10.1172/JC134324, 10.1172/JCI34324]; May NA, 2010, J VIROL, V84, P3738, DOI 10.1128/JVI.01782-09; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; Molinero LL, 2003, J LEUKOCYTE BIOL, V73, P815, DOI 10.1189/jlb.0602329; Nice TJ, 2010, J IMMUNOL, V185, P5369, DOI 10.4049/jimmunol.1000247; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Robinson J, 2001, IMMUNOGENETICS, V53, P150, DOI 10.1007/s002510100303; Satomaa T, 2009, CANCER RES, V69, P5811, DOI 10.1158/0008-5472.CAN-08-0289; Schneider CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002362; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Suemizu H, 2002, P NATL ACAD SCI USA, V99, P2971, DOI 10.1073/pnas.052701099; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Welte SA, 2003, EUR J IMMUNOL, V33, P194, DOI 10.1002/immu.200390022; Wu J, 2003, J IMMUNOL, V170, P4196, DOI 10.4049/jimmunol.170.8.4196; Zwirner NW, 2007, CYTOKINE GROWTH F R, V18, P159, DOI 10.1016/j.cytogfr.2007.01.013; Zwirner NW, 1998, IMMUNOGENETICS, V47, P139	58	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20078	20091		10.1074/jbc.M114.573238	http://dx.doi.org/10.1074/jbc.M114.573238			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24872415	Green Published, hybrid			2022-12-28	WOS:000339395200022
J	Qin, XJ; Hao, ZT; Tian, QN; Zhang, ZM; Zhou, C; Xie, W				Qin, Xiangjing; Hao, Zhitai; Tian, Qingnan; Zhang, Zhemin; Zhou, Chun; Xie, Wei			Cocrystal Structures of Glycyl-tRNA Synthetase in Complex with tRNA Suggest Multiple Conformational States in Glycylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; MUTATIONS; PURIFICATION; SEQUENCES; GARS; 2D	Aminoacyl-tRNA synthetases are an ancient enzyme family that specifically charges tRNA molecules with cognate amino acids for protein synthesis. Glycyl-tRNA synthetase (GlyRS) is one of the most intriguing aminoacyl-tRNA synthetases due to its divergent quaternary structure and abnormal charging properties. In the past decade, mutations of human GlyRS (hGlyRS) were also found to be associated with Charcot-Marie-Tooth disease. However, the mechanisms of traditional and alternative functions of hGlyRS are poorly understood due to a lack of studies at the molecular basis. In this study we report crystal structures of wild type and mutant hGlyRS in complex with tRNA and with small substrates and describe the molecular details of enzymatic recognition of the key tRNA identity elements in the acceptor stem and the anticodon loop. The cocrystal structures suggest that insertions 1 and 3 work together with the active site in a cooperative manner to facilitate efficient substrate binding. Both the enzyme and tRNA molecules undergo significant conformational changes during glycylation. A working model of multiple conformations for hGlyRS catalysis is proposed based on the crystallographic and biochemical studies. This study provides insights into the catalytic pathway of hGlyRS and may also contribute to our understanding of Charcot-Marie-Tooth disease.	[Qin, Xiangjing; Hao, Zhitai; Tian, Qingnan; Zhang, Zhemin; Xie, Wei] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Qin, Xiangjing; Hao, Zhitai; Tian, Qingnan; Zhang, Zhemin; Xie, Wei] Sun Yat Sen Univ, Ctr Cellular & Struct Biol, Guangzhou 510006, Guangdong, Peoples R China; [Zhou, Chun] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Sun Yat Sen University; Sun Yat Sen University; Memorial Sloan Kettering Cancer Center	Xie, W (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol,Sch Life Sci, 132 E Circle Rd, Guangzhou 510275, Guangdong, Peoples R China.	xiewei6@mail.sysu.edu.cn		Xie, Wei/0000-0003-2410-2135; zhou, chun/0000-0002-9257-468X; Hao, Zhitai/0000-0001-9369-976X	National Sciences Foundation of China [4103041]; Fundamental Research Funds for the Central Universities SYSU [11lgjc09]; Guangdong Innovative Research Team Program Grant [201001Y0104687244]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities SYSU; Guangdong Innovative Research Team Program Grant	This work was supported by National Sciences Foundation of China Grant 4103041, Fundamental Research Funds for the Central Universities SYSU 11lgjc09, and Guangdong Innovative Research Team Program Grant 201001Y0104687244.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Bienfait HME, 2007, NEUROLOGY, V68, P1658, DOI 10.1212/01.wnl.0000263479.97552.94; Chen SJ, 2011, ACS CHEM BIOL, V6, P1182, DOI 10.1021/cb200240a; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; DIGNAM SS, 1984, J BIOL CHEM, V259, P4043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Freist W, 1996, BIOL CHEM H-S, V377, P343; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Guo RT, 2009, J BIOL CHEM, V284, P28968, DOI 10.1074/jbc.M109.030692; He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108; Jani-Acsadi A, 2008, SEMIN NEUROL, V28, P185, DOI 10.1055/s-2008-1062264; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Lee HJ, 2012, J PERIPHER NERV SYST, V17, P418, DOI 10.1111/j.1529-8027.2012.00442.x; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001; Nameki N, 1997, Nucleic Acids Symp Ser, P123; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Sambuughin N, 1998, J NEUROL SCI, V161, P23, DOI 10.1016/S0022-510X(98)00264-0; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; SCHIMMEL P, 1995, J MOL EVOL, V40, P531; SHIBA K, 1994, J BIOL CHEM, V269, P30049; SKRE H, 1974, CLIN GENET, V6, P98; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; SURGUCHOV AP, 1975, EUR J BIOCHEM, V54, P175, DOI 10.1111/j.1432-1033.1975.tb04127.x; Tan Kemin, 2012, Journal of Structural and Functional Genomics, V13, P233, DOI 10.1007/s10969-012-9142-6; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Xie W, 2006, ACTA CRYSTALLOGR F, V62, P1243, DOI 10.1107/S1744309106046434; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626	44	35	37	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20359	20369		10.1074/jbc.M114.557249	http://dx.doi.org/10.1074/jbc.M114.557249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898252	Green Published, hybrid			2022-12-28	WOS:000339395200046
J	Hans, F; Fiesel, FC; Strong, JC; Jackel, S; Rasse, TM; Geisler, S; Springer, W; Schulz, JB; Voigt, A; Kahle, PJ				Hans, Friederike; Fiesel, Fabienne C.; Strong, Jennifer C.; Jaeckel, Sandra; Rasse, Tobias M.; Geisler, Sven; Springer, Wolfdieter; Schulz, Joerg B.; Voigt, Aaron; Kahle, Philipp J.			UBE2E Ubiquitin-conjugating Enzymes and Ubiquitin Isopeptidase Y Regulate TDP-43 Protein Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HISTONE DEACETYLASE 6; MESSENGER-RNA; PROTEASOME SYSTEM; MOLECULAR-BASIS; DEGRADATION; COMPLEX; ALS; CLEARANCE	Trans-activation element DNA-binding protein of 43 kDa (TDP-43) characterizes insoluble protein aggregates in distinct subtypes of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. TDP-43 mediates many RNA processing steps within distinct protein complexes. Here we identify novel TDP-43 protein interactors found in a yeast two-hybrid screen using an adult human brain cDNA library. We confirmed the TDP-43 interaction of seven hits by co-immunoprecipitation and assessed their co-localization in HEK293E cells. As pathological TDP-43 is ubiquitinated, we focused on the ubiquitin- conjugating enzyme UBE2E3 and the ubiquitin isopeptidase Y (UBPY). When cells were treated with proteasome inhibitor, ubiquitinated and insoluble TDP-43 species accumulated. All three UBE2E family members could enhance the ubiquitination of TDP-43, whereas catalytically inactive UBE2E3(C145S) was much less efficient. Conversely, silencing of UBE2E3 reduced TDP-43 ubiquitination. We examined 15 of the 48 known disease-associated TDP-43 mutants and found that one was excessively ubiquitinated. This strong TDP-43(K263E) ubiquitination was further enhanced by proteasomal inhibition as well as UBE2E3 expression. Conversely, UBE2E3 silencing and expression of UBPY reduced TDP-43(K263E) ubiquitination. Moreover, wild-type but not active site mutant UBPY reduced ubiquitination of TDP-43 C-terminal fragments and of a nuclear import-impaired mutant. In Drosophila melanogaster, UBPY silencing enhanced neurodegenerative TDP-43 phenotypes and the accumulation of insoluble high molecular weight TDP-43 and ubiquitin species. Thus, UBE2E3 and UBPY participate in the regulation of TDP-43 ubiquitination, solubility, and neurodegeneration.	[Hans, Friederike; Kahle, Philipp J.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72076 Tubingen, Germany; [Hans, Friederike; Springer, Wolfdieter; Kahle, Philipp J.] German Ctr Neurodegenerat Dis DZNE, Lab Funct Neurogenet, Dept Neurodegenerat, D-72076 Tubingen, Germany; [Hans, Friederike; Fiesel, Fabienne C.; Strong, Jennifer C.; Jaeckel, Sandra; Geisler, Sven; Springer, Wolfdieter; Kahle, Philipp J.] Hertie Inst Clin Brain Res, Lab Funct Neurogenet, Dept Neurodegenerat, D-72076 Tubingen, Germany; [Rasse, Tobias M.] Hertie Inst Clin Brain Res, Synapt Plast Grp, D-72076 Tubingen, Germany; [Schulz, Joerg B.; Voigt, Aaron] Univ Med Ctr, Dept Neurol, D-52074 Aachen, Germany; [Schulz, Joerg B.] JARA, Translat Brain Med, D-52074 Aachen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Kahle, PJ (corresponding author), Univ Tubingen, Lab Funct Neurogenet, German Ctr Neurodegenerat Dis, Dept Neurodegenerat, Otfried Muller Str 27, D-72076 Tubingen, Germany.	philipp.kahle@uni-tuebingen.de	Schulz, Jörg B/D-9786-2012	Schulz, Jörg B/0000-0002-8903-0593; Fiesel, Fabienne/0000-0002-1919-9676; Springer, Wolfdieter/0000-0002-1178-3149	German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; DZNE Ph.D. stipend; DZNE Virtual Institute; German Research Foundation (Deutsche Forschungsgemeinschaft) [KA1675/3-1, KA1675/3-2]; German Competence Network; Hertie Foundation	German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; DZNE Ph.D. stipend; DZNE Virtual Institute; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Competence Network; Hertie Foundation	This work was supported by the German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, specifically a DZNE Ph.D. stipend (to F. H.) and the DZNE Virtual Institute "RNA Dysmetabolism in ALS"; German Research Foundation (Deutsche Forschungsgemeinschaft) Grants KA1675/3-1 and KA1675/3-2; the German Competence Network "Degenerative Dementias"; and the Hertie Foundation.	Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Collins M, 2012, ACTA NEUROPATHOL, V124, P717, DOI 10.1007/s00401-012-1045-x; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Dammer EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038658; Fallini C, 2012, HUM MOL GENET, V21, P3703, DOI 10.1093/hmg/dds205; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Fiesel FC, 2011, FEBS J, V278, P3550, DOI 10.1111/j.1742-4658.2011.08258.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Furukawa Y, 2011, BBA-MOL BASIS DIS, V1812, P1577, DOI 10.1016/j.bbadis.2011.09.005; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gibson TJ, 2012, FEBS LETT, V586, P2787, DOI 10.1016/j.febslet.2012.04.048; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hebron ML, 2013, J BIOL CHEM, V288, P4103, DOI 10.1074/jbc.M112.419945; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hong S, 2008, BIOCHEM BIOPH RES CO, V371, P256, DOI 10.1016/j.bbrc.2008.04.066; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kovacs GG, 2009, MOVEMENT DISORD, V24, P1843, DOI 10.1002/mds.22697; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Seiberlich V, 2012, BBA-MOL CELL RES, V1823, P2057, DOI 10.1016/j.bbamcr.2012.04.011; Shiina Y, 2010, CELL MOL NEUROBIOL, V30, P641, DOI 10.1007/s10571-009-9489-9; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600; Tharun S, 2009, INT REV CEL MOL BIO, V272, P149, DOI 10.1016/S1937-6448(08)01604-3; Tsuiji H, 2013, EMBO MOL MED, V5, P221, DOI 10.1002/emmm.201202303; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Yu ZP, 2012, J BIOL CHEM, V287, P22560, DOI 10.1074/jbc.M112.357582; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	69	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19164	19179		10.1074/jbc.M114.561704	http://dx.doi.org/10.1074/jbc.M114.561704			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24825905	Green Published, hybrid			2022-12-28	WOS:000339062900045
J	Hanuszkiewicz, A; Pittock, P; Humphries, F; Moll, H; Rosales, AR; Molinaro, A; Moynagh, PN; Lajoie, GA; Valvano, MA				Hanuszkiewicz, Anna; Pittock, Paula; Humphries, Fiachra; Moll, Hermann; Rosales, Amanda Roa; Molinaro, Antonio; Moynagh, Paul N.; Lajoie, Gilles A.; Valvano, Miguel A.			Identification of the Flagellin Glycosylation System in Burkholderia cenocepacia and the Contribution of Glycosylated Flagellin to Evasion of Human Innate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; CEPACIA COMPLEX; BIOCHEMICAL-CHARACTERIZATION; AMINO-ACIDS; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; PATHWAYS; MOTILITY; RECONSTITUTION; AMINOARABINOSE	Burkholderia cenocepacia is an opportunistic pathogen threatening patients with cystic fibrosis. Flagella are required for biofilm formation, as well as adhesion to and invasion of epithelial cells. Recognition of flagellin via the Toll-like receptor 5 (TLR5) contributes to exacerbate B. cenocepacia-induced lung epithelial inflammatory responses. In this study, we report that B. cenocepacia flagellin is glycosylated on at least 10 different sites with a single sugar, 4,6-dideoxy-4-(3-hydroxybutanoylamino)- D-glucose. We have identified key genes that are required for flagellin glycosylation, including a predicted glycosyltransferase gene that is linked to the flagellin biosynthesis cluster and a putative acetyltransferase gene located within the O-antigen lipopolysaccharide cluster. Another O-antigen cluster gene, rmlB, which is required for flagellin glycan and O-antigen biosynthesis, was essential for bacterial viability, uncovering a novel target against Burkholderia infections. Using glycosylated and nonglycosylated purified flagellin and a cell reporter system to assess TLR5-mediated responses, we also show that the presence of glycan in flagellin significantly impairs the inflammatory response of epithelial cells. We there-fore suggest that flagellin glycosylation reduces recognition of flagellin by host TLR5, providing an evasive strategy to infecting bacteria.	[Hanuszkiewicz, Anna; Moynagh, Paul N.; Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast BT9 7AE, Antrim, North Ireland; [Pittock, Paula; Lajoie, Gilles A.] Univ Western Ontario, Dept Biochem, Don Rix Prot Identificat Facil, London, ON N6A 5C1, Canada; [Humphries, Fiachra; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Dept Biol, Maynooth, Kildare, Ireland; [Moll, Hermann] Res Ctr Borstel, D-23845 Borstel, Germany; [Rosales, Amanda Roa; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Molinaro, Antonio] Univ Naples Federico II, Dipartimento Sci Chim, I-80134 Naples, Italy	Queens University Belfast; Western University (University of Western Ontario); Maynooth University; Forschungszentrum Borstel; Western University (University of Western Ontario); University of Naples Federico II	Valvano, MA (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	m.valvano@qub.ac.uk	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641; Moynagh, Paul/0000-0002-4139-3061; Humphries, Fiachra/0000-0003-0216-5776; Molinaro, Antonio/0000-0002-3456-7369	Canadian Institutes of Health Research; United Kingdom Cystic Fibrosis Trust; COST Action [BM1003]; Cystic Fibrosis Trust [PJ564] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); United Kingdom Cystic Fibrosis Trust; COST Action(European Cooperation in Science and Technology (COST)); Cystic Fibrosis Trust	This work was supported by grants from the Canadian Institutes of Health Research and the United Kingdom Cystic Fibrosis Trust (to M. A. V.) and COST Action BM1003 "Microbial Cell Surface Determinants of Virulence as Targets for New Therapeutics in Cystic Fibrosis" (to A. M. and M. A. V.).	Batt SM, 2010, J BIOL CHEM, V285, P37741, DOI 10.1074/jbc.M110.165407; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; BRETT PJ, 1994, INFECT IMMUN, V62, P1914, DOI 10.1128/IAI.62.5.1914-1919.1994; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; De Soyza A, 2004, THORAX, V59, P526, DOI 10.1136/thx.2003.010801; de Zoete MR, 2010, J BIOL CHEM, V285, P12149, DOI 10.1074/jbc.M109.070227; DRAKE D, 1988, J GEN MICROBIOL, V134, P43; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Graindorge A, 2010, DIAGN MICR INFEC DIS, V66, P29, DOI 10.1016/j.diagmicrobio.2009.06.008; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Hamad MA, 2012, MOL MICROBIOL, V85, P962, DOI 10.1111/j.1365-2958.2012.08154.x; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hirai H, 2011, J BIOL CHEM, V286, P25519, DOI 10.1074/jbc.M111.254029; Hitchen PG, 2010, BIOCHEM SOC T, V38, P1307, DOI 10.1042/BST0381307; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Katsiari M, 2012, HIPPOKRATIA, V16, P317; Knirel YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P1, DOI 10.1007/978-3-7091-0733-1; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lee S, 2013, AM J INFECT CONTROL, V41, pE93, DOI 10.1016/j.ajic.2013.01.024; LIU HW, 1994, ANNU REV MICROBIOL, V48, P223, DOI 10.1146/annurev.micro.48.1.223; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2005, Chron Respir Dis, V2, P209, DOI 10.1191/1479972305cd053ra; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Marolda CL, 1999, MICROBIOL-UK, V145, P2485, DOI 10.1099/00221287-145-9-2485; MAROLDA CL, 1990, J BACTERIOL, V172, P3590, DOI 10.1128/jb.172.7.3590-3599.1990; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; McDowell A, 2004, J MED MICROBIOL, V53, P663, DOI 10.1099/jmm.0.45557-0; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Morrison MJ, 2013, J BIOL CHEM, V288, P32248, DOI 10.1074/jbc.M113.510560; Morrison MJ, 2013, ARCH BIOCHEM BIOPHYS, V536, P72, DOI 10.1016/j.abb.2013.05.011; Nguyen LC, 2009, MOL GENET GENOMICS, V282, P595, DOI 10.1007/s00438-009-0489-8; Novotny LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067629; Ortega X, 2005, J BACTERIOL, V187, P1324, DOI 10.1128/JB.187.4.1324-1333.2005; Ortega X, 2009, J BIOL CHEM, V284, P21738, DOI 10.1074/jbc.M109.008532; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Ovchinnikova OG, 2007, CARBOHYD RES, V342, P1116, DOI 10.1016/j.carres.2007.02.028; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Saldias MS, 2008, INFECT IMMUN, V76, P1059, DOI 10.1128/IAI.01167-07; Saldias MS, 2009, J MED MICROBIOL, V58, P1542, DOI 10.1099/jmm.0.013235-0; Sambrook J., 2001, MOL CLONING LAB MANU, P1881; Satpute MG, 2011, AM J INFECT CONTROL, V39, pE21, DOI 10.1016/j.ajic.2010.10.034; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Scott AE, 2011, J BACTERIOL, V193, P3577, DOI 10.1128/JB.01385-10; Seo ST, 2005, FEMS MICROBIOL LETT, V245, P19, DOI 10.1016/j.femsle.2005.02.020; Shanks KK, 2010, CLIN VACCINE IMMUNOL, V17, P1196, DOI 10.1128/CVI.00167-10; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Vandamme P, 2003, RES MICROBIOL, V154, P91, DOI 10.1016/S0923-2508(03)00026-3; VanDamme P, 2003, J NEMATOL, V35, P208; Ventura GMDC, 2008, FEMS IMMUNOL MED MIC, V54, P37, DOI 10.1111/j.1574-695X.2008.00453.x; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Wang Y, 2007, J BACTERIOL, V189, P8626, DOI 10.1128/JB.00777-07; Wei CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041056; West TE, 2013, J IMMUNOL, V190, P3373, DOI 10.4049/jimmunol.1202974	75	42	43	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19231	19244		10.1074/jbc.M114.562603	http://dx.doi.org/10.1074/jbc.M114.562603			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841205	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000339062900050
J	Poirier, S; Samami, S; Mamarbachi, M; Demers, A; Chang, TY; Vance, DE; Hatch, GM; Mayer, G				Poirier, Steve; Samami, Samaneh; Mamarbachi, Maya; Demers, Annie; Chang, Ta Yuan; Vance, Dennis E.; Hatch, Grant M.; Mayer, Gaetan			The Epigenetic Drug 5-Azacytidine Interferes with Cholesterol and Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ELEMENT-BINDING PROTEIN-2; DNA METHYLTRANSFERASE INHIBITORS; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; MYELODYSPLASTIC SYNDROMES; KNOCKOUT MICE; TARGET GENES; LIVER; CANCER	DNA methylation and histone acetylation inhibitors are widely used to study the role of epigenetic marks in the regulation of gene expression. In addition, several of these molecules are being tested in clinical trials or already in use in the clinic. Antimetabolites, such as the DNA-hypomethylating agent 5-azacytidine (5-AzaC), have been shown to lower malignant progression to acute myeloid leukemia and to prolong survival in patients with myelodysplastic syndromes. Here we examined the effects of DNA methylation inhibitors on the expression of lipid biosynthetic and uptake genes. Our data demonstrate that, independently of DNA methylation, 5-AzaC selectively and very potently reduces expression of key genes involved in cholesterol and lipid metabolism (e. g. PCSK9, HMGCR, and FASN) in all tested cell lines and in vivo in mouse liver. Treatment with 5-AzaC disturbed subcellular cholesterol homeostasis, thereby impeding activation of sterol regulatory element-binding proteins (key regulators of lipid metabolism). Through inhibition of UMP synthase, 5-AzaC also strongly induced expression of 1-acylglycerol-3-phosphate O-acyltransferase 9 (AGPAT9) and promoted triacylglycerol synthesis and cytosolic lipid droplet formation. Remarkably, complete reversal was obtained by the co-addition of either UMP or cytidine. Therefore, this study provides the first evidence that inhibition of the de novo pyrimidine synthesis by 5-AzaC disturbs cholesterol and lipid homeostasis, probably through the glycerolipid biosynthesis pathway, which may contribute mechanistically to its beneficial cytostatic properties.	[Poirier, Steve; Samami, Samaneh; Mamarbachi, Maya; Demers, Annie; Mayer, Gaetan] Montreal Heart Inst, Mol Cell Biol Lab, Montreal, PQ H1T 1C8, Canada; [Poirier, Steve; Samami, Samaneh; Mayer, Gaetan] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Chang, Ta Yuan] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Hatch, Grant M.] Univ Manitoba, DREAM Theme, Manitoba Inst Child Hlth, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0T6, Canada; [Hatch, Grant M.] Univ Manitoba, DREAM Theme, Manitoba Inst Child Hlth, Dept Biochem, Winnipeg, MB R3E 0T6, Canada; [Hatch, Grant M.] Univ Manitoba, DREAM Theme, Manitoba Inst Child Hlth, Dept Med Genet, Winnipeg, MB R3E 0T6, Canada; [Mayer, Gaetan] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Dartmouth College; University of Alberta; University of Alberta; University of Manitoba; University of Manitoba; University of Manitoba; Universite de Montreal	Mayer, G (corresponding author), Montreal Heart Inst, Mol Cell Biol Lab, Montreal, PQ H1T 1C8, Canada.	gaetan.mayer@icm-mhi.org		Chang, Ta-Yuan/0000-0002-3249-0468	TFF Oncometabolism Team Grant [116128]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060306] Funding Source: NIH RePORTER	TFF Oncometabolism Team Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Gilles Corbeil (University of Montreal Hospital Research Centre) for excellent technical and analytical support regarding microarray data. We also thank Susanne Lingrell (University of Alberta) and Dr. Fred Xu (University of Manitoba) for excellent technical assistance. We also thank Gaelle Bridon and Dr. Daina Avizonis (Rosalind and Morris Goodman Cancer Research Centre Metabolomics Core Facility), who performed nucleotide measurements. We thank Gaelle Bridon and Dr. Daina Avizonis who performed nucleotide measurements at the Rosalind and Morris Goodman Cancer Research Centre Metabolomics Core Facility, which is supported by the Canada Foundation for Innovation, the Dr. John R. and Clara M. Fraser Memorial Trust, the Terry Fox Foundation (TFF Oncometabolism Team Grant 116128), and McGill University.	Abbas KS, 2012, J CLIN ONCOL, V30; Abidi P, 2005, ARTERIOSCL THROM VAS, V25, P2170, DOI 10.1161/01.ATV.0000181761.16341.2b; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Aimiuwu J, 2012, BLOOD, V119, P5229, DOI 10.1182/blood-2011-11-382226; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; CARTER JR, 1966, J LIPID RES, V7, P678; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CIHAK A, 1974, ONCOLOGY-BASEL, V30, P405; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Ehara T, 2012, DIABETES, V61, P2442, DOI 10.2337/db11-1834; Ellis MH, 2012, EXP HEMATOL, V40, P540, DOI 10.1016/j.exphem.2012.02.003; Estey EH, 2013, LEUKEMIA, V27, P1803, DOI 10.1038/leu.2013.173; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Gnyszka A, 2013, ANTICANCER RES, V33, P2989; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Keating GM, 2012, DRUGS, V72, P1111, DOI 10.2165/11209430-000000000-00000; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Lehner R, 2012, ARTERIOSCL THROM VAS, V32, P1087, DOI 10.1161/ATVBAHA.111.241497; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Meza-Avina ME, 2010, BIOORGAN MED CHEM, V18, P4032, DOI 10.1016/j.bmc.2010.04.017; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; PELECH SL, 1981, J BIOL CHEM, V256, P8283; Poirier S, 2013, DRUG DES DEV THER, V7, P1135, DOI 10.2147/DDDT.S36984; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Sturley SL, 2012, J LIPID RES, V53, P1800, DOI 10.1194/jlr.R028290; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; van Besien H, 2013, LEUKEMIA LYMPHOMA, V54, P2601, DOI 10.3109/10428194.2013.790022; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Vigna E, 2011, EXPERT OPIN INV DRUG, V20, P465, DOI 10.1517/13543784.2011.559164; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T	55	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18736	18751		10.1074/jbc.M114.563650	http://dx.doi.org/10.1074/jbc.M114.563650			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855646	Green Published, hybrid			2022-12-28	WOS:000339062900011
J	Bhattacharyya, S; Feferman, L; Tobacman, JK				Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.			Increased Expression of Colonic Wnt9A through Sp1-mediated Transcriptional Effects involving Arylsulfatase B, Chondroitin 4-Sulfate, and Galectin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; CANCER CELLS; SULFATASE ACTIVITY; COLORECTAL-CANCER; PROMOTER ACTIVITY; PROSTATE-CANCER; SP-SITES; SP1; CARRAGEENAN; ACTIVATION	In cultured human colonic epithelial cells and mouse colonic tissue, exposure to the common food additive carrageenan leads to inflammation, activation of Wnt signaling, increased Wnt9A expression, and decline in the activity of the enzyme arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase). In this study, the novel transcriptional mechanism by which carrageenan and decline in ARSB increase Wnt9A expression in NCM460 and HT-29 human colonic epithelial cells and in mouse colon is presented. Increased expression of Wnt9A has been associated with multiple malignancies, including colon carcinoma, and with ectodermal and mesoendodermal morphogenesis. When ARSB activity was reduced by siRNA or by exposure to carrageenan (1 mu g/ml for 24 h), degradation of chondroitin 4-sulfate (C4S) was inhibited, leading to accumulation of more highly sulfated C4S, which binds less galectin-3, a beta-galactoside-binding protein. Nuclear galectin-3 increased and mediated increased binding of Sp1 to the Sp1 consensus sequence in the Wnt9A promoter, shown by oligonucleotide-binding assay and by chromatin immunoprecipitation assay. When galectin-3 was silenced, the increases in Sp1 binding to the Wnt9A promoter and in Wnt9A expression, which followed carrageenan or ARSB silencing, were inhibited. Mithramycin A, a specific inhibitor of Sp1 oligonucleotide binding, and Sp1 siRNA blocked the carrageenanand ARSB siRNA-induced increases in Wnt9A expression. These studies reveal how carrageenan exposure can lead to transcriptional events in colonic epithelial cells through decline in arylsulfatase B activity, with subsequent impact on C4S, galectin-3, Sp1, and Wnt9A and can exert significant effects on Wnt-initiated signaling and related vital cell processes.	[Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, CSN 440,M-C 718, Chicago, IL 60612 USA.	jkt@uic.edu						An CH, 2010, PATHOLOGY, V42, P583, DOI 10.3109/00313025.2010.508735; [Anonymous], 1983, IARC Monogr Eval Carcinog Risk Chem Hum, V31, P79; [Anonymous], 2010, ENC BRIT MACR, V13, P236; ARAKAWA S, 1986, J NUTR SCI VITAMINOL, V32, P481, DOI 10.3177/jnsv.32.481; Bhattacharyya S, 2014, ONCOGENE, V33, P5467, DOI 10.1038/onc.2013.483; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2008, J BIOL CHEM, V283, P9523, DOI 10.1074/jbc.M707967200; Bhattacharyya S, 2007, DIGEST DIS SCI, V52, P2766, DOI 10.1007/s10620-006-9531-4; Bhattacharyya S, 2007, J STEROID BIOCHEM, V103, P20, DOI 10.1016/j.jsbmb.2006.08.002; Bhattacharyya S, 2014, NUTR CANCER, V66, P117, DOI 10.1080/01635581.2014.852228; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; Bhattacharyya S, 2010, J NUTR BIOCHEM, V21, P906, DOI 10.1016/j.jnutbio.2009.07.002; Bhattacharyya S, 2009, CLIN EXP METASTAS, V26, P535, DOI 10.1007/s10585-009-9253-z; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cox AA, 2010, GENE EXPR PATTERNS, V10, P251, DOI 10.1016/j.gep.2010.05.005; Curtain M. M., 2009, JACKSON LAB J; Encarnacao PC, 2013, BIOCHEM J, V452, P519, DOI 10.1042/BJ20121666; Feferman L, 2013, PROSTATE CANCER P D, V16, P277, DOI 10.1038/pcan.2013.18; Funato Y, 2010, FREE RADICAL RES, V44, P379, DOI 10.3109/10715761003610745; Gold L. S., 1997, HDB CARCINOGENIC POT, P116; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Iwaki J, 2008, BIOCHEM BIOPH RES CO, V373, P206, DOI 10.1016/j.bbrc.2008.05.190; Johar K, 2014, EUR J NEUROSCI, V39, P566, DOI 10.1111/ejn.12415; KAWAURA A, 1982, Tokushima Journal of Experimental Medicine, V29, P125; Keith W Nicol, 2004, BMC Blood Disord, V4, P3, DOI 10.1186/1471-2326-4-3; Kirikoshi H, 2001, INT J ONCOL, V19, P1221; Kovarik A, 1996, J BIOL CHEM, V271, P18140, DOI 10.1074/jbc.271.30.18140; Kumawat K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094801; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lin HM, 2002, ONCOGENE, V21, P8001, DOI 10.1038/sj.onc.1205820; MAJELLO B, 1995, ONCOGENE, V10, P1841; Maurer GD, 2007, CLIN CANCER RES, V13, P1123, DOI 10.1158/1078-0432.CCR-06-1668; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Olender T, 2013, ISR J CHEM, V53, P185, DOI 10.1002/ijch.201200094; Onishi T, 2001, BBA-MOL CELL RES, V1538, P218, DOI 10.1016/S0167-4889(01)00068-4; Pagliuca A, 2000, J CELL BIOCHEM, V76, P360, DOI 10.1002/(SICI)1097-4644(20000301)76:3<360::AID-JCB3>3.0.CO;2-1; Prabhu SV, 2011, J HISTOCHEM CYTOCHEM, V59, P328, DOI 10.1369/0022155410395511; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rozen S, 2000, Methods Mol Biol, V132, P365; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; SERAFINI EP, 1981, GUT, V22, P648, DOI 10.1136/gut.22.8.648; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Song SM, 2005, GASTROENTEROLOGY, V129, P1581, DOI 10.1053/j.gastro.2005.09.002; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; WANG L, 1995, BIOCHEM BIOPH RES CO, V217, P292, DOI 10.1006/bbrc.1995.2777; WATANABE K, 1978, CANCER RES, V38, P4427; Yang B, 2012, BIOCHIMIE, V94, P1309, DOI 10.1016/j.biochi.2012.02.031; Yokoyama KD, 2012, GENOME BIOL EVOL, V4, P1102, DOI 10.1093/gbe/evs085; Yoo BC, 2009, CELL MOL LIFE SCI, V66, P350, DOI 10.1007/s00018-009-8562-3; Yu B, 2003, NUCLEIC ACIDS RES, V31, P5368, DOI 10.1093/nar/gkg706; Zhao YY, 2013, ONCOL REP, V30, P1782, DOI 10.3892/or.2013.2627; Zhu GH, 2002, ONCOGENE, V21, P8477, DOI 10.1038/sj.onc.1206030	59	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17564	17575		10.1074/jbc.M114.561589	http://dx.doi.org/10.1074/jbc.M114.561589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24778176	Green Published, hybrid			2022-12-28	WOS:000338018100022
J	Geng, XR; Yang, G; Li, M; Song, JP; Liu, ZQ; Qiu, SQ; Liu, ZG; Yang, PC				Geng, Xiao-Rui; Yang, Gui; Li, Meng; Song, Jiang-Ping; Liu, Zhi-Qiang; Qiu, Shuqi; Liu, Zhigang; Yang, Ping-Chang			Insulin-like Growth Factor-2 Enhances Functions of Antigen (Ag)-specific Regulatory B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; IGF-II; AUTOIMMUNE-DISEASE; SIGNALING PATHWAYS; DENDRITIC CELLS; STEM-CELLS; B10 CELLS; IN-VITRO; T-CELLS; MICE	Regulatory B cells (Bregs) are important in immune regulation. The factors that regulate Breg functions are less clear. Insulin-like growth factor 2 (IGF2) is capable of inducing hematopoietic stem cell differentiation. This study aimed to investigate the role of IGF2 in the development of Bregs and the enhancement of their function. In this study, the expression of IGF1 receptor (IGF1R) and IGF2R in ovalbumin (OVA)-specific B cells (OVAsBCs) was assessed by real time RT-PCR and Western blotting. The release of interleukin (IL)-10 from OVAsBCs and OVAsBC proliferation were assessed by enzyme-linked immunoassay and proliferation assay. The role of IGF2 in enhancing the function of OVAsBCs was tested with an intestinal allergic inflammation mouse model. The results showed that OVAsBCs expressed high levels of IGF2R. Exposure to both IGF2 and a specific antigen (Ag), OVA, markedly enhanced the expression of IL-10 in OVAsBCs as well as enhanced the IL-10(+) OVAsBC proliferation. The concurrent exposure to IGF2 and specific Ag markedly induced the IL-10 promoter DNA demethylation via activating the STAT5 pathway. IGF2 also enhanced both the OVAsBC proliferation in vivo and the effect of Ag-specific immunotherapy on inhibiting allergic inflammation in the intestine. We conclude that OVAsBCs express high levels of IGF2R and that IGF2 increases the expression of IL-10 in OVAsBCs and enhances OVAsBC proliferation and the inhibitory effect on allergic inflammation.	[Geng, Xiao-Rui; Yang, Gui; Li, Meng; Liu, Zhi-Qiang; Qiu, Shuqi; Liu, Zhigang; Yang, Ping-Chang] Shenzhen Univ, Sch Med, Otolaryngol Inst, Shenzhen Key Lab Allergy & Immunol, Shenzhen 518060, Peoples R China; [Geng, Xiao-Rui; Yang, Gui; Li, Meng; Liu, Zhi-Qiang; Qiu, Shuqi; Liu, Zhigang; Yang, Ping-Chang] Shenzhen Univ, State Key Lab Resp Dis Allergy, Shenzhen 518060, Peoples R China; [Geng, Xiao-Rui; Yang, Gui; Liu, Zhi-Qiang; Qiu, Shuqi] Longgang Cent Hosp, Shenzhen ENT Inst, ENT Hosp, Shenzhen 518116, Peoples R China; [Song, Jiang-Ping] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp, Beijing 100037, Peoples R China; [Song, Jiang-Ping] Peking Union Med Coll, Beijing 100037, Peoples R China	Shenzhen University; Shenzhen University; State Key Laboratory of Respiratory Disease; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, ZG (corresponding author), Shenzhen Univ, Med Sch Bldg,Rm 204,3688 Nanhai Ave, Shenzhen 518060, Peoples R China.	lzg@szu.edu.cn; pcy2356@szu.edu.cn	Yang, Ping-Chang/K-4669-2019; Li, Meng/K-3172-2012	Li, Meng/0000-0001-8675-0758	Natural Science Foundation of Shenzhen University [000004]; Innovation of Science and Technology Commission of Shenzhen Municipality Grant [JCYJ20120613172559904]; Natural Science Foundation of China Grants [30871752, 31101280, 81373176]	Natural Science Foundation of Shenzhen University; Innovation of Science and Technology Commission of Shenzhen Municipality Grant; Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of Shenzhen University Grant 000004; Innovation of Science and Technology Commission of Shenzhen Municipality Grant JCYJ20120613172559904; and Natural Science Foundation of China Grants 30871752, 31101280, and 81373176.	Akhter S, 2013, PROTEIN CELL, V4, P220, DOI 10.1007/s13238-013-2066-5; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Chen X, 2011, J LEUKOCYTE BIOL, V90, P751, DOI 10.1189/jlb.1210696; Coelho V, 2013, CURR OPIN ORGAN TRAN, V18, P13, DOI 10.1097/MOT.0b013e32835c8043; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Feng BS, 2008, J ALLERGY CLIN IMMUN, V122, P55, DOI 10.1016/j.jaci.2008.04.036; Goode I, 2014, TRANSPL P, V46, P3, DOI 10.1016/j.transproceed.2013.08.075; Halje M, 2012, IN VIVO, V26, P519; Hansenne I, 2006, J IMMUNOL, V176, P4651, DOI 10.4049/jimmunol.176.8.4651; Harris LK, 2012, GROWTH FACTORS, V30, P1, DOI 10.3109/08977194.2011.640325; He SH, 2011, GASTROENTEROLOGY, V141, P249, DOI 10.1053/j.gastro.2011.04.006; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Horikawa M, 2013, J IMMUNOL, V190, P1158, DOI 10.4049/jimmunol.1201427; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; Kleiman A, 2013, EXP MOL PATHOL, V94, P126, DOI 10.1016/j.yexmp.2012.09.023; Kovesdi D, 2004, CELL SIGNAL, V16, P881, DOI 10.1016/S0898-6568(04)00016-6; Leonard SA, 2012, J ALLERGY CLIN IMMUN, V129, P1579, DOI 10.1016/j.jaci.2012.04.009; Lundell AC, 2012, J IMMUNOL, V188, P4315, DOI 10.4049/jimmunol.1103223; Luo ZC, 2012, J CLIN ENDOCR METAB, V97, P1720, DOI 10.1210/jc.2011-3296; Martin JL, 2011, GROWTH FACTORS, V29, P235, DOI 10.3109/08977194.2011.614237; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; Morva A, 2012, BLOOD, V119, P106, DOI 10.1182/blood-2011-06-360768; Nishioka C, 2014, INT J CANCER, V134, P55, DOI 10.1002/ijc.28348; Noh J, 2012, CELL IMMUNOL, V273, P140, DOI 10.1016/j.cellimm.2011.12.006; Okada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044338; Schwartz GN, 1996, STEM CELLS, V14, P337, DOI 10.1002/stem.140337; Simons FER, 2013, INT ARCH ALLERGY IMM, V162, P193, DOI 10.1159/000354543; Taylor JJ, 2012, J EXP MED, V209, P2065, DOI 10.1084/jem.20112272; Till SJ, 2004, J ALLERGY CLIN IMMUN, V113, P1025, DOI 10.1016/j.jaci.2004.03.024; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Vogt B, 2009, AUTOIMMUNITY, V42, P380, DOI 10.1080/08916930902832470; Volchenkov R, 2013, SCAND J IMMUNOL, V77, P246, DOI 10.1111/sji.12039; Wisniewski J, 2013, CLIN EXP ALLERGY, V43, P164, DOI 10.1111/cea.12016; Wong SH, 2010, IMMUNOLOGY, V131, P77, DOI 10.1111/j.1365-2567.2010.03276.x; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109	39	21	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17941	17950		10.1074/jbc.M113.515262	http://dx.doi.org/10.1074/jbc.M113.515262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24811165	hybrid, Green Published			2022-12-28	WOS:000338018100054
J	Kitazawa, M; Kubo, Y; Nakajo, K				Kitazawa, Masahiro; Kubo, Yoshihiro; Nakajo, Koichi			The Stoichiometry and Biophysical Properties of the Kv4 Potassium Channel Complex with K+ Channel-interacting Protein (KChIP) Subunits Are Variable, Depending on the Relative Expression Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNITS; 3-DIMENSIONAL STRUCTURE; CARDIAC REPOLARIZATION; FUNCTIONAL INTERACTION; MOLECULAR PHYSIOLOGY; PYRAMIDAL NEURONS; MODULATION; INACTIVATION; BINDING; TRAFFICKING	Kv4 is a voltage-gated K+ channel, which underlies somatodendritic subthreshold A-type current (I-SA) and cardiac transient outward K+ (I-to) current. Various ion channel properties of Kv4 are known to be modulated by its auxiliary subunits, such as K+ channel-interacting protein (KChIP) or dipeptidyl peptidase-like protein. KChIP is a cytoplasmic protein and increases the current amplitude, decelerates the inactivation, and accelerates the recovery from inactivation of Kv4. Crystal structure analysis demonstrated that Kv4 and KChIP form an octameric complex with four Kv4 subunits and four KChIP subunits. However, it remains unknown whether the Kv4.KChIP complex can have a different stoichiometry other than 4:4. In this study, we expressed Kv4.2 and KChIP4 with various ratios in Xenopus oocytes and observed that the biophysical properties of Kv4.2 gradually changed with the increase in co-expressed KChIP4. The tandem repeat constructs of Kv4.2 and KChIP4 revealed that the 4:4 (Kv4.2/KChIP4) channel shows faster recovery than the 4:2 channel, suggesting that the biophysical properties of Kv4.2 change, depending on the number of bound KChIP4s. Subunit counting by single-molecule imaging revealed that the bound number of KChIP4 in each Kv4.2.KChIP4 complex was dependent on the expression level of KChIP4. Taken together, we conclude that the stoichiometry of Kv4.KChIP complex is variable, and the biophysical properties of Kv4 change depending on the number of bound KChIP subunits.	[Kitazawa, Masahiro; Kubo, Yoshihiro; Nakajo, Koichi] Natl Inst Physiol Sci, Dept Mol Physiol, Div Biophys & Neurobiol, Okazaki, Aichi 4448585, Japan; [Kitazawa, Masahiro; Kubo, Yoshihiro; Nakajo, Koichi] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Hayama, Kanagawa 2400155, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Nakajo, K (corresponding author), Natl Inst Physiol Sci, Dept Mol Physiol, Div Biophys & Neurobiol, Okazaki, Aichi 4448585, Japan.	knakajo@nips.ac.jp	Nakajo, Koichi/J-2601-2019	Nakajo, Koichi/0000-0003-0766-7281; Kubo, Yoshihiro/0000-0001-6707-0837	Japan Society for the Promotion of Science Grant KAKENHI	Japan Society for the Promotion of Science Grant KAKENHI	This study was supported by Japan Society for the Promotion of Science Grant KAKENHI (to K. N. and Y. K.).	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Hastie P, 2013, P NATL ACAD SCI USA, V110, P5163, DOI 10.1073/pnas.1218765110; Hatano N, 2002, PFLUG ARCH EUR J PHY, V444, P80, DOI 10.1007/s00424-002-0798-9; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Hovind LJ, 2011, CHANNELS, V5, P225, DOI 10.4161/chan.5.3.15313; Jerng HH, 2008, J BIOL CHEM, V283, P36046, DOI 10.1074/jbc.M806852200; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kim LA, 2004, J BIOL CHEM, V279, P5549, DOI 10.1074/jbc.M311332200; Liang P, 2009, J BIOL CHEM, V284, P4960, DOI 10.1074/jbc.M807704200; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Patel SP, 2002, J PHYSIOL-LONDON, V545, P5, DOI 10.1113/jphysiol.2002.031856; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; Ren XM, 2003, J BIOL CHEM, V278, P43564, DOI 10.1074/jbc.M302337200; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Tang YQ, 2013, J BIOL CHEM, V288, P14727, DOI 10.1074/jbc.M113.466052; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang KW, 2008, NEUROCHEM RES, V33, P1964, DOI 10.1007/s11064-008-9705-x; Yamashita T, 2003, CIRCULATION, V107, P1917, DOI 10.1161/01.CIR.0000058752.79734.F0; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	46	22	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17597	17609		10.1074/jbc.M114.563452	http://dx.doi.org/10.1074/jbc.M114.563452			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24811166	hybrid, Green Published			2022-12-28	WOS:000338018100025
J	Li, LT; Miao, R; Jia, X; Ward, DM; Kaplan, J				Li, Liangtao; Miao, Ren; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry			Expression of the Yeast Cation Diffusion Facilitators Mmt1 and Mmt2 Affects Mitochondrial and Cellular Iron Homeostasis EVIDENCE FOR MITOCHONDRIAL IRON EXPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; SIGNALING PATHWAY; TRANSPORTERS; PROTEINS; GENES; IDENTIFICATION; BIOGENESIS; METABOLISM; MITOFERRIN; FRATAXIN	Mmt1 and Mmt2 are highly homologous yeast members of the cation diffusion facilitator transporter family localized to mitochondria. Overexpression of MMT1/2 led to changes in cellular metal homeostasis (increased iron sensitivity, decreased cobalt sensitivity, increased sensitivity to copper), oxidant generation, and increased sensitivity to H2O2. The phenotypes due to overexpression of MMT1&2 were similar to that seen in cells with deletions in MRS3 and MRS4, genes that encode the mitochondrial iron importers. Overexpression of MMT1&2 resulted in induction of the low iron transcriptional response, similar to that seen in Delta mrs3 Delta mr4 cells. This low iron transcriptional response was suppressed by deletion of CCC1, the gene that encodes the vacuolar iron importer. Measurement of the activity of the iron-dependent gentisate 1,2-dioxygenase from Pseudaminobacter salicylatoxidans expressed in yeast cytosol, showed that changes in Mmt1/2 levels affected cytosol iron concentration even in the absence of Ccc1. Overexpression of MMT1 resulted in increased cytosolic iron whereas deletion of MMT1/MMT2 led to decreased cytosolic iron. These results support the hypothesis that Mmt1/2 function as mitochondrial iron exporters.	[Li, Liangtao; Miao, Ren; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu			National Institutes of Health [DK052380, DK035034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052380, R01DK030534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052380 and DK035034.	Bashir K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1326; Bedekovics T, 2011, J BIOL CHEM, V286, P40878, DOI 10.1074/jbc.M111.270082; Bostanci Z, 2014, EXP CELL RES, V321, P190, DOI 10.1016/j.yexcr.2013.12.005; Chen OS, 1998, J NUTR, V128, P525, DOI 10.1093/jn/128.3.525; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Diab HI, 2013, J BIOL CHEM, V288, P11366, DOI 10.1074/jbc.M112.419259; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Gustin JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-76; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Li LT, 2012, J BIOL CHEM, V287, P35709, DOI 10.1074/jbc.M112.395533; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 1997, J BIOL CHEM, V272, P28485, DOI 10.1074/jbc.272.45.28485; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Lin HL, 2008, J BIOL CHEM, V283, P33865, DOI 10.1074/jbc.M804377200; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Metzendorf C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-68; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Seo YA, 2011, AM J PHYSIOL-CELL PH, V300, pC1479, DOI 10.1152/ajpcell.00420.2010; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Stadler JA, 2002, J BIOL CHEM, V277, P39649, DOI 10.1074/jbc.M203924200; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Xu N, 2014, BBA-MOL CELL RES, V1843, P629, DOI 10.1016/j.bbamcr.2013.12.009; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200	30	26	27	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17132	17141		10.1074/jbc.M114.574723	http://dx.doi.org/10.1074/jbc.M114.574723			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24798331	Green Published, hybrid			2022-12-28	WOS:000338016200046
J	Wang, DDH; Guo, XE; Modrek, AS; Chen, CF; Chen, PL; Lee, WH				Wang, Dennis Ding-Hwa; Guo, Xuning Emily; Modrek, Aram Sandaldjian; Chen, Chi-Fen; Chen, Phang-Lang; Lee, Wen-Hwa			Helicase SUV3, Polynucleotide Phosphorylase, and Mitochondrial Polyadenylation Polymerase Form a Transient Complex to Modulate Mitochondrial mRNA Polyadenylated Tail Lengths in Response to Energetic Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLY(A) POLYMERASE; RAT-LIVER; INORGANIC-PHOSPHATE; DEGRADATION; PNPASE; DECAY; TRANSLATION; EXONUCLEASE; TURNOVER	Mammalian mitochondrial mRNA (mt-mRNA) transcripts are polyadenylated at the 3' end with different lengths. The SUV3.PNPase complex and mtPAP have been shown to degrade and polyadenylate mt mRNA, respectively. How these two opposite actions are coordinated to modulate mt-mRNA poly(A) lengths is of interest to pursue. Here, we demonstrated that a fraction of the SUV3.PNPase complex interacts with mitochondrial polyadenylation polymerase (mtPAP) under low mitochondrial matrix inorganic phosphate (P-i) conditions. In vitro binding experiments using purified proteins suggested that SUV3 binds to mtPAP through the N-terminal region around amino acids 100-104, distinctive from the C-terminal region around amino acids 510-514 of SUV3 for PNPase binding. mtPAP does not interact with PNPase directly, and SUV3 served as a bridge capable of simultaneously binding with mtPAP and PNPase. The complex consists of a SUV3 dimer, a mtPAP dimer, and a PNPase trimer, based on the molecular sizing experiments. Mechanistically, SUV3 provides a robust single strand RNA binding domain to enhance the polyadenylation activity of mtPAP. Furthermore, purified SUV3.PNPase.mtPAP complex is capable of lengthening or shortening the RNA poly(A) tail lengths in low or high P-i/ATP ratios, respectively. Consistently, the poly(A) tail lengths of mt-mRNA transcripts can be lengthened or shortened by altering the mitochondrial matrix P-i levels via selective inhibition of the electron transport chain or ATP synthase, respectively. Taken together, these results suggested that SUV3.PNPase.mtPAP form a transient complex to modulate mt-mRNA poly(A) tail lengths in response to cellular energy changes.	[Wang, Dennis Ding-Hwa; Guo, Xuning Emily; Modrek, Aram Sandaldjian; Chen, Chi-Fen; Chen, Phang-Lang; Lee, Wen-Hwa] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Lee, Wen-Hwa] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan	University of California System; University of California Irvine; China Medical University Taiwan	Lee, WH (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA.	whlee@uci.edu		Chen, Phang-Lang/0000-0002-0357-9017; Modrek, Aram/0000-0001-7586-9833; Chen, Chi-Fen/0000-0002-6391-821X	National Institutes of Health [AG027877, T32 CA113265]; NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027877 (to W. H. L.).; Supported by National Institutes of Health training Grant T32 CA113265. Present address: Dept. of Medicine, Baylor College of Medicine, Houston, TX 77030.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bai Y, 2011, MOL CELL, V41, P311, DOI 10.1016/j.molcel.2011.01.013; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bollenbach TJ, 2004, PROG NUCLEIC ACID RE, V78, P305, DOI 10.1016/S0079-6603(04)78008-3; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; CAO GJ, 1992, P NATL ACAD SCI USA, V89, P10380, DOI 10.1073/pnas.89.21.10380; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Carpousis AJ, 2001, METHOD ENZYMOL, V342, P333, DOI 10.1016/S0076-6879(01)42556-0; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013; Das SK, 2011, ONCOGENE, V30, P1733, DOI 10.1038/onc.2010.572; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Guo XE, 2011, J BIOL CHEM, V286, P38783, DOI 10.1074/jbc.M111.257956; HAJNSDORF E, 1994, EMBO J, V13, P3368, DOI 10.1002/j.1460-2075.1994.tb06639.x; JACOB ST, 1972, BIOCHEM BIOPH RES CO, V48, P126, DOI 10.1016/0006-291X(72)90353-1; Jedrzejczak R, 2011, ACTA CRYSTALLOGR D, V67, P988, DOI 10.1107/S0907444911040248; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; MANLEY JL, 1994, GENE DEV, V8, P259, DOI 10.1101/gad.8.3.259; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nagao A, 2008, METHOD ENZYMOL, V447, P489, DOI 10.1016/S0076-6879(08)02223-4; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; Poulsen JB, 2011, NUCLEIC ACIDS RES, V39, P3754, DOI 10.1093/nar/gkq1282; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Sarkar D, 2006, CELL CYCLE, V5, P1080, DOI 10.4161/cc.5.10.2741; Shu ZY, 2004, BIOCHEMISTRY-US, V43, P4781, DOI 10.1021/bi0356449; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Slomovic S, 2008, RNA, V14, P310, DOI 10.1261/rna.697308; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238; THIAUDIERE E, 1993, FEBS LETT, V330, P231, DOI 10.1016/0014-5793(93)80280-8; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Tomita K, 1996, NUCLEIC ACIDS RES, V24, P4987, DOI 10.1093/nar/24.24.4987; Vidal G, 1997, ARCH BIOCHEM BIOPHYS, V337, P317, DOI 10.1006/abbi.1996.9775; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Wydro M, 2010, NUCLEIC ACIDS RES, V38, P3732, DOI 10.1093/nar/gkq068; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001; Yokobori S, 1997, J MOL BIOL, V265, P95, DOI 10.1006/jmbi.1996.0728	52	25	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16727	16735		10.1074/jbc.M113.536540	http://dx.doi.org/10.1074/jbc.M113.536540			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24770417	Green Published, hybrid			2022-12-28	WOS:000338016200012
J	De Vos, M; El Ramy, R; Quenet, D; Wolf, P; Spada, F; Magroun, N; Babbio, F; Schreiber, V; Leonhardt, H; Bonapace, IM; Dantzer, F				De Vos, Mike; El Ramy, Rosy; Quenet, Delphine; Wolf, Patricia; Spada, Fabio; Magroun, Najat; Babbio, Federica; Schreiber, Valerie; Leonhardt, Heinrich; Bonapace, Ian Marc; Dantzer, Francoise			Poly(ADP-ribose) Polymerase 1 (PARP1) Associates with E3 Ubiquitin-Protein Ligase UHRF1 and Modulates UHRF1 Biological Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; HEMI-METHYLATED DNA; PERICENTRIC HETEROCHROMATIN; BINDING-PROTEIN; UNMETHYLATED STATE; MAMMALIAN-CELLS; HISTONE-BINDING; DNMT1; NP95; REPLICATION	Poly(ADP-ribose) polymerase 1 (PARP1, also known as ARTD1) is an abundant nuclear enzyme that plays important roles in DNA repair, gene transcription, and differentiation through the modulation of chromatin structure and function. In this work we identify a physical and functional poly(ADP-ribose)-mediated interaction of PARP1 with the E3 ubiquitin ligase UHRF1 (also known as NP95, ICBP90) that influences two UHRF1-regulated cellular processes. On the one hand, we uncovered a cooperative interplay between PARP1 and UHRF1 in the accumulation of the heterochromatin repressive mark H4K20me3. The absence of PARP1 led to reduced accumulation of H4K20me3 onto pericentric heterochromatin that coincided with abnormally enhanced transcription. The loss of H4K20me3 was rescued by the additional depletion of UHRF1. In contrast, although PARP1 also seemed to facilitate the association of UHRF1 with DNMT1, its absence did not impair the loading of DNMT1 onto heterochromatin or the methylation of pericentric regions, possibly owing to a compensating interaction of DNMT1 with PCNA. On the other hand, we showed that PARP1 controls the UHRF1-mediated ubiquitination of DNMT1 to timely regulate its abundance during S and G(2) phase. Together, this report identifies PARP1 as a novel modulator of two UHRF1-regulated heterochromatin-associated events: the accumulation of H4K20me3 and the clearance of DNMT1.	[De Vos, Mike; El Ramy, Rosy; Quenet, Delphine; Magroun, Najat; Schreiber, Valerie; Dantzer, Francoise] Univ Strasbourg, Poly ADP Ribosyl Ation & Genome Integr Grp, Lab Excellence Medalis,Equipe Labellisee Ligue Na, CNRS,Inst Rech,UMR7242,Ecole Biotechnol Strasbour, F-67412 Illkirch Graffenstaden, France; [Wolf, Patricia; Spada, Fabio; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Babbio, Federica; Bonapace, Ian Marc] Univ Insubria, Dept Struct & Funct Biol, I-21052 Busto Arsizio, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Munich; University of Insubria	Dantzer, F (corresponding author), Univ Strasbourg, Poly ADP Ribosyl Ation & Genome Integr Grp, Lab Excellence Medalis,Equipe Labellisee Ligue Na, CNRS,Inst Rech,UMR7242,Ecole Biotechnol Strasbour, Blvd Sebastien Brant,BP10413, F-67412 Illkirch Graffenstaden, France.	francoise.dantzer@unistra.fr	Dantzer, Françoise/O-2126-2016; Leonhardt, Heinrich/B-2791-2014; Spada, Fabio/J-4354-2013; Schreiber, Valérie/M-5007-2016	Spada, Fabio/0000-0002-7148-9013; Schreiber, Valérie/0000-0003-0507-639X; BONAPACE, IAN MARC/0000-0001-6580-8893; Dantzer, Francoise/0000-0003-0945-8483	Association pour le Recherche Contre le Cancer (ARC); CNRS; Universite de Strasbourg; French government via the Agence Nationale de la Recherche under the Programme d'Investissement d'Avenir; Fonds National de la Recherche (Luxembourg); Deutsche Forschungsgemeinschaft (DFG) [SFB 684]	Association pour le Recherche Contre le Cancer (ARC); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; French government via the Agence Nationale de la Recherche under the Programme d'Investissement d'Avenir(French National Research Agency (ANR)); Fonds National de la Recherche (Luxembourg)(Luxembourg National Research Fund); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Association pour le Recherche Contre le Cancer (ARC), the CNRS, and the Universite de Strasbourg. This work has also been published within the LABEX ANR-10-LABX-0034_Medalis and received financial support from the French government via the Agence Nationale de la Recherche under the Programme d'Investissement d'Avenir.; Supported by the Fonds National de la Recherche (Luxembourg).; Supported by Deutsche Forschungsgemeinschaft (DFG) Grant SFB 684.	Achour M, 2009, BIOCHEM BIOPH RES CO, V390, P523, DOI 10.1016/j.bbrc.2009.09.131; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; De Capoa A, 1999, FASEB J, V13, P89; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; El Ramy R, 2009, CELL MOL LIFE SCI, V66, P3219, DOI 10.1007/s00018-009-0105-4; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016627; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Hopfner R, 2000, CANCER RES, V60, P121; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kalisch T, 2012, TRENDS BIOCHEM SCI, V37, P381, DOI 10.1016/j.tibs.2012.06.001; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kashima L, 2012, J BIOL CHEM, V287, P12975, DOI 10.1074/jbc.M111.321828; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Mistry Helena, 2010, Genome Integr, V1, P7, DOI 10.1186/2041-9414-1-7; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Pageau GJ, 2006, J CELL BIOL, V175, P693, DOI 10.1083/jcb.200602055; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Quenet D, 2008, FASEB J, V22, P3853, DOI 10.1096/fj.08-113464; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zardo G, 2002, FASEB J, V16, P1319, DOI 10.1096/fj.01-0827fje; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517; Zardo G, 1997, BIOCHEMISTRY-US, V36, P7937, DOI 10.1021/bi970241s; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	58	33	33	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16223	16238		10.1074/jbc.M113.527424	http://dx.doi.org/10.1074/jbc.M113.527424			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24782312	Green Published, hybrid			2022-12-28	WOS:000337965700027
J	Garyali, P; Segvich, DM; DePaoli-Roach, AA; Roach, PJ				Garyali, Punitee; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.			Protein Degradation and Quality Control in Cells from Laforin and Malin Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; E3 UBIQUITIN LIGASE; GLYCOGEN ACCUMULATION; ENDOPLASMIC-RETICULUM; DISEASE; AUTOPHAGY; PHOSPHATASE; METABOLISM; BODIES; BINDING	Lafora disease is a progressive myoclonus epilepsy caused by mutations in the EPM2A or EPM2B genes that encode a glycogen phosphatase, laforin, and an E3 ubiquitin ligase, malin, respectively. Lafora disease is characterized by accumulation of insoluble, poorly branched, hyperphosphorylated glycogen in brain, muscle, heart, and liver. The laforinmalin complex has been proposed to play a role in the regulation of glycogen metabolism and protein quality control. We evaluated three arms of the protein degradation/quality control process (the autophago-lysosomal pathway, the ubiquitin-proteasomal pathway, and the endoplasmic reticulum (ER) stress response) in mouse embryonic fibroblasts from Epm2a(-/-), Epm2b(-/-), and Epm2a(-/-) Epm2b(-/-) mice. The levels of LC3-II, a marker of autophagy, were decreased in all knock-out cells as compared with wild type even though they still showed a slight response to starvation and rapamycin. Furthermore, ribosomal protein S6 kinase and S6 phosphorylation were increased. Under basal conditions there was no effect on the levels of ubiquitinated proteins in the knock-out cells, but ubiquitinated protein degradation was decreased during starvation or stress. Lack of malin (Epm2b(-/-) and Epm2a(-/-) Epm2b(-/-) cells) but not laforin (Epm2a(-/-) cells) decreased LAMP1, a lysosomal marker. CHOP expression was similar in wild type and knock-out cells under basal conditions or with ER stress-inducing agents. In conclusion, both laforin and malin knock-out cells display mTOR-dependent autophagy defects and reduced proteasomal activity but no defects in the ER stress response. We speculate that these defects may be secondary to glycogen overaccumulation. This study also suggests a malin function independent of laforin, possibly in lysosomal biogenesis and/or lysosomal glycogen disposal.	[Garyali, Punitee; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Roach, PJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	proach@iu.edu			National Institutes of Health [DK27221, NS056454]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK027221, R37DK027221, R01DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 and NS056454.	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; DePaoli-Roach AA, 2012, HUM MOL GENET, V21, P1604, DOI 10.1093/hmg/ddr598; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Freie B, 2003, BLOOD, V102, P4146, DOI 10.1182/blood-2003-03-0971; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Kannourakis G, 2002, SEMIN HEMATOL, V39, P103, DOI 10.1053/shem.2002.31920; Knecht E, 2012, AUTOPHAGY, V8, P701, DOI 10.4161/auto.19522; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pederson BA, 2013, ANN NEUROL, V74, P297, DOI 10.1002/ana.23899; Puri R, 2012, HUM MOL GENET, V21, P175, DOI 10.1093/hmg/ddr452; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sharma J, 2011, NEUROBIOL DIS, V44, P133, DOI 10.1016/j.nbd.2011.06.013; Shin Yoon S, 2006, Semin Pediatr Neurol, V13, P115, DOI 10.1016/j.spen.2006.06.007; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Turnbull J, 2014, ANN NEUROL, V75, P442, DOI 10.1002/ana.24104; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	46	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20606	20614		10.1074/jbc.M114.580167	http://dx.doi.org/10.1074/jbc.M114.580167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24914213	Green Published, hybrid			2022-12-28	WOS:000339396600020
J	Haldeman, BD; Brizendine, RK; Facemyer, KC; Baker, JE; Cremo, CR				Haldeman, Brian D.; Brizendine, Richard K.; Facemyer, Kevin C.; Baker, Josh E.; Cremo, Christine R.			The Kinetics Underlying the Velocity of Smooth Muscle Myosin Filament Sliding on Actin Filaments in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; PHOSPHORYLATION-DEPENDENT REGULATION; RABBIT SKELETAL-MUSCLE; HEAVY-MEROMYOSIN; NONMUSCLE MYOSIN; SIDE-POLAR; NONLINEAR ELASTICITY; NUCLEOTIDE-BINDING; MASS DETERMINATION; WORKING STROKE	Actin-myosin interactions are well studied using soluble myosin fragments, but little is known about effects of myosin filament structure on mechanochemistry. We stabilized unphosphorylated smooth muscle myosin (SMM) and phosphorylated smooth muscle myosin (pSMM) filaments against ATP-induced depolymerization using a cross-linker and attached fluorescent rhodamine (XL-Rh-SMM). Electron micrographs showed that these side polar filaments are very similar to unmodified filaments. They are similar to 0.63 mu m long and contain similar to 176 molecules. Rate constants for ATP-induced dissociation and ADP release from acto-myosin for filaments and S1 heads were similar. Actin-activated ATPases of SMM and XL-Rh-SMM were similarly regulated. XL-Rh-pSMM filaments moved processively on F-actin that was bound to a PEG brush surface. ATP dependence of filament velocities was similar to that for solution ATPases at high [actin], suggesting that both processes are limited by the same kinetic step (weak to strong transition) and therefore are attachment-limited. This differs from actin sliding over myosin monomers, which is primarily detachment-limited. Fitting filament data to an attachment-limited model showed that approximately half of the heads are available to move the filament, consistent with a side polar structure. We suggest the low stiffness subfragment 2 (S2) domain remains unhindered during filament motion in our assay. Actin-bound negatively displaced heads will impart minimal drag force because of S2 buckling. Given the ADP release rate, the velocity, and the length of S2, these heads will detach from actin before slack is taken up into a backwardly displaced high stiffness position. This mechanism explains the lack of detachment-limited kinetics at physiological [ATP]. These findings address how nonlinear elasticity in assemblies of motors leads to efficient collective force generation.	[Haldeman, Brian D.; Brizendine, Richard K.; Facemyer, Kevin C.; Baker, Josh E.; Cremo, Christine R.] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Cremo, CR (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA.	cremo@unr.edu			National Institutes of Health [5R01HL110214]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01HL110214 (to C. R. C., K. C. F., and J. E. B.).	Adamovic I, 2008, BIOPHYS J, V94, P3779, DOI 10.1529/biophysj.107.122028; APPLEGATE D, 1992, J CELL BIOL, V117, P1223, DOI 10.1083/jcb.117.6.1223; Baker JE, 2003, J BIOL CHEM, V278, P28533, DOI 10.1074/jbc.M303583200; Baker JE, 2002, BIOPHYS J, V82, P2134, DOI 10.1016/S0006-3495(02)75560-4; Billington N, 2013, J BIOL CHEM, V288, P33398, DOI 10.1074/jbc.M113.499848; CHACKO S, 1977, P NATL ACAD SCI USA, V74, P129, DOI 10.1073/pnas.74.1.129; COATES JH, 1985, BIOCHEM J, V232, P351, DOI 10.1042/bj2320351; COOKE PH, 1989, J MUSCLE RES CELL M, V10, P206, DOI 10.1007/BF01739811; CRAIG R, 1977, J CELL BIOL, V75, P990, DOI 10.1083/jcb.75.3.990; CRAIG R, 1987, J CELL BIOL, V105, P1319, DOI 10.1083/jcb.105.3.1319; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; Cremo CR, 2007, MYOS SUP MOL MOT, P171; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; CROSS RA, 1991, J MOL BIOL, V222, P455, DOI 10.1016/0022-2836(91)90487-Q; CROSS RA, 1984, FEBS LETT, V176, P197, DOI 10.1016/0014-5793(84)80940-0; CROSS RA, 1991, EMBO J, V10, P747, DOI 10.1002/j.1460-2075.1991.tb08006.x; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; Eddinger TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC493, DOI 10.1152/ajpcell.00131.2007; Ellison PA, 2000, J BIOL CHEM, V275, P15142, DOI 10.1074/jbc.275.20.15142; Ellison PA, 2003, J BIOL CHEM, V278, P4410, DOI 10.1074/jbc.M211016200; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; HARRIS DE, 1993, CIRC RES, V72, P219, DOI 10.1161/01.RES.72.1.219; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Hooft AM, 2007, BIOCHEMISTRY-US, V46, P3513, DOI 10.1021/bi0614840; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Ikebe M, 1999, BIOCHEMISTRY-US, V38, P10768, DOI 10.1021/bi990915u; IKEBE M, 1986, J BIOL CHEM, V261, P8249; IKEBE M, 1985, J BIOL CHEM, V260, P3146; IKEBE M, 1984, BIOCHEMISTRY-US, V23, P5062, DOI 10.1021/bi00316a036; IKEBE M, 1985, BIOCHEMISTRY-US, V24, P2380, DOI 10.1021/bi00330a038; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; IKEBE M, 1988, J BIOL CHEM, V263, P6432; Kaya M, 2013, CELL MOL LIFE SCI, V70, P4275, DOI 10.1007/s00018-013-1353-x; Kaya M, 2010, SCIENCE, V329, P686, DOI 10.1126/science.1191484; KENDRICKJONES J, 1987, J MOL BIOL, V198, P241, DOI 10.1016/0022-2836(87)90310-X; KUMON A, 1986, EUR J BIOCHEM, V160, P499, DOI 10.1111/j.1432-1033.1986.tb10067.x; Lewalle A, 2008, BIOPHYS J, V94, P2160, DOI 10.1529/biophysj.107.119396; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Milton DL, 2011, P NATL ACAD SCI USA, V108, P1421, DOI 10.1073/pnas.1011784108; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Robblee JP, 2005, BIOCHEMISTRY-US, V44, P10238, DOI 10.1021/bi050232g; Robblee JP, 2004, J BIOL CHEM, V279, P38608, DOI 10.1074/jbc.M403504200; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; Seow CY, 2005, AM J PHYSIOL-CELL PH, V289, pC1363, DOI 10.1152/ajpcell.00329.2005; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stewart TJ, 2013, CELL MOL BIOENG, V6, P26, DOI 10.1007/s12195-013-0274-y; Tonino P, 2002, J MOL BIOL, V318, P999, DOI 10.1016/S0022-2836(02)00191-2; Trybus KM, 1991, CURR OPIN CELL BIOL, V3, P105, DOI 10.1016/0955-0674(91)90172-U; TRYBUS KM, 1989, J CELL BIOL, V109, P2887, DOI 10.1083/jcb.109.6.2887; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; WALSH MP, 1983, METHOD ENZYMOL, V99, P279; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; Xu JQ, 1996, J CELL BIOL, V134, P53, DOI 10.1083/jcb.134.1.53	61	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21055	21070		10.1074/jbc.M114.564740	http://dx.doi.org/10.1074/jbc.M114.564740			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907276	Green Published, hybrid			2022-12-28	WOS:000339396600057
J	Mehne, FMP; Schroder-Tittmann, K; Eijlander, RT; Herzberg, C; Hewitt, L; Kaever, V; Lewis, RJ; Kuipers, OP; Tittmann, K; Stulke, J				Mehne, Felix M. P.; Schroeder-Tittmann, Kathrin; Eijlander, Robyn T.; Herzberg, Christina; Hewitt, Lorraine; Kaever, Volkhard; Lewis, Richard J.; Kuipers, Oscar P.; Tittmann, Kai; Stuelke, Joerg			Control of the Diadenylate Cyclase CdaS in Bacillus subtilis AN AUTOINHIBITORY DOMAIN LIMITS CYCLIC DI-AMP PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA INTEGRITY; CHECKPOINT PROTEIN; GMP; BACTERIA; REVEALS; PATHWAY; GENES; IDENTIFICATION; BIOSYNTHESIS; SPORULATION	The Gram-positive bacterium Bacillus subtilis encodes three diadenylate cyclases that synthesize the essential signaling nucleotide cyclic di-AMP. The activities of the vegetative enzymes DisA and CdaA are controlled by protein-protein interactions with their conserved partner proteins. Here, we have analyzed the regulation of the unique sporulation-specific diadenylate cyclase CdaS. Very low expression of CdaS as the single diadenylate cyclase resulted in the appearance of spontaneous suppressor mutations. Several of these mutations in the cdaS gene affected the N-terminal domain of CdaS. The corresponding CdaS mutant proteins exhibited a significantly increased enzymatic activity. The N-terminal domain of CdaS consists of two alpha-helices and is attached to the C-terminal catalytically active diadenylate cyclase (DAC) domain. Deletion of the first or both helices resulted also in strongly increased activity indicating that the N-terminal domain serves to limit the enzyme activity of the DAC domain. The structure of YojJ, a protein highly similar to CdaS, indicates that the protein forms hexamers that are incompatible with enzymatic activity of the DAC domains. In contrast, the mutations and the deletions of the N-terminal domain result in conformational changes that lead to highly increased enzymatic activity. Although the full-length CdaS protein was found to form hexamers, a truncated version with a deletion of the first N-terminal helix formed dimers with high enzyme activity. To assess the role of CdaS in sporulation, we assayed the germination of wild type and cdaS mutant spores. The results indicate that cyclic di-AMP formed by CdaS is required for efficient germination.	[Mehne, Felix M. P.; Herzberg, Christina; Stuelke, Joerg] Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Schroeder-Tittmann, Kathrin; Tittmann, Kai] Univ Gottingen, Gottingen Ctr Mol Biosci, Albrecht von Haller Inst Plant Sci, Dept Bioanalyt, Groningen, Germany; [Eijlander, Robyn T.; Kuipers, Oscar P.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, NL-9747 AG Groningen, Netherlands; [Hewitt, Lorraine; Lewis, Richard J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Mass Spectrometry, D-30625 Hannover, Germany; [Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany; [Eijlander, Robyn T.; Kuipers, Oscar P.] Top Inst Food & Nutr TIFN, NL-6709 PA Wageningen, Netherlands	University of Gottingen; University of Gottingen; University of Groningen; Newcastle University - UK; Hannover Medical School; Hannover Medical School; Top Institute Food & Nutrition	Stulke, J (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany.	jstuelk@gwdg.de	Kaever, Volkhard/G-3280-2013; Stülke, Jörg/AAD-1600-2021; Kuipers, Oscar/B-6752-2009	lewis, richard/0000-0003-2641-8643; Kuipers, Oscar/0000-0001-5596-7735; Stulke, Jorg/0000-0001-5881-5390	Deutsche Forschungsgemeinschaft [SFB860]; Biotechnology and Biological Sciences Research Council [BB/I004572/1] Funding Source: researchfish; BBSRC [BB/I004572/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to J. S.).; Supported through SFB860 by the Deutsche Forschungsgemeinschaft.	Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Cannon W, 1999, GENE DEV, V13, P357, DOI 10.1101/gad.13.3.357; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen Y, 2012, J BACTERIOL, V194, P5080, DOI 10.1128/JB.01092-12; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Diethmaier C, 2011, J BACTERIOL, V193, P5997, DOI 10.1128/JB.05360-11; Gao XH, 2013, J BACTERIOL, V195, P4782, DOI 10.1128/JB.00373-13; Gardan R, 1997, MOL MICROBIOL, V24, P825, DOI 10.1046/j.1365-2958.1997.3881754.x; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gorke B., 2008, NAT REV MICROBIOL, V6, P613; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; Jervis AJ, 2007, J BACTERIOL, V189, P4534, DOI 10.1128/JB.00130-07; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Michna RH, 2014, NUCLEIC ACIDS RES, V42, pD692, DOI 10.1093/nar/gkt1002; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Nicholson WL, 1990, SPORULATION GERMINAT, P391; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sambrook J., 2001, MOL CLONING LAB MANU; Segev E, 2012, CELL, V148, P139, DOI 10.1016/j.cell.2011.11.059; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Song JH, 2005, MOL CELLS, V19, P365; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; van der Voort M, 2010, INT J FOOD MICROBIOL, V139, P108, DOI 10.1016/j.ijfoodmicro.2010.01.028; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zaprasis A, 2014, ENVIRON MICROBIOL, V16, P701, DOI 10.1111/1462-2920.12193; Zeevi MK, 2013, J BACTERIOL, V195, P5250, DOI 10.1128/JB.00794-13; Zhang L, 2013, J BIOL CHEM, V288, P22426, DOI 10.1074/jbc.M113.464883	46	46	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21098	21107		10.1074/jbc.M114.562066	http://dx.doi.org/10.1074/jbc.M114.562066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24939848	Green Published, hybrid			2022-12-28	WOS:000339396600060
J	Otero, YF; Stafford, JM; McGuinness, OP				Otero, Yolanda F.; Stafford, John M.; McGuinness, Owen P.			Pathway-selective Insulin Resistance and Metabolic Disease: The Importance of Nutrient Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DE-NOVO LIPOGENESIS; LOW-DENSITY LIPOPROTEIN; VLDL-TRIGLYCERIDE SECRETION; HEPATIC GLUCOSE-METABOLISM; DIABETIC FATTY RATS; ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; IN-VIVO; REGULATORY PROTEIN; ACID OXIDATION	Hepatic glucose and lipid metabolism are altered in metabolic disease (e. g. obesity, metabolic syndrome, and Type 2 diabetes). Insulin-dependent regulation of glucose metabolism is impaired. In contrast, lipogenesis, hypertriglyceridemia, and hepatic steatosis are increased. Because insulin promotes lipogenesis and liver fat accumulation, to explain the elevation in plasma and tissue lipids, investigators have suggested the presence of pathway-selective insulin resistance. In this model, insulin signaling to glucose metabolism is impaired, but insulin signaling to lipid metabolism is intact. We discuss the evidence for the differential regulation of hepatic lipid and glucose metabolism. We suggest that the primary phenotypic driver is altered substrate delivery to the liver, as well as the repartitioning of hepatic nutrient handling. Specific alterations in insulin signaling serve to amplify the alterations in hepatic substrate metabolism. Thus, hyperinsulinemia and its resultant increased signaling may facilitate lipogenesis, but are not the major drivers of the phenotype of pathway-selective insulin resistance.	[Otero, Yolanda F.; McGuinness, Owen P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Stafford, John M.] Vanderbilt Univ, Dept Internal Med, Sch Med, Nashville, TN 37232 USA; [Stafford, John M.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	McGuinness, OP (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 702 Light Hall, Nashville, TN 37232 USA.	owen.mcguinness@vanderbilt.edu	Stafford, John/K-7763-2017	Stafford, John/0000-0001-6527-959X	National Institutes of Health [DK043748, DK078188]; Department of Veterans Affairs Career Development Award and Merit [BX002223]; Vanderbilt Diabetes and Research and Training Center [DK020593]; Vanderbilt Mouse Metabolic Phenotyping Center [DK059637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059637, U24DK059637, R56DK043748, R01DK043748, R01DK078188, P30DK020593, R29DK043748, P60DK020593] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Career Development Award and Merit(US Department of Veterans Affairs); Vanderbilt Diabetes and Research and Training Center; Vanderbilt Mouse Metabolic Phenotyping Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK043748 and DK078188 (to O. P. M.). This work was also supported by Department of Veterans Affairs Career Development Award and Merit Award BX002223 (to J. M. S.), the Vanderbilt Diabetes and Research and Training Center (Grant DK020593), and the Vanderbilt Mouse Metabolic Phenotyping Center (Grant DK059637).	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2012, J BIOL CHEM, V287, P12578, DOI 10.1074/jbc.M111.309559; Anderka O, 2008, J BIOL CHEM, V283, P31333, DOI 10.1074/jbc.M805434200; Banarer S, 2004, MED CLIN N AM, V88, P1107, DOI 10.1016/j.mcna.2004.04.003; Bandsma RHJ, 2001, DIABETES, V50, P2591, DOI 10.2337/diabetes.50.11.2591; Bandsma RHJ, 2008, PEDIATR RES, V63, P702, DOI 10.1203/PDR.0b013e31816c9013; Barrows BR, 2006, J CLIN ENDOCR METAB, V91, P1446, DOI 10.1210/jc.2005-1709; Basu A, 2004, J INVEST MED, V52, P366, DOI 10.1136/jim-52-06-30; Basu A, 2009, DIABETES CARE, V32, P866, DOI 10.2337/dc08-1826; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Beaven SW, 2013, CELL METAB, V18, P106, DOI 10.1016/j.cmet.2013.04.021; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Beysen C, 2008, J LIPID RES, V49, P2657, DOI 10.1194/jlr.M800165-JLR200; Bock G, 2007, DIABETES, V56, P1703, DOI 10.2337/db06-1776; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Carey M, 2013, J BIOL CHEM, V288, P34981, DOI 10.1074/jbc.R113.506782; Catchpole B, 2008, J SMALL ANIM PRACT, V49, P4, DOI 10.1111/j.1748-5827.2007.00398.x; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen ZJ, 2008, J LIPID RES, V49, P2013, DOI 10.1194/jlr.M800240-JLR200; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Chong MFF, 2007, P NUTR SOC, V66, P52, DOI 10.1017/S0029665107005290; Chueh FY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1206, DOI 10.1152/ajpendo.00608.2005; Clore JN, 2000, DIABETES, V49, P969, DOI 10.2337/diabetes.49.6.969; Conte C, 2012, DIABETES CARE, V35, P1316, DOI 10.2337/dc11-1951; Cryer PE, 2012, ENDOCRINOLOGY, V153, P1039, DOI 10.1210/en.2011-1499; Cryer PE, 2010, ENDOCRIN METAB CLIN, V39, P641, DOI 10.1016/j.ecl.2010.05.003; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Edgerton DS, 2009, DIABETES, V58, P2766, DOI 10.2337/db09-0328; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; Erion DM, 2013, ENDOCRINOLOGY, V154, P36, DOI 10.1210/en.2012-1725; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; Froissart R, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-27; Fujimoto Y, 2006, DIABETES, V55, P2479, DOI 10.2337/db05-1511; GIACCARI A, 1992, J CLIN INVEST, V89, P36, DOI 10.1172/JCI115583; GRUNDY SM, 1979, J CLIN INVEST, V63, P1274, DOI 10.1172/JCI109422; Grundy SM, 2000, ENDOCRINE, V13, P155, DOI 10.1385/ENDO:13:2:155; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hellerstein MK, 1999, EUR J CLIN NUTR, V53, pS53, DOI 10.1038/sj.ejcn.1600744; Hornbuckle LA, 2004, AM J PHYSIOL-ENDOC M, V286, pE795, DOI 10.1152/ajpendo.00455.2003; Hudgins LC, 2011, J CLIN ENDOCR METAB, V96, P861, DOI 10.1210/jc.2010-2007; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Jensen KK, 2012, AM J PHYSIOL-ENDOC M, V302, pE209, DOI 10.1152/ajpendo.00436.2011; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; King GL, 1996, ENDOCRIN METAB CLIN, V25, P255, DOI 10.1016/S0889-8529(05)70324-8; Lambert JE, 2012, BBA-MOL CELL BIOL L, V1821, P721, DOI 10.1016/j.bbalip.2012.01.006; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; Lewis GF, 1997, CURR OPIN LIPIDOL, V8, P146, DOI 10.1097/00041433-199706000-00004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; McGuinness OP, 2003, CURR OPIN CLIN NUTR, V6, P441, DOI 10.1097/01.mco.0000078990.96795.cd; Miles JM, 2003, DIABETES, V52, P675, DOI 10.2337/diabetes.52.3.675; Mittendorfer B, 2003, AM J PHYSIOL-ENDOC M, V284, pE708, DOI 10.1152/ajpendo.00411.2002; Mittendorfer B, 2003, AM J PHYSIOL-ENDOC M, V284, pE549, DOI 10.1152/ajpendo.00379.2002; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Moore MC, 2003, BEST PRACT RES CL EN, V17, P343, DOI 10.1016/S1521-690X(03)00036-8; MOORE MC, 1991, J CLIN INVEST, V88, P578, DOI 10.1172/JCI115342; Mutel E, 2011, J HEPATOL, V54, P529, DOI 10.1016/j.jhep.2010.08.014; Nordlie RC, 2010, LIFE SCI, V87, P339, DOI 10.1016/j.lfs.2010.06.021; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; O'Brien TD, 2002, MOL CELL ENDOCRINOL, V197, P213, DOI 10.1016/S0303-7207(02)00265-4; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Otero YF, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.250; PAGLIASSOTTI MJ, 1992, ANNU REV PHYSIOL, V54, P847, DOI 10.1146/annurev.physiol.54.1.847; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Poupeau A, 2011, BBA-MOL BASIS DIS, V1812, P995, DOI 10.1016/j.bbadis.2011.03.015; Prahl A, 2007, J FELINE MED SURG, V9, P351, DOI 10.1016/j.jfms.2007.02.004; Ramnanan CJ, 2010, DIABETES, V59, P1302, DOI 10.2337/db09-1625; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Rizzo M, 2011, CURR PHARM DESIGN, V17, P943, DOI 10.2174/138161211795428768; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Ros S, 2011, DIABETOLOGIA, V54, P2639, DOI 10.1007/s00125-011-2238-x; Ros S, 2010, J BIOL CHEM, V285, P37170, DOI 10.1074/jbc.M110.157396; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432; Shah P, 2003, DIABETES, V52, P38, DOI 10.2337/diabetes.52.1.38; Shah P, 2002, DIABETES, V51, P301, DOI 10.2337/diabetes.51.2.301; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sidossis LS, 1998, AM J PHYSIOL-ENDOC M, V275, pE798, DOI 10.1152/ajpendo.1998.275.5.E798; Smith GI, 2013, J CLIN ENDOCR METAB, V98, P3454, DOI 10.1210/jc.2013-1786; Sorensen LP, 2011, DIABETES, V60, P2257, DOI 10.2337/db11-0040; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; Stanhope KL, 2011, J CLIN ENDOCR METAB, V96, pE1596, DOI 10.1210/jc.2011-1251; Stanhope KL, 2009, J NUTR, V139, pS1236, DOI 10.3945/jn.109.106641; STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Sullivan S, 2012, HEPATOLOGY, V55, P1738, DOI 10.1002/hep.25548; Tao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071997; Timlin MT, 2005, DIABETES, V54, P2694, DOI 10.2337/diabetes.54.9.2694; Torres TP, 2011, DIABETES, V60, P2225, DOI 10.2337/db09-1156; Torres TP, 2009, DIABETES, V58, P78, DOI 10.2337/db08-1119; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Vedala A, 2006, J LIPID RES, V47, P2562, DOI 10.1194/jlr.M600200-JLR200; Wu K, 2010, ENDOCRINOLOGY, V151, P3566, DOI 10.1210/en.2010-0204; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718	104	59	61	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20462	20469		10.1074/jbc.R114.576355	http://dx.doi.org/10.1074/jbc.R114.576355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907277	Green Published, hybrid			2022-12-28	WOS:000339396600005
J	Sheng, R; Zhang, TT; Felice, VD; Qin, T; Qin, ZH; Smith, CD; Sapp, E; Difiglia, M; Waeber, C				Sheng, Rui; Zhang, Tong-Tong; Felice, Valeria D.; Qin, Tao; Qin, Zheng-Hong; Smith, Charles D.; Sapp, Ellen; Difiglia, Marian; Waeber, Christian			Preconditioning Stimuli Induce Autophagy via Sphingosine Kinase 2 in Mouse Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELLS; PROTEASOMAL DEGRADATION; ISCHEMIC TOLERANCE; CEREBRAL-ISCHEMIA; ACTIVATION; DEATH; MICE; SPHINGOSINE-1-PHOSPHATE; FTY720; NEUROPROTECTION	Sphingosine kinase 2 (SPK2) and autophagy are both involved in brain preconditioning, but whether preconditioning-induced SPK2 up-regulation and autophagy activation are linked mechanistically remains to be elucidated. In this study, we used in vitro and in vivo models to explore the role of SPK2-mediated autophagy in isoflurane and hypoxic preconditioning. In primary mouse cortical neurons, both isoflurane and hypoxic preconditioning induced autophagy. Isoflurane and hypoxic preconditioning protected against subsequent oxygen glucose deprivation or glutamate injury, whereas pretreatment with autophagy inhibitors (3-methyladenine or KU55933) abolished preconditioning-induced tolerance. Pretreatment with SPK2 inhibitors (ABC294640 and SKI-II) or SPK2 knockdown prevented preconditioning-induced autophagy. Isoflurane also induced autophagy in mouse in vivo as shown by Western blots for LC3 and p62, LC3 immunostaining, and electron microscopy. Isoflurane-induced autophagy in mice lacking the SPK1 isoform (SPK1(-/-)), but not in SPK2(-/-) mice. Sphingosine 1-phosphate and the sphingosine 1-phosphate receptor agonist FTY720 did not protect against oxygen glucose deprivation in cultured neurons and did not alter the expression of LC3 and p62, suggesting that SPK2-mediated autophagy and protections are not S1P-dependent. Beclin 1 knockdown abolished preconditioning-induced autophagy, and SPK2 inhibitors abolished isoflurane-induced disruption of the Beclin 1/Bcl-2 association. These results strongly indicate that autophagy is involved in isoflurane preconditioning both in vivo and in vitro and that SPK2 contributes to preconditioning-induced autophagy, possibly by disrupting the Beclin 1/Bcl-2 interaction.	[Sheng, Rui; Zhang, Tong-Tong; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou 215123, Peoples R China; [Sheng, Rui; Zhang, Tong-Tong; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis, Suzhou 215123, Peoples R China; [Sheng, Rui; Qin, Tao; Waeber, Christian] Massachusetts Gen Hosp, Stroke & Neurovascular Regulat Lab, Dept Radiol, Charlestown, MA 02129 USA; [Sapp, Ellen; Difiglia, Marian] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Sapp, Ellen; Difiglia, Marian] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Felice, Valeria D.; Waeber, Christian] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Dept Pharmacol & Therapeut, Cork, Ireland; [Smith, Charles D.] Apogee Biotechnol Corp, Hummelstown, PA 17036 USA	Soochow University - China; Soochow University - China; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University College Cork	Waeber, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cavanagh Pharm Bldg,Rm 1-26,Coll Rd, Cork, Ireland.	c.waeber@ucc.ie	Sheng, Rui/AAE-6335-2022; Waeber, Christian/A-8333-2009; Waeber, Christian/B-3171-2016	Waeber, Christian/0000-0001-6078-0027; Waeber, Christian/0000-0001-6078-0027	National Institutes of Health [NS049263, NS055104]; Jiangsu Government Scholarship for Overseas Studies [631246, P30NS045776]; Natural Science Foundation of China [81173057, 81373402]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776, P01NS055104, R01NS049263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jiangsu Government Scholarship for Overseas Studies; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS049263 and NS055104 (to C. W.). This work was also supported by Marie Curie Career Integration Grant 631246 (to C. W.) and Interdepartmental Neuroscience Center Grant P30NS045776, grants from the Jiangsu Government Scholarship for Overseas Studies, and Natural Science Foundation of China Grants 81173057 and 81373402 (to R. S.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Beljanski V, 2010, J PHARMACOL EXP THER, V333, P454, DOI 10.1124/jpet.109.163337; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Blondeau N, 2007, J NEUROCHEM, V103, P509, DOI 10.1111/j.1471-4159.2007.04755.x; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Chang CL, 2009, AM J PHYSIOL-CELL PH, V297, pC451, DOI 10.1152/ajpcell.00586.2008; Di Menna L, 2013, PHARMACOL RES, V67, P1, DOI 10.1016/j.phrs.2012.10.004; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Farkas T, 2011, J BIOL CHEM, V286, P38904, DOI 10.1074/jbc.M111.269134; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Jin ZQ, 2008, CARDIOVASC RES, V79, P134, DOI 10.1093/cvr/cvn065; Jin ZQ, 2004, CIRCULATION, V110, P1980, DOI 10.1161/01.CIR.0000143632.06471.93; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim M, 2007, AM J PHYSIOL-RENAL, V293, pF1827, DOI 10.1152/ajprenal.00290.2007; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Liu JF, 2013, INT J NEUROSCI, V123, P163, DOI 10.3109/00207454.2012.749255; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; McMurtrey RJ, 2010, BRAIN RES, V1358, P184, DOI 10.1016/j.brainres.2010.08.015; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Samy ET, 2007, J IMMUNOL, V179, P5644, DOI 10.4049/jimmunol.179.9.5644; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Sheng R, 2012, AUTOPHAGY, V8, P310, DOI 10.4161/auto.18673; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Shimada K, 2012, NEUROBIOL DIS, V46, P101, DOI 10.1016/j.nbd.2011.12.050; Taniguchi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416552; Tonges L, 2006, RNA, V12, P1431, DOI 10.1261/rna.2252206; Tonelli F, 2010, CELL SIGNAL, V22, P1536, DOI 10.1016/j.cellsig.2010.05.022; Vessey DA, 2008, BIOCHEM BIOPH RES CO, V375, P425, DOI 10.1016/j.bbrc.2008.08.022; Vessey DA, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/961059; Wacker BK, 2012, J NEUROCHEM, V123, P954, DOI 10.1111/jnc.12047; Wacker BK, 2012, J CEREBR BLOOD F MET, V32, P1014, DOI 10.1038/jcbfm.2012.3; Wacker BK, 2009, STROKE, V40, P3342, DOI 10.1161/STROKEAHA.109.560714; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Wick A, 2002, J NEUROSCI, V22, P6401; Xia MQ, 2000, J NEUROIMMUNOL, V108, P227, DOI 10.1016/S0165-5728(00)00285-X; Yung LM, 2012, STROKE, V43, P199, DOI 10.1161/STROKEAHA.111.626911; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang N, 2010, AUTOPHAGY, V6, P1157, DOI 10.4161/auto.6.8.13614; Zhao P, 2004, ANESTHESIOLOGY, V101, P695, DOI 10.1097/00000542-200409000-00018; Zheng S, 2003, NEUROSCIENCE, V118, P99, DOI 10.1016/S0306-4522(02)00767-4	54	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20845	20857		10.1074/jbc.M114.578120	http://dx.doi.org/10.1074/jbc.M114.578120			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928515	Green Published, hybrid			2022-12-28	WOS:000339396600039
J	Smith, ED; Prieto, GA; Tong, LQ; Sears-Kraxberger, I; Rice, JD; Steward, O; Cotman, CW				Smith, Erica D.; Prieto, G. Aleph; Tong, Liqi; Sears-Kraxberger, Ilse; Rice, Jeffrey D.; Steward, Oswald; Cotman, Carl W.			Rapamycin and Interleukin-1 beta Impair Brain-derived Neurotrophic Factor-dependent Neuron Survival by Modulating Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTENDS LIFE-SPAN; CELL-DEATH; MAMMALIAN TARGET; SIGNALING PATHWAY; SYNAPTIC PLASTICITY; INSULIN-RESISTANCE; IN-VITRO; MTOR; GROWTH; KINASE	The mammalian target of rapamycin (mTOR) pathway has multiple important physiological functions, including regulation of protein synthesis, cell growth, autophagy, and synaptic plasticity. Activation of mTOR is necessary for the many beneficial effects of brain-derived neurotrophic factor (BDNF), including dendritic translation and memory formation in the hippocampus. At present, however, the role of mTOR in BDNF's support of survival is not clear. We report that mTOR activation is necessary for BDNF-dependent survival of primary rat hippocampal neurons, as either mTOR inhibition by rapamycin or genetic manipulation of the downstream molecule p70S6K specifically blocked BDNF rescue. Surprisingly, however, BDNF did not promote neuron survival by up-regulating mTOR-dependent protein synthesis or through mTOR-dependent suppression of caspase-3 activation. Instead, activated mTOR was responsible for BDNF's suppression of autophagic flux. shRNA against the autophagic machinery Atg7 or Atg5 prolonged the survival of neurons co-treated with BDNF and rapamycin, suggesting that suppression of mTORin BDNF-treated cells resulted in excessive autophagy. Finally, acting as a physiological analog of rapamycin, IL-1 beta impaired BDNF signaling by way of inhibiting mTOR activation as follows: the cytokine induced caspase-independent neuronal death and accelerated autophagic flux in BDNF-treated cells. These findings reveal a novel mechanism of BDNF neuroprotection; BDNF not only prevents apoptosis through inhibiting caspase activation but also promotes neuron survival through modulation of autophagy. This protection mechanism is vulnerable under chronic inflammation, which deregulates autophagy through impairing mTOR signaling. These results may be relevant to age-related changes observed in neurodegenerative diseases.	[Smith, Erica D.; Prieto, G. Aleph; Tong, Liqi; Rice, Jeffrey D.; Cotman, Carl W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Sears-Kraxberger, Ilse; Steward, Oswald] Univ Calif Irvine, Reeve Irvine Res Ctr, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Cotman, CW (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	cwcotman@uci.edu		Smith, Erica/0000-0002-5424-580X; Prieto, G. Aleph/0000-0001-9517-6989; Steward, Oswald/0000-0001-7069-8756	National Institutes of Health [P01-AG000538, RO1-NS073857]; NRSA from the NIMH [MH14599-29]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA from the NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-AG000538 (to C. W. C.) and by NRSA Award MH14599-29 (to E. D. S.) from the NIMH.; Supported by National Institutes of Health Grant RO1-NS073857.	Alirezaei M, 2010, AUTOPHAGY, V6, P702, DOI 10.4161/auto.6.6.12376; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CACERES A, 1984, J NEUROSCI, V4, P394; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Pastor MD, 2009, J BIOL CHEM, V284, P22067, DOI 10.1074/jbc.M109.033100; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Dziedzic SA, 2012, AUTOPHAGY, V8, P731, DOI 10.4161/auto.19314; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Francis BM, 2012, NEUROBIOL AGING, V33, P555, DOI 10.1016/j.neurobiolaging.2010.04.003; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; He CC, 2012, AUTOPHAGY, V8, P1548, DOI 10.4161/auto.21327; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Higgins GC, 2011, CELL MOL LIFE SCI, V68, P3725, DOI 10.1007/s00018-011-0667-9; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hyman BT, 2011, NAT NEUROSCI, V14, P5, DOI 10.1038/nn0111-5; Jaeger PA, 2010, ARCH NEUROL-CHICAGO, V67, P1181, DOI 10.1001/archneurol.2010.258; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klionsky DJ, 2005, AUTOPHAGY, V1, P59, DOI 10.4161/auto.1.1.1536; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mitra S, 2009, AUTOPHAGY, V5, P1037, DOI 10.4161/auto.5.7.9291; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Neely KM, 2011, J NEUROSCI, V31, P2781, DOI 10.1523/JNEUROSCI.5156-10.2010; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Park HYL, 2012, BRAIN RES, V1469, P10, DOI 10.1016/j.brainres.2012.06.006; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Petralia RS, 2013, BIOL OPEN, V2, P499, DOI 10.1242/bio.20134275; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sekulic A, 2000, CANCER RES, V60, P3504; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shehata M, 2012, J NEUROSCI, V32, P10413, DOI 10.1523/JNEUROSCI.4533-11.2012; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sun J, 2011, J BIOL CHEM, V286, P6791, DOI 10.1074/jbc.M110.172882; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tong LQ, 2008, NEUROBIOL AGING, V29, P1380, DOI 10.1016/j.neurobiolaging.2007.02.027; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018; Walls KC, 2010, J BIOL CHEM, V285, P10497, DOI 10.1074/jbc.M110.103747; Wu XH, 2004, J BIOL CHEM, V279, P9167, DOI 10.1074/jbc.M312397200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamada M, 1997, J BIOL CHEM, V272, P30334, DOI 10.1074/jbc.272.48.30334; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165	86	67	74	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20615	20629		10.1074/jbc.M114.568659	http://dx.doi.org/10.1074/jbc.M114.568659			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917666	Green Published, hybrid			2022-12-28	WOS:000339396600021
J	Gupta, A; Gomes, I; Wardman, J; Devi, LA				Gupta, Achla; Gomes, Ivone; Wardman, Jonathan; Devi, Lakshmi A.			Opioid Receptor Function Is Regulated by Post-endocytic Peptide Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIN-CONVERTING ENZYME-2; PROTEIN-COUPLED RECEPTORS; BOVINE ADRENAL-MEDULLA; NEUROKININ 1 RECEPTOR; CEREBRAL-CORTEX; ACTIVITY INVIVO; BETA-ARRESTINS; PROENKEPHALIN; TRAFFICKING; INTERNALIZATION	Most neuroendocrine peptides are generated in the secretory compartment by proteolysis of the precursors at classical cleavage sites consisting of basic residues by well studied endopeptidases belonging to the subtilisin superfamily. In contrast, a subset of bioactive peptides is generated by processing at non-classical cleavage sites that do not contain basic residues. Neither the peptidases responsible for non-classical cleavages nor the compartment involved in such processing has been well established. Members of the endothelin-converting enzyme (ECE) family are considered good candidate enzymes because they exhibit functional properties that are consistent with such a role. In this study we have explored a role for ECE2 in endocytic processing of delta opioid peptides and its effect on modulating delta opioid receptor function by using selective inhibitors of ECE2 that we had identified previously by homology modeling and virtual screening of a library of small molecules. We found that agonist treatment led to intracellular co-localization of ECE2 with delta opioid receptors. Furthermore, selective inhibitors of ECE2 and reagents that increase the pH of the acidic compartment impaired receptor recycling by protecting the endocytosed peptide from degradation. This, in turn, led to a substantial decrease in surface receptor signaling. Finally, we showed that treatment of primary neurons with the ECE2 inhibitor during recycling led to increased intracellular co-localization of the receptors and ECE2, which in turn led to decreased receptor recycling and signaling by the surface receptors. Together, these results support a role for differential modulation of opioid receptor signaling by post-endocytic processing of peptide agonists by ECE2.	[Gupta, Achla; Gomes, Ivone; Wardman, Jonathan; Devi, Lakshmi A.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Devi, Lakshmi A.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Devi, LA (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, 19-84 Annenberg Bldg,One Gustave L Levy Pl, New York, NY 10029 USA.	lakshmi.devi@mssm.edu	Devi P, Lakshmi/GXM-5982-2022	Devi P, Lakshmi/0000-0001-9274-4776	National Institutes of Health [NS26880, DA 019521, T32 DA-007135]; National Institute on Drug Abuse [DA007135]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026880, R29NS026880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA008863, T32DA007135, K05DA019521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS26880, DA 019521, and T32 DA-007135 (to L. A. D.).; Supported by Training Grant DA007135 from the National Institute on Drug Abuse.	Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Bunnett NW, 2010, CNS NEUROL DISORD-DR, V9, P539; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; CHAVKIN C, 1985, J NEUROSCI, V5, P808; Cheng SB, 2012, J BIOL CHEM, V287, P14178, DOI 10.1074/jbc.M111.323782; Chow KM, 2003, BIOCHEMISTRY-US, V42, P2239, DOI 10.1021/bi027178d; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Cvejic S, 1996, J BIOL CHEM, V271, P4073; DAVIS TP, 1990, EUR J PHARMACOL, V191, P253, DOI 10.1016/0014-2999(90)94157-S; DAVIS TP, 1985, EUR J PHARMACOL, V111, P177, DOI 10.1016/0014-2999(85)90754-X; DRAY A, 1985, J PHARMACOL EXP THER, V235, P670; EIPPER BA, 1988, ANNU REV PHYSIOL, V50, P333, DOI 10.1146/annurev.ph.50.030188.002001; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Fricker L.D., 2012, NEUROPEPTIDES OTHER; Gagnidze K, 2008, J MED CHEM, V51, P3378, DOI 10.1021/jm7015478; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2003, METH MOLEC MED, V84, P157; Gomes I, 2013, P NATL ACAD SCI USA, V110, P16211, DOI 10.1073/pnas.1312938110; Gomes I, 2013, METHOD ENZYMOL, V521, P219, DOI 10.1016/B978-0-12-391862-8.00012-0; Gupta A, 2008, J BIOL CHEM, V283, P10735, DOI 10.1074/jbc.M709454200; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hasdemir B, 2012, MOL ENDOCRINOL, V26, P681, DOI 10.1210/me.2011-1361; HOLLT V, 1982, LIFE SCI, V31, P1883, DOI 10.1016/0024-3205(82)90234-X; Hong YG, 2004, BRIT J PHARMACOL, V141, P423, DOI 10.1038/sj.bjp.0705637; Hook VYH, 1996, ARCH BIOCHEM BIOPHYS, V328, P107, DOI 10.1006/abbi.1996.0149; HURLBUT DE, 1987, EUR J PHARMACOL, V138, P359, DOI 10.1016/0014-2999(87)90474-2; Ippoliti R, 1998, CELL MOL LIFE SCI, V54, P866, DOI 10.1007/s000180050214; KUKKOLA PJ, 1995, J CARDIOVASC PHARM, V26, pS65; Law IKM, 2012, J BIOL CHEM, V287, P15066, DOI 10.1074/jbc.M111.327262; Law PY, 2000, J BIOL CHEM, V275, P32057, DOI 10.1074/jbc.M002395200; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; MCGINTY JF, 1985, NEUROPEPTIDES, V5, P465, DOI 10.1016/0143-4179(85)90055-1; MCGINTY JF, 1984, J NEUROSCI, V4, P1104; MIZUNO K, 1980, BIOCHEM BIOPH RES CO, V97, P1283, DOI 10.1016/S0006-291X(80)80005-2; MIZUNO K, 1980, BIOCHEM BIOPH RES CO, V95, P1482, DOI 10.1016/S0006-291X(80)80064-7; Molineaux C, 1991, PEPTIDE BIOSYNTHESIS, P251; Mzhavia N, 2003, J BIOL CHEM, V278, P14704, DOI 10.1074/jbc.M211242200; Oliveira V, 2005, FEBS J, V272, P2978, DOI 10.1111/j.1742-4658.2005.04692.x; Ouimet T, 2010, J BIOL CHEM, V285, P34390, DOI 10.1074/jbc.M110.120576; Pacheco-Quinto J, 2013, J BIOL CHEM, V288, P5606, DOI 10.1074/jbc.M112.422964; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pan H, 2004, PROTEIN PEPTIDE LETT, V11, P461, DOI 10.2174/0929866043406463; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Rodriguiz RM, 2008, GENES BRAIN BEHAV, V7, P418, DOI 10.1111/j.1601-183X.2007.00365.x; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rozenfeld R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029239; Schulz R, 1991, J Enzyme Inhib, V4, P347, DOI 10.3109/14756369109030399; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seto S, 1989, Adv Exp Med Biol, V247B, P49; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Swanson TA, 2004, PROTEIN PEPTIDE LETT, V11, P471, DOI 10.2174/0929866043406607; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; Turner AJ, 1996, BIOCHEM PHARMACOL, V51, P91, DOI 10.1016/0006-2952(95)02036-5; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Turner AJ, 1996, ADV EXP MED BIOL, V389, P141; UMEZAWA H, 1976, J ANTIBIOT, V29, P97, DOI 10.7164/antibiotics.29.97; Vermeirssen V, 2002, J BIOCHEM BIOPH METH, V51, P75, DOI 10.1016/S0165-022X(02)00006-4; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Yanagisawa H, 2000, J CLIN INVEST, V105, P1373, DOI 10.1172/JCI7447; Zhang L, 2006, MOL PHARMACOL, V69, P1810, DOI 10.1124/mol.105.021352; Zhao PS, 2013, J BIOL CHEM, V288, P25689, DOI 10.1074/jbc.M113.496414	66	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19613	19626		10.1074/jbc.M113.537704	http://dx.doi.org/10.1074/jbc.M113.537704			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24847082	hybrid, Green Published			2022-12-28	WOS:000339326800034
J	Cheung, CT; Singh, R; Kalra, RS; Kaul, SC; Wadhwa, R				Cheung, Caroline T.; Singh, Rumani; Kalra, Rajkumar S.; Kaul, Sunil C.; Wadhwa, Renu			Collaborator of ARF (CARF) Regulates Proliferative Fate of Human Cells by Dose-dependent Regulation of DNA Damage Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; ERK; P53; ACTIVATION; APOPTOSIS; PROTEIN; ARREST; ATM; CHECKPOINT; SENESCENCE	Collaborator of ARF (CARF) has been shown to directly bind to and regulate p53, a central protein that controls tumor suppression via cellular senescence and apoptosis. However, the cellular functions of CARF and the mechanisms governing its effect on senescence, apoptosis, or proliferation are still unknown. Our previous studies have shown that (i) CARF is up-regulated during replicative and stress-induced senescence, and its exogenous overexpression caused senescence-like growth arrest of cells, and (ii) suppression of CARF induces aneuploidy, DNA damage, and mitotic catastrophe, resulting in apoptosis via the ATR/CHK1 pathway. In the present study, we dissected the cellular role of CARF by investigating the molecular pathways triggered by its overexpression in vitro and in vivo. We found that the dosage of CARF is a critical factor in determining the proliferation potential of cancer cells. Most surprisingly, although a moderate level of CARF overexpression induced senescence, a very high level of CARF resulted in increased cell proliferation. We demonstrate that the level of CARF is crucial for DNA damage and checkpoint response of cells through ATM/CHK1/CHK2, p53, and ERK pathways that in turn determine the proliferative fate of cancer cells toward growth arrest or proproliferative and malignant phenotypes. To the best of our knowledge, this is the first report that demonstrates the capability of a fundamental protein, CARF, in controlling cell proliferation in two opposite directions and hence may play a key role in tumor biology and cancer therapeutics.	[Kalra, Rajkumar S.; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Kalra, Rajkumar S.; Kaul, Sunil C.; Wadhwa, Renu] Int Lab Adv Biomed, Tsukuba, Ibaraki 3058562, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Wadhwa, Renu/L-8898-2018; Kalra, RAJKUMAR S/L-6944-2018; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kalra, RAJKUMAR S/0000-0002-8181-457X; Kaul, Sunil C/0000-0002-0046-3916	Japan Society for Promotion of Science, New Energy & Industrial Technology Development Organization of Japan; Japan Society for Promotion of Science; Canadian Institutes of Health Research; La Ligue Contre le Cancer; Fondation de France; Grants-in-Aid for Scientific Research [13F03918] Funding Source: KAKEN	Japan Society for Promotion of Science, New Energy & Industrial Technology Development Organization of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for Promotion of Science, New Energy & Industrial Technology Development Organization of Japan.; Supported by fellowships from the Japan Society for Promotion of Science, Canadian Institutes of Health Research, La Ligue Contre le Cancer, and Fondation de France. Present address: Institute of Molecular Genetics of Montpellier/University of Montpellier I & II/CNRS, 1919 Route de Mende, Montpellier 34293, France.; Supported by a fellowship from the Japan Society for Promotion of Science.	Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Cheung CT, 2011, CELL DEATH DIFFER, V18, P589, DOI 10.1038/cdd.2010.129; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dai BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1404; Dai Y, 2008, BLOOD, V112, P2439, DOI 10.1182/blood-2008-05-159392; Hasan MK, 2008, INT J ONCOL, V32, P663; Hasan MK, 2009, J BIOL CHEM, V284, P1664, DOI 10.1074/jbc.M805778200; Hasan MK, 2004, BIOCHEM J, V380, P605, DOI 10.1042/BJ20040337; Hasan MK, 2002, J BIOL CHEM, V277, P37765, DOI 10.1074/jbc.M204177200; Heo JI, 2012, MOL BIOL REP, V39, P8007, DOI 10.1007/s11033-012-1647-3; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khalil A, 2011, CELL CYCLE, V10, P481, DOI 10.4161/cc.10.3.14713; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Lee SJ, 2013, NEOPLASIA, V15, P727, DOI 10.1593/neo.121862; Ljungman M, 2005, MUTAT RES-FUND MOL M, V577, P203, DOI 10.1016/j.mrfmmm.2005.02.014; Marchetti A, 2004, CELL DEATH DIFFER, V11, P596, DOI 10.1038/sj.cdd.4401368; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singh R, 2014, EXP CELL RES, V322, P324, DOI 10.1016/j.yexcr.2014.01.022; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tentner AR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.1; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104	25	26	30	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18258	18269		10.1074/jbc.M114.547208	http://dx.doi.org/10.1074/jbc.M114.547208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825908	Green Published, hybrid			2022-12-28	WOS:000338042000026
J	Cho, HJ; Hwang, YS; Mood, K; Ji, YJ; Lim, J; Morrison, DK; Daar, IO				Cho, Hee Jun; Hwang, Yoo-Seok; Mood, Kathleen; Ji, Yon Ju; Lim, Junghwa; Morrison, Deborah K.; Daar, Ira O.			EphrinB1 Interacts with CNK1 and Promotes Cell Migration through c-Jun N-terminal Kinase (JNK) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; EPH-RECEPTOR; TRANSMEMBRANE LIGANDS; SCAFFOLD PROTEIN; GASTRIC-CANCER; MORPHOGENESIS; SIGNALS; RHO; ANGIOGENESIS; MAINTENANCE	The Eph receptors and their membrane-bound ligands, ephrins, play important roles in various biological processes such as cell adhesion and movement. The transmembrane ephrinBs transduce reverse signaling in a tyrosine phosphorylation-dependent or -independent, as well as PDZ-dependent manner. Here, we show that ephrinB1 interacts with Connector Enhancer of KSR1 (CNK1) in an EphB receptor-independent manner. In cultured cells, cotransfection of ephrinB1 with CNK1 increases JNK phosphorylation. EphrinB1/CNK1-mediated JNK activation is reduced by overexpression of dominant-negative RhoA. Overexpression of CNK1 alone is sufficient for activation of RhoA; however, both ephrinB1 and CNK1 are required for JNK phosphorylation. Co-immunoprecipitation data showed that ephrinB1 and CNK1 act as scaffold proteins that connect RhoA and JNK signaling components, such as p115RhoGEF and MKK4. Furthermore, adhesion to fibronectin or active Src overexpression increases ephrinB1/CNK1 binding, whereas blocking Src activity by a pharmacological inhibitor decreases not only ephrinB1/CNK1 binding, but also JNK activation. EphrinB1 overexpression increases cell motility, however, CNK1 depletion by siRNA abrogates ephrinB1-mediated cell migration and JNK activation. Moreover, Rho kinase inhibitor or JNK inhibitor treatment suppresses ephrinB1-mediated cell migration. Taken together, our findings suggest that CNK1 is required for ephrinB1-induced JNK activation and cell migration.	[Cho, Hee Jun; Hwang, Yoo-Seok; Mood, Kathleen; Ji, Yon Ju; Lim, Junghwa; Morrison, Deborah K.; Daar, Ira O.] NCI, Lab Cell & Dev Signaling, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Daar, IO (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA.	daar@ncifcrf.gov		Daar, Ira/0000-0003-2657-526X	Intramural Research Program of the National Institutes of Health, NCI; NATIONAL CANCER INSTITUTE [ZIABC010958, ZIABC010006, ZIABC011107] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, NCI.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; Bong YS, 2004, BIOCHEM J, V377, P499, DOI 10.1042/BJ20031449; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Castano J, 2008, HISTOL HISTOPATHOL, V23, P1011, DOI 10.14670/HH-23.1011; Chong LD, 2000, MOL CELL BIOL, V20, P724, DOI 10.1128/MCB.20.2.724-734.2000; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Douziech M, 2003, EMBO J, V22, P5068, DOI 10.1093/emboj/cdg506; Dravis C, 2011, DEV BIOL, V355, P138, DOI 10.1016/j.ydbio.2011.04.020; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Fritz RD, 2011, BBA-MOL CELL RES, V1813, P1971, DOI 10.1016/j.bbamcr.2011.02.008; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hwang YS, 2013, GENE DEV, V27, P491, DOI 10.1101/gad.208355.112; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Jaffe AB, 2004, MOL CELL BIOL, V24, P1736, DOI 10.1128/MCB.24.4.1736-1746.2004; Kalo MS, 2001, J BIOL CHEM, V276, P38940, DOI 10.1074/jbc.M105815200; Kandouz M., CANC METASTASIS REV, V31, P353; Kataoka H, 2002, J CANCER RES CLIN, V128, P343, DOI 10.1007/s00432-002-0355-0; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Lee HS, 2006, NAT CELL BIOL, V8, P55, DOI 10.1038/ncb1344; Lee HS, 2008, NAT CELL BIOL, V10, P979, DOI 10.1038/ncb1758; Lee HS, 2009, MOL BIOL CELL, V20, P124, DOI 10.1091/mbc.E08-06-0662; Lee YN, 2004, J BIOL CHEM, V279, P54896, DOI 10.1074/jbc.M407581200; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rohani N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000597; Sawai Y, 2003, J HEPATOL, V39, P991, DOI 10.1016/S0168-8278(03)00498-7; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Tanaka M, 2010, CANCER SCI, V101, P87, DOI 10.1111/j.1349-7006.2009.01352.x; Uyen HD, 2002, J CELL SCI, V115, P3073; Varelias A, 2002, CANCER, V95, P862, DOI 10.1002/cncr.10749; Vaught D, 2009, MOL BIOL CELL, V20, P2572, DOI 10.1091/mbc.E08-04-0378; Wu C, 2009, J NEUROSCI, V29, P7404, DOI 10.1523/JNEUROSCI.5841-08.2009; Xu Z, 2003, J BIOL CHEM, V278, P24767, DOI 10.1074/jbc.M302454200; Yamauchi J, 1999, J BIOL CHEM, V274, P1957, DOI 10.1074/jbc.274.4.1957; Ziogas A, 2005, J BIOL CHEM, V280, P24205, DOI 10.1074/jbc.M413327200	52	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18556	18568		10.1074/jbc.M114.558809	http://dx.doi.org/10.1074/jbc.M114.558809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825906	Green Published, hybrid			2022-12-28	WOS:000338042000052
J	Dimitrov, JD; Planchais, C; Scheel, T; Ohayon, D; Mesnage, S; Berek, C; Kaveri, SV; Lacroix-Desmazes, S				Dimitrov, Jordan D.; Planchais, Cyril; Scheel, Tobias; Ohayon, Delphine; Mesnage, Stephane; Berek, Claudia; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien			A Cryptic Polyreactive Antibody Recognizes Distinct Clades of HIV-1 Glycoprotein 120 by an Identical Binding Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; CELL TOLERANCE CHECKPOINTS; MONOCLONAL-ANTIBODIES; V3 LOOP; ENVELOPE GLYCOPROTEIN; VACCINE DEVELOPMENT; ANTIGEN-BINDING; HEME; GP120	Polyreactive antibodies play an important role for neutralization of human immunodeficiency virus (HIV). In addition to intrinsic polyreactive antibodies, the immune system of healthy individuals contains antibodies with cryptic polyreactivity. These antibodies acquire promiscuous antigen binding potential post-translationally, after exposure to various redox-active substances such as reactive oxygen species, iron ions, and heme. Here, we characterized the interaction of a prototypic human antibody that acquires binding potential to glycoprotein (gp) 120 after exposure to heme. The kinetic and thermodynamic analyses of interaction of the polyreactive antibody with distinct clades of gp120 demonstrated that the antigen-binding promiscuity of the antibody compensates for the molecular heterogeneity of the target antigen. Thus, the polyreactive antibody recognized divergent gp120 clades with similar values of the binding kinetics and quantitatively identical changes in the activation thermodynamic parameters. Moreover, this antibody utilized the same type of noncovalent forces for formation of complexes with gp120. In contrast, HIV-1-neutralizing antibodies isolated from HIV-1-infected individuals, F425 B4a1 and b12, demonstrated different binding behavior upon interaction with distinct variants of gp120. This study contributes to a better understanding of the physiological role and binding mechanism of antibodies with cryptic polyreactivity. Moreover, this study might be of relevance for understanding the basic aspects of HIV-1 interaction with human antibodies.	[Dimitrov, Jordan D.; Planchais, Cyril; Ohayon, Delphine; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien] Univ Paris 06, Ctr Rech Cordeliers, Unite Mixte Rech S 1138, F-75006 Paris, France; [Dimitrov, Jordan D.; Planchais, Cyril; Ohayon, Delphine; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien] Univ Paris 05, Unite Mixte Rech S 1138, Paris, France; [Dimitrov, Jordan D.; Planchais, Cyril; Ohayon, Delphine; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien] INSERM, U1138, F-75006 Paris, France; [Scheel, Tobias; Berek, Claudia] Deutsch Rheuma Forschungszentrum, Inst Leibniz Gemeinschaft, D-13092 Berlin, Germany; [Mesnage, Stephane] Univ Sheffield, Krebs Inst, Western Bank, Sheffield S10 2TN, S Yorkshire, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Sheffield	Dimitrov, JD (corresponding author), INSERM, UMR 1138, Equipe 16, Ctr Rech Cordeliers, F-75006 Paris, France.	jordan.dimitrov@crc.jussieu.fr	Dimitrov, Jordan/N-2141-2014; MESNAGE, Stephane/H-7156-2019	MESNAGE, Stephane/0000-0003-1648-4890; Kaveri, Srini/0000-0002-0837-4053; Dimitrov, Jordan/0000-0001-8536-8995; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447	INSERM; CNRS; UPMC-Paris 6 (France); Centre de Recherche des Cordeliers (Prix Jeunes Chercheurs); Agence Nationale de la Recherche [ANR-13-JCV1-006-01]; Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC-Paris 6 (France); Centre de Recherche des Cordeliers (Prix Jeunes Chercheurs); Agence Nationale de la Recherche(French National Research Agency (ANR)); Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France)	This work was supported by INSERM, CNRS, and UPMC-Paris 6 (France) and by grants from Centre de Recherche des Cordeliers (Prix Jeunes Chercheurs 2008), Agence Nationale de la Recherche Grant ANR-13-JCV1-006-01, and Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France).	Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Amzel LM, 2000, METHOD ENZYMOL, V323, P167; Argyris EG, 1999, J BIOL CHEM, V274, P1549, DOI 10.1074/jbc.274.3.1549; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cavacini L, 2003, AIDS, V17, P685, DOI 10.1097/00002030-200303280-00006; Chomont N, 2008, VIROLOGY, V370, P246, DOI 10.1016/j.virol.2007.09.006; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Dairou J, 2004, ANTIVIR RES, V61, P37, DOI 10.1016/S0166-3542(03)00176-1; DEBNATH AK, 1994, J MED CHEM, V37, P1099, DOI 10.1021/jm00034a007; Devadas K, 2006, J IMMUNOL, V176, P4252, DOI 10.4049/jimmunol.176.7.4252; Dimitrov JD, 2006, J BIOL CHEM, V281, P439, DOI 10.1074/jbc.M509190200; Dimitrov JD, 2007, J BIOL CHEM, V282, P26696, DOI 10.1074/jbc.M702751200; Dimitrov JD, 2013, J IMMUNOL, V191, P993, DOI 10.4049/jimmunol.1300880; Dimitrov JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002095; Dimitrov JD, 2010, BIOCHEM BIOPH RES CO, V398, P266, DOI 10.1016/j.bbrc.2010.06.073; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Ditzel HJ, 1996, J IMMUNOL, V157, P739; DITZEL HJ, 1994, P NATL ACAD SCI USA, V91, P3710, DOI 10.1073/pnas.91.9.3710; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Eisen HN, 2010, P NATL ACAD SCI USA, V107, P22373, DOI 10.1073/pnas.1012051108; Gassmann C, 1997, J MED VIROL, V51, P242, DOI 10.1002/(SICI)1096-9071(199703)51:3&lt;242::AID-JMV17&gt;3.0.CO;2-M; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2010, NAT STRUCT MOL BIOL, V17, P543, DOI 10.1038/nsmb0510-543; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; LEVERE RD, 1991, P NATL ACAD SCI USA, V88, P1756, DOI 10.1073/pnas.88.5.1756; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Manivel V, 2002, J IMMUNOL, V169, P888, DOI 10.4049/jimmunol.169.2.888; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; McIntyre JA, 2004, THROMB RES, V114, P579, DOI 10.1016/j.thromres.2004.08.008; McIntyre JA, 2009, CLIN REV ALLERG IMMU, V37, P49, DOI 10.1007/s12016-008-8093-y; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Mihaylova NM, 2008, INFLAMM RES, V57, P1, DOI 10.1007/s00011-007-6213-4; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Neurath AR, 1995, J MOL RECOGNIT, V8, P345, DOI 10.1002/jmr.300080604; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Nouraie M, 2012, SEX TRANSM INFECT, V88, P528, DOI 10.1136/sextrans-2011-050459; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Scheel T., 2009, THESIS HUMBOLDT U BE; Scheel T, 2011, ARTHRITIS RHEUM-US, V63, P63, DOI 10.1002/art.27767; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Schmidt WN, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00129; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Staudinger R, 1996, P ASSOC AM PHYSICIAN, V108, P47; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vzorov AN, 2002, ANTIMICROB AGENTS CH, V46, P3917, DOI 10.1128/AAC.46.12.3917-3925.2002; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Warter L, 2012, IMMUNOL RES, V53, P148, DOI 10.1007/s12026-012-8268-8; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015; Zhou ZH, 2007, CELL HOST MICROBE, V1, P51, DOI 10.1016/j.chom.2007.01.002; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11	74	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17767	17779		10.1074/jbc.M114.556266	http://dx.doi.org/10.1074/jbc.M114.556266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24802758	Green Published, hybrid			2022-12-28	WOS:000338018100040
J	Reineke, EL; Benham, A; Soibam, B; Stashi, E; Taegtmeyer, H; Entman, ML; Schwartz, RJ; O'Malley, BW				Reineke, Erin L.; Benham, Ashley; Soibam, Benjamin; Stashi, Erin; Taegtmeyer, Heinrich; Entman, Mark L.; Schwartz, Robert J.; O'Malley, Bert W.			Steroid Receptor Coactivator-2 Is a Dual Regulator of Cardiac Transcription Factor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; DILATED CARDIOMYOPATHY; PRESSURE-OVERLOAD; TRANSGENIC MICE; IN-VIVO; HEART; GATA4; MOUSE; HYPERTROPHY	We have previously demonstrated the potential role of steroid receptor coactivator-2 (SRC-2) as a co-regulator in the transcription of critical molecules modulating cardiac function and metabolism in normal and stressed hearts. The present study seeks to extend the previous information by demonstrating SRC-2 fulfills this role by serving as a critical coactivator for the transcription and activity of critical transcription factors known to control cardiac growth and metabolism as well as in their downstream signaling. This knowledge broadens our understanding of the mechanism by which SRC-2 acts in normal and stressed hearts and allows further investigation of the transcriptional modifications mediating different types and degrees of cardiac stress. Moreover, the genetic manipulation of SRC-2 in this study is specific for the heart and thereby eliminating potential indirect effects of SRC-2 deletion in other organs. We have shown that SRC-2 is critical to transcriptional control modulated by MEF2, GATA-4, and Tbx5, thereby enhancing gene expression associated with cardiac growth. Additionally, we describe SRC-2 as a novel regulator of PPAR alpha expression, thus controlling critical steps in metabolic gene expression. We conclude that through regulation of cardiac transcription factor expression and activity, SRC-2 is a critical transcriptional regulator of genes important for cardiac growth, structure, and metabolism, three of the main pathways altered during the cardiac stress response.	[Reineke, Erin L.; Stashi, Erin; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Benham, Ashley; Soibam, Benjamin; Schwartz, Robert J.] St Lukes Episcopal Hosp, Texas Heart Inst, Stem Cell Engn Dept, Houston, TX 77030 USA; [Taegtmeyer, Heinrich] Univ Texas Houston, Med Sch Houston, Div Cardiol, Dept Internal Med, Houston, TX 77030 USA; [Entman, Mark L.] Baylor Coll Med, Dept Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Schwartz, Robert J.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA	Baylor College of Medicine; Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Houston System; University of Houston	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.	berto@bcm.tmc.edu			National Institutes of Health from the NIDDK [5P01-DK059820]; National Institutes of Health from the NICHD [5R01-HD007857]; DUNN Foundation from the NHLBI [5R01-HL089902-02, R01-HL113601]; Center for the Advancement of Science in Space Request for Funding Proposals; NHLBI [R01-HL089792, R01-HL061483, 1K99-HL118159-01]; American Heart Association [12POST11830003]; National Institutes of Health from the NCI [P30-CA125123]; Mouse Metabolic Core Core at Baylor College of Medicine under the Diabetes Research Center [P30 DK079638]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD008188, R01HD007857] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089902, R01HL061483, R01HL113601, R01HL089792, K99HL118159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, P30DK079638] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; National Institutes of Health from the NICHD; DUNN Foundation from the NHLBI; Center for the Advancement of Science in Space Request for Funding Proposals; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mouse Metabolic Core Core at Baylor College of Medicine under the Diabetes Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P01-DK059820 from the NIDDK and 5R01-HD007857 from the NICHD, and the DUNN Foundation (to B. W. O.'M.); Grants 5R01-HL089902-02 and R01-HL113601 from the NHLBI and Center for the Advancement of Science in Space Request for Funding Proposals 2013-2 (to R. J. S.); R01-HL089792 from the NHLBI (to M. L. E.); R01-HL061483 from the NHLBI (to H. T.); and American Heart Association Postdoctoral Fellowship 12POST11830003 and NHLBI Grant 1K99-HL118159-01 (to E. L. R.). Histological analyses were supported by the Human Tissue Acquisition and Pathology Core and Baylor College of Medicine with funding from the National Institutes of Health Grant P30-CA125123 from the NCI. Seahorse analyses were supported by the Mouse Metabolic Core Core at Baylor College of Medicine under the Diabetes Research Center Grant P30 DK079638.	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; el Azzouzi H, 2010, EUR J HEART FAIL, V12, P4, DOI 10.1093/eurjhf/hfp165; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Moore ML, 2001, J BIOL CHEM, V276, P1026, DOI 10.1074/jbc.M009352200; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Mukherjee A, 2006, MOL CELL BIOL, V26, P6571, DOI 10.1128/MCB.00654-06; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; NURRISH SJ, 1995, MOL CELL BIOL, V15, P4076; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Qi C, 1999, P NATL ACAD SCI USA, V96, P1585, DOI 10.1073/pnas.96.4.1585; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Sepulveda JL, 2002, J BIOL CHEM, V277, P25775, DOI 10.1074/jbc.M203122200; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; van Berlo JH, 2011, P NATL ACAD SCI USA, V108, P12331, DOI 10.1073/pnas.1104499108; Wu WW, 2011, MOL BIOL EVOL, V28, P501, DOI 10.1093/molbev/msq214; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	39	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17721	17731		10.1074/jbc.M113.539908	http://dx.doi.org/10.1074/jbc.M113.539908			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24811170	hybrid, Green Published			2022-12-28	WOS:000338018100036
J	Koeppen, K; Coutermarsh, BA; Madden, DR; Stanton, BA				Koeppen, Katja; Coutermarsh, Bonita A.; Madden, Dean R.; Stanton, Bruce A.			Serum- and Glucocorticoid-induced Protein Kinase 1 (SGK1) Increases the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Airway Epithelial Cells by Phosphorylating Shank2E Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-INTERACTING DOMAIN; PLASMA-MEMBRANE; POSTSYNAPTIC DENSITY; SURFACE EXPRESSION; APICAL MEMBRANE; BINDING-PROTEIN; DELTA-F508-CFTR; ENDOCYTOSIS; TRAFFICKING; ASSOCIATION	The glucocorticoid dexamethasone increases cystic fibrosis transmembrane conductance regulator (CFTR) abundance in human airway epithelial cells by a mechanism that requires serum- and glucocorticoid-induced protein kinase 1 (SGK1) activity. The goal of this study was to determine whether SGK1 increases CFTR abundance by phosphorylating Shank2E, a PDZ domain protein that contains two SGK1 phosphorylation consensus sites. We found that SGK1 phosphorylates Shank2E as well as a peptide containing the first SGK1 consensus motif of Shank2E. The dexamethasone-induced increase in CFTR abundance was diminished by overexpression of a dominant-negative Shank2E in which the SGK1 phosphorylation sites had been mutated. siRNA-mediated reduction of Shank2E also reduced the dexamethasone-induced increase in CFTR abundance. Taken together, these data demonstrate that the glucocorticoid-induced increase in CFTR abundance requires phosphorylation of Shank2E at an SGK1 consensus site.	[Koeppen, Katja; Coutermarsh, Bonita A.; Stanton, Bruce A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Madden, Dean R.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Koeppen, K (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, N Coll St, Hanover, NH 03755 USA.	Katja.UU.Koeppen@Dartmouth.edu			National Institutes of Health [R01-HL074175, R01-DK/HL45881]; NIGMS, National Institutes of Health [P30GM106394]; Cystic Fibrosis Foundation Research Development Program [STANTO07R0, R01-DK075309]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045881, R01DK075309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cystic Fibrosis Foundation Research Development Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by National Institutes of Health Grants R01-HL074175 and R01-DK/HL45881 (to B. A. S.) and by NIGMS, National Institutes of Health Grant P30GM106394. This work was also supported by Cystic Fibrosis Foundation Research Development Program Grants STANTO07R0 (to B. A. S.) and R01-DK075309 (to D. R. M.).	Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Bomberger JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089599; Bomberger JM, 2011, METHODS MOL BIOL, V741, P271, DOI 10.1007/978-1-61779-117-8_18; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Dobrinskikh E, 2013, AM J PHYSIOL-CELL PH, V304, pC561, DOI 10.1152/ajpcell.00189.2012; Dobrinskikh E, 2010, AM J PHYSIOL-CELL PH, V299, pC1324, DOI 10.1152/ajpcell.00183.2010; Dransfield MT, 2013, CHEST, V144, P498, DOI 10.1378/chest.13-0274; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Hastie AT, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-25; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Jung ES, 2014, J PHYSIOL-LONDON, V592, P1809, DOI 10.1113/jphysiol.2013.268631; Kenche H, 2013, FASEB J, V27, P965, DOI 10.1096/fj.12-216234; Kim JY, 2004, J BIOL CHEM, V279, P10389, DOI 10.1074/jbc.M312871200; Koeppen K, 2012, AM J PHYSIOL-LUNG C, V303, pL720, DOI 10.1152/ajplung.00409.2011; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Lee JS, 2010, J BIOL CHEM, V285, P8104, DOI 10.1074/jbc.M109.055079; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Lukacs GL, 1997, BIOCHEM J, V328, P353; McWilliams RR, 2005, AM J PHYSIOL-CELL PH, V289, pC1042, DOI 10.1152/ajpcell.00568.2004; McWilliams RR, 2004, BIOCHEM J, V380, P181, DOI 10.1042/BJ20031577; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; Ostedgaard LS, 2003, P NATL ACAD SCI USA, V100, P1937, DOI 10.1073/pnas.2627982100; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Piserchio A, 2005, BIOCHEMISTRY-US, V44, P16158, DOI 10.1021/bi0516475; Prota LFM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047405; Rab A, 2013, AM J PHYSIOL-LUNG C, V305, pL530, DOI 10.1152/ajplung.00039.2013; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200	47	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17142	17150		10.1074/jbc.M114.555599	http://dx.doi.org/10.1074/jbc.M114.555599			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24811177	Green Published, hybrid			2022-12-28	WOS:000338016200047
J	Brown, WS; Khalili, JS; Rodriguez-Cruz, TG; Lizee, G; McIntyre, BW				Brown, Wells S.; Khalili, Jahan S.; Rodriguez-Cruz, Tania G.; Lizee, Greg; McIntyre, Bradley W.			B-Raf Regulation of Integrin alpha 4 beta 1-mediated Resistance to Shear Stress through Changes in Cell Spreading and Cytoskeletal Association in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; KINASE INHIBITOR; BRAF MUTATIONS; ERK PATHWAY; GTPASE RAP1; ADHESION; ACTIVATION; PHOSPHORYLATION; PAXILLIN; AFFINITY	The regulation of integrin-mediated adhesion is of vital importance to adaptive and innate immunity. Integrins are versatile proteins and mediate T cell migration and trafficking by binding to extracellular matrix or other cells as well as initiating intracellular signaling cascades promoting survival or activation. The MAPK pathway is known to be downstream from integrins and to regulate survival, differentiation, and motility. However, secondary roles for canonical MAPK pathway members are being discovered. We show that chemical inhibition of RAF by sorafenib or shRNA-mediated knockdown of B-Raf reduces T cell resistance to shear stress to alpha 4 beta 1 integrin ligands vascular cell adhesion molecule 1 (VCAM-1) and fibronectin, whereas inhibition of MEK/ERK by U0126 had no effect. Microscopy showed that RAF inhibition leads to significant inhibition of T cell spreading on VCAM-1. The association of alpha 4 beta 1 integrin with the actin cytoskeleton was shown to be dependent on B-Raf activity or expression, whereas alpha 4 beta 1 integrin affinity for soluble VCAM-1 was not. These effects were shown to be specific for alpha 4 beta 1 integrin and not other integrins, such as alpha 5 beta 1 or LFA-1, or a variety of membrane proteins. We demonstrate a novel role for B-Raf in the selective regulation of alpha 4 beta 1 integrin-mediated adhesion.	[Brown, Wells S.; McIntyre, Bradley W.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Khalili, Jahan S.; Rodriguez-Cruz, Tania G.; Lizee, Greg] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	McIntyre, BW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	bmcintyr@mdanderson.org		Lizee, Gregory/0000-0003-4449-7461	National Institutes of Health [2-T32-CA-09598, 1S10RR029552-01]; NCI, National Institutes of Health, Cancer Center Support Grant [P30CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health, Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 2-T32-CA-09598 (to W. S. B.), National Institutes of Health High-End Instrumentation Grant 1S10RR029552-01 (to the Immunology Imaging Core facility), and NCI, National Institutes of Health, Cancer Center Support Grant P30CA16672 (to the Flow Cytometry Core Facility at the University of Texas MD Anderson Cancer Center).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; BEDNARCZYK JL, 1994, J BIOL CHEM, V269, P8348; Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Broustas CG, 2002, J BIOL CHEM, V277, P3053, DOI 10.1074/jbc.M106343200; Cabrera R, 2013, CANCER IMMUNOL IMMUN, V62, P737, DOI 10.1007/s00262-012-1380-8; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cao MD, 2011, LAB INVEST, V91, P598, DOI 10.1038/labinvest.2010.205; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; CHAMPE M, 1995, J BIOL CHEM, V270, P1388, DOI 10.1074/jbc.270.3.1388; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Davidsson J, 2008, LEUKEMIA, V22, P1619, DOI 10.1038/leu.2008.14; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; Desar IME, 2011, INT J CANCER, V129, P507, DOI 10.1002/ijc.25674; Deswal S, 2013, J IMMUNOL, V190, P1927, DOI 10.4049/jimmunol.1200653; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dillon TJ, 2003, J BIOL CHEM, V278, P35940, DOI 10.1074/jbc.M301506200; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; EYCHENE A, 1995, ONCOGENE, V10, P1159; GEPPERT TD, 1991, J IMMUNOL, V146, P3298; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Han JW, 2003, J BIOL CHEM, V278, P34845, DOI 10.1074/jbc.M304691200; Hindley A, 2007, CELL SIGNAL, V19, P547, DOI 10.1016/j.cellsig.2006.08.004; Houben R, 2009, MOL CANCER THER, V8, P433, DOI 10.1158/1535-7163.MCT-08-1051; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Hyduk SJ, 2011, J IMMUNOL, V187, P4360, DOI 10.4049/jimmunol.1003725; Ibrahim N, 2012, ONCOL REP, V27, P1303, DOI 10.3892/or.2012.1675; Janosch P, 2000, FASEB J, V14, P2008, DOI 10.1096/fj.99-0883com; Jin A, 2006, ONCOGENE, V25, P4332, DOI 10.1038/sj.onc.1209459; Johnson DB, 2013, CURR TREAT OPTION ON, V14, P280, DOI 10.1007/s11864-013-0226-8; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu L, 2002, J BIOL CHEM, V277, P40893, DOI 10.1074/jbc.M206208200; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Maqueda A, 2006, J CELL PHYSIOL, V207, P746, DOI 10.1002/jcp.20624; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Mielgo A, 2011, NAT MED, V17, P1641, DOI 10.1038/nm.2464; Mitchell JS, 2009, IMMUNOL CELL BIOL, V87, P324, DOI 10.1038/icb.2008.103; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; Miyamoto YJ, 2001, J IMMUNOL, V166, P5129, DOI 10.4049/jimmunol.166.8.5129; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Nakamura K, 2000, J BIOL CHEM, V275, P27155; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Pribic J, 2012, CELL SIGNAL, V24, P1531, DOI 10.1016/j.cellsig.2012.03.015; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Romanova LY, 2004, J CELL SCI, V117, P3759, DOI 10.1242/jcs.01206; Rose DM, 2002, IMMUNOL REV, V186, P118, DOI 10.1034/j.1600-065X.2002.18611.x; Rose DM, 2001, J IMMUNOL, V167, P2824, DOI 10.4049/jimmunol.167.5.2824; Rullo J, 2012, J CELL BIOL, V197, P115, DOI 10.1083/jcb.201107140; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Tsukamoto H, 2004, J BIOL CHEM, V279, P48457, DOI 10.1074/jbc.M403087200; Tsukamoto H, 2008, EUR J IMMUNOL, V38, P518, DOI 10.1002/eji.200737430; Tsukamoto H, 2006, EUR J IMMUNOL, V36, P1926, DOI 10.1002/eji.200535803; Vial E, 2004, ANN NY ACAD SCI, V1030, P208, DOI 10.1196/annals.1329.027; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Woodrow MA, 2003, EXP CELL RES, V287, P325, DOI 10.1016/S0014-4827(03)00122-8; Woodside DG, 2006, J IMMUNOL, V176, P5041, DOI 10.4049/jimmunol.176.8.5041; Wooten DK, 1999, J LEUKOCYTE BIOL, V65, P127, DOI 10.1002/jlb.65.1.127; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zhao W, 2008, LEUKEMIA, V22, P1226, DOI 10.1038/leu.2008.58	79	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23141	23153		10.1074/jbc.M114.562918	http://dx.doi.org/10.1074/jbc.M114.562918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24936068	Green Published, hybrid			2022-12-28	WOS:000341017200051
J	Liu, J; Han, L; Li, B; Yang, J; Huen, MSY; Pan, X; Tsao, SW; Cheung, ALM				Liu, Jia; Han, Liang; Li, Bin; Yang, Jie; Huen, Michael S. Y.; Pan, Xin; Tsao, Sai Wah; Cheung, Annie L. M.			F-Box Only Protein 31 (FBXO31) Negatively Regulates p38 Mitogen-activated Protein Kinase (MAPK) Signaling by Mediating Lysine 48-linked Ubiquitination and Degradation of Mitogen-activated Protein Kinase Kinase 6 (MKK6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL REGULATION; LIGASE; GENE; PHOSPHORYLATION; TRANSDUCTION; EXPRESSION; INDUCTION; PATHWAYS	The p38 MAPK signal transduction pathway plays an important role in inflammatory and stress responses. MAPKK6 (MKK6), a dual specificity protein kinase, is a p38 activator. Activation of the MKK6-p38 pathway is kept in check by multiple layers of regulations, including autoinhibition, dimerization, scaffold proteins, and Lys-63-linked polyubiquitination. However, the mechanisms underlying deactivation of MKK6-p38, which is crucial for maintaining the magnitude and duration of signal transduction, are not well understood. Lys-48-linked ubiquitination, which marks substrates for proteasomal degradation, is an important negative posttranslational regulatory machinery for signal pathway transduction. Here we report that the accumulation of F-box only protein 31 (FBXO31), a component of Skp1.Cul1.F-box protein E3 ligase, negatively regulated p38 activation in cancer cells upon genotoxic stresses. Our results show that FBXO31 binds to MKK6 and mediates its Lys-48-linked polyubiquitination and degradation, thereby functioning as a negative regulator of MKK6-p38 signaling and protecting cells from stress-induced cell apoptosis. Taken together, our findings uncover a new mechanism of deactivation of MKK6-p38 and substantiate a novel regulatory role of FBXO31 in stress response.	[Liu, Jia; Han, Liang; Li, Bin; Yang, Jie; Huen, Michael S. Y.; Tsao, Sai Wah; Cheung, Annie L. M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Pan, Xin] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA	University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cheung, ALM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	lmcheung@hku.hk	; /C-4230-2009	Pan, Xin/0000-0002-1982-2261; /0000-0003-3217-1456				Ahn YH, 2009, J BIOL CHEM, V284, P29399, DOI 10.1074/jbc.M109.044958; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Asthagiri AR, 2001, BIOTECHNOL PROGR, V17, P227, DOI 10.1021/bp010009k; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Hui CM, 2006, INT J CANCER, V119, P508, DOI 10.1002/ijc.21874; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Johnson GL, 2005, CURR OPIN CHEM BIOL, V9, P325, DOI 10.1016/j.cbpa.2005.04.004; Kawamata H, 2003, CANCER SCI, V94, P699, DOI 10.1111/j.1349-7006.2003.tb01505.x; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; Kuo WL, 2004, J BIOL CHEM, V279, P23073, DOI 10.1074/jbc.M313696200; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shiloh Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.296pe73; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	35	36	37	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21508	21518		10.1074/jbc.M114.560342	http://dx.doi.org/10.1074/jbc.M114.560342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936062	Green Published, hybrid			2022-12-28	WOS:000340558300027
J	Ruangprasert, A; Maehigashi, T; Miles, SJ; Giridharan, N; Liu, JX; Dunham, CM				Ruangprasert, Ajchareeya; Maehigashi, Tatsuya; Miles, Stacey J.; Giridharan, Nisha; Liu, Julie X.; Dunham, Christine M.			Mechanisms of Toxin Inhibition and Transcriptional Repression by Escherichia coli DinJ-YafQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ANTITOXIN SYSTEM; YOEB TOXIN; YEFM-YOEB; STRUCTURAL BASIS; 3-GUANYLIC ACID; STRESS-RESPONSE; LON PROTEASE; RELE; RIBONUCLEASE	Bacteria encounter environmental stresses that regulate a gene expression program required for adaptation and survival. Here, we report the 1.8-angstrom crystal structure of the Escherichia coli toxin-antitoxin complex YafQ-(DinJ)(2)-YafQ, a key component of the stress response. The antitoxin DinJ dimer adopts a ribbon-helix-helix motif required for transcriptional autorepression, and toxin YafQ contains a microbial RNase fold whose proposed active site is concealed by DinJ binding. Contrary to previous reports, our studies indicate that equivalent levels of transcriptional repression occur by direct interaction of either YafQ-(DinJ)(2)-YafQ or a DinJ dimer at a single inverted repeat of its recognition sequence that overlaps with the -10 promoter region. Surprisingly, multiple YafQ-(DinJ)(2)-YafQ complexes binding to the operator region do not appear to amplify the extent of repression. Our results suggest an alternative model for transcriptional autorepression that may be novel to DinJ-YafQ.	[Ruangprasert, Ajchareeya; Maehigashi, Tatsuya; Miles, Stacey J.; Giridharan, Nisha; Liu, Julie X.; Dunham, Christine M.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Dunham, CM (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE,Ste G223, Atlanta, GA 30322 USA.	christine.m.dunham@emory.edu			National Institutes of Health from NCRR [RR-15301]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank K. Rajashankar and S. Banerjee at the Northeastern Collaborative Access Team beamline for assistance during data collection and G. L. Conn and M. A. Schureck for helpful discussions throughout the project and critical reading of the manuscript. This work is based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, National Institutes of Health Grant RR-15301 from NCRR, and at the SER-CAT beamline. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Armalyte J, 2012, J BACTERIOL, V194, P1523, DOI 10.1128/JB.06104-11; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Chan WT, 2011, J BACTERIOL, V193, P4612, DOI 10.1128/JB.05187-11; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; DeLano W.L, PYMOL MOL GRAPHICS S; Diago-Navarro E, 2013, PLASMID, V70, P78, DOI 10.1016/j.plasmid.2013.01.010; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2013, PROKARYOTIC TOXIN AN, P69; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Griffin MA, 2013, BIOCHEMISTRY-US, V52, P8633, DOI 10.1021/bi401325c; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Johnson EP, 1996, J BACTERIOL, V178, P1420, DOI 10.1128/jb.178.5.1420-1429.1996; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Lazazzera BA, 2005, CURR OPIN MICROBIOL, V8, P222, DOI 10.1016/j.mib.2005.02.015; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Magnuson R, 1998, J BACTERIOL, V180, P6342; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2013, STRUCTURE, V21, P627, DOI 10.1016/j.str.2013.02.008; Miller J. H, 1972, EXPT MOL GENETICS; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park SJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1155, DOI 10.1016/j.bbapap.2013.02.027; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; ROBERTS RC, 1994, J MOL BIOL, V237, P35, DOI 10.1006/jmbi.1994.1207; Schreiter ER, 2007, NAT REV MICROBIOL, V5, P710, DOI 10.1038/nrmicro1717; Schureck MA, 2014, J BIOL CHEM, V289, P1060, DOI 10.1074/jbc.M113.512095; SEVCIK J, 1991, ACTA CRYSTALLOGR B, V47, P240, DOI 10.1107/S0108768190009569; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shinagawa H, 1996, EXS, V77, P221; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; ZEGERS I, 1994, J BIOL CHEM, V269, P127; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084	67	36	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20559	20569		10.1074/jbc.M114.573006	http://dx.doi.org/10.1074/jbc.M114.573006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898247	hybrid, Green Published			2022-12-28	WOS:000339396600016
J	Shiina, N; Nakayama, K				Shiina, Nobuyuki; Nakayama, Kei			RNA Granule Assembly and Disassembly Modulated by Nuclear Factor Associated with Double-stranded RNA 2 and Nuclear Factor 45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE FORMATION; STRESS GRANULES; MESSENGER-RNA; BINDING PROTEINS; ENDORIBONUCLEASE G3BP; TRANSLATIONAL CONTROL; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; NFAR PROTEINS; NF90	RNA granules are large messenger ribonucleoprotein complexes that regulate translation and mRNA translocation to control the timing and location of protein synthesis. The regulation of RNA granule assembly and disassembly is a structural basis of translational control, and its disorder is implicated in degenerative disease. Here, we used proteomic analysis to identify proteins associated with RNA granule protein 105 (RNG105)/caprin1, an RNA-binding protein in RNA granules. Among the identified proteins, we focused on nuclear factor (NF) 45 and its binding partner, nuclear factor associated with dsRNA 2 (NFAR2), and we demonstrated that NF45 promotes disassembly of RNA granules, whereas NFAR2 enhances the assembly of RNA granules in cultured cells. The GQSY domain of NFAR2 was required to associate with messenger ribonucleoprotein complexes containing RNG105/caprin1, and it was structurally and functionally related to the low complexity sequence domain of the fused in sarcoma protein, which drives the assembly of RNA granules. Another domain of NFAR2, the DZF domain, was dispensable for association with the RNG105 complex, but it was involved in positive and negative regulation of RNA granule assembly by being phosphorylated at double-stranded RNA-activated kinase sites and by association with NF45, respectively. These results suggest a novel molecular mechanism for the modulation of RNA granule assembly and disassembly by NFAR2, NF45, and phosphorylation at double-stranded RNA-activated kinase PKR sites.	[Shiina, Nobuyuki; Nakayama, Kei] Okazaki Inst Integrat Biosci, Lab Neuronal Cell Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki; Nakayama, Kei] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki; Nakayama, Kei] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Shiina, N (corresponding author), Okazaki Inst Integrat Biosci, Lab Neuronal Cell Biol, Nishigonaka 38, Okazaki, Aichi 4448585, Japan.	nshiina@nibb.ac.jp	Nakayama, Kei/C-1182-2009	Shiina, Nobuyuki/0000-0002-1854-4239; Nakayama, Kei/0000-0001-8032-7940	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Uehara Memorial Foundation (to N. S.).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Bentmann E, 2013, FEBS J, V280, P4348, DOI 10.1111/febs.12287; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; El Fatimy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039338; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kotani T, 2013, J CELL BIOL, V202, P1041, DOI 10.1083/jcb.201302139; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Orford RL, 1998, MOL CELL BIOL, V18, P5557, DOI 10.1128/MCB.18.9.5557; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Saunders LR, 2001, GENOMICS, V71, P256, DOI 10.1006/geno.2000.6423; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 1999, MOL BIOL CELL, V10, P597, DOI 10.1091/mbc.10.3.597; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Shiina N, 2010, J BIOL CHEM, V285, P24260, DOI 10.1074/jbc.M110.108944; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wolkowicz UM, 2012, NUCLEIC ACIDS RES, V40, P9356, DOI 10.1093/nar/gks696; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zekri L, 2005, MOL CELL BIOL, V25, P8703, DOI 10.1128/MCB.25.19.8703-8716.2005; Zhang JW, 2011, J CELL SCI, V124, P4087, DOI 10.1242/jcs.090951	61	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21163	21180		10.1074/jbc.M114.556365	http://dx.doi.org/10.1074/jbc.M114.556365			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24920670	hybrid, Green Published			2022-12-28	WOS:000339396600066
J	Tso, SC; Gui, WJ; Wu, CY; Chuang, JL; Qi, XB; Skvorak, KJ; Dorko, K; Wallace, AL; Morlock, LK; Lee, BH; Hutson, SM; Strom, SC; Williams, NS; Tambar, UK; Wynn, RM; Chuang, DT				Tso, Shih-Chia; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Qi, Xiangbing; Skvorak, Kristen J.; Dorko, Kenneth; Wallace, Amy L.; Morlock, Lorraine K.; Lee, Brendan H.; Hutson, Susan M.; Strom, Stephen C.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.			Benzothiophene Carboxylate Derivatives as Novel Allosteric Inhibitors of Branched-chain alpha-Ketoacid Dehydrogenase Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2CM; AMINO-ACID CATABOLISM; INSULIN-RESISTANCE; CLOFIBRIC ACID; OBESE; RAT; MECHANISMS; SURVIVAL; DISEASE; COMPLEX	The mitochondrial branched-chain alpha-ketoacid dehydrogenase complex (BCKDC) is negatively regulated by reversible phosphorylation. BCKDCkinase (BDK) inhibitors that augment BCKDC flux have been shown to reduce branched-chain amino acid (BCAA) concentrations in vivo. In the present study, we employed high-throughput screens to identify compound 3,6-dichlorobenzo[b]thiophene-2-carboxylic acid (BT2) as a novel BDK inhibitor (IC50 = 3.19 mu M). BT2 binds to the same site in BDK as other known allosteric BDK inhibitors, including (S)-alpha-cholorophenylproprionate ((S)-CPP). BT2 binding to BDK triggers helix movements in the N-terminal domain, resulting in the dissociation of BDK from the BCKDC accompanied by accelerated degradation of the released kinase in vivo. BT2 shows excellent pharmacokinetics (terminal T-1/2 = 730 min) and metabolic stability (no degradation in 240 min), which are significantly better than those of (S)-CPP. BT2, its analog 3-chloro-6-fluorobenzo-[b]thiophene-2-carboxylic acid (BT2F), and a prodrug of BT2 (i.e. N-(4-acetamido-1,2,5-oxadiazol-3-yl)-3,6-dichlorobenzo[b]thiophene-2-carboxamide (BT3)) significantly increase residual BCKDC activity in cultured cells and primary hepatocytes from patients and a mouse model of maple syrup urine disease. Administration of BT2 at 20 mg/kg/day to wild-type mice for 1 week leads to nearly complete dephosphorylation and maximal activation of BCKDC in heart, muscle, kidneys, and liver with reduction in plasma BCAA concentrations. The availability of benzothiophene carboxylate derivatives as stable BDK inhibitors may prove useful for the treatment of metabolic disease caused by elevated BCAA concentrations.	[Tso, Shih-Chia; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Qi, Xiangbing; Wallace, Amy L.; Morlock, Lorraine K.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Skvorak, Kristen J.] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA; [Dorko, Kenneth] KU Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan H.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Hutson, Susan M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Strom, Stephen C.] Karolinska Inst, Dept Lab Med, S-14186 Stockholm, Sweden	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kansas; University of Kansas Medical Center; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Virginia Polytechnic Institute & State University; Karolinska Institutet	Wynn, RM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Richard.wynn@utsouthwestern.edu; david.chuang@utsouthwestern.edu	qi, xiangbing/A-4043-2019	qi, xiangbing/0000-0002-7139-5164; Wu, Cheng-Yang/0000-0002-3582-083X; Wynn, Richard/0000-0002-1879-2136	Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092921, R01DK062306, R01DK026758, R56DK062306] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to Drs. Shuquang Wei and Bruce Posner for assistance in the high-throughput screens of BDK inhibitors, Dr. Changguang Wang for conducting measurements of protein binding for BT2 and (S)-CPP, and Dr. Laszlo Kurti for help in the HPLC separation of compounds BT1 and BT2. We are grateful to Dr. Yibin Wang for the generous supply of wild-type and BDP<SUP>-/-</SUP> MEF cells, Crystal structures presented in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, operated under Department of Energy Contract DE-AC02-06CH11357.	AEvarsson A, 1999, NAT STRUCT BIOL, V6, P785; Banerjee T, 2011, IUBMB LIFE, V63, P1101, DOI 10.1002/iub.553; Brunetti-Pierri N, 2011, HUM MOL GENET, V20, P631, DOI 10.1093/hmg/ddq507; Capek P, 2011, ACS CHEM NEUROSCI, V2, P288, DOI 10.1021/cn200021q; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Chuang D. T., 2008, ONLINE METABOLIC MOL, P1; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; Chuang JL, 2002, J BIOL CHEM, V277, P36905, DOI 10.1074/jbc.C200430200; Chuang JL, 2000, METHOD ENZYMOL, V324, P413; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; DAVIE JR, 1995, J BIOL CHEM, V270, P19861, DOI 10.1074/jbc.270.34.19861; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; HARRIS RA, 1994, J NUTR, V124, pS1499, DOI 10.1093/jn/124.suppl_8.1499S; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; HARRIS RA, 1982, J BIOL CHEM, V257, P3915; Homanics GE, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-33; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Iwasa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070309; Kobayashi R, 2002, ARCH BIOCHEM BIOPHYS, V407, P231, DOI 10.1016/S0003-9861(02)00472-1; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Mukakami T, 2005, J NUTR SCI VITAMINOL, V51, P48, DOI 10.3177/jnsv.51.48; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; PAXTON R, 1984, ARCH BIOCHEM BIOPHYS, V231, P48, DOI 10.1016/0003-9861(84)90361-8; PAXTON R, 1984, ARCH BIOCHEM BIOPHYS, V231, P58, DOI 10.1016/0003-9861(84)90362-X; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; Skvorak KJ, 2009, MOL THER, V17, P1266, DOI 10.1038/mt.2009.99; Tso SC, 2013, P NATL ACAD SCI USA, V110, P9728, DOI 10.1073/pnas.1303220110; Wang CG, 2013, J PHARMACEUT BIOMED, V75, P112, DOI 10.1016/j.jpba.2012.11.018; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Wynn RM, 2012, J BIOL CHEM, V287, P9178, DOI 10.1074/jbc.M111.314963; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZHAO Y, 1994, J BIOL CHEM, V269, P18583; Zhou MY, 2012, J BIOL CHEM, V287, P23397, DOI 10.1074/jbc.M112.351031	44	42	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20583	20593		10.1074/jbc.M114.569251	http://dx.doi.org/10.1074/jbc.M114.569251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895126	Green Published, hybrid			2022-12-28	WOS:000339396600018
J	Hashimoto, M; Koen, T; Takahashi, H; Suda, C; Kitamoto, K; Fujii, I				Hashimoto, Makoto; Koen, Tsukasa; Takahashi, Hiroaki; Suda, Chihiro; Kitamoto, Katsuhiko; Fujii, Isao			Aspergillus oryzae CsyB Catalyzes the Condensation of Two beta-Ketoacyl-CoAs to Form 3-Acetyl-4-hydroxy-6-alkyl-alpha-pyrone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III POLYKETIDE SYNTHASE; ACID; BIOSYNTHESIS; SUPERFAMILY; DISCOVERY; STARTER; PATHWAY	The type III polyketide synthases from fungi produce a variety of secondary metabolites including pyrones, resorcinols, and resorcylic acids. We previously reported that CsyB from Aspergillus oryzae forms alpha-pyrone csypyrone B compounds when expressed in A. oryzae. Feeding experiments of labeled acetates indicated that a fatty acyl starter is involved in the reaction catalyzed by CsyB. Here we report the in vivo and in vitro reconstitution analysis of CsyB. When CsyB was expressed in Escherichia coli, we observed the production of 3-acetyl-4-hydroxy-alpha-pyrones with saturated or unsaturated straight aliphatic chains of C-9-C-17 in length at the 6 position. Subsequent in vitro analysis using recombinant CsyB revealed that CsyB could accept butyryl-CoA as a starter substrate and malonyl-CoA and acetoacetyl-CoA as extender substrates to form 3-acetyl-4-hydroxy-6-propyl-alpha-pyrone. CsyB also afforded dehydroacetic acid from two molecules of acetoacetyl-CoA. Furthermore, synthetic N-acetylcysteamine thioester of beta-ketohexanoic acid was converted to 3-butanoyl-4-hydroxy-6-propyl-alpha-pyrone by CsyB. These results therefore confirmed that CsyB catalyzed the synthesis of beta-ketoacyl-CoA from the reaction of the starter fatty acyl CoA thioesters with malonyl-CoA as the extender through decarboxylative condensation and further coupling with acetoacetyl-CoA to form 3-acetyl-4-hydroxy-6-alkyl-alpha-pyrone. CsyB is the first type III polyketide synthase that synthesizes3-acetyl-4-hydroxy-6-alkyl-alpha-pyrone by catalyzed the coupling of two beta-ketoacyl-CoAs.	[Hashimoto, Makoto; Koen, Tsukasa; Takahashi, Hiroaki; Suda, Chihiro; Fujii, Isao] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan; [Kitamoto, Katsuhiko] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Iwate Medical University; University of Tokyo	Fujii, I (corresponding author), Iwate Med Univ, Sch Pharm, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	ifujii@iwate-med.ac.jp	橋元, 誠/GVU-4362-2022	橋元, 誠/0000-0002-8716-4985	Ministry of Education, Culture, Sports, Science and Technology, Japan; Keiryokai Research Foundation, Japan; Grants-in-Aid for Scientific Research [25108722] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keiryokai Research Foundation, Japan(Keiryokai Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and grant from Keiryokai Research Foundation, Japan.	Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Erol O, 2010, CHEMBIOCHEM, V11, P1253, DOI 10.1002/cbic.201000085; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Funa N, 2002, J BIOL CHEM, V277, P4628, DOI 10.1074/jbc.M110357200; Funa N, 2007, J BIOL CHEM, V282, P14476, DOI 10.1074/jbc.M701239200; GILBERT IH, 1995, BIOORG MED CHEM LETT, V5, P1587, DOI 10.1016/0960-894X(95)00276-Y; Hashimoto M, 2013, BIOORG MED CHEM LETT, V23, P5637, DOI 10.1016/j.bmcl.2013.08.036; Hashimoto M, 2013, BIOORG MED CHEM LETT, V23, P650, DOI 10.1016/j.bmcl.2012.11.119; Jeong JC, 2005, J AM CHEM SOC, V127, P64, DOI 10.1021/ja0441559; Jeya M, 2012, MOL BIOSYST, V8, P2864, DOI 10.1039/c2mb25282a; KANESHIRO T, 1961, J BIOL CHEM, V236, P2615; Katsuyama Y, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P147; Li J, 2011, BIOORG MED CHEM LETT, V21, P6085, DOI 10.1016/j.bmcl.2011.08.058; MARR AG, 1962, J BACTERIOL, V84, P1260, DOI 10.1128/JB.84.6.1260-1267.1962; Morita H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P171; OIKAWA Y, 1978, J ORG CHEM, V43, P2087, DOI 10.1021/jo00404a066; Piasecki SK, 2011, CHEM BIOL, V18, P1331, DOI 10.1016/j.chembiol.2011.07.021; Ramkumar K, 2008, BIOORGAN MED CHEM, V16, P8988, DOI 10.1016/j.bmc.2008.08.067; Seshime Y, 2005, BIOCHEM BIOPH RES CO, V331, P253, DOI 10.1016/j.bbrc.2005.03.160; Seshime Y, 2010, BIOORGAN MED CHEM, V18, P4542, DOI 10.1016/j.bmc.2010.04.058; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Sucipto H, 2013, CHEMBIOCHEM, V14, P1581, DOI 10.1002/cbic.201300289; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Yu DY, 2010, ENZYME MICROB TECH, V46, P575, DOI 10.1016/j.enzmictec.2010.02.011	26	16	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19976	19984		10.1074/jbc.M114.569095	http://dx.doi.org/10.1074/jbc.M114.569095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895122	hybrid, Green Published			2022-12-28	WOS:000339395200014
J	Boyer, A; Dumans, A; Beaumont, E; Etienne, L; Roingeard, P; Meunier, JC				Boyer, Audrey; Dumans, Amelie; Beaumont, Elodie; Etienne, Loic; Roingeard, Philippe; Meunier, Jean-Christophe			The Association of Hepatitis C Virus Glycoproteins with Apolipoproteins E and B Early in Assembly Is Conserved in Lipoviral Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY; CULTURE; DETERMINANTS; LOCALIZATION; SECRETION; INTERACTS; CELLS; GENE	In patients chronically infected with hepatitis C virus and in the HCV cell culture system (HCVcc), it is known that highly infectious virus particles have low to very low buoyant densities. These low densities have been attributed to the association of HCV with lipoprotein components, which occur during the viral morphogenesis. The resulting hybrid particles are known as lipoviral particles (LVP); however, very little is known about how these particles are created. In our study, we used Huh7.5 cells to investigate the intracellular association between envelope proteins and apolipoproteins B and E (ApoB and ApoE, respectively). In particular, we were interested in the role of this association in initiating LVP morphogenesis. Co-immunoprecipitation assays revealed that ApoB, ApoE, and HCV glycoproteins formed a protein complex early in the HCV lifecycle. Confocal analyses of naive, E1E2-transduced and HCVcc-infected cells showed that HCV glycoproteins, ApoB and ApoE were found strongly colocalized only in the endoplasmic reticulum. We also found that HCV glycoproteins, ApoB and ApoE were already associated with intracellular infectious viral particles and, furthermore, that the protein complex was conserved in the infectious viral particles present in the supernatant of infected Huh7.5 cells. The association of HCV glycoproteins with ApoE was also evidenced in the HCVpp system, using the non-hepatic HEK293T cell line. We suggest that the complex formed by HCV E1E2, ApoB, and ApoE may initiate lipoviral particle morphogenesis.	Univ Tours, INSERM, U966, F-37032 Tours, France; CHRU Tours, F-37032 Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Meunier, JC (corresponding author), Univ Tours, INSERM, U966, Morphogenese & Antigenicite VIH & Virus Hepatites, 10 Bvd Tonnelle BP3223, F-37032 Tours 1, France.	Jean.meunier@univ-tours.fr			"APOVIR" grant from Region Centre; INSERM-Region Centre; Cluster Infectiologie (Region Centre)	"APOVIR" grant from Region Centre(Region Centre-Val de Loire); INSERM-Region Centre(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Centre-Val de Loire); Cluster Infectiologie (Region Centre)(Region Centre-Val de Loire)	This work was supported by the "APOVIR" grant from Region Centre.; Supported by a PhD fellowship from INSERM-Region Centre.; Supported by a fellowship from the Cluster Infectiologie (Region Centre).	Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Chang K. S., 2007, J VIROL; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Mazumdar B, 2011, HEPATOLOGY, V54, P1149, DOI 10.1002/hep.24523; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pecheur EI, 2010, J BIOL CHEM, V285, P25802, DOI 10.1074/jbc.M110.131664; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Prince AM, 1996, J VIRAL HEPATITIS, V3, P11, DOI 10.1111/j.1365-2893.1996.tb00075.x; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; SMITH JD, 1988, J BIOL CHEM, V263, P8300; Steinmann E, 2013, J VIROL, V87, P13297, DOI 10.1128/JVI.01708-13; Suzuki T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00038; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang XY, 2000, ARTERIOSCL THROM VAS, V20, P1301, DOI 10.1161/01.ATV.20.5.1301	37	67	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18904	18913		10.1074/jbc.M113.538256	http://dx.doi.org/10.1074/jbc.M113.538256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24838241	Green Published, hybrid			2022-12-28	WOS:000339062900024
J	Chan, NC; den Besten, W; Sweredoski, MJ; Hess, S; Deshaies, RJ; Chan, DC				Chan, Nickie C.; den Besten, Willem; Sweredoski, Michael J.; Hess, Sonja; Deshaies, Raymond J.; Chan, David C.			Degradation of the Deubiquitinating Enzyme USP33 Is Mediated by p97 and the Ubiquitin Ligase HERC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA-ATPASE; PROTEASOME SYSTEM; LARGE PROTEIN; CDC48; VCP/P97; COMPLEX; IDENTIFICATION; DEFICIENT; SUBUNIT; BINDING	Because the deubiquitinating enzyme USP33 is involved in several important cellular processes (beta-adrenergic receptor recycling, centrosome amplification, RalB signaling, and cancer cell migration), its levels must be carefully regulated. Using quantitative mass spectrometry, we found that the intracellular level of USP33 is highly sensitive to the activity of p97. Knockdown or chemical inhibition of p97 causes robust accumulation of USP33 due to inhibition of its degradation. The p97 adaptor complex involved in this function is the Ufd1-Npl4 heterodimer. Furthermore, we identified HERC2, a HECT domain-containing E3 ligase, as being responsible for polyubiquitination of USP33. Inhibition of p97 causes accumulation of polyubiquitinated USP33, suggesting that p97 is required for postubiquitination processing. Thus, our study has identified several key molecules that control USP33 degradation within the ubiquitin-proteasome system.	[Chan, Nickie C.; den Besten, Willem; Sweredoski, Michael J.; Hess, Sonja; Deshaies, Raymond J.; Chan, David C.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Chan, Nickie C.; Deshaies, Raymond J.; Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Hess, Sonja] CALTECH, Proteome Explorat Lab, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Chan, DC (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd,MC114-96, Pasadena, CA 91125 USA.	dchan@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Tomohiko Ohta for HERC2 constructs that helped us reconstruct full-length HERC2; William G. Kaelin Jr. for the 786-O and RCC4 cell lines; Tsui-Fen Chou (Harbor-UCLA Medical Center) for helpful discussions and reagents during the early stage of this work; Robert Graham (currently at University of Manchester) from the Proteosome Exploration Laboratory (PEL) for technical help with the mass spectrometry experiments; and Michael Walters and Lev G. Lis (University of Minnesota) for NMS-873. The PEL is supported by the Gordon and Betty Moore Foundation through Grant GBMF775 and the Beckman Institute.	Al-Hakim AK, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014233; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Baek G.H., 2013, J AMINO ACIDS, V2013, DOI DOI 10.1155/2013/183421; Barbin L, 2010, BIOCHEM BIOPH RES CO, V394, P335, DOI 10.1016/j.bbrc.2010.03.005; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Garcia-Gonzalo FR, 2005, CELL MOL LIFE SCI, V62, P1826, DOI 10.1007/s00018-005-5119-y; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Harlalka GV, 2013, J MED GENET, V50, P65, DOI 10.1136/jmedgenet-2012-101367; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Kalli A, 2013, J PROTEOME RES, V12, P3071, DOI 10.1021/pr3011588; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Polucci P, 2013, J MED CHEM, V56, P437, DOI 10.1021/jm3013213; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Simicek M, 2013, NAT CELL BIOL, V15, P1220, DOI 10.1038/ncb2847; Soetandyo N, 2010, J BIOL CHEM, V285, P32352, DOI 10.1074/jbc.M110.131649; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Thorne C, 2011, TRAFFIC, V12, P1563, DOI 10.1111/j.1600-0854.2011.01261.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yuasa-Kawada J, 2009, NAT NEUROSCI, V12, P1087, DOI 10.1038/nn.2382; Yuasa-Kawada J, 2009, P NATL ACAD SCI USA, V106, P14530, DOI 10.1073/pnas.0801262106; Zhang ZR, 2013, CELL, V154, P609, DOI 10.1016/j.cell.2013.06.038	54	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19789	19798		10.1074/jbc.M114.569392	http://dx.doi.org/10.1074/jbc.M114.569392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855649	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000339326800050
J	Dong, NZ; Zhou, TT; Zhang, Y; Liu, M; Li, H; Huang, XY; Liu, ZZ; Wu, Y; Fukuda, K; Qin, J; Wu, QY				Dong, Ningzheng; Zhou, Tiantian; Zhang, Yue; Liu, Meng; Li, Hui; Huang, Xiaoyi; Liu, Zhenzhen; Wu, Yi; Fukuda, Koichi; Qin, Jun; Wu, Qingyu			Corin Mutations K317E and S472G from Preeclamptic Patients Alert Zymogen Activation and Cell Surface Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; SERINE-PROTEASE CORIN; PLASMA SOLUBLE CORIN; FAMILIAL HYPERCHOLESTEROLEMIA; TROPHOBLAST INVASION; RECEPTOR GENE; VARIANT; HYPERTENSION; EXPRESSION; HEART	Corin is a membrane-bound serine protease that acts as the atrial natriuretic peptide (ANP) convertase in the heart. Recent studies show that corin also activates ANP in the pregnant uterus to promote spiral artery remodeling and prevent pregnancy-induced hypertension. Two CORIN gene mutations, K317E and S472G, were identified in preeclamptic patients and shown to have reduced activity in vitro. In this study, we carried out molecular modeling and biochemical experiments to understand how these mutations impair corin function. By molecular modeling, the mutation K317E was predicted to alter corin LDL receptor-2 module conformation. Western blot analysis of K317E mutant in HEK293 cells showed that the mutation did not block corin expression on the cell surface but inhibited corin zymogen activation. In contrast, the mutation S472G was predicted to abolish a beta-sheet critical for corin frizzled-2 module structure. In Western blot analysis and flow cytometry, S472G mutant was not detected on the cell surface in transfected HEK293cells. By immunostaining, the S472G mutant was found in the ER, indicating that the mutation S472G disrupted the beta-sheet, causing corin misfolding and ER retention. Thus, these results show that mutations in the CORIN gene may impair corin function by entirely different mechanisms. Together, our data provide important insights into the molecular basis underlying corin mutations that may contribute to preeclampsia in patients.	[Dong, Ningzheng; Zhou, Tiantian; Zhang, Yue; Liu, Meng; Li, Hui; Liu, Zhenzhen; Wu, Yi; Wu, Qingyu] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Dong, Ningzheng; Zhou, Tiantian; Zhang, Yue; Liu, Meng; Li, Hui; Liu, Zhenzhen; Wu, Yi; Wu, Qingyu] Soochow Univ, MOE Engn Ctr Hematol Dis, Suzhou 215123, Peoples R China; [Dong, Ningzheng] Soochow Univ, MOH Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou 215123, Peoples R China; [Dong, Ningzheng; Wu, Yi; Wu, Qingyu] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou 215123, Peoples R China; [Huang, Xiaoyi] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China; [Fukuda, Koichi; Qin, Jun; Wu, Qingyu] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Shanghai Jiao Tong University; Cleveland Clinic Foundation	Wu, QY (corresponding author), Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org		Wu, Qingyu/0000-0003-0561-9315; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [HL089298, HD064634]; National Natural Science Foundation of China [81170247, 81370718, 31161130356]; Chinese Ministry of Education [213016A]; Danish-Chinese Center for Proteases and Cancer; Priority Academic Program Development of Jiangsu Higher Education Institutions; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Danish-Chinese Center for Proteases and Cancer; Priority Academic Program Development of Jiangsu Higher Education Institutions; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by grants from the National Institutes of Health (HL089298 and HD064634) and grants from the National Natural Science Foundation of China (81170247, 81370718, and 31161130356), the Key Project of Chinese Ministry of Education (213016A), the Danish-Chinese Center for Proteases and Cancer, and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Barbato E, 2012, J AM COLL CARDIOL, V59, P1763, DOI 10.1016/j.jacc.2012.02.017; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Cannone V, 2013, HYPERTENSION, V62, P860, DOI 10.1161/HYPERTENSIONAHA.113.01344; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cootauco AC, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.019; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dechend R, 2008, NAT MED, V14, P1187, DOI 10.1038/nm1108-1187; Dong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033263; Dong NZ, 2013, J BIOL CHEM, V288, P7867, DOI 10.1074/jbc.M112.411512; Dong NZ, 2012, CLIN CHIM ACTA, V413, P378, DOI 10.1016/j.cca.2011.10.032; Dong NZ, 2010, CLIN CHIM ACTA, V411, P1998, DOI 10.1016/j.cca.2010.08.021; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; GILILLAND JL, 1992, J CLIN ENDOCR METAB, V75, P547, DOI 10.1210/jc.75.2.547; Gladysheva IP, 2008, BIOCHEM BIOPH RES CO, V373, P130, DOI 10.1016/j.bbrc.2008.05.181; Hatta K, 2011, REPROD SCI, V18, P383, DOI 10.1177/1933719110385136; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hooper JD, 2000, EUR J BIOCHEM, V267, P6931, DOI 10.1046/j.1432-1327.2000.01806.x; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; Ichiki T, 2011, CLIN CHEM, V57, P40, DOI 10.1373/clinchem.2010.153908; ITOH H, 1994, BIOCHEM BIOPH RES CO, V203, P602, DOI 10.1006/bbrc.1994.2225; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Kaitu'u-Lino TJ, 2013, HUM REPROD, V28, P1172, DOI 10.1093/humrep/det028; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Lynch AI, 2009, CURR HYPERTENS REP, V11, P35, DOI 10.1007/s11906-009-0008-7; Nakayama T, 2000, CIRC RES, V86, P841, DOI 10.1161/01.RES.86.8.841; Parikh SM, 2008, NAT MED, V14, P810, DOI 10.1038/nm0808-810; Peleg A, 2013, EUR HEART J-ACUTE CA, V2, P159, DOI 10.1177/2048872613483588; Peleg A, 2009, CLIN CHIM ACTA, V409, P85, DOI 10.1016/j.cca.2009.09.004; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reis AM, 1997, J ENDOCRINOL, V153, P345, DOI 10.1677/joe.0.1530345; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sciarretta S, 2013, CIRC RES, V112, P1355, DOI 10.1161/CIRCRESAHA.113.301325; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu F, 2002, J BIOL CHEM, V277, P16900, DOI 10.1074/jbc.M201503200; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Zhou Y, 2013, PLACENTA, V34, P89, DOI 10.1016/j.placenta.2012.11.016	51	38	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17909	17916		10.1074/jbc.M114.551424	http://dx.doi.org/10.1074/jbc.M114.551424			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24828501	Green Published, hybrid			2022-12-28	WOS:000338018100051
J	Spencer, B; Verma, I; Desplats, P; Morvinski, D; Rockenstein, E; Adame, A; Masliah, E				Spencer, Brian; Verma, Inder; Desplats, Paula; Morvinski, Dinorah; Rockenstein, Ed; Adame, Anthony; Masliah, Eliezer			A Neuroprotective Brain-penetrating Endopeptidase Fusion Protein Ameliorates Alzheimer Disease Pathology and Restores Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; DENSITY-LIPOPROTEIN RECEPTOR; NEPRILYSIN GENE-TRANSFER; APP TRANSGENIC MICE; A-BETA; MOUSE MODEL; HIPPOCAMPAL NEUROGENESIS; NEUTRAL ENDOPEPTIDASE; PLAQUE-FORMATION; PREMATURE DEATH	Alzheimer disease (AD) is characterized by widespread neurodegeneration throughout the association cortex and limbic system, deposition of amyloid-beta peptide (A beta) in the neuropil and around the blood vessels, and formation of neurofibrillary tangles. The endopeptidase neprilysin has been successfully used to reduce the accumulation of A beta following intracranial viral vector delivery or ex vivo manipulated intracranial delivery. These therapies have relied on direct injections into the brain, whereas a clinically desirable therapy would involve i.v. infusion of a recombinant enzyme. We previously characterized a recombinant neprilysin that contained a 38-amino acid brain-targeting domain. Recombinant cell lines have been generated expressing this brain-targeted enzyme (ASN12). In this report, we characterize the ASN12 recombinant protein for pharmacology in a mouse as well as efficacy in two APPtg mouse models of AD. The recombinant ASN12 transited to the brain with a t(1/2) of 24 h and accumulated to 1.7% of injected dose at 24 h following i.v. delivery. We examined pharmacodynamics in the tg2576 APPtg mouse with the prion promoter APP695 SWE mutation and in the Line41 mThy1 APP751 mutation mouse. Treatment of either APPtg mouse resulted in reduced A beta, increased neuronal synapses, and improved learning and memory. In addition, the Line41 APPtg mice showed increased levels of C-terminal neuropeptide Y fragments and increased neurogenesis. These results suggest that the recombinant brain-targeted neprilysin, ASN12, may be an effective treatment for AD and warrant further investigation in clinical trials.	[Spencer, Brian] NeuroTransit Inc, San Diego, CA 92121 USA; [Verma, Inder; Morvinski, Dinorah] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Desplats, Paula; Rockenstein, Ed; Adame, Anthony; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, San Diego, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Spencer, B (corresponding author), NeuroTransit Inc, San Diego, CA 92121 USA.	spencer@neurotransit.com	Desplats, Paula/AFW-5030-2022	Lipton, Stuart/0000-0002-3490-1259; Desplats, Paula/0000-0002-4758-4280	National Institutes of Health [AG5131, AG022074, AG188440, AG010435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, P50AG005131, P01AG010435, R37AG018440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG5131, AG022074, AG188440, and AG010435. B. S. was the principal investigator at NeuroTransit, Inc., during the course of these studies. The pharmacokinetics and the pharmacodynamics in the APPtg2576 line were completed at NeuroTransit.	Arvanitis DN, 2007, J NEUROCHEM, V103, P216, DOI 10.1111/j.1471-4159.2007.04704.x; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Cuello AC, 2008, NEURODEGENER DIS, V5, P146, DOI 10.1159/000113686; Cuello AC, 2005, BRAIN PATHOL, V15, P66; Decressac M, 2011, HIPPOCAMPUS, V21, P233, DOI 10.1002/hipo.20765; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Fan QW, 2001, J AM AGING ASSOC, V24, P1, DOI 10.1007/s11357-001-0001-9; Fukami S, 2002, NEUROSCI RES, V43, P39, DOI 10.1016/S0168-0102(02)00015-9; Gerenu G, 2013, BBA-MOL BASIS DIS, V1832, P837, DOI 10.1016/j.bbadis.2013.02.018; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Guan H, 2009, J NEUROSCI RES, V87, P1462, DOI 10.1002/jnr.21944; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hong CS, 2006, GENE THER, V13, P1068, DOI 10.1038/sj.gt.3302719; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Li CW, 1996, ANN NY ACAD SCI, V780, P145, DOI 10.1111/j.1749-6632.1996.tb15118.x; Liu YX, 2007, PEPTIDES, V28, P2348, DOI 10.1016/j.peptides.2007.09.015; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Mandler M, 2012, J ALZHEIMERS DIS, V28, P783, DOI 10.3233/JAD-2011-111208; Marr RA, 2010, CURR ALZHEIMER RES, V7, P223, DOI 10.2174/156720510791050849; Marr RA, 2003, J NEUROSCI, V23, P1992; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Misra S, 2013, NEUROL SCI, V34, P831, DOI 10.1007/s10072-013-1316-x; Mordenti J, 1996, TOXICOL APPL PHARM, V136, P75, DOI 10.1006/taap.1996.0008; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; Redrobe JP, 2004, J MOL NEUROSCI, V22, P159, DOI 10.1385/JMN:22:3:159; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rose JB, 2009, J NEUROSCI, V29, P1115, DOI 10.1523/JNEUROSCI.4220-08.2009; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Scotti E, 2013, MOL CELL BIOL, V33, P1503, DOI 10.1128/MCB.01716-12; Skidgel RA, 2004, PEPTIDES, V25, P521, DOI 10.1016/j.peptides.2003.12.010; Spencer B. J., 2007, P NATL ACAD SCI US; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; SRIVASTAVA RAK, 1995, J LIPID RES, V36, P1434; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Terry Robert D., 1994, P179; Walker JR, 2013, J NEUROSCI, V33, P2457, DOI 10.1523/JNEUROSCI.3407-12.2013; Zhou QH, 2012, DRUG METAB DISPOS, V40, P329, DOI 10.1124/dmd.111.042903	64	30	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17917	17931		10.1074/jbc.M114.557439	http://dx.doi.org/10.1074/jbc.M114.557439			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24825898	hybrid, Green Published			2022-12-28	WOS:000338018100052
J	Zou, MR; Cao, J; Liu, ZZ; Huh, SJ; Polyak, K; Yan, Q				Zou, Mike Ran; Cao, Jian; Liu, Zongzhi; Huh, Sung Jin; Polyak, Kornelia; Yan, Qin			Histone Demethylase Jumonji AT-rich Interactive Domain 1B (JARID1B) Controls Mammary Gland Development by Regulating Key Developmental and Lineage Specification Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; REPRESSOR PLU-1/JARID1B; DUCTAL MORPHOGENESIS; H3K4 METHYLATION; SELF-RENEWAL; BINDING; FOXA1; TRANSCRIPTION; DIFFERENTIATION; PROLIFERATION	The JmjC domain-containing H3K4 histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) (also known as KDM5B and PLU1) is overexpressed in breast cancer and is a potential target for breast cancer treatment. To investigate the in vivo function of JARID1B, we developed Jarid1b(-/-) mice and characterized their phenotypes in detail. Unlike previously reported Jarid1b(-/-) strains, the majority of these Jarid1b(-/-) mice were viable beyond embryonic and neonatal stages. This allowed us to further examine phenotypes associated with the loss of JARID1B in pubertal development and pregnancy. These Jarid1b(-/-) mice exhibited decreased body weight, premature mortality, decreased female fertility, and delayed mammary gland development. Related to these phenotypes, JARID1B loss decreased serum estrogen level and reduced mammary epithelial cell proliferation in early puberty. In mammary epithelial cells, JARID1B loss diminished the expression of key regulators for mammary morphogenesis and luminal lineage specification, including FOXA1 and estrogen receptor alpha. Mechanistically, JARID1B was required for GATA3 recruitment to the Foxa1 promoter to activate Foxa1 expression. These results indicate that JARID1B positively regulates mammary ductal development through both extrinsic and cell-autonomous mechanisms.	[Zou, Mike Ran; Cao, Jian; Liu, Zongzhi; Yan, Qin] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Huh, Sung Jin; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02215 USA; [Huh, Sung Jin; Polyak, Kornelia] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Polyak, Kornelia] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Yale University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Yan, Q (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St,BML 348C,POB 208023, New Haven, CT 06520 USA.	qin.yan@yale.edu	Yan, Qin/E-8893-2012; Cao, Jian/K-2440-2014	Yan, Qin/0000-0003-4077-453X; Cao, Jian/0000-0003-3424-6802	Alexander and Margaret Stewart Trust fellowship; Breast Cancer Alliance young investigator grant; Melanoma Research Foundation career development award; United States Department of Defense Peer-reviewed Cancer Research Program Career Development Award [W81XWH-13-1-0235]; American Cancer Society Research Scholar Grant [RSG-13-384-01-DMC]; National Institutes of Health from the NCI [R01 CA076120, P01 CA080111]; NCI fellowship [F32 CA156991]; NATIONAL CANCER INSTITUTE [P01CA080111, R01CA076120, F32CA156991] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	Alexander and Margaret Stewart Trust fellowship; Breast Cancer Alliance young investigator grant; Melanoma Research Foundation career development award; United States Department of Defense Peer-reviewed Cancer Research Program Career Development Award; American Cancer Society Research Scholar Grant(American Cancer Society); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by an Alexander and Margaret Stewart Trust fellowship (to Q. Y.), a Breast Cancer Alliance young investigator grant (to Q. Y.), a Melanoma Research Foundation career development award (to Q. Y.), United States Department of Defense Peer-reviewed Cancer Research Program Career Development Award W81XWH-13-1-0235 (to Q. Y.), and American Cancer Society Research Scholar Grant RSG-13-384-01-DMC (to Q. Y.). This work was also supported in part by National Institutes of Health Grants R01 CA076120 (to W. G. K.) and P01 CA080111 (to K. P.) from the NCI and F32 CA156991, an NCI fellowship (to S. J. H.).	Albert M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003461; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Blair LP, 2012, DNA CELL BIOL, V31, pS49, DOI 10.1089/dna.2012.1654; Blair Lauren P, 2011, Cancers (Basel), V3, P1383, DOI 10.3390/cancers3011383; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Cao J, 2014, CELL REP, V6, P868, DOI 10.1016/j.celrep.2014.02.004; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; Islam ABMMK, 2011, CELL CYCLE, V10, P413, DOI 10.4161/cc.10.3.14705; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jackson-Fisher AJ, 2004, P NATL ACAD SCI USA, V101, P17138, DOI 10.1073/pnas.0407057101; Kidder BL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r32; Klein BJ, 2014, CELL REP, V6, P325, DOI 10.1016/j.celrep.2013.12.021; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Madsen Bente, 2002, Gene Expression Patterns, V2, P275, DOI 10.1016/S1567-133X(02)00051-0; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Outchkourov NS, 2013, CELL REP, V3, P1071, DOI 10.1016/j.celrep.2013.02.030; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sayegh J, 2013, J BIOL CHEM, V288, P9408, DOI 10.1074/jbc.M112.419861; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wiesen JF, 1999, DEVELOPMENT, V126, P335; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91; Yamaguchi N, 2008, BIOCHEM BIOPH RES CO, V365, P711, DOI 10.1016/j.bbrc.2007.11.064; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	49	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17620	17633		10.1074/jbc.M114.570853	http://dx.doi.org/10.1074/jbc.M114.570853			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24802759	hybrid, Green Published			2022-12-28	WOS:000338018100027
J	Rice, LM; Donigan, M; Yang, MH; Liu, WD; Pandya, D; Joseph, BK; Sodi, V; Gearhart, TL; Yip, J; Bouchard, M; Nickels, JT				Rice, Lyndi M.; Donigan, Melissa; Yang, Muhua; Liu, Weidong; Pandya, Devanshi; Joseph, Biny K.; Sodi, Valerie; Gearhart, Tricia L.; Yip, Jenny; Bouchard, Michael; Nickels, Joseph T., Jr.			Protein Phosphatase 2A (PP2A) Regulates Low Density Lipoprotein Uptake through Regulating Sterol Response Element-binding Protein-2 (SREBP-2) DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC KIDNEY-DISEASE; TRANSCRIPTION FACTORS; STATIN THERAPY; FATTY-ACID; RECEPTOR PROMOTER; CATALYTIC SUBUNIT; CHOLESTEROL; INHIBITION; EXPRESSION; PHOSPHORYLATION	LDL-cholesterol (LDL-C) uptake by Ldlr is regulated at the transcriptional level by the cleavage-dependent activation of membrane-associated sterol response element-binding protein (SREBP-2). Activated SREBP-2 translocates to the nucleus, where it binds to an LDLR promoter sterol response element (SRE), increasing LDLR gene expression and LDL-C uptake. SREBP-2 cleavage and translocation steps are well established. Several SREBP-2 phosphorylation sites have been mapped and functionally characterized. The phosphatases dephosphorylating these sites remain elusive. The phosphatase(s) regulating SREBP-2 represents a novel pharmacological target for treating hypercholesterolemia. Here we show that protein phosphatase 2A (PP2A) promotes SREBP-2 LDLR promoter binding in response to cholesterol depletion. No binding to an LDLR SRE was observed in the presence of the HMG-CoA reductase inhibitor, lovastatin, when PP2A activity was inhibited by okadaic acid or depleted by siRNA methods. SREBP-2 cleavage and nuclear translocation were not affected by loss of PP2A. PP2A activity was required for SREBP-2 DNA binding. In response to cholesterol depletion, PP2A directly interacted with SREBP-2 and altered its phosphorylation state, causing an increase in SREBP-2 binding to an LDLR SRE site. Increased binding resulted in induced LDLR gene expression and increased LDL uptake. We conclude that PP2A activity regulates cholesterol homeostasis and LDL-C uptake.	[Rice, Lyndi M.; Sodi, Valerie] Genesis Biotechnol Grp, Oncoveda Canc Inst, Hamilton, NJ 08691 USA; [Donigan, Melissa; Yang, Muhua; Liu, Weidong; Pandya, Devanshi; Joseph, Biny K.; Yip, Jenny; Nickels, Joseph T., Jr.] Genesis Biotechnol Grp, Inst Metab Disorders, Hamilton, NJ 08691 USA; [Gearhart, Tricia L.; Bouchard, Michael] Drexel Univ, Coll Med, Dept Mol Biol & Biochem, Philadelphia, PA 19129 USA	Drexel University	Nickels, JT (corresponding author), Inst Metab Disorders LLC, Genesis Biotechnol Grp, 1000 Waterview Dr, Hamilton, NJ 08691 USA.	jnickels@venenumbiodesign.com			Genesis Biotechnology Group; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER	Genesis Biotechnology Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Genesis Biotechnology Group.	Ahmed MH, 2009, DIABETES OBES METAB, V11, P188, DOI 10.1111/j.1463-1326.2008.00926.x; Bengoechea-Alonso MT, 2006, CELL CYCLE, V5, P1708, DOI 10.4161/cc.5.15.3131; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; Breitling R, 2007, BIOESSAYS, V29, P1085, DOI 10.1002/bies.20663; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chroinin DN, 2013, STROKE, V44, P448, DOI 10.1161/STROKEAHA.112.668277; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Colbert JD, 2012, CAN J CARDIOL, V28, P581, DOI 10.1016/j.cjca.2012.03.021; Datta S, 2005, J BIOL CHEM, V280, P3338, DOI 10.1074/jbc.M411222200; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; Elson EL, 2010, ANNU REV BIOPHYS, V39, P207, DOI 10.1146/annurev.biophys.093008.131238; Frey T, 2007, MOL MED, V13, P592, DOI 10.2119/2007-00054.Frey; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hernandez ML, 1997, BBA-LIPID LIPID MET, V1349, P233, DOI 10.1016/S0005-2760(97)00141-0; HOLEN I, 1993, EUR J BIOCHEM, V215, P113, DOI 10.1111/j.1432-1033.1993.tb18013.x; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Illingworth R, 2000, MED CLIN N AM, V84, P23, DOI 10.1016/S0025-7125(05)70205-4; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jefcoate CR, 2011, MOL CELL ENDOCRINOL, V336, P53, DOI 10.1016/j.mce.2010.12.006; Jones PM, 2000, J MOL ENDOCRINOL, V24, P233, DOI 10.1677/jme.0.0240233; Jukema JW, 2012, J AM COLL CARDIOL, V60, P875, DOI 10.1016/j.jacc.2012.07.007; Katz SD, 2008, CURR ATHEROSCLER REP, V10, P318, DOI 10.1007/s11883-008-0049-4; Khoo Michael C K, 2013, IEEE Rev Biomed Eng, V6, P143, DOI 10.1109/RBME.2012.2232651; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Kotzka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032609; Kotzka J, 2010, ATHEROSCLEROSIS, V213, P156, DOI 10.1016/j.atherosclerosis.2010.08.046; Kurachi S, 2009, P NATL ACAD SCI USA, V106, P7921, DOI 10.1073/pnas.0902191106; LEE J, 1993, J BIOL CHEM, V268, P19192; Li C, 1999, J BIOL CHEM, V274, P6747, DOI 10.1074/jbc.274.10.6747; Li YK, 2008, J VIROL, V82, P3612, DOI 10.1128/JVI.02435-07; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; LLOYD DB, 1995, J BIOL CHEM, V270, P25812, DOI 10.1074/jbc.270.43.25812; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Matsui M, 2010, CHEM BIOL, V17, P1344, DOI 10.1016/j.chembiol.2010.10.009; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mui MZ, 2010, J VIROL, V84, P4798, DOI 10.1128/JVI.02434-09; Nagoshi E, 2001, MOL CELL BIOL, V21, P2779, DOI 10.1128/MCB.21.8.2779-2789.2001; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Pak YK, 1996, BIOCHEM MOL BIOL INT, V38, P31; Pallai R, 2012, TRANSCR-AUSTIN, V3, P323, DOI 10.4161/trns.22518; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sato Ken-Ichi, 2008, Open Biochem J, V2, P49, DOI 10.2174/1874091X00802010049; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shen Ling, 2012, J Vis Exp, DOI 10.3791/3917; Sonnino S, 2013, CURR MED CHEM, V20, P4; Stein EA, 2013, CURR OPIN LIPIDOL, V24, P510, DOI 10.1097/MOL.0000000000000021; Stein O, 2005, ATHEROSCLEROSIS, V178, P217, DOI 10.1016/j.atherosclerosis.2004.10.008; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tenenbaum A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-125; Upadhyay A, 2012, ANN INTERN MED, V157, P251, DOI 10.7326/0003-4819-157-4-201208210-00005; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; WANG XD, 1993, J BIOL CHEM, V268, P14497; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Wood WG, 2011, J NEUROCHEM, V116, P684, DOI 10.1111/j.1471-4159.2010.07017.x; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; Zhang ZY, 2011, J VIROL, V85, P286, DOI 10.1128/JVI.01381-10	66	13	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17268	17279		10.1074/jbc.M114.570390	http://dx.doi.org/10.1074/jbc.M114.570390			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24770487	hybrid, Green Published			2022-12-28	WOS:000338016200058
J	Mazzaferro, S; Gasparri, F; New, K; Alcaino, C; Faundez, M; Vasquez, PI; Vijayan, R; Biggin, PC; Bermudez, I				Mazzaferro, Simone; Gasparri, Federica; New, Karina; Alcaino, Constanza; Faundez, Manuel; Iturriaga Vasquez, Patricio; Vijayan, Ranjit; Biggin, Philip C.; Bermudez, Isabel			Non-equivalent Ligand Selectivity of Agonist Sites in (alpha 4 beta 2)(2)alpha 4 Nicotinic Acetylcholine Receptors A KEY DETERMINANT OF AGONIST EFFICACY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOKING-CESSATION DRUGS; ACH BINDING-SITE; RB-86(+) EFFLUX; LOW-SENSITIVITY; MOLECULAR DETERMINANTS; SUBUNIT; STOICHIOMETRY; EXPRESSION; INTERFACE; RESIDUES	The alpha 4 beta 2 nicotinic acetylcholine receptor (nAChR) is the most abundant nAChR type in the brain, and this receptor type exists in alternate (alpha 4 beta 2)(2)alpha 4 and (alpha 4 beta 2)(2)beta 2 forms, which are activated by agonists with strikingly differing efficacies. Recent breakthroughs have identified an additional operational agonist binding site in the (alpha 4 beta 2)(2)alpha 4 nAChR that is responsible for the signature sensitivity of this receptor to activation by agonists, yet the structural mechanisms determining agonist efficacy at this receptor type are not yet fully understood. In this study, we characterized the ligand selectivity of the individual agonist sites of the (alpha 4 beta 2)(2)alpha 4 nAChR to determine whether differences in agonist selectivity influence agonist efficacy. Applying the substituted cysteine accessibility method to individual agonist sites in concatenated (alpha 4 beta 2)(2)alpha 4 receptors, we determined the agonist selectivity of the agonist sites of the (alpha 4 beta 2)(2)alpha 4 receptor. We show that (a) accessibility of substituted cysteines to covalent modification by methanesulfonate reagent depends on the agonist site at which the modification occurs and (b) that agonists such as sazetidine-A and TC-2559 are excluded from the site at the alpha 4/alpha 4 interface. Given that additional binding to the agonist site in the alpha 4/alpha 4 interface increases acetylcholine efficacy and that agonists excluded from the agonist site at the alpha 4/alpha 4 interface behave as partial agonists, we conclude that the ability to engage all agonist sites in (alpha 4 beta 2)(2)alpha 4 nAChRs is a key determinant of agonist efficacy. The findings add another level of complexity to the structural mechanisms that govern agonist efficacy in heteromeric nAChRs and related ligand-gated ion channels.	[Bermudez, Isabel] Oxford Brookes Univ, Dept Biol & Med Sci, Fac Hlth & Life Sci, Oxford OX3 0BP, England; [Faundez, Manuel; Iturriaga Vasquez, Patricio] Univ Chile, Fac Sci, Dept Chem, Santiago, Chile; [Vijayan, Ranjit] United Arab Emirates Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates; [Biggin, Philip C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Oxford Brookes University; Universidad de Chile; United Arab Emirates University; University of Oxford	Bermudez, I (corresponding author), Oxford Brookes Univ, Dept Biol & Med Sci, Fac Hlth & Life Sci, Gipsy Lane, Oxford OX3 0BP, England.	ibermudez@brookes.ac.uk	Alcaino, Constanza/AAD-9788-2020; Yoo, James J./L-4850-2017; Vijayan, Ranjit/GXF-4345-2022; Vijayan, Ranjit/AAH-6015-2019	Alcaino, Constanza/0000-0001-9595-4330; Vijayan, Ranjit/0000-0002-3830-7409; Vijayan, Ranjit/0000-0002-3830-7409; Faundez Parraguez, Manuel/0000-0002-1621-5327; Mazzaferro, Simone/0000-0003-4402-5325; Bermudez, Isabel/0000-0001-7692-1509; Biggin, Philip/0000-0001-5100-8836	Oxford Brookes University; Comision Nacional de Investigacion Cientifica and Tecnologica (CONiCYT) [1100542]	Oxford Brookes University; Comision Nacional de Investigacion Cientifica and Tecnologica (CONiCYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Oxford Brookes University funding (to I. B., S. M., C. A. A., and K. N.) and Comision Nacional de Investigacion Cientifica and Tecnologica (CONiCYT) Grant 1100542 (to P. I. V.).	Baumann SW, 2003, J NEUROSCI, V23, P11158; Benallegue N, 2013, BRIT J PHARMACOL, V170, P304, DOI 10.1111/bph.12268; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Blum AP, 2013, J BIOL CHEM, V288, P6991, DOI 10.1074/jbc.M112.439968; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; CACHELIN AB, 1989, J PHYSIOL-LONDON, V415, P159, DOI 10.1113/jphysiol.1989.sp017717; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Faundez-Parraguez M, 2013, BIOORGAN MED CHEM, V21, P2687, DOI 10.1016/j.bmc.2013.03.024; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gotti C, 2008, MOL PHARMACOL, V73, P1796, DOI 10.1124/mol.108.045203; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Harpsoe K, 2013, J BIOL CHEM, V288, P2559, DOI 10.1074/jbc.M112.436337; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Horenstein NA, 2007, J BIOL CHEM, V282, P5899, DOI 10.1074/jbc.M609202200; Iturriaga-Vasquez P, 2010, MOL PHARMACOL, V78, P366, DOI 10.1124/mol.110.065490; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Mantione E, 2012, FUTURE MED CHEM, V4, P2217, DOI [10.4155/FMC.12.172, 10.4155/fmc.12.172]; Marks MJ, 2007, NEUROPHARMACOLOGY, V53, P390, DOI 10.1016/j.neuropharm.2007.05.021; Marks MJ, 2010, BIOCHEM PHARMACOL, V80, P1238, DOI 10.1016/j.bcp.2010.06.040; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Rode F, 2012, BRAIN RES, V1458, P67, DOI 10.1016/j.brainres.2012.03.064; Rucktooa P, 2012, J BIOL CHEM, V287, P23283, DOI 10.1074/jbc.M112.360347; Sine SM, 1997, J BIOL CHEM, V272, P23521, DOI 10.1074/jbc.272.38.23521; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Tavares XDS, 2012, J AM CHEM SOC, V134, P11474, DOI 10.1021/ja3011379; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u	40	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21795	21806		10.1074/jbc.M114.555136	http://dx.doi.org/10.1074/jbc.M114.555136			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936069	hybrid, Green Published			2022-12-28	WOS:000340558300052
J	Liu, X; Song, ZW; Huo, YD; Zhang, JH; Zhu, TG; Wang, JY; Zhao, XN; Aikhionbare, F; Zhang, JC; Duan, HQ; Wu, JH; Dou, Z; Shi, YY; Yao, XB				Liu, Xing; Song, Zhenwei; Huo, Yuda; Zhang, Jiahai; Zhu, Tongge; Wang, Jianyu; Zhao, Xuannv; Aikhionbare, Felix; Zhang, Jiancun; Duan, Hequan; Wu, Jihui; Dou, Zhen; Shi, Yunyu; Yao, Xuebiao			Chromatin Protein HP1 alpha Interacts with the Mitotic Regulator Borealin Protein and Specifies the Centromere Localization of the Chromosomal Passenger Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE AURORA B; CELL-DIVISION; PHOSPHORYLATION; SURVIVIN; SPINDLE; HP1; INCENP; HETEROCHROMATIN; MITOSIS; KINETOCHORE	Accurate mitosis requires the chromosomal passenger protein complex (CPC) containing Aurora B kinase, borealin, INCENP, and survivin, which orchestrates chromosome dynamics. However, the chromatin factors that specify the CPC to the centromere remain elusive. Here we show that borealin interacts directly with heterochromatin protein 1 alpha (HP1 alpha) and that this interaction is mediated by an evolutionarily conserved PXVXL motif in the C-terminal borealin with the chromo shadow domain of HP1 alpha. This borealin-HP1 alpha interaction recruits the CPC to the centromere and governs an activation of Aurora B kinase judged by phosphorylation of Ser-7 in CENP-A, a substrate of Aurora B. Consistently, modulation of the motif PXVXL leads to defects in CPC centromere targeting and aberrant Aurora B activity. On the other hand, the localization of the CPC in the midzone is independent of the borealin-HP1 alpha interaction, demonstrating the spatial requirement of HP1 alpha in CPC localization to the centromere. These findings reveal a previously unrecognized but direct link between HP1 alpha and CPC localization in the centromere and illustrate the critical role of borealin-HP1 alpha interaction in orchestrating an accurate cell division.	[Liu, Xing; Huo, Yuda; Zhu, Tongge; Wang, Jianyu; Zhao, Xuannv; Duan, Hequan; Dou, Zhen; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Anhui, Peoples R China; [Liu, Xing; Song, Zhenwei; Huo, Yuda; Zhang, Jiahai; Zhu, Tongge; Zhao, Xuannv; Wu, Jihui; Dou, Zhen; Shi, Yunyu; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Nanoscale, Hefei 230026, Anhui, Peoples R China; [Liu, Xing; Zhu, Tongge; Aikhionbare, Felix; Duan, Hequan] Morehouse Sch Med, Mol Imaging Ctr, Atlanta, GA 30310 USA; [Zhang, Jiancun] Guangzhou Inst Biomed Hlth, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Yao, XB (corresponding author), Univ Sci & Technol China, Sch Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Anhui, Peoples R China.	yaoxb@ustc.edu.cn	Song, Zhenwei/W-6191-2019; Liu, Xing/H-2989-2018; Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013	Liu, Xing/0000-0002-7480-5085; DOU, ZHEN/0000-0003-3303-9393; Song, Zhenwei/0000-0002-9679-5113	National Institutes of Health [DK56292, CA164133, 8G12MD007602, G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB917204, 2013CB911203]; Chinese Academy of Sciences [KSCX1-YW-R-65, KSCX2-YW-R-195]; Chinese Natural Science Foundation [91313303, 31320103904, 90508002, 91129714, 81270466, 31271518, 31371363, 90913016]; China Fellowship [2012M510210]; Fundamental Research Funds for Central Universities [WK2340000032, WK2060190018];  [MOST 2009DFA31010];  [MOE 20113402130010];  [IRT13038]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Fellowship; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, 8G12MD007602, and G12RR03034. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, and 2013CB911203; by Chinese Academy of Sciences Grants KSCX1-YW-R-65 and KSCX2-YW-R-195; by Grant MOST 2009DFA31010; by Grants MOE 20113402130010 and IRT13038; by Chinese Natural Science Foundation Grants 91313303, 31320103904, 90508002, 91129714, 81270466, 31271518, 31371363, and 90913016; by China Fellowship 2012M510210; and by Fundamental Research Funds for Central Universities Grants WK2340000032 and WK2060190018.	Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kang J, 2011, MOL BIOL CELL, V22, P1181, DOI 10.1091/mbc.E11-01-0009; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; Ren J, 2010, NUCLEIC ACIDS RES, V38, pD155, DOI 10.1093/nar/gkp784; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Yuan K, 2009, J BIOL CHEM, V284, P23072, DOI 10.1074/jbc.M109.001990; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	40	26	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20638	20649		10.1074/jbc.M114.572842	http://dx.doi.org/10.1074/jbc.M114.572842			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917673	hybrid, Green Published			2022-12-28	WOS:000339396600023
J	Neo, WH; Yap, K; Lee, SH; Looi, LS; Khandelia, P; Neo, SX; Makeyev, EV; Su, IH				Neo, Wen Hao; Yap, Karen; Lee, Suet Hoay; Looi, Liang Sheng; Khandelia, Piyush; Neo, Sheng Xiong; Makeyev, Eugene V.; Su, I-hsin			MicroRNA miR-124 Controls the Choice between Neuronal and Astrocyte Differentiation by Fine-tuning Ezh2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; DEVELOPMENTAL REGULATORS; MAMMALIAN MICRORNAS; GENE-EXPRESSION; SMALL RNAS; POLYCOMB; IDENTITY; NEUROGENESIS; MOUSE	Polycomb group protein Ezh2 is a histone H3 Lys-27 histone methyltransferase orchestrating an extensive epigenetic regulatory program. Several nervous system-specific genes are known to be repressed by Ezh2 in stem cells and derepressed during neuronal differentiation. However, the molecular mechanisms underlying this regulation remain poorly understood. Here we show that Ezh2 levels are dampened during neuronal differentiation by brain-enriched microRNA miR-124. Expression of miR-124 in a neuroblastoma cells line was sufficient to up-regulate a significant fraction of nervous system-specific Ezh2 target genes. On the other hand, naturally elevated expression of miR-124 in embryonic carcinoma cells undergoing neuronal differentiation correlated with down-regulation of Ezh2 levels. Importantly, overexpression of Ezh2 mRNA with a 3'-untranslated region (3'-UTR) lacking a functional miR-124 binding site, but not with the wild-type Ezh2 3'-UTR, hampered neuronal and promoted astrocyte-specific differentiation in P19 and embryonic mouse neural stem cells. Overall, our results uncover a molecular mechanism that allows miR-124 to balance the choice between alternative differentiation possibilities through fine-tuning the expression of a critical epigenetic regulator.	[Neo, Wen Hao; Yap, Karen; Lee, Suet Hoay; Looi, Liang Sheng; Khandelia, Piyush; Neo, Sheng Xiong; Makeyev, Eugene V.; Su, I-hsin] Nanyang Technol Univ, Sch Biol Sci, Div Mol Genet & Cell Biol, Coll Sci, Singapore 637551, Singapore; [Makeyev, Eugene V.] Kings Coll London, Med Res Council Ctr Dev Neurobiol, London SE1 1UL, England	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of London; King's College London	Su, IH (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Mol Genet & Cell Biol, Coll Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ihsu@ntu.edu.sg	Su, I-hsin/A-2207-2011	Su, I-hsin/0000-0002-5894-9580; Yap, Karen/0000-0002-0182-4795; Makeyev, Eugene/0000-0001-6034-6896; Neo, Wen Hao/0000-0002-6827-3027	National Medical Research Council [NMRC/IRG/1269/2010, NMRC/CBRG/0028/2013]; National Research Foundation Singapore [NRF-RF2008-06]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation Singapore(National Research Foundation, Singapore)	This work was supported by research funding from National Medical Research Council Grants NMRC/IRG/1269/2010 (to W. H. N. and I. S.) and NMRC/CBRG/0028/2013 (to E. V. M.) and National Research Foundation Singapore Grant NRF-RF2008-06 (to E. V. M.).	Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berninger B, 2007, EUR J NEUROSCI, V25, P2581, DOI 10.1111/j.1460-9568.2007.05509.x; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fode C, 2000, GENE DEV, V14, P67; Geoffroy CG, 2009, STEM CELLS, V27, P847, DOI 10.1002/stem.17; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P231, DOI 10.1093/abbs/gmp006; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Juvvuna PK, 2012, NUCLEIC ACIDS RES, V40, P6808, DOI 10.1093/nar/gks293; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kazama H, 1999, CELL GROWTH DIFFER, V10, P565; Khandelia P, 2011, P NATL ACAD SCI USA, V108, P12799, DOI 10.1073/pnas.1103532108; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koshkin A. A., 2012, MOL THER, V20, P1590; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Sparmann A, 2013, EMBO J, V32, P1598, DOI 10.1038/emboj.2013.93; Staines WA, 1996, NEUROSCIENCE, V71, P845, DOI 10.1016/0306-4522(95)00494-7; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	62	90	91	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20788	20801		10.1074/jbc.M113.525493	http://dx.doi.org/10.1074/jbc.M113.525493			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24878960	Green Published, hybrid			2022-12-28	WOS:000339396600034
J	Aman, TK; Maki, BA; Ruffino, TJ; Kasperek, EM; Popescu, GK				Aman, Teresa K.; Maki, Bruce A.; Ruffino, Thomas J.; Kasperek, Eileen M.; Popescu, Gabriela K.			Separate Intramolecular Targets for Protein Kinase A Control N-Methyl-D-aspartate Receptor Gating and Ca2+ Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTORS; CALCIUM PERMEABILITY; HIPPOCAMPAL-NEURONS; PHOSPHORYLATION; DESENSITIZATION; INACTIVATION; CHANNELS; NR2A; PLASTICITY; INHIBITOR	Protein kinase A (PKA) enhances synaptic plasticity in the central nervous system by increasing NMDA receptor current amplitude and Ca2+ flux in an isoform-dependent yet poorly understood manner. PKA phosphorylates multiple residues on GluN1, GluN2A, and GluN2B subunits in vivo, but the functional significance of this multiplicity is unknown. We examined gating and permeation properties of recombinant NMDA receptor isoforms and of receptors with altered C-terminal domain (CTDs) prior to and after pharmacological inhibition of PKA. We found that PKA inhibition decreased GluN1/GluN2B but not GluN1/GluN2A gating; this effect was due to slower rates for receptor activation and resensitization and was mediated exclusively by the GluN2B CTD. In contrast, PKA inhibition reduced NMDA receptor-relative Ca2+ permeability (PCa/PNa) regardless of the GluN2 isoform and required the GluN1 CTD; this effect was due primarily to decreased unitary Ca2+ conductance, because neither Na+ conductance nor Ca2+- dependent block was altered substantially. Finally, we show that both the gating and permeation effects can be reproduced by changing the phosphorylation state of a single residue: GluN2B Ser-1166 and GluN1 Ser-897, respectively. We conclude that PKA effects on NMDA receptor gating and Ca2+ permeability rely on distinct phosphorylation sites located on the CTD of GluN2B and GluN1 subunits. This separate control of NMDA receptor properties by PKA may account for the specific effects of PKA on plasticity during synaptic development and may lead to drugs targeted to alter NMDA receptor gating or Ca2+ permeability.	[Aman, Teresa K.; Maki, Bruce A.; Ruffino, Thomas J.; Kasperek, Eileen M.; Popescu, Gabriela K.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Maki, Bruce A.; Popescu, Gabriela K.] SUNY Buffalo, Sch Med & Biomed Sci, Neurosci Program, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, GK (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY 14214 USA.	popescu@buffalo.edu	popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002; Maki, Bruce/0000-0002-6760-375X	National Institutes of Health Grants [R01052669, F32NS077622]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077622, R01NS052669] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01052669 (to G. K. P.) and F32NS077622 (to T. K. A.).	Amico-Ruvio SA, 2011, BIOPHYS J, V100, P1910, DOI 10.1016/j.bpj.2011.02.042; Amico-Ruvio SA, 2010, BIOPHYS J, V98, P1160, DOI 10.1016/j.bpj.2009.12.4276; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; Bird GC, 2005, J PHYSIOL-LONDON, V564, P907, DOI 10.1113/jphysiol.2005.084780; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borschel WF, 2012, J NEUROPHYSIOL, V108, P3105, DOI 10.1152/jn.00551.2012; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; CERNE R, 1993, NEUROSCI LETT, V161, P124, DOI 10.1016/0304-3940(93)90275-P; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chatterjea D, 2010, J NEUROPHYSIOL, V104, P2203, DOI 10.1152/jn.01081.2009; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gambrill AC, 2011, J NEUROPHYSIOL, V105, P162, DOI 10.1152/jn.00457.2010; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Kussius CL, 2009, J NEUROSCI, V29, P6819, DOI 10.1523/JNEUROSCI.0281-09.2009; Lau CG, 2009, BIOCHEM SOC T, V37, P1369, DOI 10.1042/BST0371369; LEGENDRE P, 1993, J NEUROSCI, V13, P674; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Li B, 2009, J NEUROSCI, V29, P11965, DOI 10.1523/JNEUROSCI.2109-09.2009; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Maki BA, 2013, CHANNELS, V7, P126, DOI 10.4161/chan.23968; Maki BA, 2012, J BIOL CHEM, V287, P36071, DOI 10.1074/jbc.M112.390013; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; TASH JS, 1980, CELL, V21, P57, DOI 10.1016/0092-8674(80)90114-2; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Townsend M, 2004, J NEUROSCI, V24, P11098, DOI 10.1523/JNEUROSCI.1207-04.2004; Watanabe J, 2002, J NEUROSCI, V22, P10209; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Xu MF, 2011, ALCOHOL, V45, P373, DOI 10.1016/j.alcohol.2010.08.015	48	27	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18805	18817		10.1074/jbc.M113.537282	http://dx.doi.org/10.1074/jbc.M113.537282			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847051	hybrid, Green Published			2022-12-28	WOS:000339062900016
J	Sanchez-Osuna, M; Garcia-Belinchon, M; Iglesias-Guimarais, V; Gil-Guinon, E; Casanelles, E; Yuste, VJ				Sanchez-Osuna, Maria; Garcia-Belinchon, Merce; Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Casanelles, Elisenda; Yuste, Victor J.			Caspase-activated DNase Is Necessary and Sufficient for Oligonucleosomal DNA Breakdown, but Not for Chromatin Disassembly during Caspase-dependent Apoptosis of LN-18 Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGMENTATION FACTOR; DFF40/CAD ENDONUCLEASE; NEUROBLASTOMA-CELLS; NUCLEAR APOPTOSIS; 40-KDA SUBUNIT; DEATH; CONDENSATION; CLEAVAGE; INHIBITOR; PROTEIN	Caspase-dependent apoptosis is a controlled type of cell death characterized by oligonucleosomal DNA breakdown and major nuclear morphological alterations. Other kinds of cell death do not share these highly distinctive traits because caspase-activated DNase (DFF40/CAD) remains inactive. Here, we report that human glioblastoma multiforme-derived LN-18 cells do not hydrolyze DNA into oligonucleosomal fragments after apoptotic insult. Furthermore, their chromatin remains packaged into a single mass, with no signs of nuclear fragmentation. However, ultrastructural analysis reveals that nuclear disassembly occurs, although compacted chromatin does not localize into apoptotic nuclear bodies. Caspases become properly activated, and ICAD, the inhibitor of DFF40/CAD, is correctly processed. Using cell-free in vitro assays, we show that chromatin from isolated nuclei of LN-18 cells is suitable for hydrolysis into oligonuclesomal fragments by staurosporine-pretreated SH-SY5Y cytoplasms. However, staurosporine-pretreated LN-18 cytoplasms do not induce DNA laddering in isolated nuclei from either LN-18 or SH-SY5Y cells because LN-18 cells express lower amounts of DFF40/CAD. DFF40/CAD overexpression makes LN-18 cells fully competent to degrade their DNA into oligonucleosome-sized fragments, and yet they remain unable to arrange their chromatin into nuclear clumps after apoptotic insult. Indeed, isolated nuclei from LN-18 cells were resistant to undergoing apoptotic nuclear morphology in vitro. The use of LN-18 cells has uncovered a previously unsuspected cellular model, whereby a caspase-dependent chromatin package is DFF40/CAD-independent, and DFF40/CAD-mediated double-strand DNA fragmentation does not warrant the distribution of the chromatin into apoptotic nuclear bodies. The studies highlight a not-yet reported DFF40/CAD-independent mechanism driving conformational nuclear changes during caspase-dependent cell death.	Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death Senescence & Survival Grp, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Fac Med, Inst Neurociencies, E-08193 Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08193, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona; CIBERNED	Yuste, VJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Campus Bellaterra, E-08193 Barcelona, Spain.	victor.yuste@uab.cat	Gil, Estel/B-9786-2015; Yuste, Victor J./C-7071-2008	Yuste, Victor J./0000-0001-5322-9261; Gil, Estel/0000-0003-4502-4623	Ministerio de Economia y Competitividad/Fondo Europeo de Desarrollo Regional (MINECO/FEDER) Grant [SAF2012-31485]; Generalitat de Catalunya Grant [SGR2009-346]; Ministerio de Ciencia e Innovacion [BES-2099-028572, TRA2009-0185]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya); Ramon y Cajal Program (Ministerio de Educacion y Ciencia)	Ministerio de Economia y Competitividad/Fondo Europeo de Desarrollo Regional (MINECO/FEDER) Grant; Generalitat de Catalunya Grant(Generalitat de Catalunya); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Ramon y Cajal Program (Ministerio de Educacion y Ciencia)(German Research Foundation (DFG))	This work was supported by Ministerio de Economia y Competitividad/Fondo Europeo de Desarrollo Regional (MINECO/FEDER) Grant SAF2012-31485 and Generalitat de Catalunya Grant SGR2009-346.; Recipient of Formacion de Personal Investigador Fellowship BES-2099-028572 from the Ministerio de Ciencia e Innovacion).; Supported by a fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya).; Held Postdoctoral Contract TRA2009-0185 from the Ministerio de Ciencia e Innovacion.; Supported by the Ramon y Cajal Program (Ministerio de Educacion y Ciencia).	Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; Boix J, 1998, EXP CELL RES, V238, P422, DOI 10.1006/excr.1997.3852; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Dini L, 1996, EXP CELL RES, V223, P340, DOI 10.1006/excr.1996.0089; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Ermakov AV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/649747; FALCIERI E, 1993, BIOCHEM BIOPH RES CO, V193, P19, DOI 10.1006/bbrc.1993.1584; Glebova K, 2015, CANCER LETT, V356, P22, DOI 10.1016/j.canlet.2013.09.005; Gozzelino R, 2008, CELL RES, V18, P1020, DOI 10.1038/cr.2008.76; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Iglesias-Guimarais V, 2013, J BIOL CHEM, V288, P9200, DOI 10.1074/jbc.M112.411371; Iglesias-Guimarais V, 2012, J BIOL CHEM, V287, P7766, DOI 10.1074/jbc.M111.290718; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Joselin AP, 2006, J BIOL CHEM, V281, P12475, DOI 10.1074/jbc.M509859200; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kuribayashi N, 1996, ANTICANCER RES, V16, P1225; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Majczak A, 2004, J ELECTRON MICROSC, V53, P635, DOI 10.1093/jmicro/dfh086; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Perez-Alvarez S, 2011, PHARMACOL RES, V63, P352, DOI 10.1016/j.phrs.2010.12.001; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Ribas J, 2008, BIOCHEM PHARMACOL, V76, P39, DOI 10.1016/j.bcp.2008.03.023; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Walker PR, 1997, BIOCHEM CELL BIOL, V75, P287, DOI 10.1139/bcb-75-4-287; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Widlak P, 2002, J BIOL CHEM, V277, P21683, DOI 10.1074/jbc.M201027200; Widlak P, 2000, ACTA BIOCHIM POL, V47, P1037; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Yuste VJ, 2005, J BIOL CHEM, V280, P35670, DOI 10.1074/jbc.M504015200; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zamzami N, 1999, NATURE, V401, P127, DOI 10.1038/43591; Zhang JH, 1999, J BIOL CHEM, V274, P37450, DOI 10.1074/jbc.274.52.37450	47	8	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18752	18769		10.1074/jbc.M114.550020	http://dx.doi.org/10.1074/jbc.M114.550020			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24838313	Green Published, hybrid			2022-12-28	WOS:000339062900012
J	Gao, R; Schellenberg, MJ; Huang, SYN; Abdelmalak, M; Marchand, C; Nitiss, KC; Nitiss, JL; Williams, RS; Pommier, Y				Gao, Rui; Schellenberg, Matthew J.; Huang, Shar-yin N.; Abdelmalak, Monica; Marchand, Christophe; Nitiss, Karin C.; Nitiss, John L.; Williams, R. Scott; Pommier, Yves			Proteolytic Degradation of Topoisomerase II (Top2) Enables the Processing of Top2.DNA and Top2.RNA Covalent Complexes by Tyrosyl-DNA-Phosphodiesterase 2 (TDP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME INTEGRITY; STRUCTURAL BASIS; CLEAVAGE; REPAIR; RIBONUCLEOTIDES; ANTICANCER; ETOPOSIDE; ADDUCTS; CHEMOTHERAPY; TOP3-BETA	Eukaryotic type II topoisomerases (Top2 alpha and Top2 beta) are homodimeric enzymes; they are essential for altering DNA topology by the formation of normally transient double strand DNA cleavage. Anticancer drugs (etoposide, doxorubicin, and mitoxantrone) and also Top2 oxidation and DNA helical alterations cause potentially irreversible Top2.DNA cleavage complexes (Top2cc), leading to Top2-linked DNA breaks. Top2cc are the therapeutic mechanism for killing cancer cells. Yet Top2cc can also generate recombination, translocations, and apoptosis in normal cells. The Top2 protein-DNA covalent complexes are excised (in part) by tyrosyl-DNA-phosphodiesterase 2 (TDP2/TTRAP/EAP2/VPg unlinkase). In this study, we show that irreversible Top2cc induced in suicidal substrates are not processed by TDP2 unless they first undergo proteolytic processing or denaturation. We also demonstrate that TDP2 is most efficient when the DNA attached to the tyrosyl is in a single-stranded configuration and that TDP2 can efficiently remove a tyrosine linked to a single misincorporated ribonucleotide or to polyribonucleotides, which expands the TDP2 catalytic profile with RNA substrates. The 1.6-angstrom resolution crystal structure of TDP2 bound to a substrate bearing a 5'-ribonucleotide defines a mechanism through which RNA can be accommodated in the TDP2 active site, albeit in a strained conformation.	[Gao, Rui; Huang, Shar-yin N.; Abdelmalak, Monica; Marchand, Christophe; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Schellenberg, Matthew J.; Williams, R. Scott] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Nitiss, Karin C.; Nitiss, John L.] Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, Rockford, IL 61107 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Illinois System; University of Illinois Chicago; University of Illinois Rockford	Pommier, Y (corresponding author), NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	pommier@nih.gov	; Williams, R Scott/A-6059-2015	Nitiss, John/0000-0002-1013-4972; Williams, R Scott/0000-0002-4610-8397	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [R01CA052814, Z01BC006150, ZIABC006161, ZIABC006150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102765] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. Pedersen of the National Institutes of Health, NIEHS, Collaborative Crystallography Group and the Advanced Photon Source (APS) Southeast Regional Collaborative Access Team (SER-CAT) for beamline access. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	ANDERSEN AH, 1991, J BIOL CHEM, V266, P9203; AUSTIN CA, 1992, BIOCHEM J, V282, P883, DOI 10.1042/bj2820883; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P6611, DOI 10.1093/nar/18.22.6611; Chen SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083582; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Gao R, 2012, J BIOL CHEM, V287, P30842, DOI 10.1074/jbc.M112.393983; Jacob DA, 2011, BIOCHEMISTRY-US, V50, P5660, DOI 10.1021/bi200438m; Khan QA, 2003, P NATL ACAD SCI USA, V100, P12498, DOI 10.1073/pnas.2032456100; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lindsey RH, 2004, BIOCHEMISTRY-US, V43, P7563, DOI 10.1021/bi049756r; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; MARKOVITS J, 1989, CANCER RES, V49, P5111; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; POMMIER Y, 1991, NUCLEIC ACIDS RES, V19, P5973, DOI 10.1093/nar/19.21.5973; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; ROBINSON MJ, 1993, BIOCHEMISTRY-US, V32, P3638, DOI 10.1021/bi00065a016; Schellenberg MJ, 2012, NAT STRUCT MOL BIOL, V19, P1363, DOI 10.1038/nsmb.2418; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Shi K, 2012, NAT STRUCT MOL BIOL, V19, P1372, DOI 10.1038/nsmb.2423; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Tumbale P, 2014, NATURE, V506, P111, DOI 10.1038/nature12824; Virgen-Slane R, 2012, P NATL ACAD SCI USA, V109, P14634, DOI 10.1073/pnas.1208096109; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Y, 1999, J BIOL CHEM, V274, P22839, DOI 10.1074/jbc.274.32.22839; Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Xu DY, 2013, NAT NEUROSCI, V16, P1238, DOI 10.1038/nn.3479; YAMASHITA Y, 1990, BIOCHEM PHARMACOL, V39, P737; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200	45	84	86	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					17960	17969		10.1074/jbc.M114.565374	http://dx.doi.org/10.1074/jbc.M114.565374			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24808172	hybrid, Green Published			2022-12-28	WOS:000338042000001
J	Landis, J; Shaw, LM				Landis, Justine; Shaw, Leslie M.			Insulin Receptor Substrate 2-mediated Phosphatidylinositol 3-kinase Signaling Selectively Inhibits Glycogen Synthase Kinase 3 beta to Regulate Aerobic Glycolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; IRS PROTEINS; TYROSINE PHOSPHORYLATION; FULL ACTIVATION; GROWTH; PATHWAY; METABOLISM; BIOLOGY; CANCER; INSULIN-RECEPTOR-SUBSTRATE-1	Insulin receptor substrate 1 (IRS-1) and IRS-2 are cytoplasmic adaptor proteins that mediate the activation of signaling pathways in response to ligand stimulation of upstream cell surface receptors. Despite sharing a high level of homology and the ability to activate PI3K, only Irs-2 positively regulates aerobic glycolysis in mammary tumor cells. To determine the contribution of Irs-2-dependent PI3K signaling to this selective regulation, we generated an Irs-2 mutant deficient in the recruitment of PI3K. We identified four tyrosine residues (Tyr-649, Tyr-671, Tyr-734, and Tyr-814) that are essential for the association of PI3K with Irs-2 and demonstrate that combined mutation of these tyrosines inhibits glucose uptake and lactate production, two measures of aerobic glycolysis. Irs-2-dependent activation of PI3K regulates the phosphorylation of specific Akt substrates, most notably glycogen synthase kinase 3 beta (Gsk-3 beta). Inhibition of Gsk-3 beta by Irs-2-dependent PI3K signaling promotes glucose uptake and aerobic glycolysis. The regulation of unique subsets of Akt substrates by Irs-1 and Irs-2 may explain their non-redundant roles in mammary tumor biology. Taken together, our study reveals a novel mechanism by which Irs-2 signaling preferentially regulates tumor cell metabolism and adds to our understanding of how this adaptor protein contributes to breast cancer progression.	[Landis, Justine; Shaw, Leslie M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Shaw, LM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB 409,364 Plantat St, Worcester, MA 01605 USA.	leslie.shaw@umassmed.edu			National Institute of Health [CA142782]; NATIONAL CANCER INSTITUTE [R01CA142782] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institute of Health Grant CA142782 (to L. M. S.).	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Backer JM, 1997, EUR J BIOCHEM, V245, P91, DOI 10.1111/j.1432-1033.1997.t01-1-00091.x; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; Clark JL, 2011, BREAST CANCER RES TR, V130, P759, DOI 10.1007/s10549-011-1353-1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Guo SD, 2006, MOL ENDOCRINOL, V20, P3389, DOI 10.1210/me.2006-0092; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; He WM, 1996, J BIOL CHEM, V271, P11641, DOI 10.1074/jbc.271.20.11641; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mardilovich K, 2009, CANCER RES, V69, P8894, DOI 10.1158/0008-5472.CAN-09-1152; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; Migliaccio I, 2010, BREAST CANCER RES TR, V123, P651, DOI 10.1007/s10549-009-0632-6; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; PATTI ME, 1995, J BIOL CHEM, V270, P24670, DOI 10.1074/jbc.270.42.24670; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; SawkaVerhelle D, 1996, J BIOL CHEM, V271, P5980, DOI 10.1074/jbc.271.11.5980; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shaw LM, 2011, CELL CYCLE, V10, P1750, DOI 10.4161/cc.10.11.15824; Simister PC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000591; Sisci D, 2007, J CLIN PATHOL, V60, P633, DOI 10.1136/jcp.2006.039107; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TOBE K, 1995, J BIOL CHEM, V270, P5698, DOI 10.1074/jbc.270.11.5698; Valverde AM, 1998, MOL ENDOCRINOL, V12, P688, DOI 10.1210/me.12.5.688; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VOLIOVITCH H, 1995, J BIOL CHEM, V270, P18083, DOI 10.1074/jbc.270.30.18083; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wu JH, 2008, NAT STRUCT MOL BIOL, V15, P251, DOI 10.1038/nsmb.1388; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300	55	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18603	18613		10.1074/jbc.M114.564070	http://dx.doi.org/10.1074/jbc.M114.564070			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24811175	Green Published, hybrid			2022-12-28	WOS:000338042000058
J	Sugeno, N; Hasegawa, T; Tanaka, N; Fukuda, M; Wakabayashi, K; Oshima, R; Konno, M; Miura, E; Kikuchi, A; Baba, T; Anan, T; Nakao, M; Geisler, S; Aoki, M; Takeda, A				Sugeno, Naoto; Hasegawa, Takafumi; Tanaka, Nobuyuki; Fukuda, Mitsunori; Wakabayashi, Koichi; Oshima, Ryuji; Konno, Masashi; Miura, Emiko; Kikuchi, Akio; Baba, Toru; Anan, Tadashi; Nakao, Mitsuyoshi; Geisler, Sven; Aoki, Masashi; Takeda, Atsushi			Lys-63-linked Ubiquitination by E3 Ubiquitin Ligase Nedd4-1 Facilitates Endosomal Sequestration of Internalized alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY BODIES; ALZHEIMERS-DISEASE; WW DOMAINS; MEMBRANE; DEGRADATION; BINDING; PHOSPHORYLATION; LOCALIZATION; PENETRATION; AGGREGATION	alpha-Synuclein (aS) is a major constituent of Lewy bodies, which are not only a pathological marker for Parkinson disease but also a trigger for neurodegeneration. Cumulative evidence suggests that aS spreads from cell to cell and thereby propagates neurodegeneration to neighboring cells. Recently, Nedd4-1 (neural precursor cell expressed developmentally down-regulated protein 4-1), an E3 ubiquitin ligase, was shown to catalyze the Lys-63-linked polyubiquitination of intracellular aS and thereby facilitate aS degradation by the endolysosomal pathway. Because Nedd4-1 exerts its activity in close proximity to the inner leaflet of the plasma membrane, we speculate that after the internalization of aS the membrane resident aS is preferentially ubiquitinated by Nedd4-1. To clarify the role of Nedd4-1 in aS internalization and endolysosomal sequestration, we generated aS mutants, including Delta PR1(1-119 and 129-140), Delta C(1-119), and Delta PR2(1-119 and 134-140), that lack the proline-rich sequence, a putative Nedd4-1 recognition site. We show that wild type aS, but not Delta PR1, Delta PR2, or Delta C aS, is modified by Nedd4-1 in vitro, acquiring a Lys-63-linked ubiquitin chain. Compared with the mutants lacking the proline-rich sequence, wild type-aS is preferentially internalized and translocated to endosomes. The overexpression of Nedd4-1 increased aS in endosomes, whereas RNAi-mediated silencing of Nedd4-1 decreased endosomal aS. Although aS freely passes through plasma membranes within minutes, a pulse-chase experiment revealed that the overexpression of Nedd4-1 markedly decreased the re-secretion of internalized aS. Together, these findings demonstrate that Nedd4-1-linked Lys-63 ubiquitination specifies the fate of extrinsic and de novo synthesized aS by facilitating their targeting to endosomes.	[Sugeno, Naoto; Hasegawa, Takafumi; Oshima, Ryuji; Konno, Masashi; Miura, Emiko; Kikuchi, Akio; Baba, Toru; Aoki, Masashi; Takeda, Atsushi] Tohoku Univ, Grad Sch Med, Dept Neurosci & Sensory Organs, Div Neurol, Sendai, Miyagi 9808574, Japan; [Tanaka, Nobuyuki; Oshima, Ryuji] Miyagi Canc Ctr, Res Inst, Div Canc Biol & Therapeut, Natori, Miyagi 9811293, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech, Sendai, Miyagi 9808578, Japan; [Wakabayashi, Koichi] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Neuropathol, Hirosaki, Aomori 0368562, Japan; [Anan, Tadashi] Kumamoto Univ, Sch Med, Dept Pediat, Kumamoto 860, Japan; [Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8600811, Japan; [Geisler, Sven] Univ Tubingen, German Ctr Neurodegenerat Dis, Hertie Inst Clin Brain Res, Lab Funct Neurogenet,Dept Neurodegenerat Dis, D-72076 Tubingen, Germany	Tohoku University; Miyagi Cancer Center; Tohoku University; Hirosaki University; Kumamoto University; Kumamoto University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Hasegawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurosci & Sensory Organs, Div Neurol, Sendai, Miyagi 9808574, Japan.	thasegawa@med.tohoku.ac.jp	Hasegawa, Takafumi/I-6668-2017; Perry, George/A-8611-2009; Fukuda, MItsunori/I-1511-2015	Perry, George/0000-0002-6547-0172; Fukuda, MItsunori/0000-0002-8620-5853; Baba, Toru/0000-0003-0936-2510	Ministry of Education, Culture, Sports, Science and Technology [25461264, 23591228, 24390219, 24659423, 24111502]; Research Committee for Ataxic Diseases; Ministry of Health, Labor, and Welfare, Japan; Symposium on Catecholamine and Neurological Disorders; 17th Takeda Science Foundation Symposium on Bioscience; Grants-in-Aid for Scientific Research [26461263] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Committee for Ataxic Diseases; Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Symposium on Catecholamine and Neurological Disorders; 17th Takeda Science Foundation Symposium on Bioscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (C) 25461264 and 23591228, Grant-in-aid for Scientific Research (B) 24390219, Grant-in-aid for Exploratory Research 24659423, Grant-in-aid for Scientific Research on Innovative Areas (Brain Environment) 24111502 from the Ministry of Education, Culture, Sports, Science and Technology, a grant from the Research Committee for Ataxic Diseases, the Ministry of Health, Labor, and Welfare, Japan, a grant from the Symposium on Catecholamine and Neurological Disorders, and a grant from the 17th Takeda Science Foundation Symposium on Bioscience.	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Davies SE, 2014, NEUROBIOL DIS, V64, P79, DOI 10.1016/j.nbd.2013.12.011; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Hara S, 2013, MOL BIOL CELL, V24, P1649, DOI 10.1091/mbc.E12-12-0903; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hasegawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029460; HAYASHIDA K, 1993, ACTA NEUROPATHOL, V85, P445, DOI 10.1007/BF00334457; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Konno M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-38; Kurashige T, 2013, NEUROPATHOLOGY, V33, P237, DOI 10.1111/j.1440-1789.2012.01346.x; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Nixon RA, 2004, AM J PATHOL, V164, P757, DOI 10.1016/S0002-9440(10)63163-X; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Soper JH, 2011, J MOL NEUROSCI, V43, P391, DOI 10.1007/s12031-010-9455-5; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Tanikawa S, 2012, NEUROSCI LETT, V527, P16, DOI 10.1016/j.neulet.2012.08.035; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Tsigelny IF, 2012, FEBS J, V279, P1000, DOI 10.1111/j.1742-4658.2012.08489.x; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	50	43	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18137	18151		10.1074/jbc.M113.529461	http://dx.doi.org/10.1074/jbc.M113.529461			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831002	hybrid, Green Published			2022-12-28	WOS:000338042000017
J	Patel, MS; Nemeria, NS; Furey, W; Jordan, F				Patel, Mulchand S.; Nemeria, Natalia S.; Furey, William; Jordan, Frank			The Pyruvate Dehydrogenase Complexes: Structure-based Function and Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							THIAMIN DIPHOSPHATE ENZYMES; ACTIVE-CENTER COMMUNICATION; ESCHERICHIA-COLI; MULTIENZYME COMPLEX; E1 COMPONENT; DIHYDROLIPOAMIDE DEHYDROGENASE; CRYSTAL-STRUCTURE; PHOSPHATASE ISOFORM-1; MAMMALIAN PYRUVATE; LIPOYL DOMAIN-2	The pyruvate dehydrogenase complexes (PDCs) from all known living organisms comprise three principal catalytic components for their mission: E1 and E2 generate acetyl-coenzyme A, whereas the FAD/NAD(+)-dependent E3 performs redox recycling. Here we compare bacterial (Escherichia coli) and human PDCs, as they represent the two major classes of the superfamily of 2-oxo acid dehydrogenase complexes with different assembly of, and interactions among components. The human PDC is subject to inactivation at E1 by serine phosphorylation by four kinases, an inactivation reversed by the action of two phosphatases. Progress in our understanding of these complexes important in metabolism is reviewed.	[Patel, Mulchand S.] SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Nemeria, Natalia S.; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Furey, William] Vet Affairs Med Ctr, Pittsburgh, PA 15240 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rutgers State University Newark; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Patel, MS (corresponding author), SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	mspatel@buffalo.edu; frjordan@rutgers.edu			National Institutes of Health [DK 20478, GM050380, GM061791]; Veterans Affairs Merit Review; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061791, R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 20478 (to M. S. P.), GM050380 (to F. J.), and GM061791 (to W. F.) and by the Veterans Affairs Merit Review (W. F.).	Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Arjunan P, 2004, BIOCHEMISTRY-US, V43, P2405, DOI 10.1021/bi030200y; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; Baykal AT, 2006, BIOCHEMISTRY-US, V45, P7522, DOI 10.1021/bi060395k; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Brautigam CA, 2009, J BIOL CHEM, V284, P13086, DOI 10.1074/jbc.M806563200; BROWN RM, 1990, SOMAT CELL MOLEC GEN, V16, P487, DOI 10.1007/BF01233198; Chandrasekhar K, 2013, J BIOL CHEM, V288, P15402, DOI 10.1074/jbc.M113.466789; Chen GL, 1996, J BIOL CHEM, V271, P28064, DOI 10.1074/jbc.271.45.28064; Ciszak EM, 2006, J BIOL CHEM, V281, P648, DOI 10.1074/jbc.M507850200; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; DEMARCUCCI O, 1985, EUR J BIOCHEM, V149, P641, DOI 10.1111/j.1432-1033.1985.tb08972.x; Devedjiev Y, 2007, J MOL BIOL, V370, P407, DOI 10.1016/j.jmb.2007.04.083; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; FLOURNOY DS, 1986, BIOCHEMISTRY-US, V25, P6036, DOI 10.1021/bi00368a030; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; GRUYS KJ, 1989, BIOCHEMISTRY-US, V28, P9071, DOI 10.1021/bi00449a018; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Imbard A, 2011, MOL GENET METAB, V104, P507, DOI 10.1016/j.ymgme.2011.08.008; Jeoung NH, 2014, REV ENDOCR METAB DIS, V15, P99, DOI 10.1007/s11154-013-9284-2; JILKA JM, 1986, J BIOL CHEM, V261, P1858; Jordan F, 2005, ACCOUNTS CHEM RES, V38, P755, DOI 10.1021/ar040244e; Jordan F, 2004, SCIENCE, V306, P818, DOI 10.1126/science.1105457; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; JORDAN F, 1982, J ORG CHEM, V47, P2748, DOI 10.1021/jo00135a012; Jordan F, 2002, BIOORG CHEM, V30, P188, DOI 10.1006/bioo.2002.1249; JORDAN F, 1978, J AM CHEM SOC, V100, P2534, DOI 10.1021/ja00476a043; Jordan F, 2009, J MOL CATAL B-ENZYM, V61, P14, DOI 10.1016/j.molcatb.2009.04.008; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; Kale S, 2009, J BIOL CHEM, V284, P33122, DOI 10.1074/jbc.M109.065508; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Karpova T, 2003, BBA-PROTEINS PROTEOM, V1652, P126, DOI 10.1016/j.bbapap.2003.08.010; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; KHAILOVA LS, 1985, BIOCHEM INT, V11, P509; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Korotchkina LG, 2006, J BIOL CHEM, V281, P9688, DOI 10.1074/jbc.M511481200; KOROTCHKINA LG, 1995, J BIOL CHEM, V270, P14297, DOI 10.1074/jbc.270.24.14297; Korotchkina LG, 2001, J BIOL CHEM, V276, P37223, DOI 10.1074/jbc.M103069200; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; Nakai T, 2008, J BIOCHEM, V143, P747, DOI 10.1093/jb/mvn033; Nemeria N, 2005, J BIOL CHEM, V280, P21473, DOI 10.1074/jbc.M502691200; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2010, J BIOL CHEM, V285, P11197, DOI 10.1074/jbc.M109.069179; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; Park YH, 2004, BIOCHEMISTRY-US, V43, P14037, DOI 10.1021/bi049027b; Park YH, 2010, BIOCHEM BIOPH RES CO, V395, P416, DOI 10.1016/j.bbrc.2010.04.038; Patel H, 2014, BIOCHEMISTRY-US, V53, P2145, DOI 10.1021/bi4015743; Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PATEL MS, 1995, FASEB J, V9, P1164, DOI 10.1096/fasebj.9.12.7672509; Patel MS, 2003, BIOCHEM MOL BIOL EDU, V31, P5, DOI 10.1002/bmb.2003.494031010156; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Patel MS, 2009, J MOL CATAL B-ENZYM, V61, P2, DOI 10.1016/j.molcatb.2009.05.001; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; REED LJ, 1990, J BIOL CHEM, V265, P8971; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; REED LJ, 1951, SCIENCE, V114, P93, DOI 10.1126/science.114.2952.93; Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Sanderson SJ, 1996, EUR J BIOCHEM, V236, P68, DOI 10.1111/j.1432-1033.1996.00068.x; Schellenberger A, 1998, BBA-PROTEIN STRUCT M, V1385, P177, DOI 10.1016/S0167-4838(98)00067-3; Schulze A, 2011, MOL CELL, V44, P846, DOI 10.1016/j.molcel.2011.12.004; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; Seifert F, 2006, BIOCHEMISTRY-US, V45, P12775, DOI 10.1021/bi061582l; Song JY, 2012, BIOCHEMISTRY-US, V51, P2795, DOI 10.1021/bi201614n; Song JY, 2010, J BIOL CHEM, V285, P4680, DOI 10.1074/jbc.M109.082842; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Tso SC, 2006, J BIOL CHEM, V281, P27197, DOI 10.1074/jbc.M604339200; Turkan A, 2004, BIOCHEMISTRY-US, V43, P15073, DOI 10.1021/bi048901y; Turkan A, 2002, J BIOL CHEM, V277, P14976, DOI 10.1074/jbc.M108434200; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; Vijayakrishnan S, 2010, J MOL BIOL, V399, P71, DOI 10.1016/j.jmb.2010.03.043; Wang JJ, 2014, J BIOL CHEM, V289, P15215, DOI 10.1074/jbc.M113.544080; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Yu XK, 2008, STRUCTURE, V16, P104, DOI 10.1016/j.str.2007.10.024	97	278	284	11	147	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16615	16623		10.1074/jbc.R114.563148	http://dx.doi.org/10.1074/jbc.R114.563148			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24798336	hybrid, Green Published			2022-12-28	WOS:000338016200001
J	Soderquist, RS; Danilov, AV; Eastman, A				Soderquist, Ryan S.; Danilov, Alexey V.; Eastman, Alan			Gossypol Increases Expression of the Pro-apoptotic BH3-only Protein NOXA through a Novel Mechanism Involving Phospholipase A2, Cytoplasmic Calcium, and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; LACTATE DEHYDROGENASE-X; NF-KAPPA-B; ARACHIDONIC-ACID; INTERFACIAL ACTIVATION; SENSITIZES LEUKEMIA; TELOMERASE ACTIVITY; A(2) ACTIVATION; BCL-2 INHIBITOR; CANCER CELLS	Gossypol is a putative BH3 mimetic proposed to inhibit BCL2 and BCLXL based on cell-free assays. We demonstrated previously that gossypol failed to directly inhibit BCL2 in cells or induce apoptosis in chronic lymphocytic leukemia (CLL) cells or platelets, which require BCL2 or BCLXL, respectively, for survival. Here, we demonstrate that gossypol rapidly increased activity of phospholipase A2 (PLA2), which led to an increase in cytoplasmic calcium, endoplasmic reticulum (ER) stress, and up-regulation of the BH3-only protein NOXA. Pretreatment with the PLA2 inhibitor, aristolochic acid, abrogated the increase in calcium, ER stress, and NOXA. Calcium chelation also abrogated the gossypol-induced increase in calcium, ER stress, and NOXA, but not the increase in PLA2 activity, indicating that PLA2 is upstream of these events. In addition, incubating cells with the two products of PLA2 (lysophosphatidic acid and arachidonic acid) mimicked treatment with gossypol. NOXA is a pro-apoptotic protein that functions by binding the BCL2 family proteins MCL1 and BFL1. The BCL2 inhibitor ABT-199 is currently in clinical trials for CLL. Resistance to ABT-199 can occur from up-regulation of other BCL2 family proteins, and this resistance can be mimicked by culturing CLL cells on CD154(+) stroma cells. We report here that AT-101, a derivative of gossypol in clinical trials, overcomes stroma-mediated resistance to ABT-199 in primary CLL cells, suggesting that a combination of these drugs may be efficacious in the clinic.	[Soderquist, Ryan S.; Eastman, Alan] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA; [Danilov, Alexey V.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH 03756 USA; [Danilov, Alexey V.; Eastman, Alan] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Eastman, A (corresponding author), Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Rubin Bldg,Level 6,1 Med Ctr Dr, Lebanon, NH 03756 USA.	alan.r.eastman@dartmouth.edu			National Institutes of Health Cancer Center Support Grant [CA23108]; Leukemia and Lymphoma Society; National Cancer Institute new faculty award (National Institutes of Health) [CA023108-31S4]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute new faculty award (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Cancer Center Support Grant CA23108 (to the Norris Cotton Cancer Center). This work was also supported by a translational research grant from the Leukemia and Lymphoma Society.; Supported by a National Cancer Institute new faculty award (National Institutes of Health Grant CA023108-31S4) to the Norris Cotton Cancer Center.	AKIRA S, 1994, THERIOGENOLOGY, V41, P1489, DOI 10.1016/0093-691X(94)90200-3; Albershardt TC, 2011, J BIOL CHEM, V286, P24882, DOI 10.1074/jbc.M111.255828; [Anonymous], 1978, Chin Med J (Engl), V4, P417; Arinbasarova Anna Yu, 2012, Open Biochem J, V6, P11, DOI 10.2174/1874091X01206010011; Balakrishnan K, 2013, INVEST NEW DRUG, V31, P1384, DOI 10.1007/s10637-013-0002-4; Balthazart J, 2003, EUR J NEUROSCI, V17, P1591, DOI 10.1046/j.1460-9568.2003.02598.x; Bates DJP, 2011, CANCER BIOL THER, V12, P314, DOI 10.4161/cbt.12.4.16909; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Nicholas JCA, 2007, EUR J PHARMACOL, V555, P106, DOI 10.1016/j.ejphar.2006.10.046; Cheng JS, 2003, CHINESE J PHYSIOL, V46, P117; Cheng JS, 2002, TOXICON, V40, P851, DOI 10.1016/S0041-0101(01)00194-5; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; DEPEYSTER A, 1986, BIOCHEM PHARMACOL, V35, P3293, DOI 10.1016/0006-2952(86)90426-0; DEPEYSTER A, 1993, MUTAT RES, V297, P293, DOI 10.1016/0165-1110(93)90021-E; Ding W, 2012, BIOCHEM BIOPH RES CO, V418, P451, DOI 10.1016/j.bbrc.2012.01.037; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guijas C, 2012, J LIPID RES, V53, P2343, DOI 10.1194/jlr.M028423; HAMASAKI Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P37, DOI 10.1016/0005-2760(85)90173-0; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hu GX, 2009, J STEROID BIOCHEM, V115, P14, DOI 10.1016/j.jsbmb.2009.02.004; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; Jan CR, 2000, BBA-MOL CELL RES, V1496, P270, DOI 10.1016/S0167-4889(00)00033-1; Javed MH, 1999, EXP MOL MED, V31, P25, DOI 10.1038/emm.1999.4; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Liu G, 2009, CLIN CANCER RES, V15, P3172, DOI 10.1158/1078-0432.CCR-08-2985; Marchlewski L., 1899, J PRAKT CHEM, V60, P84, DOI [DOI 10.1002/PRAC.18990600108, 10.1002/prac.18990600108]; MCCLARTY GA, 1985, BIOCHEM BIOPH RES CO, V133, P300, DOI 10.1016/0006-291X(85)91875-3; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829; Mignen O, 2003, J BIOL CHEM, V278, P10174, DOI 10.1074/jbc.M212536200; Moon DO, 2008, FEBS LETT, V582, P3367, DOI 10.1016/j.febslet.2008.08.029; Ni ZH, 2013, LEUKEMIA LYMPHOMA, V54, P2263, DOI 10.3109/10428194.2013.775437; OLGIATI KL, 1984, ARCH BIOCHEM BIOPHYS, V231, P411, DOI 10.1016/0003-9861(84)90404-1; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; PENNING TM, 1984, BIOCHEM J, V222, P601, DOI 10.1042/bj2220601; Perez A, 2009, AM J PHYSIOL-CELL PH, V297, pC86, DOI 10.1152/ajpcell.00501.2008; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; REYES J, 1984, J BIOL CHEM, V259, P9607; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Rosenberger S, 2007, J BIOL CHEM, V282, P6126, DOI 10.1074/jbc.M610529200; Salerni BL, 2010, MOL CANCER THER, V9, P791, DOI 10.1158/1535-7163.MCT-10-0028; Senarisoy M, 2013, CELL BIOCHEM BIOPHYS, V66, P199, DOI 10.1007/s12013-012-9468-5; Soderquist R, 2013, LEUKEMIA, V27, P2262, DOI 10.1038/leu.2013.138; Soderquist R, 2014, APOPTOSIS, V19, P201, DOI 10.1007/s10495-013-0910-y; Song BC, 2013, IMMUNOPHARM IMMUNOT, V35, P615, DOI 10.3109/08923973.2013.830126; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; STEINER M, 1984, INT J ANDROL, V7, P521, DOI 10.1111/j.1365-2605.1984.tb00809.x; Stuhlmeier KM, 1997, J BIOL CHEM, V272, P24679, DOI 10.1074/jbc.272.39.24679; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; TANG F, 1982, CONTRACEPTION, V26, P515, DOI 10.1016/0010-7824(82)90150-0; Tatulian SA, 2001, BIOPHYS J, V80, P789, DOI 10.1016/S0006-3495(01)76058-4; Vento R, 2000, EXP EYE RES, V70, P503, DOI 10.1006/exer.1998.0810; Wang J, 2013, MOL BIOSYST, V9, P1489, DOI 10.1039/c3mb25461e; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wolter KG, 2006, NEOPLASIA, V8, P163, DOI 10.1593/neo.05691; Xu YJ, 2008, J CELL MOL MED, V12, P942, DOI 10.1111/j.1582-4934.2008.00139.x; YAO KQ, 1987, J ETHNOPHARMACOL, V20, P25; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yu BZ, 1997, BIOCHEMISTRY-US, V36, P12400, DOI 10.1021/bi962972i; Zerp SF, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-47; Zhang MC, 2003, BIOCHEM PHARMACOL, V66, P93, DOI 10.1016/S0006-2952(03)00248-X; Zhong JT, 2012, CANCER LETT, V323, P180, DOI 10.1016/j.canlet.2012.04.009; Zhu XD, 2001, J IMMUNOL, V167, P461, DOI 10.4049/jimmunol.167.1.461	69	36	36	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16190	16199		10.1074/jbc.M114.562900	http://dx.doi.org/10.1074/jbc.M114.562900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778183	Green Published, hybrid			2022-12-28	WOS:000337965700024
J	Ilinykh, PA; Tigabu, B; Ivanov, A; Ammosova, T; Obukhov, Y; Garron, T; Kumari, N; Kovalskyy, D; Platonov, MO; Naumchik, VS; Freiberg, AN; Nekhai, S; Bukreyev, A				Ilinykh, Philipp A.; Tigabu, Bersabeh; Ivanov, Andrey; Ammosova, Tatiana; Obukhov, Yuri; Garron, Tania; Kumari, Namita; Kovalskyy, Dmytro; Platonov, Maxim O.; Naumchik, Vasiliy S.; Freiberg, Alexander N.; Nekhai, Sergei; Bukreyev, Alexander			Role of Protein Phosphatase 1 in Dephosphorylation of Ebola Virus VP30 Protein and Its Targeting for the Inhibition of Viral Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MARBURG-VIRUS; MESSENGER-RNA; P-PROTEIN; ELONGATION-FACTOR; SPLICING FACTOR; PHOSPHORYLATION; REPLICATION; SEQUENCE; COMPLEX	The filovirus Ebola (EBOV) causes the most severe hemorrhagic fever known. The EBOV RNA-dependent polymerase complex includes a filovirus-specific VP30, which is critical for the transcriptional but not replication activity of EBOV polymerase; to support transcription, VP30 must be in a dephosphorylated form. Here we show that EBOV VP30 is phosphorylated not only at the N-terminal serine clusters identified previously but also at the threonine residues at positions 143 and 146. We also show that host cell protein phosphatase 1 (PP1) controls VP30 dephosphorylation because expression of a PP1-binding peptide cdNIPP1 increased VP30 phosphorylation. Moreover, targeting PP1 mRNA by shRNA resulted in the overexpression of SIPP1, a cytoplasm-shuttling regulatory subunit of PP1, and increased EBOV transcription, suggesting that cytoplasmic accumulation of PP1 induces EBOV transcription. Furthermore, we developed a small molecule compound, 1E7-03, that targeted a non-catalytic site of PP1 and increased VP30 dephosphorylation. The compound inhibited the transcription but increased replication of the viral genome and completely suppressed replication of EBOV in cultured cells. Finally, mutations of Thr(143) and Thr(146) of VP30 significantly inhibited EBOV transcription and strongly induced VP30 phosphorylation in the N-terminal Ser residues 29-46, suggesting a novel mechanism of regulation of VP30 phosphorylation. Our findings suggest that targeting PP1 with small molecules is a feasible approach to achieve dysregulation of the EBOV polymerase activity. This novel approach may be used for the development of antivirals against EBOV and other filovirus species.	[Ilinykh, Philipp A.; Tigabu, Bersabeh; Garron, Tania; Freiberg, Alexander N.; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Garron, Tania; Bukreyev, Alexander] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Ilinykh, Philipp A.; Tigabu, Bersabeh; Garron, Tania; Freiberg, Alexander N.; Bukreyev, Alexander] Galveston Natl Lab, Galveston, TX 77555 USA; [Ivanov, Andrey; Ammosova, Tatiana; Obukhov, Yuri; Kumari, Namita; Nekhai, Sergei] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; [Ammosova, Tatiana; Nekhai, Sergei] Howard Univ, Dept Med, Washington, DC 20059 USA; [Nekhai, Sergei] Howard Univ, Dept Microbiol, Washington, DC 20059 USA; [Kovalskyy, Dmytro; Platonov, Maxim O.; Naumchik, Vasiliy S.] Kiev Natl Taras Shevchenko Univ, UA-01601 Kiev, Ukraine; [Kovalskyy, Dmytro; Platonov, Maxim O.; Naumchik, Vasiliy S.] Enamine Ltd, UA-01103 Kiev, Ukraine	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Howard University; Howard University; Howard University; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Enamine Ltd	Nekhai, S (corresponding author), Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA.	snekhai@howard.edu; alexander.bukreyev@utmb.edu	Ilinykh, Philipp/L-5404-2014; , nekhai/AFO-2652-2022; Platonov, Maxim/D-3238-2015; Ammosova, Tatiana/J-7564-2018; Ammosova, Tatiana/HIA-0704-2022; , nekhai/AAW-3105-2021	Platonov, Maxim/0000-0002-3205-3305; Ammosova, Tatiana/0000-0001-8777-1032; Freiberg, Alexander N/0000-0001-8413-8960; Kumari, Namita/0000-0003-0893-9939	National Institutes of Health [1 U19 AI109664-01, 1SC1GM082325, 1P50HL118006-01, 8G12MD007597]; departmental start-up grant from the University of Texas Medical Branch; District of Columbia Developmental Center for AIDS Research Grant [P30AI087714]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL118006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714, UC7AI094660, U19AI109664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM082325] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); departmental start-up grant from the University of Texas Medical Branch; District of Columbia Developmental Center for AIDS Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 1 U19 AI109664-01 (to A. B.), 1SC1GM082325, 1P50HL118006-01, 8G12MD007597, and 1 U19 AI109664-01(to S. N.). This work was also supported by a departmental start-up grant from the University of Texas Medical Branch (to A. B.) and by District of Columbia Developmental Center for AIDS Research Grant P30AI087714 (to S. N.).	Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Ammosova T, 2003, J BIOL CHEM, V278, P32189, DOI 10.1074/jbc.M300521200; Ammosova T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039481; Ammosova Tatiana, 2011, PLoS One, V6, pe18985, DOI 10.1371/journal.pone.0018985; Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Ammosova T, 2014, BRIT J PHARMACOL, V171, P5059, DOI 10.1111/bph.12863; Asenjo A, 2005, J GEN VIROL, V86, P1109, DOI 10.1099/vir.0.80692-0; Asenjo A, 2006, J GEN VIROL, V87, P3637, DOI 10.1099/vir.0.82165-0; BARIK S, 1992, J VIROL, V66, P1109, DOI 10.1128/JVI.66.2.1109-1118.1992; BARIK S, 1995, VIROLOGY, V213, P405, DOI 10.1006/viro.1995.0013; Bermingham A, 1999, P NATL ACAD SCI USA, V96, P11259, DOI 10.1073/pnas.96.20.11259; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Biedenkopf N, 2013, J BIOL CHEM, V288, P11165, DOI 10.1074/jbc.M113.461285; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BUKREYEV AA, 1995, BIOCHEM MOL BIOL INT, V35, P605; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Centers for Disease Control and Prevention, 2014, OUTBR EB GUIN LIB SI; Collins PL, 1996, P NATL ACAD SCI USA, V93, P81, DOI 10.1073/pnas.93.1.81; COLLINS PL, 1995, P NATL ACAD SCI USA, V92, P11563, DOI 10.1073/pnas.92.25.11563; Dibben O, 2008, VIRUS RES, V131, P47, DOI 10.1016/j.virusres.2007.08.006; Fujiki H., 2009, V46, P221, DOI 10.1007/978-3-540-87895-7_8; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; JAGIELLO I, 1995, J BIOL CHEM, V270, P17257, DOI 10.1074/jbc.270.29.17257; Kuhn J. H., 2008, FILOVIRUSES, P190; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Llorian M, 2005, J BIOL CHEM, V280, P38862, DOI 10.1074/jbc.M509185200; Llorian M, 2004, BIOCHEM J, V378, P229, DOI 10.1042/BJ20030950; Martinez MJ, 2011, J INFECT DIS, V204, pS934, DOI 10.1093/infdis/jir320; Martinez MJ, 2008, J VIROL, V82, P12569, DOI 10.1128/JVI.01395-08; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Modrof J, 2002, J BIOL CHEM, V277, P33099, DOI 10.1074/jbc.M203775200; Modrof J, 2001, VIROLOGY, V287, P171, DOI 10.1006/viro.2001.1027; Muhlberger E, 1998, J VIROL, V72, P8756; Muhlberger E, 1999, J VIROL, V73, P2333; Muhlberger E, 1996, VIROLOGY, V223, P376, DOI 10.1006/viro.1996.0490; Neumann G, 2002, J VIROL, V76, P406, DOI 10.1128/JVI.76.1.406-410.2002; O'Connell N, 2012, STRUCTURE, V20, P1746, DOI 10.1016/j.str.2012.08.003; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Stittelaar KJ, 2008, ANTIVIR RES, V80, P225, DOI 10.1016/j.antiviral.2008.06.014; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Watanabe S, 2007, J INFECT DIS, V196, pS284, DOI 10.1086/520582; Weik M, 2002, J VIROL, V76, P8532, DOI 10.1128/JVI.76.17.8532-8539.2002	48	62	66	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22723	22738		10.1074/jbc.M114.575050	http://dx.doi.org/10.1074/jbc.M114.575050			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24936058	Green Published, hybrid			2022-12-28	WOS:000341017200018
J	Inoue, Y; Hasegawa, S; Ban, S; Yamada, T; Date, Y; Mizutani, H; Nakata, S; Tanaka, M; Hirashima, N				Inoue, Yu; Hasegawa, Seiji; Ban, Sadanori; Yamada, Takaaki; Date, Yasushi; Mizutani, Hiroshi; Nakata, Satoru; Tanaka, Masahiko; Hirashima, Naohide			ZIP2 Protein, a Zinc Transporter, Is Associated with Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS; IRON; SKIN; TRANSCRIPTION; EXPRESSION; PSORIASIS; CELLS	Zinc is essential for the proper functioning of various enzymes and transcription factors, and its homeostasis is rigorously controlled by zinc transporters (SLC39/ZIP, importers; SLC30/ZnT, exporters). Skin disease is commonly caused by a zinc deficiency. Dietary and inherited zinc deficiencies are known to cause alopecia and the development of vesicular or pustular dermatitis. A previous study demonstrated that zinc played crucial roles in the survival of keratinocytes and their unique functions. High levels of zinc have been detected in the epidermis. Epidermal layers are considered to use a mechanism that preferentially takes in zinc, which is involved with the unique functions of keratinocytes. However, few studies have investigated the ZIP (Zrt- and Irt-like protein) proteins specifically expressed in keratinocytes and their functions. We explored the ZIP proteins specifically expressed in the epidermis and analyzed their functions. Gene expression analysis showed that the expression of ZIP2 was consistently higher in the epidermis than in the dermis. Immunohistochemistry analysis confirmed the expression of ZIP2 in differentiating keratinocytes. The expression of ZIP2 was found to be up-regulated by the differentiation induction of cultured keratinocytes. Intracellular zinc levels were decreased in keratinocytes when ZIP2 was knocked down by siRNA, and this subsequently inhibited the differentiation of keratinocytes. Moreover, we demonstrated that ZIP2 knockdown inhibited the normal formation of a three-dimensional cultured epidermis. Taken together, the results of this study suggest that ZIP2, a zinc transporter expressed specifically in the epidermis, and zinc taken up by ZIP2 are necessary for the differentiation of keratinocytes.	[Inoue, Yu; Hasegawa, Seiji; Ban, Sadanori; Yamada, Takaaki; Date, Yasushi; Mizutani, Hiroshi; Nakata, Satoru] Nippon Menard Cosmet Co Ltd, Res Labs, Nishi Ku, Nagoya, Aichi 4510071, Japan; [Inoue, Yu; Tanaka, Masahiko; Hirashima, Naohide] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biophys, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Hasegawa, Seiji; Yamada, Takaaki] Fujita Hlth Univ, Sch Med, Dept Dermatol, Nagoya, Aichi 4701192, Japan; [Yamada, Takaaki] Fujita Hlth Univ, Sch Med, Dept Appl Cell & Regenerat Med, Nagoya, Aichi 4701192, Japan; [Hasegawa, Seiji] Nagoya Univ, Grad Sch Med, Menard Collaborat Res Chair, Showa Ku, Nagoya, Aichi 4668560, Japan	Nagoya City University; Fujita Health University; Fujita Health University; Nagoya University	Inoue, Y (corresponding author), Nippon Menard Cosmet Co Ltd, Res Labs, Nishi Ku, 2-7 Torimicho, Nagoya, Aichi 4510071, Japan.	inoue.yuu@menard.co.jp	Date, Yasushi/C-5349-2016; Hasegawa, Seiji/A-3514-2016	Hasegawa, Seiji/0000-0001-9797-1900; Inoue, Yu/0000-0002-7540-6940				Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Cao J, 2001, J LEUKOCYTE BIOL, V70, P559; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Deters A, 2003, FORSCH KOMP KLAS NAT, V10, P19, DOI 10.1159/000069903; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; HODGE L, 1977, DRUGS, V13, P288, DOI 10.2165/00003495-197713040-00004; HOFFBRAND AV, 1976, BRIT J HAEMATOL, V33, P517, DOI 10.1111/j.1365-2141.1976.tb03570.x; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kodera H, 2008, ANAL SCI, V24, P1545, DOI 10.2116/analsci.24.1545; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MICHAELSSON G, 1980, ACTA DERM-VENEREOL, V60, P295; Peters JL, 2007, GENESIS, V45, P339, DOI 10.1002/dvg.20297; Pinheiro T, 2014, ACTA DERM-VENEREOL, V94, P14, DOI 10.2340/00015555-1601; Rezaei KA, 2008, INVEST OPHTH VIS SCI, V49, P1665, DOI 10.1167/iovs.07-0959; SAKAMOTO M, 1980, BIOCHIM BIOPHYS ACTA, V624, P205, DOI 10.1016/0005-2795(80)90239-1; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Stork CJ, 2010, INT J MOL MED, V26, P463, DOI 10.3892/ijmm_00000486; SUN TT, 1979, P NATL ACAD SCI USA, V76, P2813, DOI 10.1073/pnas.76.6.2813; Underwood EJ, 1977, TRACE ELEMENTS HUMAN, P196; VOORHEES JJ, 1977, ANNU REV MED, V28, P467, DOI 10.1146/annurev.me.28.020177.002343; Wilson D, 2006, IMMUNOL CELL BIOL, V84, P28, DOI 10.1111/j.1440-1711.2005.01391.x; Xue ML, 2004, EXP CELL RES, V299, P119, DOI 10.1016/j.yexcr.2004.05.015; Yamazaki T, 2004, J BIOL CHEM, V279, P32191, DOI 10.1074/jbc.M404029200; Ylva W., 1998, SCANNING MICROSCOPY, V12, P599	27	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21451	21462		10.1074/jbc.M114.560821	http://dx.doi.org/10.1074/jbc.M114.560821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936057	Green Published, hybrid			2022-12-28	WOS:000340558300023
J	Kraemer, BR; Snow, JP; Vollbrecht, P; Pathak, A; Valentine, WM; Deutch, AY; Carter, BD				Kraemer, Bradley R.; Snow, John P.; Vollbrecht, Peter; Pathak, Amrita; Valentine, William M.; Deutch, Ariel Y.; Carter, Bruce D.			A Role for the p75 Neurotrophin Receptor in Axonal Degeneration and Apoptosis Induced by Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; STRIATAL CHOLINERGIC NEURONS; NERVE GROWTH-FACTOR; CELL-DEATH; SYMPATHETIC NEURONS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; INTRACELLULAR DOMAIN; DOPAMINERGIC-NEURONS; MEDIATED APOPTOSIS	The p75 neurotrophin receptor (p75(NTR)) mediates the death of specific populations of neurons during the development of the nervous system or after cellular injury. The receptor has also been implicated as a contributor to neurodegeneration caused by numerous pathological conditions. Because many of these conditions are associated with increases in reactive oxygen species, we investigated whether p75(NTR) has a role in neurodegeneration in response to oxidative stress. Here we demonstrate that p75(NTR) signaling is activated by 4-hydroxynonenal (HNE), a lipid peroxidation product generated naturally during oxidative stress. Exposure of sympathetic neurons to HNE resulted in neurite degeneration and apoptosis. However, these effects were reduced markedly in neurons from p75(NTR-/-) mice. The neurodegenerative effects of HNE were not associated with production of neurotrophins and were unaffected by pretreatment with a receptor-blocking antibody, suggesting that oxidative stress activates p75(NTR) via a ligand-independent mechanism. Previous studies have established that proteolysis of p75(NTR) by the metalloprotease TNF alpha-converting enzyme and gamma-secretase is necessary for p75(NTR)-mediated apoptotic signaling. Exposure of sympathetic neurons to HNE resulted in metalloprotease- and gamma-secretase-dependent cleavage of p75(NTR). Pharmacological blockade of p75(NTR) proteolysis protected sympathetic neurons from HNE-induced neurite degeneration and apoptosis, suggesting that cleavage of p75(NTR) is necessary for oxidant-induced neurodegeneration. In vivo, p75(NTR-/-) mice exhibited resistance to axonal degeneration associated with oxidative injury following administration of the neurotoxin 6-hydroxydopamine. Together, these data suggest a novel mechanism linking oxidative stress to ligand-independent cleavage of p75(NTR), resulting in axonal fragmentation and neuronal death.	[Kraemer, Bradley R.; Snow, John P.; Pathak, Amrita; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Dept Biochem, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Vollbrecht, Peter; Deutch, Ariel Y.] Vanderbilt Univ, Sch Med, Dept Psychiat, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Vollbrecht, Peter; Deutch, Ariel Y.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Valentine, William M.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Vanderbilt Brain Inst, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 625 Light Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu	Pathak, Amrita/O-2363-2019; Pathak, Amrita/AAV-3371-2020; Pathak, Amrita/O-8190-2017	Pathak, Amrita/0000-0003-1396-9868; Pathak, Amrita/0000-0003-1396-9868; Vollbrecht, Peter/0000-0003-4677-3132	National Institutes of Health [R01NS038220, R01MH077298, R01ES019969]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS038220 (to B. D. C.), R01MH077298 (to A. Y. D.), and R01ES019969 (to W. M. V.).	Alavian KN, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-11; ANGELETTI PU, 1970, P NATL ACAD SCI USA, V65, P114, DOI 10.1073/pnas.65.1.114; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bloch A, 2006, NEUROPATH APPL NEURO, V32, P284, DOI 10.1111/j.1365-2990.2006.00727.x; Bothwell M, 2014, Handb Exp Pharmacol, V220, P3, DOI 10.1007/978-3-642-45106-5_1; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Brill A, 2009, CARDIOVASC RES, V84, P137, DOI 10.1093/cvr/cvp176; Bruckner SR, 2002, J NEUROSCI RES, V70, P665, DOI 10.1002/jnr.10437; Caldeira GL, 2013, J ALZHEIMERS DIS, V34, P115, DOI 10.3233/JAD-121444; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Choi S, 2014, NEUROSCIENCE, V257, P11, DOI 10.1016/j.neuroscience.2013.10.058; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; COHEN G, 1974, J BIOL CHEM, V249, P2447; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Del Tredici K, 2010, ACTA NEUROPATHOL, V119, P703, DOI 10.1007/s00401-010-0665-2; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; DEUTCH AY, 1992, NEUROSCIENCE, V46, P49, DOI 10.1016/0306-4522(92)90007-O; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Fischer-Hayes LR, 2013, EXP NEUROL, V246, P6, DOI 10.1016/j.expneurol.2013.05.001; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1996, NATURE, V383, P166; Gerdts J, 2011, J BIOL CHEM, V286, P28011, DOI 10.1074/jbc.M111.250472; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Grau Cristina Malagelada, 2012, Methods Mol Biol, V846, P201, DOI 10.1007/978-1-61779-536-7_18; Greferath U, 2002, NEUROSCI LETT, V332, P57, DOI 10.1016/S0304-3940(02)00928-X; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Irmady K, 2014, J NEUROSCI, V34, P3419, DOI 10.1523/JNEUROSCI.1982-13.2014; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kokaia Z, 1998, NEUROSCIENCE, V84, P1113, DOI 10.1016/S0306-4522(97)00579-4; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; Kraemer B R, 2014, Handb Exp Pharmacol, V220, P121, DOI 10.1007/978-3-642-45106-5_6; Kruman I, 1997, J NEUROSCI, V17, P5089; Kurangi RF, 2006, LIPIDS, V41, P877, DOI 10.1007/s11745-006-5043-4; Kuru S, 2013, NEUROPATH APPL NEURO, V39, P585, DOI 10.1111/nan.12043; Kutuk O, 2004, BIOFACTORS, V20, P1, DOI 10.1002/biof.5520200101; Lee JY, 2006, TOXICOL LETT, V166, P212, DOI 10.1016/j.toxlet.2006.07.305; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Liu W, 2000, J CELL SCI, V113, P635; Lorentz CU, 2013, EXP NEUROL, V249, P111, DOI 10.1016/j.expneurol.2013.08.015; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002; Oh JD, 2000, BRAIN RES, V853, P174, DOI 10.1016/S0006-8993(99)02054-5; Orimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302; Overk CR, 2014, BIOCHEM PHARMACOL, V88, P508, DOI 10.1016/j.bcp.2014.01.015; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Perluigi M, 2012, ANTIOXID REDOX SIGN, V17, P1590, DOI 10.1089/ars.2011.4406; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Sachs BD, 2007, J CELL BIOL, V177, P1119, DOI 10.1083/jcb.200701040; SANER A, 1971, MOL PHARMACOL, V7, P147; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Sgado P, 2006, P NATL ACAD SCI USA, V103, P15242, DOI 10.1073/pnas.0602116103; Shin EJ, 2011, NEUROCHEM INT, V59, P122, DOI 10.1016/j.neuint.2011.03.025; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; THOENEN H, 1973, ANNU REV PHARMACOL, V13, P169, DOI 10.1146/annurev.pa.13.040173.001125; TRANZER JP, 1968, EXPERIENTIA, V24, P155, DOI 10.1007/BF02146956; Turner BJ, 2003, J NEUROCHEM, V87, P752, DOI 10.1046/j.1471-4159.2003.02053.x; Tyurina YY, 2005, AGING CELL, V4, P187, DOI 10.1111/j.1474-9726.2005.00160.x; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Wakabayashi K, 2010, ACTA NEUROPATHOL, V120, P1, DOI 10.1007/s00401-010-0706-x; Wang YQ, 2008, NEUROCHEM INT, V53, P56, DOI 10.1016/j.neuint.2008.06.007; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Zeng F, 2011, BIOCHEM PHARMACOL, V82, P1500, DOI 10.1016/j.bcp.2011.06.040; Zhang ZL, 2001, FASEB J, V15, P303; Zuo L, 2013, GENE, V532, P18, DOI 10.1016/j.gene.2013.07.085	87	43	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21205	21216		10.1074/jbc.M114.563403	http://dx.doi.org/10.1074/jbc.M114.563403			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939843	hybrid, Green Published			2022-12-28	WOS:000340558300001
J	Cheng, F; Cappai, R; Lidfeldt, J; Belting, M; Fransson, LA; Mani, K				Cheng, Fang; Cappai, Roberto; Lidfeldt, Jon; Belting, Mattias; Fransson, Lars-Ake; Mani, Katrin			Amyloid Precursor Protein (APP)/APP-like Protein 2 (APLP2) Expression Is Required to Initiate Endosome-Nucleus-Autophagosome Trafficking of Glypican-1-derived Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; ALZHEIMERS-DISEASE; MAMMALIAN-CELLS; A-BETA; NEURODEGENERATIVE DISEASE; DEPENDENT AUTOCLEAVAGE; DEGRADATION-PRODUCTS; DEAMINATIVE CLEAVAGE; APP; LOCALIZATION	Anhydromannose (anMan)-containing heparan sulfate (HS) derived from the proteoglycan glypican-1 is generated in endosomes by an endogenously or ascorbate-induced S-nitrosothiol-catalyzed reaction. Processing of the amyloid precursor protein (APP) and APP-like protein 2 (APLP2) by beta- and gamma-secretases into amyloid beta (A beta) and A beta-like peptides also takes place in these compartments. Moreover, anMan-containing HS suppresses the formation of toxic A beta assemblies in vitro. We showed by using deconvolution immunofluorescence microscopy with an anMan-specific monoclonal antibody as well as S-35 labeling experiments that expression of APP/APLP2 is required for ascorbate-induced transport of HS from endosomes to the nucleus. Nuclear translocation was observed in wild-type mouse embryonic fibroblasts (WT MEFs), Tg2576 MEFs, and N2a neuroblastoma cells but not in APP(-/-) and APLP2(-/-) MEFs. Transfection of APP(-/-) cells with a vector encoding APP restored nuclear import of anMan-containing HS. In WT MEFs and N2a neuroblastoma cells exposed to beta- or gamma-secretase inhibitors, nuclear translocation was greatly impeded, suggesting involvement of APP/APLP2 degradation products. In Tg2576 MEFs, the beta-inhibitor blocked transport, but the gamma-inhibitor did not. During chase in ascorbate-free medium, anMan-containing HS disappeared from the nuclei of WT MEFs. Confocal immunofluorescence microscopy showed that they appeared in acidic, LC3-positive vesicles in keeping with an autophagosomal location. There was increased accumulation of anMan-containing HS in nuclei and cytosolic vesicles upon treatment with chloroquine, indicating that HS was degraded in lysosomes. Manipulations of APP expression and processing may have deleterious effects upon HS function in the nucleus.	[Cheng, Fang; Fransson, Lars-Ake; Mani, Katrin] Lund Univ, Div Neurosci, Dept Expt Med Sci, Glycobiol Grp,Biomed Ctr A13, SE-22184 Lund, Sweden; [Cappai, Roberto] Univ Melbourne, Dept Pathol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Lidfeldt, Jon; Belting, Mattias] Lund Univ, Dept Clin Sci, Sect Oncol & Pathol, SE-22185 Lund, Sweden; [Belting, Mattias] Skane Oncol Clin, SE-22185 Lund, Sweden	Lund University; University of Melbourne; Lund University	Mani, K (corresponding author), Lund Univ, Div Neurosci, Dept Expt Med Sci, Glycobiol Grp,Biomed Ctr A13, SE-22184 Lund, Sweden.	katrin.mani@med.lu.se	Cappai, Roberto/B-3347-2010	Cappai, Roberto/0000-0002-9505-8496; Lidfeldt, Jon/0000-0002-8440-6512; Belting, Mattias/0000-0003-1585-5434; Mani, Katrin/0000-0002-1821-0634	Swedish Research Council; Alfred Osterlund Foundation; Olle Engkvist Foundation; Kock Foundation; National Health and Medical Research Council of Australia; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Alfred Osterlund Foundation; Olle Engkvist Foundation; Kock Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants from the Swedish Research Council; Alfred Osterlund, Kock, and Olle Engkvist Foundations (to F. C., L.-A. F., and K. M.); National Health and Medical Research Council of Australia (to R. C.); and Swedish Cancer Society (to M. B.).	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; BHAVANANDAN VP, 1975, P NATL ACAD SCI USA, V72, P2032, DOI 10.1073/pnas.72.6.2032; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Cappai R, 2005, J BIOL CHEM, V280, P13913, DOI 10.1074/jbc.M409179200; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Cheng F, 2013, GLYCOBIOLOGY, V23, P1510, DOI 10.1093/glycob/cwt079; Cheng F, 2012, GLYCOBIOLOGY, V22, P1480, DOI 10.1093/glycob/cws111; Cheng F, 2011, J BIOL CHEM, V286, P27559, DOI 10.1074/jbc.M111.243345; Ding K, 2002, J BIOL CHEM, V277, P33353, DOI 10.1074/jbc.M203383200; Ding K, 2001, J BIOL CHEM, V276, P46779, DOI 10.1074/jbc.M105419200; Dudas J., BIOCH J, V350, P245; FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587; Gouras GK, 2012, LIFE SCI, V91, P1153, DOI 10.1016/j.lfs.2012.06.004; HISCOCK DRR, 1994, J BIOL CHEM, V269, P4539; Hogl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021337; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; Kagan BL, 2012, PROG MOL BIOL TRANSL, V107, P295, DOI [10.1016/B978-0-12-385883-2.00001-1, 10.1016/B978-0-12-385883-2.00009-6]; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; Mani K, 2003, J BIOL CHEM, V278, P38956, DOI 10.1074/jbc.M300394200; Mani K, 2007, J BIOL CHEM, V282, P21934, DOI 10.1074/jbc.M701200200; Mani K, 2006, GLYCOBIOLOGY, V16, P1251, DOI 10.1093/glycob/cwl045; Mani K, 2006, GLYCOBIOLOGY, V16, P711, DOI 10.1093/glycob/cwj121; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Regberg Jakob, 2013, Front Biosci (Elite Ed), V5, P509; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Shariati SAM, 2013, FEBS LETT, V587, P2036, DOI 10.1016/j.febslet.2013.05.026; Stewart MD, 2014, MATRIX BIOL, V35, P56, DOI 10.1016/j.matbio.2013.10.009; Svensson G, 2009, GLYCOCONJUGATE J, V26, P1247, DOI 10.1007/s10719-009-9243-z; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Watanabe N, 2004, FASEB J, V18, P1013, DOI 10.1096/fj.03-1040fje; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215	36	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20871	20878		10.1074/jbc.M114.552810	http://dx.doi.org/10.1074/jbc.M114.552810			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898256	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000339396600041
J	He, WX; Hu, JX; Xia, YX; Yan, RQ				He, Wanxia; Hu, Jinxuan; Xia, Yuxing; Yan, Riqiang			beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) Regulates Notch Signaling by Controlling the Cleavage of Jagged 1 (Jag1) and Jagged 2 (Jag2) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; SECRETASE BACE1; ALAGILLE-SYNDROME; INTRACELLULAR DOMAIN; ALPHA-SECRETASE; LIGAND JAGGED1; MICE; MYELINATION; GENERATION; RELEASE	BACE1 is a type I transmembrane aspartyl protease that cleaves amyloid precursor protein at the beta-secretase site to initiate the release of beta-amyloid peptide. As a secretase, BACE1 also cleaves additional membrane-bound molecules by exerting various cellular functions. In this study, we showed that BACE1 can effectively shed the membrane-anchored signaling molecule Jagged 1 (Jag1). We also mapped the cleavage sites of Jag1 by ADAM10 and ADAM17. Although Jag1 shares a high degree of homology with Jag2 in the ectodomain region, BACE1 fails to cleave Jag2 effectively, indicating a selective cleavage of Jag1. Abolished cleavage of Jag1 in BACE1-null mice leads to enhanced astrogenesis and, concomitantly, reduced neurogenesis. This characterization provides biochemical evidence that the Jag1-Notch pathway is under the control of BACE1 activity.	[He, Wanxia; Hu, Jinxuan; Xia, Yuxing; Yan, Riqiang] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Yan, RQ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	yanr@ccf.org		Yan, Riqiang/0000-0001-7195-7617; Xia, Yuxing/0000-0002-8415-8256	National Institutes of Health [AG025493, AG046929, NS074256]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025493, R01AG046929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health Grants AG025493, AG046929, and NS074256. To whom correspondence should be addressed: Dept. of Neurosciences, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-2690; Fax: 216-444-7927; E-mail: yanr@ccf.org.	Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2013, CELL REP, V4, P40, DOI 10.1016/j.celrep.2013.06.005; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Parr-Sturgess CA, 2010, BIOCHEM J, V432, P283, DOI 10.1042/BJ20100321; Ponio JBD, 2007, HUM MOL GENET, V16, P2683, DOI 10.1093/hmg/ddm222; Qahwash I, 2004, J BIOL CHEM, V279, P39010, DOI 10.1074/jbc.M407101200; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; Turner RT, 2002, BIOCHEMISTRY-US, V41, P8742, DOI 10.1021/bi025926t; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yuan ZR, 1998, HUM MOL GENET, V7, P1363, DOI 10.1093/hmg/7.9.1363	44	26	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20630	20637		10.1074/jbc.M114.579862	http://dx.doi.org/10.1074/jbc.M114.579862			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907271	Green Published, hybrid			2022-12-28	WOS:000339396600022
J	Janes, K; Little, JW; Li, C; Bryant, L; Chen, C; Chen, ZM; Kamocki, K; Doyle, T; Snider, A; Esposito, E; Cuzzocrea, S; Bieberich, E; Obeid, L; Petrache, I; Nicol, G; Neumann, WL; Salvemini, D				Janes, Kali; Little, Joshua W.; Li, Chao; Bryant, Leesa; Chen, Collin; Chen, Zhoumou; Kamocki, Krzysztof; Doyle, Timothy; Snider, Ashley; Esposito, Emanuela; Cuzzocrea, Salvatore; Bieberich, Erhard; Obeid, Lina; Petrache, Irina; Nicol, Grant; Neumann, William L.; Salvemini, Daniela			The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NERVE GROWTH-FACTOR; PERIPHERAL NEUROPATHY; S1P(1) RECEPTOR; PROTEIN-KINASE; LYMPHOCYTE EGRESS; SENSORY NEURONS; NITRIC-OXIDE; DORSAL-HORN; SPINAL-CORD	The ceramide-sphingosine 1-phosphate (S1P) rheostat is important in regulating cell fate. Several chemotherapeutic agents, including paclitaxel (Taxol), involve pro-apoptotic ceramide in their anticancer effects. The ceramide-to-S1P pathway is also implicated in the development of pain, raising the intriguing possibility that these sphingolipids may contribute to chemotherapy-induced painful peripheral neuropathy, which can be a critical dose-limiting side effect of many widely used chemotherapeutic agents. We demonstrate that the development of paclitaxel-induced neuropathic pain was associated with ceramide and S1P formation in the spinal dorsal horn that corresponded with the engagement of S1P receptor subtype 1 (S1PR(1))-dependent neuroinflammatory processes as follows: activation of redox-sensitive transcription factors (NF kappa B) and MAPKs (ERK and p38) as well as enhanced formation of pro-inflammatory and neuroexcitatory cytokines (TNF-alpha and IL-1 beta). Intrathecal delivery of the S1PR1 antagonist W146 reduced these neuroinflammatory processes but increased IL-10 and IL-4, potent anti-inflammatory/neuroprotective cytokines. Additionally, spinal W146 reversed established neuropathic pain. Noteworthy, systemic administration of the S1PR1 modulator FTY720 (Food and Drug Administration-approved for multiple sclerosis) attenuated the activation of these neuroinflammatory processes and abrogated neuropathic pain without altering anticancer properties of paclitaxel and with beneficial effects extended to oxaliplatin. Similar effects were observed with other structurally and chemically unrelated S1PR1 modulators (ponesimod and CYM-5442) and S1PR1 antagonists (NIBR-14/15) but not S1PR1 agonists (SEW2871). Our findings identify for the first time the S1P/S1PR(1) axis as a promising molecular and therapeutic target in chemotherapy-induced painful peripheral neuropathy, establish a mechanistic insight into the biomolecular signaling pathways, and provide the rationale for the clinical evaluation of FTY720 in chronic pain patients.	[Janes, Kali; Little, Joshua W.; Bryant, Leesa; Chen, Collin; Chen, Zhoumou; Doyle, Timothy; Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Li, Chao; Nicol, Grant] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Kamocki, Krzysztof; Petrache, Irina] Indiana Univ Sch Med, Dept Biochem & Mol Biol & Med, Indianapolis, IN 46202 USA; [Snider, Ashley; Obeid, Lina] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Snider, Ashley; Obeid, Lina] Northport Vet Affairs Med Ctr, Northport, NY 11768 USA; [Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Dept Clin & Expt Med & Pharmacol, I-98122 Messina, Italy; [Bieberich, Erhard] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Neumann, William L.] So Illinois Univ, Sch Pharm, Dept Pharmaceut Sci, Edwardsville, IL 62026 USA	Saint Louis University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Messina; University System of Georgia; Augusta University; Southern Illinois University System; Southern Illinois University Edwardsville	Salvemini, D (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 South Grand Blvd, St Louis, MO 63104 USA.	salvemd@slu.edu	Petrache, Irina/AAZ-9648-2020	obeid, lina/0000-0002-0734-0847; Esposito, Emanuela/0000-0002-2663-6387; Cuzzocrea, Salvatore/0000-0001-6131-3690	Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health [C06 RR015481-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328] Funding Source: NIH RePORTER	Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr Gary J. Bennett (McGill University, Montreal, Canada) for pertinent insight, guidance, and helpful suggestions with the writing of this paper. The studies performed in GDN's laboratory were conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR015481-01 from the National Center for Research Resources, National Institutes of Health.	Adan-Gokbulut A, 2013, CURR MED CHEM, V20, P108; Angst D, 2012, J MED CHEM, V55, P9722, DOI 10.1021/jm3009508; Bennett GJ, 2010, ONCOLOGIST, V15, P9, DOI 10.1634/theoncologist.2009-S503; Bigaud M., 2013, BIOCHIM BIOPHYS ACTA, P745; Blondeau N, 2007, J NEUROCHEM, V103, P509, DOI 10.1111/j.1471-4159.2007.04755.x; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brossard P, 2013, BRIT J CLIN PHARMACO, V76, P888, DOI 10.1111/bcp.12129; Burgos E, 2012, EUR J PHARMACOL, V682, P62, DOI 10.1016/j.ejphar.2012.02.008; Cata JP, 2006, MINERVA ANESTESIOL, V72, P151; Cata JP, 2006, NEUROSCIENCE, V138, P329, DOI 10.1016/j.neuroscience.2005.11.009; Chen ZM, 2012, FASEB J, V26, P1855, DOI 10.1096/fj.11-201541; Chi XX, 2010, J NEUROPHYSIOL, V104, P2741, DOI 10.1152/jn.00709.2010; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Coste O, 2008, J BIOL CHEM, V283, P32442, DOI 10.1074/jbc.M806410200; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; Dahan L, 2009, BRIT J PHARMACOL, V158, P610, DOI 10.1111/j.1476-5381.2009.00341.x; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dobrowsky RT, 2001, METHOD CELL BIOL, V66, P135; Doyle T, 2011, FASEB J, V25, P2782, DOI 10.1096/fj.10-178095; Doyle T, 2011, NEUROSCI LETT, V499, P4, DOI 10.1016/j.neulet.2011.05.018; Doyle T, 2012, J NEUROSCI, V32, P6149, DOI 10.1523/JNEUROSCI.6343-11.2012; Durafourt BA, 2011, J NEUROIMMUNOL, V230, P10, DOI 10.1016/j.jneuroim.2010.08.006; Farquhar-Smith Paul, 2011, Curr Opin Support Palliat Care, V5, P1, DOI 10.1097/SPC.0b013e328342f9cc; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrier J, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0364-5; Finley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055255; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Fryer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052985; Gao M, 2013, NEUROSCIENCE, V254, P301, DOI 10.1016/j.neuroscience.2013.09.033; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Gonzalez-Cabrera PJ, 2012, MOL PHARMACOL, V81, P166, DOI 10.1124/mol.111.076109; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Huwiler A, 2003, BIOL CHEM, V384, P1379, DOI 10.1515/BC.2003.154; Itamochi H, 2011, CLIN CANCER RES, V17, P4742, DOI 10.1158/1078-0432.CCR-11-0190; Jackson SJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-76; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jin SX, 2003, J NEUROSCI, V23, P4017; Joseph EK, 2004, EUR J NEUROSCI, V20, P2896, DOI 10.1111/j.1460-9568.2004.03750.x; Kriedt Christopher L, 2010, J Exp Ther Oncol, V8, P287; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Lee MK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-57; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Little JW, 2012, J NEUROSCI, V32, P10797, DOI 10.1523/JNEUROSCI.6345-11.2012; Mair N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017268; Marvizon JCG, 2009, J COMP NEUROL, V517, P51, DOI 10.1002/cne.22130; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Muscoli C, 2010, J NEUROSCI, V30, P15400, DOI 10.1523/JNEUROSCI.2391-10.2010; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Nicol Grant D., 2008, Shengli Xuebao, V60, P603; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Paterniti I, 2012, SURGERY, V152, P90, DOI 10.1016/j.surg.2012.02.004; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perrotta C, 2010, PHYSIOLOGY, V25, P64, DOI 10.1152/physiol.00048.2009; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Salvemini D, 2013, TRENDS PHARMACOL SCI, V34, P110, DOI 10.1016/j.tips.2012.12.001; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah MR, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-84; Snider AJ, 2010, BIOCHIMIE, V92, P707, DOI 10.1016/j.biochi.2010.02.008; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Verzijl D, 2010, MOL CELLS, V29, P99, DOI 10.1007/s10059-010-0041-z; Wang XM, 2012, CYTOKINE, V59, P3, DOI 10.1016/j.cyto.2012.03.027; Warwick RA, 2013, EUR J PAIN, V17, P571, DOI 10.1002/j.1532-2149.2012.00219.x; Welch SP, 2012, BIOCHEM PHARMACOL, V84, P1551, DOI 10.1016/j.bcp.2012.08.010; Weng HR, 2005, NEUROSCI LETT, V386, P18, DOI 10.1016/j.neulet.2005.05.049; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Won JS, 2006, FREE RADICAL BIO MED, V40, P1875, DOI 10.1016/j.freeradbiomed.2006.01.035; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023; Yan XS, 2013, J BIOL CHEM, V288, P30544, DOI 10.1074/jbc.M113.495465; Youle M, 2007, HIV MED, V8, P241, DOI 10.1111/j.1468-1293.2007.00467.x; Zhang H., 2012, J PAIN, V3, P239; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhang YH, 2004, NEUROSCI LETT, V366, P187, DOI 10.1016/j.neulet.2004.05.042; Zheng FY, 2011, NEUROSCIENCE, V176, P447, DOI 10.1016/j.neuroscience.2010.12.052	91	93	101	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21082	21097		10.1074/jbc.M114.569574	http://dx.doi.org/10.1074/jbc.M114.569574			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24876379	hybrid, Green Published			2022-12-28	WOS:000339396600059
J	Mori, Y; Fukuda, M; Henley, JM				Mori, Yasunori; Fukuda, Mitsunori; Henley, Jeremy M.			Small GTPase Rab17 Regulates the Surface Expression of Kainate Receptors but Not alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors in Hippocampal Neurons via Dendritic Trafficking of Syntaxin-4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECYCLING ENDOSOMES; SYNAPTIC PLASTICITY; EPITHELIAL-CELLS; LOCALIZATION; MORPHOGENESIS; SPINES; LTP	Glutamate receptors are fundamental for control synaptic transmission, synaptic plasticity, and neuronal excitability. However, many of the molecular mechanisms underlying their trafficking remain elusive. We previously demonstrated that the small GTPase Rab17 regulates dendritic trafficking in hippocampal neurons. Here, we investigated the role(s) of Rab17 in AMPA receptor (AMPAR) and kainate receptor (KAR) trafficking. Although Rab17 knockdown did not affect surface expression of the AMPAR subunit GluA1 under basal or chemically induced long term potentiation conditions, it significantly reduced surface expression of the KAR subunit GluK2. Rab17 co-localizes with Syntaxin-4 in the soma, dendritic shaft, the tips of developing hippocampal neurons, and in spines. Rab17 knockdown caused Syntaxin-4 redistribution away from dendrites and into axons in developing hippocampal neurons. Syntaxin-4 knockdown reduced GluK2 but had no effect on GluA1 surface expression. Moreover, overexpression of constitutively active Rab17 promoted dendritic surface expression of GluK2 by enhancing Syntaxin-4 translocation to dendrites. These data suggest that Rab17 mediates the dendritic trafficking of Syntaxin-4 to selectively regulate dendritic surface insertion of GluK2-containing KARs in rat hippocampal neurons.	[Mori, Yasunori; Henley, Jeremy M.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan	University of Bristol; Tohoku University	Mori, Y (corresponding author), Doshisha Univ, Lab Neural Membrane Biol, Grad Sch Brain Sci, 1-3 Miyakodani, Kyotanabe, Kyoto 6100394, Japan.	yasumori@mail.doshisha.ac.jp; j.m.henley@bristol.ac.uk	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; Henley, Jeremy/0000-0003-3589-8335	Uehara Memorial Foundation; Ministry of Education, Culture, Sports, and Technology of Japan; Daiichi-Sankyo Foundation of Life Science; European Research Council; Medical Research Council; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/F00723X/1] Funding Source: researchfish; Medical Research Council [MR/L003791/1] Funding Source: researchfish; BBSRC [BB/F00723X/1] Funding Source: UKRI; MRC [MR/L003791/1] Funding Source: UKRI	Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiichi-Sankyo Foundation of Life Science; European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Uehara Memorial Foundation (to Y. M.), grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology of Japan, the Daiichi-Sankyo Foundation of Life Science (to M. F.), the European Research Council, the Medical Research Council, and the Biotechnology and Biological Sciences Research Council (to J. M. H.).	Band AM, 2002, FEBS LETT, V531, P513, DOI 10.1016/S0014-5793(02)03605-0; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Feligioni M, 2006, J NEUROCHEM, V99, P549, DOI 10.1111/j.1471-4159.2006.04087.x; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Gonzalez-Gonzalez IM, 2013, TRAFFIC, V14, P810, DOI 10.1111/tra.12071; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Jaafari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052345; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Li L, 2001, J BIOL CHEM, V276, P5265, DOI 10.1074/jbc.M003883200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Martin S, 2008, J BIOL CHEM, V283, P36435, DOI 10.1074/jbc.M806447200; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Monnerie H, 2006, J NEUROSCI RES, V83, P944, DOI 10.1002/jnr.20805; Mori Y, 2013, BIOCHEM BIOPH RES CO, V435, P113, DOI 10.1016/j.bbrc.2013.04.051; Mori Y, 2013, J BIOL CHEM, V288, P9835, DOI 10.1074/jbc.M112.427591; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; Nakamura K, 2007, EUR J NEUROSCI, V26, P3054, DOI 10.1111/j.1460-9568.2007.05868.x; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Rocca DL, 2013, NEURON, V79, P293, DOI 10.1016/j.neuron.2013.05.003; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suzuki F, 1997, EXP NEUROL, V145, P203, DOI 10.1006/exnr.1997.6469; Veale KJ, 2010, TRAFFIC, V11, P1370, DOI 10.1111/j.1600-0854.2010.01094.x; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yatsu A, 2013, J INVEST DERMATOL, V133, P2237, DOI 10.1038/jid.2013.156; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039	34	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20773	20787		10.1074/jbc.M114.550632	http://dx.doi.org/10.1074/jbc.M114.550632			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895134	hybrid, Green Published			2022-12-28	WOS:000339396600033
J	Perez, WB; Kinzy, TG				Perez, Winder B.; Kinzy, Terri Goss			Translation Elongation Factor 1A Mutants with Altered Actin Bundling Activity Show Reduced Aminoacyl-tRNA Binding and Alter Initiation via eIF2 alpha Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; F-ACTIN; NUCLEOTIDE EXCHANGE; GUANINE-NUCLEOTIDE; TERNARY COMPLEX; PROTEIN-SYNTHESIS; OSMOTIC-STRESS; FACTOR TU; YEAST; CYTOSKELETON	Apart from its canonical function in translation elongation, eukaryotic translation elongation factor 1A (eEF1A) has been shown to interact with the actin cytoskeleton. Amino acid substitutions in eEF1A that reduce its ability to bind and bundle actin in vitro cause improper actin organization in vivo and reduce total translation. Initial in vivo analysis indicated the reduced translation was through initiation. The mutant strains exhibit increased levels of phosphorylated initiation factor 2 alpha (eIF2 alpha) dependent on the presence of the general control non-derepressible 2 (Gcn2p) protein kinase. Gcn2p causes down-regulation of total protein synthesis at initiation in response to increases in deacylated tRNA levels in the cell. Increased levels of eIF2 alpha phosphorylation are not due to a general reduction in translation elongation as eEF2 and eEF3 mutants do not exhibit this effect. Deletion of GCN2 from the eEF1A actin bundling mutant strains revealed a second defect in translation. The eEF1A actin-bundling proteins exhibit changes in their elongation activity at the level of aminoacyl-tRNA binding in vitro. These findings implicate eEF1A in a feedback mechanism for regulating translation at initiation.	[Perez, Winder B.; Kinzy, Terri Goss] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	kinzytg@rutgers.edu		Kinzy, Terri/0000-0003-1394-9226	National Institutes of Health [GM57483, T32AI007403, R25 GM055145]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483, R25GM055145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57483 (to T. G. K.) and T32AI007403 and R25 GM055145 (Initiative to Maximize Student Diversity) (to W. B. P).	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; Beznoskova P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003962; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; Bretscher A, 2003, J CELL BIOL, V160, P811, DOI 10.1083/jcb.200301035; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; Chang YWE, 1998, EUR J BIOCHEM, V251, P201, DOI 10.1046/j.1432-1327.1998.2510201.x; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; DANG CV, 1983, J CELL BIOL, V96, P1138, DOI 10.1083/jcb.96.4.1138; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; DUFFY LK, 1981, BIOCHEMISTRY-US, V20, P4663, DOI 10.1021/bi00519a022; Edmonds BT, 1998, J BIOL CHEM, V273, P10288, DOI 10.1074/jbc.273.17.10288; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; HOWE JG, 1984, CELL, V37, P85; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; KINZY TG, 1992, J BIOL CHEM, V267, P1623; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; Lin KW, 2010, CURR BIOL, V20, P1615, DOI 10.1016/j.cub.2010.08.017; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Muaddi H, 2010, MOL BIOL CELL, V21, P3220, DOI 10.1091/mbc.E10-01-0023; Munshi R, 2001, GENETICS, V157, P1425; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; SAFER B, 1975, J BIOL CHEM, V250, P9076; SANDBAKEN MG, 1988, GENETICS, V120, P923; Sasikumar AN, 2014, J BIOL CHEM, V289, P4853, DOI 10.1074/jbc.M113.536201; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Uesono Y, 2004, MOL BIOL CELL, V15, P1544, DOI 10.1091/mbc.E03-12-0877; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; Umikawa M, 1998, ONCOGENE, V16, P2011, DOI 10.1038/sj.onc.1201724; Visweswaraiah J, 2011, J BIOL CHEM, V286, P36568, DOI 10.1074/jbc.M111.248898; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877	50	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20928	20938		10.1074/jbc.M114.570077	http://dx.doi.org/10.1074/jbc.M114.570077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936063	hybrid, Green Published			2022-12-28	WOS:000339396600046
J	Hudson, BD; Shimpukade, B; Milligan, G; Ulven, T				Hudson, Brian D.; Shimpukade, Bharat; Milligan, Graeme; Ulven, Trond			The Molecular Basis of Ligand Interaction at Free Fatty Acid Receptor 4 (FFA4/GPR120)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; AGONIST RECOGNITION; CRYSTAL-STRUCTURE; GPR120; GPR40; IDENTIFICATION; POTENT; GPCRS; ANTAGONIST; CHALLENGES	The long-chain fatty acid receptor FFA4 (previously GPR120) is receiving substantial interest as a novel target for the treatment of metabolic and inflammatory disease. This study examines for the first time the detailed mode of binding of both long-chain fatty acid and synthetic agonist ligands at FFA4 by integrating molecular modeling, receptor mutagenesis, and ligand structure-activity relationship approaches in an iterative format. In doing so, residues required for binding of fatty acid and synthetic agonists to FFA4 have been identified. This has allowed for the refinement of a well validated model of the mode of ligand-FFA4 interaction that will be invaluable in the identification of novel ligands and the future development of this receptor as a therapeutic target. The model reliably predicted the effects of substituent variations on agonist potency, and it was also able to predict the qualitative effect of binding site mutations in the majority of cases.	[Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Shimpukade, Bharat; Ulven, Trond] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense M, Denmark	University of Glasgow; University of Southern Denmark	Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk; ulven@sdu.dk	Ulven, Trond/H-5500-2015; Hudson, B. D./H-4845-2013	Ulven, Trond/0000-0002-8135-1755; Hudson, B. D./0000-0001-7059-0091; Shimpukade, Bharat/0000-0001-7468-2348	Danish Council for Strategic Research Grant [11-116196]; Biotechnology and Biosciences Research Council [BB/K019864/1]; Canadian Institutes of Health Research; BBSRC [BB/K019864/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K019864/1] Funding Source: researchfish	Danish Council for Strategic Research Grant(Danske Strategiske Forskningsrad (DSF)); Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Danish Council for Strategic Research Grant 11-116196 (to T. U. and G. M.), the Biotechnology and Biosciences Research Council Grant BB/K019864/1 (to G. M.), and the Canadian Institutes of Health Research fellowship (to B. D. H.).	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Congreve M, 2011, ADV PHARMACOL, V62, P1, DOI 10.1016/B978-0-12-385952-5.00011-7; Correll C. C., 2014, J MED CHEM, DOI 10.1021/jm401677g; Dranse HJ, 2013, BRIT J PHARMACOL, V170, P696, DOI 10.1111/bph.12327; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; Genheden S, 2012, J CHEM INF MODEL, V52, P3013, DOI [10.1021/ci300349a, 10.1021/ci300349s]; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holliday Nicholas D, 2011, Front Endocrinol (Lausanne), V2, P112, DOI 10.3389/fendo.2011.00112; Hudson BD, 2011, ADV PHARMACOL, V62, P175, DOI 10.1016/B978-0-12-385952-5.00006-3; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Hudson BD, 2013, CURR TOP MED CHEM, V13, P14; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Schrodinger, 2013, LIGPREP VERSION 2 6; Schrodinger L, 2013, SCHRODINGER SUITE 20; Schrodinger LLC, 2012, MACROMODEL VERSION 9; Schrodinger LLC, 2013, PRIME VERSION 3 2; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sun Q, 2010, MOL PHARMACOL, V78, P804, DOI 10.1124/mol.110.066324; Suzuki T, 2008, J MED CHEM, V51, P7640, DOI 10.1021/jm800970b; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004	39	51	52	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20345	20358		10.1074/jbc.M114.561449	http://dx.doi.org/10.1074/jbc.M114.561449			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24860101	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000339395200045
J	Kumar, S; Tepper, K; Kaniyappan, S; Biernat, J; Wegmann, S; Mandelkow, EM; Muller, DJ; Mandelkow, E				Kumar, Satish; Tepper, Katharina; Kaniyappan, Senthilvelrajan; Biernat, Jacek; Wegmann, Susanne; Mandelkow, Eva-Maria; Mueller, Daniel J.; Mandelkow, Eckhard			Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; PATHOLOGICAL TAU; ENDOGENOUS-TAU; BETA-STRUCTURE; MOUSE MODEL; PROTEIN-TAU; IN-VITRO; OLIGOMERS	Several neurodegenerative diseases are characterized by the aggregation and posttranslational modifications of Tau protein. Its "repeat domain" (TauRD) is mainly responsible for the aggregation properties, and oligomeric forms are thought to dominate the toxic effects of Tau. Here we investigated the conformational transitions of this domain during oligomerization and aggregation in different states of beta-propensity and pseudophosphorylation, using several complementary imaging and spectroscopic methods. Although the repeat domain generally aggregates more readily than full-length Tau, its aggregation was greatly slowed down by phosphorylation or pseudo-phosphorylation at the KXGS motifs, concomitant with an extended phase of oligomerization. Analogous effects were observed with pro-aggregant variants of TauRD. Oligomers became most evident in the case of the pro-aggregant mutant TauRD Delta K280, as monitored by atomic force microscopy, and the fluorescence lifetime of Alexa-labeled Tau (time-correlated single photon counting (TCSPC)), consistent with its pronounced toxicity in mouse models. In cell models or primary neurons, neither oligomers nor fibrils of TauRD or TauRD Delta K280 had a toxic effect, as seen by assays with lactate dehydrogenase and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, respectively. However, oligomers of pro-aggregant TauRD Delta K280 specifically caused a loss of spine density in differentiated neurons, indicating a locally restricted impairment of function.	[Kumar, Satish; Tepper, Katharina; Kaniyappan, Senthilvelrajan; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Tepper, Katharina; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] Ctr Adv European Studies & Res CAESAR, D-53175 Bonn, Germany; [Kumar, Satish; Kaniyappan, Senthilvelrajan; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] DESY, Max Planck Inst Neurol Res, Hamburg Outstn, D-22607 Hamburg, Germany; [Wegmann, Susanne; Mueller, Daniel J.] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mandelkow, E (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany.	Eckhard.Mandelkow@dzne.de	Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665; Kaniyappan, Senthilvelrajan/0000-0002-0606-2769	German Center for Neurodegenerative Diseases; Max-Planck-Gesellschaft (MPG); Bundesministerium fur Bildung und Forschung (BMBF; Kompetenznetz Neurodegenerative Demenzen (KNDD program); Wellcome Trust/MRC; Tau Consortium	German Center for Neurodegenerative Diseases; Max-Planck-Gesellschaft (MPG)(Max Planck Society); Bundesministerium fur Bildung und Forschung (BMBF; Kompetenznetz Neurodegenerative Demenzen (KNDD program)(Federal Ministry of Education & Research (BMBF)); Wellcome Trust/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Tau Consortium	This work was supported by the German Center for Neurodegenerative Diseases, Max-Planck-Gesellschaft (MPG), Bundesministerium fur Bildung und Forschung (BMBF; Kompetenznetz Neurodegenerative Demenzen (KNDD program), the Wellcome Trust/MRC, and the Tau Consortium.	Akoury E, 2013, J AM CHEM SOC, V135, P2853, DOI 10.1021/ja312471h; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Blair LJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt207; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Combs B, 2011, BIOCHEMISTRY-US, V50, P9446, DOI 10.1021/bi2010569; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Fath T, 2002, J NEUROSCI, V22, P9733; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Giurleo JT, 2008, J MOL BIOL, V381, P1332, DOI 10.1016/j.jmb.2008.06.043; Gotz J, 2010, NEURODEGENER DIS, V7, P10, DOI 10.1159/000283475; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Guzman-Martinez L, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00167; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Jones EM, 2012, BIOCHEMISTRY-US, V51, P2539, DOI 10.1021/bi201857v; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Lakowicz JR, 2006, PLASMONICS, V1, P5, DOI 10.1007/s11468-005-9002-3; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Liu C, 2011, J AM CHEM SOC, V133, P6736, DOI 10.1021/ja200222n; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Meraz-Rios MA, 2010, J NEUROCHEM, V112, P1353, DOI 10.1111/j.1471-4159.2009.06511.x; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Ren Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00102; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Sahoo B, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2969110; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Trojanowski JQ, 2005, NAT NEUROSCI, V8, P1136, DOI 10.1038/nn0905-1136; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wang YP, 2012, BIOCHEM SOC T, V40, P644, DOI 10.1042/BST20120071; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xu SH, 2010, ALZHEIMERS DEMENT, V6, P110, DOI 10.1016/j.jalz.2009.06.002; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	81	53	54	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20318	20332		10.1074/jbc.M114.554725	http://dx.doi.org/10.1074/jbc.M114.554725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24825901	Green Published, hybrid			2022-12-28	WOS:000339395200043
J	Watanabe, R; Matsukage, Y; Yukawa, A; Tabata, KV; Noji, H				Watanabe, Rikiya; Matsukage, Yuki; Yukawa, Ayako; Tabata, Kazuhito V.; Noji, Hiroyuki			Robustness of the Rotary Catalysis Mechanism of F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP SYNTHASE; ESCHERICHIA-COLI; TORQUE GENERATION; F0F1-ATP SYNTHASE; PHOSPHATE RELEASE; MOLECULAR MOTOR; F-1 MOTOR; ROTATION; SUBUNIT; MYOSIN	F-1-ATPase (F-1) is the rotary motor protein fueled by ATP hydrolysis. Previous studies have suggested that three charged residues are indispensable for catalysis of F-1 as follows: the P-loop lysine in the phosphate-binding loop, GXXXXGK(T/S); a glutamic acid that activates water molecules for nucleophilic attack on the gamma-phosphate of ATP (general base); and an arginine directly contacting the gamma-phosphate (arginine finger). These residues are well conserved among P-loop NTPases. In this study, we investigated the role of these charged residues in catalysis and torque generation by analyzing alanine-substituted mutants in the single-molecule rotation assay. Surprisingly, all mutants continuously drove rotary motion, even though the rotational velocity was at least 100,000 times slower than that of wild type. Thus, although these charged residues contribute to highly efficient catalysis, they are not indispensable to chemo-mechanical energy coupling, and the rotary catalysis mechanism of F-1 is far more robust than previously thought.	[Watanabe, Rikiya; Yukawa, Ayako; Tabata, Kazuhito V.; Noji, Hiroyuki] Univ Tokyo, Dept Appl Chem, Tokyo 1138656, Japan; [Watanabe, Rikiya; Tabata, Kazuhito V.] Japan Sci & Technol Agcy, PRESTO, Bunkyo Ku, Tokyo 1138656, Japan; [Matsukage, Yuki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Osaka University	Noji, H (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Watanabe, Rikiya/AAO-1390-2021; 田端, 和仁/GON-3471-2022	Watanabe, Rikiya/0000-0001-7146-2745; 田端, 和仁/0000-0002-0463-1374	Ministry of Education, Culture, Sports, Science and Technology, Japan [18074005, 30540108]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 18074005 (to H. N.) and 30540108 (to R. W.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; AMANO T, 1994, FEBS LETT, V348, P93, DOI 10.1016/0014-5793(94)00588-5; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cherepanov DA, 2001, BIOPHYS J, V81, P1234, DOI 10.1016/S0006-3495(01)75781-5; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Dittrich M, 2004, BIOPHYS J, V87, P2954, DOI 10.1529/biophysj.104.046128; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Hayashi S, 2012, J AM CHEM SOC, V134, P8447, DOI 10.1021/ja211027m; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Iko Y, 2001, J BIOL CHEM, V276, P47508, DOI 10.1074/jbc.M108803200; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kohori A, 2011, BIOPHYS J, V101, P188, DOI 10.1016/j.bpj.2011.05.008; Komoriya Y, 2012, J BIOL CHEM, V287, P15134, DOI 10.1074/jbc.M111.328153; Le NP, 2000, BIOCHEMISTRY-US, V39, P2778, DOI 10.1021/bi992530h; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; McGrath MJ, 2013, J AM CHEM SOC, V135, P8908, DOI 10.1021/ja401540g; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, P20550, DOI 10.1073/pnas.1117024108; Muneyuki E, 2000, BBA-BIOENERGETICS, V1458, P467, DOI 10.1016/S0005-2728(00)00095-5; NAKAMOTO RK, 1992, ANN NY ACAD SCI, V671, P335, DOI 10.1111/j.1749-6632.1992.tb43807.x; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Spetzler D, 2009, BIOCHEMISTRY-US, V48, P7979, DOI 10.1021/bi9008215; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Tanigawara M, 2012, BIOPHYS J, V103, P970, DOI 10.1016/j.bpj.2012.06.054; Usukura E, 2012, J BIOL CHEM, V287, P1884, DOI 10.1074/jbc.M111.305938; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; Yagi H, 2009, J BIOL CHEM, V284, P2374, DOI 10.1074/jbc.M808212200; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	48	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19331	19340		10.1074/jbc.M114.569905	http://dx.doi.org/10.1074/jbc.M114.569905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24876384	Green Published, hybrid			2022-12-28	WOS:000339326800010
J	Touhara, KK; Nihira, T; Kitaoka, M; Nakai, H; Fushinobu, S				Touhara, Kouki K.; Nihira, Takanori; Kitaoka, Motomitsu; Nakai, Hiroyuki; Fushinobu, Shinya			Structural Basis for Reversible Phosphorolysis and Hydrolysis Reactions of 2-O-alpha-Glucosylglycerol Phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-D-GLUCOSYLGLYCEROL; THERMOANAEROBACTER-BROCKII; MALTOSE PHOSPHORYLASE; DIRECTED EVOLUTION; TREHALOSE; THERMOSTABILITY; RECOGNITION; ENZYMES; CLONING; GENE	2-O-alpha-Glucosylglycerol phosphorylase (GGP) from Bacillus selenitireducens catalyzes both the reversible phosphorolysis of 2-O-alpha-glucosylglycerol (GG) and the hydrolysis of beta-D-glucose 1-phosphate (beta Glc1P). GGP belongs to the glycoside hydrolase (GH) family 65 and can efficiently and specifically produce GG. However, its structural basis has remained unclear. In this study, the crystal structures of GGP complexed with glucose and the glucose analog isofagomine and glycerol were determined. Subsite -1 of GGP is similar to those of other GH65 enzymes, maltose phosphorylase and kojibiose phosphorylase, whereas subsite +1 is largely different and is well designed for GG recognition. An automated docking analysis was performed to complement these crystal structures, beta Glc1P being docked at an appropriate position. To investigate the importance of residues at subsite +1 in the bifunctionality of GGP, we constructed mutants at these residues. Y327F and K587A did not show detectable activities for either reverse phosphorolysis or beta Glc1P hydrolysis. Y572F also showed significantly reduced activities for both of these reactions. In contrast, W381F showed significantly reduced reverse phosphorolytic activity but retained beta Glc1P hydrolysis. The mode of substrate recognition and the reaction mechanisms of GGP were proposed based on these analyses. Specifically, an extensive hydrogen bond network formed by Tyr-327, Tyr-572, Lys-587, and water molecules contributes to fixing the acceptor molecule in both reverse phosphorolysis( glycerol) and beta Glc1P hydrolysis(water) for a glycosyl transfer reaction. This study will contribute to the development of a large scale production system of GG by facilitating the rational engineering of GGP.	[Touhara, Kouki K.; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Nihira, Takanori; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Kitaoka, Motomitsu/R-1536-2019	Fushinobu, Shinya/0000-0003-1346-6435; Kitaoka, Motomitsu/0000-0002-0083-1838; Touhara, Kouki/0000-0003-3167-9784	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; MEXT; NISR; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NISR; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, and in part by the MEXT program "Promotion of Environmental Improvement for Independence of Young Researchers" under the Special Coordination Funds for Promoting Science and Technology, a NISR Young Investigator Research Grant in 2012, and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Andersson U, 2001, J BIOL CHEM, V276, P42707, DOI 10.1074/jbc.M108279200; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Cerdobbel A, 2011, PROTEIN ENG DES SEL, V24, P829, DOI 10.1093/protein/gzr042; De Groeve MRM, 2009, PROTEIN ENG DES SEL, V22, P393, DOI 10.1093/protein/gzp017; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Ehrmann MA, 1998, FEMS MICROBIOL LETT, V169, P81, DOI 10.1016/S0378-1097(98)00467-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FITTING C, 1952, J BIOL CHEM, V199, P153; Fushinobu S, 2007, J APPL GLYCOSCI, V54, P95; Hagemann M, 1998, MICR EXTREM UNUSUAL, P177; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Koyama Y, 2013, PROTEIN ENG DES SEL, V26, P755, DOI 10.1093/protein/gzt049; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Luley-Goedl C, 2010, FOOD TECHNOL BIOTECH, V48, P276; Luley-Goedl C, 2010, CARBOHYD RES, V345, P1736, DOI 10.1016/j.carres.2010.05.022; Luley-Goedl C, 2010, CARBOHYD RES, V345, P1492, DOI 10.1016/j.carres.2010.03.035; Maruta K, 2002, BIOSCI BIOTECH BIOCH, V66, P1976, DOI 10.1271/bbb.66.1976; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakai H, 2010, PROTEIN ENG DES SEL, V23, P781, DOI 10.1093/protein/gzq055; Nihira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086548; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nihira T, 2012, CARBOHYD RES, V350, P94, DOI 10.1016/j.carres.2011.12.019; Nishimoto M, 2012, J MOL CATAL B-ENZYM, V74, P97, DOI 10.1016/j.molcatb.2011.09.004; Okada S, 2014, FEBS J, V281, P778, DOI 10.1111/febs.12622; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Sawangwan T, 2010, BIOTECHNOL J, V5, P187, DOI 10.1002/biot.200900197; Takenaka F, 2000, BIOSCI BIOTECH BIOCH, V64, P1821, DOI 10.1271/bbb.64.1821; Takenaka F, 2000, BIOSCI BIOTECH BIOCH, V64, P378, DOI 10.1271/bbb.64.378; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yamamoto T, 2004, J BIOSCI BIOENG, V98, P99, DOI 10.1263/jbb.98.99; Yamamoto T, 2006, J BIOSCI BIOENG, V101, P427, DOI 10.1263/jbb.101.427	36	14	15	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18067	18075		10.1074/jbc.M114.573212	http://dx.doi.org/10.1074/jbc.M114.573212			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828502	Green Published, hybrid			2022-12-28	WOS:000338042000010
J	van der Hagen, EAE; Tudpor, K; Verkaart, S; Lavrijsen, M; van der Kemp, A; van Zeeland, F; Bindels, RJM; Hoenderop, JGJ				van der Hagen, Eline A. E.; Tudpor, Kukiat; Verkaart, Sjoerd; Lavrijsen, Marla; van der Kemp, Annemiete; van Zeeland, Femke; Bindels, Rene J. M.; Hoenderop, Joost G. J.			beta 1-Adrenergic Receptor Signaling Activates the Epithelial Calcium Channel, Transient Receptor Potential Vanilloid Type 5 (TRPV5), via the Protein Kinase A Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGESTIVE-HEART-FAILURE; CONVOLUTED TUBULE CELLS; BETA-ADRENERGIC-RECEPTORS; BETA(2)-ADRENERGIC RECEPTORS; PARATHYROID-HORMONE; CA2+ TRANSPORT; RAT-KIDNEY; EXPRESSION; EPINEPHRINE; MODULATION	Epinephrine and norepinephrine are present in the pro-urine. beta-Adrenergic receptor (beta-AR) blockers administered to counteract sympathetic overstimulation in patients with congestive heart failure have a negative inotropic effect, resulting in reduced cardiac contractility. Positive inotropes, beta 1-AR agonists, are used to improve cardiac functions. Active Ca2+ reabsorption in the late distal convoluted and connecting tubules (DCT2/CNT) is initiated by Ca2+ influx through the transient receptor potential vanilloid type 5 (TRPV5) Ca2+ channel. Although it was reported that beta-ARs are present in the DCT2/CNT region, their role in active Ca2+ reabsorption remains elusive. Here we revealed that beta 1-AR, but not beta 2-AR, is localized with TRPV5 in DCT2/CNT. Subsequently, treatment of TRPV5-expressing mouse DCT2/CNT primary cell cultures with the beta 1-AR agonist dobutamine showed enhanced apical-to-basolateral transepithelial Ca2+ transport. In human embryonic kidney (HEK293) cells, dobutamine was shown to stimulate cAMP production, signifying functional beta 1-AR expression. Fura-2 experiments demonstrated increased activity of TRPV5 in response to dobutamine, which could be prevented by the PKA inhibitor H89. Moreover, nonphosphorylable T709A-TRPV5 and phosphorylation-mimicking T709D-TRPV5 mutants were unresponsive to dobutamine. Surface biotinylation showed that dobutamine did not affect plasma membrane abundance of TRPV5. In conclusion, activation of beta 1-AR stimulates active Ca2+ reabsorption in DCT2/CNT; an increase in TRPV5 activity via PKA phosphorylation of residue Thr-709 possibly plays an important role. These data explicate a calciotropic role in addition to the inotropic property of beta 1-AR.	[van der Hagen, Eline A. E.; Tudpor, Kukiat; Verkaart, Sjoerd; Lavrijsen, Marla; van der Kemp, Annemiete; van Zeeland, Femke; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Joost.Hoenderop@radboudumc.nl	Tudpor, Kukiat/GSM-7368-2022; Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; Tudpor, Kukiat/0000-0002-8533-5891	Netherlands Organization for Scientific Research (NWO-ALW) [819.02.012]	Netherlands Organization for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Netherlands Organization for Scientific Research (NWO-ALW) Grant 819.02.012.	Alsafwah S, 2007, CLIN MED RES, V5, P238, DOI 10.3121/cmr.2007.737; Boivin V, 2001, KIDNEY INT, V59, P515, DOI 10.1046/j.1523-1755.2001.059002515.x; Bollano E, 2003, HEART, V89, P621, DOI 10.1136/heart.89.6.621; Borkowski BJ, 2011, EUR HEART J, V32, P1846, DOI 10.1093/eurheartj/ehr063; Bylund DB, 2007, AM J PHYSIOL-ENDOC M, V293, pE1479, DOI 10.1152/ajpendo.00664.2007; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Charoenphandhu N, 2006, AM J PHYSIOL-GASTR L, V291, pG446, DOI 10.1152/ajpgi.00108.2006; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; ELALOUF JM, 1993, J CLIN INVEST, V91, P264, DOI 10.1172/JCI116180; Erraji-Benchekroun L, 2005, AM J PHYSIOL-ENDOC M, V288, pE715, DOI 10.1152/ajpendo.00113.2004; Evans BA, 1998, BRIT J PHARMACOL, V124, P763, DOI 10.1038/sj.bjp.0701867; FURCHGOTT RF, 1959, PHARMACOL REV, V11, P429; GEFFNER DL, 1992, AM J MED, V93, P61, DOI 10.1016/0002-9343(92)90681-Z; GESEK FA, 1992, J CLIN INVEST, V90, P429, DOI 10.1172/JCI115878; Gesek FA, 1997, AM J PHYSIOL-RENAL, V272, pF712, DOI 10.1152/ajprenal.1997.272.6.F712; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; HAYES JR, 1983, IRISH J MED SCI, V152, P422, DOI 10.1007/BF02958811; Hellgren I, 2000, BIOL PHARM BULL, V23, P700; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2002, BBA-PROTEINS PROTEOM, V1600, P6, DOI 10.1016/S1570-9639(02)00438-7; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Hofmeister MV, 2009, AM J PHYSIOL-RENAL, V296, pF194, DOI 10.1152/ajprenal.90495.2008; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Kang HS, 2000, AM J PHYSIOL-RENAL, V279, pF1116, DOI 10.1152/ajprenal.2000.279.6.F1116; Lambers TT, 2006, EMBO J, V25, P2978, DOI 10.1038/sj.emboj.7601186; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; MALLIANI A, 1983, EUR HEART J, V4, P49, DOI 10.1093/eurheartj/4.suppl_A.49; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; Motoyama HI, 2002, AM J PHYSIOL-RENAL, V283, pF399, DOI 10.1152/ajprenal.00346.2001; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nordin BEC, 1997, NUTRITION, V13, P664, DOI 10.1016/S0899-9007(97)00136-6; Shane E, 1997, AM J MED, V103, P197, DOI 10.1016/S0002-9343(97)00142-3; SNAVELY MD, 1985, ENDOCRINOLOGY, V117, P2182, DOI 10.1210/endo-117-5-2182; Taylor SH, 1996, EUR HEART J, V17, P43, DOI 10.1093/eurheartj/17.suppl_B.43; Topala CN, 2009, CELL CALCIUM, V45, P331, DOI 10.1016/j.ceca.2008.12.003; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Zannad F, 2001, HYPERTENSION, V38, P1227, DOI 10.1161/hy1101.099484; Ziegler MG, 1997, KIDNEY INT, V51, P324, DOI 10.1038/ki.1997.40	40	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18489	18496		10.1074/jbc.M113.491274	http://dx.doi.org/10.1074/jbc.M113.491274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828496	hybrid, Green Published			2022-12-28	WOS:000338042000045
J	Ye, F; Kim, SJ; Kim, C				Ye, Feng; Kim, Se-Jong; Kim, Chungho			Intermolecular Transmembrane Domain Interactions Activate Integrin alpha IIb beta 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE COMPLEMENTATION; MECHANISM; AFFINITY; BINDING; ROLES	Integrins are the major cell adhesion molecules responsible for cell attachment to the extracellular matrix. The strength of integrin-mediated adhesion is controlled by the affinity of individual integrins (integrin activation) as well as by the number of integrins involved in such adhesion. The positive correlation between integrin activation and integrin clustering had been suggested previously, but several trials to induce integrin clustering by dimerization of the transmembrane domain or tail region of integrin alpha subunits failed to demonstrate any change in integrin activation. Here, using platelet integrin alpha IIb beta 3 as a model system, we showed that there is intermolecular lateral interaction between integrins through the transmembrane domains, and this interaction can enhance the affinity state of integrins. In addition, when integrin clustering was induced through heteromeric lateral interactions using bimolecular fluorescence complementation, we could observe a significant increase in the number of active integrin molecules. Because the possibility of intermolecular interaction would be increased by a higher local concentration of integrins, we propose that integrin clustering can shift the equilibrium in favor of integrin activation.	[Ye, Feng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kim, Se-Jong; Kim, Chungho] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	University of California System; University of California San Diego; Korea University	Kim, C (corresponding author), Korea Univ, Dept Life Sci, Seoul 136701, South Korea.	chungho@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A1007773]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Education Grant NRF-2013R1A1A1007773.	Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim CH, 2012, J CELL BIOL, V197, P605, DOI 10.1083/jcb.201112141; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shyu YJ, 2008, TRENDS BIOTECHNOL, V26, P622, DOI 10.1016/j.tibtech.2008.07.006; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050	21	8	8	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18507	18513		10.1074/jbc.M113.541888	http://dx.doi.org/10.1074/jbc.M113.541888			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24838247	Green Published, hybrid			2022-12-28	WOS:000338042000047
J	Chen, KQ; Xiang, Y; Huang, JQ; Gong, WH; Yoshimura, T; Jiang, Q; Tessarollo, L; Le, YY; Wang, JM				Chen, Keqiang; Xiang, Yi; Huang, Jiaqiang; Gong, Wanghua; Yoshimura, Teizo; Jiang, Qun; Tessarollo, Lino; Le, Yingying; Wang, Ji Ming			The Formylpeptide Receptor 2 (Fpr2) and Its Endogenous Ligand Cathelin-related Antimicrobial Peptide (CRAMP) Promote Dendritic Cell Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-DEFENSE; CHEMOTACTIC AGONIST; IDENTIFICATION; RESPONSES; INFLAMMATION; ACTIVATION; EXPRESSION; BINDING	Mouse formylpeptide receptor 2 (Fpr2) is a homologue of the human G-protein coupled chemoattractant receptor FPR2, which interacts with pathogen and host-derived chemotactic agonists. Our previous studies revealed reduced allergic airway inflammation and immune responses in Fpr2-deficient (Fpr2(-/-)) mice in association with diminished dendritic cell (DC) recruitment into the airway and draining lymph nodes. These defects prompted us to investigate the potential changes in the differentiation and maturation of DCs caused by Fpr2 deficiency. Bone marrow monocytes from Fpr2(-/-) mouse mice incubated with GM-CSF and IL-4 in vitro showed normal expression of markers of immature DCs. However, upon stimulation with the TLR4 agonist LPS, Fpr2(-/-) mouse DCs failed to express normal levels of maturation markers with reduced production of IL-12 and diminished chemotaxis in response to the DC homing chemokine CCL21. Fpr2(-/-) DCs also failed to induce allogeneic T-cell proliferation in vitro, and their recruitment into the T-cell zones of the spleen was reduced after antigen immunization. The capacity of Fpr2 to sustain normal DC maturation was dependent on its interaction with an endogenous ligand CRAMP expressed by DCs, because neutralization of either Fpr2 or CRAMP inhibited DC maturation in response to LPS. We additionally observed that the presence of exogenous CRAMP in culture increased the sensitivity of WT mouse DCs to LPS stimulation. The importance of CRAMP for DC maturation was further demonstrated by the observations that DCs from CRAMP(-/-) mice expressed lower levels of costimulatory molecules and MHC II and exhibited poor chemotaxis in response to CCL21 after LPS stimulation. Our observations indicate a nonredundant role for Fpr2 and its agonist CRAMP in DC maturation in immune responses.	[Chen, Keqiang; Xiang, Yi; Huang, Jiaqiang; Yoshimura, Teizo; Wang, Ji Ming] NCI, Lab Mol Immunoregulat, Canc & Inflammat Program, Frederick, MD 21702 USA; [Jiang, Qun] NCI, Lab Expt Immunol, Canc & Inflammat Program, Frederick, MD 21702 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA; [Xiang, Yi] Shanghai Jiao Tong Univ, Dept Pulm Med, Rui Jin Hosp, Sch Med, Shanghai 200025, Peoples R China; [Huang, Jiaqiang] Beijing Jiaotong Univ, Sch Sci, Coll Life Sci & Bioengn, Beijing 100044, Peoples R China; [Gong, Wanghua] SAIC Frederick, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Le, Yingying] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Shanghai Jiao Tong University; Beijing Jiaotong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, JM (corresponding author), NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Bldg 560,Rm 31-76, Frederick, MD 21702 USA.	wangji@mail.nih.gov	Le, Yingying/L-9785-2017; Huang, Jiaqiang/C-2375-2011	Le, Yingying/0000-0002-7990-3899; Huang, Jiaqiang/0000-0002-6610-8159; Yoshimura, Teizo/0000-0002-3853-2075	National Institutes of Health [HHSN261200800001E]; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC011265, ZIABC010015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN261200800001E. This work was also supported by the Intramural Research Program of the NCI, National Institutes of Health.	Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen KQ, 2013, J BIOL CHEM, V288, P16262, DOI 10.1074/jbc.M113.450635; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Horibe K, 2013, IMMUNOLOGY, V140, P344, DOI 10.1111/imm.12146; Hu JY, 2001, J LEUKOCYTE BIOL, V70, P155; Huggins A, 2009, FASEB J, V23, P985, DOI 10.1096/fj.08-119040; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Lim LHK, 1998, P NATL ACAD SCI USA, V95, P14535, DOI 10.1073/pnas.95.24.14535; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Liu Y, 2013, CANCER RES, V73, P550, DOI 10.1158/0008-5472.CAN-12-2290; Lukacs-Kornek V, 2008, FRONT BIOSCI-LANDMRK, V13, P2238, DOI 10.2741/2838; Menard S, 2008, J EXP MED, V205, P183, DOI 10.1084/jem.20071022; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sun RH, 2004, J IMMUNOL, V173, P428, DOI 10.4049/jimmunol.173.1.428; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	36	29	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17553	17563		10.1074/jbc.M113.535674	http://dx.doi.org/10.1074/jbc.M113.535674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24808174	Green Published, hybrid			2022-12-28	WOS:000338018100021
J	Li, XH; Thompson, D; Kumar, B; DeMartino, GN				Li, Xiaohua; Thompson, David; Kumar, Brajesh; DeMartino, George N.			Molecular and Cellular Roles of PI31 (PSMF1) Protein in Regulation of Proteasome Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S PROTEASOME; 20S PROTEASOME; HUMAN-ERYTHROCYTES; STRUCTURAL BASIS; SUBSTRATE ENTRY; CORE PARTICLE; CDNA CLONING; AAA SUBUNITS; ATP BINDING; C-TERMINI	We investigated molecular features and cellular roles of PI31 (PSMF1) on regulation of proteasome function. PI31 has a C-terminal HbYX (where Hb is a hydrophobic amino acid, Y is tyrosine, and X is any amino acid) motif characteristic of several proteasome activators. Peptides corresponding to the PI31 C terminus also bind to and activate the 20 S proteasome in an HbYX-dependent manner, but intact PI31protein inhibits in vitro 20 S activity. Binding to and inhibition of the proteasome by PI31 are conferred by the HbYX-containing proline-rich C-terminal domain but do not require HbYX residues. Thus, multiple regions of PI31 bind independently to the proteasome and collectively determine effects on activity. PI31 blocks the ATP-dependent in vitro assembly of 26 S proteasome from 20 S proteasome and PA700 subcomplexes but has no effect on in vitro activity of the intact 26 S proteasome. To determine the physiologic significance of these in vitro effects, we assessed multiple aspects of cellular proteasome content and function after altering PI31 levels. We detected no change in overall cellular proteasome content or function when PI31 levels were either increased by moderate ectopic overexpression or decreased by RNA interference (RNAi). We also failed to identify a role of PI31 ADP-ribosylation as a mechanism for regulation of overall 26 S proteasome content and function, as recently proposed. Thus, despite its in vitro effects on various proteasome activities and its structural relationship to established proteasome regulators, cellular roles and mechanisms of PI31 in regulation of proteasome function remain unclear and require future definition.	[Li, Xiaohua; Thompson, David; Kumar, Brajesh; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu			National Institutes of Health (NIDDK) [DK46181]; Welch Foundation [I-1500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046181, R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46181 (NIDDK; to G. N. D.). This work was also supported by the Welch Foundation (I-1500; to G. N. D.).	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; AKIYAMA KY, 1994, SCIENCE, V265, P1231, DOI 10.1126/science.8066462; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gaczynska M, 1996, J BIOL CHEM, V271, P17275, DOI 10.1074/jbc.271.29.17275; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; MA CP, 1994, J BIOL CHEM, V269, P3539; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MA CP, 1992, J BIOL CHEM, V267, P10515; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; Murata S, 2008, CURR OPIN IMMUNOL, V20, P192, DOI 10.1016/j.coi.2008.03.002; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Sasaki K, 2010, MOL CELL BIOL, V30, P3864, DOI 10.1128/MCB.00216-10; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Stadtmueller BM, 2012, J BIOL CHEM, V287, P37371, DOI 10.1074/jbc.M112.367003; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807	53	39	42	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17392	17405		10.1074/jbc.M114.561183	http://dx.doi.org/10.1074/jbc.M114.561183			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24770418	Green Published, hybrid			2022-12-28	WOS:000338018100009
J	Loerch, S; Maucuer, A; Manceau, V; Green, MR; Kielkopf, CL				Loerch, Sarah; Maucuer, Alexandre; Manceau, Valerie; Green, Michael R.; Kielkopf, Clara L.			Cancer-relevant Splicing Factor CAPER alpha Engages the Essential Splicing Factor SF3b155 in a Specific Ternary Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-RECOGNITION MOTIF; N-TERMINAL DOMAIN; BINDING; PROTEIN; PHOSPHORYLATION; SPLICEOSOME; MUTATIONS; U2AF(65); KINASE; SF1	U2AF homology motifs (UHMs) mediate protein-protein interactions with U2AF ligand motifs (ULMs) of pre-mRNA splicing factors. The UHM-containing alternative splicing factor CAPER alpha regulates splicing of tumor-promoting VEGF isoforms, yet the molecular target of the CAPER alpha UHM is unknown. Here we present structures of the CAPER alpha UHM bound to a representative SF3b155 ULM at 1.7 angstrom resolution and, for comparison, in the absence of ligand at 2.2 angstrom resolution. The prototypical UHM/ULM interactions authenticate CAPER alpha as a bona fide member of the UHM family of proteins. We identify SF3b155 as the relevant ULM-containing partner of full-length CAPER alpha in human cell extracts. Isothermal titration calorimetry comparisons of the purified CAPER alpha UHM binding known ULM-containing proteins demonstrate that high affinity interactions depend on the presence of an intact, intrinsically unstructured SF3b155 domain containing seven ULM-like motifs. The interplay among bound CAPER alpha molecules gives rise to the appearance of two high affinity sites in the SF3b155 ULM-containing domain. In conjunction with the previously identified, UHM/ULM-mediated complexes of U2AF(65) and SPF45 with SF3b155, this work demonstrates the capacity of SF3b155 to offer a platform for coordinated recruitment of UHM-containing splicing factors.	[Loerch, Sarah; Kielkopf, Clara L.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Maucuer, Alexandre; Manceau, Valerie; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Maucuer, Alexandre; Manceau, Valerie; Green, Michael R.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Maucuer, Alexandre; Manceau, Valerie; Green, Michael R.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Rochester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kielkopf, CL (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	clara_kielkopf@urmc.rochester.edu	Maucuer, Alexandre/B-1069-2019	Maucuer, Alexandre/0000-0003-2947-6654; Loerch, Sarah/0000-0002-1731-516X; Kielkopf, Clara/0000-0002-7648-8271	National Institutes of Health [R01 GM070503, R01 GM035490, S10 RR026501]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035490, R01GM070503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM070503 (to C. L. K.), R01 GM035490 (to M. R. G.), and S10 RR026501.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Cass DM, 2006, BIOCHEMISTRY-US, V45, P10092, DOI 10.1021/bi060429o; Cazalla D, 2005, MOL CELL BIOL, V25, P2969, DOI 10.1128/MCB.25.8.2969-2980.2005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Corsini L, 2009, J BIOL CHEM, V284, P630, DOI 10.1074/jbc.M805395200; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dowhan DH, 2005, MOL CELL, V17, P429, DOI 10.1016/j.molcel.2004.12.025; Dutta J, 2008, J VIROL, V82, P10792, DOI 10.1128/JVI.00903-08; Ellis JD, 2008, J CELL BIOL, V181, P921, DOI 10.1083/jcb.200710051; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang GX, 2012, CANCER-AM CANCER SOC, V118, P2106, DOI 10.1002/cncr.26488; Hubbard SJ, 1993, NACCESS COMPUTER PRO; IMAI H, 1993, J CLIN INVEST, V92, P2419, DOI 10.1172/JCI116848; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jung DJ, 2002, J BIOL CHEM, V277, P1229, DOI 10.1074/jbc.M110417200; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konde E, 2010, BIOCHEMISTRY-US, V49, P8020, DOI 10.1021/bi101153w; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Lemieux ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024153; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Manceau V, 2008, J MOL BIOL, V381, P748, DOI 10.1016/j.jmb.2008.06.026; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Maucuer A, 2000, EUR J BIOCHEM, V267, P4456, DOI 10.1046/j.1432-1327.2000.01493.x; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Page-McCaw PS, 1999, RNA, V5, P1548, DOI 10.1017/S1355838299991938; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shao W, 2012, MOL CELL BIOL, V32, P470, DOI 10.1128/MCB.06234-11; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Uversky Vladimir N, 2012, Methods Mol Biol, V896, P179, DOI 10.1007/978-1-4614-3704-8_11; Wan YZ, 2013, BLOOD, V121, P4627, DOI 10.1182/blood-2013-02-427641; Wang WH, 2013, STRUCTURE, V21, P197, DOI 10.1016/j.str.2012.10.020; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Webb TR, 2013, DRUG DISCOV TODAY, V18, P43, DOI 10.1016/j.drudis.2012.07.013; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; Zhang Y, 2013, NUCLEIC ACIDS RES, V41, P1343, DOI 10.1093/nar/gks1097	56	33	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17325	17337		10.1074/jbc.M114.558825	http://dx.doi.org/10.1074/jbc.M114.558825			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24795046	Green Published, hybrid			2022-12-28	WOS:000338018100004
J	Flynn, R; Chapman, K; Iftinca, M; Aboushousha, R; Varela, D; Altier, C				Flynn, Robyn; Chapman, Kevin; Iftinca, Mircea; Aboushousha, Reem; Varela, Diego; Altier, Christophe			Targeting the Transient Receptor Potential Vanilloid Type 1 (TRPV1) Assembly Domain Attenuates Inflammation-induced Hypersensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED ION-CHANNEL; CAPSAICIN RECEPTOR; PAIN; OSTEOARTHRITIS; MODEL; IDENTIFICATION; SENSITIZATION; DETERMINANTS; SENSITIVITY; ANTAGONIST	The transient receptor potential channel vanilloid type 1 (TRPV1) is a non-selective cation channel expressed in sensory neurons of the dorsal root and trigeminal ganglia. TRPV1 is a polymodal channel activated by noxious heat, capsaicin, and protons. As a sensor for noxious stimuli, TRPV1 channel has been described as a key contributor to pain signaling. To form a functional channel, TRPV1 subunits must assemble into tetramers, and several studies have identified the TRPV1 C terminus as an essential element in subunit association. Here we combined biochemical assays with electrophysiology and imaging-based bimolecular fluorescence complementation (BiFC) and bioluminescence resonance energy transfer (BRET) in live cells to identify a short motif in the C-terminal tail of the TRPV1 subunit that governs channel assembly. Removing this region through early truncation or targeted deletion results in loss of subunit association and channel function. Importantly, we found that interfering with TRPV1 subunit association using a plasma membrane-tethered peptide attenuated mechanical and thermal hypersensitivity in two mouse models of inflammatory hyperalgesia. This represents a novel mechanism to disrupt TRPV1 subunit assembly and hence may offer a new analgesic tool for pain relief.	[Flynn, Robyn; Chapman, Kevin; Iftinca, Mircea; Aboushousha, Reem; Altier, Christophe] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Flynn, Robyn; Chapman, Kevin; Iftinca, Mircea; Aboushousha, Reem; Altier, Christophe] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada; [Varela, Diego] Univ Chile, Ctr Estudios Mol Celula, Santiago 8380453, Chile; [Varela, Diego] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago 8380453, Chile	University of Calgary; University of Calgary; Universidad de Chile; Universidad de Chile	Altier, C (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	altier@ucalgary.ca	Varela, Diego/AAG-7489-2019	Varela, Diego/0000-0002-9352-414X; Aboushousha, Reem/0000-0003-2284-2180	Heart and Stroke Foundation of Canada; Canadian Institute of Health Research; Fondo Nacional de Ciencia y Tecnologia [1120240]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fondo Nacional de Ciencia y Tecnologia	This work was supported by the Heart and Stroke Foundation of Canada and the Canadian Institute of Health Research.; Recipient of Fondo Nacional de Ciencia y Tecnologia Grant 1120240.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Bourinet E, 2014, PHYSIOL REV, V94, P81, DOI 10.1152/physrev.00023.2013; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chu KL, 2011, BRAIN RES, V1369, P158, DOI 10.1016/j.brainres.2010.10.101; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; De-la-Rosa V, 2013, J BIOL CHEM, V288, P29506, DOI 10.1074/jbc.M113.479618; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Fischer MJM, 2013, J NEUROSCI, V33, P7407, DOI 10.1523/JNEUROSCI.3721-12.2013; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Harvey VL, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-18; Heroux M, 2007, J BIOL CHEM, V282, P31610, DOI 10.1074/jbc.M701790200; Honore P, 2009, PAIN, V142, P27, DOI 10.1016/j.pain.2008.11.004; Jeske NA, 2009, PAIN, V146, P301, DOI 10.1016/j.pain.2009.08.002; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Jung J, 1999, J NEUROSCI, V19, P529; Kalff KM, 2010, EUR J PHARMACOL, V641, P108, DOI 10.1016/j.ejphar.2010.05.022; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kelly S, 2015, ANN RHEUM DIS, V74, P252, DOI 10.1136/annrheumdis-2013-203413; Kim YH, 2012, NEURON, V74, P640, DOI 10.1016/j.neuron.2012.02.039; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Ogbonna AC, 2013, EUR J PAIN, V17, P514, DOI 10.1002/j.1532-2149.2012.00223.x; Okun A, 2012, PAIN, V153, P924, DOI 10.1016/j.pain.2012.01.022; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Puttfarcken PS, 2010, PAIN, V150, P319, DOI 10.1016/j.pain.2010.05.015; Robitaille M, 2009, METHODS MOL BIOL, V574, P215, DOI 10.1007/978-1-60327-321-3_18; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Storti B, 2012, J BIOL CHEM, V287, P7803, DOI 10.1074/jbc.M111.332296; SZALLASI A, 1993, N-S ARCH PHARMACOL, V347, P84; Valente P, 2011, FASEB J, V25, P1628, DOI 10.1096/fj.10-174433; Vonsy JL, 2009, EUR J PAIN, V13, P786, DOI 10.1016/j.ejpain.2008.09.008; Wang S, 2011, J BIOL CHEM, V286, P40601, DOI 10.1074/jbc.M111.256669; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941; Zhang RX, 2013, OSTEOARTHR CARTILAGE, V21, P1308, DOI 10.1016/j.joca.2013.06.013; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	44	26	27	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16675	16687		10.1074/jbc.M114.558668	http://dx.doi.org/10.1074/jbc.M114.558668			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24808184	Green Published, hybrid			2022-12-28	WOS:000338016200008
J	Zielonka, J; Cheng, G; Zielonka, M; Ganesh, T; Sun, AM; Joseph, J; Michalski, R; O'Brien, WJ; Lambeth, JD; Kalyanaraman, B				Zielonka, Jacek; Cheng, Gang; Zielonka, Monika; Ganesh, Thota; Sun, Aiming; Joseph, Joy; Michalski, Radoslaw; O'Brien, William J.; Lambeth, J. David; Kalyanaraman, Balaraman			High-throughput Assays for Superoxide and Hydrogen Peroxide DESIGN OF A SCREENING WORKFLOW TO IDENTIFY INHIBITORS OF NADPH OXIDASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES GENERATION; REACTIVE OXYGEN; 4 NOX4; OXIDATIVE STRESS; HYDROETHIDINE; PEROXYNITRITE; DISEASE; TARGETS; PROBES; MITOCHONDRIA	Recent progress characterizing the reaction mechanism(s) of fluorescent probes with reactive oxygen species has made it possible to rigorously analyze these reactive species in biological systems. We have developed rapid high throughput-compatible assays for monitoring cellular production of superoxide radical anion and hydrogen peroxide using hydropropidine and coumarin boronic acid probes, respectively. Coupling plate reader-based fluorescence measurements with HPLC-based simultaneous monitoring of superoxide radical anion and hydrogen peroxide provides the basis for the screening protocol for NADPH oxidase (Nox) inhibitors. Using this newly developed approach along with the medium-throughput plate reader-based oximetry and EPR spin trapping as confirmatory assays, it is now eminently feasible to rapidly and reliably identify Nox enzyme inhibitors with a markedly lower rate of false positives. These methodological advances provide an opportunity to discover selective inhibitors of Nox isozymes, through enhanced conceptual understanding of their basic mechanisms of action.	[Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [O'Brien, William J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Ganesh, Thota] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Lambeth, J. David] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Sun, Aiming] Yerkes Natl Primate Res Ctr, Emory Inst Drug Dev, Atlanta, GA 30322 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Emory University; Emory University	Zielonka, J (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jzielonk@mcw.edu; balarama@mcw.edu	Zielonka, Jacek/N-9546-2014; Michalski, Radoslaw/X-1505-2018	Zielonka, Jacek/0000-0002-2524-0145; Michalski, Radoslaw/0000-0001-5601-0839	National Institutes of Health [R01 HL063119, R01 HL073056]; Harry R. and Angeline E. Quadracci endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073056, R01HL063119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI102197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry R. and Angeline E. Quadracci endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL063119 and R01 HL073056 (to B. K.). This work was also supported by the Harry R. and Angeline E. Quadracci endowment (to B. K.).	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; Cifuentes-Pagano E, 2013, MEDCHEMCOMM, V4, P1085, DOI 10.1039/c3md00061c; Cifuentes-Pagano E, 2012, CELL MOL LIFE SCI, V69, P2315, DOI 10.1007/s00018-012-1009-2; Dranka BP, 2013, NEUROSCI LETT, V549, P57, DOI 10.1016/j.neulet.2013.05.034; Dranka BP, 2012, J NEUROCHEM, V122, P941, DOI 10.1111/j.1471-4159.2012.07836.x; FAULKNER K, 1993, FREE RADICAL BIO MED, V15, P447, DOI 10.1016/0891-5849(93)90044-U; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Hecker L, 2012, CELL MOL LIFE SCI, V69, P2365, DOI 10.1007/s00018-012-1012-7; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Jaquet V, 2009, J LEUKOCYTE BIOL, V86, P461, DOI 10.1189/jlb.0409243; Kalyanaraman B, 2014, BBA-GEN SUBJECTS, V1840, P739, DOI 10.1016/j.bbagen.2013.05.008; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kalyanaraman B, 2011, BIOCHEM SOC T, V39, P1221, DOI 10.1042/BST0391221; Koto T, 2014, FREE RADICAL RES, V48, P478, DOI 10.3109/10715762.2014.886774; Krause KH, 2012, CELL MOL LIFE SCI, V69, P2279, DOI 10.1007/s00018-012-1006-5; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Liochev SI, 1997, ARCH BIOCHEM BIOPHYS, V337, P115, DOI 10.1006/abbi.1997.9766; Maghzal GJ, 2014, J BIOL CHEM, V289, P5580, DOI 10.1074/jbc.M113.539486; McCann SK, 2008, J NEUROSCI RES, V86, P2524, DOI 10.1002/jnr.21700; Michalski R, 2014, FREE RADICAL BIO MED, V67, P278, DOI 10.1016/j.freeradbiomed.2013.10.816; Michalski R, 2013, FREE RADICAL BIO MED, V54, P135, DOI 10.1016/j.freeradbiomed.2012.09.018; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Rivera J, 2010, REDOX REP, V15, P50, DOI 10.1179/174329210X12650506623401; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Streeter J, 2013, CARDIOVASC THER, V31, P125, DOI 10.1111/j.1755-5922.2011.00310.x; Sun QA, 2012, FREE RADICAL BIO MED, V52, P1897, DOI 10.1016/j.freeradbiomed.2012.02.046; Teufelhofer O, 2003, TOXICOL SCI, V76, P376, DOI 10.1093/toxsci/kfg234; Topchiy E, 2013, DEV NEUROSCI-BASEL, V35, P293, DOI 10.1159/000350502; Varga ZV, 2013, J MOL CELL CARDIOL, V62, P111, DOI 10.1016/j.yjmcc.2013.05.009; Williams HC, 2007, J CARDIOVASC PHARM, V50, P9, DOI 10.1097/FJC.0b013e318063e820; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao BZ, 2012, FREE RADICAL BIO MED, V53, P1080, DOI 10.1016/j.freeradbiomed.2012.06.034; Zielonka J, 2005, FREE RADICAL BIO MED, V39, P853, DOI 10.1016/j.freeradbiomed.2005.05.001; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2006, FREE RADICAL BIO MED, V41, P1050, DOI 10.1016/j.freeradbiomed.2006.04.017; Zielonka J, 2013, FREE RADICAL BIO MED, V65, P1310, DOI 10.1016/j.freeradbiomed.2013.09.017; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	54	53	54	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16176	16189		10.1074/jbc.M114.548693	http://dx.doi.org/10.1074/jbc.M114.548693			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764302	Green Published, hybrid			2022-12-28	WOS:000337965700023
J	Ghosh, D; Mueller, GA; Schramm, G; Edwards, LL; Petersen, A; London, RE; Haas, H; Bhattacharya, SG				Ghosh, Debajyoti; Mueller, Geoffrey A.; Schramm, Gabriele; Edwards, Lori L.; Petersen, Arnd; London, Robert E.; Haas, Helmut; Bhattacharya, Swati Gupta			Primary Identification, Biochemical Characterization, and Immunologic Properties of the Allergenic Pollen Cyclophilin Cat r 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETULA-VERRUCOSA POLLEN; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; WEB SERVER; PROTEIN FAMILIES; HIGHER-PLANTS; L. POLLEN; IGE; CLONING; EXPRESSION	Cyclophilin (Cyp) allergens are considered pan-allergens due to frequently reported cross-reactivity. In addition to well studied fungal Cyps, a number of plant Cyps were identified as allergens (e. g. Bet v 7 from birch pollen, Cat r 1 from periwinkle pollen). However, there are conflicting data regarding their antigenic/allergenic cross-reactivity, with no plant Cyp allergen structures available for comparison. Because amino acid residues are fairly conserved between plant and fungal Cyps, it is particularly interesting to check whether they can cross-react. Cat r 1 was identified by immunoblotting using allergic patients' sera followed by N-terminal sequencing. Cat r 1 (similar to 91% sequence identity to Bet v 7) was cloned from a cDNA library and expressed in Escherichia coli. Recombinant Cat r 1 was utilized to confirm peptidyl-prolyl cis-trans-isomerase (PPIase) activity by a PPIase assay and the allergenic property by an IgE-specific immunoblotting and rat basophil leukemia cell (RBL-SX38) mediator release assay. Inhibition-ELISA showed cross-reactive binding of serum IgE from Cat r 1-allergic individuals to fungal allergenic Cyps Asp f 11 and Mala s 6. The molecular structure of Cat r 1 was determined by NMR spectroscopy. The antigenic surface was examined in relation to its plant, animal, and fungal homologues. The structure revealed a typical cyclophilin fold consisting of a compact beta-barrel made up of seven anti-parallel beta-strands along with two surrounding alpha-helices. This is the first structure of an allergenic plant Cyp revealing high conservation of the antigenic surface particularly near the PPIase active site, which supports the pronounced cross-reactivity among Cyps from various sources.	[Ghosh, Debajyoti; Bhattacharya, Swati Gupta] Bose Inst, Kolkata 700009, W Bengal, India; [Mueller, Geoffrey A.; Edwards, Lori L.; London, Robert E.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Schramm, Gabriele; Haas, Helmut] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Petersen, Arnd] Airway Res Ctr North ARCN, Res Ctr Borstel, Div Clin & Mol Allergol, D-23845 Borstel, Germany	Department of Science & Technology (India); Bose Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Forschungszentrum Borstel; Forschungszentrum Borstel	Ghosh, D (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Allergy Immunol & Rheumatol, Cincinnati, OH 45267 USA.	djghosh@yahoo.com; swati@jcbose.ac.in	Mueller, Geoffrey A/I-2909-2017; London, Robert E/F-7990-2019	Mueller, Geoffrey A/0000-0001-8361-5323; London, Robert E/0000-0001-9108-8463	National Institutes of Health (NIEHS intramural program) [Z01-ES102885-01]; German Academic Exchange Service (DAAD); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102906] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS intramural program); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health (NIEHS intramural program) Research Project Z01-ES102885-01 (to R. E. L.).; Supported by a fellowship from the German Academic Exchange Service (DAAD). To whom correspondence may be addressed: Division of Allergy, Immunology and Rheumatology, Dept. of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267.	Appenzeller U, 2001, ARCH IMMUNOL THER EX, V49, P19; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANIK S, 1992, GRANA, V31, P72, DOI 10.1080/00173139209427829; Berjanskii M, 2009, NUCLEIC ACIDS RES, V37, pW670, DOI 10.1093/nar/gkp280; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Cadot P, 2006, MOL IMMUNOL, V43, P226, DOI 10.1016/j.molimm.2005.02.001; CADOT P, 1995, ALLERGY, V50, P431, DOI 10.1111/j.1398-9995.1995.tb01173.x; Cadot P, 2000, J ALLERGY CLIN IMMUN, V105, P286, DOI 10.1016/S0091-6749(00)90078-2; Chakraborty P, 2005, ALLERGY, V60, P920, DOI 10.1111/j.1398-9995.2005.00634.x; Chakraborty P, 2001, ANN AGR ENV MED, V8, P123; Chakraborty P, 2009, INT ARCH ALLERGY IMM, V149, P305, DOI 10.1159/000205576; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Clastre M., 1995, PLANT PHYSIOL, V109, P1497; Crameri R, 1999, Contrib Microbiol, V2, P44; De Canio M, 2009, J PROTEOME RES, V8, P4383, DOI 10.1021/pr900315a; Dibbern DA, 2003, J IMMUNOL METHODS, V274, P37, DOI 10.1016/S0022-1759(02)00369-1; Fluckiger S, 2002, EUR J IMMUNOL, V32, P10, DOI 10.1002/1521-4141(200201)32:1<10::AID-IMMU10>3.0.CO;2-I; Fujita C, 2001, INT ARCH ALLERGY IMM, V125, P44, DOI 10.1159/000053795; Galat A, 1999, ARCH BIOCHEM BIOPHYS, V371, P149, DOI 10.1006/abbi.1999.1434; GASSER CS, 1990, P NATL ACAD SCI USA, V87, P9519, DOI 10.1073/pnas.87.24.9519; Ghosh D, 2008, MOL IMMUNOL, V45, P456, DOI 10.1016/j.molimm.2007.05.025; Ghosh D, 2007, ANN AGR ENV MED, V14, P39; Glaser AG, 2006, BIOCHEM J, V396, P41, DOI 10.1042/BJ20051708; de Olano DG, 2010, ANN ALLERG ASTHMA IM, V104, P98, DOI 10.1016/j.anai.2009.11.019; HAENDLER B, 1990, EUR J BIOCHEM, V190, P477, DOI 10.1111/j.1432-1033.1990.tb15598.x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 1996, NUCLEIC ACIDS RES, V24, P206, DOI 10.1093/nar/24.1.206; HORNER WE, 1995, INT ARCH ALLERGY IMM, V107, P298, DOI 10.1159/000237007; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Limacher A, 2006, STRUCTURE, V14, P185, DOI 10.1016/j.str.2005.10.015; Lindborg M, 1999, J INVEST DERMATOL, V113, P156, DOI 10.1046/j.1523-1747.1999.00661.x; Loeffler PA, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-37; Marin-Menendez A, 2012, MOL BIOCHEM PARASIT, V184, P44, DOI 10.1016/j.molbiopara.2012.04.006; Marzban G, 2008, MOL NUTR FOOD RES, V52, P1497, DOI 10.1002/mnfr.200700518; Mayer C, 1999, J EXP MED, V189, P1507, DOI 10.1084/jem.189.9.1507; Nigro EA, 2009, J IMMUNOL, V183, P4530, DOI 10.4049/jimmunol.0900842; Petersen A, 1996, J ALLERGY CLIN IMMUN, V98, P805, DOI 10.1016/S0091-6749(96)70130-6; Petersen A, 2006, PROTEOMICS, V6, P6317, DOI 10.1002/pmic.200600173; Peterson MR, 2000, J MOL BIOL, V298, P123, DOI 10.1006/jmbi.2000.3633; Radauer C, 2006, J ALLERGY CLIN IMMUN, V117, P141, DOI 10.1016/j.jaci.2005.09.010; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; Roy D, 2003, BIOCHEM BIOPH RES CO, V307, P422, DOI 10.1016/S0006-291X(03)01193-8; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Sedrani R, 2003, J AM CHEM SOC, V125, P3849, DOI 10.1021/ja021327y; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Vangelista L, 2005, J IMMUNOL, V174, P5602, DOI 10.4049/jimmunol.174.9.5602; Wang Y, 2013, J AGR FOOD CHEM, V61, P1573, DOI 10.1021/jf303861p; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Yokota E, 2004, PLANTA, V218, P1008, DOI 10.1007/s00425-003-1177-2; Zafred D, 2013, J ALLERGY CLIN IMMUN, V132, P696, DOI 10.1016/j.jaci.2013.03.021; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x	58	22	24	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21374	21385		10.1074/jbc.M114.559971	http://dx.doi.org/10.1074/jbc.M114.559971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939849	Green Published, hybrid			2022-12-28	WOS:000340558300017
J	Liefhebber, JMP; Hague, CV; Zhang, QF; Wakelam, MJO; McLauchlan, J				Liefhebber, Jolanda M. P.; Hague, Charlotte V.; Zhang, Qifeng; Wakelam, Michael J. O.; McLauchlan, John			Modulation of Triglyceride and Cholesterol Ester Synthesis Impairs Assembly of Infectious Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; DIFFERENTIATION-RELATED PROTEIN; LIPID DROPLET-BINDING; LOW-DENSITY LIPOPROTEINS; RNA-CONTAINING PARTICLES; CORE PROTEIN; FATTY-ACID; POSTTRANSLATIONAL REGULATION; INTRAMEMBRANE PROTEOLYSIS; NORDIHYDROGUAIARETIC ACID	In hepatitis C virus infection, replication of the viral genome and virion assembly are linked to cellular metabolic processes. In particular, lipid droplets, which store principally triacylglycerides (TAGs) and cholesterol esters (CEs), have been implicated in production of infectious virus. Here, we examine the effect on productive infection of triacsin C and YIC-C8-434, which inhibit synthesis of TAGs and CEs by targeting long-chain acyl-CoA synthetase and acyl-CoA: cholesterol acyltransferase, respectively. Our results present high resolution data on the acylglycerol and cholesterol ester species that were affected by the compounds. Moreover, triacsin C, which blocks both triglyceride and cholesterol ester synthesis, cleared most of the lipid droplets in cells. By contrast, YIC-C8-434, which only abrogates production of cholesterol esters, induced an increase in size of droplets. Although both compounds slightly reduced viral RNA synthesis, they significantly impaired assembly of infectious virions in infected cells. In the case of triacsin C, reduced stability of the viral core protein, which forms the virion nucleocapsid and is targeted to the surface of lipid droplets, correlated with lower virion assembly. In addition, the virus particles that were released from cells had reduced specific infectivity. YIC-C8-434 did not alter the association of core with lipid droplets but appeared to decrease production of infectious virus particles, suggesting a block in virion assembly. Thus, the compounds have antiviral properties, indicating that targeting synthesis of lipids stored in lipid droplets might be an option for therapeutic intervention in treating chronic hepatitis C virus infection.	[Liefhebber, Jolanda M. P.; Hague, Charlotte V.; McLauchlan, John] Univ Glasgow, Ctr Virus Res, Med Res Council, Glasgow G11 5JR, Lanark, Scotland; [Zhang, Qifeng; Wakelam, Michael J. O.] Babraham Inst, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	McLauchlan, J (corresponding author), Univ Glasgow, Ctr Virus Res, Med Res Council, 8 Church St, Glasgow G11 5JR, Lanark, Scotland.	john.mclauchlan@glasgow.ac.uk		Hague, Charlotte/0000-0003-2625-102X; Wakelam, Michael/0000-0003-4059-9276	Seventh Framework Program of the European Union [202272]; United Kingdom Medical Research Council Grant [4050295596]; Biotechnology and Biological Sciences Research Council; BBSRC [BBS/E/B/0000S227, BBS/E/B/000C0415] Funding Source: UKRI; MRC [MC_UU_12014/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415, BBS/E/B/0000S227] Funding Source: researchfish; Medical Research Council [MC_UU_12014/1] Funding Source: researchfish	Seventh Framework Program of the European Union(European Commission); United Kingdom Medical Research Council Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Seventh Framework Program of the European Union-funded "LipidomicNet" (Proposal 202272) United Kingdom Medical Research Council Grant 4050295596 (to J. M. P. L., C. V. H., and J. M.) and the Biotechnology and Biological Sciences Research Council(to Q. Z. and M. J. O. W.).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Fazio S, 2006, NEW ENGL J MED, V354, P1307, DOI 10.1056/NEJMe068012; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Gross DN, 2006, MOL ENDOCRINOL, V20, P459, DOI 10.1210/me.2005-0323; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Iro M, 2009, ANTIVIR RES, V83, P148, DOI 10.1016/j.antiviral.2009.04.007; Kaddai V, 2011, EXPERT REV GASTROENT, V5, P503, DOI [10.1586/EGH.11.43, 10.1586/egh.11.43]; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lee MS, 2010, BIOCHEM BIOPH RES CO, V401, P92, DOI 10.1016/j.bbrc.2010.09.016; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Leu GZ, 2004, BIOCHEM BIOPH RES CO, V318, P275, DOI 10.1016/j.bbrc.2004.04.019; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meuwese MC, 2009, JAMA-J AM MED ASSOC, V301, P1131, DOI 10.1001/jama.301.11.1131; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Nielsen SU, 2008, J GEN VIROL, V89, P2507, DOI 10.1099/vir.0.2008/000083-0; Oehler V, 2012, J VIROL, V86, P7818, DOI 10.1128/JVI.00457-12; Ohishi K, 2003, BIOL PHARM BULL, V26, P1125; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Suzuki M, 2012, MOL BIOL CELL, V23, P800, DOI 10.1091/mbc.E11-11-0950; Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Targett-Adams P, 2010, VIRUSES-BASEL, V2, P1195, DOI 10.3390/v2051195; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Vauloup-Fellous C, 2006, J BIOL CHEM, V281, P27679, DOI 10.1074/jbc.M602587200; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	73	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21276	21288		10.1074/jbc.M114.582999	http://dx.doi.org/10.1074/jbc.M114.582999			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24917668	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000340558300007
J	Singh, S; Thakur, N; Oliveira, A; Petruk, AA; Hade, MD; Sethi, D; Bidon-Chanal, A; Marti, MA; Datta, H; Parkesh, R; Estrin, DA; Luque, FJ; Dikshit, KL				Singh, Sandeep; Thakur, Naveen; Oliveira, Ana; Petruk, Ariel A.; Hade, Mangesh Dattu; Sethi, Deepti; Bidon-Chanal, Axel; Marti, Marcelo A.; Datta, Himani; Parkesh, Raman; Estrin, Dario A.; Luque, F. Javier; Dikshit, Kanak L.			Mechanistic Insight into the Enzymatic Reduction of Truncated Hemoglobin N of Mycobacterium tuberculosis ROLE OF THE CD LOOP AND PRE-A MOTIF IN ELECTRON CYCLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE DIOXYGENASE; ESCHERICHIA-COLI; COMPUTER-SIMULATION; DYNAMICAL REGULATION; TUNNELING PATHWAYS; MOLECULAR-BASIS; CYTOCHROME-C; PROTEIN; FLAVOHEMOGLOBIN; HBN	Many pathogenic microorganisms have evolved hemoglobin-mediated nitric oxide (NO) detoxification mechanisms, where a globin domain in conjunction with a partner reductase catalyzes the conversion of toxic NO to innocuous nitrate. The truncated hemoglobin HbN of Mycobacterium tuberculosis displays a potent NO dioxygenase activity despite lacking a reductase domain. The mechanism by which HbN recycles itself during NO dioxygenation and the reductase that participates in this process are currently unknown. This study demonstrates that the NADH-ferredoxin/flavodoxin system is a fairly efficient partner for electron transfer to HbN with an observed reduction rate of 6.2 mu M/min(-1), which is nearly 3- and 5-fold faster than reported for Vitreoscilla hemoglobin and myoglobin, respectively. Structural docking of the HbN with Escherichia coli NADH-flavodoxin reductase (FdR) together with site-directed mutagenesis revealed that the CD loop of the HbN forms contacts with the reductase, and that Gly(48) may have a vital role. The donor to acceptor electron coupling parameters calculated using the semiempirical pathway method amounts to an average of about 6.4 10(-5) eV, which is lower than the value obtained for E. coli flavoHb (8.0 10(-4) eV), but still supports the feasibility of an efficient electron transfer. The deletion of Pre-A abrogated the heme iron reduction by FdR in the HbN, thus signifying its involvement during intermolecular interactions of the HbN and FdR. The present study, thus, unravels a novel role of the CD loop and Pre-A motif in assisting the interactions of the HbN with the reductase and the electron cycling, which may be vital for its NO-scavenging function.	[Datta, Himani; Parkesh, Raman; Dikshit, Kanak L.] Inst Microbial Technol, CSIR, Chandigarh 160036, India; [Oliveira, Ana; Bidon-Chanal, Axel; Luque, F. Javier] Univ Barcelona, Fac Farm, Dept Fisicoquim, Santa Coloma De Gramenet, Spain; [Oliveira, Ana; Bidon-Chanal, Axel; Luque, F. Javier] Univ Barcelona, Fac Farm, Inst Biomed IBUB, Santa Coloma De Gramenet, Spain; [Petruk, Ariel A.; Marti, Marcelo A.; Estrin, Dario A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, INQUIMAE CONICET, Buenos Aires, DF, Argentina	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Barcelona; University of Barcelona; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Dikshit, KL (corresponding author), Inst Microbial Technol, CSIR, Sect 39A, Chandigarh 160036, India.	kanak@imtech.res.in	Luque, F. Javier/L-9652-2014; Hade, Mangesh/AAF-7217-2019; Estrin, Dario/AAY-7549-2020; Hade, Mangesh/ABD-8535-2021; Bidon-Chanal, Axel/C-4536-2017	Luque, F. Javier/0000-0002-8049-3567; Hade, Mangesh/0000-0002-5937-9049; Bidon-Chanal, Axel/0000-0002-1666-1490; Marti, Marcelo/0000-0002-7911-9340; Estrin, Dario/0000-0002-5006-7225; Singh, Sandeep/0000-0001-9322-2929; Oliveira, Ana/0000-0001-6594-6022	CSIR Supra institutional project [BSC0210]; European Commission under FP7 program on health (NOstress); Spanish Ministerio de Ciencia e Innovacion [SAF2011-27642, PIB2010AR-00455]; Generalitat de Catalunya [2014SGR1189]; CSIR; Dept. of Biotechnology, Government of India	CSIR Supra institutional project; European Commission under FP7 program on health (NOstress); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Dept. of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by CSIR Supra institutional project BSC0210, European Commission under FP7 program on health (NOstress), Spanish Ministerio de Ciencia e Innovacion Grants SAF2011-27642 and PIB2010AR-00455 and Generalitat de Catalunya Grant 2014SGR1189, and fellowships from CSIR and the Dept. of Biotechnology, Government of India (to S. S., D. S., and H. D.).	Alvarez-Paggi D, 2010, J AM CHEM SOC, V132, P5769, DOI 10.1021/ja910707r; Antony J, 2000, J AM CHEM SOC, V122, P1057, DOI 10.1021/ja993784t; Appleby C A, 1978, Methods Enzymol, V52, P157; Arya S, 2013, J BIOL CHEM, V288, P29987, DOI 10.1074/jbc.M113.507301; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Beratan DN, 2008, P NATL ACAD SCI USA, V105, P403, DOI 10.1073/pnas.0711343105; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Bidon-Chanal A, 2006, PROTEINS, V64, P457, DOI 10.1002/prot.21004; Capece L, 2013, BBA-PROTEINS PROTEOM, V1834, P1722, DOI 10.1016/j.bbapap.2013.02.038; Case DA, 2012, AMBER 12; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DIKSHIT KL, 1988, GENE, V70, P377, DOI 10.1016/0378-1119(88)90209-0; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Ferreiro DN, 2013, J INORG BIOCHEM, V119, P75, DOI 10.1016/j.jinorgbio.2012.10.015; Forrester MT, 2012, FREE RADICAL BIO MED, V52, P1620, DOI 10.1016/j.freeradbiomed.2012.01.028; Frey AD, 2005, TRENDS BIOTECHNOL, V23, P69, DOI 10.1016/j.tibtech.2004.12.002; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Hallstrom CK, 2004, FREE RADICAL BIO MED, V37, P216, DOI 10.1016/j.freeradbiomed.2004.04.031; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Ingelman M, 1997, J MOL BIOL, V268, P147, DOI 10.1006/jmbi.1997.0957; Jasaitis A, 2007, P NATL ACAD SCI USA, V104, P20811, DOI 10.1073/pnas.0709876105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohlhoff M, 2012, J PROTEOMICS, V75, P2181, DOI 10.1016/j.jprot.2012.01.020; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Lama A, 2009, J BIOL CHEM, V284, P14457, DOI 10.1074/jbc.M807436200; Marti MA, 2008, METHOD ENZYMOL, V437, P477, DOI 10.1016/S0076-6879(07)37024-9; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; NAGAI M, 1981, J BIOL CHEM, V256, P9195; Oliveira A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049291; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2007, MICROB PATHOGENESIS, V42, P119, DOI 10.1016/j.micpath.2006.12.001; Petruk AA, 2012, ARCH BIOCHEM BIOPHYS, V525, P82, DOI 10.1016/j.abb.2012.05.012; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Thomas MT, 2011, ENVIRON MICROBIOL, V13, P48, DOI 10.1111/j.1462-2920.2010.02307.x; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Yeh SR, 2000, J BIOL CHEM, V275, P1679, DOI 10.1074/jbc.275.3.1679	47	13	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21573	21583		10.1074/jbc.M114.578187	http://dx.doi.org/10.1074/jbc.M114.578187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24928505	Green Published, hybrid			2022-12-28	WOS:000340558300032
J	Buscetta, M; Papasergi, S; Firon, A; Pietrocola, G; Biondo, C; Mancuso, G; Midiri, A; Romeo, L; Teti, G; Speziale, P; Trieu-Cuot, P; Beninati, C				Buscetta, Marco; Papasergi, Salvatore; Firon, Arnaud; Pietrocola, Giampiero; Biondo, Carmelo; Mancuso, Giuseppe; Midiri, Angelina; Romeo, Letizia; Teti, Giuseppe; Speziale, Pietro; Trieu-Cuot, Patrick; Beninati, Concetta			FbsC, a Novel Fibrinogen-binding Protein, Promotes Streptococcus agalactiae-Host Cell Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; HUMAN EPITHELIAL-CELLS; MICROVASCULAR ENDOTHELIAL-CELLS; REGULATORY SYSTEM; HUMAN FIBRONECTIN; NEONATAL SEPSIS; GROUP-A; INVASION; ADHERENCE; COLONIZATION	Streptococcus agalactiae (group B Streptococcus or GBS) is a common cause of invasive infections in newborn infants and adults. The ability of GBS to bind human fibrinogen is of crucial importance in promoting colonization and invasion of host barriers. We characterized here a novel fibrinogen-binding protein of GBS, designated FbsC (Gbs0791), which is encoded by the prototype GBS strain NEM316. FbsC, which bears two bacterial immunoglobulin-like tandem repeat domains and a C-terminal cell wall-anchoring motif (LPXTG), was found to be covalently linked to the cell wall by the housekeeping sortase A. Studies using recombinant FbsC indicated that it binds fibrinogen in a dose-dependent and saturable manner, and with moderate affinity. Expression of FbsC was detected in all clinical GBS isolates, except those belonging to the hypervirulent lineage ST17. Deletion of fbsC decreases NEM316 abilities to adhere to and invade human epithelial and endothelial cells, and to form biofilm in vitro. Notably, bacterial adhesion to fibrinogen and fibrinogen binding to bacterial cells were abolished following fbsC deletion in NEM316. Moreover, the virulence of the fbsC deletion mutant and its ability to colonize the brain were impaired in murine models of infection. Finally, immunization with recombinant FbsC significantly protected mice from lethal GBS challenge. In conclusion, FbsC is a novel fibrinogen-binding protein expressed by most GBS isolates that functions as a virulence factor by promoting invasion of epithelial and endothelial barriers. In addition, the protein has significant immunoprotective activity and may be a useful component of an anti-GBS vaccine.	[Buscetta, Marco; Papasergi, Salvatore; Biondo, Carmelo; Mancuso, Giuseppe; Midiri, Angelina; Romeo, Letizia; Teti, Giuseppe; Beninati, Concetta] Univ Messina, Metchnikoff Lab, Dipartimento Sci Pediat Ginecol Microbiol & Biome, I-98125 Messina, Italy; [Firon, Arnaud; Trieu-Cuot, Patrick] Inst Pasteur, CNRS, Unite Biol Bacteries Pathogenes Gram Positif, ERL3526, F-75015 Paris, France; [Pietrocola, Giampiero; Speziale, Pietro] Univ Pavia, Dept Mol Med, Biochem Unit, I-27100 Pavia, Italy	University of Messina; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Pavia	Teti, G (corresponding author), Policlin Univ, Torre Biol 2 P,Via Consolare Valeria 1, I-98125 Messina, Italy.	gteti@unime.it	papasergi, salvatore/AAE-8818-2021; Biondo, Carmelo/AAA-3391-2019; Romeo, Letizia/Z-2735-2019; Romeo, Letizia/Z-4819-2019	Romeo, Letizia/0000-0002-7460-8815; Midiri, Angelina/0000-0002-4128-9678; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155; BENINATI, Concetta/0000-0001-8305-1337; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Mancuso, Giuseppe/0000-0001-5454-3228; Buscetta, Marco/0000-0001-8313-2647; FIRON, Arnaud/0000-0002-5323-5212	CLUSTER MEDINTECH [CTN01_00177_962865]; Ministero dell'Istruzione [PON01_00117]; dell'Universita e della Ricerca of Italy; Institut Pasteur; CNRS; French Government's Investissement d'Avenir program; Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Fondation pour la Recherche Medicale [DEQ20130326538]	CLUSTER MEDINTECH; Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR)); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Government's Investissement d'Avenir program(French National Research Agency (ANR)); Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by CLUSTER MEDINTECH Project CTN01_00177_962865 and Ministero dell'Istruzione Grant PON01_00117, the dell'Universita e della Ricerca of Italy.; Supported by the Institut Pasteur, CNRS, French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" Grant ANR-10-LABX-62-IBEID, and Fondation pour la Recherche Medicale Grant DEQ20130326538.	Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; Al Safadi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014658; Brega S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065832; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Cardaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036588; CAREY RB, 1980, INFECT IMMUN, V28, P195, DOI 10.1128/IAI.28.1.195-203.1980; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; CHHATWAL GS, 1985, MICROBIOL IMMUNOL, V29, P973, DOI 10.1111/j.1348-0421.1985.tb02961.x; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Danne C, 2013, RES MICROBIOL, V164, P973, DOI 10.1016/j.resmic.2013.09.002; Dombek PE, 1999, MOL MICROBIOL, V31, P859, DOI 10.1046/j.1365-2958.1999.01223.x; Dramsi S, 2012, MICROB DRUG RESIST, V18, P286, DOI 10.1089/mdr.2012.0005; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Firon A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003179; Garibaldi M, 2010, VACCINE, V28, P3609, DOI 10.1016/j.vaccine.2010.01.009; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Guadiz G, 1997, AM J RESP CELL MOL, V17, P60, DOI 10.1165/ajrcmb.17.1.2730; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Jiang SM, 2014, INFECT IMMUN, V82, P1007, DOI 10.1128/IAI.01014-13; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Margarit I, 2009, FASEB J, V23, P3100, DOI 10.1096/fj.09-131458; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Papasergi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075266; Papasergi S, 2013, J PROTEOMICS, V89, P154, DOI 10.1016/j.jprot.2013.06.003; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Park SE, 2012, INFECT IMMUN, V80, P3975, DOI 10.1128/IAI.00699-12; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; RUBENS CE, 1992, INFECT IMMUN, V60, P5157, DOI 10.1128/IAI.60.12.5157-5163.1992; RUBENS CE, 1991, J INFECT DIS, V164, P320, DOI 10.1093/infdis/164.2.320; SCHONBECK C, 1981, INFECT IMMUN, V31, P856; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P939, DOI 10.1097/01.inf.0000239267.42561.06; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Seo HS, 2013, J BIOL CHEM, V288, P35982, DOI 10.1074/jbc.M113.513358; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; van Gennip M, 2012, INFECT IMMUN, V80, P2601, DOI 10.1128/IAI.06215-11; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje	55	44	49	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21003	21015		10.1074/jbc.M114.553073	http://dx.doi.org/10.1074/jbc.M114.553073			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24904056	hybrid, Green Published			2022-12-28	WOS:000339396600053
J	Stein, KC; Bengoechea, R; Harms, MB; Weihl, CC; True, HL				Stein, Kevin C.; Bengoechea, Rocio; Harms, Matthew B.; Weihl, Conrad C.; True, Heather L.			Myopathy-causing Mutations in an HSP40 Chaperone Disrupt Processing of Specific Client Conformers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; RNQ(+) PRION; PROTEIN AGGREGATION; AMYLOID STRUCTURES; DNAJB6 MYOPATHY; RICH DOMAIN; YEAST; PROPAGATION; SIS1; DISEASE	The molecular chaperone network protects against the toxic misfolding and aggregation of proteins. Disruption of this network leads to a variety of protein conformational disorders. One such example recently discovered is limb-girdle muscular dystrophy type 1D (LGMD1D), which is caused by mutation of the HSP40 chaperone DNAJB6. All LGMD1D-associated mutations localize to the conserved G/F domain of DNAJB6, but the function of this domain is largely unknown. Here, we exploit the yeast HSP40 Sis1, which has known aggregation-prone client proteins, to gain insight into the role of the G/F domain and its significance in LGMD1D pathogenesis. Strikingly, we demonstrate that LGMD1D mutations in a Sis1-DNAJB6 chimera differentially impair the processing of specific conformers of two yeast prions, [RNQ+] and [PSI+]. Importantly, these differences do not simply correlate to the sensitivity of these prion strains to changes in chaperone levels. Additionally, we analyzed the effect of LGMD1D-associated DNAJB6 mutations on TDP-43, a protein known to form inclusions in LGMD1D. We show that the DNAJB6 G/F domain mutants disrupt the processing of nuclear TDP-43 stress granules in mammalian cells. These data suggest that the G/F domain mediates chaperone-substrate interactions in a manner that extends beyond recognition of a particular client and to a subset of client conformers. We propose that such selective chaperone disruption may lead to the accumulation of toxic aggregate conformers and result in the development of LGMD1D and perhaps other protein conformational disorders.	[Stein, Kevin C.; True, Heather L.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bengoechea, Rocio; Harms, Matthew B.; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Weihl, CC (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	weihlc@neuro.wustl.edu; heather.true@wustl.edu		Stein, Kevin/0000-0002-0622-8319	National Institutes of Health [F31AG040899, T32GM007067, GM072778, AG031867, AG042095]; Muscular Dystrophy Association; Hope Center for Neurological Disorders; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067, R01GM072778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031867, K02AG042095, F31AG040899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Hope Center for Neurological Disorders; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F31AG040899 and T32GM007067 (to K. C. S.), GM072778 (to H. L. T.), and AG031867 and AG042095 (to C. C. W.). This work was also supported by the Muscular Dystrophy Association (to C. C. W.) and the Hope Center for Neurological Disorders (to C. C. W., M. B. H., and H. L. T.).	Aron R, 2007, EMBO J, V26, P3794, DOI 10.1038/sj.emboj.7601811; Bardill JP, 2009, PRION, V3, P151, DOI 10.4161/pri.3.3.9662; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Couthouis J, 2014, NEUROMUSCULAR DISORD, V24, P431, DOI 10.1016/j.nmd.2014.01.014; Derkatch IL, 1996, GENETICS, V144, P1375; Dulle JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087521; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Hines JK, 2011, PRION, V5, P238, DOI [10.4161/pri.5.4.17818, 10.4161/pri.17818]; Huang VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079582; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kakkar V, 2012, CURR TOP MED CHEM, V12, P2479; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lopez N, 2003, MOL BIOL CELL, V14, P1172, DOI 10.1091/mbc.E02-09-0593; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; Pereira C, 2012, FEBS J, V279, P697, DOI 10.1111/j.1742-4658.2012.08477.x; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Sato T, 2013, NEUROMUSCULAR DISORD, V23, P269, DOI 10.1016/j.nmd.2012.12.010; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Stein KC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004337; Stein KC, 2011, PRION, V5, P291, DOI [10.4161/pri.5.4.18213, 10.4161/pri.18213]; Suarez-Cedeno G, 2014, MUSCLE NERVE, V49, P607, DOI 10.1002/mus.24106; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tenreiro S, 2013, J NEUROCHEM, V127, P438, DOI 10.1111/jnc.12271; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; True HL, 2006, TRENDS GENET, V22, P110, DOI 10.1016/j.tig.2005.12.004; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Udan-Johns M, 2014, HUM MOL GENET, V23, P157, DOI 10.1093/hmg/ddt408; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Walker AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081170; Watson ED, 2007, DEVELOPMENT, V134, P1809, DOI 10.1242/dev.02843; Westergard L, 2014, MOL MICROBIOL, V92, P698, DOI 10.1111/mmi.12579; Westergard L, 2014, MOL MICROBIOL, V92, P183, DOI 10.1111/mmi.12543; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	48	33	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21120	21130		10.1074/jbc.M114.572461	http://dx.doi.org/10.1074/jbc.M114.572461			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24920671	hybrid, Green Published			2022-12-28	WOS:000339396600062
J	Bracey, NA; Gershkovich, B; Chun, J; Vilaysane, A; Meijndert, HC; Wright, JR; Fedak, PW; Beck, PL; Muruve, DA; Duff, HJ				Bracey, Nathan A.; Gershkovich, Benjamin; Chun, Justin; Vilaysane, Akosua; Meijndert, H. Christopher; Wright, James R., Jr.; Fedak, Paul W.; Beck, Paul L.; Muruve, Daniel A.; Duff, Henry J.			Mitochondrial NLRP3 Protein Induces Reactive Oxygen Species to Promote Smad Protein Signaling and Fibrosis Independent from the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; ANGIOTENSIN-II; MYOFIBROBLAST DIFFERENTIATION; MYOCARDIAL-INFARCTION; CARDIAC FIBROBLASTS; ACTIVATION; PATHWAYS; DYSFUNCTION; MECHANISM; INJURY	Nucleotide-binding domain and leucine-rich repeat containing PYD-3 (NLRP3) is a pattern recognition receptor that is implicated in the pathogenesis of inflammation and chronic diseases. Although much is known regarding the NLRP3 inflammasome that regulates proinflammatory cytokine production in innate immune cells, the role of NLRP3 in non-professional immune cells is unclear. Here we report that NLRP3 is expressed in cardiac fibroblasts and increased during TGF beta stimulation. NLRP3-deficient cardiac fibroblasts displayed impaired differentiation and R-Smad activation in response to TGF beta. Only the central nucleotide binding domain of NLRP3 was required to augment R-Smad signaling because the N-terminal Pyrin or C-terminal leucine- rich repeat domains were dispensable. Interestingly, NLRP3 regulation of myofibroblast differentiation proceeded independently from the inflammasome, IL-1 beta /IL-18, or caspase 1. Instead, mitochondrially localized NLRP3 potentiated reactive oxygen species to augment R-Smad activation. In vivo, NLRP3-deficient mice were protected against angiotensin II-induced cardiac fibrosis with preserved cardiac architecture and reduced collagen 1. Together, these results support a distinct role for NLRP3 in non-professional immune cells independent from the inflammasome to regulate differential aspects of wound healing and chronic disease.	[Bracey, Nathan A.; Gershkovich, Benjamin; Meijndert, H. Christopher; Fedak, Paul W.; Duff, Henry J.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB T2N 4N1, Canada; [Chun, Justin; Vilaysane, Akosua; Beck, Paul L.; Muruve, Daniel A.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada; [Wright, James R., Jr.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 4N1, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Calgary	Duff, HJ (corresponding author), Univ Calgary, Libin Cardiovasc Inst, HRIC, GAC 72,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	hduff@ucalgary.ca	Chun, Justin/R-8487-2019	Fedak, Paul/0000-0003-0658-9381; Chun, Justin/0000-0002-3820-7192	Alberta Heart and Stroke Foundation; Canadian Institutes for Health Research; Alberta HEART Initiative; Alberta Innovates Health Solutions	Alberta Heart and Stroke Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta HEART Initiative; Alberta Innovates Health Solutions	This work was supported by operating grants from the Alberta Heart and Stroke Foundation and Canadian Institutes for Health Research.; Supported in part by a studentship award from the Alberta HEART Initiative and an MD/PhD studentship from Alberta Innovates Health Solutions.; Holder of a Tier II Canada Research Chair in Inflammation and Kidney Disease and recipient of a Clinical Senior Scholar award from Alberta Innovates Health Solutions.	Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Artlett CM, 2011, ARTHRITIS RHEUM-US, V63, P3563, DOI 10.1002/art.30568; Bracey NA, 2013, EXP PHYSIOL, V98, P462, DOI 10.1113/expphysiol.2012.068338; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Fedak PWM, 2012, CIRC-HEART FAIL, V5, P349, DOI 10.1161/CIRCHEARTFAILURE.111.965889; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matsui Y, 2011, CIRC RES, V108, P1328, DOI 10.1161/CIRCRESAHA.110.235689; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Sandanger O, 2013, CARDIOVASC RES, V99, P164, DOI 10.1093/cvr/cvt091; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Zhang GX, 2007, CARDIOVASC RES, V76, P204, DOI 10.1016/j.cardiores.2007.07.014; Zhang HY, 1997, J IMMUNOL, V158, P1392; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zimmerman MC, 2002, CIRC RES, V91, P1038, DOI 10.1161/01.RES.0000043501.47934.FA; Zuurbier CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040643	37	107	112	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19571	19584		10.1074/jbc.M114.550624	http://dx.doi.org/10.1074/jbc.M114.550624			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24841199	Green Published, hybrid			2022-12-28	WOS:000339326800031
J	Chan, CY; Parra, KJ				Chan, Chun-Yuan; Parra, Karlett J.			Yeast Phosphofructokinase-1 Subunit Pfk2p Is Necessary for pH Homeostasis and Glucose-dependent Vacuolar ATPase Reassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; H+-ATPASE; V-ATPASE; SACCHAROMYCES-CEREVISIAE; GLYCOLYTIC OSCILLATIONS; CYTOSOLIC PH; PROTON PUMPS; V-0 SUBUNIT; CELLULAR PH; ALDOLASE	V-ATPases are conserved ATP-driven proton pumps that acidify organelles. Yeast V-ATPase assembly and activity are glucose-dependent. Glucose depletion causes V-ATPase disassembly and its inactivation. Glucose readdition triggers reassembly and resumes proton transport and organelle acidification. We investigated the roles of the yeast phosphofructokinase-1 subunits Pfk1p and Pfk2p for V-ATPase function. The pfk1 Delta and pfk2 Delta mutants grew on glucose and assembled wild-type levels of V-ATPase pumps at the membrane. Both phosphofructokinase-1 subunits co-immunoprecipitated with V-ATPase in wild-type cells; upon deletion of one subunit, the other subunit retained binding to V-ATPase. The pfk2 Delta cells exhibited a partialvmagrowth phenotype. In vitro ATP hydrolysis and proton transport were reduced by 35% in pfk2 Delta membrane fractions; they were normal in pfk1 Delta. In vivo, the pfk1 Delta and pfk2 Delta vacuoles were alkalinized and the cytosol acidified, suggestive of impaired V-ATPase proton transport. Overall the pH alterations were more dramatic in pfk2 Delta than pfk1 Delta at steady state and after readdition of glucose to glucose-deprived cells. Glucose-dependent reassembly was 50% reduced in pfk2 Delta, and the vacuolar lumen was not acidified after reassembly. RAVE-assisted glucose-dependent reassembly and/or glucose signals were disturbed in pfk2 Delta. Binding of disassembled V-ATPase (V-1 domain) to its assembly factor RAVE (subunit Rav1p) was 5-fold enhanced, indicating that Pfk2p is necessary for V-ATPase regulation by glucose. Because Pfk1p and Pfk2p are necessary for V-ATPase proton transport at the vacuole in vivo, a role for glycolysis at regulating V-ATPase proton transport is discussed.	[Chan, Chun-Yuan; Parra, Karlett J.] Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Parra, KJ (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, MSC08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu	Chan, Chun Yuan/F-5811-2010		National Institutes of Health [R01GM086495]; American Heart Association [0855228F, 14PRE19020015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM086495 (to K. J. P.). This work was also supported by American Heart Association Grants 0855228F (to K. J. P.) and 14PRE19020015 (to C.-Y. C.).	ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Avnet S, 2013, BBA-MOL BASIS DIS, V1832, P1105, DOI 10.1016/j.bbadis.2013.04.003; Banaszak K, 2011, J MOL BIOL, V407, P284, DOI 10.1016/j.jmb.2011.01.019; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fogarty FM, 2014, ONCOGENE, V33, P4653, DOI 10.1038/onc.2013.403; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; HSU SC, 1991, J BIOL CHEM, V266, P21745; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Klinder A, 1998, YEAST, V14, P323, DOI 10.1002/(SICI)1097-0061(19980315)14:4<323::AID-YEA223>3.0.CO;2-W; Kohio HP, 2013, VIROLOGY, V444, P301, DOI 10.1016/j.virol.2013.06.026; Konishi H, 2004, PLANT MOL BIOL, V56, P839, DOI 10.1007/s11103-004-5920-2; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Merkulova M, 2011, AM J PHYSIOL-CELL PH, V300, pC1442, DOI 10.1152/ajpcell.00076.2010; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Muller S, 1997, MICROBIOL-UK, V143, P3055, DOI 10.1099/00221287-143-9-3055; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schroder TD, 2013, FEBS J, V280, P6033, DOI 10.1111/febs.12522; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Stewart AG, 2012, STRUCTURE, V20, P1799, DOI 10.1016/j.str.2012.10.003; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2003, J BIOENERG BIOMEMBR, V35, P347, DOI 10.1023/A:1025780932403; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Tiburcy F, 2013, J EXP BIOL, V216, P881, DOI 10.1242/jeb.078360; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Williamson T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-108	59	20	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19448	19457		10.1074/jbc.M114.569855	http://dx.doi.org/10.1074/jbc.M114.569855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860096	Green Published, hybrid			2022-12-28	WOS:000339326800020
J	Haerteis, S; Krappitz, A; Krappitz, M; Murphy, JE; Bertog, M; Krueger, B; Nacken, R; Chung, H; Hollenberg, MD; Knecht, W; Bunnett, NW; Korbmacher, C				Haerteis, Silke; Krappitz, Annabel; Krappitz, Matteus; Murphy, Jane E.; Bertog, Marko; Krueger, Bettina; Nacken, Regina; Chung, Hyunjae; Hollenberg, Morley D.; Knecht, Wolfgang; Bunnett, Nigel W.; Korbmacher, Christoph			Proteolytic Activation of the Human Epithelial Sodium Channel by Trypsin IV and Trypsin I Involves Distinct Cleavage Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; NA+ TRANSPORT; HUMAN MESOTRYPSIN; SERINE PROTEASES; PROSTATE-CANCER; HUMAN BRAIN; ENAC; EXPRESSION; CELLS; RECEPTOR-2	Proteolytic activation is a unique feature of the epithelial sodium channel (ENaC). However, the underlying molecular mechanisms and the physiologically relevant proteases remain to be identified. The serine protease trypsin I can activate ENaC in vitro but is unlikely to be the physiologically relevant activating protease in ENaC-expressing tissues in vivo. Herein, we investigated whether human trypsin IV, a form of trypsin that is co-expressed in several extrapancreatic epithelial cells with ENaC, can activate human ENaC. In Xenopus laevis oocytes, we monitored proteolytic activation of ENaC currents and the appearance of gamma ENaC cleavage products at the cell surface. We demonstrated that trypsin IV and trypsin I can stimulate ENaC heterologously expressed in oocytes. ENaC cleavage and activation by trypsin IV but not by trypsin I required a critical cleavage site (Lys-189) in the extracellular domain of the gamma-subunit. In contrast, channel activation by trypsin I was prevented by mutating three putative cleavage sites (Lys-168, Lys-170, and Arg-172) in addition to mutating previously described prostasin (RKRK178), plasmin (Lys-189), and neutrophil elastase (Val-182 and Val-193) sites. Moreover, we found that trypsin IV is expressed in human renal epithelial cells and can increase ENaC-mediated sodium transport in cultured human airway epithelial cells. Thus, trypsin IV may regulate ENaC function in epithelial tissues. Our results show, for the first time, that trypsin IV can stimulate ENaC and that trypsin IV and trypsin I activate ENaC by cleavage at distinct sites. The presence of distinct cleavage sites may be important for ENaC regulation by tissue-specific proteases.	[Haerteis, Silke; Krappitz, Annabel; Krappitz, Matteus; Bertog, Marko; Krueger, Bettina; Nacken, Regina; Korbmacher, Christoph] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany; [Murphy, Jane E.] Univ Calif San Francisco, Dept Surg, Ctr Neurobiol Digest Dis, San Francisco, CA USA; [Chung, Hyunjae; Hollenberg, Morley D.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Knecht, Wolfgang] AstraZeneca Res & Dev, CVGI iMed, Biosci, S-43181 Molndal, Sweden; [Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Erlangen Nuremberg; University of California System; University of California San Francisco; University of Calgary; AstraZeneca; University of Melbourne	Korbmacher, C (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Zellulare & Mol Physiol, Waldstr 6, D-91054 Erlangen, Germany.	christoph.korbmacher@fau.de	Haerteis, Silke/AGS-5314-2022; Hollenberg, Morley/AFV-6966-2022	Bunnett, Nigel W./0000-0003-3367-0644; Bertog, Marko/0000-0002-1504-9582; Haerteis, Silke/0000-0002-9440-3307	National Institutes of Health [DK43207, DK57840]; Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsfoerderung (ELAN) program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); National Health and Medical Research Council [63303, 1049682, 1031886]; Monash University; Prostate Cancer Canada; Canadian Institutes of Health Research (CIHR); Biomedical Research Technology Program of the National Institutes of Health, NCRR [P41RR001614, 1S10RR014606]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057840, R01DK043207, R56DK043207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsfoerderung (ELAN) program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Prostate Cancer Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Biomedical Research Technology Program of the National Institutes of Health, NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43207 and DK57840 (to N. W. B.). This work was also supported by grants from the Interdisziplinares Zentrum fur Klinische Forschung (IZKF) (to S. H. and M. K.) and the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsfoerderung (ELAN) program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) (to S. H.), by National Health and Medical Research Council Grants 63303, 1049682, 1031886 and Monash University (to N. W. B.), and by grants from Prostate Cancer Canada and the Canadian Institutes of Health Research (CIHR) (to M. D. H.). The Bio-Organic Biomedical Mass Spectrometry Resource at the University of California, San Francisco, is supported by the Biomedical Research Technology Program of the National Institutes of Health, NCRR, Grants P41RR001614 and 1S10RR014606.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Bertog M, 1999, J PHYSIOL-LONDON, V521, P3, DOI 10.1111/j.1469-7793.1999.00003.x; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Cattaruzza F, 2014, BRIT J PHARMACOL, V171, P3814, DOI 10.1111/bph.12738; Ceppa EP, 2011, AM J PHYSIOL-GASTR L, V300, pG1033, DOI 10.1152/ajpgi.00305.2010; Chen J. M., 2012, HDB PROTEOLYTIC ENZY, P2600; Chung H, 2013, J BIOL CHEM, V288, P37319, DOI 10.1074/jbc.M113.492793; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; EMI M, 1986, GENE, V41, P305; Gallatz Katalin, 2007, Ideggyogy Sz, V60, P118; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Ghilardi C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-201; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; Haerteis S, 2012, PFLUG ARCH EUR J PHY, V464, P353, DOI 10.1007/s00424-012-1138-3; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Hummler E, 2010, CELL PHYSIOL BIOCHEM, V25, P63, DOI 10.1159/000272051; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Krueger B, 2012, INVEST OPHTH VIS SCI, V53, P596, DOI 10.1167/iovs.11-8581; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Navarrete M, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-17; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Patel AB, 2012, AM J PHYSIOL-RENAL, V303, pF540, DOI 10.1152/ajprenal.00133.2012; Radisky ES, 2013, ASIAN J ANDROL, V15, P439, DOI 10.1038/aja.2013.14; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sahin-Toth M, 2005, PROTEIN PEPTIDE LETT, V12, P457, DOI 10.2174/0929866054395356; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Tan CD, 2011, PFLUG ARCH EUR J PHY, V462, P431, DOI 10.1007/s00424-011-0982-x; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; Woollhead AM, 2005, J PHYSIOL-LONDON, V566, P781, DOI 10.1113/jphysiol.2005.088674; Zeissig S, 2008, GASTROENTEROLOGY, V134, P1436, DOI 10.1053/j.gastro.2008.02.030	47	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19067	19078		10.1074/jbc.M113.538470	http://dx.doi.org/10.1074/jbc.M113.538470			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841206	Green Published, hybrid			2022-12-28	WOS:000339062900037
J	Kawai, T; Katayama, Y; Guo, LJ; Liu, DS; Suzuki, T; Hayakawa, K; Lee, JM; Nagamine, T; Hull, JJ; Matsumoto, S; Nagasawa, H; Tanokura, M; Nagata, K				Kawai, Takeshi; Katayama, Yukie; Guo, Linjun; Liu, Desheng; Suzuki, Tatsuya; Hayakawa, Kou; Lee, Jae Min; Nagamine, Toshihiro; Hull, J. Joe; Matsumoto, Shogo; Nagasawa, Hiromichi; Tanokura, Masaru; Nagata, Koji			Identification of Functionally Important Residues of the Silkmoth Pheromone Biosynthesis-activating Neuropeptide Receptor, an Insect Ortholog of the Vertebrate Neuromedin U Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; A(2A) ADENOSINE RECEPTOR; BOMBYX-MORI; SEX-PHEROMONE; PBAN RECEPTOR; LEPIDOPTERA-NOCTUIDAE; CARBOXYL-TERMINUS; CRYSTAL-STRUCTURE; SILKWORM MOTH; PEPTIDES	The biosynthesis of sex pheromone components in many lepidopteran insects is regulated by the interaction between pheromone biosynthesis-activating neuropeptide (PBAN) and the PBAN receptor (PBANR), a class A G-protein-coupled receptor. To identify functionally important amino acid residues in the silkmoth PBANR, a series of 27 alanine substitutions was generated using a PBANR chimera C-terminally fused with enhanced GFP. The PBANR mutants were expressed in Sf9 insect cells, and their ability to bind and be activated by a core PBAN fragment (C10PBAN(R2K)) was monitored. Among the 27 mutants, 23 localized to the cell surface of transfected Sf9 cells, whereas the other four remained intracellular. Reduced binding relative to wild type was observed with 17 mutants, and decreased Ca2+ mobilization responses were observed with 12 mutants. Ala substitution of Glu-95, Glu-120, Asn-124, Val-195, Phe-276, Trp-280, Phe-283, Arg-287, Tyr-307, Thr-311, and Phe-319 affected both binding and Ca2+ mobilization. The most pronounced effects were observed with the E120A mutation. A molecular model of PBANR indicated that the functionally important PBANR residues map to the 2nd, 3rd, 6th, and 7th transmembrane helices, implying that the same general region of class A G-protein-coupled receptors recognizes both peptidic and nonpeptidic ligands. Docking simulations suggest similar ligand-receptor recognition interactions for PBAN-PBANR and the orthologous vertebrate pair, neuromedin U (NMU) and NMU receptor (NMUR). The simulations highlight the importance of two glutamate residues, Glu-95 and Glu-120, in silkmoth PBANR and Glu-117 and Glu-142 in human NMUR1, in the recognition of the most functionally critical region of the ligands, the C-terminal residue and amide.	[Kawai, Takeshi; Katayama, Yukie; Guo, Linjun; Liu, Desheng; Suzuki, Tatsuya; Hayakawa, Kou; Nagasawa, Hiromichi; Tanokura, Masaru; Nagata, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Lee, Jae Min; Nagamine, Toshihiro; Matsumoto, Shogo] RIKEN, Mol Entomol Lab, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Hull, J. Joe] USDA, Arid Land Agr Res Ctr, Maricopa, AZ 85138 USA	University of Tokyo; RIKEN; United States Department of Agriculture (USDA)	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp; aknagata@mail.ecc.u-tokyo.ac.jp	Hayakawa, Kou/AAC-9018-2022	Nagata, Koji/0000-0002-4704-0603; Tanokura, Masaru/0000-0001-5072-2480	Targeted Proteins Research Project; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [17681026]	Targeted Proteins Research Project; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Targeted Proteins Research Project and the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Grant-in-aid for Young Scientists (A) 17681026 from the Japan Society for the Promotion of Science. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the United States Department of Agriculture. United States Department of Agriculture is an equal opportunity provider and employer.	ANDO T, 1988, AGR BIOL CHEM TOKYO, V52, P141; ANDO T, 1988, AGR BIOL CHEM TOKYO, V52, P473; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Bylund David B, 2004, Methods Mol Biol, V259, P1; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V335, P14, DOI 10.1016/j.bbrc.2005.07.038; Cheng YX, 2010, ARCH INSECT BIOCHEM, V75, P13, DOI 10.1002/arch.20379; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choi MY, 2007, INSECT BIOCHEM MOLEC, V37, P296, DOI 10.1016/j.ibmb.2006.12.004; Choi MY, 2010, FEBS LETT, V584, P1212, DOI 10.1016/j.febslet.2010.02.033; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; Clark BA, 1996, INT J PEPT PROT RES, V47, P361; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; COOK LL, 1988, J BIOL CHEM, V263, P13991; DeLano W. L., 2002, CCP4 NEWSLETT PROTEI, V40, P44; Fonagy A, 2001, ARTHROPOD STRUCT DEV, V30, P113, DOI 10.1016/S1467-8039(01)00027-5; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Hosoya M, 2000, J BIOL CHEM, V275, P29528, DOI 10.1074/jbc.M004261200; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Hull JJ, 2011, INSECT MOL BIOL, V20, P801, DOI 10.1111/j.1365-2583.2011.01110.x; Hull JJ, 2007, BIOSCI BIOTECH BIOCH, V71, P1993, DOI 10.1271/bbb.70175; Hull JJ, 2005, BIOCHEM BIOPH RES CO, V334, P69, DOI 10.1016/j.bbrc.2005.06.050; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; IMAI K, 1991, P JPN ACAD B-PHYS, V67, P98, DOI 10.2183/pjab.67.98; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jurenka R, 2011, INSECT MOL BIOL, V20, P323, DOI 10.1111/j.1365-2583.2010.01065.x; Kawai T., 2011, P SCI, P126; Kawai Takeshi, 2012, Front Endocrinol (Lausanne), V3, P42, DOI 10.3389/fendo.2012.00042; KAWANO T, 1992, BIOCHEM BIOPH RES CO, V189, P221, DOI 10.1016/0006-291X(92)91547-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; KITAMURA A, 1989, BIOCHEM BIOPH RES CO, V163, P520, DOI 10.1016/0006-291X(89)92168-2; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUNIYOSHI H, 1992, BIOSCI BIOTECH BIOCH, V56, P167, DOI 10.1271/bbb.56.167; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DW, 2011, INSECT BIOCHEM MOLEC, V41, P236, DOI 10.1016/j.ibmb.2011.01.001; Lee Jae Min, 2012, Front Endocrinol (Lausanne), V3, P6, DOI 10.3389/fendo.2012.00006; Matsumoto S., 1990, J INSECT PHYSL, V53, P752; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Mobarec JC, 2009, J MED CHEM, V52, P5207, DOI 10.1021/jm9005252; Mori K, 2005, EMBO J, V24, P325, DOI 10.1038/sj.emboj.7600526; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; NACHMAN RJ, 1986, BIOCHEM BIOPH RES CO, V137, P936, DOI 10.1016/0006-291X(86)90315-3; NACHMAN RJ, 1993, BIOCHEM BIOPH RES CO, V193, P661, DOI 10.1006/bbrc.1993.1675; Nagata K., 2009, P 21 AM PEPT S, P345; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Nusawardani T, 2013, INSECT MOL BIOL, V22, P331, DOI 10.1111/imb.12025; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Rafaeli A, 2007, INSECT MOL BIOL, V16, P287, DOI 10.1111/j.1365-2583.2007.00725.x; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; ROELOFS W, 1984, BIOORG CHEM, V12, P279, DOI 10.1016/0045-2068(84)90011-7; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; Sabio M, 2008, BIOORG MED CHEM LETT, V18, P5391, DOI 10.1016/j.bmcl.2008.09.046; SCHOOFS L, 1992, INSECT BIOCHEM MOLEC, V22, P447, DOI 10.1016/0965-1748(92)90140-A; SMITH GE, 1985, P NATL ACAD SCI USA, V82, P8404, DOI 10.1073/pnas.82.24.8404; Stern PS, 2007, J INSECT PHYSIOL, V53, P803, DOI 10.1016/j.jinsphys.2007.03.012; Szekeres PG, 2000, J BIOL CHEM, V275, P20247, DOI 10.1074/jbc.C000244200; Thomas CJ, 1998, J VIROL, V72, P10207, DOI 10.1128/JVI.72.12.10207-10212.1998; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zdarek J, 1998, EUR J ENTOMOL, V95, P9; Zheng L, 2007, GENE, V393, P20, DOI 10.1016/j.gene.2006.12.025	79	13	13	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19150	19163		10.1074/jbc.M113.488999	http://dx.doi.org/10.1074/jbc.M113.488999			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847080	Green Published, hybrid			2022-12-28	WOS:000339062900044
J	Kobayashi, H; Saito, T; Sato, K; Furusawa, K; Hosokawa, T; Tsutsumi, K; Asada, A; Kamada, S; Ohshima, T; Hisanaga, S				Kobayashi, Hiroyuki; Saito, Taro; Sato, Ko; Furusawa, Kotaro; Hosokawa, Tomohisa; Tsutsumi, Koji; Asada, Akiko; Kamada, Shinji; Ohshima, Toshio; Hisanaga, Shin-ichi			Phosphorylation of Cyclin-dependent Kinase 5 (Cdk5) at Tyr-15 Is Inhibited by Cdk5 Activators and Does Not Contribute to the Activation of Cdk5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P35; COMPLEXES; SUBUNIT; PROTEIN; BRAIN; LOCALIZATION; SUPPRESSION; STABILITY; MECHANISM; DENDRITE	Cdk5 is a member of the cyclin-dependent kinase (Cdk) family. In contrast to other Cdks that promote cell proliferation, Cdk5 plays a role in regulating various neuronal functions, including neuronal migration, synaptic activity, and neuron death. Cdks responsible for cell proliferation need phosphorylation in the activation loop for activation in addition to binding a regulatory subunit cyclin. Cdk5, however, is activated only by binding to its activator, p35 or p39. Furthermore, in contrast to Cdk1 and Cdk2, which are inhibited by phosphorylation at Tyr-15, the kinase activity of Cdk5 is reported to be stimulated when phosphorylated at Tyr-15 by Src family kinases or receptor-type tyrosine kinases. We investigated the activation mechanism of Cdk5 by phosphorylation at Tyr-15. Unexpectedly, however, it was found that Tyr-15 phosphorylation occurred only on monomeric Cdk5, and the coexpression of activators, p35/p25, p39, or Cyclin I, inhibited the phosphorylation. In neuron cultures, too, the activation of Fyn tyrosine kinase did not increase Tyr-15 phosphorylation of Cdk5. Further, phospho-Cdk5 at Tyr-15 was not detected in the p35-bound Cdk5. In contrast, expression of active Fyn increased p35 in neurons. These results indicate that phosphorylation at Tyr-15 is not an activation mechanism of Cdk5 but, rather, indicate that tyrosine kinases could activate Cdk5 by increasing the protein amount of p35. These results call for reinvestigation of how Cdk5 is regulated downstream of Src family kinases or receptor tyrosine kinases in neurons, which is an important signaling cascade in a variety of neuronal activities.	[Kobayashi, Hiroyuki; Saito, Taro; Sato, Ko; Furusawa, Kotaro; Hosokawa, Tomohisa; Tsutsumi, Koji; Asada, Akiko; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Kamada, Shinji] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Tokyo Metropolitan University; Kobe University; Waseda University	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp		Hosokawa, Tomohisa/0000-0001-7522-6141; Suzuki, Ko/0000-0003-0045-7919	MEXT of Japan	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research on a priority area from MEXT of Japan (to S. H.).	Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; Barnett DGS, 2011, BRAIN RES BULL, V85, P9, DOI 10.1016/j.brainresbull.2010.11.016; Brinkkoetter PT, 2009, J CLIN INVEST, V119, P3089, DOI 10.1172/JCI37978; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Cheung Zelda H., 2007, Biotechnology Journal, V2, P949, DOI 10.1002/biot.200700056; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hisatsune C, 1999, GENES CELLS, V4, P657, DOI 10.1046/j.1365-2443.1999.00287.x; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lee KY, 1996, J BIOL CHEM, V271, P1538, DOI 10.1074/jbc.271.3.1538; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lin H, 2007, CELL DEATH DIFFER, V14, P607, DOI 10.1038/sj.cdd.4402033; Mapelli M, 2005, J MED CHEM, V48, P671, DOI 10.1021/jm049323m; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Minegishi S, 2010, BIOCHEMISTRY-US, V49, P5482, DOI 10.1021/bi100631f; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nagano T, 2013, CELL CYCLE, V12, P2617, DOI 10.4161/cc.25623; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Saito T, 2013, J BIOL CHEM, V288, P32433, DOI 10.1074/jbc.M113.512293; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Tanabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092291; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; UCHIDA T, 1994, FEBS LETT, V355, P35, DOI 10.1016/0014-5793(94)01163-X; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x; Zhu YS, 2005, J NEUROCHEM, V94, P1535, DOI 10.1111/j.1471-4159.2005.03301.x; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	40	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19627	19636		10.1074/jbc.M113.501148	http://dx.doi.org/10.1074/jbc.M113.501148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872417	hybrid, Green Published			2022-12-28	WOS:000339326800035
J	Li, PY; Ji, P; Li, CY; Zhang, Y; Wang, GL; Zhang, XY; Xie, BB; Qin, QL; Chen, XL; Zhou, BC; Zhang, YZ				Li, Ping-Yi; Ji, Peng; Li, Chun-Yang; Zhang, Yi; Wang, Guang-Long; Zhang, Xi-Ying; Xie, Bin-Bin; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Structural Basis for Dimerization and Catalysis of a Novel Esterase from the GTSAG Motif Subfamily of the Bacterial Hormone-sensitive Lipase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; METAGENOMIC LIBRARY; FUNCTIONAL-ANALYSIS; CARBOXYLESTERASE; STABILITY; SOFTWARE; HOMOLOG; GENES; TOOLS; ESTE1	Hormone-sensitive lipases (HSLs) are widely distributed in microorganisms, plants, and animals. Microbial HSLs are classified into two subfamilies, an unnamed new subfamily and the GDSAG motif subfamily. Due to the lack of structural information, the detailed catalytic mechanism of the new subfamily is not yet clarified. Based on sequence analysis, we propose to name the new subfamily as the GTSAG motif subfamily. We identified a novel HSL esterase E25, a member of the GTSAG motif subfamily, by functional metagenomic screening, and resolved its structure at 2.05 angstrom. E25 is mesophilic (optimum temperature at 50 degrees C), salt-tolerant, slightly alkaline (optimum pH at 8.5) for its activity, and capable of hydrolyzing short chain monoesters (C2-C10). E25 tends to form dimers both in the crystal and in solution. An E25 monomer contains an N-terminal CAP domain, and a classical alpha/beta hydrolase-fold domain. Residues Ser(186), Asp(282), and His(312) comprise the catalytic triad. Structural and mutational analyses indicated that E25 adopts a dimerization pattern distinct from other HSLs. E25 dimer is mainly stabilized by an N-terminal loop intersection from the CAP domains and hydrogen bonds and salt bridges involving seven highly conserved hydrophilic residues from the catalytic domains. Further analysis indicated that E25 also has some catalytic profiles different from other HSLs. Dimerization is essential for E25 to exert its catalytic activity by keeping the accurate orientation of the catalytic Asp282 within the catalytic triad. Our results reveal the structural basis for dimerization and catalysis of an esterase from the GTSAG motif subfamily of the HSL family.	[Li, Ping-Yi; Ji, Peng; Li, Chun-Yang; Zhang, Yi; Wang, Guang-Long; Zhang, Xi-Ying; Xie, Bin-Bin; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Li, Ping-Yi; Ji, Peng; Li, Chun-Yang; Zhang, Yi; Wang, Guang-Long; Zhang, Xi-Ying; Xie, Bin-Bin; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China; [Zhang, Xi-Ying; Xie, Bin-Bin; Qin, Qi-Long; Chen, Xiu-Lan; Zhang, Yu-Zhong] Shandong Univ, Collaborat Innovat Ctr Deep Sea Biol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Zhang, YZ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn		Zhang, Yu-Zhong/0000-0002-2017-1005; Li, Chun-Yang/0000-0002-1151-4897	National Natural Science Foundation of China [91228210, 31290230, 31290231, 31025001]; Hi-Tech Research and Development Program of China [2012AA092105, 2012AA092103]; China Ocean Mineral Resources R & D Association (COMRA) Special Foundation [DY125-15-T-05]; Program of Shandong for Taishan Scholars [2008BS02019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R & D Association (COMRA) Special Foundation; Program of Shandong for Taishan Scholars	This work was supported by National Natural Science Foundation of China Grants 91228210, 31290230, 31290231, and 31025001, Hi-Tech Research and Development Program of China Grants 2012AA092105 and 2012AA092103, China Ocean Mineral Resources R & D Association (COMRA) Special Foundation Grant DY125-15-T-05, and Program of Shandong for Taishan Scholars Grant 2008BS02019.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angkawidjaja C, 2012, FEBS J, V279, P3071, DOI 10.1111/j.1742-4658.2012.08687.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Benavente R, 2013, FEBS J, V280, P6658, DOI 10.1111/febs.12569; Bornscheuer UT, 2002, CURR OPIN BIOTECH, V13, P543, DOI 10.1016/S0958-1669(02)00350-6; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Hu YF, 2010, FEMS MICROBIOL ECOL, V72, P228, DOI 10.1111/j.1574-6941.2010.00851.x; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jensen LH, 1997, METHOD ENZYMOL, V277, P353, DOI 10.1016/S0076-6879(97)77020-4; Jeon JH, 2012, APPL MICROBIOL BIOT, V93, P623, DOI 10.1007/s00253-011-3433-x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Li PY, 2012, ENVIRON MICROBIOL, V14, P467, DOI 10.1111/j.1462-2920.2011.02637.x; Mandrich L, 2005, J MOL BIOL, V345, P501, DOI 10.1016/j.jmb.2004.10.035; Nam KH, 2009, PROTEINS, V74, P1036, DOI 10.1002/prot.22313; Nam KH, 2009, BIOCHEM BIOPH RES CO, V379, P553, DOI 10.1016/j.bbrc.2008.12.085; Ngo TD, 2013, ACTA CRYSTALLOGR D, V69, P1726, DOI 10.1107/S0907444913013425; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palm GJ, 2011, APPL MICROBIOL BIOT, V91, P1061, DOI 10.1007/s00253-011-3337-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Rhee JK, 2006, APPL ENVIRON MICROB, V72, P3021, DOI 10.1128/AEM.72.4.3021-3025.2006; Schiefner A, 2014, PROTEINS, V82, P268, DOI 10.1002/prot.24383; Singleton MR, 1999, STRUCT FOLD DES, V7, P237, DOI 10.1016/S0969-2126(99)80034-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vonrhein C, 1998, J MOL BIOL, V282, P167, DOI 10.1006/jmbi.1998.2003; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	33	46	49	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19031	19041		10.1074/jbc.M114.574913	http://dx.doi.org/10.1074/jbc.M114.574913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24867954	Green Published, hybrid			2022-12-28	WOS:000339062900034
J	Pan, GD; Cao, J; Yang, NL; Ding, KH; Fan, C; Xiong, WC; Hamrick, M; Isales, CM; Shi, XM				Pan, Guodong; Cao, Jay; Yang, Nianlan; Ding, Kehong; Fan, Cheng; Xiong, Wen-Cheng; Hamrick, Mark; Isales, Carlos M.; Shi, Xing-Ming			Role of Glucocorticoid-induced Leucine Zipper (GILZ) in Bone Acquisition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; ACTIVATED PROTEIN-KINASE; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CELL-DIFFERENTIATION; GENE-TRANSCRIPTION; ADDISONS-DISEASE; BINDING-PROTEINS; TRANSGENIC MICE	Glucocorticoids (GCs) have both anabolic and catabolic effects on bone. However, no GC anabolic effect mediator has been identified to date. Here we show that targeted expression of glucocorticoid-induced leucine zipper (GILZ), a GC anti-inflammatory effect mediator, enhances bone acquisition in mice. Transgenic mice, in which the expression of GILZ is under the control of a 3.6-kb rat type I collagen promoter, exhibited a high bone mass phenotype with significantly increased bone formation rate and osteoblast numbers. The increased osteoblast activity correlates with enhanced osteogenic differentiation and decreased adipogenic differentiation of bone marrow stromal cell cultures in vitro. In line with these changes, the mRNA levels of key osteogenic regulators (Runx2 and Osx) increased, and the level of adipogenic regulator peroxisome proliferator-activated receptor (PPAR) gamma 2 decreased significantly. We also found that GILZ physically interacts with C/EBPs and disrupts C/EBP-mediated PPAR gamma gene transcription. In conclusion, our results showed that GILZ is capable of increasing bone acquisition in vivo, and this action is mediated via a mechanism involving the inhibition of PPAR gamma gene transcription and shifting of bone marrow MSC/progenitor cell lineage commitment in favor of the osteoblast pathway.	[Pan, Guodong; Yang, Nianlan; Ding, Kehong; Fan, Cheng; Xiong, Wen-Cheng; Isales, Carlos M.; Shi, Xing-Ming] Georgia Regents Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Hamrick, Mark] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Isales, Carlos M.; Shi, Xing-Ming] Georgia Regents Univ, Dept Orthopaed Surg, Augusta, GA 30912 USA; [Pan, Guodong] Wuhan Univ, Wuhan 430072, Peoples R China; [Cao, Jay] ARS, Grand Forks Human Nutr Res Ctr, USDA, Grand Forks, ND 58203 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Wuhan University; United States Department of Agriculture (USDA)	Shi, XM (corresponding author), Georgia Regents Univ, Dept Neurosci & Regenerat Med, 1120 15th St,CA-2003, Augusta, GA 30912 USA.	xshi@gru.edu	pan, guodong/F-3794-2017; Isales, Carlos/J-9902-2013	Isales, Carlos/0000-0002-4480-3484	National Institutes of Health [R01DK76045, R01AG046248, P01AG036675]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046248, P01AG036675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK76045, R01AG046248, and P01AG036675.	Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Beaulieu E, 2010, ARTHRITIS RHEUM-US, V62, P2651, DOI 10.1002/art.27566; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Clowes JA, 2001, CURR OPIN RHEUMATOL, V13, P326, DOI 10.1097/00002281-200107000-00015; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Elberg G, 2000, J BIOL CHEM, V275, P27815; Gimble JM, 2009, OBES REV, V10, P46, DOI 10.1111/j.1467-789X.2009.00661.x; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; He LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031717; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kassem M, 2000, EUR J CLIN INVEST, V30, P429; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; MORRISON N, 1993, J BONE MINER RES, V8, P969; Nishimura J, 2000, J BONE MINER METAB, V18, P350, DOI 10.1007/s007740070008; Park OJ, 2010, J BIOL CHEM, V285, P3568, DOI 10.1074/jbc.M109.055053; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Rutter MM, 2005, BONE, V36, P224, DOI 10.1016/j.bone.2004.10.005; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Sher LB, 2004, ENDOCRINOLOGY, V145, P922, DOI 10.1210/en.2003-0655; Shi XM, 2001, J BIOL CHEM, V276, P850, DOI 10.1074/jbc.M005955200; Shi XM, 2000, J CELL BIOCHEM, V76, P518, DOI 10.1002/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Soule S, 1999, CLIN ENDOCRINOL, V50, P115, DOI 10.1046/j.1365-2265.1999.00625.x; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; VALERO MA, 1994, BONE MINER, V26, P9, DOI 10.1016/S0169-6009(08)80158-4; Woitge HW, 2001, ENDOCRINOLOGY, V142, P1341, DOI 10.1210/en.142.3.1341; Xia WF, 2013, J BONE MINER RES, V28, P2122, DOI 10.1002/jbmr.1954; Yang MB, 2010, BONE, V47, P573, DOI 10.1016/j.bone.2010.06.002; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200	38	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19373	19382		10.1074/jbc.M113.535237	http://dx.doi.org/10.1074/jbc.M113.535237			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860090	Green Published, hybrid			2022-12-28	WOS:000339326800014
J	Lin, YC; Li, L; Makarova, AV; Burgers, PM; Stone, MP; Lloyd, RS				Lin, Ying-Chih; Li, Liang; Makarova, Alena V.; Burgers, Peter M.; Stone, Michael P.; Lloyd, R. Stephen			Error-prone Replication Bypass of the Primary Aflatoxin B-1 DNA Adduct, AFB(1)-N7-Gua	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; POLYMERASE-ZETA; RAT-LIVER; P53 GENE; MUTATIONS; IDENTIFICATION; SUBSTITUTION; EXONUCLEASE; MUTAGENESIS; FIDELITY	Hepatocellular carcinomas (HCCs) are the third leading cause of cancer deaths worldwide. The highest rates of early onset HCCs occur in geographical regions with high aflatoxin B-1 (AFB(1)) exposure, concomitant with hepatitis B infection. Although the carcinogenic basis of AFB1 has been ascribed to its mutagenic effects, the mutagenic property of the primary AFB(1)-DNA adduct, AFB(1)-N7-Gua, in mammalian cells has not been studied extensively. Taking advantage of the ability to create vectors containing a site-specific DNA adduct, the mutagenic potential was determined in primate cells. This adduct was highly mutagenic following replication in COS-7 cells, with a mutation frequency of 45%. The spectrum of mutations was predominantly G to T base substitutions, a result that is consistent with previous mutation data derived from aflatoxin-associated HCCs. To assess which DNA polymerases (pol) might contribute to the mutational outcome, in vitro replication studies were performed. Unexpectedly, replicative pol delta and the error-prone translesion synthesis pol sigma were able to accurately bypass AFB(1)-N7-Gua. In contrast, replication bypass using pol kappa was shown to occur with low fidelity and could account for the commonly detected G to T transversions.	[Lin, Ying-Chih] Oregon Hlth & Sci Univ, Canc Biol Program, Portland, OR 97239 USA; [Lin, Ying-Chih; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Li, Liang; Stone, Michael P.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Makarova, Alena V.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Vanderbilt University; Washington University (WUSTL)	Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA.	lloydst@ohsu.edu	Makarova, Alena Vladimirovna/I-1338-2014; Burgers, Peter M/AAW-6621-2021	Lloyd, R. Stephen/0000-0001-7273-372X; Stone, Michael/0000-0002-0922-0216	National Institutes of Health [R01 CA055678, GM032431, P30 ES00267]; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA055678, P30CA068485, P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA055678 (to M. P. S. and R. S. L.), GM032431 (to P. M. B.), and P30 ES00267 (to M. P. S.) and by the OHSU Knight Cancer Institute graduate fellowship (to Y.-C. L.).	AGUILAR F, 1993, P NATL ACAD SCI USA, V90, P8586, DOI 10.1073/pnas.90.18.8586; BAERTSCHI SW, 1988, J AM CHEM SOC, V110, P7929, DOI 10.1021/ja00231a083; Bailey EA, 1996, P NATL ACAD SCI USA, V93, P1535, DOI 10.1073/pnas.93.4.1535; Banerjee S, 2011, J AM CHEM SOC, V133, P12556, DOI 10.1021/ja2015668; Besaratinia A, 2009, GASTROENTEROLOGY, V137, P1127, DOI 10.1053/j.gastro.2009.06.002; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Brown KL, 2006, J AM CHEM SOC, V128, P15188, DOI 10.1021/ja063781y; CROY RG, 1981, CANCER RES, V41, P197; CROY RG, 1978, P NATL ACAD SCI USA, V75, P1745, DOI 10.1073/pnas.75.4.1745; ESSIGMANN JM, 1977, P NATL ACAD SCI USA, V74, P1870, DOI 10.1073/pnas.74.5.1870; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandes PH, 2007, MUTAT RES-FUND MOL M, V625, P40, DOI 10.1016/j.mrfmmm.2007.05.003; FORRESTER LM, 1990, P NATL ACAD SCI USA, V87, P8306, DOI 10.1073/pnas.87.21.8306; FOSTER PL, 1983, P NATL ACAD SCI-BIOL, V80, P2695, DOI 10.1073/pnas.80.9.2695; GOPALAKRISHNAN S, 1990, BIOCHEMISTRY-US, V29, P10438, DOI 10.1021/bi00498a002; GROOPMAN JD, 1981, P NATL ACAD SCI-BIOL, V78, P5445, DOI 10.1073/pnas.78.9.5445; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Jin YH, 2005, MOL CELL BIOL, V25, P461, DOI 10.1128/MCB.25.1.461-471.2005; Johnston DS, 2000, CHEM RES TOXICOL, V13, P1158, DOI 10.1021/tx000129m; Kensler TW, 2003, NAT REV CANCER, V3, P321, DOI 10.1038/nrc1076; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; LEVY DD, 1992, CANCER RES, V52, P5668; Lin Y.-C., 2014, CARCINOGENE IN PRESS; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Maddukuri L, 2012, J BIOL CHEM, V287, P42312, DOI 10.1074/jbc.M112.410332; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Mao H, 1998, BIOCHEMISTRY-US, V37, P4374, DOI 10.1021/bi9718292; MARTIN CN, 1977, NATURE, V267, P863, DOI 10.1038/267863a0; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Roze LV, 2013, ANNU REV FOOD SCI T, V4, P293, DOI 10.1146/annurev-food-083012-123702; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Smela ME, 2002, P NATL ACAD SCI USA, V99, P6655, DOI 10.1073/pnas.102167699; Yamanaka K, 2013, DNA REPAIR AND CANCER: FROM BENCH TO CLINIC, P325; Yamanaka K, 2011, J BACTERIOL, V193, P3815, DOI 10.1128/JB.01550-10	35	35	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18497	18506		10.1074/jbc.M114.561563	http://dx.doi.org/10.1074/jbc.M114.561563			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24838242	Green Published, hybrid			2022-12-28	WOS:000338042000046
J	Steenblock, C; Heckel, T; Czupalla, C; Santo, AIE; Niehage, C; Sztacho, M; Hoflack, B				Steenblock, Charlotte; Heckel, Tobias; Czupalla, Cornelia; Santo, Ana Isabel Espirito; Niehage, Christian; Sztacho, Martin; Hoflack, Bernard			The Cdc42 Guanine Nucleotide Exchange Factor FGD6 Coordinates Cell Polarity and Endosomal Membrane Recycling in Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACIOGENITAL DYSPLASIA; PLECKSTRIN HOMOLOGY; BONE; PROTEIN; INTEGRINS; COMPLEX; BINDING; WASH; TRAFFICKING; EXPRESSION	The initial step of bone digestion is the adhesion of osteoclasts onto bone surfaces and the assembly of podosomal belts that segregate the bone-facing ruffled membrane from other membrane domains. During bone digestion, membrane components of the ruffled border also need to be recycled after macropinocytosis of digested bone materials. How osteoclast polarity and membrane recycling are coordinated remains unknown. Here, we show that the Cdc42-guanine nucleotide exchange factor FGD6coordinates these events through its Src-dependent interaction with different actin-based protein networks. At the plasma membrane, FGD6 couples cell adhesion and actin dynamics by regulating podosome formation through the assembly of complexes comprising the Cdc42-interactor IQGAP1, the Rho GTPase-activating protein ARHGAP10, and the integrin interactors Talin-1/2 or Filamin A. On endosomes and transcytotic vesicles, FGD6 regulates retromer-dependent membrane recycling through its interaction with the actin nucleation-promoting factor WASH. These results provide a mechanism by which a single Cdc42-exchange factor controlling different actin-based processes coordinates cell adhesion, cell polarity, and membrane recycling during bone degradation.	[Steenblock, Charlotte; Heckel, Tobias; Czupalla, Cornelia; Santo, Ana Isabel Espirito; Niehage, Christian; Sztacho, Martin; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Technische Universitat Dresden	Hoflack, B (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-51, D-01307 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020; Steenblock, Charlotte/C-9038-2018	Heckel, Tobias/0000-0002-2433-8319; Sztacho, Martin/0000-0002-8496-1364; Steenblock, Charlotte/0000-0002-9635-4860	Deutsche Forschungsgemeinschaft [TRR 83/1-2010, TRR 83/2-2014, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1]; TU-Dresden	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TU-Dresden	This work was supported in part by Deutsche Forschungsgemeinschaft Grants TRR 83/1-2010, TRR 83/2-2014, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1, and TU-Dresden.	Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Czupalla C, 2005, PROTEOMICS, V5, P3868, DOI 10.1002/pmic.200402059; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dixon MJ, 2012, J BIOL CHEM, V287, P22483, DOI 10.1074/jbc.M112.352773; Dixon MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003178; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Egorov MV, 2009, MOL BIOL CELL, V20, P2413, DOI 10.1091/mbc.E08-11-1136; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heckel T, 2009, P NATL ACAD SCI USA, V106, P1451, DOI 10.1073/pnas.0804464106; Huber C, 2008, J BIOL CHEM, V283, P34002, DOI 10.1074/jbc.M803957200; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Leung R, 2010, J BONE MINER RES, V25, P1077, DOI 10.1359/jbmr.091114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luxenburg C, 2012, J CELL SCI, V125, P1666, DOI 10.1242/jcs.075903; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; NAKAMURA I, 1995, FEBS LETT, V361, P79, DOI 10.1016/0014-5793(95)00153-Z; Ono Y, 2000, ONCOGENE, V19, P3050, DOI 10.1038/sj.onc.1203631; Orrico A, 2004, EUR J HUM GENET, V12, P16, DOI 10.1038/sj.ejhg.5201081; Pasteris NG, 2000, GENE, V242, P237, DOI 10.1016/S0378-1119(99)00518-1; Pelikan-Conchaudron A, 2011, J BIOL CHEM, V286, P35119, DOI 10.1074/jbc.M111.258772; Pellegrin Stephanie, 2008, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1408s38; Pocha SM, 2011, CURR BIOL, V21, P1111, DOI 10.1016/j.cub.2011.05.007; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Stenbeck G, 2004, J CELL SCI, V117, P827, DOI 10.1242/jcs.00935; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Yamaki M, 2005, ARCH BIOCHEM BIOPHYS, V440, P10, DOI 10.1016/j.abb.2005.05.021; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	46	43	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18347	18359		10.1074/jbc.M113.504894	http://dx.doi.org/10.1074/jbc.M113.504894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24821726	hybrid, Green Published			2022-12-28	WOS:000338042000034
J	Valentin-Hansen, L; Park, M; Huber, T; Grunbeck, A; Naganathan, S; Schwartz, TW; Sakmar, TP				Valentin-Hansen, Louise; Park, Minyoung; Huber, Thomas; Grunbeck, Amy; Naganathan, Saranga; Schwartz, Thue W.; Sakmar, Thomas P.			Mapping Substance P Binding Sites on the Neurokinin-1 Receptor Using Genetic Incorporation of a Photoreactive Amino Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; NK-1 RECEPTOR; CRYSTAL-STRUCTURE; NK1 RECEPTOR; TACHYKININ RECEPTOR; COVALENT ATTACHMENT; AGONIST; SEPTIDE; COMPLEX; DOMAIN	Substance P (SP) is a neuropeptide that mediates numerous physiological responses, including transmission of pain and inflammation through the neurokinin-1 (NK1) receptor, a G protein-coupled receptor. Previous mutagenesis studies and photoaffinity labeling using ligand analogues suggested that the binding site for SP includes multiple domains in the N-terminal (Nt) segment and the second extracellular loop (ECLII) of NK1. To map precisely the NK1 residues that interact with SP, we applied a novel receptor-based targeted photocross-linking approach. We used amber codon suppression to introduce the photoreactive unnatural amino acid p-benzoyl-L-phenylalanine (BzF) at 11 selected individual positions in the Nt tail (residues 11-21) and 23 positions in the ECLII (residues 170(C-10)-193(C+13)) of NK1. The 34 NK1 variants were expressed in mammalian HEK293 cells and retained the ability to interact with a fluorescently labeled SP analog. Notably, 10 of the receptor variants with BzF in the Nt tail and 4 of those with BzF in ECLII cross-linked efficiently to SP, indicating that these 14 sites are juxtaposed to SP in the ligand-bound receptor. These results show that two distinct regions of the NK1 receptor possess multiple determinants for SP binding and demonstrate the utility of genetically encoded photocross-linking to map complex multitopic binding sites on G protein-coupled receptors in a cell-based assay format.	[Valentin-Hansen, Louise; Schwartz, Thue W.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; [Valentin-Hansen, Louise; Park, Minyoung; Schwartz, Thue W.; Sakmar, Thomas P.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Receptol & Enteroendocrinol, DK-2200 Copenhagen, Denmark; [Park, Minyoung; Huber, Thomas; Grunbeck, Amy; Naganathan, Saranga; Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, New York, NY 10065 USA	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Rockefeller University	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10065 USA.	sakmar@rockefeller.edu	Sakmar, Thomas P/D-1833-2015; Huber, Thomas/A-8016-2008	Sakmar, Thomas P/0000-0002-2836-8953; Huber, Thomas/0000-0002-1844-262X; Schwartz, Thue W./0000-0002-0261-6904	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank the Proteomic Resource Center at the Rockefeller University for the synthesis of the F-SP and F-SP(BzF8) peptide analogues. The Novo Nordisk Foundation Center for Basic Metabolic Research is supported by an unconditional grant from the Novo Nordisk Foundation to the University of Copenhagen.	BOYD ND, 1995, ANN NY ACAD SCI, V757, P405, DOI 10.1111/j.1749-6632.1995.tb17498.x; Boyd ND, 1996, P NATL ACAD SCI USA, V93, P433, DOI 10.1073/pnas.93.1.433; Bremer AA, 2001, J BIOL CHEM, V276, P22857, DOI 10.1074/jbc.M100824200; Elling CE, 2000, BIOCHEMISTRY-US, V39, P667, DOI 10.1021/bi991777b; FONG TM, 1992, BIOCHEMISTRY-US, V31, P11806, DOI 10.1021/bi00162a019; FONG TM, 1993, NATURE, V362, P350; FONG TM, 1993, REGUL PEPTIDES, V46, P43, DOI 10.1016/0167-0115(93)90010-6; Gayen A, 2011, BBA-BIOMEMBRANES, V1808, P127, DOI 10.1016/j.bbamem.2010.09.023; Girault S, 1996, EUR J BIOCHEM, V240, P215, DOI 10.1111/j.1432-1033.1996.0215h.x; Grunbeck A, 2013, BIOCHEMISTRY-US, V52, P8625, DOI 10.1021/bi401300y; Grunbeck A, 2013, METHOD ENZYMOL, V520, P307, DOI 10.1016/B978-0-12-391861-1.00014-9; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; Hastrup H, 1996, FEBS LETT, V399, P264, DOI 10.1016/S0014-5793(96)01337-3; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; HUANG RRC, 1994, BIOCHEMISTRY-US, V33, P3007, DOI 10.1021/bi00176a033; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lequin O, 2002, J BIOL CHEM, V277, P22386, DOI 10.1074/jbc.M110614200; Li HZ, 2001, J BIOL CHEM, V276, P10589, DOI 10.1074/jbc.M007397200; LI YM, 1995, J BIOL CHEM, V270, P1213, DOI 10.1074/jbc.270.3.1213; Macdonald D, 2001, BIOCHEMISTRY-US, V40, P2530, DOI 10.1021/bi001880x; Maggi CA, 2000, REGUL PEPTIDES, V93, P53, DOI 10.1016/S0167-0115(00)00177-4; Maggi CA, 1997, TRENDS PHARMACOL SCI, V18, P351, DOI 10.1016/S0165-6147(97)90663-5; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Nguyen ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067302; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Pellegrini M, 2001, J BIOL CHEM, V276, P22862, DOI 10.1074/jbc.M101057200; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; PRADIER L, 1994, MOL PHARMACOL, V45, P287; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; REGOLI D, 1994, PHARMACOL REV, V46, P551; Riitano D, 1997, J BIOL CHEM, V272, P7646, DOI 10.1074/jbc.272.12.7646; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Sachon E, 2002, J BIOL CHEM, V277, P50409, DOI 10.1074/jbc.M207242200; Sachon E, 2002, J PEPT RES, V59, P232, DOI 10.1034/j.1399-3011.2002.01977.x; Sato S, 2011, BIOCHEMISTRY-US, V50, P250, DOI 10.1021/bi1016183; Turcatti G, 1997, J BIOL CHEM, V272, P21167, DOI 10.1074/jbc.272.34.21167; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wijkhuisen A, 1999, FEBS LETT, V447, P155, DOI 10.1016/S0014-5793(99)00298-7; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200	48	36	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18045	18054		10.1074/jbc.M113.527085	http://dx.doi.org/10.1074/jbc.M113.527085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831006	hybrid, Green Published			2022-12-28	WOS:000338042000008
J	Yokoyama, A; Igarashi, K; Sato, T; Takagi, K; Otsuka, IM; Shishido, Y; Baba, T; Ito, R; Kanno, J; Ohkawa, Y; Morohashi, K; Sugawara, A				Yokoyama, Atsushi; Igarashi, Katsuhide; Sato, Tetsuya; Takagi, Kiyoshi; Otsuka, Maky, I; Shishido, Yurina; Baba, Takashi; Ito, Ryo; Kanno, Jun; Ohkawa, Yasuyuki; Morohashi, Ken-ichirou; Sugawara, Akira			Identification of Myelin Transcription Factor 1 (MyT1) as a Subunit of the Neural Cell Type-specific Lysine-specific Demethylase 1 (LSD1) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEX; HISTONE DEMETHYLASE; ZINC-FINGER; DEPENDENT TRANSCRIPTION; NERVOUS-SYSTEM; BREAST-CANCER; PROTEIN PHOSPHATASE; NUCLEAR RECEPTORS; TUMOR-SUPPRESSOR; GENE ACTIVATION	Regulation of spatiotemporal gene expression in higher eukaryotic cells is critical for the precise and orderly development of undifferentiated progenitors into committed cell types of the adult. It is well known that dynamic epigenomic regulation (including chromatin remodeling and histone modifications by transcriptional coregulator complexes) is involved in transcriptional regulation. Precisely how these coregulator complexes exert their cell type and developing stage-specific activity is largely unknown. In this study we aimed to isolate the histone demethylase lysine-specific demethylase 1 (LSD1) complex from neural cells by biochemical purification. In so doing, we identified myelin transcription factor 1 (MyT1) as a novel LSD1 complex component. MyT1 is a neural cell-specific zinc finger factor, and it forms a stable multiprotein complex with LSD1 through direct interaction. Target gene analysis using microarray and ChIP assays revealed that the Pten gene was directly regulated by the LSD1-MyT1 complex. Knockdown of either LSD1 or MyT1 derepressed the expression of endogenous target genes and inhibited cell proliferation of a neuroblastoma cell line, Neuro2a. We propose that formation of tissue-specific combinations of coregulator complexes is a critical mechanism for tissue-specific transcriptional regulation.	[Yokoyama, Atsushi; Ito, Ryo; Sugawara, Akira] Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yokoyama, Atsushi; Ito, Ryo] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Igarashi, Katsuhide; Otsuka, Maky, I; Kanno, Jun] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Setagaya Ku, Tokyo 1588501, Japan; [Igarashi, Katsuhide; Otsuka, Maky, I] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, Tokyo 1428501, Japan; [Sato, Tetsuya] Kyushu Univ, Med Inst Bioregulat, Div Bioinformat, Higashi Ku, Fukuoka 8128582, Japan; [Takagi, Kiyoshi] Tohoku Univ, Grad Sch Med, Dept Pathol & Histotechnol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Shishido, Yurina; Baba, Takashi; Morohashi, Ken-ichirou] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Div Epigenet,Higashi Ku, Fukuoka 8128582, Japan	Tohoku University; University of Tokyo; National Institute of Health Sciences - Japan; Hoshi University; Kyushu University; Tohoku University; Kyushu University; Kyushu University	Yokoyama, A (corresponding author), Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	ayokoyama@med.tohoku.ac.jp	Ohkawa, Yasuyuki/C-4087-2016; Baba, Takashi/ABI-2727-2020; Yokoyama, Atsushi/W-3519-2019; Ito, Ryo/F-8571-2016; Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954; Sugawara, Akira/0000-0003-4511-8101; Yokoyama, Atsushi/0000-0003-2842-4334	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a research fellowship for young scientists from the Japan Society for the Promotion of Science (to A. Y.).	Blasie CA, 2000, INORG CHEM, V39, P348, DOI 10.1021/ic990913y; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Fiaschi T, 2001, J BIOL CHEM, V276, P49156, DOI 10.1074/jbc.M107538200; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; Jones KA, 2007, GENE DEV, V21, P2113, DOI 10.1101/gad.1598007; Kanno J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-64; Kato S, 2011, TRENDS BIOCHEM SCI, V36, P272, DOI 10.1016/j.tibs.2011.01.001; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; Kimura M, 2001, CYTOGENET CELL GENET, V95, P177, DOI 10.1159/000059342; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lucentini L, 2003, INT J BIOCHEM CELL B, V35, P1378, DOI 10.1016/S1357-2725(03)00099-2; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2006, CURR OPIN GENET DEV, V16, P513, DOI 10.1016/j.gde.2006.08.013; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sanosaka T, 2008, NEUROSCIENCE, V155, P780, DOI 10.1016/j.neuroscience.2008.06.039; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Yang MJ, 2007, BIOCHEMISTRY-US, V46, P8058, DOI 10.1021/bi700664y; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; Yokoyama A, 2011, COLD SH Q B, V76, P165, DOI 10.1101/sqb.2011.76.010736; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; Yokoyama A, 2010, GENES CELLS, V15, P867, DOI 10.1111/j.1365-2443.2010.01424.x; Zhang YZ, 2010, NEUROSCI RES, V68, P66, DOI 10.1016/j.neures.2010.06.002; Zibetti C, 2010, J NEUROSCI, V30, P2521, DOI 10.1523/JNEUROSCI.5500-09.2010	65	29	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18152	18162		10.1074/jbc.M114.566448	http://dx.doi.org/10.1074/jbc.M114.566448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828497	Green Published, hybrid			2022-12-28	WOS:000338042000018
J	Acharya, KR; Ackerman, SJ				Acharya, K. Ravi; Ackerman, Steven J.			Eosinophil Granule Proteins: Form and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MAJOR BASIC-PROTEIN; LEYDEN CRYSTAL PROTEIN; EXTRACELLULAR DNA TRAPS; RIBONUCLEOLYTIC ACTIVE-SITE; REGULATORY T-CELLS; CATIONIC PROTEIN; ANGSTROM RESOLUTION; MOLECULAR-CLONING; MUSCARINIC RECEPTORS; GENE POLYMORPHISM	Experimental and clinical data strongly support a role for the eosinophil in the pathogenesis of asthma, allergic and parasitic diseases, and hypereosinophilic syndromes, in addition to more recently identified immunomodulatory roles in shaping innate host defense, adaptive immunity, tissue repair/remodeling, and maintenance of normal tissue homeostasis. A seminal finding was the dependence of allergic airway inflammation on eosinophil-induced recruitment of Th2-polarized effector T-cells to the lung, providing a missing link between these innate immune effectors (eosinophils) and adaptive T-cell responses. Eosinophils come equipped with preformed enzymatic and nonenzymatic cationic proteins, stored in and selectively secreted from their large secondary (specific) granules. These proteins contribute to the functions of the eosinophil in airway inflammation, tissue damage, and remodeling in the asthmatic diathesis. Studies using eosinophil-deficient mouse models, including eosinophil-derived granule protein double knock-out mice (major basic protein-1/eosinophil peroxidase dual gene deletion) show that eosinophils are required for all major hallmarks of asthma pathophysiology: airway epithelial damage and hyperreactivity, and airway remodeling including smooth muscle hyperplasia and subepithelial fibrosis. Here we review key molecular aspects of these eosinophil-derived granule proteins in terms of structure-function relationships to advance understanding of their roles in eosinophil cell biology, molecular biology, and immunobiology in health and disease.	[Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Ackerman, Steven J.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Bath; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk		Acharya, K. Ravi/0000-0002-3009-4058	University of Bath	University of Bath	Recipient of a David Parkin Visiting Professorship from the University of Bath. To whom correspondence may be addressed: Dept. of Biochemistry and Molecular Genetics, the University of Illinois at Chicago, College of Medicine, 900 S. Ashland Ave., Chicago, IL 60607. Tel.: 312-996-6149; E-mail: sackerma@uic.edu.	ABUGHAZALEH RI, 1992, J LEUKOCYTE BIOL, V52, P611, DOI 10.1002/jlb.52.6.611; ACKERMAN SJ, 1993, J IMMUNOL, V150, P456; ACKERMAN SJ, 1983, J IMMUNOL, V131, P2977; ACKERMAN SJ, 1982, J EXP MED, V155, P1597, DOI 10.1084/jem.155.6.1597; Ackerman SJ, 2002, J BIOL CHEM, V277, P14859, DOI 10.1074/jbc.M200221200; ACKERMAN SJ, 1983, J EXP MED, V158, P946, DOI 10.1084/jem.158.3.946; Ackerman SJ, 2013, BLOOD, V122, P621, DOI 10.1182/blood-2013-06-508507; AURIAULT C, 1982, CELL IMMUNOL, V66, P59, DOI 10.1016/0008-8749(82)90157-5; Blom K, 2012, WORLD J GASTROENTERO, V18, P6409, DOI 10.3748/wjg.v18.i44.6409; Boix E, 1999, BIOCHEMISTRY-US, V38, P16794, DOI 10.1021/bi9919145; Boix E, 1999, J BIOL CHEM, V274, P15605, DOI 10.1074/jbc.274.22.15605; Boix E, 2001, J LEUKOCYTE BIOL, V69, P1027; Boix E, 2012, BIOL CHEM, V393, P801, DOI 10.1515/hsz-2012-0160; Bryborn M, 2010, ALLERGY, V65, P220, DOI 10.1111/j.1398-9995.2009.02141.x; Chua JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042549; Denzler KL, 2000, J IMMUNOL, V165, P5509, DOI 10.4049/jimmunol.165.10.5509; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Domachowske JB, 1998, J INFECT DIS, V177, P1458, DOI 10.1086/515322; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P3358, DOI 10.1093/nar/26.14.3358; Doyle AD, 2013, BLOOD, V122, P781, DOI 10.1182/blood-2013-01-473405; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; Dyer KD, 1997, GENOMICS, V40, P217, DOI 10.1006/geno.1996.4590; Eriksson J, 2007, INT J PARASITOL, V37, P1359, DOI 10.1016/j.ijpara.2007.04.001; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Fabre V, 2009, J IMMUNOL, V182, P1577, DOI 10.4049/jimmunol.182.3.1577; FREDENS K, 1982, J ALLERGY CLIN IMMUN, V70, P361, DOI 10.1016/0091-6749(82)90025-2; Furuta GT, 2013, GUT, V62, P1395, DOI 10.1136/gutjnl-2012-303171; Gebreselassie NG, 2012, J IMMUNOL, V188, P417, DOI 10.4049/jimmunol.1101980; Gleich G. J., 2000, ASTHMA RHINITIS, V1; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; GOLIGHTLY LM, 1992, J LEUKOCYTE BIOL, V51, P386, DOI 10.1002/jlb.51.4.386; GUNDEL RH, 1991, J CLIN INVEST, V87, P1470, DOI 10.1172/JCI115155; HAMANN KJ, 1987, J PARASITOL, V73, P523, DOI 10.2307/3282130; HAMANN KJ, 1990, J IMMUNOL, V144, P3166; HAMANN KJ, 1990, GENOMICS, V7, P535, DOI 10.1016/0888-7543(90)90197-3; HENDERSON WR, 1982, J IMMUNOL, V128, P2609; HENDERSON WR, 1980, J IMMUNOL, V124, P1383; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Jacobsen EA, 2014, ALLERGY, V69, P315, DOI 10.1111/all.12321; JACOBY DB, 1993, J CLIN INVEST, V91, P1314, DOI 10.1172/JCI116331; Jonsson UB, 2002, CLIN EXP ALLERGY, V32, P1092, DOI 10.1046/j.1365-2222.2002.01410.x; Jonsson UB, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-36; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Lacy P, 2003, J IMMUNOL, V170, P2670, DOI 10.4049/jimmunol.170.5.2670; Larson KA, 1996, P NATL ACAD SCI USA, V93, P12370, DOI 10.1073/pnas.93.22.12370; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; LEIFERMAN KM, 1986, J IMMUNOL, V136, P852; Leonidas DD, 1995, STRUCTURE, V3, P1379, DOI 10.1016/S0969-2126(01)00275-1; Leonidas DD, 2001, J BIOL CHEM, V276, P15009, DOI 10.1074/jbc.M010585200; LOCKSLEY RM, 1982, J CLIN INVEST, V69, P1099, DOI 10.1172/JCI110545; Mohan CG, 2002, BIOCHEMISTRY-US, V41, P12100, DOI 10.1021/bi0264521; Morshed M, 2012, ALLERGY, V67, P1127, DOI 10.1111/j.1398-9995.2012.02868.x; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; NEWTON DL, 1994, J BIOL CHEM, V269, P26739; OXVIG C, 1994, FEBS LETT, V341, P213, DOI 10.1016/0014-5793(94)80459-1; PATTHY L, 1989, MOL IMMUNOL, V26, P1151, DOI 10.1016/0161-5890(89)90059-X; Pegorier S, 2006, J IMMUNOL, V177, P4861, DOI 10.4049/jimmunol.177.7.4861; Plager DA, 1999, J BIOL CHEM, V274, P14464, DOI 10.1074/jbc.274.20.14464; Pulido D, 2013, ANTIMICROB AGENTS CH, V57, P3797, DOI 10.1128/AAC.00428-13; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; ROSENBERG HF, 1989, J EXP MED, V170, P163, DOI 10.1084/jem.170.1.163; Rothenberg ME, 2008, NEW ENGL J MED, V358, P1215, DOI 10.1056/NEJMoa070812; Rubin J, 2009, J IMMUNOL, V183, P445, DOI 10.4049/jimmunol.0803912; Sanchez D, 2011, BIOCHIMIE, V93, P331, DOI 10.1016/j.biochi.2010.10.005; Schmetterer KG, 2012, FASEB J, V26, P2253, DOI 10.1096/fj.11-193672; Simon D, 2013, ALLERGY, V68, P409, DOI 10.1111/all.12111; Simon D, 2011, J ALLERGY CLIN IMMUN, V127, P194, DOI 10.1016/j.jaci.2010.11.002; SORRENTINO S, 1992, J BIOL CHEM, V267, P14859; Specht S, 2006, INFECT IMMUN, V74, P5236, DOI 10.1128/IAI.00329-06; Sur S, 1998, J LEUKOCYTE BIOL, V63, P715, DOI 10.1002/jlb.63.6.715; Svensson L, 2005, MICROBES INFECT, V7, P720, DOI 10.1016/j.micinf.2005.01.010; Swaminathan GJ, 1999, BIOCHEMISTRY-US, V38, P13837, DOI 10.1021/bi990756e; Swaminathan GJ, 2005, BIOCHEMISTRY-US, V44, P14152, DOI 10.1021/bi051112b; Swaminathan GJ, 2001, J BIOL CHEM, V276, P26197, DOI 10.1074/jbc.M100848200; Temkin V, 2004, J ALLERGY CLIN IMMUN, V113, P703, DOI 10.1016/j.jaci.2003.11.038; Thomas LL, 2002, J IMMUNOL, V169, P993, DOI 10.4049/jimmunol.169.2.993; Torrent M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003005; Torrent M, 2011, J MED CHEM, V54, P5237, DOI 10.1021/jm200701g; Trulson A, 2007, CLIN EXP ALLERGY, V37, P208, DOI 10.1111/j.1365-2222.2007.02644.x; Ulrich M, 2008, J BIOL CHEM, V283, P28629, DOI 10.1074/jbc.M801196200; Wang JG, 2006, BLOOD, V107, P558, DOI 10.1182/blood-2005-05-2152; Wang JG, 2006, J IMMUNOL, V177, P8714, DOI 10.4049/jimmunol.177.12.8714; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Wehling-Henricks M, 2008, HUM MOL GENET, V17, P2280, DOI 10.1093/hmg/ddn129; WELLER PF, 1984, J BIOL CHEM, V259, P5100; Woschnagg C, 2009, J IMMUNOL, V183, P3949, DOI 10.4049/jimmunol.0900509; Yang D, 2004, J IMMUNOL, V173, P6134, DOI 10.4049/jimmunol.173.10.6134; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Yost BL, 1999, J APPL PHYSIOL, V87, P1272, DOI 10.1152/jappl.1999.87.4.1272; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Yousefi S, 2012, CURR OPIN IMMUNOL, V24, P736, DOI 10.1016/j.coi.2012.08.010; Zhang JZ, 2000, P NATL ACAD SCI USA, V97, P4701, DOI 10.1073/pnas.080071397	98	269	277	4	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17406	17415		10.1074/jbc.R113.546218	http://dx.doi.org/10.1074/jbc.R113.546218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24802755	hybrid, Green Published			2022-12-28	WOS:000338018100010
J	Altintas, MM; Moriwaki, K; Wei, CL; Moller, CC; Flesche, J; Li, J; Yaddanapudi, S; Faridi, MH; Godel, M; Huber, TB; Preston, RA; Jiang, JX; Kerjaschki, D; Sever, S; Reiser, J				Altintas, Mehmet M.; Moriwaki, Kumiko; Wei, Changli; Moeller, Clemens C.; Flesche, Jan; Li, Jing; Yaddanapudi, Suma; Faridi, Mohd Hafeez; Goedel, Markus; Huber, Tobias B.; Preston, Richard A.; Jiang, Jean X.; Kerjaschki, Dontscho; Sever, Sanja; Reiser, Jochen			Reduction of Proteinuria through Podocyte Alkalinization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC FLUX ANALYSIS; HUMAN CARBOHYDRATE-METABOLISM; AMINO-ACID-TRANSPORT; NEPHROTIC-SYNDROME; INTRACELLULAR PH; CELL-METABOLISM; KIDNEY-DISEASE; SLIT DIAPHRAGM; GENE FAMILY; CATHEPSIN-L	Podocytes are highly differentiated cells and critical elements for the filtration barrier of the kidney. Loss of their foot process (FP) architecture (FP effacement) results in urinary protein loss. Here we show a novel role for the neutral amino acid glutamine in structural and functional regulation of the kidney filtration barrier. Metabolic flux analysis of cultured podocytes using genetic, toxic, and immunologic injury models identified increased glutamine utilization pathways. We show that glutamine uptake is increased in diseased podocytes to couple nutrient support to increased demand during the disease state of FP effacement. This feature can be utilized to transport increased amounts of glutamine into damaged podocytes. The availability of glutamine determines the regulation of podocyte intracellular pH (pH(i)). Podocyte alkalinization reduces cytosolic cathepsin L protease activity and protects the podocyte cytoskeleton. Podocyte glutamine supplementation reduces proteinuria in LPS-treated mice, whereas acidification increases glomerular injury. In summary, our data provide a metabolic opportunity to combat urinary protein loss through modulation of podocyte amino acid utilization and pH(i).	[Faridi, Mohd Hafeez] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60035 USA; [Moriwaki, Kumiko] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Dept Med, Miami, FL 33136 USA; [Moeller, Clemens C.; Flesche, Jan; Yaddanapudi, Suma; Sever, Sanja] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02129 USA; [Moeller, Clemens C.; Flesche, Jan; Yaddanapudi, Suma; Sever, Sanja] Massachusetts Gen Hosp, Program Glomerular Dis, Boston, MA 02129 USA; [Moeller, Clemens C.; Flesche, Jan; Yaddanapudi, Suma; Sever, Sanja] Harvard Univ, Sch Med, Boston, MA 02129 USA; [Goedel, Markus; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Preston, Richard A.] Univ Miami, Miller Sch Med, Dept Med, Div Clin Pharmacol, Miami, FL 33136 USA; [Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Kerjaschki, Dontscho] Med Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria	Rush University; University of Miami; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Freiburg; University of Freiburg; University of Miami; University of Texas System; University of Texas Health San Antonio; Medical University of Vienna	Reiser, J (corresponding author), Rush Univ, Med Ctr, Dept Med, 1735 W Harrison St,Cohn Res Bldg,Ste 724, Chicago, IL 60612 USA.	jochen_reiser@rush.edu	Altintas, Mehmet Mete/T-5333-2018; Altintas, Mehmet Mete/ABI-5904-2020	Altintas, Mehmet Mete/0000-0002-1871-6985; Huber, Tobias B./0000-0001-7175-5062; Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [DK073495]; Ajinomoto Amino Acid Research Program; Welch Foundation [AQ-1507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto Amino Acid Research Program; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK073495 (to J. R.). This work was also supported by funds from the Ajinomoto Amino Acid Research Program (to J. R.) and Welch Foundation Grant AQ-1507 (to J. X. J.). D. Reiser is an inventor of issued and pending patents related to proteinuric kidney disease diagnostic and treatment, and he stands to gain royalties from future commercializations.	Altintas M. M., 2008, CURR CHEM BIOL, V2, P68; Andrews FJ, 2002, BRIT J NUTR, V87, pS3, DOI 10.1079/BJN2001451; Arai K, 2001, HEPATOLOGY, V34, P360, DOI 10.1053/jhep.2001.26515; Arthur JM, 2002, KIDNEY INT, V62, P1314, DOI 10.1111/j.1523-1755.2002.kid588.x; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Balcarcel RR, 2003, BIOTECHNOL PROGR, V19, P98, DOI 10.1021/bp025617u; Baverel G, 2003, BIOCHIMIE, V85, P863, DOI 10.1016/j.biochi.2003.10.001; BAVEREL G, 1995, P NUTR SOC, V54, P197, DOI 10.1079/PNS19950049; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Bonarius HPJ, 1996, BIOTECHNOL BIOENG, V50, P299, DOI 10.1002/(SICI)1097-0290(19960505)50:3<299::AID-BIT9>3.0.CO;2-B; Chan C, 2003, BIOTECHNOL BIOENG, V81, P33, DOI 10.1002/bit.10453; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; DECHELOTTE P, 1991, AM J PHYSIOL, V260, pG677, DOI 10.1152/ajpgi.1991.260.5.G677; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; FLEMING SE, 1991, J NUTR, V121, P869, DOI 10.1093/jn/121.6.869; Follstad BD, 1999, BIOTECHNOL BIOENG, V63, P675, DOI 10.1002/(SICI)1097-0290(19990620)63:6<675::AID-BIT5>3.0.CO;2-R; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Gloy J, 2000, AM J PHYSIOL-RENAL, V278, pF999, DOI 10.1152/ajprenal.2000.278.6.F999; Grant RL, 1997, IN VITRO CELL DEV-AN, V33, P256; GUDER WG, 1984, KIDNEY INT, V26, P101, DOI 10.1038/ki.1984.143; He L, 2008, J AM SOC NEPHROL, V19, P260, DOI 10.1681/ASN.2007050588; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karinch AM, 2007, AM J PHYSIOL-RENAL, V292, pF448, DOI 10.1152/ajprenal.00168.2006; Karp PD, 2000, NUCLEIC ACIDS RES, V28, P56, DOI 10.1093/nar/28.1.56; Kovesdy CP, 2010, NAT REV NEPHROL, V6, P15, DOI 10.1038/nrneph.2009.204; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Leverve XM, 2002, CRIT CARE, V6, P284; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lindskog A, 2010, J AM SOC NEPHROL, V21, P1290, DOI 10.1681/ASN.2009101025; Llaneras F, 2008, J BIOSCI BIOENG, V105, P1, DOI 10.1263/jbb.105.1; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; MANCUSO A, 1994, BIOTECHNOL BIOENG, V44, P563, DOI 10.1002/bit.260440504; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V280, pE323, DOI 10.1152/ajpendo.2001.280.2.E323; Moret C, 2007, AM J PHYSIOL-RENAL, V292, pF555, DOI 10.1152/ajprenal.00113.2006; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; Nadeau I, 2000, METAB ENG, V2, P277, DOI 10.1006/mben.2000.0152; Nadeau I, 2000, BIOTECHNOL PROGR, V16, P872, DOI 10.1021/bp000098l; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Nyberg GB, 1999, BIOTECHNOL BIOENG, V62, P324, DOI 10.1002/(SICI)1097-0290(19990205)62:3<324::AID-BIT9>3.3.CO;2-3; Palsson B., 2006, SYSTEMS BIOL PROPERT, P309; Ransom RF, 2005, KIDNEY INT, V67, P1275, DOI 10.1111/j.1523-1755.2005.00205.x; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Reiser J, 2000, KIDNEY INT, V57, P2035, DOI 10.1046/j.1523-1755.2000.00070.x; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Salvi A, 2002, AAPS PHARMSCI, V4, DOI 10.1208/ps040421; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; SHARFSTEIN ST, 1994, BIOTECHNOL BIOENG, V43, P1059, DOI 10.1002/bit.260431109; Stephanopoulos GN, 1998, METABOLIC ENG PRINCI, P309, DOI DOI 10.1016/B978-012666260-3/50009-1; Stumvoll M, 1999, MED HYPOTHESES, V52, P363, DOI 10.1054/mehy.1997.0655; Stumvoll M, 1999, KIDNEY INT, V55, P778, DOI 10.1046/j.1523-1755.1999.055003778.x; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; United States Renal Data System, 2013, USRDS 2013 ANN DAT R, P333; Van Noorden CJF, 1998, CLIN EXP METASTAS, V16, P159; Welbourne T, 2001, NEWS PHYSIOL SCI, V16, P157, DOI 10.1152/physiologyonline.2001.16.4.157; WIRTHENSOHN G, 1986, PHYSIOL REV, V66, P469, DOI 10.1152/physrev.1986.66.2.469; Wischmeyer PE, 2007, CRIT CARE MED, V35, pS541, DOI 10.1097/01.CCM.0000278064.32780.D3; Xie LZ, 1996, BIOTECHNOL BIOENG, V52, P579, DOI 10.1002/(SICI)1097-0290(19961205)52:5<579::AID-BIT5>3.0.CO;2-G; Yaddanapudi S, 2011, J CLIN INVEST, V121, P3965, DOI 10.1172/JCI58552; YUN CHC, 1995, AM J PHYSIOL-GASTR L, V269, pG1, DOI 10.1152/ajpgi.1995.269.1.G1	64	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17454	17467		10.1074/jbc.M114.568998	http://dx.doi.org/10.1074/jbc.M114.568998			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24817115	Green Published, hybrid			2022-12-28	WOS:000338018100014
J	Brewer, PD; Habtemichael, EN; Romenskaia, I; Mastick, CC; Coster, ACF				Brewer, Paul Duffield; Habtemichael, Estifanos N.; Romenskaia, Irina; Mastick, Cynthia Corley; Coster, Adelle C. F.			Insulin-regulated Glut4 Translocation MEMBRANE PROTEIN TRAFFICKING WITH SIX DISTINCTIVE STEPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR TRAFFICKING; GLUCOSE-TRANSPORT; STORAGE-VESICLES; RATE-CONSTANT; CELL-SURFACE; PROTEIN; COMPARTMENTS; MINIMIZATION; ENDOCYTOSIS; EXOCYTOSIS	The trafficking kinetics of Glut4, the transferrin (Tf) receptor, and LRP1 were quantified in adipocytes and undifferentiated fibroblasts. Six steps were identified that determine steady state cell surface Glut4: (i) endocytosis, (ii) degradation, (iii) sorting, (iv) sequestration, (v) release, and (vi) tethering/docking/fusion. Endocytosis of Glut4 is 3 times slower than the Tf receptor in fibroblasts (k(en) = 0.2 min(-1) versus 0.6 min(-1)). Differentiation decreases Glut4 k(en) 40% (k(en) = 0.12 min(-1)). Differentiation also decreases Glut4 degradation, increasing total and cell surface Glut4 3-fold. In fibroblasts, Glut4 is recycled from endosomes through a slow constitutive pathway (k(ex) = 0.025-0.038 min(-1)), not through the fast Tf receptor pathway (k(ex) = 0.2 min(-1)). The kex measured in adipocytes after insulin stimulation is similar (k(ex) = 0.027 min(-1)). Differentiation decreases the rate constant for sorting into the Glut4 recycling pathway (k(sort)) 3-fold. In adipocytes, Glut4 is also sorted from endosomes into a second exocytic pathway through Glut4 storage vesicles (GSVs). Surprisingly, transfer from endosomes into GSVs is highly regulated; insulin increases the rate constant for sequestration (k(seq)) 8-fold. Release from sequestration in GSVs is rate-limiting for Glut4 exocytosis in basal adipocytes. AS160 regulates this step. Tethering/docking/fusion of GSVs to the plasma membrane is regulated through an AS160-independent process. Insulin increases the rate of release and fusion of GSVs (k(fuseG)) 40-fold. LRP1 cycles with the Tf receptor and Glut4 in fibroblasts but predominantly with Glut4 after differentiation. Surprisingly, AS160 knockdown accelerated LRP1 exocytosis in basal and insulin-stimulated adipocytes. These data indicate that AS160 may regulate trafficking into as well as release from GSVs.	[Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Habtemichael, Estifanos N.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Coster, Adelle C. F.] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia	Nevada System of Higher Education (NSHE); University of Nevada Reno; Yale University; University of New South Wales Sydney	Mastick, CC (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Coster, Adelle/AAX-4829-2020; Coster, Adelle CF/A-7234-2013; Mastick, Cynthia/G-9841-2017	Coster, Adelle/0000-0002-5572-6832; Coster, Adelle CF/0000-0002-5572-6832; Mastick, Cynthia/0000-0003-4769-5412	American Diabetes Association [7-08-RA-100, 1-12-BS-132, 1-12-BS-16]; National Institutes of Health [T32 DK007058]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007058] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research supported by grants from the American Diabetes Association (7-08-RA-100, 1-12-BS-132, and 1-12-BS-16) and from the National Institutes of Health (Grant T32 DK007058 to E. N. H.)	[Anonymous], 1908, BIOMETRIKA, V6, P1; Antonescu CN, 2009, BIOSCIENCE REP, V29, P1, DOI 10.1042/BSR20080105; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Branch MA, 1999, SIAM J SCI COMPUT, V21, P1, DOI 10.1137/S1064827595289108; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; BYRD RH, 1988, MATH PROGRAM, V40, P247, DOI 10.1007/BF01580735; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; CLARK AE, 1991, BIOCHEM J, V278, P235, DOI 10.1042/bj2780235; Coleman TF, 2001, COMPUT OPTIM APPL, V20, P61, DOI 10.1023/A:1011271406353; CORVERA, 1994, J CELL BIOL, V126, P1625; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Dormand J.R., 1980, J COMPUT APPL MATH, V6, P19, DOI [10.1016/0771-050X(80)90013-3, DOI 10.1016/0771-050X(80)90013-3]; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Fazakerley DJ, 2010, J BIOL CHEM, V285, P1653, DOI 10.1074/jbc.M109.051185; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Habtemichael EN, 2011, J BIOL CHEM, V286, P10115, DOI 10.1074/jbc.M111.217935; Hatakeyama H, 2011, TRAFFIC, V12, P1805, DOI 10.1111/j.1600-0854.2011.01279.x; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; KONO T, 1981, J BIOL CHEM, V256, P6400; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; MORE JJ, 1983, SIAM J SCI STAT COMP, V4, P553, DOI 10.1137/0904038; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Pryor PR, 2000, BIOCHEM J, V348, P83, DOI 10.1042/0264-6021:3480083; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; SATOH S, 1993, J BIOL CHEM, V268, P17820; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2008, J BIOL CHEM, V283, P30311, DOI 10.1074/jbc.M805182200; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sorensen DC, 1997, SIAM J OPTIMIZ, V7, P141, DOI 10.1137/S1052623494274374; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Taguchi T, 2013, J BIOCHEM, V153, P505, DOI 10.1093/jb/mvt034; Wang Y, 2009, SCI CHINA SER C, V52, P665, DOI 10.1007/s11427-009-0081-9; WILEY HS, 1982, J BIOL CHEM, V257, P4222; YANG J, 1993, J BIOL CHEM, V268, P4600; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	49	44	47	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17280	17298		10.1074/jbc.M114.555714	http://dx.doi.org/10.1074/jbc.M114.555714			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24778187	Green Published, hybrid			2022-12-28	WOS:000338018100001
J	Ceschin, J; Saint-Marc, C; Laporte, J; Labriet, A; Philippe, C; Moenner, M; Daignan-Fornier, B; Pinson, B				Ceschin, Johanna; Saint-Marc, Christelle; Laporte, Jean; Labriet, Adrien; Philippe, Chloe; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit			Identification of Yeast and Human 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAr) Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NICOTINAMIDE RIBOSIDE; GENE-EXPRESSION; SHUTTLE VECTORS; AMP; INHIBITION; PHOSPHORYLATION; SENSITIVITY; AGONISTS; THIAMIN	5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAr) is the precursor of the active monophosphate form (AICAR), a small molecule with potent anti-proliferative and low energy mimetic properties. The molecular bases for AICAR toxicity at the cellular level are poorly understood. Here, we report the isolation and characterization of several yeast AICAr-hypersensitive mutants. Identification of the cognate genes allowed us to establish that thiamine transporters Thi7 and Thi72 can efficiently take up AICAr under conditions where they are overexpressed. We establish that, under standard growth conditions, Nrt1, the nicotinamide riboside carrier, is the major AICAr transporter in yeast. A study of AICAR accumulation in human cells revealed substantial disparities among cell lines and confirmed that AICAr enters cells via purine nucleoside transporters. Together, our results point to significant differences between yeast and human cells for both AICAr uptake and AICAR accumulation.	[Ceschin, Johanna; Saint-Marc, Christelle; Laporte, Jean; Labriet, Adrien; Philippe, Chloe; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit] Univ Bordeaux, IBGC, UMR 5095 1, F-33077 Bordeaux, France; [Ceschin, Johanna; Saint-Marc, Christelle; Laporte, Jean; Labriet, Adrien; Philippe, Chloe; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095 1, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pinson, B (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue C St Saens CS 61390, F-33077 Bordeaux, France.	benoit.pinson@ibgc.cnrs.fr		ceschin, johanna/0000-0001-7771-531X; Pinson, Benoit/0000-0003-2936-9058	Association de la Recherche contre le Cancer [SFI-2012-120-5915]; Ligue contre le Cancer du Perigord	Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer du Perigord	This work was supported by Association de la Recherche contre le Cancer Grant SFI-2012-120-5915 (to B. D.-F.) and a grant from Ligue contre le Cancer du Perigord (to M. M.).	Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Huang ZW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003083; Hurlimann HC, 2011, J BIOL CHEM, V286, P30994, DOI 10.1074/jbc.M111.262659; IWASHIMA A, 1992, FEBS LETT, V311, P60, DOI 10.1016/0014-5793(92)81367-U; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Laporte D, 2011, J CELL BIOL, V192, P949, DOI 10.1083/jcb.201009028; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Lopez JM, 2003, BIOCHEM J, V370, P1027, DOI 10.1042/BJ20021053; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Mojzita D, 2006, MOL GENET GENOMICS, V276, P147, DOI 10.1007/s00438-006-0130-z; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Nakamaru K, 2005, BIOCHEM BIOPH RES CO, V328, P449, DOI 10.1016/j.bbrc.2005.01.004; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Oishi K, 2002, HUM MOL GENET, V11, P2951, DOI 10.1093/hmg/11.23.2951; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Reidling JC, 2010, GASTROENTEROLOGY, V138, P1802, DOI 10.1053/j.gastro.2009.10.042; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Saint-Marc C, 2009, GENETICS, V183, P529, DOI 10.1534/genetics.109.105858; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton CK, 1997, GENE, V199, P111, DOI 10.1016/S0378-1119(97)00354-5; SULLIVAN JE, 1994, BIOCHEM BIOPH RES CO, V200, P1551, DOI 10.1006/bbrc.1994.1627; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Thomas D, 2000, J BIOL CHEM, V275, P40718, DOI 10.1074/jbc.M005967200; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Wang CM, 2013, BIOCHEM PHARMACOL, V86, P1531, DOI 10.1016/j.bcp.2013.08.063; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007	37	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16844	16854		10.1074/jbc.M114.551192	http://dx.doi.org/10.1074/jbc.M114.551192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24778186	Green Published, hybrid			2022-12-28	WOS:000338016200022
J	Lee, CC; Freinkman, E; Sabatini, DM; Ploegh, HL				Lee, Clarissa C.; Freinkman, Elizaveta; Sabatini, David M.; Ploegh, Hidde L.			The Protein Synthesis Inhibitor Blasticidin S Enters Mammalian Cells via Leucine-rich Repeat-containing Protein 8D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN; APOPTOSIS; RELEASE	Leucine-rich repeat-containing 8 (LRRC8) proteins have been identified as putative receptors involved in lymphocyte development and adipocyte differentiation. They remain poorly characterized, and no specific function has been assigned to them. There is no consensus on how this family of proteins might function because homology searches suggest that members of the LRRC8 family act not as plasma membrane receptors, but rather as channels that mediate cell-cell signaling. Here we provide experimental evidence that supports a role for LRRC8s in the transport of small molecules. We show that LRRC8D is a mammalian protein required for the import of the antibiotic blasticidin S. We characterize localization and topology of LRRC8A and LRRC8D and demonstrate that LRRC8D interacts with LRRC8A, LRRC8B, and LRRC8C. Given the suggested involvement in solute transport, our results support a model in which LRRC8s form one or more complexes that may mediate cell-cell communication by transporting small solutes.	[Lee, Clarissa C.; Freinkman, Elizaveta; Sabatini, David M.; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lee, Clarissa C.; Sabatini, David M.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu		/0000-0002-1446-7256	NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014051] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; CHASIS JA, 1992, BLOOD, V80, P1869; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Hayashi T, 2011, BIOL PHARM BULL, V34, P1257, DOI 10.1248/bpb.34.1257; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; Lee CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070339; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; REDMAN CM, 1995, TRANSFUS CLIN BIOL, V2, P243, DOI 10.1016/S1246-7820(05)80090-4; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Smits G, 2004, MOL IMMUNOL, V41, P561, DOI 10.1016/j.molimm.2004.04.001; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200; Voss F. K., 2014, SCIENCE IN PRESS	19	56	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17124	17131		10.1074/jbc.M114.571257	http://dx.doi.org/10.1074/jbc.M114.571257			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782309	Green Published, hybrid			2022-12-28	WOS:000338016200045
J	Carraro, M; Giorgio, V; Sileikyte, J; Sartori, G; Forte, M; Lippe, G; Zoratti, M; Szabo, I; Bernardi, P				Carraro, Michela; Giorgio, Valentina; Sileikyte, Justina; Sartori, Geppo; Forte, Michael; Lippe, Giovanna; Zoratti, Mario; Szabo, Ildiko; Bernardi, Paolo			Channel Formation by Yeast F-ATP Synthase and the Role of Dimerization in the Mitochondrial Permeability Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HEART-MITOCHONDRIA; INNER-MEMBRANE; COMPLEX I; PORE; CYCLOSPORINE; DIMER; INHIBITION; CRISTAE; ORGANIZATION	Purified F-ATP synthase dimers of yeast mitochondria display Ca2+ -dependent channel activity with properties resembling those of the permeability transition pore (PTP) of mammals. After treatment with the Ca2+ ionophore ETH129, which allows electrophoretic Ca2+ uptake, isolated yeast mitochondria undergo inner membrane permeabilization due to PTP opening. Yeast mutant strains Delta TIM11 and Delta ATP20 (lacking the e and g F-ATP synthase subunits, respectively, which are necessary for dimer formation) display a striking resistance to PTP opening. These results show that the yeast PTP originates from F-ATP synthase and indicate that dimerization is required for pore formation in situ.	[Carraro, Michela; Giorgio, Valentina; Sileikyte, Justina; Sartori, Geppo; Zoratti, Mario; Bernardi, Paolo] Univ Padua, Consiglio Nazl Ric, Inst Neurosci, I-35121 Padua, Italy; [Carraro, Michela; Giorgio, Valentina; Sileikyte, Justina; Sartori, Geppo; Zoratti, Mario; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Szabo, Ildiko] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Forte, Michael] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Lippe, Giovanna] Univ Udine, Dept Food Sci, I-33100 Udine, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Padua; Oregon Health & Science University; University of Udine	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35121 Padua, Italy.	bernardi@bio.unipd.it	Padova, Ildiko/K-5344-2016; Szabo, Ildiko/AAW-5972-2021; Giorgio, Valentina/O-1969-2015; Giorgio, Valentina/I-6110-2016; Bernardi, Paolo/C-3656-2008	Szabo, Ildiko/0000-0002-3637-3947; Giorgio, Valentina/0000-0002-4229-3054; Bernardi, Paolo/0000-0001-9187-3736; Sileikyte, Justina/0000-0002-6795-6344; Carraro, Michela/0000-0002-4573-9306	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG13392, IG11814]; Progetti di Ricerca di Interesse Nazionale Programs [20107Z8XBW, 2010CSJX4F]; National Institutes of Health/Public Health Service Grant [1R01GM069883]; Consiglio Nazionale delle Ricerche (CNR) Project of Special Interest on Aging; University of Padova Progetti Strategici di Ateneo "Models of Mitochondrial Diseases"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Progetti di Ricerca di Interesse Nazionale Programs; National Institutes of Health/Public Health Service Grant; Consiglio Nazionale delle Ricerche (CNR) Project of Special Interest on Aging; University of Padova Progetti Strategici di Ateneo "Models of Mitochondrial Diseases"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Associazione Italiana per la Ricerca sul Cancro (AIRC) Grants IG13392 (to P. B.) and IG11814 (to I. S.), Progetti di Ricerca di Interesse Nazionale Programs 20107Z8XBW (to P. B.) and 2010CSJX4F (to I. S.), National Institutes of Health/Public Health Service Grant 1R01GM069883 (to M. F. and P. B.), a Consiglio Nazionale delle Ricerche (CNR) Project of Special Interest on Aging (to M. Z.), and the University of Padova Progetti Strategici di Ateneo "Models of Mitochondrial Diseases" (to P. B.).	Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Azzolin L, 2010, FEBS LETT, V584, P2504, DOI 10.1016/j.febslet.2010.04.023; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bradshaw PC, 2013, YEAST, V30, P471, DOI 10.1002/yea.2984; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; Costantini P, 1998, BBA-BIOENERGETICS, V1365, P385, DOI 10.1016/S0005-2728(98)00090-5; CROMPTON M, 1988, BIOCHEM J, V255, P357; Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Fronzes R, 2006, BIOCHEMISTRY-US, V45, P6715, DOI 10.1021/bi0601407; Gavin PD, 2005, J BIOENERG BIOMEMBR, V37, P55, DOI 10.1007/s10863-005-4128-8; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Gutierrez-Aguilar M, 2007, BBA-BIOENERGETICS, V1767, P1245, DOI 10.1016/j.bbabio.2007.07.002; Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Jung DW, 1997, J BIOL CHEM, V272, P21104, DOI 10.1074/jbc.272.34.21104; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; Kowaltowski AJ, 2000, FEBS LETT, V473, P177, DOI 10.1016/S0014-5793(00)01526-X; Li B, 2012, BBA-BIOENERGETICS, V1817, P1628, DOI 10.1016/j.bbabio.2012.05.011; Manon S, 1998, J BIOENERG BIOMEMBR, V30, P419, DOI 10.1023/A:1020533928491; MATOUSCHEK A, 1995, P NATL ACAD SCI USA, V92, P6319, DOI 10.1073/pnas.92.14.6319; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Prieto S, 1996, ARCH BIOCHEM BIOPHYS, V334, P43, DOI 10.1006/abbi.1996.0427; PRIETO S, 1992, EUR J BIOCHEM, V208, P487, DOI 10.1111/j.1432-1033.1992.tb17212.x; PRIETO S, 1995, BIOCHEM J, V307, P657, DOI 10.1042/bj3070657; RASSOW J, 1995, MOL CELL BIOL, V15, P2654; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Roucou X, 1997, BBA-BIOMEMBRANES, V1324, P120, DOI 10.1016/S0005-2736(96)00215-5; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; SZABO I, 1992, J BIOL CHEM, V267, P2940; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; SZABO I, 1995, BBA-BIOMEMBRANES, V1235, P115, DOI 10.1016/0005-2736(94)00306-A; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; Uribe-Carvajal S, 2011, MITOCHONDRION, V11, P382, DOI 10.1016/j.mito.2011.02.004; Velours J, 2011, J BIOL CHEM, V286, P35477, DOI 10.1074/jbc.M111.275776; von Stockum S, 2011, J BIOL CHEM, V286, P41163, DOI 10.1074/jbc.M111.268375; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; Woodfield KY, 1997, BBA-GENE STRUCT EXPR, V1351, P27, DOI 10.1016/S0167-4781(97)00017-1; Yamada A, 2009, BBA-BIOENERGETICS, V1787, P1486, DOI 10.1016/j.bbabio.2009.07.001	48	116	116	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15980	15985		10.1074/jbc.C114.559633	http://dx.doi.org/10.1074/jbc.C114.559633			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24790105	Green Published, hybrid			2022-12-28	WOS:000337965700009
J	Kennedy, BE; Madreiter, CT; Vishnu, N; Malli, R; Graier, WF; Karten, B				Kennedy, Barry E.; Madreiter, Corina T.; Vishnu, Neelanjan; Malli, Roland; Graier, Wolfgang F.; Karten, Barbara			Adaptations of Energy Metabolism Associated with Increased Levels of Mitochondrial Cholesterol in Niemann-Pick Type C1-deficient Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; LIPID-COMPOSITION; RAT-LIVER; ENDOSOMAL CHOLESTEROL; MEMBRANE-PROPERTIES; START DOMAINS; MLN64; PROTEIN; BINDING; NPC2	Niemann-Pick type C1 (NPC1) is a late endosomal transmembrane protein, which, together with NPC2 in the endosome lumen, mediates the transport of endosomal cholesterol to the plasma membrane and endoplasmic reticulum. Loss of function of NPC1 or NPC2 leads to cholesterol accumulation in late endosomes and causes neuronal dysfunction and neurodegeneration. Recent studies indicate that cholesterol also accumulates in mitochondria of NPC1-deficient cells and brain tissue and that NPC1 deficiency leads to alterations in mitochondrial function and energy metabolism. Here, we have investigated the effects of increased mitochondrial cholesterol levels on energy metabolism, using RNA interference to deplete Chinese hamster ovary cells of NPC1 alone or in combination with MLN64, which mediates endosomal cholesterol transport to mitochondria. Mitochondrial cholesterol levels were also altered by depletion of NPC2 in combination with the expression of NPC2 mutants. We found that the depletion of NPC1 increased lactate secretion, decreased glutamine-dependent mitochondrial respiration, and decreased ATP transport across mitochondrial membranes. These metabolic alterations did not occur when transport of endosomal cholesterol to mitochondria was blocked. In addition, the elevated mitochondrial cholesterol levels in NPC1-depleted cells and in NPC2-depleted cells expressing mutant NPC2 that allows endosomal cholesterol trafficking to mitochondria were associated with increased expression of the antioxidant response factor Nrf2. Antioxidant treatment not only prevented the increase in Nrf2 mRNA levels but also prevented the increased lactate secretion in NPC1-depleted cells. These results suggest that mitochondrial cholesterol accumulation can increase oxidative stress and in turn cause increased glycolysis to lactate and other metabolic alterations.	[Kennedy, Barry E.; Karten, Barbara] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Madreiter, Corina T.; Vishnu, Neelanjan; Malli, Roland; Graier, Wolfgang F.] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria	Dalhousie University; Medical University of Graz	Karten, B (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Sir Charles Tupper Med Bldg 9G,5850 Coll St, Halifax, NS B3H 4R2, Canada.	bkarten@dal.ca	Madreiter-Sokolowski, Corina/AAK-4722-2020; Graier, Wolfgang F./B-7052-2008	Madreiter-Sokolowski, Corina/0000-0002-8631-9949; Graier, Wolfgang F./0000-0003-1871-3298; Malli, Roland/0000-0001-6327-8729; Karten, Barbara/0000-0003-2395-3333; Vishnu, Neelanjan/0000-0001-6395-4686	Nova Scotia Health Research Foundation [MED-PROJECT-2010-6804]; Natural Sciences and Engineering Research Council of Canada [401978-2011]; Austrian Science Fund (FWF) [P 22553] Funding Source: researchfish	Nova Scotia Health Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Nova Scotia Health Research Foundation Grant MED-PROJECT-2010-6804 and Natural Sciences and Engineering Research Council of Canada Discovery Grant 401978-2011.	Ahn WS, 2013, METAB ENG, V15, P34, DOI 10.1016/j.ymben.2012.10.001; Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002; Alpy F, 2001, J BIOL CHEM, V276, P4261, DOI 10.1074/jbc.M006279200; BAGGETTO LG, 1992, CANCER RES, V52, P4935; Barbero-Camps E, 2013, HUM MOL GENET, V22, P3460, DOI 10.1093/hmg/ddt201; Bell KF, 2011, P NATL ACAD SCI USA, V108, pE1, DOI 10.1073/pnas.1015229108; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Campbell AM, 2007, ARCH BIOCHEM BIOPHYS, V466, P203, DOI 10.1016/j.abb.2007.06.012; Charman M, 2010, J LIPID RES, V51, P1023, DOI 10.1194/jlr.M002345; Colell A, 2003, J BIOL CHEM, V278, P33928, DOI 10.1074/jbc.M210943200; Colell A, 2009, J BIOENERG BIOMEMBR, V41, P417, DOI 10.1007/s10863-009-9242-6; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; DAHL NK, 1992, J BIOL CHEM, V267, P4889; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; ECHEGOYEN S, 1993, BIOCHEM J, V289, P703, DOI 10.1042/bj2890703; FEO F, 1975, BIOCHIM BIOPHYS ACTA, V413, P116, DOI 10.1016/0005-2736(75)90063-2; Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009; Fu R, 2013, HUM MOL GENET, V22, P3508, DOI 10.1093/hmg/ddt206; Fu R, 2010, MOL GENET METAB, V101, P214, DOI 10.1016/j.ymgme.2010.06.018; Garcia-Ruiz C, 2009, HISTOL HISTOPATHOL, V24, P117, DOI 10.14670/HH-24.117; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Kennedy BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082685; Kennedy BE, 2012, J LIPID RES, V53, P2632, DOI 10.1194/jlr.M029942; Klein A, 2011, NEUROBIOL DIS, V41, P209, DOI 10.1016/j.nbd.2010.09.008; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Mlayeh L, 2010, BIOPHYS J, V99, P2097, DOI 10.1016/j.bpj.2010.07.067; Montero J, 2008, CANCER RES, V68, P5246, DOI 10.1158/0008-5472.CAN-07-6161; Montero J, 2010, BBA-BIOENERGETICS, V1797, P1217, DOI 10.1016/j.bbabio.2010.02.010; Murcia M, 2006, J LIPID RES, V47, P2614, DOI 10.1194/jlr.M600232-JLR200; Ordonez MP, 2012, HUM MOL GENET, V21, P2651, DOI 10.1093/hmg/dds090; PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H; PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2; PARADIES G, 1991, BIOCHIM BIOPHYS ACTA, V1070, P180, DOI 10.1016/0005-2736(91)90161-Z; Paradis S, 2013, CARDIOVASC RES, V98, P420, DOI 10.1093/cvr/cvt079; PARLO RA, 1984, J BIOL CHEM, V259, P9997; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Prabhu AV, 2013, FEBS LETT, V587, P983, DOI 10.1016/j.febslet.2013.02.040; Reitz J, 2008, FEBS J, V275, P1790, DOI 10.1111/j.1742-4658.2008.06337.x; ROUSLIN W, 1982, AM J PHYSIOL, V242, pH254, DOI 10.1152/ajpheart.1982.242.2.H254; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Thinnes FP, 2012, MOL GENET METAB, V107, P632, DOI 10.1016/j.ymgme.2012.08.015; Tuckey RC, 2004, ENDOCRINOLOGY, V145, P1700, DOI 10.1210/en.2003-1034; Vazquez MC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/205713; Vishnu N, 2014, MOL BIOL CELL, V25, P368, DOI 10.1091/mbc.E13-07-0433; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200; Zhang M, 2002, J BIOL CHEM, V277, P33300, DOI 10.1074/jbc.M200003200	56	50	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16278	16289		10.1074/jbc.M114.559914	http://dx.doi.org/10.1074/jbc.M114.559914			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24790103	hybrid, Green Published			2022-12-28	WOS:000337965700032
J	Bai, Y; Tan, XG; Zhang, HF; Liu, CD; Zhao, BB; Li, Y; Lu, L; Liu, YZ; Zhou, JF				Bai, Yan; Tan, Xungang; Zhang, Haifeng; Liu, Chengdong; Zhao, Beibei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng			Ror2 Receptor Mediates Wnt11 Ligand Signaling and Affects Convergence and Extension Movements in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; TYROSINE KINASE ROR2; NEURAL-TUBE DEFECTS; GASTRULATION MOVEMENTS; XENOPUS GASTRULATION; ACTS DOWNSTREAM; MORPHOGENESIS; PATHWAY; WNT5A; FRIZZLED-7	The receptor-tyrosine kinase Ror2 acts as an alternative receptor or co-receptor for Wnt5a and mediates Wnt5a-induced convergent extension movements during embryogenesis in mice and Xenopus as well as the polarity and migration of several cell types during development. However, little is known about whether Ror2 function is conserved in other vertebrates or is involved in other non-canonical Wnt ligands in vivo. In this study we demonstrated that overexpression of dominant-negative ror2 (ror2-TM) mRNA in zebrafish embryos resulted in convergence and extension defects and incompletely separated eyes, which is consistent with observations from slb/wnt11 mutants or wnt11 knockdown morphants. Moreover, the co-injection of ror2-TM mRNA and a wnt11 morpholino or the coexpression of ror2 and wnt11 in zebrafish embryos synergetically induced more severe convergence and extension defects. Transplantation studies further demonstrated that the Ror2 receptor responded to the Wnt11 ligand and regulated cell migration and cell morphology during gastrulation. DnRor2 inhibited the action of Wnt11, which was revealed by a decreased percentage of Wnt11-induced convergence and extension defects. Ror2 physically interacts with Wnt11. The intracellular Tyr-647 and Ser-863 sites of Ror2 are essential for mediating the action of Wnt11. Dishevelled and RhoA act downstream of Wnt11-Ror2 to regulate convergence and extension movements. Overall, our data suggest an important role of Ror2 in mediating Wnt11 signaling and in regulating convergence and extension movements in zebrafish.	[Bai, Yan; Zhang, Haifeng; Liu, Chengdong; Zhao, Beibei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng] Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao 266003, Shandong, Peoples R China; [Bai, Yan; Zhang, Haifeng; Liu, Chengdong; Zhao, Beibei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng] Ocean Univ China, Sch Med & Pharm, Qingdao 266003, Shandong, Peoples R China; [Tan, Xungang] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China	Ocean University of China; Ocean University of China; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhou, JF (corresponding author), Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.	jfzhou@ouc.edu.cn			Major Science Programs of China [2011CB943800]; National Science Foundation of China [30972238, 40876064, 30970357, 30928021]	Major Science Programs of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Science Programs of China Grant 2011CB943800 and National Science Foundation of China Grants 30972238, 40876064, 30970357, and 30928021.	Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Djiane A, 2000, DEVELOPMENT, V127, P3091; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Heisenberg CP, 2002, SEMIN CELL DEV BIOL, V13, P471, DOI 10.1016/S1084952102001003; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim Gun-Hwa, 2012, Methods Mol Biol, V839, P79, DOI 10.1007/978-1-61779-510-7_7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuhl M, 2002, SEMIN CELL DEV BIOL, V13, P243, DOI 10.1016/S1084-9521(02)00050-2; Li X, 2013, DEVELOPMENT, V140, P3028, DOI 10.1242/dev.094839; Li Y, 2005, J BIOL CHEM, V280, P3613, DOI 10.1074/jbc.M411479200; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Macheda ML, 2012, J BIOL CHEM, V287, P29312, DOI 10.1074/jbc.M112.362681; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ossipova O, 2011, DEVELOPMENT, V138, P5441, DOI 10.1242/dev.067280; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Skoglund P., 2000, PHILOS T R SOC LON B, V355, P897; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Stemple DL, 1996, DEVELOPMENT, V123, P117; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Tahinci E, 2003, DEV BIOL, V259, P318, DOI 10.1016/S0012-1606(03)00206-9; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	52	29	29	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20664	20676		10.1074/jbc.M114.586099	http://dx.doi.org/10.1074/jbc.M114.586099			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928507	hybrid, Green Published			2022-12-28	WOS:000339396600025
J	Zhao, Y; Wang, CL; Li, RM; Hui, TQ; Su, YY; Yuan, Q; Zhou, XD; Ye, L				Zhao, Yuan; Wang, Chen-Lin; Li, Rui-Min; Hui, Tian-Qian; Su, Ying-Ying; Yuan, Quan; Zhou, Xue-Dong; Ye, Ling			Wnt5a Promotes Inflammatory Responses via Nuclear Factor kappa B (NF-kappa B) and Mitogen-activated Protein Kinase (MAPK) Pathways in Human Dental Pulp Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WINGLESS HOMOLOG; TISSUE; ROLES; MACROPHAGES; EXPRESSION; CYTOKINES; ALPHA; JNK	Wnt5a has been found recently to be involved in inflammation regulation through a mechanism that remains unclear. Immunohistochemical staining of infected human dental pulp and tissue from experimental dental pulpitis in rats showed that Wnt5a levels were increased. In vitro, Wnt5a was increased 8-fold in human dental pulp cells (HDPCs) after TNF-alpha stimulation compared with control cells. We then investigated the role of Wnt5a in HDPCs. In the presence of TNF-alpha, Wnt5a further increased the production of cytokines/chemokines, whereas Wnt5a knockdown markedly reduced cytokine/chemokine production induced by TNF-alpha. In addition, in HDPCs, Wnt5a efficiently induced cytokine/chemokine expression and, in particular, expression of IL-8 (14.5-fold) and CCL2 (25.5-fold), as assessed by a Luminex assay. The cytokine subsets regulated by Wnt5a overlap partially with those induced by TNF-alpha. However, no TNF-alpha and IL-1 beta was detected after Wnt5a treatment. We then found that Wnt5a alone and the supernatants of Wnt5a-treated HDPCs significantly increased macrophage migration, which supports a role for Wnt5a in macrophage recruitment and as an inflammatory mediator in human dental pulp inflammation. Finally, Wnt5a participates in dental pulp inflammation in a MAPK-dependent (p38-, JNK-, and ERK-dependent) and NF-kappa B-dependent manner. Our data suggest that Wnt5a, as an inflammatory mediator that drives the integration of cytokines and chemokines, acts downstream of TNF-alpha.	[Zhao, Yuan; Wang, Chen-Lin; Li, Rui-Min; Hui, Tian-Qian; Yuan, Quan; Zhou, Xue-Dong; Ye, Ling] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China; [Zhao, Yuan] Lanzhou Univ, Stomatol Coll, Dept Oral Basic Sci, Lanzhou 730000, Peoples R China; [Su, Ying-Ying] Capital Med Univ, Sch Stomatol, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Beijing 100050, Peoples R China	Sichuan University; Lanzhou University; Capital Medical University	Ye, L (corresponding author), 17 Renmin Nan Lu, Chengdu 610041, Peoples R China.	yeling@scu.edu.cn	ZHOU, XUE/F-6129-2013; ye, ling/AFP-0048-2022; yuan, quan/GZM-5597-2022	ye, ling/0000-0002-8417-7676; Yuan, Quan/0000-0002-2836-1081; Zhou, Xuedong/0000-0002-9319-7302	National Nature Science Foundation of China [81070801, 813220170]; Science and Technology Planning Project of Sichuan Province [2012SZ0034]; Innovative Research Team of Education Department of Sichuan Province [13TD0038]; Program of International ST Cooperation [2014DFA31990]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Sichuan Province; Innovative Research Team of Education Department of Sichuan Province; Program of International ST Cooperation	This work was supported by National Nature Science Foundation of China Grants 81070801 and 813220170, by Science and Technology Planning Project of Sichuan Province Grant 2012SZ0034, by Innovative Research Team of Education Department of Sichuan Province Grant 13TD0038, and by Program of International S&T Cooperation Grant 2014DFA31990.	[Anonymous], BLOOD, V114, P1366; Bergenfelz C, 2012, J IMMUNOL, V188, P5448, DOI 10.4049/jimmunol.1103378; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bouldin CM, 2012, CELL RES, V22, P1621, DOI 10.1038/cr.2012.104; Briolay A, 2013, BIOCHEM BIOPH RES CO, V430, P1072, DOI 10.1016/j.bbrc.2012.12.036; Briolay A., 2007, INT ENDOD J, V40, P198; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen L, 2011, INT J ORAL SCI, V3, P66, DOI 10.4248/IJOS11022; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Cooper P R, 2011, Adv Dent Res, V23, P290, DOI 10.1177/0022034511405389; Dammaschke T, 2003, J ENDODONT, V29, P638, DOI 10.1097/00004770-200310000-00006; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Ghosh MC, 2009, BLOOD, V114, P1366, DOI 10.1182/blood-2008-08-175869; Hahn CL, 2007, J ENDODONT, V33, P773, DOI 10.1016/j.joen.2007.01.002; Horst OV, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-9; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jung YS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.48; Kilander MBC, 2011, CELL SIGNAL, V23, P550, DOI 10.1016/j.cellsig.2010.11.004; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kim JM, 2014, INT J ORAL SCI, V6, P150, DOI 10.1038/ijos.2013.63; Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI [10.1089/ten.tea.2010.0181, 10.1089/ten.TEA.2010.0181]; Kim J, 2012, CYTOKINE, V60, P242, DOI 10.1016/j.cyto.2012.06.013; Komada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046436; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Li B, 2013, J BIOL CHEM, V288, P13610, DOI 10.1074/jbc.M112.381046; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Maiti G, 2012, P NATL ACAD SCI USA, V109, P16600, DOI 10.1073/pnas.1207789109; Martinez EF, 2004, INT ENDOD J, V37, P749, DOI 10.1111/j.1365-2591.2004.00864.x; Martinez EF, 2012, TISSUE CELL, V44, P325, DOI 10.1016/j.tice.2012.04.011; Nanbara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034434; Nusse R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011163; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Oderup C, 2013, J IMMUNOL, V190, P6126, DOI 10.4049/jimmunol.1203002; Ohshima H, 1995, CONNECT TISSUE RES, V32, P303, DOI 10.3109/03008209509013738; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Pezelj-Ribaric S, 2002, ARCH MED RES, V33, P482, DOI 10.1016/S0188-4409(02)00396-X; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; RYAN GB, 1977, AM J PATHOL, V86, P183; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schmalz G, 2011, J DENT RES, V90, P828, DOI 10.1177/0022034511405331; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.0.CO;2-L; Slusarski DC, 2007, DEV BIOL, V307, P1, DOI 10.1016/j.ydbio.2007.04.043; Staquet MJ, 2008, J DENT RES, V87, P256, DOI 10.1177/154405910808700304; TAGGER M, 1975, ORAL SURG ORAL MED O, V39, P304, DOI 10.1016/0030-4220(75)90234-0; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Whyte JL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008078; Ye L, 2006, J ENDODONT, V32, P736, DOI 10.1016/j.joen.2006.01.007; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zhao CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085058; Zhou W, 2012, CANCER LETT, V316, P178, DOI 10.1016/j.canlet.2011.10.033	54	64	67	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21028	21039		10.1074/jbc.M113.546523	http://dx.doi.org/10.1074/jbc.M113.546523			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24891513	hybrid, Green Published			2022-12-28	WOS:000339396600055
J	Halliday, M; Radford, H; Mallucci, GR				Halliday, Mark; Radford, Helois; Mallucci, Giovanna R.			Prions: Generation and Spread Versus Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UNFOLDED PROTEIN RESPONSE; PATHOLOGICAL ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; IN-VIVO; TRANSGENIC MICE; MESSENGER-RNA; SCRAPIE PRION; PRP; NEURODEGENERATION; TRANSMISSION	Neurodegenerative diseases are characterized by the aggregation of misfolded proteins in the brain. Among these disorders are the prion diseases, which are transmissible, and in which the misfolded proteins ("prions") are also the infectious agent. Increasingly, it appears that misfolded proteins in Alzheimer and Parkinson diseases and the tauopathies also propagate in a "prion-like" manner. However, the association between prion formation, spread, and neurotoxicity is not clear. Recently, we showed that in prion disease, protein misfolding leads to neurodegeneration through dysregulation of generic proteostatic mechanisms, specifically, the unfolded protein response. Genetic and pharmacological manipulation of the unfolded protein response was neuroprotective despite continuing prion replication, hence dissociating this from neurotoxicity. The data have clear implications for treatment across the spectrum of these disorders, targeting pathogenic processes downstream of protein misfolding.	[Halliday, Mark; Radford, Helois; Mallucci, Giovanna R.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester	Mallucci, GR (corresponding author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	grm7@le.ac.uk		Mallucci, Giovanna/0000-0001-8504-1191	MRC [MC_U132692719] Funding Source: UKRI; Medical Research Council [MC_U132692719] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andre R, 2012, PRION, V6, P32, DOI 10.4161/pri.6.1.18272; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; COLLINGE J, 1990, LANCET, V336, P7, DOI 10.1016/0140-6736(90)91518-F; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Frigg R, 1999, J VIROL, V73, P9584, DOI 10.1128/JVI.73.11.9584-9588.1999; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hill AF, 2003, BRIT MED BULL, V66, P161, DOI 10.1093/bmb/66.1.161; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853; Kober L, 2012, BIOTECHNOL BIOENG, V109, P2599, DOI 10.1002/bit.24527; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PRUSINER S B, 1989, Alzheimer Disease and Associated Disorders, V3, P52, DOI 10.1097/00002093-198903010-00007; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Stutzbach LD, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-31; Thackray AM, 2003, J VIROL, V77, P7991, DOI 10.1128/JVI.77.14.7991-7998.2003; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Watts JC, 2014, J BIOL CHEM, V289, P19841, DOI 10.1074/jbc.R114.550707; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105	54	37	38	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19862	19868		10.1074/jbc.R114.568477	http://dx.doi.org/10.1074/jbc.R114.568477			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24860100	Green Published, hybrid			2022-12-28	WOS:000339395200005
J	Li, Q; Li, CY; Mahtani, HK; Du, J; Patel, AR; Lancaster, JR				Li, Qian; Li, Chuanyu; Mahtani, Harry K.; Du, Jian; Patel, Aashka R.; Lancaster, Jack R., Jr.			Nitrosothiol Formation and Protection against Fenton Chemistry by Nitric Oxide-induced Dinitrosyliron Complex Formation from Anoxia-initiated Cellular Chelatable Iron Increase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; MITOCHONDRIAL PERMEABILITY TRANSITION; INTRACELLULAR FREE IRON; REPERFUSION INJURY; REACTIVE OXYGEN; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; RAT HEPATOCYTES; LIVER ISCHEMIA; SPIN-RESONANCE	Dinitrosyliron complexes (DNIC) have been found in a variety of pathological settings associated with (NO)-N-center dot. However, the iron source of cellular DNIC is unknown. Previous studies on this question using prolonged (NO)-N-center dot exposure could be misleading due to the movement of intracellular iron among different sources. We here report that brief (NO)-N-center dot exposure results in only barely detectable DNIC, but levels increase dramatically after 1-2 h of anoxia. This increase is similar quantitatively and temporally with increases in the chelatable iron, and brief (NO)-N-center dot-treatment prevents detection of this anoxia-induced increased chelatable iron by deferoxamine. DNIC formation is so rapid that it is limited by the availability of (NO)-N-center dot and chelatable iron. We utilize this ability to selectively manipulate cellular chelatable iron levels and provide evidence for two cellular functions of endogenous DNIC formation, protection against anoxia-induced reactive oxygen chemistry from the Fenton reaction and formation by transnitrosation of protein nitrosothiols (RSNO). The levels of RSNO under these high chelatable iron levels are comparable with DNIC levels and suggest that under these conditions, both DNIC and RSNO are the most abundant cellular adducts of (NO)-N-center dot.	[Li, Qian; Li, Chuanyu; Mahtani, Harry K.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Li, Qian; Li, Chuanyu; Mahtani, Harry K.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Du, Jian] Anhui Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Hefei 230032, Peoples R China; [Patel, Aashka R.] Vestavia Hills High Sch, Vestavia Hills, AL 35216 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Anhui Medical University	Li, Q (corresponding author), Univ Alabama Birmingham, Dept Anesthesiol, 901 19th St S, Birmingham, AL 35294 USA.	qianli@uab.edu			National Institutes of Health [RO1 CA-131653]; NATIONAL CANCER INSTITUTE [R01CA131653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA-131653 (to J. R. L.).	Aggarwal Rajiv, 2001, Indian Journal of Pediatrics, V68, P1149, DOI 10.1007/BF02722933; Aldinucci C, 2007, FREE RADICAL BIO MED, V42, P1749, DOI 10.1016/j.freeradbiomed.2007.03.010; Aldinucci C, 2010, NEUROCHEM RES, V35, P1691, DOI 10.1007/s11064-010-0231-2; Aldinucci C, 2010, NEUROCHEM RES, V35, P42, DOI 10.1007/s11064-009-0028-3; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Arkadopoulos N, 2010, HEMOGLOBIN, V34, P265, DOI 10.3109/03630269.2010.484766; AVRAMOVICIGRISARU S, 1983, J MED CHEM, V26, P298, DOI 10.1021/jm00356a037; BERTON G, 1983, IMMUNOLOGY, V49, P693; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Ciccoli L, 2004, BBA-GEN SUBJECTS, V1672, P203, DOI 10.1016/j.bbagen.2004.04.003; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; FERREIRARAJABI L, 1989, BIOCHEMISTRY-US, V28, P8028, DOI 10.1021/bi00446a009; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; HEALING G, 1990, BIOCHEM PHARMACOL, V39, P1239, DOI 10.1016/0006-2952(90)90269-Q; Hickok JR, 2012, ANTIOXID REDOX SIGN, V17, P962, DOI 10.1089/ars.2012.4543; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hines IN, 2011, J CLIN BIOCHEM NUTR, V48, P50, DOI 10.3164/jcbn.11-016FR; Hines IN, 2002, MOL CELL BIOCHEM, V234, P229, DOI 10.1023/A:1015952926016; JACOBS A, 1977, BLOOD, V50, P433; Jacobs A, 1976, Ciba Found Symp, P91; Kagan VE, 2001, ANTIOXID REDOX SIGN, V3, P189, DOI 10.1089/152308601300185160; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; KANNER J, 1991, ARCH BIOCHEM BIOPHYS, V289, P130, DOI 10.1016/0003-9861(91)90452-O; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kharitonov V. G., 1996, METHODS NITRIC OXIDE, P44; Kim JS, 2012, AM J PHYSIOL-GASTR L, V302, pG723, DOI 10.1152/ajpgi.00082.2011; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; KOSAKA H, 1989, CARCINOGENESIS, V10, P563, DOI 10.1093/carcin/10.3.563; KOZLOV AV, 1992, FREE RADICAL BIO MED, V13, P9, DOI 10.1016/0891-5849(92)90159-E; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Lancaster JR, 2004, AM J PHYSIOL-LUNG C, V287, pL465, DOI 10.1152/ajplung.00151.2004; LANGREHR JM, 1993, TRANSPLANTATION, V55, P1205, DOI 10.1097/00007890-199306000-00001; LEAF CD, 1989, CANCER SURV, V8, P323; Lewandowska H, 2011, DALTON T, V40, P8273, DOI 10.1039/c0dt01244k; Li Q, 2009, NITRIC OXIDE-BIOL CH, V21, P69, DOI 10.1016/j.niox.2009.04.001; MALLARD JR, 1964, NATURE, V204, P1192, DOI 10.1038/2041192a0; Marzocchi B, 2005, PEDIATR RES, V58, P660, DOI 10.1203/01.PDR.0000180545.24457.AC; MCDONALD CC, 1965, J AM CHEM SOC, V87, P3319, DOI 10.1021/ja01093a007; MIWA M, 1987, CARCINOGENESIS, V8, P955, DOI 10.1093/carcin/8.7.955; Moller MN, 2007, CHEM RES TOXICOL, V20, P709, DOI 10.1021/tx700010h; Muller B, 1996, BRIT J PHARMACOL, V119, P1281, DOI 10.1111/j.1476-5381.1996.tb16034.x; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Phillips L, 2009, J INVEST SURG, V22, P46, DOI 10.1080/08941930802709470; Postl A, 2011, SHOCK, V36, P501, DOI 10.1097/SHK.0b013e318231822d; Rana MW, 2002, SHOCK, V17, P339, DOI 10.1097/00024382-200204000-00018; Sergent O, 2005, BIOMETALS, V18, P567, DOI 10.1007/s10534-005-8488-7; Shupik MA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1197, DOI 10.1134/S0006297911110010; Signorini C, 2009, J PINEAL RES, V46, P148, DOI 10.1111/j.1600-079X.2008.00639.x; STADLER J, 1993, ARCH BIOCHEM BIOPHYS, V302, P4, DOI 10.1006/abbi.1993.1173; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; VANEIJK HG, 1992, BIOL TRACE ELEM RES, V35, P13, DOI 10.1007/BF02786234; Vanin A. F., 2011, J BIOPHYS, V2011; VANIN AF, 1992, BIOCHIM BIOPHYS ACTA, V1135, P275, DOI 10.1016/0167-4889(92)90231-Y; Vanin AF, 2007, NITRIC OXIDE-BIOL CH, V16, P82, DOI 10.1016/j.niox.2006.07.005; VITHAYATHIL AJ, 1965, NATURE, V207, P1246, DOI 10.1038/2071246a0; VOOGD A, 1992, J CLIN INVEST, V90, P2050, DOI 10.1172/JCI116086; Wang J, 2005, MOL CELL BIOL, V25, P1347, DOI 10.1128/MCB.25.4.1347-1353.2005; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Wink DA, 1996, ARCH BIOCHEM BIOPHYS, V331, P241, DOI 10.1006/abbi.1996.0304; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; WOOLUM JC, 1970, BIOCHIM BIOPHYS ACTA, V201, P131, DOI 10.1016/0304-4165(70)90018-8; Zhang X, 2013, FREE RADICAL BIO MED, V63, P243, DOI 10.1016/j.freeradbiomed.2013.05.004	67	31	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19917	19927		10.1074/jbc.M114.569764	http://dx.doi.org/10.1074/jbc.M114.569764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24891512	Green Published, hybrid			2022-12-28	WOS:000339395200010
J	Tajrishi, MM; Shin, J; Hetman, M; Kumar, A				Tajrishi, Marjan M.; Shin, Jonghyun; Hetman, Michal; Kumar, Ashok			DNA Methyltransferase 3a and Mitogen-activated Protein Kinase Signaling Regulate the Expression of Fibroblast Growth Factor-inducible 14 (Fn14) during Denervation-induced Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; METHYLATION PATTERNS; TARGETED ABLATION; TWEAK-FN14 SYSTEM; EARLY RESPONSE; UBIQUITIN; REGENERATION; MICE; CYTOKINE; PATHWAYS	The TWEAK-fibroblast growth factor-inducible 14 (Fn14) system is a critical regulator of denervation-induced skeletal muscle atrophy. Although the expression of Fn14 is a rate-limiting step in muscle atrophy on denervation, mechanisms regulating gene expression of Fn14 remain unknown. Methylation of CpG sites within promoter region is an important epigenetic mechanism for gene silencing. Our study demonstrates that Fn14 promoter contains a CpG island close to transcription start site. Fn14 promoter also contains multiple consensus DNA sequence for transcription factors activator protein 1 (AP1) and specificity protein 1 (SP1). Denervation diminishes overall genomic DNA methylation and causes hypomethylation at specific CpG sites in Fn14 promoter leading to the increased gene expression of Fn14 in skeletal muscle. Abundance of DNA methyltransferase 3a (Dnmt3a) and its interaction with Fn14 promoter are repressed in denervated skeletal muscle of mice. Overexpression of Dnmt3a inhibits the gene expression of Fn14 and attenuates skeletal muscle atrophy upon denervation. Denervation also causes the activation of ERK1/2, JNK1/2, and ERK5 MAPKs and AP1 and SP1, which stimulate the expression of Fn14 in skeletal muscle. Collectively, our study provides novel evidence that Dnmt3a and MAPK signaling regulate the levels of Fn14 in skeletal muscle on denervation.	[Tajrishi, Marjan M.; Shin, Jonghyun; Kumar, Ashok] Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, Louisville, KY 40202 USA; [Hetman, Michal] Univ Louisville, Dept Neurol Surg, Sch Med, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Kumar, A (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, 500 South Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu		Kumar, Ashok/0000-0001-8571-2848	National Institutes of Health [R01 AG029623, R01 AR059810, R01 NS073584]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG029623 and R01 AR059810 (to A. K.) and R01 NS073584 (to M. H.).	Acharyya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012479; Alamdari N, 2013, METABOLISM, V62, P1, DOI 10.1016/j.metabol.2012.03.019; Bhatnagar S, 2012, CURR MOL MED, V12, P3, DOI 10.2174/156652412798376107; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2001, SCIENCE, V294, P2113, DOI 10.1126/science.1066726; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Casaccia-Bonnefil P, 2008, PROG NEUROBIOL, V86, P368, DOI 10.1016/j.pneurobio.2008.09.012; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Choi MC, 2012, MOL CELL, V47, P122, DOI 10.1016/j.molcel.2012.04.025; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Guasconi V, 2008, CURR OPIN CLIN NUTR, V11, P233, DOI 10.1097/MCO.0b013e3282fa1810; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; Mastroeni D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006617; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Ordway JM, 2002, CELL GROWTH DIFFER, V13, P149; Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Proserpio V, 2013, GENE DEV, V27, P1299, DOI 10.1101/gad.217240.113; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480; Zheng TS, 2008, J LEUKOCYTE BIOL, V84, P338, DOI 10.1189/jlb.0308165	51	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19985	19999		10.1074/jbc.M114.568626	http://dx.doi.org/10.1074/jbc.M114.568626			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895120	Green Published, hybrid			2022-12-28	WOS:000339395200015
J	Behrens, M; Frank, O; Rawel, H; Ahuja, G; Potting, C; Hofmann, T; Meyerhof, W; Korsching, S				Behrens, Maik; Frank, Oliver; Rawel, Harshadrai; Ahuja, Gaurav; Potting, Christoph; Hofmann, Thomas; Meyerhof, Wolfgang; Korsching, Sigrun			ORA1, a Zebrafish Olfactory Receptor Ancestral to All Mammalian V1R Genes, Recognizes 4-Hydroxyphenylacetic Acid, a Putative Reproductive Pheromone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOMERONASAL RECEPTOR; TASTE RECEPTORS; BITTER TASTE; FUNCTIONAL EXPRESSION; SENSORY NEURONS; ODORANT; BULB; FAMILIES; COMBINATORIAL; SPECIFICITY	The teleost v1r-related ora genes are a small, highly conserved olfactory receptor gene family of only six genes, whose direct orthologues can be identified in lineages as far as that of cartilaginous fish. However, no ligands for fish olfactory receptor class A related genes (ORA) had been uncovered so far. Here we have deorphanized the ORA1 receptor using heterologous expression and calcium imaging. We report that zebrafish ORA1 recognizes with high specificity and sensitivity 4-hydroxyphenylacetic acid. The carboxyl group of this compound is required in a particular distance from the aromatic ring, whereas the hydroxyl group in the para-position is not essential, but strongly enhances the binding efficacy. Low concentrations of 4-hydroxyphenylacetic acid elicit increases in oviposition frequency in zebrafish mating pairs. This effect is abolished by naris closure. We hypothesize that 4-hydroxyphenylacetic acid might function as a pheromone for reproductive behavior in zebrafish. ORA1 is ancestral to mammalian V1Rs, and its putative function as pheromone receptor is reminiscent of the role of several mammalian V1Rs as pheromone receptors.	[Behrens, Maik; Meyerhof, Wolfgang] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, D-14558 Nuthetal, Germany; [Frank, Oliver; Hofmann, Thomas] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, D-85354 Freising Weihenstephan, Germany; [Rawel, Harshadrai] Univ Potsdam, Inst Nutr Sci, D-14558 Nuthetal, Germany; [Ahuja, Gaurav; Potting, Christoph; Korsching, Sigrun] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Technical University of Munich; University of Potsdam; University of Cologne	Korsching, S (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47A, D-50674 Cologne, Germany.	sigrun.korsching@uni-koeln.de	/ABE-5591-2020; Frank, Oliver/AAO-9888-2021; Rawel, Harshadrai/AFL-5307-2022; Behrens, Maik/B-6753-2016	/0000-0002-2837-9361; Frank, Oliver/0000-0003-0437-5005; Rawel, Harshadrai/0000-0003-2768-1531; Behrens, Maik/0000-0003-2082-8860				Ahuja G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04037; Ahuja G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02063; Ammon C., 2002, Archives of Physiology and Biochemistry, V110, P137, DOI 10.1076/apab.110.1.137.908; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DETTNER K, 1980, BIOCHEM SYST ECOL, V8, P89, DOI 10.1016/0305-1978(80)90032-0; Friedrich RW, 2013, ANNU REV NEUROSCI, V36, P383, DOI 10.1146/annurev-neuro-062111-150504; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Fuss SH, 2001, J NEUROSCI, V21, P8396, DOI 10.1523/JNEUROSCI.21-21-08396.2001; Gossauer A., 2006, STRUKTUR REAKTIVITAE; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hussain A, 2013, P NATL ACAD SCI USA, V110, P19579, DOI 10.1073/pnas.1318596110; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Ko HS, 2009, CURR MICROBIOL, V59, P608, DOI 10.1007/s00284-009-9481-0; Kreuzer OJ, 2001, J NEUROENDOCRINOL, V13, P279, DOI 10.1046/j.1365-2826.2001.00630.x; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; MICHEL WC, 1995, J COMP PHYSIOL A, V177, P191; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Ohtani K, 2011, Z NATURFORSCH C, V66, P31; Oka Y, 2012, CHEM SENSES, V37, P219, DOI 10.1093/chemse/bjr095; Oka Y, 2011, CHEM SENSES, V36, P357, DOI 10.1093/chemse/bjq138; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Pageat P, 2003, VET CLIN N AM-SMALL, V33, P187, DOI 10.1016/S0195-5616(02)00128-6; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saraiva LR, 2007, GENOME RES, V17, P1448, DOI 10.1101/gr.6553207; Schack HB, 2008, J EXP BIOL, V211, P2079, DOI 10.1242/jeb.015081; Stacey N.E., 2005, FISH PHYSIOL, P359; Takahama U, 2002, FEBS LETT, V518, P116, DOI 10.1016/S0014-5793(02)02659-5; Ueda T, 2003, J NEUROSCI, V23, P7376; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008633	40	26	28	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19778	19788		10.1074/jbc.M114.573162	http://dx.doi.org/10.1074/jbc.M114.573162			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24831010	Green Published, hybrid			2022-12-28	WOS:000339326800049
J	Li, SH; Izumi, T; Hu, J; Jin, HH; Siddiqui, AAA; Jacobson, SG; Bok, D; Jin, MH				Li, Songhua; Izumi, Tadahide; Hu, Jane; Jin, Heather H.; Siddiqui, Ahmed-Abdul A.; Jacobson, Samuel G.; Bok, Dean; Jin, Minghao			Rescue of Enzymatic Function for Disease-associated RPE65 Proteins Containing Various Missense Mutations in Non-active Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; LEBER CONGENITAL AMAUROSIS; 2 POINT MUTATIONS; ISOMEROHYDROLASE ACTIVITY; VISUAL CYCLE; GENE-THERAPY; RETINITIS-PIGMENTOSA; BINDING PROTEIN; ER-STRESS; MUTANT MYOCILINS	Over 70 different missense mutations, including a dominant mutation, in RPE65 retinoid isomerase are associated with distinct forms of retinal degeneration; however, the disease mechanisms for most of these mutations have not been studied. Although some mutations have been shown to abolish enzyme activity, the molecular mechanisms leading to the loss of enzymatic function and retinal degeneration remain poorly understood. Here we show that the 26 S proteasome non-ATPase regulatory subunit 13 (PSMD13), a newly identified negative regulator of RPE65, plays a critical role in regulating pathogenicity of three mutations (L22P, T101I, and L408P) by mediating rapid degradation of mutated RPE65s via a ubiquitinationand proteasome-dependent non-lysosomal pathway. These mutant RPE65s were misfolded and formed aggregates or high molecular complexes via disulfide bonds. Interaction of PSMD13 with mutant RPE65s promoted degradation of misfolded but not properly folded mutant RPE65s. Many mutations, including L22P, T101I, and L408P, were mapped on non-active sites. Although their activities were very low, these mutant RPE65s were catalytically active and could be significantly rescued at low temperature, whereas mutant RPE65s with a distinct active site mutation could not be rescued under the same conditions. Sodium 4-phenylbutyrate and glycerol displayed a significant synergistic effect on the low temperature rescue of the mutant RPE65s by promoting proper folding, reducing aggregation, and increasing membrane association. Our results suggest that a low temperature eye mask and sodium 4-phenylbutyrate, a United States Food and Drug Administration- approved oral medicine, may provide a promising "protein repair therapy" that can enhance the efficacy of gene therapy by reducing the cytotoxic effect of misfolded mutant RPE65s.	[Li, Songhua; Jin, Minghao] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [Li, Songhua; Jin, Minghao] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr, New Orleans, LA 70112 USA; [Izumi, Tadahide] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Hu, Jane; Bok, Dean] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Hu, Jane; Bok, Dean] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Jin, Heather H.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Siddiqui, Ahmed-Abdul A.] Tulane Univ, Dept Neurosci, New Orleans, LA 70118 USA; [Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Kentucky; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Washington University (WUSTL); Tulane University; University of Pennsylvania; Pennsylvania Medicine	Jin, MH (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, 2020 Gravier St, New Orleans, LA 70112 USA.	mjin@lsuhsc.edu		Jacobson, Samuel/0000-0003-2122-169X	National Institutes of Health [EY021208, CA098664, EY017280, P30-GM103340]; Macula Vision Research Foundation; Research to Prevent Blindness; NATIONAL CANCER INSTITUTE [R01CA098664, R56CA098664] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021208, U10EY017280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY021208 (to M. J.), CA098664 (to T. I.), EY017280 (to S. G. J.), and P30-GM103340 (to Louisiana State University Neuroscience Center of Biomedical Research Excellence core facility). This work was also supported by a Macula Vision Research Foundation grant (to D. B.) and a Research to Prevent Blindness grant (to Louisiana State University Department of Ophthalmology).	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bonapace G, 2004, P NATL ACAD SCI USA, V101, P12300, DOI 10.1073/pnas.0404764101; Bowne SJ, 2011, EUR J HUM GENET, V19, P1074, DOI 10.1038/ejhg.2011.86; Busso CS, 2009, ONCOGENE, V28, P1616, DOI 10.1038/onc.2009.5; Carlson A, 1999, INVEST OPHTH VIS SCI, V40, P533; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; Chen Y, 2006, FEBS LETT, V580, P4200, DOI 10.1016/j.febslet.2006.06.078; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hu J, 2001, MOL VIS, V7, P14; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Li SH, 2013, J BIOL CHEM, V288, P11395, DOI 10.1074/jbc.M112.418251; Li SH, 2013, J NEUROSCI, V33, P3178, DOI 10.1523/JNEUROSCI.2428-12.2013; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; MAESTRI NE, 1991, J PEDIATR-US, V119, P923, DOI 10.1016/S0022-3476(05)83044-6; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Nikolaeva O, 2010, BIOCHEM BIOPH RES CO, V391, P1757, DOI 10.1016/j.bbrc.2009.12.149; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; Pang JJ, 2005, MOL VIS, V11, P152; Philpa AR, 2009, HUM MUTAT, V30, P1183, DOI 10.1002/humu.21033; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein Ronald C., 1998, Current Opinion in Pediatrics, V10, P250, DOI 10.1097/00008480-199806000-00005; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Samardzija M, 2008, HUM MOL GENET, V17, P281, DOI 10.1093/hmg/ddm304; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Shang F, 2012, PROG MOL BIOL TRANSL, V109, P347, DOI 10.1016/B978-0-12-397863-9.00010-9; SHIRASAWA H, 1994, VIROLOGY, V203, P36, DOI 10.1006/viro.1994.1452; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Takahashi Y, 2006, J BIOL CHEM, V281, P21820, DOI 10.1074/jbc.M603725200; Takahashi Y, 2009, J BIOL CHEM, V284, P3211, DOI 10.1074/jbc.M807248200; Takeuchi J, 1999, MOL CELL BIOL, V19, P6575; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Wright CB, 2014, INVEST OPHTH VIS SCI, V55, P2500, DOI 10.1167/iovs.13-13574; Wright CB, 2013, INVEST OPHTH VIS SCI, V54, P5111, DOI 10.1167/iovs.13-12336; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	63	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18943	18956		10.1074/jbc.M114.552117	http://dx.doi.org/10.1074/jbc.M114.552117			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849605	hybrid, Green Published			2022-12-28	WOS:000339062900027
J	Yamasaki, T; Ariyoshi, W; Okinaga, T; Adachi, Y; Hosokawa, R; Mochizuki, S; Sakurai, K; Nishihara, T				Yamasaki, Toru; Ariyoshi, Wataru; Okinaga, Toshinori; Adachi, Yoshiyuki; Hosokawa, Ryuji; Mochizuki, Shinichi; Sakurai, Kazuo; Nishihara, Tatsuji			The Dectin 1 Agonist Curdlan Regulates Osteoclastogenesis by Inhibiting Nuclear Factor of Activated T cells Cytoplasmic 1 (NFATc1) through Syk Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECEPTOR; NECROSIS-FACTOR RECEPTOR; C-TYPE LECTINS; NF-KAPPA-B; TYROSINE KINASE; BONE-RESORPTION; ANTIFUNGAL IMMUNITY; ADAPTER PROTEINS; GENE-EXPRESSION; DIFFERENTIATION	Several immune system cell surface receptors are reported to be associated with osteoclastogenesis. Dectin 1, a lectin receptor for beta-glucan, is found predominantly on cells of the myeloid lineage. In this study, we examined the effect of the dectin 1 agonist curdlan on osteoclastogenesis. In mouse bone marrow cells and dectin 1-overexpressing RAW 264.7 cells (d-RAWs), curdlan suppressed receptor activator of NF-kappa B ligand (RA NKL)-induced osteoclast differentiation, bone resorption, and actin ring formation in a dose-dependent manner. This was achieved within non-growth inhibitory concentrations at the early stage. Conversely, curdlan had no effect on macrophage colony-stimulating factor-induced differentiation. Furthermore, curdlan inhibited RANKL-induced nuclear factor of activated T cell cytoplasmic 1 (NFATc1) expression, thereby decreasing osteoclastogenesis-related marker gene expression, including tartrate-resistant acid phosphatase, osteoclast stimulatory transmembrane protein, cathepsin K, and matrix metallopeptidase 9. Curdlan inhibited RANKL-induced c-fos expression, followed by suppression of NFATc1 autoamplification, without significantly affecting the NF-kappa B signaling pathway. We also observed that curdlan treatment decreased Syk protein in d-RAWs. Inhibition of the dectin 1-Syk kinase pathway by Syk-specific siRNA or chemical inhibitors suppressed osteoclast formation and NFATc1 expression stimulated by RANKL. In conclusion, our results demonstrate that curdlan potentially inhibits osteoclast differentiation, especially NFATc1 expression, and that Syk kinase plays a crucial role in the transcriptional pathways. This suggests that the activation of dectin 1-Syk kinase interaction critically regulates the genes required for osteoclastogenesis.	[Yamasaki, Toru; Ariyoshi, Wataru; Okinaga, Toshinori; Nishihara, Tatsuji] Kyushu Dent Univ, Div Infect & Mol Biol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan; [Yamasaki, Toru; Hosokawa, Ryuji] Kyushu Dent Univ, Div Oral Reconstruct & Rehabil, Dept Oral Funct, Kitakyushu, Fukuoka, Japan; [Adachi, Yoshiyuki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Hachioji, Tokyo 1920392, Japan; [Mochizuki, Shinichi; Sakurai, Kazuo] Univ Kitakyushu, Dept Chem & Biochem, Kitakyushu, Fukuoka 8080135, Japan	Kyushu Dental University; Kyushu Dental University; Tokyo University of Pharmacy & Life Sciences; University of Kitakyushu	Ariyoshi, W (corresponding author), Kyushu Dent Univ, Div Infect & Mol Biol, Dept Hlth Promot, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka, Japan.	arikichi@kyu-dent.ac.jp		Nishihara, Tatsuji/0000-0001-7075-9678				Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; Castro GR, 2007, MOL PHARMACEUT, V4, P33, DOI 10.1021/mp060100x; Chaung HC, 2009, VET IMMUNOL IMMUNOP, V131, P147, DOI 10.1016/j.vetimm.2009.04.004; CZOP JK, 1986, PATHOL IMMUNOPATH R, V5, P286, DOI 10.1159/000157022; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; EISEMAN E, 1992, NATURE, V355, P78; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; FULLER K, 1994, J BONE MINER RES, V9, P17; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Halleen JM, 1999, J BIOL CHEM, V274, P22907, DOI 10.1074/jbc.274.33.22907; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Ishibashi O, 2006, LIFE SCI, V79, P1657, DOI 10.1016/j.lfs.2006.05.024; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishikawa T, 2001, MOL CARCINOGEN, V32, P84, DOI 10.1002/mc.1067; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Mocanu G, 2009, INT J BIOL MACROMOL, V44, P215, DOI 10.1016/j.ijbiomac.2008.12.005; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Solski PA, 2004, J BIOL CHEM, V279, P25226, DOI 10.1074/jbc.M313792200; Song I, 2009, FEBS LETT, V583, P2435, DOI 10.1016/j.febslet.2009.06.047; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takahashi N, 2003, METH MOLEC MED, V80, P129; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Williams DL, 1997, MEDIAT INFLAMM, V6, P247, DOI 10.1080/09629359791550; Williams DL, 1996, CLIN IMMUNOTHER, V5, P392, DOI 10.1007/BF03259335; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	62	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19191	19203		10.1074/jbc.M114.551416	http://dx.doi.org/10.1074/jbc.M114.551416			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24821724	Green Published, hybrid			2022-12-28	WOS:000339062900047
J	Dalla Rosa, I; Huang, SYN; Agama, K; Khiati, S; Zhang, HL; Pommier, Y				Dalla Rosa, Ilaria; Huang, Shar-yin N.; Agama, Keli; Khiati, Salim; Zhang, Hongliang; Pommier, Yves			Mapping Topoisomerase Sites in Mitochondrial DNA with a Poisonous Mitochondrial Topoisomerase I (Top1mt)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION SEQUENCE; ACTIVE-SITE; TRANSCRIPTION; CAMPTOTHECIN; REPLICATION; MECHANISM; CLEAVAGE; TEMPLATE; DAMAGE; ELONGATION	Mitochondrial topoisomerase I (Top1mt) is a type IB topoisomerase present in vertebrates and exclusively targeted to mitochondria. Top1mt relaxes mitochondrial DNA (mtDNA) supercoiling by introducing transient cleavage complexes wherein the broken DNA strand swivels around the intact strand. Top1mt cleavage complexes (Top1mtcc) can be stabilized in vitro by camptothecin (CPT). However, CPT does not trap Top1mtcc efficiently in cells and is highly cytotoxic due to nuclear Top1 targeting. To map Top1mtcc on mtDNA in vivo and to overcome the limitations of CPT, we designed two substitutions (T546A and N550H) in Top1mt to stabilize Top1mtcc. We refer to the double-mutant enzyme as Top1mt*. Using retroviral transduction and ChIP-on-chip assays with Top1mt* in Top1mt knock-out murine embryonic fibroblasts, we demonstrate that Top1mt* forms high levels of cleavage complexes preferentially in the noncoding regulatory region of mtDNA, accumulating especially at the heavy strand replication origin O-H, in the ribosomal genes (12S and 16S) and at the light strand replication origin O-L. Expression of Top1mt* also caused rapid mtDNA depletion without affecting mitochondria mass, suggesting the existence of specific mitochondrial pathways for the removal of damaged mtDNA.	[Dalla Rosa, Ilaria; Huang, Shar-yin N.; Agama, Keli; Khiati, Salim; Zhang, Hongliang; Pommier, Yves] NCI, Mol Pharmacol Lab, Dev Therapeut Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Dev Therapeut Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	pommier@nih.gov		Dalla Rosa, Ilaria/0000-0003-4801-2396; khiati, Salim/0000-0002-2402-4790	Intramural Program of the NCI, National Institutes of Health, Department of Health and Human Services Grant [Z01 BC 006161]; NATIONAL CANCER INSTITUTE [ZIABC006161] Funding Source: NIH RePORTER	Intramural Program of the NCI, National Institutes of Health, Department of Health and Human Services Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Program of the NCI, National Institutes of Health, Department of Health and Human Services Grant Z01 BC 006161.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BOGENHAGEN D, 1978, J MOL BIOL, V119, P49, DOI 10.1016/0022-2836(78)90269-3; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; BURKE TG, 1993, BIOCHEMISTRY-US, V32, P5352, DOI 10.1021/bi00071a010; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Colley WC, 2004, J BIOL CHEM, V279, P54069, DOI 10.1074/jbc.M409764200; Croce AC, 2004, BIOCHEM PHARMACOL, V67, P1035, DOI 10.1016/j.bcp.2003.10.034; Dexheimer TS, 2008, NAT PROTOC, V3, P1736, DOI 10.1038/nprot.2008.174; Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519; Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; Douarre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041094; DROLET M, 1994, J BIOL CHEM, V269, P2068; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fertala J, 2000, J BIOL CHEM, V275, P15246, DOI 10.1074/jbc.275.20.15246; French SL, 2011, MOL CELL BIOL, V31, P482, DOI 10.1128/MCB.00589-10; GILLUM AM, 1978, P NATL ACAD SCI USA, V75, P677, DOI 10.1073/pnas.75.2.677; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; JAXEL C, 1991, J BIOL CHEM, V266, P20418; Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Khiati S, 2014, CLIN CANCER RES, V20, P4873, DOI 10.1158/1078-0432.CCR-13-3373; Koster DA, 2010, CELL, V142, P519, DOI 10.1016/j.cell.2010.08.001; KROGH S, 1991, NUCLEIC ACIDS RES, V19, P1235, DOI 10.1093/nar/19.6.1235; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; PARKER LH, 1993, J MOL BIOL, V231, P6, DOI 10.1006/jmbi.1993.1252; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Rosa ID, 2009, NUCLEIC ACIDS RES, V37, P6414, DOI 10.1093/nar/gkp708; Seol Y, 2012, P NATL ACAD SCI USA, V109, P16125, DOI 10.1073/pnas.1206480109; Sobek S, 2013, NUCLEIC ACIDS RES, V41, P9848, DOI 10.1093/nar/gkt768; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; TANIZAWA A, 1994, J NATL CANCER I, V86, P836, DOI 10.1093/jnci/86.11.836; Zhang HL, 2004, NUCLEIC ACIDS RES, V32, P2087, DOI 10.1093/nar/gkh525; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998; Zhang HL, 2008, BIOCHEMISTRY-US, V47, P11196, DOI 10.1021/bi800774b; Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384	47	19	19	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18595	18602		10.1074/jbc.M114.555367	http://dx.doi.org/10.1074/jbc.M114.555367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24798329	hybrid, Green Published			2022-12-28	WOS:000338042000057
J	Lou, Y; Schwender, J; Shanklin, J				Lou, Ying; Schwender, Jorg; Shanklin, John			FAD2 and FAD3 Desaturases Form Heterodimers That Facilitate Metabolic Channeling in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER-PROTEIN DESATURASE; FATTY-ACID DESATURASES; ENDOPLASMIC-RETICULUM; TRANSGENIC PLANTS; CRYSTAL-STRUCTURE; ARABIDOPSIS; ENZYME; GENE; HYDROXYLASE; ACCUMULATION	Plant desaturases comprise two independently evolved classes, a structurally well characterized soluble class responsible for the production of monoenes in the plastids of higher plants and the poorly structurally characterized integral membrane class that has members in the plastid and endoplasmic reticulum that are responsible for producing mono-and polyunsaturated fatty acids. Both require iron and oxygen for activity and are inhibited by azide and cyanide underscoring their common chemical imperatives. We previously showed that the Delta(9) acyl-CoA integral membrane desaturase Ole1p from Saccharomyces cerevisiae exhibits dimeric organization, like the soluble plastidial acyl-ACP desaturases. Here we use two independent bimolecular complementation assays, i.e. yeast two-hybrid analysis and Arabidopsis leaf protoplast split luciferase assay, to demonstrate that members of the plant integral membrane fatty acid desaturase (FAD) family, FAD2, FAD3, FAD6, FAD7, and FAD8, self-associate. Further, the endoplasmic reticulum-localized desaturase FAD2 can associate with FAD3, as can the plastid-localized FAD6 desaturase with either FAD7 or FAD8. These pairings appear to be specific because pairs such as FAD3 and FAD7 (or FAD8) and FAD2 and FAD6 do not interact despite their high amino acid similarity. These results are consistent also with their known endoplasmic reticulum and plastid subcellular localizations. Chemical cross-linking experiments confirm that FAD2 and FAD3 can form dimers like the yeast Ole1p and, when coexpressed, can form FAD2-FAD3 heterodimers. Metabolic flux analysis of yeast coexpressing FAD2 and FAD3 indicates that heterodimers can form a metabolic channel in which 18:1-PC is converted to 18:3-PC without releasing a free 18:2-PC intermediate.	[Lou, Ying; Schwender, Jorg; Shanklin, John] Brookhaven Natl Lab, Biosci Dept, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Shanklin, J (corresponding author), Brookhaven Natl Lab, Dept Biol, Bldg 463,50 Bell Ave, Upton, NY 11973 USA.	shanklin@bnl.gov	Schwender, Jorg/P-2282-2014	Schwender, Jorg/0000-0003-1350-4171; Shanklin, John/0000-0002-6774-8043	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (DOE) [DOE KC0304000]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE))	work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (DOE) under Grant DOE KC0304000.	ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; BLOCH K, 1969, ACCOUNTS CHEM RES, V2, P193, DOI 10.1021/ar50019a001; Broadwater JA, 1998, BIOCHEMISTRY-US, V37, P14664, DOI 10.1021/bi981839i; Broun P, 1998, PLANT J, V13, P201, DOI 10.1046/j.1365-313X.1998.00023.x; Broun P, 1997, PLANT PHYSIOL, V113, P933, DOI 10.1104/pp.113.3.933; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; Cahoon EB, 1999, P NATL ACAD SCI USA, V96, P12935, DOI 10.1073/pnas.96.22.12935; Chapman KD, 2001, J AM OIL CHEM SOC, V78, P941, DOI 10.1007/s11746-001-0368-y; Chapman KD, 2008, CROP SCI, V48, P1470, DOI 10.2135/cropsci2007.11.0618; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Dyer JM, 2001, FEBS LETT, V494, P44, DOI 10.1016/S0014-5793(01)02315-8; Fox BG, 2004, ACCOUNTS CHEM RES, V37, P421, DOI 10.1021/ar030186h; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Guy JE, 2007, J BIOL CHEM, V282, P19863, DOI 10.1074/jbc.M702520200; Horiguchi G, 2000, PLANT J, V24, P805, DOI 10.1046/j.1365-313x.2000.00925.x; Khuu N, 2011, PLANT SIGNAL BEHAV, V6, P422, DOI 10.4161/psb.6.3.14522; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; Lindqvist Y., 2001, DELTA 9 STEAROYL ACY; Lou Y, 2010, J BIOL CHEM, V285, P19384, DOI 10.1074/jbc.M110.125377; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; Napier JA, 2005, P NUTR SOC, V64, P387, DOI 10.1079/PNS2005447; Napier JA, 2007, ANNU REV PLANT BIOL, V58, P295, DOI 10.1146/annurev.arplant.58.032806.103811; O'Quin JB, 2010, J BIOL CHEM, V285, P21781, DOI 10.1074/jbc.M110.135236; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; OHLROGGE JB, 1991, BIOCHIM BIOPHYS ACTA, V1082, P1, DOI 10.1016/0005-2760(91)90294-R; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 1997, P NATL ACAD SCI USA, V94, P2981, DOI 10.1073/pnas.94.7.2981; Sobrado P, 2006, BIOCHEMISTRY-US, V45, P4848, DOI 10.1021/bi0600547; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; SOMERVILLE C, 1995, P NATL ACAD SCI USA, V92, P6215, DOI 10.1073/pnas.92.14.6215; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Sturino JM, 2006, NAT REV MICROBIOL, V4, P395, DOI 10.1038/nrmicro1393; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; THOMPSON GA, 1991, P NATL ACAD SCI USA, V88, P2578, DOI 10.1073/pnas.88.6.2578; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xu CC, 2010, PLANT CELL PHYSIOL, V51, P1019, DOI 10.1093/pcp/pcq053	41	55	61	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					17996	18007		10.1074/jbc.M114.572883	http://dx.doi.org/10.1074/jbc.M114.572883			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24811169	Green Published, hybrid			2022-12-28	WOS:000338042000004
J	Mitchell, DA; Hamel, LD; Reddy, KD; Farh, L; Rettew, LM; Sanchez, PR; Deschenes, RJ				Mitchell, David A.; Hamel, Laura D.; Reddy, Krishna D.; Farh, Lynn; Rettew, Logan M.; Sanchez, Phillip R.; Deschenes, Robert J.			Mutations in the X-linked Intellectual Disability Gene, zDHHC9, Alter Autopalmitoylation Activity by Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN PALMITOYLATION; MENTAL-RETARDATION; INTEGRIN ALPHA-6-BETA-4; LOCALIZATION; RAS; ACYLTRANSFERASE; TRANSFORMATION; EXPRESSION; STABILITY	Early onset intellectual disabilities result in significant societal and economic costs and affect 1-3% of the population. The underlying genetic determinants are beginning to emerge and are interpreted in the context of years of work characterizing postsynaptic receptor and signaling functions of learning and memory. DNA sequence analysis of intellectual disability patients has revealed greater than 80 loci on the X-chromosome that are potentially linked to disease. One of the loci is zDHHC9, a gene encoding a Ras protein acyltransferase. Protein palmitoylation is a reversible modification that controls the subcellular localization and distribution of membrane receptors, scaffolds, and signaling proteins required for neuronal plasticity. Palmitoylation occurs in two steps. In the first step, autopalmitoylation, an enzyme-palmitoyl intermediate is formed. During the second step, the palmitoyl moiety is transferred to a protein substrate, or if no substrate is available, hydrolysis of the thioester linkage produces the enzyme and free palmitate. In this study, we demonstrate that two naturally occurring variants of zDHHC9, encoding R148W and P150S, affect the autopalmitoylation step of the reaction by lowering the steady state amount of the palmitoyl-zDHHC9 intermediate.	[Mitchell, David A.; Hamel, Laura D.; Reddy, Krishna D.; Rettew, Logan M.; Sanchez, Phillip R.; Deschenes, Robert J.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Farh, Lynn] Natl Pingtung Univ, Dept Biol Chem, Pingtung 90003, Taiwan	State University System of Florida; University of South Florida; National Pingtung University	Deschenes, RJ (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, MDC 7, Tampa, FL 33612 USA.	rdeschen@health.usf.edu	; Reddy, Krishna/M-5177-2013	Sanchez, Phillip/0000-0002-6354-0368; Reddy, Krishna/0000-0002-0475-8375	National Institutes of Health [GM073977, CA050211]; NATIONAL CANCER INSTITUTE [R01CA050211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM073977 and CA050211 (to R. J. D.).	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOSEPH M, 1995, J BIOL CHEM, V270, P19439, DOI 10.1074/jbc.270.33.19439; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Maak S, 2010, MOL CELL PROBE, V24, P32, DOI 10.1016/j.mcp.2009.09.001; Mansilla F, 2007, BRIT J CANCER, V96, P1896, DOI 10.1038/sj.bjc.6603818; MASSEY V, 1960, BIOCHIM BIOPHYS ACTA, V38, P447, DOI 10.1016/0006-3002(60)91280-4; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2012, J BIOL CHEM, V287, P34337, DOI 10.1074/jbc.M112.379297; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Ohta E, 2003, J BIOL CHEM, V278, P51957, DOI 10.1074/jbc.M310014200; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Raymond FL, 2006, J MED GENET, V43, P193, DOI 10.1136/jmg.2005.033043; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Scheffer KD, 2013, J VIROL, V87, P3435, DOI 10.1128/JVI.02906-12; Sharma C, 2012, CELL MOL LIFE SCI, V69, P2233, DOI 10.1007/s00018-012-0924-6; Sherman F, 1986, LAB COURSE MANUAL ME; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Young E, 2014, MOL CELL BIOL, V34, P374, DOI 10.1128/MCB.01248-13; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhang MZM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001597; Zhang MM, 2010, P NATL ACAD SCI USA, V107, P8627, DOI 10.1073/pnas.0912306107; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhou B, 2004, CANCER RES, V64, P7455, DOI 10.1158/0008-5472.CAN-04-1574	35	36	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18582	18592		10.1074/jbc.M114.567420	http://dx.doi.org/10.1074/jbc.M114.567420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24811172	Green Published, hybrid			2022-12-28	WOS:000338042000054
J	Walport, LJ; Hopkinson, RJ; Vollmar, M; Madden, SK; Gileadi, C; Oppermann, U; Schofield, CJ; Johansson, C				Walport, Louise J.; Hopkinson, Richard J.; Vollmar, Melanie; Madden, Sarah K.; Gileadi, Carina; Oppermann, Udo; Schofield, Christopher J.; Johansson, Catrine			Human UTY(KDM6C) Is a Male-specific N-epsilon-Methyl Lysyl Demethylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METHYLATION; MOLECULAR-MECHANISMS; HISTONE; UTX; JMJD3; HYDROXYLASE; INHIBITOR; DYNAMICS; MODEL; FOLD	The Jumonji C lysine demethylases (KDMs) are 2-oxoglutarateand Fe(II)-dependent oxygenases. KDM6A (UTX) and KDM6B (JMJD3) are KDM6 subfamily members that catalyze demethylation of N-epsilon-methylated histone 3 lysine 27 (H3K27), a mark important for transcriptional repression. Despite reports stating thatUTY(KDM6C) is inactive as a KDM, we demonstrate by biochemical studies, employing MS and NMR, that UTY(KDM6C) is an active KDM. Crystallographic analyses reveal that the UTY(KDM6C) active site ishighly conserved with those of KDM6B and KDM6A. UTY(KDM6C) catalyzes demethylation of H3K27 peptides in vitro, analogously to KDM6B and KDM6A, but with reduced activity, due to point substitutions involved in substrate binding. The results expand the set of human KDMs and will be of use in developing selective KDM inhibitors.	[Walport, Louise J.; Hopkinson, Richard J.; Madden, Sarah K.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Vollmar, Melanie; Gileadi, Carina; Oppermann, Udo; Johansson, Catrine] Univ Oxford, Struct Genom Consortium, Headington OX3 7DQ, England; [Oppermann, Udo] Botnar Res Ctr, Oxford Biomed Res Unit, Oxford OX3 7LD, England	University of Oxford; University of Oxford; University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk; catrine.johansson@sgc.ox.ac.uk	Walport, Louise/ABB-3578-2020; Hopkinson, Richard J/K-8372-2013	Walport, Louise/0000-0002-3795-8365; Hopkinson, Richard J/0000-0001-7610-8163; Schofield, Christopher/0000-0002-0290-6565; Madden, Sarah/0000-0001-6858-7651; Vollmar, Melanie/0000-0002-9162-9159	Biotechnology and Biological Sciences Research Council (United Kingdom); Engineering and Physical Sciences Research Council; Wellcome Trust; Arthritis Research UK; NIHR Oxford Biomedical Research Unit; St. Edmund Hall, Oxford; Abbvie; Bayer Healthcare; Boehringer Ingelheim; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Lilly; Genome Canada; GlaxoSmithKline; Ontario Ministry of Economic Development and Innovation; Janssen; Novartis Research Foundation; Pfizer; Takeda	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); NIHR Oxford Biomedical Research Unit; St. Edmund Hall, Oxford; Abbvie(AbbVie); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Lilly(Eli Lilly); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Ontario Ministry of Economic Development and Innovation; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd)	This work was supported in part by the Biotechnology and Biological Sciences Research Council (United Kingdom), the Engineering and Physical Sciences Research Council, the Wellcome Trust, Arthritis Research UK, the NIHR Oxford Biomedical Research Unit, and St. Edmund Hall, Oxford. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from Abbvie, Bayer Healthcare, Boehringer Ingelheim, the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Lilly, Genome Canada, GlaxoSmithKline, the Ontario Ministry of Economic Development and Innovation, Janssen, the Novartis Research Foundation, Pfizer, Takeda, and the Wellcome Trust.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Aguilar JA, 2012, CHEM COMMUN, V48, P811, DOI 10.1039/c1cc16699a; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berletch JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003489; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Bloomer LDS, 2013, ARTERIOSCL THROM VAS, V33, P1722, DOI 10.1161/ATVBAHA.113.301608; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Carr SM, 2012, ESSAYS BIOCHEM, V52, P79, DOI [10.1042/bse0520079, 10.1042/BSE0520079]; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Herz HM, 2012, MOL CELL BIOL, V32, P1683, DOI 10.1128/MCB.06503-11; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Hopkinson RJ, 2013, CHEM SCI, V4, P3110, DOI [10.1039/c3sc51122g, 10.1039/C3SC51122G]; Hopkinson RJ, 2010, CHEMBIOCHEM, V11, P506, DOI 10.1002/cbic.200900713; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawamura A, 2010, ANAL BIOCHEM, V404, P86, DOI 10.1016/j.ab.2010.04.030; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kristensen JBL, 2011, FEBS LETT, V585, P1951, DOI 10.1016/j.febslet.2011.05.023; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Laaser I, 2011, OMICS, V15, P141, DOI 10.1089/omi.2010.0107; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Leslie M, 2013, SCIENCE, V340, P25, DOI 10.1126/science.340.6128.27; Lu T, 2013, P NATL ACAD SCI USA, V110, P13510, DOI 10.1073/pnas.1311770110; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Miller SA, 2010, IMMUNOL REV, V238, P233, DOI 10.1111/j.1600-065X.2010.00952.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rose NR, 2012, J MED CHEM, V55, P6639, DOI 10.1021/jm300677j; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Sanchez-Fernandez EM, 2013, BIOCHEM J, V449, P491, DOI 10.1042/BJ20121155; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Vogt MHJ, 2000, BLOOD, V96, P3126, DOI 10.1182/blood.V96.9.3126.h8003126_3126_3132; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Walters ZS, 2014, ONCOGENE, V33, P1148, DOI 10.1038/onc.2013.46; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109	58	125	131	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18302	18313		10.1074/jbc.M114.555052	http://dx.doi.org/10.1074/jbc.M114.555052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24798337	Green Published, hybrid			2022-12-28	WOS:000338042000030
J	Garcia-Fernandez, E; Medrano, FJ; Galan, B; Garcia, JL				Garcia-Fernandez, Esther; Javier Medrano, Francisco; Galan, Beatriz; Luis Garcia, Jose			Deciphering the Transcriptional Regulation of Cholesterol Catabolic Pathway in Mycobacteria IDENTIFICATION OF THE INDUCER OF KstR REPRESSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN; ESCHERICHIA-COLI; TUBERCULOSIS; DEGRADATION; MACROPHAGES; ACTIVATION; CONVERSION; ADAPTATION; EXPRESSION; SMEGMATIS	Cholesterol degradation plays a prominent role in Mycobacterium tuberculosis infection; therefore, to develop new tools to combat this disease, we need to decipher the components comprising and regulating the corresponding pathway. A TetR-like repressor (KstR) regulates the upper part of this complex catabolic pathway, but the induction mechanism remains unknown. Using a biophysical approach, we have discovered that the inducer molecule of KstR in M. smegmatis mc(2)155 is not cholesterol but 3-oxo-4-cholestenoic acid, one of the first metabolic intermediates. Binding this compound induces dramatic conformational changes in KstR that promote the KstR-DNA interaction to be released from the operator, retaining its dimeric state. Our findings suggest a regulatory model common to all cholesterol degrading bacteria in which the first steps of the pathway are critical to its mineralization and explain the high redundancy of the enzymes involved in these initial steps.	[Garcia-Fernandez, Esther; Galan, Beatriz; Luis Garcia, Jose] CSIC, Dept Environm Biol, Ctr Invest Biol, E-28040 Madrid, Spain; [Javier Medrano, Francisco] CSIC, Dept Chem & Phys Biol, Ctr Invest Biol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Garcia, JL (corresponding author), CSIC, Dept Environm Biol, Plaza Murillo 2, E-28040 Madrid, Spain.	jlgarcia@cib.csic.es	Medrano, Francisco Javier/ABF-9860-2020; Garcia Lopez, Jose Luis/G-9139-2015	Garcia Lopez, Jose Luis/0000-0002-9238-2485; Galan, Beatriz/0000-0002-2596-6034	Spanish Ministry of Economy and Competitiveness [BFU2009-11545-CO3-03, BFU2012-39695-CO2-01, BFU2011-24615, CSD2009-00088]; Spanish Ministry of Education and Science	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education and Science(Spanish Government)	This work was supported by Spanish Ministry of Economy and Competitiveness Grants BFU2009-11545-CO3-03, BFU2012-39695-CO2-01, BFU2011-24615, and CSD2009-00088.; Recipient of a predoctoral fellowship from the Spanish Ministry of Education and Science.	BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brzostek A, 2013, J STEROID BIOCHEM, V134, P1, DOI 10.1016/j.jsbmb.2012.09.028; Capyk JK, 2011, J BIOL CHEM, V286, P40717, DOI 10.1074/jbc.M111.289975; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Carette X, 2012, NUCLEIC ACIDS RES, V40, P3018, DOI 10.1093/nar/gkr1113; Cerda-Maira FA, 2008, J BACTERIOL, V190, P7441, DOI 10.1128/JB.00584-08; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dermer J, 2012, J BIOL CHEM, V287, P36905, DOI 10.1074/jbc.M112.407304; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; de las Heras LF, 2011, MICROBIOL RES, V166, P403, DOI 10.1016/j.micres.2010.05.003; Gagne F, 2006, ECOTOX ENVIRON SAFE, V64, P329, DOI 10.1016/j.ecoenv.2005.04.004; Garcia JL, 2012, MICROB BIOTECHNOL, V5, P679, DOI 10.1111/j.1751-7915.2012.00331.x; Garcia-Fernandez E, 2013, ENVIRON MICROBIOL, V15, P2342, DOI 10.1111/1462-2920.12108; Gomez M, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P111; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Johnston JB, 2010, J BIOL CHEM, V285, P36352, DOI 10.1074/jbc.M110.161117; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Klepp LI, 2012, MICROBES INFECT, V14, P590, DOI 10.1016/j.micinf.2012.01.007; Lack NA, 2010, J BIOL CHEM, V285, P434, DOI 10.1074/jbc.M109.058081; Lei HT, 2011, PROTEIN SCI, V20, P712, DOI 10.1002/pro.602; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Manso I, 2009, J BIOL CHEM, V284, P21218, DOI 10.1074/jbc.M109.008243; Marschall C, 1998, J MOL BIOL, V276, P339, DOI 10.1006/jmbi.1997.1533; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; REYNOLDS JA, 1985, METHOD ENZYMOL, V117, P41; Sambrook J., 2001, MOL CLONING LAB MANU; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SIH CJ, 1967, J AM CHEM SOC, V89, P1957, DOI 10.1021/ja00984a039; SIH CJ, 1968, BIOCHEMISTRY-US, V7, P808, DOI 10.1021/bi00842a039; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tahlan K, 2008, J MOL BIOL, V383, P753, DOI 10.1016/j.jmb.2008.08.081; Uhia I, 2011, ENVIRON MICROBIOL, V13, P943, DOI 10.1111/j.1462-2920.2010.02398.x; Uhia I, 2012, ENV MICROBIOL REP, V4, P168, DOI 10.1111/j.1758-2229.2011.00314.x; Uhia I, 2011, MICROBIOL-SGM, V157, P2670, DOI 10.1099/mic.0.049213-0; Veiga P, 2005, FEMS MICROBIOL LETT, V242, P81, DOI 10.1016/j.femsle.2004.10.042; Vrielink A, 2010, SUBCELL BIOCHEM, V51, P137, DOI 10.1007/978-90-481-8622-8_5; Wilbrink MH, 2011, APPL ENVIRON MICROB, V77, P4455, DOI 10.1128/AEM.00380-11; Xiong GM, 2003, CHEM-BIOL INTERACT, V143, P425, DOI 10.1016/S0009-2797(02)00252-1; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x	54	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17576	17588		10.1074/jbc.M113.545715	http://dx.doi.org/10.1074/jbc.M113.545715			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24802756	Green Published, hybrid			2022-12-28	WOS:000338018100023
J	Huang, P; Zou, YJ; Zhong, XZ; Cao, Q; Zhao, KX; Zhu, MX; Murrell-Lagnado, R; Dong, XP				Huang, Peng; Zou, Yuanjie; Zhong, Xi Zoe; Cao, Qi; Zhao, Kexin; Zhu, Michael X.; Murrell-Lagnado, Ruth; Dong, Xian-Ping			P2X4 Forms Functional ATP-activated Cation Channels on Lysosomal Membranes Regulated by Luminal pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(4) RECEPTORS; RELEASE; MECHANISM; IDENTIFICATION; ACIDIFICATION; PHYSIOLOGY; CALCIUM; STORAGE	P2X receptors are commonly known as plasma membrane cation channels involved in a wide variety of cell functions. The properties of these channels have been extensively studied on the plasma membrane. However, studies in amoeba suggest that P2X receptors are also present intracellularly and involved in vesicle fusion with the plasma membrane. Recently, it was shown that in addition to plasma membrane expression, mammalian P2X4 was also localized intracellularly in lysosomes. However, it was not clear whether the lysosomal P2X4 receptors function as channels and how they are activated and regulated. In this paper, we show that both P2X4 and its natural ligand, ATP, are enriched in lysosomes of COS1 and HEK293 cells. By directly recording membrane currents from enlarged lysosomal vacuoles, we demonstrated that lysosomal P2X4 formed channels activated by ATP from the luminal side in a pH-dependent manner. While the acidic pH at the luminal side inhibited P2X4 activity, increasing the luminal pH in the presence of ATP caused P2X4 activation. We further showed that, as for the plasma membrane P2X4, the lysosomal P2X4 was potentiated by ivermectin but insensitive to suramin and PPADS, and it permeated the large cation N-methyl-D-glucamine upon activation. Our data suggest that P2X4 forms functional ATP-activated cation channels on lysosomal membranes regulated by luminal pH. Together with the reported fusion effect of intracellular P2X in lower organisms, we speculate that the lysosome-localized P2X4 may play specific roles in membrane trafficking of acidic organelles in mammalian cells.	[Huang, Peng; Zou, Yuanjie; Zhong, Xi Zoe; Cao, Qi; Zhao, Kexin; Dong, Xian-Ping] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Murrell-Lagnado, Ruth] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	Dalhousie University; University of Texas System; University of Texas Health Science Center Houston; University of Cambridge	Dong, XP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada.	xpdong@dal.ca		Dong, Xianping/0000-0002-4496-7104; Murrell-Lagnado, Ruth/0000-0003-2743-7977	National Institutes of Health R01 grant [GM081658]; Dept. of Physiology and Biophysics, Dalhousie University; DMRF Equipment Grant; DMRF new investigator award; CIHR [MOP-119349]; CIHR New Investigator award [201109MSH-261462-208625]; NSHRF Establishment Grant [MED-PRO-2011-7485]; CFI Leaders Opportunity Fund-Funding for Research Infrastructure [29291]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER	National Institutes of Health R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Physiology and Biophysics, Dalhousie University; DMRF Equipment Grant; DMRF new investigator award; CIHR(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator award(Canadian Institutes of Health Research (CIHR)); NSHRF Establishment Grant; CFI Leaders Opportunity Fund-Funding for Research Infrastructure; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by a National Institutes of Health R01 grant (GM081658, to M. X. Z.), by start-up funds (to X. D.) from the Dept. of Physiology and Biophysics, Dalhousie University, DMRF Equipment Grant, DMRF new investigator award, CIHR grant (MOP-119349), CIHR New Investigator award (201109MSH-261462-208625), NSHRF Establishment Grant (MED-PRO-2011-7485), and CFI Leaders Opportunity Fund-Funding for Research Infrastructure (29291).	Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chataigneau T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00273; Clarke CE, 2000, J PHYSIOL-LONDON, V523, P697, DOI 10.1111/j.1469-7793.2000.00697.x; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Holtzman E., 1989, CELLULAR ORGANELLES; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Miklavc P, 2011, P NATL ACAD SCI USA, V108, P14503, DOI 10.1073/pnas.1101039108; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Parkinson K, 2014, NAT CELL BIOL, V16, P87, DOI 10.1038/ncb2887; Patel S, 2011, CELL CALCIUM, V50, P109, DOI 10.1016/j.ceca.2011.03.009; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Sivaramakrishnan V, 2012, J BIOL CHEM, V287, P28315, DOI 10.1074/jbc.M112.372565; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Sumoza-Toledo A, 2011, FASEB J, V25, P3529, DOI 10.1096/fj.10-178483; Zalk R, 2006, FEBS LETT, V580, P5894, DOI 10.1016/j.febslet.2006.09.055; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	37	86	87	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17658	17667		10.1074/jbc.M114.552158	http://dx.doi.org/10.1074/jbc.M114.552158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24817123	hybrid, Green Published			2022-12-28	WOS:000338018100030
J	Scopelliti, AJ; Heinzelmann, G; Kuyucak, S; Ryan, RM; Vandenberg, RJ				Scopelliti, Amanda J.; Heinzelmann, Germano; Kuyucak, Serdar; Ryan, Renae M.; Vandenberg, Robert J.			Na+ Interactions with the Neutral Amino Acid Transporter ASCT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUTAMATE TRANSPORTER; EXTRACELLULAR GATE; ION-BINDING; SUBSTRATE; RESIDUE; CLONING; EXPRESSION; MECHANISM; EXCHANGER; CYSTEINE	The alanine, serine, cysteine transporters (ASCTs) belong to the solute carrier family 1A (SLC1A), which also includes the excitatory amino acid transporters (EAATs) and the prokaryotic aspartate transporter Glt(Ph). Acidic amino acid transport by the EAATs is coupled to the co-transport of three Na+ ions and one proton, and the counter-transport of one K+ ion. In contrast, neutral amino acid exchange by the ASCTs does not require protons or the counter-transport of K+ ions and the number of Na+ ions required is not well established. One property common to SLC1A family members is a substrate-activated anion conductance. We have investigated the number and location of Na+ ions required by ASCT1 by mutating residues in ASCT1 that correspond to residues in the EAATs and GltPh that are involved in Na+ binding. Mutations to all three proposed Na+ sites influence the binding of substrate and/or Na+, or the rate of substrate exchange. A G422S mutation near the Na2 site reduced Na+ affinity, without affecting the rate of exchange. D467T and D467A mutations in the Na1 site reduce Na+ and substrate affinity and also the rate of substrate exchange. T124A and D380A mutations in the Na3 site selectively reduce the affinity for Na+ and the rate of substrate exchange without affecting substrate affinity. In many of the mutants that reduce the rate of substrate transport the amplitudes of the substrate-activated anion conductances are not substantially affected indicating altered ion dependence for channel activation compared with substrate exchange.	[Scopelliti, Amanda J.; Ryan, Renae M.; Vandenberg, Robert J.] Univ Sydney, Discipline Pharmacol, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia; [Heinzelmann, Germano; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Vandenberg, RJ (corresponding author), Univ Sydney, Discipline Pharmacol, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia.	robert.vandenberg@sydney.edu.au	Vandenberg, Robert John/E-6018-2016; Ryan, Renae/AAC-3540-2021; Kuyucak, Serdar/AAH-8417-2021; Heinzelmann, Germano/C-3460-2016	Vandenberg, Robert John/0000-0003-1523-4814; Ryan, Renae/0000-0002-8680-4610; Heinzelmann, Germano/0000-0001-7168-6941; Kuyucak, Serdar/0000-0003-4315-9532	National Health and Medical Research Council of Australia [APP1048784]; University of Sydney; John Lamberton Scholarship; National Health and Medical Research Council [571093]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); John Lamberton Scholarship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant APP1048784.; Supported by a University of Sydney Postgraduate Award and a John Lamberton Scholarship.; Supported by National Health and Medical Research Council Career Development Fellowship 571093.	ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Broer A, 2000, BIOCHEM J, V346, P705, DOI 10.1042/0264-6021:3460705; Broer A, 1999, J NEUROCHEM, V73, P2184; CHRISTENSEN HN, 1967, J BIOL CHEM, V242, P5237; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grewer C, 2004, J PHYSIOL-LONDON, V557, P747, DOI 10.1113/jphysiol.2004.062521; Heinzelmann G, 2011, BIOPHYS J, V101, P2380, DOI 10.1016/j.bpj.2011.10.010; Huang S, 2009, J BIOL CHEM, V284, P4510, DOI 10.1074/jbc.M808495200; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Mwaura J, 2012, ACS CHEM NEUROSCI, V3, P1073, DOI 10.1021/cn300163p; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poulsen MV, 2001, J PHYSIOL-LONDON, V534, P159, DOI 10.1111/j.1469-7793.2001.00159.x; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; Shigeri Y, 2001, J NEUROCHEM, V79, P297, DOI 10.1046/j.1471-4159.2001.00588.x; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zander CB, 2013, J GEN PHYSIOL, V141, P659, DOI 10.1085/jgp.201210948; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710	42	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17468	17479		10.1074/jbc.M114.565242	http://dx.doi.org/10.1074/jbc.M114.565242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24808181	hybrid, Green Published			2022-12-28	WOS:000338018100015
J	Gupta, M; Qi, XJ; Thakur, V; Manor, D				Gupta, Meghana; Qi, Xiaojun; Thakur, Varsha; Manor, Danny			Tyrosine Phosphorylation of Dbl Regulates GTPase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; PLECKSTRIN HOMOLOGY DOMAIN; MEDIATE TRANSFORMATION; DEPENDENT ACTIVATION; ONCOGENE PRODUCT; FAMILY PROTEINS; RHO GTPASES; PROTO-DBL; CDC42; RAS	Rho GTPases are molecular "switches" that cycle between "on" (GTP-bound) and "off" (GDP-bound) states and regulate numerous cellular activities such as gene expression, protein synthesis, cytoskeletal rearrangements, and metabolic responses. Dysregulation of GTPases is a key feature of many diseases, especially cancers. Guanine nucleotide exchange factors (GEFs) of the Dbl family are activated by mitogenic cell surface receptors and activate the Rho family GTPases Cdc42, Rac1, and RhoA. The molecular mechanisms that regulate GEFs from the Dbl family are poorly understood. Our studies reveal that Dbl is phosphorylated on tyrosine residues upon stimulation by growth factors and that this event is critical for the regulated activation of the GEF. These findings uncover a novel layer of complexity in the physiological regulation of this protein.	[Gupta, Meghana; Manor, Danny] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Gupta, Meghana; Qi, Xiaojun; Thakur, Varsha; Manor, Danny] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, WG 48, Cleveland, OH 44106 USA.	dxm178@case.edu			National Institutes of Health [CA082391]; NATIONAL CANCER INSTITUTE [R55CA082391, R01CA082391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Award CA082391 from the National Institutes of Health.	BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Blajecka K., PLOS ONE, V7; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Colucci-D'Amato G L, 1990, J Neurosurg Sci, V34, P187; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Fields A. P., ADV ENZYME REGUL, V50, P190; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; HART MJ, 1994, J BIOL CHEM, V269, P62; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; Hynes NE, 2011, MOL CELL, V41, P5, DOI 10.1016/j.molcel.2010.12.024; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Ishikawa K, 2006, NEUROPATHOLOGY, V26, P352, DOI 10.1111/j.1440-1789.2006.00719.x; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Katzav S, 2009, INT J BIOCHEM CELL B, V41, P1245, DOI 10.1016/j.biocel.2008.11.006; Kauppinen KP, 2005, J BIOL CHEM, V280, P21638, DOI 10.1074/jbc.M413984200; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; LEONARD DA, 1994, BIOCHEMISTRY-US, V33, P12323, DOI 10.1021/bi00206a040; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Minard ME, 2005, ONCOGENE, V24, P2568, DOI 10.1038/sj.onc.1208503; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; NAVARRO S, 1993, DIAGN MOL PATHOL, V2, P158, DOI 10.1097/00019606-199300020-00025; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PASTERIS NG, 1994, CELL, V79, P669; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, COLD SPRING HARB SYM, V57, P661, DOI 10.1101/SQB.1992.057.01.072; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; RON D, 1991, NEW BIOL, V3, P372; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; SRIVASTAVA SK, 1986, P NATL ACAD SCI USA, V83, P8868, DOI 10.1073/pnas.83.23.8868; Suzuki N, 2009, J BIOL CHEM, V284, P5000, DOI 10.1074/jbc.M804073200; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Vanni C, 2004, ONCOGENE, V23, P4098, DOI 10.1038/sj.onc.1207509; VECCHIO G, 1989, ONCOGENE, V4, P897; VELASCO JA, 1995, ONCOGENE, V10, P2253; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Wu WJ, 1997, J BIOL CHEM, V272, P26153, DOI 10.1074/jbc.272.42.26153; Yohe ME, 2008, BIOCHEMISTRY-US, V47, P6827, DOI 10.1021/bi702543p; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zheng Y, 1996, J BIOL CHEM, V271, P19017, DOI 10.1074/jbc.271.32.19017	60	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17195	17202		10.1074/jbc.M114.573782	http://dx.doi.org/10.1074/jbc.M114.573782			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24778185	Green Published, hybrid			2022-12-28	WOS:000338016200052
J	Malhotra, P; Soni, V; Kumar, A; Anbazhagan, AN; Dudeja, A; Saksena, S; Gill, RK; Dudeja, PK; Alrefai, WA				Malhotra, Pooja; Soni, Vinay; Kumar, Anoop; Anbazhagan, Arivarasu N.; Dudeja, Amish; Saksena, Seema; Gill, Ravinder K.; Dudeja, Pradeep K.; Alrefai, Waddah A.			Epigenetic Modulation of Intestinal Cholesterol Transporter Niemann-Pick C1-like 1 (NPC1L1) Gene Expression by DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SMALL-INTESTINE; HUMAN CANCER-CELLS; ABSORPTION; REVEALS; DIETARY; PROTEIN; DNMT1; GATA4; MICE	Intestinal NPC1L1 transporter is essential for cholesterol absorption and the maintenance of cholesterol homeostasis in the body. NPC1L1 is differentially expressed along the gastrointestinal tract with very low levels in the colon as compared with the small intestine. This study was undertaken to examine whether DNA methylation was responsible for segment-specific expression of NPC1L1. Treatment of mice with 5-azacytidine (i.p.) resulted in a significant dose-dependent increase in NPC1L1 mRNA expression in the colon. The lack of expression of NPC1L1 in the normal colon was associated with high levels of methylation in the area flanking the 3-kb fragment upstream of the initiation site of the mouse NPC1L1 gene in mouse colon as analyzed by EpiTYPER (R) Mass-ARRAY (R). The high level of methylation in the colon was observed in specific CpG dinucleotides and was significantly decreased in response to 5-azacytidine. Similar to mouse NPC1L1, 5-azacytidine treatment also increased the level of human NPC1L1 mRNA expression in the intestinal HuTu-80 cell line in a dose-and time-dependent manner. Silencing the expression of DNA methyltransferase DNMT1, -2, -3A, and -3B alone by siRNA did not affect NPC1L1 expression in HuTu-80 cells. However, the simultaneous attenuation of DNMT1 and -3B expression caused a significant increase in NPC1L1 mRNA expression as compared with control. Also, in vitro methylation of the human NPC1L1 promoter significantly decreased NPC1L1 promoter activity in human intestinal Caco2 cells. In conclusion, our data demonstrated for the first time that DNA methylation in the promoter region of the NPC1L1 gene appears to be a major mechanism underlying differential expression of NPC1L1 along the length of the gastrointestinal tract.	[Dudeja, Pradeep K.; Alrefai, Waddah A.] Univ Illinois, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Malhotra, Pooja; Soni, Vinay; Kumar, Anoop; Anbazhagan, Arivarasu N.; Dudeja, Amish; Saksena, Seema; Gill, Ravinder K.; Dudeja, Pradeep K.; Alrefai, Waddah A.] Univ Illinois, Div Gastroenterol & Hepatol, Dept Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alrefai, WA (corresponding author), Univ Illinois, Jesse Brown VA Med Ctr, Med Res Serv 600 151, 820 South Damen Ave, Chicago, IL 60612 USA.	walrefai@uic.edu		Gill, Ravinder/0000-0002-5337-2567	National Institutes of Health from NIDDK [DK54016, DK81858, DK92441, DK96258, DK96245, DK71596]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081858, R56DK071596, R03DK096258, R21DK096254, R01DK092441, R01DK071596, R01DK054016] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000152] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK54016, DK81858, and DK92441 (to P. K. D.), DK96258 (to R. K. G.), DK96245 (to S. S.), and DK71596 (to W. A. A.) from NIDDK. This work was also supported by the Department of Veterans Affairs (to W. A. A. and P. K. D.).	Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V292, pG369, DOI 10.1152/ajpgi.00306.2006; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Berger J, 2007, MOL CELL BIOL, V27, P4049, DOI 10.1128/MCB.02023-06; Beuling E, 2010, GUT, V59, P888, DOI 10.1136/gut.2009.204990; Bird LM, 2011, AM J MED GENET A, V155A, P2956, DOI 10.1002/ajmg.a.34297; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2007, ARTERIOSCL THROM VAS, V27, P841, DOI 10.1161/01.ATV.0000257627.40486.46; Engelking LJ, 2012, J LIPID RES, V53, P1359, DOI 10.1194/jlr.M027599; Fernandez A. Z., INT J VASC MED, DOI [10.1155/2010/437809, DOI 10.1155/2010/437809]; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Iwayanagi Y, 2008, PHARM RES, V25, P1134, DOI 10.1007/s11095-007-9496-9; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lally S, 2006, DIABETOLOGIA, V49, P1008, DOI 10.1007/s00125-006-0177-8; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Saetrom P, 2007, PEDIATR RES, V61, p17R, DOI 10.1203/pdr.0b013e318045760e; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Ting AH, 2006, CANCER RES, V66, P729, DOI 10.1158/0008-5472.CAN-05-1537; van der Wulp MYM, 2013, MOL CELL ENDOCRINOL, V368, P1, DOI 10.1016/j.mce.2012.06.007; Wang LJ, 2012, BBA-MOL CELL BIOL L, V1821, P964, DOI 10.1016/j.bbalip.2012.03.004; WILSON MD, 1994, J LIPID RES, V35, P943; Wong WK, 2003, J BIOL CHEM, V278, P36227, DOI 10.1074/jbc.M305549200; Xie C, 2012, J LIPID RES, V53, P2092, DOI 10.1194/jlr.M027359; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Zhang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-155	32	18	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23132	23140		10.1074/jbc.M113.546283	http://dx.doi.org/10.1074/jbc.M113.546283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24904062	Green Published, hybrid			2022-12-28	WOS:000341017200050
J	Strader, MB; Hicks, WA; Kassa, T; Singleton, E; Soman, J; Olson, JS; Weiss, MJ; Mollan, TL; Wilson, MT; Alayash, AI				Strader, Michael Brad; Hicks, Wayne A.; Kassa, Tigist; Singleton, Eileen; Soman, Jayashree; Olson, John S.; Weiss, Mitchell J.; Mollan, Todd L.; Wilson, Michael T.; Alayash, Abdu I.			Post-translational Transformation of Methionine to Aspartate Is Catalyzed by Heme Iron and Driven by Peroxide A NOVEL SUBUNIT-SPECIFIC MECHANISM IN HEMOGLOBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUMMERER REARRANGEMENT; INTRAMOLECULAR CAPTURE; OXIDATION REACTIONS; HB-BRISTOL; BINDING; PROTEINS; ADULT; ALPHA; MYOGLOBIN; ANEMIA	A pathogenic V67M mutation occurs at the E11 helical position within the heme pockets of variant human fetal and adult hemoglobins (Hb). Subsequent post-translational modification of Met to Asp was reported in gamma subunits of human fetal Hb Toms River (gamma 67(E11) Val -> Met) and beta subunits of adult Hb (HbA) Bristol-Alesha (beta 67(E11) Val -> Met) that were associated with hemolytic anemia. Using kinetic, proteomic, and crystal structural analysis, we were able to show that the Met -> Asp transformation involves heme cycling through its oxoferryl state in the recombinant versions of both proteins. The conversion to Met and Asp enhanced the spontaneous autoxidation of the mutants relative to wild-type HbA and human fetal Hb, and the levels of Asp were elevated with increasing levels of hydrogen peroxide (H2O2). Using H-2 O-18(2), we verified incorporation of (18)Ointo the Asp carboxyl side chain confirming the role ofH(2)O(2) in the oxidation of the Met side chain. Under similar experimental conditions, there was no conversion to Asp at the alpha Met(E11) position in the correspondingHbAEvans (alpha 62(E11) Val -> Met). The crystal structures of the three recombinant Met(E11) mutants revealed similar thioether side chain orientations. However, asinthesolutionexperiments, autoxidationof theHbmutantcrystals leads to electron density maps indicative of Asp(E11) formation in beta subunits but not in alpha subunits. This novel post-translational modification highlights the nonequivalence of human Hb alpha, beta, and gamma subunits with respect to redox reactivity and may have direct implications to alpha/beta hemoglobinopathies and design of oxidatively stable Hb-based oxygen therapeutics.	[Mollan, Todd L.; Alayash, Abdu I.] US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Singleton, Eileen; Soman, Jayashree; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Weiss, Mitchell J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Wilson, Michael T.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	US Food & Drug Administration (FDA); Rice University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Essex	Alayash, AI (corresponding author), US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	abdu.alayash@fda.hhs.gov	Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403	National Institutes of Health from NHLBI [P01-HL110900]; Welch Grant [C-0612]; United States Food and Drug Administration [MODSCI 2012, P30 DK090969, R01 DK61692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900, U01HL099993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061692, P30DK090969, R01DK061692] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Welch Grant; United States Food and Drug Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL110900 from NHLBI (to A. I. A. and J. S. O.). This work was also supported by Welch Grant C-0612 (to J. S. O.) and United States Food and Drug Administration Grants MODSCI 2012 (to A. I. A.), P30 DK090969 (to M. J. W.), and R01 DK61692 (to M. J. W.).	Aebi H, 1984, Methods Enzymol, V105, P121; BANERJEE R, 1969, BIOCHEMISTRY-US, V8, P2862, DOI 10.1021/bi00835a025; BATES DK, 1986, J HETEROCYCLIC CHEM, V23, P695, DOI 10.1002/jhet.5570230311; BATES DK, 1992, J ORG CHEM, V57, P3094, DOI 10.1021/jo00037a027; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; Birukou I, 2011, J BIOL CHEM, V286, P10515, DOI 10.1074/jbc.M110.176271; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Bonaventura C, 2013, ANTIOXID REDOX SIGN, V18, P2298, DOI 10.1089/ars.2012.4947; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Buehler P.W., 2007, TRANSFUS ALTERN TRAN, V9, P204, DOI DOI 10.1111/j.1778-428X.2007.00081.x; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Butt OI, 2011, AM J PATHOL, V178, P1316, DOI 10.1016/j.ajpath.2010.12.006; Cooper CE, 2005, DALTON T, P3483, DOI 10.1039/b505786h; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Crowley MA, 2011, NEW ENGL J MED, V364, P1837, DOI 10.1056/NEJMoa1013579; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Guengerich FP, 2007, J BIOCHEM MOL TOXIC, V21, P163, DOI 10.1002/jbt.20174; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Hersleth HP, 2002, J BIOL INORG CHEM, V7, P299, DOI 10.1007/s007750100296; Jia YP, 2004, BBA-GEN SUBJECTS, V1672, P164, DOI 10.1016/j.bbagen.2004.03.009; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; Kowalik-Jankowska T, 2006, J INORG BIOCHEM, V100, P1623, DOI 10.1016/j.jinorgbio.2006.05.010; LEVINE RL, 1983, J BIOL CHEM, V258, P1828; Miyazaki A, 1996, J MASS SPECTROM, V31, P1311, DOI 10.1002/(SICI)1096-9888(199611)31:11<1311::AID-JMS427>3.0.CO;2-1; MOLCHANOVA TP, 1993, HEMOGLOBIN, V17, P217, DOI 10.3109/03630269308998896; Mollan TL, 2013, J BIOL CHEM, V288, P4288, DOI 10.1074/jbc.M112.412064; OHBA Y, 1985, HEMOGLOBIN, V9, P79, DOI 10.3109/03630268508996986; Reeder BJ, 2012, J AM CHEM SOC, V134, P7741, DOI 10.1021/ja211745g; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; Rees DC, 1996, BLOOD, V88, P341; REISBERG PI, 1980, J BIOL CHEM, V255, P4151; SAKURAGAWA M, 1984, ACTA HAEMATOL JAPON, V47, P896; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Slotta DJ, 2010, PROTEOMICS, V10, P3035, DOI 10.1002/pmic.200900370; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; STEADMAN JH, 1970, BRIT J HAEMATOL, V18, P435, DOI 10.1111/j.1365-2141.1970.tb01457.x; Thom CS, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011858; WIEDERMANN BL, 1975, J BIOL CHEM, V250, P5273; WILSON JB, 1989, HEMOGLOBIN, V13, P557, DOI 10.3109/03630268908993106; Yi J, 2011, ACTA CRYSTALLOGR F, V67, P647, DOI 10.1107/S1744309111012528; Zanotto MI, 2010, ARCH ARGENT PEDIATR, V108, pE130, DOI 10.1590/S0325-00752010000600015; Zurbriggen K, 2005, CLIN CHEM, V51, P989, DOI 10.1373/clinchem.2005.047985	48	24	25	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22342	22357		10.1074/jbc.M114.568980	http://dx.doi.org/10.1074/jbc.M114.568980			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24939847	Green Published, hybrid			2022-12-28	WOS:000340593500045
J	Maehama, T; Kawahara, K; Nishio, M; Suzuki, A; Hanada, K				Maehama, Tomohiko; Kawahara, Kohichi; Nishio, Miki; Suzuki, Akira; Hanada, Kentaro			Nucleolar Stress Induces Ubiquitination-independent Proteasomal Degradation of PICT1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR CANDIDATE; C-MYC; RIBOSOME BIOGENESIS; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; P53 ACTIVATION; GENE-PRODUCT; IN-VIVO; L11; PREDICTION; STABILITY	The nucleolar protein PICT1 regulates tumor suppressor p53 by tethering ribosomal protein L11 within the nucleolus to repress the binding of L11 to the E3 ligase MDM2. PICT1 depletion results in the release of L11 to the nucleoplasm to inhibit MDM2, leading to p53 activation. Here, we demonstrate that nucleolar stress induces proteasome-mediated degradation of PICT1 in a ubiquitin-independent manner. Treatment of H1299 cells with nucleolar stress inducers, such as actinomycin D, 5-fluorouridine, or doxorubicin, induced the degradation of PICT1 protein. The proteasome inhibitors MG132, lactacystin, and epoxomicin blocked PICT1 degradation, whereas the inhibition of E1 ubiquitin-activating enzyme by a specific inhibitor and genetic inactivation fail to repress PICT1 degradation. In addition, the 20 S proteasome was able to degrade purified PICT1 protein in vitro. We also found a PICT1 mutant showing nucleoplasmic localization did not undergo nucleolar stress-induced degradation, although the same mutant underwent in vitro degradation by the 20 S proteasome, suggesting that nucleolar localization is indispensable for the stress-induced PICT1 degradation. These results suggest that PICT1 employs atypical proteasome-mediated degradation machinery to sense nucleolar stress within the nucleolus.	[Maehama, Tomohiko; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo 1628640, Japan; [Kawahara, Kohichi; Nishio, Miki; Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Fukuoka 8128582, Japan	National Institute of Infectious Diseases (NIID); Kyushu University	Maehama, T (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	tmaehama@niid.go.jp	Maehama, Tomohiko/HGB-4896-2022; Kawahara, Kohichi/AAQ-5381-2021; Maehama, Tomohiko/AAX-8926-2020; Suzuki, Akira/GYD-6697-2022	Maehama, Tomohiko/0000-0002-9685-2317; Suzuki, Akira/0000-0002-5950-8808; Hanada, Kentaro/0000-0003-1383-2781	Ministry of Education, Culture, Sports, and Technology of Japan; Grants-in-Aid for Scientific Research [23592132] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (KAKENHI) from the Ministry of Education, Culture, Sports, and Technology of Japan.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Bursac S, 2012, P NATL ACAD SCI USA, V109, P20467, DOI 10.1073/pnas.1218535109; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2010, J BIOL CHEM, V285, P12587, DOI 10.1074/jbc.M109.056259; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Donati G, 2013, CELL REP, V4, P87, DOI 10.1016/j.celrep.2013.05.045; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Gautam AKS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034864; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalt I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030825; Kalt I, 2010, J VIROL, V84, P2935, DOI 10.1128/JVI.00757-09; Lee S, 2012, CELL DEATH DIFFER, V19, P1613, DOI 10.1038/cdd.2012.40; Lo D, 2012, J BIOL CHEM, V287, P10013, DOI 10.1074/jbc.M111.335141; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Okahara F, 2005, ANAL BIOCHEM, V336, P138, DOI 10.1016/j.ab.2004.09.018; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Pena MMO, 2009, J BIOL CHEM, V284, P31597, DOI 10.1074/jbc.M109.038455; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	47	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20802	20812		10.1074/jbc.M114.571893	http://dx.doi.org/10.1074/jbc.M114.571893			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923447	hybrid, Green Published			2022-12-28	WOS:000339396600035
J	Padilla-Benavides, T; Thompson, AMG; McEvoy, MM; Arguello, JM				Padilla-Benavides, Teresita; Thompson, Alayna M. George; McEvoy, Megan M.; Argueello, Jose M.			Mechanism of ATPase-mediated Cu+ Export and Delivery to Periplasmic Chaperones THE INTERACTION OF ESCHERICHIA COLI CopA AND CusF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER HOMEOSTASIS; FUNCTIONAL ROLES; TRANSPORT; EFFLUX; METALLOCHAPERONES; REQUIREMENT; DIVERSITY; DOCKING	Cellular copper homeostasis requires transmembrane transport and compartmental trafficking while maintaining the cell essentially free of uncomplexed Cu2+/+. In bacteria, soluble cytoplasmic and periplasmic chaperones bind and deliver Cu+ to target transporters or metalloenzymes. Transmembrane Cu+-ATPases couple the hydrolysis of ATP to the efflux of cytoplasmic Cu+. Cytosolic Cu+ chaperones (CopZ) interact with a structural platform in Cu+-ATPases (CopA) and deliver copper into the ion permeation path. CusF is a periplasmic Cu+ chaperone that supplies Cu+ to the CusCBA system for efflux to the extracellular milieu. In this report, using Escherichia coli CopA and CusF, direct Cu+ transfer from the ATPase to the periplasmic chaperone was observed. This required the specific interaction of the Cu+-bound form of CopA with apo-CusF for subsequent metal transfer upon ATP hydrolysis. As expected, the reverse Cu+ transfer from CusF to CopA was not observed. Mutation of CopA extracellular loops or the electropositive surface of CusF led to a decrease in Cu+ transfer efficiency. On the other hand, mutation of Met and Glu residues proposed to be part of the metal exit site in the ATPase yielded enzymes with lower turnover rates, although Cu+ transfer was minimally affected. These results show how soluble chaperones obtain Cu+ from transmembrane transporters. Furthermore, by explaining the movement of Cu+ from the cytoplasmic pool to the extracellular milieu, these data support a mechanism by which cytoplasmic Cu+ can be precisely directed to periplasmic targets via specific transporter-chaperone interactions.	[Padilla-Benavides, Teresita; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Thompson, Alayna M. George; McEvoy, Megan M.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	Worcester Polytechnic Institute; University of Arizona	McEvoy, MM (corresponding author), Univ Arizona, Dept Chem & Biochem, 1041 E Lowell St, Tucson, AZ 85721 USA.	mcevoy@arizona.edu; arguello@wpi.edu	Padilla-Benavides, Teresita/K-1968-2012; Arguello, Jose/D-1997-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822; Arguello, Jose/0000-0003-3940-6297	National Institutes of Health [GM079192, T32 GM008659]; National Science Foundation [MCB-0743901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079192, T32GM008659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079192 (to M. M. M.) and T32 GM008659 (for support of A. M. G. T.). This work was supported by the National Science Foundation Grant MCB-0743901 (to J. M. A.).	Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Banci L, 2010, NAT PROD REP, V27, P695, DOI 10.1039/b906678k; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Gonzalez-Guerrero M, 2009, J BIOL CHEM, V284, P20804, DOI 10.1074/jbc.M109.016329; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Hernandez-Montes G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-249; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim EH, 2011, J BACTERIOL, V193, P2381, DOI 10.1128/JB.01323-10; Kim EH, 2010, NAT PROD REP, V27, P711, DOI 10.1039/b906681k; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Loftin IR, 2005, BIOCHEMISTRY-US, V44, P10533, DOI 10.1021/bi050827b; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; Mealman TD, 2011, BIOCHEMISTRY-US, V50, P2559, DOI 10.1021/bi102012j; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Otoikhian A, 2012, J AM CHEM SOC, V134, P10458, DOI 10.1021/ja301221s; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Patel SJ, 2014, MICROBIOL-SGM, V160, P1237, DOI 10.1099/mic.0.079137-0; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Raimunda D, 2012, MOL MICROBIOL, V84, P1139, DOI 10.1111/j.1365-2958.2012.08082.x; Raimunda D, 2011, BIOMETALS, V24, P467, DOI 10.1007/s10534-010-9404-3; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Rensing C, 2013, METAL IONS LIFE SCI, V12, P417, DOI 10.1007/978-94-007-5561-1_12; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635	46	49	50	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20492	20501		10.1074/jbc.M114.577668	http://dx.doi.org/10.1074/jbc.M114.577668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917681	hybrid, Green Published			2022-12-28	WOS:000339396600011
J	Zach, L; Braunstein, I; Stanhill, A				Zach, Lolita; Braunstein, Ilana; Stanhill, Ariel			Stress-induced Start Codon Fidelity Regulates Arsenite-inducible Regulatory Particle-associated Protein (AIRAP) Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							40S RIBOSOMAL-SUBUNIT; INITIATION-FACTORS; MODULATES AUTOREGULATION; MESSENGER-RNAS; SITE SELECTION; EIF1; PHOSPHORYLATION; COMPLEX; GENE; REINITIATION	Initial steps in protein synthesis are highly regulated processes as they define the reading frame of the translation machinery. Eukaryotic translation initiation is a process facilitated by numerous factors (eIFs), aimed to form a "scanning" mechanism toward the initiation codon. Translation initiation of the main open reading frame (ORF) in an mRNA transcript has been reported to be regulated by upstream open reading frames (uORFs) in a manner of re-initiation. This mode of regulation is governed by the phosphorylation status of eIF2 alpha and controlled by cellular stresses. Another mode of translational initiation regulation is leaky scanning, and this regulatory process has not been extensively studied. We have identified arsenite-inducible regulatory particle-associated protein (AIRAP) transcript to be translationally induced during arsenite stress conditions. AIRAP transcript contains a single uORF in a poor-kozak context. AIRAP translation induction is governed by means of leaky scanning and not re-initiation. This induction of AIRAP is solely dependent on eIF1 and the uORF kozak context. We show that eIF1 is phosphorylated under specific conditions that induce protein misfolding and have biochemically characterized this site of phosphorylation. Our data indicate that leaky scanning like re-initiation is responsive to stress conditions and that leaky scanning can induce ORF translation by bypassing poor kozak context of a single uORF transcript.	[Zach, Lolita; Braunstein, Ilana; Stanhill, Ariel] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Stanhill, A (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel.	stanhill@tx.technion.ac.il		stanhill, ariel/0000-0002-0318-2212	John Hopkins-Technion grant foundation; Israeli Science Foundation [168/12]	John Hopkins-Technion grant foundation; Israeli Science Foundation(Israel Science Foundation)	This work was supported by the John Hopkins-Technion grant foundation and the Israeli Science Foundation Grant 168/12.	Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Chaudhuri J, 1999, J BIOL CHEM, V274, P17975, DOI 10.1074/jbc.274.25.17975; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Elfakess R, 2011, NUCLEIC ACIDS RES, V39, P7598, DOI 10.1093/nar/gkr484; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Glinka Tal, 2014, Biochem J, V457, P253, DOI 10.1042/BJ20130710; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Martin-Marcos P, 2013, J BIOL CHEM, V288, P27546, DOI 10.1074/jbc.M113.498642; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Sok J, 2001, CELL STRESS CHAPERON, V6, P6, DOI 10.1379/1466-1268(2001)006<0006:AIRAPA>2.0.CO;2; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; ZITOMER RS, 1984, MOL CELL BIOL, V4, P1191, DOI 10.1128/MCB.4.7.1191	35	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20706	20716		10.1074/jbc.M114.547828	http://dx.doi.org/10.1074/jbc.M114.547828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898249	hybrid, Green Published			2022-12-28	WOS:000339396600028
J	Alhasan, AA; Spielhofer, J; Kusche-Gullberg, M; Kirby, JA; Ali, S				Alhasan, Abd A.; Spielhofer, Julia; Kusche-Gullberg, Marion; Kirby, John A.; Ali, Simi			Role of 6-O-Sulfated Heparan Sulfate in Chronic Renal Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; IN-VIVO; FGF; EXPRESSION; ANTIBODIES; BINDING; KIDNEY; CELLS; PROTEOGLYCANS; DOMAINS	Heparan sulfate (HS) plays a crucial role in the fibrosis associated with chronic allograft dysfunction by binding and presenting cytokines and growth factors to their receptors. These interactions critically depend on the distribution of 6-O-sulfated glucosamine residues, which is generated by glucosaminyl-6-O-sulfotransferases (HS6STs) and selectively removed by cell surface HS-6-O-endosulfatases (SULFs). Using human renal allografts we found increased expression of 6-O-sulfated HS domains in tubular epithelial cells during chronic rejection as compared with the controls. Stimulation of renal epithelial cells with TGF-beta induced SULF2 expression. To examine the role of 6-O-sulfated HS in the development of fibrosis, we generated stable HS6ST1 and SULF2 overexpressing renal epithelial cells. Compared with mock transfectants, the HS6ST1 transfectants showed significantly increased binding of FGF2 (p = 0.0086) and pERK activation. HS6ST1 transfectants displayed a relative increase in mono-6-O-sulfated disaccharides accompanied by a decrease in iduronic acid 2-O-sulfated disaccharide structures. In contrast, SULF2 transfectants showed significantly reduced FGF2 binding and phosphorylation of ERK. Structural analysis of HS showed about 40% down-regulation in 6-O-sulfation with a parallel increase in iduronic acid mono-2-O-sulfated disaccharides. To assess the relevance of these data in vivo we established a murine model of fibrosis (unilateral ureteric obstruction (UUO)). HS-specific phage display antibodies (HS3A8 and RB4EA12) showed significant increase in 6-O-sulfation in fibrotic kidney compared with the control. These results suggest an important role of 6-O-sulfation in the pathogenesis of fibrosis associated with chronic rejection.	[Alhasan, Abd A.; Spielhofer, Julia; Kirby, John A.; Ali, Simi] Newcastle Univ, Appl Immunobiol & Transplantat Res Grp, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kusche-Gullberg, Marion] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	Newcastle University - UK; University of Bergen	Kirby, JA (corresponding author), Newcastle Univ, Appl Immunobiol & Transplantat Res Grp, Inst Cellular Med, Sch Med, 3rd Floor Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	john.kirby@ncl.ac.uk; simi.ali@newcastle.ac.uk	Kusche-Gullberg, Marion/P-4466-2016	Kusche-Gullberg, Marion/0000-0002-5636-1695; Kirby, John/0000-0003-2543-4131	Ministry of Higher Education, Syrian Arab Republic; Norwegian Cancer Society [3292722-2012]	Ministry of Higher Education, Syrian Arab Republic; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by a grant from the Ministry of Higher Education, Syrian Arab Republic (to A. A. A.) and by the Norwegian Cancer Society Grant 3292722-2012 (to M. K.-G.).	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ali S, 2003, TRANSPLANTATION, V75, P1773, DOI 10.1097/01.TP.0000065805.97974.93; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Celie JWAM, 2012, KIDNEY INT, V81, P651, DOI 10.1038/ki.2011.425; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Do AT, 2006, J BIOL CHEM, V281, P5348, DOI 10.1074/jbc.M509584200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; Feyzi E, 1997, J BIOL CHEM, V272, P5518, DOI 10.1074/jbc.272.9.5518; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Habuchi H, 2003, BIOCHEM J, V371, P131, DOI 10.1042/BJ20021259; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Joosten SA, 2002, AM J PATHOL, V160, P1301, DOI 10.1016/S0002-9440(10)62557-6; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LYON M, 1994, J BIOL CHEM, V269, P11216; Masola V, 2012, J BIOL CHEM, V287, P1478, DOI 10.1074/jbc.M111.279836; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Robertson H, 2004, J AM SOC NEPHROL, V15, P390, DOI 10.1097/01.ASN.0000108521.39082.E1; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tatrai P, 2010, J HISTOCHEM CYTOCHEM, V58, P429, DOI 10.1369/jhc.2010.955161; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; vandenBorn J, 1996, J BIOL CHEM, V271, P22802, DOI 10.1074/jbc.271.37.22802; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wong WK, 2003, TRANSPLANTATION, V75, P505, DOI 10.1097/01.TP.0000045708.39879.C7; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	44	20	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20295	20306		10.1074/jbc.M114.554691	http://dx.doi.org/10.1074/jbc.M114.554691			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24878958	Green Published, hybrid			2022-12-28	WOS:000339395200041
J	Chang, FMJ; Coyne, HJ; Cubillas, C; Vinuesa, P; Fang, XY; Ma, Z; Ma, DJ; Helmann, JD; Garcia-de los Santos, A; Wang, YX; Dann, CE; Giedroc, DP				Chang, Feng-Ming James; Coyne, H. Jerome; Cubillas, Ciro; Vinuesa, Pablo; Fang, Xianyang; Ma, Zhen; Ma, Dejian; Helmann, John D.; Garcia-de los Santos, Alejandro; Wang, Yun-Xing; Dann, Charles E., III; Giedroc, David P.			Cu(I)-mediated Allosteric Switching in a Copper-sensing Operon Repressor (CsoR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; ESCHERICHIA-COLI RCNR; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-SUBTILIS; LISTERIA-MONOCYTOGENES; STREPTOMYCES-LIVIDANS; STAPHYLOCOCCUS-AUREUS; PROTEIN; HOMEOSTASIS; RESISTANCE	The copper-sensing operon repressor (CsoR) is representative of a major Cu(I)-sensing family of bacterial metalloregulatory proteins that has evolved to prevent cytoplasmic copper toxicity. It is unknown how Cu(I) binding to tetrameric CsoRs mediates transcriptional derepression of copper resistance genes. A phylogenetic analysis of 227 DUF156 protein members, including biochemically or structurally characterized CsoR/RcnR repressors, reveals that Geobacillus thermodenitrificans (Gt) CsoR characterized here is representative of CsoRs from pathogenic bacilli Listeria monocytogenes and Bacillus anthracis. The 2.56 structure of Cu(I)-bound Gt CsoR reveals that Cu(I) binding induces a kink in the alpha 2-helix between two conserved copper-ligating residues and folds an N-terminal tail (residues 12-19) over the Cu(I) binding site. NMR studies of Gt CsoR reveal that this tail is flexible in the apo-state with these dynamics quenched upon Cu(I) binding. Small angle x-ray scattering experiments on an N-terminally truncated Gt CsoR (Delta 2-10) reveal that the Cu(I)-bound tetramer is hydrodynamically more compact than is the apo-state. The implications of these findings for the allosteric mechanisms of other CsoR/RcnR repressors are discussed.	[Chang, Feng-Ming James; Coyne, H. Jerome; Ma, Dejian; Dann, Charles E., III; Giedroc, David P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Cubillas, Ciro; Vinuesa, Pablo; Garcia-de los Santos, Alejandro] Univ Nacl Autonoma Mexico, Programa Ingn Genom, Ctr Ciencias Genom, Cuernavaca 04510, Morelos, Mexico; [Fang, Xianyang; Wang, Yun-Xing] NCI, Struct Biophys Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Ma, Zhen; Helmann, John D.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Indiana University System; Indiana University Bloomington; Universidad Nacional Autonoma de Mexico; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University	Giedroc, DP (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	giedroc@indiana.edu	Santos, Alejandro García-de los/AAQ-1047-2020; Giedroc, David/A-8608-2018; Vinuesa, Pablo/AAJ-1851-2020; Dann, Charles E/C-2747-2018	Giedroc, David/0000-0002-2342-1620; Vinuesa, Pablo/0000-0001-6119-2956; Fang, Xianyang/0000-0001-9432-9736; Cubillas, Ciro/0000-0002-2238-8048	National Institutes of Health [GM042569]; Consejo Nacional de Ciencia y Tecnologia (Mexico) [CVU 269108]; Ciencia Basica Grant [179133]; Universidad Nacional Autonoma de Mexico/PAPIIT (Programa de Apoyo a Projectos de Investigacion e Innovacion Tecnologica) [IN201112]; Lilly Endowment, Inc.; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, 22978]; NATIONAL CANCER INSTITUTE [ZICBC011535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042569, R29GM042569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ciencia Basica Grant; Universidad Nacional Autonoma de Mexico/PAPIIT (Programa de Apoyo a Projectos de Investigacion e Innovacion Tecnologica); Lilly Endowment, Inc.; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM042569 (to D. P. G.). This work was also supported by Consejo Nacional de Ciencia y Tecnologia (Mexico) Ph.D. Scholarship CVU 269108 (to C. C.), Ciencia Basica Grant 179133 (to P. V.), and Universidad Nacional Autonoma de Mexico/PAPIIT (Programa de Apoyo a Projectos de Investigacion e Innovacion Tecnologica) Grant IN201112 (to A. G. S.). The NMR instrumentation at Indiana University was supported by the Indiana METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357 and under Partner User Proposal 22978.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; Chang FMJ, 2011, ANAL CHEM, V83, P9092, DOI 10.1021/ac202154r; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Coyne HJ, 2013, BIOMOL NMR ASSIGN, V7, P279, DOI 10.1007/s12104-012-9428-4; Cubillas C, 2013, METALLOMICS, V5, P1634, DOI 10.1039/c3mt00204g; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Dwarakanath S, 2012, J BIOL CHEM, V287, P17833, DOI 10.1074/jbc.M112.352740; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Foster AW, 2014, MOL MICROBIOL, V92, P797, DOI 10.1111/mmi.12594; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Francis MS, 1997, MICROB PATHOGENESIS, V22, P67, DOI 10.1006/mpat.1996.0092; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fu Y, 2013, NAT CHEM BIOL, V9, P177, DOI [10.1038/NCHEMBIO.1168, 10.1038/nchembio.1168]; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Higgins KA, 2014, CHEM LETT, V43, P20, DOI 10.1246/cl.130965; Higgins KA, 2013, BIOCHEMISTRY-US, V52, P84, DOI 10.1021/bi300886q; Higgins KA, 2012, J AM CHEM SOC, V134, P7081, DOI 10.1021/ja300834b; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Luebke JL, 2013, METALLOMICS, V5, P335, DOI 10.1039/c3mt20205d; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tan BG, 2014, NUCLEIC ACIDS RES, V42, P1326, DOI 10.1093/nar/gkt902; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; Zhu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017367	55	42	42	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19204	19217		10.1074/jbc.M114.556704	http://dx.doi.org/10.1074/jbc.M114.556704			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831014	hybrid, Green Published			2022-12-28	WOS:000339062900048
J	Jin, J; Colin, P; Staropoli, I; Lima-Fernandes, E; Ferret, C; Demir, A; Rogee, S; Hartley, O; Randriamampita, C; Scott, MGH; Marullo, S; Sauvonnet, N; Arenzana-Seisdedos, F; Lagane, B; Brelot, A				Jin, Jun; Colin, Philippe; Staropoli, Isabelle; Lima-Fernandes, Evelyne; Ferret, Cecile; Demir, Arzu; Rogee, Sophie; Hartley, Oliver; Randriamampita, Clotilde; Scott, Mark G. H.; Marullo, Stefano; Sauvonnet, Nathalie; Arenzana-Seisdedos, Fernando; Lagane, Bernard; Brelot, Anne			Targeting Spare CC Chemokine Receptor 5 (CCR5) as a Principle to Inhibit HIV-1 Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-COUPLED RECEPTORS; N-TERMINAL MODIFICATIONS; HIGHLY POTENT; BETA(2)-ADRENERGIC RECEPTOR; ANTI-HIV-1 ACTIVITY; RANTES; ENDOCYTOSIS; ANTAGONIST; INFECTION	CCR5 binds the chemokines CCL3, CCL4, and CCL5 and is the major coreceptor for HIV-1 entry into target cells. Chemokines are supposed to form a natural barrier against human immunodeficiency virus, type 1 (HIV-1) infection. However, we showed that their antiviral activity is limited by CCR5 adopting low-chemokine affinity conformations at the cell surface. Here, we investigated whether a pool of CCR5 that is not stabilized by chemokines could represent a target for inhibiting HIV infection. We exploited the characteristics of the chemokine analog PSC-RANTES (N-alpha-(n-nonanoyl)- des-Ser(1)-[ L-thioprolyl(2), L-cyclohexylglycyl(3)]RANTES( 4-68)), which displays potent anti-HIV-1 activity. We show that native chemokines fail to prevent high-affinity binding of PSC-RANTES, analog-mediated calcium release (in desensitization assays), and analog-mediated CCR5 internalization. These results indicate that a pool of spare CCR5 may bind PSC-RANTES but not native chemokines. Improved recognition of CCR5 by PSC-RANTES may explain why the analog promotes higher amounts of beta-arrestin2 .CCR5 complexes, thereby increasing CCR5 down-regulation and HIV-1inhibition. Together, these results highlight that spare CCR5, which might permit HIV-1 to escape from chemokines, should be targeted for efficient viral blockade.	[Jin, Jun; Colin, Philippe; Staropoli, Isabelle; Ferret, Cecile; Demir, Arzu; Arenzana-Seisdedos, Fernando; Lagane, Bernard; Brelot, Anne] Inst Pasteur, INSERM U1108, Viral Pathogenesis Unit, Dept Virol, F-75724 Paris 15, France; [Colin, Philippe] Univ Paris Diderot, Sorbonne Paris Cite, F-75015 Paris, France; [Lima-Fernandes, Evelyne; Rogee, Sophie; Randriamampita, Clotilde; Scott, Mark G. H.; Marullo, Stefano] Univ Paris 05, Inst Cochin, CNRS UMR 8104, INSERM U1016, F-75014 Paris, France; [Hartley, Oliver] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Sauvonnet, Nathalie] Inst Pasteur, Unite Biol Interact Cellulaires, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Geneva; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brelot, A (corresponding author), Inst Pasteur, 28 Rue Docteur Roux, F-75724 Paris 15, France.	anne.brelot@pasteur.fr	Colin, Philippe/AAM-3923-2020; Marullo, Stefano/C-6142-2008; Lagane, Bernard/K-8446-2016; Lagane, Bernard/AAA-2205-2019; Brelot, Anne/P-4129-2017; Arenzana-Seisdedos, Fernando/E-5835-2016; Scott, Mark/R-3521-2019	Colin, Philippe/0000-0002-5552-8908; Marullo, Stefano/0000-0001-9604-9973; Lagane, Bernard/0000-0002-3459-7867; Brelot, Anne/0000-0002-8095-4909; sauvonnet, nathalie/0000-0003-0306-3376; Lima Fernandes, Evelyne/0000-0002-3628-9745; Scott, Mark G.H./0000-0002-1557-1856; Randriamampita, Clotilde/0000-0001-8594-7831	Agence Nationale de Recherche sur le SIDA (ANRS); Fondation ARC; Fondation pour la Recherche Medicale (FRM); SIDACTION; INSERM; Institut Pasteur; Swiss National Science Foundation; China Scholarship Council;  [ANR-10-LabEx-62-IBEID]	Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Fondation ARC; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); SIDACTION; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); China Scholarship Council(China Scholarship Council); 	This work was supported by Agence Nationale de Recherche sur le SIDA (ANRS), Fondation ARC, Fondation pour la Recherche Medicale (FRM), SIDACTION, INSERM, Institut Pasteur, the Swiss National Science Foundation, and by Grant ANR-10-LabEx-62-IBEID.; Supported by a fellowship from the China Scholarship Council.	Abrol R, 2013, METHOD ENZYMOL, V520, P31, DOI 10.1016/B978-0-12-391861-1.00002-2; Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Barretina J, 2000, TRANSFUSION, V40, P461, DOI 10.1046/j.1537-2995.2000.40040461.x; Basquin C, 2013, J CELL SCI, V126, P1099, DOI 10.1242/jcs.110932; Benmerah A, 1999, J CELL SCI, V112, P1303; Berro R, 2013, J VIROL, V87, P6569, DOI 10.1128/JVI.00099-13; Berro R, 2011, J VIROL, V85, P8227, DOI 10.1128/JVI.00767-11; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Choi WT, 2012, J VIROL, V86, P10218, DOI 10.1128/JVI.00353-12; Colin P, 2013, P NATL ACAD SCI USA, V110, P9475, DOI 10.1073/pnas.1222205110; Conche C, 2009, IMMUNITY, V30, P33, DOI 10.1016/j.immuni.2008.10.020; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Fish Kenneth N, 2009, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1218s50; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Haqqani AA, 2013, ANTIVIR RES, V98, P158, DOI 10.1016/j.antiviral.2013.03.017; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jacquin L, 2013, FEBS OPEN BIO, V3, P1, DOI 10.1016/j.fob.2012.11.004; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Mueller A, 2006, BIOCHEM PHARMACOL, V72, P739, DOI 10.1016/j.bcp.2006.06.001; Nakajima T, 2008, CYTOGENET GENOME RES, V123, P156, DOI 10.1159/000184703; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Randriamampita C, 2003, EUR J IMMUNOL, V33, P1215, DOI 10.1002/eji.200323844; Ray Neelanjana, 2009, Drug Des Devel Ther, V2, P151; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schols D, 1998, ANTIVIR RES, V39, P175, DOI 10.1016/S0166-3542(98)00039-4; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Tarancon Diez L., 2014, HISTOCHEM C IN PRESS; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565	45	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19042	19052		10.1074/jbc.M114.559831	http://dx.doi.org/10.1074/jbc.M114.559831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855645	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000339062900035
J	Kawano, Y; Fujiwara, T; Yao, A; Housen, Y; Hayashi, K; Shimamoto, K				Kawano, Yoji; Fujiwara, Tadashi; Yao, Ai; Housen, Yusuke; Hayashi, Keiko; Shimamoto, Ko			Palmitoylation-dependent Membrane Localization of the Rice Resistance Protein Pit Is Critical for the Activation of the Small GTPase OsRac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-RESISTANCE; PLASMA-MEMBRANE; INNATE IMMUNITY; NADPH OXIDASE; HYPERSENSITIVE RESPONSE; ARABIDOPSIS EDS1; EFFECTOR AVRRPT2; RAC GTPASE; RECEPTOR; DEFENSE	Nucleotide binding domain and leucine-rich repeat (NLR)-containing family proteins function as intracellular immune sensors in both plants and animals. In plants, the downstream components activated by NLR family proteins and the immune response mechanisms induced by these downstream molecules are largely unknown. We have previously found that the small GTPase OsRac1, which acts as a molecular switch in rice immunity, is activated by Pit, an NLR-type resistance (R) protein to rice blast fungus, and this activation plays critical roles in Pit-mediated immunity. However, the sites and mechanisms of activation of Pit in vivo remain unknown. To clarify the mechanisms involved in the localization of Pit, we searched for consensus sequences in Pit that specify membrane localization and found a pair of potential palmitoylation sites in the N-terminal coiled-coil region. Although wild-type Pit was localized mainly to the plasma membrane, this membrane localization was compromised in a palmitoylation-deficient mutant of Pit. The palmitoylation- deficient Pit displayed significantly lower affinity for OsRac1 on the plasma membrane, thereby resulting in failures of the Pit-mediated cell death, the production of reactive oxygen species, and disease resistance to rice blast fungus. These results indicate that palmitoylation-dependent membrane localization of Pit is required for the interaction with and the activation of OsRac1 and that OsRac1 activation by Pit is vital for Pit-mediated disease resistance to rice blast fungus.	[Kawano, Yoji; Fujiwara, Tadashi; Yao, Ai; Housen, Yusuke; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Nara 6300101, Japan; [Hayashi, Keiko] Natl Agr & Food Res Org, Natl Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan	Nara Institute of Science & Technology; National Agriculture & Food Research Organization - Japan	Kawano, Y (corresponding author), Nara Inst Sci & Technol, Plant Mol Genet Lab, 8916-5 Takayama, Nara 6300101, Japan.	y-kawano@bs.naist.jp	Kawano, Yoji/C-7484-2011	Kawano, Yoji/0000-0003-0687-2777	MAFF Genomics for Agricultural Innovation [PMI0007]; Japan Society for the Promotion of Science KAKENHI [19108005, 2377044, 24113515, 26113712, 26450055]	MAFF Genomics for Agricultural Innovation; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MAFF Genomics for Agricultural Innovation Grant PMI0007 (to K. S.) and by Japan Society for the Promotion of Science KAKENHI Grants 19108005 (to K. S.) and 2377044, 24113515, 26113712, and 26450055 (to Y. K.).	Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Berken A, 2006, CELL MOL LIFE SCI, V63, P2446, DOI 10.1007/s00018-006-6197-1; Berruyer R, 2006, PHYTOPATHOLOGY, V96, P346, DOI 10.1094/PHYTO-96-0346; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gao ZY, 2011, P NATL ACAD SCI USA, V108, P7619, DOI 10.1073/pnas.1104410108; Hayashi K, 2009, PLANT J, V57, P413, DOI 10.1111/j.1365-313X.2008.03694.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Hemsley PA, 2009, MOL MEMBR BIOL, V26, P114, DOI 10.1080/09687680802680090; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jones MA, 2007, J EXP BOT, V58, P1261, DOI 10.1093/jxb/erl279; Kakita M, 2007, PLANT CELL, V19, P3961, DOI 10.1105/tpc.106.049999; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; Kawano Y, 2010, RICE, V3, P112, DOI 10.1007/s12284-010-9049-4; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Lee YJ, 2008, CURR OPIN PLANT BIOL, V11, P662, DOI 10.1016/j.pbi.2008.10.002; Lieberherr D, 2005, PLANT PHYSIOL, V138, P1644, DOI 10.1104/pp.104.057414; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Moeder W, 2005, MOL PLANT MICROBE IN, V18, P116, DOI 10.1094/MPMI-18-0116; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Purwestri YA, 2009, PLANT CELL PHYSIOL, V50, P429, DOI 10.1093/pcp/pcp012; Qi D, 2012, PLANT PHYSIOL, V158, P1819, DOI 10.1104/pp.112.194035; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Thao NP, 2007, PLANT CELL, V19, P4035, DOI 10.1105/tpc.107.055517; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384	46	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19079	19088		10.1074/jbc.M114.569756	http://dx.doi.org/10.1074/jbc.M114.569756			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841201	Green Published, hybrid			2022-12-28	WOS:000339062900038
J	Koch, B; Schmidt, C; Ploier, B; Daum, G				Koch, Barbara; Schmidt, Claudia; Ploier, Birgit; Daum, Guenther			Modifications of the C terminus Affect Functionality and Stability of Yeast Triacylglycerol Lipase Tgl3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LIPID PARTICLES; ENDOPLASMIC-RETICULUM; PROTEINS; DROPLETS; IDENTIFICATION; PURIFICATION; MITOCHONDRIA; MEMBRANES; ENCODES	Lipid droplets are specific organelles for the storage of triacylglycerols and steryl esters. They are surrounded by a phospholipid monolayer with a small but specific set of proteins embedded. Assembly and insertion of proteins into this surface membrane is an intriguing question of lipid droplet biology. To address this question we studied the topology of Tgl3p, the major triacylglycerol lipase of the yeast Saccharomyces cerevisiae, on lipid droplets. Employing the method of limited proteolysis of lipid droplet surface proteins, we found that the C terminus of Tgl3p faces the inside of the organelle, whereas the N terminus is exposed at the cytosolic side of lipid droplets. Detailed analysis of the C terminus revealed a stretch of seven amino acids that are critical for protein stability and functionality. The negative charge of two aspartate residues within this stretch is crucial for lipase activity of Tgl3p. A portion of Tgl3p, which is located to the endoplasmic reticulum, exhibits a different topology. In the phospholipid bilayer of the endoplasmic reticulum the C terminus faces the cytosol, which results in instability of the protein. Thus, the topology of Tgl3p is important for its function and strongly dependent on the membrane environment.	[Koch, Barbara; Schmidt, Claudia; Ploier, Birgit; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at			Austrian Science Fund (FWF) [P23029, W901]; Austrian Science Fund (FWF) [P 23029] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) projects P23029 and W901 DK Molecular Enzymology (to G. D.).	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2000, J BIOL CHEM, V275, P235, DOI 10.1074/jbc.275.1.235; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HAID A, 1983, METHOD ENZYMOL, V96, P192; Ham HJ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.046946; HEESEN ST, 1991, EUR J CELL BIOL, V56, P8; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mullner H, 2004, BBA-BIOMEMBRANES, V1663, P9, DOI 10.1016/S0005-2736(04)00079-3; Ploier B, 2013, J BIOL CHEM, V288, P36061, DOI 10.1074/jbc.M113.509927; Pu J, 2011, PROTEIN CELL, V2, P487, DOI 10.1007/s13238-011-1061-y; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schmidt C, 2013, J BIOL CHEM, V288, P19939, DOI 10.1074/jbc.M113.459610; SIKORSKI RS, 1989, GENETICS, V122, P19; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	32	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19306	19316		10.1074/jbc.M114.556944	http://dx.doi.org/10.1074/jbc.M114.556944			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24847060	Green Published, hybrid			2022-12-28	WOS:000339326800008
J	Singh, R; Brewer, MK; Mashburn, CB; Lou, DY; Bondada, V; Graham, B; Geddes, JW				Singh, Ranjana; Brewer, M. Kathryn; Mashburn, Charles B.; Lou, Dingyuan; Bondada, Vimala; Graham, Brantley; Geddes, James W.			Calpain 5 Is Highly Expressed in the Central Nervous System (CNS), Carries Dual Nuclear Localization Signals, and Is Associated with Nuclear Promyelocytic Leukemia Protein Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; SUBCELLULAR-LOCALIZATION; IMPORTIN BETA; GENE; CLEAVAGE; DOMAINS; IDENTIFICATION; HUNTINGTIN; INHIBITION; BRAIN	Calpain 5 (CAPN5) is a non-classical member of the calpain family. It lacks the EF hand motif characteristic of classical calpains but retains catalytic and Ca2+ binding domains, and it contains a unique C-terminal domain. TRA-3, an ortholog of CAPN5, has been shown to be involved in necrotic cell death in Caenorhabditis elegans. CAPN5 is expressed throughout the CNS, but its expression relative to other calpains and subcellular distribution has not been investigated previously. Based on relative mRNA levels, Capn5 is the second most highly expressed calpain in the rat CNS, with Capn2 mRNA being the most abundant. Unlike classical calpains, CAPN5 is a non-cytosolic protein localized to the nucleus and extra-nuclear locations. CAPN5 possesses two nuclear localization signals (NLS): an N-terminal monopartite NLS and a unique bipartite NLS closer to the C terminus. The C-terminal NLS contains a SUMO-interacting motif that contributes to nuclear localization, and mutation or deletion of both NLS renders CAPN5 exclusively cytosolic. Dual NLS motifs are common among transcription factors. Interestingly, CAPN5 is found in punctate domains associated with promyelocytic leukemia (PML) protein within the nucleus. PML nuclear bodies are implicated in transcriptional regulation, cell differentiation, cellular response to stress, viral defense, apoptosis, and cell senescence as well as protein sequestration, modification, and degradation. The roles of nuclear CAPN5 remain to be determined.	[Singh, Ranjana; Brewer, M. Kathryn; Mashburn, Charles B.; Lou, Dingyuan; Bondada, Vimala; Graham, Brantley; Geddes, James W.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Singh, Ranjana; Geddes, James W.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Geddes, JW (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, 741 S Limestone St, Lexington, KY 40536 USA.	jgeddes@uky.edu		Brewer, M. Kathryn/0000-0001-5089-3570	National Institutes of Health [P01NS058484, P30NS051220]; Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS051220, P01NS058484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01NS058484 and P30NS051220. This work was also supported by the Kentucky Spinal Cord and Head Injury Research Trust.	Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Barnes TM, 1996, EMBO J, V15, P4477, DOI 10.1002/j.1460-2075.1996.tb00825.x; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bhat RV, 1996, GLIA, V17, P169; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; de The H, 2012, J CELL BIOL, V198, P11, DOI 10.1083/jcb.201112044; Dear N, 1997, GENOMICS, V45, P175, DOI 10.1006/geno.1997.4870; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franz T, 2004, MOL CELL BIOL, V24, P1649, DOI 10.1128/MCB.24.4.1649-1654.2004; Fu LW, 2005, NEUROBIOL DIS, V20, P656, DOI 10.1016/j.nbd.2005.05.015; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gonzalez A, 2006, HUM REPROD, V21, P943, DOI 10.1093/humrep/dei443; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; Haacke A, 2007, J BIOL CHEM, V282, P18851, DOI 10.1074/jbc.M611914200; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hubener J, 2013, HUM MOL GENET, V22, P508, DOI 10.1093/hmg/dds449; Joyce PI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002602; KAGEYAMA GH, 1982, NEUROSCIENCE, V7, P2337, DOI 10.1016/0306-4522(82)90199-3; Kaur G, 2011, FASEB J, V25, P665, DOI 10.1096/fj.10-173351; Kaytor MD, 1999, HUM MOL GENET, V8, P1657, DOI 10.1093/hmg/8.9.1657; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Konig N, 2003, J CHEM NEUROANAT, V25, P129, DOI 10.1016/S0891-0618(02)00102-3; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; Mahajan VB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003001; Maki M, 2012, FEBS J, V279, P1414, DOI 10.1111/j.1742-4658.2012.08560.x; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matena K, 1998, GENOMICS, V48, P117, DOI 10.1006/geno.1997.5133; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Moore MW, 2005, E SCHERING RES FDN W, V50, P27; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MURAYAMA A, 1984, J BIOCHEM-TOKYO, V95, P1697, DOI 10.1093/oxfordjournals.jbchem.a134783; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Ozaki T, 2009, BBA-MOL CELL RES, V1793, P1848, DOI 10.1016/j.bbamcr.2009.10.002; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Pang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091025; Pelley RP, 2006, CANCER RES, V66, P11754, DOI 10.1158/0008-5472.CAN-06-2918; Penna I, 2008, MOL HUM REPROD, V14, P613, DOI 10.1093/molehr/gan055; Raynaud F, 2008, INT J DEV BIOL, V52, P383, DOI 10.1387/ijdb.072448fr; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Saez ME, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-23; Saez ME, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-1; Santiago A, 2009, CELL CYCLE, V8, P76, DOI 10.4161/cc.8.1.7493; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seilhean D, 2004, ACTA NEUROPATHOL, V108, P81, DOI 10.1007/s00401-004-0855-x; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Shin SJ, 2004, PROTEOMICS, V4, P3359, DOI 10.1002/pmic.200400961; Simoes AT, 2012, BRAIN, V135, P2428, DOI 10.1093/brain/aws177; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; STUURMAN N, 1992, J CELL SCI, V101, P773; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Takahashi J, 2003, NEUROBIOL DIS, V13, P230, DOI 10.1016/S0969-9961(03)00080-9; Takahashi J, 2002, BRAIN, V125, P1534, DOI 10.1093/brain/awf154; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Truant R, 1999, MOL CELL BIOL, V19, P1210; Waghray A, 2004, BIOCHEM BIOPH RES CO, V324, P46, DOI 10.1016/j.bbrc.2004.09.012; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yamada M, 2001, AM J PATHOL, V159, P1785, DOI 10.1016/S0002-9440(10)63025-8; Yamada M, 2001, ANN NEUROL, V49, P14, DOI 10.1002/1531-8249(200101)49:1<14::AID-ANA5>3.0.CO;2-X; Yang HJ, 2008, J CELL PHYSIOL, V217, P569, DOI 10.1002/jcp.21565; Yeurl PL, 2008, J CELL BIOCHEM, V103, P456, DOI 10.1002/jcb.21408; YOSHIMURA N, 1984, J BIOL CHEM, V259, P9847	86	32	34	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19383	19394		10.1074/jbc.M114.575159	http://dx.doi.org/10.1074/jbc.M114.575159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24838245	hybrid, Green Published			2022-12-28	WOS:000339326800015
J	Li, M; Xia, PY; Du, Y; Liu, SW; Huang, GL; Chen, J; Zhang, HL; Hou, N; Cheng, X; Zhou, LY; Li, PF; Yang, X; Fan, ZS				Li, Man; Xia, Pengyan; Du, Ying; Liu, Shengwu; Huang, Guanling; Chen, Jun; Zhang, Honglian; Hou, Ning; Cheng, Xuan; Zhou, Luyu; Li, Peifeng; Yang, Xiao; Fan, Zusen			T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-gamma Production of Natural Killer Cells via beta-Arrestin 2-mediated Negative Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NK CELLS; ACTIVATION; TRAF6; KINASE; CYTOTOXICITY; INHIBITION; RESPONSES; PROTEIN; SHIP	Natural killer (NK) cell activation is well orchestrated by a wide array of NK cell receptor repertoire. T-cell immunoglobulin and ITIM domain (TIGIT) receptor was recently defined as an inhibitory receptor that is expressed on NK cells and T cells. TIGIT receptor/poliovirus receptor (PVR) ligand engagement signaling inhibits cytotoxicity mediated by NK and CD8(+) T cells. However, it is unclear how TIGIT/PVR signaling regulates cytokine secretion in NK cells. Here we show that TIGIT/PVR engagement suppresses interferon-gamma (IFN-gamma) production of NK cells. TIGIT transgenic NK cells generate less IFN-gamma undergoing TIGIT/PVR ligation. Moreover, TIGIT knock-out NK cells produce much more IFN-gamma. TIGIT/PVR ligation signaling mediates suppression of IFN-gamma production via the NF-kappa B pathway. We identified a novel adaptor beta-arrestin 2 that associates with phosphorylated TIGIT for further recruitment of SHIP1 (SH2-containing inositol phosphatase 1) through the ITT-like motif. Importantly, SHIP1, but not other phosphatases, impairs the TNF receptor-associated factor 6 (TRAF6) autoubiquitination to abolish NF-kappa B activation, leading to suppression of IFN-gamma production in NK cells.	[Li, Man; Xia, Pengyan; Du, Ying; Liu, Shengwu; Huang, Guanling; Chen, Jun; Zhang, Honglian; Fan, Zusen] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China; [Li, Man; Xia, Pengyan; Liu, Shengwu; Huang, Guanling; Chen, Jun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Hou, Ning; Cheng, Xuan; Yang, Xiao] Inst Biotechnol, Genet Lab Dev & Dis, State Key Lab Prote, Beijing 100071, Peoples R China; [Zhou, Luyu; Li, Peifeng] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS	Yang, X (corresponding author), Inst Biotechnol, Genet Lab Dev & Dis, State Key Lab Prote, Beijing 100071, Peoples R China.	yangx@bmi.ac.cn; fanz@moon.ibp.ac.cn	Huang, Guanling/AAE-3779-2020; Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021	Li, Peifeng/0000-0002-0969-9407; Huang, Guanling/0000-0002-2597-6195	National Natural Science Foundation of China [81330047, 31170837, 30830030, 30972676]; 973 Program of the MOST of China [2010CB911902]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDA01010407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of the MOST of China(National Basic Research Program of China); Strategic Priority Research Programs of the Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China Grants 81330047, 31170837, 30830030, and 30972676, 973 Program of the MOST of China Grant 2010CB911902, and Strategic Priority Research Programs of the Chinese Academy of Sciences Grant XDA01010407.	Banh C, 2012, BLOOD, V120, P4583, DOI 10.1182/blood-2012-04-425009; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bi JC, 2014, HEPATOLOGY, V59, P1715, DOI 10.1002/hep.26968; Boles KS, 2009, EUR J IMMUNOL, V39, P695, DOI 10.1002/eji.200839116; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Collazo MM, 2009, BLOOD, V113, P2934, DOI 10.1182/blood-2008-09-181164; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Engels N, 2011, CURR OPIN IMMUNOL, V23, P324, DOI 10.1016/j.coi.2011.01.005; Fan ZS, 2006, BLOOD, V107, P1342, DOI 10.1182/blood-2005-08-3485; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hazen AL, 2009, BLOOD, V113, P2924, DOI 10.1182/blood-2008-02-138008; Hoffmann SC, 2011, J IMMUNOL, V186, P2757, DOI 10.4049/jimmunol.1002867; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Kerr WG, 2011, J INNATE IMMUN, V3, P249, DOI 10.1159/000323920; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Liu H. P., 2008, NAT IMMUNOL, V9, P898; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lozano E, 2012, J IMMUNOL, V188, P3869, DOI 10.4049/jimmunol.1103627; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; ORANGE JS, 1995, J EXP MED, V182, P1045, DOI 10.1084/jem.182.4.1045; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Trotta R, 2005, BLOOD, V105, P3011, DOI 10.1182/blood-2004-10-4072; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Xia PY, 2013, EMBO J, V32, P2685, DOI 10.1038/emboj.2013.189; Yan DP, 2012, NAT IMMUNOL, V13, P1063, DOI 10.1038/ni.2417; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977	50	147	153	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17647	17657		10.1074/jbc.M114.572420	http://dx.doi.org/10.1074/jbc.M114.572420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24817116	Green Published, hybrid			2022-12-28	WOS:000338018100029
J	Pang, XM; Zhang, JJ; Lopez, H; Wang, YS; Li, WY; O'Neill, KL; Evans, JJD; George, NM; Long, JH; Chen, Y; Luo, X				Pang, Xiaming; Zhang, Jingjing; Lopez, Hernando; Wang, Yushu; Li, Wenyang; O'Neill, Katelyn L.; Evans, Jacquelynn J. D.; George, Nicholas M.; Long, Jianhong; Chen, Yi; Luo, Xu			The Carboxyl-terminal Tail of Noxa Protein Regulates the Stability of Noxa and Mcl-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PROTEASOMAL DEGRADATION; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; BCL-2 FAMILY; APOPTOSIS; MECHANISM; LEUKEMIA; BAX	The BH3-only protein Noxa is a critical mediator of apoptosis and functions primarily by sequestering/inactivating the antiapoptotic Bcl-2 family protein Mcl-1. Although Noxa is a highly labile protein, recent studies suggested that it is degraded by the proteasome in a ubiquitylation-independent manner. In the present study, we investigated the mechanism of Noxa degradation and its ability to regulate the stability of Mcl-1. We found that the ubiquitylation-independent degradation of Noxa does not require a physical association with Mcl-1. A short stretch of amino acid residues in the C-terminal tail was found to mediate the proteasome-dependent degradation of Noxa. Ectopic placement of this degron was able to render other proteins unstable. Surprisingly, mutation of this sequence not only attenuated the rapid degradation of Noxa, but also stabilized endogenous Mcl-1 through the BH3-mediated direct interaction. Together, these results suggest that the C-terminal tail of Noxa regulates the stability of both Noxa and Mcl-1.	[Pang, Xiaming; Zhang, Jingjing; Lopez, Hernando; Wang, Yushu; Li, Wenyang; O'Neill, Katelyn L.; Evans, Jacquelynn J. D.; George, Nicholas M.; Chen, Yi; Luo, Xu] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Jingjing; Long, Jianhong] Cent S Univ, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China; [Wang, Yushu] Shandong Univ, Sch Med, Jinan 250100, Peoples R China	University of Nebraska System; University of Nebraska Medical Center; Central South University; Shandong University	Luo, X (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	xuluo@unmc.edu	Lopez, Hernando/AAY-7655-2020	Lopez, Hernando/0000-0001-6618-1092	Nebraska Center for Cellular Signaling (National Institutes of Health) [8P20GM103489]; Nebraska Research Initiative funds; Eppley Institute; University of Nebraska Medical Center; China Scholarship Council (CSC) program at University of Nebraska Medical Center (UNMC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103489] Funding Source: NIH RePORTER	Nebraska Center for Cellular Signaling (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiative funds; Eppley Institute; University of Nebraska Medical Center; China Scholarship Council (CSC) program at University of Nebraska Medical Center (UNMC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by pilot grants from the Nebraska Center for Cellular Signaling (National Institutes of Health Grant 8P20GM103489) and Nebraska Research Initiative funds (to X. L.).; Supported by the Eppley Institute and a graduate fellowship from the University of Nebraska Medical Center.; Supported by the China Scholarship Council (CSC) program at University of Nebraska Medical Center (UNMC).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Baou M, 2010, HAEMATOL-HEMATOL J, V95, P1510, DOI 10.3324/haematol.2010.022368; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Craxton A, 2012, CELL DEATH DIFFER, V19, P1424, DOI 10.1038/cdd.2012.16; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gores GJ, 2012, GENE DEV, V26, P305, DOI 10.1101/gad.186189.111; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; HIJIKATA M, 1990, J VIROL, V64, P4632, DOI 10.1128/JVI.64.10.4632-4639.1990; Hwang J, 2011, BBA-REV CANCER, V1816, P147, DOI 10.1016/j.bbcan.2011.05.005; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Schmidt T, 1999, CELL DEATH DIFFER, V6, P873, DOI 10.1038/sj.cdd.4400562; Seo YW, 2003, J BIOL CHEM, V278, P48292, DOI 10.1074/jbc.M308785200; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Weber A, 2013, APOPTOSIS, V18, P1093, DOI 10.1007/s10495-013-0868-9; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yoon JH, 2002, CANCER RES, V62, P6500; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	27	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17802	17811		10.1074/jbc.M114.548172	http://dx.doi.org/10.1074/jbc.M114.548172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24811167	hybrid, Green Published			2022-12-28	WOS:000338018100043
J	Meiners, MJ; Tahmaseb, K; Matson, SW				Meiners, Matthew J.; Tahmaseb, Kambiz; Matson, Steven W.			The UvrD303 Hyper-helicase Exhibits Increased Processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; RECQ HELICASES; GENE-PRODUCT; CRYSTAL-STRUCTURES; DEPENDENT MANNER; MISMATCH REPAIR; MECHANISM; BINDING; PROTEIN	DNA helicases use energy derived from nucleoside 5'-triphosphate hydrolysis to catalyze the separation of double-stranded DNA into single-stranded intermediates for replication, recombination, and repair. Escherichia coli helicase II (UvrD) functions in methyl-directed mismatch repair, nucleotide excision repair, and homologous recombination. A previously discovered 2-amino acid substitution of residues 403 and 404 (both Asp -> Ala) in the 2B subdomain of UvrD (uvrD303) confers an antimutator and UV-sensitive phenotype on cells expressing this allele. The purified protein exhibits a "hyper-helicase" unwinding activity in vitro. Using rapid quench, pre-steady state kinetic experiments we show the increased helicase activity of UvrD303 is due to an increase in the processivity of the unwinding reaction. We suggest that this mutation in the 2B subdomain results in a weakened interaction with the 1B subdomain, allowing the helicase to adopt a more open conformation. This is consistent with the idea that the 2B subdomain may have an autoregulatory role. The UvrD303 mutation may enable the helicase to unwind DNA via a "strand displacement" mechanism, which is similar to the mechanism used to processively translocate along single-stranded DNA, and the increased unwinding processivity may contribute directly to the antimutator phenotype.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Matson, Steven W.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Matson, SW (corresponding author), Univ N Carolina, CB 3280,Coker Hall, Chapel Hill, NC 27599 USA.	smatson@bio.unc.edu			National Institutes of Health [GM33476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33476.	Abdelhaleem M, 2010, METHODS MOL BIOL, V587, P1, DOI 10.1007/978-1-60327-355-8_1; Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; BRUNI R, 1988, NUCLEIC ACIDS RES, V16, P4875, DOI 10.1093/nar/16.11.4875; Centore RC, 2007, J BACTERIOL, V189, P2915, DOI 10.1128/JB.01777-06; Centore RC, 2009, J BACTERIOL, V191, P1429, DOI 10.1128/JB.01415-08; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; Egelman EH, 1998, J STRUCT BIOL, V124, P123, DOI 10.1006/jsbi.1998.4050; Geng H, 2012, J BIOL CHEM, V287, P9777, DOI 10.1074/jbc.M111.316919; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gupta R, 2007, CURR MED CHEM, V14, P503, DOI 10.2174/092986707780059706; Hall MC, 1998, J MOL BIOL, V277, P257, DOI 10.1006/jmbi.1997.1614; HICKSON ID, 1983, MOL GEN GENET, V190, P265, DOI 10.1007/BF00330649; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Maluf NK, 2003, J BIOL CHEM, V278, P31930, DOI 10.1074/jbc.M304223200; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1986, J BIOL CHEM, V261, P169; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tahmaseb K, 2010, METHODS, V51, P322, DOI 10.1016/j.ymeth.2010.02.008; Tomko EJ, 2012, J MOL BIOL, V418, P32, DOI 10.1016/j.jmb.2012.02.013; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; WASHBURN BK, 1991, J BACTERIOL, V173, P2569, DOI 10.1128/jb.173.8.2569-2575.1991; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Zhang G, 1998, J BACTERIOL, V180, P377, DOI 10.1128/JB.180.2.377-387.1998	42	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17100	17110		10.1074/jbc.M114.565309	http://dx.doi.org/10.1074/jbc.M114.565309			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24798324	Green Published, hybrid			2022-12-28	WOS:000338016200043
J	Sankari, S; O'Brian, MR				Sankari, Siva; O'Brian, Mark R.			A Bacterial Iron Exporter for Maintenance of Iron Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR IRR; BRADYRHIZOBIUM-JAPONICUM; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; OXIDATIVE STRESS; GENE ENCODES; PROTEIN; TRANSPORTER; EXPRESSION; MANGANESE	Nutritional iron acquisition by bacteria is well described, but almost nothing is known about bacterial iron export even though it is likely to be an important homeostatic mechanism. Here, we show that Bradyrhizobium japonicum MbfA (Blr7895) is an inner membrane protein expressed in cells specifically under high iron conditions. MbfA contains an N-terminal ferritin-like domain (FLD) and a C-terminal domain homologous to the eukaryotic vacuolar membrane Fe2+/Mn2+ transporter CCC1. An mbfA deletion mutant is severely defective in iron export activity, contains >2-fold more intracellular iron than the parent strain, and displays an aberrant iron-dependent gene expression phenotype. B. japonicum is highly resistant to iron and H2O2 stresses, and MbfA contributes substantially to this as determined by phenotypes of the mbfA mutant strain. The N-terminal FLD was localized to the cytoplasmic side of the inner membrane. Substitution mutations in the putative iron-binding amino acid residues E20A and E107A within the N-terminal FLD abrogate iron export activity and stress response function. Purified soluble FLD oxidizes ferrous iron (Fe2+) to incorporate ferric iron (Fe3+) in a 2: 1 iron: protein ratio, which does not occur in the E20A/E107A mutant. The FLD fragment is a dimer in solution, implying that the MbfA exporter functions as a dimer. MbfA belongs to a protein family found in numerous prokaryotic genera. The findings strongly suggest that iron export plays an important role in bacterial iron homeostasis.	[Sankari, Siva; O'Brian, Mark R.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY 14214 USA.	mrobrian@buffalo.edu	sankaran, Siva Sankari iyer mani/AAB-5222-2020		National Institutes of Health [R01 099667]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 099667 (to M.R. O'B.).	Anderson ES, 2011, J BACTERIOL, V193, P5359, DOI 10.1128/JB.00372-11; BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Escamilla-Hernandez R, 2012, J BACTERIOL, V194, P3137, DOI 10.1128/JB.00071-12; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Hohle TH, 2011, P NATL ACAD SCI USA, V108, P15390, DOI 10.1073/pnas.1110137108; Hohle TH, 2009, MOL MICROBIOL, V72, P399, DOI 10.1111/j.1365-2958.2009.06650.x; Jaggavarapu S, 2014, MOL MICROBIOL, V92, P609, DOI 10.1111/mmi.12584; Lapinskas PJ, 1996, MOL MICROBIOL, V21, P519, DOI 10.1111/j.1365-2958.1996.tb02561.x; LEBRUN NE, 1993, FEBS LETT, V333, P197, DOI 10.1016/0014-5793(93)80404-I; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Martinez M, 2005, MICROBIOL-SGM, V151, P3427, DOI 10.1099/mic.0.28213-0; Nicolaou SA, 2013, APPL ENVIRON MICROB, V79, P7210, DOI 10.1128/AEM.02322-13; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Puri S, 2006, J BACTERIOL, V188, P6476, DOI 10.1128/JB.00737-06; Puri S, 2010, P NATL ACAD SCI USA, V107, P10691, DOI 10.1073/pnas.1002342107; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Ruangkiattikul N, 2012, FEMS MICROBIOL LETT, V329, P87, DOI 10.1111/j.1574-6968.2012.02509.x; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sangwan I, 2008, J BACTERIOL, V190, P5172, DOI 10.1128/JB.00495-08; Serventi F, 2012, J BIOL CHEM, V287, P38812, DOI 10.1074/jbc.M112.406173; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Small SK, 2011, J BACTERIOL, V193, P4088, DOI 10.1128/JB.05064-11; Small S, 2009, BIOMETALS, V22, P89, DOI 10.1007/s10534-008-9192-1; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; VALLEJO AN, 1994, PCR METH APPL, V4, pS123; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x	35	21	23	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16498	16507		10.1074/jbc.M114.571562	http://dx.doi.org/10.1074/jbc.M114.571562			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24782310	hybrid, Green Published			2022-12-28	WOS:000337965700051
J	Towle-Weicksel, JB; Dalal, S; Sohl, CD; Doublie, S; Anderson, KS; Sweasy, JB				Towle-Weicksel, Jamie B.; Dalal, Shibani; Sohl, Christal D.; Doublie, Sylvie; Anderson, Karen S.; Sweasy, Joann B.			Fluorescence Resonance Energy Transfer Studies of DNA Polymerase beta THE CRITICAL ROLE OF FINGERS DOMAIN MOVEMENTS AND A NOVEL NON-COVALENT STEP DURING NUCLEOTIDE SELECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC HINGE REGION; CRYSTAL-STRUCTURES; TERNARY COMPLEXES; MUTATOR MUTANT; CONFORMATIONAL-CHANGES; CATALYTIC MECHANISM; NUCLEOTIDE-BINDING; BASE SUBSTITUTION; KINETIC MECHANISM; STRUCTURAL BASIS	During DNA repair, DNA polymerase beta (Pol beta) is a highly dynamic enzyme that is able to select the correct nucleotide opposite a templating base from a pool of four different deoxynucleoside triphosphates (dNTPs). To gain insight into nucleotide selection, we use a fluorescence resonance energy transfer (FRET)-based system to monitor movement of the Pol beta fingers domain during catalysis in the presence of either correct or incorrect dNTPs. By labeling the fingers domain with ((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonicacid(IAEDANS) and the DNA substrate with Dabcyl, we are able to observe rapid fingers closing in the presence of correct dNTPs as the IAEDANS comes into contact with a Dabcyl-labeled, one-base gapped DNA. Our findings show that not only do the fingers close after binding to the correct dNTP, but that there is a second conformational change associated with a non-covalent step not previously reported for Pol beta. Further analyses suggest that this conformational change corresponds to the binding of the catalytic metal into the polymerase active site. FRET studies with incorrect dNTP result in no changes in fluorescence, indicating that the fingers do not close in the presence of incorrect dNTP. Together, our results show that nucleotide selection initially occurs in an open fingers conformation and that the catalytic pathways of correct and incorrect dNTPs differ from each other. Overall, this study provides new insight into the mechanism of substrate choice by a polymerase that plays a critical role in maintaining genome stability.	[Towle-Weicksel, Jamie B.; Dalal, Shibani; Sweasy, Joann B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Sohl, Christal D.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	Yale University; Yale University; University of Vermont	Sweasy, JB (corresponding author), 333 Cedar St,POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu		Doublie, Sylvie/0000-0002-6294-5304	National Institutes of Health [CA 080830, GM49551, GM099289]; NATIONAL CANCER INSTITUTE [R01CA080830, U19CA177547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049551, F32GM099289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 080830 (to J. B. S.), GM49551(to K. S. A.), and GM099289 (to C. D. S.).	Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; Bakhtina M, 2007, BIOCHEMISTRY-US, V46, P5463, DOI 10.1021/bi700084w; Balbo PB, 2011, BIOCHEMISTRY-US, V50, P9865, DOI 10.1021/bi200954r; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Basu RS, 2013, J BIOL CHEM, V288, P3305, DOI 10.1074/jbc.M112.387712; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Eckenroth BE, 2013, J BIOL CHEM, V288, P34850, DOI 10.1074/jbc.M113.510891; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Gridley CL, 2013, BIOCHEMISTRY-US, V52, P4422, DOI 10.1021/bi301368f; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Klvana M, 2012, BIOCHEMISTRY-US, V51, P8829, DOI 10.1021/bi300783t; Kosa JL, 1999, J BIOL CHEM, V274, P35866, DOI 10.1074/jbc.274.50.35866; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; Li SX, 1999, BIOCHEMISTRY-US, V38, P4800, DOI 10.1021/bi9827058; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lin GC, 2007, NUCLEIC ACIDS RES, V35, P2924, DOI 10.1093/nar/gkm126; Lin GC, 2009, DNA REPAIR, V8, P182, DOI 10.1016/j.dnarep.2008.10.006; Maitra M, 2002, J BIOL CHEM, V277, P35550, DOI 10.1074/jbc.M204953200; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Maxwell BA, 2013, J BIOL CHEM, V288, P11590, DOI 10.1074/jbc.M113.459982; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Murphy DL, 2012, BIOCHEMISTRY-US, V51, P5269, DOI 10.1021/bi3003583; Murphy DL, 2011, J AM CHEM SOC, V133, P6279, DOI 10.1021/ja111099b; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Nemec AA, 2014, J BIOL CHEM, V289, P13708, DOI 10.1074/jbc.M114.550400; Opresko PL, 1998, BIOCHEMISTRY-US, V37, P2111, DOI 10.1021/bi9722711; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12778, DOI 10.1021/bi960790i; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Perumal SK, 2013, P NATL ACAD SCI USA, V110, P99, DOI 10.1073/pnas.1212748110; PETERMAN BF, 1979, ANAL BIOCHEM, V93, P442, DOI 10.1016/S0003-2697(79)80176-1; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Shah AM, 2001, J BIOL CHEM, V276, P10824, DOI 10.1074/jbc.M008680200; Shah AM, 2001, BIOCHEMISTRY-US, V40, P11372, DOI 10.1021/bi010755y; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; Starcevic D, 2005, J BIOL CHEM, V280, P28388, DOI 10.1074/jbc.M502178200; Starcevic D, 2005, BIOCHEMISTRY-US, V44, P3775, DOI 10.1021/bi047956x; Sucato CA, 2008, BIOCHEMISTRY-US, V47, P870, DOI 10.1021/bi7014162; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Xia SL, 2011, BIOCHEMISTRY-US, V50, P9114, DOI 10.1021/bi201260h; Xu CL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000225; Yamtich J, 2010, BIOCHEMISTRY-US, V49, P2326, DOI 10.1021/bi901735a; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	59	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16541	16550		10.1074/jbc.M114.561878	http://dx.doi.org/10.1074/jbc.M114.561878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764311	hybrid, Green Published			2022-12-28	WOS:000337965700055
J	Pysz, MA; Hao, F; Hizli, AA; Lum, MA; Swetzig, WM; Black, AR; Black, JD				Pysz, Marybeth A.; Hao, Fang; Hizli, A. Asli; Lum, Michelle A.; Swetzig, Wendy M.; Black, Adrian R.; Black, Jennifer D.			Differential Regulation of Cyclin D1 Expression by Protein Kinase C alpha and epsilon Signaling in Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BREAST-CANCER CELLS; PKC-EPSILON; GENE-EXPRESSION; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTORS; DEPENDENT PATHWAY; POTENTIAL ROLE; ACTIVATION; GROWTH	Cellular accumulation of cyclin D1, a key regulator of cell proliferation and tumorigenesis, is subject to tight control. Our previous studies have identified PKC alpha as a negative regulator of cyclin D1 in the intestinal epithelium. However, treatment of non-transformed IEC-18 ileal crypt cells with PKC agonists has a biphasic effect on cyclin D1 expression. Initial PKC alpha-mediated down-regulation is followed by recovery and subsequent accumulation of the cyclin to levels markedly higher than those seen in untreated cells. Using protein overexpression strategies, siRNA, and pharmacological inhibitors, we now demonstrate that the recovery and hyperinduction of cyclin D1 reflect the combined effects of (a) loss of negative signals from PKC alpha due to agonist-induced PKC alpha down-regulation and (b) positive effects of PKC epsilon. PKC epsilon-mediated up-regulation of cyclin D1 requires sustained ERK stimulation and transcriptional activation of the proximal cyclin D1 (CCDN1) promoter, without apparent involvement of changes in protein stability or translation. PKC epsilon also up-regulates cyclin D1 expression in colon cancer cells, through mechanisms that parallel those in IEC-18 cells. Although induction of cyclin D1 by PKC epsilon is dependent on non-canonical NF-kappa B activation, the NF-kappa B site in the proximal promoter is not required. Instead, cyclin D1 promoter activity is regulated by a novel interaction between NF-kappa B and factors that associate with the cyclic AMP-response element adjacent to the NF-kappa B site. The differential effects of PKC alpha and PKC epsilon on cyclin D1 accumulation are likely to contribute to the opposing tumor-suppressive and tumor-promoting activities of these PKC family members in the intestinal epithelium.	[Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Pysz, Marybeth A.; Hao, Fang; Hizli, A. Asli; Swetzig, Wendy M.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute	Black, JD (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.			HIZLI DENIZ, AYSEN ASLI/0000-0003-0490-7737	National Institutes of Health [DK60632, DK54909, CA16056, CA036727]; National Institutes of Health Postdoctoral Fellowship [CA113048]; National Science Foundation [DBI-0353490]; NATIONAL CANCER INSTITUTE [P30CA036727, F32CA113048, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054909, R56DK060632, R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60632, DK54909, CA16056, and CA036727 and National Institutes of Health Postdoctoral Fellowship CA113048 (to M. A. P.). This work was also supported by National Science Foundation Grant DBI-0353490.	Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Besson A, 2001, ONCOGENE, V20, P7398, DOI 10.1038/sj.onc.1204899; Black AR, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00423; Cavicchi M, 1999, GUT, V45, P367, DOI 10.1136/gut.45.3.367; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Cheng JJ, 2001, J BIOL CHEM, V276, P31368, DOI 10.1074/jbc.M011317200; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; De Plaen IG, 2006, IMMUNOLOGY, V118, P153, DOI 10.1111/j.1365-2567.2006.02344.x; Faisal A, 2008, J BIOL CHEM, V283, P18591, DOI 10.1074/jbc.M710330200; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Frey MR, 2000, J CELL BIOL, V151, P763, DOI 10.1083/jcb.151.4.763; Frey MR, 1997, J BIOL CHEM, V272, P9424; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Garg R, 2012, J BIOL CHEM, V287, P37570, DOI 10.1074/jbc.M112.398925; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Guo Xiaoling, 2011, Genes Cancer, V2, P818, DOI 10.1177/1947601911431082; Guo Y, 2005, ONCOGENE, V24, P1032, DOI 10.1038/sj.onc.1208299; Guo ZY, 2011, CLIN EPIGENETICS, V2, P63, DOI 10.1007/s13148-010-0018-y; Hao F, 2011, J BIOL CHEM, V286, P18104, DOI 10.1074/jbc.M110.208488; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hellmuth M, 2002, CARCINOGENESIS, V23, P1273, DOI 10.1093/carcin/23.8.1273; Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Hong DH, 1999, AM J PHYSIOL-GASTR L, V277, pG1041, DOI 10.1152/ajpgi.1999.277.5.G1041; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Kang DW, 2008, J BIOL CHEM, V283, P4094, DOI 10.1074/jbc.M707416200; Kazanietz MG, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P1, DOI 10.1007/978-1-60761-543-9; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Li XY, 2011, J CELL BIOCHEM, V112, P211, DOI 10.1002/jcb.22925; Lim JH, 2008, CANCER SCI, V99, P1798, DOI 10.1111/j.1349-7006.2008.00892.x; Lum MA, 2013, J BIOL CHEM, V288, P27112, DOI 10.1074/jbc.M112.437095; Morais C, 2006, NEPHROL DIAL TRANSPL, V21, P3377, DOI 10.1093/ndt/gfl543; Murray NR, 2009, CANCER RES, V69, P656, DOI 10.1158/0008-5472.CAN-08-3001; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Page K, 2002, AM J RESP CELL MOL, V27, P204, DOI 10.1165/ajrcmb.27.2.20010016oc; Perletti GP, 1998, ONCOGENE, V16, P3345, DOI 10.1038/sj.onc.1201871; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; Rao VU, 2004, AM J PHYSIOL-HEART C, V286, pH2195, DOI 10.1152/ajpheart.00475.2003; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; SAXON ML, 1994, J CELL BIOL, V126, P747, DOI 10.1083/jcb.126.3.747; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tanaka M, 2004, BIOORG MED CHEM LETT, V14, P5171, DOI 10.1016/j.bmcl.2004.07.061; Tang J, 2010, J BIOL CHEM, V285, P34072, DOI 10.1074/jbc.M110.137380; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Toncheva D, 2004, TUMOR BIOL, V25, P157, DOI 10.1159/000081097; Toualbi-Abed K, 2008, CARCINOGENESIS, V29, P536, DOI 10.1093/carcin/bgm293; Wang BB, 2012, MOL ENDOCRINOL, V26, P1356, DOI 10.1210/me.2012-1035; Wang F, 2010, TOXICOLOGY, V273, P12, DOI 10.1016/j.tox.2010.04.009; Wang XF, 2004, ONCOGENE, V23, P1885, DOI 10.1038/sj.onc.1207312; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Wilding J, 2002, CANCER RES, V62, P4562; Wilson L, 1999, GASTROENTEROLOGY, V117, P106, DOI 10.1016/S0016-5085(99)70556-1; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Yan SC, 2001, J CELL PHYSIOL, V186, P338, DOI 10.1002/1097-4652(2000)9999:9999<000::AID-JCP1032>3.0.CO;2-B; Zhang JP, 2007, ENDOCRINOLOGY, V148, P268, DOI 10.1210/en.2006-0500	70	17	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22268	22283		10.1074/jbc.M114.571554	http://dx.doi.org/10.1074/jbc.M114.571554			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24914206	hybrid, Green Published			2022-12-28	WOS:000340593500040
J	Canver, MC; Bauer, DE; Dass, A; Yien, YY; Chung, J; Masuda, T; Maeda, T; Paw, BH; Orkin, SH				Canver, Matthew C.; Bauer, Daniel E.; Dass, Abhishek; Yien, Yvette Y.; Chung, Jacky; Masuda, Takeshi; Maeda, Takahiro; Paw, Barry H.; Orkin, Stuart H.			Characterization of Genomic Deletion Efficiency Mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas9 Nuclease System in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE ERYTHROLEUKEMIA-CELLS; CHROMOSOMAL DELETIONS; CRISPR-CAS9 SYSTEM; CAS9; SPECIFICITY; CRISPR/CAS; DNA; ENDONUCLEASE; MUTAGENESIS; INVERSIONS	The clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 nuclease system has provided a powerful tool for genome engineering. Double strand breaks may trigger nonhomologous end joining repair, leading to frameshift mutations, or homology-directed repair using an extrachromosomal template. Alternatively, genomic deletions may be produced by a pair of double strand breaks. The efficiency of CRISPR/Cas9-mediated genomic deletions has not been systematically explored. Here, we present a methodology for the production of deletions in mammalian cells, ranging from 1.3 kb to greater than 1 Mb. We observed a high frequency of intended genomic deletions. Nondeleted alleles are nonetheless often edited with inversions or small insertion/deletions produced at CRISPR recognition sites. Deleted alleles also typically include small insertion/deletions at predicted deletion junctions. We retrieved cells with biallelic deletion at a frequency exceeding that of probabilistic expectation. We demonstrate an inverse relationship between deletion frequency and deletion size. This work suggests that CRISPR/Cas9 is a robust system to produce a spectrum of genomic deletions to allow investigation of genes and genetic elements.	[Canver, Matthew C.; Bauer, Daniel E.; Yien, Yvette Y.; Chung, Jacky; Maeda, Takahiro; Paw, Barry H.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bauer, Daniel E.; Dass, Abhishek; Paw, Barry H.; Orkin, Stuart H.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Bauer, Daniel E.; Paw, Barry H.; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Yien, Yvette Y.; Chung, Jacky; Masuda, Takeshi; Maeda, Takahiro; Paw, Barry H.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	Stuart_Orkin@dfci.harvard.edu	Maeda, Takahiro/AAC-4563-2019	Maeda, Takahiro/0000-0003-4530-6460; Paw, Barry/0000-0002-0492-1419; Canver, Matthew/0000-0002-8146-3992	National Institutes of Health [R01HL032259, P30DK049216]; NIDDK [K08DK093705]; NIAID [R01AI084905]; Canadian Institutes of Health Research fellowship;  [T32HL007574];  [F32DK098866];  [R01DK070838];  [P01HL032262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, T32HL007574, R01HL032259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, K08DK093705, R01DK070838, F32DK098866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL032259 and P30DK049216 (Center of Excellence in Molecular Hematology to S. H. O.), Grant K08DK093705 from NIDDK (to D. E. B.), Grant R01AI084905 from NIAID (to T. M.), Grants T32HL007574 and F32DK098866 (to Y. Y. Y.), and Grants R01DK070838 and P01HL032262 (to B. H. P.).; Supported by a Canadian Institutes of Health Research fellowship.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MAMAEVA SE, 1985, CANCER GENET CYTOGEN, V16, P199, DOI 10.1016/0165-4608(85)90046-9; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MILLER DA, 1979, CANCER GENET CYTOGEN, V1, P103, DOI 10.1016/0165-4608(79)90016-5; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	35	210	229	0	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21312	21324		10.1074/jbc.M114.564625	http://dx.doi.org/10.1074/jbc.M114.564625			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24907273	Green Published, hybrid			2022-12-28	WOS:000340558300012
J	Shi, WW; Jiang, YL; Zhu, F; Yang, YH; Shao, QY; Yang, HB; Ren, YM; Wu, H; Chen, YX; Zhou, CZ				Shi, Wei-Wei; Jiang, Yong-Liang; Zhu, Fan; Yang, Yi-Hu; Shao, Qiu-Yan; Yang, Hong-Bo; Ren, Yan-Min; Wu, Hui; Chen, Yuxing; Zhou, Cong-Zhao			Structure of a Novel O-Linked N-Acetyl-D-glucosamine (O-GlcNAc) Transferase, GtfA, Reveals Insights into the Glycosylation of Pneumococcal Serine-rich Repeat Adhesins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ENZYME COMPLEX; PROTEINS; FAMILY; DOMAIN; GLYCOSYLTRANSFERASES; GLCNACYLATION; RECOGNITION; BIOGENESIS; MECHANISM	Protein glycosylation catalyzed by the O-GlcNAc transferase (OGT) plays a critical role in various biological processes. In Streptococcus pneumoniae, the core enzyme GtfA and co-activator GtfB form an OGT complex to glycosylate the serine-rich repeat (SRR) of adhesin PsrP (pneumococcal serine-rich repeat protein), which is involved in the infection and pathogenesis. Here we report the 2.0 angstrom crystal structure of GtfA, revealing a beta-meander add-on domain beyond the catalytic domain. It represents a novel add-on domain, which is distinct from the all alpha-tetratricopeptide repeats in the only two structure-known OGTs. Structural analyses combined with binding assays indicate that this add-on domain contributes to forming an active GtfA-GtfB complex and recognizing the acceptor protein. In addition, the in vitro glycosylation system enables us to map the O-linkages to the serine residues within the first SRR of PsrP. These findings suggest that fusion with an add-on domain might be a universal mechanism for diverse OGTs that recognize varying acceptor proteins/peptides.	[Shi, Wei-Wei; Jiang, Yong-Liang; Yang, Yi-Hu; Shao, Qiu-Yan; Yang, Hong-Bo; Ren, Yan-Min; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Shi, Wei-Wei; Jiang, Yong-Liang; Yang, Yi-Hu; Shao, Qiu-Yan; Yang, Hong-Bo; Ren, Yan-Min; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, Birmingham, AL 35294 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Microbiol, Birmingham, AL 35294 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Pediat Dent, Birmingham, AL 35294 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	hwu@uab.edu; cyxing@ustc.edu.cn; zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Shao, Qiuyan/J-8765-2019; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936; Yang, Hong-Bo/0000-0002-9639-7166	National Institutes of Health [F33DE022215, R01DE 017954]; Ministry of Science and Technology of China [2013CB835300, 2014CB910100, 2009CB918800]; National Natural Science Foundation of China [31270781]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954, F33DE022215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants F33DE022215 and R01DE 017954. This work was also supported by the Ministry of Science and Technology of China Grants 2013CB835300, 2014CB910100, and 2009CB918800 and National Natural Science Foundation of China Grant 31270781.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Cottee MA, 2013, ELIFE, V2, DOI 10.7554/eLife.01071; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Greenwald J, 2009, MOL MICROBIOL, V72, P1246, DOI 10.1111/j.1365-2958.2009.06721.x; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Hao Q, 2000, J APPL CRYSTALLOGR, V33, P980, DOI 10.1107/S0021889800001424; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kawai F, 2011, J BIOL CHEM, V286, P38546, DOI 10.1074/jbc.M111.237602; King NP, 2011, MICROBIOL-SGM, V157, P1161, DOI 10.1099/mic.0.047639-0; Kukita K, 2013, INFECT IMMUN, V81, P1870, DOI 10.1128/IAI.00011-13; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Makabe K, 2006, P NATL ACAD SCI USA, V103, P17753, DOI 10.1073/pnas.0606690103; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Qasba PK, 2007, GLYCOBIOLOGY, V17, p7G, DOI 10.1093/glycob/cwm013; Ruane KM, 2008, PROTEINS, V73, P784, DOI 10.1002/prot.22171; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Seepersaud R, 2012, J BACTERIOL, V194, P5564, DOI 10.1128/JB.01000-12; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen AM, 2006, GENE DEV, V20, P3283, DOI 10.1101/gad.1492606; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vaidyanathan K, 2014, CRIT REV BIOCHEM MOL, V49, P140, DOI 10.3109/10409238.2014.884535; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Wu R, 2011, J BIOL CHEM, V286, P34923, DOI 10.1074/jbc.M111.239350; Wu R, 2010, APPL ENVIRON MICROB, V76, P7966, DOI 10.1128/AEM.01434-10; Yang Yong Ryoul, 2014, Advances in Biological Regulation, V54, P68, DOI 10.1016/j.jbior.2013.09.007; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	61	39	44	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20898	20907		10.1074/jbc.M114.581934	http://dx.doi.org/10.1074/jbc.M114.581934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936067	hybrid, Green Published			2022-12-28	WOS:000339396600043
J	Kim, CH; Paik, D; Rus, F; Silverman, N				Kim, Chan-Hee; Paik, Donggi; Rus, Florentina; Silverman, Neal			The Caspase-8 Homolog Dredd Cleaves Imd and Relish but Is Not Inhibited by p35	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; DROSOPHILA; ACTIVATION; PROTEIN; SPECIFICITY; COMPLEX; DRONC; EXPRESSION; DEFENSE; PATHWAY	In Drosophila, the Imd pathway is activated by diaminopimelic acid-type peptidoglycan and triggers the humoral innate immune response, including the robust induction of antimicrobial peptide gene expression. Imd and Relish, two essential components of this pathway, are both endoproteolytically cleaved upon immune stimulation. Genetic analyses have shown that these cleavage events are dependent on the caspase-8 like Dredd, suggesting that Imd and Relish are direct substrates of Dredd. Among the seven Drosophila caspases, we find that Dredd uniquely promotes Imd and Relish processing, and purified recombinant Dredd cleaves Imd and Relish in vitro. In addition, interdomain cleavage of Dredd is not required for Imd or Relish processing and is not observed during immune stimulation. Baculovirus p35, a suicide substrate of executioner caspases, is not cleaved by purified Dredd in vitro. Consistent with this biochemistry but contrary to earlier reports, p35 does not interfere with Imd signaling in S2* cells or in vivo.	[Kim, Chan-Hee; Paik, Donggi; Rus, Florentina; Silverman, Neal] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Silverman, N (corresponding author), 364 Plantat St, Worcester, MA 01605 USA.	Neal.Silverman@umassmed.edu	Kim, Chan-Hee/C-6849-2016	Kim, Chan-Hee/0000-0002-5315-4981; Silverman, Neal/0000-0002-4259-456X; Paik, Donggi/0000-0003-1031-0371	National Institutes of Health [AI60025]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-357-2007-1-C00085, NRF-352-2009-1-C00105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060025, R01AI060025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI60025 (to N. S.) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science and Technology Grants NRF-357-2007-1-C00085 (to C. K.) and NRF-352-2009-1-C00105 (to D. P.).	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Baum JS, 2007, CELL DEATH DIFFER, V14, P1508, DOI 10.1038/sj.cdd.4402155; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chen P, 1998, DEV BIOL, V201, P202, DOI 10.1006/dbio.1998.9000; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Denault Jean-Bernard, 2008, V414, P191; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Green DR, 2011, MEANS END APOPTOSIS; Guntermann S, 2011, J BIOL CHEM, V286, P30284, DOI 10.1074/jbc.M111.220285; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Hu SM, 2000, J BIOL CHEM, V275, P30761, DOI 10.1074/jbc.C000341200; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Lee G, 2011, J COMP NEUROL, V519, P34, DOI 10.1002/cne.22498; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Vernooy SY, 2000, J CELL BIOL, V150, pF69, DOI 10.1083/jcb.150.2.F69; WHITE E, 1987, J VIROL, V61, P426, DOI 10.1128/JVI.61.2.426-435.1987; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	40	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20092	20101		10.1074/jbc.M113.544841	http://dx.doi.org/10.1074/jbc.M113.544841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24891502	Green Published, hybrid			2022-12-28	WOS:000339395200023
J	Lee, J; Miyazaki, M; Romeo, GR; Shoelson, SE				Lee, Jongsoon; Miyazaki, Masaya; Romeo, Giulio R.; Shoelson, Steven E.			Insulin Receptor Activation with Transmembrane Domain Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE; BETA-SUBUNIT; ERYTHROPOIETIN RECEPTOR; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; POINT MUTATION; SIGNAL-TRANSDUCTION; NEU ONCOGENE; IN-VITRO	Complementary surfaces are buried when peptide hormones, growth factors, or cytokines bind and activate cellular receptors. Although these extended surfaces provide high affinity and specificity to the interactions, they also present great challenges to the design of small molecules that might either mimic or antagonize the process. We show that the insulin receptor (IR) and downstream signals can be activated by targeting a site outside of its ligand-binding domain. A 24-residue peptide having the IR transmembrane (TM) domain sequence activates IR, but not related growth factor receptors, through specific interactions with the receptor TM domain. Like insulin-dependent activation, IR-TM requires that IR have a competent ATP-binding site and kinase activation loop. IR-TM also activates mutated receptors from patients with severe insulin resistance, which do not respond to insulin. These results show that IR can be activated through a pathway that bypasses its canonical ligand-binding domain.	[Lee, Jongsoon; Shoelson, Steven E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Lee, J (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, One Joslin Pl, Boston, MA 02115 USA.	jongsoon.lee@joslin.harvard.edu; m.miyazaki@aist.go.jp; steven.shoelson@joslin.harvard.edu	Miyazaki, Masaya/F-8520-2012; Lee, Jongsoon/AAG-1674-2020	Miyazaki, Masaya/0000-0003-4031-7224; Lee, Jongsoon/0000-0002-0891-5059	National Institutes of Health [R21 DK80380, R01 DK45943, R37 DK51729, R01 DK73547, T32 DK007260, P30 DK36836]; American Diabetes Association [RA 110BS97]; Helen and Morton Adler Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051729, P30DK036836, R21DK080380, R01DK051729, T32DK007260, R01DK073547, R01DK043123, R01DK045943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Helen and Morton Adler Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DK80380 (to J. L.), R01 DK45943, R37 DK51729, and R01 DK73547 (to S. E. S.), T32 DK007260 (to G. R. R.), and P30 DK36836 (to Joslin Diabetes Research Center). This work was also supported by American Diabetes Association Grant RA 110BS97 (to J. L.) and the Helen and Morton Adler Chair (to S. E. S.).	ACCILI D, 1995, DIABETES METAB REV, V11, P47, DOI 10.1002/dmr.5610110105; Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARON V, 1992, J BIOL CHEM, V267, P23290; BARON V, 1990, BIOCHEMISTRY-US, V29, P4634, DOI 10.1021/bi00471a019; BONISCHNETZLER M, 1988, J BIOL CHEM, V263, P6822; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; CHEATHAM B, 1993, P NATL ACAD SCI USA, V90, P7336, DOI 10.1073/pnas.90.15.7336; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CLARK S, 1993, BIOCHEM J, V292, P217, DOI 10.1042/bj2920217; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FRATTALI AL, 1992, J BIOL CHEM, V267, P19521; Gardin A, 1999, FASEB J, V13, P1347, DOI 10.1096/fasebj.13.11.1347; HERRERA R, 1986, J BIOL CHEM, V261, P1980; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Lee J, 1997, BIOCHEMISTRY-US, V36, P2701, DOI 10.1021/bi961815g; LEE JS, 1993, J BIOL CHEM, V268, P4092; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Li QX, 2014, BBA-BIOMEMBRANES, V1838, P1313, DOI 10.1016/j.bbamem.2014.01.005; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MADDUX BA, 1991, J BIOL CHEM, V266, P6731; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Ottensmeyer FP, 2000, BIOCHEMISTRY-US, V39, P12103, DOI 10.1021/bi0015921; PERLMAN R, 1989, J BIOL CHEM, V264, P8946; Petti LM, 1998, ONCOGENE, V16, P843, DOI 10.1038/sj.onc.1201590; PILCH PF, 1980, J BIOL CHEM, V255, P1722; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; SCHENKER E, 1988, BIOCHEM BIOPH RES CO, V157, P140, DOI 10.1016/S0006-291X(88)80024-X; SHOELSON SE, 1991, BIOCHEMISTRY-US, V30, P7740, DOI 10.1021/bi00245a010; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; STAGSTED J, 1990, CELL, V62, P297, DOI 10.1016/0092-8674(90)90367-N; STAGSTED J, 1993, J BIOL CHEM, V268, P1770; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TAKAHASHI K, 1995, J BIOL CHEM, V270, P19041, DOI 10.1074/jbc.270.32.19041; TAOUIS M, 1994, J BIOL CHEM, V269, P27762; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; TREUTLEIN HR, 1992, BIOCHEMISTRY-US, V31, P12726, DOI 10.1021/bi00166a003; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P2722, DOI 10.1021/bi00432a053; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P3448, DOI 10.1021/bi00434a045; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; Wells JA, 2014, SCIENCE, V344, P703, DOI 10.1126/science.1254799; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; WHITE MF, 1988, J BIOL CHEM, V263, P2969; WILDEN PA, 1992, J BIOL CHEM, V267, P16660; WILDEN PA, 1992, J BIOL CHEM, V267, P13719; YAMADA K, 1992, J BIOL CHEM, V267, P12452; Yip CC, 2003, J BIOL CHEM, V278, P27329, DOI 10.1074/jbc.R300021200; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974	66	39	41	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19769	19777		10.1074/jbc.M114.578641	http://dx.doi.org/10.1074/jbc.M114.578641			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867955	Green Published, hybrid			2022-12-28	WOS:000339326800048
J	Mahesh, G; Jeong, E; Ng, FS; Liu, YX; Gunawardhana, K; Houl, JH; Yildirim, E; Amunugama, R; Jones, R; Allen, DL; Edery, I; Kim, EY; Hardin, PE				Mahesh, Guruswamy; Jeong, EunHee; Ng, Fanny S.; Liu, Yixiao; Gunawardhana, Kushan; Houl, Jerry H.; Yildirim, Evrim; Amunugama, Ravi; Jones, Richard; Allen, David L.; Edery, Isaac; Kim, Eun Young; Hardin, Paul E.			Phosphorylation of the Transcription Activator CLOCK Regulates Progression through a similar to 24-h Feedback Loop to Influence the Circadian Period in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLEEP PHASE SYNDROME; DOUBLE-TIME; PROTEIN; KINASE; GENE; RHYTHMS; OSCILLATOR; SITE; MELANOGASTER; MECHANISMS	Circadian (congruent to 24 h) clocks control daily rhythms in metabolism, physiology, and behavior in animals, plants, and microbes. In Drosophila, these clocks keep circadian time via transcriptional feedback loops in which CLOCK-CYCLE (CLK-CYC) initiates transcription of period (per) and timeless (tim), accumulating levels of PER and TIM proteins feed back to inhibit CLK-CYC, and degradation of PER andTIM allows CLK-CYC to initiate the next cycle of transcription. The timing of key events in this feedback loop are controlled by, or coincide with, rhythms in PER and CLK phosphorylation, where PER and CLK phosphorylation is high during transcriptional repression. PER phosphorylation at specific sites controls its subcellular localization, activity, and stability, but comparatively little is known about the identity and function of CLK phosphorylation sites. Here we identify eight CLK phosphorylation sites via mass spectrometry and determine how phosphorylation at these sites impacts behavioral and molecular rhythms by transgenic rescue of a new Clk null mutant. Eliminating phosphorylation at four of these sites accelerates the feedback loop to shorten the circadian period, whereas loss of CLK phosphorylation at serine 859 increases CLK activity, thereby increasing PER levels and accelerating transcriptional repression. These results demonstrate that CLK phosphorylation influences the circadian period by regulating CLK activity and progression through the feedback loop.	[Mahesh, Guruswamy; Ng, Fanny S.; Liu, Yixiao; Gunawardhana, Kushan; Houl, Jerry H.; Hardin, Paul E.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Mahesh, Guruswamy; Ng, Fanny S.; Liu, Yixiao; Gunawardhana, Kushan; Houl, Jerry H.; Hardin, Paul E.] Texas A&M Univ, Ctr Biol Clocks Res, College Stn, TX 77843 USA; [Jeong, EunHee; Kim, Eun Young] Ajou Univ, Dept Brain Sci, Sch Med, Suwon 443380, South Korea; [Amunugama, Ravi; Jones, Richard; Allen, David L.] MS Bioworks LLC, Ann Arbor, MI 48108 USA; [Yildirim, Evrim; Edery, Isaac] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Ajou University; Rutgers State University New Brunswick	Hardin, PE (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	phardin@bio.tamu.edu	Mahesh, Guruswamy/G-2004-2019	Mahesh, Guruswamy/0000-0002-4873-0091; Hardin, Paul/0000-0002-3370-9011	National Institutes of Health [NS034958, NS052854]; Korean National Research Foundation [NRF-2012R1A5A051422, NRF-2012R1A5A048183]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052854, R01NS034958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean National Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS034958 (to I. E.) and NS052854 (to P. E. H.) and Korean National Research Foundation Grants NRF-2012R1A5A051422 and NRF-2012R1A5A048183 (to E. Y. K.).	Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Allada R, 2003, EMBO J, V22, P3367, DOI 10.1093/emboj/cdg318; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 2000, J NEUROSCI, V20, P1746; BAYLIES MK, 1992, NEURON, V9, P575, DOI 10.1016/0896-6273(92)90194-I; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bischof Johannes, 2008, V420, P175, DOI 10.1007/978-1-59745-583-1_10; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Chiu JC, 2011, CELL, V145, P357, DOI 10.1016/j.cell.2011.04.002; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Garbe DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003749; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Hao HP, 1999, J NEUROSCI, V19, P987; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Houl JH, 2006, J BIOL RHYTHM, V21, P93, DOI 10.1177/0748730405283697; Hung HC, 2009, J BIOL CHEM, V284, P23734, DOI 10.1074/jbc.M109.025064; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Kim EY, 2012, GENE DEV, V26, P490, DOI 10.1101/gad.182378.111; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lin JM, 2005, J NEUROSCI, V25, P11175, DOI 10.1523/JNEUROSCI.2159-05.2005; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Luo WF, 2012, GENE DEV, V26, P2536, DOI 10.1101/gad.200584.112; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Nawathean P, 2005, METHOD ENZYMOL, V393, P610, DOI 10.1016/S0076-6879(05)93032-2; Pfeiffenberger C., 2010, DROSOPHILA NEUROBIOL, P483; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; SMITH RF, 1981, MOL GEN GENET, V183, P243, DOI 10.1007/BF00270625; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Szabo A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001645; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yang P, 2006, PROTEOMICS, V6, P927, DOI 10.1002/pmic.200500230; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Yu WJ, 2011, CURR BIOL, V21, P756, DOI 10.1016/j.cub.2011.02.037; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406	58	22	22	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19681	19693		10.1074/jbc.M114.568493	http://dx.doi.org/10.1074/jbc.M114.568493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872414	hybrid, Green Published			2022-12-28	WOS:000339326800040
J	Mohanan, V; Grimes, CL				Mohanan, Vishnu; Grimes, Catherine Leimkuhler			The Molecular Chaperone HSP70 Binds to and Stabilizes NOD2, an Important Protein Involved in Crohn Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; MURAMYL DIPEPTIDE; INNATE; RECOGNITION; ACTIVATION; INHIBITION; EXPRESSION; INDUCTION; MUTATION; CELLS	Microbes are detected by the pathogen-associated molecular patterns through specific host pattern recognition receptors. Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is an intracellular pattern recognition receptor that recognizes fragments of the bacterial cell wall. NOD2 is important to human biology; when it is mutated it loses the ability to respond properly to bacterial cell wall fragments. To determine the mechanisms of misactivation in the NOD2 Crohn mutants, we developed a cell-based system to screen for protein-protein interactors of NOD2. We identified heat shock protein 70 (HSP70) as a protein interactor of both wild type and Crohn mutant NOD2. HSP70 has previously been linked to inflammation, especially in the regulation of anti-inflammatory molecules. Induced HSP70 expression in cells increased the response of NOD2 to bacterial cell wall fragments. In addition, an HSP70 inhibitor, KNK437, was capable of decreasing NOD2-mediated NF-kappa B activation in response to bacterial cell wall stimulation. We found HSP70 to regulate the half-life of NOD2, as increasing the HSP70 level in cells increased the half-life of NOD2, and down-regulating HSP70 decreased the half-life of NOD2. The expression levels of the Crohn-associated NOD2 variants were less compared with wild type. The overexpression of HSP70 significantly increased NOD2 levels as well as the signaling capacity of the mutants. Thus, our study shows that restoring the stability of the NOD2 Crohn mutants is sufficient for rescuing the ability of these mutations to signal the presence of a bacterial cell wall ligand.	[Mohanan, Vishnu; Grimes, Catherine Leimkuhler] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Grimes, Catherine Leimkuhler] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	University of Delaware; University of Delaware	Grimes, CL (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	cgrimes@udel.edu			Delaware IDeA Network of Biomedical Research Excellence, National Institutes of Health [8 P20 GM103446-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446, P20GM103541] Funding Source: NIH RePORTER	Delaware IDeA Network of Biomedical Research Excellence, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Dr. John C. Kappes (University of Alabama, Birmingham) for kindly providing lentiviral vector K2605. We acknowledge Leila Choe and Professor Kelvin Lee at the University of Delaware Proteomics and Mass Spectrometry Facility, which is supported in part by the Delaware IDeA Network of Biomedical Research Excellence, National Institutes of Health Grant 8 P20 GM103446-13, for the mass spectrometry and protein identification. We thank Dr. Brian Bahnson and Amy Schaefer for critical reading of the manuscript.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Afrazi A, 2012, J IMMUNOL, V188, P4543, DOI 10.4049/jimmunol.1103114; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Benabdellah K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023734; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Borzutzky A, 2010, CLIN IMMUNOL, V134, P251, DOI 10.1016/j.clim.2009.05.005; Brodsky I, 2007, CELL, V130, P979, DOI 10.1016/j.cell.2007.09.009; De Felipe P, 2000, HUM GENE THER, V11, P1921, DOI 10.1089/10430340050129530; Fava F, 2010, NAT REV GASTRO HEPAT, V7, P126, DOI 10.1038/nrgastro.2010.1; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kinnebrew MA, 2012, IMMUNOL REV, V245, P113, DOI 10.1111/j.1600-065X.2011.01081.x; Lee KH, 2005, EXP CELL RES, V307, P276, DOI 10.1016/j.yexcr.2005.03.014; Lee KH, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410027; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li PL, 2011, CIRC RES, V108, P458, DOI 10.1161/CIRCRESAHA.110.227835; Lipinski S, 2012, P NATL ACAD SCI USA, V109, P21426, DOI 10.1073/pnas.1209673109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Mohanan V, 2013, CLIN EXP METASTAS, V30, P507, DOI 10.1007/s10585-012-9555-4; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Onesto C, 2004, J BIOL CHEM, V279, P34217, DOI 10.1074/jbc.M400219200; Richmond AL, 2012, GASTROENTEROLOGY, V142, P1483, DOI 10.1053/j.gastro.2012.02.040; Rossi FMV, 1998, NAT GENET, V20, P389, DOI 10.1038/3871; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Springer ML, 1997, SOMAT CELL MOLEC GEN, V23, P203, DOI 10.1007/BF02721371; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Vinokurov M, 2012, CELL STRESS CHAPERON, V17, P89, DOI 10.1007/s12192-011-0288-0; Warner N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003305; Wiech M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051426; Wright SD, 1999, J EXP MED, V189, P605, DOI 10.1084/jem.189.4.605; Yokota S, 2000, CANCER RES, V60, P2942; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhao L, 2007, J BIOL CHEM, V282, P11618, DOI 10.1074/jbc.M608644200	51	29	33	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18987	18998		10.1074/jbc.M114.557686	http://dx.doi.org/10.1074/jbc.M114.557686			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24790089	Green Published, hybrid			2022-12-28	WOS:000339062900031
J	Thom, SR; Bhopale, VM; Yang, M				Thom, Stephen R.; Bhopale, Veena M.; Yang, Ming			Neutrophils Generate Microparticles during Exposure to Inert Gases Due to Cytoskeletal Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROTEIN DISULFIDE-ISOMERASE; ACTIN S-NITROSYLATION; NITRIC-OXIDE SYNTHASE; CNS OXYGEN-TOXICITY; SINGLET OXYGEN; DECOMPRESSION; ACTIVATION; AIR; MECHANISM	This investigation was to elucidate the mechanism for microparticle (MP) formation triggered by exposures to high pressure inert gases. Human neutrophils generate MPs at a threshold of similar to 186 kilopascals with exposures of 30 min or more. Murine cells are similar, but MP production occurs at a slower rate and continues for similar to 4 h, whether or not cells remain under pressure. Neutrophils exposed to elevated gas but not hydrostatic pressure produce MPs according to the potency series: argon similar or equal to nitrogen > helium. Following a similar pattern, gases activate type-2 nitric-oxide synthase (NOS-2) and NADPH oxidase (NOX). MP production does not occur with neutrophils exposed to a NOX inhibitor (Nox2ds) or a NOS-2 inhibitor (1400W) or with cells from mice lacking NOS-2. Reactive species cause S-nitrosylation of cytosolic actin that enhances actin polymerization. Protein cross-linking and immunoprecipitation studies indicate that increased polymerization occurs because of associations involving vasodilator-stimulated phosphoprotein, focal adhesion kinase, the H+/K+ ATPase beta (flippase), the hematopoietic cell multidrug resistance protein ABC transporter (floppase), and protein-disulfide isomerase in proximity to short actin filaments. Using chemical inhibitors or reducing cell concentrations of any of these proteins with small inhibitory RNA abrogates NOS-2 activation, reactive species generation, actin polymerization, and MP production. These effects were also inhibited in cells exposed to UV light, which photoreverses S-nitrosylated cysteine residues and by co-incubations with the antioxidant ebselen or cytochalasin D. The autocatalytic cycle of protein activation is initiated by inert gas-mediated singlet O-2 production.	[Thom, Stephen R.; Bhopale, Veena M.; Yang, Ming] Univ Maryland, Dept Emergency Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Thom, SR (corresponding author), Univ Maryland, Dept Emergency Med, 655 W Baltimore St,Bressler Res Bldg,Rm 4-01, Baltimore, MD 21201 USA.	sthom@smail.umaryland.edu			Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work was supported by a grant from the Office of Naval Research.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Alfonso P, 2006, PROTEOMICS, V6, pS262, DOI 10.1002/pmic.200500350; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; Arieli R, 2005, J APPL PHYSIOL, V98, P144, DOI 10.1152/japplphysiol.00506.2004; BELL RM, 1981, J LIPID RES, V22, P391; BERGHAGE TE, 1979, UNDERSEA BIOMED RES, V6, P379; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; BITTERMAN N, 1987, UNDERSEA BIOMED RES, V14, P477; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Brandes RP, 2014, ANTIOXID REDOX SIGN, V20, P887, DOI 10.1089/ars.2013.5414; BRAUER RW, 1982, J APPL PHYSIOL, V53, P192, DOI 10.1152/jappl.1982.53.1.192; Cauwenberghs S, 2006, FEBS LETT, V580, P5313, DOI 10.1016/j.febslet.2006.08.082; Chapple SJ, 2013, REDOX BIOL, V1, P319, DOI 10.1016/j.redox.2013.04.001; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; Daniliuc S, 2003, J IMMUNOL, V171, P3225, DOI 10.4049/jimmunol.171.6.3225; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; Di Mascio P, 1997, BIOL CHEM, V378, P1071; ECKENHOFF RG, 1990, J APPL PHYSIOL, V69, P914, DOI 10.1152/jappl.1990.69.3.914; Enjeti AK, 2008, SEMIN THROMB HEMOST, V34, P683, DOI 10.1055/s-0028-1104547; Flynn E. T. J., 1971, P 4 S UND PHYS NEW Y, P179, DOI [10.1016/b978-0-12-434750-2.50028-9, DOI 10.1016/B978-0-12-434750-2.50028-9]; Freyssinet JM, 2010, THROMB RES, V125, pS46, DOI 10.1016/j.thromres.2010.01.036; Gharib B, 2001, CR ACAD SCI III-VIE, V324, P719, DOI 10.1016/S0764-4469(01)01350-6; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; Gollmer A, 2011, PHOTOCHEM PHOTOBIOL, V87, P671, DOI 10.1111/j.1751-1097.2011.00900.x; Hild M, 1999, J PHYS CHEM A, V103, P6091, DOI 10.1021/jp9906942; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Jackson TS, 1998, CIRC RES, V83, P916; JANDL RC, 1978, J CLIN INVEST, V61, P1176, DOI 10.1172/JCI109033; Kasorn A, 2009, J IMMUNOL, V183, P1032, DOI 10.4049/jimmunol.0802984; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Kramarenko GG, 2006, PHOTOCHEM PHOTOBIOL, V82, P1634, DOI 10.1562/2006-01-12-RN-774; Li MY, 2001, PHOTOCHEM PHOTOBIOL, V74, P760, DOI 10.1562/0031-8655(2001)074<0760:QOSMOO>2.0.CO;2; Lillo RS, 2000, J APPL PHYSIOL, V89, P2107, DOI 10.1152/jappl.2000.89.6.2107; Madden LA, 2010, AVIAT SPACE ENVIR MD, V81, P41, DOI 10.3357/ASEM.2610.2010; MILLER SL, 1969, NATURE, V221, P468, DOI 10.1038/221468a0; Minaev BF, 2003, SPECTROCHIM ACTA A, V59, P3387, DOI 10.1016/S1386-1425(03)00165-3; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; OSTLUND A, 1994, J APPL PHYSIOL, V76, P439, DOI 10.1152/jappl.1994.76.1.439; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Pagel PS, 2008, ANESTH ANALG, V107, P762, DOI 10.1213/ane.0b013e3181815995; Pecci L, 2001, BIOCHEM BIOPH RES CO, V289, P305, DOI 10.1006/bbrc.2001.5971; Pescatore LA, 2012, J BIOL CHEM, V287, P29290, DOI 10.1074/jbc.M112.394551; Pirro M, 2008, ATHEROSCLEROSIS, V197, P757, DOI 10.1016/j.atherosclerosis.2007.07.012; Pontier JM, 2012, APPL PHYSIOL NUTR ME, V37, P888, DOI [10.1139/h2012-067, 10.1139/H2012-067]; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Sanders RD, 2010, CRIT CARE, V14, DOI 10.1186/cc8847; Santos CXC, 2009, J LEUKOCYTE BIOL, V86, P989, DOI 10.1189/jlb.0608354; SHIMAMORI H, 1984, J CHEM PHYS, V81, P1271, DOI 10.1063/1.447813; Swift LM, 2000, AM J PHYSIOL-HEART C, V278, pH982, DOI 10.1152/ajpheart.2000.278.3.H982; THOM SR, 1987, UNDERSEA BIOMED RES, V14, P485; THOM SR, 1984, APPL ENVIRON MICROB, V47, P780, DOI 10.1128/AEM.47.4.780-787.1984; THOM SR, 1992, ARCH BIOCHEM BIOPHYS, V295, P391, DOI 10.1016/0003-9861(92)90532-2; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2013, J APPL PHYSIOL, V114, P1396, DOI 10.1152/japplphysiol.00106.2013; Thom SR, 2013, J APPL PHYSIOL, V114, P550, DOI 10.1152/japplphysiol.01386.2012; Thom SR, 2013, J BIOL CHEM, V288, P4810, DOI 10.1074/jbc.M112.426353; Thom SR, 2012, J BIOL CHEM, V287, P30346, DOI 10.1074/jbc.M112.355875; Thom SR, 2012, J APPL PHYSIOL, V112, P1268, DOI 10.1152/japplphysiol.01305.2011; Thom SR, 2011, J BIOL CHEM, V286, P32854, DOI 10.1074/jbc.M111.255778; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Tomazzolli R, 2006, ANAL BIOCHEM, V350, P105, DOI 10.1016/j.ab.2005.11.037; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Vince RV, 2009, EUR J APPL PHYSIOL, V105, P507, DOI 10.1007/s00421-008-0927-z; von Montfort C, 2006, BIOL CHEM, V387, P1399, DOI 10.1515/BC.2006.175; Weast R. C., 1984, HDB CHEM PHYS; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Yang M, 2013, J APPL PHYSIOL, V115, P1481, DOI 10.1152/japplphysiol.00745.2013; Yang M, 2012, J APPL PHYSIOL, V112, P204, DOI 10.1152/japplphysiol.00953.2011	69	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18831	18845		10.1074/jbc.M113.543702	http://dx.doi.org/10.1074/jbc.M113.543702			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24867949	Green Published, hybrid			2022-12-28	WOS:000339062900018
J	Tu, CF; Tsao, KC; Lee, SJ; Yang, RB				Tu, Cheng-Fen; Tsao, Ku-Chi; Lee, Shyh-Jye; Yang, Ruey-Bing			SCUBE3 (Signal Peptide-CUB-EGF Domain-containing Protein 3) Modulates Fibroblast Growth Factor Signaling during Fast Muscle Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; IN-VIVO; EMBRYONIC-DEVELOPMENT; CRYSTAL-STRUCTURE; ZEBRAFISH; EXPRESSION; FGF8; DIFFERENTIATION; GENE; IDENTIFICATION	SCUBE3 (signal peptide CUB-EGF-like domain-containing protein 3) belongs to a newly identified secreted and cell membrane- associated SCUBE family, which is evolutionarily conserved in vertebrates. Scube3 is predominantly expressed in a variety of developing tissues in mice such as somites, neural tubes, and limb buds. However, its function during development remains unclear. In this study, we first showed that knockdown of SCUBE3 in C2C12 myoblasts inhibited FGF receptor 4 expression and FGF signaling, thus resulting in reduced myogenic differentiation. Furthermore, knockdown of zebrafish scube3 by antisense morpholino oligonucleotides specifically suppressed the expression of the myogenic marker myod1 within the lateral fast muscle precursors, whereas its expression in the adaxial slow muscle precursors was largely unaffected. Consistent with these findings, immunofluorescent staining of fast but not slow muscle myosin was markedly decreased in scube3 morphants. Further genetic studies identified fgf8 as a key regulator in scube3-mediated fast muscle differentiation in zebrafish. Biochemical and molecular analysis showed that SCUBE3 acts as a FGF co-receptor to augment FGF8 signaling. Scube3 may be a critical upstream regulator of fast fiber myogenesis by modulating fgf8 signaling during zebrafish embryogenesis.	[Tu, Cheng-Fen; Tsao, Ku-Chi; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Tsao, Ku-Chi; Yang, Ruey-Bing] Acad Sinica, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Program Mol Med, Taiwan Int Grad Program, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Yang, Ruey-Bing] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Yang, Ruey-Bing] Natl Yang Ming Univ, Inst Pharmacol, Taipei 11221, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Dept Life Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University	Yang, RB (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	rbyang@ibms.sinica.edu.tw	Lee, Shyh-Jye/C-6092-2008; Yang, Ruey-Bing/O-1494-2018	Lee, Shyh-Jye/0000-0001-8452-9152; Yang, Ruey-Bing/0000-0003-3017-3714; Tu, Cheng-Fen/0000-0003-3624-7884	United States NICHD, National Institutes of Health	United States NICHD, National Institutes of Health	We thank the Taiwan Zebrafish Core Facility at Academia Sinica for providing zebrafish and some ISH probes used in this study. RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center of Academia Sinica. The F59, F310, and MF20 monoclonal antibodies developed by F. E. Stockdale and D. A. Fischman were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the United States NICHD, National Institutes of Health and maintained by the Department of Biology of the University of Iowa (Iowa City, IA).	Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; CADENA DL, 1992, FASEB J, V6, P2332, DOI 10.1096/fasebj.6.6.1312047; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Feng XS, 2006, DEV BIOL, V300, P736, DOI 10.1016/j.ydbio.2006.08.056; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09; Hamade A, 2006, DEV BIOL, V289, P127, DOI 10.1016/j.ydbio.2005.10.019; Hammond CL, 2007, DEV BIOL, V302, P504, DOI 10.1016/j.ydbio.2006.10.009; Haworth K, 2007, GENE EXPR PATTERNS, V7, P630, DOI 10.1016/j.modgep.2006.12.004; Hughes SM, 1999, CURR OPIN NEUROBIOL, V9, P54, DOI 10.1016/S0959-4388(99)80007-5; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; Kim GY, 2012, MOL CELL BIOL, V32, P4482, DOI 10.1128/MCB.00872-12; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwiatkowski BA, 2008, J CELL PHYSIOL, V215, P803, DOI 10.1002/jcp.21365; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lin YC, 2011, J BIOL CHEM, V286, P27039, DOI 10.1074/jbc.M111.244418; Marics I, 2002, DEVELOPMENT, V129, P4559; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Reifers F, 1998, DEVELOPMENT, V125, P2381; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Scata KA, 1999, EXP CELL RES, V250, P10, DOI 10.1006/excr.1999.4506; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Stickney HL, 2000, DEV DYNAM, V219, P287; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsai MT, 2009, BIOCHEM J, V422, P119, DOI 10.1042/BJ20090341; Tsao KC, 2013, J BIOL CHEM, V288, P5017, DOI 10.1074/jbc.M112.375196; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Wu YY, 2011, ONCOGENE, V30, P3682, DOI 10.1038/onc.2011.85; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xavier GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055274; Xavier GM, 2011, J MOL HISTOL, V42, P383, DOI 10.1007/s10735-011-9341-7; Yang HY, 2007, CARDIOVASC RES, V75, P139, DOI 10.1016/j.cardiores.2007.03.014; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	43	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18928	18942		10.1074/jbc.M114.551929	http://dx.doi.org/10.1074/jbc.M114.551929			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849601	Green Published, hybrid			2022-12-28	WOS:000339062900026
J	Gealekman, O; Gurav, K; Chouinard, M; Straubhaar, J; Thompson, M; Malkani, S; Hartigan, C; Corvera, S				Gealekman, Olga; Gurav, Kunal; Chouinard, My; Straubhaar, Juerg; Thompson, Michael; Malkani, Samir; Hartigan, Celia; Corvera, Silvia			Control of Adipose Tissue Expandability in Response to High Fat Diet by the Insulin-like Growth Factor-binding Protein-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL PROLIFERATION; FACTOR-I; OBESITY; ANGIOGENESIS; HYPOXIA; RESISTANCE; MACROPHAGES; EXPRESSION; WHITE; RAT	Adipose tissue expansion requires growth and proliferation of adipocytes and the concomitant expansion of their stromovascular network. We have used an ex vivo angiogenesis assay to study the mechanisms involved in adipose tissue expansion. In this assay, adipose tissue fragments placed under pro-angiogenic conditions form sprouts composed of endothelial, perivascular, and other proliferative cells. We find that sprouting was directly stimulated by insulin and was enhanced by prior treatment of mice with the insulin sensitizer rosiglitazone. Moreover, basal and insulin-stimulated sprouting increased progressively over 30 weeks of high fat diet feeding, correlating with tissue expansion during this period. cDNA microarrays analyzed to identify genes correlating with insulin-stimulated sprouting surprisingly revealed only four positively correlating (Fads3, Tmsb10, Depdc6, and Rasl12) and four negatively correlating (Asph, IGFbp4, Ppm1b, and Adcyap1r1) genes. Amongthe proteins encoded by these genes, IGFbp4, which suppresses IGF-1 signaling, has been previously implicated in angiogenesis, suggesting a role for IGF-1 in adipose tissue expandability. Indeed, IGF-1 potently stimulated sprouting, and the presence of activated IGF-1 receptors in the vasculature was revealed by immunostaining. Recombinant IGFbp4 blocked the effects of insulin and IGF-1 on mouse adipose tissue sprouting and also suppressed sprouting from human subcutaneous adipose tissue. These results reveal an important role of IGF-1/IGFbp4signaling in post-developmental adipose tissue expansion.	[Gealekman, Olga; Gurav, Kunal; Chouinard, My; Straubhaar, Juerg; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Thompson, Michael; Malkani, Samir; Hartigan, Celia] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Thompson, Michael] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantation St, Worcester, MA 01605 USA.	silvia.corvera@umassmed.edu	Gurav, Kunal/Y-3579-2019		University of Massachusetts Diabetes Center of Excellence; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089101] Funding Source: NIH RePORTER	University of Massachusetts Diabetes Center of Excellence; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Morphology and Bioinformatics Core Services were supported by the University of Massachusetts Diabetes Center of Excellence.	ALARID ET, 1992, ENDOCRINOLOGY, V130, P2305, DOI 10.1210/en.130.4.2305; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouloumie A, 2002, ANN ENDOCRINOL-PARIS, V63, P91; Carnesecchi S, 2006, EXP CELL RES, V312, P3413, DOI 10.1016/j.yexcr.2006.07.003; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Clemmons D. R., 2012, ENDOCRINOL METAB CLI; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Gealekman O, 2011, CIRCULATION, V123, P186, DOI 10.1161/CIRCULATIONAHA.110.970145; Goossens GH, 2011, CIRCULATION, V124, P67, DOI 10.1161/CIRCULATIONAHA.111.027813; Gousseva N, 2001, J CELL BIOCHEM, V81, P523, DOI 10.1002/1097-4644(20010601)81:3<523::AID-JCB1066>3.0.CO;2-E; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Jehle PM, 1998, J ENDOCRINOL, V159, P297, DOI 10.1677/joe.0.1590297; Jo J, 2010, BIOPHYS J, V99, P3535, DOI 10.1016/j.bpj.2010.10.009; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Lassance L, 2013, J CLIN ENDOCR METAB, V98, pE1438, DOI 10.1210/jc.2013-1210; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; Mazzatti D, 2012, ARCH PHYSIOL BIOCHEM, V118, P112, DOI 10.3109/13813455.2012.654611; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Owen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032700; Pasarica M, 2010, J CLIN ENDOCR METAB, V95, P4052, DOI 10.1210/jc.2009-2377; PHILLIPS LS, 1991, DIABETES, V40, P1525, DOI 10.2337/diabetes.40.11.1525; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Qiao JG, 2005, WORLD J GASTROENTERO, V11, P5978, DOI 10.3748/wjg.v11.i38.5978; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rojas-Rodriguez R, 2014, METHOD ENZYMOL, V537, P75, DOI 10.1016/B978-0-12-411619-1.00005-7; RUSSELLJONES DL, 1992, J MOL ENDOCRINOL, V9, P257, DOI 10.1677/jme.0.0090257; Ryan AJ, 2009, BRIT J CANCER, V101, P278, DOI 10.1038/sj.bjc.6605141; SCHEIWILLER E, 1986, NATURE, V323, P169, DOI 10.1038/323169a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Spencer M, 2011, J CLIN ENDOCR METAB, V96, pE1990, DOI 10.1210/jc.2011-1567; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tchoukalova YD, 2009, BIOCHEM BIOPH RES CO, V380, P679, DOI 10.1016/j.bbrc.2009.01.149; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509	50	39	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18327	18338		10.1074/jbc.M113.545798	http://dx.doi.org/10.1074/jbc.M113.545798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24778188	Green Published, hybrid			2022-12-28	WOS:000338042000032
J	Hansbro, PM; Hamilton, MJ; Fricker, M; Gellatly, SL; Jarnicki, AG; Zheng, D; Frei, SM; Wong, GW; Hamadi, S; Zhou, SJ; Foster, PS; Krilis, SA; Stevens, RL				Hansbro, Philip M.; Hamilton, Matthew J.; Fricker, Michael; Gellatly, Shaan L.; Jarnicki, Andrew G.; Zheng, Dominick; Frei, Sandra M.; Wong, G. William; Hamadi, Sahar; Zhou, Saijun; Foster, Paul S.; Krilis, Steven A.; Stevens, Richard L.			Importance of Mast Cell Prss31/Transmembrane Tryptase/Tryptase-gamma in Lung Function and Experimental Chronic Obstructive Pulmonary Disease and Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-INFECTIONS; ACTIVATED RECEPTOR-2; ULCERATIVE-COLITIS; SERINE PROTEASES; TRYPTASE MMCP-6; MICE DEFICIENT; BONE-MARROW; MOUSE MODEL; GENE; TRANSCRIPTION	Protease serine member S31 (Prss31)/transmembrane tryptase/tryptase-gamma is a mast cell (MC)-restricted protease of unknown function that is retained on the outer leaflet of the plasma membrane when MCs are activated. We determined the nucleotide sequences of the Prss31 gene in different mouse strains and then used a Cre/loxP homologous recombination approach to create a novel Prss31(-/-) C57BL/6 mouse line. The resulting animals exhibited no obvious developmental abnormality, contained normal numbers of granulated MCs in their tissues, and did not compensate for their loss of the membrane tryptase by increasing their expression of other granule proteases. When Prss31-null MCs were activated with a calcium ionophore or by their high affinity IgE receptors, they degranulated in a pattern similar to that of WT MCs. Prss31-null mice had increased baseline airway reactivity to methacholine but markedly reduced experimental chronic obstructive pulmonary disease and colitis, thereby indicating both beneficial and adverse functional roles for the tryptase. In a cigarette smoke-induced model of chronic obstructive pulmonary disease, WT mice had more pulmonary macrophages, higher histopathology scores, and more fibrosis in their small airways than similarly treated Prss31-null mice. In a dextran sodium sulfate-induced acute colitis model, WT mice lost more weight, had higher histopathology scores, and contained more Cxcl-2 and IL-6 mRNA in their colons than similarly treated Prss31-null mice. The accumulated data raise the possibility that inhibitors of this membrane tryptase may provide additional therapeutic benefit in the treatment of humans with these MC-dependent inflammatory diseases.	[Hansbro, Philip M.; Fricker, Michael; Gellatly, Shaan L.; Jarnicki, Andrew G.; Foster, Paul S.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2308, Australia; [Hansbro, Philip M.; Fricker, Michael; Gellatly, Shaan L.; Jarnicki, Andrew G.; Foster, Paul S.] Hunter Med Res Inst, Newcastle, NSW 2308, Australia; [Hamilton, Matthew J.; Zheng, Dominick; Frei, Sandra M.; Hamadi, Sahar; Stevens, Richard L.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Hamilton, Matthew J.; Zheng, Dominick; Frei, Sandra M.; Hamadi, Sahar; Stevens, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Zhou, Saijun; Krilis, Steven A.] St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Kogarah, NSW 2217, Australia; [Zhou, Saijun; Krilis, Steven A.] Univ New S Wales, Kogarah, NSW 2217, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; St George Hospital; University of New South Wales Sydney	Stevens, RL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 616B,1 Jimmy Fund Way, Boston, MA 02115 USA.	rstevens@rics.bwh.harvard.edu	Gellatly, Shaan/AAT-1638-2021; Foster, Paul/G-5057-2013; Hansbro, Phil/G-7486-2013; FRICKER, MICHAEL/ABE-2316-2021	Gellatly, Shaan/0000-0002-7361-2337; Hansbro, Phil/0000-0002-4741-3035; Fricker, Michael/0000-0002-8587-1774; Zheng, Dominick/0000-0002-2399-9916; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK094971, AI059746]; National Health and Medical Research Council of Australia; Harvard Digestive Diseases Center; Saint George Medical Research Foundation; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK094971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Harvard Digestive Diseases Center; Saint George Medical Research Foundation; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK094971 and AI059746. This work was also supported by the National Health and Medical Research Council of Australia, the Harvard Digestive Diseases Center, the Saint George Medical Research Foundation, and by research fellowship grants from the Harvard Club of Australia Foundation (to S. A. K., R. L. S., P. S. F., and D. Z.).	Bar-Shavit R, 2002, IMMUNOLOGY, V105, P35, DOI 10.1046/j.0019-2805.2001.01351.x; Beckett EL, 2013, J ALLERGY CLIN IMMUN, V131, P752, DOI 10.1016/j.jaci.2012.11.053; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; COHEN BH, 1977, AM J EPIDEMIOL, V105, P223, DOI 10.1093/oxfordjournals.aje.a112378; De Campo BA, 2005, BRIT J PHARMACOL, V144, P1100, DOI 10.1038/sj.bjp.0706150; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P303, DOI 10.1111/apm.1966.66.3.303; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Fricker M, 2014, EXPERT OPIN DRUG DIS, V9, P629, DOI 10.1517/17460441.2014.909805; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; GALLI SJ, 1993, AGENT ACTION SUPPL, V43, P209; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; GHILDYAL N, 1993, J IMMUNOL, V151, P3206; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; GRUBER BL, 1988, J IMMUNOL, V140, P3936; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; KITAMURA Y, 1978, BLOOD, V52, P447; Magarinos NJ, 2013, J IMMUNOL, V191, P1404, DOI 10.4049/jimmunol.1300856; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; Morii E, 2001, BIOCHEM BIOPH RES CO, V289, P1243, DOI 10.1006/bbrc.2001.6077; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; POLLER W, 1989, HUM GENET, V83, P93, DOI 10.1007/BF00274157; Prieto-Garcia A, 2012, J BIOL CHEM, V287, P7834, DOI 10.1074/jbc.M111.325712; RAZIN E, 1984, J IMMUNOL, V132, P1479; RAZIN E, 1982, P NATL ACAD SCI-BIOL, V79, P4665, DOI 10.1073/pnas.79.15.4665; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Wong GW, 2002, J BIOL CHEM, V277, P41906, DOI 10.1074/jbc.M205868200; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784; Yuan J, 2006, PROTEIN EXPRES PURIF, V49, P47, DOI 10.1016/j.pep.2006.04.018	49	64	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18214	18227		10.1074/jbc.M114.548594	http://dx.doi.org/10.1074/jbc.M114.548594			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24821729	Green Published, hybrid			2022-12-28	WOS:000338042000023
J	Johansson, P; Jeffery, J; Al-Ejeh, F; Schulz, RB; Callen, DF; Kumar, R; Khanna, KK				Johansson, Pegah; Jeffery, Jessie; Al-Ejeh, Fares; Schulz, Renee B.; Callen, David F.; Kumar, Raman; Khanna, Kum Kum			SCF-FBXO31 E3 Ligase Targets DNA Replication Factor Cdt1 for Proteolysis in the G(2) Phase of Cell Cycle to Prevent Re-replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCF UBIQUITIN LIGASE; LICENSING FACTOR CDT1; F-BOX PROTEINS; HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS; GEMININ BINDING; D1 DEGRADATION; S-PHASE; CANCER	FBXO31 was originally identified as a putative tumor suppressor gene in breast, ovarian, hepatocellular, and prostate cancers. By screening a set of cell cycle-regulated proteins as potential FBXO31 interaction partners, we have now identified Cdt1 as a novel substrate. Cdt1 DNA replication licensing factor is part of the pre-replication complex and essential for the maintenance of genomic integrity. We show that FBXO31 specifically interacts with Cdt1 and regulates its abundance by ubiquitylation leading to subsequent degradation. We also show that Cdt1 regulation by FBXO31 is limited to the G(2) phase of the cell cycle and is independent of the pathways previously described for Cdt1 proteolysis in S and G(2) phase. FBXO31 targeting of Cdt1 is mediated through the N terminus of Cdt1, a region previously shown to be responsible for its cell cycle regulation. Finally, we show that Cdt1 stabilization due to FBXO31 depletion results in re-replication. Our data present an additional pathway that contributes to the FBXO31 function as a tumor suppressor.	[Johansson, Pegah] Sahlgrens Univ Hosp, Dept Clin Chem, S-41345 Gothenburg, Sweden; [Schulz, Renee B.; Callen, David F.] Univ Adelaide, Ctr Personalised Canc Med, Adelaide, SA 5000, Australia; [Schulz, Renee B.; Callen, David F.] Univ Adelaide, Discipline Med, Adelaide, SA 5000, Australia; [Kumar, Raman] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5006, Australia; [Kumar, Raman] Univ Adelaide, Discipline Med, Adelaide, SA 5006, Australia; [Kumar, Raman] Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Jeffery, Jessie; Al-Ejeh, Fares; Khanna, Kum Kum] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Brisbane, Qld 4006, Australia	Sahlgrenska University Hospital; University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; Womens & Childrens Hospital Australia; QIMR Berghofer Medical Research Institute	Kumar, R (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5006, Australia.	raman.sharma@adelaide.edu.au; KumKum.Khanna@qimrberghofer.edu.au	Kumar, Raman/AHE-0538-2022; Al-Ejeh, Fares/M-7032-2016	Kumar, Raman/0000-0001-7976-8386; Al-Ejeh, Fares/0000-0002-1553-0077; Callen, David/0000-0002-6189-9991; Khanna, Kum Kum/0000-0001-8650-5381	Cancer Council of South Australia; Swedish Research Council; National Breast Cancer Foundation; Cancer Council Queensland, Australia	Cancer Council of South Australia(Cancer Council South Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Breast Cancer Foundation; Cancer Council Queensland, Australia(Cancer Council Queensland)	This work was supported by the Cancer Council of South Australia, the Swedish Research Council, the National Breast Cancer Foundation, and the Cancer Council Queensland, Australia.	Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chan CH, 2010, THESCIENTIFICWORLDJO, V10, P1001, DOI 10.1100/tsw.2010.89; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Harkonen P, 2005, PROSTATE, V62, P267, DOI 10.1002/pros.20147; Huang HL, 2010, ONCOL REP, V24, P715, DOI 10.3892/or_00000912; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kanie T, 2012, MOL CELL BIOL, V32, P590, DOI 10.1128/MCB.06570-11; Klotz-Noack K, 2012, J CELL SCI, V125, P2436, DOI 10.1242/jcs.100883; Kogo R, 2011, INT J ONCOL, V39, P155, DOI 10.3892/ijo.2011.1018; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Launonen V, 2000, CANCER GENET CYTOGEN, V122, P49, DOI 10.1016/S0165-4608(00)00279-X; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lin YW, 2001, INT J CANCER, V93, P74, DOI 10.1002/ijc.1287; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; Miller BJ, 2003, AM J HUM GENET, V73, P748, DOI 10.1086/378522; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Schwartz AL, 1999, ANNU REV MED, V50, P57; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Soderberg Ola, 2007, Genet Eng (N Y), V28, P85, DOI 10.1007/978-0-387-34504-8_5; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Vadhvani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057530; Varma D, 2012, NAT CELL BIOL, V14, P593, DOI 10.1038/ncb2489; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yoshida K, 2005, GENES CELLS, V10, P63, DOI 10.1111/j.1365-2443.2005.00815.x; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	46	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18514	18525		10.1074/jbc.M114.559930	http://dx.doi.org/10.1074/jbc.M114.559930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828503	Green Published, hybrid			2022-12-28	WOS:000338042000048
J	Xu, C; Liu, K; Tempel, W; Demetriades, M; Aik, W; Schofield, CJ; Min, JR				Xu, Chao; Liu, Ke; Tempel, Wolfram; Demetriades, Marina; Aik, WeiShen; Schofield, Christopher J.; Min, Jinrong			Structures of Human ALKBH5 Demethylase Reveal a Unique Binding Mode for Specific Single-stranded N-6-Methyladenosine RNA Demethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DEMETHYLATION; CRYSTAL-STRUCTURES; ALKYLATION DAMAGE; JMJD2 FAMILY; NUCLEAR-RNA; FTO GENE; PROTEIN; DNA; SUBSTRATE; OBESITY	N-6-Methyladenosine (m(6)A) is the most prevalent internal RNA modification in eukaryotes. ALKBH5 belongs to the AlkB family of dioxygenases and has been shown to specifically demethylate m6A in single-stranded RNA. Here we report crystal structures of ALKBH5 in the presence of either its cofactors or the ALKBH5 inhibitor citrate. Catalytic assays demonstrate that the ALKBH5 catalytic domain can demethylate both single-stranded RNA and single-stranded DNA. We identify the TCA cycle intermediate citrate as a modest inhibitor of ALKHB5 (IC50, similar to 488 mu M). The structural analysis reveals that a loop region of ALKBH5 is immobilized by a disulfide bond that apparently excludes the binding of dsDNA to ALKBH5. We identify the m(6)A binding pocket of ALKBH5 and the key residues involved in m(6)A recognition using mutagenesis and ITC binding experiments.	[Xu, Chao; Liu, Ke; Tempel, Wolfram; Min, Jinrong] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China; [Xu, Chao; Liu, Ke; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Liu, Ke; Min, Jinrong] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Demetriades, Marina; Aik, WeiShen; Schofield, Christopher J.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	Central China Normal University; University of Toronto; Structural Genomics Consortium; University of Oxford; University of Toronto	Min, JR (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; , KE/0000-0002-7082-262X; Schofield, Christopher/0000-0002-0290-6565; Aik, Wei Shen/0000-0003-4414-173X	Biotechnological and Biological Research Council; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada through Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Biotechnology and Biological Sciences Research Council [BB/L009846/1] Funding Source: researchfish; BBSRC [BB/L009846/1] Funding Source: UKRI	Biotechnological and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnological and Biological Research Council. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada through Ontario Genomics Institute Grant OGI-055, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and Wellcome Trust Grant 092809/Z/10/Z.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aik W, 2014, NUCLEIC ACIDS RES, V42, P4741, DOI 10.1093/nar/gku085; Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Bokar JA, 1997, RNA, V3, P1233; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Fu D, 2013, GENE DEV, V27, P1089, DOI 10.1101/gad.215533.113; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gildea RJ, 2011, J APPL CRYSTALLOGR, V44, P1259, DOI 10.1107/S0021889811041161; Globisch D, 2011, ANGEW CHEM INT EDIT, V50, P9739, DOI 10.1002/anie.201103229; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lu LH, 2010, NUCLEIC ACIDS RES, V38, P4415, DOI 10.1093/nar/gkq129; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; SANEYOSHI M, 1969, BIOCHIM BIOPHYS ACTA, V190, P264, DOI 10.1016/0005-2787(69)90078-1; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	58	110	125	3	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17299	17311		10.1074/jbc.M114.550350	http://dx.doi.org/10.1074/jbc.M114.550350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24778178	Green Published, hybrid			2022-12-28	WOS:000338018100002
J	Liburd, J; Chitayat, S; Crawley, SW; Munro, K; Miller, E; Denis, CM; Spencer, HL; Cote, GP; Smith, SP				Liburd, Janine; Chitayat, Seth; Crawley, Scott W.; Munro, Kim; Miller, Emily; Denis, Chris M.; Spencer, Holly L.; Cote, Graham P.; Smith, Steven P.			Structure of the Small Dictyostelium discoideum Myosin Light Chain MlcB Provides Insights into MyoB IQ Motif Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; NMR-SPECTROSCOPY; CORTICAL TENSION; APO-CALMODULIN; PROTEIN; MOTILITY; DOMAIN; MOTOR; MUTANTS; COMPLEX	Dictyostelium discoideum MyoB is a class I myosin involved in the formation and retraction of membrane projections, cortical tension generation, membrane recycling, and phagosome maturation. The MyoB-specific, single-lobe EF-hand light chain MlcB binds the sole IQ motif of MyoB with submicromolar affinity in the absence and presence of Ca2+. However, the structural features of this novel myosin light chain and its interaction with its cognate IQ motif remain uncharacterized. Here, we describe the NMR-derived solution structure of apoMlcB, which displays a globular four-helix bundle. Helix 1 adopts a unique orientation when compared with the apo states of the EF-hand calcium-binding proteins calmodulin, S100B, and calbindin D-9k. NMR-based chemical shift perturbation mapping identified a hydrophobic MyoB IQ binding surface that involves amino acid residues in helices I and IV and the functional N-terminal Ca2+ binding loop, a site that appears to be maintained when MlcB adopts the holo state. Complementary mutagenesis and binding studies indicated that residues Ile-701, Phe-705, and Trp-708 of the MyoB IQ motif are critical for recognition of MlcB, which together allowed the generation of a structural model of the apoMlcB-MyoB IQ complex. We conclude that the mode of IQ motif recognition by the novel single-lobe MlcB differs considerably from that of stereotypical bilobal light chains such as calmodulin.	[Liburd, Janine; Chitayat, Seth; Crawley, Scott W.; Miller, Emily; Denis, Chris M.; Spencer, Holly L.; Cote, Graham P.; Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Munro, Kim; Cote, Graham P.; Smith, Steven P.] Queens Univ, Prot Funct Discovery Grp, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Cote, GP (corresponding author), Rm 617 Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada.	coteg@queensu.ca; steven.smith@queensu.ca		Smith, Steven/0000-0003-2710-4400	Natural Science and Engineering Research Council of Canada [RGPIN 391522, RGPIN 398305]; Natural Science and Engineering Research Council	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Science and Engineering Research Council of Canada Discovery Grants RGPIN 391522 (to G. P. C.) and RGPIN 398305 (to S. P. S.).; Recipient of a Natural Science and Engineering Research Council PGS-D doctoral fellowship.	BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Barylko B, 2000, BBA-MOL CELL RES, V1496, P23, DOI 10.1016/S0167-4889(00)00006-9; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzeska H, 2012, J BIOL CHEM, V287, P14923, DOI 10.1074/jbc.M111.318667; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crawley SW, 2011, BIOCHEMISTRY-US, V50, P6579, DOI 10.1021/bi2007178; Crawley SW, 2006, J BIOL CHEM, V281, P6307, DOI 10.1074/jbc.M508670200; Dai JW, 1999, BIOPHYS J, V77, P1168, DOI 10.1016/S0006-3495(99)76968-7; Damo Steven M, 2013, Methods Mol Biol, V963, P173, DOI 10.1007/978-1-62703-230-8_11; De La Roche MA, 2003, BIOCHEM J, V374, P697, DOI 10.1042/BJ20030656; de la Roche MA, 2001, BBA-GEN SUBJECTS, V1525, P245, DOI 10.1016/S0304-4165(01)00110-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Drohat AC, 1996, BIOCHEMISTRY-US, V35, P11577, DOI 10.1021/bi9612226; Drohat AC, 1999, PROTEIN SCI, V8, P800; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Falk DL, 2003, J CELL SCI, V116, P3985, DOI 10.1242/jcs.00696; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Ishida H, 2008, J BIOL CHEM, V283, P14619, DOI 10.1074/jbc.M801398200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1990, J CELL BIOL, V110, P1955, DOI 10.1083/jcb.110.6.1955; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Kollmar M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-183; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORDEL J, 1993, J MOL BIOL, V231, P711, DOI 10.1006/jmbi.1993.1322; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Malik S, 2008, PROTEINS, V73, P28, DOI 10.1002/prot.22037; Marlatt NM, 2007, BIOCHEMISTRY-US, V46, P7478, DOI 10.1021/bi6026242; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; Nelson MR, 1998, PROTEIN SCI, V7, P270; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Osherov N, 2000, CELL MOTIL CYTOSKEL, V47, P163, DOI 10.1002/1097-0169(200011)47:3<163::AID-CM1>3.0.CO;2-U; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Schwarz EC, 2000, J CELL SCI, V113, P621; SKELTON NJ, 1995, J MOL BIOL, V249, P441, DOI 10.1006/jmbi.1995.0308; Soldati Thierry, 1999, Cell Biochemistry and Biophysics, V30, P389, DOI 10.1007/BF02738121; TITUS MA, 1993, MOL BIOL CELL, V4, P233, DOI 10.1091/mbc.4.2.233; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Wessels D, 1996, CELL MOTIL CYTOSKEL, V33, P64, DOI 10.1002/(SICI)1097-0169(1996)33:1<64::AID-CM7>3.0.CO;2-I; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; Wright NT, 2008, J BIOMOL NMR, V42, P279, DOI 10.1007/s10858-008-9282-y; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	58	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17030	17042		10.1074/jbc.M113.536532	http://dx.doi.org/10.1074/jbc.M113.536532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24790102	Green Published, hybrid			2022-12-28	WOS:000338016200037
J	Bianchi, R; Fischer, E; Yuen, D; Ernst, E; Ochsenbein, AM; Chen, L; Otto, VI; Detmar, M				Bianchi, Roberta; Fischer, Eliane; Yuen, Don; Ernst, Ellen; Ochsenbein, Alexandra M.; Chen, Lu; Otto, Vivianne I.; Detmar, Michael			Mutation of Threonine 34 in Mouse Podoplanin-Fc Reduces CLEC-2 Binding and Toxicity in Vivo While Retaining Anti-lymphangiogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHATIC ENDOTHELIAL-CELLS; AGGREGATION-INDUCING FACTOR; ACTIVATION RECEPTOR CLEC-2; LECTIN-LIKE RECEPTORS; PLATELET-AGGREGATION; BLOOD; SEPARATION; MIGRATION; PROTEIN; IDENTIFICATION	The lymphatic system plays an important role in cancer metastasis and inhibition of lymphangiogenesis could be valuable in fighting cancer dissemination. Podoplanin (Pdpn) is a small, transmembrane glycoprotein expressed on the surface of lymphatic endothelial cells (LEC). During mouse development, binding of Pdpn to the C-type lectin-like receptor 2 (CLEC-2) on platelets is critical for the separation of the lymphatic and blood vascular systems. Competitive inhibition of Pdpn functions with a soluble form of the protein, Pdpn-Fc, leads to reduced lymphangiogenesis in vitro and in vivo. However, the transgenic overexpression of human Pdpn-Fc in mouse skin causes disseminated intravascular coagulation due to platelet activation via CLEC-2. In the present study, we produced and characterized a mutant form of mouse Pdpn-Fc, in which threonine 34, which is considered essential for CLEC-2 binding, was mutated to alanine (PdpnT34A-Fc). Indeed, PdpnT34A-Fc displayed a 30-fold reduced binding affinity for CLEC-2 compared with Pdpn-Fc. This also translated into fewer side effects due to platelet activation in vivo. Mice showed less prolonged bleeding time and fewer embolized vessels in the liver, when PdpnT34A-Fc was injected intravenously. However, PdpnT34A-Fc was still as active as wild-type Pdpn-Fc in inhibiting lymphangiogenesis in vitro and also inhibited lymphangiogenesis in vivo. These data suggest that the function of Pdpn in lymphangiogenesis does not depend on threonine 34 in the CLEC-2 binding domain and that PdpnT34A-Fc might be an improved inhibitor of lymphangiogenesis with fewer toxic side effects.	[Bianchi, Roberta; Ernst, Ellen; Ochsenbein, Alexandra M.; Otto, Vivianne I.; Detmar, Michael] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Fischer, Eliane] Paul Scherrer Inst, Ctr Radiopharmaceut Sci, CH-5232 Villigen, Switzerland; [Yuen, Don; Chen, Lu] Univ Calif Berkeley, Ctr Eye Dis & Dev, Program Vis Sci, Berkeley, CA 94720 USA; [Yuen, Don; Chen, Lu] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Detmar, M (corresponding author), ETH, Vladimir Prelog Weg 3,HCI H303, CH-8093 Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Fischer, Eliane/M-2590-2013	Fischer, Eliane/0000-0002-3399-3737; Otto, Vivianne/0000-0002-1157-0186	National Institutes of Health; Swiss National Science Foundation [31003A-130627]; European Research Council Grant LYVICAM; Oncosuisse; Leducq Foundation; Krebsliga Zurich; NATIONAL EYE INSTITUTE [R01EY017392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council Grant LYVICAM; Oncosuisse; Leducq Foundation(Leducq Foundation); Krebsliga Zurich; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health, Swiss National Science Foundation Grant 31003A-130627, European Research Council Grant LYVICAM, Oncosuisse, Krebsliga Zurich, and the Leducq Foundation.	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Cueni LN, 2010, BLOOD, V116, P4376, DOI 10.1182/blood-2010-04-278564; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hess PR, 2014, J CLIN INVEST, V124, P273, DOI 10.1172/JCI70422; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Kaneko M, 2004, J BIOL CHEM, V279, P38838, DOI 10.1074/jbc.M407210200; Kaneko MK, 2006, GENE, V378, P52, DOI 10.1016/j.gene.2006.04.023; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kerrigan AM, 2012, J THROMB HAEMOST, V10, P484, DOI 10.1111/j.1538-7836.2011.04614.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; NOVAKHOFER I, 1992, J NUCL MED, V33, P231; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Pyz E, 2008, EUR J IMMUNOL, V38, P1157, DOI 10.1002/eji.200738057; Pyz E, 2011, METHODS MOL BIOL, V748, P1, DOI 10.1007/978-1-61779-139-0_1; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Scholl FG, 1999, J CELL SCI, V112, P4601; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2011, PLATELETS, V22, P380, DOI 10.3109/09537104.2011.556274; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Valtcheva N, 2013, J BIOL CHEM, V288, P35736, DOI 10.1074/jbc.M113.512954; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; Zhang H, 2011, INVEST OPHTH VIS SCI, V52, P6529, DOI 10.1167/iovs.11-7454; Zuberbuhler K, 2009, PROTEIN ENG DES SEL, V22, P169, DOI 10.1093/protein/gzn068	41	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21016	21027		10.1074/jbc.M114.550525	http://dx.doi.org/10.1074/jbc.M114.550525			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907275	Green Published, hybrid			2022-12-28	WOS:000339396600054
J	Lee, CW; Yang, FC; Chang, HY; Chou, HY; Tan, BCM; Lee, SC				Lee, Chia-Wei; Yang, Fu-Chia; Chang, Hsin-Yun; Chou, Hanyi; Tan, Bertrand Chin-Ming; Lee, Sheng-Chung			Interaction between Salt-inducible Kinase 2 and Protein Phosphatase 2A Regulates the Activity of Calcium/Calmodulin-dependent Protein Kinase I and Protein Phosphatase Methylesterase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE CARBOXYL METHYLTRANSFERASE; TUMOR-SUPPRESSOR PP2A; HISTONE DEACETYLASE-5; CATALYTIC SUBUNIT; COACTIVATOR TORC2; DOWN-REGULATION; B-SUBUNITS; SIK2; PHOSPHORYLATION; METHYLATION	Salt-inducible kinase 2 (SIK2) is the only AMP-activated kinase (AMPK) family member known to interact with protein phosphatase 2 (PP2A). However, the functional aspects of this complex are largely unknown. Here we report that the SIK2 center dot PP2A complex preserves both kinase and phosphatase activities. In this capacity, SIK2 attenuates the association of the PP2A repressor, the protein phosphatase methylesterase-1 (PME-1), thus preserving the methylation status of the PP2A catalytic subunit. Furthermore, the SIK2 center dot PP2A holoenzyme complex dephosphorylates and inactivates Ca2+/calmodulin-dependent protein kinase I (CaMKI), an upstream kinase for phosphorylating PME-1/Ser(15). The functionally antagonistic SIK2 center dot PP2A and CaMKI and PME-1 networks thus constitute a negative feedback loop that modulates the phosphatase activity of PP2A. Depletion of SIK2 led to disruption of the SIK2 center dot PP2A complex, activation of CaMKI, and downstream effects, including phosphorylation of HDAC5/Ser259, sequestration of HDAC5 in the cytoplasm, and activation of myocyte-specific enhancer factor 2C (MEF2C)-mediated gene expression. These results suggest that the SIK2 center dot PP2A complex functions in the regulation of MEF2C-dependent transcription. Furthermore, this study suggests that the tightly linked regulatory loop comprised of the SIK2 center dot PP2A and CaMKI and PME-1 networks may function in fine-tuning cell proliferation and stress response.	[Lee, Chia-Wei; Yang, Fu-Chia; Chang, Hsin-Yun; Lee, Sheng-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 10051, Taiwan; [Chou, Hanyi] Natl Taiwan Univ, Inst Oral Biol, Taipei 10051, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 33302, Taiwan; [Lee, Sheng-Chung] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan	National Taiwan University; National Taiwan University; Chang Gung University; Academia Sinica - Taiwan	Lee, SC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10051, Taiwan.	slee@ntu.edu.tw		Lee, Chia-Wei/0000-0002-8925-7421; Tan, Bertrand/0000-0002-2218-7115	Department of Medical Research, National Taiwan University Hospital	Department of Medical Research, National Taiwan University Hospital	We thank Dr. Mitsuhiro Okamoto for the GST-Syntide construct and Dr. Sheng-Liang Chen for the 3xMEF2-Luc reporter and pcDNA-MEF2C expression vector. We are indebted to Yi-Li Liu and I-Ching Huang for technical assistance with DNA sequencing, supported in part by the Department of Medical Research, National Taiwan University Hospital.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Bachovchin DA, 2011, J MED CHEM, V54, P5229, DOI 10.1021/jm200502u; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Du HJ, 2013, J BIOL CHEM, V288, P21341, DOI 10.1074/jbc.M113.481093; Finsterwald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054545; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Leulliot N, 2004, J BIOL CHEM, V279, P8351, DOI 10.1074/jbc.M311484200; Li XH, 2002, EUR J BIOCHEM, V269, P546, DOI 10.1046/j.0014-2956.2001.02680.x; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Ogris E, 1999, J VIROL, V73, P7390, DOI 10.1128/JVI.73.9.7390-7398.1999; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ortega-Gutierrez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002486; Puustinen P, 2009, CANCER RES, V69, P2870, DOI 10.1158/0008-5472.CAN-08-2760; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Schoenthal Axel H., 1998, Frontiers in Bioscience, V3, pD1262; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Yang FC, 2013, J BIOL CHEM, V288, P33861, DOI 10.1074/jbc.M113.492199; Yang FC, 2013, J BIOL CHEM, V288, P6227, DOI 10.1074/jbc.M112.431239	49	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21108	21119		10.1074/jbc.M113.540229	http://dx.doi.org/10.1074/jbc.M113.540229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24841198	Green Published, hybrid			2022-12-28	WOS:000339396600061
J	Slevin, LK; Romes, EM; Dandulakis, MG; Slep, KC				Slevin, Lauren K.; Romes, Erin M.; Dandulakis, Mary G.; Slep, Kevin C.			The Mechanism of Dynein Light Chain LC8-mediated Oligomerization of the Ana2 Centriole Duplication Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE CHAIN; STRUCTURAL-CHARACTERIZATION; CENTROSOME DUPLICATION; PROTEIN; SAS-6; ELEGANS; COMPLEX; BINDING; PLK4; SIL	Centrioles play a key role in nucleating polarized microtubule networks. In actively dividing cells, centrioles establish the bipolar mitotic spindle and are essential for genomic stability. Drosophila anastral spindle-2 (Ana2) is a conserved centriole duplication factor. Although recent work has demonstrated that an Ana2-dynein light chain (LC8) centriolar complex is critical for proper spindle positioning in neuroblasts, how Ana2 and LC8 interact is yet to be established. Here we examine the Ana2-LC8 interaction and map two LC8-binding sites within the central region of Ana2, Ana2M (residues 156-251). Ana2 LC8-binding site 1 contains a signature TQT motif and robustly binds LC8 (K-D of 1.1 mu M), whereas site 2 contains a TQC motif and binds LC8 with lower affinity (K-D of 13 mu M). Both LC8-binding sites flank a predicted similar to 34-residue alpha-helix. We present two independent atomic structures of LC8 dimers in complex with Ana2 LC8-binding site 1 and site 2 peptides. The Ana2 peptides form beta-strands that extend a central composite LC8 beta-sandwich. LC8 recognizes the signature TQT motif in the first LC8 binding site of Ana2, forming extensive van der Waals contacts and hydrogen bonding with the peptide, whereas the Ana2 site 2 TQC motif forms a uniquely extended beta-strand, not observed in other dynein light chain-target complexes. Size exclusion chromatography coupled with multiangle static light scattering demonstrates that LC8 dimers bind Ana2M sites and induce Ana2 tetramerization, yielding an Ana2M(4)-LC8(8) complex. LC8-mediated Ana2 oligomerization probably enhances Ana2 avidity for centriole-binding factors and may bridge multiple factors as required during spindle positioning and centriole biogenesis.	[Slevin, Lauren K.; Dandulakis, Mary G.; Slep, Kevin C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Romes, Erin M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Slep, KC (corresponding author), Univ N Carolina, Dept Biol, 402 Fordham Hall,Campus Box 3280, Chapel Hill, NC 27599 USA.	kslep@bio.unc.edu			National Institutes of Health [R01GM094415, T32GM008570]; National Science Foundation [DGE-0646083]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094415, T32GM008570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM094415 (to K. C. S.) and T32GM008570 (to the University of North Carolina Program in Molecular and Cellular Biophysics). This work was also supported by a National Science Foundation Graduate Research Fellowship under Grant DGE-0646083 (to L. K. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; APLAN PD, 1991, MOL CELL BIOL, V11, P5462, DOI 10.1128/MCB.11.11.5462; Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887; Asthana J, 2012, J BIOL CHEM, V287, P40793, DOI 10.1074/jbc.M112.394353; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chaudhury A, 2008, AM J PHYSIOL-GASTR L, V295, pG442, DOI 10.1152/ajpgi.90280.2008; Cottee MA, 2013, ELIFE, V2, DOI 10.7554/eLife.01071; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erez A, 2004, ONCOGENE, V23, P5371, DOI 10.1038/sj.onc.1207685; Gallego P, 2013, J BIOL CHEM, V288, P12283, DOI 10.1074/jbc.M113.459149; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Guichard P, 2013, CURR BIOL, V23, P1620, DOI 10.1016/j.cub.2013.06.061; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hatzopoulos GN, 2013, STRUCTURE, V21, P2069, DOI 10.1016/j.str.2013.08.019; Hilbert M, 2013, P NATL ACAD SCI USA, V110, P11373, DOI 10.1073/pnas.1302721110; Izraeli S, 1997, CELL GROWTH DIFFER, V8, P1171; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Lerit DA, 2013, J CELL BIOL, V202, P1013, DOI 10.1083/jcb.201303141; Lettman MM, 2013, DEV CELL, V25, P284, DOI 10.1016/j.devcel.2013.03.011; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Nyarko A, 2013, J BIOL CHEM, V288, P2614, DOI 10.1074/jbc.M112.432831; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Qiao RP, 2012, EMBO J, V31, P4334, DOI 10.1038/emboj.2012.280; Rao L, 2013, MOL BIOL CELL, V24, P2362, DOI 10.1091/mbc.E13-03-0166; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Romes EM, 2012, J BIOL CHEM, V287, P15862, DOI 10.1074/jbc.M111.336172; Shimanovskaya Ekaterina, 2013, Worm, V2, pe25214, DOI 10.4161/worm.25214; Slevin LK, 2012, STRUCTURE, V20, P1905, DOI 10.1016/j.str.2012.08.025; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016; Stuchell-Brereton MD, 2011, MOL BIOL CELL, V22, P2690, DOI 10.1091/mbc.E11-01-0075; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Wang C, 2011, DEV CELL, V21, P520, DOI 10.1016/j.devcel.2011.08.002; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	53	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20727	20739		10.1074/jbc.M114.576041	http://dx.doi.org/10.1074/jbc.M114.576041			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24920673	Green Published, hybrid			2022-12-28	WOS:000339396600030
J	Jensen, DD; Halls, ML; Murphy, JE; Canals, M; Cattaruzza, F; Poole, DP; Lieu, T; Koon, HW; Pothoulakis, C; Bunnett, NW				Jensen, Dane D.; Halls, Michelle L.; Murphy, Jane E.; Canals, Meritxell; Cattaruzza, Fiore; Poole, Daniel P.; Lieu, TinaMarie; Koon, Hon-Wai; Pothoulakis, Charalabos; Bunnett, Nigel W.			Endothelin-converting Enzyme 1 and beta-Arrestins Exert Spatiotemporal Control of Substance P-induced Inflammatory Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INTERLEUKIN-8 EXPRESSION; PROTEIN-COUPLED RECEPTORS; COLONIC EPITHELIAL-CELLS; NEUTRAL ENDOPEPTIDASE; NEUROKININ RECEPTORS; TRAFFICKING; ENDOSOMES; BETA-ARRESTIN-1; COLITIS; RESENSITIZATION	Although the intracellular trafficking of G protein-coupled receptors controls specific signaling events, it is unclear how the spatiotemporal control of signaling contributes to complex pathophysiological processes such as inflammation. By using bioluminescence resonance energy transfer and superresolution microscopy, we found that substance P (SP) induces the association of the neurokinin 1 receptor(NK1R) with two classes of proteins that regulate SP signaling from plasma and endosomal membranes: the scaffolding proteins beta-arrestin (beta ARRs) 1 and 2 and the transmembrane metallopeptidases ECE-1c and ECE-1d. In HEK293 cells and non-transformed human colonocytes, we observed that G protein-coupled receptor kinase 2 and beta ARR1/2 terminate plasma membrane Ca2+ signaling and initiate receptor trafficking to endosomes that is necessary for sustained activation of ERKs in the nucleus. beta ARRs deliver the SP-NK1R endosomes, where ECE-1 associates with the complex, degrades SP, and allows the NK1R, freed from beta ARRs, to recycle. Thus, both ECE-1 and beta ARRs mediate the resensitization of NK1R Ca2+ signaling at the plasma membrane. Sustained exposure of colonocytes to SP activates NF-kappa B and stimulates IL-8 secretion. This proinflammatory signaling is unaffected by inhibition of the endosomal ERK pathway but is suppressed by ECE-1 inhibition or beta ARR2 knockdown. Inhibition of protein phosphatase 2A, which also contributes to sustained NK1R signaling at the plasma membrane, similarly attenuates IL-8 secretion. Thus, the primary function of beta ARRs and ECE-1 in SP-dependent inflammatory signaling is to promote resensitization, which allows the sustained NK1R signaling from the plasma membrane that drives inflammation.	[Jensen, Dane D.; Halls, Michelle L.; Canals, Meritxell; Poole, Daniel P.; Lieu, TinaMarie; Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Murphy, Jane E.; Cattaruzza, Fiore] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Poole, Daniel P.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Koon, Hon-Wai; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Inflammatory Bowel Dis Res Ctr, Div Digest Dis, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of Melbourne; University of Melbourne; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	Nigel.Bunnett@Monash.edu	Poole, Daniel/AET-6645-2022; Lieu, TinaMarie/AAM-7691-2020	Poole, Daniel/0000-0002-6168-8422; Canals, Meritxell/0000-0002-7942-5006; Bunnett, Nigel W./0000-0003-3367-0644; Jensen, Dane D./0000-0001-6540-2375; Halls, Michelle/0000-0001-8555-8959	National Institutes of Health [DK47343]; National Health and Medical Research Council [63303, 1049682, 1031886]; Monash University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47343 (to C. P.). This work was also supported by National Health and Medical Research Council Grants 63303, 1049682, and 1031886 and by Monash University (to N. W. B.).	Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DRAPEAU G, 1987, NEUROPEPTIDES, V10, P43, DOI 10.1016/0143-4179(87)90088-6; Fan HK, 2007, MOL IMMUNOL, V44, P3092, DOI 10.1016/j.molimm.2007.02.009; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Jorgensen R, 2008, MOL PHARMACOL, V73, P349, DOI 10.1124/mol.107.038877; Koon HW, 2005, J PHARMACOL EXP THER, V314, P1393, DOI 10.1124/jpet.105.088013; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lee S, 2009, INFLAMM BOWEL DIS, V15, P1007, DOI 10.1002/ibd.20877; Lee T, 2013, AM J PATHOL, V182, P1114, DOI 10.1016/j.ajpath.2012.12.025; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Murphy JE, 2011, AM J PHYSIOL-CELL PH, V301, pC780, DOI 10.1152/ajpcell.00096.2011; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; OKAMOTO A, 1994, BIOCHEM J, V299, P683, DOI 10.1042/bj2990683; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Wang HY, 2010, FASEB J, V24, P1971, DOI 10.1096/fj.09-137646; Zhao DZ, 2002, BIOCHEM J, V368, P665, DOI 10.1042/BJ20020950; Zhao PS, 2013, J BIOL CHEM, V288, P25689, DOI 10.1074/jbc.M113.496414	31	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20283	20294		10.1074/jbc.M114.578179	http://dx.doi.org/10.1074/jbc.M114.578179			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898255	hybrid, Green Published			2022-12-28	WOS:000339395200040
J	Karabasheva, D; Cole, NB; Donaldson, JG				Karabasheva, Darya; Cole, Nelson B.; Donaldson, Julie G.			Roles for Trafficking and O-Linked Glycosylation in the Turnover of Model Cell Surface Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; DI-LEUCINE MOTIF; MEMBRANE-PROTEIN; SOLUBLE INTERLEUKIN-2-RECEPTOR; CYTOPLASMIC TAIL; FUSION PROTEINS; LIGAND-BINDING; RECEPTOR; CLEAVAGE; ENDOCYTOSIS	Proteins targeted to the plasma membrane (PM) of cells are degraded at different rates. Sorting motifs contained within the cytoplasmic domains of transmembrane proteins, post-translational modifications (e. g. ubiquitination), and assembly into multiprotein or protein-lipid complexes all may affect the efficiency of endocytosis and recycling and influence the delivery to degradative compartments. Using the SNAP-tag labeling system, we examined the turnover of a model PM protein, the alpha chain of the interleukin-2 receptor (Tac). The surface lifetimes of SNAP-Tac fusions were influenced by their mode of entry into cells (clathrin-dependent versus clathrin-independent), their orientation in the PM (transmembrane versus glycosylphosphatidylinositol-anchored), and ubiquitination in their cytosolic domains. In addition, shedding of SNAP-Tac into the medium was greatly influenced by its O-linked glycosylation status. For a number of PM proteins, delivery to lysosomes and ectodomain shedding represent distinct parallel mechanisms to determine protein half-life.	[Karabasheva, Darya; Cole, Nelson B.; Donaldson, Julie G.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cole, NB (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	ncole@mail.nih.gov			National Institutes of Health from the Intramural Research Program in the NHLBI [HL006060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006060] Funding Source: NIH RePORTER	National Institutes of Health from the Intramural Research Program in the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL006060 from the Intramural Research Program in the NHLBI.	Agueznay NEH, 2007, CLIN EXP IMMUNOL, V150, P114, DOI 10.1111/j.1365-2249.2007.03464.x; Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bodor Dani L, 2012, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0808s55; Bojkowska K, 2011, CHEM BIOL, V18, P805, DOI 10.1016/j.chembiol.2011.03.014; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Cole N.B., 2013, CURR PROTOC PROTEIN, V73; Cole NB, 2012, ACS CHEM BIOL, V7, P464, DOI 10.1021/cb2004252; De Paiva CS, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-31; Emami-Nemini A, 2013, NAT PROTOC, V8, P1307, DOI 10.1038/nprot.2013.073; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Foraker AB, 2012, J CELL BIOL, V198, P591, DOI 10.1083/jcb.201205116; Gautier A, 2009, J AM CHEM SOC, V131, P17954, DOI 10.1021/ja907818q; Godlee C, 2013, J CELL BIOL, V203, P717, DOI 10.1083/jcb.201307100; GREENE WC, 1986, ANNU REV IMMUNOL, V4, P69, DOI 10.1146/annurev.iy.04.040186.000441; HAFT CR, 1994, J BIOL CHEM, V269, P26286; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Harder JL, 2012, TRAFFIC, V13, P1170, DOI 10.1111/j.1600-0854.2012.01376.x; HARE JF, 1991, P NATL ACAD SCI USA, V88, P5902, DOI 10.1073/pnas.88.13.5902; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Horiuchi Keisuke, 2013, Keio Journal of Medicine, V62, P29, DOI 10.2302/kjm.2012-0003-RE; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Keppler A, 2006, BIOTECHNIQUES, V41, P167, DOI 10.2144/000112216; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kinlough CL, 2011, J BIOL CHEM, V286, P39072, DOI 10.1074/jbc.M111.289504; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; KOZARSKY KF, 1988, MOL CELL BIOL, V8, P3357, DOI 10.1128/MCB.8.8.3357; KUAN SF, 1989, J BIOL CHEM, V264, P19271; LEMANSKY P, 1990, J CELL BIOL, V110, P1525, DOI 10.1083/jcb.110.5.1525; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Li RL, 2003, BIOCHEM BIOPH RES CO, V303, P446, DOI 10.1016/S0006-291X(03)00354-1; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Maldonado-Baez L, 2013, EXP CELL RES, V319, P2759, DOI 10.1016/j.yexcr.2013.08.008; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; MIEDEL MC, 1989, J BIOL CHEM, V264, P21097; Morris JC, 2000, ANN RHEUM DIS, V59, P109, DOI 10.1136/ard.59.suppl_1.i109; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; REDDY P, 1989, J BIOL CHEM, V264, P17329; ROBB RJ, 1987, J IMMUNOL, V139, P855; RUBIN LA, 1990, ANN INTERN MED, V113, P619, DOI 10.7326/0003-4819-113-8-619; RUBIN LA, 1985, J IMMUNOL, V135, P3172; RUTLEDGE EA, 1994, BLOOD, V83, P580; Rutledge EA, 1996, J CELL PHYSIOL, V168, P284, DOI 10.1002/(SICI)1097-4652(199608)168:2<284::AID-JCP7>3.0.CO;2-L; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schwager SLU, 1999, BIOCHEMISTRY-US, V38, P10388, DOI 10.1021/bi990357j; Sheu BC, 2001, CANCER RES, V61, P237; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wright MH, 2011, CELL BIOCHEM BIOPHYS, V60, P39, DOI 10.1007/s12013-011-9181-9; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	64	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19477	19490		10.1074/jbc.M114.564666	http://dx.doi.org/10.1074/jbc.M114.564666			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891503	Green Published, hybrid			2022-12-28	WOS:000339326800023
J	Yabas, M; Coupland, LA; Cromer, D; Winterberg, M; Teoh, NC; D'Rozario, J; Kirk, K; Broer, S; Parish, CR; Enders, A				Yabas, Mehmet; Coupland, Lucy A.; Cromer, Deborah; Winterberg, Markus; Teoh, Narci C.; D'Rozario, James; Kirk, Kiaran; Broeer, Stefan; Parish, Christopher R.; Enders, Anselm			Mice Deficient in the Putative Phospholipid Flippase ATP11C Exhibit Altered Erythrocyte Shape, Anemia, and Reduced Erythrocyte Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; BIOLOGICAL-MEMBRANES; PHOSPHATIDYLSERINE; IDENTIFICATION; ASYMMETRY; ATPASE; TRANSLOCATION; PURIFICATION; DISEASE; GENE	Transmembrane lipid transporters are believed to establish and maintain phospholipid asymmetry in biological membranes; however, little is known about the in vivo function of the specific transporters involved. Here, we report that developing erythrocytes from mice lacking the putative phosphatidylserine flippase ATP11Cshowed a lower rate of PS translocation in vitro compared with erythrocytes from wild-type littermates. Furthermore, the mutant mice had an elevated percentage of phosphatidylserine exposing mature erythrocytes in the periphery. Although erythro-cyte development in ATP11C-deficient mice was normal, the mature erythrocytes had an abnormal shape ( stomatocytosis), and the life span of mature erythrocytes was shortened relative to that in control littermates, resulting in anemia in the mutant mice. Thus, our findings uncover an essential role for ATP11C in erythrocyte morphology and survival and provide a new candidate for the rare inherited blood disorder stomatocytosis with uncompensated anemia.	[Yabas, Mehmet; Enders, Anselm] Australian Natl Univ, John Curtin Sch Med Res, Ramaciotti Immunizat Genom Lab, Canberra, ACT 2601, Australia; [Coupland, Lucy A.; Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Canc & Vasc Biol Grp, Dept Immunol, Canberra, ACT 2601, Australia; [Winterberg, Markus; Kirk, Kiaran; Broeer, Stefan] Australian Natl Univ, Div Biomed Sci & Biochem, Res Sch Biol, Canberra, ACT 2601, Australia; [Coupland, Lucy A.; D'Rozario, James] Canberra Hosp, Clin Haematol Unit, Canberra, ACT 2605, Australia; [Cromer, Deborah] Univ New S Wales, Complex Syst Biol Grp, Ctr Vasc Res, Kensington, NSW 2052, Australia; [Teoh, Narci C.] Australian Natl Univ, Sch Med, Canberra Hosp, Liver Res Grp, Canberra, ACT 2605, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Australian National University; Australian National University; Canberra Hospital; University of New South Wales Sydney; Australian National University; Canberra Hospital	Enders, A (corresponding author), Australian Natl Univ, Dept Immunol, John Curtin Sch Med Res, GPO Box 334, Canberra, ACT 2601, Australia.	anselm.enders@anu.edu.au	Kirk, Kiaran/C-8299-2009; Yabas, Mehmet/D-9513-2012; Broer, Stefan/A-1286-2008; Enders, Anselm/B-1165-2011; Coupland, Lucy/W-2001-2019	Kirk, Kiaran/0000-0002-5613-2622; Yabas, Mehmet/0000-0002-3462-5389; Broer, Stefan/0000-0002-8040-1634; Enders, Anselm/0000-0001-5933-6463; Cromer, Deborah/0000-0002-5276-5094; Coupland, Lucy/0000-0002-8912-9534; Parish, Christopher/0000-0001-7740-0430; Winterberg, Markus/0000-0002-8529-9317	National Health and Medical Research Council [GNT1061288, GNT1035858]; Ministry of National Education, Republic of Turkey; University of New South Wales; Ramaciotti Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ministry of National Education, Republic of Turkey(Ministry of National Education - Turkey); University of New South Wales; Ramaciotti Foundation	This work was supported in part by National Health and Medical Research Council Grant GNT1061288.; Supported by a postgraduate award from the Ministry of National Education, Republic of Turkey.; Supported by National Health and Medical Research Council program grants.; Supported by a University of New South Wales Vice-Chancellor's postdoctoral fellowship.; Supported by National Health and Medical Research Council Career Development Fellowship GNT1035858 and by the Ramaciotti Foundation. To whom correspondence should be addressed: Ramaciotti Immunization Genomics Laboratory, Dept. of Immunology, The John Curtin School of Medical Research, Australian National University, GPO Box 334, Canberra, ACT 2601, Australia. Tel.: 61-2-6125-7605; Fax: 61-2-6125-8512; E-mail: anselm.enders@anu.edu.au.	An XL, 2004, BIOCHEMISTRY-US, V43, P310, DOI 10.1021/bi035653h; AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; AULAND ME, 1994, ARCH BIOCHEM BIOPHYS, V312, P272, DOI 10.1006/abbi.1994.1309; Bruce LJ, 2009, BLOOD CELL MOL DIS, V42, P216, DOI 10.1016/j.bcmd.2009.01.014; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cacciagli P, 2010, EUR J HUM GENET, V18, P1360, DOI 10.1038/ejhg.2010.126; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Coupland LA, 2010, EXP HEMATOL, V38, P453, DOI 10.1016/j.exphem.2010.03.003; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; DALEKE DL, 1992, ANN NY ACAD SCI, V671, P468, DOI 10.1111/j.1749-6632.1992.tb43832.x; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; DALEKE DL, 1985, BIOCHEMISTRY-US, V24, P5406, DOI 10.1021/bi00341a019; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; DUCROU W, 1969, MED J AUSTRALIA, V2, P1087, DOI 10.5694/j.1326-5377.1969.tb107626.x; Kean LS, 2002, EXP HEMATOL, V30, P394, DOI 10.1016/S0301-472X(02)00780-4; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuypers FA, 1998, BLOOD, V91, P3044, DOI 10.1182/blood.V91.8.3044.3044_3044_3051; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; MCEVOY L, 1986, P NATL ACAD SCI USA, V83, P3311, DOI 10.1073/pnas.83.10.3311; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; MORIYAMA Y, 1988, J BIOL CHEM, V263, P8521; MORROT G, 1990, FEBS LETT, V266, P29, DOI 10.1016/0014-5793(90)81498-D; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Soupene E, 2006, BRIT J HAEMATOL, V133, P436, DOI 10.1111/j.1365-2141.2006.06051.x; Stewart GW, 2004, CURR OPIN HEMATOL, V11, P244, DOI 10.1097/01.moh.0000132240.20671.33; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Winterberg M, 2012, BLOOD, V119, P3604, DOI 10.1182/blood-2011-10-386003; Wood BL, 1996, BLOOD, V88, P1873; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yasin Z, 2003, BLOOD, V102, P365, DOI 10.1182/blood-2002-11-3416; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	42	46	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19531	19537		10.1074/jbc.C114.570267	http://dx.doi.org/10.1074/jbc.C114.570267			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24898253	hybrid, Green Published			2022-12-28	WOS:000339326800028
J	Zhang, H; von Gise, A; Liu, QZ; Hu, TY; Tian, XY; He, LJ; Pu, WJ; Huang, XZ; He, L; Cai, CL; Camargo, FD; Pu, WT; Zhou, B				Zhang, Hui; von Gise, Alexander; Liu, Qiaozhen; Hu, Tianyuan; Tian, Xueying; He, Lingjuan; Pu, Wenjuan; Huang, Xiuzhen; He, Liang; Cai, Chen-Leng; Camargo, Fernando D.; Pu, William T.; Zhou, Bin			Yap1 Is Required for Endothelial to Mesenchymal Transition of the Atrioventricular Cushion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YES-ASSOCIATED PROTEIN; GROWTH-FACTOR-BETA; CONGENITAL HEART-DISEASE; HOLT-ORAM-SYNDROME; CELL-TRANSFORMATION; CARDIOMYOCYTE PROLIFERATION; EMBRYONIC HEART; TRANSCRIPTION FACTORS; PATHWAY; DOMAIN	Cardiac malformations due to aberrant development of the atrioventricular (AV) valves are among the most common forms of congenital heart diseases. Normally, heart valve mesenchyme is formed from an endothelial to mesenchymal transition (EMT) of endothelial cells of the endocardial cushions. Yes-associated protein 1 (YAP1) has been reported to regulate EMT in vitro, in addition to its known role as a major regulator of organ size and cell proliferation in vertebrates, leading us to hypothesize that YAP1 is required for heart valve development. We tested this hypothesis by conditional inactivation of YAP1 in endothelial cells and their derivatives. This resulted in markedly hypocellular endocardial cushions due to impaired formation of heart valve mesenchyme by EMT and to reduced endocardial cell proliferation. In endothelial cells, TGF beta induces nuclear localization of Smad2/3/4 complex, which activates expression of Snail, Twist1, and Slug, key transcription factors required for EMT. YAP1 interacts with this complex, and loss of YAP1 disrupts TGF beta-induced up-regulation of Snail, Twist1, and Slug. Together, our results identify a role of YAP1 in regulating EMT through modulation of TGF beta-Smad signaling and through proliferative activity during cardiac cushion development.	[Zhang, Hui; Liu, Qiaozhen; Hu, Tianyuan; Tian, Xueying; He, Lingjuan; Pu, Wenjuan; Huang, Xiuzhen; He, Liang; Pu, William T.; Zhou, Bin] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai 200031, Peoples R China; [von Gise, Alexander] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Cai, Chen-Leng] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, Ctr Mol Cardiol, Child Hlth & Dev Inst,Black Family Stem Cell Inst, New York, NY 10029 USA; [Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [von Gise, Alexander] MHH Hannover Med Sch, Dept Pediat Cardiol & Intens Care, D-30669 Hannover, Germany	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Boston Children's Hospital; Icahn School of Medicine at Mount Sinai; Harvard University; Hannover Medical School	Zhou, B (corresponding author), Chinese Acad Sci, Shanghai 200031, Peoples R China.	zhoubin@sibs.ac.cn	von Gise, Alexander/C-3997-2016; Pu, William/AAJ-8301-2020	von Gise, Alexander/0000-0001-7886-3031; Pu, William/0000-0002-4551-8079; Zhou, Bin/0000-0001-5278-5522	National Basic Research Program of China [2013CB945302, 2012CB945102]; National Natural Science Foundation of China [91339104, 31271552, 31222038, 31301188]; Chinese Academy of Sciences [KSCX2-EW-R-09]; Shanghai Pujiang Program [11PJ1411400]; Basic Research Key Project [14JC1407400]; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship [SIBS-2013KIP311, China-2013M541561]; National Institutes of Health [R01 HL094683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094683] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program); Basic Research Key Project; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca(AstraZeneca); Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Basic Research Program of China (2013CB945302 and 2012CB945102), National Natural Science Foundation of China (91339104, 31271552, 31222038, 31301188), Chinese Academy of Sciences (Hundred Talents Program and KSCX2-EW-R-09), Shanghai Pujiang Program (11PJ1411400) and Basic Research Key Project (14JC1407400), Organization Department of the CPC Central Committee Bajian Talents Program, AstraZeneca, Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship, and Postdoc Fund (SIBS-2013KIP311, China-2013M541561).; Supported by funding from National Institutes of Health R01 HL094683.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Barnett Joey V., 2003, Birth Defects Research, V69, P58, DOI 10.1002/bdrc.10006; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Boogerd KJ, 2008, CARDIOVASC RES, V78, P485, DOI 10.1093/cvr/cvn049; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Brandl M, 2010, J CELL SCI, V123, P4231, DOI 10.1242/jcs.071100; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MARKWALD RR, 1981, SCAN ELECTRON MICROS, P261; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Onuzo OC, 2006, ARCH DIS CHILD-FETAL, V91, pF236, DOI 10.1136/adc.2006.094789; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shelton EL, 2008, DEV BIOL, V317, P282, DOI 10.1016/j.ydbio.2008.02.037; Song LY, 2011, DEV DYNAM, V240, P211, DOI 10.1002/dvdy.22493; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yin X, 2010, J CELL SCI, V123, P3558, DOI 10.1242/jcs.064915; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723	54	112	117	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18681	18692		10.1074/jbc.M114.554584	http://dx.doi.org/10.1074/jbc.M114.554584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831012	Green Published, hybrid			2022-12-28	WOS:000339062900007
J	Chu, DT; Malinowska, E; Gawronska-Kozak, B; Kozak, LP				Dinh-Toi Chu; Malinowska, Elzbieta; Gawronska-Kozak, Barbara; Kozak, Leslie P.			Expression of Adipocyte Biomarkers in a Primary Cell Culture Models Reflects Preweaning Adipobiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE DEVELOPMENT; ACTIVATED RECEPTOR-GAMMA; DIET-INDUCED OBESITY; GENE-EXPRESSION; BROWN FAT; WHITE FAT; DIFFERENTIATION; ADIPOGENESIS; DISTINCT; ACIDS	A cohort of genes was selected to characterize the adipogenic phenotype in primary cell cultures from three tissue sources. We compared the quantitative expression of biomarkers in culture relative to their expression in vivo because the mere presence or absence of expression is minimally informative. Although all biomarkers analyzed have biochemical functions in adipocytes, the expression of some of the biomarkers varied enormously in culture relative to their expression in the adult fat tissues in vivo, i.e. inguinal fat for white adipocytes and brite cells, interscapular brown adipose tissue for brown adipocytes, and ear mesenchymal stem cells for white adipocytes from adult mice. We propose that the pattern of expression in vitro does not reflect gene expression in the adult mouse; rather it is predominantly the expression pattern of adipose tissue of the developing mouse between birth and weaning. The variation in gene expression among fat depots in both human and rodent has been an extensively studied phenomenon, and as recently reviewed, it is related to subphenotypes associated with immune function, the inflammatory response, fat depot blood flow, and insulin sensitivity. We suggest that adipose tissue biology in the period from birth to weaning is not just a staging platform for the emergence of adult white fat but that it has properties to serve the unique needs of energy metabolism in the newborn. A case in point is the differentiation of brite cells that occurs during this period followed by their involution immediately following weaning.	[Dinh-Toi Chu; Malinowska, Elzbieta; Gawronska-Kozak, Barbara; Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, PL-10748 Olsztyn, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Kozak, LP (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Ul Tuwima 10, PL-10748 Olsztyn, Poland.	l.kozak@pan.olsztyn.pl	Gawronska-Kozak, Barbara/A-2980-2017; Chu, Dinh-Toi/I-7414-2019	Gawronska-Kozak, Barbara/0000-0002-2006-8534; Chu, Dinh-Toi/0000-0002-4596-2022	Foundation for Polish Science program WELCOME Grant - European Union Structural Funds in Poland within the Innovative Economy Programme [WELCOME/2010-4/3]; REFRESH Project [FP7-REGPOT-2010-1-264103]	Foundation for Polish Science program WELCOME Grant - European Union Structural Funds in Poland within the Innovative Economy Programme; REFRESH Project	This work was supported by Foundation for Polish Science program WELCOME Grant WELCOME/2010-4/3 (to L. P. K.) entitled "Nutrition and ambient temperature during early development can reduce susceptibility to obesity" financed by European Union Structural Funds in Poland within the Innovative Economy Programme and REFRESH Project Grant FP7-REGPOT-2010-1-264103.	Anunciado-Koza R, 2008, J BIOL CHEM, V283, P27688, DOI 10.1074/jbc.M804268200; Bays HE, 2013, J CLIN LIPIDOL, V7, P304, DOI 10.1016/j.jacl.2013.04.001; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; deVries JE, 1997, J LIPID RES, V38, P1384; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hammarstedt A, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-42; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Lafontan M, 2014, DIABETES METAB, V40, P16, DOI 10.1016/j.diabet.2013.08.002; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lijnen HR, 2002, ARTERIOSCL THROM VAS, V22, P374, DOI 10.1161/hq0302.104522; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rim JS, 2004, J BIOL CHEM, V279, P25916, DOI 10.1074/jbc.M402102200; Rim JS, 2005, FASEB J, V19, P1205, DOI 10.1096/fj.04-3204fje; Riquelme CA, 2011, SCIENCE, V334, P528, DOI 10.1126/science.1210558; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Si YG, 2007, J LIPID RES, V48, P826, DOI 10.1194/jlr.M600343-JLR200; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Van der Lee KAJM, 2000, FASEB J, V14, P495, DOI 10.1096/fasebj.14.3.495; Voigt A, 2013, MOL NUTR FOOD RES, V57, P1423, DOI 10.1002/mnfr.201200671; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Zhang HB, 2010, MOL CELL BIOL, V30, P4224, DOI 10.1128/MCB.00363-10	41	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18478	18488		10.1074/jbc.M114.555821	http://dx.doi.org/10.1074/jbc.M114.555821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24808178	hybrid, Green Published			2022-12-28	WOS:000338042000044
J	Chakraborty, S; Umasankar, PK; Preston, GM; Khandelwal, P; Apodaca, G; Watkins, SC; Traub, LM				Chakraborty, Souvik; Umasankar, Perunthottathu K.; Preston, G. Michael; Khandelwal, Puneet; Apodaca, Gerard; Watkins, Simon C.; Traub, Linton M.			A Phosphotyrosine Switch for Cargo Sequestration at Clathrin-coated Buds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; GROWTH-FACTOR RECEPTOR; PROTEIN-COUPLED RECEPTORS; GREEN FLUORESCENT PROTEIN; ADAPTER BETA-2 APPENDAGE; TYROSINE PHOSPHORYLATION; MEDIATED ENDOCYTOSIS; COMPLEX AP-2; PLASMA-MEMBRANE; AP2 COMPLEX	The AP-2 clathrin adaptor complex oversees endocytic cargo selection in two parallel but independent manners. First, by physically engaging peptide-based endocytic sorting signals, a subset of clathrin-dependent transmembrane cargo is directly collected into assembling buds. Synchronously, by interacting with an assortment of clathrin-associated sorting proteins (CLASPs) that independently select different integral membrane cargo for inclusion within the incipient bud, AP-2 handles additional cargo capture indirectly. The distal platform subdomain of the AP-2 beta 2 subunit appendage is a privileged CLASP-binding surface that recognizes a cognate, short alpha-helical interaction motif. This signal, found in the CLASPs beta-arrestin and the autosomal recessive hypercholesterolemia (ARH) protein, docks into an elongated groove on the beta 2 appendage platform. Tyr-888 is a critical constituent of this spatially confined beta 2 appendage contact interface and is phosphorylated in numerous high-throughput proteomic studies. We find that a phosphomimetic Y888E substitution does not interfere with incorporation of expressed beta 2-YFP subunit into AP-2 or alter AP-2 deposition at surface clathrin-coated structures. The Y888E mutation does not affect interactions involving the sandwich subdomain of the beta 2 appendage, indicating that the mutated appendage is folded and operational. However, the Y888E, but not Y888F, switch selectively uncouples interactions with ARH and beta-arrestin. Phyogenetic conservation of Tyr-888 suggests that this residue can reversibly control occupancy of the beta 2 platform-binding site and, hence, cargo sorting.	[Chakraborty, Souvik; Umasankar, Perunthottathu K.; Preston, G. Michael; Watkins, Simon C.; Traub, Linton M.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Apodaca, Gerard] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Traub, LM (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, 3500 Terrace St,S312 BST, Pittsburgh, PA 15261 USA.	traub@pitt.edu	Watkins, Simon/ABG-2590-2021; Apodaca, Gerard/HCJ-0048-2022	Watkins, Simon/0000-0003-4092-1552; Traub, Linton/0000-0002-1303-0298; Umasankar, Perunthottathu/0000-0001-5548-1022	National Institutes of Health [R01 GM106963-17]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106963, U54GM103529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM106963-17 (to L. M. T.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; ANDERSON RGW, 1976, P NATL ACAD SCI USA, V73, P2434, DOI 10.1073/pnas.73.7.2434; Aran V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-19; Betts GN, 2008, J BIOL CHEM, V283, P15656, DOI 10.1074/jbc.M709514200; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bosch E, 1997, ONCOGENE, V15, P1021, DOI 10.1038/sj.onc.1201270; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; CAMIDGE DR, 1994, J CELL SCI, V107, P709; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Chetrit D, 2009, BIOCHEM J, V418, P701, DOI 10.1042/BJ20081288; CHIN DJ, 1989, P NATL ACAD SCI USA, V86, P9289, DOI 10.1073/pnas.86.23.9289; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Chowdhury D, 2013, J NEUROSCI, V33, P4151, DOI 10.1523/JNEUROSCI.2721-12.2013; Clayton EL, 2007, J PHYSIOL-LONDON, V585, P687, DOI 10.1113/jphysiol.2007.137539; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Colo GP, 2012, J CELL SCI, V125, P5338, DOI 10.1242/jcs.105270; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Eden ER, 2002, J CLIN INVEST, V110, P1695, DOI 10.1172/JCI200216445; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1995, DOI 10.1016/j.cellsig.2008.07.008; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; GREEN M, 1963, VIROLOGY, V20, P199, DOI 10.1016/0042-6822(63)90157-0; Groarke DA, 1999, J BIOL CHEM, V274, P23263, DOI 10.1074/jbc.274.33.23263; Grossier JP, 2014, EMBO J, V33, P35, DOI 10.1002/embj.201385284; Gu MY, 2013, ELIFE, V2, DOI 10.7554/eLife.00190; Guilbaud C, 1997, MAMM GENOME, V8, P651, DOI 10.1007/s003359900531; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Hazra S, 2011, BIOCHEMISTRY-US, V50, P2870, DOI 10.1021/bi2001032; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Henkel JR, 1998, MOL BIOL CELL, V9, P2477, DOI 10.1091/mbc.9.9.2477; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Honda M, 2011, EMBO J, V30, P3368, DOI 10.1038/emboj.2011.238; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huang FT, 2003, J BIOL CHEM, V278, P43411, DOI 10.1074/jbc.M306072200; Huang YL, 2014, J BIOL CHEM, V289, P3677, DOI 10.1074/jbc.M113.508077; HUNTER T, 1981, CELL, V24, P741, DOI 10.1016/0092-8674(81)90100-8; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Jha A, 2012, MOL BIOL CELL, V23, P1742, DOI 10.1091/mbc.E11-11-0939; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; Kang RS, 2011, J CELL BIOL, V193, P51, DOI 10.1083/jcb.201012121; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kern RC, 2009, BIOCHEMISTRY-US, V48, P7190, DOI 10.1021/bi900369c; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Keyel PA, 2008, MOL BIOL CELL, V19, P5309, DOI 10.1091/mbc.E08-07-0712; KIRCHHAUSEN T, 1989, P NATL ACAD SCI USA, V86, P2612, DOI 10.1073/pnas.86.8.2612; Kittler JT, 2008, P NATL ACAD SCI USA, V105, P3616, DOI 10.1073/pnas.0707920105; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Lagache T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080914; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Lemeer S, 2009, CURR OPIN CHEM BIOL, V13, P414, DOI 10.1016/j.cbpa.2009.06.022; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Li W, 2010, CLEFT PALATE-CRAN J, V47, P566, DOI 10.1597/09-145; Lie PPY, 2012, P NATL ACAD SCI USA, V109, P12562, DOI 10.1073/pnas.1202316109; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Mahabaleshwar H, 2012, DEVELOPMENT, V139, P2897, DOI 10.1242/dev.080408; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Mitsunari T, 2005, MOL CELL BIOL, V25, P9318, DOI 10.1128/MCB.25.21.9318-9323.2005; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Muratore KE, 2007, ACS CHEM BIOL, V2, P454, DOI 10.1021/cb7001285; Nagai M, 2003, MOL BIOL CELL, V14, P4984, DOI 10.1091/mbc.E03-06-0385; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; Nishi H, 2013, MOL BIOSYST, V9, P1620, DOI 10.1039/c3mb25514j; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; PAGE LJ, 1995, J CELL BIOL, V131, P619, DOI 10.1083/jcb.131.3.619; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; PONNAMBALAM S, 1990, J BIOL CHEM, V265, P4814; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Sadowski I, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat026; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Shah M, 2013, J CELL BIOL, V202, P113, DOI 10.1083/jcb.201211110; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; SIBLEY DR, 1986, P NATL ACAD SCI USA, V83, P9408, DOI 10.1073/pnas.83.24.9408; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Sochacki KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2158; Sondermann H, 2005, CELL, V121, P158, DOI 10.1016/j.cell.2005.04.001; SORKIN A, 1995, J BIOL CHEM, V270, P619, DOI 10.1074/jbc.270.2.619; Sorkina T, 2002, J BIOL CHEM, V277, P27433, DOI 10.1074/jbc.M201595200; Sosa RT, 2012, TRAFFIC, V13, P305, DOI 10.1111/j.1600-0854.2011.01310.x; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; Uezu A, 2012, P NATL ACAD SCI USA, V109, pE2929, DOI 10.1073/pnas.1207358109; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wagner MJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008987; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; Xie JM, 2007, ACS CHEM BIOL, V2, P474, DOI 10.1021/cb700083w; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	135	1	1	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17497	17514		10.1074/jbc.M114.556589	http://dx.doi.org/10.1074/jbc.M114.556589			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24798335	Green Published, hybrid			2022-12-28	WOS:000338018100017
J	Chen, L; Zhou, Y; Qu, MB; Zhao, Y; Yang, Q				Chen, Lei; Zhou, Yong; Qu, Mingbo; Zhao, Yong; Yang, Qing			Fully Deacetylated Chitooligosaccharides Act as Efficient Glycoside Hydrolase Family 18 Chitinase Inhibitors.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOCLADIUM SP FTD-0668; SERRATIA-MARCESCENS; PRODUCT; ALLOSAMIDIN; COMPLEX; MECHANISM; ARGIFIN; BINDING; CLONING; CHITOTRIOSIDASE	Small molecule inhibitors against chitinases have potential applications as pesticides, fungicides, and antiasthmatics. Here, we report that a series of fully deacetylated chitooligosaccharides (GlcN)(2-7) can act as inhibitors against the insect chitinase OfChtI, the human chitinase HsCht, and the bacterial chitinases SmChiA and SmChiB with IC50 values at micromolar to millimolar levels. The injection of mixed (GlcN)(2-7) into the fifth instar larvae of the insect Ostrinia furnacalis resulted in 85% of the larvae being arrested at the larval stage and death after 10 days, also suggesting that (GlcN)(2-7) might inhibit OfChtI in vivo. Crystal structures of the catalytic domain of OfChtI (OfChtI-CAD) complexed with (GlcN)(5,6) were obtained at resolutions of 2.0 angstrom. These structures, together with mutagenesis and thermodynamic analysis, suggested that the inhibition was strongly related to the interaction between the -1 GlcN residue of the inhibitor and the catalytic Glu(148) of the enzyme. Structure-based comparison showed that the fully deacetylated chitooligosaccharides mimic the substrate chitooligosaccharides by binding to the active cleft. This work first reports the inhibitory activity and proposed inhibitory mechanism of fully deacetylated chitooligosaccharides. Because the fully deacetylated chitooligosaccharides can be easily derived from chitin, one of the most abundant materials in nature, this work also provides a platform for developing eco-friendly inhibitors against chitinases.	[Chen, Lei; Qu, Mingbo; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Liaoning, Peoples R China; [Zhou, Yong] Dalian Univ Technol, Sch Software, Dalian 116620, Peoples R China; [Zhao, Yong] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian 116023, Peoples R China	Dalian University of Technology; Dalian University of Technology; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, 2 Linggong Rd, Dalian 116024, Liaoning, Peoples R China.	qingyang@dlut.edu.cn	Qu, Mingbo/L-6231-2016; Qu, Mingbo/F-5037-2014; Yang, Qing/GZK-2526-2022	Qu, Mingbo/0000-0003-0397-1630; Qu, Mingbo/0000-0003-0397-1630; Yang, Qing/0000-0001-8623-7532	National High Technology Research and Development Program of China [2011AA10A204]; National Key Project for Basic Research Grant [2010CB126100]; National Natural Science Foundation of China [61202252]; National Key Technology RD Program Grant [2011BAE06B05]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120041120052]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Project for Basic Research Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program Grant(National Key Technology R&D Program); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National High Technology Research and Development Program of China Grant 2011AA10A204; National Key Project for Basic Research Grant 2010CB126100; National Natural Science Foundation of China Grant 61202252; National Key Technology R&D Program Grant 2011BAE06B05; and Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20120041120052.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen OA, 2005, NAT PROD REP, V22, P563, DOI 10.1039/b416660b; Andersen OA, 2008, CHEM BIOL, V15, P295, DOI 10.1016/j.chembiol.2008.02.015; Arai N, 2000, J ANTIBIOT, V53, P609, DOI 10.7164/antibiotics.53.609; Arai N, 2000, CHEM PHARM BULL, V48, P1442, DOI 10.1248/cpb.48.1442; Barone R, 2003, CLIN CHIM ACTA, V331, P79, DOI 10.1016/S0009-8981(03)00089-5; Bortone K, 2002, J MOL BIOL, V320, P293, DOI 10.1016/S0022-2836(02)00444-8; Cederkvist F, 2006, ANGEW CHEM INT EDIT, V45, P2429, DOI 10.1002/anie.200503168; Cederkvist FH, 2008, CARBOHYD POLYM, V74, P41, DOI 10.1016/j.carbpol.2008.01.020; Cederkvist FH, 2007, BIOCHEMISTRY-US, V46, P12347, DOI 10.1021/bi701029u; Chen L, 2014, ACTA CRYSTALLOGR D, V70, P932, DOI 10.1107/S1399004713033841; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dixon MJ, 2005, BIOORG MED CHEM LETT, V15, P4717, DOI 10.1016/j.bmcl.2005.07.068; Donnelly LE, 2004, TRENDS PHARMACOL SCI, V25, P509, DOI 10.1016/j.tips.2004.08.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUCHS RL, 1986, APPL ENVIRON MICROB, V51, P504, DOI 10.1128/AEM.51.3.504-509.1986; FUKAMIZO T, 1985, INSECT BIOCHEM, V15, P141, DOI 10.1016/0020-1790(85)90001-0; Genta FA, 2006, INSECT BIOCHEM MOLEC, V36, P789, DOI 10.1016/j.ibmb.2006.07.007; Houston DR, 2004, J MED CHEM, V47, P5713, DOI 10.1021/jm049940a; Houston DR, 2002, BIOCHEM J, V368, P23, DOI 10.1042/BJ20021034; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; JONES JDG, 1986, EMBO J, V5, P467, DOI 10.1002/j.1460-2075.1986.tb04235.x; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Labadaridis I, 2005, ARCH DIS CHILD-FETAL, V90, pF531, DOI 10.1136/adc.2004.051284; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Macdonald JM, 2010, ANGEW CHEM INT EDIT, V49, P2599, DOI 10.1002/anie.200906644; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Omura S, 2000, J ANTIBIOT, V53, P603, DOI 10.7164/antibiotics.53.603; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papanikolau Y, 2003, ACTA CRYSTALLOGR D, V59, P400, DOI 10.1107/S0907444902021923; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Qu MB, 2011, BIOCHEM BIOPH RES CO, V404, P302, DOI 10.1016/j.bbrc.2010.11.111; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; Rush CL, 2010, CHEM BIOL, V17, P1275, DOI 10.1016/j.chembiol.2010.07.018; SAKUDA S, 1987, J ANTIBIOT, V40, P296, DOI 10.7164/antibiotics.40.296; SAKUDA S, 1986, TETRAHEDRON LETT, V27, P2475, DOI 10.1016/S0040-4039(00)84560-8; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P27278, DOI 10.1074/jbc.M604048200; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Wu QY, 2013, INSECT SCI, V20, P147, DOI 10.1111/j.1744-7917.2012.01512.x	46	42	47	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17932	17940		10.1074/jbc.M114.564534	http://dx.doi.org/10.1074/jbc.M114.564534			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24828498	Green Published, hybrid			2022-12-28	WOS:000338018100053
J	Zhang, YY; Guo, H; Deis, JA; Mashek, MG; Zhao, M; Ariyakumar, D; Armien, AG; Bernlohr, DA; Mashek, DG; Chen, XL				Zhang, Yuanyuan; Guo, Hong; Deis, Jessica A.; Mashek, Mara G.; Zhao, Ming; Ariyakumar, DonSanjiv; Armien, Anibal G.; Bernlohr, David A.; Mashek, Douglas G.; Chen, Xiaoli			Lipocalin 2 Regulates Brown Fat Activation via a Nonadrenergic Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; ENERGY-EXPENDITURE; PROTEIN-KINASE; COLD-EXPOSURE; BETA; ADIPOCYTES; INSULIN; GENE	In this study, we report that lipocalin 2 (Lcn2), a recently characterized adipokine/cytokine, is a novel regulator of brown adipose tissue (BAT) activation by modulating the adrenergic independent p38 MAPK-PGC-1 alpha-UCP1 pathway. Global Lcn2 knock-out (Lcn2(-/-)) mice have defective BAT thermogenic activation caused by cold stimulation and decreased BAT activity under high fat diet-induced obesity. Nevertheless, Lcn2(-/-) mice maintain normal sympathetic nervous system activation as evidenced by normal catecholamine release and lipolytic activity in response to cold stimulation. Further studies showed that Lcn2 deficiency impairs peroxisomal and mitochondrial oxidation of lipids and attenuates cold-induced Pgc1a and Ucp1 expression and p38 MAPK phosphorylation in BAT. Moreover, in vitro studies showed that Lcn2 deficiency reduces the thermogenic activity of brown adipocytes. Lcn2(-/-) differentiated brown adipocytes have significantly decreased expression levels of brown fat markers, decreased p38 MAPK phosphorylation, and decreased mitochondrial oxidation capacity. However, Lcn2(-/-) brown adipocytes have normal norepinephrine-stimulated p38 MAPK and hormone-sensitive lipase phosphorylation and Pgc1a and Ucp1 expression, suggesting an intact beta-adrenergic signaling activation. More intriguingly, recombinant Lcn2 was able to significantly stimulate p38 MAPK phosphorylation in brown adipocytes. Activating peroxisome proliferator-activated receptor gamma, a downstream effector of PGC-1 alpha, by thiazolidinedione administration fully reverses the BAT function of Lcn2(-/-) mice. Our findings provide evidence for the novel role Lcn2 plays in oxidative metabolism and BAT activation via an adrenergic independent mechanism.	[Zhang, Yuanyuan; Guo, Hong; Deis, Jessica A.; Mashek, Mara G.; Zhao, Ming; Mashek, Douglas G.; Chen, Xiaoli] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA; [Ariyakumar, DonSanjiv; Armien, Anibal G.] Univ Minnesota, Dept Vet Populat Med, Minnesota Vet Diagnost Lab, St Paul, MN 55108 USA; [Bernlohr, David A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Chen, XL (corresponding author), Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN 55108 USA.	xlchen@umn.edu	Mashek, Douglas/ABD-6844-2021; Zhao, Ming/B-3341-2018	Guo, Hong/0000-0001-8024-7086; Mashek, Douglas/0000-0001-7033-3386	National Institutes of Health from the NIDDK [R01DK080743, 2P30DK050456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456, R01DK080743] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK080743 (to X. C.) and 2P30DK050456 (to Minnesota Obesity Center) from the NIDDK.	Bagattin A, 2010, P NATL ACAD SCI USA, V107, P20376, DOI 10.1073/pnas.1009176107; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chen XL, 1997, BBA-MOL CELL RES, V1359, P136, DOI 10.1016/S0167-4889(97)00083-9; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fujishiro M, 2001, J BIOL CHEM, V276, P19800, DOI 10.1074/jbc.M101087200; Geiger PC, 2005, AM J PHYSIOL-ENDOC M, V288, pE782, DOI 10.1152/ajpendo.00477.2004; Guo H, 2013, ENDOCRINOLOGY, V154, P3525, DOI 10.1210/en.2013-1289; Guo H, 2012, ENDOCRINOLOGY, V153, P1183, DOI 10.1210/en.2011-1642; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Jin DZ, 2011, FASEB J, V25, P754, DOI 10.1096/fj.10-165175; KRAMAR R, 1986, J CLIN CHEM CLIN BIO, V24, P109; LALONDE JM, 1994, FASEB J, V8, P1240, DOI 10.1096/fasebj.8.15.8001736; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; NEDERGAARD J, 1980, AM J PHYSIOL, V239, pC208, DOI 10.1152/ajpcell.1980.239.5.C208; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Paton CM, 2013, OBESITY, V21, pE640, DOI 10.1002/oby.20507; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Somwar R, 2000, DIABETES, V49, P1794, DOI 10.2337/diabetes.49.11.1794; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TRAYHURN P, 1981, BIOCHIM BIOPHYS ACTA, V664, P549, DOI 10.1016/0005-2760(81)90132-6; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Warszawska JM, 2013, J CLIN INVEST, V123, P3363, DOI 10.1172/JCI67911; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096997; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	47	47	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22063	22077		10.1074/jbc.M114.559104	http://dx.doi.org/10.1074/jbc.M114.559104			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24917675	Green Published, hybrid			2022-12-28	WOS:000340593500023
J	Zheng, M; Chiang, YL; Lee, HL; Kong, LR; Hsu, STD; Hwang, IS; Rothfield, LI; Shih, YL				Zheng, Min; Chiang, Ya-Ling; Lee, Hsiao-Lin; Kong, Lih-Ren; Hsu, Shang-Te Danny; Hwang, Ing-Shouh; Rothfield, Lawrence I.; Shih, Yu-Ling			Self-Assembly of MinE on the Membrane Underlies Formation of the MinE Ring to Sustain Function of the Escherichia coli Min System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOLOGICAL SPECIFICITY FACTOR; DIVISION SITE SELECTION; TO-POLE OSCILLATION; CELL-DIVISION; CORRECT PLACEMENT; PROPER PLACEMENT; INHIBITOR MINC; RAPID POLE; IN-VITRO; PROTEIN	The pole-to-pole oscillation of the Min proteins in Escherichia coli results in the inhibition of aberrant polar division, thus facilitating placement of the division septum at the midcell. MinE of the Min system forms a ring-like structure that plays a critical role in triggering the oscillation cycle. However, the mechanism underlying the formation of the MinE ring remains unclear. This study demonstrates that MinE self-assembles into fibrillar structures on the supported lipid bilayer. The MinD-interacting domain of MinE shows amyloidogenic properties, providing a possible mechanism for self-assembly of MinE. Supporting the idea, mutations in residues Ile-24 and Ile-25 of the MinD-interacting domain affect fibril formation, membrane binding ability of MinE and MinD, and subcellular localization of three Min proteins. Additional mutations in residues Ile-72 and Ile-74 suggest a role of the C-terminal domain of MinE in regulating the folding propensity of the MinD-interacting domain for different molecular interactions. The study suggests a self-assembly mechanism that may underlie the ring-like structure formed by MinE-GFP observed in vivo.	[Zheng, Min; Lee, Hsiao-Lin; Kong, Lih-Ren; Hsu, Shang-Te Danny; Shih, Yu-Ling] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Chiang, Ya-Ling; Hwang, Ing-Shouh] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 013, Taiwan; [Hsu, Shang-Te Danny; Shih, Yu-Ling] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan; [Hwang, Ing-Shouh] Acad Sinica, Inst Phys, Taipei 115, Taiwan; [Rothfield, Lawrence I.] Univ Connecticut, Ctr Hlth, Dept Struct Microbial & Mol Biol, Farmington, CT 06032 USA	Academia Sinica - Taiwan; National Tsing Hua University; National Taiwan University; Academia Sinica - Taiwan; University of Connecticut	Shih, YL (corresponding author), Acad Sinica, Inst Biol Chem, 128 Sec 2 Acad Rd, Taipei 115, Taiwan.	ylshih10@gate.sinica.edu.tw	Hsu, Shang-Te Danny/L-2826-2014; Hsu, Shang-Te Danny/B-2324-2009; Hwang, Ing-Shouh/AAP-3963-2021; Shih, Yu-Ling/F-8396-2011	Hsu, Shang-Te Danny/0000-0002-7231-0185; Hwang, Ing-Shouh/0000-0002-7670-1212; Shih, Yu-Ling/0000-0002-8232-2569; LEE, Hsiao-Lin/0000-0002-4828-3383	Career Development Award from Academia Sinica [AS-98-CDA-L07]; Ministry of Science and Technology of Taiwan [NSC 102-2311-B-001-020-MY3, NSC 102-2811-B-001-076, NSC 99-2112-B-001-029-MY3]; International Human Frontier Science Program [HFSP CDA-00025/2010-C]; National Institutes of Health [R37-06032]	Career Development Award from Academia Sinica; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); International Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Career Development Award from Academia Sinica (AS-98-CDA-L07) and a general research grant from the Ministry of Science and Technology of Taiwan (NSC 102-2311-B-001-020-MY3) (to Y.-L. S.).; Supported by a postdoctoral fellowship from the Ministry of Science and Technology of Taiwan (NSC 102-2811-B-001-076).; Supported in part by a Career Development Award from the International Human Frontier Science Program (HFSP CDA-00025/2010-C).; Supported by Ministry of Science and Technology of Taiwan (NSC 99-2112-B-001-029-MY3).; Supported by Grant R37-06032 from the National Institutes of Health.	Adamcik J, 2012, MACROMOLECULES, V45, P1137, DOI 10.1021/ma202157h; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani H, 2010, P NATL ACAD SCI USA, V107, P18416, DOI 10.1073/pnas.1007141107; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Hwang IS, 2013, ULTRAMICROSCOPY, V135, P121, DOI 10.1016/j.ultramic.2012.07.001; Kang GB, 2010, MOL MICROBIOL, V76, P1222, DOI 10.1111/j.1365-2958.2010.07160.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; King GF, 1999, MOL MICROBIOL, V31, P1161, DOI 10.1046/j.1365-2958.1999.01256.x; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Ma LY, 2003, J BACTERIOL, V185, P4948, DOI 10.1128/JB.185.16.4948-4955.2003; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rowland SL, 2000, J BACTERIOL, V182, P613, DOI 10.1128/JB.182.3.613-619.2000; Sambrook J., 2006, CONDENSED PROTOCOLS, P756; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Shih YL, 2005, MOL MICROBIOL, V58, P917, DOI 10.1111/j.1365-2958.2005.04841.x; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Shih YL, 2013, ENVIRON MICROBIOL, V15, P3229, DOI 10.1111/1462-2920.12119; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Zhou H, 2003, J BACTERIOL, V185, P4326, DOI 10.1128/JB.185.15.4326-4335.2003	41	12	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21252	21266		10.1074/jbc.M114.571976	http://dx.doi.org/10.1074/jbc.M114.571976			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24914211	hybrid, Green Published			2022-12-28	WOS:000340558300005
J	Ido, K; Nield, J; Fukao, Y; Nishimura, T; Sato, F; Ifuku, K				Ido, Kunio; Nield, Jon; Fukao, Yoichiro; Nishimura, Taishi; Sato, Fumihiko; Ifuku, Kentaro			Cross-linking Evidence for Multiple Interactions of the PsbP and PsbQ Proteins in a Higher Plant Photosystem II Supercomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; 33 KDA PROTEIN; EXTRINSIC PROTEINS; CRYSTAL-STRUCTURE; FUNCTIONAL-PROPERTIES; BINDING; REVEALS; PSII; ARABIDOPSIS; ASSEMBLY/STABILITY	The extrinsic subunits of membrane-bound photosystem II (PSII) maintain an essential role in optimizing the water-splitting reaction of the oxygen-evolving complex (OEC), even though they have undergone drastic change during the evolution of oxyphototrophs from symbiotic cyanobacteria to chloroplasts. Two specific extrinsic proteins, PsbP and PsbQ, bind to the lumenal surface of PSII in green plants and maintain OEC conformation and stabilize overall enzymatic function; however, their precise location has not been fully resolved. In this study, PSII-enriched membranes, isolated from spinach, were subjected to chemical cross-linking combined with release-reconstitution experiments. We observed direct interactions between PsbP and PsbE, as well as with PsbR. Intriguingly, PsbP and PsbQ were further linked to the CP26 and CP43 light-harvesting proteins. In addition, two cross-linked sites, between PsbP and PsbR, and that of PsbP and CP26, were identified by tandem mass spectrometry. These data were used to estimate the binding topology and location of PsbP, and the putative positioning of PsbQ and PsbR on the lumenal surface of the PSII. Our model gives new insights into the organization of PSII extrinsic subunits in higher plants and their function in stabilizing the OEC of the PSII supercomplex.	[Ido, Kunio; Nishimura, Taishi; Sato, Fumihiko; Ifuku, Kentaro] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Nield, Jon] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Global Educ Project, Ikoma 6300192, Japan	Kyoto University; University of London; Queen Mary University London; Nara Institute of Science & Technology	Ifuku, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan.	ifuku@kais.kyoto-u.ac.jp	Nield, Jon/C-5892-2013; Ifuku, Kentaro/H-2455-2013; Sato, Fumihiko/C-1078-2011	Nield, Jon/0000-0001-9983-0239; Sato, Fumihiko/0000-0001-9497-4452; Ifuku, Kentaro/0000-0003-0241-8008	Japan Science and Technology Agency PRESTO; JSPS [18770032]; The Royal Society; Grants-in-Aid for Scientific Research [26660087] Funding Source: KAKEN	Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); The Royal Society(Royal Society of London); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from Japan Science and Technology Agency PRESTO (to Ke. I.) and by Grant-in-aid for Young Scientists (B) from 18770032JSPS (to Ke. I.).; Supported by The Royal Society through their University Research Fellowship program.	Allahverdiyeva Y, 2013, PLANT J, V75, P671, DOI 10.1111/tpj.12230; Balsera M, 2005, J MOL BIOL, V350, P1051, DOI 10.1016/j.jmb.2005.05.044; BERNIER M, 1995, FEBS LETT, V360, P251, DOI 10.1016/0014-5793(95)00101-E; Bricker TM, 2013, PHOTOSYNTH RES, V116, P235, DOI 10.1007/s11120-013-9820-7; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Calderone V, 2003, EMBO REP, V4, P900, DOI 10.1038/sj.embor.embor923; De Las Rivas J, 2005, PHOTOCH PHOTOBIO SCI, V4, P1003, DOI 10.1039/b506874f; Ido K, 2012, J BIOL CHEM, V287, P26377, DOI 10.1074/jbc.M112.385286; Ido K, 2009, BBA-BIOENERGETICS, V1787, P873, DOI 10.1016/j.bbabio.2009.03.004; Ifuku K, 2004, EMBO REP, V5, P362, DOI 10.1038/sj.embor.7400113; Ifuku K, 2001, BBA-PROTEIN STRUCT M, V1546, P196, DOI 10.1016/S0167-4838(01)00139-X; Ifuku K, 2011, J PHOTOCH PHOTOBIO B, V104, P158, DOI 10.1016/j.jphotobiol.2011.02.006; Kakiuchi S, 2012, BBA-BIOENERGETICS, V1817, P1346, DOI 10.1016/j.bbabio.2012.01.009; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kopecky V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046694; Liu HJ, 2014, P NATL ACAD SCI USA, V111, P4638, DOI 10.1073/pnas.1323063111; Liu HJ, 2009, ARCH BIOCHEM BIOPHYS, V489, P34, DOI 10.1016/j.abb.2009.07.014; Meades GD, 2005, BIOCHEMISTRY-US, V44, P15216, DOI 10.1021/bi051704u; MIYAO M, 1988, BIOCHIM BIOPHYS ACTA, V936, P465, DOI 10.1016/0005-2728(88)90024-2; MIYAO M, 1989, BIOCHIM BIOPHYS ACTA, V977, P315, DOI 10.1016/S0005-2728(89)80086-6; Nagao R, 2010, J BIOL CHEM, V285, P29191, DOI 10.1074/jbc.M110.146092; Nagao R, 2010, PLANT CELL PHYSIOL, V51, P718, DOI 10.1093/pcp/pcq042; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; Nishimura T, 2014, BBA-BIOENERGETICS, V1837, P1447, DOI 10.1016/j.bbabio.2013.12.012; Ohta H, 2003, EUR J BIOCHEM, V270, P4156, DOI 10.1046/j.1432-1033.2003.03810.x; Pagliano C, 2014, BBA-BIOENERGETICS, V1837, P1454, DOI 10.1016/j.bbabio.2013.11.004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; SEIDLER A, 1994, BBA-BIOENERGETICS, V1187, P73, DOI 10.1016/0005-2728(94)90168-6; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; Tohri A, 2004, EUR J BIOCHEM, V271, P962, DOI 10.1111/j.1432-1033.2004.03998.x; Tomita M, 2009, BIOCHEMISTRY-US, V48, P6318, DOI 10.1021/bi9006308; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vinyard DJ, 2013, ANNU REV BIOCHEM, V82, P577, DOI 10.1146/annurev-biochem-070511-100425; Xu H, 2010, J PROTEOME RES, V9, P3384, DOI 10.1021/pr100369y; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; YAMAMOTO Y, 1988, J BIOL CHEM, V263, P497; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2006, J BIOL CHEM, V281, P26260, DOI 10.1074/jbc.M603582200; Yu H, 2006, BIOCHEMISTRY-US, V45, P3404, DOI 10.1021/bi051604o	44	39	42	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20150	20157		10.1074/jbc.M114.574822	http://dx.doi.org/10.1074/jbc.M114.574822			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24914208	hybrid, Green Published			2022-12-28	WOS:000339395200028
J	Hsu, HM; Chu, CH; Wang, YT; Lee, Y; Wei, SY; Liu, HW; Ong, SJ; Chen, CP; Tai, JH				Hsu, Hong-Ming; Chu, Chien-Hsin; Wang, Ya-Ting; Lee, Yu; Wei, Shu-Yi; Liu, Hsing-Wei; Ong, Shiou-Jeng; Chen, Chinpan; Tai, Jung-Hsiang			Regulation of Nuclear Translocation of the Myb1 Transcription Factor by TvCyclophilin 1 in the Protozoan Parasite Trichomonas vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-FERREDOXIN OXIDOREDUCTASE; HUMAN-IMMUNODEFICIENCY-VIRUS; CIS-TRANS ISOMERASES; DNA-BINDING DOMAIN; AP65-1 GENE; HUMAN CYCLOPHILIN; ANKYRIN REPEAT; PROTEIN; IRON; PROMOTER	In Trichomonas vaginalis, a Myb1 protein was previously demonstrated to repress transcription of an iron-inducible ap65-1 gene. In this study, a human cyclophilin A homologue, TvCyclophilin 1 (TvCyP1), was identified as a Myb1-binding protein using a bacterial two-hybrid library screening system. The recombinant TvCyP1 exhibited typical peptidyl-prolyl isomerase activity with k(cat)/K-m of similar to 7.1 mu M-1 s(-1). In a pulldown assay, the His-tagged Myb1 interacted with a GST-TvCyP1 fusion protein, which had an enzymatic proficiency half that of recombinant TvCyP1. Both the enzymatic proficiency of GST-TvCyP1 and its binding to His-Myb1 were eliminated by mutation of Arg(63) in the catalytic motif or inhibited by cyclosporin A. TvCyP1 was primarily localized to the hydrogenosomes by immunofluorescence assay, but it was also co-purified with Myb1 in certain vesicle fractions from differential and gradient centrifugations. Transgenic cells overexpressing HA-TvCyP1 had a higher level of nuclear Myb1 but a much lower level of Myb1 associated with the vesicles than control and those overexpressing HA-TvCyP1(R63A). Myb1 was detected at a much higher level in the HA-TvCyP1 protein complex than in the HA-TvCyP1(R63A) protein complex immunoprecipitated from P15 and P100, but not S100, fractions of postnuclear lysates. A TvCyP1-binding motif, (105)YGPKWNK(111), was identified in Myb1 in which Gly(106) and Pro(107) were essential for its binding to TvCyP1. Mutation of Gly(106) and Pro(107), respectively, in HA-Myb1 resulted in cytoplasmic retention and elevated nuclear translocation of the overexpressed protein. These results suggest that TvCyP1 may induce the release of Myb1 that is restrained to certain cytoplasmic vesicles prior to its nuclear translocation.	[Chu, Chien-Hsin; Wang, Ya-Ting; Ong, Shiou-Jeng; Tai, Jung-Hsiang] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 11529, Taiwan; [Hsu, Hong-Ming; Chu, Chien-Hsin; Lee, Yu; Liu, Hsing-Wei; Tai, Jung-Hsiang] Acad Sinica, Inst Biomed Sci, Div Infect Dis & Immunol, Taipei 11529, Taiwan; [Wei, Shu-Yi; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Div Struct Biol, Taipei 11529, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Tai, JH (corresponding author), Acad Sinica, Inst Biomed Sci, Div Infect Dis, Taipei 11529, Taiwan.	taijh@gate.sinica.edu.tw	Tai, Jung-Hsiang/S-7019-2018; Chen, Chinpan/O-4202-2018; Chu, Chu/T-6038-2019	HSU, HONG-MING/0000-0002-7579-5106; Chu, Chien-Hsin/0000-0002-5490-8378	National Science Council [NSC101-2320-B-001-026]; Institute of Biomedical Sciences, Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant NSC101-2320-B-001-026 and the Institute of Biomedical Sciences, Academia Sinica.	ALDERETE JF, 1995, MICROB PATHOGENESIS, V19, P93, DOI 10.1006/mpat.1995.0049; ARRIBAS J, 1990, J BIOL CHEM, V265, P13969; Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003; Beltran NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065148; Bergholtz S, 2001, NUCLEIC ACIDS RES, V29, P3546, DOI 10.1093/nar/29.17.3546; Berriman M, 1998, BIOCHEM J, V334, P437, DOI 10.1042/bj3340437; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Carrello A, 2004, CELL STRESS CHAPERON, V9, P167, DOI 10.1379/CSC-26R.1; Chou CF, 1996, BIOTECHNIQUES, V20, P790; Chu CH, 2011, EUKARYOT CELL, V10, P1607, DOI 10.1128/EC.05177-11; Dietrich L, 2001, J VIROL, V75, P4721, DOI 10.1128/JVI.75.10.4721-4733.2001; Dornan J, 1999, J BIOL CHEM, V274, P34877, DOI 10.1074/jbc.274.49.34877; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; Galat A, 1999, ARCH BIOCHEM BIOPHYS, V371, P149, DOI 10.1006/abbi.1999.1434; Garcia AF, 2003, MOL MICROBIOL, V47, P1207, DOI 10.1046/j.1365-2958.2003.03366.x; Garcia AF, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-116; Gourlay LJ, 2007, J BIOL CHEM, V282, P24851, DOI 10.1074/jbc.M702714200; Harlow E., 1988, ANTIBODIES LAB MANUA, P55; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Hsu HM, 2012, EUKARYOT CELL, V11, P1441, DOI 10.1128/EC.00190-12; Hsu HM, 2009, EUKARYOT CELL, V8, P362, DOI 10.1128/EC.00317-08; Jiang I, 2011, NUCLEIC ACIDS RES, V39, P8992, DOI 10.1093/nar/gkr558; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Kucknoor AS, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-5; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lou YC, 2009, NUCLEIC ACIDS RES, V37, P2381, DOI 10.1093/nar/gkp097; Meza-Cervantez P, 2011, MICROBIOL-SGM, V157, P3469, DOI 10.1099/mic.0.053033-0; Moreno-Brito V, 2005, CELL MICROBIOL, V7, P245, DOI 10.1111/j.1462-5822.2004.00455.x; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mundodi V, 2004, MOL MICROBIOL, V53, P1099, DOI 10.1111/j.1365-2958.2004.04192.x; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Ong SJ, 2007, J BIOL CHEM, V282, P6716, DOI 10.1074/jbc.M610484200; Ong SJ, 2006, EUKARYOT CELL, V5, P391, DOI 10.1128/EC.5.2.391-399.2006; Ong SJ, 2004, MOL MICROBIOL, V52, P1721, DOI 10.1111/j.1365-2958.2004.04088.x; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Piotukh K, 2005, J BIOL CHEM, V280, P23668, DOI 10.1074/jbc.M503405200; SCHONBRUNNER ER, 1991, J BIOL CHEM, V266, P3630; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shafir SC, 2009, CLIN MICROBIOL REV, V22, P37, DOI 10.1128/CMR.00002-08; Song F, 2011, J BIOL CHEM, V286, P8197, DOI 10.1074/jbc.C110.181347; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; Torres-Romero JC, 2009, INFECT GENET EVOL, V9, P1065, DOI 10.1016/j.meegid.2009.06.003; Tsai CD, 2002, J BIOL CHEM, V277, P5153, DOI 10.1074/jbc.M110234200; Vajdos FE, 1997, PROTEIN SCI, V6, P2297; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wei SY, 2012, NUCLEIC ACIDS RES, V40, P449, DOI 10.1093/nar/gkr707; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x	53	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19120	19136		10.1074/jbc.M114.549410	http://dx.doi.org/10.1074/jbc.M114.549410			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831011	Green Published, hybrid			2022-12-28	WOS:000339062900042
J	Mayer, MC; Kaden, D; Schauenburg, L; Hancock, MA; Voigt, P; Roeser, D; Barucker, C; Than, ME; Schaefer, M; Multhaup, G				Mayer, Magnus C.; Kaden, Daniela; Schauenburg, Linda; Hancock, Mark A.; Voigt, Philipp; Roeser, Dirk; Barucker, Christian; Than, Manuel E.; Schaefer, Michael; Multhaup, Gerhard			Novel Zinc-binding Site in the E2 Domain Regulates Amyloid Precursor-like Protein 1 (APLP1) Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; APP FAMILY-MEMBERS; ALZHEIMERS-DISEASE; POSTSYNAPTIC DENSITY; HEPARIN; MICE; DIMERIZATION; COPPER; MOUSE; SYNAPTOGENESIS	The amyloid precursor protein (APP) and the APP-like proteins 1 and 2 (APLP1 and APLP2) are a family of multidomain transmembrane proteins possessing homo-and heterotypic contact sites in their ectodomains. We previously reported that divalent metal ions dictate the conformation of the extracellular APP E2 domain (Dahms, S. O., Konnig, I., Roeser, D., G hrs, K.-H., Mayer, M. C., Kaden, D., Multhaup, G., and Than, M. E. (2012) J. Mol. Biol. 416, 438-452), but unresolved is the nature and functional importance of metal ion binding to APLP1 and APLP2. We found here that zinc ions bound to APP and APLP1 E2 domains and mediated their oligomerization, whereas the APLP2 E2 domain interacted more weakly with zinc possessing a less surface-exposed zinc-binding site, and stayed monomeric. Copper ions bound to E2 domains of all three proteins. Fluorescence resonance energy transfer (FRET) analyses examined the effect of metal ion binding to APP and APLPs in the cellular context in real time. Zinc ions specifically induced APP and APLP1 oligomerization and forced APLP1 into multimeric clusters at the plasma membrane consistent with zinc concentrations in the blood and brain. The observed effects were mediated by a novel zinc-binding site within the APLP1 E2 domain as APLP1 deletion mutants revealed. Based upon its cellular localization and its dominant response to zinc ions, APLP1 is mainly affected by extracellular zinc among the APP family proteins. We conclude that zinc binding and APP/APLP oligomerization are intimately linked, and we propose that this represents a novel mechanism for regulating APP/APLP protein function at the molecular level.	[Mayer, Magnus C.; Kaden, Daniela; Schauenburg, Linda; Multhaup, Gerhard] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Hancock, Mark A.; Barucker, Christian; Multhaup, Gerhard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Voigt, Philipp] Charite, Neurowissenschaftliches Forschungszentrum, D-14195 Berlin, Germany; [Roeser, Dirk; Than, Manuel E.] Fritz Lipmann Inst, Leibniz Inst Age Res, Prot Crystallog Grp, D-07745 Jena, Germany; [Schaefer, Michael] Univ Leipzig, Rudolf Boehm Inst Pharmakol & Toxikol, Fak Med, D-04107 Leipzig, Germany	Free University of Berlin; McGill University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leipzig University	Multhaup, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	gerhard.multhaup@mcgill.ca	Than, Manuel/F-7536-2015	Than, Manuel/0000-0002-4707-9225; Voigt, Philipp/0000-0003-4366-0490	Deutsche Forschungsgemeinschaft [MU901, SFB740, GRK1123, Exc 257 NeuroCure]; German Federal Ministry of Education and Research through the Kompetenznetz Degenerative Demenzen Forderkennzeichen [01 GI 1004G]; Canadian Institute of Health Research [MOP-133411]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research through the Kompetenznetz Degenerative Demenzen Forderkennzeichen; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Deutsche Forschungsgemeinschaft Grants MU901, SFB740, GRK1123, and Exc 257 NeuroCure, German Federal Ministry of Education and Research through the Kompetenznetz Degenerative Demenzen Forderkennzeichen 01 GI 1004G, and Canadian Institute of Health Research Grant MOP-133411 (to G. M.).	Akatsu H, 2012, BIOMETALS, V25, P337, DOI 10.1007/s10534-011-9504-8; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Ball LJ, 2002, FEBS LETT, V513, P45, DOI 10.1016/S0014-5793(01)03291-4; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Baumkotter F, 2012, EXP BRAIN RES, V217, P389, DOI 10.1007/s00221-011-2878-6; Bayer TA, 1997, ACTA NEUROPATHOL, V94, P519, DOI 10.1007/s004010050745; Brocca S, 1998, PROTEIN SCI, V7, P1415, DOI 10.1002/pro.5560070618; BUSH AI, 1994, J BIOL CHEM, V269, P26618; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Coburger I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081926; Coulson EJ, 2000, NEUROCHEM INT, V36, P175, DOI 10.1016/S0197-0186(99)00125-4; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Gaier ED, 2013, J NEUROSCI RES, V91, P2, DOI 10.1002/jnr.23143; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Gu CG, 1999, ANAL CHIM ACTA, V397, P247, DOI 10.1016/S0003-2670(99)00409-2; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; HEMDAN ES, 1989, P NATL ACAD SCI USA, V86, P1811, DOI 10.1073/pnas.86.6.1811; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Isbert S, 2012, CELL MOL LIFE SCI, V69, P1353, DOI 10.1007/s00018-011-0882-4; Jansen J, 2012, J NUTR BIOCHEM, V23, P1458, DOI 10.1016/j.jnutbio.2011.09.008; Kaden D, 2012, EUR J CELL BIOL, V91, P234, DOI 10.1016/j.ejcb.2011.01.017; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; KIM TW, 1995, MOL BRAIN RES, V32, P36, DOI 10.1016/0169-328X(95)00328-P; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; LORENT K, 1995, NEUROSCIENCE, V65, P1009, DOI 10.1016/0306-4522(94)00555-J; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; MULTHAUP G, 1994, BIOCHIMIE, V76, P304, DOI 10.1016/0300-9084(94)90163-5; MULTHAUP G, 1995, J MOL RECOGNIT, V8, P247; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; PARR RM, 1964, BIOCHEM J, V91, P424, DOI 10.1042/bj0910424; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; SEGREST JP, 1973, ARCH BIOCHEM BIOPHYS, V155, P167, DOI 10.1016/S0003-9861(73)80019-0; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Shariati SAM, 2013, J CELL SCI, V126, P1268, DOI 10.1242/jcs.122440; Shen C, 2008, PROTEINS, V71, P1744, DOI 10.1002/prot.21857; Sindreu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00068; SMALL DH, 1994, J NEUROSCI, V14, P2117; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Tamano H, 2011, METALLOMICS, V3, P656, DOI 10.1039/c1mt00008j; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Wattenberg A, 2002, J AM SOC MASS SPECTR, V13, P772, DOI 10.1016/S1044-0305(02)00414-2; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Xue Y, 2011, P NATL ACAD SCI USA, V108, P16229, DOI 10.1073/pnas.1103407108; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	68	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19019	19030		10.1074/jbc.M114.570382	http://dx.doi.org/10.1074/jbc.M114.570382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855651	Green Published, hybrid			2022-12-28	WOS:000339062900033
J	Rai, R; Tate, JJ; Shanmuganatham, K; Howe, MM; Cooper, TG				Rai, Rajendra; Tate, Jennifer J.; Shanmuganatham, Karthik; Howe, Martha M.; Cooper, Terrance G.			A Domain in the Transcription Activator Gln3 Specifically Required for Rapamycin Responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGEN CATABOLITE REPRESSION; NUCLEAR-LOCALIZATION; STRUCTURE PREDICTION; SACCHAROMYCES-CEREVISIAE; CARBON STARVATION; CONTROLS TORC1; URE2P; PHOSPHORYLATION; PHOSPHATASE; LIMITATION	Nitrogen-responsive control of Gln3 localization is implemented through TorC1-dependent (rapamycin-responsive) and TorC1-independent (nitrogen catabolite repression-sensitive and methionine sulfoximine (Msx)-responsive) regulatory pathways. W epreviously demonstrated amino acid substitutions in a putative Gln3 alpha-helix(656-666), which are required for a two-hybrid Gln3-Tor1 interaction, also abolished rapamycin responsiveness of Gln3 localization and partially abrogated cytoplasmic Gln3 sequestration in cells cultured under nitrogen-repressive conditions. Here, we demonstrate these three characteristics are not inextricably linked together. A second distinct Gln3 region (Gln3(510-589)) is specifically required for rapamycin responsiveness of Gln3 localization, but not for cytoplasmic Gln3 sequestration under repressive growth conditions or relocation to the nucleus following Msx addition. Aspartate or alanine substitution mutations throughout this region uniformly abolish rapamycin responsiveness. Contained within this region is a sequence with a predicted propensity to form an alpha-helix(583-591), one side of which consists of three hydrophobic amino acids flanked by serine residues. Substitution of aspartate for even one of these serines abolishes rapamycin responsiveness and increases rapamycin resistance without affecting either of the other two Gln3 localization responses. In contrast, alanine substitutions decrease rapamycin resistance. Together, these data suggest that targets in the C-terminal portion of Gln3 required for the Gln3-Tor1 interaction, cytoplasmic Gln3 sequestration, and Gln3 responsiveness to Msx addition and growth in poor nitrogen sources are distinct from those needed for rapamycin responsiveness.	[Rai, Rajendra; Tate, Jennifer J.; Howe, Martha M.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Shanmuganatham, Karthik] St Jude Childrens Res Hosp, Div Virol, Dept Infect Dis, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health from NIGMS [GM-35642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642 from the NIGMS.	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Binda M, 2010, CELL CYCLE, V9, P221, DOI 10.4161/cc.9.2.10585; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; CHISHOLM G, 1982, MOL CELL BIOL, V2, P1088, DOI 10.1128/MCB.2.9.1088; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2004, J BIOL CHEM, V279, P37512, DOI 10.1074/jbc.M407372200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, J BIOL CHEM, V286, P44897, DOI 10.1074/jbc.M111.290577; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lorberg A, 2003, CURR TOP MICROBIOL, V279, P1; Magasanik B, 2005, P NATL ACAD SCI USA, V102, P16537, DOI 10.1073/pnas.0507116102; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Powers T, 2007, CELL METAB, V6, P1, DOI 10.1016/j.cmet.2007.06.009; Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105; Rai R, 2013, J BIOL CHEM, V288, P2789, DOI 10.1074/jbc.M112.421826; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2013, J BIOL CHEM, V288, P27243, DOI 10.1074/jbc.M113.484386; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zhang TL, 2012, STRUCTURE, V20, P2151, DOI 10.1016/j.str.2012.09.019	49	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18999	19018		10.1074/jbc.M114.563668	http://dx.doi.org/10.1074/jbc.M114.563668			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847055	Green Published, hybrid			2022-12-28	WOS:000339062900032
J	Veiga-da-Cunha, M; Chevalier, N; Stroobant, V; Vertommen, D; Van Schaftingen, E				Veiga-da-Cunha, Maria; Chevalier, Nathalie; Stroobant, Vincent; Vertommen, Didier; Van Schaftingen, Emile			Metabolite Proofreading in Carnosine and Homocarnosine Synthesis MOLECULAR IDENTIFICATION OF PM20D2 AS beta-ALANYL-LYSINE DIPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-2-HYDROXYGLUTARIC ACIDURIA; MOLECULAR-IDENTIFICATION; SERUM CARNOSINASE; BRAIN; PURIFICATION; REPAIR; GENE; ENZYME; DEHYDROGENASE; MUTATIONS	Carnosine synthase is the ATP-dependent ligase responsible for carnosine (beta-alanyl-histidine) and homocarnosine (gamma-aminobutyryl- histidine) synthesis in skeletal muscle and brain, respectively. This enzyme uses, also at substantial rates, lysine, ornithine, and arginine instead of histidine, yet the resulting dipeptides are virtually absent from muscle or brain, suggesting that they are removed by a "metaboliterepair" enzyme. Usingaradiolabeledsubstrate, we found that rat skeletal muscle, heart, and brain contained a cytosolic beta-alanyl-lysine dipeptidase activity. This enzyme, which has the characteristics of a metalloenzyme, was purified approximate to 200-fold from rat skeletal muscle. Mass spectrometry analysis of the fractions obtained at different purification stages indicated parallel enrichment of PM20D2, a peptidase of unknown function belonging to the metallopeptidase 20 family. Western blotting showed coelution of PM20D2 with beta-alanyl-lysine dipeptidase activity. Recombinant mouse PM20D2 hydrolyzed beta-alanyl-lysine, beta-alanyl-ornithine, gamma-aminobutyryl-lysine, and gamma-aminobutyryl-ornithine as its best substrates. It also actedat lower rateson beta-alanyl-arginine and gamma-aminobutyryl-arginine but virtually not on carnosine or homocarnosine. Although acting preferentially on basic dipeptides derived from beta-alanine or gamma-aminobutyrate,PM20D2 also acted at lower rates on some "classic dipeptides" like alpha-alanyl-lysine and alpha-lysyl-lysine. The same activity profile was observed with human PM20D2, yet this enzyme was similar to 100-200-fold less active on all substrates tested than the mouse enzyme. Cotransfection in HEK293T cells of mouse or human PM20D2 together with carnosine synthase prevented the accumulation of abnormal dipeptides (beta-alanyl-lysine, beta-alanyl-ornithine, gamma-aminobutyryl-lysine), thus favoring the synthesis of carnosine and homocarnosine and confirming the metabolite repair role of PM20D2.	[Veiga-da-Cunha, Maria; Chevalier, Nathalie; Van Schaftingen, Emile] Catholic Univ Louvain, de Duve Inst, Welbio, B-1200 Brussels, Belgium; [Veiga-da-Cunha, Maria; Chevalier, Nathalie; Van Schaftingen, Emile] Catholic Univ Louvain, de Duve Inst, Physiol Chem Lab, B-1200 Brussels, Belgium; [Stroobant, Vincent] Catholic Univ Louvain, de Duve Inst, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, de Duve Inst, Prot Phosphorylat Unit, B-1200 Brussels, Belgium	Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Veiga-da-Cunha, M (corresponding author), Catholic Univ Louvain, de Duve Inst, BCHM 7539,Ave Hippocrate 75, B-1200 Brussels, Belgium.	maria.veiga@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Van Schaftingen, Emile/0000-0002-6199-7647; Vertommen, Didier/0000-0001-7648-8282	Fonds National de la Recherche Scientifique (FNRS); Interuniversity Attraction Poles Programme, Belgian Science Policy [Networks P7/43]	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme, Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS) and the Interuniversity Attraction Poles Programme, Belgian Science Policy (Networks P7/43).	Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Bauer K, 2005, NEUROCHEM RES, V30, P1339, DOI 10.1007/s11064-005-8806-z; Bitto E, 2009, PROTEINS, V74, P61, DOI 10.1002/prot.22124; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Botelho TO, 2011, J BIOL CHEM, V286, P25697, DOI 10.1074/jbc.M111.247437; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Gjessing L R, 1990, J Neural Transm Suppl, V29, P91; Green JM, 2010, J BACTERIOL, V192, P2407, DOI 10.1128/JB.01362-09; Haliloglu G, 2008, NEUROPEDIATRICS, V39, P119, DOI 10.1055/s-2008-1081217; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; JACKSON MC, 1991, CLIN CHIM ACTA, V196, P193, DOI 10.1016/0009-8981(91)90073-L; KALYANKAR GD, 1959, J BIOL CHEM, V234, P3210; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; KUMON A, 1970, BIOCHIM BIOPHYS ACTA, V200, P466, DOI 10.1016/0005-2795(70)90103-0; KUNZE N, 1986, EUR J BIOCHEM, V160, P605, DOI 10.1111/j.1432-1033.1986.tb10081.x; LENNEY JF, 1983, CLIN CHIM ACTA, V132, P157, DOI 10.1016/0009-8981(83)90243-7; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/nchembio.1141, 10.1038/NCHEMBIO.1141]; Linster CL, 2011, J BIOL CHEM, V286, P42992, DOI 10.1074/jbc.M111.281527; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; MATSUOKA M, 1969, BIOCHIM BIOPHYS ACTA, V177, P169, DOI 10.1016/0304-4165(69)90083-X; NAKAJIMA T, 1969, J NEUROCHEM, V16, P417, DOI 10.1111/j.1471-4159.1969.tb10382.x; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Sass JO, 2006, AM J HUM GENET, V78, P401, DOI 10.1086/500563; Stellingwerff T, 2012, AMINO ACIDS, V42, P2461, DOI 10.1007/s00726-011-1054-4; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Veiga-da-Cunha M, 2012, J BIOL CHEM, V287, P7246, DOI 10.1074/jbc.M111.323485; Veiga-da-Cunha M, 2010, J BIOL CHEM, V285, P18888, DOI 10.1074/jbc.M110.110924	33	26	28	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19726	19736		10.1074/jbc.M114.576579	http://dx.doi.org/10.1074/jbc.M114.576579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891507	Green Published, hybrid			2022-12-28	WOS:000339326800044
J	Eaton, JM; Takkellapati, S; Lawrence, RT; McQueeney, KE; Boroda, S; Mullins, GR; Sherwood, SG; Finck, BN; Villen, J; Harris, TE				Eaton, James M.; Takkellapati, Sankeerth; Lawrence, Robert T.; McQueeney, Kelley E.; Boroda, Salome; Mullins, Garrett R.; Sherwood, Samantha G.; Finck, Brian N.; Villen, Judit; Harris, Thurl E.			Lipin 2 Binds Phosphatidic Acid by the Electrostatic Hydrogen Bond Switch Mechanism Independent of Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; SEIPIN; LIPODYSTROPHY; LOCALIZATION; BIOGENESIS; ENZYMES; PH	Lipin 2 is a phosphatidic acid phosphatase (PAP) responsible for the penultimate step of triglyceride synthesis and dephosphorylation of phosphatidic acid (PA) to generate diacylglycerol. The lipin family of PA phosphatases is composed of lipins 1-3, which are members of the conserved haloacid dehalogenase superfamily. Although genetic alteration of LPIN2 in humans is known to cause Majeed syndrome, little is known about the biochemical regulation of its PAP activity. Here, in an attempt to gain a better general understanding of the biochemical nature of lipin 2, we have performed kinetic and phosphorylation analyses. We provide evidence that lipin 2, like lipin 1, binds PA via the electrostatic hydrogen bond switch mechanism but has a lower rate of catalysis. Like lipin 1, lipin 2 is highly phosphorylated, and we identified 15 phosphosites. However, unlike lipin 1, the phosphorylation of lipin 2 is not induced by insulin signaling nor is it sensitive to inhibition of the mammalian target of rapamycin. Importantly, phosphorylation of lipin 2 does not negatively regulate either membrane binding or PAP activity. This suggests that lipin 2 functions as a constitutively active PA phosphatase in stark contrast to the high degree of phosphorylation-mediated regulation of lipin 1. This knowledge of lipin 2 regulation is important for a deeper understanding of how the lipin family functions with respect to lipid synthesis and, more generally, as an example of how the membrane environment around PA can influence its effector proteins.	[Eaton, James M.; Takkellapati, Sankeerth; McQueeney, Kelley E.; Boroda, Salome; Mullins, Garrett R.; Sherwood, Samantha G.; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Lawrence, Robert T.; Villen, Judit] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA	University of Virginia; Washington University (WUSTL); University of Washington; University of Washington Seattle	Harris, TE (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, POB 800735,1300 Jefferson Pk Ave,Jordan Hall, Charlottesville, VA 22908 USA.	teh3c@virginia.edu		Finck, Brian/0000-0001-5411-3674; Villen, Judit/0000-0002-1005-1739	National Institutes of Health [R00CA140789, R01 DK078187]; American Diabetes Association [7-11-JF-21]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R00CA140789] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078187, P30DK056341, R01DK101946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R00CA140789 and R01 DK078187 (to B. N. F.). This work was also supported by American Diabetes Association Junior Faculty Grant 7-11-JF-21 (to T. E. H.) and an Ellison Medical Foundation New Scholar award (to J. V.).	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Binns D, 2010, BIOCHEMISTRY-US, V49, P10747, DOI 10.1021/bi1013003; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Creutz CE, 2013, BIOCHEMISTRY-US, V52, P5092, DOI 10.1021/bi4004765; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Dwyer JR, 2012, P NATL ACAD SCI USA, V109, pE2486, DOI 10.1073/pnas.1205221109; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han Gil-Soo, 2004, Methods Mol Biol, V284, P209; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Hofer CT, 2010, METHODS MOL BIOL, V606, P69, DOI 10.1007/978-1-60761-447-0_6; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KENNEDY EP, 1956, CAN J BIOCHEM PHYS, V34, P334, DOI 10.1139/o56-036; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Liu GH, 2010, BIOCHEM J, V432, P65, DOI 10.1042/BJ20100584; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Majeed HA, 2001, EUR J PEDIATR, V160, P705, DOI 10.1007/s004310100799; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Sembongi H, 2013, J BIOL CHEM, V288, P34502, DOI 10.1074/jbc.M113.488445; Shin JJH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-85; Sim MFM, 2013, MOL METAB, V2, P38, DOI 10.1016/j.molmet.2012.11.002; Sim MFM, 2013, DIABETOLOGIA, V56, P2498, DOI 10.1007/s00125-013-3029-3; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026	40	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18055	18066		10.1074/jbc.M114.547604	http://dx.doi.org/10.1074/jbc.M114.547604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24811178	Green Published, hybrid			2022-12-28	WOS:000338042000009
J	Roth-Walter, F; Gomez-Casado, C; Pacios, LF; Mothes-Luksch, N; Roth, GA; Singer, J; Diaz-Perales, A; Jensen-Jarolim, E				Roth-Walter, Franziska; Gomez-Casado, Cristina; Pacios, Luis F.; Mothes-Luksch, Nadine; Roth, Georg A.; Singer, Josef; Diaz-Perales, Araceli; Jensen-Jarolim, Erika			Bet v 1 from Birch Pollen Is a Lipocalin-like Protein Acting as Allergen Only When Devoid of Iron by Promoting Th2 Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE ALIGNMENT; IGE; BET-V-1; IMMUNOTHERAPY; ANTIBODIES; BINDING; ACTIVATION; INDUCTION; APOPTOSIS; RESPONSES	It is hypothesized that allergens are at the borderline of self and non-self and, through as yet elusive circumstances, mount a Th2 response for allergic sensitization. The major birch pollen allergen Bet v 1 is considered the prototype for the PR-10 protein family causing respiratory allergy. Here, we give structural evidence that Bet v 1 is a lipocalin-like protein with a striking structural resemblance to human lipocalin 2. Lipocalin 2 is highly expressed in the lung where it exerts immunoregulatory functions dependent on being loaded with siderophore-bound iron (holo-form) or not (apo-form). We demonstrate that similar to lipocalin 2, Bet v 1 is capable of binding iron via catechol-based siderophores. Thereby, calculated K-d values of 66 nM surpassed affinities to known ligands nearly by a power of 10. Moreover, we give functional evidence of the immunomodulatory capacity of Bet v 1 being dependent on its iron-loaded state. When incubated to human immune cells, only the apo-form of Bet v 1, but not the holo-form, was able to promote Th2 cells secreting IL13. These results provide for the first time a functional understanding on the allergenicity of Bet v 1 and a basis for future allergen immunotherapies counteracting Th2 immune responses on a molecular basis.	[Roth-Walter, Franziska; Jensen-Jarolim, Erika] Med Univ Vienna, Comparat Med Unit, Messerli Res Inst, Univ Vet Med Vienna, A-1210 Vienna, Austria; [Roth-Walter, Franziska; Jensen-Jarolim, Erika] Univ Vienna, A-1210 Vienna, Austria; [Gomez-Casado, Cristina; Pacios, Luis F.; Diaz-Perales, Araceli] Tech Univ Madrid, Ctr Plant Biotechnol & Genom, Dept Biotechnol, Madrid 28040, Spain; [Mothes-Luksch, Nadine] AllergyCare, A-1220 Vienna, Austria; [Roth, Georg A.] Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Med, Vienna, Austria; [Singer, Josef] Med Univ Vienna, Unit Comparat Immunol & Oncol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, A-1090 Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Universidad Politecnica de Madrid; Medical University of Vienna; Medical University of Vienna	Jensen-Jarolim, E (corresponding author), Med Univ Vienna, Comparat Med Unit, Messerli Res Inst, Univ Vet Med Vienna, Veterinaer Pl 1, A-1210 Vienna, Austria.	erika.jensen-jarolim@meduniwien.ac.at	Pacios, Luis F./AAL-6124-2021; Roth-Walter, Franziska/V-4651-2017; Jensen-Jarolim, Erika/C-5120-2018; Gomez-Casado, Cristina/AAE-4826-2021; Díaz-Perales, Araceli/D-8433-2016; Pacios, Luis F/I-5164-2015; Gomez-Casado, Cristina/K-4031-2016	Pacios, Luis F./0000-0002-0585-4289; Roth-Walter, Franziska/0000-0001-5005-9228; Jensen-Jarolim, Erika/0000-0003-4019-5765; Díaz-Perales, Araceli/0000-0002-1093-3627; Pacios, Luis F/0000-0002-0585-4289; Gomez-Casado, Cristina/0000-0002-7707-6367; Roth, Georg/0000-0002-3984-3107	Austrian Science Fund (FWF) [F4606-B19]; FPI Program from the Spanish Government (MICINN/MINECO) [BES-2010-034628]; FWF [CCHD W1205-B09]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FPI Program from the Spanish Government (MICINN/MINECO); FWF(Austrian Science Fund (FWF))	This work was supported by the F4606-B19 of the Austrian Science Fund (FWF). F. Roth-Walter, C. Gomez-Casado, A. Diaz-Perales, L. F. Pacios, J. Singer, and E. Jensen-Jarolim disclose that a patent application based on part of this work has been filed. Others declare no conflict of interest.; Supported by Grant BES-2010-034628 from the FPI Program from the Spanish Government (MICINN/MINECO).; Supported by Grant CCHD W1205-B09 from the FWF.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; Cho EA, 2013, J CELL BIOCHEM, V114, P864, DOI 10.1002/jcb.24423; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; EBNER C, 1995, J IMMUNOL, V154, P1932; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Ganglberger E, 2000, FASEB J, V14, P2177, DOI 10.1096/fj.99-1000com; Gomez-Casado C, 2013, J MOL GRAPH MODEL, V45, P111, DOI 10.1016/j.jmgm.2013.08.013; IPSEN H, 1992, CLIN EXP ALLERGY, V22, P391, DOI 10.1111/j.1365-2222.1992.tb03101.x; JAROLIM E, 1989, INT ARCH ALLER A IMM, V88, P180, DOI 10.1159/000234778; KALDJIAN E, 1988, FASEB J, V2, P2801, DOI 10.1096/fasebj.2.12.3261700; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; Mobs C, 2012, J ALLERGY CLIN IMMUN, V130, P1108, DOI 10.1016/j.jaci.2012.07.056; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mutschlechner S, 2010, J ALLERGY CLIN IMMUN, V125, P711, DOI 10.1016/j.jaci.2009.10.052; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Purohit A, 2008, CLIN EXP ALLERGY, V38, P1514, DOI 10.1111/j.1365-2222.2008.03042.x; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Sekerkova A, 2011, INT ARCH ALLERGY IMM, V154, P278, DOI 10.1159/000321819; Seutter von Loetzen C, 2014, BIOCHEM J, V457, P379, DOI 10.1042/BJ20130413; Smole U, 2010, IMMUNOBIOLOGY, V215, P903, DOI 10.1016/j.imbio.2009.11.003; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Virtanen T, 2001, ALLERGY, V56, P48, DOI 10.1034/j.1398-9995.2001.00915.x; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430	32	41	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17416	17421		10.1074/jbc.M114.567875	http://dx.doi.org/10.1074/jbc.M114.567875			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24798325	Green Published, hybrid			2022-12-28	WOS:000338018100011
J	Bjerregaard-Andersen, K; Sommer, T; Jensen, JK; Jochimsen, B; Etzerodt, M; Morth, JP				Bjerregaard-Andersen, Kaare; Sommer, Theis; Jensen, Jan K.; Jochimsen, Bjarne; Etzerodt, Michael; Morth, J. Preben			A Proton Wire and Water Channel Revealed in the Crystal Structure of Isatin Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; STRESS	The high resolution crystal structures of isatin hydrolase from Labrenzia aggregata in the apo and the product state are described. These are the first structures of a functionally characterized metal-dependent hydrolase of this fold. Isatin hydrolase converts isatin to isatinate and belongs to a novel family of metalloenzymes that include the bacterial kynurenine formamidase. The product state, mimicked by bound thioisatinate, reveals a water molecule that bridges the thioisatinate to a proton wire in an adjacent water channel and thus allows the proton released by the reaction to escape only when the product is formed. The functional proton wire present in isatin hydrolase isoform b represents a unique catalytic feature common to all hydrolases is here trapped and visualized for the first time. The local molecular environment required to coordinate thioisatinate allows stronger and more confident identification of orthologous genes encoding isatin hydrolases within the prokaryotic kingdom. The isatin hydrolase orthologues found in human gut bacteria raise the question as to whether the indole-3-acetic acid degradation pathway is present in human gut flora.	[Bjerregaard-Andersen, Kaare; Sommer, Theis; Morth, J. Preben] Nord EMBL Partnership Univ Oslo, Norwegian Ctr Mol Med, N-0349 Oslo, Norway; [Morth, J. Preben] Oslo Univ Hosp, Expt Med Res Inst, N-0424 Oslo, Norway; [Bjerregaard-Andersen, Kaare; Jensen, Jan K.; Jochimsen, Bjarne; Etzerodt, Michael] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	University of Oslo; Aarhus University	Morth, JP (corresponding author), Univ Oslo, Ctr Mol Med Norway, POB 1137 Blindern, N-0318 Oslo, Norway.	j.p.morth@ncmm.uio.no	Morth, Jens Preben/AAP-7834-2021; Morth, Jens Preben/G-4450-2013	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Bjerregaard-Andersen, Kaare/0000-0003-3609-3408	Lundbeck Foundation [R34-2009-3616] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berry A, 2002, J IND MICROBIOL BIOT, V28, P127, DOI 10.1038/sj/jim/7000228; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Chernyshev A, 2006, BIOPHYS J, V91, P580, DOI 10.1529/biophysj.106.083352; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; CHRISTENSEN JH, 1991, FEBS LETT, V281, P181, DOI 10.1016/0014-5793(91)80388-J; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Cukierman S, 2006, BBA-BIOENERGETICS, V1757, P876, DOI 10.1016/j.bbabio.2005.12.001; de Grotthuss C, 1806, ANN CHIM, V58, P54; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englert DL, 2009, APPL ENVIRON MICROB, V75, P4557, DOI 10.1128/AEM.02952-08; Glover V, 1998, STRESS MEDICINE, V14, P225, DOI 10.1002/(SICI)1099-1700(1998100)14:4<225::AID-SMI801>3.0.CO;2-P; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; Hamaue N, 2000, RES COMMUN MOL PATH, V108, P63; Han Q, 2012, BIOCHEM J, V446, P253, DOI 10.1042/BJ20120416; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; JENSEN JB, 1995, J BACTERIOL, V177, P5762, DOI 10.1128/jb.177.20.5762-5766.1995; Kurnasov O, 2003, FEMS MICROBIOL LETT, V227, P219, DOI 10.1016/S0378-1097(03)00684-0; Lee J, 2007, APPL ENVIRON MICROB, V73, P4100, DOI 10.1128/AEM.00360-07; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mawatari K, 2001, ANALYST, V126, P33, DOI 10.1039/b006484j; Medvedev A, 2005, STRESS, V8, P175, DOI 10.1080/10253890500342321; Medvedev AE, 2004, NEUROTOXICOLOGY, V25, P185, DOI 10.1016/S0161-813X(03)00098-6; NORMAN TR, 1992, STRESS MEDICINE, V8, P141, DOI 10.1002/smi.2460080302; Olesen MR, 1996, PLANT SOIL, V186, P143, DOI 10.1007/BF00035068; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shinobu A, 2009, J PHYS CHEM A, V113, P7253, DOI 10.1021/jp8102047; Thomaeus A, 2008, PROTEIN SCI, V17, P1275, DOI 10.1110/ps.034173.107; WATKINS P, 1990, NEUROCHEM INT, V17, P321, DOI 10.1016/0197-0186(90)90154-L; WEYLER W, 1999, Patent No. 5866396	35	17	18	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21351	21359		10.1074/jbc.M114.568824	http://dx.doi.org/10.1074/jbc.M114.568824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24917679	Green Published, hybrid			2022-12-28	WOS:000340558300015
J	Guo, HT; Gao, JM; Taxman, DJ; Ting, JPY; Su, LS				Guo, Haitao; Gao, Jianmei; Taxman, Debra J.; Ting, Jenny P. Y.; Su, Lishan			HIV-1 Infection Induces Interleukin-1 beta Production via TLR8 Protein-dependent and NLRP3 Inflammasome Mechanisms in Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SINGLE-STRANDED RNA; NALP3 INFLAMMASOME; IMMUNE ACTIVATION; PORPHYROMONAS-GINGIVALIS; CUTTING EDGE; CELLS; RECOGNITION; EXPRESSION; GENE	The induction of inflammatory cytokines such as IL-1 beta is associated with the progression of human immunodeficiency virus, type 1 (HIV-1) disease or AIDS. Unlike most inflammatory cytokines that are regulated by NF-kappa B at the transcriptional level, production of mature IL-1 beta also depends on inflammasome activation. The mechanism by which HIV-1 induces pro-IL-1 beta expression and activates inflammasomes to cleave pro-IL-1 beta into its bioactive form is not clearly defined. We report here that HIV-1 infection in human monocytes efficiently induced IL-1 beta expression and inflammasome activation. Toll-like receptor 8 (TLR8) was required for inducing pro-IL-1 beta expression, whereas the NLRP3 inflammasome was required for IL-1 beta maturation and release. Furthermore, the lysosomal protease cathepsin B and HIV-1 induced production of reactive oxygen species were critical for HIV-induced inflammasome activation and IL-1 beta production. HIV-1 entry, reverse transcription, and integration were all required for both pro-IL-1 beta expression and inflammasome activation. Finally, we show that HIV-1-derived RNA was sufficient to induce both pro-IL-1 beta expression and inflammasome activation. We conclude that HIV-1 infection induced the expression of pro-IL-1 beta via TLR8-mediated mechanisms and activated caspase-1 through the NLRP3 inflammasome to cleave pro-IL-1 beta into bioactive IL-1 beta. These findings help to elucidate mechanisms of HIV-1 disease progression and identify novel targets for treating HIV-1 induced inflammation and immune activation.	[Guo, Haitao; Gao, Jianmei; Taxman, Debra J.; Ting, Jenny P. Y.; Su, Lishan] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Taxman, Debra J.; Ting, Jenny P. Y.; Su, Lishan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Su, LS (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	lsu@med.unc.edu			National Institute of Health [AI077454, AI080432, AI095097, AI029564, AI057157, CA156330]; NATIONAL CANCER INSTITUTE [R01CA156330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080432, R01AI077454, R01AI095097, U54AI057157, R37AI029564, R01AI029564, R56AI029564] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institute of Health Grants AI077454, AI080432, and AI095097 (to L. S.) and AI029564, AI057157, and CA156330 (to J. P. T.).	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; ARDITI M, 1991, PEDIATR INFECT DIS J, V10, P450, DOI 10.1097/00006454-199106000-00007; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Barlan AU, 2011, VIROLOGY, V412, P306, DOI 10.1016/j.virol.2011.01.019; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Chan ML, 2010, P ROY SOC B-BIOL SCI, V277, P3773, DOI 10.1098/rspb.2010.0972; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fischer WB, 2002, BBA-BIOMEMBRANES, V1561, P27, DOI 10.1016/S0304-4157(01)00009-0; GENDELMAN HE, 1990, J EXP MED, V172, P1433, DOI 10.1084/jem.172.5.1433; GLIENKE W, 1994, RES VIROLOGY, V145, P193, DOI 10.1016/S0923-2516(07)80022-7; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Han XB, 2012, J BIOL CHEM, V287, P13778, DOI 10.1074/jbc.M112.342683; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hartigan-O'Connor DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003941; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang MTH, 2009, J IMMUNOL, V182, P2395, DOI 10.4049/jimmunol.0800909; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Meissner EG, 2005, VIROLOGY, V336, P184, DOI 10.1016/j.virol.2005.03.032; Meissner EG, 2004, VIROLOGY, V328, P74, DOI 10.1016/j.virol.2004.07.019; MELTZER MS, 1991, PATHOBIOLOGY, V59, P209, DOI 10.1159/000163647; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Nour AM, 2011, J BIOL CHEM, V286, P17921, DOI 10.1074/jbc.M110.210575; Pontillo A, 2012, AIDS, V26, P11, DOI 10.1097/QAD.0b013e32834d697f; Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4; Rahman MM, 2011, J VIROL, V85, P12505, DOI 10.1128/JVI.00410-11; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Segovia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029695; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159; Zhang LG, 2011, BLOOD, V117, P6184, DOI 10.1182/blood-2011-01-331173	58	94	97	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21716	21726		10.1074/jbc.M114.566620	http://dx.doi.org/10.1074/jbc.M114.566620			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939850	hybrid, Green Published			2022-12-28	WOS:000340558300045
J	Sammond, DW; Yarbrough, JM; Mansfield, E; Bomble, YJ; Hobdey, SE; Decker, SR; Taylor, LE; Resch, MG; Bozell, JJ; Himmel, ME; Vinzant, TB; Crowley, MF				Sammond, Deanne W.; Yarbrough, John M.; Mansfield, Elisabeth; Bomble, Yannick J.; Hobdey, Sarah E.; Decker, Stephen R.; Taylor, Larry E.; Resch, Michael G.; Bozell, Joseph J.; Himmel, Michael E.; Vinzant, Todd B.; Crowley, Michael F.			Predicting Enzyme Adsorption to Lignin Films by Calculating Enzyme Surface Hydrophobicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; ACIDOTHERMUS-CELLULOLYTICUS; THERMOMYCES-LANUGINOSUS; CELLOBIOHYDROLASE-I; CATALYTIC CORE; PROTEIN; HYDROLYSIS; CELLULOSE	The inhibitory action of lignin on cellulase cocktails is a major challenge to the biological saccharification of plant cell wall polysaccharides. Although the mechanism remains unclear, hydrophobic interactions between enzymes and lignin are hypothesized to drive adsorption. Here we evaluate the role of hydrophobic interactions in enzyme-lignin binding. The hydrophobicity of the enzyme surface was quantified using an estimation of the clustering of nonpolar atoms, identifying potential interaction sites. The adsorption of enzymes to lignin surfaces, measured using the quartz crystal microbalance, correlates to the hydrophobic cluster scores. Further, these results suggest a minimum hydrophobic cluster size for a protein to preferentially adsorb to lignin. The impact of electrostatic contribution was ruled out by comparing the isoelectric point (pI) values to the adsorption of proteins to lignin surfaces. These results demonstrate the ability to predict enzyme-lignin adsorption and could potentially be used to design improved cellulase cocktails, thus lowering the overall cost of biofuel production.	[Sammond, Deanne W.; Yarbrough, John M.; Bomble, Yannick J.; Hobdey, Sarah E.; Decker, Stephen R.; Taylor, Larry E.; Resch, Michael G.; Himmel, Michael E.; Vinzant, Todd B.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Resch, Michael G.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Mansfield, Elisabeth] NIST, Appl Chem & Mat Div, Boulder, CO 80305 USA; [Bozell, Joseph J.] Univ Tennessee, Ctr Renewable Carbon, Ctr Catalyt Convers Biomass C3Bio, Knoxville, TN 37917 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; National Institute of Standards & Technology (NIST) - USA; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Crowley, MF (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, 16253 Denver West Pkwy, Golden, CO 80401 USA.	Michael.Crowley@nrel.gov	Mansfield, Elisabeth/C-5258-2012; Mansfield, Elisabeth/N-8387-2019; crowley, michael/A-4852-2013	Mansfield, Elisabeth/0000-0003-2463-0966; Mansfield, Elisabeth/0000-0003-2463-0966; Decker, Stephen/0000-0001-7002-9034; Bomble, Yannick/0000-0001-7624-8000; crowley, michael/0000-0001-5163-9398; Yarbrough, John/0000-0001-5424-552X	U.S. Department of Energy [DE-AC36-08GO28308]; National Renewable Energy Laboratory; Department of Energy Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office; Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000997]	U.S. Department of Energy(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); Department of Energy Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office(United States Department of Energy (DOE)); Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy under Contract DE-AC36-08GO28308 with the National Renewable Energy Laboratory and by the Department of Energy Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office. This work was also supported by the Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number DE-SC0000997.	Baker JO, 2005, APPL BIOCHEM BIOTECH, V121, P129, DOI 10.1385/ABAB:121:1-3:0129; Ballesteros I, 1998, APPL BIOCHEM BIOTECH, V70-2, P369, DOI 10.1007/BF02920152; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brethauer S, 2011, BIORESOURCE TECHNOL, V102, P6295, DOI 10.1016/j.biortech.2011.02.016; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Bujacz A, 2012, ACTA CRYSTALLOGR D, V68, P1278, DOI 10.1107/S0907444912027047; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; DEMELER B, 2005, ULTRASCAN COMPREHENS, P210; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Dutta AK, 2008, J COLLOID INTERF SCI, V324, P55, DOI 10.1016/j.jcis.2008.04.065; El Hage R, 2010, POLYM DEGRAD STABIL, V95, P997, DOI 10.1016/j.polymdegradstab.2010.03.012; El Hage R, 2009, POLYM DEGRAD STABIL, V94, P1632, DOI 10.1016/j.polymdegradstab.2009.07.007; Erdtman H., 1972, J POLYM SCI B, V10, P228, DOI [10.1002/pol.1972.110100315, DOI 10.1002/POL.1972.110100315]; Eriksson T, 2002, ENZYME MICROB TECH, V31, P353, DOI 10.1016/S0141-0229(02)00134-5; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Gruber K, 1998, BIOCHEMISTRY-US, V37, P13475, DOI 10.1021/bi980864l; Hakulinen N, 2000, J STRUCT BIOL, V132, P180, DOI 10.1006/jsbi.2000.4318; Haven MO, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-165; Jacak R, 2012, PROTEINS, V80, P825, DOI 10.1002/prot.23241; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Kaar WE, 1998, BIOTECHNOL BIOENG, V59, P419, DOI 10.1002/(SICI)1097-0290(19980820)59:4&lt;419::AID-BIT4&gt;3.0.CO;2-J; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; KURAKAKE M, 1994, BIORESOURCE TECHNOL, V49, P247, DOI 10.1016/0960-8524(94)90048-5; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lijnzaad P, 1996, PROTEINS, V25, P389, DOI 10.1002/(SICI)1097-0134(199607)25:3<389::AID-PROT10>3.3.CO;2-S; Lijnzaad P, 1996, PROTEINS, V26, P192; Lou HM, 2013, CHEMSUSCHEM, V6, P919, DOI 10.1002/cssc.201200859; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Nakagame S, 2011, BIORESOURCE TECHNOL, V102, P4507, DOI 10.1016/j.biortech.2010.12.082; Nakagame S, 2011, BIOTECHNOL BIOENG, V108, P538, DOI 10.1002/bit.22981; Pingali SV, 2011, J BIOL CHEM, V286, P32801, DOI 10.1074/jbc.M111.263004; Qing Q, 2010, BIORESOURCE TECHNOL, V101, P5941, DOI 10.1016/j.biortech.2010.03.003; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V133, P270, DOI 10.1016/j.biortech.2013.01.075; Rahikainen JL, 2013, ENZYME MICROB TECH, V53, P315, DOI 10.1016/j.enzmictec.2013.07.003; Rastogi P A, 2000, Methods Mol Biol, V132, P47; Resch MG, 2013, ENERG ENVIRON SCI, V6, P1858, DOI 10.1039/c3ee00019b; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Selig MJ, 2008, BIORESOURCE TECHNOL, V99, P4997, DOI 10.1016/j.biortech.2007.09.064; Shrivastava S, 2013, WORLD J MICROB BIOT, V29, P2407, DOI 10.1007/s11274-013-1409-y; SUNDBERG M, 1991, BIOTECHNOL APPL BIOC, V13, P1; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; TORRONEN A, 1995, BIOCHEMISTRY-US, V34, P847, DOI 10.1021/bi00003a019; Turon X, 2008, LANGMUIR, V24, P3880, DOI 10.1021/la7032753; Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391; Wilkins MR, 1999, METH MOL B, V112, P531; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	53	91	95	5	96	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20960	20969		10.1074/jbc.M114.573642	http://dx.doi.org/10.1074/jbc.M114.573642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24876380	Green Published, hybrid			2022-12-28	WOS:000339396600049
J	Zhao, KX; Li, SS; Wu, LY; Lai, C; Yang, GD				Zhao, Kexin; Li, Shuangshuang; Wu, Lingyun; Lai, Christopher; Yang, Guangdong			Hydrogen Sulfide Represses Androgen Receptor Transactivation by Targeting at the Second Zinc Finger Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; POSTTRANSLATIONAL MODIFICATION; ENDOGENOUS H2S; CANCER; GENE; INACTIVATION; DIMERIZATION; SURVIVAL; DOMAINS; SRC-1	Androgen receptor (AR) signaling is indispensable for the development of prostate cancer from the initial androgen-dependent state to a later aggressive androgen-resistant state. This study examined the role of hydrogen sulfide (H2S), a novel gasotransmitter, in the regulation of AR signaling as well as its mediation in androgen-independent cell growth in prostate cancer cells. Here we found that H2S inhibits cell proliferation of both androgen-dependent (LNCaP) and antiandrogen-resistant prostate cancer cells (LNCaP-B), with more significance on the latter, which was established by long term treatment of parental LNCaP cells with bicalutamide. The expression of cystathionine gamma-lyase(CSE), a major H2S-producing enzyme in prostate tissue, was reduced in both human prostate cancer tissues and LNCaP-B cells. LNCaP-B cells were resistant to bicalutamide-induced cell growth inhibition, and CSE overexpression could rebuild the sensitivity of LNCaP-B cells to bicalutamide. H2S significantly repressed the expression of prostate-specific antigen (PSA) and TMPRSS2, two AR-targeted genes. In addition, H2S inhibited AR binding with PSA promoter and androgen-responsive element(ARE) luciferase activity. We further found that AR is post-translationally modified by H2S through S-sulfhydration. Mutation of cysteine 611 and cysteine 614 in the second zinc finger module of AR-DNA binding domain diminished the effects of H2S on AR S-sulfhydration and AR dimerization. These data suggest that reduced CSE/H2S signaling contributes to antiandrogen-resistant status, and sufficient level of H2S is able to inhibit AR transactivation and treat castration-resistant prostate cancer.	[Zhao, Kexin; Li, Shuangshuang; Wu, Lingyun; Lai, Christopher; Yang, Guangdong] Lakehead Univ, Cardiovasc & Metab Res Unit, Thunder Bay, ON P7B 5E1, Canada; [Zhao, Kexin; Li, Shuangshuang; Yang, Guangdong] Lakehead Univ, Sch Kinesiol, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON P7B 6V4, Canada; [Lai, Christopher] Lakehead Univ, Northern Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada	Lakehead University; Lakehead University; Lakehead University; Northern Ontario School of Medicine; Lakehead University; Northern Ontario School of Medicine	Yang, GD (corresponding author), Lakehead Univ, Sch Kinesiol, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	gyang@lakeheadu.ca	Yang, Guangdong/G-4129-2011		Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was supported by a grant-in-aid from the Heart and Stroke Foundation of Canada.; Supported by a New Investigator award from the Heart and Stroke Foundation of Canada. To whom correspondence should be addressed: the School of Kinesiology, Lakehead University, 955 Oliver Rd., Thunder Bay, Ontario P7B 5E1, Canada. Tel.: 807-346-7937; Fax: 807-346-7873; E-mail: gyang@lakeheadu.ca.	Al-Awadi F, 2008, ANTICANCER RES, V28, P2541; Bernard D, 2003, J CLIN INVEST, V112, P1724; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Clinckemalie L, 2013, MOL ENDOCRINOL, V27, P2028, DOI 10.1210/me.2013-1098; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Guo H, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.013; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Helsen C, 2012, MOL CELL BIOL, V32, P3033, DOI 10.1128/MCB.00151-12; Hirawat S, 2003, CANCER INVEST, V21, P400, DOI 10.1081/CNV-120018232; Kaczmarczyk SJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng087; Kim SH, 2009, MOL CANCER THER, V8, P1946, DOI 10.1158/1535-7163.MCT-09-0104; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Lallous N, 2013, INT J MOL SCI, V14, P12496, DOI 10.3390/ijms140612496; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Ma KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020525; McCourt C, 2012, CLIN CANCER RES, V18, P3822, DOI 10.1158/1078-0432.CCR-11-3277; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nazareth LV, 1999, MOL ENDOCRINOL, V13, P2065, DOI 10.1210/me.13.12.2065; Pei YX, 2011, TOXICOL APPL PHARM, V257, P420, DOI 10.1016/j.taap.2011.09.026; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Qin Y, 2013, CANCER RES, V73, P6690, DOI 10.1158/0008-5472.CAN-13-1042; Schoenmakers E, 1999, BIOCHEM J, V341, P515, DOI 10.1042/0264-6021:3410515; Sen U, 2012, AM J PHYSIOL-CELL PH, V303, pC41, DOI 10.1152/ajpcell.00398.2011; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; van der Steen T, 2013, INT J MOL SCI, V14, P14833, DOI 10.3390/ijms140714833; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; WONG CI, 1993, J BIOL CHEM, V268, P19004; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang GD, 2011, AM J PATHOL, V179, P869, DOI 10.1016/j.ajpath.2011.04.028; Yang GD, 2011, J BIOL CHEM, V286, P26450, DOI 10.1074/jbc.M111.266643; Yu S, 2013, CANCER LETT, V328, P83, DOI 10.1016/j.canlet.2012.09.006	41	49	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20824	20835		10.1074/jbc.M114.559518	http://dx.doi.org/10.1074/jbc.M114.559518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24942741	hybrid, Green Published			2022-12-28	WOS:000339396600037
J	Kurth, F; Duprez, W; Premkumar, L; Schembri, MA; Fairlie, DP; Martin, JL				Kurth, Fabian; Duprez, Wilko; Premkumar, Lakshmanane; Schembri, Mark A.; Fairlie, David P.; Martin, Jennifer L.			Crystal Structure of the Dithiol Oxidase DsbA Enzyme from Proteus Mirabilis Bound Non-covalently to an Active Site Peptide Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; URINARY-TRACT-INFECTION; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; OXIDOREDUCTASE DSBA; CLINICAL ISOLATE; REDOX PROPERTIES; RESISTANCE; VIRULENCE; MUTANTS	The disulfide bond forming DsbA enzymes and their DsbB interaction partners are attractive targets for development of antivirulence drugs because both are essential for virulence factor assembly in Gram-negative pathogens. Here we characterize PmDsbA from Proteus mirabilis, a bacterial pathogen increasingly associated with multidrug resistance. PmDsbA exhibits the characteristic properties of a DsbA, including an oxidizing potential, destabilizing disulfide, acidic active site cysteine, and dithiol oxidase catalytic activity. We evaluated a peptide, PWATCDS, derived from the partner protein DsbB and showed by thermal shift and isothermal titration calorimetry that it binds to PmDsbA. The crystal structures of PmDsbA, and the active site variant PmDsbAC30S were determined to high resolution. Analysis of these structures allows categorization of PmDsbA into the DsbA class exemplified by the archetypal Escherichia coli DsbA enzyme. We also present a crystal structure of PmDsbAC30S in complex with the peptide PWATCDS. The structure shows that the peptide binds non-covalently to the active site CXXC motif, the cis-Pro loop, and the hydrophobic groove adjacent to the active site of the enzyme. This high-resolution structural data provides a critical advance for future structure-based design of non-covalent peptidomimetic inhibitors. Such inhibitors would represent an entirely new antibacterial class that work by switching off the DSB virulence assembly machinery.	[Kurth, Fabian; Duprez, Wilko; Premkumar, Lakshmanane; Fairlie, David P.; Martin, Jennifer L.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, St Lucia, Qld 4067, Australia; [Schembri, Mark A.; Fairlie, David P.; Martin, Jennifer L.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4067, Australia	University of Queensland; University of Queensland	Martin, JL (corresponding author), Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, St Lucia, Qld 4067, Australia.	j.martin@imb.uq.edu.au	Schembri, Mark A/C-7262-2009; Fairlie, David P/F-8865-2014; Martin, Jennifer L./A-6039-2010	Schembri, Mark A/0000-0003-4863-9260; Fairlie, David P/0000-0002-7856-8566; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council Australian Laureate Fellowship [FL0992138]; Australian Research Council Future Fellowship [FT100100662]; National Health and Medical Research Council Senior Principal Research Fellowship [1027369]; Honorary National Health and Medical Research Council [455829]	Australian Research Council Australian Laureate Fellowship(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council); National Health and Medical Research Council Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Honorary National Health and Medical Research Council	Supported through an Australian Research Council Australian Laureate Fellowship FL0992138 to J. L. M.; Supported by an Australian Research Council Future Fellowship FT100100662.; Supported by National Health and Medical Research Council Senior Principal Research Fellowship 1027369.; Supported by Australian Research Council Australian Laureate Fellowship FL0992138 and Honorary National Health and Medical Research Council Research Fellowship 455829. To whom correspondence should be addressed. E-mail: j.martin@imb.uq.edu.au.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Burall LS, 2004, INFECT IMMUN, V72, P2922, DOI 10.1128/IAI.72.5.2922-2938.2004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; COETZEE JN, 1975, J GEN MICROBIOL, V87, P173, DOI 10.1099/00221287-87-1-173; COETZEE JN, 1960, J GEN MICROBIOL, V23, P445, DOI 10.1099/00221287-23-3-445; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELSEA SH, 1992, J BIOL CHEM, V267, P13150; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRANKLIN TJ, 1973, J BACTERIOL, V115, P235, DOI 10.1128/JB.115.1.235-242.1973; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guay DRP, 2008, DRUGS, V68, P1169, DOI 10.2165/00003495-200868090-00002; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HITCHINGS GH, 1973, J INFECT DIS, V128, pS433, DOI 10.1093/infdis/128.Supplement_3.S433; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jacobsen SM, 2011, VIRULENCE, V2, P460, DOI 10.4161/viru.2.5.17783; Jansen AM, 2004, INFECT IMMUN, V72, P7294, DOI 10.1128/IAI.72.12.7294-7305.2004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurth F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080210; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MEHTAR S, 1991, J ANTIMICROB CHEMOTH, V28, P612, DOI 10.1093/jac/28.4.612; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; OHNISHI K, 1987, J BACTERIOL, V169, P1485, DOI 10.1128/jb.169.4.1485-1488.1987; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; SABATH LD, 1969, NEW ENGL J MED, V280, P91, DOI 10.1056/NEJM196901092800208; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Shouldice SR, 2010, ANTIOXID REDOX SIGN, V12, P921, DOI 10.1089/ars.2009.2736; Sperling LJ, 2013, J PHYS CHEM B, V117, P6052, DOI 10.1021/jp400795d; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tibbetts R, 2008, J CLIN MICROBIOL, V46, P3080, DOI 10.1128/JCM.00979-08; Totsika M, 2012, CURR DRUG TARGETS, V13, P1386, DOI 10.2174/138945012803530206; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Walden PM, 2012, ACTA CRYSTALLOGR D, V68, P1290, DOI 10.1107/S0907444912026388; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998; Zhao WH, 2013, CRIT REV MICROBIOL, V39, P79, DOI 10.3109/1040841X.2012.691460	74	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19810	19822		10.1074/jbc.M114.552380	http://dx.doi.org/10.1074/jbc.M114.552380			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24831013	Green Published, hybrid			2022-12-28	WOS:000339326800052
J	Butcher, AJ; Hudson, BD; Shimpukade, B; Alvarez-Curto, E; Prihandoko, R; Ulven, T; Milligan, G; Tobin, AB				Butcher, Adrian J.; Hudson, Brian D.; Shimpukade, Bharat; Alvarez-Curto, Elisa; Prihandoko, Rudi; Ulven, Trond; Milligan, Graeme; Tobin, Andrew B.			Concomitant Action of Structural Elements and Receptor Phosphorylation Determines Arrestin-3 Interaction with the Free Fatty Acid Receptor FFA4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-BLIND; GPR120; POTENT; PHARMACOLOGY; CHALLENGES; DISCOVERY; LIGANDS; TAK-875; AGONIST	In addition to being nutrients, free fatty acids act as signaling molecules by activating a family of G protein-coupled receptors. Among these is FFA4, previously called GPR120, which responds to medium and long chain fatty acids, including health-promoting omega-3 fatty acids, which have been implicated in the regulation of metabolic and inflammatory responses. Here we show, using mass spectrometry, mutagenesis, and phosphospecific antibodies, that agonist-regulated phosphorylation of the human FFA4 receptor occurred primarily at five residues (Thr(347), Thr(349), Ser(350), Ser(357), and Ser(360)) in the C-terminal tail. Mutation of these residues reduced both the efficacy and potency of ligand-mediated arrestin-3 recruitment as well as affecting recruitment kinetics. Combined mutagenesis of all five of these residues was insufficient to fully abrogate interaction with arrestin-3, but further mutagenesis of negatively charged residues revealed additional structural components for the interaction with arrestin-3 within the C-terminal tail of the receptor. These elements consist of the acidic residues Glu(341), Asp(348), and Asp(355) located close to the phosphorylation sites. Receptor phosphorylation thus operates in concert with structural elements within the C-terminal tail of FFA4 to allow for the recruitment of arrestin-3. Importantly, these mechanisms of arrestin-3recruitmentoperateindependentlyfromG(q/11) coupling, thereby offering the possibility that ligands showing stimulus bias could be developed that exploit these differential coupling mecha-nisms. Furthermore, this provides a strategy for the design of biased receptors to probe physiologically relevant signaling.	[Butcher, Adrian J.; Prihandoko, Rudi; Tobin, Andrew B.] Univ Leicester, Med Res Council Toxicol Unit, Leicester LE1 9HN, Leics, England; [Hudson, Brian D.; Alvarez-Curto, Elisa; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Shimpukade, Bharat; Ulven, Trond] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense M, Denmark	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; University of Glasgow; University of Southern Denmark	Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk; tba@le.ac.uk	Ulven, Trond/H-5500-2015; Hudson, B. D./H-4845-2013	Ulven, Trond/0000-0002-8135-1755; Hudson, B. D./0000-0001-7059-0091; Shimpukade, Bharat/0000-0001-7468-2348	Biotechnology and Biosciences Research Council [BB/K019864/1, BB/K019856/1]; Medical Research Council Toxicology Unit; Danish Council for Strategic Research Grant [11-116196]; Canadian Institutes of Health Research; Biotechnology and Biological Sciences Research Council [1653478, BB/K019864/1, 1062317, BB/K019856/1] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1110] Funding Source: researchfish; BBSRC [BB/K019864/1, BB/K019856/1] Funding Source: UKRI; MRC [MC_UP_A600_1110] Funding Source: UKRI	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Toxicology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Council for Strategic Research Grant(Danske Strategiske Forskningsrad (DSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Biotechnology and Biosciences Research Council Grants BB/K019864/1 (to G. M.) and BB/K019856/1 (to A. B. T.), core funding from the Medical Research Council Toxicology Unit (to A. B. T.), Danish Council for Strategic Research Grant 11-116196 (to T. U. and G. M.), and a Canadian Institutes of Health Research fellowship (to B. D. H.).	Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Burns RN, 2014, BIOCHEM PHARMACOL, V87, P650, DOI 10.1016/j.bcp.2013.12.016; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Gehret AU, 2010, BIOCHEM J, V428, P235, DOI 10.1042/BJ20100139; Ghosh M, 2011, J BIOL CHEM, V286, P13561, DOI 10.1074/jbc.M110.215723; Hinkle PM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00180; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holliday Nicholas D, 2011, Front Endocrinol (Lausanne), V2, P112, DOI 10.3389/fendo.2011.00112; Hudson BD, 2011, ADV PHARMACOL, V62, P175, DOI 10.1016/B978-0-12-385952-5.00006-3; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Hudson BD, 2013, CURR TOP MED CHEM, V13, P14; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Ichimura A, 2009, PROSTAG OTH LIPID M, V89, P82, DOI 10.1016/j.prostaglandins.2009.05.003; Kaku K, 2013, DIABETES CARE, V36, P245, DOI 10.2337/dc12-0872; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin Terry, 2009, F1000 Biol Rep, V1, P87, DOI 10.3410/B1-87; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Martini L, 2002, MOL PHARMACOL, V62, P30, DOI 10.1124/mol.62.1.30; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ryan KK, 2013, SCIENCE, V339, P918, DOI 10.1126/science.1234062; Sanchez-Reyes OB, 2014, EUR J PHARMACOL, V723, P368, DOI 10.1016/j.ejphar.2013.11.003; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006	33	50	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18451	18465		10.1074/jbc.M114.568816	http://dx.doi.org/10.1074/jbc.M114.568816			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24817122	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000338042000042
J	Linck, R; Fu, XF; Lin, JF; Ouch, C; Schefter, A; Steffen, W; Warren, P; Nicastro, D				Linck, Richard; Fu, Xiaofeng; Lin, Jianfeng; Ouch, Christna; Schefter, Alexandra; Steffen, Walter; Warren, Peter; Nicastro, Daniela			Insights into the Structure and Function of Ciliary and Flagellar Doublet Microtubules TEKTINS, Ca2+-BINDING PROTEINS, AND STABLE PROTOFILAMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYOCLONIC EPILEPSY; DYNEIN REGULATORY COMPLEX; INTERMEDIATE-FILAMENT PROTEINS; URCHIN SPERM FLAGELLA; INNER-ARM DYNEIN; PROTEOMIC ANALYSIS; CRYOELECTRON TOMOGRAPHY; IMMUNOELECTRON MICROSCOPY; MOLECULAR ARCHITECTURE; CHLAMYDOMONAS FLAGELLA	Cilia and flagella are conserved, motile, and sensory cell organelles involved in signal transduction and human disease. Their scaffold consists of a 9-fold array of remarkably stable doublet microtubules (DMTs), along which motor proteins transmit force for ciliary motility and intraflagellar transport. DMTs possess Ribbons of three to four hyper-stable protofilaments whose location, organization, and specialized functions have been elusive. We performed a comprehensive analysis of the distribution and structural arrangements of Ribbon proteins from sea urchin sperm flagella, using quantitative immunobio-chemistry, proteomics, immuno-cryo-electron microscopy, and tomography. Isolated Ribbons contain acetylated alpha-tubulin, beta-tubulin, conserved protein Rib45, > 95% of the axonemal tektins, and > 95% of the calcium-binding proteins, Rib74 and Rib85.5, whose human homologues are related to the cause of juvenile myoclonic epilepsy. DMTs contain only one type of Ribbon, corresponding to protofilaments A11-12-13-1 of the A-tubule. Rib74 and Rib85.5 are associated with the Ribbon in the lumen of the A-tubule. Ribbons contain a single similar to 5-nm wide filament, composed of equimolar tektins A, B, and C, which interact with the nexin-dynein regulatory complex. A summary of findings is presented, and the functions of Ribbon proteins are discussed in terms of the assembly and stability of DMTs, ciliary motility, and other microtubule systems.	[Linck, Richard; Ouch, Christna; Schefter, Alexandra] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Fu, Xiaofeng; Lin, Jianfeng; Warren, Peter; Nicastro, Daniela] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Fu, Xiaofeng; Lin, Jianfeng; Warren, Peter; Nicastro, Daniela] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Steffen, Walter] Hannover Med Sch, Inst Mol & Cell Physiol, D-30625 Hannover, Germany	University of Minnesota System; University of Minnesota Twin Cities; Brandeis University; Brandeis University; Hannover Medical School	Linck, R (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	linck001@umn.edu; nicastro@brandeis.edu		Ouch, Christna/0000-0003-4116-1217; Nicastro, Daniela/0000-0002-0122-7173	National Science Foundation (NSF) [1024963]; National Institutes of Health [GM083122]; Characterization Facility, University of Minnesota (UM) from the NSF through the MRSEC program; UM Department of Genetics, Cell Biology and Development; Div Of Molecular and Cellular Bioscience [1024963] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083122] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Characterization Facility, University of Minnesota (UM) from the NSF through the MRSEC program; UM Department of Genetics, Cell Biology and Development; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (NSF Award 1024963 to R. L.), by the National Institutes of Health (Award GM083122 to D. N.), by the Characterization Facility, University of Minnesota (UM), which receives partial support from the NSF through the MRSEC program, and by funds from the UM Department of Genetics, Cell Biology and Development, through Dr. Brian Van Ness.	Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; AMOS WB, 1986, J CELL SCI, P55; BEHNKE O, 1967, J CELL SCI, V2, P169; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; BRENNER S, 1959, BIOCHIM BIOPHYS ACTA, V34, P103, DOI 10.1016/0006-3002(59)90237-9; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; CHEN R, 1993, J CELL SCI, V106, P909; Cunha-Ferreira I, 2009, TRAFFIC, V10, P482, DOI 10.1111/j.1600-0854.2009.00905.x; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; de Nijs L, 2006, EXP CELL RES, V312, P2872, DOI 10.1016/j.yexcr.2006.05.011; de Nijs L, 2012, HUM MOL GENET, V21, P5106, DOI 10.1093/hmg/dds356; de Nijs L, 2009, NAT NEUROSCI, V12, P1266, DOI 10.1038/nn.2390; Durcan TM, 2008, J CELL BIOL, V181, P595, DOI 10.1083/jcb.200711160; Dymek EE, 2007, J CELL BIOL, V179, P515, DOI 10.1083/jcb.200703107; Engel BD, 2012, J CELL BIOL, V199, P151, DOI 10.1083/jcb.201206068; GATTASS C R, 1979, Journal of Cell Biology, V83, pA; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Goldie KN, 2007, J STRUCT BIOL, V158, P378, DOI 10.1016/j.jsb.2006.12.007; Gu WL, 2005, EPILEPSY RES, V66, P91, DOI 10.1016/j.eplepsyres.2005.07.003; Guichard P, 2013, CURR BIOL, V23, P1620, DOI 10.1016/j.cub.2013.06.061; HASTIE A, 1992, CHEST, V101, pS47, DOI 10.1378/chest.101.3_Supplement.47S-a; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hinchcliffe EH, 1998, J CELL SCI, V111, P585; HOLWILL MEJ, 1976, J EXP BIOL, V65, P229; HYAMS JS, 1978, J CELL SCI, V33, P235; Ikeda K, 2003, J BIOL CHEM, V278, P7725, DOI 10.1074/jbc.M210751200; Ikeda T, 2005, FEBS LETT, V579, P819, DOI 10.1016/j.febslet.2004.12.070; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kourkoutis LF, 2012, ANNU REV MATER RES, V42, P33, DOI 10.1146/annurev-matsci-070511-155004; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Larsson M, 2000, EUR J CELL BIOL, V79, P718, DOI 10.1078/0171-9335-00097; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Li S, 2012, EMBO J, V31, P552, DOI 10.1038/emboj.2011.460; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Linck RW, 2007, CELL MOTIL CYTOSKEL, V64, P489, DOI 10.1002/cm.20202; LINCK RW, 1981, J CELL BIOL, V89, P323, DOI 10.1083/jcb.89.2.323; LINCK RW, 1985, J CELL BIOL, V100, P126, DOI 10.1083/jcb.100.1.126; LINCK RW, 1982, J CELL SCI, V58, P1; LINCK RW, 1987, J CELL BIOL, V104, P1069, DOI 10.1083/jcb.104.4.1069; LINCK RW, 1976, J CELL SCI, V20, P405; LINCK RW, 1987, J CELL SCI, V88, P453; LINCK RW, 1990, ADV CELL BIOL, V3, P35; Lindemann CB, 2007, ANN NY ACAD SCI, V1101, P477, DOI 10.1196/annals.1389.024; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MEZA I, 1972, EXP CELL RES, V74, P535, DOI 10.1016/0014-4827(72)90413-2; Mizuno N, 2012, J MOL BIOL, V422, P163, DOI 10.1016/j.jmb.2012.05.040; MOHRI H, 1968, NATURE, V217, P1053, DOI 10.1038/2171053a0; NAITOH Y, 1995, METHOD CELL BIOL, V47, P211, DOI 10.1016/S0091-679X(08)60812-2; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nicastro D, 2011, P NATL ACAD SCI USA, V108, pE845, DOI 10.1073/pnas.1106178108; Nicastro D, 2009, METHOD CELL BIOL, V91, P1, DOI 10.1016/S0091-679X(08)91001-3; NOJIMA D, 1995, CURR BIOL, V5, P158, DOI 10.1016/S0960-9822(95)00037-6; Norrander J, 1998, J NEUROSCI, V18, P8912; NORRANDER JM, 1992, P NATL ACAD SCI USA, V89, P8567, DOI 10.1073/pnas.89.18.8567; Norrander JM, 1996, J MOL BIOL, V257, P385, DOI 10.1006/jmbi.1996.0170; Norrander JM, 2000, MOL BIOL CELL, V11, P201, DOI 10.1091/mbc.11.1.201; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Patel-King RS, 2002, J BIOL CHEM, V277, P34271, DOI 10.1074/jbc.M204137200; PAZOUR GJ, 1995, J CELL BIOL, V131, P427, DOI 10.1083/jcb.131.2.427; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; PIRNER MA, 1994, J BIOL CHEM, V269, P31800; PIRNER MA, 1995, METHOD CELL BIOL, V47, P373, DOI 10.1016/S0091-679X(08)60832-8; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Setter PW, 2006, EXP CELL RES, V312, P2880, DOI 10.1016/j.yexcr.2006.05.014; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; STEFFEN W, 1988, P NATL ACAD SCI USA, V85, P2643, DOI 10.1073/pnas.85.8.2643; STEFFEN W, 1989, CELL MOTIL CYTOSKEL, V14, P359, DOI 10.1002/cm.970140306; STEFFEN W, 1994, J CELL SCI, V107, P2095; Steffen W., 1989, CELL MOVEMENT, P67; STEPHENS R E, 1970, Journal of Molecular Biology, V47, P353, DOI 10.1016/0022-2836(70)90307-4; Stephens RE, 2008, ACS CHEM BIOL, V3, P84, DOI 10.1021/cb8000217; STEPHENS RE, 1989, J CELL SCI, V92, P403; Stephens RE, 2000, CELL MOTIL CYTOSKEL, V47, P130, DOI 10.1002/1097-0169(200010)47:2<130::AID-CM4>3.0.CO;2-0; Stephens RE, 1998, CELL MOTIL CYTOSKEL, V40, P379, DOI 10.1002/(SICI)1097-0169(1998)40:4<379::AID-CM6>3.0.CO;2-6; STEPHENS RE, 1989, J CELL SCI, V92, P391; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; TALIAN JC, 1983, J CELL BIOL, V97, P1277, DOI 10.1083/jcb.97.4.1277; Tanaka H, 2004, MOL CELL BIOL, V24, P7958, DOI 10.1128/MCB.24.18.7958-7964.2004; TILNEY LG, 1973, J CELL BIOL, V59, P267, DOI 10.1083/jcb.59.2.267; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Yanagisawa H, 2004, MOL BIOL CELL, V15, P2105, DOI 10.1091/mbc.E03-11-0854	89	52	53	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17427	17444		10.1074/jbc.M114.568949	http://dx.doi.org/10.1074/jbc.M114.568949			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24794867	Green Published, hybrid			2022-12-28	WOS:000338018100012
J	Surve, CR; Lehmann, D; Smrcka, AV				Surve, Chinmay R.; Lehmann, David; Smrcka, Alan V.			A Chemical Biology Approach Demonstrates G Protein beta gamma Subunits Are Sufficient to Mediate Directional Neutrophil Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE DISRUPTION; CELL; ACTIVATION; MIGRATION; BINDING; RECOGNITION; ARRESTIN; SURFEN; ROLES	Our laboratory has identified a number of small molecules that bind to G protein beta gamma subunits (G beta gamma) by competing for peptide binding to the G beta gamma "hot spot." M119/Gallein were identified as inhibitors of G beta gamma subunit signaling. Here we examine the activity of another molecule identified in this screen, 12155, which we show that in contrast to M119/Gallein had no effect on G beta gamma-mediated phospholipase C or phosphoinositide 3-kinase (PI3K) gamma activation in vitro. Also in direct contrast to M119/Gallein, 12155 caused receptor-independent Ca2+ release, and activated other downstream targets of G beta gamma including extracellular signal regulated kinase (ERK), protein kinase B (Akt) in HL60 cells differentiated to neutrophils. We show that 12155 releases G beta gamma in vitro from G alpha(11)beta(1)gamma(2) heterotrimers by causing its dissociation from G alpha GDP without inducing nucleotide exchange in the G alpha subunit. We used this novel probe to examine the hypothesis that G beta gamma release is sufficient to direct chemotaxis of neutrophils in the absence of receptor or G protein alpha subunit activation. 12155 directed chemotaxis of HL60 cells and primary neutrophils in a transwell migration assay with responses similar to those seen for the natural chemotactic peptide n-formyl-Met-Leu-Phe. These data indicate that release of free G beta gamma is sufficient to drive directional chemotaxis in a G protein-coupled receptor signaling-independent manner.	[Surve, Chinmay R.; Smrcka, Alan V.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Lehmann, David; Smrcka, Alan V.] Univ Rochester, Dept Pharmacol & Physiol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Smrcka, AV (corresponding author), Univ Rochester, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	alan_smrcka@urmc.rochester.edu			National Institutes of Health [R01GM081772]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM081772 (to A. V. S.).	Bidlack Jean M., 2003, V237, P135; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Mathews JL, 2008, J NEUROSCI, V28, P12183, DOI 10.1523/JNEUROSCI.2326-08.2008; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Panchal RG, 2004, NAT STRUCT MOL BIOL, V11, P67, DOI 10.1038/nsmb711; PARISH CA, 1995, BIOCHEMISTRY-US, V34, P7722, DOI 10.1021/bi00023a019; Penela P, 2009, CELL ADHES MIGR, V3, P19, DOI 10.4161/cam.3.1.7149; Roan NR, 2010, J BIOL CHEM, V285, P1861, DOI 10.1074/jbc.M109.066167; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Scott JK, 2001, EMBO J, V20, P767, DOI 10.1093/emboj/20.4.767; Seneviratne AMPB, 2011, BBA-PROTEINS PROTEOM, V1814, P1210, DOI 10.1016/j.bbapap.2011.05.010; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Smrcka AV, 2002, METHOD ENZYMOL, V344, P557; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Wu DQ, 2000, J CELL SCI, V113, P2935; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221	36	34	34	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17791	17801		10.1074/jbc.M114.576827	http://dx.doi.org/10.1074/jbc.M114.576827			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24808183	Green Published, hybrid			2022-12-28	WOS:000338018100042
J	Xu, F; Kotarba, AE; Ou-Yang, MH; Fu, Z; Davis, J; Smith, SO; Van Nostrand, WE				Xu, Feng; Kotarba, AnnMarie E.; Ou-Yang, Ming-Hsuan; Fu, Ziao; Davis, Judianne; Smith, Steven O.; Van Nostrand, William E.			Early-onset Formation of Parenchymal Plaque Amyloid Abrogates Cerebral Microvascular Amyloid Accumulation in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROTEIN; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; MOUSE MODEL; DUTCH-TYPE; BEHAVIORAL DEFICITS; HUMAN BRAIN; HEMORRHAGE; ANGIOPATHY; PATHOLOGY	The fibrillar assembly and deposition of amyloid beta (A beta) protein, a key pathology of Alzheimer disease, can occur in the form of parenchymal amyloid plaques and cerebral amyloid angiopathy (CAA). Familial forms of CAA exist in the absence of appreciable parenchymal amyloid pathology. The molecular interplay between parenchymal amyloid plaques and CAA is unclear. Here we investigated how early-onset parenchymal amyloid plaques impact the development of microvascular amyloid in transgenic mice. Tg-5xFAD mice, which produce non-mutated human A beta and develop early-onset parenchymal amyloid plaques, were bred to Tg-SwDI mice, which produce familial CAA mutant human A beta and develop cerebral microvascular amyloid. The bigenic mice presented with an elevated accumulation of A beta and fibrillar amyloid in the brain compared with either single transgenic line. Tg-SwDI/Tg-5xFAD mice were devoid of microvascular amyloid, the prominent pathology of Tg-SwDI mice, but exhibited larger parenchymal amyloid plaques compared with Tg-5xFAD mice. The larger parenchymal amyloid deposits were associated with a higher loss of cortical neurons and elevated activated microglia in the bigenic Tg-SwDI/Tg-5xFAD mice. The periphery of parenchymal amyloid plaques was largely composed of CAA mutant A beta. Non-mutated A beta fibril seeds promoted CAA mutant A beta fibril formation in vitro. Further, intrahippocampal administration of biotin-labeled CAA mutant A beta peptide accumulated on and adjacent to pre-existing parenchymal amyloid plaques in Tg-5xFAD mice. These findings indicate that early-onset parenchymal amyloid plaques can serve as a scaffold to capture CAA mutant A beta peptides and prevent their accumulation in cerebral microvessels.	[Xu, Feng; Kotarba, AnnMarie E.; Ou-Yang, Ming-Hsuan; Davis, Judianne; Van Nostrand, William E.] SUNY Stony Brook, Dept Neurosurg & Med, Stony Brook, NY 11794 USA; [Fu, Ziao; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Nostrand, WE (corresponding author), SUNY Stony Brook, Dept Neurosurg, HSC T-12-089, Stony Brook, NY 11794 USA.	William.VanNostrand@sbumed.org	Smith, Steven/HDM-9496-2022; Fu, Ziao/K-8758-2017	Fu, Ziao/0000-0001-5036-1945	National Institutes of Health [AG033209, AG027317]; Alzheimer's Association [IIRG-09-15254]; NATIONAL INSTITUTE ON AGING [R21AG033209, R01AG027317, RF1AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG033209 (to W. E. V. N.) and AG027317 (to S. O. S.). This work was also supported by Alzheimer's Association Grant IIRG-09-15254 and by a gift from the Cowles Charitable Trust.	Allen N, 2014, NEUROPATH APPL NEURO, V40, P136, DOI 10.1111/nan.12070; Attems J, 2004, ACTA NEUROPATHOL, V107, P83, DOI 10.1007/s00401-003-0796-9; Attems J, 2011, NEUROPATH APPL NEURO, V37, P75, DOI 10.1111/j.1365-2990.2010.01137.x; Bailey TL, 2004, NEUROL RES, V26, P573, DOI 10.1179/016164104225016272; BAKKER E, 1991, AM J HUM GENET, V49, P518; Davis J, 1996, P NATL ACAD SCI USA, V93, P2996, DOI 10.1073/pnas.93.7.2996; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; DAVISSALINAS J, 1994, J BIOL CHEM, V269, P22623; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harkness KAC, 2004, EUR J NEUROL, V11, P59, DOI 10.1046/j.1351-5101.2003.00707.x; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Herzig MC, 2009, AM J PATHOL, V174, P722, DOI 10.2353/ajpath.2009.080790; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWAI M, 1993, BRAIN RES, V623, P142, DOI 10.1016/0006-8993(93)90021-E; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Long JM, 1998, J NEUROSCI METH, V84, P101, DOI 10.1016/S0165-0270(98)00100-9; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McCarter JF, 2013, ACTA NEUROPATHOL, V126, P179, DOI 10.1007/s00401-013-1137-2; Melchor JP, 2000, J NEUROCHEM, V74, P2209, DOI 10.1046/j.1471-4159.2000.0742209.x; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Monro OR, 2002, NEUROBIOL AGING, V23, P405, DOI 10.1016/S0197-4580(01)00317-7; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Nilsson KPR, 2010, J NEUROSCI, V30, P12094, DOI 10.1523/JNEUROSCI.2417-10.2010; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Oshima K, 2008, INT J CLIN EXP PATHO, V1, P403; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Rensink AAM, 2003, BRAIN RES REV, V43, P207, DOI 10.1016/j.brainresrev.2003.08.001; Richard E, 2010, J NEUROPATH EXP NEUR, V69, P1158, DOI 10.1097/NEN.0b013e3181fab558; Rosen RF, 2012, J NEUROCHEM, V120, P660, DOI 10.1111/j.1471-4159.2011.07551.x; ROZEMULLER AJM, 1993, AM J PATHOL, V142, P1449; Rozemuller AJM, 2005, CNS NEUROL DISORD-DR, V4, P223, DOI 10.2174/1568007054038229; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tagliavini F., 1999, ALZHEIMERS REP, V2, pS28; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thal DR, 2008, ACTA NEUROPATHOL, V115, P599, DOI 10.1007/s00401-008-0366-2; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; Thal DR, 2002, J NEUROPATH EXP NEUR, V61, P282, DOI 10.1093/jnen/61.3.282; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verbeek MM, 1997, J NEUROCHEM, V68, P1135; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WATTENDORFF AR, 1995, J NEUROL NEUROSUR PS, V58, P699, DOI 10.1136/jnnp.58.6.699; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu F, 2007, NEUROSCIENCE, V146, P98, DOI 10.1016/j.neuroscience.2007.01.043; Xu F, 2012, J ALZHEIMERS DIS, V31, P359, DOI 10.3233/JAD-2012-120421; Xu WJ, 2014, J ALZHEIMERS DIS, V38, P621, DOI 10.3233/JAD-130758; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; Yamamoto N, 2006, NEUROREPORT, V17, P1735, DOI 10.1097/01.wnr.0000239958.53072.14; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	75	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17895	17908		10.1074/jbc.M113.536565	http://dx.doi.org/10.1074/jbc.M113.536565			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24828504	Green Published, hybrid			2022-12-28	WOS:000338018100050
J	Tu, LN; Morohaku, K; Manna, PR; Pelton, SH; Butler, WR; Stocco, DM; Selvaraj, V				Tu, Lan N.; Morohaku, Kanako; Manna, Pulak R.; Pelton, Susanne H.; Butler, W. Ronald; Stocco, Douglas M.; Selvaraj, Vimal			Peripheral Benzodiazepine Receptor/Translocator Protein Global Knock-out Mice Are Viable with No Effects on Steroid Hormone Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenal; Cholesterol; Gene Knock-out; Mitochondria; Steroidogenesis; STAR; TSPO	ACUTE-REGULATORY-PROTEIN; INNER MITOCHONDRIAL-MEMBRANES; LIPOID ADRENAL-HYPERPLASIA; KDA TRANSLOCATOR PROTEIN; CHOLESTEROL TRANSPORT; TARGETED DISRUPTION; LEYDIG-CELLS; RECEPTOR; TSPO; STEROIDOGENESIS	Background: Translocator protein (TSPO) has been considered a mitochondrial cholesterol transporter critical for steroid hormone production. TSPO knock-out mice were reported to be embryonic lethal. Results: TSPO knock-out mice are viable with no effects on steroidogenesis. Conclusion: TSPO is not essential for steroidogenesis and is not necessary for sustaining life. Significance: This study rectifies a serious inaccuracy in the current understanding that is critical for treating steroid hormone disorders. Translocator protein (TSPO), previously known as the peripheral benzodiazepine receptor, is a mitochondrial outer membrane protein implicated as essential for cholesterol import to the inner mitochondrial membrane, the rate-limiting step in steroid hormone biosynthesis. Previous research on TSPO was based entirely on in vitro experiments, and its critical role was reinforced by an early report that claimed TSPO knock-out mice were embryonic lethal. In a previous publication, we examined Leydig cell-specific TSPO conditional knock-out mice that suggested TSPO was not required for testosterone production in vivo. This raised controversy and several questions regarding TSPO function. To examine the definitive role of TSPO in steroidogenesis and embryo development, we generated global TSPO null (Tspo(-/-)) mice. Contrary to the early report, Tspo(-/-) mice survived with no apparent phenotypic abnormalities and were fertile. Examination of adrenal and gonadal steroidogenesis showed no defects in Tspo(-/-) mice. Adrenal transcriptome comparison of gene expression profiles showed that genes involved in steroid hormone biosynthesis (Star, Cyp11a1, and Hsd3b1) were unchanged in Tspo(-/-) mice. Adrenocortical ultrastructure illustrated no morphological alterations in Tspo(-/-) mice. In an attempt to correlate our in vivo findings to previously used in vitro models, we also determined that siRNA knockdown or the absence of TSPO in different mouse and human steroidogenic cell lines had no effect on steroidogenesis. These findings directly refute the dogma that TSPO is indispensable for steroid hormone biosynthesis and viability. By amending the current model, this study advances our understanding of steroidogenesis with broad implications in biology and medicine.	[Tu, Lan N.; Morohaku, Kanako; Pelton, Susanne H.; Butler, W. Ronald; Selvaraj, Vimal] Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, Ithaca, NY 14853 USA; [Manna, Pulak R.; Stocco, Douglas M.] Texas Tech Univ, Sch Med, Dept Cell Biol & Biochem, Hlth Sci Ctr, Lubbock, TX 79430 USA	Cornell University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Selvaraj, V (corresponding author), Cornell Univ, Dept Anim Sci, 204 Morrison Hall, Ithaca, NY 14853 USA.	vs88@cornell.edu	Butler, Walter/GQH-5350-2022; Selvaraj, Vimal/AAC-2853-2022	Butler, Walter/0000-0001-5195-7433	National Science Foundation [DMR-112-296]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017481, R01HD017481] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr. Jim Giovannoni and Dr. Zhangjun Fei at the Boyce Thompson Institute for assistance in RNA-seq and data analysis; John Grazul at Cornell Center for Materials Research (supported by National Science Foundation Grant DMR-112-296); University of California at Davis Diagnostic and Research Electron Microscopy Laboratory for assistance in transmission electron microscopy; Dr. Johanna Dela Cruz at the Cornell University Biotechnology Resource Center for assistance in whole animal imaging; and Dr. Mario Ascoli for MA-10 cells.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANHOLT RRH, 1985, EUR J PHARMACOL, V110, P41, DOI 10.1016/0014-2999(85)90026-3; ANHOLT RRH, 1985, J PHARMACOL EXP THER, V233, P517; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Baker BY, 2006, J CLIN ENDOCR METAB, V91, P4781, DOI 10.1210/jc.2006-1565; Beam SW, 1997, BIOL REPROD, V56, P133, DOI 10.1095/biolreprod56.1.133; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Chung JY, 2013, ENDOCRINOLOGY, V154, P2156, DOI 10.1210/en.2012-2226; CHURCHILL PF, 1979, J BIOL CHEM, V254, P443; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; DAVIES LP, 1981, EUR J PHARMACOL, V73, P209, DOI 10.1016/0014-2999(81)90092-3; Decker C, 2012, AM SOC BON MIN RES 2; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gatliff J, 2012, CURR MOL MED, V12, P356; Gavish M, 1999, PHARMACOL REV, V51, P629; Hatty CR, 2014, BBA-BIOMEMBRANES, V1838, P1019, DOI 10.1016/j.bbamem.2013.12.013; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li RS, 2007, J LIPID RES, V48, P709, DOI 10.1194/jlr.M600501-JLR200; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDONALD R, 1978, NATURE, V271, P563, DOI 10.1038/271563a0; Mack JT, 2007, MOL CELL BIOL, V27, P44, DOI 10.1128/MCB.01824-06; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manna PR, 2013, J BIOL CHEM, V288, P8505, DOI 10.1074/jbc.M112.417873; Mariani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054488; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Morohaku K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074509; MUKHIN AG, 1989, P NATL ACAD SCI USA, V86, P9813, DOI 10.1073/pnas.86.24.9813; Murail S, 2008, BBA-BIOMEMBRANES, V1778, P1375, DOI 10.1016/j.bbamem.2008.03.012; Nieters A, 2012, BLOOD, V120, P4645, DOI 10.1182/blood-2012-05-427989; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2014, ENDOCRINOLOGY, V155, P15, DOI 10.1210/en.2013-2033; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; Qi XL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/162934; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; REGAN JW, 1981, LIFE SCI, V28, P991, DOI 10.1016/0024-3205(81)90744-X; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Schaller T, 2007, J VIROL, V81, P11713, DOI 10.1128/JVI.01468-07; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seneviratne MSD, 2012, CURR MOL MED, V12, P476; Sileikyte J, 2014, J BIOL CHEM, V289, P13769, DOI 10.1074/jbc.M114.549634; SIMPSON ER, 1978, J BIOL CHEM, V253, P3135; SIMPSON ER, 1967, EUR J BIOCHEM, V2, P275, DOI 10.1111/j.1432-1033.1967.tb00136.x; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stocco DM, 2014, ENDOCRINOLOGY, V155, P6, DOI 10.1210/en.2013-2041; TAKAHASHI H, 1958, NATURE, V182, P1443, DOI 10.1038/1821443a0; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Vlodavsky E., 2014, CNS NEUROL DISORD-DR, V12, P1; Wang HJ, 2012, CELL TISSUE RES, V350, P261, DOI 10.1007/s00441-012-1478-5; YAGO N, 1969, J BIOCHEM-TOKYO, V65, P215; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	72	167	170	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27444	27454		10.1074/jbc.M114.578286	http://dx.doi.org/10.1074/jbc.M114.578286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	24936060	Green Published, hybrid			2022-12-28	WOS:000342852800008
J	Pandey, MS; Weigel, PH				Pandey, Madhu S.; Weigel, Paul H.			A Hyaluronan Receptor for Endocytosis (HARE) Link Domain N-Glycan Is Required for Extracellular Signal-regulated Kinase (ERK) and Nuclear Factor-kappa B (NF-kappa B) Signaling in Response to the Uptake of Hyaluronan but Not Heparin, Dermatan Sulfate, or Acetylated Low Density Lipoprotein (LDL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC SINUSOIDAL ENDOTHELIUM; ASIALOGLYCOPROTEIN RECEPTOR; CHONDROITIN SULFATE; BINDING-PROTEINS; CD44 BINDING; GLYCOSYLATION; STABILIN-2; CLEARANCE; ADHESION; LIGAND	The human hyaluronan (HA) receptor for endocytosis (HARE; the 190-kDa C terminus of Stab2) is a major clearance receptor for multiple circulating ligands including HA, heparin (Hep), acetylated LDL (AcLDL), dermatan sulfate (DS), apoptotic debris, and chondroitin sulfate types A, C, D, and E. We previously found that HARE contains an N-glycan in the HA binding Link domain (at Asn(2280)), and cells expressing membrane-bound HARE(N2280A) bind and endocytose HA normally (Harris, E. N., Parry, S., Sutton-Smith, M., Pandey, M. S., Panico, M., Morris, H. R., Haslam, S. M., Dell, A., and Weigel, P. H. (2010) Glycobiology 20, 991-1001). Also, NF-kappa B-mediated signaling is activated by HARE-mediated endocytosis of HA, Hep, AcLDL, or DS but not by chondroitin sulfates (Pandey, M. S., and Weigel, P. H. (2014) J. Biol. Chem. 289, 1756-1767). Here we investigated the role of Link N-glycans in ligand uptake and NF-kappa B and ERK1/2 signaling. HA.HARE-mediated ERK1/2 activation was HA size-dependent, as found for NF-kappa B activation. HARE(N2280A) cells internalized HA, Hep, AcLDL, and DS normally. No ERK1/2 activation occurred during HA endocytosis by HARE(N2280A) cells, but activation did occur with Hep. Dual-luciferase recorder assays showed that NF-kappa B-mediated gene expression occurred normally in HARE(N2280A) cells endocytosing Hep, AcLDL, or DS but did not occur with HA. Activation of NF-kappa B by endogenous degradation of I kappa B-alpha was observed for HARE(N2280A) cells endocytosing Hep, AcLDL, or DS but not HA. We conclude that a Link domain complex N-glycan is required specifically for HARE.HA-mediated activation of ERK1/2 and NF-kappa B-mediated gene expression and that this initial activation mechanism is different from and independent of the initial mechanisms for HARE-mediated signaling in response to Hep, AcLDL, or DS uptake.	[Weigel, Paul H.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	paul-weigel@ouhsc.edu			National Institutes of Health [GM69961]; Oklahoma Center for the Advancement of Science and Technology (OCAST) from the State of Oklahoma [HR10-074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology (OCAST) from the State of Oklahoma; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69961 (NIGMS). This work was also supported by Oklahoma Center for the Advancement of Science and Technology (OCAST) Grant HR10-074 from the State of Oklahoma.	Baggenstoss BA, 2006, ANAL BIOCHEM, V352, P243, DOI 10.1016/j.ab.2006.01.019; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; Bloem K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066266; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREITFELD PP, 1985, INT REV CYTOL, V97, P47, DOI 10.1016/S0074-7696(08)62348-7; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; Dasgupta A, 1996, BIOCHEM BIOPH RES CO, V227, P110, DOI 10.1006/bbrc.1996.1475; Elliott AL, 2005, ARTHRITIS RHEUM-US, V52, P105, DOI 10.1002/art.20724; English NM, 1998, CANCER RES, V58, P3736; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2010, GLYCOBIOLOGY, V20, P991, DOI 10.1093/glycob/cwq057; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Jung MY, 2007, J LEUKOCYTE BIOL, V82, P1156, DOI 10.1189/jlb.0107052; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653; LESLEY J, 1995, J EXP MED, V182, P431, DOI 10.1084/jem.182.2.431; Lien EC, 2013, BIOCHEMISTRY-US, V52, P115, DOI 10.1021/bi3009483; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; McGary CT, 2003, METHOD ENZYMOL, V363, P354; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; OKA JA, 1983, J BIOL CHEM, V258, P253; Pandey MS, 2008, J BIOL CHEM, V283, P21453, DOI 10.1074/jbc.M800886200; Pandey MS, 2014, J BIOL CHEM, V289, P1756, DOI 10.1074/jbc.M113.510339; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Romero-Fernandez W, 2011, GLYCOBIOLOGY, V21, P1663, DOI 10.1093/glycob/cwr105; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Weigel P. H., 2012, STRUCTURE FUNCTION B, P293; Weigel P. H., 2002, HYALURONAN 2000, V1, P401; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Wyatt PJ, 1997, LC GC-MAG SEP SCI, V15, P160; YU Q, 1995, BIOTECHNIQUES, V19, P122; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	46	16	16	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21807	21817		10.1074/jbc.M114.565846	http://dx.doi.org/10.1074/jbc.M114.565846			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942734	Green Published, hybrid			2022-12-28	WOS:000340593500001
J	Pertusa, M; Gonzalez, A; Hardy, P; Madrid, R; Viana, F				Pertusa, Maria; Gonzalez, Alejandro; Hardy, Paulina; Madrid, Rodolfo; Viana, Felix			Bidirectional Modulation of Thermal and Chemical Sensitivity of TRPM8 Channels by the Initial Region of the N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; ENDOPLASMIC-RETICULUM; CATION CHANNEL; COLD; RECEPTOR; PREDICTION; TEMPERATURE; REVEALS; ACTIVATION; PROTEINS	TRPM8, a nonselective cation channel activated by cold, voltage, and cooling compounds such as menthol, is the principal molecular detector of cold temperatures in primary sensory neurons of the somatosensory system. The N-terminal domain of TRPM8 consists of 693 amino acids, but little is known about its contribution to channel function. Here, we identified two distinct regions within the initial N terminus of TRPM8 that contribute differentially to channel activity and proper folding and assembly. Deletion or substitution of the first 40 residues yielded channels with augmented responses to cold and menthol. The thermal threshold of activation of these mutants was shifted 2 degrees C to higher temperatures, and the menthol dose-response curve was displaced to lower concentrations. Site-directed mutagenesis screening revealed that single point mutations at positions Ser-26 or Ser-27 by proline caused a comparable increase in the responses to cold and menthol. Electrophysiological analysis of the S27P mutant revealed that the enhanced sensitivity to agonists is related to a leftward shift in the voltage dependence of activation, increasing the probability of channel openings at physiological membrane potentials. In addition, we found that the region encompassing positions 40-60 is a key element in the proper folding and assembly of TRPM8. Different deletions and mutations within this region rendered channels with an impaired function that are retained within the endoplasmic reticulum. Our results suggest a critical contribution of the initial region of the N-terminal domain of TRPM8 to thermal and chemical sensitivity and the proper biogenesis of this polymodal ion channel.	[Pertusa, Maria; Gonzalez, Alejandro; Hardy, Paulina; Madrid, Rodolfo] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9160000, Chile; [Pertusa, Maria; Viana, Felix] Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alicante 03550, Spain	Universidad de Santiago de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Pertusa, M (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9160000, Chile.	maria.pertusa@usach.cl	Viana, Felix/U-8533-2017; Gonzalez, Alejandro/AAG-4444-2020	Viana, Felix/0000-0003-1439-949X; Gonzalez, Alejandro/0000-0001-7513-2516; Madrid, Rodolfo/0000-0002-8623-5761; Pertusa, Maria/0000-0003-3856-9019	Chilean Fondo Nacional de Ciencia y Tecnologia [11130144, 3110128, 1131064]; Comision Nacional de Investigacion Cientifica y Tecnologica [ACT-1113]; Spanish Ministerio de Ciencia e Innovacion [SAF2010-14990, SAF2013-4608-R]; DICYT-VRIDEI of the University of Santiago de Chile	Chilean Fondo Nacional de Ciencia y Tecnologia; Comision Nacional de Investigacion Cientifica y Tecnologica; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); DICYT-VRIDEI of the University of Santiago de Chile	This work was supported by Chilean Fondo Nacional de Ciencia y Tecnologia Grants 11130144 and 3110128 (to M. P.) and 1131064 (to R. M.), Comision Nacional de Investigacion Cientifica y Tecnologica Grant Anillo ACT-1113 (to R. M. and M. P.), and Spanish Ministerio de Ciencia e Innovacion Projects SAF2010-14990 and SAF2013-4608-R (to F. V.).; Recipient of support from DICYT-VRIDEI of the University of Santiago de Chile. To whom correspondence should be addressed: Dept. de Biologia, Facultad de Quimica y Biologia, Universidad de Santiago de Chile, 9160000 Santiago, Chile. Tel.: 56-2-27181109; E-mail: maria.pertusa@usach.cl.	Almaraz L, 2014, HANDB EXP PHARMACOL, V222, P547, DOI 10.1007/978-3-642-54215-2_22; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bavencoffe A, 2010, J BIOL CHEM, V285, P9410, DOI 10.1074/jbc.M109.069377; Bidaux G, 2012, J BIOL CHEM, V287, P2948, DOI 10.1074/jbc.M111.270256; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Choi UB, 2013, J BIOL CHEM, V288, P22506, DOI 10.1074/jbc.M113.477810; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; de Groot T, 2011, J BIOL CHEM, V286, P32132, DOI 10.1074/jbc.M111.226878; de la Pena E, 2005, J PHYSIOL-LONDON, V567, P415, DOI 10.1113/jphysiol.2005.086546; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Grieve AG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005298; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; HENSEL H, 1951, ACTA PHYSIOL SCAND, V22, P96, DOI 10.1111/j.1748-1716.1951.tb00758.x; HEPPELMANN B, 1990, J COMP NEUROL, V292, P103, DOI 10.1002/cne.902920107; IRIUCHIJIMA J, 1960, ACTA PHYSIOL SCAND, V49, P267, DOI 10.1111/j.1748-1716.1960.tb01952.x; Janssens A, 2011, J PHYSIOL-LONDON, V589, P4827, DOI 10.1113/jphysiol.2011.216523; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kuhn FJP, 2013, PFLUG ARCH EUR J PHY, V465, P1599, DOI 10.1007/s00424-013-1302-4; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Latorre R, 2011, PHYSIOLOGY, V26, P273, DOI 10.1152/physiol.00004.2011; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lis A, 2005, N-S ARCH PHARMACOL, V371, P315, DOI 10.1007/s00210-005-1050-x; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Madrid R, 2014, CURR TOP MEMBR, V74, P293, DOI 10.1016/B978-0-12-800181-3.00011-7; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Malkia A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-62; McCoy DD, 2011, AM J PHYSIOL-REG I, V300, pR1278, DOI 10.1152/ajpregu.00631.2010; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Montell C., 2001, SCI STKE, DOI [10.1126/stke.2001,90.re1, DOI 10.1126/STKE.2001,90.RE1]; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Pedretti A, 2009, BBA-BIOMEMBRANES, V1788, P973, DOI 10.1016/j.bbamem.2009.02.007; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Pertusa M., 2012, MUTAGENESIS, P221; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Richter D, 2011, J BIOL CHEM, V286, P34234, DOI 10.1074/jbc.M111.278564; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stewart AP, 2010, BIOCHEM BIOPH RES CO, V394, P383, DOI 10.1016/j.bbrc.2010.03.027; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Valero M, 2011, PFLUG ARCH EUR J PHY, V461, P99, DOI 10.1007/s00424-010-0895-0; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Vazquez E, 2006, SEMIN CELL DEV BIOL, V17, P607, DOI 10.1016/j.semcdb.2006.11.004; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529	78	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21828	21843		10.1074/jbc.M114.565994	http://dx.doi.org/10.1074/jbc.M114.565994			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24917670	Green Published, hybrid			2022-12-28	WOS:000340593500003
J	Shimizu, E; Nakatani, T; He, ZM; Partridge, NC				Shimizu, Emi; Nakatani, Teruyo; He, Zhiming; Partridge, Nicola C.			Parathyroid Hormone Regulates Histone Deacetylase (HDAC) 4 through Protein Kinase A-mediated Phosphorylation and Dephosphorylation in Osteoblastic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT; GENE-EXPRESSION; IN-VIVO; HYPERTROPHY; REPRESSION; SKELETOGENESIS; IDENTIFICATION	Histone deacetylases (HDACs) are crucial regulators of gene expression in transcriptional co-repressor complexes. Previously, we reported that HDAC4 was a basal repressor of matrix metalloproteinase-13 (MMP-13) transcription and parathyroid hormone (PTH) regulates HDAC4 to control MMP-13 promoter activity through dissociation from Runx2. Here, we show that PTH induces the protein kinase A (PKA)-dependent phosphorylation of HDAC4 in the nucleus of the rat osteoblastic cell line, UMR 106-01. We demonstrate that PKA-dependent phosphorylated HDAC4 is released from Runx2 bound to the MMP-13 promoter in these cells. Point mutation of Ser-740 in rHDAC4 prevents the release of HDAC4 from Runx2 on the MMP-13 promoter and also prevents the PTH stimulation of MMP-13 transcription. Thus, PTH-induced phosphorylation of rHDAC4 at Ser-740 is crucial for regulating MMP-13 transcription in osteoblasts. PTH causes degradation of HDAC4, and this product appears in the cytoplasm. The cytoplasmic degradation of HDAC4 is blocked by PKA and lysosomal inhibitors, but is not affected by proteasome, caspase-3, or serine and aspartic protease inhibitors. In addition, the phosphatase inhibitor, okadaic acid, prevents degradation indicating that dephosphorylation is associated with degradation. These mechanisms regulating HDAC4 and their roles in such processes are crucial for bone and chondrocyte development. Our data support a link between PTH regulating HDAC4 phosphorylation by PKA, trafficking, partial degradation, and the control of MMP-13 transcription through association with Runx2.	[Shimizu, Emi; Nakatani, Teruyo; He, Zhiming; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Shimizu, Emi] NYU, Coll Dent, Dept Endodont, New York, NY 10010 USA	New York University; New York University	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 East 24th St, New York, NY 10010 USA.	ncp234@nyu.edu		Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [DK47420]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK047420, R01DK047420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47420 (to N. C. P.).	Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bradley EW, 2011, CRIT REV EUKAR GENE, V21, P101; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gao CZ, 2006, FEBS LETT, V580, P5096, DOI 10.1016/j.febslet.2006.08.038; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Liu F, 2004, J BIOL CHEM, V279, P34537, DOI 10.1074/jbc.M402475200; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Selvamurugan N, 2009, FEBS LETT, V583, P1141, DOI 10.1016/j.febslet.2009.02.040; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Westendorf JJ, 2007, J CELL BIOCHEM, V102, P332, DOI 10.1002/jcb.21486; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	30	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21340	21350		10.1074/jbc.M114.550699	http://dx.doi.org/10.1074/jbc.M114.550699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24904057	hybrid, Green Published			2022-12-28	WOS:000340558300014
J	Tao, WJ; Leng, XH; Chakraborty, SN; Ma, H; Arlinghaus, RB				Tao, Wenjing; Leng, Xiaohong; Chakraborty, Sandip N.; Ma, Helen; Arlinghaus, Ralph B.			c-Abl Activates Janus Kinase 2 in Normal Hematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAK2 TYROSINE KINASE; COLONY-STIMULATING FACTOR; FAMILY KINASES; ONCOGENIC ACTIVATION; POLYCYTHEMIA-VERA; CYTOKINE RECEPTOR; MUTATION; GROWTH; LEUKEMIA; BCR	Jak2 is involved in cytokine growth factor-stimulated signal transduction, but the mechanism of its activation is largely unknown. Here, we investigated Jak2 activation in a normal hematopoietic cell line, 32D mouse myeloid cells. The bimolecular fluorescence complementation studies showed that c-Abl formed a stable complex with Jak2 in live cells. Co-immunoprecipitation results showed that c-Abl bound to the beta c chain of IL-3/IL-5/GM-CSF receptors. The kinase activities of both c-Abl and Jak2 were stimulated by IL-3 in 32D cells. Decreasing c-Abl protein expression in 32D cells by inducible shRNA decreased Jak2 activity and resulted in the failure of Jak2 activation in response to IL-3. Treatment of IL-3 and serum-starved 32D cells with 1 mu M imatinib mysylate inhibited IL-3 stimulated kinase activities of both c-Abl and Jak2. In addition, the kinase-deficient Bcr-Abl mutant (p210K1172R) was defective for activation of Jak2 in 32D cells and impaired IL-3 independent growth, which was rescued by overexpression of c-Abl (+Abl). IL-3 efficiently inhibited apoptosis of 32Dp210K/R + Abl cells induced by imatinib mysylate but not Jak2 kinase inhibitor TG101209. In summary, our findings provide evidence that the kinase function of c-Abl and its C-terminal CT4 region is crucial for its interaction with Jak2 and its activation. c-Abl kinase activity induced by IL-3 is required for IL-3-stimulated Jak2 and Jak1 activation. Our findings reveal a novel regulatory role of c-Abl in Jak2 activation induced by IL-3 cytokine growth factor in 32D hematopoietic cells.	[Tao, Wenjing; Leng, Xiaohong; Chakraborty, Sandip N.; Ma, Helen; Arlinghaus, Ralph B.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Arlinghaus, RB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Unit 951, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rarlingh@mdanderson.org			National Institutes of Health from NCI [CA P01 49639]; NATIONAL CANCER INSTITUTE [P01CA049639] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA P01 49639, Project 5, from NCI.	ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; CAMPBELL GS, 1994, P NATL ACAD SCI USA, V91, P5232, DOI 10.1073/pnas.91.12.5232; Chakraborty S, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.41; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dey R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005188; Glover RT, 2000, J BIOL CHEM, V275, P12725, DOI 10.1074/jbc.275.17.12725; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; Huang HM, 2005, J CELL BIOCHEM, V96, P361, DOI 10.1002/jcb.20513; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kirk Rebecca, 2012, Nat Rev Clin Oncol, V9, P608, DOI 10.1038/nrclinonc.2012.174; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Ling XY, 2003, CANCER RES, V63, P298; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Moresco E. M, 2006, ABL FAMILY KINASES D, V1-120; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pradhan A, 2010, J BIOL CHEM, V285, P16651, DOI 10.1074/jbc.M109.071191; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Samanta A, 2011, LEUKEMIA, V25, P463, DOI 10.1038/leu.2010.287; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; Silvennoinen O, 2013, BIOCHEM SOC T, V41, P1002, DOI 10.1042/BST20130005; Tao WJ, 2008, ONCOGENE, V27, P3194, DOI 10.1038/sj.onc.1210979; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84; Zipfel PA, 2000, J IMMUNOL, V165, P6872, DOI 10.4049/jimmunol.165.12.6872	57	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21463	21472		10.1074/jbc.M114.554501	http://dx.doi.org/10.1074/jbc.M114.554501			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24923444	hybrid, Green Published			2022-12-28	WOS:000340558300024
J	Fujinaga, K; Luo, ZP; Peterlin, BM				Fujinaga, Koh; Luo, Zeping; Peterlin, B. Matija			Genetic Analysis of the Structure and Function of 7SK Small Nuclear Ribonucleoprotein (snRNP) in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR-B; LONG TERMINAL REPEAT; BROMODOMAIN PROTEIN BRD4; P-TEFB; TRANSCRIPTION ELONGATION; POSITIVE TRANSCRIPTION; HIV-1 TAT; NASCENT RNA; CYCLIN T1	The positive transcription elongation factor b (P-TEFb), comprised of cyclin-dependent kinase 9 (CDK9) and cyclins T1 (CycT1) or T2 (CycT2), activates eukaryotic transcription elongation. In growing cells, P-TEFb exists in active and inactive forms. In the latter, it is incorporated into the 7SK small nuclear ribonucleoprotein, which contains hexamethylene bisacetamide-induced proteins (HEXIM) 1 or 2, La-related protein 7 (LaRP7), methyl phosphate capping enzyme, and 7SK small nuclear RNA (7SK). HEXIM1 inhibits the kinase activity of CDK9 via interactions between 7SK, HEXIM1, and CycT1. LaRP7 and methyl phosphate capping enzyme interact with 7SK independently of HEXIM1 and P-TEFb. To analyze genetic interactions between HEXIM1 and/or LaRP7 and 7SK using a cell-based system, we established artificial heterologous RNA tethering assays in which reporter gene expression depended on interactions between selected regions of 7SK and its cognate binding partners fused to a strong activator. This system enabled us to map the HEXIM1- and LaRP7-binding regions of 7SK. Assays with various mutant 7SK plasmid targets revealed that the 5' U-U bulge and central loop of stem-loop I or RNA motif 3 of 7SK are required for transactivation, suggesting that HEXIM1 and CycT1 form a combinatorial binding surface for 7SK. Moreover, a region in HEXIM1 C-terminal to its previously mapped RNA-binding motif was also required for interactions between HEXIM1 and 7SK. Finally, a tyrosine-to-alanine mutation in HEXIM1, which is critical for its inhibitory effect on CDK9, changed HEXIM1 into an activator. These cell-based assays elucidate this important aspect of transcription elongation in vivo.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Rm U432,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu			National Institute of Health CARE Center [U19 AI076113]; HARC Center [P50 GM082250, AI076113]; American Foundation of AIDS [108241-51-RGRL]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049104, U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institute of Health CARE Center; HARC Center; American Foundation of AIDS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health CARE Center Grant U19 AI076113, HARC Center Grant P50 GM082250, and Grant AI076113 (to B. M. P.). This work was also supported by American Foundation of AIDS Research Grant 108241-51-RGRL (to K. F.).	Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Belanger F, 2009, J MOL BIOL, V386, P1094, DOI 10.1016/j.jmb.2009.01.015; Bieniasz PD, 1999, P NATL ACAD SCI USA, V96, P7791, DOI 10.1073/pnas.96.14.7791; Bigalke JM, 2011, J MOL BIOL, V414, P639, DOI 10.1016/j.jmb.2011.10.022; Blazek D, 2005, NUCLEIC ACIDS RES, V33, P7000, DOI 10.1093/nar/gki997; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Fujinaga K, 2002, J VIROL, V76, P10873, DOI 10.1128/JVI.76.21.10873-10881.2002; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2011, J NEUROIMMUNE PHARM, V6, P260, DOI 10.1007/s11481-011-9267-6; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lebars I, 2010, NUCLEIC ACIDS RES, V38, P7749, DOI 10.1093/nar/gkq660; Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; LU XB, 1993, J VIROL, V67, P1752, DOI 10.1128/JVI.67.4.1752-1760.1993; Marz M, 2009, MOL BIOL EVOL, V26, P2821, DOI 10.1093/molbev/msp198; McNamara RP, 2013, CELL REP, V5, P1256, DOI 10.1016/j.celrep.2013.11.003; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Muniz L, 2013, NUCLEIC ACIDS RES, V41, P4686, DOI 10.1093/nar/gkt159; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Peterlin BM, 2010, CELL CYCLE, V9, P2933, DOI 10.4161/cc.9.15.12698; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Richter S, 2002, P NATL ACAD SCI USA, V99, P7928, DOI 10.1073/pnas.122119999; Richter S, 2002, BIOCHEMISTRY-US, V41, P6391, DOI 10.1021/bi0159579; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; SELBY MJ, 1989, GENE DEV, V3, P547, DOI 10.1101/gad.3.4.547; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; SOUTHGATE C, 1990, NATURE, V345, P640, DOI 10.1038/345640a0; TILEY LS, 1992, GENE DEV, V6, P2077, DOI 10.1101/gad.6.11.2077; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	54	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21181	21190		10.1074/jbc.M114.557751	http://dx.doi.org/10.1074/jbc.M114.557751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917669	hybrid, Green Published			2022-12-28	WOS:000339396600067
J	De Marchi, U; Santo-Domingo, J; Castelbou, C; Sekler, I; Wiederkehr, A; Demaurex, N				De Marchi, Umberto; Santo-Domingo, Jaime; Castelbou, Cyril; Sekler, Israel; Wiederkehr, Andreas; Demaurex, Nicolas			NCLX Protein, but Not LETM1, Mediates Mitochondrial Ca2+ Extrusion, Thereby Limiting Ca2+-induced NAD(P)H Production and Modulating Matrix Redox State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN-SYNDROME; PERMEABILITY TRANSITION PORE; RAT KIDNEY MITOCHONDRIA; INDUCED CELL-DEATH; ESSENTIAL COMPONENT; CALCIUM UNIPORTER; HEART-MITOCHONDRIA; ATP SYNTHASE; METABOLISM; CHANNELS	Mitochondria capture and subsequently release Ca2+ ions, thereby sensing and shaping cellular Ca2+ signals. The Ca2+ uniporter MCU mediates Ca2+ uptake, whereas NCLX (mitochondrial Na/Ca exchanger) and LETM1 (leucine zipper-EF-hand-containing transmembrane protein 1) were proposed to exchange Ca2+ against Na+ or H+, respectively. Here we study the role of these ion exchangers in mitochondrial Ca2+ extrusion and in Ca2+-metabolic coupling. Both NCLX and LETM1 proteins were expressed in HeLa cells mitochondria. The rate of mitochondrial Ca2+ efflux, measured with a genetically encoded indicator during agonist stimulations, increased with the amplitude of mitochondrial Ca2+ ([Ca2+](mt)) elevations. NCLX overexpression enhanced the rates of Ca2+ efflux, whereas increasing LETM1 levels had no impact on Ca2+ extrusion. The fluorescence of the redox-sensitive probe roGFP increased during [Ca2+](mt) elevations, indicating a net reduction of the matrix. This redox response was abolished by NCLX overexpression and restored by the Na+/Ca2+ exchanger inhibitor CGP37157. The [Ca2+](mt) elevations were associated with increases in the autofluorescence of NAD(P)H, whose amplitude was strongly reduced by NCLX overexpression, an effect reverted by Na+/Ca2+ exchange inhibition. We conclude that NCLX, but not LETM1, mediates Ca2+ extrusion from mitochondria. By controlling the duration of matrix Ca2+ elevations, NCLX contributes to the regulation of NAD(P)H production and to the conversion of Ca2+ signals into redox changes.	[De Marchi, Umberto; Santo-Domingo, Jaime; Wiederkehr, Andreas] Nestle Inst Hlth Sci, CH-1015 Lausanne, Switzerland; [De Marchi, Umberto; Santo-Domingo, Jaime; Castelbou, Cyril; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Sekler, Israel] Ben Gurion Univ Negev, Dept Physiol, IL-84105 Beer Sheva, Israel	Nestle SA; University of Geneva; Ben Gurion University	De Marchi, U (corresponding author), Nestle Inst Hlth Sci, EPFL Innovat Pk,Bldg G, CH-1015 Lausanne, Switzerland.	Umberto.DeMarchi@rd.nestle.com; Nicolas.Demaurex@unige.ch	Domingo, Jaime Santo/AAA-4995-2020	Domingo, Jaime Santo/0000-0001-5501-0482; De Marchi, Umberto/0000-0002-6011-5446; Demaurex, Nicolas/0000-0002-9933-6772	Swiss National Foundation [310030B_133126]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation Grant 310030B_133126 (to N. D.).	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; CROMPTON M, 1977, EUR J BIOCHEM, V79, P549, DOI 10.1111/j.1432-1033.1977.tb11839.x; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Da Cruz S, 2010, CELL CALCIUM, V47, P11, DOI 10.1016/j.ceca.2009.10.005; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gouriou Y, 2011, BIOCHIMIE, V93, P2060, DOI 10.1016/j.biochi.2011.08.001; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Jean-Quartier C, 2012, MOL CELL ENDOCRINOL, V353, P114, DOI 10.1016/j.mce.2011.10.033; Jiang DW, 2013, P NATL ACAD SCI USA, V110, pE2249, DOI 10.1073/pnas.1308558110; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; LEHNINGER AL, 1963, BIOCHEM BIOPH RES CO, V10, P444, DOI 10.1016/0006-291X(63)90377-2; Leloup C, 2011, ANTIOXID REDOX SIGN, V14, P519, DOI 10.1089/ars.2010.3424; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; Morris BJ, 2013, FREE RADICAL BIO MED, V56, P133, DOI 10.1016/j.freeradbiomed.2012.10.525; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Nowikovsky K, 2012, J GEN PHYSIOL, V139, P445, DOI 10.1085/jgp.201110757; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2012, J BIOL CHEM, V287, P31650, DOI 10.1074/jbc.R112.355867; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pizzo P, 2012, PFLUG ARCH EUR J PHY, V464, P3, DOI 10.1007/s00424-012-1122-y; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; POZZAN T, 1977, BIOCHEMISTRY-US, V16, P5618, DOI 10.1021/bi00644a036; PRALONG WF, 1994, J BIOL CHEM, V269, P27310; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Voronina S, 2002, J PHYSIOL-LONDON, V539, P41, DOI 10.1113/jphysiol.2001.013134; Wang SB, 2013, TRENDS CARDIOVAS MED, V23, P14, DOI 10.1016/j.tcm.2012.08.005; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027; Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006; Zoratti M, 2010, FEBS LETT, V584, P1997, DOI 10.1016/j.febslet.2010.01.012	70	80	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20377	20385		10.1074/jbc.M113.540898	http://dx.doi.org/10.1074/jbc.M113.540898			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898248	Green Published, hybrid			2022-12-28	WOS:000339395200048
J	Zhu, BK; Ferry, CH; Markell, LK; Blazanin, N; Glick, AB; Gonzalez, FJ; Peters, JM				Zhu, Bokai; Ferry, Christina H.; Markell, Lauren K.; Blazanin, Nicholas; Glick, Adam B.; Gonzalez, Frank J.; Peters, Jeffrey M.			The Nuclear Receptor Peroxisome Proliferator-activated Receptor-beta/delta (PPAR beta/delta) Promotes Oncogene-induced Cellular Senescence through Repression of Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED SKIN TUMORIGENESIS; LIGAND ACTIVATION; SIGNALING NETWORK; CELLS; CARCINOGENESIS; EXPRESSION; CANCER; DIFFERENTIATION; TRANSCRIPTION; INHIBITION	Endoplasmic reticulum (ER) stress and ER stress-associated unfolded protein response (UPR) can promote cancer cell survival, but it remains unclear whether they can influence oncogene-induced senescence. The present study examined the role of ER stress in senescence using oncogene-dependent models. Increased ER stress attenuated senescence in part by up-regulating phosphorylated protein kinase B (p-AKT) and decreasing phosphorylated extracellular signal-regulated kinase (p-ERK). A positive feed forward loop between p-AKT, ER stress, and UPR was discovered whereby a transient increase of ER stress caused reduced senescence and promotion of tumorigenesis. Decreased ER stress was further correlated with increased senescence in both mouse and human tumors. Interestingly, H-RAS-expressing Ppar beta/delta null cells and tumors having increased cell proliferation exhibited enhanced ER stress, decreased cellular senescence, and/or enhanced tumorigenicity. Collectively, these results demonstrate a new role for ER stress and UPR that attenuates H-RAS-induced senescence and suggest that PPAR beta/delta can repress this oncogene-induced ER stress to promote senescence in accordance with its role as a tumor modifier that suppresses carcinogenesis.	[Zhu, Bokai; Ferry, Christina H.; Markell, Lauren K.; Blazanin, Nicholas; Glick, Adam B.; Peters, Jeffrey M.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Zhu, Bokai; Ferry, Christina H.; Markell, Lauren K.; Blazanin, Nicholas; Glick, Adam B.; Peters, Jeffrey M.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peters, JM (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	jmp21@psu.edu	Zhu, Bokai/AAF-7502-2020	Zhu, Bokai/0000-0003-0827-5757; Peters, Jeffrey/0000-0003-2782-2998	National Institutes of Health [CA124533, CA141029, CA140369, AA018863, CA122109, CA117957, ZIABC005561, ZIABC005562, ZIABC005708]; NATIONAL CANCER INSTITUTE [ZIABC005562, R01CA117957, ZIABC005561, R01CA140369, ZIABC005708, R01CA141029, R01CA122109, R01CA124533, R01CA126826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124533, CA141029, CA140369, and AA018863 (to J. M. P.), CA122109 and CA117957 (to A. B. G.), and ZIABC005561, ZIABC005562, and ZIABC005708 (NCI Intramural Research Program; to F. J. G.).	Bility MT, 2010, TOXICOL SCI, V113, P27, DOI 10.1093/toxsci/kfp212; Bility MT, 2008, CARCINOGENESIS, V29, P2406, DOI 10.1093/carcin/bgn219; Bobrovnikova-Marjon E, 2012, MOL CELL BIOL, V32, P2268, DOI 10.1128/MCB.00063-12; Borland MG, 2011, CELL SIGNAL, V23, P2039, DOI 10.1016/j.cellsig.2011.07.020; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dai CY, 2000, GASTROENTEROLOGY, V119, P929, DOI 10.1053/gast.2000.17952; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; He PF, 2008, TOXICOLOGY, V254, P112, DOI 10.1016/j.tox.2008.09.023; Horiguchi M, 2012, CANCER RES, V72, P395, DOI 10.1158/0008-5472.CAN-11-1891; Hsieh YH, 2007, BIOCHEM BIOPH RES CO, V359, P643, DOI 10.1016/j.bbrc.2007.05.154; Hu MC, 2007, BIOCHEM BIOPH RES CO, V359, P778, DOI 10.1016/j.bbrc.2007.05.183; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020; Kim DJ, 2006, CARCINOGENESIS, V27, P1105, DOI 10.1093/carcin/bgi346; Kim DJ, 2004, J BIOL CHEM, V279, P23719, DOI 10.1074/jbc.M312063200; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MORGAN D, 1992, CANCER RES, V52, P3145; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Palkar PS, 2010, MOL PHARMACOL, V78, P419, DOI 10.1124/mol.110.065508; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004; Seufferlein T, 1996, CANCER RES, V56, P3895; STRICKLAND JE, 1988, CANCER RES, V48, P165; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Vijayachandra K, 2003, CANCER RES, V63, P3447; YUSPA SH, 1981, NATURE, V293, P72, DOI 10.1038/293072a0; Zhu B, 2014, ONCOGENE, V33, P5348, DOI 10.1038/onc.2013.477; Zhu BK, 2012, MOL CELL BIOL, V32, P2065, DOI 10.1128/MCB.00092-12; Zhu BK, 2010, MOL CANCER THER, V9, P3267, DOI 10.1158/1535-7163.MCT-10-0820	40	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20102	20119		10.1074/jbc.M114.551069	http://dx.doi.org/10.1074/jbc.M114.551069			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898257	Green Published, hybrid			2022-12-28	WOS:000339395200024
J	Chang, HY; Chou, CC; Hsu, MF; Wang, AHJ				Chang, Hsin-Yang; Chou, Chia-Cheng; Hsu, Min-Feng; Wang, Andrew H. J.			Proposed Carrier Lipid-binding Site of Undecaprenyl Pyrophosphate Phosphatase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL-DIPHOSPHATE SYNTHASE; P-LOOP MOTIF; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; ACTIVE-SITE; BACILLUS-STEAROTHERMOPHILUS; DIRECTED MUTAGENESIS; RECA PROTEIN; BACA GENE; METAL-ION	Undecaprenyl pyrophosphate phosphatase (UppP), an integral membrane protein, catalyzes the dephosphorylation of undecaprenyl pyrophosphate to undecaprenyl phosphate, which is an essential carrier lipid in the bacterial cell wall synthesis. Sequence alignment reveals two consensus regions, containing glutamate-rich (E/Q)XXXE plus PGXSRSXXT motifs and a histidine residue, specific to the bacterial UppP enzymes. The predicted topological model suggests that both of these regions are localized near the aqueous interface of UppP and face the periplasm, implicating that its enzymatic function is on the outer side of the plasma membrane. The mutagenesis analysis demonstrates that most of the mutations (E17A/E21A, H30A, S173A, R174A, and T178A) within the consensus regions are completely inactive, indicating that the catalytic site of UppP is constituted by these two regions. Enzymatic analysis also shows an absolute requirement of magnesium or calcium ions in enzyme activity. The three-dimensional structural model and molecular dynamics simulation studies have shown a plausible structure of the catalytic site of UppP and thus provides insights into the molecular basis of the enzyme-substrate interaction in membrane bilayers.	[Chang, Hsin-Yang; Chou, Chia-Cheng; Hsu, Min-Feng; Wang, Andrew H. J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Chou, Chia-Cheng; Hsu, Min-Feng; Wang, Andrew H. J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 11529, Taiwan; [Wang, Andrew H. J.] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei 11529, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Medical University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	ahjwang@gate.sinica.edu.tw		Chou, Chia-Cheng/0000-0002-0467-1755	 [NSC 10102325-B-492-001]		We thank the National Research Program for Biopharmaceuticals (supported by Grant NSC 10102325-B-492-001) and the National Center for High Performance Computing, National Applied Research Laboratories of Taiwan, for providing computing resources.	Apfel CM, 1999, J BACTERIOL, V181, P483, DOI 10.1128/JB.181.2.483-492.1999; Barreteau H, 2009, J CHROMATOGR B, V877, P213, DOI 10.1016/j.jchromb.2008.12.010; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bickford JS, 2013, MICROBIOL-SGM, V159, P2444, DOI 10.1099/mic.0.070474-0; CAIN BD, 1993, J BACTERIOL, V175, P3784, DOI 10.1128/JB.175.12.3784-3789.1993; Chang SY, 2004, PROTEIN SCI, V13, P971, DOI 10.1110/ps.03519904; Chang SY, 2003, J BIOL CHEM, V278, P29298, DOI 10.1074/jbc.M302687200; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; Economou NJ, 2013, P NATL ACAD SCI USA, V110, P14207, DOI 10.1073/pnas.1308268110; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; El Ghachi M, 2004, J BIOL CHEM, V279, P30106, DOI 10.1074/jbc.M401701200; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; Fothergill-Gilmore L. A., 1989, ADV ENZYMOLOGY RELAT, V62, P227; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Ghosh A, 2002, J BIOL CHEM, V277, P32837, DOI 10.1074/jbc.M201853200; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Guo RT, 2004, J BIOL CHEM, V279, P4903, DOI 10.1074/jbc.M310161200; Hsu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056363; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishikawa K, 2000, EMBO J, V19, P2412, DOI 10.1093/emboj/19.11.2412; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JOLY A, 1993, J BIOL CHEM, V268, P26983; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; KONOLA JT, 1994, J MOL BIOL, V237, P20, DOI 10.1006/jmbi.1994.1206; Koyama T, 1996, BIOCHEMISTRY-US, V35, P9533, DOI 10.1021/bi960137v; LASKOVICS FM, 1981, BIOCHEMISTRY-US, V20, P1893, DOI 10.1021/bi00510a027; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; LOGAN KM, 1993, J MOL BIOL, V232, P1048, DOI 10.1006/jmbi.1993.1459; Makde RD, 2007, BIOCHEMISTRY-US, V46, P2079, DOI 10.1021/bi062180g; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ogino T, 1998, MOL MICROBIOL, V27, P573, DOI 10.1046/j.1365-2958.1998.00703.x; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PILKIS SJ, 1987, J BIOL CHEM, V262, P12672; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Renirie R, 2000, J BIOL CHEM, V275, P11650, DOI 10.1074/jbc.275.16.11650; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rush JS, 2002, J BIOL CHEM, V277, P45226, DOI 10.1074/jbc.M207076200; Segel I. H., 1993, ENZYME KINETICS BEHA, P100; Shimizu N, 1998, J BIOL CHEM, V273, P19476, DOI 10.1074/jbc.273.31.19476; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Stukey J, 1997, PROTEIN SCI, V6, P469; Tatar LD, 2007, MICROBIOL-SGM, V153, P2518, DOI 10.1099/mic.0.2007/006312-0; Touze T, 2008, J BIOL CHEM, V283, P16573, DOI 10.1074/jbc.M800394200; van Berkel MAA, 1999, GLYCOBIOLOGY, V9, P243, DOI 10.1093/glycob/9.3.243; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181	54	29	29	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18719	18735		10.1074/jbc.M114.575076	http://dx.doi.org/10.1074/jbc.M114.575076			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855653	Green Published, hybrid			2022-12-28	WOS:000339062900010
J	Jiang, J; Yang, JF; Feng, P; Zuo, B; Dong, NZ; Wu, QY; He, Y				Jiang, Jiang; Yang, Jianfeng; Feng, Ping; Zuo, Bin; Dong, Ningzheng; Wu, Qingyu; He, Yang			N-Glycosylation Is Required for Matriptase-2 Autoactivation and Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-DEFICIENCY ANEMIA; SERINE-PROTEASE MATRIPTASE-2; CELL-SURFACE; MOLECULAR-MECHANISMS; ZYMOGEN ACTIVATION; BREAST-CANCER; TMPRSS6 GENE; CORIN; EXPRESSION; MUTATIONS	Matriptase-2 is a hepatic membrane serine protease that regulates iron homeostasis. Defects in matriptase-2 cause iron deficiency anemia. In cells, matriptase-2 is synthesized as a zymogen. To date, how matriptase-2 expression and activation are regulated remains poorly understood. Here we expressed human matriptase-2 in HEK293 and hepatic BEL-7402, SMMC7721, and QGY-7703 cells. By labeling cell surface proteins and Western analysis, we examined matriptase-2 cell surface expression, zymogen activation, and ectodomain shedding. Our results show that matriptase-2 was activated on the cell surface but not intracellularly. Activated matriptase-2 underwent ectodomain shedding, producing soluble fragments in the conditioned medium. By testing inactive mutants, R576A and S762A, we found that matriptase-2 activation and shedding were mediated by its own catalytic activity and that the one-chain form of matriptase-2 had little activity in ectodomain shedding. We made additional matriptase-2 mutants, N136Q, N184Q, N216Q, N338Q, N433Q, N453Q, and N518Q, in which each of the predicted N-glycosylation sites was mutated. All of these mutants were expressed on the cell surface. However, mutants N216Q, N453Q, and N518Q, but not the other mutants, had impaired zymogen activation and ectodomain shedding. Our results indicate that N-glycans at specific sites are critical for matriptase-2 activation. Together, these data provide new insights into the cell surface expression, zymogen activation, and ectodomain shedding of matriptase-2.	[Jiang, Jiang; Yang, Jianfeng; Zuo, Bin; Dong, Ningzheng; Wu, Qingyu; He, Yang] Soochow Univ, Cyrus Tang Hematol Ctr, Affiliated Hosp 2, Suzhou 215006, Peoples R China; [Jiang, Jiang; Yang, Jianfeng; Zuo, Bin; Dong, Ningzheng; Wu, Qingyu; He, Yang] Soochow Univ, Minist Educ, Engn Ctr Hematol Dis, Affiliated Hosp 2, Suzhou 215006, Peoples R China; [Jiang, Jiang; Feng, Ping] Soochow Univ, Dept Clin Labs, Affiliated Hosp 2, Suzhou 215006, Peoples R China; [Dong, Ningzheng; He, Yang] Soochow Univ, Minist Hlth, Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol,Affiliated Hosp 1, Suzhou 215006, Peoples R China; [Dong, Ningzheng; Wu, Qingyu; He, Yang] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou 215006, Peoples R China; [Wu, Qingyu] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Cleveland Clinic Foundation	Wu, QY (corresponding author), Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org; heyang1963@163.com		Wu, Qingyu/0000-0003-0561-9315	National Natural Science Foundation of China [81170247, 81370718, 31161130356]; Danish-Chinese Center on Proteases and Cancer; Chinese Ministry of Education [213016A]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Special Program of Medical Science Grant [BL2012005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Danish-Chinese Center on Proteases and Cancer; Chinese Ministry of Education(Ministry of Education, China); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Special Program of Medical Science Grant	This work was supported in part by National Natural Science Foundation of China Grants 81170247, 81370718, and 31161130356; the Danish-Chinese Center on Proteases and Cancer; Key Project of Chinese Ministry of Education Grant 213016A; Priority Academic Program Development of Jiangsu Higher Education Institutions; and Jiangsu Special Program of Medical Science Grant BL2012005.	Altamura S, 2010, BIOCHEM J, V431, P363, DOI 10.1042/BJ20100668; Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Becherer JD, 2003, CURR TOP DEV BIOL, V54, P101, DOI 10.1016/S0070-2153(03)54006-6; Beliveau F, 2011, J BIOL CHEM, V286, P29035, DOI 10.1074/jbc.M111.223461; Beutler E, 2010, BLOOD CELL MOL DIS, V44, P16, DOI 10.1016/j.bcmd.2009.09.001; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Cui YJ, 2009, KIDNEY INT, V76, P1137, DOI 10.1038/ki.2009.357; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; De Falco L, 2010, HUM MUTAT, V31, pE1390, DOI 10.1002/humu.21243; Dong NZ, 2013, J BIOL CHEM, V288, P7867, DOI 10.1074/jbc.M112.411512; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Edison ES, 2009, BRIT J HAEMATOL, V147, P766, DOI 10.1111/j.1365-2141.2009.07879.x; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Gladysheva IP, 2008, BIOCHEM BIOPH RES CO, V373, P130, DOI 10.1016/j.bbrc.2008.05.181; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hartikainen JM, 2006, CLIN CANCER RES, V12, P1454, DOI 10.1158/1078-0432.CCR-05-1417; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Jiang JJ, 2010, CLIN CHEM, V56, P959, DOI 10.1373/clinchem.2009.140558; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Miyake Y, 2010, BBA-PROTEINS PROTEOM, V1804, P156, DOI 10.1016/j.bbapap.2009.09.025; Moharir A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074299; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Ramsay AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P569, DOI 10.2741/2702; Ramsay AJ, 2009, HUM MOL GENET, V18, P3673, DOI 10.1093/hmg/ddp315; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; RODRIGUEZ CG, 1995, J BIOL CHEM, V270, P25178, DOI 10.1074/jbc.270.42.25178; Sato T, 2011, INT J HEMATOL, V94, P101, DOI 10.1007/s12185-011-0881-0; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Tuhkanen H, 2013, INT J CANCER, V133, P2334, DOI 10.1002/ijc.28254; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Webb SL, 2012, ONCOL REP, V28, P1491, DOI 10.3892/or.2012.1945; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225	47	28	28	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19500	19507		10.1074/jbc.M114.555110	http://dx.doi.org/10.1074/jbc.M114.555110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867957	Green Published, hybrid			2022-12-28	WOS:000339326800025
J	McTernan, PM; Chandrayan, SK; Wu, CH; Vaccaro, BJ; Lancaster, WA; Yang, QY; Fu, D; Hura, GL; Tainer, JA; Adams, MWW				McTernan, Patrick M.; Chandrayan, Sanjeev K.; Wu, Chang-Hao; Vaccaro, Brian J.; Lancaster, W. Andrew; Yang, Qingyuan; Fu, Dax; Hura, Greg L.; Tainer, John A.; Adams, Michael W. W.			Intact Functional Fourteen-subunit Respiratory Membrane-bound [NiFe]-Hydrogenase Complex of the Hyperthermophilic Archaeon Pyrococcus furiosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTING NIFE HYDROGENASES; SMALL-ANGLE SCATTERING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; METHANOSARCINA-BARKERI; CATALYTIC-PROPERTIES; BIOLOGICAL FUNCTION; ATP SYNTHASE; ACTIVE-SITE; PURIFICATION	The archaeon Pyrococcus furiosus grows optimally at 100 degrees C by converting carbohydrates to acetate, CO2, and H-2, obtaining energy from a respiratory membrane-bound hydrogenase (MBH). This conserves energy by coupling H-2 production to oxidation of reduced ferredoxin with generation of a sodium ion gradient. MBH is encoded by a 14-gene operon with both hydrogenase and Na+/H+ antiporter modules. Herein a His-tagged MBH was expressed in P. furiosus and the detergent-solubilized complex purified under anaerobic conditions by affinity chromatography. Purified MBH contains all 14 subunits by electrophoretic analysis (13 subunits were also identified by mass spectrometry) and had a measured iron: nickel ratio of 15:1, resembling the predicted value of 13:1. The as-purified enzyme exhibited a rhombic EPR signal characteristic of the ready nickel-boron state. The purified and membrane-bound forms of MBH both preferentially evolved H-2 with the physiological donor (reduced ferredoxin) as well as with standard dyes. The O-2 sensitivities of the two forms were similar (half-lives of similar to 15 h in air), but the purified enzyme was more thermolabile (half-lives at 90 degrees C of 1 and 25 h, respectively). Structural analysis of purified MBH by small angle x-ray scattering indicated a Z-shaped structure with a mass of 310 kDa, resembling the predicted value (298 kDa). The angle x-ray scattering analyses reinforce and extend the conserved sequence relationships of group 4 enzymes and complex I (NADH quinone oxidoreductase). This is the first report on the properties of a solubilized form of an intact respiratory MBH complex that is proposed to evolve H-2 and pump Na+ ions.	[McTernan, Patrick M.; Chandrayan, Sanjeev K.; Wu, Chang-Hao; Vaccaro, Brian J.; Lancaster, W. Andrew; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Yang, Qingyuan; Fu, Dax] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Hura, Greg L.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University System of Georgia; University of Georgia; Johns Hopkins University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	McTernan, Patrick/HGV-0762-2022; Vaccaro, Brian/F-8526-2017; CHANDRAYAN, SANJEEV/M-1662-2016; Tainer, John/GWQ-4878-2022	CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Tainer, John/0000-0003-1659-2429; Adams, Michael/0000-0002-9796-5014; Fu, Dax/0000-0002-2663-1316; Hura, Greg/0000-0003-0501-8464	National Institutes of Health [GM105404]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DE-FG05-95ER20175]; Department of Energy project Integrated Diffraction Analysis Technologies; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy; Department of Energy project Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM105404 (to J. A. T.). This work was also supported by Grant DE-FG05-95ER20175 (to M. W. W. A.) from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy. SAXS analyses were supported by Department of Energy project Integrated Diffraction Analysis Technologies.	Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; BOHM R, 1990, MOL MICROBIOL, V4, P231, DOI 10.1111/j.1365-2958.1990.tb00590.x; Brereton PS, 1998, BIOCHEMISTRY-US, V37, P7351, DOI 10.1021/bi972864b; Chandrayan SK, 2012, J BIOL CHEM, V287, P3257, DOI 10.1074/jbc.M111.290916; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Foerster S, 2003, J AM CHEM SOC, V125, P83, DOI 10.1021/ja027522u; Fontecilla-Camps Juan C., 2009, V6, P151, DOI [10.1039/9781847559159-00151, 10.1039/BK9781847559159-00151]; Friedrich B, 2011, CURR OPIN BIOTECH, V22, P358, DOI 10.1016/j.copbio.2011.01.006; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Hopkins RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026569; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kim MS, 2013, APPL ENVIRON MICROB, V79, P2048, DOI 10.1128/AEM.03298-12; Kurkin S, 2002, EUR J BIOCHEM, V269, P6101, DOI 10.1046/j.1432-1033.2002.03328.x; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Lipscomb GL, 2014, J BIOL CHEM, V289, P2873, DOI 10.1074/jbc.M113.530725; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Marreiros BC, 2013, BBA-BIOENERGETICS, V1827, P198, DOI 10.1016/j.bbabio.2012.09.012; Meuer J, 1999, EUR J BIOCHEM, V265, P325, DOI 10.1046/j.1432-1327.1999.00738.x; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sapra R, 2000, J BACTERIOL, V182, P3423, DOI 10.1128/JB.182.12.3423-3428.2000; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Singer SW, 2006, BBA-BIOENERGETICS, V1757, P1582, DOI 10.1016/j.bbabio.2006.10.003; Soboh B, 2002, EUR J BIOCHEM, V269, P5712, DOI 10.1046/j.1432-1033.2002.03282.x; Soboh B, 2004, MICROBIOL-SGM, V150, P2451, DOI 10.1099/mic.0.27159-0; STULTS LW, 1986, J BACTERIOL, V166, P795, DOI 10.1128/jb.166.3.795-800.1986; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 2013, STRUCTURE, V21, P184, DOI 10.1016/j.str.2012.11.010; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200	44	30	35	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19364	19372		10.1074/jbc.M114.567255	http://dx.doi.org/10.1074/jbc.M114.567255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860091	Green Published, hybrid			2022-12-28	WOS:000339326800013
J	Noriega, TR; Tsai, A; Elvekrog, MM; Petrov, A; Neher, SB; Chen, J; Bradshaw, N; Puglisi, JD; Walter, P				Noriega, Thomas R.; Tsai, Albert; Elvekrog, Margaret M.; Petrov, Alexey; Neher, Saskia B.; Chen, Jin; Bradshaw, Niels; Puglisi, Joseph D.; Walter, Peter			Signal Recognition Particle-ribosome Binding Is Sensitive to Nascent Chain Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE FLUORESCENCE; ESCHERICHIA-COLI; SRP RNA; 4.5S RNA; TRANSLATION ELONGATION; SUBSTRATE SELECTION; MEMBRANE-PROTEIN; REAL-TIME; RECEPTOR; SEQUENCE	The signal recognition particle (SRP) directs ribosome-nascent chain complexes (RNCs) displaying signal sequences to protein translocation channels in the plasma membrane of prokaryotes and endoplasmic reticulum of eukaryotes. It was initially proposed that SRP binds the signal sequence when it emerges from an RNC and that successful binding becomes impaired as translation extends the nascent chain, moving the signal sequence away from SRP on the ribosomal surface. Later studies drew this simple model into question, proposing that SRP binding is unaffected by nascent chain length. Here, we reinvestigate this issue using two novel and independent fluorescence resonance energy transfer assays. We show that the arrival and dissociation rates of SRP binding to RNCs vary according to nascent chain length, resulting in the highest affinity shortly after a functional signal sequence emerges from the ribosome. Moreover, we show that SRP binds RNCs in multiple and interconverting conformations, and that conversely, RNCs exist in two conformations distinguished by SRP interaction kinetics.	[Noriega, Thomas R.; Elvekrog, Margaret M.; Neher, Saskia B.; Bradshaw, Niels; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Noriega, Thomas R.; Elvekrog, Margaret M.; Neher, Saskia B.; Bradshaw, Niels; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Tsai, Albert; Petrov, Alexey; Chen, Jin; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Tsai, Albert; Chen, Jin] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University	Puglisi, JD (corresponding author), Stanford Univ, Sch Med, D105 Fairchild Sci Bldg,299 Campus Dr West, Stanford, CA 94305 USA.	puglisi@stanford.edu		Tsai, Albert/0000-0002-1643-0780; Neher, Saskia/0000-0003-4165-6674; Bradshaw, Niels/0000-0002-6845-4717	Howard Hughes Medical Institute; National Institutes of Health [GM032384, GM51266, GM099687]; National Institute of General Medical Sciences initiative for maximizing student development; National Science Foundation graduate research fellowship program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384, R01GM099687, R01GM051266, T32GM007810, R37GM032384] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences initiative for maximizing student development; National Science Foundation graduate research fellowship program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute and National Institutes of Health Grants GM032384 (to T. R. N., M. M. E., S. B. N., N. B., and P. W.), GM51266 (to A. T., J. C., and J. D. P.), and GM099687 (to A. P. and J. D. P.).; Supported by Juliet Girard, the National Institute of General Medical Sciences initiative for maximizing student development, and the National Science Foundation graduate research fellowship program.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; BERNSTEIN HD, 1993, P NATL ACAD SCI USA, V90, P5229, DOI 10.1073/pnas.90.11.5229; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Bradshaw N, 2007, MOL BIOL CELL, V18, P2728, DOI 10.1091/mbc.e07-02-0117; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Buskiewicz I, 2005, RNA, V11, P947, DOI 10.1261/rna.7242305; Buskiewicz I, 2005, J MOL BIOL, V351, P417, DOI 10.1016/j.jmb.2005.06.023; Chen J, 2014, P NATL ACAD SCI USA, V111, P664, DOI 10.1073/pnas.1315735111; Chen J, 2012, J AM CHEM SOC, V134, P5734, DOI 10.1021/ja2119964; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Hainzl T, 2007, P NATL ACAD SCI USA, V104, P14911, DOI 10.1073/pnas.0702467104; Hainzl T, 2011, NAT STRUCT MOL BIOL, V18, P389, DOI 10.1038/nsmb.1994; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Holtkamp W, 2012, NAT STRUCT MOL BIOL, V19, P1332, DOI 10.1038/nsmb.2421; Houben ENG, 2005, J CELL BIOL, V170, P27, DOI 10.1083/jcb.200503035; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; JENSEN CG, 1994, J BACTERIOL, V176, P7148, DOI 10.1128/JB.176.23.7148-7154.1994; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; Matsuura T, 2007, BIOCHEM BIOPH RES CO, V352, P372, DOI 10.1016/j.bbrc.2006.11.050; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Saraogi I, 2014, J CELL BIOL, V205, P693, DOI 10.1083/jcb.201311028; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shen K, 2013, J BIOL CHEM, V288, P36385, DOI 10.1074/jbc.M113.513614; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; Spedding G., 1990, RIBOSOMES PROTEIN SY; Tsai A, 2012, NATURE, V487, P390, DOI 10.1038/nature11172; Zhang DW, 2012, J BIOL CHEM, V287, P7652, DOI 10.1074/jbc.M111.325001; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	44	36	36	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19294	19305		10.1074/jbc.M114.563239	http://dx.doi.org/10.1074/jbc.M114.563239			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24808175	hybrid, Green Published			2022-12-28	WOS:000339326800007
J	Yang, XM; Hegde, VL; Rao, R; Zhang, JJ; Nagarkatti, PS; Nagarkatti, M				Yang, Xiaoming; Hegde, Venkatesh L.; Rao, Roshni; Zhang, Jiajia; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			Histone Modifications Are Associated with Delta 9-Tetrahydrocannabinol-mediated Alterations in Antigen-specific T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID-RECEPTOR; DEVELOPMENTAL REGULATORS; LEGIONELLA-PNEUMOPHILA; SUPPRESSOR-CELLS; DELTA(9)-TETRAHYDROCANNABINOL; METHYLATION; ACETYLATION; ACTIVATION; GENE; APOPTOSIS	Marijuana is one of the most abused drugs due to its psychotropic effects. Interestingly, it is also used for medicinal purposes. The main psychotropic component in marijuana, Delta 9-tetrahydrocannabinol (THC), has also been shown to mediate potent anti-inflammatory properties. Whether the immunomodulatory activity of THC is mediated by epigenetic regulation has not been investigated previously. In this study, we employed ChIP-Seq technology to examine the in vivo effect of THC on global histone methylation in lymph node cells of mice immunized with a superantigen, staphylococcal enterotoxin B. We compared genome-wide histone H3 Lys-4, Lys-27, Lys-9, and Lys-36 trimethylation and histone H3 Lys-9 acetylation patterns in such cells exposed to THC or vehicle. Our results showed that THC treatment leads to the association of active histone modification signals to Th2 cytokine genes and suppressive modification signals to Th1 cytokine genes, indicating that such a mechanism may play a critical role in the THC-mediated switch from Th1 to Th2. At the global level, a significant portion of histone methylation and acetylation regions were altered by THC. However, the overall distribution of these histone methylation signals among the genomic features was not altered significantly by THC, suggesting that THC activates the expression of a subset of genes while suppressing the expression of another subset of genes through histone modification. Functional classification of these histone marker-associated genes showed that these differentially associated genes were involved in various cellular functions, from cell cycle regulation to metabolism, suggesting that THC had a pleiotropic effect on gene expression in immune cells. Altogether, the current study demonstrates for the first time that THC may modulate immune response through epigenetic regulation involving histone modifications.	[Yang, Xiaoming; Hegde, Venkatesh L.; Rao, Roshni; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA; [Zhang, Jiajia] Univ S Carolina, Sch Publ Hlth, Columbia, SC 29209 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ S Carolina, Sch Med, 6439 Garners Ferry Rd, Columbia, SC 29209 USA.	Mitzi.Nagarkatti@uscmed.sc.edu	; Hegde, Venkatesh/E-8519-2014	Nagarkatti, Prakash/0000-0003-2663-0759; Hegde, Venkatesh/0000-0002-0949-919X; Nagarkatti, Mitzi/0000-0002-5977-5615	National Institutes of Health Grants [P01AT003961, R01AT006888, R01ES019313, R01MH094755, P20GM103641]; Veterans Affairs Merit Award [BX001357]; National Center for Complementary & Integrative Health [P01AT003961, R01AT006888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001357] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants P01AT003961, R01AT006888, R01ES019313, R01MH094755, and P20GM103641. This work was also supported by Veterans Affairs Merit Award BX001357.	Aguado T, 2007, J BIOL CHEM, V282, P6854, DOI 10.1074/jbc.M608900200; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chioccarelli T, 2010, ENDOCRINOLOGY, V151, P5017, DOI 10.1210/en.2010-0133; Cinti Sandro, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P342, DOI 10.1177/1545109709351167; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Ellert-Miklaszewska A, 2005, CELL SIGNAL, V17, P25, DOI 10.1016/j.cellsig.2004.05.011; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Greenhough A, 2007, INT J CANCER, V121, P2172, DOI 10.1002/ijc.22917; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guenther MG, 2003, METHOD ENZYMOL, V364, P246; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Hegde VL, 2013, J BIOL CHEM, V288, P36810, DOI 10.1074/jbc.M113.503037; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; Karmaus PWF, 2013, TOXICOL SCI, V131, P419, DOI 10.1093/toxsci/kfs315; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Khare M, 2006, MOL HUM REPROD, V12, P321, DOI 10.1093/molehr/gal036; Klein TW, 2000, J IMMUNOL, V164, P6461, DOI 10.4049/jimmunol.164.12.6461; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kozela E, 2013, J NEUROIMMUNE PHARM, V8, P1265, DOI 10.1007/s11481-013-9493-1; Kumar P, 2014, BIOCHEM BIOPH RES CO, V443, P144, DOI 10.1016/j.bbrc.2013.11.071; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lim PS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r107; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu Y, 2013, FEBS LETT, V587, P847, DOI 10.1016/j.febslet.2013.02.023; Lombard C, 2011, J PHARMACOL EXP THER, V339, P607, DOI 10.1124/jpet.111.181206; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; NEWTON CA, 1994, INFECT IMMUN, V62, P4015, DOI 10.1128/IAI.62.9.4015-4020.1994; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Pandey R, 2011, J PHARMACOL EXP THER, V338, P819, DOI 10.1124/jpet.111.182717; Paradisi A, 2008, J BIOL CHEM, V283, P6005, DOI 10.1074/jbc.M707964200; Prather PL, 2013, BIOCHEM BIOPH RES CO, V441, P339, DOI 10.1016/j.bbrc.2013.10.057; Rao GK, 2004, J LEUKOCYTE BIOL, V75, P884, DOI 10.1189/jlb.1203638; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; SAUER MA, 1983, J PHARMACOL EXP THER, V224, P404; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Substance Abuse and Mental Health Services Administration, 2010, RES 2009 NAT SURV DR; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Terlou A, 2012, J INVEST DERMATOL, V132, P658, DOI 10.1038/jid.2011.369; Todaro B, 2012, J NATL COMPR CANC NE, V10, P487, DOI 10.6004/jnccn.2012.0048; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; von Bueren AO, 2008, ANTICANCER RES, V28, P85; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yuan M, 2002, J NEUROIMMUNOL, V133, P124, DOI 10.1016/S0165-5728(02)00370-3; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373; Zhu WG, 1998, J PHARMACOL EXP THER, V286, P1103; Zuo T, 2011, CANCER RES, V71, P1752, DOI 10.1158/0008-5472.CAN-10-3573	77	52	53	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18707	18718		10.1074/jbc.M113.545210	http://dx.doi.org/10.1074/jbc.M113.545210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841204	Green Published, hybrid			2022-12-28	WOS:000339062900009
J	Siamer, S; Guillas, I; Shimobayashi, M; Kunz, C; Hall, MN; Barny, MA				Siamer, Sabrina; Guillas, Isabelle; Shimobayashi, Mitsugu; Kunz, Caroline; Hall, Michael N.; Barny, Marie-Anne			Expression of the Bacterial Type III Effector DspA/E in Saccharomyces cerevisiae Down-regulates the Sphingolipid Biosynthetic Pathway Leading to Growth Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEWARTII SUBSP STEWARTII; CHAIN FATTY-ACIDS; HRP GENE-CLUSTER; ERWINIA-AMYLOVORA; CELL-DEATH; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; SERINE PALMITOYLTRANSFERASE; CERAMIDE SYNTHESIS; CATALYTIC SUBUNIT	Erwinia amylovora, the bacterium responsible for fire blight, relies on a type III secretion system and a single injected effector, DspA/E, to induce disease in host plants. DspA/E belongs to the widespread AvrE family of type III effectors that suppress plant defense responses and promote bacterial growth following infection. Ectopic expression of DspA/E in plant or in Saccharomyces cerevisiae is toxic, indicating that DspA/E likely targets a cellular process conserved between yeast and plant. To unravel the mode of action of DspA/E, we screened the Euroscarf S. cerevisiae library for mutants resistant to DspA/E-induced growth arrest. The most resistant mutants (Delta sur4,Delta fen1,Delta ipt1,Delta skn1,Delta csg1, Delta csg2,Delta orm1, and Delta orm2) were impaired in the sphingolipid biosynthetic pathway. Exogenously supplied sphingolipid precursors such as the long chain bases (LCBs) phytosphingosine and dihydrosphingosine also suppressed the DspA/E-induced yeast growth defect. Expression of DspA/E in yeast down-regulated LCB biosynthesis and induced a rapid decrease in LCB levels, indicating that serine palmitoyltransferase (SPT), the first and rate-limiting enzyme of the sphingolipid biosynthetic pathway, was repressed. SPT down-regulation was mediated by dephosphorylation and activation of Orm proteins that negatively regulate SPT. A Delta cdc55 mutation affecting Cdc55-PP2A protein phosphatase activity prevented Orm dephosphorylation and suppressed DspA/E-induced growth arrest.	[Siamer, Sabrina; Barny, Marie-Anne] Univ Paris 06, INRA UMR1392, IEES, F-75252 Paris, France; [Guillas, Isabelle] Univ Paris 06, Sorbonne Univ, UMR1166, INSERM,Pitie Salpetriere Univ Hosp, F-75013 Paris, France; [Siamer, Sabrina; Shimobayashi, Mitsugu; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Kunz, Caroline] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Kunz, Caroline] Museum Natl Hist Nat, UMR7245, F-75005 Paris, France	INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Basel; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Barny, MA (corresponding author), Univ Paris 06, INRA UMR1392, IEES, Bat A-7eme Etage Case 237,7 Quai St Bernard, F-75252 Paris, France.	barny@agroparistech.fr		Hall, Michael N/0000-0002-2998-0757; marie-anne, barny/0000-0002-2005-1388; Shimobayashi, Mitsugu/0000-0002-6936-0990; Guillas, Isabelle/0000-0002-6073-0529	Agence Nationale de la Recherche Jeune Chercheur DspCellDeath grant; Contrat Jeune Scientifique "Institut National de la Recherche Agronomique" Ph.D. fellowship; European Molecular Biology Organization	Agence Nationale de la Recherche Jeune Chercheur DspCellDeath grant(French National Research Agency (ANR)); Contrat Jeune Scientifique "Institut National de la Recherche Agronomique" Ph.D. fellowship; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported in part by the Agence Nationale de la Recherche Jeune Chercheur DspCellDeath grant.; Recipient of a Contrat Jeune Scientifique "Institut National de la Recherche Agronomique" Ph.D. fellowship and a European Molecular Biology Organization short term fellowship.	Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Bach L, 2011, J CELL SCI, V124, P3223, DOI 10.1242/jcs.074575; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; BARNY MA, 1990, MOL MICROBIOL, V4, P777, DOI 10.1111/j.1365-2958.1990.tb00648.x; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Birch PRJ, 1999, MOL PLANT MICROBE IN, V12, P356, DOI 10.1094/MPMI.1999.12.4.356; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; Boureau T, 2006, MOL PLANT MICROBE IN, V19, P16, DOI 10.1094/MPMI-19-0016; Boureau T, 2011, MOL PLANT MICROBE IN, V24, P577, DOI 10.1094/MPMI-09-10-0212; Boyer J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r72; Brandwagt BF, 2000, P NATL ACAD SCI USA, V97, P4961, DOI 10.1073/pnas.97.9.4961; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x; Curak J, 2009, CURR OPIN MICROBIOL, V12, P18, DOI 10.1016/j.mib.2008.11.004; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Degrave A, 2008, MOL PLANT MICROBE IN, V21, P1076, DOI 10.1094/MPMI-21-8-1076; Degrave A, 2013, MOL PLANT PATHOL, V14, P506, DOI 10.1111/mpp.12022; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dietrich CR, 2008, PLANT J, V54, P284, DOI 10.1111/j.1365-313X.2008.03420.x; Dutton MF, 1996, PHARMACOL THERAPEUT, V70, P137, DOI 10.1016/0163-7258(96)00006-X; Frederick RD, 2001, MOL PLANT MICROBE IN, V14, P1213, DOI 10.1094/MPMI.2001.14.10.1213; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guillas I, 2003, J BIOL CHEM, V278, P37083, DOI 10.1074/jbc.M307554200; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Ham JH, 2008, MOL PLANT PATHOL, V9, P633, DOI 10.1111/J.1364-3703.2008.00489.X; Ham JH, 2006, MOL PLANT MICROBE IN, V19, P1092, DOI 10.1094/MPMI-19-1092; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Lester RL, 2001, ANAL BIOCHEM, V298, P283, DOI 10.1006/abio.2001.5368; Malnoy M, 2012, ANNU REV PHYTOPATHOL, V50, P475, DOI 10.1146/annurev-phyto-081211-172931; Markham JE, 2011, PLANT CELL, V23, P2362, DOI 10.1105/tpc.110.080473; Mor H, 2001, MOL PLANT MICROBE IN, V14, P431, DOI 10.1094/MPMI.2001.14.3.431; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Oh CS, 2007, MOL PLANT PATHOL, V8, P255, DOI [10.1111/j.1364-3703.2007.00390.x, 10.1111/j.1364-3703.2007.00390.X]; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Saucedo-Garcia M, 2011, NEW PHYTOL, V191, P943, DOI 10.1111/j.1469-8137.2011.03727.x; Shi LH, 2007, CELL RES, V17, P1030, DOI 10.1038/cr.2007.100; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Siamer S, 2011, FEBS OPEN BIO, V1, P23, DOI 10.1016/j.fob.2011.11.001; Siamer S, 2013, FEMS MICROBIOL LETT, V342, P54, DOI 10.1111/1574-6968.12108; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Tanoue D, 2005, ARCH BIOCHEM BIOPHYS, V437, P29, DOI 10.1016/j.abb.2005.02.030; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Voynova NS, 2012, BIOCHEM J, V447, P103, DOI 10.1042/BJ20120712; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	60	16	17	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18466	18477		10.1074/jbc.M114.562769	http://dx.doi.org/10.1074/jbc.M114.562769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828506	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000338042000043
J	Alqarni, SSM; Murthy, A; Zhang, W; Przewloka, MR; Silva, APG; Watson, AA; Lejon, S; Pei, XY; Smits, AH; Kloet, SL; Wang, HX; Shepherd, NE; Stokes, PH; Blobel, GA; Vermeulen, M; Glover, DM; Mackay, JP; Laue, ED				Alqarni, Saad S. M.; Murthy, Andal; Zhang, Wei; Przewloka, Marcin R.; Silva, Ana P. G.; Watson, Aleksandra A.; Lejon, Sara; Pei, Xue Y.; Smits, Arne H.; Kloet, Susan L.; Wang, Hongxin; Shepherd, Nicholas E.; Stokes, Philippa H.; Blobel, Gerd A.; Vermeulen, Michiel; Glover, David M.; Mackay, Joel P.; Laue, Ernest D.			Insight into the Architecture of the NuRD Complex STRUCTURE OF THE RbAp48-MTA1 SUBCOMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; TRANSCRIPTIONAL REPRESSION; MI-2/NURD COMPLEX; STRUCTURAL BASIS; DNA METHYLATION; SOMATIC-CELLS; ZINC-FINGER; PROTEIN; BINDING; DOMAINS	The nucleosome remodeling and deacetylase (NuRD) complex is a widely conserved transcriptional co-regulator that harbors both nucleosome remodeling and histone deacetylase activities. It plays a critical role in the early stages of ES cell differentiation and the reprogramming of somatic to induced pluripotent stem cells. Abnormalities in several NuRD proteins are associated with cancer and aging. We have investigated the architecture of NuRDby determining the structure of a subcomplex comprising RbAp48 and MTA1. Surprisingly, RbAp48 recognizes MTA1 using the same site that it uses to bind histone H4, showing that assembly into NuRD modulates RbAp46/48 interactions with histones. Taken together with other results, our data show that the MTA proteins act as scaffolds for NuRD complex assembly. We further show that the RbAp48-MTA1 interaction is essential for the in vivo integration of RbAp46/48 into the NuRD complex.	[Alqarni, Saad S. M.; Silva, Ana P. G.; Shepherd, Nicholas E.; Stokes, Philippa H.; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Murthy, Andal; Zhang, Wei; Watson, Aleksandra A.; Lejon, Sara; Pei, Xue Y.; Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Przewloka, Marcin R.; Glover, David M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Smits, Arne H.; Kloet, Susan L.; Vermeulen, Michiel] UMC Utrecht, Dept Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Wang, Hongxin; Blobel, Gerd A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Sydney; University of Cambridge; University of Cambridge; Utrecht University; Utrecht University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mackay, JP (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au; e.d.laue@bioc.cam.ac.uk	Alqarni, Saad/AAH-2502-2020; Przewloka, Marcin R./AAA-5137-2020; Shepherd, Nicholas/H-6781-2016; Kloet, Susan L./Y-5513-2018; Vermeulen, Michiel/C-8883-2013; Mackay, Joel/D-6834-2011	Przewloka, Marcin R./0000-0002-0329-9162; Shepherd, Nicholas/0000-0001-6234-4456; Kloet, Susan L./0000-0001-9189-0640; Vermeulen, Michiel/0000-0003-0836-6894; Mackay, Joel/0000-0001-7508-8033; Glover, David/0000-0003-0956-0103; Smits, Arne H/0000-0001-5011-0898; Laue, Ernest/0000-0002-7476-4148	National Institutes of Health [OD010949-10]; European Commission through 4DCell-Fate project (EC FP7) [CP 277899]; Cancer Research UK [11431] Funding Source: researchfish; Medical Research Council [G1001696] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER; MRC [G1001696] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission through 4DCell-Fate project (EC FP7); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Janusz Debski and Michal Dadlez (Institute of Biochemistry and Biophysics, Polish Academy of Sciences) for the mass spectrometry analysis of protein samples purified from D. melanogaster cells. We also thank the Drosophila Genomics Resource Center, which is supported by the National Institutes of Health Grant OD010949-10, for Drosophila cDNA clones. We are grateful to Prof. Ben F. Luisi for help with X-ray data collection. We also thank the European Commission for support through the 4DCell-Fate project (EC FP7 CP 277899).	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; D'Avino PP, 2009, METHODS MOL BIOL, V545, P99, DOI 10.1007/978-1-60327-993-2_6; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee BM, 2007, J MOL BIOL, V371, P1274, DOI 10.1016/j.jmb.2007.06.021; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Li DQ, 2012, CANCER RES, V72, P387, DOI 10.1158/0008-5472.CAN-11-2345; Li W, 2009, TISSUE CELL, V41, P390, DOI 10.1016/j.tice.2009.04.002; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Mackay JP, 2007, TRENDS BIOCHEM SCI, V32, P530, DOI 10.1016/j.tibs.2007.09.006; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Morra R, 2012, FEBS LETT, V586, P2513, DOI 10.1016/j.febslet.2012.06.017; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Musselman CA, 2012, P NATL ACAD SCI USA, V109, P787, DOI 10.1073/pnas.1113655109; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Nair SS, 2013, MOL CELL, V49, P704, DOI 10.1016/j.molcel.2012.12.016; Nowak AJ, 2011, J BIOL CHEM, V286, P23388, DOI 10.1074/jbc.M110.207407; Pavlopoulos E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006373; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Przewloka MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000478; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Ramirez J, 2012, MOL CELL BIOL, V32, P5078, DOI 10.1128/MCB.00819-12; Roche AE, 2008, J MOL CELL CARDIOL, V44, P352, DOI 10.1016/j.yjmcc.2007.10.023; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Wu M, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-1; Zhang W, 2013, NAT STRUCT MOL BIOL, V20, P29, DOI 10.1038/nsmb.2446; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	64	59	59	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21844	21855		10.1074/jbc.M114.558940	http://dx.doi.org/10.1074/jbc.M114.558940			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24920672	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000340593500004
J	Cohen, A; Kupiec, M; Weisman, R				Cohen, Adiel; Kupiec, Martin; Weisman, Ronit			Glucose Activates TORC2-Gad8 Protein via Positive Regulation of the cAMP/cAMP-dependent Protein Kinase A (PKA) Pathway and Negative Regulation of the Pmk1 Protein-Mitogen-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-INDUCIBLE KINASE; CELL INTEGRITY PATHWAY; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SEXUAL DEVELOPMENT; NITROGEN STARVATION; SIGNALING PATHWAY; GENOME STABILITY; GROWTH-FACTOR	The target of rapamycin (TOR) kinase belongs to the highly conserved eukaryotic family of phosphatidylinositol 3-kinase-related kinases. TOR proteins are found at the core of two evolutionary conserved complexes, known as TORC1 and TORC2. In fission yeast, TORC2 is dispensable for proliferation under optimal growth conditions but is required for starvation and stress responses. TORC2 has been implicated in a wide variety of functions; however, the signals that regulate TORC2 activity have so far remained obscure. TORC2 has one known direct substrate, the AGC kinase Gad8, which is related to AKT in human cells. Gad8 is phosphorylated by TORC2 at Ser-546 (equivalent to AKT Ser-473), leading to its activation. Here, we show that glucose is necessary and sufficient to induce Gad8 Ser-546 phosphorylation in vivo and Gad8 kinase activity in vitro. The glucose signal that activates TORC2-Gad8 is mediated via the cAMP/PKA pathway, a major glucose-sensing pathway. By contrast, Pmk1, similar to human extracellular signal-regulated kinases and a major stress-induced mitogen activated protein kinase (MAPK) in fission yeast, inhibits TORC2-dependent Gad8 phosphorylation and activation. Inhibition of TORC2-Gad8 also occurs in response to ionic or osmotic stress, in a manner dependent on the cAMP/PKA and Pmk1-MAPK signaling pathways. Our findings highlight the significance of glucose availability in regulation of TORC2-Gad8 and indicate a novel link between the cAMP/PKA, Pmk1/MAPK, and TORC2-Gad8 signaling.	[Cohen, Adiel; Weisman, Ronit] Open Univ Israel, Dept Nat & Life Sci, IL-4353701 Ranana, Israel; [Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Open University Israel; Tel Aviv University	Weisman, R (corresponding author), Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Ranana, Israel.	ronitwe@openu.ac.il	weisman, ronit/D-3741-2016; weisman, ronit/R-6969-2016		Association for International Research Grant [11-0281]; Open University of Israel Research Fund Grant [37076]	Association for International Research Grant; Open University of Israel Research Fund Grant	This work was supported by Association for International Research Grant 11-0281 and by Open University of Israel Research Fund Grant 37076 (to R. W.).	Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Busti S, 2010, SENSORS-BASEL, V10, P6195, DOI 10.3390/s100606195; Chen CH, 2013, J BIOL CHEM, V288, P27019, DOI 10.1074/jbc.M113.498055; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Halova L, 2013, J CELL BIOL, V203, P595, DOI 10.1083/jcb.201305103; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; Hayashi M, 2001, J BIOL CHEM, V276, P8631, DOI 10.1074/jbc.C000838200; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; JIN M, 1995, GENETICS, V140, P457; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Laor D, 2014, MOL CELL BIOL, V34, P794, DOI 10.1128/MCB.01473-13; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Loewith R, 2011, BIOCHEM SOC T, V39, P437, DOI 10.1042/BST0390437; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-34; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Matsuzawa T, 2012, EUKARYOT CELL, V11, P159, DOI 10.1128/EC.05268-11; MEGNET R, 1965, J BACTERIOL, V90, P1032, DOI 10.1128/JB.90.4.1032-1035.1965; MOCHIZUKI N, 1992, MOL GEN GENET, V233, P17, DOI 10.1007/BF00587556; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Rallis C, 2013, AGING CELL, V12, P563, DOI 10.1111/acel.12080; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sanchez-Mir L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088020; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schonbrun M, 2013, J BIOL CHEM, V288, P19649, DOI 10.1074/jbc.M113.464974; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Sengar AS, 1997, MOL CELL BIOL, V17, P3508, DOI 10.1128/MCB.17.7.3508; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Stiefel J, 2004, EUKARYOT CELL, V3, P610, DOI 10.1128/EC.3.3.610-619.2004; Sugiura R, 2002, GENES CELLS, V7, P619, DOI 10.1046/j.1365-2443.2002.00557.x; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Valbuena N, 2012, J CELL SCI, V125, P2655, DOI 10.1242/jcs.098533; Valbuena N, 2012, J CELL SCI, V125, P1920, DOI 10.1242/jcs.094219; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 1997, J BACTERIOL, V179, P6325, DOI 10.1128/jb.179.20.6325-6334.1997; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Welton RM, 2000, GENETICS, V156, P513; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie JL, 2013, NAT CELL BIOL, V15, P1263, DOI 10.1038/ncb2877; Yanagida M, 2011, PHILOS T R SOC B, V366, P3508, DOI 10.1098/rstb.2011.0124	62	31	31	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21727	21737		10.1074/jbc.M114.573824	http://dx.doi.org/10.1074/jbc.M114.573824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24928510	Green Published, hybrid			2022-12-28	WOS:000340558300046
J	Isaji, T; Im, S; Gu, W; Wang, YQ; Hang, QL; Lu, JS; Fukuda, T; Hashii, N; Takakura, D; Kawasaki, N; Miyoshi, H; Gu, JG				Isaji, Tomoya; Im, Sanghun; Gu, Wei; Wang, Yuqin; Hang, Qinglei; Lu, Jishun; Fukuda, Tomohiko; Hashii, Noritaka; Takakura, Daisuke; Kawasaki, Nana; Miyoshi, Hiroyuki; Gu, Jianguo			An Oncogenic Protein Golgi Phosphoprotein 3 Up-regulates Cell Migration via Sialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; BETA-PROPELLER DOMAIN; HUMAN COLON-CANCER; I-LIKE DOMAIN; INCREASED EXPRESSION; SAMBUCUS-NIGRA; BREAST-CANCER; GLYCOSYLATION; SIALYLTRANSFERASE; BINDING	Recently, the Golgi phosphoprotein 3 (GOLPH3) and its yeast homolog Vps74p have been characterized as essential for the Golgi localization of glycosyltransferase in yeast. GOLPH3 has been identified as a new oncogene that is commonly amplified in human cancers to modulate mammalian target of rapamycin signaling. However, the molecular mechanisms of the carcinogenic signaling pathway remain largely unclear. To investigate whether the expression of GOLPH3 was involved in the glycosylation processes in mammalian cells, and whether it affected cell behavior, we performed a loss-of-function study. Cell migration was suppressed in GOLPH3 knockdown (KD) cells, and the suppression was restored by a re-introduction of the GOLPH3 gene. HPLC and LC/MS analysis showed that the sialylation of N-glycans was specifically decreased in KD cells. The specific interaction between sialyltransferases and GOLPH3 was important for the sialylation. Furthermore, overexpression of alpha 2,6-sialyltransferase-I rescued cell migration and cellular signaling, both of which were blocked in GOLPH3 knockdown cells. These results are the first direct demonstration of the role of GOLPH3 in N-glycosylation to regulate cell biological functions.	[Isaji, Tomoya; Im, Sanghun; Gu, Wei; Wang, Yuqin; Hang, Qinglei; Lu, Jishun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi 9818558, Japan; [Hashii, Noritaka; Takakura, Daisuke; Kawasaki, Nana] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1580098, Japan; [Miyoshi, Hiroyuki] RIKEN BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan	Tohoku Medical & Pharmaceutical University; National Institute of Health Sciences - Japan; RIKEN	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Miyoshi, Hiroyuki/G-9808-2013; Hang, Qinglei/GOP-0218-2022; Gu, Jianguo/ABC-9257-2020	Hang, Qinglei/0000-0003-0419-6621; 	Japan Society for the Promotion of Science [21370059, 24570169, 23651196]; Scientific Research on Innovative Areas [23110002]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research [24570169] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 21370059 (to J. G.) and 24570169 (to T. I.), Challenging Exploratory Research 23651196 (to J. G.) from the Japan Society for the Promotion of Science, Grants from the Scientific Research on Innovative Areas 23110002 (to J. G.), the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and The Mizutani Foundation for Glycoscience.	Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; Asada M, 1997, CANCER RES, V57, P1073; Chen CL, 2002, EUR J GYNAECOL ONCOL, V23, P514; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Chiricolo M, 2006, GLYCOBIOLOGY, V16, P146, DOI 10.1093/glycob/cwj045; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2000, INT J CANCER, V88, P58, DOI 10.1002/1097-0215(20001001)88:1<58::AID-IJC9>3.0.CO;2-Q; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; DWIVEDI C, 1988, CANCER DETECT PREV, V11, P191; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Kaneko Y, 1996, ACTA NEUROPATHOL, V91, P284, DOI 10.1007/s004010050427; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kawasaki N, 2009, BIOL PHARM BULL, V32, P796, DOI 10.1248/bpb.32.796; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; LEMARER N, 1992, GLYCOBIOLOGY, V2, P49, DOI 10.1093/glycob/2.1.49; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Ma H, 2015, ONCOGENE, V34, P726, DOI 10.1038/onc.2014.7; Miyagi T, 2008, PROTEOMICS, V8, P3303, DOI 10.1002/pmic.200800248; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Nakagawa H, 1996, EUR J BIOCHEM, V237, P76, DOI 10.1111/j.1432-1033.1996.0076n.x; Pan D, 2010, BIOPHYS J, V99, P208, DOI 10.1016/j.bpj.2010.03.063; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Recchi MA, 1998, GLYCOCONJUGATE J, V15, P19, DOI 10.1023/A:1006983214918; SATA T, 1991, AM J PATHOL, V139, P1435; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2012, TRAFFIC, V13, P1496, DOI 10.1111/j.1600-0854.2012.01403.x; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Wang Peng-Hui, 2007, J Chin Med Assoc, V70, P152; Wang PH, 2005, GYNECOL ONCOL, V99, P631, DOI 10.1016/j.ygyno.2005.07.016; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9	54	61	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20694	20705		10.1074/jbc.M113.542688	http://dx.doi.org/10.1074/jbc.M113.542688			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895123	Green Published, hybrid			2022-12-28	WOS:000339396600027
J	Moreno-Dominguez, A; El-Yazbi, AF; Zhu, HL; Colinas, O; Zhong, XZ; Walsh, EJ; Cole, DM; Kargacin, GJ; Walsh, MP; Cole, WC				Moreno-Dominguez, Alejandro; El-Yazbi, Ahmed F.; Zhu, Hai-Lei; Colinas, Olaia; Zhong, X. Zoe; Walsh, Emma J.; Cole, Dylan M.; Kargacin, Gary J.; Walsh, Michael P.; Cole, William C.			Cytoskeletal Reorganization Evoked by Rho-associated kinase- and Protein Kinase C-catalyzed Phosphorylation of Cofilin and Heat Shock Protein 27, Respectively, Contributes to Myogenic Constriction of Rat Cerebral Arteries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; STIMULATED ACTIN POLYMERIZATION; LIGHT-CHAIN PHOSPHORYLATION; SIGNAL-TRANSDUCTION; CA2+ SENSITIZATION; MAP KINASE; MYOSIN PHOSPHORYLATION; DEPOLYMERIZING FACTOR; RESISTANCE ARTERIES; FORCE AUGMENTATION	Our understanding of the molecular events contributing to myogenic control of diameter in cerebral resistance arteries in response to changes in intravascular pressure, a fundamental mechanism regulating blood flow to the brain, is incomplete. Myosin light chain kinase and phosphatase activities are known to be increased and decreased, respectively, to augment phosphorylation of the 20-kDa regulatory light chain subunits (LC20) of myosin II, which permits cross-bridge cycling and force development. Here, we assessed the contribution of dynamic reorganization of the actin cytoskeleton and thin filament regulation to the myogenic response and serotonin-evoked constriction of pressurized rat middle cerebral arteries. Arterial diameter and the levels of phosphorylated LC20, calponin, caldesmon, cofilin, and HSP27, as well as G-actin content, were determined. A decline in G-actin content was observed following pressurization from 10 mm Hg to between 40 and 120 mm Hg and in three conditions in which myogenic or agonist-evoked constriction occurred in the absence of a detectable change in LC20 phosphorylation. No changes in thin filament protein phosphorylation were evident. Pressurization reduced G-actin content and elevated the levels of cofilin and HSP27 phosphorylation. Inhibitors of Rho-associated kinase and PKC prevented the decline in G-actin; reduced cofilin and HSP27 phosphoprotein content, respectively; and blocked the myogenic response. Furthermore, phosphorylation modulators of HSP27 and cofilin induced significant changes in arterial diameter and G-actin content of myogenically active arteries. Taken together, our findings suggest that dynamic reorganization of the cytoskeleton involving increased actin polymerization in response to Rho-associated kinase and PKC signaling contributes significantly to force generation in myogenic constriction of cerebral resistance arteries.	[Moreno-Dominguez, Alejandro; El-Yazbi, Ahmed F.; Zhu, Hai-Lei; Colinas, Olaia; Zhong, X. Zoe; Walsh, Emma J.; Cole, Dylan M.; Kargacin, Gary J.; Cole, William C.] Univ Calgary, Dept Physiol & Pharmacol, Smooth Muscle Res Grp, Libin Cardiovasc Inst, Calgary, AB T2N 4N1, Canada; [Walsh, Michael P.] Univ Calgary, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, Libin Cardiovasc Inst, Calgary, AB T2N 4N1, Canada; Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary	Cole, WC (corresponding author), Univ Calgary, Fac Med, Smooth Muscle Res Grp, Dept Physiol & Pharmacol,Libin Cardiovasc Inst, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	wcole@ucalgary.ca	Zhu, Hai-Lei/AFY-5595-2022; El-Yazbi, Ahmed/AAT-6837-2021; Moreno, Alejandro/AAB-5021-2019	El-Yazbi, Ahmed/0000-0003-3432-3038; Moreno, Alejandro/0000-0003-2341-2297; Colinas, Olalla/0000-0002-1190-0157	Canadian Institutes of Health Research [MOP-97988, MOP-13505]; Kertland Family Fellowship Fund & Andrew Family Professorship; Alberta Heritage Foundation for Medical Research/Canadian Institutes of Health Research; Spanish Ministry of Education; Alberta Innovates-Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kertland Family Fellowship Fund & Andrew Family Professorship; Alberta Heritage Foundation for Medical Research/Canadian Institutes of Health Research; Spanish Ministry of Education(Spanish Government); Alberta Innovates-Health Solutions	This work was supported by Canadian Institutes of Health Research Grants MOP-97988 and MOP-13505; fellowship awards from the Kertland Family Fellowship Fund & Andrew Family Professorship (to A. M.-D.), Alberta Heritage Foundation for Medical Research/Canadian Institutes of Health Research (to A. F. E.), the Spanish Ministry of Education (to O. C.), and Alberta Innovates-Health Solutions (to H.-L. Z.); and a Studentship award from Alberta Innovates-Health Solutions (to X. Z. Z.).	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Bakker ENTP, 1999, CARDIOVASC RES, V41, P229, DOI 10.1016/S0008-6363(98)00161-8; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001; CAIRNS J, 1994, J BIOL CHEM, V269, P9176; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen XS, 2008, AM J PHYSIOL-HEART C, V295, pH2172, DOI 10.1152/ajpheart.91437.2007; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Cipolla MJ, 1998, STROKE, V29, P1223, DOI 10.1161/01.STR.29.6.1223; Cole WC, 2011, ARCH BIOCHEM BIOPHYS, V510, P160, DOI 10.1016/j.abb.2011.02.024; Coulson RJ, 2002, AM J PHYSIOL-HEART C, V283, pH2268, DOI 10.1152/ajpheart.00542.2002; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dessy C, 2000, AM J PHYSIOL-HEART C, V279, pH916, DOI 10.1152/ajpheart.2000.279.3.H916; Dessy C, 1998, AM J PHYSIOL-CELL PH, V275, pC1081, DOI 10.1152/ajpcell.1998.275.4.C1081; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Dowell ML, 2005, J APPL PHYSIOL, V98, P489, DOI 10.1152/japplphysiol.01378.2003; Dubroca C, 2005, HYPERTENSION, V45, P974, DOI 10.1161/01.HYP.0000164582.63421.2d; Eddinger TJ, 2007, J PHARMACOL EXP THER, V320, P865, DOI 10.1124/jpet.106.109363; El-Yazbi AF, 2010, J PHYSIOL-LONDON, V588, P1747, DOI 10.1113/jphysiol.2010.187146; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Flavahan NA, 2005, AM J PHYSIOL-HEART C, V288, pH660, DOI 10.1152/ajpheart.00608.2004; Gallant C, 2011, AM J PHYSIOL-CELL PH, V300, pC1356, DOI 10.1152/ajpcell.00450.2010; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; Gokina NI, 2002, AM J PHYSIOL-HEART C, V282, pH1410, DOI 10.1152/ajpheart.00441.2001; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; HILL MA, 1990, AM J PHYSIOL, V259, pH1586, DOI 10.1152/ajpheart.1990.259.5.H1586; Hirano K, 2007, J PHARMACOL SCI, V104, P109, DOI 10.1254/jphs.CP0070027; Horowitz A, 1996, AM J PHYSIOL-HEART C, V270, pH1858, DOI 10.1152/ajpheart.1996.270.5.H1858; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P1516, DOI 10.1002/cncr.25599; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Jaggar JH, 2001, AM J PHYSIOL-CELL PH, V281, pC439, DOI 10.1152/ajpcell.2001.281.2.C439; JAWOROWSKI A, 1995, FEBS LETT, V365, P167, DOI 10.1016/0014-5793(95)00451-E; Jin JP, 2000, BIOCHEM J, V350, P579, DOI 10.1042/0264-6021:3500579; Johnson RP, 2009, J PHYSIOL-LONDON, V587, P2537, DOI 10.1113/jphysiol.2008.168252; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kaneko T, 2000, BIOCHEM BIOPH RES CO, V273, P110, DOI 10.1006/bbrc.2000.2901; Karibe A, 1997, AM J PHYSIOL-HEART C, V272, pH1165, DOI 10.1152/ajpheart.1997.272.3.H1165; Kato K, 2001, CELL STRESS CHAPERON, V6, P16, DOI 10.1379/1466-1268(2001)006<0016:PKICSS>2.0.CO;2; KAYE D, 1993, CIRCULATION, V88, P1101, DOI 10.1161/01.CIR.88.3.1101; Khromov AS, 2004, BIOPHYS J, V86, P2318, DOI 10.1016/S0006-3495(04)74289-7; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Kim HR, 2010, AM J PHYSIOL-CELL PH, V298, pC559, DOI 10.1152/ajpcell.00431.2009; Kim YS, 2008, CLIN SCI, V115, P255, DOI 10.1042/CS20070458; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Koltsova SV, 2008, CELL PHYSIOL BIOCHEM, V21, P29, DOI 10.1159/000113744; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Larsen JK, 1997, AM J PHYSIOL-LUNG C, V273, pL930, DOI 10.1152/ajplung.1997.273.5.L930; Maizels ET, 1998, BIOCHEM J, V332, P703, DOI 10.1042/bj3320703; Malmqvist U, 1997, P NATL ACAD SCI USA, V94, P7655, DOI 10.1073/pnas.94.14.7655; MARSTON SB, 1992, J BIOL CHEM, V267, P16796; Massett MP, 2002, AM J PHYSIOL-HEART C, V283, pH2282, DOI 10.1152/ajpheart.00544.2002; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; McVicker CG, 2007, AM J RESP CELL MOL, V36, P721, DOI 10.1165/rcmb.2006-0409OC; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; Moreno-Dominguez A, 2013, J PHYSIOL-LONDON, V591, P1235, DOI 10.1113/jphysiol.2012.243576; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Mufti RE, 2010, J PHYSIOL-LONDON, V588, P3983, DOI 10.1113/jphysiol.2010.193300; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murphy RA, 2005, CAN J PHYSIOL PHARM, V83, P857, DOI 10.1139/Y05-090; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Ohanian V, 2005, HYPERTENSION, V46, P93, DOI 10.1161/01.HYP.0000167990.82235.3c; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; OSOL G, 1991, CIRC RES, V68, P359, DOI 10.1161/01.RES.68.2.359; OSOL G, 1993, AM J PHYSIOL, V265, pH415, DOI 10.1152/ajpheart.1993.265.1.H415; PAVALKO FM, 1995, AM J PHYSIOL-CELL PH, V268, pC563, DOI 10.1152/ajpcell.1995.268.3.C563; Pohl J, 1997, AM J PHYSIOL-LUNG C, V272, pL115, DOI 10.1152/ajplung.1997.272.1.L115; RATZ PH, 1989, AM J PHYSIOL, V256, pC96, DOI 10.1152/ajpcell.1989.256.1.C96; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Saito Shin-Ya, 1996, Journal of Smooth Muscle Research, V32, P51; Shaw L, 2003, J VASC RES, V40, P1, DOI 10.1159/000068940; Shin KD, 2005, J BIOL CHEM, V280, P41439, DOI 10.1074/jbc.M507209200; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Srinivasan R, 2008, AM J PHYSIOL-HEART C, V294, pH961, DOI 10.1152/ajpheart.00939.2007; Staiculescu MC, 2013, CARDIOVASC RES, V98, P428, DOI 10.1093/cvr/cvt034; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Straub SV, 2007, TRENDS CARDIOVAS MED, V17, P183, DOI 10.1016/j.tcm.2007.05.001; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Tejani AD, 2011, AM J PHYSIOL-CELL PH, V301, pC1470, DOI 10.1152/ajpcell.00149.2011; Tejani AD, 2010, AM J PHYSIOL-CELL PH, V298, pC182, DOI 10.1152/ajpcell.00326.2009; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Walsh MP, 2013, J CEREBR BLOOD F MET, V33, P1, DOI 10.1038/jcbfm.2012.144; Walsh MP, 2011, AM J PHYSIOL-RENAL, V300, pF73, DOI 10.1152/ajprenal.00011.2010; Walsh MP, 1996, BIOCHEM CELL BIOL, V74, P485, DOI 10.1139/o96-053; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; Wier WG, 2008, J PHYSIOL-LONDON, V586, P2437, DOI 10.1113/jphysiol.2008.151522; Wieske M, 2001, EUR J BIOCHEM, V268, P2083, DOI 10.1046/j.1432-1327.2001.02082.x; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; Xiao DL, 2004, AM J PHYSIOL-HEART C, V286, pH1615, DOI 10.1152/ajpheart.00981.2003; Yamin R, 2012, J PHYSIOL-LONDON, V590, P4145, DOI 10.1113/jphysiol.2012.232306; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200; ZOU H, 1995, AM J PHYSIOL-HEART C, V269, pH1590, DOI 10.1152/ajpheart.1995.269.5.H1590	102	34	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20939	20952		10.1074/jbc.M114.553743	http://dx.doi.org/10.1074/jbc.M114.553743			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24914207	Green Published, hybrid			2022-12-28	WOS:000339396600047
J	Rayner, LE; Hui, GK; Gor, J; Heenan, RK; Dalby, PA; Perkins, SJ				Rayner, Lucy E.; Hui, Gar Kay; Gor, Jayesh; Heenan, Richard K.; Dalby, Paul A.; Perkins, Stephen J.			The Fab Conformations in the Solution Structure of Human Immunoglobulin G4 (IgG4) Restrict Access to Its Fc Region IMPLICATIONS FOR FUNCTIONAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY; HYDRODYNAMIC PROPERTIES; SOLUTION SCATTERING; NEUTRON-SCATTERING; CRYSTAL-STRUCTURE; GAMMA RECEPTOR; ARM EXCHANGE; COMPLEMENT C1Q; HUMAN-ANTIBODY; FRAGMENT	Human IgG4 antibody shows therapeutically useful properties compared with the IgG1, IgG2, and IgG3 subclasses. Thus IgG4 does not activate complement and shows conformational variability. These properties are attributable to its hinge region, which is the shortest of the four IgG subclasses. Using high throughput scattering methods, we studied the solution structure of wild-type IgG4(Ser(222)) and a hinge mutant IgG4(Pro(222)) in different buffers and temperatures where the proline substitution suppresses the formation of half-antibody. Analytical ultracentrifugation showed that both IgG4 forms were principally monomeric with sedimentation coefficients s(20,w)(0) of 6.6-6.8 S. A monomer-dimer equilibrium was observed in heavy water buffer at low temperature. Scattering showed that the x-ray radius of gyration R-g was unchanged with concentration in 50-250 mM NaCl buffers, whereas the neutron R-g values showed a concentration-dependent increase as the temperature decreased in heavy water buffers. The distance distribution curves (P(r)) revealed two peaks, M1 and M2, that shifted below 2 mg/ml to indicate concentration-dependent IgG4 structures in addition to IgG4 dimer formation at high concentration in heavy water. Constrained x-ray and neutron scattering modeling revealed asymmetric solution structures for IgG4(Ser(222)) with extended hinge structures. The IgG4(Pro(222)) structure was similar. Both IgG4 structures showed that their Fab regions were positioned close enough to the Fc region to restrict C1q binding. Our new molecular models for IgG4 explain its inability to activate complement and clarify aspects of its stability and function for therapeutic applications.	[Rayner, Lucy E.; Hui, Gar Kay; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Dalby, Paul A.] UCL, Dept Biochem Engn, Div Engn, London WC1E 6BT, England; [Heenan, Richard K.] ISIS Facil, Sci & Technol Facil Council, Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England	University of London; University College London; University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Div Biosci, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk	Dalby, Paul A/C-1639-2008	Dalby, Paul A/0000-0002-0980-8167	Biotechnology and Biological Sciences Research Council; Collaborative Computational Project for advanced analyses of structural data in chemical biology and soft condensed matter (CCP-SAS), a joint Engineering and Physical Sciences Research Council [EP/K039121/1]; National Science Foundation [CHE-1265821]; BBSRC [BB/E013104/1, BB/I017119/1] Funding Source: UKRI; EPSRC [EP/K039121/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I017119/1, BB/E013104/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K039121/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Collaborative Computational Project for advanced analyses of structural data in chemical biology and soft condensed matter (CCP-SAS), a joint Engineering and Physical Sciences Research Council; National Science Foundation(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and in part by the Collaborative Computational Project for advanced analyses of structural data in chemical biology and soft condensed matter (CCP-SAS), a joint Engineering and Physical Sciences Research Council (Grant EP/K039121/1) and National Science Foundation (Grant CHE-1265821) project.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Aalberse RC, 1999, INT ARCH ALLERGY IMM, V118, P187, DOI 10.1159/000024062; Abe Y, 2010, BIOCHEM J, V432, P101, DOI 10.1042/BJ20100641; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Bloom JW, 1997, PROTEIN SCI, V6, P407; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; BRADY RL, 1991, J MOL BIOL, V219, P603, DOI 10.1016/0022-2836(91)90656-Q; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BYRON O, 1990, BIOCHEM SOC T, V18, P1030, DOI 10.1042/bst0181030; Clark MR, 1997, CHEM IMMUNOL, V65, P88; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; Davies AM, 2013, MOL IMMUNOL, V54, P1, DOI 10.1016/j.molimm.2012.10.029; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Glatter O., 1982, SMALL ANGLE XRAY SCA; GREGORY L, 1987, MOL IMMUNOL, V24, P821, DOI 10.1016/0161-5890(87)90184-2; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Hamilton R.G., 2001, HUMAN IGG SUBCLASSES; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Heenan R. K., 2011, NEUTRON NEWS, V22, P19, DOI DOI 10.1080/10448632.2011.569531; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Kato K, 2000, IMMUNOL TODAY, V21, P310, DOI 10.1016/S0167-5699(00)01666-2; Kato K, 2000, J MOL BIOL, V295, P213, DOI 10.1006/jmbi.1999.3351; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Longman E, 2003, EUR BIOPHYS J BIOPHY, V32, P503, DOI 10.1007/s00249-003-0314-y; Lu JH, 2011, J BIOL CHEM, V286, P40608, DOI 10.1074/jbc.M111.257550; Lu YL, 2008, J PHARM SCI-US, V97, P960, DOI 10.1002/jps.21016; Lu YL, 2007, BIOPHYS J, V93, P3733, DOI 10.1529/biophysj.107.108993; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Owens R, 1997, IMMUNOTECHNOLOGY, V3, P107, DOI 10.1016/S1380-2933(97)00066-3; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; Perkins S, 2008, BIOCHEM SOC T, V36, P37, DOI 10.1042/BST0360037; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; PILZ I, 1973, BIOCHEMISTRY-US, V12, P4998, DOI 10.1021/bi00748a028; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2002, MOL IMMUNOL, V38, P1073, DOI 10.1016/S0161-5890(02)00036-6; Rayner LE, 2013, J MOL BIOL, V425, P506, DOI 10.1016/j.jmb.2012.11.019; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; Rispens T, 2011, J AM CHEM SOC, V133, P10302, DOI 10.1021/ja203638y; Rispens T, 2010, MOL IMMUNOL, V47, P1592, DOI 10.1016/j.molimm.2010.02.021; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; Rose RJ, 2011, STRUCTURE, V19, P1274, DOI 10.1016/j.str.2011.06.016; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schneider S, 2012, MOL IMMUNOL, V51, P66, DOI 10.1016/j.molimm.2012.02.111; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; TAO MH, 1991, J EXP MED, V173, P1025, DOI 10.1084/jem.173.4.1025; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; Thommesen JE, 2000, MOL IMMUNOL, V37, P995, DOI 10.1016/S0161-5890(01)00010-4; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1	73	30	30	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20740	20756		10.1074/jbc.M114.572404	http://dx.doi.org/10.1074/jbc.M114.572404			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24876381	Green Published, hybrid			2022-12-28	WOS:000339396600031
J	Wu, KY; Ren, RT; Su, WT; Wen, B; Zhang, YY; Yi, F; Qiao, XH; Yuan, TT; Wang, JH; Liu, LM; Belmonte, JCI; Liu, GH; Chen, C				Wu, Kaiyuan; Ren, Ruotong; Su, Wenting; Wen, Bo; Zhang, Yuying; Yi, Fei; Qiao, Xinhua; Yuan, Tingting; Wang, Jinhui; Liu, Limin; Belmonte, Juan Carlos Izpisua; Liu, Guang-Hui; Chen, Chang			A Novel Suppressive Effect of Alcohol Dehydrogenase 5 in Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-NITROSOGLUTATHIONE REDUCTASE; CLASS-III; CELLS; NITROSYLATION; EXPRESSION; ADH; NITROSOTHIOLS; NEUROGENESIS; ROLES; BRAIN	Alcohol dehydrogenase 5 (ADH5) is a conserved enzyme for alcohol and aldehyde metabolism in mammals. Despite dynamic expression throughout neurogenesis, its role in neuronal development remains unknown. Here we present the first evidence that ADH5 is a negative regulator of neuronal differentiation. Gene expression analyses identify a constant reduction of ADH5 levels throughout neuronal development. Overexpression of ADH5 reduces both development and adult neuronal differentiation of mouse neurons. This effect depends on the catalytic activity of ADH5 and involves ADH5-mediated denitrosation of histone deacetylase 2 (HDAC2). Our results indicate that ADH5 counteracts neuronal differentiation of human neural stem cells and that this effect can be reversed by pharmacological inhibition of ADH5. Based on these observations, we propose that ADH5 is a novel suppressor of neuronal differentiation and maturation. Inhibition of ADH5 may improve adult neurogenesis in a physiological or pathological setting.	[Wu, Kaiyuan; Ren, Ruotong; Su, Wenting; Wen, Bo; Zhang, Yuying; Qiao, Xinhua; Yuan, Tingting; Wang, Jinhui; Liu, Guang-Hui; Chen, Chang] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Yi, Fei; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Liu, Limin] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Liu, Guang-Hui; Chen, Chang] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Salk Institute; University of California System; University of California San Francisco	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu; ghliu@ibp.ac.cn; changchen@moon.ibp.ac.cn	wu, kaiyuan/AAD-6635-2020; Ren, Ruotong/AAF-4046-2020	wu, kaiyuan/0000-0001-7395-4524; chen, chang/0000-0003-1008-1062	National Basic Research Program of China (973 Program) [2012CB911000, 2011CB503900, 2011CB910900, 2014CB964600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020312]; National Natural Sciences Foundation of China [31225012, 31030023, 81271266, 31222039, 81330008, 81300677, 31201111]; Beijing Natural Science Foundation [7141005]; Thousand Young Talents program of China; National Laboratory of Biomacromolecules [2013kf05, 2013kf1, 2014kf02]; State Key Laboratory of Drug Research [SIMM1302KF-17]; G. Harold and Leila Y. Mathers Charitable Foundation; The Leona M. and Harry B. Helmsley Charitable Trust	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Thousand Young Talents program of China(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; State Key Laboratory of Drug Research; G. Harold and Leila Y. Mathers Charitable Foundation; The Leona M. and Harry B. Helmsley Charitable Trust	This work was supported by the National Basic Research Program of China (973 Program: Grants 2012CB911000, 2011CB503900, 2011CB910900, and 2014CB964600), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant XDA01020312), the National Natural Sciences Foundation of China (Grants 31225012, 31030023, 81271266, 31222039, 81330008, 81300677, and 31201111), the Beijing Natural Science Foundation (Grant 7141005), the Thousand Young Talents program of China, National Laboratory of Biomacromolecules (Grants 2013kf05, 2013kf1, and 2014kf02), and the State Key Laboratory of Drug Research (Grant SIMM1302KF-17).; Supported by the G. Harold and Leila Y. Mathers Charitable Foundation and The Leona M. and Harry B. Helmsley Charitable Trust. To whom correspondence may be addressed: Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., La Jolla, CA 92037. E-mail: belmonte@salk.edu.	Beigi F, 2012, P NATL ACAD SCI USA, V109, P4314, DOI 10.1073/pnas.1113319109; BEISSWENGER TB, 1985, P NATL ACAD SCI USA, V82, P8369, DOI 10.1073/pnas.82.24.8369; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; ENGELAND K, 1993, P NATL ACAD SCI USA, V90, P2491, DOI 10.1073/pnas.90.6.2491; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grove EA, 1999, CEREB CORTEX, V9, P551, DOI 10.1093/cercor/9.6.551; He J, 2007, J NEUROCHEM, V102, P1863, DOI 10.1111/j.1471-4159.2007.04651.x; Hoog JO, 2001, J BIOMED SCI, V8, P71, DOI 10.1159/000054015; Huang B, 2010, FREE RADICAL BIO MED, V49, P447, DOI 10.1016/j.freeradbiomed.2010.05.001; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Nott A, 2013, P NATL ACAD SCI USA, V110, P3113, DOI 10.1073/pnas.1218126110; Parsch J, 2000, GENETICS, V156, P219; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Sarthy V, 2007, NEUROSCIENCE, V144, P1087, DOI 10.1016/j.neuroscience.2006.09.061; SHOLL DA, 1953, J ANAT, V87, P387; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Westerlund M, 2005, CELL TISSUE RES, V322, P227, DOI 10.1007/s00441-005-0038-7; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Yang ZY, 2010, J IMMUNOL, V185, P6664, DOI 10.4049/jimmunol.1000080	30	16	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20193	20199		10.1074/jbc.C114.561860	http://dx.doi.org/10.1074/jbc.C114.561860			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895131	hybrid, Green Published			2022-12-28	WOS:000339395200032
J	Altamirano, F; Eltit, JM; Robin, G; Linares, N; Ding, XD; Pessah, IN; Allen, PD; Lopez, JR				Altamirano, Francisco; Eltit, Jose M.; Robin, Gaelle; Linares, Nancy; Ding, Xudong; Pessah, Isaac N.; Allen, Paul D.; Lopez, Jose R.			Ca2+ Influx via the Na+/Ca2+ Exchanger Is Enhanced in Malignant Hyperthermia Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; TRANSVERSE TUBULES; EXTERNAL SODIUM; FROG; FIBERS; RYR1; ATPASE; CONTRACTION; DEPRIVATION; INHIBITOR	Malignant hyperthermia (MH) is potentially fatal pharmacogenetic disorder of skeletal muscle caused by intracellular Ca2+ dysregulation. NCX is a bidirectional transporter that effluxes (forward mode) or influxes (reverse mode) Ca2+ depending on cellular activity. Resting intracellular calcium ([Ca2+](r)) and sodium ([Na+](r)) concentrations are elevated in MH susceptible (MHS) swine and murine muscles compared with their normal (MHN) counterparts, although the contribution of NCX is unclear. Lowering [Na+](e) elevates [Ca2+](r) in both MHN and MHS swine muscle fibers and it is prevented by removal of extracellular Ca2+ or reduced by t-tubule disruption, in both genotypes. KB-R7943, a nonselective NCX3 blocker, reduced [Ca2+](r) in both swine and murine MHN and MHS muscle fibers at rest and decreased the magnitude of the elevation of [Ca2+](r) observed in MHS fibers after exposure to halothane. YM-244769, a high affinity reverse mode NCX3 blocker, reduces [Ca2+](r) in MHS muscle fibers and decreases the amplitude of [Ca2+](r) rise triggered by halothane, but had no effect on [Ca2+](r) in MHN muscle. In addition, YM-244769 reduced the peak and area under the curve of the Ca2+ transient elicited by high [K+](e) and increased its rate of decay in MHS muscle fibers. siRNA knockdown of NCX3 in MHS myotubes reduced [Ca2+](r) and the Ca2+ transient area induced by high [K+](e). These results demonstrate a functional NCX3 in skeletal muscle whose activity is enhanced in MHS. Moreover reverse mode NCX3 contributes to the Ca2+ transients associated with K+-induced depolarization and the halothane-triggered MH episode in MHS muscle fibers.	[Altamirano, Francisco; Robin, Gaelle; Pessah, Isaac N.; Allen, Paul D.; Lopez, Jose R.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Linares, Nancy; Lopez, Jose R.] Inst Venezolano Invest Cient, Ctr Biofis & Bioquim, Caracas 1020A, Venezuela; [Eltit, Jose M.; Ding, Xudong; Allen, Paul D.; Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Eltit, Jose M.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA	University of California System; University of California Davis; Venezuelan Institute Science Research; Harvard University; Brigham & Women's Hospital; Virginia Commonwealth University	Lopez, JR (corresponding author), Univ Calif Davis, Dept Mol Biosci, 1089 Vet Med Dr, Davis, CA 95616 USA.	jrlopez@ucdavis.edu	Pessah, Isaac N/K-7985-2017; Altamirano, Francisco/I-1928-2013	Pessah, Isaac N/0000-0002-8149-588X; Altamirano, Francisco/0000-0002-1612-2729	National Institutes of Health [AR43140, AR052534, 4P42 ES04699]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052354, R01AR043140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR43140 (to P. D. A., J. R. L., and I. N. P.), AR052534 (to P. D. A. and J. R. L.), and 4P42 ES04699 (to I. N. P.).	Akabas MH, 2004, MOL PHARMACOL, V66, P8, DOI 10.1124/mol.104.000232.; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Barrientos G, 2009, MOL PHARMACOL, V76, P560, DOI 10.1124/mol.109.057265; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BLINKS JR, 1965, J PHYSIOL-LONDON, V177, P42, DOI 10.1113/jphysiol.1965.sp007574; BOLANOS P, 1986, J PHYSIOL-LONDON, V370, P39, DOI 10.1113/jphysiol.1986.sp015921; CAPUTO C, 1978, J MEMBRANE BIOL, V41, P1, DOI 10.1007/BF01873337; CAPUTO C, 1967, J GEN PHYSIOL, V50, P2177, DOI 10.1085/jgp.50.9.2177; CASTILLO E, 1991, ANN NY ACAD SCI, V639, P554, DOI 10.1111/j.1749-6632.1991.tb17349.x; Cifuentes F, 2000, AM J PHYSIOL-CELL PH, V279, pC89, DOI 10.1152/ajpcell.2000.279.1.C89; COTA G, 1981, J PHYSIOL-LONDON, V317, P303, DOI 10.1113/jphysiol.1981.sp013826; DAVEY DF, 1980, J MEMBRANE BIOL, V53, P223, DOI 10.1007/BF01868828; Despa S, 2003, BIOPHYS J, V85, P3388, DOI 10.1016/S0006-3495(03)74758-4; Deval E, 2002, NEUROMUSCULAR DISORD, V12, P665, DOI 10.1016/S0960-8966(02)00022-6; DONOSO P, 1989, BIOCHIM BIOPHYS ACTA, V978, P8, DOI 10.1016/0005-2736(89)90491-4; EDMAN KAP, 1982, J PHYSIOL-LONDON, V329, P1; EISENBERG B, 1968, SCIENCE, V160, P1243, DOI 10.1126/science.160.3833.1243; Eltit JM, 2013, FASEB J, V27, P991, DOI 10.1096/fj.12-218354; Eltit JM, 2012, P NATL ACAD SCI USA, V109, P7923, DOI 10.1073/pnas.1119207109; Esteve E, 2010, J GEN PHYSIOL, V135, P619, DOI 10.1085/jgp.200910328; EVERTS ME, 1992, MUSCLE NERVE, V15, P162, DOI 10.1002/mus.880150206; FORD LE, 1972, J PHYSIOL-LONDON, V223, P21, DOI 10.1113/jphysiol.1972.sp009831; Fraysse B, 2001, AM J PHYSIOL-CELL PH, V280, pC146, DOI 10.1152/ajpcell.2001.280.1.C146; GARCIA MC, 1992, J MUSCLE RES CELL M, V13, P354, DOI 10.1007/BF01766463; GILBERT JR, 1982, J MEMBRANE BIOL, V69, P77, DOI 10.1007/BF01871244; GODT RE, 1974, J GEN PHYSIOL, V63, P722, DOI 10.1085/jgp.63.6.722; GonzalezSerratos H, 1996, ANN NY ACAD SCI, V779, P556, DOI 10.1111/j.1749-6632.1996.tb44837.x; HIDALGO C, 1991, ANN NY ACAD SCI, V639, P483; HODGKIN AL, 1957, J PHYSIOL-LONDON, V137, pP30; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; IAIZZO PA, 1988, PFLUG ARCH EUR J PHY, V411, P648, DOI 10.1007/BF00580861; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Iwamoto T, 2006, MOL PHARMACOL, V70, P2075, DOI 10.1124/mol.106.028464; JUEL C, 1995, BBA-MOL CELL RES, V1265, P127, DOI 10.1016/0167-4889(94)00209-W; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; KAWATA H, 1990, JPN J PHYSIOL, V40, P243, DOI 10.2170/jjphysiol.40.243; Kraft R, 2007, BIOCHEM BIOPH RES CO, V361, P230, DOI 10.1016/j.bbrc.2007.07.019; LI ZP, 1994, J BIOL CHEM, V269, P17434; LOPEZ JR, 1988, MUSCLE NERVE, V11, P82; LOPEZ JR, 1985, MUSCLE NERVE, V8, P355, DOI 10.1002/mus.880080502; LOPEZ JR, 1983, BIOPHYS J, V43, P1, DOI 10.1016/S0006-3495(83)84316-1; LUTTGAU HC, 1979, J PHYSIOL-LONDON, V296, P411; Mackiewicz U, 2009, CARDIOVASC RES, V81, P546, DOI 10.1093/cvr/cvn285; Manno C, 2013, J PHYSIOL-LONDON, V591, P4439, DOI 10.1113/jphysiol.2013.259572; Meme W, 1999, PFLUG ARCH EUR J PHY, V438, P851, DOI 10.1007/s004240051115; MIURA Y, 1989, J GEN PHYSIOL, V93, P1129, DOI 10.1085/jgp.93.6.1129; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; MUNIZ J, 1991, ANN NY ACAD SCI, V639, P573, DOI 10.1111/j.1749-6632.1991.tb17354.x; NAKAMURA H, 1992, J BIOCHEM, V112, P750, DOI 10.1093/oxfordjournals.jbchem.a123970; Nelson Thomas E., 2002, Current Molecular Medicine (Hilversum), V2, P347, DOI 10.2174/1566524023362429; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Sacchetto R, 1996, EUR J BIOCHEM, V237, P483, DOI 10.1111/j.1432-1033.1996.0483k.x; VOGELI P, 1994, ANIM GENET, V25, P59, DOI 10.1111/j.1365-2052.1994.tb00404.x; Wanaverbecq N, 2003, J PHYSIOL-LONDON, V550, P83, DOI 10.1113/jphysiol.2002.035782; Watano T, 1996, BRIT J PHARMACOL, V119, P555, DOI 10.1111/j.1476-5381.1996.tb15708.x; WICTOME M, 1992, FEBS LETT, V304, P109, DOI 10.1016/0014-5793(92)80599-C; WUYTACK F, 1992, ANN NY ACAD SCI, V671, P82, DOI 10.1111/j.1749-6632.1992.tb43786.x; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yang T, 2007, J BIOL CHEM, V282, P37471, DOI 10.1074/jbc.M701379200; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; YU ASL, 1992, AM J PHYSIOL, V263, pF680, DOI 10.1152/ajprenal.1992.263.4.F680	64	22	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19180	19190		10.1074/jbc.M114.550764	http://dx.doi.org/10.1074/jbc.M114.550764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847052	Green Published, hybrid			2022-12-28	WOS:000339062900046
J	Fiebig, T; Freiberger, F; Pinto, V; Romano, MR; Black, A; Litschko, C; Bethe, A; Yashunsky, D; Adamo, R; Nikolaev, A; Berti, F; Gerardy-Schahn, R				Fiebig, Timm; Freiberger, Friedrich; Pinto, Vittoria; Romano, Maria Rosaria; Black, Alan; Litschko, Christa; Bethe, Andrea; Yashunsky, Dmitry; Adamo, Roberto; Nikolaev, Andrei; Berti, Francesco; Gerardy-Schahn, Rita			Molecular Cloning and Functional Characterization of Components of the Capsule Biosynthesis Complex of Neisseria meningitidis Serogroup A TOWARD IN VITRO VACCINE PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C MENINGOCOCCAL POLYSACCHARIDES; CONJUGATE VACCINE; BIOCHEMICAL-CHARACTERIZATION; GLYCOCONJUGATE VACCINES; ESCHERICHIA-COLI; GENE RECOGNITION; HUMAN IMMUNITY; O-ACETYLATION; ACETYLTRANSFERASE; AFRICA	The human pathogen Neisseria meningitidis (Nm) is a leading cause of bacterial meningitis and sepsis globally. A major virulence factor of Nm is the capsular polysaccharide (CPS), which in Nm serogroup A consists of N-acetyl-mannosamine-1-phosphate units linked together by phosphodiester linkages [-> 6)-alpha-D-ManNAc-(1 -> OPO3-->](n). Acetylation in O-3 (to a minor extent in O-4) position results in immunologically active polymer. In the capsule gene cluster (cps) of Nm, region A contains the genetic information for CPSA biosynthesis. Thereby the open reading frames csaA, -B, and -C are thought to encode the UDP-N-acetyl-D-glucosamine-2-epimerase, poly-ManNAc-1-phosphate- transferase, and O-acetyltransferase, respectively. With the aim to use a minimal number of recombinant enzymes to produce immunologically active CPSA, we cloned the genes csaA, csaB, and csaC and functionally characterized the purified recombinant proteins. If recombinant CsaA and CsaB were combined in one reaction tube, priming CPSA-oligosaccharides were efficiently elongated with UDP-GlcNAc as the donor substrate, confirming that CsaA is the functional UDP-N-acetyl-D-glucosamine-2-epimerase and CsaB the functional poly-ManNAc-1-phosphate-transferase. Subsequently, CsaB was shown to transfer ManNAc-1P onto O-6 of the non-reducing end sugar of priming oligosaccharides, to prefer non-O-acetylated over O-acetylated primers, and to efficiently elongate the dimer of ManNAc-1-phosphate. The in vitro synthesized CPSA was purified, O-acetylated with recombinant CsaC, and proven to be identical to the natural CPSA by H-1 NMR, P-31 NMR, and immunoblotting. If all three enzymes and their substrates were combined in a one-pot reaction, nature identical CPSA was obtained. These data provide the basis for the development of novel vaccine production protocols.	[Fiebig, Timm; Freiberger, Friedrich; Litschko, Christa; Bethe, Andrea; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Pinto, Vittoria; Romano, Maria Rosaria; Adamo, Roberto; Berti, Francesco] Novartis Vaccines, Res, I-53100 Siena, Italy; [Black, Alan; Nikolaev, Andrei] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [Yashunsky, Dmitry] Russian Acad Med Sci, Inst Biomed Chem, Moscow 119832, Russia	Hannover Medical School; Novartis; University of Dundee; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry	Berti, F (corresponding author), Novartis Vaccines, Res, Via Fiorentina 1, I-53100 Siena, Italy.	francesco.berti@novartis.com; gerardy-schahn.rita@mh-hannover.de	Adamo, Roberto/Q-9284-2017	Adamo, Roberto/0000-0001-5228-6088; Fiebig, Timm/0000-0002-2021-7296; Litschko, Christa/0000-0001-9114-4832	Deutsche Forschungsgemeinschaft (DFG) [Ge801/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in the framework of DFG Research Unit 548 (Ge801/10-1).	Bardotti A, 2008, VACCINE, V26, P2284, DOI 10.1016/j.vaccine.2008.01.022; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; Berry DS, 2002, INFECT IMMUN, V70, P3707, DOI 10.1128/IAI.70.7.3707-3713.2002; Berti F, 2012, VACCINE, V30, P6409, DOI 10.1016/j.vaccine.2012.08.021; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Black A., 2010, 4 BALT M MICR CARB S, P56; Black A., 2011, 16 EUR CARB S JUL 3, P61; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; BUNDLE DR, 1974, J BIOL CHEM, V249, P2275; Caini S, 2013, VACCINE, V31, P1597, DOI 10.1016/j.vaccine.2013.01.015; Chang R, 2004, CARBOHYD RES, V339, P1531, DOI 10.1016/j.carres.2004.03.014; Costantino P, 2011, EXPERT OPIN DRUG DIS, V6, P1045, DOI 10.1517/17460441.2011.609554; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Frasch CE, 2012, HUM VACC IMMUNOTHER, V8, P715, DOI 10.4161/hv.19619; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; GOTSCHLICH EC, 1969, J EXP MED, V129, P1349, DOI 10.1084/jem.129.6.1349; GOTSCHLICH EC, 1969, J EXP MED, V129, P1367, DOI 10.1084/jem.129.6.1367; Gudlavalleti SK, 2004, J BIOL CHEM, V279, P42765, DOI 10.1074/jbc.M313552200; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Keys TG, 2012, ANAL BIOCHEM, V427, P107, DOI 10.1016/j.ab.2012.05.011; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; LAI ECK, 1994, BIOCHEMISTRY-US, V33, P14743, DOI 10.1021/bi00253a012; Lemercinier X, 1996, CARBOHYD RES, V296, P83, DOI 10.1016/S0008-6215(96)00253-4; LIU TY, 1971, J BIOL CHEM, V246, P2849; McCarthy PC, 2013, GLYCOCONJUGATE J, V30, P857, DOI 10.1007/s10719-013-9490-x; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Muindi KM, 2014, GLYCOBIOLOGY, V24, P139, DOI 10.1093/glycob/cwt091; Nikolaev A. V., 2011, CARB GORD RES C JUN, P4; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Peterson DC, 2011, J BACTERIOL, V193, P1576, DOI 10.1128/JB.00924-10; Ravenscroft N, 1999, VACCINE, V17, P2802, DOI 10.1016/S0264-410X(99)00092-4; Roberts L, 2010, SCIENCE, V330, P1466, DOI 10.1126/science.330.6010.1466; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Sala RF, 1996, J AM CHEM SOC, V118, P3033, DOI 10.1021/ja960266z; Schwarzer D, 2009, J BIOL CHEM, V284, P9465, DOI 10.1074/jbc.M808475200; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Swartley JS, 1998, J BACTERIOL, V180, P1533, DOI 10.1128/JB.180.6.1533-1539.1998; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002	45	32	32	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19395	19407		10.1074/jbc.M114.575142	http://dx.doi.org/10.1074/jbc.M114.575142			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24849599	Green Published, hybrid			2022-12-28	WOS:000339326800016
J	Kalamajski, S; Liu, CP; Tillgren, V; Rubin, K; Oldberg, A; Rai, J; Weis, M; Eyre, DR				Kalamajski, Sebastian; Liu, Cuiping; Tillgren, Viveka; Rubin, Kristofer; Oldberg, Ake; Rai, Jyoti; Weis, MaryAnn; Eyre, David R.			Increased C-telopeptide Cross-linking of Tendon Type I Collagen in Fibromodulin-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUMICAN-NULL MICE; TARGETED DISRUPTION; DECORIN; FIBRILLOGENESIS; BINDING; FIBRILS; PROTEOGLYCAN; MUTATIONS; KERATOCAN; BIGLYCAN	The controlled assembly of collagen monomers into fibrils, with accompanying intermolecular cross-linking by lysyl oxidase-mediated bonds, is vital to the structural and mechanical integrity of connective tissues. This process is influenced by collagen-associated proteins, including small leucine-rich proteins (SLRPs), but the regulatory mechanisms are not well understood. Deficiency in fibromodulin, an SLRP, causes abnormal collagen fibril ultrastructure and decreased mechanical strength in mouse tendons. In this study, fibromodulin deficiency rendered tendon collagen more resistant to nonproteolytic extraction. The collagen had an increased and altered cross-linking pattern at an early stage of fibril formation. Collagen extracts contained a higher proportion of stably crosslinked alpha 1(I) chains as a result of their C-telopeptide lysines being more completely oxidized to aldehydes. The findings suggest that fibromodulin selectively affects the extent and pattern of lysyl oxidase-mediated collagen cross-linking by sterically hindering access of the enzyme to telopeptides, presumably through binding to the collagen. Such activity implies a broader role for SLRP family members	[Kalamajski, Sebastian; Tillgren, Viveka] Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden; [Liu, Cuiping; Rubin, Kristofer; Oldberg, Ake] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Rubin, Kristofer] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Rai, Jyoti; Weis, MaryAnn; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	Lund University; Lund University; Uppsala University; University of Washington; University of Washington Seattle	Kalamajski, S (corresponding author), Lund Univ, Dept Clin Sci, BMC C12,Klinikgatan 28, S-22184 Lund, Sweden.	Sebastian.Kalamajski@med.lu.se	Rubin, Kristofer/AAC-1810-2020	Rubin, Kristofer/0000-0003-2789-6276; Kalamajski, Sebastian/0000-0002-6600-9302	National Institutes of Health Grants [AR036794, AR037318]; Swedish Research Council; Swedish Cancer Foundation; Crafoord Foundation; King Gustaf V's 80th Anniversary Fund; Magnus Bergvall Foundation; Ake Wiberg Foundation; Greta and Johan Kock's Foundation; Alfred Osterlund's Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R01AR036794, R37AR037318, R37AR036794] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Crafoord Foundation; King Gustaf V's 80th Anniversary Fund; Magnus Bergvall Foundation; Ake Wiberg Foundation; Greta and Johan Kock's Foundation; Alfred Osterlund's Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR036794 and AR037318 (to D. R. E.). This work was also supported by grants from the Swedish Research Council, Swedish Cancer Foundation, Crafoord Foundation, King Gustaf V's 80th Anniversary Fund, Magnus Bergvall Foundation, Ake Wiberg Foundation, Greta and Johan Kock's Foundation, and Alfred Osterlund's Foundation.	Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; CUTRONEO KR, 1975, MOL PHARMACOL, V11, P632; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; FLANDIN F, 1984, BIOCHIM BIOPHYS ACTA, V791, P205, DOI 10.1016/0167-4838(84)90010-4; Font B, 1998, EUR J BIOCHEM, V254, P580, DOI 10.1046/j.1432-1327.1998.2540580.x; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Gill MR, 2002, OSTEOARTHR CARTILAGE, V10, P751, DOI 10.1053/joca.2002.0527; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HORGAN DJ, 1990, ARCH BIOCHEM BIOPHYS, V281, P21, DOI 10.1016/0003-9861(90)90407-P; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; Schlessinger J, 1997, CELL, V91, P869, DOI 10.1016/S0092-8674(00)80477-8; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Sini P, 1997, GLYCOCONJUGATE J, V14, P871, DOI 10.1023/A:1018550307649; Stamov DR, 2013, J STRUCT BIOL, V183, P394, DOI 10.1016/j.jsb.2013.05.022; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; WU JJ, 1992, J BIOL CHEM, V267, P23007; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Yeh JT, 2010, BRIT J DERMATOL, V163, P1174, DOI 10.1111/j.1365-2133.2010.10008.x; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	37	46	46	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18873	18879		10.1074/jbc.M114.572941	http://dx.doi.org/10.1074/jbc.M114.572941			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849606	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000339062900021
J	Pace, DA; McKnight, CA; Liu, J; Jimenez, V; Moreno, SNJ				Pace, Douglas A.; McKnight, Ciara A.; Liu, Jing; Jimenez, Veronica; Moreno, Silvia N. J.			Calcium Entry in Toxoplasma gondii and Its Enhancing Effect of Invasion-linked Traits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CALCIUM; HOST-CELLS; CA2+ RELEASE; CHANNELS; TACHYZOITES; SECRETION; MOBILIZATION; MEMBRANE; PROTEINS; MOTILITY	During invasion and egress from their host cells, Apicomplexan parasites face sharp changes in the surrounding calcium ion (Ca2+) concentration. Our work with Toxoplasma gondii provides evidence for Ca2+ influx from the extracellular milieu leading to cytosolic Ca2+ increase and enhancement of virulence traits, such as gliding motility, conoid extrusion, microneme secretion, and host cell invasion. Assays of Mn2+ and Ba2+ uptake do not support a canonical store-regulated Ca2+ entry mechanism. Ca2+ entry was blocked by the L-type Ca2+ channel inhibitor nifedipine and stimulated by the increase in cytosolic Ca2+ and by the specific L-type Ca2+ channel agonist Bay K-8644. Our results demonstrate that Ca2+ entry is critical for parasite virulence. We propose a regulated Ca2+ entry mechanism activated by cytosolic Ca2+ that has an enhancing effect on invasion-linked traits.	[Pace, Douglas A.; McKnight, Ciara A.; Liu, Jing; Jimenez, Veronica; Moreno, Silvia N. J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [McKnight, Ciara A.; Moreno, Silvia N. J.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Liu, Jing] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; China Agricultural University	Moreno, SNJ (corresponding author), Univ Georgia, Dept Cellular Biol, 350A Paul D Coverdell Ctr, Athens, GA 30602 USA.	smoreno@uga.edu			National Institutes of Health [AI096836, AI101167, AI060546]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096836, T32AI060546, R00AI101167, K99AI101167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI096836 (to S. N. J. M.) and AI101167 (to V. J.) and National Institutes of Health T32 Training Grant AI060546 (to D. A. P. and the Center for Tropical and Emerging Global Diseases).	Arrizabalaga G, 2004, INT J PARASITOL, V34, P361, DOI 10.1016/j.ijpara.2003.11.017; Beraldo FH, 2007, J PINEAL RES, V43, P360, DOI 10.1111/j.1600-079X.2007.00486.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Collins SR, 2011, TRENDS CELL BIOL, V21, P202, DOI 10.1016/j.tcb.2011.01.002; Docampo R., 2014, EUR J PHARM; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Koshy AA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002825; LACAMPAGNE A, 1994, BBA-BIOMEMBRANES, V1191, P205, DOI 10.1016/0005-2736(94)90250-X; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; MONDRAGON R, 1994, J EUKARYOT MICROBIOL, V41, P330, DOI 10.1111/j.1550-7408.1994.tb06086.x; Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pezzella N, 1997, EUR J CELL BIOL, V74, P92; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Tomita T, 2009, J IMMUNOL, V183, P6667, DOI 10.4049/jimmunol.0900516; Vieira MCF, 2000, MOL BIOCHEM PARASIT, V106, P157, DOI 10.1016/S0166-6851(99)00182-6; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; YAMAMOTO H, 1984, EUR J PHARMACOL, V102, P555, DOI 10.1016/0014-2999(84)90581-8	36	40	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19637	19647		10.1074/jbc.M114.565390	http://dx.doi.org/10.1074/jbc.M114.565390			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867952	Green Published, hybrid			2022-12-28	WOS:000339326800036
J	Porsch, H; Mehic, M; Olofsson, B; Heldin, P; Heldin, CH				Porsch, Helena; Mehic, Merima; Olofsson, Berit; Heldin, Paraskevi; Heldin, Carl-Henrik			Platelet-derived Growth Factor beta-Receptor, Transforming Growth Factor beta Type I Receptor, and CD44 Protein Modulate Each Other's Signaling and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; EPITHELIAL-CELLS; TUMOR-CELLS; PROXIMITY LIGATION; CARCINOMA-CELLS; BREAST-CANCER; PDGF; ACTIVATION; INTEGRIN; PROLIFERATION	Growth factors, such as platelet-derived growth factor BB (PDGF-BB) and transforming growth factor beta(TGF beta), are key regulators of cellular functions, including proliferation, migration, and differentiation. Growth factor signaling is modulated by context-dependent cross-talk between different signaling pathways. We demonstrate in this study that PDGF-BB induces phosphorylation of Smad2, a downstream mediator of the canonical TGF beta pathway, in primary dermal fibroblasts. The PDGF-BB-mediated Smad2 phosphorylation was dependent on the kinase activities of both TGF beta type I receptor (T beta RI) and PDGF beta-receptor (PDGFR beta), and it was prevented by inhibitory antibodies against TGF beta. Inhibition of the activity of the T beta RI kinase greatly reduced the PDGF-BB-dependent migration in dermal fibroblasts. Moreover, we demonstrate that the receptors for PDGF-BB and TGF beta interact physically in primary dermal fibroblasts and that stimulation with PDGF-BB induces internalization not only of PDGFR beta but also of T beta RI. In addition, silencing of PDGFR beta by siRNA decreased the stability of T beta RI and delayed TGF beta-induced signaling. We further show that the hyaluronan receptor CD44 interacts with both PDGFR beta and T beta RI. Depletion of CD44 by siRNA increased signaling via PDGFR beta and T beta RI by stabilizing the receptor proteins. Our data suggest that cross-talk between PDGFR beta and T beta RI occurs in dermal fibroblasts and that CD44 negatively modulates signaling via these receptors.	[Porsch, Helena; Mehic, Merima; Olofsson, Berit; Heldin, Paraskevi; Heldin, Carl-Henrik] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Sci Life Lab, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Heldin, P (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Sci Life Lab, Box 595, SE-75124 Uppsala, Sweden.	Evi.Heldin@LICR.uu.se; C-H.Heldin@LICR.uu.se		Mehic, Merima/0000-0001-8249-5526	Swedish Cancer Society; Agnes and Mac Rudberg Foundation; Gurli and Edward Brunnberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Agnes and Mac Rudberg Foundation; Gurli and Edward Brunnberg Foundation	This work was supported in part by grants from the Swedish Cancer Society, the Agnes and Mac Rudberg Foundation, and the Gurli and Edward Brunnberg Foundation.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellberg C, 2009, MOL BIOL CELL, V20, P2856, DOI 10.1091/mbc.E08-12-1228; Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; JALKANEN S, 1987, J CELL BIOL, V105, P983, DOI 10.1083/jcb.105.2.983; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Karlsson S, 2006, MOL BIOL CELL, V17, P4846, DOI 10.1091/mbc.E06-04-0306; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Ludbrook SB, 2003, BIOCHEM J, V369, P311, DOI 10.1042/BJ20020809; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; MURRAYRUST J, 1993, STRUCTURE, V1, P153, DOI 10.1016/0969-2126(93)90029-G; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Piek E, 1999, J CELL SCI, V112, P4557; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; SEYMOUR L, 1993, BREAST CANCER RES TR, V26, P247, DOI 10.1007/BF00665802; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIBANAKA Y, 1994, BIOCHEM BIOPH RES CO, V198, P613, DOI 10.1006/bbrc.1994.1089; Skandalis SS, 2010, IUBMB LIFE, V62, P833, DOI 10.1002/iub.392; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steller EJA, 2013, NEOPLASIA, V15, P204, DOI 10.1593/neo.121726; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wakahara K, 2005, J CELL BIOCHEM, V94, P995, DOI 10.1002/jcb.20364; Woodard AS, 1998, J CELL SCI, V111, P469; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Yu Q, 2004, CLIN EXP METASTAS, V21, P235, DOI 10.1023/B:CLIN.0000037705.25256.d3; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	58	47	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19747	19757		10.1074/jbc.M114.547273	http://dx.doi.org/10.1074/jbc.M114.547273			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860093	Green Published, hybrid			2022-12-28	WOS:000339326800046
J	Samarelli, AV; Riccitelli, E; Bizzozero, L; Silveira, TN; Seano, G; Pergolizzi, M; Vitagliano, G; Cascone, I; Carpentier, G; Bottos, A; Primo, L; Bussolino, F; Arese, M				Samarelli, Anna Valeria; Riccitelli, Elena; Bizzozero, Laura; Silveira, Tatiana Nunes; Seano, Giorgio; Pergolizzi, Margherita; Vitagliano, Grazia; Cascone, Ilaria; Carpentier, Gilles; Bottos, Alessia; Primo, Luca; Bussolino, Federico; Arese, Marco			Neuroligin 1 Induces Blood Vessel Maturation by Cooperating with the alpha 6 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; TUMOR ANGIOGENESIS; BASEMENT-MEMBRANE; ENDOTHELIAL-CELLS; EXPRESSION; VASCULATURE; NEUREXINS; JUNCTIONS; LAMININ; MICE	The synaptic protein Neuroligin 1 (NLGN1), a cell adhesion molecule, is critical for the formation and consolidation of synaptic connectivity and is involved in vascular development. The mechanism through which NLGN1 acts, especially in vascular cells, is unknown. Here, we aimed at deepening our knowledge on the cellular activities and molecular pathways exploited by endothelial NLGN1 both in vitro and in vivo. We analyzed the phenotypic consequences of NLGN1 expression modulation in endothelial cells through in vitro angiogenesis assays and the mouse postnatal retinal angiogenesis model. We demonstrate that NLGN1, whereas not affecting endothelial cell proliferation or migration, modulates cell adhesion to the vessel stabilizing protein laminin through cooperation with the alpha 6 integrin, a specific laminin receptor. Finally, we show that in vivo, NLGN1 and alpha 6 integrin preferentially colocalize in the mature retinal vessels, whereas NLGN1 deletion causes an aberrant VE-cadherin, laminin and alpha 6 integrin distribution in vessels, along with significant structural defects in the vascular tree.	[Samarelli, Anna Valeria; Riccitelli, Elena; Bizzozero, Laura; Silveira, Tatiana Nunes; Seano, Giorgio; Pergolizzi, Margherita; Vitagliano, Grazia; Bottos, Alessia; Primo, Luca; Bussolino, Federico; Arese, Marco] Univ Turin, Sch Med, Dept Oncol, I-10060 Candiolo, TO, Italy; [Samarelli, Anna Valeria; Riccitelli, Elena; Bizzozero, Laura; Silveira, Tatiana Nunes; Pergolizzi, Margherita; Vitagliano, Grazia; Bottos, Alessia; Arese, Marco] Candiolo Canc Inst, Lab Neurovasc Biol, I-10060 Turin, Italy; [Seano, Giorgio; Primo, Luca] Candiolo Canc Inst, I-10060 Turin, Italy; [Cascone, Ilaria; Carpentier, Gilles] Univ Paris Est Creteil Val de Marne, Lab CRRET, Fac Sci & Technol, F-94010 Creteil, France	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione del Piemonte per l'Oncologia; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Arese, M (corresponding author), Candiolo Canc Inst, Lab Neurovasc Biol, Str Prov 142 Km 3,95, I-10060 Turin, Italy.	marco.arese@unito.it	Bussolino, Federico/AES-3951-2022; Cascone, Ilaria/Q-7844-2018; Seano, Giorgio/R-6611-2016; arese, marco/J-6119-2013; Bussolino, Federico/K-2500-2016	Cascone, Ilaria/0000-0003-4903-8926; Seano, Giorgio/0000-0002-7294-302X; arese, marco/0000-0002-7384-9406; Bizzozero, Laura/0000-0003-2038-7356; Carpentier, Gilles/0000-0002-3730-7263; Pergolizzi, Margherita/0000-0002-8486-1478; Bussolino, Federico/0000-0002-5348-1341; PRIMO, Luca/0000-0002-1294-0441	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 11503, 10133]; AIRC [12182]; Fondazione Umberto Veronesi; Young Investigator Grant; Regione Piemonte: Ricerca Sanitaria Finalizzata; Converging Technologies Program grant "Photonic Biosensors for Early Cancer Diagnostics," Industrial Research; Fondo Investimenti per la Ricerca di Base [RBAP11BYNP]; University of Torino-Compagnia di San Paolo Grant RETHE; Grant GeneRNet; FP7-ICT Biloba [318035]; Consiglio Nazionale delle Ricerche grant "Personalized Medicine"	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Young Investigator Grant; Regione Piemonte: Ricerca Sanitaria Finalizzata(Regione Piemonte); Converging Technologies Program grant "Photonic Biosensors for Early Cancer Diagnostics," Industrial Research; Fondo Investimenti per la Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); University of Torino-Compagnia di San Paolo Grant RETHE; Grant GeneRNet; FP7-ICT Biloba; Consiglio Nazionale delle Ricerche grant "Personalized Medicine"	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) investigator Grants IG 11503 (to M. A.), 10133 (to F. B.), AIRC 5 x 1000 (code 12182), Fondazione Umberto Veronesi, Young Investigator Grant 2014 (to M. A.), Regione Piemonte: Ricerca Sanitaria Finalizzata, 2008, Converging Technologies Program grant "Photonic Biosensors for Early Cancer Diagnostics," Industrial Research 2009 (Grant BANP) Fondo Investimenti per la Ricerca di Base RBAP11BYNP (Newton) (to F. B.), and University of Torino-Compagnia di San Paolo Grant RETHE (to F. B.), Grant GeneRNet (to M. A.), FP7-ICT-2011-8 Biloba (contract 318035), and Consiglio Nazionale delle Ricerche grant "Personalized Medicine" (to F. B.).	Bedell VM, 2012, ARTERIOSCL THROM VAS, V32, P1546, DOI 10.1161/ATVBAHA.112.251272; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Carpentier G, 2012, 4 IMAGEJ US DEV C P, P198; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Estrach S, 2011, CIRC RES, V109, P172, DOI 10.1161/CIRCRESAHA.111.240622; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Germain M, 2010, J PATHOL, V220, P370, DOI 10.1002/path.2654; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; KENNEL SJ, 1990, HYBRIDOMA, V9, P243, DOI 10.1089/hyb.1990.9.243; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Primo L, 2010, CANCER RES, V70, P5759, DOI 10.1158/0008-5472.CAN-10-0507; Ribatti D, 2012, DEV BIOL, V372, P157, DOI 10.1016/j.ydbio.2012.09.018; Rissone A, 2012, ARTERIOSCL THROM VAS, V32, P1563, DOI 10.1161/ATVBAHA.111.243006; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Sawamiphak S, 2010, NAT PROTOC, V5, P1659, DOI 10.1038/nprot.2010.130; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Stenzel D, 2011, EMBO REP, V12, P1135, DOI 10.1038/embor.2011.194; TSAI WH, 1985, COMPUT VISION GRAPH, V29, P377, DOI 10.1016/0734-189X(85)90133-1; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791	28	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19466	19476		10.1074/jbc.M113.530972	http://dx.doi.org/10.1074/jbc.M113.530972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860089	Green Published, hybrid			2022-12-28	WOS:000339326800022
J	Contreras, H; Joens, MS; McMath, LM; Le, VP; Tullius, MV; Kimmey, JM; Bionghi, N; Horwitz, MA; Fitzpatrick, JAJ; Goulding, CW				Contreras, Heidi; Joens, Matthew S.; McMath, Lisa M.; Le, Vincent P.; Tullius, Michael V.; Kimmey, Jaqueline M.; Bionghi, Neda; Horwitz, Marcus A.; Fitzpatrick, James A. J.; Goulding, Celia W.			Characterization of a Mycobacterium tuberculosis Nanocompartment and Its Potential Cargo Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-JOSTII RHA1; CRYSTAL-STRUCTURE; HYPOXIC RESPONSE; PEROXIDASE; HEME; IDENTIFICATION; ORGANELLES; PURIFICATION; MECHANISMS; EXOSOMES	Mycobacterium tuberculosis has evolved various mechanisms by which the bacterium can maintain homeostasis under numerous environmental assaults generated by the host immune response. M. tuberculosis harbors enzymes involved in the oxidative stress response that aid in survival during the production of reactive oxygen species in activated macrophages. Previous studies have shown that a dye-decolorizing peroxidase (DyP) is encapsulated by a bacterial nanocompartment, encapsulin (Enc), whereby packaged DyP interacts with Enc via a unique C-terminal extension. M. tuberculosis also harbors an encapsulin homolog (CFP-29, Mt-Enc), within an operon with M. tuberculosis DyP (Mt-DyP), which contains a C-terminal extension. Together these observations suggest that Mt-DyP interacts with Mt-Enc. Furthermore, it has been suggested that DyPs may function as either a heme-dependent peroxidase or a deferrochelatase. Like Mt-DyP, M. tuberculosis iron storage ferritin protein, Mt-BfrB, and an M. tuberculosis protein involved in folate biosynthesis, 7,8-dihydroneopterin aldolase (Mt-FolB), have C-terminal tails that could also interact with Mt-Enc. For the first time, we show by co-purification and electron microscopy that mycobacteria via Mt-Enc can encapsulate Mt-DyP, Mt-BfrB, and Mt-FolB. Functional studies of free or encapsulated proteins demonstrate that they retain their enzymatic activity within the Mt-Enc nanocompartment. Mt-DyP, Mt-FolB, and Mt-BfrB all have antioxidant properties, suggesting that if these proteins are encapsulated by Mt-Enc, then this nanocage may play a role in the M. tuberculosis oxidative stress response. This report provides initial structural and biochemical clues regarding the molecular mechanisms that utilize compartmentalization by which the mycobacterial cell may aid in detoxification of the local environment to ensure long term survival.	[Contreras, Heidi; McMath, Lisa M.; Le, Vincent P.; Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Goulding, Celia W.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Joens, Matthew S.; Fitzpatrick, James A. J.] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Tullius, Michael V.; Kimmey, Jaqueline M.; Bionghi, Neda; Horwitz, Marcus A.] Univ Calif Los Angeles, Div Infect Dis, Dept Med, Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Salk Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goulding, CW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	celia.goulding@uci.edu	Kimmey, Jacqueline/GXV-9323-2022	Kimmey, Jacqueline M/0000-0003-1330-8525	National Institutes of Health [AI081161, GM101945, AI078691, AI095208, AI068413]; Waitt Advanced Biophotonics Center; W. M. Keck Foundation; NCI, National Institutes of Health [CA014195-40]; NINDS, National Institutes of Health [NS072031-03A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI078691, P01AI095208, R01AI068413, R01AI081161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM101945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waitt Advanced Biophotonics Center; W. M. Keck Foundation(W.M. Keck Foundation); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI081161 (to C. W. G.), GM101945 (to H. C.), AI078691 (to L. M. M.), AI095208 (to C. W. G.), and AI068413 (to M. A. H.).; Supported by the Waitt Advanced Biophotonics Center, W. M. Keck Foundation, NCI, National Institutes of Health, P30 Cancer Support Grant CA014195-40, and NINDS, National Institutes of Health, P30 Neuroscience Center Core Grant NS072031-03A1.	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Akita F, 2007, J MOL BIOL, V368, P1469, DOI 10.1016/j.jmb.2007.02.075; Bannantine JP, 2001, J MED MICROBIOL, V50, P795, DOI 10.1099/0022-1317-50-9-795; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; Choudhary S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033342; Corchero JL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-92; Czekster CM, 2012, J AM CHEM SOC, V134, P19758, DOI 10.1021/ja308350f; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; Dantola ML, 2008, HELV CHIM ACTA, V91, P411, DOI 10.1002/hlca.200890046; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Dunford H. B., 1999, HEME PEROXIDASES, P15; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Garbe TR, 1999, INFECT IMMUN, V67, P460, DOI 10.1128/IAI.67.1.460-465.1999; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Goulding CW, 2005, J MOL BIOL, V349, P61, DOI 10.1016/j.jmb.2005.03.023; Gupta V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008028; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kaur A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.50; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Khare G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018570; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; KODURI RS, 1995, J BIOL CHEM, V270, P22254, DOI 10.1074/jbc.270.38.22254; Lassila JK, 2014, J MOL BIOL, V426, P2217, DOI 10.1016/j.jmb.2014.02.025; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McMath LM, 2010, ACTA CRYSTALLOGR F, V66, P1657, DOI 10.1107/S1744309110042958; McMath LM, 2013, J PORPHYR PHTHALOCYA, V17, P229, DOI 10.1142/S1088424613500211; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; Rahmanpour R, 2013, FEBS J, V280, P2097, DOI 10.1111/febs.12234; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; Rosenkrands I, 1998, INFECT IMMUN, V66, P2728, DOI 10.1128/IAI.66.6.2728-2735.1998; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schobersberger W, 1996, FEBS LETT, V397, P263, DOI 10.1016/S0014-5793(96)01194-5; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shin KS, 2000, ARCH BIOCHEM BIOPHYS, V384, P109, DOI 10.1006/abbi.2000.2083; Sil S, 2004, J BIOSCIENCES, V29, P281, DOI 10.1007/BF02702610; Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Turlin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056529; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	62	59	61	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18279	18289		10.1074/jbc.M114.570119	http://dx.doi.org/10.1074/jbc.M114.570119			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24855650	hybrid, Green Published			2022-12-28	WOS:000338042000028
J	Lin, J; Oh, SH; Jones, R; Garnett, JA; Salgado, PS; Rusnakova, S; Matthews, SJ; Hoyer, LL; Cota, E				Lin, Jing; Oh, Soon-Hwan; Jones, Rhian; Garnett, James A.; Salgado, Paula S.; Rusnakova, Sophia; Matthews, Steve J.; Hoyer, Lois L.; Cota, Ernesto			The Peptide-binding Cavity Is Essential for Als3-mediated Adhesion of Candida albicans to Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOFILM FORMATION; ALS FAMILY; PROTEIN; GENE; EPIDEMIOLOGY; SPECIFICITY; SEQUENCE; SURVEILLANCE; LIGANDS	The adhesive phenotype of Candida albicans contributes to its ability to colonize the host and cause disease. Als proteins are one of the most widely studied C. albicans virulence attributes; deletion of ALS3 produces the greatest reduction in adhesive function. Although adhesive activity is thought to reside within the N-terminal domain of Als proteins (NT-Als), the molecular mechanism of adhesion remains unclear. We designed mutations in NT-Als3 that test the contribution of the peptide-binding cavity (PBC) to C. albicans adhesion and assessed the adhesive properties of other NT-Als3 features in the absence of a functional PBC. Structural analysis of purified loss-of-PBC-function mutant proteins showed that the mutations did not alter the overall structure or surface properties of NT-Als3. The mutations were incorporated into full-length ALS3 and integrated into the ALS3 locus of a deletion mutant, under control of the native ALS3 promoter. The PBC mutant phenotype was evaluated in assays using monolayers of human pharyngeal epithelial and umbilical vein endothelial cells, and freshly collected human buccal epithelial cells in suspension. Loss of PBC function resulted in an adhesion phenotype that was indistinguishable from the Delta als3/Delta als3 strain. The adhesive contribution of the Als3 amyloid-forming-region (AFR) was also tested using these methods. C. albicans strains producing cell surface Als3 in which the amyloidogenic potential was destroyed showed little contribution of the AFR to adhesion, instead suggesting an aggregative function for the AFR. Collectively, these results demonstrate the essential and principal role of the PBC in Als3 adhesion.	[Lin, Jing; Jones, Rhian; Garnett, James A.; Rusnakova, Sophia; Matthews, Steve J.; Cota, Ernesto] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Oh, Soon-Hwan; Hoyer, Lois L.] Univ Illinois, Dept Pathobiol, Urbana, IL 61802 USA; [Salgado, Paula S.] Newcastle Univ, Inst Cell & Mol Biosci, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Imperial College London; University of Illinois System; University of Illinois Urbana-Champaign; Newcastle University - UK	Hoyer, LL (corresponding author), Univ Illinois, Dept Pathobiol, 2001 S Lincoln Ave, Urbana, IL 61802 USA.	lhoyer@illinois.edu; e.cota@imperial.ac.uk	Salgado, Paula/AAR-5782-2021; Hoyer, Lois/G-2004-2015	Jones, Rhian/0000-0001-5513-5939; Hoyer, Lois/0000-0002-0827-4984; Salgado, Paula S./0000-0002-2820-3024; Matthews, Steve/0000-0003-0676-0927	Diamond Light Source (Didcot, UK); Centre of Structural Biology at Imperial College London; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014158] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/K003887/1, 983152] Funding Source: researchfish; BBSRC [BB/K003887/1] Funding Source: UKRI; MRC [MR/J006874/1] Funding Source: UKRI	Diamond Light Source (Didcot, UK); Centre of Structural Biology at Imperial College London; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank beamline scientists at I04-1 and I24 of the Diamond Light Source (Didcot, UK) for technical assistance and support as well as members of the Cota and Matthews laboratories and the Centre of Structural Biology at Imperial College London for generous support. We thank the staff at the Roy J. Carver Biotechnology Center (University of Illinois Urbana-Champaign) for generating DNA sequence data.	Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Coleman DA, 2012, FEMS IMMUNOL MED MIC, V64, P321, DOI 10.1111/j.1574-695X.2011.00914.x; Coleman DA, 2009, J MICROBIOL METH, V78, P71, DOI 10.1016/j.mimet.2009.05.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Gaur NK, 2004, MICROBIOL-SGM, V150, P277, DOI 10.1099/mic.0.26738-0; Gaur NK, 2002, CELL COMMUN ADHES, V9, P45, DOI 10.1080/15419060212187; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; Liu YP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002305; Loza L, 2004, YEAST, V21, P473, DOI 10.1002/yea.1111; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Porta A, 1999, J BACTERIOL, V181, P7516, DOI 10.1128/JB.181.24.7516-7523.1999; Salgado PS, 2011, P NATL ACAD SCI USA, V108, P15775, DOI 10.1073/pnas.1103496108; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; Silverman RJ, 2010, INFECT IMMUN, V78, P4644, DOI 10.1128/IAI.00685-10; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Thompson GR, 2010, ORAL SURG ORAL MED O, V109, P488, DOI 10.1016/j.tripleo.2009.11.026; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yan R, 2010, BIOMOL NMR ASSIGN, V4, P187, DOI 10.1007/s12104-010-9243-8; Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0; Zhao XM, 2011, FEMS IMMUNOL MED MIC, V61, P245, DOI 10.1111/j.1574-695X.2010.00769.x; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0; Zhu WD, 2012, P NATL ACAD SCI USA, V109, P14194, DOI 10.1073/pnas.1117676109; Zwart P. H., 2005, CCP4 NEWSL, V43	40	48	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18401	18412		10.1074/jbc.M114.547877	http://dx.doi.org/10.1074/jbc.M114.547877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24802757	Green Published, hybrid			2022-12-28	WOS:000338042000038
J	Tanaka, R; Seki, Y; Saito, Y; Kamiya, S; Fujita, M; Okutsu, H; Iyoda, T; Takai, T; Owaki, T; Yajima, H; Taira, J; Hayashi, R; Kodama, H; Matsunaga, T; Fukai, F				Tanaka, Rika; Seki, Yutaka; Saito, Yohei; Kamiya, Sadahiro; Fujita, Motomichi; Okutsu, Hiroaki; Iyoda, Takuya; Takai, Tatsuya; Owaki, Toshiyuki; Yajima, Hirofumi; Taira, Junichi; Hayashi, Ryo; Kodama, Hiroaki; Matsunaga, Takuya; Fukai, Fumio			Tenascin-C-derived Peptide TNIIIA2 Highly Enhances Cell Survival and Platelet-derived Growth Factor (PDGF)-dependent Cell Proliferation through Potentiated and Sustained Activation of Integrin alpha 5 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR PROGRESSION; LUNG-CANCER; FIBRONECTIN-RECEPTOR; ENDOTHELIAL-CELLS; SYNTHETIC PEPTIDE; GENE-EXPRESSION; FOCAL ADHESION; MIGRATION; SYNDECAN-4; TRANSFORMATION	Tenascin-C is an adhesion modulatory matrix protein that is highly expressed in tumors; however, its biochemical activity involved in tumorigenesis is not fully understood. On the other hand, increasing evidence indicates the importance of integrin alpha 5 beta 1 in cancer development. We previously demonstrated that tenascin-C harbors a functional site that can be released as a proadhesive peptide such as TNIIIA2. Peptide TNIIIA2 is capable of inducing activation of beta 1-integrins including alpha 5 beta 1 via syndecan-4. In this study the proadhesive effect of TNIIIA2 was characterized by potentiated and sustained activation of integrin alpha 5 beta 1. Based on this effect, TNIIIA2 rendered nontransformed fibroblasts (NIH3T3) resistant to serum deprivation-elicited anoikis through activation of the Akt/Bcl-2 pathway. Moreover, TNIIIA2 hyperstimulated PDGF-dependent proliferation of NIH3T3 by activating integrin alpha 5 beta 1. Tenascin-C, a parental protein of TNIIIA2, also stimulated PDGF-dependent proliferation, which was blocked by a matrix metalloproteinase-2/9 inhibitor and an anti-TNIIIA2 function-blocking antibody, suggesting proteolytic exposure of the proadhesive effect of TNIIIA2. Mechanistic analyses revealed that TNIIIA2 induced a lateral association of PDGF receptor beta with the molecular complex of activated integrin alpha 5 beta 1 and syndecan-4 in the membrane microdomains enriched with cholesterol/caveolin-1, resulting in prolonged activation of PDGF receptor beta and the subsequent Ras/mitogen-activated protein kinase pathway in a PDGF-dependent manner. Of note, TNIIIA2 induced continuous proliferation in NIH3T3 in an integrin alpha 5 beta 1-dependent manner even after they formed a confluent monolayer. Thus, it was proposed that tenascin-C might be involved in deregulated cell growth through potentiated and sustained activation of integrin alpha 5 beta 1 after exposure of the proadhesive effect of TNIIIA2.	[Tanaka, Rika; Seki, Yutaka; Saito, Yohei; Fujita, Motomichi; Okutsu, Hiroaki; Iyoda, Takuya; Takai, Tatsuya; Owaki, Toshiyuki; Fukai, Fumio] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, Noda, Chiba 2788510, Japan; [Kamiya, Sadahiro] Josai Int Univ, Fac Pharmaceut Sci, Dept Drug Informat, Togane, Chiba 2838555, Japan; [Yajima, Hirofumi] Tokyo Univ Sci, Fac Sci, Dept Appl Chem, Tokyo 1628601, Japan; [Taira, Junichi] Kurume Univ, Sch Med, Dept Chem, Kurume, Fukuoka 8300011, Japan; [Hayashi, Ryo; Kodama, Hiroaki] Saga Univ, Fac Sci & Engn, Saga 8490922, Japan; [Matsunaga, Takuya] Kagawa Univ, Dept Internal Med, Takamatsu, Kagawa 7610793, Japan	Tokyo University of Science; Tokyo University of Science; Kurume University; Saga University; Kagawa University	Fukai, F (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	fukai@rs.noda.tus.ac.jp		Taira, Junichi/0000-0002-8438-865X				Adachi M, 2000, CLIN CANCER RES, V6, P96; Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977; Castellon R, 2002, INVEST OPHTH VIS SCI, V43, P2758; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; CHIQUETEHRISMANN R, 1986, CELL, V47, P131, DOI 10.1016/0092-8674(86)90374-0; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; DANEN EHJ, 1994, HISTOPATHOLOGY, V24, P249, DOI 10.1111/j.1365-2559.1994.tb00517.x; DEDHAR S, 1987, J CELL BIOL, V105, P1175, DOI 10.1083/jcb.105.3.1175; Faull RJ, 1996, J AM SOC NEPHROL, V7, P1091; FLEMING TP, 1992, EXP GERONTOL, V27, P523, DOI 10.1016/0531-5565(92)90007-M; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Huang WT, 2001, CANCER RES, V61, P8586; Hudecz F., 2008, BIOCONJUG CHEM, V19, P1757; Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614; Itagaki K, 2012, J BIOL CHEM, V287, P16037, DOI 10.1074/jbc.M111.308122; Jones PL, 1999, J CELL SCI, V112, P435; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; JOSHI P, 1993, J CELL SCI, V106, P389; Kanda R, 2013, CANCER RES, V73, P6243, DOI 10.1158/0008-5472.CAN-12-4502; Kita D, 2001, CANCER RES, V61, P7985; Lange K, 2008, CANCER RES, V68, P6942, DOI 10.1158/0008-5472.CAN-08-0347; Lange K, 2007, CANCER RES, V67, P6163, DOI 10.1158/0008-5472.CAN-06-3348; LESSEY BA, 1995, AM J PATHOL, V146, P717; LIGHTNER VA, 1990, ANN NY ACAD SCI, V580, P260, DOI 10.1111/j.1749-6632.1990.tb17935.x; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Lokker NA, 2002, CANCER RES, V62, P3729; Maglott A, 2006, CANCER RES, V66, P6002, DOI 10.1158/0008-5472.CAN-05-4105; Marko K, 2008, BIOCONJUGATE CHEM, V19, P1757, DOI 10.1021/bc8000134; Martin S, 2009, BBA-MOL CELL RES, V1793, P354, DOI 10.1016/j.bbamcr.2008.09.019; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Midwood KS, 2004, MOL BIOL CELL, V15, P5670, DOI 10.1091/mbc.E04-08-0759; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; NATALI PG, 1995, BRIT J CANCER, V71, P1243, DOI 10.1038/bjc.1995.240; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Perlstein I, 2003, GENE THER, V10, P1420, DOI 10.1038/sj.gt.3302043; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; Ravid D, 2010, J VIROL, V84, P9749, DOI 10.1128/JVI.01079-10; Riddell DR, 2001, J LIPID RES, V42, P998; Roman J, 2010, AM J RESP CELL MOL, V43, P684, DOI 10.1165/rcmb.2009-0375OC; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Saito Y, 2010, J BIOL CHEM, V285, P7006, DOI 10.1074/jbc.M109.027581; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; SCHILLER JH, 1995, CANCER RES, V55, P6215; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; Tanaka R, 2009, J BIOL CHEM, V284, P19817, DOI 10.1074/jbc.M109.009860; TENNENBAUM T, 1992, CANCER RES, V52, P2966; Wenk MB, 2000, J CELL BIOL, V150, P913, DOI 10.1083/jcb.150.4.913; WOODS A, 1993, MOL BIOL CELL, V4, P605, DOI 10.1091/mbc.4.6.605	54	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17699	17708		10.1074/jbc.M113.546622	http://dx.doi.org/10.1074/jbc.M113.546622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24808173	hybrid, Green Published			2022-12-28	WOS:000338018100034
J	Neppl, RL; Kataoka, M; Wang, DZ				Neppl, Ronald L.; Kataoka, Masaharu; Wang, Da-Zhi			Crystallin-alpha B Regulates Skeletal Muscle Homeostasis via Modulation of Argonaute2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL QUIESCENCE; ARTERIOGENIC RESPONSE; MICRORNAS; CHAPERONE; MICE; RNAI; DISEASE; CARDIOMYOPATHY; AGGREGATION; BIOGENESIS	The core functional machinery of the RNAi pathway is the RNA-induced silencing complex (RISC), wherein Argonaute2 (Ago2) is essential for siRNA-directed endonuclease activity and RNAi/microRNA-mediated gene silencing. Crystallin-alpha B (CryAB) is a small heat shock protein involved in preventing protein aggregation. We demonstrate that CryAB interacts with the N and C termini of Ago2, not the catalytic site defined by the convergence of the PAZ, MID, and PIWI domains. We further demonstrate significantly reduced Ago2 activity in the absence of CryAB, highlighting a novel role of CryAB in the mammalian RNAi/microRNA pathway. In skeletal muscle of CryAB null mice, we observe a shift in the hypertrophy-atrophy signaling axis toward atrophy under basal conditions. Moreover, loss of CryAB altered the capability of satellite cells to regenerate skeletal muscle. These studies establish that CryAB is necessary for normal Ago2/RISC activity and cellular homeostasis in skeletal muscle.	[Neppl, Ronald L.; Kataoka, Masaharu; Wang, Da-Zhi] Harvard Univ, Dept Cardiol, Sch Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Neppl, Ronald L.; Kataoka, Masaharu; Wang, Da-Zhi] Harvard Univ, Dept Pediat, Sch Med, Boston, MA 02115 USA; [Wang, Da-Zhi] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Neppl, RL (corresponding author), Harvard Univ, Dept Cardiol, Sch Med, Boston Childrens Hosp, John Enders Res Bldg,320 Longwood Ave, Boston, MA 02115 USA.	rneppl@enders.tch.harvard.edu; dwang@enders.tch.harvard.edu	Neppl, Ronald L/AAW-1257-2020	Neppl, Ronald L/0000-0003-1497-6058	National Institutes of Health [HL110666, HL085635, HL116919]; March of Dimes Foundation; Banyu Life Science Foundation International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116919, R01HL085635, F32HL110666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Banyu Life Science Foundation International(Banyu Life Science Foundation International); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grant HL110666 (to R. L. N.), as well as National Institutes of Health Grants HL085635 and HL116919 (to D. Z. W.) and the March of Dimes Foundation (to D. Z. W.). This work was also supported by Banyu Life Science Foundation International (to M. K.).	Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Huang ZP, 2011, METHODS MOL BIOL, V709, P197, DOI 10.1007/978-1-61737-982-6_12; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688	42	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17240	17248		10.1074/jbc.M114.549584	http://dx.doi.org/10.1074/jbc.M114.549584			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782307	hybrid, Green Published			2022-12-28	WOS:000338016200056
J	Theiler, R; Fujita, M; Nagae, M; Yamaguchi, Y; Maeda, Y; Kinoshita, T				Theiler, Romina; Fujita, Morihisa; Nagae, Masamichi; Yamaguchi, Yoshiki; Maeda, Yusuke; Kinoshita, Taroh			The alpha-Helical Region in p24 gamma(2) Subunit of p24 Protein Cargo Receptor Is Pivotal for the Recognition and Transport of Glycosylphosphatidylinositol-anchored Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPII-COATED VESICLES; ENDOPLASMIC-RETICULUM; ER EXIT; COMPLEX; FAMILY; EMP24P; COMPONENT; ERV25P	Glycosylphosphatidylinositol-anchored proteins (GPI-APs) are group of proteins that depend on p24 cargo receptors for their transport from the endoplasmic reticulum to the Golgi apparatus. The GPI anchor is expected to act as a sorting and transport signal, but so far little is known about the recognition mechanism. In the present study we investigate the GPI-AP transport in cell knockdown of p24 gamma, the most diverse p24 subfamily. Knockdown of p24 gamma(2) but not of other p24 gamma family members impaired the transport of a reporter GPI-AP. Restoration of the knockdown-induced phenotype using chimeric constructs between p24 gamma(2) and the related p24 gamma(1) further implied a role of the alpha-helical region of p24 gamma(2) but not its GOLD domain in the specific binding of GPI-APs. We conclude that motifs in the membrane-adjacent alpha-helical region of p24 gamma(2) are involved in recognition of GPI-APs and are consequently responsible for the incorporation of these proteins into coat protein complex II-coated transport vesicles.	[Theiler, Romina; Fujita, Morihisa; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, World Premier Int WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Theiler, Romina; Fujita, Morihisa; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Nagae, Masamichi; Yamaguchi, Yoshiki] RIKEN Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Syst Glycobiol Res Grp, Struct Glycobiol Team, Wako, Saitama 3510198, Japan	Osaka University; Osaka University; RIKEN	Kinoshita, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	tkinoshi@biken.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009; Yamaguchi, Yoshiki/N-5246-2015; Fujita, Morihisa/AAM-4142-2020	Yamaguchi, Yoshiki/0000-0003-0100-5439; Nagae, Masamichi/0000-0002-5470-3807	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Government scholarship (Ministry of Education, Culture, Sports, Science, and Technology of Japan); Grants-in-Aid for Scientific Research [25460054] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government scholarship (Ministry of Education, Culture, Sports, Science, and Technology of Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. K. and M. F.).; Supported by a Japanese Government scholarship (Ministry of Education, Culture, Sports, Science, and Technology of Japan).	Anantharaman V, 2002, GENOME BIOL, V3; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Hirata R, 2013, J BIOL CHEM, V288, P37057, DOI 10.1074/jbc.M113.518340; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Strating JRPM, 2009, MOL BIOL EVOL, V26, P1707, DOI 10.1093/molbev/msp099; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200	23	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16835	16843		10.1074/jbc.M114.568311	http://dx.doi.org/10.1074/jbc.M114.568311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24778190	hybrid, Green Published			2022-12-28	WOS:000338016200021
J	Xu, H; Li, HG; Woo, SL; Kim, SM; Shende, VR; Neuendorff, N; Guo, X; Guo, T; Qi, T; Pei, Y; Zhao, Y; Hu, X; Zhao, JJ; Chen, LL; Chen, LL; Ji, JY; Alaniz, RC; Earnest, DJ; Wu, CD				Xu, Hang; Li, Honggui; Woo, Shih-Lung; Kim, Sam-Moon; Shende, Vikram R.; Neuendorff, Nichole; Guo, Xin; Guo, Ting; Qi, Ting; Pei, Ya; Zhao, Yan; Hu, Xiang; Zhao, Jiajia; Chen, Lili; Chen, Lulu; Ji, Jun-Yuan; Alaniz, Robert C.; Earnest, David J.; Wu, Chaodong			Myeloid Cell-specific Disruption of Period1 and Period2 Exacerbates Diet-induced Inflammation and Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA ACTIVATION; REV-ERB-ALPHA; HIGH-FAT DIET; ADIPOSE-TISSUE; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; PPAR-GAMMA; MACROPHAGE POLARIZATION; CIRCADIAN CLOCK; ENERGY-BALANCE; OBESITY	The circadian clockworks gate macrophage inflammatory responses. Given the association between clock dysregulation and metabolic disorders, we conducted experiments to determine the extent to which over-nutrition modulates macrophage clock function and whether macrophage circadian dysregulation is a key factor linking over-nutrition to macrophage proinflammatory activation, adipose tissue inflammation, and systemic insulin resistance. Our results demonstrate that 1) macrophages from high fat diet-fed mice are marked by dysregulation of the molecular clockworks in conjunction with increased proinflammatory activation, 2) global disruption of the clock genes Period1 (Per1) and Per2 recapitulates this amplified macrophage proinflammatory activation, 3) adoptive transfer of Per1/2-disrupted bone marrow cells into wild-type mice potentiates high fat diet-induced adipose and liver tissue inflammation and systemic insulin resistance, and 4) Per1/2-disrupted macrophages similarly exacerbate inflammatory responses and decrease insulin sensitivity in co-cultured adipocytes in vitro. Furthermore, PPAR gamma levels are decreased in Per1/2-disrupted macrophages and PPAR gamma 2 overexpression ameliorates Per1/2 disruption-associated macrophage proinflammatory activation, suggesting that this transcription factor may link the molecular clockworks to signaling pathways regulating macrophage polarization. Thus, macrophage circadian clock dysregulation is a key process in the physiological cascade by which diet-induced obesity triggers macrophage proinflammatory activation, adipose tissue inflammation, and insulin resistance.	[Xu, Hang; Li, Honggui; Woo, Shih-Lung; Guo, Xin; Guo, Ting; Qi, Ting; Pei, Ya; Zhao, Yan; Hu, Xiang; Zhao, Jiajia; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA; [Kim, Sam-Moon; Shende, Vikram R.; Neuendorff, Nichole; Earnest, David J.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Coll Med, Bryan, TX 77807 USA; [Hu, Xiang; Chen, Lulu] Huazhong Univ Sci & Technol, Dept Endocrinol, Union Hosp, Tongji Coll Med, Wuhan 430022, Hubei, Peoples R China; [Zhao, Jiajia; Chen, Lili] Huazhong Univ Sci & Technol, Dept Stomatol, Union Hosp, Tongji Coll Med, Wuhan 430022, Hubei, Peoples R China; [Ji, Jun-Yuan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Alaniz, Robert C.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Earnest, DJ (corresponding author), Texas A&M Hlth Sci Ctr, 8447 State Highway 47, Bryan, TX 77807 USA.	DEARNEST@medicine.tamhsc.edu; cdwu@tamu.edu	Shende, Vikram/M-2816-2017; zhao, yan/N-6096-2014	Ji, Jun-yuan/0000-0002-4483-4336; Earnest, David/0000-0003-4433-6481	National Institutes of Health [1R01DK095828, 1R01DK095862]; American Diabetes Association [1-10-JF-54, 1-13-BS-214-BR]; American Heart Association [12BGIA9050003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095013, R01DK095862, R01DK095828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK095828 and 1R01DK095862) (NIDDK; to C. W.). This work was also supported, in whole or in part, by American Diabetes Association Grants 1-10-JF-54 and 1-13-BS-214-BR, American Heart Association Grant 12BGIA9050003 (to C. W.).	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928; Farnell YF, 2011, EUR J NEUROSCI, V33, P1533, DOI 10.1111/j.1460-9568.2011.07629.x; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Guo X, 2013, J NUTR BIOCHEM, V24, P770, DOI 10.1016/j.jnutbio.2012.04.007; Guo X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039286; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huo YQ, 2012, J BIOL CHEM, V287, P21492, DOI 10.1074/jbc.M112.370379; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Jensen MK, 2008, CIRCULATION, V117, P3062, DOI 10.1161/CIRCULATIONAHA.107.759951; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Ko ML, 2011, J BIOL RHYTHM, V26, P412, DOI 10.1177/0748730411414170; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	54	51	53	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16374	16388		10.1074/jbc.M113.539601	http://dx.doi.org/10.1074/jbc.M113.539601			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24770415	Green Published, hybrid			2022-12-28	WOS:000337965700040
J	Teramoto, T; Boonyasuppayakorn, S; Handley, M; Choi, KH; Padmanabhan, R				Teramoto, Tadahisa; Boonyasuppayakorn, Siwaporn; Handley, Misty; Choi, Kyung H.; Padmanabhan, Radhakrishnan			Substitution of NS5 N-terminal Domain of Dengue Virus Type 2 RNA with Type 4 Domain Caused Impaired Replication and Emergence of Adaptive Mutants with Enhanced Fitness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO SYNTHESIS; IN-VITRO; VIRAL-RNA; POLYMERASE; HELICASE; REGION; IDENTIFICATION; NUCLEOTIDE; ELEMENTS; VACCINE	Flavivirus NS3 and NS5 are required in viral replication and 5'-capping. NS3 has NS2B-dependent protease, RNA helicase, and 5'-RNA triphosphatase activities. NS5 has 5'-RNA methyltransferase (MT)/guanylyltransferase (GT) activities within the N-terminal 270 amino acids and the RNA-dependent RNA polymerase (POL) activity within amino acids 271-900. A chimeric NS5 containing the D4MT/D4GT and the D2POL domains in the context of wild-type (WT) D2 RNA was constructed. RNAs synthesized in vitro were transfected into baby hamster kidney cells. The viral replication was analyzed by an indirect immunofluorescence assay to monitor NS1 expression and by quantitative real-time PCR. WT D2 RNA-transfected cells were NS1- positive by day 5, whereas the chimeric RNA-transfected cells became NS1-positive similar to 30 days post-transfection in three independent experiments. Sequence analysis covering the entire genome revealed the appearance of a single K74I mutation within the D4MT domain similar to 16 days post-transfection in two experiments. In the third, D290N mutation in the conserved NS3 Walker B motif appeared >= 16 days post-transfection. A time course study of serial passages revealed that the 30-day supernatant had gradually evolved to gain replication fitness. Trans-complementation by co-expression of WT D2 NS5 accelerated viral replication of chimeric RNA without changing the K74I mutation. However, the MT and POL activities of NS5 WT D2 and the chimeric NS5 proteins with or without the K74I mutation are similar. Taken together, our results suggest that evolution of the functional interactions involving the chimeric NS5 protein encoded by the viral genome species is essential for gain of viral replication fitness.	[Teramoto, Tadahisa; Boonyasuppayakorn, Siwaporn; Handley, Misty; Padmanabhan, Radhakrishnan] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA; [Choi, Kyung H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Georgetown University; University of Texas System; University of Texas Medical Branch Galveston	Padmanabhan, R (corresponding author), Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA.	rp55@georgetown.edu	Boonyasuppayakorn, Siwaporn/AIF-3692-2022		National Institutes of Health [R01 AI087856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI087856 (to K. H. C and R. P).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Arroyo J, 2001, TRENDS MOL MED, V7, P350, DOI 10.1016/S1471-4914(01)02048-2; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082; Boonyasuppayakorn S, 2014, METHODS MOL BIOL, V1138, P361, DOI 10.1007/978-1-4939-0348-1_22; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642; Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039; Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kapoor M., 1995, THESIS U KANSAS MED; Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Liu Lihui, 2010, Front Biol (Beijing), V5, P286; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P1882, DOI 10.1001/jama.2013.4903; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Padmanabhan R, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P13; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Spencer F., 1993, Methods (Orlando), V5, P161, DOI 10.1006/meth.1993.1021; Takahashi H, 2012, ANTIVIR RES, V96, P305, DOI 10.1016/j.antiviral.2012.09.023; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Teramoto T, 2008, RNA, V14, P2645, DOI 10.1261/rna.1051208; Vasudevan SG, 2001, FARMACO, V56, P33, DOI 10.1016/S0014-827X(01)01014-X; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06; Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189	55	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22385	22400		10.1074/jbc.M114.584466	http://dx.doi.org/10.1074/jbc.M114.584466			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24904061	Green Published, hybrid			2022-12-28	WOS:000340593500049
J	Lorenzen, N; Nielsen, SB; Yoshimura, Y; Vad, BS; Andersen, CB; Betzer, C; Kaspersen, JD; Christiansen, G; Pedersen, JS; Jensen, PH; Mulder, FAA; Otzen, DE				Lorenzen, Nikolai; Nielsen, Soren B.; Yoshimura, Yuichi; Vad, Brian S.; Andersen, Camilla Bertel; Betzer, Cristine; Kaspersen, Jorn D.; Christiansen, Gunna; Pedersen, Jan S.; Jensen, Poul Henning; Mulder, Frans A. A.; Otzen, Daniel E.			How Epigallocatechin Gallate Can Inhibit alpha-Synuclein Oligomer Toxicity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; FIBRIL FORMATION; AMYLOID FIBRILS; ELEVATED LEVELS; BILAYER CHARGE; DOPAMINE; FIBRILLIZATION; DEMENTIA; DEPENDS; EVENTS	Oligomeric species of various proteins are linked to the pathogenesis of different neurodegenerative disorders. Consequently, there is intense focus on the discovery of novel inhibitors, e. g. small molecules and antibodies, to inhibit the formation and block the toxicity of oligomers. In Parkinson disease, the protein alpha-synuclein (alpha SN) forms cytotoxic oligomers. The flavonoid epigallocatechin gallate (EGCG) has previously been shown to redirect the aggregation of alpha SN monomers and remodel alpha SN amyloid fibrils into disordered oligomers. Here, we dissect EGCG's mechanism of action. EGCG inhibits the ability of preformed oligomers to permeabilize vesicles and induce cytotoxicity in a rat brain cell line. However, EGCG does not affect oligomer size distribution or secondary structure. Rather, EGCG immobilizes the C-terminal region and moderately reduces the degree of binding of oligomers to membranes. We interpret our data to mean that the oligomer acts by destabilizing the membrane rather than by direct pore formation. This suggests that reduction (but not complete abolition) of the membrane affinity of the oligomer is sufficient to prevent cytotoxicity.	[Lorenzen, Nikolai; Nielsen, Soren B.; Yoshimura, Yuichi; Vad, Brian S.; Andersen, Camilla Bertel; Kaspersen, Jorn D.; Pedersen, Jan S.; Mulder, Frans A. A.; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; [Lorenzen, Nikolai; Nielsen, Soren B.; Yoshimura, Yuichi; Vad, Brian S.; Andersen, Camilla Bertel; Mulder, Frans A. A.; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct, DK-8000 Aarhus C, Denmark; [Yoshimura, Yuichi; Kaspersen, Jorn D.; Pedersen, Jan S.; Mulder, Frans A. A.] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Betzer, Cristine; Jensen, Poul Henning] Aarhus Univ, Dept Biomed Med Biochem, DK-8000 Aarhus C, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed Med Immunol, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.	dao@inano.au.dk	Kaspersen, Jørn Døvling/O-6317-2015; Nielsen, Søren B/D-5936-2011; Yoshimura, Yuichi/G-8924-2019; Pedersen, Jan Skov/A-8346-2008; Andersen, Camilla Bertel/AAN-8607-2020; Mulder, Frans AA/C-7158-2017	Yoshimura, Yuichi/0000-0002-9905-453X; Pedersen, Jan Skov/0000-0002-7768-0206; Andersen, Camilla Bertel/0000-0003-1298-0598; Mulder, Frans AA/0000-0001-9427-8406; Jensen, Poul Henning/0000-0002-4439-9020; Betzer, Cristine/0000-0001-5429-3548; Christiansen, Gunna/0000-0003-0540-1367; Otzen, Daniel/0000-0002-2918-8989	Michael J. Fox Foundation; Danish Council for Independent Research/Natural Sciences; Lundbeckfonden; EMBO Long Term Fellowship [ALTF 687-2013]; Danish Research Foundation (inSPIN); Novo Nordisk Fonden [NNF13OC0006627] Funding Source: researchfish	Michael J. Fox Foundation; Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeckfonden(Lundbeckfonden); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Danish Research Foundation (inSPIN); Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by the Michael J. Fox Foundation. Present address: Dept. of Protein Biophysics and Formulation, Novo Nordisk A/S, 2760 Malov, Denmark.; Supported by the Danish Council for Independent Research/Natural Sciences. Present address: Arla Foods Ingredients Group P/S, Sonderupvej 26, DK-6920 Videbaek, Denmark.; Supported by Lundbeckfonden.; Supported by an EMBO Long Term Fellowship ALTF 687-2013.; Supported by the Danish Research Foundation (inSPIN).	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Chandrashekaran IR, 2010, BIOCHEMISTRY-US, V49, P5899, DOI 10.1021/bi902197x; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Ferreira N, 2011, FEBS LETT, V585, P2424, DOI 10.1016/j.febslet.2011.06.030; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Goddard TD, 2008, SPARKY VERSION 3; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Hudson SA, 2009, J MOL BIOL, V392, P689, DOI 10.1016/j.jmb.2009.07.031; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Meng XY, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/650794; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Mysling S, 2013, BIOCHEMISTRY-US, V52, P9097, DOI 10.1021/bi4009193; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Paslawski W, 2014, ANGEW CHEM INT EDIT, V53, P7560, DOI 10.1002/anie.201400491; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Pedersen JS, 1996, MACROMOLECULES, V29, P1363, DOI 10.1021/ma9512115; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Roberts BE, 2009, NAT CHEM BIOL, V5, P936, DOI 10.1038/nchembio.246; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stckl MT, 2013, MOL NEUROBIOL, V47, P613, DOI 10.1007/s12035-012-8331-4; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; van Rooijen BD, 2008, FEBS LETT, V582, P3788, DOI 10.1016/j.febslet.2008.10.009; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200; Zijlstra N, 2012, ANGEW CHEM INT EDIT, V51, P8821, DOI 10.1002/anie.201200813	50	130	132	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21299	21310		10.1074/jbc.M114.554667	http://dx.doi.org/10.1074/jbc.M114.554667			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24907278	Green Published, hybrid			2022-12-28	WOS:000340558300011
J	Katz, A; Tal, DM; Heller, D; Haviv, H; Rabah, B; Barkana, Y; Marcovich, AL; Karlish, SJD				Katz, Adriana; Tal, Daniel M.; Heller, Dan; Haviv, Haim; Rabah, Bilal; Barkana, Yaniv; Marcovich, Arie L.; Karlish, Steven J. D.			Digoxin Derivatives with Enhanced Selectivity for the alpha 2 Isoform of Na, K-ATPase EFFECTS ON INTRAOCULAR PRESSURE IN RABBITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY EPITHELIAL-CELLS; OUABAIN-BINDING-SITE; DEPENDENT ADENOSINE-TRIPHOSPHATASE; DISSOCIATION RATE CONSTANTS; CARDIOTONIC STEROIDS; CARDIAC-GLYCOSIDES; CRYSTAL-STRUCTURE; OUTFLOW FACILITY; NA,K-ATPASE; INHIBITION	In the ciliary epithelium of the eye, the pigmented cells express the alpha 1 beta 1 isoform of Na, K-ATPase, whereas the nonpigmented cells express mainly the alpha 2 beta 3 isoform of Na, K-ATPase. In principle, a Na, K-ATPase inhibitor with selectivity for alpha 2 could effectively reduce intraocular pressure with only minimal local and systemic toxicity. Such an inhibitor could be applied topically provided it was sufficiently permeable via the cornea. Previous experiments with recombinant human alpha 1 beta 1, alpha 2 beta 1, and alpha 3 beta 1 isoforms showed that the classical cardiac glycoside, digoxin, is partially alpha 2-selective and also that the tris-digitoxose moiety is responsible for isoform selectivity. This led to a prediction that modification of the third digitoxose might increase alpha 2 selectivity. A series of perhydro-1,4-oxazepine derivatives of digoxin have been synthesized by periodate oxidation and reductive amination using a variety of R-NH2 substituents. Several derivatives show enhanced selectivity for alpha 2 over alpha 1, close to 8-fold in the best case. Effects of topically applied cardiac glycosides on intraocular pressure in rabbits have been assessed by their ability to either prevent or reverse acute intraocular pressure increases induced by 4-aminopyridine or a selective agonist of the A3 adenosine receptor. Two relatively alpha 2-selective digoxin derivatives efficiently normalize the ocular hypertension, by comparison with digoxin, digoxigenin, or ouabain. This observation is consistent with a major role of alpha 2 in aqueous humor production and suggests that, potentially, alpha 2-selective digoxin derivatives could be of interest as novel drugs for control of intraocular pressure.	[Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Heller, Dan; Barkana, Yaniv] Asaf Harofeh Hosp, Dept Ophthalmol, IL-608183 Zerifin, Israel; [Rabah, Bilal; Marcovich, Arie L.] Kaplan Hosp, Dept Ophthalmol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Kaplan Medical Center	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il		Heller, Dan/0000-0001-5441-9278	Israel Science Foundation [789/12]; Israel Ministry of Trade and Industry Kamin-Yeda Program [47146]	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Trade and Industry Kamin-Yeda Program	This work was supported by Israel Science Foundation Grant 789/12 and Israel Ministry of Trade and Industry Kamin-Yeda Program Project 47146.	ADAMCZYK M, 1995, STEROIDS, V60, P753, DOI 10.1016/0039-128X(95)00115-7; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Carre DA, 2000, AM J PHYSIOL-CELL PH, V279, pC440, DOI 10.1152/ajpcell.2000.279.2.C440; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Cornelius F, 2013, J BIOL CHEM, V288, P6602, DOI 10.1074/jbc.M112.442137; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Dismuke WM, 2009, BRIT J OPHTHALMOL, V93, P104, DOI 10.1136/bjo.2008.142133; Do CW, 2004, J MEMBRANE BIOL, V200, P1, DOI 10.1007/s00232-004-0688-5; EDELMAN JL, 1994, AM J PHYSIOL, V266, pC1210, DOI 10.1152/ajpcell.1994.266.5.C1210; FERRAIOLO BL, 1979, EUR J PHARMACOL, V55, P19, DOI 10.1016/0014-2999(79)90143-2; FROM AHL, 1990, MOL CELL BIOCHEM, V94, P157, DOI 10.1007/BF00214122; HALL C, 1980, P NATL ACAD SCI-BIOL, V77, P4529, DOI 10.1073/pnas.77.8.4529; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Huang B, 2003, ARCH OPHTHALMOL-CHIC, V121, P840, DOI 10.1001/archopht.121.6.840; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Li A, 2012, EXP EYE RES, V96, P4, DOI 10.1016/j.exer.2012.01.009; Li A, 2010, AM J PHYSIOL-CELL PH, V299, pC1308, DOI 10.1152/ajpcell.00333.2010; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Ruoho A E, 1980, Ann N Y Acad Sci, V346, P90, DOI 10.1111/j.1749-6632.1980.tb22093.x; Sandtner W, 2011, J BIOL CHEM, V286, P38177, DOI 10.1074/jbc.M111.267682; SATOH D, 1970, Chemical and Pharmaceutical Bulletin (Tokyo), V18, P94; SIMON KA, 1962, ARCH OPHTHALMOL-CHIC, V68, P227; Socci RR, 2003, PHARMACOLOGY, V69, P108, DOI 10.1159/000072364; Tamiya S, 2003, INVEST OPHTH VIS SCI, V44, P4395, DOI 10.1167/iovs.03-0287; TICHO U, 1979, BRIT J OPHTHALMOL, V63, P646, DOI 10.1136/bjo.63.9.646; Tsai J., 2004, MED MANAGEMENT GLAUC MED MANAGEMENT GLAUC, V2nd; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Wetzel RK, 2001, INVEST OPHTH VIS SCI, V42, P763; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; YODA A, 1973, MOL PHARMACOL, V9, P51; YODA A, 1974, MOL PHARMACOL, V10, P494	37	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21153	21162		10.1074/jbc.M114.557629	http://dx.doi.org/10.1074/jbc.M114.557629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917667	hybrid, Green Published			2022-12-28	WOS:000339396600065
J	Selwa, E; Davi, M; Chenal, A; Sotomayor-Perez, AC; Ladant, D; Malliavin, TE				Selwa, Edithe; Davi, Marilyne; Chenal, Alexandre; Sotomayor-Perez, Ana-Cristina; Ladant, Daniel; Malliavin, Therese E.			Allosteric Activation of Bordetella pertussis Adenylyl Cyclase by Calmodulin MOLECULAR DYNAMICS AND MUTAGENESIS STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-CHANGES; CATALYTIC DOMAIN; TOXIN; CALCIUM; PROTEIN; BINDING; PATHWAYS; STABILIZATION; EQUILIBRIUM; MACROPHAGES	Adenylyl cyclase (AC) toxin is an essential toxin that allows Bordetella pertussis to invade eukaryotic cells, where it is activated after binding to calmodulin (CaM). Based on the crystal structure of the AC catalytic domain in complex with the C-terminal half of CaM (C-CaM), our previous molecular dynamics simulations (Selwa, E., Laine, E., and Malliavin, T. (2012) Differential role of calmodulin and calcium ions in the stabilization of the catalytic domain of adenyl cyclase CyaA from Bordetella pertussis. Proteins 80, 1028-040) suggested that three residues (i.e. Arg(338), Asn(347), and Asp(360)) might be important for stabilizing the AC/CaM interaction. These residues belong to a loop-helix-loop motif at the C-terminal end of AC, which is located at the interface between CaM and the AC catalytic loop. In the present study, we conducted the in silico and in vitro characterization of three AC variants, where one (Asn(347); ACm1A), two (Arg(338) and Asp(360); ACm2A), or three residues (Arg(338), Asn(347), and Asp(360); ACm3A) were substituted with Ala. Biochemical studies showed that the affinities of ACm1A and ACm2A for CaM were not affected significantly, whereas that of ACm3A was reduced dramatically. To understand the effects of these modifications, molecular dynamics simulations were performed based on the modified proteins. The molecular dynamics trajectories recorded for the ACm3A center dot C-CaM complex showed that the calcium-binding loops of C-CaM exhibited large fluctuations, which could be related to the weakened interaction between ACm3A and its activator. Overall, our results suggest that the loop-helix-loop motif at the C-terminal end of AC is crucial during CaM binding for stabilizing the AC catalytic loop in an active configuration.	[Davi, Marilyne; Chenal, Alexandre; Sotomayor-Perez, Ana-Cristina; Ladant, Daniel; Malliavin, Therese E.] Inst Pasteur, F-75015 Paris, France; [Malliavin, Therese E.] CNRS, UMR 3528, Unite Bioinformat Struct, F-75015 Paris, France; [Davi, Marilyne; Chenal, Alexandre; Sotomayor-Perez, Ana-Cristina; Ladant, Daniel] CNRS, UMR 3528, Unite Biochim Interact Macromol, F-75015 Paris, France; [Selwa, Edithe] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Ladant, D (corresponding author), CNRS, UMR 3528, Unite Biochim Interact Macromol, Rue Dr Roux, F-75015 Paris, France.	daniel.ladant@pasteur.fr; therese.malliavin@pasteur.fr	Chenal, Alexandre/C-2240-2009	Chenal, Alexandre/0000-0002-4959-1003; LADANT, Daniel/0000-0003-1955-548X; Malliavin, Therese/0000-0002-3276-3366	Institut Pasteur [PTR 374]; CNRS [UMR 3528]; MENRT	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); MENRT	This work was supported by the Institut Pasteur and CNRS (UMR 3528, Biologie Structurale et Agents Infectieux).; Supported by an allocation doctorale from MENRT, which was distributed by Universite Pierre et Marie Curie (Paris VI).; Supported by Institut Pasteur Grant PTR 374.	AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Cheung GYC, 2008, MICROB PATHOGENESIS, V44, P61, DOI 10.1016/j.micpath.2007.08.007; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; Cilia E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002794; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dickson RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011082; Dubay KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002168; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; GLASER P, 1989, EMBO J, V8, P967, DOI 10.1002/j.1460-2075.1989.tb03459.x; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Hamacher K, 2006, PLOS COMPUT BIOL, V2, P80, DOI 10.1371/journal.pcbi.0020010; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; Kuzu G, 2012, CURR OPIN STRUC BIOL, V22, P367, DOI 10.1016/j.sbi.2012.04.004; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Laine E, 2010, P NATL ACAD SCI USA, V107, P11277, DOI 10.1073/pnas.0914611107; Laine E, 2009, BIOPHYS J, V96, P1249, DOI 10.1016/j.bpj.2008.10.055; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Nussinov R, 2013, STRUCTURE, V21, P1509, DOI 10.1016/j.str.2013.06.002; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; Seifert R, 2012, TRENDS MICROBIOL, V20, P343, DOI 10.1016/j.tim.2012.04.002; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Selwa E, 2012, PROTEINS, V80, P1028, DOI 10.1002/prot.24005; Shen YQ, 2002, EMBO J, V21, P6721, DOI 10.1093/emboj/cdf681; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Vougier S, 2004, J BIOL CHEM, V279, P30210, DOI 10.1074/jbc.M400604200; Weinkam P, 2013, J MOL BIOL, V425, P647, DOI 10.1016/j.jmb.2012.11.041; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; WOLFF J, 1980, P NATL ACAD SCI-BIOL, V77, P3841, DOI 10.1073/pnas.77.7.3841; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhang Y, 2008, FEBS LETT, V582, P1355, DOI 10.1016/j.febslet.2008.03.010	50	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21131	21141		10.1074/jbc.M113.530410	http://dx.doi.org/10.1074/jbc.M113.530410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907274	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000339396600063
J	Watts, JC; Prusiner, SB				Watts, Joel C.; Prusiner, Stanley B.			Mouse Models for Studying the Formation and Propagation of Prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CHRONIC WASTING DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; PATHOLOGICAL ALPHA-SYNUCLEIN; CREUTZFELDT-JAKOB-DISEASE; MICE EXPRESSING HUMAN; TRANSGENIC MICE; SPONTANEOUS GENERATION; A-BETA; INCUBATION-TIME; WILD-TYPE	Prions are self-propagating protein conformers that cause a variety of neurodegenerative disorders in humans and animals. Mouse models have played key roles in deciphering the biology of prions and in assessing candidate therapeutics. The development of transgenic mice that form prions spontaneously in the brain has advanced our understanding of sporadic and genetic prion diseases. Furthermore, the realization that many proteins can become prions has necessitated the development of mouse models for assessing the potential transmissibility of common neurodegenerative diseases. As the universe of prion diseases continues to expand, mouse models will remain crucial for interrogating these devastating illnesses.	[Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, 675 Nelson Rising Ln,Rm 318, San Francisco, CA 94143 USA.	stanley@ind.ucsf.edu		Watts, Joel/0000-0002-2604-2925	National Institutes of Health [AG031220, AG021601, AG002132, AG010770]; NATIONAL INSTITUTE ON AGING [R37AG031220, P01AG021601, P01AG010770, P01AG002132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG031220, AG021601, AG002132, and AG010770 (to S. B. P.) and by gifts from the Sherman Fairchild Foundation, Rainwater Charitable Foundation, Dana Foundation, and Mrs. Mary Jane Brinton.	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Asante EA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003643; Asante EA, 2009, J GEN VIROL, V90, P546, DOI 10.1099/vir.0.007930-0; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Buschmann A, 2000, ARCH VIROL, P75; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; CHANDLER RL, 1961, LANCET, V1, P1378; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Di Bari MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003219; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Friedman-Levi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002350; Giles K, 2012, J VIROL, V86, P6033, DOI 10.1128/JVI.07027-11; Giles K, 2010, ANN NEUROL, V68, P151, DOI 10.1002/ana.22104; Groschup MH, 2008, VET RES, V39, DOI 10.1051/vetres:2008008; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jackson WS, 2013, P NATL ACAD SCI USA, V110, P14759, DOI 10.1073/pnas.1312006110; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; Kawasaki Y, 2007, J VIROL, V81, P12889, DOI 10.1128/JVI.01563-07; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Lu D, 2013, J PHARMACOL EXP THER, V347, P325, DOI 10.1124/jpet.113.205799; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meade-White K, 2007, J VIROL, V81, P4533, DOI 10.1128/JVI.02762-06; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Saijo E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003692; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Sigurdson CJ, 2011, J NEUROSCI, V31, P13840, DOI 10.1523/JNEUROSCI.3504-11.2011; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; Tamguney G, 2009, P NATL ACAD SCI USA, V106, P15002, DOI 10.1073/pnas.0907339106; Tamguney G, 2009, J GEN VIROL, V90, P1035, DOI 10.1099/vir.0.007500-0; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Tateishi J, 1996, NEUROLOGY, V46, P532, DOI 10.1212/WNL.46.2.532; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Torres JM, 2013, EMERG INFECT DIS, V19, P1938, DOI 10.3201/eid1912.130106; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Wagner J, 2013, ACTA NEUROPATHOL, V125, P795, DOI 10.1007/s00401-013-1114-9; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Watts JC, 2012, P NATL ACAD SCI USA, V109, P3498, DOI 10.1073/pnas.1121556109; Watts JC, 2011, P NATL ACAD SCI USA, V108, P2528, DOI 10.1073/pnas.1019034108; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Yang WB, 2009, J NEUROSCI, V29, P10072, DOI 10.1523/JNEUROSCI.2542-09.2009	100	55	55	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19841	19849		10.1074/jbc.R114.550707	http://dx.doi.org/10.1074/jbc.R114.550707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24860095	Green Published, hybrid			2022-12-28	WOS:000339395200002
J	Carter, AM; Gutowski, S; Sternweis, PC				Carter, Angela M.; Gutowski, Stephen; Sternweis, Paul C.			Regulated Localization Is Sufficient for Hormonal Control of Regulator of G Protein Signaling Homology Rho Guanine Nucleotide Exchange Factors (RH-RhoGEFs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE RECRUITMENT; P115 RHOGEF; GTPASE ACTIVATION; PDZ-RHOGEF; DOMAIN; P115-RHOGEF; G-ALPHA(13); REQUIRES; RAC; STIMULATION	The regulator of Gprotein signaling homology (RH) Rho guanine nucleotide exchange factors (RhoGEFs) (p115RhoGEF, leukemia-associated RhoGEF, and PDZ-RhoGEF) contain an RH domain and are specific GEFs for the monomeric GTPase RhoA. The RH domains interact specifically with the alpha subunits of G(12) heterotrimeric GTPases. Activated G alpha(13) modestly stimulates the exchange activity of both p115RhoGEF and leukemia-associated RhoGEF but not PDZ-RhoGEF. Because all three RH-RhoGEFs can localize to the plasma membrane upon expression of activated G alpha(13), cellular localization of these RhoGEFs has been proposed as a mechanism for controlling their activity. We use a small molecule-regulated heterodimerization system to rapidly control the localization of RH-RhoGEFs. Acute localization of the proteins to the plasma membrane activates RhoA within minutes and to levels that are comparable with activation of RhoA by hormonal stimulation of G protein-coupled receptors. The catalytic activity of membrane-localized RhoGEFs is not dependent on activated G alpha(13). We further show that the conserved RH domains can rewire two different RacGEFs to activate Rac1 in response to a traditional activator of RhoA. Thus, RH domains act as independent detectors for activated G alpha(13) and are sufficient to modulate the activity of RhoGEFs by hormones via mediating their localization to substrate, membrane-associated RhoA.	[Carter, Angela M.; Gutowski, Stephen; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Sternweis, PC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Paul.Sternweis@UTsouthwestern.edu		Carter, Angela/0000-0001-5766-3743	National Institute of Health [GM31954]; National Institutes of Health Pharmacological Sciences Training Grant [GM007062]; Robert A. Welch Foundation [I-1262]; Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031954, T32GM007062] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Pharmacological Sciences Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health Grant GM31954 (to P. C. S.) and by National Institutes of Health Pharmacological Sciences Training Grant GM007062 (to A. M. C.). This work was also supported by Robert A. Welch Foundation Grant I-1262 (to P. C. S.) and by the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).	Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Banerjee J, 2009, BIOCHEMISTRY-US, V48, P8032, DOI 10.1021/bi9010013; Benard V, 2002, METHOD ENZYMOL, V345, P349; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Bhattacharyya R, 2009, CELL SIGNAL, V21, P996, DOI 10.1016/j.cellsig.2009.02.010; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hirotani M, 2002, BIOCHEM BIOPH RES CO, V297, P32, DOI 10.1016/S0006-291X(02)02122-8; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200	33	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19737	19746		10.1074/jbc.M114.564930	http://dx.doi.org/10.1074/jbc.M114.564930			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855647	hybrid, Green Published			2022-12-28	WOS:000339326800045
J	Lu, W; Khatri, L; Ziff, EB				Lu, Wei; Khatri, Latika; Ziff, Edward B.			Trafficking of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor (AMPA) Receptor Subunit GluA2 from the Endoplasmic Reticulum Is Stimulated by a Complex Containing Ca2+/Calmodulin-activated Kinase II (CaMKII) and PICK1 Protein and by Release of Ca2+ from Internal Stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; GLUR2; NEURONS; DOMAIN; LTP; PHOSPHORYLATION; PERMEABILITY; STARGAZIN	The GluA2 subunit of the AMPA receptor (AMPAR) dominantly blocks AMPAR Ca2+ permeability, and its trafficking to the synapse regulates AMPAR-dependent synapse Ca2+ permeability. Here we show that GluA2 trafficking from the endoplasmic reticulum (ER) to the plasma membrane of cultured hippocampal neurons requires Ca2+ release from internal stores, the activity of Ca2+/calmodulin activated kinase II (CaMKII), and GluA2 interaction with the PDZ protein, PICK1. We show that upon Ca2+ release from the ER via the IP3 and ryanodine receptors, CaMKII that is activated enters a complex that contains PICK1, dependent upon the PICK1 BAR (Bin-amphiphysin- Rvs) domain, and that interacts with the GluA2 C-terminal domain and stimulates GluA2 ER exit and surface trafficking. This study reveals a novel mechanism of regulation of trafficking of GluA2-containing receptors to the surface under the control of intracellular Ca2+ dynamics and CaMKII activity.	[Lu, Wei; Khatri, Latika; Ziff, Edward B.] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA	New York University	Ziff, EB (corresponding author), NYU, Dept Biochem & Mol Pharmacol, Sch Med, 550 First Ave, New York, NY 10016 USA.	edward.ziff@nyumc.org	Lu, Wei/S-5617-2018	Lu, Wei/0000-0001-6668-8432; Ziff, Edward/0000-0001-7389-8649	National Institutes of Health [R01NS061920]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS061920 (NINDS; to E. B. Z.).	Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BRAUN AP, 1995, J PHYSIOL-LONDON, V488, P37, DOI 10.1113/jphysiol.1995.sp020944; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chung HJ, 2000, J NEUROSCI, V20, P7258; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Menard C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00182; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shimshek DR, 2006, J NEUROSCI, V26, P8428, DOI 10.1523/JNEUROSCI.5410-05.2006; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	50	29	32	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19218	19230		10.1074/jbc.M113.511246	http://dx.doi.org/10.1074/jbc.M113.511246			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831007	hybrid, Green Published			2022-12-28	WOS:000339062900049
J	Nakasone, N; Nakamura, YS; Higaki, K; Oumi, N; Ohno, K; Ninomiya, H				Nakasone, Naoe; Nakamura, Yuko S.; Higaki, Katsumi; Oumi, Nao; Ohno, Kousaku; Ninomiya, Haruaki			Endoplasmic Reticulum-associated Degradation of Niemann-Pick C1 EVIDENCE FOR THE ROLE OF HEAT SHOCK PROTEINS AND IDENTIFICATION OF LYSINE RESIDUES THAT ACCEPT UBIQUITIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; STEROL-SENSING DOMAIN; DISEASE TYPE-C; QUALITY-CONTROL; UBIQUITIN LIGASE; NPC1 PROTEIN; CHOLESTEROL; CHIP; ACCUMULATION; FIBROBLASTS	Most cases with Niemann-Pick disease type C carry mutations in NPC1. Some of the mutations, including the most frequent I1061T, give rise to unstable proteins selected for endoplasmic reticulum-associated degradation. The purpose of the current study was to shed mechanistic insights into the degradation process. A proteasome inhibitor MG132 prolonged the life span of the wild-type NPC1 expressed in COS cells. The expressed protein associated with multiple chaperones including heat shock protein 90 (Hsp90), Hsp70, heat shock cognate protein 70 (Hsc70), and calnexin. Accordingly, expression of an E3 ligase CHIP (carboxyl terminus of Hsp70-interacting protein) enhanced MG132-induced accumulation of ubiquitylated NPC1. Co-expression and RNAi knockdown experiments in HEK cells indicated that Hsp70/Hsp90 stabilized NPC1, whereas Hsc70 destabilized it. In human fibroblasts carrying the I1061T mutation, adenovirus-mediated expression of Hsp70 or treatment with an HSP-inducer geranylgeranylacetone (GGA) increased the level of the mutant protein. In GGA-treated cells, the rescued protein was localized in the late endosome and ameliorated cholesterol accumulation. MALDI-TOF mass spectrometry revealed three lysine residues at amino acids 318, 792, and 1180 as potential ubiquitin-conjugation sites. Substitutions of the three residues with alanine yielded a mutant protein with a steady-state level more than three times higher than that of the wild-type. Introduction of the same substitutions to the I1061T mutant resulted in an increase in its protein level and functional restoration. These findings indicated the role of HSPs in quality control of NPC1 and revealed the role of three lysine residues as ubiquitin-conjugation sites.	[Nakasone, Naoe; Ninomiya, Haruaki] Tottori Univ, Fac Med, Dept Regulat Biol, Yonago, Tottori 6838503, Japan; [Ohno, Kousaku] Tottori Univ, Fac Med, Dept Child Neurol, Yonago, Tottori 6838503, Japan; [Nakamura, Yuko S.] Tottori Inst Ind Technol, Dept Appl Biotechnol, Yonago, Tottori 6840041, Japan; [Higaki, Katsumi] Tottori Univ, Div Funct Genom, Res Ctr Biosci & Technol, Yonago, Tottori 6838503, Japan; [Oumi, Nao] Tottori Univ Hosp, Ctr Canc, Yonago, Tottori 6838504, Japan	Tottori University; Tottori University; Tottori University; Tottori University	Ninomiya, H (corresponding author), Tottori Univ, Fac Med, Dept Regulat Biol, Yonago, Tottori 6838503, Japan.	ninomiya@med.tottori-u.ac.jp			Ara Parseghian Medical Research Foundation	Ara Parseghian Medical Research Foundation	This work was supported in part by a research grant from Ara Parseghian Medical Research Foundation (to H. N.).	Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Iwai C, 2013, CARDIOVASC RES, V100, P520, DOI 10.1093/cvr/cvt200; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Li PL, 2011, CIRC RES, V108, P458, DOI 10.1161/CIRCRESAHA.110.227835; Lin H, 2004, BBA-MOL BASIS DIS, V1689, P219, DOI 10.1016/j.bbadis.2004.03.007; Matsumura Y, 2013, J BIOL CHEM, V288, P31069, DOI 10.1074/jbc.M113.479345; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Millat G, 2001, AM J HUM GENET, V68, P1373, DOI 10.1086/320606; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Ohgane K, 2013, CHEM BIOL, V20, P391, DOI 10.1016/j.chembiol.2013.02.009; Ohsaki Y, 2006, J CELL SCI, V119, P2643, DOI 10.1242/jcs.02993; Patterson M., 2001, METABOLIC MOL BASES, VII, P3611; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Sevin M, 2007, BRAIN, V130, P120, DOI 10.1093/brain/awl260; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Ting YK, 2011, BRIT J PHARMACOL, V162, P1832, DOI 10.1111/j.1476-5381.2011.01204.x; Vanier MT, 2004, BBA-MOL CELL BIOL L, V1685, P14, DOI 10.1016/j.bbalip.2004.08.007; Wang DX, 2005, ANAL CHEM, V77, P1458, DOI 10.1021/ac048834d; Yamamoto T, 2000, J MED GENET, V37, P707, DOI 10.1136/jmg.37.9.707; Yamamoto T, 2004, BRAIN DEV-JPN, V26, P245, DOI 10.1016/S0387-7604(03)00162-1; Yu T, 2012, HUM MOL GENET, V21, P3205, DOI 10.1093/hmg/dds145; Zampieri S, 2012, JIMD REP, V2, P59, DOI 10.1007/8904_2011_49	38	46	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19714	19725		10.1074/jbc.M114.549915	http://dx.doi.org/10.1074/jbc.M114.549915			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891511	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000339326800043
J	Matsuda, S; Kominato, K; Koide-Yoshida, S; Miyamoto, K; Isshiki, K; Tsuji, A; Yuasa, K				Matsuda, Shinya; Kominato, Kyohei; Koide-Yoshida, Shizuyo; Miyamoto, Kenji; Isshiki, Kinuka; Tsuji, Akihiko; Yuasa, Keizo			PCTAIRE Kinase 3/Cyclin-dependent Kinase 18 Is Activated through Association with Cyclin A and/or Phosphorylation by Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK COMPLEXES; SUBSTRATE-SPECIFICITY; DEPENDENT KINASES; NUCLEAR-LOCALIZATION; CANCER; ACTIN; PATHWAYS; OOCYTES; BINDING; FAMILY	PCTAIRE kinase 3 (PCTK3)/cyclin-dependent kinase 18 (CDK18) is an uncharacterized member of the CDK family because its activator(s) remains unidentified. Here we describe the mechanisms of catalytic activation of PCTK3 by cyclin A2 and cAMP-dependent protein kinase (PKA). Using a pulldown experiment with HEK293T cells, cyclin A2 and cyclin E1 were identified as proteins that interacted with PCTK3. An in vitro kinase assay using retinoblastoma protein as the substrate showed that PCTK3 was specifically activated by cyclin A2 but not by cyclin E1, although its activity was lower than that of CDK2. Furthermore, immunocytochemistry analysis showed that PCTK3 colocalized with cyclin A2 in the cytoplasm and regulated cyclin A2 stability. Amino acid sequence analysis revealed that PCTK3 contained four putative PKA phosphorylation sites. In vitro and in vivo kinase assays showed that PCTK3 was phosphorylated by PKA at Ser(12), Ser(66), and Ser(109) and that PCTK3 activity significantly increased via phosphorylation at Ser(12) by PKA even in the absence of cyclin A2. In the presence of cyclin A2, PCTK3 activity was comparable to CDK2 activity. We also found that PCTK3 knockdown in HEK293T cells induced polymerized actin accumulation in peripheral areas and cofilin phosphorylation. Taken together, our results provide the first evidence for the mechanisms of catalytic activation of PCTK3 by cyclin A2 and PKA and a physiological function of PCTK3.	[Matsuda, Shinya; Kominato, Kyohei; Koide-Yoshida, Shizuyo; Miyamoto, Kenji; Isshiki, Kinuka; Tsuji, Akihiko; Yuasa, Keizo] Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, Tokushima 7708506, Japan	Tokushima University	Yuasa, K (corresponding author), Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, 2-1 Minamijosanjima, Tokushima 7708506, Japan.	yuasa@bio.tokushima-u.ac.jp		Matsuda, Shinya/0000-0002-0169-1347	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. Y.).	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Arsic N, 2012, J CELL BIOL, V196, P147, DOI 10.1083/jcb.201102085; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cole AR, 2009, NEUROSIGNALS, V17, P288, DOI 10.1159/000231895; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Eyers PA, 2005, J BIOL CHEM, V280, P24339, DOI 10.1074/jbc.M412442200; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Graeser R, 2002, J CELL SCI, V115, P3479; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; Hirose T, 2000, EUR J BIOCHEM, V267, P2113, DOI 10.1046/j.1432-1327.2000.01218.x; Horton LE, 1997, ONCOGENE, V14, P491, DOI 10.1038/sj.onc.1200851; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang M, 2009, FEBS LETT, V583, P2171, DOI 10.1016/j.febslet.2009.06.010; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Liu F, 2001, AM J PHYSIOL-LUNG C, V280, pL1309, DOI 10.1152/ajplung.2001.280.6.L1309; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MARIDOR G, 1993, J CELL SCI, V106, P535; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nadella KS, 2009, EMBO REP, V10, P599, DOI 10.1038/embor.2009.58; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Odajima J, 2011, DEV CELL, V21, P655, DOI 10.1016/j.devcel.2011.08.009; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sarcevic B, 1997, J BIOL CHEM, V272, P33327, DOI 10.1074/jbc.272.52.33327; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shehata SN, 2012, CELL SIGNAL, V24, P2085, DOI 10.1016/j.cellsig.2012.06.018; Shibuya EK, 2003, CELL CYCLE, V2, P39, DOI 10.4161/cc.2.1.291; Shu F, 2007, P NATL ACAD SCI USA, V104, P9248, DOI 10.1073/pnas.0703327104; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Yamochi T, 2001, BIOCHEM BIOPH RES CO, V286, P1045, DOI 10.1006/bbrc.2001.5493; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Yuasa K, 2011, CELL SIGNAL, V23, P1179, DOI 10.1016/j.cellsig.2011.03.005; Zacksenhaus E, 1999, BBA-MOL CELL RES, V1451, P288, DOI 10.1016/S0167-4889(99)00103-2	51	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18387	18400		10.1074/jbc.M113.542936	http://dx.doi.org/10.1074/jbc.M113.542936			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831015	hybrid, Green Published			2022-12-28	WOS:000338042000037
J	Xia, B; Liu, YL; Li, W; Brice, AR; Dominy, BN; Cao, WG				Xia, Bo; Liu, Yinling; Li, Wei; Brice, Allyn R.; Dominy, Brian N.; Cao, Weiguo			Specificity and Catalytic Mechanism in Family 5 Uracil DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; EUBACTERIUM THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MOLECULAR-DYNAMICS; ACTIVE-SITE; ENZYME MUTY; SUBSTRATE PROPERTIES; ADENINE GLYCOSYLASE	UDGb belongs to family 5 of the uracil DNA glycosylase (UDG) superfamily. Here, we report that family 5 UDGb from Thermus thermophilus HB8 is not only a uracil DNA glycosyase acting on G/U, T/U, C/U, and A/U base pairs, but also a hypoxanthine DNA glycosylase acting on G/I, T/I, and A/I base pairs and a xanthine DNA glycosylase acting on all double-stranded and single-stranded xanthine-containing DNA. Analysis of potentials of mean force indicates that the tendency of hypoxanthine base flipping follows the order of G/I> T/I, A/I> C/I, matching the trend of hypoxanthine DNA glycosylase activity observed in vitro. Genetic analysis indicates that family 5 UDGb can also act as an enzyme to remove uracil incorporated into DNA through the existence of dUTP in the nucleotide pool. Mutational analysis coupled with molecular modeling and molecular dynamics analysis reveals that although hydrogen bonding to O-2 of uracil underlies the UDG activity in a dissociative fashion, Tth UDGb relies on multiple catalytic residues to facilitate its excision of hypoxanthine and xanthine. This study underscores the structural and functional diversity in the UDG superfamily.	[Xia, Bo; Li, Wei; Cao, Weiguo] Clemson Univ, Dept Biochem & Genet, South Carolina Expt Stn, Clemson, SC 29634 USA; [Liu, Yinling; Brice, Allyn R.; Dominy, Brian N.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University; Clemson University	Cao, WG (corresponding author), Clemson Univ, Dept Biochem & Genet, Rm 049 Life Sci Facil,190 Collings St, Clemson, SC 29634 USA.	wgc@clemson.edu	Dominy, Brian/AAA-4541-2020	Dominy, Brian/0000-0002-5635-2879	National Institutes of Health [GM090141]; South Carolina Experiment Station [SC-1700274, 6233]; Department of Defense [W81XWH-10-1-0385]; National Science Foundation [MCB-0953783]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Experiment Station; Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM090141. This work was also supported by South Carolina Experiment Station Grant SC-1700274 (technical contribution No. 6233), Department of Defense Grant W81XWH-10-1-0385, and National Science Foundation Career Award MCB-0953783 (to B. N. D.).	ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Berti PJ, 2006, CHEM REV, V106, P506, DOI 10.1021/cr040461t; Brinkmeyer MK, 2012, CHEM BIOL, V19, P276, DOI 10.1016/j.chembiol.2011.11.011; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunk E, 2012, J AM CHEM SOC, V134, P8608, DOI 10.1021/ja301714j; CASEGREEN SC, 1994, NUCLEIC ACIDS RES, V22, P131, DOI 10.1093/nar/22.2.131; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong L, 2008, DNA REPAIR, V7, P1962, DOI 10.1016/j.dnarep.2008.08.006; Drohat AC, 2000, BIOCHEMISTRY-US, V39, P11865, DOI 10.1021/bi000922e; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Francis AW, 2003, J AM CHEM SOC, V125, P16235, DOI 10.1021/ja0374426; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kosaka H, 2007, J MOL BIOL, V373, P839, DOI 10.1016/j.jmb.2007.08.022; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Kulikowska E, 2004, ACTA BIOCHIM POL, V51, P493; KUMAR VD, 1992, BIOCHEMISTRY-US, V31, P1541, DOI 10.1021/bi00120a035; Lee HW, 2011, J BIOL CHEM, V286, P31282, DOI 10.1074/jbc.M111.249524; Lee HW, 2010, J BIOL CHEM, V285, P41483, DOI 10.1074/jbc.M110.150003; Lee S, 2009, P NATL ACAD SCI USA, V106, P18497, DOI 10.1073/pnas.0902908106; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Malshetty VS, 2010, MICROBIOL-SGM, V156, P940, DOI 10.1099/mic.0.034363-0; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Matsubara M, 2004, NUCLEIC ACIDS RES, V32, P5291, DOI 10.1093/nar/gkh859; McCann JAB, 2008, J AM CHEM SOC, V130, P5789, DOI 10.1021/ja711363s; Mi RJ, 2012, MUTAT RES-FUND MOL M, V735, P12, DOI 10.1016/j.mrfmmm.2012.05.003; Mi RJ, 2009, J MOL BIOL, V385, P761, DOI 10.1016/j.jmb.2008.09.038; Michelson AZ, 2012, J AM CHEM SOC, V134, P19839, DOI 10.1021/ja309082k; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poznanski J, 2003, NUCLEOS NUCLEOT NUCL, V22, P249, DOI 10.1081/NCN-120021425; Priyakumar UD, 2006, CHEM REV, V106, P489, DOI 10.1021/cr040475z; Sakai T, 2008, DNA REPAIR, V7, P663, DOI 10.1016/j.dnarep.2008.01.006; Sandigursky M, 1999, CURR BIOL, V9, P531, DOI 10.1016/S0960-9822(99)80237-1; Sartori AA, 2002, EMBO J, V21, P3182, DOI 10.1093/emboj/cdf309; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Shroyer MJN, 1999, BIOCHEMISTRY-US, V38, P4834, DOI 10.1021/bi982986j; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Srinath T, 2007, DNA REPAIR, V6, P1517, DOI 10.1016/j.dnarep.2007.05.001; Starkuviene V, 2002, NUCLEIC ACIDS RES, V30, P2097, DOI 10.1093/nar/30.10.2097; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; TAYLOR AF, 1982, J BACTERIOL, V151, P351, DOI 10.1128/JB.151.1.351-357.1982; Wanner RM, 2009, J BACTERIOL, V191, P6312, DOI 10.1128/JB.00613-09; WARNER HR, 1981, J BACTERIOL, V145, P687, DOI 10.1128/JB.145.2.687-695.1981; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918; Wright PM, 1999, J BIOL CHEM, V274, P29011, DOI 10.1074/jbc.274.41.29011; ZOLTEWICZ JA, 1970, J AM CHEM SOC, V92, P1741, DOI 10.1021/ja00709a055	61	20	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18413	18426		10.1074/jbc.M114.567354	http://dx.doi.org/10.1074/jbc.M114.567354			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24838246	hybrid, Green Published			2022-12-28	WOS:000338042000039
J	Lackman, JJ; Markkanen, PMH; Hogue, M; Bouvier, M; Petaja-Repo, UE				Lackman, Jarkko J.; Markkanen, Piia M. H.; Hogue, Mireille; Bouvier, Michel; Petaja-Repo, Ulla E.			N-Glycan-dependent and -independent Quality Control of Human delta Opioid Receptor N-terminal Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; RETICULUM-ASSOCIATED DEGRADATION; LUTEINIZING-HORMONE RECEPTOR; PHARMACOLOGICAL CHAPERONES; ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; INFLUENZA HEMAGGLUTININ; PROTEIN; GLYCOSYLATION; ER	Quality control (QC) in the endoplasmic reticulum (ER) scrutinizes newly synthesized proteins and directs them either to ER export or ER-associated degradation (ERAD). Here, we demonstrate that the human delta-opioid receptor (h delta OR) is subjected to ERQC in both N-glycan-dependent and -independent manners. This was shown by investigating the biosynthesis and trafficking of wild-type and non-N-glycosylated F27C variants in metabolic pulse-chase assays coupled with flow cytometry and cell surface biotinylation. Both QC mechanisms distinguished the minute one-amino acid difference between the variants, targeting a large fraction of h delta OR-Cys(27) to ERAD. However, the N-glycan-independent QC was unable to compensate the N-glycan-dependent pathway, and some incompletely folded non-N-glycosylated h delta OR-Cys(27) reached the cell surface in conformation incompatible with ligand binding. The turnover of receptors associating with the molecular chaperone calnexin (CNX) was significantly slower for the h delta OR-Cys(27), pointing to an important role of CNX in the h delta ORN-glycan-dependent QC. This was further supported by the fact that inhibiting the co-translational interaction of h delta OR-Cys(27) precursors with CNX led to their ERAD. Opioid receptor pharmacological chaperones released the CNX-bound receptors to ER export and, furthermore, were able to rescue the Cys(27) variant from polyubiquitination and retrotranslocation to the cytosol whether carrying N-glycans or not. Taken together, the h delta OR appears to rely primarily on the CNX-mediated N-glycan-dependent QC that has the capacity to assist in folding, whereas the N-glycan-independent mechanism constitutes an alternative, although less accurate, system for directing misfolded/incompletely folded receptors to ERAD, possibly in altered cellular conditions.	[Lackman, Jarkko J.; Markkanen, Piia M. H.; Petaja-Repo, Ulla E.] Univ Oulu, Dept Anat & Cell Biol, FI-90014 Oulu, Finland; [Lackman, Jarkko J.; Markkanen, Piia M. H.; Petaja-Repo, Ulla E.] Univ Oulu, Inst Biomed, Med Res Ctr Oulu, FI-90014 Oulu, Finland; [Hogue, Mireille; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Hogue, Mireille; Bouvier, Michel] Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	University of Oulu; University of Oulu; Universite de Montreal; Universite de Montreal	Petaja-Repo, UE (corresponding author), Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, POB 5000, FI-90014 Oulu, Finland.	ulla.petaja-repo@oulu.fi	Petäjä-Repo, Ulla/AAV-6115-2021; Markkanen, Piia/ABD-8843-2020; Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100; Lackman, Jarkko/0000-0002-0422-5157; Markkanen, Piia/0000-0002-7200-6490	Sigrid Juselius Foundation; Medical Research Center Oulu; Academy of Finland [127199]; Finnish Cultural Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Research Center Oulu; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the Sigrid Juselius Foundation, the Medical Research Center Oulu and Grant 127199 from the Academy of Finland (to U.E.P.-R.).; Supported by the Finnish Cultural Foundation.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; Boyd RE, 2013, J MED CHEM, V56, P2705, DOI 10.1021/jm301557k; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Conn PM, 2010, TRENDS ENDOCRIN MET, V21, P190, DOI 10.1016/j.tem.2009.11.003; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Fujimori T, 2013, FEBS J, V280, P1563, DOI 10.1111/febs.12157; Gelernter J., 2000, HUM GENET, V107, P86; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hakalahti AE, 2013, MOL PHARMACOL, V83, P129, DOI 10.1124/mol.112.080440; Hawtin SR, 2001, BIOCHEM J, V357, P73, DOI 10.1042/0264-6021:3570073; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; Lanctot PM, 2006, BIOCHEM BIOPH RES CO, V340, P395, DOI 10.1016/j.bbrc.2005.12.016; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Leskela TT, 2012, J BIOL CHEM, V287, P5008, DOI 10.1074/jbc.M111.305656; Leskela TT, 2009, TRAFFIC, V10, P116, DOI 10.1111/j.1600-0854.2008.00846.x; Li JG, 2007, BIOCHEMISTRY-US, V46, P10960, DOI 10.1021/bi700443j; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Markkanen P. M., 2008, J BIOL CHEM, V283, P29086; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Petaja-Repo UE, 2014, PHARMACOL RES, V83, P52, DOI 10.1016/j.phrs.2013.12.001; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Rene P, 2010, J PHARMACOL EXP THER, V335, P520, DOI 10.1124/jpet.110.172098; Sarajarvi T, 2011, MOL CELL BIOL, V31, P2326, DOI 10.1128/MCB.05015-11; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shenkman M, 2013, J BIOL CHEM, V288, P2167, DOI 10.1074/jbc.M112.438275; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Tzekov R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007492; Ushioda R, 2013, MOL BIOL CELL, V24, P3155, DOI 10.1091/mbc.E13-03-0138; Valenzano K. J., 2010, GPCR MOL PHARM DRUG; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940	50	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17830	17842		10.1074/jbc.M114.566273	http://dx.doi.org/10.1074/jbc.M114.566273			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24798333	Green Published, hybrid			2022-12-28	WOS:000338018100045
J	You, DJ; Park, CR; Lee, HB; Moon, MJ; Kang, JH; Lee, C; Oh, SH; Ahn, C; Seong, JY; Hwang, JI				You, Dong-Joo; Park, Cho Rong; Lee, Hyun Bok; Moon, Mi Jin; Kang, Ju-Hee; Lee, Cheolju; Oh, Seong-Hyun; Ahn, Curie; Seong, Jae Young; Hwang, Jong-Ik			A Splicing Variant of NME1 Negatively Regulates NF-kappa B Signaling and Inhibits Cancer Metastasis by Interacting with IKK beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE IKK; 3'-5'-EXONUCLEASE ACTIVITY; EXONUCLEASE ACTIVITY; SUPPRESSOR NM23-H1; LINKS INFLAMMATION; TUMOR ANGIOGENESIS; CARCINOMA-CELLS; MELANOMA-CELLS; TARGETING IKK; BREAST-CANCER	IKK beta functions as a principal upstream activator of the canonical NF-kappa B pathway by phosphorylating I kappa B, leading to its proteasomal degradation. Because IKK beta is considered a therapeutic target, understanding its regulation may facilitate the design of efficient regulators of this molecule. Here, we report a novel IKK beta-interacting molecule, NME1L, a splicing variant of the NME1 protein. NME1 has attracted attention in cancer research because of its antimetastatic activity and reduced expression in multiple aggressive types of cancer. However, the effect was just moderate but not dramatic in anti-cancer activities. We found that only NME1L interacts with IKK beta. Exogenous expression of NME1L resulted in a potent decrease in TNF alpha-stimulated NF-kappa B activation, whereas knockdown of NME1/NME1L with shRNA enhanced activity of NF-kappa B. NME1L down-regulates IKK beta signaling by blocking IKK beta-mediated I kappa B degradation. When NME1L was introduced into highly metastatic HT1080 cells, the mobility was efficiently inhibited. Furthermore, in a metastasis assay, NME1L-expressing cells did not colonize the lung. Based on these results, NME1L is a potent antimetastatic protein and may be a useful weapon in the fight against cancers.	[You, Dong-Joo; Park, Cho Rong; Lee, Hyun Bok; Moon, Mi Jin; Seong, Jae Young; Hwang, Jong-Ik] Korea Univ, Grad Sch Med, Seoul 136705, South Korea; [Kang, Ju-Hee] Natl Canc Ctr, Goyang Si 410769, Gyeonggi Do, South Korea; [Lee, Cheolju] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [Oh, Seong-Hyun] Gachon Univ, Coll Pharm, Inchon 406840, South Korea; [Ahn, Curie] Seoul Natl Univ, Canc Res Inst, Transplantat Res Inst, Seoul 110799, South Korea	Korea University; Korea University Medicine (KU Medicine); National Cancer Center - Korea (NCC); Korea Institute of Science & Technology (KIST); Gachon University; Seoul National University (SNU)	Hwang, JI (corresponding author), Korea Univ, Grad Sch Med, 73 Inchon Ro, Seoul 136705, South Korea.	hjibio@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	Korea Research Foundation - Korean Government (Ministry of Science, ICT, and Future Planning) [NRF-2013R1A1A2005949]	Korea Research Foundation - Korean Government (Ministry of Science, ICT, and Future Planning)	This work was supported by Korea Research Foundation Grant NRF-2013R1A1A2005949 (to J.-I.H.) funded by the Korean Government (Ministry of Science, ICT, and Future Planning).	Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Chapuis N, 2010, BLOOD, V116, P4240, DOI 10.1182/blood-2009-12-260711; Freije JMP, 1997, J BIOL CHEM, V272, P5525, DOI 10.1074/jbc.272.9.5525; Gasparian AV, 2002, J CELL SCI, V115, P141; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kaetzel DM, 2006, J BIOENERG BIOMEMBR, V38, P163, DOI 10.1007/s10863-006-9040-3; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kim SH, 2006, BBA-MOL CELL RES, V1763, P823, DOI 10.1016/j.bbamcr.2006.03.011; Kim YL, 2008, CELL SIGNAL, V20, P2127, DOI 10.1016/j.cellsig.2008.08.001; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Lim J, 2011, CANCER RES, V71, P7216, DOI 10.1158/0008-5472.CAN-11-2015; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Ma DQ, 2004, J BIOL CHEM, V279, P18073, DOI 10.1074/jbc.M400185200; MARTINEZ JA, 1995, GUT, V37, P712, DOI 10.1136/gut.37.5.712; Mochizuki Y, 2004, CLIN EXP METASTAS, V21, P39, DOI 10.1023/B:CLIN.0000017181.01474.35; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Ouatas T, 2003, J BIOENERG BIOMEMBR, V35, P73, DOI 10.1023/A:1023497924277; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Salerno M, 2005, MOL CELL BIOL, V25, P1379, DOI 10.1128/MCB.25.4.1379-1388.2005; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; STEEG PS, 1988, CANCER RES, V48, P6550; Suzuki E, 2004, INT J CANCER, V108, P207, DOI 10.1002/ijc.11546; Tang ED, 2003, J BIOL CHEM, V278, P38566, DOI 10.1074/jbc.M304374200; TOKUNAGA Y, 1993, INT J CANCER, V55, P66, DOI 10.1002/ijc.2910550113; Tseng YH, 2001, CANCER RES, V61, P2071; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yang JM, 2001, CANCER RES, V61, P4901; Yang MM, 2009, MUTAT RES-FUND MOL M, V660, P74, DOI 10.1016/j.mrfmmm.2008.09.015; Yin YM, 2009, BIOMED PHARMACOTHER, V63, P421, DOI 10.1016/j.biopha.2009.04.032; Yoon JH, 2005, BIOCHEMISTRY-US, V44, P15774, DOI 10.1021/bi0515974; Zhang QB, 2011, INT J CANCER, V128, P40, DOI 10.1002/ijc.25307; Zhao MM, 2001, J EXP MED, V194, P265, DOI 10.1084/jem.194.3.265; Zhu JH, 1999, P NATL ACAD SCI USA, V96, P14911, DOI 10.1073/pnas.96.26.14911; Zhu JH, 1996, J BIOL CHEM, V271, P768, DOI 10.1074/jbc.271.2.768	57	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17709	17720		10.1074/jbc.M114.553552	http://dx.doi.org/10.1074/jbc.M114.553552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24811176	hybrid, Green Published			2022-12-28	WOS:000338018100035
J	Linetsky, M; Raghavan, CT; Johar, K; Fan, XJ; Monnier, VM; Vasavada, AR; Nagaraj, RH				Linetsky, Mikhail; Raghavan, Cibin T.; Johar, Kaid; Fan, Xingjun; Monnier, Vincent M.; Vasavada, Abhay R.; Nagaraj, Ram H.			UVA Light-excited Kynurenines Oxidize Ascorbate and Modify Lens Proteins through the Formation of Advanced Glycation End Products IMPLICATIONS FOR HUMAN LENS AGING AND CATARACT FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAILLARD REACTION; VITAMIN-C; ULTRAVIOLET-RADIATION; AMINO-ACIDS; SINGLET OXYGEN; OXIDATION; FILTER; TRYPTOPHAN; MECHANISM; EXPOSURE	Advanced glycation end products (AGEs) contribute to lens protein pigmentation and cross-linking during aging and cataract formation. In vitro experiments have shown that ascorbate (ASC) oxidation products can form AGEs in proteins. However, the mechanisms of ASC oxidation and AGE formation in the human lens are poorly understood. Kynurenines are tryptophan oxidation products produced from the indoleamine 2,3-dioxygenase (IDO)-mediated kynurenine pathway and are present in the human lens. This study investigated the ability of UVA light-excited kynurenines to photooxidize ASC and to form AGEs in lens proteins. UVA light-excited kynurenines in both free and protein-bound forms rapidly oxidized ASC, and such oxidation occurred even in the absence of oxygen. High levels of GSH inhibited but did not completely block ASC oxidation. Upon UVA irradiation, pigmented proteins from human cataractous lenses also oxidized ASC. When exposed to UVA light (320-400 nm, 100 milliwatts/cm(2), 45 min to 2 h), young human lenses (20-36 years), which contain high levels of free kynurenines, lost a significant portion of their ASC content and accumulated AGEs. A similar formation of AGEs was observed in UVA-irradiated lenses from human IDO/human sodium-dependent vitamin C transporter-2 mice, which contain high levels of kynurenines and ASC. Our data suggest that kynurenine-mediated ASC oxidation followed by AGE formation may be an important mechanism for lens aging and the development of senile cataracts in humans.	[Linetsky, Mikhail] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Linetsky, Mikhail; Raghavan, Cibin T.; Nagaraj, Ram H.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Fan, Xingjun; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Monnier, Vincent M.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Johar, Kaid; Vasavada, Abhay R.] Iladevi Cataract & IOL Res Ctr, Ahmadabad 380052, Gujarat, India	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Linetsky, M (corresponding author), Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA.	mdl78@case.edu; ram.nagaraj@case.edu	Johar, Kaid/AAC-9182-2021; Johar, Kaid/F-5034-2013	Johar, Kaid/0000-0002-1703-6611	National Institutes of Health [EY022061, EY023286, P30EY-11373, EY07099]; Research to Prevent Blindness, New York (Case Western Reserve University); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY022061, P30EY011373, R01EY023286, R01EY007099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, New York (Case Western Reserve University); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY022061, EY023286 (to R. H. N.), P30EY-11373 (Visual Sciences Research Center of Case Western Reserve University), and EY07099 (to V. M. M.). This work was also supported by Research to Prevent Blindness, New York (Case Western Reserve University) and the Ohio Lions Eye Research Foundation.	Ahmed N, 2002, BIOCHEM J, V364, P1; Argirov OK, 2004, J BIOL CHEM, V279, P6487, DOI 10.1074/jbc.M309090200; Balasubramanian D, 2000, J OCUL PHARMACOL TH, V16, P285, DOI 10.1089/jop.2000.16.285; BASSNETT S, 1990, J PHYSIOL-LONDON, V431, P445, DOI 10.1113/jphysiol.1990.sp018339; Bors W., 1997, Vitamin C in health and disease., P75; Bova LM, 2001, INVEST OPHTH VIS SCI, V42, P200; Chen YC, 1997, EXP EYE RES, V65, P835, DOI 10.1006/exer.1997.0393; Cheng RZ, 2006, BBA-MOL BASIS DIS, V1762, P533, DOI 10.1016/j.bbadis.2006.01.009; Cheng RZ, 2004, J BIOL CHEM, V279, P45441, DOI 10.1074/jbc.M405664200; Cheng RZ, 2002, BBA-MOL BASIS DIS, V1587, P65, DOI 10.1016/S0925-4439(02)00069-8; de La Rochette A, 2003, BBA-GEN SUBJECTS, V1621, P235, DOI 10.1016/S0304-4165(03)00072-2; Dillon J, 1999, EXP EYE RES, V68, P785, DOI 10.1006/exer.1999.0687; Dillon J, 1999, JAMA-J AM MED ASSOC, V281, P229, DOI 10.1001/jama.281.3.229; DOLIN PJ, 1994, BRIT J OPHTHALMOL, V78, P478, DOI 10.1136/bjo.78.6.478; Fan XJ, 2008, ANN NY ACAD SCI, V1126, P194, DOI 10.1196/annals.1433.064; Fan XJ, 2006, P NATL ACAD SCI USA, V103, P16912, DOI 10.1073/pnas.0605101103; Francis Simpanya M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1589, DOI 10.1111/j.1751-1097.2008.00390.x; Garner B, 1999, J BIOL CHEM, V274, P20847, DOI 10.1074/jbc.274.30.20847; Giblin FJ, 2000, J OCUL PHARMACOL TH, V16, P121, DOI 10.1089/jop.2000.16.121; Giblin FJ, 2002, EXP EYE RES, V75, P445, DOI 10.1006/exer.2002.2039; Godar DE, 2001, PHOTOCHEM PHOTOBIOL, V73, P621, DOI 10.1562/0031-8655(2001)073<0621:UDOA>2.0.CO;2; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; HEWITT EJ, 1961, BIOCHEM J, V78, P384, DOI 10.1042/bj0780384; HILLER R, 1977, AM J EPIDEMIOL, V105, P450, DOI 10.1093/oxfordjournals.aje.a112404; JAVITT JC, 1994, DOC OPHTHALMOL, V88, P307, DOI 10.1007/BF01203684; Kessel L, 2002, PHOTOCHEM PHOTOBIOL, V76, P549, DOI 10.1562/0031-8655(2002)076<0549:TRASSF>2.0.CO;2; Kopylova LV, 2007, EXP EYE RES, V85, P242, DOI 10.1016/j.exer.2007.04.008; Korlimbinis A, 2006, BIOCHEMISTRY-US, V45, P1950, DOI 10.1021/bi051744y; Korlimbinis A, 2007, EXP EYE RES, V85, P219, DOI 10.1016/j.exer.2007.04.004; Korlimbinis A, 2007, INVEST OPHTH VIS SCI, V48, P1718, DOI 10.1167/iovs.06-1134; Kramarenko GG, 2006, PHOTOCHEM PHOTOBIOL, V82, P1634, DOI 10.1562/2006-01-12-RN-774; Lee KW, 1999, BBA-MOL BASIS DIS, V1453, P141, DOI 10.1016/S0925-4439(98)00097-0; Linetsky M, 1997, PHOTOCHEM PHOTOBIOL, V65, P522, DOI 10.1111/j.1751-1097.1997.tb08598.x; Linetsky M, 1996, PHOTOCHEM PHOTOBIOL, V63, P649, DOI 10.1111/j.1751-1097.1996.tb05669.x; Linetsky M, 1996, EXP EYE RES, V63, P67, DOI 10.1006/exer.1996.0092; Linetsky M, 2008, BBA-MOL BASIS DIS, V1782, P22, DOI 10.1016/j.bbadis.2007.10.003; LOU MF, 1988, EXP EYE RES, V46, P517, DOI 10.1016/S0014-4835(88)80009-5; Lou MF, 1999, EXP EYE RES, V68, P547, DOI 10.1006/exer.1998.0638; Mailankot M, 2009, LAB INVEST, V89, P498, DOI 10.1038/labinvest.2009.22; McNulty R, 2004, J PHYSIOL-LONDON, V559, P883, DOI 10.1113/jphysiol.2004.068619; Mizdrak J, 2008, FREE RADICAL BIO MED, V44, P1108, DOI 10.1016/j.freeradbiomed.2007.12.003; Nagaraj RH, 2012, AMINO ACIDS, V42, P1205, DOI 10.1007/s00726-010-0778-x; Nagaraj RH, 2010, BBA-PROTEINS PROTEOM, V1804, P829, DOI 10.1016/j.bbapap.2009.12.008; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Nagaraj RH, 1999, FEBS LETT, V453, P327, DOI 10.1016/S0014-5793(99)00571-2; Neale RE, 2003, EPIDEMIOLOGY, V14, P707, DOI 10.1097/01.ede.0000086881.84657.98; Ortwerth BJ, 2009, INVEST OPHTH VIS SCI, V50, P3311, DOI 10.1167/iovs.08-2927; Ortwerth BJ, 1997, PHOTOCHEM PHOTOBIOL, V65, P666, DOI 10.1111/j.1751-1097.1997.tb01909.x; Ortwerth BJ, 2003, INVEST OPHTH VIS SCI, V44, P3094, DOI 10.1167/iovs.02-0857; Parker NR, 2007, INVEST OPHTH VIS SCI, V48, P3705, DOI 10.1167/iovs.06-1061; Parker NR, 2004, FREE RADICAL BIO MED, V37, P1479, DOI 10.1016/j.freeradbiomed.2004.07.015; Reszka KJ, 1996, FREE RADICAL BIO MED, V20, P23, DOI 10.1016/0891-5849(95)02018-7; Sabburg J, 2001, PHOTOCHEM PHOTOBIOL, V74, P412, DOI 10.1562/0031-8655(2001)074<0412:EOCOUA>2.0.CO;2; Saxena P, 2000, INVEST OPHTH VIS SCI, V41, P1473; Sherin PS, 2009, J PHYS CHEM B, V113, P4953, DOI 10.1021/jp900541b; Shipanova IN, 1997, ARCH BIOCHEM BIOPHYS, V344, P29, DOI 10.1006/abbi.1997.0195; Simat T, 1996, ADV EXP MED BIOL, V398, P655; Simpson GLW, 2000, BBA-MOL BASIS DIS, V1501, P12, DOI 10.1016/S0925-4439(00)00009-0; SLINEY DH, 1987, J CATARACT REFR SURG, V13, P296, DOI 10.1016/S0886-3350(87)80074-3; Smuda M, 2013, ANGEW CHEM INT EDIT, V52, P4887, DOI 10.1002/anie.201300399; Snytnikova OA, 2007, RUSS CHEM B+, V56, P732, DOI 10.1007/s11172-007-0109-x; Snytnikova OA, 2008, EXP EYE RES, V86, P951, DOI 10.1016/j.exer.2008.03.013; Staniszewska M, 2007, J IMMUNOL METHODS, V324, P63, DOI 10.1016/j.jim.2007.05.002; Staniszewska MM, 2005, J BIOL CHEM, V280, P22154, DOI 10.1074/jbc.M501419200; Streete IM, 2004, INVEST OPHTH VIS SCI, V45, P4091, DOI 10.1167/iovs.04-0178; Takikawa O, 2003, ADV EXP MED BIOL, V527, P277; Taylor LM, 2002, EXP EYE RES, V75, P165, DOI 10.1006/exer.2002.2012; Tessier F, 1999, J BIOL CHEM, V274, P20796, DOI 10.1074/jbc.274.30.20796; Tessier F, 1998, INT J VITAM NUTR RES, V68, P309; Tessier F, 1996, INT J VITAM NUTR RES, V66, P166; VARMA SD, 1987, ANN NY ACAD SCI, V498, P280, DOI 10.1111/j.1749-6632.1987.tb23768.x; WALRANT P, 1975, PHOTOCHEM PHOTOBIOL, V22, P63, DOI 10.1111/j.1751-1097.1975.tb06723.x; Wilker SC, 2001, ANAL BIOCHEM, V290, P353, DOI 10.1006/abio.2001.4992; ZIGMAN S, 1979, INVEST OPHTH VIS SCI, V18, P462	75	53	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17111	17123		10.1074/jbc.M114.554410	http://dx.doi.org/10.1074/jbc.M114.554410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24798334	Green Published, hybrid			2022-12-28	WOS:000338016200044
J	Rios-Esteves, J; Haugen, B; Resh, MD				Rios-Esteves, Jessica; Haugen, Brittany; Resh, Marilyn D.			Identification of Key Residues and Regions Important for Porcupine-mediated Wnt Acylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL DERMAL HYPOPLASIA; SONIC-HEDGEHOG; PORCN GENE; STEM-CELLS; ACYLTRANSFERASE; PROTEINS; CANCER; GROWTH; SITE; PALMITOYLATION	Wnts comprise a family of lipid-modified, secreted signaling proteins that control embryogenesis, as well as tissue homeostasis in adults. Post-translational attachment of palmitoleate (C16:1) to a conserved Ser in Wnt proteins is catalyzed by Porcupine (Porcn), a member of the membrane bound O-acyltransferase (MBOAT) family, and is required for Wnt secretion and signaling. Moreover, genetic alterations in the PORCN gene lead to focal dermal hypoplasia, an X-linked developmental disorder. Despite its physiological importance, the biochemical mechanism governing Wnt acylation by Porcn is poorly understood. Here, we use a cell-based fatty acylation assay that is a direct readout of Porcn acyltransferase activity to perform structure-function analysis of highly conserved residues in Porcn and Wnt3a. In total, 16-point mutations in Porcn and 13 mutations in Wnt3a were generated and analyzed. We identified key residues within Porcn required for enzymatic activity, stability, and Wnt3a binding and mapped these active site residues to predicted transmembrane domain 9. Analysis of focal dermal hypoplasia-associated mutations in Porcn revealed that loss of enzymatic activity arises from altered stability. A consensus sequence within Wnt3a was identified (CXCHGXSXXCXXKXC) that contains residues that mediate Porcn binding, fatty acid transfer, and Wnt signaling. We also showed that Ser or Thr, but not Cys, can serve as a fatty acylation site in Wnt, establishing Porcn as an O-acyltransferase. This analysis sheds light into the mechanism by which Porcn transfers fatty acids to Wnt proteins and provides insight into the mechanisms of fatty acid transfer by MBOAT family members.	[Rios-Esteves, Jessica; Haugen, Brittany; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Rios-Esteves, Jessica; Haugen, Brittany; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA.	reshm@mskcc.org		Resh, Marilyn/0000-0001-6118-9466	National Institutes of Health [GM57966, F31GM100691]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM100691, R01GM057966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57966 (to M. D. R.) and F31GM100691 (to J. R. E.).	ALLAND L, 1994, J BIOL CHEM, V269, P16701; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chu MLH, 2013, STRUCTURE, V21, P1235, DOI 10.1016/j.str.2013.05.006; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Das A, 2008, J LIPID RES, V49, P1770, DOI 10.1194/jlr.M800131-JLR200; Froyen G, 2009, CLIN GENET, V76, P535, DOI 10.1111/j.1399-0004.2009.01248.x; Green JL, 2013, P NATL ACAD SCI USA, V110, P6991, DOI 10.1073/pnas.1303671110; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Hardy RY, 2012, J BIOL CHEM, V287, P42881, DOI 10.1074/jbc.M112.426833; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Leoyklang P, 2008, CLIN GENET, V73, P373, DOI 10.1111/j.1399-0004.2008.00975.x; Lim X.H., 2013, COLD SPRING HARBOR P, V5; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Lombardi MP, 2011, HUM MUTAT, V32, P723, DOI 10.1002/humu.21505; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Nakanishi G, 2013, EUR J DERMATOL, V23, P64, DOI 10.1684/ejd.2012.1911; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	47	57	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17009	17019		10.1074/jbc.M114.561209	http://dx.doi.org/10.1074/jbc.M114.561209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24798332	Green Published, hybrid			2022-12-28	WOS:000338016200035
J	Yano, M; Kawao, N; Okumoto, K; Tamura, Y; Okada, K; Kaji, H				Yano, Masato; Kawao, Naoyuki; Okumoto, Katsumi; Tamura, Yukinori; Okada, Kiyotaka; Kaji, Hiroshi			Fibrodysplasia Ossificans Progressiva-related Activated Activin-like Kinase Signaling Enhances Osteoclast Formation during Heterotopic Ossification in Muscle Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; BONE-FORMATION; PARATHYROID-HORMONE; PROTEIN-KINASE; DIFFERENTIATION; CELLS; OSTEOBLAST; MUTATION	Fibrodysplasia ossificans progressiva is characterized by extensive ossification within muscle tissues, and its molecular pathogenesis is responsible for the constitutively activating mutation (R206H) of the bone morphogenetic protein type 1 receptor, activin-like kinase 2 (ALK2). In this study, we investigated the effects of implanting ALK2 (R206H)-transfected myoblastic C2C12 cells into nude mice on osteoclast formation during heterotopic ossification in muscle and subcutaneous tissues. The implantation of ALK2 (R206H)-transfected C2C12 cells with BMP-2 in nude mice induced robust heterotopic ossification with an increase in the formation of osteoclasts in muscle tissues but not in subcutaneous tissues. The implantation of ALK2 (R206H)-transfected C2C12 cells in muscle induced heterotopic ossification more effectively than that of empty vector-transfected cells. A co-culture of ALK2 (R206H)-transfected C2C12 cells as well as the conditioned medium from ALK2 (R206H)-transfected C2C12 cells enhanced osteoclast formation in Raw264.7 cells more effectively than those with empty vector-transfected cells. The transfection of ALK2 (R206H) into C2C12 cells elevated the expression of transforming growth factor (TGF)-beta, whereas the inhibition of TGF-beta signaling suppressed the enhanced formation of osteoclasts in the co-culture with ALK2 (R206H)-transfected C2C12 cells and their conditioned medium. In conclusion, this study demonstrated that the causal mutation transfection of fibrodysplasia ossificans progressiva in myoblasts enhanced the formation of osteoclasts from its precursor through TGF-beta in muscle tissues.	[Yano, Masato; Kawao, Naoyuki; Tamura, Yukinori; Okada, Kiyotaka; Kaji, Hiroshi] Kinki Univ Fac Med, Dept Physiol & Regenerat Med, Osakasayama 5898511, Japan; [Okumoto, Katsumi] Kinki Univ, Life Sci Res Inst, Osakasayama 5898511, Japan	Kindai University (Kinki University)	Kaji, H (corresponding author), Kinki Univ Fac Med, Dept Physiol & Regenerat Med, 377-2 Ohno Higashi, Osakasayama 5898511, Japan.	hkaji@med.kindai.ac.jp	Kaji, Hiroshi/AAI-5628-2020	Kawao, Naoyuki/0000-0002-4148-5476	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25861347, 25460305, 24590289]; Osaka Medical Research Foundation for Intractable Diseases; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka Medical Research Foundation for Intractable Diseases; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research C: 25861347, C: 25460305, and C: 24590289 (to M. Y, N. K, and H. K, respectively) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Osaka Medical Research Foundation for Intractable Diseases (to N. K.), and a grant from the Global COE Program F11 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. K.).	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brantus JF, 1998, CLIN ORTHOP RELAT R, P117; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; Henriksen K, 2011, ENDOCR REV, V32, P31, DOI 10.1210/er.2010-0006; Henriksen K, 2014, CALCIFIED TISSUE INT, V94, P88, DOI 10.1007/s00223-013-9741-7; Henriksen K, 2012, BONE, V51, P353, DOI 10.1016/j.bone.2012.06.007; Hisa I., 2012, OPEN J ENDOCR METAB, V2, P1; Hisa I, 2011, J BIOL CHEM, V286, P9787, DOI 10.1074/jbc.M110.179127; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Inoue Y, 2009, J CELL BIOCHEM, V108, P285, DOI 10.1002/jcb.22252; Ishida A, 2002, J BIOL CHEM, V277, P26217, DOI 10.1074/jbc.M111093200; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jensen ED, 2010, J CELL BIOCHEM, V109, P672, DOI 10.1002/jcb.22462; Kaji H, 2013, CURR OPIN CLIN NUTR, V16, P272, DOI 10.1097/MCO.0b013e32835fe6a5; KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110; Kaplan FS, 2012, DIS MODEL MECH, V5, P756, DOI 10.1242/dmm.010280; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; Koseki T, 2002, CELL SIGNAL, V14, P31, DOI 10.1016/S0898-6568(01)00221-2; Lang TF, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/702735; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Li XT, 2003, ENDOCRINOLOGY, V144, P4999, DOI 10.1210/en.2003-0166; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Nakaoka D, 2001, OSTEOPOROSIS INT, V12, P548, DOI 10.1007/s001980170075; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; Otsuka E, 2003, CALCIFIED TISSUE INT, V73, P72, DOI 10.1007/s00223-002-1071-0; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Quinn JMW, 2000, J BONE MINER RES, V15, P1459, DOI 10.1359/jbmr.2000.15.8.1459; RICHARDS RR, 1991, J BONE JOINT SURG AM, V73A, P1323, DOI 10.2106/00004623-199173090-00006; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1; Song GA, 2010, J BIOL CHEM, V285, P22542, DOI 10.1074/jbc.M109.094557; Tanaka K, 2012, BONE, V51, P158, DOI 10.1016/j.bone.2012.04.017; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Tanaka K, 2012, BIOCHEM BIOPH RES CO, V418, P134, DOI 10.1016/j.bbrc.2011.12.147; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Ulusoy H, 2012, RHEUMATOL INT, V32, P1379, DOI 10.1007/s00296-010-1426-1; Utvag SE, 2003, J ORTHOP TRAUMA, V17, P430, DOI 10.1097/00005131-200307000-00007; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357	44	23	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16966	16977		10.1074/jbc.M113.526038	http://dx.doi.org/10.1074/jbc.M113.526038			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24798338	Green Published, hybrid			2022-12-28	WOS:000338016200031
J	Sirajuddin, S; Barupala, D; Helling, S; Marcus, K; Stemmler, TL; Rosenzweig, AC				Sirajuddin, Sarah; Barupala, Dulmini; Helling, Stefan; Marcus, Katrin; Stemmler, Timothy L.; Rosenzweig, Amy C.			Effects of Zinc on Particulate Methane Monooxygenase Activity and Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ABSORPTION; CYTOCHROME-C-OXIDASE; METHYLOCOCCUS-CAPSULATUS BATH; BACTERIAL REACTION CENTERS; CRYSTAL-STRUCTURE; METAL CENTERS; CRYSTALLOGRAPHIC LOCATION; RIBONUCLEOTIDE REDUCTASE; BIOLOGICAL OXIDATION; PROTON-TRANSFER	Particulate methane monooxygenase (pMMO) is a membrane-bound metalloenzyme that oxidizes methane to methanol in methanotrophic bacteria. Zinc is a known inhibitor of pMMO, but the details of zinc binding and the mechanism of inhibition are not understood. Metal binding and activity assays on membrane-bound pMMO from Methylococcus capsulatus (Bath) reveal that zinc inhibits pMMO at two sites that are distinct from the copper active site. The 2.6 angstrom resolution crystal structure of Methylocystis species strain Rockwell pMMO reveals two previously undetected bound lipids, and metal soaking experiments identify likely locations for the two zinc inhibition sites. The first is the crystallographic zinc site in the pmoC subunit, and zinc binding here leads to the ordering of 10 previously unobserved residues. A second zinc site is present on the cytoplasmic side of the pmoC subunit. Parallels between these results and zinc inhibition studies of several respiratory complexes suggest that zinc might inhibit proton transfer inpMMO.	[Sirajuddin, Sarah; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Sirajuddin, Sarah; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Barupala, Dulmini; Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Helling, Stefan; Marcus, Katrin] Ruhr Univ Bochum, Med Proteome Ctr, Dept Funct Prote, D-44801 Bochum, Germany	Northwestern University; Northwestern University; Wayne State University; Ruhr University Bochum	Stemmler, TL (corresponding author), Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA.	timothy.stemmler@wayne.edu; amyr@northwestern.edu			United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant [085P1000817]; National Institutes of Health from NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, NCRR, Biomedical Technology Program; United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences [DE-AC02-98CH10886]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070473] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR, Biomedical Technology Program; United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor Grant 085P1000817. GM/CA-CAT has been funded in whole or in part with Federal funds from the National Institutes of Health Grant Y1-CO-1020 from NCI and Grant Y1-GM-1104 from NIGMS. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource and at the National Synchrotron Light Source. SSRL is a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by National Institutes of Health, NCRR, Biomedical Technology Program. NSLS, located at Brookhaven National Laboratory, is supported by the United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences, under Contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Axelrod HL, 2000, P NATL ACAD SCI USA, V97, P1542, DOI 10.1073/pnas.97.4.1542; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Berry EA, 2000, BBA-BIOENERGETICS, V1459, P440, DOI 10.1016/S0005-2728(00)00182-1; BOWMAN JP, 1991, FEMS MICROBIOL ECOL, V85, P15, DOI 10.1016/0378-1097(91)90627-M; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Chen CL, 2004, J INORG BIOCHEM, V98, P2125, DOI 10.1016/j.jinorgbio.2004.09.021; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Conrado RJ, 2014, SCIENCE, V343, P621, DOI 10.1126/science.1246929; Cook SA, 2002, ARCH BIOCHEM BIOPHYS, V398, P32, DOI 10.1006/abbi.2001.2628; Cook SA, 1996, J INORG BIOCHEM, V63, P273, DOI 10.1016/0162-0134(95)00239-1; Culpepper MA, 2012, CRIT REV BIOCHEM MOL, V47, P483, DOI 10.3109/10409238.2012.697865; Culpepper MA, 2012, J AM CHEM SOC, V134, P7640, DOI 10.1021/ja302195p; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang JS, 2000, FEMS MICROBIOL LETT, V189, P67, DOI 10.1016/S0378-1097(00)00253-6; Faxen K, 2006, BBA-BIOENERGETICS, V1757, P388, DOI 10.1016/j.bbabio.2006.05.010; Giachini L, 2007, BIOPHYS J, V93, P2934, DOI 10.1529/biophysj.107.110957; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Helling Stefan, 2012, Methods Mol Biol, V893, P345, DOI 10.1007/978-1-61779-885-6_21; Kuznetsova SS, 2005, BIOCHEMISTRY-MOSCOW+, V70, P128, DOI 10.1007/s10541-005-0091-6; Lee DW, 2011, BIOCHEMISTRY-US, V50, P4263, DOI 10.1021/bi200230e; LEE PA, 1981, REV MOD PHYS, V53, P769, DOI 10.1103/RevModPhys.53.769; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Lukehart, 2007, APPL PHYS METHODS IN, P513; Martinho M, 2007, J AM CHEM SOC, V129, P15783, DOI 10.1021/ja077682b; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Mills DA, 2002, J BIOL CHEM, V277, P14894, DOI 10.1074/jbc.M111922200; Monson CF, 2012, J AM CHEM SOC, V134, P7773, DOI 10.1021/ja212138e; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddock ML, 1999, P NATL ACAD SCI USA, V96, P6183, DOI 10.1073/pnas.96.11.6183; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Qin L, 2007, BIOCHEMISTRY-US, V46, P6239, DOI 10.1021/bi700173w; Reidegeld KA, 2008, PROTEOMICS, V8, P1129, DOI 10.1002/pmic.200701073; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Rosenzweig AC, 2008, BIOCHEM SOC T, V36, P1134, DOI 10.1042/BST0361134; Segel I. H, 1975, ENZYME KINETICS, P465; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; SHIEMKE AK, 1995, ARCH BIOCHEM BIOPHYS, V321, P421, DOI 10.1006/abbi.1995.1413; Shiemke AK, 2004, J BACTERIOL, V186, P928, DOI 10.1128/JB.186.4.928-937.2004; Smith SM, 2011, BIOCHEMISTRY-US, V50, P10231, DOI 10.1021/bi200801z; Smith SM, 2011, METHOD ENZYMOL, P195, DOI 10.1016/B978-0-12-386905-0.00013-9; Stemmler TL, 1997, BIOCHEMISTRY-US, V36, P9847, DOI 10.1021/bi9702795; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takeguchi M, 1999, J MOL CATAL A-CHEM, V137, P161, DOI 10.1016/S1381-1169(98)00123-X; Tinberg CE, 2011, ACCOUNTS CHEM RES, V44, P280, DOI 10.1021/ar1001473; Utschig LM, 1998, BIOCHEMISTRY-US, V37, P8278, DOI 10.1021/bi980395n; Voegtli WC, 2003, J AM CHEM SOC, V125, P15822, DOI 10.1021/ja0370387; Vygodina TV, 2008, FEBS LETT, V582, P4158, DOI 10.1016/j.febslet.2008.11.018; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; WANG S, 1994, INORG CHEM, V33, P1589, DOI 10.1021/ic00086a006; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Yamashita S, 2014, STRUCTURE, V22, P315, DOI 10.1016/j.str.2013.12.002	63	46	47	1	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21782	21794		10.1074/jbc.M114.581363	http://dx.doi.org/10.1074/jbc.M114.581363			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942740	hybrid, Green Published			2022-12-28	WOS:000340558300051
J	Kuo, CY; Li, X; Kong, XQ; Luo, C; Chang, CC; Chung, YY; Shih, HM; Li, KK; Ann, DK				Kuo, Ching-Ying; Li, Xu; Kong, Xiang-Qian; Luo, Cheng; Chang, Che-Chang; Chung, Yiyin; Shih, Hsiu-Ming; Li, Keqin Kathy; Ann, David K.			An Arginine-rich Motif of Ring Finger Protein 4 (RNF4) Oversees the Recruitment and Degradation of the Phosphorylated and SUMOylated Kruppel-associated Box Domain-associated Protein 1 (KAP1)/TRIM28 Protein during Genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN E3 LIGASE; DNA-DAMAGE; POSTTRANSLATIONAL MODIFICATIONS; FAMILY PROTEINS; SUMO; PML; REPAIR; KAP1; IDENTIFICATION; REPLICATION	Kruppel-associated box domain-associated protein 1 (KAP1) is a universal transcriptional corepressor that undergoes multiple posttranslational modifications (PTMs), including SUMOylation and Ser-824 phosphorylation. However, the functional interplay of KAP1 PTMs in regulating KAP1 turnover during DNA damage response remains unclear. To decipher the role and cross-talk of multiple KAP1 PTMs, we show here that DNA double strand break-induced KAP1 Ser-824 phosphorylation promoted the recruitment of small ubiquitin-like modifier (SUMO)-targeted ubiquitin E3 ligase, ring finger protein 4 (RNF4), and subsequent RNF4-mediated, SUMO-dependent degradation. Besides the SUMO interacting motif (SIM), a previously unrecognized, but evolutionarily conserved, arginine-rich motif (ARM) in RNF4 acts as a novel recognition motif for selective target recruitment. Results from combined mutagenesis and computational modeling studies suggest that RNF4 utilizes concerted bimodular recognition, namely SIM for Lys-676 SUMOylation and ARM for Ser(P)-824 of simultaneously phosphorylated and SUMOylated KAP1 (Ser(P)-824-SUMO-KAP1). Furthermore, we proved that arginines 73 and 74 within the ARM of RNF4 are required for efficient recruitment to KAP1 or accelerated degradation of promyelocytic leukemia protein (PML) under stress. In parallel, results of bimolecular fluorescence complementation assays validated the role of the ARM in recognizing Ser(P)-824 in living cells. Taken together, we establish that the ARM is required for RNF4 to efficiently target Ser(P)-824-SUMO-KAP1, conferring ubiquitin Lys-48-mediated proteasomal degradation in the context of double strand breaks. The conservation of such a motif may possibly explain the requirement for timely substrate selectivity determination among a myriad of SUMOylated proteins under stress conditions. Thus, the ARM dynamically regulates the SIM-dependent recruitment of targets to RNF4, which could be critical to dynamically fine-tune the abundance of Ser(P)-824-SUMO-KAP1 and, potentially, other SUMOylated proteins during DNA damage response.	[Kuo, Ching-Ying; Li, Xu; Chung, Yiyin; Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Kuo, Ching-Ying; Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Kong, Xiang-Qian; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Chang, Che-Chang; Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Li, Keqin Kathy] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Inst Hematol,Rui Jin Hosp, Shanghai 200025, Peoples R China	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Academia Sinica - Taiwan; Chinese Academy of Sciences; Shanghai Jiao Tong University	Li, KK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Inst Hematol,Rui Jin Hosp, 197 Ruijin 2 Rd, Shanghai 200025, Peoples R China.	kli@epigenetic.us; dann@coh.org	Shih, Hsiu-Ming/S-7023-2018; Kong, Xiangqian/J-4500-2017	Kong, Xiangqian/0000-0002-9596-7825; KUO, CHING-YING/0000-0003-1555-3057	National Institute of Health [R01DE10742, R01DE14183]; National Science Council [99-2321-B-001-010, 98-2321-B-001-012]; National 973 Program [2011CB510102]; National Natural Science Foundation [81270622]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council(Ministry of Science and Technology, Taiwan); National 973 Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institute of Health Grants R01DE10742 and R01DE14183 (to D. K. A.). This work was also supported by National Science Council Grants 99-2321-B-001-010 and 98-2321-B-001-012 (to H. M. S.), by National 973 Program Grant 2011CB510102 (to K. K. L.), and by National Natural Science Foundation Grant 81270622 (to K. K. L.).	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bologna Serena, 2013, Frontiers in Genetics, V4, P106, DOI 10.3389/fgene.2013.00106; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Cammas F, 2000, DEVELOPMENT, V127, P2955; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Garvin A. J., 2013, EMBO REP, DOI [10.1038/ncb1446, DOI 10.1038/NCB1446]; Geoffroy MC, 2010, MOL BIOL CELL, V21, P4227, DOI 10.1091/mbc.E10-05-0449; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Guo BQ, 2009, MOL CELL BIOL, V29, P3204, DOI 10.1128/MCB.01128-08; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Izumiya Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003506; Keusekotten K, 2014, BIOCHEM J, V457, P207, DOI 10.1042/BJ20130753; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee DH, 2012, EMBO J, V31, P2403, DOI 10.1038/emboj.2012.86; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Li X, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000781; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Liu JP, 2012, CELL CYCLE, V11, P2643, DOI 10.4161/cc.20957; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nguyen HV, 2006, AM J PATHOL, V168, P1452, DOI 10.2353/ajpath.2006.050782; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Ouyang KJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000252; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Sun H., 2007, EMBO J, V26, P4053; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Vyas R, 2013, CELL DEATH DIFFER, V20, P490, DOI 10.1038/cdd.2012.145; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Xie Y, 2010, GENE DEV, V24, P893, DOI 10.1101/gad.1906510; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Yang YC, 2013, J BIOL CHEM, V288, P12866, DOI 10.1074/jbc.M112.413393; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	58	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20757	20772		10.1074/jbc.M114.555672	http://dx.doi.org/10.1074/jbc.M114.555672			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907272	Green Published, hybrid			2022-12-28	WOS:000339396600032
J	Quan, JH; Yusufzai, T				Quan, Jinhua; Yusufzai, Timur			The Tumor Suppressor Chromodomain Helicase DNA-binding Protein 5 (CHD5) Remodels Nucleosomes by Unwrapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; XENOPUS-LAEVIS; IN-VITRO; CHROMATIN; COMPLEX; GENE; SWI/SNF; ACF; TRANSLOCATION; SUBFAMILIES	Although mutations or deletions of chromodomain helicase DNA-binding protein 5 (CHD5) have been linked to cancer and implicate CHD5 in tumor suppression, the ATP-dependent activity of CHD5 is currently unknown. In this study, we discovered that CHD5 is a chromatin remodeling factor with a unique enzymatic activity. CHD5 can expose nucleosomal DNA at one or two discrete positions in the nucleosome. The exposure of the nucleosomal DNA by CHD5 is dependent on ATP hydrolysis, but continued ATP hydrolysis is not required to maintain the nucleosomes in their remodeled state. The activity of CHD5 is distinct from other related chromatin remodeling ATPases, such as ACF and BRG1, and does not lead to complete disruption or destabilization of the nucleosome. Rather, CHD5 likely initiates remodeling in a manner similar to that of other remodeling factors but does not significantly reposition the nucleosome. While the related factor CHD4 shows strong ATPase activity, it does not unwrap nucleosomes as efficiently as CHD5. Our findings add to the growing evidence that chromatin remodeling ATPases have diverse roles in modulating chromatin structure.	Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Yusufzai, T (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,JF520, Boston, MA 02115 USA.	timur_yusufzai@dfci.harvard.edu			Dana-Farber Cancer Institute; William F. Milton Fund; Claudia Adams Barr Program	Dana-Farber Cancer Institute; William F. Milton Fund; Claudia Adams Barr Program	This work was supported by the Dana-Farber Cancer Institute, the William F. Milton Fund, and the Claudia Adams Barr Program.	Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Cho I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003407; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Garcia I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-277; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Mulero-Navarro S, 2008, EPIGENETICS-US, V3, P210, DOI 10.4161/epi.3.4.6610; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Oliver SS, 2012, BIOCHEMISTRY-US, V51, P6534, DOI 10.1021/bi3006972; Paul S, 2013, CELL REP, V3, P92, DOI 10.1016/j.celrep.2012.12.009; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang L, 2013, J CLIN NEUROSCI, V20, P958, DOI 10.1016/j.jocn.2012.07.021; WOLFFE AP, 1986, CELL, V44, P381, DOI 10.1016/0092-8674(86)90459-9; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; YOUNG D, 1983, MOL CELL BIOL, V3, P720, DOI 10.1128/MCB.3.4.720; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	42	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20717	20726		10.1074/jbc.M114.568568	http://dx.doi.org/10.1074/jbc.M114.568568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923445	Green Published, hybrid			2022-12-28	WOS:000339396600029
J	Subramanian, H; Gupta, K; Parameswaran, N; Ali, H				Subramanian, Hariharan; Gupta, Kshitij; Parameswaran, Narayanan; Ali, Hydar			Regulation of Fc epsilon RI Signaling in Mast Cells by G Protein-coupled Receptor Kinase 2 and Its RH Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE PRODUCTION; HOMOLOGY DOMAIN; IN-VIVO; PHOSPHORYLATION; GRK2; SYK; DESENSITIZATION; ACTIVATION; INTERNALIZATION; DEGRANULATION	Agonist-induced phosphorylation of G protein-coupled receptors (GPCRs) by GPCR kinases (GRKs) promotes their desensitization and internalization. Here, we sought to determine the role of GRK2 on Fc epsilon RI signaling and mediator release in mast cells. The strategies utilized included lentiviral shRNA-mediated GRK2 knockdown, GRK2 gene deletion (GRK2(flox/flox)/cre recombinase) and overexpression of GRK2 and its regulator of G protein signaling homology (RH) domain (GRK2-RH). We found that silencing GRK2 expression caused similar to 50% decrease in antigen-induced Ca2+ mobilization and degranulation but resulted in ablation of cytokine (IL-6 and IL-13) generation. The effect of GRK2 on cytokine generation does not require its catalytic activity but is mediated via the phosphorylation of p38 and Akt. Overexpression of GRK2 or its RH domain (GRK2-RH) enhanced antigen-induced mast cell degranulation and cytokine generation without affecting the expression levels of any of the Fc epsilon RI subunits (alpha, beta, and gamma). GRK2 or GRK2-RH had no effect on antigen-induced phosphorylation of Fc epsilon RI gamma or Src but enhanced tyrosine phosphorylation of Syk. These data demonstrate that GRK2 modulates Fc epsilon RI signaling in mast cells via at least two mechanisms. One involves GRK2-RH and modulates tyrosine phosphorylation of Syk, and the other is mediated via the phosphorylation of p38 and Akt.	[Subramanian, Hariharan; Gupta, Kshitij; Ali, Hydar] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Parameswaran, Narayanan] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	University of Pennsylvania; Michigan State University	Ali, H (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, 240 South 40th St, Philadelphia, PA 19104 USA.	alih@upenn.edu	Subramanian, Hariharan/AHC-5755-2022; Parameswaran, Narayanan/V-1969-2019	Parameswaran, Narayanan/0000-0002-8894-5564	National Institutes of Health [HL085774, AI094896]; American Heart Association [12POST9260009];  [K99-HL121073]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL121073, R01HL085774, R01HL095637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094896, R21AI099404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085774 and AI094896 (to H. A.). It was also supported by K99-HL121073 and an American Heart Association Grant 12POST9260009 (to H. S.).	Ahamed J, 2002, J BIOL CHEM, V277, P22685, DOI 10.1074/jbc.M110210200; Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Andrade MV, 2011, EUR J IMMUNOL, V41, P760, DOI 10.1002/eji.201040718; Cannavo A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00264; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; DeFord-Watts LM, 2007, J BIOL CHEM, V282, P16126, DOI 10.1074/jbc.M609418200; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Diviani D, 1996, J BIOL CHEM, V271, P5049; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Fernandez N, 2011, J BIOL CHEM, V286, P28697, DOI 10.1074/jbc.M111.269613; Fukuoka Y, 2008, J IMMUNOL, V180, P6307, DOI 10.4049/jimmunol.180.9.6307; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Guo Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022559; Gupta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046369; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kamal FA, 2011, J MOL CELL CARDIOL, V51, P462, DOI 10.1016/j.yjmcc.2011.01.006; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V115, P791, DOI 10.1016/j.jaci.2005.01.040; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Pao C. S., 2002, SCI STKE, V2002, ppe42; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; Rivera J, 2008, CURR ALLERGY ASTHM R, V8, P14, DOI 10.1007/s11882-008-0004-z; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Rockman HA, 1996, J CLIN INVEST, V97, P1618, DOI 10.1172/JCI118587; Sanderson MP, 2010, MOL IMMUNOL, V48, P171, DOI 10.1016/j.molimm.2010.08.012; Sanderson MP, 2010, CELL IMMUNOL, V262, P28, DOI 10.1016/j.cellimm.2009.12.004; Schafer B, 2013, J ALLERGY CLIN IMMUN, V131, P541, DOI 10.1016/j.jaci.2012.05.009; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Sterne-Marr R, 2004, METHOD ENZYMOL, V390, P310; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Strunk RC, 2006, NEW ENGL J MED, V354, P2689, DOI 10.1056/NEJMct055184; Subramanian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051355; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Wex E, 2011, EUR J IMMUNOL, V41, P3208, DOI 10.1002/eji.201141502; Wong BR, 2004, EXPERT OPIN INV DRUG, V13, P743, DOI 10.1517/13543784.13.7.743	47	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20917	20927		10.1074/jbc.M113.523969	http://dx.doi.org/10.1074/jbc.M113.523969			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24904059	hybrid, Green Published			2022-12-28	WOS:000339396600045
J	Hong, J; Kim, BW; Choo, HJ; Park, JJ; Yi, JS; Yu, DM; Lee, H; Yoon, GS; Lee, JS; Ko, YG				Hong, Jin; Kim, Bong-Woo; Choo, Hyo-Jung; Park, Jung-Jin; Yi, Jae-Sung; Yu, Dong-Min; Lee, Hyun; Yoon, Gye-Soon; Lee, Jae-Seon; Ko, Young-Gyu			Mitochondrial Complex I Deficiency Enhances Skeletal Myogenesis but Impairs Insulin Signaling through SIRT1 Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-PHOSPHORYLATION; AUTOREGULATORY LOOP; ACTIVATING SIRT1; MUSCLE; DYSFUNCTION; PGC-1-ALPHA; DIFFERENTIATION; MUTATIONS; DELETION; PROTECTS	To address whether mitochondrial biogenesis is essential for skeletal myogenesis, C2C12 myogenesis was investigated after knockdown of NADH dehydrogenase (ubiquintone) flavoprotein 1 (NDUFV1), which is an oxidative phosphorylation complex I subunit that is the first subunit to accept electrons from NADH. The NDUFVI knockdown enhanced C2C12 myogenesis by decreasing the NAD(+)/NADH ratio and subsequently inactivating SIRT1 and SIRT1 activators (pyruvate, SRT1720, and resveratrol) abolished the NDUFV1 knockdown-induced myogenesis enhancement. However, the insulin-elicited activation of insulin receptor beta (IR beta) and insulin receptor substrate-1 (IRS-1) was reduced with elevated levels of protein-tyrosine phosphatase 1B after NDUFV1 knockdown in C2C12 myotubes. The NDUFV1 knockdown-induced blockage of insulin signaling was released by protein-tyrosine phosphatase 1B knockdown in C2C12 myotubes, and we found that NDUFV1 or SIRT1 knockdown did not affect mitochondria biogenesis during C2C12 myogenesis. Based on these data, we can conclude that complex I dysfunction-induced SIRT1 inactivation leads to myogenesis enhancement but blocks insulin signaling without affecting mitochondria biogenesis.	[Hong, Jin; Choo, Hyo-Jung; Park, Jung-Jin; Yi, Jae-Sung; Yu, Dong-Min; Lee, Hyun; Ko, Young-Gyu] Korea Univ, Div Life Sci, Seoul 136701, South Korea; [Kim, Bong-Woo] Seowon Univ, Dept Cosmet Sci & Technol, Cheongju, Cheongju 361742, South Korea; [Yoon, Gye-Soon] Ajou Univ, Dept Biochem & Mol Biol, Suwon 443721, South Korea; [Lee, Jae-Seon] Inha Univ, Dept Biomed Sci, Coll Med, Inchon 400712, South Korea	Korea University; Seowon University; Ajou University; Inha University	Ko, YG (corresponding author), Korea Univ, Div Life Sci, 145 Anam Ro, Seoul 136701, South Korea.	ygko@korea.ac.kr		Choo, Hyojung/0000-0002-6280-0332	Korea Research Foundation [2011-0017562, C00286]; Korea University Research Fund	Korea Research Foundation(National Research Foundation of Korea); Korea University Research Fund	This work was supported by Korea Research Foundation Grants 2011-0017562 and C00286 (to Y.-G. K.) and by the Korea University Research Fund.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Barbieri Elena, 2011, J Aging Res, V2011, P845379, DOI 10.4061/2011/845379; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Choo HJ, 2008, EXP MOL MED, V40, P220, DOI 10.3858/emm.2008.40.2.220; Del Prete A, 2008, FREE RADICAL BIO MED, V44, P1443, DOI 10.1016/j.freeradbiomed.2007.12.037; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Holloszy JO, 2013, DIABETES, V62, P1036, DOI 10.2337/db12-1107; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Jafri MS, 2001, ANNU REV BIOMED ENG, V3, P57, DOI 10.1146/annurev.bioeng.3.1.57; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Jung SY, 2010, BIOCHEM BIOPH RES CO, V396, P238, DOI 10.1016/j.bbrc.2010.04.072; Kim BW, 2010, PROTEOMICS, V10, P2498, DOI 10.1002/pmic.200900826; Kim BW, 2004, EXP MOL MED, V36, P476, DOI 10.1038/emm.2004.60; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Krag TO, 2013, MITOCHONDRION, V13, P63, DOI 10.1016/j.mito.2013.01.009; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; Lim JH, 2006, DIABETOLOGIA, V49, P1924, DOI 10.1007/s00125-006-0278-4; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Menzies KJ, 2012, MITOCHONDRION, V12, P5, DOI 10.1016/j.mito.2011.03.001; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pawlikowska P, 2006, CELL PROLIFERAT, V39, P127, DOI 10.1111/j.1365-2184.2006.00376.x; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Wagatsuma A, 2013, THESCIENTIFICWORLDJO, V2013, DOI DOI 10.1155/2013/593267; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006; Zhang XT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3703	57	19	20	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20012	20025		10.1074/jbc.M114.560078	http://dx.doi.org/10.1074/jbc.M114.560078			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895128	Green Published, hybrid			2022-12-28	WOS:000339395200017
J	Chen, B; Zhao, L; Li, X; Ji, YS; Li, N; Xu, XF; Chen, ZY				Chen, Bing; Zhao, Ling; Li, Xian; Ji, Yun-Song; Li, Na; Xu, Xu-Feng; Chen, Zhe-Yu			Syntaxin 8 Modulates the Post-synthetic Trafficking of the TrkA Receptor and Inflammatory Pain Transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NEUROTROPHIN RECEPTORS; NOCICEPTIVE NEURONS; GENE-TRANSFER; SURVIVAL; NGF; LOCALIZATION; EXPRESSION; ENDOSOMES; ROLES	Nerve growth factor (NGF) promotes the survival, maintenance, and neurite outgrowth of sensory and sympathetic neurons, and the effects are mediated by TrkA receptor signaling. Thus, the cell surface location of the TrkA receptor is crucial for NGF-mediated functions. However, the regulatory mechanism underlying TrkA cell surface levels remains incompletely understood. In this study, we identified syntaxin 8 (STX8), a Q-SNARE protein, as a novel TrkA-binding protein. Overexpression and knockdown studies showed that STX8 facilitates TrkA transport from the Golgi to the plasma membrane and regulates the surface levels of TrkA but not TrkB receptors. Furthermore, STX8 modulates downstream NGF-induced TrkA signaling and, consequently, the survival of NGF-dependent dorsal root ganglia neurons. Finally, knockdown of STX8 in rat dorsal root ganglia by recombinant adeno-associated virus serotype 6-mediated RNA interference led to analgesic effects on formalin-induced inflammatory pain. These findings demonstrate that STX8 is a modulator of TrkA cell surface levels and biological functions.	[Chen, Bing; Zhao, Ling; Li, Xian; Ji, Yun-Song; Li, Na; Xu, Xu-Feng; Chen, Zhe-Yu] Shandong Univ, Sch Med, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Sch Med, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn			National 973 Basic Research Program of China [2012CB911000, 2010CB912004]; National Natural Science Foundation of China [31130026, 31101027]; State Program of National Natural Science Foundation of China for Innovative Research Group [81321061]; Foundation for Excellent Young Scientist of Shandong Province [BS2010SW023]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scientist of Shandong Province	This work was supported by National 973 Basic Research Program of China Grants 2012CB911000 and 2010CB912004, National Natural Science Foundation of China Grants 31130026 and 31101027, the State Program of National Natural Science Foundation of China for Innovative Research Group Grant 81321061, and the Foundation for Excellent Young Scientist of Shandong Province Grant BS2010SW023.	Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Bilan F, 2004, J CELL SCI, V117, P1923, DOI 10.1242/jcs.01070; Bodmer D, 2011, NEURON, V70, P1085, DOI 10.1016/j.neuron.2011.04.025; Chao M, 1998, BRAIN RES REV, V26, P295, DOI 10.1016/S0165-0173(97)00036-2; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Gee HY, 2010, J BIOL CHEM, V285, P35519, DOI 10.1074/jbc.M110.162438; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang SH, 2009, J BIOL CHEM, V284, P15126, DOI 10.1074/jbc.M809763200; Jacques SJ, 2012, MOL CELL NEUROSCI, V49, P464, DOI 10.1016/j.mcn.2012.03.002; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Ma WY, 2010, J PHARMACOL SCI, V114, P79, DOI 10.1254/jphs.10119FP; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Mantyh PW, 2011, ANESTHESIOLOGY, V115, P189, DOI 10.1097/ALN.0b013e31821b1ac5; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MU XJ, 1993, J NEUROSCI, V13, P4029; NAKAGAWARA A, 1995, GENOMICS, V25, P538, DOI 10.1016/0888-7543(95)80055-Q; Prekeris R, 1999, MOL BIOL CELL, V10, P3891, DOI 10.1091/mbc.10.11.3891; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Subramaniam VN, 2000, J CELL SCI, V113, P997; Teng FYH, 2001, GENOME BIOL, V2; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Ugolini G, 2007, P NATL ACAD SCI USA, V104, P2985, DOI 10.1073/pnas.0611253104; Ulrich E, 1998, ONCOGENE, V16, P825, DOI 10.1038/sj.onc.1201842; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Vulchanova L, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-31; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Watson JJ, 2006, J PHARMACOL EXP THER, V316, P1122, DOI 10.1124/jpet.105.095844; White FA, 1996, J NEUROSCI, V16, P4662; Wright KM, 2007, CELL DEATH DIFFER, V14, P625, DOI 10.1038/sj.cdd.4402024; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yu T, 2011, TRAFFIC, V12, P521, DOI 10.1111/j.1600-0854.2010.01156.x; Zhang Y, 2009, J BIOL CHEM, V284, P12469, DOI 10.1074/jbc.M809214200; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712	43	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19556	19569		10.1074/jbc.M114.567925	http://dx.doi.org/10.1074/jbc.M114.567925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872407	Green Published, hybrid			2022-12-28	WOS:000339326800030
J	Kohorn, BD; Kohorn, SL; Saba, NJ; Martinez, VM				Kohorn, Bruce D.; Kohorn, Susan L.; Saba, Nicholas J.; Martinez, Victoriano Meco			Requirement for Pectin Methyl Esterase and Preference for Fragmented over Native Pectins for Wall-associated Kinase-activated, EDS1/PAD4-dependent Stress Response in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; RECEPTOR KINASE; WAK1; EXPANSION; GROWTH; OLIGOGALACTURONIDES; METHYLESTERASES; BIOSYNTHESIS; MECHANICS; IMMUNITY	The wall-associated kinases (WAKs) have a cytoplasmic protein kinase domain that spans the plasma membrane and binds pectin in the extracellular matrix of plants. WAKs are required for cell expansion during Arabidopsis seedling development but are also an integral part of the response to pathogens and stress that present oligogalacturonides (OGs), which subsequently bind to WAKs and activate a MPK6 (mitogen-activated protein kinase)-dependent pathway. It was unclear how WAKs distinguish native pectin polymers and OGs to activate one or the other of these two pathways. A dominant allele of WAK2 constitutively activates the stress response, and we show here that the effect is dependent upon EDS1 and PAD4, transcriptional activators involved in the pathogen response. Moreover, the WAK2 dominant allele is suppressed by a null allele of a pectin methyl esterase (PME3) whose activity normally leads to cross-linking of pectins in the cell wall. Although OGs activate a transcriptional response in wild type, the response is enhanced in a pme3/pme3 null, consistent with a competition by OG and native polymers for activation of WAKs. This provides a plausible mechanism for WAKs to distinguish an expansion from a stress pathway.	[Kohorn, Bruce D.; Kohorn, Susan L.; Saba, Nicholas J.; Martinez, Victoriano Meco] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA	Bowdoin College	Kohorn, BD (corresponding author), Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA.	bkohorn@bowdoin.edu	MEDRANO, Vicente/AAW-3249-2020; Meco, Victoriano/A-8398-2016; Meco, Victoriano/GQY-6674-2022	MEDRANO, Vicente/0000-0003-1839-0150; Meco, Victoriano/0000-0003-2244-4967	National Science Foundation [IOS-1146245]; National Center for Research Resources [5P20RR016463-12]; NIGMS from the National Institutes of Health [8 P20 GM103423-12]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation Grant IOS-1146245 (to B. D. K.). Students were also supported by grants from the National Center for Research Resources (5P20RR016463-12) and the NIGMS (8 P20 GM103423-12) from the National Institutes of Health.	Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; Bethke G, 2014, PLANT PHYSIOL, V164, P1093, DOI 10.1104/pp.113.227637; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Christensen U, 2010, PHYTOCHEMISTRY, V71, P62, DOI 10.1016/j.phytochem.2009.09.019; Decreux A, 2005, PLANT CELL PHYSIOL, V46, P268, DOI 10.1093/pcp/pci026; Decreux A, 2006, PHYTOCHEMISTRY, V67, P1068, DOI 10.1016/j.phytochem.2006.03.009; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Espino JJ, 2010, PROTEOMICS, V10, P3020, DOI 10.1002/pmic.201000037; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Guenin S, 2011, NEW PHYTOL, V192, P114, DOI 10.1111/j.1469-8137.2011.03797.x; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; He ZH, 1998, PLANT J, V14, P55, DOI 10.1046/j.1365-313X.1998.00092.x; He ZH, 1999, PLANT MOL BIOL, V39, P1189, DOI 10.1023/A:1006197318246; Kohorn BD, 2006, PLANT J, V46, P307, DOI 10.1111/j.1365-313X.2006.02695.x; Kohorn BD, 2000, PLANT PHYSIOL, V124, P31, DOI 10.1104/pp.124.1.31; Kohorn BD, 2006, J CELL SCI, V119, P2282, DOI 10.1242/jcs.02968; Kohorn BD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00088; Kohorn BD, 2009, PLANT J, V60, P974, DOI 10.1111/j.1365-313X.2009.04016.x; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Peaucelle A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00121; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157; Rojas ER, 2011, BIOPHYS J, V101, P1844, DOI 10.1016/j.bpj.2011.08.016; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Wagner S, 2013, CELL HOST MICROBE, V14, P619, DOI 10.1016/j.chom.2013.11.006; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Winship LJ, 2010, TRENDS PLANT SCI, V15, P363, DOI 10.1016/j.tplants.2010.04.005; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066	31	43	49	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18978	18986		10.1074/jbc.M114.567545	http://dx.doi.org/10.1074/jbc.M114.567545			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855660	hybrid, Green Published			2022-12-28	WOS:000339062900030
J	Desai, AJ; Harikumar, KG; Miller, LJ				Desai, Aditya J.; Harikumar, Kaleeckal G.; Miller, Laurence J.			A Type 1 Cholecystokinin Receptor Mutant That Mimics the Dysfunction Observed for Wild Type Receptor in a High Cholesterol Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SELECTIVE CCK1R AGONISTS; CONSERVED DRY MOTIF; HAMSTER OVARY CELLS; MEMBRANE CHOLESTEROL; MOLECULAR-BASIS; IMIDAZOLE CARBOXAMIDES; HUMAN GALLBLADDERS; II-RECEPTOR; A RECEPTORS	Cholecystokinin (CCK) stimulates the type 1 CCK receptor (CCK1R) to elicit satiety after a meal. Agonists with this activity, although potentially useful for treatment of obesity, can also have side effects and toxicities of concern, making the development of an intrinsically inactive positive allosteric modulator quite attractive. Positive allosteric modulators also have the potential to correct the defective receptor-G protein coupling observed in the high membrane cholesterol environment described in metabolic syndrome. Current model systems to study CCK1R in such an environment are unstable and expensive to maintain. We now report that the Y140A mutation within a cholesterol-binding motif and the conserved, class A G protein-coupled receptor-specific (E/D) RY signature sequence results in ligand binding and activity characteristics similar to wild type CCK1R in a high cholesterol environment. This is true for natural CCK, as well as ligands with distinct chemistries and activity profiles. Additionally, the Y140A construct also behaved like CCK1R in high cholesterol in regard to its internalization, sensitivity to a nonhydrolyzable GTP analog, and anisotropy of a bound fluorescent CCK analog. Chimeric CCK1R/CCK2R constructs that systematically changed the residues in the allosteric ligand-binding pocket were studied in the presence of Y140A. This established increased importance of unique residues within TM3 and reduced the importance of TM2 for binding in the presence of this mutation, with the agonist trigger likely pulled away from its Leu(356) target on TM7. The distinct conformation of this intramembranous pocket within Y140A CCK1R provides an opportunity to normalize this by using a small molecule allosteric ligand, thereby providing safe and effective correction of the coupling defect in metabolic syndrome.	[Desai, Aditya J.; Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Miller, LJ (corresponding author), Mayo Clin, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu			National Institutes of Health [DK032878]; Mayo Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032878, R01DK032878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK032878. This work was also supported by the Mayo Clinic.	Akgun E, 2009, J MED CHEM, V52, P2138, DOI 10.1021/jm801439x; Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; Aquino CJ, 1996, J MED CHEM, V39, P562, DOI 10.1021/jm950626d; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; Beglinger C, 2001, AM J PHYSIOL-REG I, V280, pR1149, DOI 10.1152/ajpregu.2001.280.4.R1149; BEHAR J, 1989, GASTROENTEROLOGY, V97, P1479, DOI 10.1016/0016-5085(89)90392-2; Berger R, 2008, BIOORG MED CHEM LETT, V18, P4833, DOI 10.1016/j.bmcl.2008.07.083; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cawston EE, 2012, J BIOL CHEM, V287, P18618, DOI 10.1074/jbc.M111.335646; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Chen Q, 1997, GASTROENTEROLOGY, V113, P930, DOI 10.1016/S0016-5085(97)70189-6; Chen Q, 1999, GASTROENTEROLOGY, V116, P678, DOI 10.1016/S0016-5085(99)70190-3; Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200; Desai Aditya J, 2012, Front Endocrinol (Lausanne), V3, P123, DOI 10.3389/fendo.2012.00123; Dong MQ, 2005, BIOCHEMISTRY-US, V44, P6693, DOI 10.1021/bi050130q; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gao F, 2008, BIOORG MED CHEM LETT, V18, P4401, DOI 10.1016/j.bmcl.2008.06.053; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Harikumar KG, 2006, J BIOL CHEM, V281, P27072, DOI 10.1074/jbc.M605098200; Harikumar KG, 2013, J BIOL CHEM, V288, P21082, DOI 10.1074/jbc.M113.480715; Harikumar KG, 2013, LIPIDS, V48, P231, DOI 10.1007/s11745-012-3744-4; Harikumar KG, 2005, J BIOL CHEM, V280, P2176, DOI 10.1074/jbc.M410385200; Harikumar KG, 2005, J BIOL CHEM, V280, P1044, DOI 10.1074/jbc.M409480200; HOSHI H, 1993, AM J PHYSIOL, V265, pG1177, DOI 10.1152/ajpgi.1993.265.6.G1177; Jordan J, 2008, CLIN PHARMACOL THER, V83, P281, DOI 10.1038/sj.clpt.6100272; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; KISSILEFF HR, 1981, AM J CLIN NUTR, V34, P154, DOI 10.1093/ajcn/34.2.154; KOPIN AS, 1995, J BIOL CHEM, V270, P5019, DOI 10.1074/jbc.270.10.5019; KOPIN AS, 1994, ANN NY ACAD SCI, V713, P67, DOI 10.1111/j.1749-6632.1994.tb44053.x; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; LIN CW, 1991, MOL PHARMACOL, V39, P346; Miller LJ, 2002, PHARMACOL TOXICOL, V91, P282, DOI 10.1034/j.1600-0773.2002.910603.x; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Ohyama K, 2002, BIOCHEM BIOPH RES CO, V292, P362, DOI 10.1006/bbrc.2002.6670; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pang L, 1999, BIOCHEMISTRY-US, V38, P12003, DOI 10.1021/bi990227a; Potter RM, 2012, J LIPID RES, V53, P137, DOI 10.1194/jlr.M020065; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; REHFELD JF, 1978, J BIOL CHEM, V253, P4022; ROETTGER BF, 1995, J CELL BIOL, V128, P1029, DOI 10.1083/jcb.128.6.1029; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Seres I, 2006, J MEMBRANE BIOL, V214, P91, DOI 10.1007/s00232-006-0020-7; Sherrill RG, 2001, BIOORG MED CHEM LETT, V11, P1145, DOI 10.1016/S0960-894X(01)00164-0; SMITH GP, 1985, ANN NY ACAD SCI, V448, P417, DOI 10.1111/j.1749-6632.1985.tb29936.x; Smith JP, 2014, AM J PHYSIOL-GASTR L, V306, pG91, DOI 10.1152/ajpgi.00301.2013; Xiao ZL, 2000, AM J PHYSIOL-GASTR L, V278, pG251, DOI 10.1152/ajpgi.2000.278.2.G251; Xiao ZL, 1999, AM J PHYSIOL-GASTR L, V276, pG1401, DOI 10.1152/ajpgi.1999.276.6.G1401; YU PR, 1995, AM J PHYSIOL-GASTR L, V269, pG659, DOI 10.1152/ajpgi.1995.269.5.G659; Yu PR, 1996, AM J PHYSIOL-GASTR L, V271, pG56, DOI 10.1152/ajpgi.1996.271.1.G56; Zhu C, 2008, BIOORG MED CHEM LETT, V18, P4393, DOI 10.1016/j.bmcl.2008.06.057; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	54	18	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18314	18326		10.1074/jbc.M114.570200	http://dx.doi.org/10.1074/jbc.M114.570200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825903	Green Published, hybrid			2022-12-28	WOS:000338042000031
J	Ueno-Shuto, K; Kato, K; Tasaki, Y; Sato, M; Sato, K; Uchida, Y; Sakai, H; Ono, T; Suico, MA; Mitsutake, K; Tokutomi, N; Kai, H; Shuto, T				Ueno-Shuto, Keiko; Kato, Kosuke; Tasaki, Yukihiro; Sato, Miki; Sato, Keizo; Uchida, Yuji; Sakai, Hiromichi; Ono, Tomomi; Suico, Mary Ann; Mitsutake, Kazunori; Tokutomi, Naofumi; Kai, Hirofumi; Shuto, Tsuyoshi			Lipopolysaccharide Decreases Single Immunoglobulin Interleukin-1 Receptor-related Molecule (SIGIRR) Expression by Suppressing Specificity Protein 1 (Sp1) via the Toll-like Receptor 4 (TLR4)-p38 Pathway in Monocytes and Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATOR; EPITHELIAL-CELLS; DENDRITIC CELLS; IMMUNE-RESPONSE; ACTIVATION; GENE; SUPERFAMILY; FAILURE; MICE	Single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) is one of the immunoglobulin-like membrane proteins that is crucial for negative regulation of toll-like receptor 4 (TLR4) and interleukin-1 receptor. Despite the importance of understanding its expression and function, knowledge is limited on the regulatory mechanism in the epithelial tissues, such as the liver, lung, and gut, where its predominant expression is originally described. Here, we found expression of SIGIRR in non-epithelial innate immune cells, including primary peripheral blood monocytes, polymorphonuclear neutrophils, monocytic RAW264 cells, and neutrophilic-differentiated HL-60 cells. Consistent with previous findings in epithelial tissues, SIGIRR gene and protein expression were also down-regulated by LPS treatment in a time-dependent manner in primary blood monocytes and polymorphonuclear neutrophils. A reduction was also observed in RAW264 and differentiated HL-60 cells. Notably, exogenous introduction of the dominant negative form of TLR4 and siRNA of p38 resulted in inhibition of LPS-induced SIGIRR down-regulation, whereas treatment with p38 activator anisomycin showed a dose-dependent decrease in SIGIRR expression, suggesting TLR4-p38 signal as a critical pathway for LPS-induced SIGIRR down-regulation. Finally, reporter gene and chromatin immunoprecipitation assays demonstrated that Sp1 is a key factor that directly binds to the proximal promoter of SIGIRR gene and consequently regulates basal SIGIRR expression, which is negatively regulated by the LPS-dependent TLR4-p38 pathway. In summary, the data precisely demonstrate how LPS down-regulates SIGIRR expression and provide a role of LPS signal that counteracts Sp1-dependent basal promoter activation of SIGIRR gene via TLR4-p38 pathway in non-epithelial innate immune cells.	[Ueno-Shuto, Keiko; Tasaki, Yukihiro; Sato, Miki; Sakai, Hiromichi; Ono, Tomomi; Suico, Mary Ann; Mitsutake, Kazunori; Kai, Hirofumi; Shuto, Tsuyoshi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan; [Ueno-Shuto, Keiko; Uchida, Yuji; Tokutomi, Naofumi] Sojo Univ, Fac Pharmaceut Sci, Div Life Sci, Pharmacol Lab, Kumamoto 8600082, Japan; [Kato, Kosuke] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Kato, Kosuke] Temple Univ, Sch Med, Lung Ctr, Philadelphia, PA 19140 USA; [Sato, Keizo] Kyushu Univ Hlth & Welf, Sch Pharm, Miyazaki 8828508, Japan	Kumamoto University; Sojo University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Shuto, T (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	tshuto@gpo.kumamoto-u.ac.jp	kato, kosuke/I-5677-2015	Shuto, Tsuyoshi/0000-0003-1275-4988	Ministry of Education, Science, Sport, and Culture (MEXT) of Japan	Ministry of Education, Science, Sport, and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Science, Sport, and Culture (MEXT) of Japan.	Aalaei-Andabili SH, 2013, J INFECTION, V67, P251, DOI 10.1016/j.jinf.2013.07.016; Baranova I, 2002, INFECT IMMUN, V70, P2995, DOI 10.1128/IAI.70.6.2995-3003.2002; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Davies JM, 2010, IMMUNOLOGY, V131, P438, DOI 10.1111/j.1365-2567.2010.03317.x; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; Jiang XY, 2012, J IMMUNOL, V189, P269, DOI 10.4049/jimmunol.1200365; Kadota C, 2010, CLIN EXP IMMUNOL, V162, P348, DOI 10.1111/j.1365-2249.2010.04254.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Lech M, 2009, J IMMUNOL, V183, P4109, DOI 10.4049/jimmunol.0900118; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Mizunoe S, 2012, J PHARMACOL SCI, V118, P512, DOI 10.1254/jphs.11240FP; Niu YN, 2011, IMMUNOLOGY, V133, P8, DOI 10.1111/j.1365-2567.2010.03374.x; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Serio KJ, 2003, J IMMUNOL, V170, P2121, DOI 10.4049/jimmunol.170.4.2121; Shuto T, 2007, LEUKEMIA RES, V31, P1721, DOI 10.1016/j.leukres.2007.06.011; Shuto T, 2010, BIOCHEM BIOPH RES CO, V398, P647, DOI 10.1016/j.bbrc.2010.06.126; Thomassen E, 1999, CYTOKINE, V11, P389, DOI 10.1006/cyto.1998.0452; Ueno K, 2008, AM J RESP CELL MOL, V38, P263, DOI 10.1165/rcmb.2007-0336RC; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Weber A., 2010, SCI SIGNAL, V3; Xiao H, 2010, GASTROENTEROLOGY, V139, P574, DOI 10.1053/j.gastro.2010.04.043; Ye XB, 2002, J BIOL CHEM, V277, P31863, DOI 10.1074/jbc.M205544200	31	25	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18097	18109		10.1074/jbc.M113.532093	http://dx.doi.org/10.1074/jbc.M113.532093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24821721	Green Published, hybrid			2022-12-28	WOS:000338042000013
J	Deramchia, K; Morand, P; Biran, M; Millerioux, Y; Mazet, M; Wargnies, M; Franconi, JM; Bringaud, F				Deramchia, Kamel; Morand, Pauline; Biran, Marc; Millerioux, Yoann; Mazet, Muriel; Wargnies, Marion; Franconi, Jean-Michel; Bringaud, Frederic			Contribution of Pyruvate Phosphate Dikinase in the Maintenance of the Glycosomal ATP/ADP Balance in the Trypanosoma brucei Procyclic Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCINATE COA-TRANSFERASE; BLOOD-STREAM FORMS; MOLECULAR CHARACTERIZATION; PHOSPHOGLYCERATE KINASES; LIPID BIOSYNTHESIS; ENERGY-METABOLISM; GENE; GLUCOSE; GLYCOLYSIS; PROLINE	Trypanosoma brucei belongs to a group of protists that sequester the first six or seven glycolytic steps inside specialized peroxisomes, named glycosomes. Because of the glycosomal membrane impermeability to nucleotides, ATP molecules consumed by the first glycolytic steps need to be regenerated in the glycosomes by kinases, such as phosphoenolpyruvate carboxykinase (PEPCK). The glycosomal pyruvate phosphate dikinase (PPDK), which reversibly converts phosphoenolpyruvate into pyruvate, could also be involved in this process. To address this question, we analyzed the metabolism of the main carbon sources used by the procyclic trypanosomes (glucose, proline, and threonine) after deletion of the PPDK gene in the wild-type (Delta ppdk) and PEPCK null (Delta ppdk/Delta pepck) backgrounds. The rate of acetate production from glucose is 30% reduced in the Delta ppdk mutant, whereas threonine-derived acetate production is not affected, showing that PPDK function in the glycolytic direction with production of ATP in the glycosomes. The Delta ppdk/Delta pepck mutant incubated in glucose as the only carbon source showed a 3.8-fold reduction of the glycolytic rate compared with the Delta pepck mutant, as a consequence of the imbalanced glycosomal ATP/ADP ratio. The role of PPDK in maintenance of the ATP/ADP balance was confirmed by expressing the glycosomal phosphoglycerate kinase (PGKC) in the Delta ppdk/Delta pepck cell line, which restored the glycolytic flux. We also observed that expression of PGKC is lethal for procyclic trypanosomes, as a consequence of ATP depletion, due to glycosomal relocation of cytosolic ATP production. This illustrates the key roles played by glycosomal and cytosolic kinases, including PPDK, to maintain the cellular ATP/ADP homeostasis.	[Deramchia, Kamel; Morand, Pauline; Biran, Marc; Millerioux, Yoann; Mazet, Muriel; Wargnies, Marion; Franconi, Jean-Michel; Bringaud, Frederic] Univ Bordeaux, CNRS, UMR 5536, Ctr Resonance Magnet Syst Biol, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bringaud, F (corresponding author), Univ Bordeaux, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	bringaud@rmsb.u-bordeaux2.fr	MILLERIOUX, Yoann/AAT-8857-2020	MILLERIOUX, Yoann/0000-0003-3782-3118	Centre National de la Recherche Scientifique (CNRS); Universite de Bordeaux; Conseil Regional d'Aquitaine; Laboratoire d'Excellence (LabEx) ParaFrap [ANR-11-LABX-0024]; Agence Nationale de la Recherche (ANR) Grant ACETOTRYP of the ANR-BLANC; ParaMet PhD programme of the Marie Curie Initial Training Network	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite de Bordeaux; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Laboratoire d'Excellence (LabEx) ParaFrap; Agence Nationale de la Recherche (ANR) Grant ACETOTRYP of the ANR-BLANC(French National Research Agency (ANR)); ParaMet PhD programme of the Marie Curie Initial Training Network	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Universite de Bordeaux, the Conseil Regional d'Aquitaine, the Laboratoire d'Excellence (LabEx) ParaFrap ANR-11-LABX-0024, Agence Nationale de la Recherche (ANR) Grant ACETOTRYP of the ANR-BLANC-2010 call, and the ParaMet PhD programme of the Marie Curie Initial Training Network (FP7).	Acosta H, 2004, COMP BIOCHEM PHYS B, V138, P347, DOI 10.1016/j.cbpc.2004.04.017; Akoka S, 1999, ANAL CHEM, V71, P2554, DOI 10.1021/ac981422i; ALEXANDER K, 1991, MOL BIOCHEM PARASIT, V46, P1, DOI 10.1016/0166-6851(91)90193-A; Allmann S, 2013, J BIOL CHEM, V288, P18494, DOI 10.1074/jbc.M113.462978; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Blattner J, 1998, P NATL ACAD SCI USA, V95, P11596, DOI 10.1073/pnas.95.20.11596; Bringaud F, 1995, MOL BIOCHEM PARASIT, V74, P119, DOI 10.1016/0166-6851(95)02486-7; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; BRUN R, 1979, ACTA TROP, V36, P289; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Coustou V, 2006, J BIOL CHEM, V281, P26832, DOI 10.1074/jbc.M601377200; CROSS GAM, 1975, PARASITOLOGY, V71, P311, DOI 10.1017/S0031182000046758; Denise H, 1999, EUR J BIOCHEM, V259, P339, DOI 10.1046/j.1432-1327.1999.00048.x; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; ELSE AJ, 1994, MOL BIOCHEM PARASIT, V64, P233, DOI 10.1016/0166-6851(93)00016-3; Estevez AM, 1999, MOL BIOCHEM PARASIT, V100, P5, DOI 10.1016/S0166-6851(99)00024-9; Fairlamb A. H., 1986, Carbohydrate metabolism in cultured cells., P183; Feng XM, 2008, BIOCHEM BIOPH RES CO, V367, P394, DOI 10.1016/j.bbrc.2007.12.139; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; Ghozlane Amine, 2012, Advances in Bioinformatics, V2012, P159423, DOI 10.1155/2012/159423; Ginger ML, 2005, J BIOL CHEM, V280, P11781, DOI 10.1074/jbc.M413821200; Gualdron-Lopez M, 2012, INT J PARASITOL, V42, P1, DOI 10.1016/j.ijpara.2011.10.007; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Harlow E., 1988, ANTIBODIES LAB MANUA, P469; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; KLEIN RA, 1975, PARASITOLOGY, V71, P93, DOI 10.1017/S003118200005318X; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lemasters J J, 1979, Methods Enzymol, V56, P530; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; LINSTEAD DJ, 1977, J GEN MICROBIOL, V101, P243, DOI 10.1099/00221287-101-2-243; Luginbuehl E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-4; Marshall JS, 2001, CURR GENET, V40, P73, DOI 10.1007/s002940100225; Mazet M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002587; MERTENS E, 1993, PARASITOL TODAY, V9, P122, DOI 10.1016/0169-4758(93)90169-G; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Millerioux Y, 2013, MOL MICROBIOL, V90, P114, DOI 10.1111/mmi.12351; Millerioux Y, 2012, J BIOL CHEM, V287, P17186, DOI 10.1074/jbc.M112.355404; MISSET O, 1987, EUR J BIOCHEM, V162, P493, DOI 10.1111/j.1432-1033.1987.tb10667.x; Nevalainen L, 1996, MOL BIOCHEM PARASIT, V77, P217, DOI 10.1016/0166-6851(96)02604-7; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; OSINGA KA, 1985, EMBO J, V4, P3811, DOI 10.1002/j.1460-2075.1985.tb04152.x; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Saavedra E, 2005, FEBS J, V272, P1767, DOI 10.1111/j.1742-4658.2005.04610.x; Sambrook J., 2001, MOL CLONING LAB MANU; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	59	26	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17365	17378		10.1074/jbc.M114.567230	http://dx.doi.org/10.1074/jbc.M114.567230			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24794874	Green Published, hybrid			2022-12-28	WOS:000338018100007
J	Aninye, IO; Matsumoto, S; Sidhaye, AR; Wondisford, FE				Aninye, Irene O.; Matsumoto, Shunichi; Sidhaye, Aniket R.; Wondisford, Fredric E.			Circadian Regulation of Tshb Gene Expression by Rev-Erb alpha (NR1D1) and Nuclear Corepressor 1 (NCOR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE ACTION; IN-VIVO; RECEPTOR-BETA; CELL-LINE; METABOLISM; THYROTROPIN; PITUITARY; BINDING; CLOCK; MICE	Thyroid hormones (TH) are critical for development, growth, and metabolism. Circulating TH levels are tightly regulated by thyroid-stimulating hormone (TSH) secretion within the hypothalamic-pituitary-thyroid axis. Although circadian TSH secretion has been well documented, the mechanism of this observation remains unclear. Recently, the nuclear corepressor, NCOR1, has been postulated to regulate TSH expression, presumably by interacting with thyroid hormone receptors (THRs) bound to TSH subunit genes. We report herein the first in vitro study of NCOR1 regulation of TSH in a physiologically relevant cell system, the T alpha T1.1 mouse thyrotroph cell line. Knockdown of NCOR1 by shRNA adenovirus increased baseline Tshb mRNA levels compared with scrambled control, but surprisingly had no affect on the T-3-mediated repression of this gene. Using ChIP, we show that NCOR1 enriches on the Tshb promoter at sites different from THR previously identified by our group. Furthermore, NCOR1 enrichment on Tshb is unaffected by T-3 treatment. Given that NCOR1 does not target THR on Tshb, we hypothesized that NCOR1 targeted Rev-Erb alpha (NR1D1), an orphan nuclear receptor that is a potent repressor of gene transcription and regulator of metabolism and circadian rhythms. Using a serum shock technique, we synchronized T alpha T1.1 cells to study circadian gene expression. Post-synchronization, Tshb and Nr1d1 mRNA levels displayed oscillations that inversely correlated with each other. Furthermore, NR1D1 was enriched at the same locus as NCOR1 on Tshb. Therefore, we propose a model for Tshb regulation whereby NR1D1 and NCOR1 interact to regulate circadian expression of Tshb independent of TH negative regulation.	Johns Hopkins Univ Sch Med, Div Metab, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ Sch Med, Div Metab, Dept Physiol, Baltimore, MD 21287 USA; Johns Hopkins Univ Sch Med, Div Metab, Dept Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wondisford, FE (corresponding author), Johns Hopkins Univ Hosp, Div Metab, Dept Pediat, 600 N Wolfe St,CMSC 10-113, Baltimore, MD 21287 USA.	fwondis1@jhmi.edu		Aninye, Irene/0000-0002-1747-9148	National Institutes of Health [R01DK49126]; Johns Hopkins University-University of Maryland Diabetes Research Center Grant [P60DK079637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637, P30DK079637, R01DK049126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University-University of Maryland Diabetes Research Center Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK49126. This work was also supported by The Johns Hopkins University-University of Maryland Diabetes Research Center Grant P60DK079637.	Abel ED, 1999, J CLIN INVEST, V104, P291, DOI 10.1172/JCI6397; Drigo RAE, 2013, BBA-GEN SUBJECTS, V1830, P3956, DOI 10.1016/j.bbagen.2012.08.019; Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Chiamolera MI, 2012, MOL ENDOCRINOL, V26, P926, DOI 10.1210/me.2011-1290; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P5049, DOI 10.1210/en.2012-1504; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P4128, DOI 10.1210/en.2012-1467; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fisher DA, 1996, CLIN CHEM, V42, P135; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; FLUG F, 1987, J BIOL CHEM, V262, P6373; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Huang YY, 2013, WORLD J GASTROENTERO, V19, P8238, DOI 10.3748/wjg.v19.i45.8238; Kim SW, 1996, MOL CELL BIOL, V16, P4465; Lande-Diner L, 2013, P NATL ACAD SCI USA, V110, P16021, DOI 10.1073/pnas.1305980110; Machado DS, 2009, P NATL ACAD SCI USA, V106, P9441, DOI 10.1073/pnas.0903227106; Mannic T, 2013, J CLIN ENDOCR METAB, V98, P4446, DOI 10.1210/jc.2013-2568; Oberste-Berghaus C, 2000, J BIOL CHEM, V275, P1787, DOI 10.1074/jbc.275.3.1787; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Ortiga-Carvalho TM, 2005, J CLIN INVEST, V115, P2517, DOI 10.1172/JCI24109; PARK EA, 1995, BIOCHEM J, V309, P913, DOI 10.1042/bj3090913; Richter CP, 2011, CELL PHYSIOL BIOCHEM, V28, P997, DOI 10.1159/000335812; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Song YY, 2011, PROTEIN CELL, V2, P358, DOI 10.1007/s13238-011-1046-x; Sviridonova MA, 2013, ENDOCR RES, V38, P24, DOI 10.3109/07435800.2012.710696; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; VANREETH O, 1994, AM J PHYSIOL, V266, pE964, DOI 10.1152/ajpendo.1994.266.6.E964; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Yusta B, 1998, ENDOCRINOLOGY, V139, P4476, DOI 10.1210/en.139.11.4476; Zamir I, 1997, P NATL ACAD SCI USA, V94, P14400, DOI 10.1073/pnas.94.26.14400	34	24	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17070	17077		10.1074/jbc.M114.569723	http://dx.doi.org/10.1074/jbc.M114.569723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24794873	Green Published, hybrid			2022-12-28	WOS:000338016200040
J	Moskot, M; Montefusco, S; Jakobkiewicz-Banecka, J; Mozolewski, P; Wegrzyn, A; Di Bernardo, D; Wegrzyn, G; Medina, DL; Ballabio, A; Gabig-Ciminska, M				Moskot, Marta; Montefusco, Sandro; Jakobkiewicz-Banecka, Joanna; Mozolewski, Pawel; Wegrzyn, Alicja; Di Bernardo, Diego; Wegrzyn, Grzegorz; Medina, Diego L.; Ballabio, Andrea; Gabig-Ciminska, Magdalena			The Phytoestrogen Genistein Modulates Lysosomal Metabolism and Transcription Factor EB (TFEB) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED ISOFLAVONE THERAPY; SUBSTRATE REDUCTION THERAPIES; GLYCOSAMINOGLYCAN SYNTHESIS; SANFILIPPO DISEASE; MEDIATED INHIBITION; CELLULAR CLEARANCE; EXPRESSION; MUCOPOLYSACCHARIDOSES; STORAGE; CELLS	Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) has been previously proposed as a potential drug for use in substrate reduction therapy for mucopolysaccharidoses, a group of inherited metabolic diseases caused by mutations leading to inefficient degradation of glycosaminoglycans (GAGs) in lysosomes. It was demonstrated that this isoflavone can cross the blood-brain barrier, making it an especially desirable potential drug for the treatment of neurological symptoms present in most lysosomal storage diseases. So far, no comprehensive genomic analyses have been performed to elucidate the molecular mechanisms underlying the effect elicited by genistein. Therefore, the aim of this work was to identify the genistein-modulated gene network regulating GAG biosynthesis and degradation, taking into consideration the entire lysosomal metabolism. Our analyses identified over 60 genes with known roles in lysosomal biogenesis and/or function whose expression was enhanced by genistein. Moreover, 19 genes whose products are involved in both GAG synthesis and degradation pathways were found to be remarkably differentially regulated by genistein treatment. We found a regulatory network linking genistein-mediated control of transcription factor EB (TFEB) gene expression, TFEB nuclear translocation, and activation of TFEB-dependent lysosome biogenesis to lysosomal metabolism. Our data indicate that the molecular mechanism of genistein action involves not only impairment of GAG synthesis but more importantly lysosomal enhancement via TFEB. These findings contribute to explaining the beneficial effects of genistein in lysosomal storage diseases as well as envisage new therapeutic approaches to treat these devastating diseases.	[Moskot, Marta; Gabig-Ciminska, Magdalena] Univ Gdansk, Polish Acad Sci, Inst Biochem & Biophys, Mol Biol Lab, PL-80308 Gdansk, Poland; [Montefusco, Sandro; Di Bernardo, Diego; Medina, Diego L.; Ballabio, Andrea] Telethon Inst Genet & Med TIGEM, High Content Screening Facil, I-80131 Naples, Italy; [Jakobkiewicz-Banecka, Joanna; Mozolewski, Pawel; Wegrzyn, Grzegorz] Univ Gdansk, Dept Mol Biol, PL-80308 Gdansk, Poland; [Wegrzyn, Alicja] Univ Szczecin, Dept Microbiol, PL-71412 Szczecin, Poland; [Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Ballabio, Andrea] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Ballabio, Andrea] Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy	Fahrenheit Universities; University of Gdansk; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Fahrenheit Universities; University of Gdansk; University of Szczecin; Baylor College of Medicine; Baylor College of Medicine; University of Naples Federico II	Medina, DL (corresponding author), Telethon Inst Genet & Med TIGEM, High Content Screening Facil, Via P Castellino 111, I-80131 Naples, Italy.	medina@tigem.it; m.gabig@biol.ug.edu.pl	Medina, Diego/AAC-9622-2020; Jakóbkiewicz-Banecka, Joanna/C-2365-2014; Gabig-Cimińska, Magdalena/E-3207-2018; di Bernardo, Diego/AAF-5881-2021; Mozolewski, Pawel/AAM-8343-2021; BALLABIO, Andrea/AAL-2672-2020; Wegrzyn, Grzegorz/ABD-6699-2020; Moskot, Marta/R-5017-2018; Wegrzyn, Grzegorz/AAL-1179-2020	Medina, Diego/0000-0002-7347-2645; Gabig-Cimińska, Magdalena/0000-0002-2664-8724; di Bernardo, Diego/0000-0002-1911-7407; BALLABIO, Andrea/0000-0003-1381-4604; Wegrzyn, Grzegorz/0000-0003-4042-7466; Moskot, Marta/0000-0002-7342-9372; Wegrzyn, Alicja/0000-0002-3073-2814; Jakobkiewicz-Banecka, Joanna/0000-0002-8846-5448	National Science Centre Project [2011/01/B/NZ1/03686, N N301 668540]; European Union [TEAM/2008-2/7]; Fondazione Telethon Funding Source: Custom	National Science Centre Project; European Union(European Commission); Fondazione Telethon(Fondazione Telethon)	This work was supported by National Science Centre Project Grants 2011/01/B/NZ1/03686 and N N301 668540 and was operated within the Foundation for Polish Science Team Programme co-financed by European Union European Regional Development Fund Grant TEAM/2008-2/7.	Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Arfi A, 2010, J INHERIT METAB DIS, V33, P61, DOI 10.1007/s10545-009-9029-2; Banecka-Majkutewicz Z, 2012, ARCH IMMUNOL THER EX, V60, P461, DOI 10.1007/s00005-012-0195-9; Chung MJ, 2006, J AGR FOOD CHEM, V54, P3819, DOI 10.1021/jf060510y; Delgadillo V, 2011, J INHERIT METAB DIS, V34, P1039, DOI 10.1007/s10545-011-9342-4; Dziedzic D, 2012, ACTA BIOCHIM POL, V59, P293; Dziedzic D, 2010, EUR J HUM GENET, V18, P200, DOI 10.1038/ejhg.2009.144; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Friso A, 2010, BRIT J PHARMACOL, V159, P1082, DOI 10.1111/j.1476-5381.2009.00565.x; Harlow Ed, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4531; Jakobkiewicz-Banecka J, 2011, CURR PHARM BIOTECHNO, V12, P1860, DOI 10.2174/138920111798376932; Jakobkiewicz-Banecka J, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-26; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Liang HW, 2008, NEUROSCI LETT, V438, P116, DOI 10.1016/j.neulet.2008.04.058; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; McDermott R, 2009, P NATL ACAD SCI USA, V106, P2118, DOI 10.1073/pnas.0808376106; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Narajczyk M, 2012, GENE, V504, P292, DOI 10.1016/j.gene.2012.05.006; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Piotrowska E, 2008, CURR THER RES CLIN E, V69, P166, DOI 10.1016/j.curtheres.2008.04.002; Piotrowska E, 2006, EUR J HUM GENET, V14, P846, DOI 10.1038/sj.ejhg.5201623; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Ponder KP, 2007, EXPERT OPIN BIOL TH, V7, P1333, DOI 10.1517/14712598.7.9.1333; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rohrbach M, 2007, DRUGS, V67, P2697, DOI 10.2165/00003495-200767180-00005; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wegrzyn A, 2012, IUBMB LIFE, V64, P307, DOI 10.1002/iub.1007; Wegrzyn G, 2010, BIOCHEM SOC T, V38, P695, DOI 10.1042/BST0380695; Winchester B, 2000, BIOCHEM SOC T, V28, P150, DOI 10.1042/bst0280150	39	94	99	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17054	17069		10.1074/jbc.M114.555300	http://dx.doi.org/10.1074/jbc.M114.555300			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24770416	hybrid, Green Published			2022-12-28	WOS:000338016200039
J	Wang, J; Wu, GS				Wang, Juan; Wu, Gen Sheng			Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES AUTOPHAGY; SIGNALING PATHWAY; DEATH; CHEMOTHERAPY; INHIBITION; INDUCTION; LINES; PHOSPHORYLATION; MODULATION; APOPTOSIS	Cisplatin-based treatment is the first line chemotherapy for several cancers including ovarian cancer. The development of cisplatin resistance results in treatment failure, but the underlying mechanisms are not fully understood. Here we show that the induction of autophagy plays an important role in cisplatin resistance in ovarian cancer cells. Specifically, we show that cisplatin resistance is correlated with autophagy induction in a panel of ovarian cancer cells but not in immortalized human ovarian surface epithelial cells. Mechanistically, cisplatin treatment activates ERK and subsequently promotes autophagy. The inhibition of ERK activation with MEK inhibitors or knockdown of ERK expression with siRNA decreases cisplatin-induced autophagy and subsequently sensitizes ovarian cancer cells to cisplatin-induced apoptosis. In ovarian cancer cells that have developed acquired cisplatin resistance, both ERK activation and autophagy induction are increased. Importantly, knockdown of ERK or inhibition of autophagy promotes cisplatin-induced apoptosis in acquired cisplatin-resistant cells. Collectively, our data indicate that ERK-mediated autophagy can lead to cisplatin resistance and suggest that cisplatin resistance can be overcome by inhibition of autophagy in ovarian cancer cells.	[Wu, Gen Sheng] Wayne State Univ Sch Med, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48201 USA; Wayne State Univ Sch Med, Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Wu, GS (corresponding author), Wayne State Univ Sch Med, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48201 USA.	wug@karmanos.org			National Institutes of Health through the NCI [1R21CA178111-01]; NATIONAL CANCER INSTITUTE [R21CA178111] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA178111-01 through the NCI.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Boeckman HJ, 2005, MOL CANCER RES, V3, P277, DOI 10.1158/1541-7786.MCR-04-0032; Bryant CS, 2011, ARCH GYNECOL OBSTET, V283, P361, DOI 10.1007/s00404-010-1462-9; Carew JS, 2007, AUTOPHAGY, V3, P464, DOI 10.4161/auto.4311; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Comes F, 2007, CELL DEATH DIFFER, V14, P693, DOI 10.1038/sj.cdd.4402076; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Cullen KJ, 2003, CANCER RES, V63, P8097; DABHOLKAR M, 1994, J CLIN INVEST, V94, P703, DOI 10.1172/JCI117388; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Go RS, 1999, J CLIN ONCOL, V17, P409, DOI 10.1200/JCO.1999.17.1.409; Henkels KM, 1997, CANCER RES, V57, P4488; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Johnson SW, 1996, EXP CELL RES, V226, P133, DOI 10.1006/excr.1996.0211; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsuzawa T, 2012, J IMMUNOL, V189, P813, DOI 10.4049/jimmunol.1102041; Maycotte P, 2011, CANCER BIOL THER, V11, P127, DOI 10.4161/cbt.11.2.14627; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Perego P, 1996, CANCER RES, V56, P556; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Sirichanchuen B, 2012, MOL CELL BIOCHEM, V364, P11, DOI 10.1007/s11010-011-1199-1; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tummala Mohan K, 2005, Clin Adv Hematol Oncol, V3, P723; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang J, 2011, J BIOL CHEM, V286, P22384, DOI 10.1074/jbc.M111.239566; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	49	185	194	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17163	17173		10.1074/jbc.M114.558288	http://dx.doi.org/10.1074/jbc.M114.558288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24794870	Green Published, hybrid			2022-12-28	WOS:000338016200049
J	Ge, XD; Antoine, DJ; Lu, YK; Arriazu, E; Leung, TM; Klepper, AL; Branch, AD; Fiel, MI; Nieto, N				Ge, Xiaodong; Antoine, Daniel J.; Lu, Yongke; Arriazu, Elena; Leung, Tung-Ming; Klepper, Arielle L.; Branch, Andrea D.; Fiel, Maria Isabel; Nieto, Natalia			High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN PROTEIN HMGB1; GROUP CHROMOSOMAL-PROTEINS; KINASE-C; ACETAMINOPHEN HEPATOTOXICITY; CYTOKINE ACTIVITY; CELL RECRUITMENT; IN-VIVO; RELEASE; DNA; ACTIVATION	Growing clinical and experimental evidence suggests that sterile inflammation contributes to alcoholic liver disease (ALD). High mobility group box-1 (HMGB1) is highly induced during liver injury; however, a link between this alarmin and ALD has not been established. Thus, the aim of this work was to determine whether HMGB1 contributes to the pathogenesis of ALD. Liver biopsies from patients with ALD showed a robust increase in HMGB1 expression and translocation, which correlated with disease stage, compared with healthy explants. Similar findings were observed in chronic ethanol-fed wild-type (WT) mice. Using primary cell culture, we validated the ability of hepatocytes from ethanol-fed mice to secrete a large amount of HMGB1. Secretion was time- and dose-dependent and responsive to prooxidants and antioxidants. Selective ablation of Hmgb1 in hepatocytes protected mice from alcohol-induced liver injury due to increased carnitine palmitoyltransferase-1, phosphorylated 5'AMP-activated protein kinase-alpha, and phosphorylated peroxisome proliferator-activated receptor-alpha expression along with elevated LDL plus VLDL export. Native and post-translationally modified HMGB1 were detected in humans and mice with ALD. In liver and serum from control mice and in serum from healthy volunteers, the lysine residues within the peptides containing nuclear localization signals (NLSs) 1 and 2 were non-acetylated, and all cysteine residues were reduced. However, in livers from ethanol-fed mice, in addition to all thiol/non-acetylated isoforms of HMGB1, we observed acetylated NLS1 and NLS2, a unique phosphorylation site in serine 35, and an increase in oxidation of HMGB1 to the disulfide isoform. In serum from ethanol-fed mice and from patients with ALD, there was disulfide-bonded hyperacetylated HMGB1, disulfide-bonded non-acetylated HMGB1, and HMGB1 phosphorylated in serine 35. Hepatocytes appeared to be a major source of these HMGB1 isoforms. Thus, hepatocyte HMGB1 participates in the pathogenesis of ALD and undergoes post-translational modifications (PTMs) that could condition its toxic effects.	[Ge, Xiaodong; Lu, Yongke; Arriazu, Elena; Leung, Tung-Ming; Klepper, Arielle L.; Branch, Andrea D.; Nieto, Natalia] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY 10029 USA; [Fiel, Maria Isabel] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Antoine, Daniel J.] Univ Liverpool, Med Res Council Ctr Drug Safety Sci Mol & Clin Ph, Liverpool L69 3GE, Merseyside, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Liverpool	Nieto, N (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, Box 1123,1425 Madison Ave,Rm 11-70, New York, NY 10029 USA.	natalia.nieto@mssm.edu		Arriazu, Elena/0000-0003-4182-2417	National Institutes of Health United States Public Health Service from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U01 AA021887, P20 AA017067, P20 AA017067-01S1, P20 AA017067-03S1]; National Institute on Drug Abuse (NIDA) [R01 DA031095]; National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK090317]; Wellcome Trust; Medical Research Council Centre for Drug Safety Science; MRC [MR/L006758/1] Funding Source: UKRI; Medical Research Council [MR/L006758/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA021887, P20AA017067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031095] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Centre for Drug Safety Science(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants U01 AA021887 (to N. N.) and P20 AA017067, P20 AA017067-01S1, and P20 AA017067-03S1 (to N. N. and M. I. F) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and R01 DA031095 from the National Institute on Drug Abuse (NIDA) and R01 DK090317 from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) (to A. D. B). This work was also supported by a Wellcome Trust research fellowship and the Medical Research Council Centre for Drug Safety Science (to D. J. A).	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Antoine DJ, 2014, MOL MED, V20, P135, DOI 10.2119/molmed.2014.00022; Antoine DJ, 2012, J HEPATOL, V56, P1070, DOI 10.1016/j.jhep.2011.12.019; Antoine DJ, 2009, TOXICOL SCI, V112, P521, DOI 10.1093/toxsci/kfp235; Antoine DJ, 2010, MOL MED, V16, P479, DOI 10.2119/molmed.2010.00126; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Carneiro VC, 2009, BIOCHEM BIOPH RES CO, V390, P1245, DOI 10.1016/j.bbrc.2009.10.129; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cubero FJ, 2012, AM J PHYSIOL-GASTR L, V303, pG228, DOI 10.1152/ajpgi.00465.2011; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; EINCK L, 1985, EXP CELL RES, V156, P295, DOI 10.1016/0014-4827(85)90539-7; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Ge XD, 2014, HEPATOLOGY, V59, P1600, DOI 10.1002/hep.26931; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Huang H, 2014, HEPATOLOGY, V59, P1984, DOI 10.1002/hep.26976; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; Kang HJ, 2009, LAB INVEST, V89, P948, DOI 10.1038/labinvest.2009.47; Krohn NM, 2002, J BIOL CHEM, V277, P32438, DOI 10.1074/jbc.M203814200; Krynetski EY, 2003, CANCER RES, V63, P100; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lee H, 2012, BIOCHEM BIOPH RES CO, V424, P321, DOI 10.1016/j.bbrc.2012.06.116; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Li W, 2013, MOL MED, V19, P203, DOI 10.2119/molmed.2013.00064; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Liu SG, 2006, AM J PHYSIOL-CELL PH, V290, pC990, DOI 10.1152/ajpcell.00308.2005; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Lu B, 2013, PROTEIN CELL, V4, P163, DOI 10.1007/s13238-012-2118-2; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lu W, 2000, J BIOL CHEM, V275, P35006, DOI 10.1074/jbc.M004735200; Nystrom S, 2013, EMBO J, V32, P86, DOI 10.1038/emboj.2012.328; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schierbeck H, 2011, MOL MED, V17, P1039, DOI 10.2119/molmed.2010.00264; Soop A, 2013, SCAND J IMMUNOL, V78, P205, DOI 10.1111/sji.12076; Stemmer C, 2002, J BIOL CHEM, V277, P1092, DOI 10.1074/jbc.M109503200; STERNER R, 1979, J BIOL CHEM, V254, P1577; Taira J, 2013, J BIOCHEM, V154, P299, DOI 10.1093/jb/mvt056; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Ueda T, 2004, BIOCHEMISTRY-US, V43, P9901, DOI 10.1021/bi035975l; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Xiao DM, 2000, J NEUROCHEM, V74, P392, DOI 10.1046/j.1471-4159.2000.0740392.x; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	56	99	103	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22672	22691		10.1074/jbc.M114.552141	http://dx.doi.org/10.1074/jbc.M114.552141			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24928512	hybrid, Green Published			2022-12-28	WOS:000341017200014
J	Hu, XM; Lu, XD; Liu, RZ; Ai, NP; Cao, ZH; Li, YN; Liu, JF; Yu, B; Liu, K; Wang, HP; Zhou, C; Wang, Y; Han, AD; Ding, F; Chen, RC				Hu, Xiangming; Lu, Xiaodong; Liu, Runzhong; Ai, Nanping; Cao, Zhenhua; Li, Yannan; Liu, Jiangfang; Yu, Bin; Liu, Kai; Wang, Huiping; Zhou, Chao; Wang, Yu; Han, Aidong; Ding, Feng; Chen, Ruichuan			Histone Cross-talk Connects Protein Phosphatase 1 alpha (PP1 alpha) and Histone Deacetylase (HDAC) Pathways to Regulate the Functional Transition of Bromodomain-containing 4 (BRD4) for Inducible Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; P-TEFB; H3 PHOSPHORYLATION; TRANSCRIPTION ELONGATION; CHROMATIN MODIFICATION; ACETYLATED CHROMATIN; BET; INHIBITION; RELEASE; BINDING	Transcription elongation has been recognized as a rate-limiting step for the expression of signal-inducible genes. Through recruitment of positive transcription elongation factor P-TEFb, the bromodomain-containing protein BRD4 plays critical roles in regulating the transcription elongation of a vast array of inducible genes that are important for multiple cellular processes. The diverse biological roles of BRD4 have been proposed to rely on its functional transition between chromatin targeting and transcription regulation. The signaling pathways and the molecular mechanism for regulating this transition process, however, are largely unknown. Here, we report a novel role of phosphorylated Ser(10) of histone H3 (H3S10ph) in governing the functional transition of BRD4. We identified that the acetylated lysines 5 and 8 of nucleosomal histone H4 (H4K5ac/K8ac) is the BRD4 binding site, and the protein phosphatase PP1 alpha and class I histone deacetylase (HDAC1/2/3) signaling pathways are essential for the stress-induced BRD4 release from chromatin. In the unstressed state, phosphorylated H3S10 prevents the deacetylation of nucleosomal H4K5ac/K8ac by HDAC1/2/3, thereby locking up the majority of BRD4 onto chromatin. Upon stress, PP1 alpha-mediated dephosphorylation of H3S10ph allows the deacetylation of nucleosomal H4K5ac/K8ac by HDAC1/2/3, thereby leading to the release of chromatin-bound BRD4 for subsequent recruitment of P-TEFb to enhance the expression of inducible genes. Therefore, our study revealed a novel mechanism that the histone cross-talk between H3S10ph and H4K5ac/K8ac connects PP1 alpha and HDACs to govern the functional transition of BRD4. Combined with previous studies on the regulation of P-TEFb activation, the intricate signaling network for the tight control of transcription elongation is established.	[Hu, Xiangming; Lu, Xiaodong; Liu, Runzhong; Ai, Nanping; Cao, Zhenhua; Li, Yannan; Liu, Jiangfang; Yu, Bin; Liu, Kai; Wang, Huiping; Zhou, Chao; Wang, Yu; Han, Aidong; Ding, Feng; Chen, Ruichuan] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361101, Peoples R China	Xiamen University	Ding, F (corresponding author), Tsinghua Univ, Yangtze Delta Reg Inst, Dept Biotechnol & Biomed, 705 Yatai Rd, Jiaxing 314006, Zhejiang, Peoples R China.	fding7@gmail.com; chenrc@xmu.edu.cn	Liu, Runzhong/B-8217-2012; Ding, Feng/AAH-7335-2019; wang, hui/GRS-4730-2022	Lu, xiaodong/0000-0003-4731-0762	National Natural Science Foundation of China [31270809, 81361120386, 30930046, 81171192, 31170752, 81070307]; 973 program [2013CB917802]; Natural Science Foundation of Fujian Province [2010J01231]; China Postdoctoral Science Foundation [2013M530304]; XMU Basic Training Program of Undergraduate Students Grant [CXB2011019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); XMU Basic Training Program of Undergraduate Students Grant	This work was supported by National Natural Science Foundation of China Grants 31270809, 81361120386, and 30930046 (to R. C.), 81171192 (to R. L.), and 31170752 and 81070307 (to F. D.), 973 program Grant 2013CB917802 (to R. C.), Natural Science Foundation of Fujian Province Grant 2010J01231 (to F. D.), China Postdoctoral Science Foundation project Grant 2013M530304 (to X. H.), and XMU Basic Training Program of Undergraduate Students Grant CXB2011019 (to Y. W).	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Alsarraj J, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/670632; Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; Banerjee T, 2011, MOL CELL BIOL, V31, P4858, DOI 10.1128/MCB.05631-11; Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Blobel GA, 2011, CANCER CELL, V20, P287, DOI 10.1016/j.ccr.2011.08.019; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chen RC, 2011, METHODS, V53, P85, DOI 10.1016/j.ymeth.2010.04.005; Chiang CM, 2009, BIOL REP, V1, P98, DOI DOI 10.3410/B1-98; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaiah BN, 2013, TRANSCR-AUSTIN, V4, P13, DOI 10.4161/trns.22542; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Fujita T, 2010, J RECEPT SIG TRANSD, V30, P31, DOI 10.3109/10799890903517921; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; He SH, 2013, J CELL PHYSIOL, V228, P1525, DOI 10.1002/jcp.24311; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Karn J, 2013, CELL CYCLE, V12, P545, DOI 10.4161/cc.23679; Koch F, 2008, TRENDS BIOCHEM SCI, V33, P265, DOI 10.1016/j.tibs.2008.04.006; Lenasi T, 2010, RNA BIOL, V7, P145, DOI 10.4161/rna.7.2.11057; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rodriguez RM, 2012, J MOL MED, V90, P587, DOI 10.1007/s00109-011-0837-0; Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Schroder S, 2012, J BIOL CHEM, V287, P1090, DOI 10.1074/jbc.M111.282855; Segura MF, 2013, CANCER RES, V73, P6264, DOI 10.1158/0008-5472.CAN-13-0122-T; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Spiltoir JI, 2013, J MOL CELL CARDIOL, V63, P175, DOI 10.1016/j.yjmcc.2013.07.017; Voigt P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-133; Wang HP, 2011, ANAL BIOCHEM, V418, P304, DOI 10.1016/j.ab.2011.07.008; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wang W, 2013, TRANSCR-AUSTIN, V4, P39, DOI 10.4161/trns.22874; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zhou MS, 2009, J VIROL, V83, P1036, DOI 10.1128/JVI.01316-08; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	63	35	35	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23154	23167		10.1074/jbc.M114.570812	http://dx.doi.org/10.1074/jbc.M114.570812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24939842	Green Published, hybrid			2022-12-28	WOS:000341017200052
J	Shukla, S; Patric, IRP; Patil, V; Shwetha, SD; Hegde, AS; Chandramouli, BA; Arivazhagan, A; Santosh, V; Somasundaram, K				Shukla, Sudhanshu; Patric, Irene Rosita Pia; Patil, Vikas; Shwetha, Shivayogi D.; Hegde, Alangar S.; Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan; Santosh, Vani; Somasundaram, Kumaravel			Methylation Silencing of ULK2, an Autophagy Gene, Is Essential for Astrocyte Transformation and Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; CELL-DEATH; MICROSATELLITE INSTABILITY; MAMMARY TUMORIGENESIS; COLORECTAL-CANCER; MALIGNANT GLIOMA; POOR-PROGNOSIS; GLIOBLASTOMA; PHENOTYPE; SURVIVAL	Glioblastoma (GBM) is the most aggressive type of brain tumor and shows very poor prognosis. Here, using genome-wide methylation analysis, we show that G-CIMP+ and G-CIMP-subtypes enrich distinct classes of biological processes. One of the hypermethylated genes in GBM, ULK2, an upstream autophagy inducer, was found to be down-regulated in GBM. Promoter hypermethylation of ULK2 was confirmed by bisulfite sequencing. GBM and glioma cell lines had low levels of ULK2 transcripts, which could be reversed upon methylation inhibitor treatment. ULK2 promoter methylation and transcript levels showed significant negative correlation. Ectopic overexpression of ULK2-induced autophagy, which further enhanced upon nutrient starvation or temozolomide chemotherapy. ULK2 also inhibited the growth of glioma cells, which required autophagy induction as kinase mutant of ULK2 failed to induce autophagy and inhibit growth. Furthermore, ULK2 induced autophagy and inhibited growth in Ras-transformed immortalized Baby Mouse Kidney (iBMK) ATG5(+/+) but not in autophagy-deficient ATG5(-/-) cells. Growth inhibition due to ULK2 induced high levels of autophagy under starvation or chemotherapy utilized apoptotic cell death but not at low levels of autophagy. Growth inhibition by ULK2 also appears to involve catalase degradation and reactive oxygen species generation. ULK2 overexpression inhibited anchorage independent growth, inhibited astrocyte transformation in vitro and tumor growth in vivo. Of all autophagy genes, we found ULK2 and its homologue ULK1 were only down-regulated in all grades of glioma. Thus these results altogether suggest that inhibition of autophagy by ULK1/2 down-regulation is essential for glioma development.	[Shukla, Sudhanshu; Patric, Irene Rosita Pia; Patil, Vikas; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Hegde, Alangar S.] Sri Satya Sai Inst Higher Med Sci, Bangalore 560066, Karnataka, India; [Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India; [Shwetha, Shivayogi D.; Santosh, Vani] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in	Shukla, Sudhanshu/L-3530-2016; Shukla, Sudhanshu/K-7830-2017; Shukla, Sudhanshu/AAC-8650-2020	Shukla, Sudhanshu/0000-0002-5069-9708; Shukla, Sudhanshu/0000-0002-5069-9708; Shukla, Sudhanshu/0000-0002-5069-9708	Indian Council of Medical Research; Department of Biotechnology; Department of Science; University Grants Commission	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology; Department of Science; University Grants Commission(University Grants Commission, India)	The results published here are in whole or part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. The use of datasets from Institute NC, 2005 and Phillips et al., 2006 is acknowledged. Infrastructural support by funding from Indian Council of Medical Research, Department of Biotechnology, Department of Science, and University Grants Commission to the Department of Microbiology and Cell Biology is acknowledged. The Central Animal Facility of the Indian Institute of Science is acknowledged for animal experiments. We thank Professors M. R. S. Rao and P. Kondaiah for valuable suggestions. We thank Dr. H. Noushmehr for help in acquiring TCGA data. We also thank B. Thota, Shruti Bhargava, K. Chandrashekar, K. Prem, and B. C. Shailaja for the help rendered.	Arcella A, 2013, BRAIN RES, V1495, P37, DOI 10.1016/j.brainres.2012.11.044; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cheong H, 2014, AUTOPHAGY, V10, P45, DOI 10.4161/auto.26505; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho DH, 2012, ANTICANCER RES, V32, P4091; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Devaney JM, 2013, PROSTATE CANCER P D, V16, P292, DOI 10.1038/pcan.2013.21; Ehrlich M, 2002, J NUTR, V132, p2424S, DOI 10.1093/jn/132.8.2424S; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Fu T, 2012, CLIN CANCER RES, V18, P4743, DOI 10.1158/1078-0432.CCR-12-0707; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Garcia-Manero G, 2008, CURR OPIN ONCOL, V20, P705, DOI 10.1097/CCO.0b013e328313699c; Goi T, 2003, SURG TODAY, V33, P702, DOI 10.1007/s00595-002-2567-y; Gonzalez-Gomez P, 2003, INT J ONCOL, V22, P601; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jung CH, 2011, AUTOPHAGY, V7, P1212, DOI 10.4161/auto.7.10.16660; Kang MR, 2009, J PATHOL, V217, P702, DOI 10.1002/path.2509; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kaza N, 2012, BRAIN PATHOL, V22, P89, DOI 10.1111/j.1750-3639.2011.00544.x; Kim MS, 2008, HUM PATHOL, V39, P1059, DOI 10.1016/j.humpath.2007.11.013; Kim SJ, 2006, BBA-GENE STRUCT EXPR, V1759, P451, DOI 10.1016/j.bbaexp.2006.09.003; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang CY, 2010, CURR OPIN CELL BIOL, V22, P226, DOI 10.1016/j.ceb.2009.11.003; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; McAfee Q, 2012, P NATL ACAD SCI USA, V109, P8253, DOI 10.1073/pnas.1118193109; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shukla S, 2013, CANCER RES, V73, P6563, DOI 10.1158/0008-5472.CAN-13-0298; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang CR, 2013, NAT NEUROSCI, V16, P532, DOI 10.1038/nn.3365; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P262, DOI 10.1016/j.bcp.2010.03.029; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	53	62	64	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22306	22318		10.1074/jbc.M114.567032	http://dx.doi.org/10.1074/jbc.M114.567032			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24923441	Green Published, hybrid			2022-12-28	WOS:000340593500042
J	Abibi, A; Ferguson, AD; Fleming, PR; Gao, N; Hajec, LI; Hu, J; Laganas, VA; McKinney, DC; McLeod, SM; Prince, DB; Shapiro, AB; Buurman, ET				Abibi, Ayome; Ferguson, Andrew D.; Fleming, Paul R.; Gao, Ning; Hajec, Laurel I.; Hu, Jun; Laganas, Valerie A.; McKinney, David C.; McLeod, Sarah M.; Prince, D. Bryan; Shapiro, Adam B.; Buurman, Ed T.			The Role of a Novel Auxiliary Pocket in Bacterial Phenylalanyl-tRNA Synthetase Druggability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL BASIS; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; INHIBITORS; MECHANISM; DISCOVERY; AMINOACYLATION; RESISTANCE; SUBUNITS	The antimicrobial activity of phenyl-thiazolylurea-sulfonamides against Staphylococcus aureus PheRS are dependent upon phenylalanine levels in the extracellular fluids. Inhibitor efficacy in animal models of infection is substantially diminished by dietary phenylalanine intake, thereby reducing the perceived clinical utility of this inhibitor class. The search for novel antibacterial compounds against Gram-negative pathogens led to a re-evaluation of this phenomenon, which is shown here to be unique to S. aureus. Inhibition of macromolecular syntheses and characterization of novel resistance mutations in Escherichia coli demonstrate that antimicrobial activity of phenylthiazolylurea-sulfonamides is mediated by PheRS inhibition, validating this enzyme as a viable drug discovery target for Gram-negative pathogens. A search for novel inhibitors of PheRS yielded three novel chemical starting points. NMR studies were used to confirm direct target engagement for phenylalanine-competitive hits. The crystallographic structure of Pseudomonas aeruginosa PheRS defined the binding modes of these hits and revealed an auxiliary hydrophobic pocket that is positioned adjacent to the phenylalanine binding site. Three viable inhibitor-resistant mutants were mapped to this pocket, suggesting that this region is a potential liability for drug discovery.	[Abibi, Ayome; Gao, Ning; Hajec, Laurel I.; Laganas, Valerie A.; McLeod, Sarah M.; Shapiro, Adam B.; Buurman, Ed T.] AstraZeneca R&D Boston, Infect Innovat Med Unit, Dept Biosci, Waltham, MA 02451 USA; [Fleming, Paul R.; McKinney, David C.] AstraZeneca R&D Boston, Infect Innovat Med Unit, Dept Chem, Waltham, MA 02451 USA; [Ferguson, Andrew D.; Hu, Jun; Prince, D. Bryan] AstraZeneca R&D Boston, Discovery Sci, Dept Struct & Biophys, Waltham, MA 02451 USA	AstraZeneca; AstraZeneca; AstraZeneca	Buurman, ET (corresponding author), AstraZeneca R&D Boston, Infect Innovat Med Unit, Dept Biosci, 35 Gatehouse Dr, Waltham, MA 02451 USA.	Ed.Buurman@astrazeneca.com		Gao, Ning/0000-0003-1605-4137; McKinney, David/0000-0003-1787-1841; Shapiro, Adam/0000-0002-2662-6146				Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALTZINGER M, 1982, BIOCHEMISTRY-US, V21, P2467, DOI 10.1021/bi00539a028; Beyer D, 2004, ANTIMICROB AGENTS CH, V48, P525, DOI 10.1128/AAC.48.2.525-532.2004; Bricogne G, 2009, BUSTER VERSION 2 8 0; Buurman ET, 2012, J BACTERIOL, V194, P5504, DOI 10.1128/JB.01103-12; Buurman ET, 2011, J BIOL CHEM, V286, P40734, DOI 10.1074/jbc.M111.274068; Buurman ET, 2006, ANTIMICROB AGENTS CH, V50, P385, DOI 10.1128/AAC.50.1.385-387.2006; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE, V29; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Evdokimov AG, 2008, J STRUCT BIOL, V162, P152, DOI 10.1016/j.jsb.2007.11.002; FRASER TH, 1975, P NATL ACAD SCI USA, V72, P3044, DOI 10.1073/pnas.72.8.3044; Gentry DR, 2003, ANTIMICROB AGENTS CH, V47, P1784, DOI 10.1128/AAC.47.6.1784-1789.2003; Hernandez V, 2013, ANTIMICROB AGENTS CH, V57, P1394, DOI 10.1128/AAC.02058-12; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; HUGHES J, 1978, BIOCHEM J, V176, P305, DOI 10.1042/bj1760305; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Jarvest RL, 2005, BIOORG MED CHEM LETT, V15, P2305, DOI 10.1016/j.bmcl.2005.03.003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; KHODYREVA SN, 1985, BIOCHIM BIOPHYS ACTA, V830, P206, DOI 10.1016/0167-4838(85)90029-9; Kotik-Kogan O, 2005, STRUCTURE, V13, P1799, DOI 10.1016/j.str.2005.08.013; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Margolis PS, 2000, ANTIMICROB AGENTS CH, V44, P1825, DOI 10.1128/AAC.44.7.1825-1831.2000; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Mermershtain I, 2011, PROTEIN SCI, V20, P160, DOI 10.1002/pro.549; Montgomery JI, 2009, BIOORG MED CHEM LETT, V19, P665, DOI 10.1016/j.bmcl.2008.12.054; Moor N, 2006, BIOCHEMISTRY-US, V45, P10572, DOI 10.1021/bi060491l; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Raczniak G, 2001, TOXICOLOGY, V160, P181, DOI 10.1016/S0300-483X(00)00454-6; Reck F, 2011, J MED CHEM, V54, P7834, DOI 10.1021/jm2008826; Reshetnikova L, 1999, J MOL BIOL, V287, P555, DOI 10.1006/jmbi.1999.2617; Rodova M, 1999, BIOCHEM BIOPH RES CO, V255, P765, DOI 10.1006/bbrc.1999.0141; SAMBROOK J, 2001, MOL CLONING LAB MANU, V2; SANNI A, 1991, P NATL ACAD SCI USA, V88, P8387, DOI 10.1073/pnas.88.19.8387; Schramm VL, 2013, ACS CHEM BIOL, V8, P71, DOI 10.1021/cb300631k; Seah C, 2012, ANTIMICROB AGENTS CH, V56, P1916, DOI 10.1128/AAC.05325-11; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; SPRINZL M, 1975, P NATL ACAD SCI USA, V72, P3049, DOI 10.1073/pnas.72.8.3049; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Yu XY, 2004, BIOORG MED CHEM LETT, V14, P1343, DOI 10.1016/j.bmcl.2003.11.082; Yu XY, 2004, BIOORG MED CHEM LETT, V14, P1339, DOI 10.1016/j.bmcl.2003.11.081	53	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21651	21662		10.1074/jbc.M114.574061	http://dx.doi.org/10.1074/jbc.M114.574061			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936059	hybrid, Green Published			2022-12-28	WOS:000340558300039
J	Satagopan, S; Chan, S; Perry, LJ; Tabita, FR				Satagopan, Sriram; Chan, Sum; Perry, L. Jeanne; Tabita, F. Robert			Structure-Function Studies with the Unique Hexameric Form II Ribulose-1,5-bisphosphate Carboxylase/Oxygenase (Rubisco) from Rhodopseudomonas palustris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE; RHODOSPIRILLUM-RUBRUM; CRYSTAL-STRUCTURE; LARGE-SUBUNIT; CATALYTIC-PROPERTIES; REGULATORY TWIST; OXYGENASE; EVOLUTION; PROTEINS; SUBSTITUTIONS	The first x-ray crystal structure has been solved for an activated transition-state analog-bound form II ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco). This enzyme, from Rhodopseudomonas palustris, assembles as a unique hexamer with three pairs of catalytic large subunit homodimers around a central 3-fold symmetry axis. This oligomer arrangement is unique among all known Rubisco structures, including the form II homolog from Rhodospirillum rubrum. The presence of a transition-state analog in the active site locked the activated enzyme in a "closed" conformation and revealed the positions of critical active site residues during catalysis. Functional roles of two form II-specific residues (Ile(165) and Met(331)) near the active site were examined via site-directed mutagenesis. Substitutions at these residues affect function but not the ability of the enzyme to assemble. Random mutagenesis and suppressor selection in a Rubisco deletion strain of Rhodobacter capsulatus identified a residue in the amino terminus of one subunit (Ala(47)) that compensated for a negative change near the active site of a neighboring subunit. In addition, substitution of the native carboxyl-terminal sequence with the last few dissimilar residues from the related R. rubrum homolog increased the enzyme's k(cat) for carboxylation. However, replacement of a longer carboxyl-terminal sequence with termini from either a form III or a form I enzyme, which varied both in length and sequence, resulted in complete loss of function. From these studies, it is evident that a number of subtle interactions near the active site and the carboxyl terminus account for functional differences between the different forms of Rubiscos found in nature.	[Satagopan, Sriram; Tabita, F. Robert] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Chan, Sum; Perry, L. Jeanne] Univ Calif Los Angeles, Dept Energy DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA	University System of Ohio; Ohio State University; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Tabita, FR (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	tabita.1@osu.edu	Satagopan, Sriram/B-3198-2011	Satagopan, Sriram/0000-0002-4867-531X	National Institutes of Health [GM095742]; Department of Energy [DE-FC02-02ER63421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095742. This work was also supported by Department of Energy Grant DE-FC02-02ER63421 (to the Protein Expression Technology Center Core Facility at UCLA).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burisch C, 2007, FEBS LETT, V581, P741, DOI 10.1016/j.febslet.2007.01.043; Chene P, 1997, BIOCHEM BIOPH RES CO, V232, P482, DOI 10.1006/bbrc.1997.6318; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabiola F, 2002, PROTEIN SCI, V11, P1415, DOI 10.1110/ps.4890102; Guadalupe-Medina V, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-125; Harpel MR, 1998, PROTEIN SCI, V7, P730, DOI 10.1002/pro.5560070322; Horken KM, 1999, J BACTERIOL, V181, P3935, DOI 10.1128/JB.181.13.3935-3941.1999; Joshi GS, 2013, J BACTERIOL, V195, P1381, DOI 10.1128/JB.02060-12; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUEHN GD, 1978, BIOCHEM J, V175, P909, DOI 10.1042/bj1750909; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEE GJ, 1993, PROTEIN SCI, V2, P1147, DOI 10.1002/pro.5560020709; Li LA, 1997, J BACTERIOL, V179, P3793, DOI 10.1128/jb.179.11.3793-3796.1997; Liggins JR, 2009, BIOCHEMISTRY-US, V48, P2226, DOI 10.1021/bi802159e; MORELL MK, 1990, FEBS LETT, V265, P41, DOI 10.1016/0014-5793(90)80879-N; Mueller-Cajar O, 2008, PHOTOSYNTH RES, V98, P667, DOI 10.1007/s11120-008-9324-z; Nakano T, 2010, BIOCHEM BIOPH RES CO, V392, P212, DOI 10.1016/j.bbrc.2010.01.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoli GC, 1998, ARCH MICROBIOL, V170, P8, DOI 10.1007/s002030050609; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Peterhansel C, 2012, CURR OPIN BIOTECH, V23, P204, DOI 10.1016/j.copbio.2011.12.013; RANTY B, 1990, EMBO J, V9, P1365, DOI 10.1002/j.1460-2075.1990.tb08251.x; Romagnoli S, 2006, J BACTERIOL, V188, P2780, DOI 10.1128/JB.188.8.2780-2791.2006; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Satagopan S, 2004, J BIOL CHEM, V279, P14240, DOI 10.1074/jbc.M313215200; Satagopan S, 2009, BIOCHEMISTRY-US, V48, P9076, DOI 10.1021/bi9006385; Satagopan S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-85; SCHNEIDER G, 1990, J MOL BIOL, V211, P989, DOI 10.1016/0022-2836(90)90088-4; Smith SA, 2004, J BIOL CHEM, V279, P25632, DOI 10.1074/jbc.M401360200; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; SPREITZER RJ, 1988, PLANT PHYSIOL, V86, P987, DOI 10.1104/pp.86.4.987; Sugawara H, 1999, J BIOL CHEM, V274, P15655, DOI 10.1074/jbc.274.22.15655; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; TERZAGHI BE, 1986, BIOCHEM J, V235, P839, DOI 10.1042/bj2350839; van Lun M, 2011, J MOL BIOL, V411, P1083, DOI 10.1016/j.jmb.2011.06.052; WHITMAN W, 1976, BIOCHEM BIOPH RES CO, V71, P1034, DOI 10.1016/0006-291X(76)90758-0; Whitney SM, 1999, PLANT PHYSIOL, V121, P579, DOI 10.1104/pp.121.2.579; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YEATES TO, 1995, J MOL BIOL, V249, P804, DOI 10.1006/jmbi.1995.0339; ZHU GH, 1990, PLANT PHYSIOL, V93, P244, DOI 10.1104/pp.93.1.244	55	30	30	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21433	21450		10.1074/jbc.M114.578625	http://dx.doi.org/10.1074/jbc.M114.578625			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942737	hybrid, Green Published			2022-12-28	WOS:000340558300022
J	Jinadasa, T; Szabo, EZ; Numata, M; Orlowski, J				Jinadasa, Tushare; Szabo, Eloed Z.; Numata, Masayuki; Orlowski, John			Activation of AMP-activated Protein Kinase Regulates Hippocampal Neuronal pH by Recruiting Na+/H+ Exchanger NHE5 to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR PH; ENERGY SENSOR; PHARMACOLOGICAL-PROPERTIES; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; PYRAMIDAL NEURONS; CA1 NEURONS; BRAIN; ACIDOSIS; CA2+	Strict regulation of intra-and extracellular pH is an important determinant of nervous system function as many voltage-, ligand-, and H+-gated cationic channels are exquisitely sensitive to transient fluctuations in pH elicited by neural activity and pathophysiologic events such as hypoxia-ischemia and seizures. Multiple Na+/H+ exchangers (NHEs) are implicated in maintenance of neural pH homeostasis. However, aside from the ubiquitous NHE1 isoform, their relative contributions are poorly understood. NHE5 is of particular interest as it is preferentially expressed in brain relative to other tissues. In hippocampal neurons, NHE5 regulates steady-state cytoplasmic pH, but intriguingly the bulk of the transporter is stored in intracellular vesicles. Here, we show that NHE5 is a direct target for phosphorylation by the AMP-activated protein kinase (AMPK), a key sensor and regulator of cellular energy homeostasis in response to metabolic stresses. In NHE5-transfected non-neuronal cells, activation of AMPK by the AMP mimetic AICAR or by antimycin A, which blocks aerobic respiration and causes acidification, increased cell surface accumulation and activity of NHE5, and elevated intracellular pH. These effects were effectively blocked by the AMPK antagonist compound C, the NHE inhibitor HOE694, and mutation of a predicted AMPK recognition motif in the NHE5 C terminus. This regulatory pathway was also functional in primary hippocampal neurons, where AMPK activation of NHE5 protected the cells from sustained antimycin A-induced acidification. These data reveal a unique role for AMPK and NHE5 in regulating the pH homeostasis of hippocampal neurons during metabolic stress.	[Jinadasa, Tushare; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Szabo, Eloed Z.] Hosp Sick Children, Toronto, ON M5S 3E2, Canada; [Numata, Masayuki] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia	Orlowski, J (corresponding author), McGill Univ, McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	john.orlowski@mcgill.ca		Orlowski, John/0000-0001-7371-175X	Canadian Foundation for Innovation (CFI); Ministere du developpement economique, innovation et exportation Quebec (MDEIE)	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ministere du developpement economique, innovation et exportation Quebec (MDEIE)	We thank Annie Boucher, Claire M. Brown, Emily C. Deane, Micaela Das Gupta, Khalid Hassan, Alina Ilie, Viktoria Lukashova, and Hans Zaun for technical assistance. Images were collected and/or image processing and analysis was performed in the McGill University Life Sciences Complex Advanced BioImaging Facility (ABIF). Purchase of equipment in the facility was made possible with funding from the Canadian Foundation for Innovation (CFI) and the Ministere du developpement economique, innovation et exportation Quebec (MDEIE). We also acknowledge the services provided by Genome Quebec.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; AMATO A, 1994, J NEUROPHYSIOL, V72, P1686, DOI 10.1152/jn.1994.72.4.1686; Amos BJ, 1998, NEUROSCIENCE, V86, P1109, DOI 10.1016/S0306-4522(98)00072-4; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Baxter KA, 1996, J PHYSIOL-LONDON, V493, P457, DOI 10.1113/jphysiol.1996.sp021396; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Benziane B, 2012, J BIOL CHEM, V287, P23451, DOI 10.1074/jbc.M111.331926; Bevensee MO, 1996, J PHYSIOL-LONDON, V494, P315, DOI 10.1113/jphysiol.1996.sp021494; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chen LM, 2008, NEUROSCIENCE, V153, P162, DOI 10.1016/j.neuroscience.2008.02.018; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Church J, 1998, J PHYSIOL-LONDON, V511, P119, DOI 10.1111/j.1469-7793.1998.119bi.x; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Day RN, 2012, BIOESSAYS, V34, P341, DOI 10.1002/bies.201100098; Deane EC, 2013, J NEUROSCI, V33, P595, DOI 10.1523/JNEUROSCI.2583-12.2013; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Diarra A, 1999, NEUROSCIENCE, V93, P1003, DOI 10.1016/S0306-4522(99)00230-4; Diering GH, 2011, MOL BIOL CELL, V22, P2246, DOI 10.1091/mbc.E11-01-0066; Dietrich CJ, 2010, J NEUROSCI, V30, P16044, DOI 10.1523/JNEUROSCI.6364-09.2010; Ding D, 2000, EXP NEUROL, V162, P1, DOI 10.1006/exnr.2000.7226; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; ENDRES W, 1986, NEUROSCI LETT, V72, P54, DOI 10.1016/0304-3940(86)90617-8; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fryer LGD, 2002, FEBS LETT, V531, P189, DOI 10.1016/S0014-5793(02)03501-9; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Handa N, 2011, ACTA CRYSTALLOGR D, V67, P480, DOI 10.1107/S0907444911010201; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Jang IS, 2006, J NEUROCHEM, V99, P1224, DOI 10.1111/j.1471-4159.2006.04168.x; Kim MS, 2005, J MOL MED, V83, P514, DOI 10.1007/s00109-005-0659-z; Kintner DB, 2010, J BIOL CHEM, V285, P35155, DOI 10.1074/jbc.M110.101212; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu CL, 2004, NEUROSCIENCE, V127, P113, DOI 10.1016/j.neuroscience.2004.03.062; Liu YF, 2013, STAT INTERFACE, V6, P1; Luckermann M, 1997, J NEUROPHYSIOL, V77, P1844, DOI 10.1152/jn.1997.77.4.1844; Lukashova V, 2013, ADV EXP MED BIOL, V961, P397, DOI 10.1007/978-1-4614-4756-6_34; Ma E, 1997, NEUROSCIENCE, V79, P591, DOI 10.1016/S0306-4522(96)00674-4; Matsuda T, 1996, EUR J NEUROSCI, V8, P951, DOI 10.1111/j.1460-9568.1996.tb01582.x; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Pizzonia JH, 1996, J NEUROSCI RES, V44, P191, DOI 10.1002/(SICI)1097-4547(19960415)44:2<191::AID-JNR12>3.0.CO;2-9; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; RALEYSUSMAN KM, 1993, BRAIN RES, V614, P308, DOI 10.1016/0006-8993(93)91049-X; RALEYSUSMAN KM, 1991, J BIOL CHEM, V266, P2739; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Rotte A, 2010, BIOCHEM BIOPH RES CO, V398, P677, DOI 10.1016/j.bbrc.2010.06.135; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Saybasili H, 1998, BRAIN RES, V786, P128, DOI 10.1016/S0006-8993(97)01461-3; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P47, DOI 10.1038/jcbfm.1985.7; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; SIMON RP, 1984, J CEREBR BLOOD F MET, V4, P350, DOI 10.1038/jcbfm.1984.52; Spasic MR, 2009, NEUROSCIENTIST, V15, P309, DOI 10.1177/1073858408327805; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; STYS PK, 1991, ANN NY ACAD SCI, V639, P328, DOI 10.1111/j.1749-6632.1991.tb17321.x; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; Takahashi KI, 1996, NEUROSCI RES, V24, P109, DOI 10.1016/0168-0102(95)00989-2; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tombaugh GC, 1996, J PHYSIOL-LONDON, V493, P719, DOI 10.1113/jphysiol.1996.sp021417; TOMBAUGH GC, 1990, BRAIN RES, V506, P343, DOI 10.1016/0006-8993(90)91277-N; Trapp S, 1996, J PHYSIOL-LONDON, V496, P695, DOI 10.1113/jphysiol.1996.sp021720; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x; Velisek L, 1998, HIPPOCAMPUS, V8, P24, DOI 10.1002/(SICI)1098-1063(1998)8:1<24::AID-HIPO3>3.0.CO;2-7; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; WICK AN, 1957, J BIOL CHEM, V224, P963; WITTERS LA, 1991, BIOCHEM BIOPH RES CO, V181, P1486, DOI 10.1016/0006-291X(91)92107-U; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiang ZM, 2000, BRAIN RES, V881, P77, DOI 10.1016/S0006-8993(00)02795-5; Xiong ZQ, 2000, J NEUROSCI, V20, P1290; Yao H, 1999, J CLIN INVEST, V104, P637, DOI 10.1172/JCI6785; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x; Zhan RZ, 1998, BRAIN RES, V780, P86, DOI 10.1016/S0006-8993(97)01149-9	97	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20879	20897		10.1074/jbc.M114.555284	http://dx.doi.org/10.1074/jbc.M114.555284			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936055	hybrid, Green Published			2022-12-28	WOS:000339396600042
J	Yang, F; Ji, QQ; Ruan, LL; Ye, Q; Wang, ED				Yang, Fang; Ji, Quan-Quan; Ruan, Liang-Liang; Ye, Qing; Wang, En-Duo			The mRNA of Human Cytoplasmic Arginyl-tRNA Synthetase Recruits Prokaryotic Ribosomes Independently	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER RNA; TRANSLATION INITIATION; SECONDARY STRUCTURE; 2 FORMS; REINITIATION; SEQUENCE; EUKARYOTES; COMPLEX; DOMAIN; SHINE	There are two isoforms of cytoplasmic arginyl-tRNA synthetase (hcArgRS) in human cells. The long form is a component of the multiple aminoacyl-tRNA synthetase complex, and the other is an N-terminal truncated form (Delta NhcArgRS), free in the cytoplasm. It has been shown that the two forms of ArgRS arise from alternative translational initiation in a single mRNA. The short form is produced from the initiation at a downstream, in-frame AUG start codon. Interestingly, our data suggest that the alternative translational initiation of hcArgRS mRNA also takes place in Escherichia coli transformants. When the gene encoding full-length hcArgRS was overexpressed in E. coli, two forms of hcArgRS were observed. The N-terminal sequencing experiment identified that the short form was identical to the Delta NhcArgRS in human cytoplasm. By constructing a bicistronic system, our data support that the mRNA encoding the N-terminal extension of hcArgRS has the capacity of independently recruiting E. coli ribosomes. Furthermore, two critical elements for recruiting prokaryotic ribosomes were identified, the "AGGA" core of the Shine-Dalgarno sequence and the "A-rich" sequence located just proximal to the alternative in-frame initiation site. Although the mechanisms of prokaryotic and eukaryotic translational initiation are distinct, they share some common features. The ability of the hcArgRS mRNA to recruit the prokaryotic ribosome may provide clues for shedding light on the mechanism of alternative translational initiation of hcArgRS mRNA in eukaryotic cells.	[Yang, Fang; Ji, Quan-Quan; Ruan, Liang-Liang; Ye, Qing; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Ctr RNA Res,State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibcb.ac.cn			Natural Science Foundation of China [31100552, 31130064]; Natural Key Basic Research Foundation of China [2012CB911001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Key Basic Research Foundation of China	This work was supported by Natural Science Foundation of China Grants 31100552 and 31130064 and by Natural Key Basic Research Foundation of China Grant 2012CB911001.	DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; DEUTSCHER MP, 1982, J BIOL CHEM, V257, P6003; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; GIRJES AA, 1995, GENE, V164, P347, DOI 10.1016/0378-1119(95)00502-W; GOLD L, 1981, ANNU REV MICROBIOL, V35, P365, DOI 10.1146/annurev.mi.35.100181.002053; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Lazard M, 2000, J MOL BIOL, V302, P991, DOI 10.1006/jmbi.2000.4102; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; MATTESON RJ, 1991, NUCLEIC ACIDS RES, V19, P3499, DOI 10.1093/nar/19.13.3499; Meng Z, 2010, J CELL BIOCHEM, V110, P531, DOI 10.1002/jcb.22569; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Park SG, 1999, J BIOL CHEM, V274, P16673, DOI 10.1074/jbc.274.24.16673; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; SCHEPER GC, 1994, FEBS LETT, V352, P271, DOI 10.1016/0014-5793(94)00975-9; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; SPANJAARD RA, 1989, NUCLEIC ACIDS RES, V17, P5501, DOI 10.1093/nar/17.14.5501; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; VELLEKAMP G, 1985, J BIOL CHEM, V260, P9843; Xia XH, 2011, GENETICS, V189, P469, DOI 10.1534/genetics.111.132068; Yang F, 2010, J BIOL CHEM, V285, P39437, DOI 10.1074/jbc.M110.159913; Zheng YG, 2006, BIOCHEMISTRY-US, V45, P1338, DOI 10.1021/bi051675n	26	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20953	20959		10.1074/jbc.M114.562454	http://dx.doi.org/10.1074/jbc.M114.562454			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898251	hybrid, Green Published			2022-12-28	WOS:000339396600048
J	Brunotte, L; Flies, J; Bolte, H; Reuther, P; Vreede, F; Schwemmle, M				Brunotte, Linda; Flies, Joe; Bolte, Hardin; Reuther, Peter; Vreede, Frank; Schwemmle, Martin			The Nuclear Export Protein of H5N1 Influenza A Viruses Recruits Matrix 1 (M1) Protein to the Viral Ribonucleoprotein to Mediate Nuclear Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS2 PROTEIN; CYTOPLASMIC TRANSPORT; ADAPTIVE MUTATIONS; RNA; BINDING; REPLICATION; MEMBRANE; SIGNAL; IDENTIFICATION; INTERMEDIATE	In influenza A virus-infected cells, replication and transcription of the viral genome occurs in the nucleus. To be packaged into viral particles at the plasma membrane, encapsidated viral genomes must be exported from the nucleus. Intriguingly, the nuclear export protein (NEP) is involved in both processes. Although NEP stimulates viral RNA synthesis by binding to the viral polymerase, its function during nuclear export implicates interaction with viral ribonucleoprotein (vRNP)-associated M1. The observation that both interactions are mediated by the C-terminal moiety of NEP raised the question whether these two features of NEP are linked functionally. Here we provide evidence that the interaction between M1 and the vRNP depends on the NEP C terminus and its polymerase activity-enhancing property for the nuclear export of vRNPs. This suggests that these features of NEP are linked functionally. Furthermore, our data suggest that the N-terminal domain of NEP interferes with the stability of the vRNP-M1-NEP nuclear export complex, probably mediated by its highly flexible intramolecular interaction with the NEP C terminus. On the basis of our data, we propose a new model for the assembly of the nuclear export complex of Influenza A vRNPs.	[Brunotte, Linda; Flies, Joe; Bolte, Hardin; Reuther, Peter; Schwemmle, Martin] Univ Med Ctr Freiburg, Inst Virol, D-79104 Freiburg, Germany; [Vreede, Frank] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX 3RE, England	University of Freiburg; University of Oxford	Schwemmle, M (corresponding author), Univ Med Ctr Freiburg, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany.	martin.schwemmle@uniklinik-freiburg.de		Reuther, Peter/0000-0002-5198-8165	Bundesministerium fur Bildung und Forschung (FluResearchNet); Deutsche Forschungsgesellschaft [SCHW 632/11-2]; Studienstiftung des deutschen Volkes fellowship; MRC [G1100138] Funding Source: UKRI; Medical Research Council [G1100138] Funding Source: researchfish	Bundesministerium fur Bildung und Forschung (FluResearchNet)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Bundesministerium fur Bildung und Forschung (FluResearchNet) and by Deutsche Forschungsgesellschaft Grant SCHW 632/11-2).; Recipient of a Studienstiftung des deutschen Volkes fellowship.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Bullido R, 2001, J VIROL, V75, P4912, DOI 10.1128/JVI.75.10.4912-4917.2001; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Huang SP, 2013, J VIROL, V87, P767, DOI 10.1128/JVI.06519-11; Hutchinson EC, 2013, VIRUSES-BASEL, V5, P2424, DOI 10.3390/v5102424; Jo S, 2010, MICROBES INFECT, V12, P1079, DOI 10.1016/j.micinf.2010.06.011; KAWAKAMI K, 1983, J BIOCHEM-TOKYO, V93, P989, DOI 10.1093/oxfordjournals.jbchem.a134254; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; Ma K, 2001, VIROLOGY, V282, P215, DOI 10.1006/viro.2001.0833; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Manz B, 2010, J VIROL, V84, P8316, DOI 10.1128/JVI.00850-10; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; Neumann G, 2000, J VIROL, V74, P547, DOI 10.1128/JVI.74.1.547-551.2000; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; REES PJ, 1981, J GEN VIROL, V53, P125, DOI 10.1099/0022-1317-53-1-125; Reuther P, 2014, J VIROL, V88, P263, DOI 10.1128/JVI.01495-13; RICHARDSON JC, 1991, ARCH VIROL, V116, P69, DOI 10.1007/BF01319232; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; RUIGROK RWH, 1995, J GEN VIROL, V76, P1009, DOI 10.1099/0022-1317-76-4-1009; SHAPIRO GI, 1987, J VIROL, V61, P764, DOI 10.1128/JVI.61.3.764-773.1987; Shimizu T, 2011, FEBS LETT, V585, P41, DOI 10.1016/j.febslet.2010.11.017; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Tchatalbachev S, 2001, RNA, V7, P979, DOI 10.1017/S1355838201002424; Turrell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2589; Whittaker G, 1996, J VIROL, V70, P2743, DOI 10.1128/JVI.70.5.2743-2756.1996; Wu WWH, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-49; YASUDA J, 1993, VIROLOGY, V196, P249, DOI 10.1006/viro.1993.1473; Ye ZP, 1999, J VIROL, V73, P7467, DOI 10.1128/JVI.73.9.7467-7473.1999; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110	42	49	52	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20067	20077		10.1074/jbc.M114.569178	http://dx.doi.org/10.1074/jbc.M114.569178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24891509	Green Published, hybrid			2022-12-28	WOS:000339395200021
J	Duttke, SHC				Duttke, Sascha H. C.			RNA Polymerase III Accurately Initiates Transcription from RNA Polymerase II Promoters in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; CORE PROMOTER; EUKARYOTIC TRANSCRIPTION; DROSOPHILA; BOX; CHROMATIN; ELEMENT; GENE; TBP; IDENTIFICATION	In eukaryotes, there are three major RNA polymerases (Pol) in the nucleus, which are commonly described as transcribing non-overlapping subsets of genes. Structural studies have highlighted a conserved core shared among all three transcription systems. Initiation of human Pol III from TATA box-containing Pol II promoters under conditions with impaired Pol II transcription activity have been described previously. RNA polymerase III and Pol II were found to co-localize at the promoters of the c-myc gene and the RPPH1 sRNA in vivo. Here, I report that Pol III can, like Pol II, initiate transcription from most tested Pol II core promoters when assayed with crude human nuclear extracts (HSK, SNF, or Dignam). Both polymerases often initiate from the same transcription start site, and depend on a TATA box or AT-rich region but not the downstream promoter element (DPE) or the motif ten element (MTE). Moderate (similar to 2-fold) changes in the ratio of DNA template to nuclear extract were sufficient to change Pol II-mediated transcription to a mixture of Pol II- and Pol III-, or to a solely Pol III-dependent initiation of transcription from Pol II promoters. Polymerase specificity is thus not fixed but a variable that depends on the properties of the promoter and the transcription conditions. These findings provide functional evidence for a close similarity between the Pol II and Pol III transcription complexes, and additionally explain previous controversies in the literature.	[Duttke, Sascha H. C.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Duttke, SHC (corresponding author), Univ Calif San Diego, Sect Mol Biol 0347, Div Biol Sci, Pacific Hall,Rm 2216,9500 Gilman Dr, La Jolla, CA 92093 USA.	sduttke@ucsd.edu		Duttke, Sascha H/0000-0003-4717-000X	National Institutes of Health [R01 GM041249]; University of California San Diego Molecular Biology/Cancer Center Fellowship; Ruth Newmark Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Molecular Biology/Cancer Center Fellowship; Ruth Newmark Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM041249 (to J. T. Kadonaga) and the University of California San Diego Molecular Biology/Cancer Center Fellowship and Ruth Newmark Fellowship (to S. D.).	Alberts B., 2008, MOL BIOL CEL, V5th ed.; BENTLEY DL, 1989, GENE DEV, V3, P1179, DOI 10.1101/gad.3.8.1179; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dumay-Odelot H., 2014, TRANSCRIPTI IN PRESS; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; Faresse NJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003028; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; George Catherine P., 1996, P133; Goodfellow Sarah J, 2013, Subcell Biochem, V61, P211, DOI 10.1007/978-94-007-4525-4_10; GUNNERY S, 1995, MOL CELL BIOL, V15, P3597; Hausner W, 2001, J BACTERIOL, V183, P3025, DOI 10.1128/JB.183.10.3025-3031.2001; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; KAMAKAKA RT, 1991, P NATL ACAD SCI USA, V88, P1024, DOI 10.1073/pnas.88.3.1024; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1992, CELL, V71, P1055, DOI 10.1016/0092-8674(92)90399-W; Knutson BA, 2013, BBA-GENE REGUL MECH, V1829, P265, DOI 10.1016/j.bbagrm.2012.08.003; Kober I, 1998, J MOL BIOL, V284, P7, DOI 10.1006/jmbi.1998.2165; Kuryan BG, 2012, P NATL ACAD SCI USA, V109, P1931, DOI 10.1073/pnas.1109994109; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lenzmeier BA, 1997, J VIROL, V71, P2577, DOI 10.1128/JVI.71.3.2577-2580.1997; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Listerman I, 2007, PLOS GENET, V3, P2268, DOI 10.1371/journal.pgen.0030212; LOBO SM, 1989, CELL, V58, P55, DOI 10.1016/0092-8674(89)90402-9; MITCHELL MT, 1992, J BIOL CHEM, V267, P1995; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Orioli A, 2012, GENE, V493, P185, DOI 10.1016/j.gene.2011.06.015; Orioli A, 2011, NUCLEIC ACIDS RES, V39, P5499, DOI 10.1093/nar/gkr074; PIRAS G, 1994, J VIROL, V68, P6170, DOI 10.1128/JVI.68.10.6170-6179.1994; PRUZAN R, 1992, NUCLEIC ACIDS RES, V20, P5705, DOI 10.1093/nar/20.21.5705; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Roeder RG, 2003, NAT MED, V9, P1239, DOI 10.1038/nm938; ROEDER RG, 1974, J BIOL CHEM, V249, P241; ROWLANDS T, 1994, SCIENCE, V264, P1326, DOI 10.1126/science.8191287; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SCHULTZ LD, 1976, P NATL ACAD SCI USA, V73, P1029, DOI 10.1073/pnas.73.4.1029; SENTENAC A, 1985, CRC CR REV BIOCH MOL, V18, P31, DOI 10.3109/10409238509082539; SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; STEINBERG TH, 1990, J BIOL CHEM, V265, P499; STEINBERG TH, 1992, J BIOL CHEM, V267, P20204; SUSSMAN DJ, 1991, NUCLEIC ACIDS RES, V19, P5045, DOI 10.1093/nar/19.18.5045; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Theisen JWM, 2013, J BIOL CHEM, V288, P7096, DOI 10.1074/jbc.M112.438697; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Verma N, 2013, J BIOL CHEM, V288, P27564, DOI 10.1074/jbc.C113.503094; WAMPLER SL, 1992, GENE DEV, V6, P1542, DOI 10.1101/gad.6.8.1542; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8606, DOI 10.1073/pnas.92.19.8606; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P3426, DOI 10.1073/pnas.71.9.3426; White R. J., 1998, RNA POLYMERASE 3 TRA	62	15	16	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20396	20404		10.1074/jbc.M114.563254	http://dx.doi.org/10.1074/jbc.M114.563254			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24917680	Green Published, hybrid			2022-12-28	WOS:000339395200050
J	Supattapone, S				Supattapone, Surachai			Synthesis of High Titer Infectious Prions with Cofactor Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL-FREE FORMATION; IN-VITRO; STRAIN PROPERTIES; MAMMALIAN PRIONS; PROTEIN; AMPLIFICATION; REPLICATION; PROPAGATION; SPECIFICITY; GENERATION	Recently, synthetic prions with a high level of specific infectivity have been produced from chemically defined components in vitro. A major insight arising from these studies is that various classes of host-encoded cofactor molecules such as phosphatidylethanolamine and RNA molecules are required to form and maintain the specific conformation of infectious prions. Synthetic mouse prions formed with phosphatidylethanolamine exhibit levels of specific infectivity similar to 1 million-fold greater than "protein-only" prions (Deleault, N. R., Walsh, D. J., Piro, J. R., Wang, F., Wang, X., Ma, J., Rees, J. R., and Supattapone, S. (2012) Proc. Natl. Acad. Sci. U.S.A. 109, E1938-E1946). Moreover, cofactor molecules also appear to regulate prion strain properties by limiting the potential conformations of the prion protein (see Deleault et al. above). The production of fully infectious synthetic prions provides new opportunities to study the mechanism of prion infectivity directly by structural and biochemical methods.	[Supattapone, Surachai] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Supattapone, Surachai] Geisel Sch Med Dartmouth, Dept Med, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Supattapone, S (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Vail Bldg,Rm 311, Hanover, NH 03755 USA.	supattapone@dartmouth.edu			National Institutes of Health [2R01 NS046478 11]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01 NS046478 11 (to S. S.).	BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; Cancellotti E, 2013, EMBO J, V32, P756, DOI 10.1038/emboj.2013.6; Carlson GA, 1996, CURR TOP MICROBIOL, V207, P35; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cosseddu GM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002370; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Gonzalez-Montalban N, 2013, FASEB J, V27, P3702, DOI 10.1096/fj.13-230466; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Makarava N, 2012, J BIOL CHEM, V287, P30205, DOI 10.1074/jbc.M112.392985; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Piro JR, 2011, BIOCHEMISTRY-US, V50, P7111, DOI 10.1021/bi200786p; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Timmes AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071081; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Zhang ZH, 2013, FASEB J, V27, P4768, DOI 10.1096/fj.13-233965	34	31	31	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19850	19854		10.1074/jbc.R113.511329	http://dx.doi.org/10.1074/jbc.R113.511329			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24860097	hybrid, Green Published			2022-12-28	WOS:000339395200003
J	Meyer, MB; Benkusky, NA; Lee, CH; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Lee, Chang-Hun; Pike, J. Wesley			Genomic Determinants of Gene Regulation by 1,25-Dihydroxyvitamin D-3 during Osteoblast-lineage Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; BINDING-SITES; TRANSCRIPTION FACTOR; OSTEOCALCIN GENE; TARGET GENES; BONE-FORMATION; NULL MICE; RUNX2; PROMOTER; ACTIVATION	The biological effects of 1 alpha,25-dihydroxyvitamin D-3 (1,25 (OH)(2)D-3) on osteoblast differentiation and function differ significantly depending upon the cellular state of maturation. To explore this phenomenon mechanistically, we examined the impact of 1,25(OH)(2)D-3 on the transcriptomes of both pre-osteoblastic (POBs) and differentiated osteoblastic (OBs) MC3T3-E1 cells, and assessed localization of the vitamin D receptor (VDR) at sites of action on a genome-scale using ChIP sequence analysis. We observed that the 1,25(OH)(2)D-3-induced transcriptomes of POBs and OBs were quantitatively and qualitatively different, supporting not only the altered biology observed but the potential for a change in VDR interaction at the genome as well. This idea was confirmed through discovery that VDR cistromes in POBs and OBs were also strikingly different. Depletion of VDR-binding sites in OBs, due in part to reduced VDR expression, was the likely cause of the loss of VDR-target gene interaction. Continued novel regulation by 1,25(OH) 2D(3), however, suggested that factors in addition to the VDR might also be involved. Accordingly, we show that transcriptomic modifications are also accompanied by changes in genome binding of the master osteoblast regulator RUNX2 and the chromatin remodeler CCAAT/enhancer-binding protein beta. Importantly, genome occupancy was also highlighted by the presence of epigenetic enhancer signatures that were selectively changed in response to both differentiation and 1,25(OH) 2D(3). The impact of VDR, RUNX2, and C/EBP beta on osteoblast differentiation is exemplified by their actions at the Runx2 and Sp7 gene loci. We conclude that each of these mechanisms may contribute to the diverse actions of 1,25(OH) 2D(3) on differentiating osteoblasts.	[Meyer, Mark B.; Benkusky, Nancy A.; Lee, Chang-Hun; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Biochem Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health from NIDDK [DK-072281]; National Institutes of Health from NIAMS [AR-045173]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-072281 from NIDDK and AR-045173 from NIAMS (to J. W. P.).	Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Bikle DD, 2012, CURR OSTEOPOROS REP, V10, P151, DOI 10.1007/s11914-012-0098-z; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bouillon R, 2008, J BONE MINER RES, V23, P974, DOI 10.1359/JBMR.080420; Carlberg C, 2007, J STEROID BIOCHEM, V103, P338, DOI 10.1016/j.jsbmb.2006.12.044; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dowd DR, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P291; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Eisman John A, 2014, Bonekey Rep, V3, P499, DOI 10.1038/bonekey.2013.233; ELFORD PR, 1987, CALCIFIED TISSUE INT, V41, P151, DOI 10.1007/BF02563795; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Gardiner EM, 2000, FASEB J, V14, P1908, DOI 10.1096/fj.99-1075com; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Inoue Y, 2005, BIOCHEM J, V390, P325, DOI 10.1042/BJ20041799; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jensen ED, 2007, CRIT REV EUKAR GENE, V17, P187; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kriebitzsch C, 2011, J BONE MINER RES, V26, P2991, DOI 10.1002/jbmr.493; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SM, 2014, ENDOCRINOLOGY, V155, P2064, DOI 10.1210/en.2014-1107; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Lian JB, 2001, STEROIDS, V66, P159, DOI 10.1016/S0039-128X(00)00160-4; Lieben L, 2013, J STEROID BIOCHEM, V136, P102, DOI 10.1016/j.jsbmb.2012.09.019; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Lieben L, 2011, BEST PRACT RES CL EN, V25, P561, DOI 10.1016/j.beem.2011.05.008; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Marcellini S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-78; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2014, J STEROID BIOCHEM, V144, P19, DOI 10.1016/j.jsbmb.2013.09.005; Meyer MB, 2013, J STEROID BIOCHEM, V136, P120, DOI 10.1016/j.jsbmb.2012.08.006; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Peng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056451; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; Pike JW, 2014, J STEROID BIOCHEM, V144, P5, DOI 10.1016/j.jsbmb.2013.11.004; Pike J Wesley, 2014, Bonekey Rep, V3, P482, DOI 10.1038/bonekey.2013.216; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Steinberg XP, 2012, BIOCHEMISTRY-US, V51, P952, DOI 10.1021/bi201593q; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Wang YJ, 2014, J BONE MINER RES, V29, P685, DOI 10.1002/jbmr.2081; Welboren WJ, 2007, MOL ONCOL, V1, P138, DOI 10.1016/j.molonc.2007.04.001; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140	67	68	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19539	19554		10.1074/jbc.M114.578104	http://dx.doi.org/10.1074/jbc.M114.578104			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891508	Green Published, hybrid			2022-12-28	WOS:000339326800029
J	Skals, M; Bjaelde, RG; Reinholdt, J; Poulsen, K; Vad, BS; Otzen, DE; Leipziger, J; Praetorius, HA				Skals, Marianne; Bjaelde, Randi G.; Reinholdt, Jesper; Poulsen, Knud; Vad, Brian S.; Otzen, Daniel E.; Leipziger, Jens; Praetorius, Helle A.			Bacterial RTX Toxins Allow Acute ATP Release from Human Erythrocytes Directly through the Toxin Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ALPHA-HEMOLYSIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; ESCHERICHIA-COLI; ANION CHANNEL; MODEL MEMBRANES; ION CHANNELS; LEUKOTOXIN; PROTEIN; CFTR; REQUIRES	ATP is as an extracellular signaling molecule able to amplify the cell lysis inflicted by certain bacterial toxins including the two RTX toxins alpha-hemolysin (HlyA) from Escherichia coli and leukotoxin A (LtxA) from Aggregatibacter actinomycetemcomitans. Inhibition of P2X receptors completely blocks the RTX toxin-induced hemolysis over a larger concentration range. It is, however, at present not known how the ATP that provides the amplification is released from the attacked cells. Here we show that both HlyA and LtxA trigger acute release of ATP from human erythrocytes that preceded and were not caused by cell lysis. This early ATP release did not occur via previously described ATP-release pathways in the erythrocyte. Both HlyA and LtxA were capable of triggering ATP release in the presence of the pannexin 1 blockers carbenoxolone and probenecid, and the HlyA-induced ATP release was found to be similar in erythrocytes from pannexin 1 wild type and knock-out mice. Moreover, the voltage-dependent anion channel antagonist TRO19622 had no effect on ATP release by either of the toxins. Finally, we showed that both HlyA and LtxA were able to release ATP from ATP-loaded lipid (1-palmitoyl-2-oleoyl-phosphatidylcholine) vesicles devoid of any erythrocyte channels or transporters. Again we were able to show that this happened in a non-lytic fashion, using calcein-containing vesicles as controls. These data show that both toxins incorporate into lipid vesicles and allow ATP to be released. We suggest that both toxins cause acute ATP release by letting ATP pass the toxin pores in both human erythrocytes and artificial membranes.	[Skals, Marianne; Bjaelde, Randi G.; Poulsen, Knud; Leipziger, Jens; Praetorius, Helle A.] Aarhus Univ, Dept Biomed, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Proteins inSPIN, DK-8000 Aarhus C, Denmark; [Reinholdt, Jesper] Aarhus Univ, Dept Dent, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Proteins inSPIN, DK-8000 Aarhus C, Denmark; [Skals, Marianne; Bjaelde, Randi G.; Leipziger, Jens; Praetorius, Helle A.] Aarhus Univ, MEMBRANES, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Proteins inSPIN, DK-8000 Aarhus C, Denmark; [Vad, Brian S.; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Proteins inSPIN, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Praetorius, HA (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3,Bldg 1170, DK-8000 Aarhus C, Denmark.	hp@fi.au.dk		Otzen, Daniel/0000-0002-2918-8989; Praetorius, Helle/0000-0002-0970-5061; Leipziger, Jens/0000-0002-6719-7034	Danish Council for Independent Research; Novo Nordisk Fonden; Lundbeck Foundation; Danish Research Foundation (inSPIN); Medical Sciences	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Danish Research Foundation (inSPIN); Medical Sciences	This work was supported by The Danish Council for Independent Research, Medical Sciences, Novo Nordisk Fonden, the Lundbeck Foundation, and the Danish Research Foundation (inSPIN).	Adderley SP, 2011, MICROCIRCULATION, V18, P128, DOI 10.1111/j.1549-8719.2010.00073.x; Adderley SP, 2009, AM J PHYSIOL-HEART C, V296, pH1617, DOI 10.1152/ajpheart.01226.2008; Amaral A, 2004, INTENS CARE MED, V30, P1032, DOI 10.1007/s00134-004-2291-8; Bakas L, 1996, BIOPHYS J, V71, P1869, DOI 10.1016/S0006-3495(96)79386-4; Bell PD, 2003, P NATL ACAD SCI USA, V100, P4322, DOI 10.1073/pnas.0736323100; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BHAKDI S, 1988, EUR J EPIDEMIOL, V4, P135, DOI 10.1007/BF00144740; Borgel D, 2007, AM J RESP CRIT CARE, V176, P878, DOI 10.1164/rccm.200611-1692OC; Brown AC, 2013, J BIOL CHEM, V288, P23607, DOI 10.1074/jbc.M113.486654; Brown AC, 2012, CELL MICROBIOL, V14, P869, DOI 10.1111/j.1462-5822.2012.01762.x; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Burnstock Geoffrey, 2011, Front Biosci (Elite Ed), V3, P896; Cantiello HF, 2001, PFLUG ARCH EUR J PHY, V443, pS22; CAVALIERI SJ, 1982, INFECT IMMUN, V36, P455, DOI 10.1128/IAI.36.2.455-461.1982; Dutta AK, 2002, J PHYSIOL-LONDON, V542, P803, DOI 10.1113/jphysiol.2002.019802; EBERSPACHER B, 1989, INFECT IMMUN, V57, P983; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Forman MS, 2010, TOXINS, V2, P2824, DOI 10.3390/toxins2122824; GAARDER A., 1961, NATURE, V192, P531, DOI 10.1038/192531a0; Grygorczyk R, 1997, AM J PHYSIOL-CELL PH, V272, pC1058; Grygorczyk R, 1996, J MEMBRANE BIOL, V151, P139, DOI 10.1007/s002329900065; Hejl JL, 2013, PFLUG ARCH EUR J PHY, V465, P529, DOI 10.1007/s00424-012-1174-z; Hjorringgaard CU, 2012, J PHYS CHEM B, V116, P7652, DOI 10.1021/jp2098679; IWASE M, 1990, INFECT IMMUN, V58, P1782, DOI 10.1128/IAI.58.6.1782-1788.1990; JORGENSEN SE, 1980, INFECT IMMUN, V27, P988, DOI 10.1128/IAI.27.3.988-994.1980; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Karakelian D, 1998, BBA-MOL BASIS DIS, V1406, P175, DOI 10.1016/S0925-4439(98)00002-7; Kieba IR, 2007, CELL MICROBIOL, V9, P2689, DOI 10.1111/j.1462-5822.2007.00989.x; KONIG B, 1993, IMMUNOLOGY, V80, P633; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Larsen CK, 2011, J MEMBRANE BIOL, V244, P131, DOI 10.1007/s00232-011-9406-2; LEAR JD, 1995, BBA-BIOMEMBRANES, V1238, P34, DOI 10.1016/0005-2736(95)00086-I; Li CH, 1996, J BIOL CHEM, V271, P11623, DOI 10.1074/jbc.271.20.11623; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Massion PB, 2012, INTENS CARE MED, V38, P1326, DOI 10.1007/s00134-012-2620-2; MENESTRINA G, 1987, BIOCHIM BIOPHYS ACTA, V905, P109, DOI 10.1016/0005-2736(87)90014-9; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Munksgaard PS, 2014, INFECT IMMUN, V82, P2219, DOI 10.1128/IAI.01647-14; Munksgaard PS, 2012, CELL MICROBIOL, V14, P1904, DOI 10.1111/cmi.12021; Nielsen SB, 2010, J COLLOID INTERF SCI, V345, P248, DOI 10.1016/j.jcis.2010.01.065; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Olearczyk J J, 2001, Med Sci Monit, V7, P669; OSTOLAZA H, 1993, BIOCHIM BIOPHYS ACTA, V1147, P81, DOI 10.1016/0005-2736(93)90318-T; Ostolaza H, 1997, J MEMBRANE BIOL, V158, P137, DOI 10.1007/s002329900251; OSTOLAZA H, 1995, FEBS LETT, V371, P303, DOI 10.1016/0014-5793(95)00927-2; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; Reinholdt J, 2013, BBA-PROTEINS PROTEOM, V1834, P546, DOI 10.1016/j.bbapap.2012.12.004; REISIN IL, 1994, J BIOL CHEM, V269, P20584; Roman RM, 1997, J BIOL CHEM, V272, P21970, DOI 10.1074/jbc.272.35.21970; Sabirov RZ, 2004, JPN J PHYSIOL, V54, P7, DOI 10.2170/jjphysiol.54.7; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Skals M, 2011, PFLUG ARCH EUR J PHY, V462, P669, DOI 10.1007/s00424-011-1010-x; Skals M, 2010, J BIOL CHEM, V285, P15557, DOI 10.1074/jbc.M109.082578; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Soloaga A, 1999, MOL MICROBIOL, V31, P1013, DOI 10.1046/j.1365-2958.1999.01225.x; Sprague RS, 2008, MICROCIRCULATION, V15, P461, DOI 10.1080/10739680701833804; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; Sridharan M, 2012, AM J PHYSIOL-HEART C, V302, pH553, DOI 10.1152/ajpheart.00998.2011; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Stumpf A, 2006, CELL PHYSIOL BIOCHEM, V17, P29, DOI 10.1159/000091457; TAICHMAN NS, 1980, INFECT IMMUN, V28, P258, DOI 10.1128/IAI.28.1.258-268.1980; Vad BS, 2010, BIOPHYS J, V98, P576, DOI 10.1016/j.bpj.2009.08.063; Walters MJ, 2013, MOL ORAL MICROBIOL, V28, P342, DOI 10.1111/omi.12028	68	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19098	19109		10.1074/jbc.M114.571414	http://dx.doi.org/10.1074/jbc.M114.571414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24860098	hybrid, Green Published			2022-12-28	WOS:000339062900040
J	Soares, F; Tattoli, I; Rahman, MA; Robertson, SJ; Belcheva, A; Liu, D; Streutker, C; Winer, S; Winer, DA; Martin, A; Philpott, DJ; Arnoult, D; Girardin, SE				Soares, Fraser; Tattoli, Ivan; Rahman, Muhammed A.; Robertson, Susan J.; Belcheva, Antoaneta; Liu, Daniel; Streutker, Catherine; Winer, Shawn; Winer, Daniel A.; Martin, Alberto; Philpott, Dana J.; Arnoult, Damien; Girardin, Stephen E.			The Mitochondrial Protein NLRX1 Controls the Balance between Extrinsic and Intrinsic Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOD-LIKE RECEPTOR; IMMUNITY; CELLS	NLRX1 is a mitochondrial Nod-like receptor (NLR) protein whose function remains enigmatic. Here, we observed that NLRX1 expression was glucose-regulated and blunted by SV40 transformation. In transformed but not primary murine embryonic fibroblasts, NLRX1 expression mediated resistance to an extrinsic apoptotic signal, whereas conferring susceptibility to intrinsic apoptotic signals, such as glycolysis inhibition, increased cytosolic calcium and endoplasmic reticulum stress. In a murine model of colorectal cancer induced by azoxymethane, NLRX1-/- mice developed fewer tumors than wild type mice. In contrast, in a colitis-associated cancer model combining azoxymethane and dextran sulfate sodium, NLRX1-/- mice developed a more severe pathology likely due to the increased sensitivity to dextran sulfate sodium colitis. Together, these results identify NLRX1 as a critical mitochondrial protein implicated in the regulation of apoptosis in cancer cells. The unique capacity of NLRX1 to regulate the cellular sensitivity toward intrinsic versus extrinsic apoptotic signals suggests a critical role for this protein in numerous physiological processes and pathological conditions.	[Soares, Fraser; Tattoli, Ivan; Rahman, Muhammed A.; Liu, Daniel; Streutker, Catherine; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M6G 2T6, Canada; [Tattoli, Ivan; Rahman, Muhammed A.; Robertson, Susan J.; Belcheva, Antoaneta; Martin, Alberto; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M6G 2T6, Canada; [Streutker, Catherine] Univ Toronto, St Michaels Hosp, Toronto, ON M6G 2T6, Canada; [Winer, Shawn; Winer, Daniel A.] Univ Toronto, Toronto Gen Hosp, Dept Pathol, Toronto, ON M6G 2T6, Canada; [Arnoult, Damien] Hop Paul Brousse, INSERM, U1014, F-94807 Villejuif, France	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Girardin, SE (corresponding author), Univ Toronto, Med Sci Bldg,Rm 6336, Toronto, ON M5S 1A8, Canada.	stephen.girardin@utoronto.ca	Tattoli, Ivan/H-2600-2017; Arnoult, Damien/R-2032-2018	Tattoli, Ivan/0000-0001-7925-4609; Soares, Fraser/0000-0002-3977-7939; Martin, Alberto/0000-0002-0795-0418; Belcheva, Antoaneta/0000-0001-5061-7533	Canadian Institutes of Health Research (CIHR); Burroughs Wellcome Fund; Banting and Best Graduate Scholarship from CIHR; Canadian Cancer Society	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Banting and Best Graduate Scholarship from CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (to D. J. P. and S. E. G.), the Burroughs Wellcome Fund (to S. E. G.), a Banting and Best Graduate Scholarship from CIHR (to F. S.), and the Canadian Cancer Society (to S. E. G.).	Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Augenlicht L, 1999, ADV EXP MED BIOL, V470, P15; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Danielsson F, 2013, P NATL ACAD SCI USA, V110, P6853, DOI 10.1073/pnas.1216436110; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Ling A, 2012, J BIOL CHEM, V287, P28705, DOI 10.1074/jbc.M111.333146; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Rebsamen M, 2011, CELL DEATH DIFFER, V18, P1387, DOI 10.1038/cdd.2011.64; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sasaki O, 2013, BBA-MOL CELL RES, V1833, P1017, DOI 10.1016/j.bbamcr.2013.01.010; Soares F, 2013, INNATE IMMUN-LONDON, V19, P438, DOI 10.1177/1753425912467383; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161	19	50	52	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19317	19330		10.1074/jbc.M114.550111	http://dx.doi.org/10.1074/jbc.M114.550111			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867956	Green Published, hybrid			2022-12-28	WOS:000339326800009
J	Chan, YL; Brown, MS; Qin, DM; Handa, N; Bishop, DK				Chan, Yuen-Ling; Brown, M. Scott; Qin, Daoming; Handa, Naofumi; Bishop, Douglas K.			The Third Exon of the Budding Yeast Meiotic Recombination Gene HOP2 Is Required for Calcium-dependent and Recombinase Dmc1-specific Stimulation of Homologous Strand Assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; METHANOCOCCUS-VOLTAE; RAD51 RECOMBINASE; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; ATP HYDROLYSIS; DMC1 ACTIVITY; MEIOSIS; DNA; PROMOTES	During meiosis in Saccharomyces cerevisiae, the HOP2 and MND1 genes are essential for recombination. A previous biochemical study has shown that budding yeast Hop2-Mnd1 stimulates the activity of the meiosis-specific strand exchange protein ScDmc1 only 3-fold, whereas analogous studies using mammalian homologs show >30-fold stimulation. The HOP2 gene was recently discovered to contain a second intron that lies near the 3'-end. We show that both HOP2 introns are efficiently spliced during meiosis, forming a predominant transcript that codes for a protein with a C-terminal sequence different from that of the previously studied version of the protein. Using the newly identified HOP2 open reading frame to direct synthesis of wild type Hop2 protein, we show that the Hop2-Mnd1 heterodimer stimulated Dmc1 D-loop activity up to 30-fold, similar to the activity of mammalian Hop2-Mnd1. ScHop2-Mnd1 stimulated ScDmc1 activity in the presence of physiological (micromolar) concentrations of Ca2+ ions, as long as Mg2+ was also present at physiological concentrations, leading us to hypothesize that ScDmc1 protomers bind both cations in the active Dmc1 filament. Cofactor requirements and order-of-addition experiments suggested that Hop2-Mnd1-mediated stimulation of Dmc1 involves a process that follows the formation of functional Dmc1-ssDNA filaments. In dramatic contrast to mammalian orthologs, the stimulatory activity of budding yeast Hop2-Mnd1 appeared to be specific to Dmc1; we observed no Hop2-Mnd1-mediated stimulation of the other budding yeast strand exchange protein Rad51. Together, these results support previous genetic experiments indicating that Hop2-Mnd1 specifically stimulates Dmc1 during meiotic recombination in budding yeast.	[Chan, Yuen-Ling; Brown, M. Scott; Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Qin, Daoming; Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Handa, Naofumi] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA	University of Chicago; University of Chicago; University of California System; University of California Davis	Bishop, DK (corresponding author), Univ Chicago, Cummings Life Sci Ctr, Dept Radiat & Cellular Oncol, CSLC821B,920 East 58th St, Chicago, IL 60637 USA.	dbishop@uchicago.edu	Handa, Naofumi/H-6640-2017	Handa, Naofumi/0000-0003-3695-1871	National Institutes of Health from NIGMS [GM050936]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, R01GM050936] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM050936 from NIGMS (to D. K. B.).	BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; CARROLL J, 1994, DEVELOPMENT, V120, P3507; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; CUNNINGHAM KW, 1994, J EXP BIOL, V196, P157; Enomoto R, 2006, J BIOL CHEM, V281, P5575, DOI 10.1074/jbc.M506506200; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Gerton JL, 2002, P NATL ACAD SCI USA, V99, P6895, DOI 10.1073/pnas.102167899; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Henry JM, 2006, MOL CELL BIOL, V26, P2913, DOI 10.1128/MCB.26.8.2913-2923.2006; Hong E. L., 2002, THESIS U CHICAGO CHI, P84; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Lao JP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003978; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Leu JY, 1999, MOL CELL BIOL, V19, P7933; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Nabeshima K, 2001, EMBO J, V20, P3871, DOI 10.1093/emboj/20.14.3871; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Ploquin M, 2007, NUCLEIC ACIDS RES, V35, P2719, DOI 10.1093/nar/gkm174; Popescu R, 2011, MUTAT RES-FUND MOL M, V709-10, P60, DOI 10.1016/j.mrfmmm.2011.03.001; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Qian XG, 2005, BIOCHEMISTRY-US, V44, P13753, DOI 10.1021/bi051222i; Qian XG, 2006, J BIOL CHEM, V281, P39380, DOI 10.1074/jbc.M607785200; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Saito TT, 2004, NUCLEIC ACIDS RES, V32, P3325, DOI 10.1093/nar/gkh654; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sehorn MG, 2004, CELL CYCLE, V3, P1375, DOI 10.4161/cc.3.11.1364; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; SIKORSKI RS, 1989, GENETICS, V122, P19; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Uanschou C, 2013, PLANT CELL, V25, P4924, DOI 10.1105/tpc.113.118521; Wang TF, 2002, BIOCHEM BIOPH RES CO, V296, P949, DOI 10.1016/S0006-291X(02)02034-X; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Zhao WX, 2014, NUCLEIC ACIDS RES, V42, P906, DOI 10.1093/nar/gkt924; Zierhut C, 2004, CURR BIOL, V14, P752, DOI 10.1016/j.cub.2004.04.030	62	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18076	18086		10.1074/jbc.M114.558601	http://dx.doi.org/10.1074/jbc.M114.558601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24798326	hybrid, Green Published			2022-12-28	WOS:000338042000011
J	Desai, LP; Zhou, Y; Estrada, AV; Ding, Q; Cheng, GJ; Collawn, JF; Thannickal, VJ				Desai, Leena P.; Zhou, Yong; Estrada, Aida V.; Ding, Qiang; Cheng, Guangjie; Collawn, James F.; Thannickal, Victor J.			Negative Regulation of NADPH Oxidase 4 by Hydrogen Peroxide-inducible Clone 5 (Hic-5) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; GROWTH-FACTOR-BETA; ALPHA-B-CRYSTALLIN; PREMATURE SENESCENCE; CELLULAR SENESCENCE; HUMAN FIBROBLASTS; BINDING-PROTEIN; IN-VITRO; CELLS; HSP27	Hydrogen peroxide-inducible clone 5 (Hic-5) is a focal adhesion adaptor protein induced by the profibrotic cytokine TGF-beta 1. We have demonstrated previously that TGF-beta 1 induces myofibroblast differentiation and lung fibrosis by activation of the reactive oxygen species-generating enzyme NADPH oxidase 4 (Nox4). Here we investigated a potential role for Hic-5 in regulating Nox4, myofibroblast differentiation, and senescence. In normal human diploid fibroblasts, TGF-beta 1 induces Hic-5 expression in a delayed manner relative to the induction of Nox4 and myofibroblast differentiation. Hic-5 silencing induced constitutive Nox4 expression and enhanced TGF-beta 1 inducible Nox4 levels. The induction of constitutive Nox4 protein in Hic-5-silenced cells was independent of transcription and translation and controlled by the ubiquitin-proteasomal system. Hic-5 associates with the ubiquitin ligase Cbl-c and the ubiquitin-binding protein heat shock protein 27 (HSP27). The interaction of these proteins is required for the ubiquitination of Nox4 and for maintaining low basal levels of this reactive oxygen species-generating enzyme. Our model suggests that TGF-beta 1-induced Hic-5 functions as a negative feedback mechanism to limit myofibroblast differentiation and senescence by promoting the ubiquitin-proteasomal system-mediated degradation of Nox4. Together, these studies indicate that endogenous Hic-5 suppresses senescence and profibrotic activities of myofibroblasts by down-regulating Nox4 protein expression. Additionally, these are the first studies, to our	[Desai, Leena P.; Zhou, Yong; Estrada, Aida V.; Ding, Qiang; Cheng, Guangjie; Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Collawn, James F.] Univ Alabama Birmingham, Div Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Thannickal, VJ (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, 1900 Univ Blvd,THT 429, Birmingham, AL 35294 USA.	vjthan@uab.edu		Cheng, Guangjie/0000-0002-9368-379X; Collawn, James/0000-0002-2528-2759	National Institutes of Health [T32 HL105346, P01 HL114470]; NATIONAL CANCER INSTITUTE [P50CA101955] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105346, R01HL085324, P01HL114470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL105346 (to L. P. D.) and P01 HL114470 (to V. J. T.).	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Bahta AW, 2008, J INVEST DERMATOL, V128, P1088, DOI 10.1038/sj.jid.5701147; Bai GX, 2014, GENE, V540, P62, DOI 10.1016/j.gene.2014.02.026; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; Du Y, 2009, INT J ORAL SCI, V1, P72, DOI 10.4248/ijos.08020; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2011, EXP CELL RES, V317, P1914, DOI 10.1016/j.yexcr.2011.03.016; Ito H, 2002, J BIOCHEM, V131, P593, DOI 10.1093/oxfordjournals.jbchem.a003139; Jia YF, 2001, J BIOL CHEM, V276, P39911, DOI 10.1074/jbc.M103510200; Kato K, 2011, INT J MOL MED, V27, P423, DOI 10.3892/ijmm.2011.595; Kodama R, 2013, GENES CELLS, V18, P32, DOI 10.1111/gtc.12015; Komatsuda A, 1999, NEPHROL DIAL TRANSPL, V14, P1385, DOI 10.1093/ndt/14.6.1385; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Liu TG, 2007, AM J RESP CELL MOL, V37, P507, DOI 10.1165/rcmb.2007-0077OC; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Peshavariya H, 2009, ANTIOXID REDOX SIGN, V11, P2399, DOI [10.1089/ars.2009.2579, 10.1089/ARS.2009.2579]; Ryan PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049428; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shibanuma M, 1997, MOL CELL BIOL, V17, P1224, DOI 10.1128/MCB.17.3.1224; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Srinivasan R, 2008, AM J PHYSIOL-HEART C, V294, pH961, DOI 10.1152/ajpheart.00939.2007; Sun Y, 2011, EXP LUNG RES, V37, P568, DOI 10.3109/01902148.2011.619627; Takahashi-Horiuchi Y, 2008, TOHOKU J EXP MED, V214, P221, DOI 10.1620/tjem.214.221; Thannickal VJ, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S23; Thannickal VJ, 2013, BIOGERONTOLOGY, V14, P609, DOI 10.1007/s10522-013-9451-6; Thannickal VJ, 2010, INT J BIOCHEM CELL B, V42, P1398, DOI 10.1016/j.biocel.2010.05.010; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Vidyasagar A, 2013, KIDNEY INT, V83, P84, DOI 10.1038/ki.2012.336; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wang XB, 2011, J BIOL CHEM, V286, P41589, DOI 10.1074/jbc.M111.250878; Wettstein G, 2013, FASEB J, V27, P1549, DOI 10.1096/fj.12-220053; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Yerbury JJ, 2013, CELL STRESS CHAPERON, V18, P251, DOI 10.1007/s12192-012-0371-1; Zhang J, 2000, MOL CARCINOGEN, V27, P177, DOI 10.1002/(SICI)1098-2744(200003)27:3<177::AID-MC4>3.3.CO;2-J	43	37	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18270	18278		10.1074/jbc.M114.562249	http://dx.doi.org/10.1074/jbc.M114.562249			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831009	Green Published, hybrid			2022-12-28	WOS:000338042000027
J	Gould, CJ; Chesarone-Cataldo, M; Alioto, SL; Salin, B; Sagot, I; Goode, BL				Gould, Christopher J.; Chesarone-Cataldo, Melissa; Alioto, Salvatore L.; Salin, Benedicte; Sagot, Isabelle; Goode, Bruce L.			Saccharomyces cerevisiae Kelch Proteins and Bud14 Protein Form a Stable 520-kDa Formin Regulatory Complex That Controls Actin Cable Assembly and Cell Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUDDING YEAST CYTOKINESIS; FISSION YEAST; POLARIZED GROWTH; MICROTUBULAR CYTOSKELETON; ORGANELLE SEGREGATION; CRYSTAL-STRUCTURE; FAMILY PROTEIN; HUMAN KEAP1; MYOSIN-V; DYNAMICS	Formins perform essential roles in actin assembly and organization in vivo, but they also require tight regulation of their activities to produce properly functioning actin structures. Saccharomyces cerevisiae Bud14 is one member of an emerging class of formin regulators that target the FH2 domain to inhibit actin polymerization, but little is known about how these regulators are themselves controlled in vivo. Kelch proteins are critical for cell polarity and morphogenesis in a wide range of organisms, but their mechanistic roles in these processes are still largely undefined. Here, we report that S. cerevisiae Kelch proteins, Kel1 and Kel2, associate with Bud14 in cell extracts to form a stable 520-kDa complex with an apparent stoichiometry of 2: 2: 1 Bud14/Kel1/Kel2. Using pairwise combinations of GFP-and red fluorescent protein-tagged proteins, we show that Kel1, Kel2, and Bud14 interdependently co-localize at polarity sites. By analyzing single, double, and triple mutants, we show that Kel1 and Kel2 function in the same pathway as Bud14 in regulating Bnr1-mediated actin cable formation. Loss of any component of the complex results in long, bent, and hyper-stable actin cables, accompanied by defects in secretory vesicle traffic during polarized growth and septum formation during cytokinesis. These observations directly link S. cerevisiae Kelch proteins to the control of formin activity, and together with previous observations made for S. pombe homologues tea1p and tea3p, they have broad implications for understanding Kelch function in other systems.	[Gould, Christopher J.; Chesarone-Cataldo, Melissa; Alioto, Salvatore L.; Goode, Bruce L.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Gould, Christopher J.; Chesarone-Cataldo, Melissa; Alioto, Salvatore L.; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Salin, Benedicte; Sagot, Isabelle] Univ Bordeaux, Inst Biochim & Genet Cellulaires, Bordeaux, France; [Salin, Benedicte; Sagot, Isabelle] CNRS, UMR5095, Bordeaux, France	Brandeis University; Brandeis University; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, 415 South St, Waltham, MA 02454 USA.	goode@brandeis.edu			National Institutes of Health [GM083137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596, T32GM007122, R01GM083137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM083137 (to B. G.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Adams JC, 1998, EMBO J, V17, P4964, DOI 10.1093/emboj/17.17.4964; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Bretscher A, 2003, J CELL BIOL, V160, P811, DOI 10.1083/jcb.200301035; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Buttery SM, 2012, MOL BIOL CELL, V23, P4041, DOI 10.1091/mbc.E12-05-0395; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; Chesarone M, 2009, DEV CELL, V16, P292, DOI 10.1016/j.devcel.2008.12.001; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone-Cataldo M, 2011, DEV CELL, V21, P217, DOI 10.1016/j.devcel.2011.07.004; Cullen PJ, 2002, EUKARYOT CELL, V1, P884, DOI 10.1128/EC.1.6.884-894.2002; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Feierbach B, 2004, J CELL BIOL, V165, P697, DOI 10.1083/jcb.200403090; Gao L, 2010, MOL BIOL CELL, V21, P1253, DOI 10.1091/mbc.E09-10-0861; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Guthrie C, 1991, GUIDE YEAST GENETICS; Hara T, 2004, MOL BIOL CELL, V15, P1172, DOI 10.1091/mbc.E03-07-0531; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hofken T, 2002, EMBO J, V21, P4851, DOI 10.1093/emboj/cdf481; Hudson Andrew M., 2008, V48, P6, DOI 10.1007/978-0-387-09595-0_2; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; Kim IF, 1999, GENE, V228, P73, DOI 10.1016/S0378-1119(99)00006-2; Knaus M, 2005, EMBO J, V24, P3000, DOI 10.1038/sj.emboj.7600783; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Li XC, 2004, ACTA CRYSTALLOGR D, V60, P2346, DOI 10.1107/S0907444904024825; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Ohta Y, 2010, INT J ONCOL, V36, P427, DOI 10.3892/ijo_00000516; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Robinson DN, 1997, ANNU REV CELL DEV BI, V13, P147, DOI 10.1146/annurev.cellbio.13.1.147; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; RODRIGUEZ JR, 1990, CELL MOTIL CYTOSKEL, V17, P301, DOI 10.1002/cm.970170405; Sasagawa K, 2002, J BIOL CHEM, V277, P44140, DOI 10.1074/jbc.M202596200; SCHMID MF, 1994, J CELL BIOL, V124, P341, DOI 10.1083/jcb.124.3.341; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schott DH, 2002, J CELL BIOL, V156, P35, DOI 10.1083/jcb.200110086; Schuyler SC, 2002, METHOD ENZYMOL, V351, P150; Seshan A, 2002, CURR BIOL, V12, P2098, DOI 10.1016/S0960-9822(02)01388-X; Snaith HA, 2005, NAT CELL BIOL, V7, P450, DOI 10.1038/ncb0505-450; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Spence HJ, 2000, ONCOGENE, V19, P1266, DOI 10.1038/sj.onc.1203433; Tilney LG, 1996, J CELL BIOL, V133, P61, DOI 10.1083/jcb.133.1.61; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Velichkova M, 2003, CELL MOTIL CYTOSKEL, V56, P109, DOI 10.1002/cm.10138; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038	61	17	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18290	18301		10.1074/jbc.M114.548719	http://dx.doi.org/10.1074/jbc.M114.548719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828508	Green Published, hybrid			2022-12-28	WOS:000338042000029
J	Iyirhiaro, GO; Zhang, Y; Estey, C; O'Hare, MJ; Safarpour, F; Parsanejad, M; Wang, SZ; Abdel-Messih, E; Callaghan, SM; During, MJ; Slack, RS; Park, DS				Iyirhiaro, Grace O.; Zhang, Yi; Estey, Carmen; O'Hare, Michael J.; Safarpour, Farzaneh; Parsanejad, Mohammad; Wang, Suzi; Abdel-Messih, Elizabeth; Callaghan, Steve M.; During, Matthew J.; Slack, Ruth S.; Park, David S.			Regulation of Ischemic Neuronal Death by E2F4-p130 Protein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; TRANSCRIPTION FACTOR E2F1; DNA-DAMAGE; INDEPENDENT FUNCTIONS; FOCAL ISCHEMIA; MICE LACKING; APOPTOSIS; SURVIVAL; P130; ACTIVATION	Inappropriate activation of cell cycle proteins, in particular cyclin D/Cdk4, is implicated in neuronal death induced by various pathologic stresses, including DNA damage and ischemia. Key targets of Cdk4 in proliferating cells include members of the E2F transcription factors, which mediate the expression of cell cycle proteins as well as death-inducing genes. However, the presence of multiple E2F family members complicates our understanding of their role in death. We focused on whether E2F4, an E2F member believed to exhibit crucial control over the maintenance of a differentiated state of neurons, may be critical in ischemic neuronal death. We observed that, in contrast to E2F1 and E2F3, which sensitize to death, E2F4 plays a crucial protective role in neuronal death evoked by DNA damage, hypoxia, and global ischemic insult both in vitro and in vivo. E2F4 occupies promoter regions of proapoptotic factors, such as B-Myb, under basal conditions. Following stress exposure, E2F4-p130 complexes are lost rapidly along with the presence of E2F4 at E2F-containing B-Myb promoter sites. In contrast, the presence of E2F1 at B-Myb sites increases with stress. Furthermore, B-Myb and C-Myb expression increases with ischemic insult. Taken together, we propose a model by which E2F4 plays a protective role in neurons from ischemic insult by forming repressive complexes that prevent prodeath factors such as Myb from being expressed.	[Iyirhiaro, Grace O.; Zhang, Yi; Estey, Carmen; O'Hare, Michael J.; Safarpour, Farzaneh; Parsanejad, Mohammad; Wang, Suzi; Abdel-Messih, Elizabeth; Callaghan, Steve M.; Slack, Ruth S.; Park, David S.] Univ Ottawa, Dept Cellular & Mol Med & Neurosci, Ottawa, ON K1H 8M5, Canada; [During, Matthew J.] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University of Ottawa; University System of Ohio; Ohio State University	Park, DS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca	During, Matthew/AAC-1388-2020	Park, David/0000-0002-4490-3784; Slack, Ruth/0000-0002-1552-2835	Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research; Center for Stroke Recovery; Neuroscience Canada/Krembil Foundation; Queen Elizabeth II Graduate Scholarships in Science and Technology award	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Center for Stroke Recovery; Neuroscience Canada/Krembil Foundation; Queen Elizabeth II Graduate Scholarships in Science and Technology award	This work was supported by grants from the Heart and Stroke Foundation of Canada, the Heart and Stroke Foundation of Ontario, the Canadian Institutes of Health Research, the Center for Stroke Recovery, and the Neuroscience Canada/Krembil Foundation (to D. S. P.).; Recipient of a Heart and Stroke Foundation of Canada doctoral award and the Queen Elizabeth II Graduate Scholarships in Science and Technology award.; Heart and Stroke Foundation of Canada scholar and recipient of the Heart and Stroke Foundation of Canada Career Investigator award. To whom correspondence should be addressed: Dept. of Cellular and Molecular Medicine, Neuroscience, University of Ottawa, 451 Smyth Rd., Ottawa, ON K1H 8M5, Canada. Tel.: 613-562-5800, ext.8816; Fax: 613-562-5403; E-mail: dpark@uottawa.ca.	Baldi A, 1997, CLIN CANCER RES, V3, P1691; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ferguson KL, 2000, J BIOL CHEM, V275, P33593, DOI 10.1074/jbc.M004879200; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gendron TF, 2001, J NEUROCHEM, V78, P316, DOI 10.1046/j.1471-4159.2001.00423.x; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Hou ST, 2000, J NEUROCHEM, V75, P91, DOI 10.1046/j.1471-4159.2000.0750091.x; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Kusek JC, 2001, BRAIN RES BULL, V54, P187, DOI 10.1016/S0361-9230(00)00447-0; LeCouter JE, 1998, DEVELOPMENT, V125, P4669; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Liu DX, 2005, GENE DEV, V19, P719, DOI 10.1101/gad.1296405; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; MacManus JP, 1999, NEUROREPORT, V10, P2711, DOI 10.1097/00001756-199909090-00004; MacManus JP, 2003, J CEREBR BLOOD F MET, V23, P1020, DOI 10.1097/01.WCB.0000084249.20114.FA; Martinez LA, 2010, MOL CELL BIOL, V30, P524, DOI 10.1128/MCB.00938-09; McClellan KA, 2007, MOL CELL BIOL, V27, P4825, DOI 10.1128/MCB.02100-06; Moh C, 2011, RESULTS PROBL CELL D, V53, P565, DOI 10.1007/978-3-642-19065-0_23; O'Hare MJ, 2000, J BIOL CHEM, V275, P25358, DOI 10.1074/jbc.M001725200; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Schwartz EI, 2007, CELL CYCLE, V6, P318, DOI 10.4161/cc.6.3.3752; Smith RA, 2003, MOL BRAIN RES, V116, P70, DOI 10.1016/S0169-328X(03)00253-5; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wen Y, 2005, FEBS LETT, V579, P4591, DOI 10.1016/j.febslet.2005.07.028; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yuan ZM, 2011, NEUROSCI LETT, V499, P164, DOI 10.1016/j.neulet.2011.05.045; Zhang Y, 2010, J NEUROCHEM, V112, P497, DOI 10.1111/j.1471-4159.2009.06476.x; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	46	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18202	18213		10.1074/jbc.M114.574145	http://dx.doi.org/10.1074/jbc.M114.574145			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828495	Green Published, hybrid			2022-12-28	WOS:000338042000022
J	Li, TZ; Simonds, L; Kovrigin, EL; Noel, KD				Li, Tiezheng; Simonds, Laurie; Kovrigin, Evgenii L.; Noel, K. Dale			In Vitro Biosynthesis and Chemical Identification of UDP-N-acetyl-D-quinovosamine (UDP-D-QuiNAc)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ANTIGENIC POLYSACCHARIDE; PSEUDOMONAS-AERUGINOSA; RHIZOBIUM-ETLI; FUNCTIONAL-CHARACTERIZATION; STRUCTURAL-CHARACTERIZATION; CAMPYLOBACTER-JEJUNI; HELICOBACTER-PYLORI; LIPOPOLYSACCHARIDE; ENZYMES; SYSTEM	N-acetyl-D-quinovosamine (2-acetamido-2,6-dideoxy-D-glucose, QuiNAc) occurs in the polysaccharide structures of many Gram-negative bacteria. In the biosynthesis of QuiNAc-containing polysaccharides, UDP-QuiNAc is the hypothetical donor of the QuiNAc residue. Biosynthesis of UDP-QuiNAc has been proposed to occur by 4,6-dehydration of UDP-N-acetyl-D-glucosamine (UDP-GlcNAc) to UDP-2-acetamido-2,6-dideoxy- D-xylo-4-hexulose followed by reduction of this 4-keto intermediate to UDP-QuiNAc. Several specific dehydratases are known to catalyze the first proposed step. A specific reductase for the last step has not been demonstrated in vitro, but previous mutant analysis suggested that Rhizobium etli gene wreQ might encode this reductase. Therefore, this gene was cloned and expressed in Escherichia coli, and the resulting His(6)-tagged WreQ protein was purified. It was tested for 4-reductase activity by adding it and NAD(P)H to reaction mixtures in which 4,6-dehydratase WbpM had acted on the precursor substrate UDP-GlcNAc. Thin layer chromatography of the nucleotide sugars in the mixture at various stages of the reaction showed that WbpM converted UDP-GlcNAc completely to what was shown to be its 4-keto-6-deoxy derivative by NMR and that addition of WreQ and NADH led to formation of a third compound. Combined gas chromatography-mass spectrometry analysis of acid hydrolysates of the final reaction mixture showed that a quinovosamine moiety had been synthesized after WreQ addition. The two-step reaction progress also was monitored in real time by NMR. The final UDP-sugar product after WreQ addition was purified and determined to be UDP-D-QuiNAc by one-dimensional and two-dimensional NMR experiments. These results confirmed that WreQ has UDP-2-acetamido-2,6-dideoxy-D-xylo-4-hexulose 4-reductase activity, completing a pathway for UDP-D-QuiNAc synthesis in vitro.	[Li, Tiezheng; Simonds, Laurie; Noel, K. Dale] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53201 USA; [Kovrigin, Evgenii L.] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA	Marquette University; Marquette University	Kovrigin, EL (corresponding author), Marquette Univ, Dept Chem, POB 1881, Milwaukee, WI 53201 USA.	evgueni.kovriguine@marquette.edu; dale.noel@marquette.edu			National Institutes of Health [1 R15 GM087699-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM087699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R15 GM087699-01A1 (to K. D. N.).	[Anonymous], 2016, HIGH RESOLUTION NMR, DOI DOI 10.1016/B978-0-08-099986-9.00009-9; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Bouhenni RA, 2010, ELECTROANAL, V22, P856, DOI 10.1002/elan.200880006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bystrova OV, 2002, EUR J BIOCHEM, V269, P2194, DOI 10.1046/j.1432-1033.2002.02875.x; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Creuzenet C, 2001, MOL MICROBIOL, V41, P1295, DOI 10.1046/j.1365-2958.2001.02589.x; DANIEL A, 1972, J BACTERIOL, V110, P110, DOI 10.1128/JB.110.1.110-116.1972; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DMITRIEV BA, 1982, EUR J BIOCHEM, V125, P229, DOI 10.1111/j.1432-1033.1982.tb06673.x; Dombrecht B, 2001, MOL PLANT MICROBE IN, V14, P426, DOI 10.1094/MPMI.2001.14.3.426; Forsberg LS, 2003, J BIOL CHEM, V278, P51347, DOI 10.1074/jbc.M309016200; Forsberg LS, 2000, J BIOL CHEM, V275, P18851, DOI 10.1074/jbc.M001090200; Goddard D., 2008, SPARKY 3; Hao YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P195, DOI 10.1007/978-3-7091-0733-1_7; HARTEL AJ, 1982, EUR J BIOCHEM, V129, P343, DOI 10.1111/j.1432-1033.1982.tb07057.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; King JD, 2009, FEBS J, V276, P2686, DOI 10.1111/j.1742-4658.2009.06993.x; Knirel YA, 1996, CARBOHYD RES, V293, P223, DOI 10.1016/0008-6215(96)00194-2; Knirel YA, 2006, J ENDOTOXIN RES, V12, P324, DOI 10.1179/096805106X118906; LUDERITZ O, 1968, J BACTERIOL, V95, P490; McNally DJ, 2006, CHEMBIOCHEM, V7, P1865, DOI 10.1002/cbic.200600298; Molinaro A, 2003, CARBOHYD RES, V338, P1251, DOI 10.1016/S0008-6215(03)00112-5; Noel KD, 2000, J BACTERIOL, V182, P5317, DOI 10.1128/JB.182.19.5317-5324.2000; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Ojeda KJ, 2013, J BACTERIOL, V195, P1949, DOI 10.1128/JB.02080-12; Ojeda KJ, 2010, J BACTERIOL, V192, P679, DOI 10.1128/JB.01154-09; Olivier NB, 2006, BIOCHEMISTRY-US, V45, P13659, DOI 10.1021/bi061456h; ORBONS LPM, 1987, J BIOMOL STRUCT DYN, V4, P939, DOI 10.1080/07391102.1987.10507691; Pinta E, 2009, CHEM-EUR J, V15, P9747, DOI 10.1002/chem.200901255; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Smith E. J., 1964, BIOCHEM BIOPH RES CO, V15, P593; Wang Q, 2011, BIOCHEMISTRY-US, V50, P10941, DOI 10.1021/bi201450v	36	7	7	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18110	18120		10.1074/jbc.M114.555862	http://dx.doi.org/10.1074/jbc.M114.555862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24817117	hybrid, Green Published			2022-12-28	WOS:000338042000014
J	Orth, P; Xiao, L; Hernandez, LD; Reichert, P; Sheth, PR; Beaumont, M; Yang, XY; Murgolo, N; Ermakov, G; DiNunzio, E; Racine, F; Karczewski, J; Secore, S; Ingram, RN; Mayhood, T; Strickland, C; Therien, AG				Orth, Peter; Xiao, Li; Hernandez, Lorraine D.; Reichert, Paul; Sheth, Payal R.; Beaumont, Maribel; Yang, Xiaoyu; Murgolo, Nicholas; Ermakov, Grigori; DiNunzio, Edward; Racine, Fred; Karczewski, Jerzy; Secore, Susan; Ingram, Richard N.; Mayhood, Todd; Strickland, Corey; Therien, Alex G.			Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; BINDING DOMAINS; RECEPTOR; INFECTION; VIRULENCE; EPIDEMIOLOGY; RECOGNITION; ENDOCYTOSIS; HAMSTERS	The symptoms of Clostridium difficile infections are caused by two exotoxins, TcdA and TcdB, which target host colonocytes by binding to unknown cell surface receptors, at least in part via their combined repetitive oligopeptide(CROP) domains. A combination of the anti-TcdA antibody actoxumab and the anti-TcdB antibody bezlotoxumab is currently under development for the prevention of recurrent C. difficile infections. We demonstrate here through various biophysical approaches that bezlotoxumab binds to specific regions within the N-terminal half of the TcdB CROP domain. Based on this information, we solved the x-ray structure of the N-terminal half of the TcdB CROP domain bound to Fab fragments of bezlotoxumab. The structure reveals that the TcdB CROP domain adopts a beta-solenoid fold consisting of long and short repeats and that bezlotoxumab binds to two homologous sites within the CROP domain, partially occluding two of the four putative carbohydrate binding pockets located in TcdB. We also show that bezlotoxumab neutralizes TcdB by blocking binding of TcdB to mammalian cells. Overall, our data are consistent with a model wherein a single molecule of bezlotoxumab neutralizes TcdB by binding via its two Fab regions to two epitopes within the N-terminal half of the TcdB CROP domain, partially blocking the carbohydrate binding pockets of the toxin and preventing toxin binding to host cells.	[Orth, Peter; Xiao, Li; Hernandez, Lorraine D.; Reichert, Paul; Sheth, Payal R.; Yang, Xiaoyu; Murgolo, Nicholas; DiNunzio, Edward; Racine, Fred; Ingram, Richard N.; Mayhood, Todd; Strickland, Corey; Therien, Alex G.] Merck & Co Inc, Kenilworth, NJ 07033 USA; [Sheth, Payal R.; Ermakov, Grigori] Merck & Co Inc, Palo Alto, CA 94304 USA; [Karczewski, Jerzy; Secore, Susan] Merck & Co Inc, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company	Strickland, C (corresponding author), Merck & Co Inc, 2000 Galloping Hill Rd,K15-ME111, Kenilworth, NJ 07033 USA.	corey.strickland@merck.com; alex_therien@merck.com	Therien, Alex/AAS-8437-2021; Karczewski, Jakub/L-7326-2018	Karczewski, Jakub/0000-0001-9322-7842				Albesa-Jove D, 2010, J MOL BIOL, V396, P1260, DOI 10.1016/j.jmb.2010.01.012; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Bassetti M, 2012, EXPERT REV ANTI-INFE, V10, P1405, DOI [10.1586/ERI.12.135, 10.1586/eri.12.135]; Carter GP, 2012, TRENDS MICROBIOL, V20, P21, DOI 10.1016/j.tim.2011.11.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coales SJ, 2009, RAPID COMMUN MASS SP, V23, P639, DOI 10.1002/rcm.3921; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; El-Hawiet A, 2011, GLYCOBIOLOGY, V21, P1217, DOI 10.1093/glycob/cwr055; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Olling A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017623; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Pothoulakis C, 1996, J CLIN INVEST, V98, P641, DOI 10.1172/JCI118835; POTHOULAKIS C, 1991, J CLIN INVEST, V88, P119, DOI 10.1172/JCI115267; Pruitt RN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00028; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schorch B, 2014, P NATL ACAD SCI USA, V111, P6431, DOI 10.1073/pnas.1323790111; Shen A, 2012, J INNATE IMMUN, V4, P149, DOI 10.1159/000332946; Sheth PR, 2011, BIOCHEMISTRY-US, V50, P7964, DOI 10.1021/bi200542r; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; TORRES JF, 1995, INFECT IMMUN, V63, P4619, DOI 10.1128/IAI.63.12.4619-4627.1995; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; US Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; VONEICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707, DOI 10.1128/JB.174.20.6707-6710.1992; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773	43	87	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18008	18021		10.1074/jbc.M114.560748	http://dx.doi.org/10.1074/jbc.M114.560748			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24821719	Green Published, hybrid			2022-12-28	WOS:000338042000005
J	Wagener, EM; Aurich, M; Aparicio-Siegmund, S; Floss, DM; Garbers, C; Breusing, K; Rabe, B; Schwanbeck, R; Grotzinger, J; Rose-John, S; Scheller, J				Wagener, Eva-Maria; Aurich, Matthias; Aparicio-Siegmund, Samadhi; Floss, Doreen M.; Garbers, Christoph; Breusing, Kati; Rabe, Bjoern; Schwanbeck, Ralf; Groetzinger, Joachim; Rose-John, Stefan; Scheller, Juergen			The Amino Acid Exchange R28E in Ciliary Neurotrophic Factor (CNTF) Abrogates Interleukin-6 Receptor-dependent but Retains CNTF Receptor-dependent Signaling via Glycoprotein 130 (gp130)/Leukemia Inhibitory Factor Receptor (LIFR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; FACTOR PREVENTS; ONCOSTATIN-M; HUNTINGTONS-DISEASE; ALPHA EXPRESSION; MOTOR-NEURONS; CYTOKINES; SURVIVAL; CELLS; MODEL	Ciliary neurotrophic factor (CNTF) is a neurotrophic factor with therapeutic potential for neurodegenerative diseases. Moreover, therapeutic application of CNTF reduced body weight in mice and humans. CNTF binds to high or low affinity receptor complexes consisting of CNTFR.gp130.LIFR or IL-6R.gp130.LIFR, respectively. Clinical studies of the CNTF derivative Axokine revealed intolerance at higher concentrations, which may rely on the low-affinity binding of CNTF to the IL-6R. Here, we aimed to generate a CNTFR-selective CNTF variant (CV). CV-1 contained the single amino acid exchange R28E. Arg(28) is in close proximity to the CNTFR binding site. Using molecular modeling, we hypothesized that Arg(28) might contribute to IL-6R/CNTFR plasticity of CNTF. CV-2 to CV-5 were generated by transferring parts of the CNTFR-binding site from cardiotrophin-like cytokine to CNTF. Cardiotrophin-like cytokine selectively signals via the CNTFR.gp130.LIFR complex, albeit with a much lower affinity compared with CNTF. As shown by immunoprecipitation, all CNTF variants retained the ability to bind to CNTFR. CV-1, CV-2, and CV-5, however, lost the ability to bind to IL-6R. Although all variants induced cytokine-dependent cellular proliferation and STAT3 phosphorylation via CNTFR.gp130.LIFR, only CV-3 induced STAT3 phosphorylation via IL-6R.gp130.LIFR. Quantification of CNTF-dependent proliferation of CNTFR.gp130.LIFR expressing cells indicated that only CV-1 was as biologically active as CNTF. Thus, the CNTFR-selective CV-1 will allow discriminating between CNTFR-and IL-6R-mediated effects in vivo.	[Wagener, Eva-Maria; Aurich, Matthias; Garbers, Christoph; Breusing, Kati; Rabe, Bjoern; Schwanbeck, Ralf; Groetzinger, Joachim; Rose-John, Stefan] Univ Kiel, Inst Biochem, Fac Med, D-24098 Kiel, Germany; [Aparicio-Siegmund, Samadhi; Floss, Doreen M.; Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany	University of Kiel; Heinrich Heine University Dusseldorf	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015; Garbers, Christoph/D-9932-2015; Schwanbeck, Ralf/A-2648-2008; Rose-John, Stefan/A-7998-2010	Garbers, Christoph/0000-0003-4939-6950; Schwanbeck, Ralf/0000-0003-0925-929X; Rose-John, Stefan/0000-0002-7519-3279; Aurich, Matthias/0000-0001-8421-4425	Deutsche Forschungsgemeinschaft (Bonn, Germany) DFG [SCHE 907/2-1, SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft (Bonn, Germany) DFG(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Bonn, Germany) DFG SCHE 907/2-1 and SFB877 Project A1, A6 and by the Cluster of Excellence "Inflammation at Interfaces."	Adam N, 2009, J VIROL, V83, P5117, DOI 10.1128/JVI.01601-08; Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chong NHV, 1999, INVEST OPHTH VIS SCI, V40, P1298; CLATTERBUCK RE, 1993, P NATL ACAD SCI USA, V90, P2222, DOI 10.1073/pnas.90.6.2222; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; de Almeida LP, 2001, NEUROBIOL DIS, V8, P433, DOI 10.1006/nbdi.2001.0388; Emerich DF, 1997, NATURE, V386, P395, DOI 10.1038/386395a0; Ettinger MP, 2003, JAMA-J AM MED ASSOC, V289, P1826, DOI 10.1001/jama.289.14.1826; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2013, J BIOL CHEM, V288, P4346, DOI 10.1074/jbc.M112.432955; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Grotzinger J, 1997, PROTEINS, V27, P96; Guillet C, 1999, J NEUROSCI, V19, P1257; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; Ichihara M, 1997, BLOOD, V90, P165; IP NY, 1991, J NEUROSCI, V11, P3124; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; Kalra SP, 2001, P NATL ACAD SCI USA, V98, P4279, DOI 10.1073/pnas.091101498; Kordower JH, 1997, J COMP NEUROL, V377, P365, DOI 10.1002/(SICI)1096-9861(19970120)377:3<365::AID-CNE5>3.0.CO;2-0; KRUTTGEN A, 1995, BIOCHEM J, V309, P215; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Larkfors L, 1996, J NEUROCHEM, V66, P1362; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lee MY, 1997, J NEUROSCI, V17, P1137; MacLennan AJ, 1996, J NEUROSCI, V16, P621; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Mullberg J, 2000, J IMMUNOL, V164, P4672, DOI 10.4049/jimmunol.164.9.4672; Peterson WM, 2000, J NEUROSCI, V20, P4081; Preti A, 2003, IDRUGS, V6, P696; SCHOOLTINK H, 1992, FEBS LETT, V314, P280, DOI 10.1016/0014-5793(92)81489-9; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Schuster B, 2003, J BIOL CHEM, V278, P9528, DOI 10.1074/jbc.M210044200; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Simon R, 1995, NEUROREPORT, V7, P153, DOI 10.1097/00001756-199512000-00037; Stefater MA, 2012, ENDOCRINOLOGY, V153, P2647, DOI 10.1210/en.2012-1024; Tormo AJ, 2012, CYTOKINE, V60, P575, DOI 10.1016/j.cyto.2012.07.002; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616	44	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18442	18450		10.1074/jbc.M114.568857	http://dx.doi.org/10.1074/jbc.M114.568857			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24802752	hybrid, Green Published			2022-12-28	WOS:000338042000041
J	Anoop, A; Ranganathan, S; Das Dhaked, B; Jha, NN; Pratihar, S; Ghosh, S; Sahay, S; Kumar, S; Das, S; Kombrabail, M; Agarwal, K; Jacob, RS; Singru, P; Bhaumik, P; Padinhateeri, R; Kumar, A; Maji, SK				Anoop, Arunagiri; Ranganathan, Srivastav; Das Dhaked, Bhagwan; Jha, Narendra Nath; Pratihar, Supriya; Ghosh, Saikat; Sahay, Shruti; Kumar, Santosh; Das, Subhadeep; Kombrabail, Mamata; Agarwal, Kumud; Jacob, Reeba S.; Singru, Praful; Bhaumik, Prasenjit; Padinhateeri, Ranjith; Kumar, Ashutosh; Maji, Samir K.			Elucidating the Role of Disulfide Bond on Amyloid Formation and Fibril Reversibility of Somatostatin-14 RELEVANCE TO ITS STORAGE AND SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GROWTH-HORMONE RELEASE; CONFORMATIONAL STABILITY; AGGREGATION; GRANULES; PEPTIDES; INSULIN; BIOGENESIS; MECHANISMS; INHIBITION	The storage of protein/peptide hormones within subcellular compartments and subsequent release are crucial for their native function, and hence these processes are intricately regulated in mammalian systems. Several peptide hormones were recently suggested to be stored as amyloids within endocrine secretory granules. This leads to an apparent paradox where storage requires formation of aggregates, and their function requires a supply of non-aggregated peptides on demand. The precise mechanism behind amyloid formation by these hormones and their subsequent release remain an open question. To address this, we examined aggregation and fibril reversibility of a cyclic peptide hormone somatostatin (SST)-14 using various techniques. After proving that SST gets stored as amyloid in vivo, we investigated the role of native structure in modulating its conformational dynamics and self-association by disrupting the disulfide bridge (Cys(3)-Cys(14)) in SST. Using two-dimensional NMR, we resolved the initial structure of somatostatin-14 leading to aggregation and further probed its conformational dynamics in silico. The perturbation in native structure (S-S cleavage) led to a significant increase in conformational flexibility and resulted in rapid amyloid formation. The fibrils formed by disulfide-reduced noncyclic SST possess greater resistance to denaturing conditions with decreased monomer releasing potency. MD simulations reveal marked differences in the intermolecular interactions in SST and noncyclic SST providing plausible explanation for differential aggregation and fibril reversibility observed experimentally in these structural variants. Our findings thus emphasize that subtle changes in the native structure of peptide hormone(s) could alter its conformational dynamics and amyloid formation, which might have significant implications on their reversible storage and secretion.	[Ghosh, Saikat; Sahay, Shruti; Das, Subhadeep; Agarwal, Kumud; Jacob, Reeba S.; Bhaumik, Prasenjit; Padinhateeri, Ranjith; Kumar, Ashutosh; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Pratihar, Supriya; Kombrabail, Mamata] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Kumar, Santosh; Singru, Praful] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar 751005, Orissa, India; [Das, Subhadeep] Indian Inst Technol, IITB Monash Res Acad, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR); National Institute of Science Education & Research (NISER); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kumar, A (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	ashutoshk@iitb.ac.in; samirmaji@iitb.ac.in	JHA, NARENDRA NATH/ABI-3727-2020; Maji, Samir K. K./B-9640-2019; Das, Subhadeep/J-4038-2016; Arunagiri, Anoop/P-2528-2018	JHA, NARENDRA NATH/0000-0002-1734-7663; Maji, Samir K. K./0000-0002-9110-1565; Arunagiri, Anoop/0000-0001-9839-1860; Supriya, Pratihar/0000-0001-6779-1490; Jacob, Reeba/0000-0002-0676-834X; Das, Subhadeep/0000-0003-1870-8456; Ghosh, Saikat/0000-0003-0937-6242; Ranganathan, Srivastav/0000-0003-4364-0959	Industrial Research and Consultancy Centre at Indian Institute of Technology Bombay, India; Department of Biotechnology, Government of India [BT/PR14344Med/30/501/2010, BT/PR13359/BRB/10/752/2009]; Council of Scientific Research and Industrial Research, India [37(1404)/10/EMR-11]; Department of Science and Technology, Government of India [SR/FR/LS-032/2009]	Industrial Research and Consultancy Centre at Indian Institute of Technology Bombay, India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific Research and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Industrial Research and Consultancy Centre at Indian Institute of Technology Bombay, India, Department of Biotechnology, Government of India, Grants BT/PR14344Med/30/501/2010 and BT/PR13359/BRB/10/752/2009, Council of Scientific Research and Industrial Research, India, Grant 37(1404)/10/EMR-11, and Department of Science and Technology Grant SR/FR/LS-032/2009 from the Government of India.	Alexandrescu A T, 2001, Pac Symp Biocomput, P67; ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; BLOOM SR, 1974, LANCET, V2, P1106; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Castellanos MM, 2013, J PHYS CHEM B, V117, P11895, DOI 10.1021/jp402994r; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COOPER A, 1992, J MOL BIOL, V225, P939, DOI 10.1016/0022-2836(92)90094-Z; Dannies PS, 2002, MOL GENET METAB, V76, P6, DOI 10.1016/S1096-7192(02)00011-2; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Dannies PS, 2001, MOL CELL ENDOCRINOL, V177, P87, DOI 10.1016/S0303-7207(01)00437-3; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dubois J, 1999, SCAND J IMMUNOL, V49, P376; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Grace CRR, 2005, J MED CHEM, V48, P523, DOI 10.1021/jm049518u; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hamada D, 2002, PROTEIN SCI, V11, P2417, DOI 10.1110/ps.0217702; Hernandez B, 2009, J PHYS CHEM B, V113, P12796, DOI 10.1021/jp904737v; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain RK, 2000, J BIOL CHEM, V275, P27032; Jha NN, 2013, BIOCHEMISTRY-US, V52, P8800, DOI 10.1021/bi401398k; KAHN PC, 1968, J AM CHEM SOC, V90, P4168, DOI 10.1021/ja01017a051; Kardos J, 2011, BIOCHEMISTRY-US, V50, P3211, DOI 10.1021/bi2000017; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li Y, 2013, PROTEINS, V81, P1862, DOI 10.1002/prot.24338; Li Y, 2012, BIOCHEM BIOPH RES CO, V423, P373, DOI 10.1016/j.bbrc.2012.05.133; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LOW MJ, 1986, J BIOL CHEM, V261, P6260; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Maeda R, 2007, BBA-PROTEINS PROTEOM, V1774, P1619, DOI 10.1016/j.bbapap.2007.08.016; Maji S. K., 2010, FUNCTIONAL AMYLOID A, P135; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; MANDARINO L, 1981, NATURE, V291, P76, DOI 10.1038/291076a0; Melquiond A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1886725; Morel B, 2010, J PHYS CHEM B, V114, P4010, DOI 10.1021/jp9102993; Mossuto Maria Francesca, 2013, Int J Cell Biol, V2013, P318319, DOI 10.1155/2013/318319; NAIKI H, 1991, LAB INVEST, V65, P104; Narimoto T, 2004, FEBS LETT, V576, P313, DOI 10.1016/j.febslet.2004.09.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Ranganathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031924; REGGIO HA, 1978, J CELL BIOL, V77, P288, DOI 10.1083/jcb.77.2.288; RORSTAD OP, 1987, PEPTIDES, V8, P849, DOI 10.1016/0196-9781(87)90071-4; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sahay S, 2014, BIOCHEMISTRY-US, V53, P807, DOI 10.1021/bi401543z; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; SILER TM, 1973, J CLIN ENDOCR METAB, V37, P632, DOI 10.1210/jcem-37-4-632; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Valery C, 2008, BIOPHYS J, V94, P1782, DOI 10.1529/biophysj.107.108175; Van Grondelle W, 2007, J STRUCT BIOL, V160, P211, DOI 10.1016/j.jsb.2007.08.006; Vaz DC, 2006, PROTEIN SCI, V15, P33, DOI 10.1110/ps.051593306; von Bergen Martin, 2004, V299, P175; ZANINI A, 1980, J CELL BIOL, V86, P260, DOI 10.1083/jcb.86.1.260; Zhu YL, 2002, ENDOCRINOLOGY, V143, P4243, DOI 10.1210/en.2002-220575	78	51	52	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16884	16903		10.1074/jbc.M114.548354	http://dx.doi.org/10.1074/jbc.M114.548354			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782311	Green Published, hybrid			2022-12-28	WOS:000338016200025
J	Chen, C; Han, X; Zou, X; Li, Y; Yang, L; Cao, K; Xu, J; Long, JG; Liu, JK; Feng, ZH				Chen, Cong; Han, Xiao; Zou, Xuan; Li, Yuan; Yang, Liang; Cao, Ke; Xu, Jie; Long, Jiangang; Liu, Jiankang; Feng, Zhihui			4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic Acid (C75), an Inhibitor of Fatty-acid Synthase, Suppresses the Mitochondrial Fatty Acid Synthesis Pathway and Impairs Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; LIPOIC ACID; COMPLEX-I; SACCHAROMYCES-CEREVISIAE; ANTIOXIDANT RESPONSE; ESCHERICHIA-COLI; EXPRESSION; GENE; NRF2; CANCER	4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid (C75) is a synthetic fatty-acid synthase (FASN) inhibitor with potential therapeutic effects in several cancer models. Human mitochondrial beta-ketoacyl-acyl carrier protein synthase (HsmtKAS) is a key enzyme in the newly discovered mitochondrial fatty acid synthesis pathway that can produce the substrate for lipoic acid (LA) synthesis. HsmtKAS shares conserved catalytic domains with FASN, which are responsible for binding to C75. In our study, we explored the possible effect of C75 on HsmtKAS and mitochondrial function. C75 treatment decreased LA content, impaired mitochondrial function, increased reactive oxygen species content, and reduced cell viability. HsmtKAS but not FASN knockdown had an effect that was similar to C75 treatment. In addition, an LA supplement efficiently inhibited C75-induced mitochondrial dysfunction and oxidative stress. Overexpression of HsmtKAS showed cellular protection against low dose C75 addition, whereas there was no protective effect upon high dose C75 addition. In summary, the mitochondrial fatty acid synthesis pathway has a vital role in mitochondrial function. Besides FASN, C75 might also inhibit HsmtKAS, thereby reducing LA production, impairing mitochondrial function, and potentially having toxic effects. LA supplements sufficiently ameliorated the toxicity of C75, showing that a combination of C75 and LA may be a reliable cancer treatment.	Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Sch Life Sci & Technol, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Peoples R China; Xi An Jiao Tong Univ, FIST, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Liu, JK (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Ctr Mitochondrial Biol & Med, FIST, 28 W,Xian Ning Rd, Xian 710049, Peoples R China.	j.liu@mail.xjtu.edu.cn; zhfeng@mail.xjtu.edu.cn	Zou, Xuan/A-6452-2015; Long, Jiangang/A-7835-2015; Liu, Jiankang/A-1610-2011; Feng, Zhihui/E-7408-2011; han, xiao/CAI-6839-2022	Long, Jiangang/0000-0002-6584-3880; Feng, Zhihui/0000-0002-2448-6565; han, xiao/0000-0002-4557-1304; Jiangang, Long/0000-0001-8074-957X	National Natural Science Foundation of China [31200620, 81201023, 31370844]; China Postdoctoral Science Foundation [2013M540739, 2013M542338]; New Century Excellent Talents in University; National "Twelfth Five-Year" Plan for Science & Technology Support; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National "Twelfth Five-Year" Plan for Science & Technology Support; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31200620,81201023, and 31370844, China Postdoctoral Science Foundation Grants 2013M540739 and 2013M542338, New Century Excellent Talents in University, National "Twelfth Five-Year" Plan for Science & Technology Support, and the Fundamental Research Funds for the Central Universities.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Alli PM, 2005, ONCOGENE, V24, P39, DOI 10.1038/sj.onc.1208174; Bentebibel A, 2006, BIOCHEMISTRY-US, V45, P4339, DOI 10.1021/bi052186q; Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Chen ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005589; Christensen CE, 2007, PROTEIN SCI, V16, P261, DOI 10.1110/ps.062473707; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Florczyk Urszula, 2010, Postepy Biochem, V56, P147; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Huang H, 2013, PPAR RES, V2013, DOI 10.1155/2013/865604; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007; Nesbitt NM, 2005, PROTEIN EXPRES PURIF, V39, P269, DOI 10.1016/j.pep.2004.10.021; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Packer L, 1997, Adv Pharmacol, V38, P79; Padmalayam I, 2009, DIABETES, V58, P600, DOI 10.2337/db08-0473; Puig T, 2008, BREAST CANCER RES TR, V109, P471, DOI 10.1007/s10549-007-9678-5; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; Smith S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047196; SULO P, 1993, J BIOL CHEM, V268, P17634; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wu M, 2011, P NATL ACAD SCI USA, V108, P5378, DOI 10.1073/pnas.1002588108; Yoshii Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064570; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200	40	28	29	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17184	17194		10.1074/jbc.M114.550806	http://dx.doi.org/10.1074/jbc.M114.550806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24784139	hybrid, Green Published			2022-12-28	WOS:000338016200051
J	Sand, KMK; Dalhus, B; Christianson, GJ; Bern, M; Foss, S; Cameron, J; Sleep, D; Bjoras, M; Roopenian, DC; Sandlie, I; Andersen, JT				Sand, Kine Marita Knudsen; Dalhus, Bjorn; Christianson, Gregory J.; Bern, Malin; Foss, Stian; Cameron, Jason; Sleep, Darrell; Bjoras, Magnar; Roopenian, Derry C.; Sandlie, Inger; Andersen, Jan Terje			Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RELATED RECEPTOR; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; BINDING-PROPERTIES; IGG HOMEOSTASIS; COMPLEX; TRANSPORT; LIFE; SITE; EXOCYTOSIS	Albumin is the most abundant protein in blood and plays a pivotal role as a multitransporter of a wide range of molecules such as fatty acids, metabolites, hormones, and toxins. In addition, it binds a variety of drugs. Its role as distributor is supported by its extraordinary serum half-life of 3 weeks. This is related to its size and binding to the cellular receptor FcRn, which rescues albumin from intracellular degradation. Furthermore, the long half-life has fostered a great and increasing interest in utilization of albumin as a carrier of protein therapeutics and chemical drugs. However, to fully understand how FcRn acts as a regulator of albumin homeostasis and to take advantage of the FcRn-albumin interaction in drug design, the interaction interface needs to be dissected. Here, we used a panel of monoclonal antibodies directed towards human FcRn in combination with site-directed mutagenesis and structural modeling to unmask the binding sites for albumin blocking antibodies and albumin on the receptor, which revealed that the interaction is not only strictly pH-dependent, but predominantly hydrophobic in nature. Specifically, we provide mechanistic evidence for a crucial role of a cluster of conserved tryptophan residues that expose a pH-sensitive loop of FcRn, and identify structural differences in proximity to these hot spot residues that explain divergent cross-species binding properties of FcRn. Our findings expand our knowledge of how FcRn is controlling albumin homeostasis at a molecular level, which will guide design and engineering of novel albumin variants with altered transport properties.	[Sand, Kine Marita Knudsen; Bern, Malin; Foss, Stian; Sandlie, Inger] Univ Oslo, CIR, N-0316 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Foss, Stian; Sandlie, Inger] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Foss, Stian; Sandlie, Inger; Andersen, Jan Terje] Natl Hosp Norway, Oslo Univ Hosp, CIR, N-0424 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Foss, Stian; Sandlie, Inger; Andersen, Jan Terje] Natl Hosp Norway, Oslo Univ Hosp, Dept Immunol, N-0424 Oslo, Norway; [Sand, Kine Marita Knudsen; Dalhus, Bjorn; Bern, Malin; Foss, Stian; Bjoras, Magnar; Sandlie, Inger; Andersen, Jan Terje] Univ Oslo, N-0424 Oslo, Norway; [Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Oslo Univ Hosp, Dept Microbiol, N-0424 Oslo, Norway; [Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Oslo Univ Hosp, Dept Med Biochem, N-0424 Oslo, Norway; [Christianson, Gregory J.; Roopenian, Derry C.] Jackson Lab, Bar Harbor, ME 04609 USA; [Cameron, Jason; Sleep, Darrell] Novozymes Biopharma UK Ltd, Nottingham NG7 1FD, England	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Jackson Laboratory; Novozymes	Andersen, JT (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Ctr Immune Regulat, POB 4956, N-0424 Oslo, Norway.	j.t.andersen@ibv.uio.no	Dalhus, Bjørn/AAK-2895-2020; Bjørås, Magnar/N-9286-2017; Andersen, Jan Terje/AAB-6209-2020	Foss, Stian/0000-0001-6527-051X; Sleep, Darrell/0000-0001-8287-9538; Christianson, Gregory/0000-0001-5532-342X; Andersen, Jan Terje/0000-0003-1710-1628	Research Council of Norway through its Centres of Excellence [179573]; University of Oslo; South-Eastern Norway Regional Health Authority [2009100, 2011040, 2012085]; Research Council of Norway through programme for Global Health and Vaccination Research (GLOBVAC) Grant [143822]; Research Council of Norway [179573/V40, 230526/F20, 233710/O30]; Southeastern Norway Regional Health Authority [39375]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	Research Council of Norway through its Centres of Excellence(Research Council of Norway); University of Oslo; South-Eastern Norway Regional Health Authority; Research Council of Norway through programme for Global Health and Vaccination Research (GLOBVAC) Grant; Research Council of Norway(Research Council of Norway); Southeastern Norway Regional Health Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Research Council of Norway through its Centres of Excellence funding scheme (Project 179573). I. S., J. T. A., B. D., J. C., and D. S. are co-inventors of pending patent applications related to the data described in this work.; Supported by the University of Oslo.; Supported by the South-Eastern Norway Regional Health Authority to establish the Regional Technology Platform for Structural Biology and Bioinformatics (Grants 2009100, 2011040, and 2012085).; Supported by the Research Council of Norway through its programme for Global Health and Vaccination Research (GLOBVAC) Grant 143822.; Supported by the Research Council of Norway (Grants 179573/V40; 230526/F20, and 233710/O30) and the Southeastern Norway Regional Health Authority (Grant 39375). To whom correspondence should be addressed: Centre for Immune Regulation and Dept. of Immunology, Oslo University Hospital Rikshospitalet, P.O. Box 4956, Oslo N-0424, Norway. E-mail: j.t.andersen@ibv.uio.no.	Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2013, J BIOL CHEM, V288, P24277, DOI 10.1074/jbc.M113.463000; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2010, CLIN BIOCHEM, V43, P367, DOI 10.1016/j.clinbiochem.2009.12.001; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; [Anonymous], 1996, ALL ALBUMIN BIOCH GE; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Christianson GJ, 2012, MABS-AUSTIN, V4, P208, DOI 10.4161/mabs.4.2.19397; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; Medesan C, 1996, EUR J IMMUNOL, V26, P2533, DOI 10.1002/eji.1830261038; Mezo AR, 2010, J BIOL CHEM, V285, P27694, DOI 10.1074/jbc.M110.120667; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Popov S, 1996, MOL IMMUNOL, V33, P521, DOI 10.1016/0161-5890(96)00004-1; Prabhat P, 2007, P NATL ACAD SCI USA, V104, P5889, DOI 10.1073/pnas.0700337104; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; Wani MA, 2006, P NATL ACAD SCI USA, V103, P5084, DOI 10.1073/pnas.0600548103; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m	42	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17228	17239		10.1074/jbc.M113.522565	http://dx.doi.org/10.1074/jbc.M113.522565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764301	Green Published, hybrid			2022-12-28	WOS:000338016200055
J	Asleh, R; Ward, J; Levy, NS; Safuri, S; Aronson, D; Levy, AP				Asleh, Rabea; Ward, John; Levy, Nina S.; Safuri, Shady; Aronson, Doron; Levy, Andrew P.			Haptoglobin Genotype-dependent Differences in Macrophage Lysosomal Oxidative Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ACUTE MYOCARDIAL-INFARCTION; INDUCED CELL-DEATH; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR-DISEASE; ALPHA-TOCOPHEROL; INTRAPLAQUE HEMORRHAGE; CHOLESTERYL ESTER; DIABETES-MELLITUS; MAJOR DETERMINANT	The major function of the Haptoglobin (Hp) protein is to control trafficking of extracorpuscular hemoglobin (Hb) thru the macrophage CD163 receptor with degradation of the Hb in the lysosome. There is a common copy number polymorphism in the Hp gene (Hp 2 allele) that has been associated with a sever-alfold increased incidence of atherothrombosis in multiple longitudinal studies. Increased plaque oxidation and apoptotic markers have been observed in Hp 2-2 atherosclerotic plaques, but the mechanism responsible for this finding has not been determined. We proposed that the increased oxidative injury in Hp 2-2 plaques is due to an impaired processing of Hp 2-2-Hb complexes within macrophage lysosomes, thereby resulting in redox active iron accumulation, lysosomal membrane oxidative injury, and macrophage apoptosis. We sought to test this hypothesis in vitro using purified Hp-Hb complex and cells genetically manipulated to express CD163. CD163-mediated endocytosis and lysosomal degradation of Hp-Hb were decreased for Hp 2-2-Hb complexes. Confocal microscopy using lysotropic pH indicator dyes demonstrated that uptake of Hp2-2-Hb complexes disrupted the lysosomal pH gradient. Cellular fractionation studies of lysosomes isolated from macrophages incubated with Hp 2-2-Hb complexes demonstrated increased lysosomal membrane oxidation and a loss of lysosomal membrane integrity leading to lysosomal enzyme leakage into the cytoplasm. Additionally, markers of apoptosis, DNA fragmentation, and active caspase 3 were increased in macrophages that had endocytosed Hp 2-2-Hb complexes. These data provide novel mechanistic insights into how the Hp genotype regulates lysosomal oxidative stress within macrophages after receptor-mediated endocytosis of Hb.	[Asleh, Rabea; Ward, John; Levy, Nina S.; Safuri, Shady; Levy, Andrew P.] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Asleh, Rabea; Aronson, Doron] Rambam Hlth Care Ctr, Dept Cardiol, IL-31096 Haifa, Israel; [Asleh, Rabea; Aronson, Doron] Rambam Hlth Care Ctr, Coronary Care Unit, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rambam Health Care Campus	Asleh, R (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, 1 Efron St,Bat Galim,POB 9649, IL-31096 Haifa, Israel.	rasleh@tx.technion.ac.il	Asleh, Rabea/K-5664-2019; Aronson, Doron/F-3390-2010	Asleh, Rabea/0000-0002-0258-7402; 	National Institutes of Health [RO1DK085226]; Israel Science Foundation; Rappaport Fund for Medical Research; Slava Smolakovski Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Rappaport Fund for Medical Research; Slava Smolakovski Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK085226. This work was also supported by the Israel Science Foundation and the Rappaport Fund for Medical Research (to A. P. L.) and by a grant from the Slava Smolakovski Fund to the Rambam-Atidim Academic Excellence Program (to R. A.). Dr. Levy is an employee of the Rappaport Faculty of Medicine at the Technion-Israel Institute of Technology, which owns patents related to the use of haptoglobin typing to predict the risk of diabetic vascular complications.	Asleh R, 2005, CIRC RES, V96, P435, DOI 10.1161/01.RES.0000156653.05853.b9; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; Bamm VV, 2004, BIOCHEMISTRY-US, V43, P3899, DOI 10.1021/bi0362626; BARGER AC, 1990, AM J CARDIOL, V66, pG41, DOI 10.1016/0002-9149(90)90394-G; Blum S, 2010, PHARMACOGENOMICS, V11, P675, DOI [10.2217/pgs.10.17, 10.2217/PGS.10.17]; Bowen HT, 1998, J AM COLL NUTR, V17, P171, DOI 10.1080/07315724.1998.10718743; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; BUNN HF, 1968, J BIOL CHEM, V243, P465; Doyle B, 2007, J AM COLL CARDIOL, V49, P2073, DOI 10.1016/j.jacc.2007.01.089; ELSAADANI M, 1989, J LIPID RES, V30, P627; ESTERBAUER H, 1991, AM J CLIN NUTR, V53, pS314, DOI 10.1093/ajcn/53.1.314S; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0306s07, 10.1002/0471143030.cb0309s10]; Hohn A, 2010, FREE RADICAL BIO MED, V48, P1100, DOI 10.1016/j.freeradbiomed.2010.01.030; Jerome WG, 2008, MICROSC MICROANAL, V14, P138, DOI 10.1017/S1431927608080069; Kalet-Litman S, 2010, ATHEROSCLEROSIS, V209, P28, DOI 10.1016/j.atherosclerosis.2009.09.002; Kockx MM, 1998, CIRCULATION, V97, P2307, DOI 10.1161/01.CIR.97.23.2307; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kurz T, 2010, ANTIOXID REDOX SIGN, V13, P511, DOI 10.1089/ars.2009.3005; Levy AP, 2007, ARTERIOSCL THROM VAS, V27, P134, DOI 10.1161/01.ATV.0000251020.24399.a2; Levy AP, 2000, NEW ENGL J MED, V343, P969, DOI 10.1056/NEJM200009283431313; Levy AP, 2004, ATHEROSCLEROSIS, V172, P361, DOI 10.1016/j.atherosclerosis.2003.10.014; Levy AP, 2002, J AM COLL CARDIOL, V40, P1984, DOI 10.1016/S0735-1097(02)02534-2; Li W, 2009, ATHEROSCLEROSIS, V202, P92, DOI 10.1016/j.atherosclerosis.2008.03.027; Li-Weber M, 2002, J CLIN INVEST, V110, P681, DOI [10.1172/JCI0215073, 10.1172/JCI200215073]; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu ZG, 2004, CELL RES, V14, P134, DOI 10.1038/sj.cr.7290212; Lyons NM, 2001, FREE RADICAL RES, V35, P329, DOI 10.1080/10715760100300861; Madsen M, 2001, REDOX REP, V6, P386, DOI 10.1179/135100001101536490; MAOR I, 1994, J LIPID RES, V35, P803; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Moreno PR, 2008, J AM COLL CARDIOL, V52, P1049, DOI 10.1016/j.jacc.2008.06.029; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Moreno PR, 2004, J AM COLL CARDIOL, V44, P2293, DOI 10.1016/j.jacc.2004.07.060; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Morgan J, 1995, J LIPID RES, V36, P2504; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Nilsson E, 1997, HISTOCHEM J, V29, P857, DOI 10.1023/A:1026441907803; Purushothaman KR, 2012, J AM COLL CARDIOL, V60, P112, DOI 10.1016/j.jacc.2012.04.011; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Roguin A, 2003, DIABETES CARE, V26, P2628, DOI 10.2337/diacare.26.9.2628; RUPAR CA, 1992, BIOCHEM CELL BIOL, V70, P486, DOI 10.1139/o92-075; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Schutt F, 2002, GRAEF ARCH CLIN EXP, V240, P983, DOI 10.1007/s00417-002-0558-8; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; Suleiman M, 2003, DIABETES CARE, V26, P2699, DOI 10.2337/diacare.26.9.2699; Tabas I, 2009, ANTIOXID REDOX SIGN, V11, P2333, DOI [10.1089/ars.2009.2469, 10.1089/ARS.2009.2469]; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Twigg SM, 2001, ENDOCRINOLOGY, V142, P1760, DOI 10.1210/endo.142.5.8141; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Wen YC, 2007, CIRC RES, V100, P1337, DOI 10.1161/CIRCRESAHA.107.151704; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; Yuan XM, 2000, FREE RADICAL BIO MED, V28, P208, DOI 10.1016/S0891-5849(99)00220-8	55	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16313	16325		10.1074/jbc.M114.554212	http://dx.doi.org/10.1074/jbc.M114.554212			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778180	Green Published, hybrid			2022-12-28	WOS:000337965700035
J	Stojanovski, BM; Hunter, GA; Jahn, M; Jahn, D; Ferreira, GC				Stojanovski, Bosko M.; Hunter, Gregory A.; Jahn, Martina; Jahn, Dieter; Ferreira, Gloria C.			Unstable Reaction Intermediates and Hysteresis during the Catalytic Cycle of 5-Aminolevulinate Synthase IMPLICATIONS FROM USING PSEUDO AND ALTERNATE SUBSTRATES AND A PROMISCUOUS ENZYME VARIANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOLEVULINIC-ACID SYNTHASE; PHOSPHATE COFACTOR-BINDING; REACTION-MECHANISM; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; 8-AMINO-7-OXONONANOATE SYNTHASE; RHODOPSEUDOMONAS-SPHEROIDES; SERINE PALMITOYLTRANSFERASE; BIOTIN BIOSYNTHESIS; CRYSTAL-STRUCTURE	5-Aminolevulinate (ALA), an essential metabolite in all heme-synthesizing organisms, results from the pyridoxal 5'-phosphate (PLP)-dependent enzymatic condensation of glycine with succinyl-CoA in non-plant eukaryotes and alpha-proteobacteria. The predicted chemical mechanism of this ALA synthase (ALAS)-catalyzed reaction includes a short-lived glycine quinonoid intermediate and an unstable 2-amino-3-ketoadipate intermediate. Using liquid chromatography coupled with tandem mass spectrometry to analyze the products from the reaction of murine erythroid ALAS (mALAS2) with O-methylglycine and succinyl-CoA, we directly identified the chemical nature of the inherently unstable 2-amino-3-ketoadipate intermediate, which predicates the glycine quinonoid species as its precursor. With stopped-flow absorption spectroscopy, we detected and confirmed the formation of the quinonoid intermediate upon reacting glycine with ALAS. Significantly, in the absence of the succinyl-CoA substrate, the external aldimine predominates over the glycine quinonoid intermediate. When instead of glycine, L-serine was reacted with ALAS, a lag phase was observed in the progress curve for the L-serine external aldimine formation, indicating a hysteretic behavior in ALAS. Hysteresis was not detected in the T148A-catalyzed L-serine external aldimine formation. These results with T148A, a mALAS2 variant, which, in contrast to wild-type mALAS2, is active with L-serine, suggest that active site Thr-148 modulates ALAS strict amino acid substrate specificity. The rate of ALA release is also controlled by a hysteretic kinetic mechanism (observed as a lag in the ALA external aldimine formation progress curve), consistent with conformational changes governing the dissociation of ALA from ALAS.	[Stojanovski, Bosko M.; Hunter, Gregory A.; Ferreira, Gloria C.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33612 USA; [Jahn, Martina; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany	State University System of Florida; University of South Florida; Braunschweig University of Technology	Ferreira, GC (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, MDC 7, Tampa, FL 33612 USA.	gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217; Jahn, Dieter/0000-0002-4064-9205	National Institutes of Health [GM080270]; American Heart Association [10GRNT4300073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grant GM080270 and the American Heart Association Greater SE Affiliate Grant 10GRNT4300073, (to G.C.F.).	ABBOUD MM, 1974, J CHEM SOC CHEM COMM, P643, DOI 10.1039/c39740000643; AKHTAR M, 1968, CHEM COMMUN, P1691, DOI 10.1039/c19680001691; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Bottomley SS, 2004, WINTROBES CLIN HEMAT, P1011; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; Fratz E. J., 2013, HDB PORPHYRIN SCI, P1; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; GIBSON KD, 1958, BIOCHEM J, V70, P71, DOI 10.1042/bj0700071; GONG J, 1995, BIOCHEMISTRY-US, V34, P1678, DOI 10.1021/bi00005a024; Gong J, 1996, BIOCHEMISTRY-US, V35, P14109, DOI 10.1021/bi961296h; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; Ikushiro H, 2011, BBA-PROTEINS PROTEOM, V1814, P1474, DOI 10.1016/j.bbapap.2011.02.005; Jahan N, 2009, J MOL BIOL, V392, P763, DOI 10.1016/j.jmb.2009.07.042; Kaufholz AL, 2013, BIOCHEM J, V451, P205, DOI 10.1042/BJ20121041; Kerbarh O, 2006, CHEM COMMUN, P60, DOI 10.1039/b511837a; KIKUCHI G, 1958, J BIOL CHEM, V233, P1214; LAGHAI A, 1977, BIOCHEM SOC T, V5, P299, DOI 10.1042/bst0050299; Lendrihas T, 2010, J BIOL CHEM, V285, P13704, DOI 10.1074/jbc.M109.074237; Lendrihas T, 2009, PROTEIN SCI, V18, P1847, DOI 10.1002/pro.195; Li JB, 2008, MOLECULES, V13, P1111, DOI 10.3390/molecules13051111; Mann S, 2011, BBA-PROTEINS PROTEOM, V1814, P1459, DOI 10.1016/j.bbapap.2010.12.004; MARCUS JP, 1993, BIOCHEM BIOPH RES CO, V190, P1066, DOI 10.1006/bbrc.1993.1157; NANDI DL, 1978, J BIOL CHEM, V253, P8872; Ploux O, 1996, EUR J BIOCHEM, V236, P301, DOI 10.1111/j.1432-1033.1996.00301.x; Raman MCC, 2009, J BIOL CHEM, V284, P17328, DOI 10.1074/jbc.M109.008680; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Shoolingin-Jordan PM, 2003, BBA-PROTEINS PROTEOM, V1647, P361, DOI 10.1016/S1570-9639(03)00095-5; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; UMANOFF H, 1988, J BACTERIOL, V170, P4969, DOI 10.1128/jb.170.10.4969-4971.1988; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; ZAMAN Z, 1973, BIOCHEM J, V135, P257, DOI 10.1042/bj1350257; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200	42	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22915	22925		10.1074/jbc.M114.574731	http://dx.doi.org/10.1074/jbc.M114.574731			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24920668	hybrid, Green Published			2022-12-28	WOS:000341017200032
J	Michalski, R; Zielonka, J; Gapys, E; Marcinek, A; Joseph, J; Kalyanaraman, B				Michalski, Radoslaw; Zielonka, Jacek; Gapys, Ewa; Marcinek, Andrzej; Joseph, Joy; Kalyanaraman, Balaraman			Real-time Measurements of Amino Acid and Protein Hydroperoxides Using Coumarin Boronic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XYLENOL ORANGE; BIOLOGICAL-SYSTEMS; TYROSINE PEROXIDE; REACTIVE OXYGEN; SINGLET OXYGEN; SIDE-CHAIN; SUPEROXIDE; OXIDATION; PEROXYNITRITE; RADICALS	Hydroperoxides of amino acid and amino acid residues (tyrosine, cysteine, tryptophan, and histidine) in proteins are formed during oxidative modification induced by reactive oxygen species. Amino acid hydroperoxides are unstable intermediates that can further propagate oxidative damage in proteins. The existing assays (oxidation of ferrous cation and iodometric assays) cannot be used in real-time measurements. In this study, we show that the profluorescent coumarin boronic acid (CBA) probe reacts with amino acid and protein hydroperoxides to form the corresponding fluorescent product, 7-hydroxycoumarin. 7-Hydroxycoumarin formation was catalase-independent. Based on this observation, we have developed a fluorometric, real-time assay that is adapted to a multiwell plate format. This is the first report showing real-time monitoring of amino acid and protein hydroperoxides using the CBA-based assay. This approach was used to detect protein hydroperoxides in cell lysates obtained from macrophages exposed to visible light and photosensitizer (rose bengal). We also measured the rate constants for the reaction between amino acid hydroperoxides (tyrosyl, tryptophan, and histidine hydroperoxides) and CBA, and these values (7-23 M-1 s(-1)) were significantly higher than that measured for H2O2 (1.5 M-1 s(-1)). Using the CBA-based competition kinetics approach, the rate constants for amino acid hydroperoxides with ebselen, a glutathione peroxidase mimic, were also determined, and the values were within the range of 1.1-1.5 x 10(3) M-1 s(-1). Both ebselen and boronates may be used as small molecule scavengers of amino acid and protein hydroperoxides. Here we also show formation of tryptophan hydroperoxide from tryptophan exposed to co-generated fluxes of nitric oxide and superoxide. This observation reveals a new mechanism for amino acid and protein hydroperoxide formation in biological systems.	[Michalski, Radoslaw; Zielonka, Jacek; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Michalski, Radoslaw; Zielonka, Jacek; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA; [Michalski, Radoslaw; Zielonka, Jacek; Gapys, Ewa; Marcinek, Andrzej] Lodz Univ Technol, Inst Appl Radiat Chem, PL-90924 Lodz, Poland	Medical College of Wisconsin; Medical College of Wisconsin; Lodz University of Technology	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu	Zielonka, Jacek/N-9546-2014; Michalski, Radoslaw/X-1505-2018; Marcinek, Andrzej/M-1775-2018	Zielonka, Jacek/0000-0002-2524-0145; Michalski, Radoslaw/0000-0001-5601-0839; Marcinek, Andrzej/0000-0002-9852-7593	National Institutes of Health [R01 HL073056, R01 HL063119]; Jagiellonian Centre for Experimental Therapeutics (JCET) [POIG.01.01.02-00-069/09]; European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme; Foundation for Polish Science (FNP) within the "Homing Plus" program; European Union within European Regional Development Fund, through the Innovative Economy Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073056, R01HL063119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jagiellonian Centre for Experimental Therapeutics (JCET); European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme; Foundation for Polish Science (FNP) within the "Homing Plus" program; European Union within European Regional Development Fund, through the Innovative Economy Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL073056 and R01 HL063119 (to B. K.). This work was also supported by a grant coordinated by Jagiellonian Centre for Experimental Therapeutics (JCET), POIG.01.01.02-00-069/09 (supported by the European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme).; Supported by a grant from the Foundation for Polish Science (FNP) within the "Homing Plus" program supported by the European Union within European Regional Development Fund, through the Innovative Economy Program.	Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Alvarez B, 1996, CHEM RES TOXICOL, V9, P390, DOI 10.1021/tx950133b; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; d'Alessandro N, 2000, J CHEM SOC PERK T 2, P1862, DOI 10.1039/b003346o; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; FOOTE CS, 1971, J AM CHEM SOC, V93, P3795, DOI 10.1021/ja00744a055; Fu S, 1998, BIOCHEM J, V333, P519, DOI 10.1042/bj3330519; Fu SL, 1998, J BIOL CHEM, V273, P28603, DOI 10.1074/jbc.273.44.28603; Gay C, 1999, ANAL BIOCHEM, V273, P143, DOI 10.1006/abio.1999.4207; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Gay C, 2000, ANAL BIOCHEM, V284, P217, DOI 10.1006/abio.2000.4696; Gay CA, 2003, ANAL BIOCHEM, V315, P29, DOI 10.1016/S0003-2697(02)00606-1; Gay CA, 2002, ANAL BIOCHEM, V304, P42, DOI 10.1006/abio.2001.5566; Gebicki S, 1999, BIOCHEM J, V338, P629, DOI 10.1042/0264-6021:3380629; Gebicki S, 2002, REDOX REP, V7, P235, DOI 10.1179/135100002125000541; Gieseg S, 2000, BIOCHEM J, V350, P215, DOI 10.1042/0264-6021:3500215; Golding JP, 2013, BRIT J CANCER, V109, P976, DOI 10.1038/bjc.2013.391; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; Hilf R, 2007, J BIOENERG BIOMEMBR, V39, P85, DOI 10.1007/s10863-006-9064-8; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; JIN FM, 1993, J CHEM SOC PERK T 2, P1583, DOI 10.1039/p29930001583; Kim CH, 2011, INT J NANOMED, V6, P1357, DOI 10.2147/IJN.S21395; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Luxford C, 1999, BIOCHEM J, V344, P125, DOI 10.1042/0264-6021:3440125; Luxford C, 2000, CHEM RES TOXICOL, V13, P665, DOI 10.1021/tx000053u; Luxford C, 2002, BIOGERONTOLOGY, V3, P95, DOI 10.1023/A:1015228001561; Moller MN, 2012, J AM CHEM SOC, V134, P16773, DOI 10.1021/ja307215z; Morgan PE, 2004, FREE RADICAL BIO MED, V36, P484, DOI 10.1016/j.freeradbiomed.2003.11.021; Morgan PE, 2008, FREE RADICAL BIO MED, V45, P1279, DOI 10.1016/j.freeradbiomed.2008.08.004; Morgan PE, 2012, FREE RADICAL BIO MED, V52, P328, DOI 10.1016/j.freeradbiomed.2011.10.448; Nagy P, 2009, J BIOL CHEM, V284, P14723, DOI 10.1074/jbc.M809396200; Nokes B, 2013, J SURG RES, V181, P262, DOI 10.1016/j.jss.2013.02.002; Pattison DI, 2012, PHOTOCH PHOTOBIO SCI, V11, P38, DOI 10.1039/c1pp05164d; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; Pietraforte D, 1997, BIOCHEM J, V321, P743, DOI 10.1042/bj3210743; Rahmanto AS, 2012, IUBMB LIFE, V64, P863, DOI 10.1002/iub.1084; Rahmanto AS, 2011, FREE RADICAL BIO MED, V51, P2288, DOI 10.1016/j.freeradbiomed.2011.09.027; Rahmanto AS, 2010, FREE RADICAL BIO MED, V49, P1505, DOI 10.1016/j.freeradbiomed.2010.08.006; Rahmanto AS, 2010, FREE RADICAL BIO MED, V48, P1071, DOI 10.1016/j.freeradbiomed.2010.01.025; ROUGEE M, 1988, PHOTOCHEM PHOTOBIOL, V47, P485, DOI 10.1111/j.1751-1097.1988.tb08835.x; Ryan K, 2012, J NEUROSCI, V32, P11250, DOI 10.1523/JNEUROSCI.0907-12.2012; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Winterbourn CC, 1997, ARCH BIOCHEM BIOPHYS, V338, P15, DOI 10.1006/abbi.1996.9773; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wright A, 2003, FREE RADICAL BIO MED, V34, P637, DOI 10.1016/S0891-5849(02)01361-8; Wright A, 2000, REDOX REP, V5, P159, DOI 10.1179/135100000101535573; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	55	50	51	3	57	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22536	22553		10.1074/jbc.M114.553727	http://dx.doi.org/10.1074/jbc.M114.553727			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24928516	Green Published, hybrid			2022-12-28	WOS:000340593500062
J	Egli, M				Egli, Martin			Intricate Protein-Protein Interactions in the Cyanobacterial Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							KAIB-KAIC COMPLEX; C-TERMINAL DOMAIN; SYNECHOCOCCUS-ELONGATUS; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; IN-VITRO; PHOSPHORYLATION; OSCILLATOR; DYNAMICS; RHYTHM	The cyanobacterial circadian clock consists of a post-translational oscillator (PTO) and a PTO-dependent transcription-translation feedback loop (TTFL). The PTO can be reconstituted in vitro with the KaiA, KaiB, and KaiC proteins, enabling detailed biochemical and biophysical investigations. Both the CI and the CII halves of the KaiC hexamer harbor ATPases, but only the C-terminal CII ring exhibits kinase and phospho-transferase activities. KaiA stimulates the kinase and KaiB associates with KaiC during the dephosphorylation phase and sequesters KaiA. Recent research has led to conflicting models of the KaiB-KaiC interaction, precluding a clear understanding of KaiB function and KaiABC clock mechanism.	[Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Egli, Martin] Vanderbilt Univ, Sch Med, Struct Biol Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu			National Institutes of Health [R01 GM073845]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073845 (to M. E.).	Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Brettschneider C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.44; Chang YG, 2012, P NATL ACAD SCI USA, V109, P16847, DOI 10.1073/pnas.1211508109; Chang YG, 2011, P NATL ACAD SCI USA, V108, P14431, DOI 10.1073/pnas.1104221108; Clodong S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100128; Dong GG, 2010, CELL, V140, P529, DOI 10.1016/j.cell.2009.12.042; Egli M, 2013, CURR OPIN NEUROBIOL, V23, P732, DOI 10.1016/j.conb.2013.02.012; Egli M, 2013, BIOCHEMISTRY-US, V52, P1208, DOI 10.1021/bi301691a; Egli M, 2012, BIOCHEMISTRY-US, V51, P1547, DOI 10.1021/bi201525n; Garces RG, 2004, EMBO J, V23, P1688, DOI 10.1038/sj.emboj.7600190; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hayashi F, 2004, BIOCHEM BIOPH RES CO, V316, P195, DOI 10.1016/j.bbrc.2004.02.034; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwase R, 2005, J BIOL CHEM, V280, P43141, DOI 10.1074/jbc.M503360200; Johnson CH, 2008, SCIENCE, V322, P697, DOI 10.1126/science.1150451; Johnson CH, 2014, ANNU REV BIOCHEM, V83, P221, DOI 10.1146/annurev-biochem-060713-035632; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kitayama Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3897; Leipe DD, 2000, GENOME RES, V10, P5; Mackey SR, 2011, ADV GENET, V74, P13, DOI 10.1016/B978-0-12-387690-4.00002-7; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Murakami R, 2012, J BIOL CHEM, V287, P29506, DOI 10.1074/jbc.M112.349092; Murayama Y, 2011, EMBO J, V30, P68, DOI 10.1038/emboj.2010.298; Mutoh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080200; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Nishiwaki T, 2012, J BIOL CHEM, V287, P18030, DOI 10.1074/jbc.M112.350660; Nishiwaki-Ohkawa T, 2014, P NATL ACAD SCI USA, V111, P4455, DOI 10.1073/pnas.1319353111; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2006, EMBO J, V25, P2017, DOI 10.1038/sj.emboj.7601086; Pattanayek R, 2014, ACTA CRYSTALLOGR D, V70, P1375, DOI 10.1107/S1399004714003228; Pattanayek R, 2013, CELL CYCLE, V12, P810, DOI 10.4161/cc.23757; Pattanayek R, 2012, BIOCHEMISTRY-US, V51, P8050, DOI 10.1021/bi301222t; Pattanayek R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023697; Pattanayek R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007529; Phong C, 2013, P NATL ACAD SCI USA, V110, P1124, DOI 10.1073/pnas.1212113110; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Snijder J, 2014, P NATL ACAD SCI USA, V111, P1379, DOI 10.1073/pnas.1314326111; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Tseng R, 2014, J MOL BIOL, V426, P389, DOI 10.1016/j.jmb.2013.09.040; Vakonakis I, 2004, P NATL ACAD SCI USA, V101, P10925, DOI 10.1073/pnas.0403037101; van Zon JS, 2007, P NATL ACAD SCI USA, V104, P7420, DOI 10.1073/pnas.0608665104; Villarreal SA, 2013, J MOL BIOL, V425, P3311, DOI 10.1016/j.jmb.2013.06.018; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Xu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007509; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200	61	16	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21267	21275		10.1074/jbc.R114.579607	http://dx.doi.org/10.1074/jbc.R114.579607			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936066	Green Published, hybrid			2022-12-28	WOS:000340558300006
J	Liang, YJ; Gao, ZQ; Wang, F; Zhang, YL; Dong, YH; Liu, QS				Liang, Yajing; Gao, Zengqiang; Wang, Fei; Zhang, Yangli; Dong, Yuhui; Liu, Quansheng			Structural and Functional Characterization of Escherichia coli Toxin-Antitoxin Complex DinJ-YafQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CRYSTAL-STRUCTURE; STRESS-RESPONSE; CELL-DEATH; YOEB TOXIN; SYSTEM; MECHANISM; RIBOSOME; MAZF; STABILIZER	Toxin YafQ functions as a ribonuclease in the dinJ-yafQ toxin-antitoxin system of Escherichia coli. Antitoxin DinJ neutralizes YafQ-mediated toxicity by forming a stable protein complex. Here, crystal structures of the (DinJ)(2)-(YafQ)(2) complex and the isolated YafQ toxin have been determined. The structure of the heterotetrameric complex (DinJ)(2)-(YafQ)(2) revealed that the N-terminal region of DinJ folds into a ribbonhelix-helix motif and dimerizes for DNA recognition, and the C-terminal portion of each DinJ exclusively wraps around a YafQ molecule. Upon incorporation into the heterotetrameric complex, a conformational change of YafQ in close proximity to the catalytic site of the typical microbial ribonuclease fold was observed and validated. Mutagenesis experiments revealed that a DinJ mutant restored YafQ RNase activity in a tetramer complex in vitro but not in vivo. An electrophoretic mobility shift assay showed that one of the palindromic sequences present in the upstream intergenic region of DinJ served as a binding sequences for both the DinJ-YafQ complex and the antitoxin DinJ alone. Based on structure-guided and site-directed mutagenesis of DinJ-YafQ, we showed that two pairs of amino acids in DinJ were important for DNA binding; the R8A and K16A substitutions and the S31A and R35A substitutions in DinJ abolished the DNA binding ability of the DinJ-YafQ complex.	[Liang, Yajing] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Liang, Yajing; Gao, Zengqiang; Wang, Fei; Dong, Yuhui; Liu, Quansheng] Chinese Acad Sci, Inst High Energy Phys, Multidiscipline Res Ctr, Beijing 100049, Peoples R China; [Zhang, Yangli] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Chongqing 400016, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chongqing Medical University	Dong, YH (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Multidiscipline Res Ctr, Beijing 100049, Peoples R China.	dongyh@ihep.ac.cn; liuqsh@ihep.ac.cn		Liu, Quansheng/0000-0001-6439-1205; Dong, Yuhui/0000-0002-4422-4685; Gao, Zengqiang/0000-0002-9100-9929	National Basic Research Program of China [2012CB917201]; National Natural Science Foundation of China [31170689, 11179022]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB917201 and National Natural Science Foundation of China Grants 31170689 and 11179022.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Armalyte J, 2012, J BACTERIOL, V194, P1523, DOI 10.1128/JB.06104-11; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Chan WT, 2011, J BACTERIOL, V193, P4612, DOI 10.1128/JB.05187-11; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evdokimov A, 2009, ACTA CRYSTALLOGR D, V65, P875, DOI 10.1107/S0907444909018800; Feng S, 2013, NUCLEIC ACIDS RES, V41, P9549, DOI 10.1093/nar/gkt742; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; GOHDA K, 1994, J BIOL CHEM, V269, P17531; Han KD, 2011, J BIOL CHEM, V286, P4842, DOI 10.1074/jbc.M109.097840; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039185; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Hu Ming-Xi, 2010, Int J Microbiol, V2010, P781430, DOI 10.1155/2010/781430; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Hurley JM, 2011, J BIOL CHEM, V286, P14770, DOI 10.1074/jbc.M110.108969; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Schureck MA, 2014, J BIOL CHEM, V289, P1060, DOI 10.1074/jbc.M113.512095; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Takahashi Y, 2000, J BIOCHEM-TOKYO, V128, P723, DOI 10.1093/oxfordjournals.jbchem.a022807; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhang F, 2012, ACTA CRYSTALLOGR F, V68, P894, DOI 10.1107/S1744309112024037; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624	51	24	27	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21191	21202		10.1074/jbc.M114.559773	http://dx.doi.org/10.1074/jbc.M114.559773			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923448	Green Published, hybrid			2022-12-28	WOS:000339396600068
J	Mei, H; Campbell, JM; Paddock, CM; Lertkiatmongkol, P; Mosesson, MW; Albrecht, R; Newman, PJ				Mei, Heng; Campbell, Jay M.; Paddock, Cathy M.; Lertkiatmongkol, Panida; Mosesson, Michael W.; Albrecht, Ralph; Newman, Peter J.			Regulation of Endothelial Cell Barrier Function by Antibody-driven Affinity Modulation of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; FLUID SHEAR-STRESS; TRANSENDOTHELIAL MIGRATION; INTEGRIN ACTIVATION; HEMOPHILIC BINDING; SURFACE EXPRESSION; CYTOPLASMIC DOMAIN; MEMBRANE-PROTEINS; ENDOTOXIC-SHOCK; IN-VIVO	PECAM-1 is a 130-kDa member of the immunoglobulin (Ig) superfamily that is expressed on the surface of platelets and leukocytes, and at the intracellular junctions of confluent endothelial cell monolayers. Previous studies have shown that PECAM-1/PECAM-1 homophilic interactions play a key role in leukocyte transendothelial migration, in allowing PECAM-1 to serve as a mechanosensory complex in endothelial cells, in its ability to confer cytoprotection to proapoptotic stimuli, and in maintaining endothelial cell junctional integrity. To examine the adhesive properties of full-length PECAM-1 in a native lipid environment, we purified it from platelets and assembled it into phospholipid nanodiscs. PECAM-1-containing nanodiscs retained not only their ability to bind homophilically to PECAM-1-expressing cells, but exhibited regulatable adhesive interactions that could be modulated by ligands that bind membrane-proximal Ig Domain 6. This property was exploited to enhance the rate of barrier restoration in endothelial cell monolayers subjected to inflammatory challenge. The finding that the adhesive properties of PECAM-1 are regulatable suggests novel approaches for controlling endothelial cell migration and barrier function in a variety of vascular permeability disorders.	[Mei, Heng; Paddock, Cathy M.; Lertkiatmongkol, Panida; Mosesson, Michael W.; Newman, Peter J.] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Campbell, Jay M.] Univ Wisconsin, Ctr Mat Sci, Madison, WI 54701 USA; [Albrecht, Ralph] Univ Wisconsin, Dept Anim Sci, Madison, WI 54701 USA; [Albrecht, Ralph] Univ Wisconsin, Dept Pediat, Madison, WI 54701 USA; [Albrecht, Ralph] Univ Wisconsin, Dept Pharmaceut Sci, Madison, WI 54701 USA; [Lertkiatmongkol, Panida; Newman, Peter J.] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin	Newman, PJ (corresponding author), Blood Ctr Wisconsin, Blood Res Inst, 638 North 18th St, Milwaukee, WI 53201 USA.	peter.newman@bcw.edu			National Institutes of Health [HL40926]; AHA [13POST16840095]; Blood Research Institute, Blood Center of Wisconsin; Institute of Hematology, Union Hospital, Huazhong University of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, R01HL040926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Blood Research Institute, Blood Center of Wisconsin; Institute of Hematology, Union Hospital, Huazhong University of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL40926 (to P. J. N.) and AHA Grant 13POST16840095 (to H. M.). This work is the result of an ongoing jointly-sponsored Research Partnership between the Blood Research Institute, Blood Center of Wisconsin and the Institute of Hematology, Union Hospital, Huazhong University of Science and Technology, Professor Yu Hu, M.D., Ph.D., Director.	ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; BALDASSARE JJ, 1985, J CLIN INVEST, V75, P35, DOI 10.1172/JCI111693; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Bergom C, 2006, CANCER BIOL THER, V5, P1699, DOI 10.4161/cbt.5.12.3467; Bird IN, 1999, J CELL SCI, V112, P1989; Cao GY, 2002, AM J PHYSIOL-CELL PH, V282, pC1181, DOI 10.1152/ajpcell.00524.2001; Carrithers M, 2005, AM J PATHOL, V166, P185, DOI 10.1016/S0002-9440(10)62243-2; Collins C, 2012, CURR BIOL, V22, P2087, DOI 10.1016/j.cub.2012.08.051; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; DeLisser HM, 1997, AM J PATHOL, V151, P671; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Evans PC, 2001, TRANSPLANTATION, V71, P457, DOI 10.1097/00007890-200102150-00020; FAWCETT J, 1995, J CELL BIOL, V128, P1229, DOI 10.1083/jcb.128.6.1229; FERRERO E, 1995, FEBS LETT, V374, P323, DOI 10.1016/0014-5793(95)01110-Z; Fornasa G, 2012, CARDIOVASC RES, V94, P30, DOI 10.1093/cvr/cvs076; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Gao CJ, 2001, BLOOD, V98, p796A; GOLDBERGER A, 1994, TISSUE ANTIGENS, V44, P285, DOI 10.1111/j.1399-0039.1994.tb02397.x; GOLDBERGER A, 1994, J BIOL CHEM, V269, P17183; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kuckleburg CJ, 2012, J IMMUNOL, V188, P2419, DOI 10.4049/jimmunol.1102540; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Maas M, 2005, AM J PHYSIOL-HEART C, V288, pH159, DOI 10.1152/ajpheart.00500.2004; MOSESSON MW, 1995, J STRUCT BIOL, V115, P88, DOI 10.1006/jsbi.1995.1033; MULLER WA, 1992, J EXP MED, V175, P1401, DOI 10.1084/jem.175.5.1401; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Newman DK, 2002, BIOCHEM BIOPH RES CO, V296, P1171, DOI 10.1016/S0006-291X(02)02060-0; Newman PJ, 1999, J CLIN INVEST, V103, P5, DOI 10.1172/JCI5928; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Newton-Nash DK, 1999, J IMMUNOL, V163, P682; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Paddock C, 2011, BLOOD, V117, P6012, DOI 10.1182/blood-2010-11-317867; Patil S, 2001, BLOOD, V97, P1727, DOI 10.1182/blood.V97.6.1727; Privratsky JR, 2011, J CELL SCI, V124, P1477, DOI 10.1242/jcs.082271; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Sheibani N, 1997, MOL BIOL CELL, V8, P1329, DOI 10.1091/mbc.8.7.1329; Stroncek D, 2002, VOX SANG, V83, P359, DOI 10.1111/j.1423-0410.2002.tb05334.x; Sun J, 2000, J CELL SCI, V113, P1459; Sun J, 1996, J BIOL CHEM, V271, P18561, DOI 10.1074/jbc.271.31.18561; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808; Varon D, 1998, BLOOD, V91, P500, DOI 10.1182/blood.V91.2.500.500_500_507; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Wakelin MW, 1996, J EXP MED, V184, P229, DOI 10.1084/jem.184.1.229; YAN HC, 1995, CELL ADHES COMMUN, V3, P45, DOI 10.3109/15419069509081277; Yan R, 2011, BIOCHEMISTRY-US, V50, P10598, DOI 10.1021/bi201351d; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; ZEHNDER JL, 1992, J BIOL CHEM, V267, P5243; ZEHNDER JL, 1995, BLOOD, V85, P1282, DOI 10.1182/blood.V85.5.1282.bloodjournal8551282; Zhao TM, 2001, J CELL BIOL, V152, P65, DOI 10.1083/jcb.152.1.65; Zhou Z, 1999, Angiogenesis, V3, P181, DOI 10.1023/A:1009092107382	59	24	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20836	20844		10.1074/jbc.M114.557454	http://dx.doi.org/10.1074/jbc.M114.557454			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936065	Green Published, hybrid			2022-12-28	WOS:000339396600038
J	Lama, S; Auer, RN; Tyson, R; Gallagher, CN; Tomanek, B; Sutherland, GR				Lama, Sanju; Auer, Roland N.; Tyson, Randy; Gallagher, Clare N.; Tomanek, Boguslaw; Sutherland, Garnette R.			Lactate Storm Marks Cerebral Metabolism following Brain Trauma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICARBOXYLIC-ACID CYCLE; OXIDATIVE STRESS; C-13 NMR; COGNITIVE DEFICITS; GLUCOSE-METABOLISM; SUBSTRATE DELIVERY; GLUTAMATE UPTAKE; INJURY; MICRODIALYSIS; ASTROCYTES	Brain metabolism is thought to be maintained by neuronalglial metabolic coupling. Glia take up glutamate from the synaptic cleft for conversion into glutamine, triggering glial glycolysis and lactate production. This lactate is shuttled into neurons and further metabolized. The origin and role of lactate in severe traumatic brain injury (TBI) remains controversial. Using a modified weight drop model of severe TBI and magnetic resonance (MR) spectroscopy with infusion of C-13-labeled glucose, lactate, and acetate, the present study investigated the possibility that neuronal-glial metabolism is uncoupled following severe TBI. Histopathology of the model showed severe brain injury with subarachnoid and hemorrhage together with glial cell activation and positive staining for Tau at 90 min post-trauma. High resolution MR spectroscopy of brain metabolites revealed significant labeling of lactate at C-3 and C-2 irrespective of the infused substrates. Increased C-13-labeled lactate in all study groups in the absence of ischemia implied activated astrocytic glycolysis and production of lactate with failure of neuronal uptake (i.e. a loss of glial sensing for glutamate). The early increase in extracellular lactate in severe TBI with the injured neurons rendered unable to pick it up probably contributes to a rapid progression toward irreversible injury and pan-necrosis. Hence, a method to detect and scavenge the excess extracellular lactate on site or early following severe TBI may be a potential primary therapeutic measure.	[Lama, Sanju; Tyson, Randy; Gallagher, Clare N.; Tomanek, Boguslaw; Sutherland, Garnette R.] Univ Calgary, Dept Clin Neurosci, Fac Med, Calgary, AB T2N 2T9, Canada; [Lama, Sanju; Tyson, Randy; Gallagher, Clare N.; Tomanek, Boguslaw; Sutherland, Garnette R.] Univ Calgary, Hotchkiss Brain Inst, Fac Med, Calgary, AB T2N 2T9, Canada; [Auer, Roland N.] Univ Montreal, Hop Ste Justine, Dept Pathol, Montreal, PQ H3T 1C5, Canada	University of Calgary; University of Calgary; Universite de Montreal	Sutherland, GR (corresponding author), Univ Calgary, Hlth Res Innovat Ctr 1C60, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	garnette@ucalgary.ca	Tomanek, Boguslaw/AAD-7594-2019; Tomanek, Boguslaw/J-4720-2014; Auer, Roland/F-6661-2017	Tomanek, Boguslaw/0000-0003-2602-0280; Auer, Roland/0000-0001-9044-3419	Canadian Institutes for Health Research [RT733596]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research grant entitled Cerebral Metabolism in Traumatic Brain Injury RT733596 (to G. R. S.).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; ALVES PM, 1995, NEUROREPORT, V6, P2201, DOI 10.1097/00001756-199511000-00024; ANDERSEN BJ, 1992, BRAIN RES, V585, P190, DOI 10.1016/0006-8993(92)91206-T; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; BECKMANN N, 1991, BIOCHEMISTRY-US, V30, P6362, DOI 10.1021/bi00240a002; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Chen T, 2000, ACT NEUR S, V76, P359; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gruetter R, 2002, NEUROCHEM INT, V41, P143, DOI 10.1016/S0197-0186(02)00034-7; Hassel B, 1997, J CEREBR BLOOD F MET, V17, P1230, DOI 10.1097/00004647-199711000-00012; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; KISHI K, 1994, BIOCHEMISTRY-US, V33, P8694, DOI 10.1021/bi00195a010; KRAIG RP, 1987, J CEREBR BLOOD F MET, V7, P379, DOI 10.1038/jcbfm.1987.80; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Magistretti PJ, 2009, AM J CLIN NUTR, V90, p875S, DOI 10.3945/ajcn.2009.27462CC; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McKenna MC, 1995, NEUROCHEM RES, V20, P1491, DOI 10.1007/BF00970599; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Mondragon-Rodriguez S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/940603; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; PEELING J, 1992, MAGNET RESON MED, V24, P123, DOI 10.1002/mrm.1910240113; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Peronnet F, 2006, RESP PHYSIOL NEUROBI, V150, P4, DOI 10.1016/j.resp.2005.04.005; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Tyson RL, 2000, NEUROREPORT, V11, P1845, DOI 10.1097/00001756-200006260-00009; Tyson RL, 2003, BRAIN RES, V992, P43, DOI 10.1016/j.brainres.2003.08.027; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vogel R, 1998, NEUROSCI LETT, V247, P123, DOI 10.1016/S0304-3940(98)00290-0; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	58	36	39	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20200	20208		10.1074/jbc.M114.570978	http://dx.doi.org/10.1074/jbc.M114.570978			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24849602	hybrid, Green Published			2022-12-28	WOS:000339395200033
J	Goldgof, M; Xiao, CY; Chanturiya, T; Jou, W; Gavrilova, O; Reitman, ML				Goldgof, Margalit; Xiao, Cuiying; Chanturiya, Tatyana; Jou, William; Gavrilova, Oksana; Reitman, Marc L.			The Chemical Uncoupler 2,4-Dinitrophenol (DNP) Protects against Diet-induced Obesity and Improves Energy Homeostasis in Mice at Thermoneutrality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; ENVIRONMENTAL TEMPERATURES; THERMOGENESIS; COLD; EXPENDITURE; METABOLISM; BALANCE; DINITROPHENOL; GENE; ANIMALS	The chemical uncoupler 2,4-dinitrophenol (DNP) was an effective and widely used weight loss drug in the early 1930s. However, the physiology of DNP has not been studied in detail because toxicity, including hyperthermia and death, reduced interest in the clinical use of chemical uncouplers. To investigate DNP action, mice fed a high fat diet and housed at 30 degrees C (to minimize facultative thermogenesis) were treated with 800 mg/liter DNP in drinking water. DNP treatment increased energy expenditure by similar to 17%, but did not change food intake. DNP-treated mice weighed 26% less than controls after 2 months of treatment due to decreased fat mass, without a change in lean mass. DNP improved glucose tolerance and reduced hepatic steatosis without observed toxicity. DNP treatment also reduced circulating T3 and T4 levels, Ucp1 expression, and brown adipose tissue activity, demonstrating that DNP-mediated heat generation substituted for brown adipose tissue thermogenesis. At 22 degrees C, a typical vivarium temperature that is below thermoneutrality, DNP treatment had no effect on body weight, adiposity, or glucose homeostasis. Thus, environmental temperature should be considered when assessing an anti-obesity drug in mice, particularly agents acting on energy expenditure. Furthermore, the beneficial effects of DNP suggest that chemical uncouplers deserve further investigation for the treatment of obesity and its comorbidities.	[Goldgof, Margalit; Xiao, Cuiying; Reitman, Marc L.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Chanturiya, Tatyana; Jou, William; Gavrilova, Oksana] NIDDK, Mouse Metab Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Reitman, ML (corresponding author), Bldg 10-CRC,Rm 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA.	marc.reitman@nih.gov	Reitman, Marc/B-4448-2013	Reitman, Marc/0000-0002-0426-9475	National Institutes of Health, NIDDK, Intramural Research Program [DK075062, DK075063]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002, ZIADK075062, ZIADK075063] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Intramural Research Program Grants DK075062 and DK075063.	Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIN; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Celi FS, 2010, EUR J ENDOCRINOL, V163, P863, DOI 10.1530/EJE-10-0627; Colman E, 2007, REGUL TOXICOL PHARM, V48, P115, DOI 10.1016/j.yrtph.2007.03.006; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; DAUNCEY MJ, 1981, BRIT J NUTR, V45, P257, DOI 10.1079/BJN19810102; Directorate-Generale for health and consumers, 2010, STRAT EUR NUTR OV OB; Du Bois E. F., 1924, BASAL METABOLISM HLT, P243; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Gavrilova O, 2000, DIABETES, V49, P1910, DOI 10.2337/diabetes.49.11.1910; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; HARVEY DG, 1959, J PHARM PHARMACOL, V11, P462, DOI 10.1111/j.2042-7158.1959.tb12583.x; Herrington LP, 1940, AM J PHYSIOL, V129, P0123, DOI 10.1152/ajplegacy.1940.129.1.123; Horner WD, 1942, ARCH OPHTHALMOL-CHIC, V27, P1097; KAISER J A, 1964, Ther Ggw, V103, P232; Karp CL, 2012, J EXP MED, V209, P1069, DOI 10.1084/jem.20120988; KLEIBER M, 1975, FIRE LIFE, P179; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lodhi IJ, 2009, CELL METAB, V9, P111, DOI 10.1016/j.cmet.2009.01.004; LOOMIS WF, 1948, J BIOL CHEM, V173, P807; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; MAYER J, 1956, AM J CLIN NUTR, V4, P169, DOI 10.1093/ajcn/4.2.169; MAYER J, 1954, AM J PHYSIOL, V177, P544, DOI 10.1152/ajplegacy.1954.177.3.544; MOUNT LE, 1971, J PHYSIOL-LONDON, V217, P315, DOI 10.1113/jphysiol.1971.sp009573; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Ogden CL, 2013, PREVALENCE OBESITY A, V131, P1; Overton JM, 2010, INT J OBESITY, V34, pS53, DOI 10.1038/ijo.2010.240; Perkins R. G., 1919, PUB HLTH REP, V24, P2335, DOI DOI 10.2307/4575357; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Ravussin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085876; Ribeiro MO, 2001, J CLIN INVEST, V108, P97, DOI 10.1172/JCI12584; Rippe C, 2000, AM J PHYSIOL-ENDOC M, V279, pE293, DOI 10.1152/ajpendo.2000.279.2.E293; Schmidt-Nielsen K, 1984, SCALING WHY IS ANIMA, P75; Stanier M. W., 1984, ENERGY BALANCE THERM, P38; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Tainter ML, 1935, J AMER MED ASSOC, V105, P0332, DOI 10.1001/jama.1935.02760310006002; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; US Food and Drug Administration, 2005, GUID IND EST MAX SAF; Wijers SLJ, 2011, J CLIN ENDOCR METAB, V96, pE598, DOI 10.1210/jc.2010-1957	51	83	86	3	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19341	19350		10.1074/jbc.M114.568204	http://dx.doi.org/10.1074/jbc.M114.568204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872412	hybrid, Green Published			2022-12-28	WOS:000339326800011
J	Schanzer, JM; Wartha, K; Croasdale, R; Moser, S; Kunkele, KP; Ries, C; Scheuer, W; Duerr, H; Pompiati, S; Pollman, J; Stracke, J; Lau, W; Ries, S; Brinkmann, U; Klein, C; Umana, P				Schanzer, Juergen M.; Wartha, Katharina; Croasdale, Rebecca; Moser, Samuel; Kuenkele, Klaus-Peter; Ries, Carola; Scheuer, Werner; Duerr, Harald; Pompiati, Sandra; Pollman, Jan; Stracke, Jan; Lau, Wilma; Ries, Stefan; Brinkmann, Ulrich; Klein, Christian; Umana, Pablo			A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LUNG-CANCER; VARIABLE-DOMAIN IMMUNOGLOBULIN; CONSERVED FRAMEWORK REGIONS; ADVANCED SOLID TUMORS; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; RECOMBINANT IMMUNOTOXINS; DISULFIDE BONDS; IGG ANTIBODIES; FREE SURVIVAL	In the present study, we have developed a novel one-arm single chain Fab heterodimeric bispecific IgG (OAscFab-IgG) antibody format targeting the insulin-like growth factor receptor type I (IGF-1R) and the epidermal growth factor receptor (EGFR) with one binding site for each target antigen. The bispecific antibody XGFR is based on the "knob-into-hole" technology for heavy chain heterodimerization with one heavy chain consisting of a single chain Fab to prevent wrong pairing of light chains. XGFR was produced with high expression yields and showed simultaneous binding to IGF-1R and EGFR with high affinity. Due to monovalent binding of XGFR to IGF-1R, IGF-1R internalization was strongly reduced compared with the bivalent parental antibody, leading to enhanced Fc-mediated cellular cytotoxicity. To further increase immune effector functions triggered by XGFR, the Fc portion of the bispecific antibody was glycoengineered, which resulted in strong antibody-dependent cell-mediated cytotoxicity activity. XGFR-mediated inhibition of IGF-1R and EGFR phosphorylation as well as A549 tumor cell proliferation was highly effective and was comparable with a combined treatment with EGFR (GA201) and IGF-1R (R1507) antibodies. XGFR also demonstrated potent anti-tumor efficacy in multiple mouse xenograft tumor models with a complete growth inhibition of AsPC1 human pancreatic tumors and improved survival of SCID beige mice carrying A549 human lung tumors compared with treatment with antibodies targeting either IGF-1R or EGFR. In summary, we have applied rational antibody engineering technology to develop a heterodimeric OAscFab-IgG bispecific antibody, which combines potent signaling inhibition with antibody-dependent cell-mediated cytotoxicity induction and results in superior molecular properties over two established tetravalent bispecific formats.	[Schanzer, Juergen M.; Wartha, Katharina; Croasdale, Rebecca; Ries, Carola; Scheuer, Werner] Roche Diagnost GmbH, Discovery Oncol, Pharmaceut Res & Early Dev, D-82372 Penzberg, Germany; [Duerr, Harald; Pompiati, Sandra; Pollman, Jan; Stracke, Jan; Lau, Wilma; Ries, Stefan; Brinkmann, Ulrich] Roche Diagnost GmbH, Large Mol Res, Pharmaceut Res & Early Dev, D-82372 Penzberg, Germany; [Moser, Samuel; Klein, Christian; Umana, Pablo] Roche Glycart AG, CH-8952 Schlieren, Switzerland; [Kuenkele, Klaus-Peter] Boehringer Ingelheim GmbH & Co KG, A-1121 Vienna, Austria	Roche Holding; Roche Holding; Roche Holding; Boehringer Ingelheim	Schanzer, JM (corresponding author), Roche Diagnost GmbH, Discovery Oncol, Pharmaceut Res & Early Dev, Nonnenwald 2, D-82372 Penzberg, Germany.	juergen_michael.schanzer@roche.com	Brinkmann, Ulrich/AAF-8216-2019; Klein, Christian/G-1336-2010	Brinkmann, Ulrich/0000-0002-5558-0212; Klein, Christian/0000-0001-7594-7280	Bavarian Ministry for Science and Education	Bavarian Ministry for Science and Education	This work was supported in part by a grant from the Bavarian Ministry for Science and Education.	BASELGA J, 1994, BREAST CANCER RES TR, V29, P127, DOI 10.1007/BF00666188; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; Chakravarti A, 2002, CANCER RES, V62, P200; Ciardiello F, 2002, EXPERT OPIN INV DRUG, V11, P755; Croasdale R, 2012, ARCH BIOCHEM BIOPHYS, V526, P206, DOI 10.1016/j.abb.2012.03.016; DiGiammarino EL, 2011, MABS-AUSTIN, V3, P487, DOI 10.4161/mabs.3.5.16326; Dong JY, 2011, J BIOL CHEM, V286, P4703, DOI 10.1074/jbc.M110.184317; Emanuel SL, 2011, MABS-AUSTIN, V3, P38, DOI 10.4161/mabs.3.1.14168; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Gerdes CA, 2013, CLIN CANCER RES, V19, P1126, DOI 10.1158/1078-0432.CCR-12-0989; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; Haluska P, 2008, MOL CANCER THER, V7, P2589, DOI 10.1158/1535-7163.MCT-08-0493; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kontermann RE, 1997, NAT BIOTECHNOL, V15, P629, DOI 10.1038/nbt0797-629; Lee HS, 1999, MOL IMMUNOL, V36, P61, DOI 10.1016/S0161-5890(98)00109-6; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Lu D, 2004, J BIOL CHEM, V279, P2856, DOI 10.1074/jbc.M310132200; Ludovini V, 2009, ANN ONCOL, V20, P842, DOI 10.1093/annonc/mdn727; Michaelson JS, 2009, MABS-AUSTIN, V1, P128, DOI 10.4161/mabs.1.2.7631; Nagorsen D, 2012, PHARMACOL THERAPEUT, V136, P334, DOI 10.1016/j.pharmthera.2012.07.013; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Paz-Ares LG, 2011, J CLIN ONCOL, V29, P3783, DOI 10.1200/JCO.2011.34.8888; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; POLLAK MN, 1987, CANCER LETT, V38, P223, DOI 10.1016/0304-3835(87)90218-7; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; REITER Y, 1994, PROTEIN ENG, V7, P697, DOI 10.1093/protein/7.5.697; REITER Y, 1994, BIOCHEMISTRY-US, V33, P5451, DOI 10.1021/bi00184a014; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rosen LS, 2012, CLIN CANCER RES, V18, P3414, DOI 10.1158/1078-0432.CCR-11-3369; Scartozzi M, 2010, INT J CANCER, V127, P1941, DOI 10.1002/ijc.25193; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Schirrmann T, 2010, MABS-AUSTIN, V2, P73, DOI 10.4161/mabs.2.1.10784; Surati M, 2011, EXPERT OPIN BIOL TH, V11, P1655, DOI 10.1517/14712598.2011.626762; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Ueda S, 2006, CANCER SCI, V97, P597, DOI 10.1111/j.1349-7006.2006.00228.x; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vecchione L, 2011, EXP CELL RES, V317, P2765, DOI 10.1016/j.yexcr.2011.08.021; Weickhardt A, 2012, J THORAC ONCOL, V7, P419, DOI 10.1097/JTO.0b013e31823c5b11; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345	43	44	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18693	18706		10.1074/jbc.M113.528109	http://dx.doi.org/10.1074/jbc.M113.528109			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841203	hybrid, Green Published			2022-12-28	WOS:000339062900008
J	Ishikawa, Y; Bachinger, HP				Ishikawa, Yoshihiro; Baechinger, Hans Peter			A Substrate Preference for the Rough Endoplasmic Reticulum Resident Protein FKBP22 during Collagen Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; CIS-TRANS-ISOMERASE; RECESSIVE OSTEOGENESIS IMPERFECTA; CAUSES HYPERELASTOSIS CUTIS; AMERICAN QUARTER HORSE; SYNDROME TYPE-VI; CYCLOPHILIN-B; TRIPLE-HELIX; BRUCK SYNDROME; FK506-BINDING PROTEIN	The biosynthesis of collagens occurs in the rough endoplasmic reticulum and requires a large numbers of molecular chaperones, foldases, and post-translational modification enzymes. Collagens contain a large number of proline residues that are post-translationally modified to 3-hydroxyproline or 4-hydroxyproline, and the rate-limiting step in formation of the triple helix is the cis-trans isomerization of peptidyl-proline bonds. This step is catalyzed by peptidylprolyl cis-trans isomerases. There are seven peptidyl-prolyl cis-trans isomerases in the rER, and so far, two of these enzymes, cyclophilin B and FKBP65, have been shown to be involved in collagen biosynthesis. The absence of either cyclophilin B or FKBP65 leads to a recessive form of osteogenesis imperfecta. The absence of FKBP22 leads to a kyphoscoliotic type of Ehlers-Danlos syndrome (EDS), and this type of EDS is classified as EDS type VI, which can also be caused by a deficiency in lysyl-hydroxylase 1. However, the lack of FKBP22 shows a wider spectrum of clinical phenotypes than the absence of lysyl-hydroxylase 1 and additionally includes myopathy, hearing loss, and aortic rupture. Here we show that FKBP22 catalyzes the folding of type III collagen and interacts with type III collagen, type VI collagen, and type X collagen, but not with type I collagen, type II collagen, or type V collagen. These restrictive interactions might help explain the broader phenotype observed in patients that lack FKBP22.	[Ishikawa, Yoshihiro; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA	Oregon Health & Science University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospitals for Children [SHC 85500, SHC 85100]	Shriners Hospitals for Children	This work was supported by Grants SHC 85500 and SHC 85100 from Shriners Hospitals for Children (to H. P. B.).	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Barnes AM, 2013, HUM MUTAT, V34, P1279, DOI 10.1002/humu.22362; Barnes AM, 2012, HUM MUTAT, V33, P1589, DOI 10.1002/humu.22139; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Boudko SP, 2014, PROTEIN SCI, V23, P67, DOI 10.1002/pro.2391; Boudko Sergei P, 2012, BMC Res Notes, V5, P626, DOI 10.1186/1756-0500-5-626; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; Budiman C, 2011, PROTEIN SCI, V20, P1755, DOI 10.1002/pro.714; Budiman C, 2011, INT J MOL SCI, V12, P5261, DOI 10.3390/ijms12085261; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; DAVIS JM, 1993, J BIOL CHEM, V268, P25965; Dong H, 2008, J MOL BIOL, V383, P455, DOI 10.1016/j.jmb.2008.08.048; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Feng M, 2011, BIOCHEM BIOPH RES CO, V408, P537, DOI 10.1016/j.bbrc.2011.04.050; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Giunta C, 2005, AM J MED GENET A, V133A, P158, DOI 10.1002/ajmg.a.30529; Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2013, J BIOL CHEM, V288, P31437, DOI 10.1074/jbc.M113.498063; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Jana B, 2012, BIOCHEMISTRY-US, V51, P7930, DOI 10.1021/bi300720g; Kelley BP, 2011, J BONE MINER RES, V26, P666, DOI 10.1002/jbmr.250; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; Mizuno K, 2013, J BIOL CHEM, V288, P19166, DOI 10.1074/jbc.M113.462002; Mizuno K, 2013, CONNECT TISSUE RES, V54, P41, DOI 10.3109/03008207.2012.734876; NATSUME T, 1994, J BIOL CHEM, V269, P31224; NIELSEN JB, 1992, P NATL ACAD SCI USA, V89, P7471, DOI 10.1073/pnas.89.16.7471; Patterson CE, 2000, MOL BIOL CELL, V11, P3925, DOI 10.1091/mbc.11.11.3925; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; Rulten SL, 2006, MAMM GENOME, V17, P322, DOI 10.1007/s00335-005-0127-7; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Setijowati ED, 2012, EUR J MED GENET, V55, P17, DOI 10.1016/j.ejmg.2011.10.002; Shaheen R, 2011, AM J MED GENET A, V155A, P1448, DOI 10.1002/ajmg.a.34025; Shaheen R, 2010, AM J HUM GENET, V87, P306, DOI 10.1016/j.ajhg.2010.05.020; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; Steinlein OK, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-152; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Steinmann B., 2003, CONNECTIVE TISSUE IT, P431; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Tremmel D, 2007, J MOL BIOL, V369, P55, DOI 10.1016/j.jmb.2007.01.092; Tremmel D, 2007, FEBS LETT, V581, P2036, DOI 10.1016/j.febslet.2007.04.042; van de Hoef DL, 2013, DEVELOPMENT, V140, P810, DOI 10.1242/dev.081356; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Venturi G, 2012, BONE, V50, P343, DOI 10.1016/j.bone.2011.10.023; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wagner K, 2000, BIOCHEM J, V352, P907, DOI 10.1042/0264-6021:3520907; Yao QZ, 2005, WORLD J SURG, V29, P276, DOI 10.1007/s00268-004-7812-7; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	67	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18189	18201		10.1074/jbc.M114.561944	http://dx.doi.org/10.1074/jbc.M114.561944			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24821723	Green Published, hybrid			2022-12-28	WOS:000338042000021
J	Tane, S; Kubota, M; Okayama, H; Ikenishi, A; Yoshitome, S; Iwamoto, N; Satoh, Y; Kusakabe, A; Ogawa, S; Kanai, A; Molkentin, JD; Nakamura, K; Ohbayashi, T; Takeuchi, T				Tane, Shoji; Kubota, Misae; Okayama, Hitomi; Ikenishi, Aiko; Yoshitome, Satoshi; Iwamoto, Noriko; Satoh, Yukio; Kusakabe, Aoi; Ogawa, Satoko; Kanai, Ayumi; Molkentin, Jeffery D.; Nakamura, Kazuomi; Ohbayashi, Tetsuya; Takeuchi, Takashi			Repression of Cyclin D1 Expression Is Necessary for the Maintenance of Cell Cycle Exit in Adult Mammalian Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZEBRAFISH HEART REGENERATION; DNA-SYNTHESIS; NUCLEAR-PROTEIN; TRANSGENIC MICE; CDK INHIBITORS; HISTONE H2AX; MOUSE HEART; PROLIFERATION; JUMONJI; KINASE	The hearts of neonatal mice and adult zebrafish can regenerate after injury through proliferation of preexisting cardiomyocytes. However, adult mammals are not capable of cardiac regeneration because almost all cardiomyocytes exit their cell cycle. Exactly how the cell cycle exit is maintained and how many adult cardiomyocytes have the potential to reenter the cell cycle are unknown. The expression and activation levels of main cyclin-cyclin-dependent kinase (CDK) complexes are extremely low or undetectable at adult stages. The nuclear DNA content of almost all cardiomyocytes is 2C, indicating the cell cycle exit from G(1)-phase. Here, we induced expression of cyclin D1, which regulates the progression of G1-phase, only in differentiated cardiomyocytes of adult mice. In these cardiomyocytes, S-phase marker-positive cardiomyocytes and the expression of main cyclins and CDKs increased remarkably, although cyclin B1-CDK1 activation was inhibited in an ATM/ATR-independent manner. The phosphorylation pattern of CDK1 and expression pattern of Cdc25 subtypes suggested that a deficiency in the increase in Cdc25 (a and -b), which is required for M-phase entry, inhibited the cyclin B1-CDK1 activation. Finally, analysis of cell cycle distribution patterns showed that >40% of adult mouse cardiomyocytes reentered the cell cycle by the induction of cyclin D1. The cell cycle of these binucleated cardiomyocytes was arrested before M-phase, and many mononucleated cardiomyocytes entered endoreplication. These data indicate that silencing the cyclin D1 expression is necessary for the maintenance of the cell cycle exit and suggest a mechanism that involves inhibition of M-phase entry.	[Tane, Shoji; Okayama, Hitomi; Ikenishi, Aiko; Yoshitome, Satoshi; Iwamoto, Noriko; Satoh, Yukio; Kanai, Ayumi; Takeuchi, Takashi] Tottori Univ, Fac Med, Sch Life Sci, Yonago, Tottori 6838503, Japan; [Nakamura, Kazuomi; Ohbayashi, Tetsuya] Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, Yonago, Tottori 6838503, Japan; [Kubota, Misae; Kusakabe, Aoi; Ogawa, Satoko; Takeuchi, Takashi] Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; [Molkentin, Jeffery D.] Univ Cincinnati, Howard Hughes Med Inst, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Tottori University; Tottori University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati	Takeuchi, T (corresponding author), Tottori Univ, Fac Med, Sch Life Sci, Yonago, Tottori 6838503, Japan.	takeuchi@med.tottori-u.ac.jp		Molkentin, Jeffery/0000-0002-3558-6529; Tane, Shoji/0000-0002-0209-347X	Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKEN) [19057011, 25113520]; Grants-in-Aid for Scientific Research [24657155] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKEN); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKEN Grants 19057011 and 25113520).	Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; Erokhina E L, 1968, Tsitologiia, V10, P1391; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Heine HL, 2005, METH MOLEC MED, V112, P109; Hogan B, 1994, MANIPULATING MOUSE E; HONDA R, 1993, FEBS LETT, V318, P331, DOI 10.1016/0014-5793(93)80540-B; Ikenishi A, 2012, DEV GROWTH DIFFER, V54, P731, DOI 10.1111/j.1440-169X.2012.01373.x; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Lee G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015561; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Liu QH, 2000, GENE DEV, V14, P1448; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Motoyama J, 1997, MECH DEVELOP, V66, P27, DOI 10.1016/S0925-4773(97)00082-8; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Nakajima K, 2011, DEVELOPMENT, V138, P1771, DOI 10.1242/dev.059295; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tane S, 2014, BIOCHEM BIOPH RES CO, V443, P1105, DOI 10.1016/j.bbrc.2013.12.109; Toyoda M, 2000, BIOCHEM BIOPH RES CO, V274, P332, DOI 10.1006/bbrc.2000.3138; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Ullah Z, 2008, GENE DEV, V22, P3024, DOI 10.1101/gad.1718108; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200	48	31	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18033	18044		10.1074/jbc.M113.541953	http://dx.doi.org/10.1074/jbc.M113.541953			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24821722	hybrid, Green Published			2022-12-28	WOS:000338042000007
J	Wang, ZS; Humphries, B; Xiao, H; Jiang, YG; Yang, CF				Wang, Zhishan; Humphries, Brock; Xiao, Hua; Jiang, Yiguo; Yang, Chengfeng			MicroRNA-200b Suppresses Arsenic-transformed Cell Migration by Targeting Protein Kinase C alpha and Wnt5b-Protein Kinase C alpha Positive Feedback Loop and Inhibiting Rac1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INDUCED MALIGNANT-TRANSFORMATION; MIR-200 FAMILY; RHO GTPASES; REPRESSORS ZEB1; CANCER-CELLS; WNT5A; TUMORIGENESIS; CYTOSKELETON; EXPRESSION	MicroRNA-200b (miR-200b) is a member of miR-200 family that has been found to inhibit cell migration and cancer metastasis; however, the underlying mechanism is not well understood. We previously reported that miR-200 expression is depleted in arsenic-transformed human bronchial epithelial cells with highly migratory and invasive characteristics, whereas stably re-expressing miR-200b strongly suppresses arsenic-transformed cell migration. This study was performed to investigate how miR-200b inhibits arsenic-transformed cell migration. We found that protein kinase C alpha (PKC alpha) is significantly up-regulated in arsenic-transformed cells. Combining bioinformatics analysis with PKC alpha 3'-untranslated region vector luciferase reporter assays, we showed that PKC alpha is a direct target of miR-200b. Inhibiting PKC alpha activity or knocking down PKC alpha expression drastically reduced cell migration, phenocoping the inhibitory effect of overexpressing miR-200b. In contrast, forced expression of PKC alpha in miR-200b overexpressing cells impaired the inhibitory effect of miR-200b on cell migration. In addition, we also found a positive feedback loop between Wnt5b and PKC alpha in arsenic-transformed cells. Knocking down Wnt5b expression reduced phospho-PKC levels and cell migration; and knocking down PKC alpha expression decreased Wnt5b level and cell migration. Moreover, forced expression of PKC alpha increased Wnt5b and phospho-PKC levels and cell migration. Further mechanistic studies revealed that Rac1 is highly activated in arsenic-transformed cells and stably expressing miR-200b abolishes Rac1 activation changing actin cytoskeleton organization. Manipulating PKC alpha or Wnt5b expression levels significantly altered the level of active Rac1. Together, these findings indicate that miR-200b suppresses arsenic-transformed cell migration by targeting PKC alpha and Wnt5b-PKC alpha positive feedback loop and subsequently inhibiting Rac1 activation.	[Wang, Zhishan; Humphries, Brock; Xiao, Hua; Yang, Chengfeng] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Jiang, Yiguo] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou 510182, Guangdong, Peoples R China; [Yang, Chengfeng] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA	Michigan State University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Michigan State University	Yang, CF (corresponding author), Michigan State Univ, Dept Physiol, 2201 Biomed Phys Sci Bldg, E Lansing, MI 48824 USA.	yangcf@msu.edu		Humphries, Brock/0000-0002-6992-3394; Jiang, Yiguo/0000-0002-9499-2594	National Institutes of Health [R01ES017777]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health (Grant R01ES017777, to C. Y.).	Achanzar WE, 2002, JNCI-J NATL CANCER I, V94, P1888, DOI 10.1093/jnci/94.24.1888; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Luna-Ulloa LB, 2011, IUBMB LIFE, V63, P915, DOI 10.1002/iub.559; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Freeley M, 2011, CELL SIGNAL, V23, P753, DOI 10.1016/j.cellsig.2010.10.013; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hill L, 2013, INT J CANCER, V132, P745, DOI 10.1002/ijc.27708; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Howe EN, 2012, J MAMMARY GLAND BIOL, V17, P65, DOI 10.1007/s10911-012-9244-6; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jiang RR, 2013, ARCH TOXICOL, V87, P991, DOI 10.1007/s00204-012-0933-0; Jonsson M, 1998, BRIT J CANCER, V78, P430, DOI 10.1038/bjc.1998.511; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li X, 2014, ONCOGENE, V33, P4077, DOI 10.1038/onc.2013.370; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Medrano EE, 2007, PIGM CELL RES, V20, P258, DOI 10.1111/j.1600-0749.2007.00383.x; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peng F, 2013, BRIT J CANCER, V109, P3092, DOI 10.1038/bjc.2013.655; Ridley AJ, 2001, J CELL SCI, V114, P2713; Saitoh T, 2001, INT J ONCOL, V19, P347; Smith KR, 2001, AM J PHYSIOL-LUNG C, V280, pL442, DOI 10.1152/ajplung.2001.280.3.L442; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Straub AC, 2009, AM J PATHOL, V174, P1949, DOI 10.2353/ajpath.2009.081016; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Urtreger AJ, 2012, IUBMB LIFE, V64, P18, DOI 10.1002/iub.574; Waalkes MP, 2008, CANCER RES, V68, P8278, DOI 10.1158/0008-5472.CAN-08-2099; Wang ZS, 2013, TOXICOL APPL PHARM, V271, P20, DOI 10.1016/j.taap.2013.04.018; Wang ZS, 2012, ENVIRON HEALTH PERSP, V120, P92, DOI 10.1289/ehp.1104061; Wang ZS, 2011, TOXICOL SCI, V121, P110, DOI 10.1093/toxsci/kfr029; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037765; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; Yoshino H, 2013, J HUM GENET, V58, P508, DOI 10.1038/jhg.2013.31; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907; Zhao Y, 2011, CANCER LETT, V313, P54, DOI 10.1016/j.canlet.2011.08.023	49	53	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18373	18386		10.1074/jbc.M114.554246	http://dx.doi.org/10.1074/jbc.M114.554246			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24841200	Green Published, hybrid			2022-12-28	WOS:000338042000036
J	Davaro, F; Forde, SD; Garfield, M; Jiang, ZZ; Halmen, K; Tamburro, ND; Kurt-Jones, E; Fitzgerald, KA; Golenbock, DT; Wang, DH				Davaro, Facundo; Forde, Sorcha D.; Garfield, Mark; Jiang, Zhaozhao; Halmen, Kristen; Tamburro, Nelsy Depaula; Kurt-Jones, Evelyn; Fitzgerald, Katherine A.; Golenbock, Douglas T.; Wang, Donghai			3-Hydroxyl-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitor (Statin)-induced 28-kDa Interleukin-1 beta Interferes with Mature IL-1 beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; AVERAGE CHOLESTEROL LEVELS; SYSTEM AUTOIMMUNE-DISEASE; C-REACTIVE PROTEIN; INFLAMMASOMES GUARDIANS; INFLAMMATORY ARTHRITIS; MEVALONATE PATHWAY; HUMAN MONOCYTES; IN-VITRO; ACTIVATION	Multiple clinical trials have shown that the 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors known as statins have anti-inflammatory effects. However, the underlying molecular mechanism remains unclear. The proinflammatory cytokine interleukin-1 beta (IL-1 beta) is synthesized as a non-active precursor. The 31-kDa pro-IL-1 beta is processed into the 17-kDa active form by caspase-1-activating inflammasomes. Here, we report a novel signaling pathway induced by statins, which leads to processing of pro-IL-1 beta into an intermediate 28-kDa form. This statin-induced IL-1 beta processing is independent of caspase-1-activating inflammasomes. The 28-kDa form of IL-1 beta cannot activate interleukin-1 receptor-1 (IL1R1) to signal inflammatory responses. Instead, it interferes with mature IL-1 beta signaling through IL-1R1 and therefore may dampen inflammatory responses initiated by mature IL-1 beta. These results may provide new clues to explain the anti-inflammatory effects of statins.	[Davaro, Facundo; Forde, Sorcha D.; Jiang, Zhaozhao; Halmen, Kristen; Tamburro, Nelsy Depaula; Kurt-Jones, Evelyn; Fitzgerald, Katherine A.; Golenbock, Douglas T.; Wang, Donghai] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Garfield, Mark] NIAID, NIH, Rockville, MD 20852 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wang, DH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, 364 Plantat St, Worcester, MA 01605 USA.	donghai.wang@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X; Davaro, Facundo/0000-0003-4116-3343	National Institutes of Health [1 R21 AI095871-01]; Arthritis Foundation Innovative Research Grant; Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation Innovative Research Grant; Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R21 AI095871-01 (to D.G. and D.W.) and an Arthritis Foundation Innovative Research Grant (to D.W.). This work was also supported in part by the Division of Intramural Research, NIAID, National Institutes of Health.	Abdin AA, 2012, EUR J PHARMACOL, V676, P34, DOI 10.1016/j.ejphar.2011.11.052; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; Bu DX, 2011, CURR OPIN LIPIDOL, V22, P165, DOI 10.1097/MOL.0b013e3283453e41; Bulcao C, 2007, AM J CARDIOVASC DRUG, V7, P219, DOI 10.2165/00129784-200707030-00007; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HAZUDA DJ, 1991, J BIOL CHEM, V266, P7081; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kalantari P, 2014, CELL REP, V6, P196, DOI 10.1016/j.celrep.2013.12.014; Kandiah N, 2009, J NEUROL SCI, V283, P230, DOI 10.1016/j.jns.2009.02.352; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kiener PA, 2001, INT IMMUNOPHARMACOL, V1, P105, DOI 10.1016/S0162-3109(00)00272-1; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008; Kurt-Jones EA, 2007, INFECT IMMUN, V75, P471, DOI 10.1128/IAI.02039-05; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Liao YH, 2013, J LEUKOCYTE BIOL, V93, P289, DOI 10.1189/jlb.0812409; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Massonnet B, 2009, EUR CYTOKINE NETW, V20, P112, DOI 10.1684/ecn.2009.0162; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Montero MT, 2000, ATHEROSCLEROSIS, V153, P303, DOI 10.1016/S0021-9150(00)00417-2; Rader DJ, 2003, CLIN CARDIOL, V26, P2, DOI 10.1002/clc.4960260103; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stehlik C, 2009, ARTHRITIS RHEUM-US, V60, P3524, DOI 10.1002/art.24961; Swaan PW, 2001, PHARMACEUT RES, V18, P1083, DOI 10.1023/A:1010958406364; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; van de Ree MA, 2003, ATHEROSCLEROSIS, V166, P129, DOI 10.1016/S0021-9150(02)00316-7; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang DH, 2013, J BIOL CHEM, V288, P4594, DOI 10.1074/jbc.M112.443077; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Weber MS, 2006, J NEUROIMMUNOL, V178, P140, DOI 10.1016/j.jneuroim.2006.06.006; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Yuan C, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-108; Zhang X, 2011, J IMMUNOL, V187, P3431, DOI 10.4049/jimmunol.1100580	45	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16214	16222		10.1074/jbc.M114.571505	http://dx.doi.org/10.1074/jbc.M114.571505			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24790079	Green Published, hybrid			2022-12-28	WOS:000337965700026
J	Dittrich-Domergue, F; Joubes, J; Moreau, P; Lessire, R; Stymne, S; Domergue, F				Dittrich-Domergue, Franziska; Joubes, Jerome; Moreau, Patrick; Lessire, Rene; Stymne, Sten; Domergue, Frederic			The Bifunctional Protein TtFARAT from Tetrahymena thermophila Catalyzes the Formation of both Precursors Required to Initiate Ether Lipid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY ACYL-COENZYME; DIHYDROXYACETONE PHOSPHATE ACYLTRANSFERASE; COA REDUCTASE 1; ARABIDOPSIS-THALIANA; SUBSTRATE SPECIFICITIES; WAX BIOSYNTHESIS; IDENTIFICATION; GENE; SYNTHASE; GLYCEROL-3-PHOSPHATE	The biosynthesis of ether lipids and wax esters requires as precursors fatty alcohols, which are synthesized by fatty acyl reductases (FARs). The presence of ether glycerolipids as well as branched wax esters has been reported in several free-living ciliate protozoa. In the genome of Tetrahymena thermophila, the only ORF sharing similarities with FARs is fused to an acyltransferase-like domain, whereas, in most other organisms, FARs are monofunctional proteins of similar size and domain structure. Here, we used heterologous expression in plant and yeast to functionally characterize the activities catalyzed by this protozoan protein. Transient expression in tobacco epidermis of a truncated form fused to the green fluorescence protein followed by confocal microscopy analysis suggested peroxisomal localization. In vivo approaches conducted in yeast indicated that the N-terminal FAR-like domain produced both 16:0 and 18:0 fatty alcohols, whereas the C-terminal acyltransferase-like domain was able to rescue the lethal phenotype of the yeast double mutant gat1 Delta gat2 Delta. Using in vitro approaches, we further demonstrated that this domain is a dihydroxyacetone phosphate acyltransferase that uses preferentially 16:0-coenzyme A as an acyl donor. Finally, coexpression in yeast with the alkyl-dihydroxyacetone phosphate synthase from T. thermophila resulted the detection of various glycerolipids with an ether bond, indicating reconstitution of the ether lipid biosynthetic pathway. Together, these results demonstrate that this FAR-like protein is peroxisomal and bifunctional, providing both substrates required by alkyl-dihydroxyacetone phosphate synthase to initiate ether lipid biosynthesis.	[Dittrich-Domergue, Franziska; Joubes, Jerome; Moreau, Patrick; Lessire, Rene; Domergue, Frederic] Univ Bordeaux, UMR 5200, Lab Biogenese Membranaire, F-33000 Bordeaux, France; [Dittrich-Domergue, Franziska; Joubes, Jerome; Moreau, Patrick; Lessire, Rene; Domergue, Frederic] Ctr Natl Rech Sci, UMR 5200, Lab Biogenese Membranaire, F-33000 Bordeaux, France; [Stymne, Sten] Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Swedish University of Agricultural Sciences	Domergue, F (corresponding author), Univ Bordeaux, CNRS UMR 5200, Lab Biogenese Membranaire, Batiment A3 INRA Bordeaux Aquitaine, F-33140 Villenave Dornon, France.	frederic.domergue@u-bordeaux.fr		Domergue, Frederic/0000-0002-0183-7000; Moreau, Patrick/0000-0001-9318-3464; Joubes, Jerome/0000-0001-5385-450X	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was part of a project entitled "Industrial Crops Producing Added Value Oils for Novel Chemicals," which was supported by a grant from the European Commission Framework 7.	Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Biermann J, 1998, BBA-LIPID LIPID MET, V1393, P137, DOI 10.1016/S0005-2760(98)00071-X; Biermann J, 1999, EUR J BIOCHEM, V261, P492, DOI 10.1046/j.1432-1327.1999.00295.x; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; BURDETT K, 1991, J BIOL CHEM, V266, P12201; Chacon MG, 2013, J BIOL CHEM, V288, P30345, DOI 10.1074/jbc.M113.499715; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; CLARKE MR, 1970, NATURE, V228, P873, DOI 10.1038/228873a0; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; DeVet ECJM, 1997, EUR J BIOCHEM, V247, P511; Domergue F, 2010, PLANT PHYSIOL, V153, P1539, DOI 10.1104/pp.110.158238; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; GHISLAIN M, 1994, PLANT MOL BIOL, V24, P835, DOI 10.1007/BF00014439; Honsho M, 2013, J BIOL CHEM, V288, P34588, DOI 10.1074/jbc.M113.498345; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0; JONES CL, 1980, J BIOL CHEM, V255, P8289; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Magnusson CD, 2011, CHEM PHYS LIPIDS, V164, P315, DOI 10.1016/j.chemphyslip.2011.04.010; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; POLLARD MR, 1979, LIPIDS, V14, P651, DOI 10.1007/BF02533451; Razeto A, 2007, STRUCTURE, V15, P683, DOI 10.1016/j.str.2007.04.009; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Rowland O, 2012, PLANT SCI, V193, P28, DOI 10.1016/j.plantsci.2012.05.002; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Salibian A, 2009, BRAZ J BIOL, V69, P437, DOI 10.1590/S1519-69842009000200029; Salim HMW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-279; Tcherkez G, 2013, PLANT CELL ENVIRON, V36, P1586, DOI 10.1111/pce.12066; Thai TP, 1997, FEBS LETT, V420, P205, DOI 10.1016/S0014-5793(97)01495-6; THOMPSON GA, 1977, BIOCHIM BIOPHYS ACTA, V472, P55, DOI 10.1016/0304-4157(77)90014-4; THOMPSON GA, 1967, BIOCHEMISTRY-US, V6, P2015, DOI 10.1021/bi00859a020; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; van Grunsven EG, 1998, P NATL ACAD SCI USA, V95, P2128, DOI 10.1073/pnas.95.5.2128; Wheeler M. A., 1795, LIPIDS, V10, P260; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zufferey R, 2006, J BIOL CHEM, V281, P7952, DOI 10.1074/jbc.M512911200	43	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21984	21994		10.1074/jbc.M114.579318	http://dx.doi.org/10.1074/jbc.M114.579318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24917677	Green Published, hybrid			2022-12-28	WOS:000340593500015
J	Seidel, A; Parker, H; Turner, R; Dickerhof, N; Khalilova, IS; Wilbanks, SM; Kettle, AJ; Jameson, GNL				Seidel, Antonia; Parker, Heather; Turner, Rufus; Dickerhof, Nina; Khalilova, Irada S.; Wilbanks, Sigurd M.; Kettle, Anthony J.; Jameson, Guy N. L.			Uric Acid and Thiocyanate as Competing Substrates of Lactoperoxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEADY-STATE KINETICS; HUMAN-BLOOD PLASMA; CATALYZED OXIDATION; HYDROGEN-PEROXIDE; CYTOCHROME-C; COMPOUND-II; MAMMALIAN PEROXIDASES; LIPID-PEROXIDATION; CYSTIC-FIBROSIS; HOST-DEFENSE	The physiological function of urate is poorly understood. It may act as a danger signal, an antioxidant, or a substrate for heme peroxidases. Whether it reacts sufficiently rapidly with lactoperoxidase (LPO) to act as a physiological substrate remains unknown. LPO is a mammalian peroxidase that plays a key role in the innate immune defense by oxidizing thiocyanate to the bactericidal and fungicidal agent hypothiocyanite. We now demonstrate that urate is a good substrate for bovine LPO. Urate was oxidized by LPO to produce the electrophilic intermediates dehydrourate and 5-hydroxyisourate, which decayed to allantoin. In the presence of superoxide, high yields of hydroperoxides were formed by LPO and urate. Using stopped-flow spectroscopy, we determined rate constants for the reaction of urate with compound I (k(1) = 1.1 x 10(7) M-1 s(-1)) and compound II (k(2) = 8.5 x 10(3) M-1 s(-1)). During urate oxidation, LPO was diverted from its peroxidase cycle because hydrogen peroxide reacted with compound II to give compound III. At physiologically relevant concentrations, urate competed effectively with thiocyanate, the main substrate of LPO for oxidation, and inhibited production of hypothiocyanite. Similarly, hypothiocyanite-dependent killing of Pseudomonas aeruginosa was inhibited by urate. Allantoin was present in human saliva and associated with the concentration of LPO. When hydrogen peroxide was added to saliva, oxidation of urate was dependent on its concentration and peroxidase activity. Our findings establish urate as a likely physiological substrate for LPO that will influence host defense and give rise to reactive electrophilic metabolites.	[Seidel, Antonia; Jameson, Guy N. L.] Univ Otago, Dept Chem, Dunedin 9054, New Zealand; [Parker, Heather; Turner, Rufus; Dickerhof, Nina; Khalilova, Irada S.; Kettle, Anthony J.] Univ Otago, Ctr Free Rad Res, Dept Pathol, Christchurch 8140, New Zealand; [Wilbanks, Sigurd M.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	University of Otago; University of Otago; University of Otago	Jameson, GNL (corresponding author), Univ Otago, Dept Chem, POB 56, Dunedin 9054, New Zealand.	gjameson@chemistry.otago.ac.nz	Khalilova, Irada/I-5103-2015; Jameson, Guy N. L./J-3258-2015; Khalilova, Irada/AGF-0824-2022	Khalilova, Irada/0000-0002-4238-3113; Jameson, Guy N. L./0000-0001-9416-699X; Dickerhof, Nina/0000-0003-2269-4595; Kettle, Tony/0000-0002-8218-7766; Wilbanks, Sigurd/0000-0001-7565-8913	University of Otago; Health Research Council of New Zealand; University of Otago International Doctoral Scholarship	University of Otago; Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago International Doctoral Scholarship	This work was supported by grants from the University of Otago and the Health Research Council of New Zealand.; Funded by a University of Otago International Doctoral Scholarship.	Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BEERS RF, 1952, J BIOL CHEM, V195, P133; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; CANELLAKIS ES, 1955, J BIOL CHEM, V213, P397; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Conner GE, 2007, FEBS LETT, V581, P271, DOI 10.1016/j.febslet.2006.12.025; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Fridovich I., 1985, HDB METHODS OXYGEN R, P51; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2005, J INORG BIOCHEM, V99, P1220, DOI 10.1016/j.jinorgbio.2005.02.021; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Ghibaudi E, 2003, J INORG BIOCHEM, V94, P146, DOI 10.1016/S0162-0134(02)00594-9; Goodarzynejad H, 2010, LABMEDICINE, V41, P40, DOI 10.1309/LMKDB9PBKZGUS20T; Harwood DT, 2009, J CHROMATOGR B, V877, P3393, DOI 10.1016/j.jchromb.2009.04.018; Horsley A, 2011, J ROY SOC MED, V104, pS36, DOI 10.1258/jrsm.2011.s11106; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Jantschko W, 2005, ARCH BIOCHEM BIOPHYS, V434, P51, DOI 10.1016/j.abb.2004.10.014; Jantschko W, 2002, ARCH BIOCHEM BIOPHYS, V398, P12, DOI 10.1006/abbi.2001.2674; Johnson RJ, 2004, NEW ENGL J MED, V350, P1071, DOI 10.1056/NEJMp048015; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; KETTLE AJ, 1994, J BIOL CHEM, V269, P17146; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; KLAND MJ, 1957, J AM CHEM SOC, V79, P6187, DOI 10.1021/ja01580a022; Krishnan E, 2011, CURR OPIN RHEUMATOL, V23, P174, DOI 10.1097/BOR.0b013e3283432dd3; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Lardinois OM, 1999, J BIOL CHEM, V274, P35441, DOI 10.1074/jbc.274.50.35441; Lehto S, 1998, STROKE, V29, P635, DOI 10.1161/01.STR.29.3.635; Lorentzen D, 2011, FREE RADICAL BIO MED, V50, P1144, DOI 10.1016/j.freeradbiomed.2011.02.013; Lovstad RA, 2004, BIOMETALS, V17, P631, DOI 10.1007/s10534-004-1228-6; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MARQUEZ LA, 1990, J BIOL CHEM, V265, P5666; Marquez LA, 1997, BIOCHEMISTRY-US, V36, P9349, DOI 10.1021/bi970595j; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Merriman TR, 2011, JOINT BONE SPINE, V78, P35, DOI 10.1016/j.jbspin.2010.02.027; METODIEWA D, 1990, BIOCHEM BIOPH RES CO, V169, P1211, DOI 10.1016/0006-291X(90)92025-U; Monzani E, 1997, BIOCHEMISTRY-US, V36, P1918, DOI 10.1021/bi961868y; Nagy P, 2006, BIOCHEMISTRY-US, V45, P12610, DOI 10.1021/bi061015y; NIRMALA J, 1975, INDIAN J BIOCHEM BIO, V12, P47; ODAJIMA T, 1970, BIOCHIM BIOPHYS ACTA, V206, P71, DOI 10.1016/0005-2744(70)90083-5; OGINO N, 1979, BIOCHEM BIOPH RES CO, V87, P184, DOI 10.1016/0006-291X(79)91664-4; Paul K. G., 1985, Immunology Series, V27, P15; PEDEN DB, 1990, P NATL ACAD SCI USA, V87, P7638, DOI 10.1073/pnas.87.19.7638; PRUITT KM, 1988, BIOCHEMISTRY-US, V27, P240, DOI 10.1021/bi00401a036; Queiroz RF, 2011, BIOCHEM J, V439, P423, DOI 10.1042/BJ20110555; Schmid R., 1982, NONFORMAL KINETICS, P32; Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108; Shi Y, 2010, J CLIN INVEST, V120, P1809, DOI 10.1172/JCI43132; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Stevenson WS, 2010, P NATL ACAD SCI USA, V107, P16625, DOI 10.1073/pnas.1010390107; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; THOMAS EL, 1994, J DENT RES, V73, P544, DOI 10.1177/00220345940730021001; Turner R, 2012, J CHROMATOGR B, V891, P85, DOI 10.1016/j.jchromb.2012.02.009; Tuynman A, 1998, EUR J BIOCHEM, V258, P906, DOI 10.1046/j.1432-1327.1998.2580906.x; UOTILA J, 1992, CLIN EXP HYPERTENS B, V11, P71, DOI 10.3109/10641959209031034; van Dalen CJ, 2001, BIOCHEM J, V358, P233, DOI 10.1042/0264-6021:3580233; van der Vliet A, 1999, AM J PHYSIOL-LUNG C, V276, pL289, DOI 10.1152/ajplung.1999.276.2.L289; vanDalen CJ, 1997, BIOCHEM J, V327, P487; VILJA P, 1991, J IMMUNOL METHODS, V141, P277, DOI 10.1016/0022-1759(91)90154-8; VOLK KJ, 1990, J PHARMACEUT BIOMED, V8, P205, DOI 10.1016/0731-7085(90)80028-N; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182	70	19	19	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21937	21949		10.1074/jbc.M113.544957	http://dx.doi.org/10.1074/jbc.M113.544957			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24928513	Green Published, hybrid			2022-12-28	WOS:000340593500011
J	Chung, L; Bailey, D; Leen, EN; Emmott, EP; Chaudhry, Y; Roberts, LO; Curry, S; Locker, N; Goodfellow, IG				Chung, Liliane; Bailey, Dalan; Leen, Eoin N.; Emmott, Edward P.; Chaudhry, Yasmin; Roberts, Lisa O.; Curry, Stephen; Locker, Nicolas; Goodfellow, Ian G.			Norovirus Translation Requires an Interaction between the C Terminus of the Genome-linked Viral Protein VPg and Eukaryotic Translation Initiation Factor 4G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE NOROVIRUS; EIF4E PHOSPHORYLATION; INFECTED-CELLS; BINDS; VIRUS; CALICIVIRUS; PURIFICATION; RECRUITMENT; EXPRESSION; RECOVERY	Viruses have evolved a variety of mechanisms to usurp the host cell translation machinery to enable translation of the viral genome in the presence of high levels of cellular mRNAs. Noroviruses, a major cause of gastroenteritis in man, have evolved a mechanism that relies on the interaction of translation initiation factors with the virus-encoded VPg protein covalently linked to the 5' end of the viral RNA. To further characterize this novel mechanism of translation initiation, we have used proteomics to identify the components of the norovirus translation initiation factor complex. This approach revealed that VPg binds directly to the eIF4F complex, with a high affinity interaction occurring between VPg and eIF4G. Mutational analyses indicated that the C-terminal region of VPg is important for the VPg-eIF4G interaction; viruses with mutations that alter or disrupt this interaction are debilitated or non-viable. Our results shed new light on unusual mechanisms of protein-directed translation	[Chung, Liliane; Bailey, Dalan; Chaudhry, Yasmin; Goodfellow, Ian G.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, London W2 1PG, England; [Bailey, Dalan] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Leen, Eoin N.; Curry, Stephen] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Emmott, Edward P.; Chaudhry, Yasmin; Goodfellow, Ian G.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge CB2 2QQ, England; [Roberts, Lisa O.; Locker, Nicolas] Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Guildford GU2 7HX, Surrey, England	Imperial College London; University of Birmingham; Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Surrey	Goodfellow, IG (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Hills Rd, Cambridge CB2 2QQ, England.	ig299@cam.ac.uk		Curry, Stephen/0000-0002-0552-8870; Goodfellow, Ian/0000-0002-9483-510X; Emmott, Edward/0000-0002-3239-8178; Bailey, Dalan/0000-0002-5640-2266; Leen, Eoin/0000-0002-1845-5949; Locker, Nicolas/0000-0002-0053-2897	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I012303/1]; Wellcome Trust [WT097997MA]; BBSRC [BB/I01232X/1];  [BB/J001708/1]; Biotechnology and Biological Sciences Research Council [BB/I01232X/1, BB/I012303/1, BB/J001708/1] Funding Source: researchfish; BBSRC [BB/J001708/1, BB/I012303/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/I012303/1) and the Wellcome Trust (WT097997MA) (to I. G.) funding from the BBSRC (BB/I01232X/1; to L. R. and N. L.) as well as BB/J001708/1 (to S. C.).	Arias A, 2012, JOVE-J VIS EXP, DOI 10.3791/4145; Bailey D, 2012, JOVE-J VIS EXP, DOI 10.3791/3643; Bartolini L, 2011, NEUROPEDIATRICS, V42, P167, DOI 10.1055/s-0031-1286349; Caddy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081596; Chan CMV, 2011, J PAEDIATR CHILD H, V47, P373, DOI 10.1111/j.1440-1754.2010.01986.x; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Coldwell MJ, 2006, MOL CELL BIOL, V26, P8448, DOI 10.1128/MCB.01248-06; Daughenbaugh KF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-33; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; Dobrikov M, 2011, MOL CELL BIOL, V31, P2947, DOI 10.1128/MCB.05589-11; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Jiang J, 2011, CURR OPIN VIROL, V1, P347, DOI 10.1016/j.coviro.2011.09.010; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; Leen EN, 2013, J VIROL, V87, P5318, DOI 10.1128/JVI.03151-12; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Liu BL, 1999, J VIROL, V73, P819, DOI 10.1128/JVI.73.1.819-825.1999; Locker N, 2006, RNA, V12, P683, DOI 10.1261/rna.2227906; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Pinto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032739; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Reineke LC, 2011, CURR OPIN VIROL, V1, P363, DOI 10.1016/j.coviro.2011.10.009; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Stuart RL, 2010, PEDIATR INFECT DIS J, V29, P644, DOI 10.1097/INF.0b013e3181d824e1; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Turcios-Ruiz RM, 2008, J PEDIATR-US, V153, P339, DOI 10.1016/j.jpeds.2008.04.015; Vashist S, 2012, J VIROL, V86, P11977, DOI 10.1128/JVI.00432-12; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wolf S, 2009, VET MICROBIOL, V133, P184, DOI 10.1016/j.vetmic.2008.06.019; Yunus MA, 2010, J VIROL METHODS, V169, P112, DOI 10.1016/j.jviromet.2010.07.006	49	33	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21738	21750		10.1074/jbc.M114.550657	http://dx.doi.org/10.1074/jbc.M114.550657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24928504	Green Published, hybrid			2022-12-28	WOS:000340558300047
J	Luth, ES; Stavrovskaya, IG; Bartels, T; Kristal, BS; Selkoe, DJ				Luth, Eric S.; Stavrovskaya, Irina G.; Bartels, Tim; Kristal, Bruce S.; Selkoe, Dennis J.			Soluble, Prefibrillar alpha-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; SUBSTANTIA-NIGRA-NEURONS; PARKINSONS-DISEASE; RESPIRATORY-CHAIN; DOPAMINERGIC-NEURONS; VESICLE PERMEABILIZATION; CALCIUM HOMEOSTASIS; OXIDATIVE STRESS; TRANSGENIC MICE; OXIDANT STRESS	alpha-Synuclein (alpha Syn) aggregation and mitochondrial dysfunction both contribute to the pathogenesis of Parkinson disease (PD). Although recent studies have suggested that mitochondrial association of alpha Syn may disrupt mitochondrial function, it is unclear what aggregation state of alpha Syn is most damaging to mitochondria and what conditions promote or inhibit the effect of toxic alpha Syn species. Because the neuronal populations most vulnerable in PD are characterized by large cytosolic Ca2+ oscillations that burden mitochondria, we examined mitochondrial Ca2+ stress in an in vitro system comprising isolated mitochondria and purified recombinant human alpha Syn in various aggregation states. Using fluorimetry to simultaneously measure four mitochondrial parameters, we observed that soluble, prefibrillar alpha Syn oligomers, but not monomeric or fibrillar alpha Syn, decreased the retention time of exogenously added Ca2+, promoted Ca2+-induced mitochondrial swelling and depolarization, and accelerated cytochrome c release. Inhibition of the permeability transition pore rescued these alpha Syn-induced changes in mitochondrial parameters. Interestingly, the mitotoxic effects of alpha Syn were specifically dependent upon both electron flow through complex I and mitochondrial uptake of exogenous Ca2+. Our results suggest that soluble prefibrillar alpha Syn oligomers recapitulate several mitochondrial phenotypes previously observed in animal and cell models of PD: complex I dysfunction, altered membrane potential, disrupted Ca2+ homeostasis, and enhanced cytochrome c release. These data reveal how the association of oligomeric alpha Syn with mitochondria can be detrimental to the function of cells with high Ca2+-handling requirements.	[Luth, Eric S.; Bartels, Tim; Selkoe, Dennis J.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Stavrovskaya, Irina G.; Kristal, Bruce S.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Inst Med, Ctr Neurol Dis, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu	Bartels, Tim/AAD-6128-2021	Bartels, Tim/0000-0002-4071-5612	Fidelity Biosciences Research Initiative; Parkinson's Disease Foundation Grant [PDF-IRG-1204]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083845] Funding Source: NIH RePORTER	Fidelity Biosciences Research Initiative; Parkinson's Disease Foundation Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Fidelity Biosciences Research Initiative (to D. J. S.) and Parkinson's Disease Foundation Grant PDF-IRG-1204 (to T. B.).	Baranov SV, 2008, J BIOL CHEM, V283, P665, DOI 10.1074/jbc.M703484200; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Buttner S, 2013, EMBO J, V32, P3041, DOI 10.1038/emboj.2013.228; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Camilleri A, 2013, BBA-BIOMEMBRANES, V1828, P2532, DOI 10.1016/j.bbamem.2013.06.026; CHANCE B, 1955, J BIOL CHEM, V217, P429; CHANCE B, 1971, BIOCHEM J, V122, P225, DOI 10.1042/bj1220225; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Foehring RC, 2009, J NEUROPHYSIOL, V102, P2326, DOI 10.1152/jn.00038.2009; FRY M, 1981, J BIOL CHEM, V256, P1874; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Goldberg JA, 2012, NAT NEUROSCI, V15, P1414, DOI 10.1038/nn.3209; Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7; Kara E, 2013, NEUROSCI LETT, V546, P67, DOI 10.1016/j.neulet.2013.04.058; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kim Han-Joon, 2013, Exp Neurobiol, V22, P77, DOI 10.5607/en.2013.22.2.77; Kristal BS, 2001, FREE RADICAL BIO MED, V30, P924, DOI 10.1016/S0891-5849(01)00484-1; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; Kristal BS, 1997, J NEUROCHEM, V69, P524; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Lemasters JJ, 1998, BIOFACTORS, V8, P283, DOI 10.1002/biof.5520080316; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nasstrom T, 2011, FREE RADICAL BIO MED, V50, P428, DOI 10.1016/j.freeradbiomed.2010.11.027; Natalello A, 2011, PROTEINS, V79, P611, DOI 10.1002/prot.22909; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675; Rhinn H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2032; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Scorrano L, 1999, J BIOL CHEM, V274, P22581, DOI 10.1074/jbc.274.32.22581; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Starkov AA, 2010, METHODS MOL BIOL, V648, P245, DOI 10.1007/978-1-60761-756-3_16; Stavrovskaya IG, 2010, FREE RADICAL BIO MED, V49, P567, DOI 10.1016/j.freeradbiomed.2010.04.037; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Surmeier DJ, 2013, J BIOL CHEM, V288, P10736, DOI 10.1074/jbc.R112.410530; Telford JE, 2009, J BIOL CHEM, V284, P9109, DOI 10.1074/jbc.M809101200; Thomas B, 2012, ANTIOXID REDOX SIGN, V16, P855, DOI 10.1089/ars.2010.3849; Tompkins MM, 1997, BRAIN RES, V775, P24, DOI 10.1016/S0006-8993(97)00874-3; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	82	179	185	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21490	21507		10.1074/jbc.M113.545749	http://dx.doi.org/10.1074/jbc.M113.545749			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942732	Green Published, hybrid			2022-12-28	WOS:000340558300026
J	Gupta, K; Brady, T; Dyer, BM; Malani, N; Hwang, Y; Male, F; Nolte, RT; Wang, LP; Velthuisen, E; Jeffrey, J; Van Duyne, GD; Bushman, FD				Gupta, Kushol; Brady, Troy; Dyer, Benjamin M.; Malani, Nirav; Hwang, Young; Male, Frances; Nolte, Robert T.; Wang, Liping; Velthuisen, Emile; Jeffrey, Jerry; Van Duyne, Gregory D.; Bushman, Frederic D.			Allosteric Inhibition of Human Immunodeficiency Virus Integrase LATE BLOCK DURING VIRAL REPLICATION AND ABNORMAL MULTIMERIZATION INVOLVING SPECIFIC PROTEIN DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; HIV-1 INTEGRASE; DNA INTEGRATION; STRAND TRANSFER; IN-VITRO; SITE PREFERENCES; TYPE-1 INTEGRASE; TERMINAL DOMAINS; BINDING-SITE; HUMAN-CELLS	HIV-1 replication in the presence of antiviral agents results in evolution of drug-resistant variants, motivating the search for additional drug classes. Here we report studies of GSK1264, which was identified as a compound that disrupts the interaction between HIV-1 integrase (IN) and the cellular factor lens epithelium-derived growth factor (LEDGF)/p75. GSK1264 displayed potent antiviral activity and was found to bind at the site occupied by LEDGF/p75 on IN by x-ray crystallography. Assays of HIV replication in the presence of GSK1264 showed only modest inhibition of the early infection steps and little effect on integration targeting, which is guided by the LEDGF/p75.IN interaction. In contrast, inhibition of late replication steps was more potent. Particle production was normal, but particles showed reduced infectivity. GSK1264 promoted aggregation of IN and preformed LEDGF/p75.IN complexes, suggesting a mechanism of inhibition. LEDGF/p75 was not displaced from IN during aggregation, indicating trapping of LEDGF/p75 in aggregates. Aggregation assays with truncated IN variants revealed that a construct with catalytic and C-terminal domains of IN only formed an open polymer associated with efficient drug-induced aggregation. These data suggest that the allosteric inhibitors of IN are promising antiviral agents and provide new information on their mechanism of action.	[Brady, Troy; Dyer, Benjamin M.; Malani, Nirav; Hwang, Young; Male, Frances; Bushman, Frederic D.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Gupta, Kushol; Van Duyne, Gregory D.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Nolte, Robert T.; Wang, Liping] GlaxoSmithKline, Chem Sci, Res Triangle Pk, NC 27709 USA; [Velthuisen, Emile; Jeffrey, Jerry] GlaxoSmithKline, Infect Dis Therapy Area Unit, HIV DPU, Res Triangle Pk, NC 27709 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; GlaxoSmithKline; GlaxoSmithKline	Jeffrey, J (corresponding author), GlaxoSmithKline, Infect Dis Therapy Area Unit, HIV DPU, Res Triangle Pk, NC 27709 USA.	jerry.l.jeffrey@gsk.com; vanduyne@mail.med.upenn.edu; bushman@mail.med.upenn.edu	Gupta, Kushol/GOE-5620-2022	Gupta, Kushol/0000-0002-7006-2667	National Institutes of Health [R01 AI 052845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, R01AI052845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI 052845 ( to F. D. B.). GlaxoSmithKline owns the patent on the compound used in this study.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Bischerour J, 2003, J VIROL, V77, P135, DOI 10.1128/JVI.77.1.135-141.2003; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2013, VIROLOGY, V435, P102, DOI 10.1016/j.virol.2012.09.033; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ciuffi A, 2006, HUM GENE THER, V17, P960, DOI 10.1089/hum.2006.17.960; Ciuffi A, 2009, METHODS, V47, P261, DOI 10.1016/j.ymeth.2008.10.028; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; Demeulemeester J, 2012, J BIOMOL SCREEN, V17, P618, DOI 10.1177/1087057111436343; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A, 2013, CURR OPIN CHEM BIOL, V17, P339, DOI 10.1016/j.cbpa.2013.04.010; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Fenwick CW, 2011, ANTIVIR THER, V16, pA9; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Gupta K, 2010, J BIOL CHEM, V285, P20303, DOI 10.1074/jbc.M110.114413; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Hou Y, 2008, J BIOMOL SCREEN, V13, P406, DOI 10.1177/1087057108317060; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Lipfert J, 2007, J PHYS CHEM B, V111, P12427, DOI 10.1021/jp073016l; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; Peat TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040147; Petit C, 1999, J VIROL, V73, P5079, DOI 10.1128/JVI.73.6.5079-5088.1999; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Silvers RM, 2010, HUM GENE THER, V21, P337, DOI 10.1089/hum.2009.134; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tintori C, 2012, BIOORG MED CHEM LETT, V22, P3109, DOI 10.1016/j.bmcl.2012.03.064; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Urbani A, 2005, ANAL BIOCHEM, V336, P117, DOI 10.1016/j.ab.2004.09.040; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Yin ZQ, 2012, PROTEIN SCI, V21, P1849, DOI 10.1002/pro.2166; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	70	56	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20477	20488		10.1074/jbc.M114.551119	http://dx.doi.org/10.1074/jbc.M114.551119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24904063	Green Published, hybrid			2022-12-28	WOS:000339396600007
J	Barone, A; Saljo, K; Benktander, J; Blomqvist, M; Mansson, JE; Johansson, BR; Molne, J; Aspegren, A; Bjorquist, P; Breimer, ME; Teneberg, S				Barone, Angela; Saljo, Karin; Benktander, John; Blomqvist, Maria; Mansson, Jan-Eric; Johansson, Bengt R.; Molne, Johan; Aspegren, Anders; Bjorquist, Petter; Breimer, Michael E.; Teneberg, Susann			Sialyl-lactotetra, a Novel Cell Surface Marker of Undifferentiated Human Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TERATOCARCINOMA CELLS; MONOCLONAL-ANTIBODY; STRUCTURAL-CHARACTERIZATION; SERIES GANGLIOSIDES; BRAIN GANGLIOSIDES; MASS-SPECTROMETRY; DIFFERENTIATION; GLYCOSPHINGOLIPIDS; GLYCOLIPIDS; ANTIGEN	Cell surface glycoconjugates are used as markers for undifferentiated pluripotent stem cells. Here, antibody binding and mass spectrometry characterization of acid glycosphingolipids isolated from a large number (1 x 10(9) cells) of human embryonic stem cell (hESC) lines allowed identification of several novel acid glycosphingolipids, like the gangliosides sialyl-lactotetraosylceramide and sialyl-globotetraosylceramide, and the sulfated glycosphingolipids sulfatide, sulf-lactosylceramide, and sulf-globopentaosylceramide. A high cell surface expression of sialyl-lactotetra on hESC and human induced pluripotent stem cells (hiPSC) was demonstrated by flow cytometry, immunohistochemistry, and electron microscopy, whereas sulfated glycosphingolipids were only found in intracellular compartments. Immunohistochemistry showed distinct cell surface anti-sialyl-lactotetra staining on all seven hESC lines and three hiPSC lines analyzed, whereas no staining of hESC-derived hepatocyte-like or cardiomyocyte-like cells was obtained. Upon differentiation of hiPSC into hepatocyte-like cells, the sialyl-lactotetra epitope was rapidly down-regulated and not detectable after 14 days. These findings identify sialyl-lactotetra as a promising marker of undifferentiated human pluripotent stem cells.	[Barone, Angela; Saljo, Karin; Breimer, Michael E.] Inst Clin Sci, Dept Surg, S-41345 Gothenburg, Sweden; [Benktander, John; Johansson, Bengt R.; Teneberg, Susann] Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden; [Blomqvist, Maria; Mansson, Jan-Eric] Inst Biomed, Dept Clin Chem & Transfus Med, S-41345 Gothenburg, Sweden; [Molne, Johan] Inst Biomed, Dept Pathol, S-41345 Gothenburg, Sweden; [Aspegren, Anders; Bjorquist, Petter] Cellartis AB, Cellectis Stem Cells, S-41346 Gothenburg, Sweden	Takara Bio Inc.; Cellartis	Breimer, ME (corresponding author), Sahlgrens Univ Hosp, Dept Surg, Inst Clin Sci, SE-41345 Gothenburg, Sweden.	michael.breimer@clinchem.gu.se; Susann.Teneberg@medkem.gu.se		Molne, Johan/0000-0001-6241-7117; Saljo, Karin/0000-0002-2839-9362	Swedish Research Council Grant [12628]; Swedish Cancer Foundation; Swedish Research Council [342-2004-4434]	Swedish Research Council Grant(Swedish Research Council); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grant 12628, the Swedish Cancer Foundation, and governmental grants to the Sahlgrenska University Hospital. The LTQ linear quadrupole ion trap mass spectrometer was obtained by Grant 342-2004-4434 from the Swedish Research Council (to G. H.).	Andrews PD, 2010, BIOCHEM J, V432, P21, DOI 10.1042/BJ20101022; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; Barone A, 2013, J BIOL CHEM, V288, P10035, DOI 10.1074/jbc.M112.436162; DICK JE, 1994, RES IMMUNOL, V145, P380, DOI 10.1016/S0923-2494(94)80203-3; FREDMAN P, 1988, J NEUROCHEM, V50, P912, DOI 10.1111/j.1471-4159.1988.tb02999.x; FREDMAN P, 1988, BIOCHEM J, V251, P17, DOI 10.1042/bj2510017; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; FUKUDA MN, 1986, J BIOL CHEM, V261, P5145; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P536, DOI 10.1016/j.jasms.2003.12.007; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Ito E, 2012, NEUROCHEM RES, V37, P1315, DOI 10.1007/s11064-012-0735-z; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KUNDU SK, 1984, BIOCHEM BIOPH RES CO, V118, P82; LEVERY SB, 1994, ARCH BIOCHEM BIOPHYS, V312, P125, DOI 10.1006/abbi.1994.1290; Liang YJ, 2011, STEM CELLS, V29, P1995, DOI 10.1002/stem.750; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Molne J, 2008, TRANSPLANTATION, V86, P1407, DOI 10.1097/TP.0b013e31818a6805; Natunen S, 2011, GLYCOBIOLOGY, V21, P1125, DOI 10.1093/glycob/cwq209; NILSSON O, 1985, FEBS LETT, V182, P398, DOI 10.1016/0014-5793(85)80341-0; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Nystedt J, 2010, STEM CELLS, V28, P258, DOI 10.1002/stem.250; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; PRIETO PA, 1986, ARCH BIOCHEM BIOPHYS, V249, P243, DOI 10.1016/0003-9861(86)90580-1; Ramirez JM, 2011, STEM CELLS, V29, P1469, DOI 10.1002/stem.681; RIVKIN MJ, 1995, ANN NEUROL, V38, P92, DOI 10.1002/ana.410380116; SCHWARTING GA, 1983, BIOCHEM BIOPH RES CO, V112, P935, DOI 10.1016/0006-291X(83)91707-2; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; SVENNERHOLM L, 1989, BIOCHIM BIOPHYS ACTA, V1005, P109, DOI 10.1016/0005-2760(89)90175-6; SVENNERHOLM L, 1991, J NEUROCHEM, V56, P1763, DOI 10.1111/j.1471-4159.1991.tb02078.x; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Ulvestad M, 2013, BIOCHEM PHARMACOL, V86, P691, DOI 10.1016/j.bcp.2013.06.029; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; WIKSTRAND CJ, 1991, J NEUROPATH EXP NEUR, V50, P756, DOI 10.1097/00005072-199111000-00007; Wright AJ, 2009, STEM CELL RES, V3, P3, DOI 10.1016/j.scr.2009.04.001	40	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18846	18859		10.1074/jbc.M114.568832	http://dx.doi.org/10.1074/jbc.M114.568832			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841197	hybrid, Green Published			2022-12-28	WOS:000339062900019
J	Brazin, KN; Mallis, RJ; Li, C; Keskin, DB; Arthanari, H; Gao, YW; Wu, SL; Karger, BL; Wagner, G; Reinherz, EL				Brazin, Kristine N.; Mallis, Robert J.; Li, Chen; Keskin, Derin B.; Arthanari, Haribabu; Gao, Yuanwei; Wu, Shiaw-Lin; Karger, Barry L.; Wagner, Gerhard; Reinherz, Ellis L.			Constitutively Oxidized CXXC Motifs within the CD3 Heterodimeric Ectodomains of the T Cell Receptor Complex Enforce the Conformation of Juxtaposed Segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; ANTIGEN RECEPTOR; ALPHA-BETA; NMR DATA; REDOX STATE; ACTIVATION; PROTEIN; THIOREDOXIN; CD3-EPSILON; LYMPHOCYTES	The CD3 epsilon gamma and CD3 epsilon delta heterodimers along with the CD3 zeta zeta homodimer are the signaling components of the T cell receptor (TCR). These invariant dimers are non-covalently associated on the T cell plasma membrane with a clone-specific (i.e. clonotypic) alpha beta heterodimer that binds its cognate ligand, a complex between a particular antigenic peptide, and an MHC molecule (pMHC). These four TCR dimers exist in a 1:1:1:1 stoichiometry. At the junction between the extracellular and transmembrane domains of each mammalianCD3 epsilon, CD3 gamma, and CD3 delta subunit is a highly conserved CXXC motif previously found to be important for thymocyte and T cell activation. The redox state of each CXXC motif is presently unknown. Here we show using LC-MS and a biotin switch assay that these CXXC segments are constitutively oxidized on resting and activated T cells, consistent with their measured reduction potential. NMR chemical shift perturbation experiments comparing a native oxidized CD3 delta CXXC-containing segment with that of a mutant SXXS-containing CD3 delta segment in LPPG (1-palmitoyl-sn-glycero-3-phospho-(1'-racglycerol) (sodium salt)) micelles show extensive chemical shift differences in residues within the membrane-proximal motif as well as throughout the transmembrane and cytoplasmic domains as a result of the elimination of the native disulfide. Likewise, direct comparison of the native CD3 delta segment in oxidizing and reducing conditions reveals numerous spectral differences. The oxidized CXXC maintains the structure within the membrane-proximal stalk region as well as that of its contiguous transmembrane and cytoplasmic domain, inclusive of the ITAM (immunoreceptor tyrosine-based activation motif) involved in signaling. These results suggest that preservation of the CD3 CXXC oxidized state may be essential for TCR mechanotransduction.	[Brazin, Kristine N.; Keskin, Derin B.; Reinherz, Ellis L.] Dana Farber Canc Inst, Lab Immunobiol, Dept Med Oncol, Boston, MA 02115 USA; [Brazin, Kristine N.; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Mallis, Robert J.; Arthanari, Haribabu; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Li, Chen; Gao, Yuanwei; Wu, Shiaw-Lin; Karger, Barry L.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northeastern University	Reinherz, EL (corresponding author), Dana Farber Canc Inst, Lab Immunobiol, HIM 419,77 Ave Louis Pasteur, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Mallis, Robert/A-2270-2015	Arthanari, Haribabu/0000-0002-7281-1289	National Institutes of Health Grants [AI100643-01, GM047467, AI375581, P41-EB002026, S10-RR029236, GM15847]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100643, R01AI037581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM015847, F32GM015847, P01GM047467, R01GM015847] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI100643-01 (to E. L. R.), GM047467 (to E. L. R. and G. W.), AI375581, P41-EB002026, and S10-RR029236 (to G. W.) and GM15847 (to B. L. K.).	ACUTO O, 1983, CELL, V34, P717, DOI 10.1016/0092-8674(83)90528-7; Arnaiz-Villena A, 1993, Immunodeficiency, V4, P121; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; Borroto A, 1998, J BIOL CHEM, V273, P12807, DOI 10.1074/jbc.273.21.12807; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Chen W, 2013, IMMUNOL REV, V256, P160, DOI 10.1111/imr.12122; Choi YI, 2014, P NATL ACAD SCI USA, V111, P379, DOI 10.1073/pnas.1314209111; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Gil J, 2011, J CLIN INVEST, V121, P3872, DOI 10.1172/JCI44254; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Hyberts SG, 2010, J AM CHEM SOC, V132, P2145, DOI 10.1021/ja908004w; Indu S, 2010, PROTEINS, V78, P1228, DOI 10.1002/prot.22641; Iqbalsyah TM, 2006, PROTEIN SCI, V15, P1945, DOI 10.1110/ps.062271506; JIN YJ, 1990, J BIOL CHEM, V265, P15850; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Judokusumo E, 2012, BIOPHYS J, V102, pL5, DOI 10.1016/j.bpj.2011.12.011; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim ST, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00076; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; KONING F, 1990, EUR J IMMUNOL, V20, P299, DOI 10.1002/eji.1830200211; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Ma ZY, 2010, TRENDS IMMUNOL, V31, P1, DOI 10.1016/j.it.2009.09.008; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; MEUER SC, 1983, SCIENCE, V222, P1239, DOI 10.1126/science.6606228; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; Miyamoto S, 2003, AM HEART J, V146, P465, DOI 10.1016/S0002-8703(03)00311-9; OHMORI H, 1986, JPN J PHARMACOL, V42, P135, DOI 10.1254/jjp.42.135; Piotukh K, 2007, FREE RADICAL BIO MED, V43, P1263, DOI 10.1016/j.freeradbiomed.2007.06.010; REINHERZ EL, 1982, CELL, V30, P735, DOI 10.1016/0092-8674(82)90278-1; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Son A, 2009, ANTIOXID REDOX SIGN, V11, P2595, DOI 10.1089/ARS.2009.2522; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Tokgoz H, 2013, PEDIAT ALLERG IMM-UK, V24, P257, DOI 10.1111/pai.12063; Touma M, 2007, J IMMUNOL, V178, P3668, DOI 10.4049/jimmunol.178.6.3668; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Zhou YF, 2014, BLOOD, V123, P1785, DOI 10.1182/blood-2013-11-523639; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	60	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18880	18892		10.1074/jbc.M114.574996	http://dx.doi.org/10.1074/jbc.M114.574996			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849600	Green Published, hybrid			2022-12-28	WOS:000339062900022
J	Gudmundsson, M; Kim, S; Wu, M; Ishida, T; Momeni, MH; Vaaje-Kolstad, G; Lundberg, D; Royant, A; Stahlberg, J; Eijsink, VGH; Beckham, GT; Sandgren, M				Gudmundsson, Mikael; Kim, Seonah; Wu, Miao; Ishida, Takuya; Momeni, Majid Hadadd; Vaaje-Kolstad, Gustav; Lundberg, Daniel; Royant, Antoine; Stahlberg, Jerry; Eijsink, Vincent G. H.; Beckham, Gregg T.; Sandgren, Mats			Structural and Electronic Snapshots during the Transition from a Cu(II) to Cu(I) Metal Center of a Lytic Polysaccharide Monooxygenase by X-ray Photoreduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCOCCUS-FAECALIS V583; GLYCOSIDE HYDROLASE FAMILY; BINDING PROTEIN CBP21; ACTIVE-SITE; LIGNOCELLULOSIC BIOMASS; MACROMOLECULAR CRYSTALS; DENSITY FUNCTIONALS; SERRATIA-MARCESCENS; CELLULOSE; MODEL	Lytic polysaccharide monooxygenases (LPMOs) are a recently discovered class of enzymes that employ a copper-mediated, oxidative mechanism to cleave glycosidic bonds. The LPMO catalytic mechanism likely requires that molecular oxygen first binds to Cu(I), but the oxidation state in many reported LPMO structures is ambiguous, and the changes in the LPMO active site required to accommodate both oxidation states of copper have not been fully elucidated. Here, a diffraction data collection strategy minimizing the deposited x-ray dose was used to solve the crystal structure of a chitin-specific LPMO from Enterococcus faecalis (EfaCBM33A) in the Cu(II)-bound form. Subsequently, the crystalline protein was photoreduced in the x-ray beam, which revealed structural changes associated with the conversion from the initial Cu(II)-oxidized form with two coordinated water molecules, which adopts a trigonal bipyramidal geometry, to a reduced Cu(I) form in a T-shaped geometry with no coordinated water molecules. A comprehensive survey of Cu(II) and Cu(I) structures in the Cambridge Structural Database unambiguously shows that the geometries observed in the least and most reduced structures reflect binding of Cu(II) and Cu(I), respectively. Quantum mechanical calculations of the oxidized and reduced active sites reveal little change in the electronic structure of the active site measured by the active site partial charges. Together with a previous theoretical investigation of a fungal LPMO, this suggests significant functional plasticity in LPMO active sites. Overall, this study provides molecular snapshots along the reduction process to activate the LPMO catalytic machinery and provides a general method for solving LPMO structures in both copper oxidation states.	[Gudmundsson, Mikael; Wu, Miao; Ishida, Takuya; Momeni, Majid Hadadd; Lundberg, Daniel; Stahlberg, Jerry; Sandgren, Mats] Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden; [Kim, Seonah; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Ishida, Takuya] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Vaaje-Kolstad, Gustav; Stahlberg, Jerry; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, NO-1432 As, Norway; [Royant, Antoine] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct, F-38042 Grenoble, France; [Royant, Antoine] European Synchrotron Radiat Facil, F-38000 Grenoble, France	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Tokyo; Norwegian University of Life Sciences; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF)	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 15013 Denver West Pkwy,MS 3322, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; mats.sandgren@slu.se	Lundberg, Daniel/K-2263-2015; Daniel Lundberg, BA/I-5714-2019; Royant, Antoine/G-3684-2012; Momeni, Majid Haddad/AAB-1857-2021; Stahlberg, Jerry/D-4163-2013	Daniel Lundberg, BA/0000-0001-9507-7614; Royant, Antoine/0000-0002-1919-8649; Momeni, Majid Haddad/0000-0001-9653-1380; Sandgren, Mats/0000-0002-2358-4534; Stahlberg, Jerry/0000-0003-4059-8580; Vaaje-Kolstad, Gustav/0000-0002-3077-8003; Gudmundsson, Mikael/0000-0002-8095-4423	Faculty for Natural Resources and Agriculture; Swedish University of Agricultural Sciences; research program MicroDrivE-Microbially Derived Energy; U.S. Department of Energy BioEnergy Technologies Office; National Science Foundation XSEDE Grant through the Texas Advanced Computing Center [MCB090159]; Norwegian Research Council [214138, 214613]	Faculty for Natural Resources and Agriculture; Swedish University of Agricultural Sciences; research program MicroDrivE-Microbially Derived Energy; U.S. Department of Energy BioEnergy Technologies Office(United States Department of Energy (DOE)); National Science Foundation XSEDE Grant through the Texas Advanced Computing Center; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Faculty for Natural Resources and Agriculture, Swedish University of Agricultural Sciences, the research program MicroDrivE-Microbially Derived Energy, U.S. Department of Energy BioEnergy Technologies Office and National Science Foundation XSEDE Grant MCB090159 (to G. T. B. and S. K.) (through the Texas Advanced Computing Center), and Grants 214138 and 214613 from the Norwegian Research Council (to G. V.-K. and V. G. H. E.).	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bohle LA, 2011, FEMS MICROBIOL LETT, V325, P123, DOI 10.1111/j.1574-6968.2011.02419.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Casella L, 1996, INORG CHEM, V35, P1101, DOI 10.1021/ic950392o; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; Dechancie J, 2007, PROTEIN SCI, V16, P1851, DOI 10.1110/ps.072963707; DeLano W.L, PYMOL MOL GRAPHICS S; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Liao RZ, 2013, J PHYS CHEM B, V117, P3954, DOI 10.1021/jp311705s; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McGeehan J, 2009, J SYNCHROTRON RADIAT, V16, P163, DOI 10.1107/S0909049509001629; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Murray JW, 2004, J APPL CRYSTALLOGR, V37, P513, DOI 10.1107/S0021889804010660; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; SORRELL TN, 1994, INORG CHIM ACTA, V218, P103, DOI 10.1016/0020-1693(93)03792-9; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a	59	73	76	0	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18782	18792		10.1074/jbc.M114.563494	http://dx.doi.org/10.1074/jbc.M114.563494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24828494	Green Published, hybrid			2022-12-28	WOS:000339062900014
J	Santra, M; Zhang, ZG; Yang, J; Santra, S; Santra, S; Chopp, M; Morris, DC				Santra, Manoranjan; Zhang, Zheng Gang; Yang, James; Santra, Sutapa; Santra, Soumi; Chopp, Michael; Morris, Daniel C.			Thymosin beta 4 Up-regulation of MicroRNA-146a Promotes Oligodendrocyte Differentiation and Suppression of the Toll-like Proinflammatory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELL DIFFERENTIATION; INNATE IMMUNE-RESPONSES; BETA(4) MESSENGER-RNA; GENE-EXPRESSION; C-JUN; BRAIN; MYELINATION; KROX-20; RAT; STROKE	Thymosin beta 4 (T beta 4), a G-actin-sequestering peptide, improves neurological outcome in rat models of neurological injury. Tissue inflammation results from neurological injury, and regulation of the inflammatory response is vital for neurological recovery. The innate immune response system, which includes the Toll-like receptor (TLR) proinflammatory signaling pathway, regulates tissue injury. We hypothesized that T beta 4 regulates the TLR proinflammatory signaling pathway. Because oligodendrogenesis plays an important role in neurological recovery, we employed an in vitro primary rat embryonic cell model of oligodendrocyte progenitor cells (OPCs) and a mouse N20.1 OPC cell line to measure the effects of T beta 4 on the TLR pathway. Cells were grown in the presence of T beta 4, ranging from 25 to 100 ng/ml (RegeneRx Biopharmaceuticals Inc., Rockville, MD), for 4 days. Quantitative real-time PCR data demonstrated that T beta 4 treatment increased expression of microRNA-146a (miR-146a), a negative regulator the TLR signaling pathway, in these two cell models. Western blot analysis showed that T beta 4 treatment suppressed expression of IL-1 receptor-associated kinase 1 (IRAK1) and tumor necrosis factor receptor-associated factor 6 (TRAF6), two proinflammatory cytokines of the TLR signaling pathway. Transfection of miR-146a into both primary rat embryonic OPCs and mouse N20.1 OPCs treated with T beta 4 demonstrated an amplification of myelin basic protein (MBP) expression and differentiation of OPC into mature MBPexpressing oligodendrocytes. Transfection of anti-miR-146a nucleotides reversed the inhibitory effect of T beta 4 on IRAK1 and TRAF6 and decreased expression of MBP. These data suggest that T beta 4 suppresses the TLR proinflammatory pathway by upregulating miR-146a.	[Santra, Manoranjan; Zhang, Zheng Gang; Santra, Sutapa; Santra, Soumi; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Yang, James] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Morris, Daniel C.] Henry Ford Hlth Syst, Dept Emergency Med, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Morris, DC (corresponding author), Henry Ford Hosp, Dept Emergency Med, 2799 West Grand Blvd,CFP 2, Detroit, MI 48202 USA.	morris@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		National Institutes of Health [R01 AG038648, R01 NS075156, R01 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038648, R01AG037506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG038648 (to D. M.), R01 NS075156 (to Z. G.), and R01 AG037506 (to M. C.). The Henry Ford Health Systems have a Material Transfer Agreement with RegeneRx Biopharmaceuticals Inc. (Rockville, MD). United States Provisional Patent 61/163,556 has been filed for use of T beta 4 in neurological injury.	Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Butcher J, 2009, J NEUROSCI, V29, P5365, DOI 10.1523/JNEUROSCI.5976-08.2009; Carpintero P, 1999, NEUROSCIENCE, V90, P1433, DOI 10.1016/S0306-4522(98)00494-1; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Dong JH, 2005, NEUROREPORT, V16, P1629, DOI 10.1097/01.wnr.0000183326.21241.48; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Hannappel E, 2007, ANN NY ACAD SCI, V1112, P21, DOI 10.1196/annals.1415.018; Hossain S, 2012, GLIA, V60, P1130, DOI 10.1002/glia.22340; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Izadi H, 2007, INFECT IMMUN, V75, P5027, DOI 10.1128/IAI.00492-07; Kim Y, 2006, BRAIN RES, V1085, P177, DOI 10.1016/j.brainres.2006.01.065; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Morris DC, 2010, NEUROSCIENCE, V169, P674, DOI 10.1016/j.neuroscience.2010.05.017; Morris DC, 2010, ANN NY ACAD SCI, V1194, P112, DOI 10.1111/j.1749-6632.2010.05469.x; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Opalinska JB, 2010, BLOOD, V116, pE128, DOI 10.1182/blood-2010-06-292920; Paez PM, 2004, GLIA, V46, P207, DOI 10.1002/glia.20001; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Popoli P, 2007, ANN NY ACAD SCI, V1112, P219, DOI 10.1196/annals.1415.033; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136; SANDERS MC, 1992, P NATL ACAD SCI USA, V89, P4678, DOI 10.1073/pnas.89.10.4678; Santra M, 2012, GLIA, V60, P1826, DOI 10.1002/glia.22400; Santra M, 2011, CANCER SCI, V102, P1350, DOI 10.1111/j.1349-7006.2011.01952.x; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Vartiainen N, 1996, NEUROREPORT, V7, P1613, DOI 10.1097/00001756-199607080-00017; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Zhang J, 2009, NEUROSCIENCE, V164, P1887, DOI 10.1016/j.neuroscience.2009.09.054; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao JL, 2013, ELIFE, V2, DOI 10.7554/eLife.00537; Zorick TS, 1999, DEVELOPMENT, V126, P1397	48	43	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19508	19518		10.1074/jbc.M113.529966	http://dx.doi.org/10.1074/jbc.M113.529966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24828499	hybrid, Green Published			2022-12-28	WOS:000339326800026
J	Ehrensberger, KM; Corkins, ME; Choi, SY; Bird, AJ				Ehrensberger, Kate M.; Corkins, Mark E.; Choi, Sangyong; Bird, Amanda J.			The Double Zinc Finger Domain and Adjacent Accessory Domain from the Transcription Factor Loss of Zinc Sensing 1 (Loz1) Are Necessary for DNA Binding and Zinc Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; TRANSITION; HELIX	The Loz1 transcription factor from Schizosaccharomyces pombe plays an essential role in zinc homeostasis by repressing target gene expression in zinc-replete cells. To determine how Loz1 function is regulated by zinc, we employed a genetic screen to isolate mutants with impaired zinc-dependent gene expression and analyzed Loz1 protein truncations to map a minimal zinc-responsive domain. In the screen, we isolated 36 new loz1 alleles. 27 of these alleles contained mutations resulting in the truncation of the Loz1 protein. The remaining nine alleles contained point mutations leading to an amino acid substitution within a C-terminal double zinc finger domain. Further analysis of two of these substitutions revealed that they disrupted Loz1 DNA activity in vitro. By analyzing Loz1 protein truncations, we found that the last 96 amino acids of Loz1 was the smallest region that was able to confer partial zinc-dependent repression in vivo. This 96-amino acid region contains the double zinc finger domain and an accessory domain that enhances DNA binding. These results were further supported by the findings that MtfA, a transcription factor from Aspergillus nidulans that contains a related double zinc finger, is unable to complement loz1 Delta, whereas a chimera of MtfA containing the Loz1 accessory domain is able to complement loz1 Delta. Together, our studies indicate that the double zinc finger domain and adjacent accessory domain preceding zinc finger 1 are necessary for DNA binding and zinc-dependent repression.	[Ehrensberger, Kate M.; Corkins, Mark E.; Bird, Amanda J.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Choi, Sangyong; Bird, Amanda J.] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Ehrensberger, Kate M.; Bird, Amanda J.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bird, AJ (corresponding author), Ohio State Univ, Dept Human Sci, 1787 Neil Ave, Columbus, OH 43210 USA.	bird.96@osu.edu	Bird, Amanda Jane/ABD-2295-2021	Bird, Amanda Jane/0000-0002-1846-7050				Andreini C, 2012, J INORG BIOCHEM, V111, P150, DOI 10.1016/j.jinorgbio.2011.11.020; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Bowers PW, 1999, NAT STRUCT BIOL, V6, P478; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Choi SY, 2014, METALLOMICS, V6, P1198, DOI 10.1039/c4mt00064a; Clemens S, 2002, J BIOL CHEM, V277, P18215, DOI 10.1074/jbc.M201031200; Corkins ME, 2013, P NATL ACAD SCI USA, V110, P15371, DOI 10.1073/pnas.1300853110; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; Dutnall RN, 1996, STRUCTURE, V4, P599, DOI 10.1016/S0969-2126(96)00064-0; Ehrensberger KM, 2013, J BIOL CHEM, V288, P759, DOI 10.1074/jbc.M112.406165; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Frey AG, 2012, MICROBIOLOGYOPEN, V1, P105, DOI 10.1002/mbo3.8; Frey AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022535; Frey AG, 2011, J BIOL CHEM, V286, P6844, DOI 10.1074/jbc.M110.203927; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; Kamashev DE, 2000, J BIOL CHEM, V275, P36056, DOI 10.1074/jbc.M001691200; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Ramamoorthy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074122; Shimizu M, 2001, J BIOL CHEM, V276, P37680, DOI 10.1074/jbc.M105342200; Sommer F, 2010, PLANT CELL, V22, P4098, DOI 10.1105/tpc.110.080069; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1	26	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18087	18096		10.1074/jbc.M114.551333	http://dx.doi.org/10.1074/jbc.M114.551333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831008	Green Published, hybrid			2022-12-28	WOS:000338042000012
J	Fuerer, C; Nostro, MC; Constam, DB				Fuerer, Christophe; Nostro, M. Cristina; Constam, Daniel B.			Nodal.Gdf1 Heterodimers with Bound Prodomains Enable Serum-independent Nodal Signaling and Endoderm Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; DEFINITIVE ENDODERM; DROSOPHILA EMBRYO; MOUSE EMBRYO; II RECEPTOR; ACTIVIN-A; VERTEBRATE DEVELOPMENT; BMP LIGAND	The TGF beta family member Nodal is central to control pluripotent stem cell fate, but its use as a stem cell differentiation factor is limited by low specific activity. During development, Nodal depends on growth and differentiation factor (Gdf)-1 and on the shared co-receptor Cryptic to specify visceral left-right axis asymmetry. We therefore asked whether the functionality of Nodal can be augmented by Gdf1. Because Nodal and Gdf1 coimmunoprecipitate each other, they were predicted to form heterodimers, possibly to facilitate diffusion or to increase the affinity for signaling receptors. Here, we report that Gdf1 suppresses an unexpected dependence of Nodal on serum proteins and that it is critically required for non-autonomous signaling in cells expressing Cryptic. Nodal, Gdf1, and their cleaved propeptides copurified as a heterodimeric low molecular weight complex that stimulated Activin receptor (Acvr) signaling far more potently than Nodal alone. Although heterodimerization with Gdf1 did not increase binding of Nodal to Fc fusions of co-receptors or Acvr extracellular domains, it was essential for soluble Acvr2 to inhibit Nodal signaling. This implies that Gdf1 potentiates Nodal activity by stabilizing a low molecular weight fraction that is susceptible to neutralization by soluble Acvr2. Finally, in differentiating human ES cells, endodermal markers were more efficiently induced by Nodal.Gdf1 than by Nodal, suggesting that Nodal.Gdf1 is an attractive new reagent to direct stem cell differentiation.	[Fuerer, Christophe; Constam, Daniel B.] Ecole Polytech Fed Lausanne, Sch Life Sci SV, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland; [Nostro, M. Cristina] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Constam, DB (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci SV, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.	Daniel.Constam@epfl.ch		Fuerer, Christophe/0000-0003-1717-6718; Constam, Daniel B./0000-0002-6256-3891; Nostro, Maria Cristina/0000-0003-1166-8252				Akiyama T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002549; Andersson O, 2007, DEV BIOL, V311, P500, DOI 10.1016/j.ydbio.2007.08.060; Andersson O, 2006, DEV BIOL, V293, P370, DOI 10.1016/j.ydbio.2006.02.002; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Blanchet MH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1165027; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chen AE, 2013, DEVELOPMENT, V140, P675, DOI 10.1242/dev.085431; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; Chu JH, 2010, DEV BIOL, V342, P63, DOI 10.1016/j.ydbio.2010.03.009; Constam DB, 2009, TRAFFIC, V10, P783, DOI 10.1111/j.1600-0854.2009.00874.x; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Andrea D, 2008, J CELL BIOL, V180, P597, DOI 10.1083/jcb.200709090; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Frisch A, 1998, DEVELOPMENT, V125, P431; Fuerer C, 2010, DEV DYNAM, V239, P184, DOI 10.1002/dvdy.22067; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; HUANG SS, 1988, J BIOL CHEM, V263, P1535; Jornvall H, 2004, MOL CELL BIOL, V24, P9383, DOI 10.1128/MCB.24.21.9383-9389.2004; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MCCAFFREY TA, 1994, ANN NY ACAD SCI, V737, P368, DOI 10.1111/j.1749-6632.1994.tb44324.x; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; Oki S, 2007, DEVELOPMENT, V134, P3893, DOI 10.1242/dev.009464; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Perron JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008198; Ramis JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000213; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; Sawala A, 2012, P NATL ACAD SCI USA, V109, P11222, DOI 10.1073/pnas.1202781109; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Srinivasan S, 2002, DEV CELL, V2, P91, DOI 10.1016/S1534-5807(01)00097-1; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tanaka C, 2007, GENE DEV, V21, P3272, DOI 10.1101/gad.1623907; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Wall NA, 2000, DEV BIOL, V227, P495, DOI 10.1006/dbio.2000.9926; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	62	33	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17854	17871		10.1074/jbc.M114.550301	http://dx.doi.org/10.1074/jbc.M114.550301			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24798330	hybrid, Green Published			2022-12-28	WOS:000338018100047
J	Hartlieb, E; Rotzer, V; Radeva, M; Spindler, V; Waschke, J				Hartlieb, Eva; Roetzer, Vera; Radeva, Mariya; Spindler, Volker; Waschke, Jens			Desmoglein 2 Compensates for Desmoglein 3 but Does Not Control Cell Adhesion via Regulation of p38 Mitogen-activated Protein Kinase in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEMPHIGUS-VULGARIS; EPIDERMAL-GROWTH; DESMOSOME; CYTOSKELETON; PLAKOGLOBIN; INHIBITION; PHENOTYPE; MECHANISM; FOLIACEUS; DISEASE	Desmosomal cadherins are transmembrane adhesion molecules that provide cell adhesion by interacting in the intercellular space of adjacent cells. In keratinocytes, several desmoglein (Dsg1-4) and desmocollin (Dsc1-3) isoforms are coexpressed. We have shown previously that Dsg2 is less important for keratinocyte cohesion compared with Dsg3 and that the latter forms a complex with p38 MAPK. In this study, we compared the involvement of Dsg2 and Dsg3 in the p38 MAPK-dependent regulation of keratinocyte cohesion. We show that loss of cell adhesion and keratin filament retraction induced by Dsg3 depletion is ameliorated by specific p38 MAPK inhibition. Furthermore, in contrast to depletion of Dsg2, siRNA-mediated silencing of Dsg3 induced p38 MAPK activation, which is in line with immunoprecipitation experiments demonstrating the interaction of activated p38 MAPK with Dsg3 but not with Dsg2. Cell fractionation into a cytoskeleton-unbound and a cytoskeleton-anchored desmosome-containing pool revealed that Dsg3, in contrast to Dsg2, is present in relevant amounts in the unbound pool in which activated p38 MAPK is predominantly detectable. Moreover, because loss of cell adhesion by Dsg3 depletion was partially rescued by p38 MAPK inhibition, we conclude that, besides its function as an adhesion molecule, Dsg3 is strengthening cell cohesion via modulation of p38 MAPK-dependent keratin filament reorganization. Nevertheless, because subsequent targeting of Dsg3 in Dsg2-depleted cells led to drastically enhanced keratinocyte dissociation and Dsg2 was enhanced at the membrane in Dsg3 knockout cells, we conclude that Dsg2 compensates for Dsg3 loss of function.	[Hartlieb, Eva; Roetzer, Vera; Radeva, Mariya; Spindler, Volker; Waschke, Jens] Univ Munich, Inst Anat & Cell Biol, Dept 1, D-80336 Munich, Germany	University of Munich	Waschke, J (corresponding author), Jens Waschke Inst Anat & Cell Biol, Pettenkoferstr 11, D-80336 Munich, Germany.	jens.waschke@med.uni-muenchen.de	Spindler, Volker/G-1704-2019	Spindler, Volker/0000-0002-1302-5421				Baron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050024; Bektas M, 2013, J BIOL CHEM, V288, P9447, DOI 10.1074/jbc.M112.438010; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/410278; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Getsios Spiro, 2010, J Invest Dermatol, V130, P1764, DOI 10.1038/jid.2010.111; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Hartlieb E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053739; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Heupel WM, 2009, J BIOL CHEM, V284, P8589, DOI 10.1074/jbc.M808813200; Heupel WM, 2009, AM J PATHOL, V174, P475, DOI 10.2353/ajpath.2009.080392; Hotchin N. A., 2010, PLOS ONE, V5; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Khan K, 2006, BRIT J CANCER, V95, P1367, DOI 10.1038/sj.bjc.6603453; Kitajima Y, 2013, KAOHSIUNG J MED SCI, V29, P1, DOI 10.1016/j.kjms.2012.08.001; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kolegraff K, 2011, MOL BIOL CELL, V22, P1121, DOI 10.1091/mbc.E10-10-0845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVER WF, 1953, MEDICINE, V32, P1; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Spindler V, 2014, J INVEST DERMATOL, V134, P1655, DOI 10.1038/jid.2014.21; Spindler V, 2013, J CLIN INVEST, V123, P800, DOI 10.1172/JCI60139; Spindler V, 2011, ANN ANAT, V193, P177, DOI 10.1016/j.aanat.2011.02.003; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Tsang SM, 2012, J PATHOL, V227, P81, DOI 10.1002/path.3982; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Wu H, 2000, NEW ENGL J MED, V343, P31, DOI 10.1056/NEJM200007063430105	40	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17043	17053		10.1074/jbc.M113.489336	http://dx.doi.org/10.1074/jbc.M113.489336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782306	Green Published, hybrid			2022-12-28	WOS:000338016200038
J	Karaca, I; Tamboli, IY; Glebov, K; Richter, J; Fell, LH; Grimm, MO; Haupenthal, VJ; Hartmann, T; Graler, MH; van Echten-Deckert, G; Walter, J				Karaca, Ilker; Tamboli, Irfan Y.; Glebov, Konstantin; Richter, Josefine; Fell, Lisa H.; Grimm, Marcus O.; Haupenthal, Viola J.; Hartmann, Tobias; Graeler, Markus H.; van Echten-Deckert, Gerhild; Walter, Jochen			Deficiency of Sphingosine-1-phosphate Lyase Impairs Lysosomal Metabolism of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GAMMA-SECRETASE; BETA-SECRETASE; ASPARTIC PROTEASE; CA2+ HOMEOSTASIS; MEMBRANE-LIPIDS; HUMAN BRAIN; SPHINGOSINE; GENERATION; PEPTIDE	Progressive accumulation of the amyloid beta protein in extracellular plaques is a neuropathological hallmark of Alzheimer disease. Amyloid beta is generated during sequential cleavage of the amyloid precursor protein (APP) by beta- and gamma-secretases. In addition to the proteolytic processing by secretases, APP is also metabolized by lysosomal proteases. Here, we show that accumulation of intracellular sphingosine-1-phosphate (S1P) impairs the metabolism of APP. Cells lacking functional S1P-lyase, which degrades intracellular S1P, strongly accumulate full-length APP and its potentially amyloidogenic C-terminal fragments (CTFs) as compared with cells expressing the functional enzyme. By cell biological and biochemical methods, we demonstrate that intracellular inhibition of S1P-lyase impairs the degradation of APP and CTFs in lysosomal compartments and also decreases the activity of gamma-secretase. Interestingly, the strong accumulation of APP and CTFs in S1P-lyase-deficient cells was reversed by selective mobilization of Ca2+ from the endoplasmic reticulum or lysosomes. Intracellular accumulation of S1P also impairs maturation of cathepsin D and degradation of Lamp-2, indicating a general impairment of lysosomal activity. Together, these data demonstrate that S1P-lyase plays a critical role in the regulation of lysosomal activity and the metabolism of APP.	[Karaca, Ilker; Tamboli, Irfan Y.; Glebov, Konstantin; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Richter, Josefine] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Fell, Lisa H.; Grimm, Marcus O.; Haupenthal, Viola J.; Hartmann, Tobias] Univ Saarland, Dept Expt Neurol, D-66421 Homburg, Germany; [Graeler, Markus H.] Univ Hosp Jena, Ctr Sepsis Control & Care, Dept Anaesthesiol & Intens Care Med, D-07740 Jena, Germany; [Graeler, Markus H.] Univ Hosp Jena, Ctr Mol Biomed, D-07740 Jena, Germany; [van Echten-Deckert, Gerhild] Univ Bonn, Membrane Biol & Lipid Biochem Unit, D-53121 Bonn, Germany; [van Echten-Deckert, Gerhild] Univ Bonn, Kekule Inst, D-53121 Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Saarland University; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Bonn; University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Mol Cell Biol Unit, Sigmund Freud Str 25, D-53127 Bonn, Germany.	Jochen.Walter@ukb.uni-bonn.de	Grimm, Marcus O. W./F-8134-2011; Karaca, Ilker/J-6484-2016; Gräler, Markus/ABH-1905-2021; Wang, Caihong/T-5837-2019; Walter, Jochen/B-3677-2014; Hartmann, Tobias/AAB-8297-2022	Grimm, Marcus O. W./0000-0002-4160-6506; Karaca, Ilker/0000-0002-2139-0015; Gräler, Markus/0000-0001-6650-7849; Wang, Caihong/0000-0002-6808-3709; Hartmann, Tobias/0000-0001-7481-6430; Walter, Jochen/0000-0002-4678-2912	Deutsche Forschungsgemeinschaft by Priority Program 1267 Grants [WA1477/8-1, EC-118/6-1, HA2985/6-2, GR1943/2-2]; Deutsche Forschungsgemeinschaft by Collaborative Research Center 645 Grant [TP A7]; Deutsche Forschungsgemeinschaft by Clinical Research Group KFO177 Grant [WA1477/4-2]	Deutsche Forschungsgemeinschaft by Priority Program 1267 Grants(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft by Collaborative Research Center 645 Grant(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft by Clinical Research Group KFO177 Grant(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft by Priority Program 1267 Grants WA1477/8-1 (to J. W.), EC-118/6-1 (to G. v. E. D.), HA2985/6-2 (to T. H. and M. O. G.), and GR1943/2-2 (to M. H. G.); by Collaborative Research Center 645 Grant TP A7 (to J. W.); and by Clinical Research Group KFO177 Grant WA1477/4-2 (to J. W.).	Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Bankowska A, 1997, Rocz Akad Med Bialymst, V42 Suppl 1, P79; Bastow ER, 2012, BIOL OPEN, V1, P318, DOI 10.1242/bio.2012547; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Bode Constantin, 2012, Methods Mol Biol, V874, P33, DOI 10.1007/978-1-61779-800-9_3; Boland B, 2010, J BIOL CHEM, V285, P37415, DOI 10.1074/jbc.M110.186411; Claas RF, 2010, CELL SIGNAL, V22, P476, DOI 10.1016/j.cellsig.2009.11.001; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Grimm MOW, 2013, INT J MOL SCI, V14, P5879, DOI 10.3390/ijms14035879; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hagen N, 2011, CELL DEATH DIFFER, V18, P1356, DOI 10.1038/cdd.2011.7; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Hagen-Euteneuer N, 2012, J BIOL CHEM, V287, P9128, DOI 10.1074/jbc.M111.302380; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ihlefeld K, 2012, BIOCHEM J, V447, P457, DOI 10.1042/BJ20120811; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kandalepas PC, 2012, J NEUROCHEM, V120, P55, DOI 10.1111/j.1471-4159.2011.07512.x; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Kiselyov KK, 2012, CHANNELS, V6, P344, DOI 10.4161/chan.21723; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Malnar M, 2012, BBA-MOL BASIS DIS, V1822, P1270, DOI 10.1016/j.bbadis.2012.04.002; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Rothhaar TL, 2012, SCI WORLD J, DOI 10.1100/2012/141240; Sandhoff K, 1998, ACTA BIOCHIM POL, V45, P373, DOI 10.18388/abp.1998_4232; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Tamboli IY, 2011, AUTOPHAGY, V7, P643, DOI 10.4161/auto.7.6.15122; Tamboli IY, 2011, J NEUROSCI, V31, P1837, DOI 10.1523/JNEUROSCI.2954-10.2011; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Van Veldhoven PP, 2000, METHOD ENZYMOL, V311, P244; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34; Winkler E, 2012, J BIOL CHEM, V287, P21326, DOI 10.1074/jbc.M112.356659; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yanagawa M, 2007, J BIOL CHEM, V282, P1851, DOI 10.1074/jbc.M604143200; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	58	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16761	16772		10.1074/jbc.M113.535500	http://dx.doi.org/10.1074/jbc.M113.535500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24808180	Green Published, hybrid			2022-12-28	WOS:000338016200015
J	Penke, LRK; Huang, SK; White, ES; Peters-Golden, M				Penke, Loka R. K.; Huang, Steven K.; White, Eric S.; Peters-Golden, Marc			Prostaglandin E-2 Inhibits alpha-Smooth Muscle Actin Transcription during Myofibroblast Differentiation via Distinct Mechanisms of Modulation of Serum Response Factor and Myocardin-related Transcription Factor-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HUMAN TENON FIBROBLASTS; TGF-BETA; LUNG FIBROBLASTS; PROTEIN-KINASE; MAP KINASE; ACTIVATION; EXPRESSION; CELLS; RESISTANCE	Differentiation of lung fibroblasts into contractile protein-expressing myofibroblasts by transforming growth factor-beta 1 (TGF-beta 1) is a critical event in the pathogenesis of pulmonary fibrosis. Transcription of the contractile protein alpha-smooth muscle actin (alpha-SMA) is mediated by the transcription factor serum-response factor (SRF) along with its co-activator, myocardin-related transcription factor-A (MRTF-A). The endogenous lipid mediator prostaglandin E-2 (PGE(2)) exerts anti-fibrotic effects, including the inhibition of myofibroblast differentiation. However, the mechanism by which PGE(2) inhibits alpha-SMA expression is incompletely understood. Here, we show in normal lung fibroblasts that PGE(2) reduced the nuclear accumulation of MRTF-A.SRF complexes and consequently inhibited alpha-SMA promoter activation. It did so both by independently inhibiting SRF gene expression and nuclear import of MRTF-A. We identified that p38 MAPK is critical for TGF-beta 1-induced SRF gene expression and that PGE(2) inhibition of SRF expression is associated with its ability to inhibit p38 activation. Its inhibition of MRTF-A import occurs via activation of cofilin 1 and inactivation of vasodilator-stimulated phosphoprotein. Similar effects of PGE(2) on SRF gene expression were observed in fibroblasts from the lungs of patients with idiopathic pulmonary fibrosis. Thus, PGE(2) is the first substance described to prevent myofibroblast differentiation by disrupting, via distinct mechanisms, the actions of both SRF and MRTF-A.	[Penke, Loka R. K.; Huang, Steven K.; White, Eric S.; Peters-Golden, Marc] Univ Michigan Med Sch, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Peters-Golden, M (corresponding author), 6301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	PENKE, LOKA RAGHU KUMAR/L-7255-2016	White, Eric/0000-0003-4060-8443; PENKE, LOKA RAGHU KUMAR/0000-0002-2780-7950	National Institutes of Health [HL094311, HL094657]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL094657, T32HL007749, R01HL094311, U01HL111016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094311 (to M. P. G.) and HL094657 (to S. K. H.).	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Choi SC, 2003, FREE RADICAL BIO MED, V35, P1171, DOI 10.1016/S0891-5849(03)00503-3; Crider BJ, 2011, J INVEST DERMATOL, V131, P2378, DOI 10.1038/jid.2011.219; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Desmouliere A, 1997, INT J BIOCHEM CELL B, V29, P19, DOI 10.1016/S1357-2725(96)00117-3; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Elberg G, 2008, AM J PHYSIOL-RENAL, V294, pF1116, DOI 10.1152/ajprenal.00142.2007; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Garrison G, 2013, AM J RESP CELL MOL, V48, P550, DOI 10.1165/rcmb.2012-0262OC; Hautmann MB, 1999, ARTERIOSCL THROM VAS, V19, P2049, DOI 10.1161/01.ATV.19.9.2049; Huang SK, 2008, CHEST, V133, P1442, DOI 10.1378/chest.08-0306; Huang SK, 2008, AM J RESP CRIT CARE, V177, P66, DOI 10.1164/rccm.200706-963OC; Huang SK, 2010, AM J PATHOL, V177, P2245, DOI 10.2353/ajpath.2010.100446; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Mack CP, 1999, CIRC RES, V84, P852; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Marinkovic A, 2013, AM J RESP CELL MOL, V48, P422, DOI 10.1165/rcmb.2012-0335OC; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Meyer-Ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P4895, DOI 10.1167/iovs.06-0118; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moore BB, 2000, J IMMUNOL, V165, P4032, DOI 10.4049/jimmunol.165.7.4032; Moore BB, 2005, J IMMUNOL, V174, P5644, DOI 10.4049/jimmunol.174.9.5644; Nakagawa N, 2012, KIDNEY INT, V82, P158, DOI 10.1038/ki.2012.115; Okunishi K, 2011, J BIOL CHEM, V286, P32231, DOI 10.1074/jbc.M111.235606; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; Sagana RL, 2009, J BIOL CHEM, V284, P32264, DOI 10.1074/jbc.M109.004796; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Serezani C. H., 2012, SCI SIGNAL, V5, pra12; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stumm CL, 2011, AM J PHYSIOL-LUNG C, V301, pL636, DOI 10.1152/ajplung.00158.2011; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Walker NM, 2012, AM J RESP CRIT CARE, V185, P77, DOI 10.1164/rccm.201105-0834OC; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Yang Y, 2003, AM J RESP CELL MOL, V29, P583, DOI 10.1165/rcmb.2002-0315OC; Zhang JY, 2006, MOL CELL BIOL, V26, P1223, DOI 10.1128/MCB.26.4.1223-1234.2006; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	51	61	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17151	17162		10.1074/jbc.M114.558130	http://dx.doi.org/10.1074/jbc.M114.558130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24802754	Green Published, hybrid			2022-12-28	WOS:000338016200048
J	Rai, AK; Chattopadhyay, K				Rai, Anand Kumar; Chattopadhyay, Kausik			Trapping of Vibrio cholerae Cytolysin in the Membrane-bound Monomeric State Blocks Membrane Insertion and Functional Pore Formation by the Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPTAMERIC TRANSMEMBRANE PORE; STAPHYLOCOCCAL ALPHA-TOXIN; EL-TOR CYTOLYSIN; CRYSTAL-STRUCTURE; STREPTOLYSIN-O; FORMATION-MECHANISM; HEMOLYSIN; CHOLESTEROL; OLIGOMERIZATION; SEQUENCE	Vibrio cholerae cytolysin (VCC) is a potent membrane-damaging cytolytic toxin that belongs to the family of beta barrel pore-forming protein toxins. VCC induces lysis of its target eukaryotic cells by forming transmembrane oligomeric beta barrel pores. The mechanism of membrane pore formation by VCC follows the overall scheme of the archetypical beta barrel pore-forming protein toxin mode of action, in which the water-soluble monomeric form of the toxin first binds to the target cell membrane, then assembles into a prepore oligomeric intermediate, and finally converts into the functional transmembrane oligomeric beta barrel pore. However, there exists a vast knowledge gap in our understanding regarding the intricate details of the membrane pore formation process employed by VCC. In particular, the membrane oligomerization and membrane insertion steps of the process have only been described to a limited extent. In this study, we determined the key residues in VCC that are critical to trigger membrane oligomerization of the toxin. Alteration of such key residues traps the toxin in its membrane-bound monomeric state and abrogates subsequent oligomerization, membrane insertion, and functional transmembrane pore-formation events. The results obtained from our study also suggest that the membrane insertion of VCC depends critically on the oligomerization process and that it cannot be initiated in the membrane-bound monomeric form of the toxin. In sum, our study, for the first time, dissects membrane binding from the subsequent oligomerization and membrane insertion steps and, thus, defines the exact sequence of events in the membrane pore formation process by VCC.	[Rai, Anand Kumar; Chattopadhyay, Kausik] Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, SAS Nagar, Mohali 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Chattopadhyay, K (corresponding author), Indian Inst Sci Educ & Res Mohali, SAS Nagar, Dept Biol Sci, Sect 81, Mohali 140306, Punjab, India.	kausik@iisermohali.ac.in	Chattopadhyay, Kausik/H-5044-2015	Chattopadhyay, Kausik/0000-0001-8529-9475	Department of Biotechnology, India [BT/PR13350/BRB/10/751/2009]; Indian Institute of Science Education and Research Mohali	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Institute of Science Education and Research Mohali	This work was supported by Department of Biotechnology, India Grant BT/PR13350/BRB/10/751/2009) (to K. C.) and by the Indian Institute of Science Education and Research Mohali.	Alouf J., 2006, COMPREHENSIVE SOURCE; Bayley H, 2005, NAT STRUCT MOL BIOL, V12, P385, DOI 10.1038/nsmb0505-385; Chattopadhyay K, 2002, EUR J BIOCHEM, V269, P4351, DOI 10.1046/j.1432-1033.2002.03137.x; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris JR, 2010, SUBCELL BIOCHEM, V51, P579, DOI 10.1007/978-90-481-8622-8_21; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Ikigai H, 2006, MICROBIOL IMMUNOL, V50, P751, DOI 10.1111/j.1348-0421.2006.tb03848.x; JURSCH R, 1994, INFECT IMMUN, V62, P2249, DOI 10.1128/IAI.62.6.2249-2256.1994; Kaper James B., 1994, P145; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Lohner S, 2009, FASEB J, V23, P2521, DOI 10.1096/fj.08-127688; Nagamune K, 1996, INFECT IMMUN, V64, P4655, DOI 10.1128/IAI.64.11.4655-4658.1996; Nagamune K, 1997, J BIOL CHEM, V272, P1338, DOI 10.1074/jbc.272.2.1338; Nguyen VT, 2002, MOL MICROBIOL, V45, P1485, DOI 10.1046/j.1365-2958.2002.03125.x; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Paul K, 2014, BIOCHEM BIOPH RES CO, V443, P189, DOI 10.1016/j.bbrc.2013.11.078; Paul K, 2012, FEBS J, V279, P4039, DOI 10.1111/j.1742-4658.2012.08809.x; Paul K, 2011, BIOCHEMISTRY-US, V50, P3936, DOI 10.1021/bi200332g; Rai AK, 2013, J BIOL CHEM, V288, P1665, DOI 10.1074/jbc.M112.430181; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sonnen AFP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140044; Subramaniam S, 1998, PROTEINS, V32, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valeva A, 2005, MOL MICROBIOL, V57, P124, DOI 10.1111/j.1365-2958.2005.04684.x; VALEVA A, 1995, BBA-BIOMEMBRANES, V1236, P213, DOI 10.1016/0005-2736(95)00060-G; WALKER B, 1995, CHEM BIOL, V2, P99, DOI 10.1016/1074-5521(95)90282-1; YAMAMOTO K, 1990, INFECT IMMUN, V58, P4106, DOI 10.1128/IAI.58.12.4106-4116.1990; Zitzer A, 2003, FEBS LETT, V553, P229, DOI 10.1016/S0014-5793(03)01023-8; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788; Zitzer A, 2000, BBA-BIOMEMBRANES, V1509, P264, DOI 10.1016/S0005-2736(00)00303-5; Zitzer A, 2001, J BIOL CHEM, V276, P14628, DOI 10.1074/jbc.M100241200	38	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16978	16987		10.1074/jbc.M114.567099	http://dx.doi.org/10.1074/jbc.M114.567099			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24794872	Green Published, hybrid			2022-12-28	WOS:000338016200032
J	Sun, XT; Momen, A; Wu, J; Noyan, H; Li, RK; von Harsdorf, R; Husain, M				Sun, Xuetao; Momen, Abdul; Wu, Jun; Noyan, Hossein; Li, Renke; von Harsdorf, Ruediger; Husain, Mansoor			p27 Protein Protects Metabolically Stressed Cardiomyocytes from Apoptosis by Promoting Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-INFARCTION; HEMODYNAMIC STRESS; HEART-FAILURE; P27(KIP1); MICE; CELLS; TUMORIGENESIS; HYPERPLASIA; FUSION; DIFFERENTIATION	p27(Kip1) (p27), a key regulator of cell division, has been implicated in autophagy of cancer cells. However, its role in autophagy, the evolutionarily conserved catabolic process that enables cells to remove unwanted proteins and damaged organelles, had not been examined in the heart. Here we report that ectopic delivery of a p27 fusion protein (TAT-p27) was sufficient to induce autophagy in neonatal rat ventricular cardiomyocytes in vitro, under basal conditions and after glucose deprivation. Conversely, lentivirus-delivered shRNA against p27 successfully reduced p27 levels and suppressed basal and glucose-deprived levels of autophagy in cardiomyocytes in vitro. Glucose deprivation mimics myocardial ischemia and induces apoptosis in cardiomyocytes. During glucose deprivation, TAT-p27 inhibited apoptosis, whereas down-regulation of p27 decreased survival of cardiomyocytes. However, inhibition of autophagy by pharmacological (3-methyladenine, chloroquine, or bafilomycin A1) or genetic approaches (siRNA-mediated knockdown of Atg5) sensitized cardiomyocytes to glucose deprivation-induced apoptosis, even in the presence of TAT-p27. TAT-p27 was also able to provoke greater levels of autophagy in resting and fasting cardiomyocytes in vivo. Further, TAT-p27 enhanced autophagy and repressed cardiomyocytes apoptosis, improved cardiac function, and reduced infarct size following myocardial infarction. Again, these effects were lost when cardiac autophagy in vivo was blocked by chloroquine. Taken together, these data show that p27 positively regulates cardiac autophagy in vitro and in vivo, at rest and after metabolic stress, and that TAT-p27 inhibits apoptosis by promoting autophagy in glucose-deprived cardiomyocytes in vitro and in post-myocardial infarction hearts in vivo.	[Sun, Xuetao; Momen, Abdul; Wu, Jun; Noyan, Hossein; Li, Renke; von Harsdorf, Ruediger; Husain, Mansoor] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2C4, Canada; [Li, Renke; von Harsdorf, Ruediger; Husain, Mansoor] Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON M5G 2C4, Canada; [von Harsdorf, Ruediger; Husain, Mansoor] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 2C4, Canada; [von Harsdorf, Ruediger; Husain, Mansoor] Univ Toronto, Dept Med, Toronto, ON M5G 1L7, Canada; [Husain, Mansoor] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Husain, M (corresponding author), Toronto Gen Res Inst, 200 Elizabeth St,MaRS 3-908, Toronto, ON M5G 2C4, Canada.	mansoor.husain@utoronto.ca		Li, Ren-Ke/0000-0002-2584-060X; Sun, Xuetao/0000-0002-4402-6187; Husain, Mansoor/0000-0002-3740-6739	Canadian Institutes for Health Research [MOP-89959]; Heart and Stroke Foundation of Ontario Career Investigator Award [CI-6824]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario Career Investigator Award(Heart & Stroke Foundation of Ontario)	This work was supported by Canadian Institutes for Health Research Operating Grant MOP-89959 (to R. v. H.).; Supported by Heart and Stroke Foundation of Ontario Career Investigator Award CI-6824. To whom correspondence should be addressed: Toronto General Research Institute, 200 Elizabeth St., MaRS 3-908, Toronto, ON M5G 2C4, Canada. Tel.: 001-416-581-7489; Fax: 001-416-581-7489; E-mail: mansoor.husain@utoronto.ca.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Borriello A, 2011, EXPERT OPIN THER TAR, V15, P677, DOI 10.1517/14728222.2011.561318; Burton PBJ, 1999, EUR HEART J, V20, P604, DOI 10.1053/euhj.1998.1231; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hauck L, 2008, NAT MED, V14, P315, DOI 10.1038/nm1729; Hoefer J, 2010, CIRC RES, V107, P923, DOI 10.1161/CIRCRESAHA.110.226464; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanamori H, 2011, CARDIOVASC RES, V91, P330, DOI 10.1093/cvr/cvr073; Kanamori H, 2011, AM J PHYSIOL-HEART C, V300, pH2261, DOI 10.1152/ajpheart.01056.2010; Kanamori H, 2009, AM J PATHOL, V174, P1705, DOI 10.2353/ajpath.2009.080875; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komata T, 2003, BRIT J CANCER, V88, P1277, DOI 10.1038/sj.bjc.6600862; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Konecny F, 2012, CARDIOVASC RES, V94, P492, DOI 10.1093/cvr/cvs138; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Noyan-Ashraf MH, 2013, CIRCULATION, V127, P74, DOI 10.1161/CIRCULATIONAHA.112.091215; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Umansky SR, 1997, CELL DEATH DIFFER, V4, P608, DOI 10.1038/sj.cdd.4400282; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Zaidi SHE, 2010, J AM COLL CARDIOL, V55, P135, DOI 10.1016/j.jacc.2009.08.041; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	43	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16924	16935		10.1074/jbc.M113.542795	http://dx.doi.org/10.1074/jbc.M113.542795			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24794871	hybrid, Green Published			2022-12-28	WOS:000338016200028
J	Choi, SG; Wang, Q; Jia, JJ; Pincas, H; Turgeon, JL; Sealfon, SC				Choi, Soon Gang; Wang, Qian; Jia, Jingjing; Pincas, Hanna; Turgeon, Judith L.; Sealfon, Stuart C.			Growth Differentiation Factor 9 (GDF9) Forms an Incoherent Feed-forward Loop Modulating Follicle-stimulating Hormone beta-Subunit (FSH beta) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONADOTROPIN-RELEASING-HORMONE; CYCLASE-ACTIVATING POLYPEPTIDE; PITUITARY; GNRH; RECEPTOR; TRANSCRIPTION; FOLLISTATIN; OVARIAN; ACTIVIN; PACAP	Gonadotropin-releasing hormone (GnRH) is secreted in brief pulses from the hypothalamus and regulates follicle-stimulating hormone beta-subunit (FSH beta) gene expression in pituitary gonadotropes in a frequency-sensitive manner. The mechanisms underlying its preferential and paradoxical induction of FSH beta by low frequency GnRH pulses are incompletely understood. Here, we identify growth differentiation factor 9 (GDF9) as a GnRH-suppressed autocrine inducer of FSH beta gene expression. GDF9 gene transcription and expression were preferentially decreased by high frequency GnRH pulses. GnRH regulation of GDF9 was concentration-dependent and involved ERK and PKA. GDF9 knockdown or immunoneutralization reduced FSH beta mRNA expression. Conversely, exogenous GDF9 induced FSH beta expression in immortalized gonadotropes and in mouse primary pituitary cells. GDF9 exposure increased FSH secretion in rat primary pituitary cells. GDF9 induced Smad2/3 phosphorylation, which was impeded by ALK5 knockdown and by activin receptor-like kinase (ALK) receptor inhibitor SB-505124, which also suppressed FSH beta expression. Smad2/3 knockdown indicated that FSH beta induction by GDF9 involved Smad2 and Smad3. FSH beta mRNA induction by GDF9 and GnRH was synergistic. We hypothesized that GDF9 contributes to a regulatory loop that tunes the GnRH frequency-response characteristics of the FSH beta gene. To test this, we determined the effects of GDF9 knockdown on FSH beta induction at different GnRH pulse frequencies using a parallel perifusion system. Reduction of GDF9 shifted the characteristic pattern of GnRH pulse frequency sensitivity. These results identify GDF9 as contributing to an incoherent feed-forward loop, comprising both intracellular and secreted components, that regulates FSH beta expression in response to activation of cell surface GnRH receptors.	[Choi, Soon Gang; Wang, Qian; Jia, Jingjing; Pincas, Hanna; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Ctr Translat Syst Biol, New York, NY 10029 USA; [Choi, Soon Gang; Wang, Qian; Jia, Jingjing; Pincas, Hanna; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Turgeon, Judith L.] Univ Calif Davis, Sch Med, Dept Internal Med, Div Endocrinol, Davis, CA 95616 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis	Sealfon, SC (corresponding author), Icahn Sch Med Mt Sinai, Ctr Translat Syst Biol, Annenberg 14-94,Box 1137,1 Gustave L Levy Pl, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	Wang, Qian/AAJ-6823-2021; choi, soon gang/AAE-3187-2019	Wang, Qian/0000-0001-5504-0008; choi, soon gang/0000-0003-0314-3958; SEALFON, Stuart/0000-0001-5791-1217	National Institutes of Health [DK46943]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046943, R01DK046943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46943.	Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bertram R, 2008, B MATH BIOL, V70, P2211, DOI 10.1007/s11538-008-9341-2; Besecke LM, 1996, ENDOCRINOLOGY, V137, P3667, DOI 10.1210/en.137.9.3667; Burrin JM, 1998, ENDOCRINOLOGY, V139, P1731, DOI 10.1210/en.139.4.1731; Choi SG, 2012, J BIOL CHEM, V287, P21550, DOI 10.1074/jbc.M112.348607; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; Counis R, 2007, PEPTIDES, V28, P1797, DOI 10.1016/j.peptides.2007.05.011; CULLER MD, 1991, ENDOCRINOLOGY, V129, P2260, DOI 10.1210/endo-129-4-2260; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Ferris HA, 2007, BIOL REPROD, V77, P1073, DOI 10.1095/biolreprod.107.064139; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Fitzpatrick SL, 1998, ENDOCRINOLOGY, V139, P2571, DOI 10.1210/en.139.5.2571; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Grafer CM, 2009, MOL ENDOCRINOL, V23, P1022, DOI 10.1210/me.2008-0477; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Hosoe M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-33; Hreinsson JG, 2002, J CLIN ENDOCR METAB, V87, P316, DOI 10.1210/jc.87.1.316; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; KAISER UB, 1992, ENDOCRINOLOGY, V130, P3048, DOI 10.1210/en.130.5.3048; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Kanasaki H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105601; Kanasaki H, 2009, BIOL REPROD, V81, P465, DOI 10.1095/biolreprod.108.074765; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Liu FJ, 2002, J BIOL CHEM, V277, P32099, DOI 10.1074/jbc.M203639200; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; MARSHALL JC, 1986, NEW ENGL J MED, V315, P1459; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P653, DOI 10.1210/me.2003-0393; McGillivray SM, 2007, ENDOCRINOLOGY, V148, P762, DOI 10.1210/en.2006-0952; Mistry DS, 2011, MOL ENDOCRINOL, V25, P1387, DOI 10.1210/me.2011-0032; NAOR Z, 1986, J BIOL CHEM, V261, P2506; Nguyen KA, 2010, ENDOCRINOLOGY, V151, P4882, DOI 10.1210/en.2009-1483; Nunez L, 2003, J PHYSIOL-LONDON, V549, P835, DOI 10.1113/jphysiol.2003.040758; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Purwana IN, 2011, BIOL REPROD, V84, P996, DOI 10.1095/biolreprod.110.088526; Reddy GR, 2013, MOL ENDOCRINOL, V27, P253, DOI 10.1210/me.2012-1168; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Sharma TP, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098442; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Silva-Rocha R, 2011, MOL BIOSYST, V7, P2982, DOI 10.1039/c1mb05264k; Thompson IR, 2013, MOL ENDOCRINOL, V27, P606, DOI 10.1210/me.2012-1281; Tsutsumi R, 2010, J BIOL CHEM, V285, P20262, DOI 10.1074/jbc.M110.132662; TURGEON JL, 1990, ENDOCRINOLOGY, V127, P773, DOI 10.1210/endo-127-2-773; Turgeon JL, 2001, ENDOCRINOLOGY, V142, P4479, DOI 10.1210/en.142.10.4479; Vitt UA, 2000, ENDOCRINOLOGY, V141, P3814, DOI 10.1210/en.141.10.3814; Wang Q, 2013, MOL ENDOCRINOL, V27, P224, DOI 10.1210/me.2012-1310; Wang Y, 2009, J ENDOCRINOL, V202, P419, DOI 10.1677/JOE-08-0563; Winters SJ, 2007, MOL CELL ENDOCRINOL, V271, P45, DOI 10.1016/j.mce.2007.03.006; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101	55	16	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16164	16175		10.1074/jbc.M113.537696	http://dx.doi.org/10.1074/jbc.M113.537696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778184	Green Published, hybrid			2022-12-28	WOS:000337965700022
J	Kuuluvainen, E; Hakala, H; Havula, E; Estime, MS; Ramet, M; Hietakangas, V; Makela, TP				Kuuluvainen, Emilia; Hakala, Heini; Havula, Essi; Estime, Michelle Sahal; Ramet, Mika; Hietakangas, Ville; Makela, Tomi P.			Cyclin-dependent Kinase 8 Module Expression Profiling Reveals Requirement of Mediator Subunits 12 and 13 for Transcription of Serpent-dependent Innate Immunity Genes in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPITZ-KAVEGGIA-SYNDROME; RNA-POLYMERASE-II; COLORECTAL-CANCER; MED12 MUTATIONS; TARGET GENES; CDK8; COMPLEX; IDENTIFICATION; PROTEIN; DIFFERENTIATION	The Cdk8 (cyclin-dependent kinase 8) module of Mediator integrates regulatory cues from transcription factors to RNA polymerase II. It consists of four subunits where Med12 and Med13 link Cdk8 and cyclinC(CycC) to core Mediator. Here we have investigated the contributions of the Cdk8 module subunits to transcriptional regulation using RNA interference in Drosophila cells. Genome-wide expression profiling demonstrated separation of Cdk8-CycC and Med12-Med13 profiles. However, transcriptional regulation by Cdk8-CycC was dependent on Med12-Med13. This observation also revealed that Cdk8-CycC and Med12-Med13 often have opposite transcriptional effects. Interestingly, Med12 and Med13 profiles overlapped significantly with that of the GATA factor Serpent. Accordingly, mutational analyses indicated that GATA sites are required for Med12-Med13 regulation of Serpent-dependent genes. Med12 and Med13 were also found to be required for Serpent-activated innate immunity genes in defense to bacterial infection. The results reveal a novel role for the Cdk8 module in Serpent-dependent transcription and innate immunity.	[Kuuluvainen, Emilia; Hakala, Heini; Havula, Essi; Estime, Michelle Sahal; Hietakangas, Ville; Makela, Tomi P.] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Havula, Essi; Hietakangas, Ville] Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; [Ramet, Mika] Univ Tampere, Inst Biomed Technol, Tampere 33014, Finland; [Ramet, Mika] Univ Tampere, BioMediTech, Tampere 33014, Finland; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere 22521, Finland; [Ramet, Mika] Univ Oulu, Dept Pediat, Inst Clin Med, Oulu 90014, Finland; [Ramet, Mika] Univ Oulu, Med Res Ctr Oulu, Oulu 90014, Finland; [Ramet, Mika] Oulu Univ Hosp, Dept Children & Adolescents, Oulu 90029, Finland	University of Helsinki; University of Helsinki; Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; University of Oulu	Makela, TP (corresponding author), Univ Helsinki, Inst Biotechnol, POB 56, Helsinki 00014, Finland.	tomi.makela@helsinki.fi	; makela, tomi/B-3734-2009	Kuuluvainen, Emilia/0000-0003-0227-4331; Havula, Essi/0000-0002-9253-5816; makela, tomi/0000-0002-4869-8044; Hietakangas, Ville/0000-0002-9900-7549	Academy of Finland; Biocentrum Helsinki; Sigrid Juselius Foundation; Finnish Cancer Organisations	Academy of Finland(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organisations	This work was supported by grants from the Academy of Finland, Biocentrum Helsinki, the Sigrid Juselius Foundation, and the Finnish Cancer Organisations.	Adler AS, 2012, CANCER RES, V72, P2129, DOI 10.1158/0008-5472.CAN-11-3886; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Bonke M, 2013, G3-GENES GENOM GENET, V3, P75, DOI 10.1534/g3.112.004283; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chen JD, 2012, RNA, V18, P2148, DOI 10.1261/rna.035725.112; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045580; Cheng G, 2009, J INTERF CYTOK RES, V29, P461, DOI 10.1089/jir.2008.0078; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Ferjoux G, 2007, DEV BIOL, V305, P726, DOI 10.1016/j.ydbio.2007.03.010; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Gesellchen V, 2005, EMBO REP, V6, P979, DOI 10.1038/sj.embor.7400530; Gobert V, 2010, MOL CELL BIOL, V30, P2837, DOI 10.1128/MCB.01625-09; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Holcroft CE, 2013, J CELL SCI, V126, P3823, DOI 10.1242/jcs.117994; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Janody F, 2011, DEV DYNAM, V240, P2051, DOI 10.1002/dvdy.22705; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kampjarvi K, 2012, BRIT J CANCER, V107, P1761, DOI 10.1038/bjc.2012.428; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Keightley MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023845; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Petersen UM, 1999, EMBO J, V18, P4013, DOI 10.1093/emboj/18.14.4013; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Stramer B, 2008, EMBO REP, V9, P465, DOI 10.1038/embor.2008.34; Tamura T, 2010, J NEUROSCI, V30, P14091, DOI 10.1523/JNEUROSCI.1319-10.2010; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Tingvall TO, 2001, P NATL ACAD SCI USA, V98, P3884, DOI 10.1073/pnas.061230198; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Tsutsui T, 2011, GENES CELLS, V16, P1208, DOI 10.1111/j.1365-2443.2011.01565.x; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Vanpoucke G, 2004, NUCLEIC ACIDS RES, V32, P4155, DOI 10.1093/nar/gkh727; Vogl MR, 2013, J NEUROSCI, V33, P6679, DOI 10.1523/JNEUROSCI.5178-12.2013; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; With S, 2003, GENESIS, V35, P143, DOI 10.1002/gene.10177; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19763, DOI 10.1073/pnas.1121120109	59	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16252	16261		10.1074/jbc.M113.541904	http://dx.doi.org/10.1074/jbc.M113.541904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778181	Green Published, hybrid			2022-12-28	WOS:000337965700029
J	Mishra, J; Kumar, N				Mishra, Jayshree; Kumar, Narendra			Adapter Protein Shc Regulates Janus Kinase 3 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CYTOSKELETAL PROTEINS; IDENTIFICATION; EXPRESSION; MUTATIONS; LYMPHOMA; RECEPTOR; COMPLEX; VILLIN; SWITCH	Although constitutive activation of Janus kinase 3 (Jak3) leads to different cancers, the mechanism of trans-molecular regulation of Jak3 activation is not known. Previously we reported that Jak3 interactions with adapter protein p52ShcA (Shc) facilitate mucosal homeostasis. In this study, we characterize the structural determinants that regulate the interactions between Jak3 and Shc and demonstrate the trans-molecular mechanism of regulation of Jak3 activation by Shc. We show that Jak3 autophosphorylation was the rate-limiting step during Jak3 transphosphorylation of Shc where Jak3 directly phosphorylated two tyrosine residues in Src homology 2 (SH2) domain and one tyrosine residue each in calponin homology 1 (CH1) domain and phosphotyrosine interaction domain (PID) of Shc. Direct interactions between mutants of Jak3 and Shc showed that although FERM domain of Jak3 was sufficient for binding to Shc, CH1 and PID domains of Shc were responsible for binding to Jak3. Functionally Jak3 was autophosphorylated under IL-2 stimulation in epithelial cells. However, Shc recruited tyrosine phosphatases SHP2 and PTP1B to Jak3 and thereby dephosphorylated Jak3. Thus we not only characterize Jak3 interaction with Shc, but also demonstrate the molecular mechanism of intracellular regulation of Jak3 activation where Jak3 interactions with Shc acted as regulators of Jak3 dephosphorylation through direct interactions of Shc with both Jak3 and tyrosine phosphatases.	[Mishra, Jayshree; Kumar, Narendra] Texas A&M Hlth Sci Ctr, Irma Lerma Rangel ILR Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Mishra, J (corresponding author), Texas A&M HSC, ILR Coll Pharm, 1010 West Ave B MSC 131, Kingsville, TX 78363 USA.	mishra@pharmacy.tamhsc.edu; nkumar@tamhsc.edu	MISHRA, JAYSHREE/O-3468-2018	MISHRA, JAYSHREE/0000-0003-0619-0629; Kumar, Narendra/0000-0002-1193-0954	Crohn's & Colitis Foundation of America (CCFA) [2188]; National Institutes of Health [DK081661]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK081661] Funding Source: NIH RePORTER	Crohn's & Colitis Foundation of America (CCFA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Crohn's & Colitis Foundation of America (CCFA) Grant 2188 and National Institutes of Health Grant DK081661 (to N. K.).	Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Cornejo MG, 2009, INT J BIOCHEM CELL B, V41, P2376, DOI 10.1016/j.biocel.2009.09.004; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Koo GC, 2012, CANCER DISCOV, V2, P591, DOI 10.1158/2159-8290.CD-12-0028; Kumar N, 2004, J BIOL CHEM, V279, P45036, DOI 10.1074/jbc.M405424200; Kumar N, 2004, J BIOL CHEM, V279, P24915, DOI 10.1074/jbc.C400110200; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Lord JD, 1998, J IMMUNOL, V161, P4627; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mishra J, 2013, J BIOL CHEM, V288, P31795, DOI 10.1074/jbc.M113.504126; Mishra J, 2012, J BIOL CHEM, V287, P41386, DOI 10.1074/jbc.C112.363507; Mishra J, 2012, AM J PHYSIOL-CELL PH, V302, pC735, DOI 10.1152/ajpcell.00316.2011; Safford MG, 1997, EXP HEMATOL, V25, P374; Sato K, 1998, BIOCHEM BIOPH RES CO, V250, P223, DOI 10.1006/bbrc.1998.9293; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Ursini-Siegel J, 2008, CELL CYCLE, V7, P1936, DOI 10.4161/cc.7.13.6205; Wills MKB, 2012, BIOCHEM J, V447, P1, DOI 10.1042/BJ20120769	20	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15951	15956		10.1074/jbc.C113.527523	http://dx.doi.org/10.1074/jbc.C113.527523			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24795043	Green Published, hybrid			2022-12-28	WOS:000337965700006
J	Harjes, U; Bridges, E; McIntyre, A; Fielding, BA; Harris, AL				Harjes, Ulrike; Bridges, Esther; McIntyre, Alan; Fielding, Barbara A.; Harris, Adrian L.			Fatty Acid-binding Protein 4, a Point of Convergence for Angiogenic and Metabolic Signaling Pathways in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; AKT; EXPRESSION; RESISTANCE; ENERGY; FOXO1	Fatty acid-binding protein 4 (FABP4) is an adipogenic protein and is implicated in atherosclerosis, insulin resistance, and cancer. In endothelial cells, FABP4 is induced by VEGFA, and inhibition of FABP4 blocks most of the VEGFA effects. We investigated the DLL4-NOTCH-dependent regulation of FABP4 in human umbilical vein endothelial cells by gene/protein expression and interaction analyses following inhibitor treatment and RNA interference. We found that FABP4 is directly induced by NOTCH. Stimulation of NOTCH signaling with human recombinant DLL4 led to FABP4 induction, independently of VEGFA. FABP4 induction by VEGFA was reduced by blockade of DLL4 binding to NOTCH or inhibition of NOTCH signal transduction. Chromatin immunoprecipitation of the NOTCH intracellular domain showed increased binding to two specific regions in the FABP4 promoter. The induction of FABP4 gene expression was dependent on the transcription factor FOXO1, which was essential for basal expression of FABP4, and FABP4 up-regulation following stimulation of the VEGFA and/or the NOTCH pathway. Thus, we show that the DLL4-NOTCH pathway mediates endothelial FABP4 expression. This indicates that induction of the angiogenesis-restricting DLL4-NOTCH can have pro-angiogenic effects via this pathway. It also provides a link between DLL4-NOTCH and FOXO1-mediated regulation of endothelial gene transcription, and it shows that DLL4-NOTCH is a nodal point in the integration of pro-angiogenic and metabolic signaling in endothelial cells. This may be crucial for angiogenesis in the tumor environment.	[Harjes, Ulrike; Bridges, Esther; McIntyre, Alan; Harris, Adrian L.] Univ Oxford, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Fielding, Barbara A.] Churchill Hosp, Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Fielding, Barbara A.] Univ Surrey, Dept Nutr Sci, Surrey GU2 7WG, England	University of Oxford; University of Oxford; University of Surrey	Harris, AL (corresponding author), Univ Oxford, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	aharris.lab@imm.ox.ac.uk	Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409; Harjes, Ulrike/0000-0003-0376-1262; McIntyre, Alan/0000-0002-4791-7292	Cancer Research United Kingdom; Breast Cancer Research Foundation; National Health Service Biomedical Research Centre; Cancer Research UK [11359] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Cancer Research United Kingdom(Cancer Research UK); Breast Cancer Research Foundation; National Health Service Biomedical Research Centre; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Cancer Research United Kingdom, Breast Cancer Research Foundation, and National Health Service Biomedical Research Centre.	Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Boiteux G, 2009, INT J CANCER, V124, P1820, DOI 10.1002/ijc.24112; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Cataltepe O, 2012, NEUROPATH APPL NEURO, V38, P400, DOI 10.1111/j.1365-2990.2011.01237.x; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Djousse L, 2012, LIPIDS, V47, P757, DOI 10.1007/s11745-012-3689-7; Elmasri H, 2012, ANGIOGENESIS, V15, P457, DOI 10.1007/s10456-012-9274-0; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Holm S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028785; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Li JL, 2011, CANCER RES, V71, P6073, DOI 10.1158/0008-5472.CAN-11-1704; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Ohnuki H, 2012, BLOOD, V119, P2688, DOI 10.1182/blood-2011-03-345306; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990	28	63	66	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23168	23176		10.1074/jbc.M114.576512	http://dx.doi.org/10.1074/jbc.M114.576512			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24939870	Green Published, hybrid			2022-12-28	WOS:000341017200053
J	Khalaf, O; Fauvet, B; Oueslati, A; Dikiy, I; Mahul-Mellier, AL; Ruggeri, FS; Mbefo, MK; Vercruysse, F; Dietler, G; Lee, SJ; Eliezer, D; Lashuel, HA				Khalaf, Ossama; Fauvet, Bruno; Oueslati, Abid; Dikiy, Igor; Mahul-Mellier, Anne-Laure; Ruggeri, Francesco Simone; Mbefo, Martial K.; Vercruysse, Filip; Dietler, Giovanni; Lee, Seung-Jae; Eliezer, David; Lashuel, Hilal A.			The H50Q Mutation Enhances alpha-Synuclein Aggregation, Secretion, and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; WILD-TYPE; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; MITOCHONDRIAL FISSION; LEWY BODIES; BINDING; PHOSPHORYLATION; PROTEIN; DYNAMICS	Over the last two decades, the identification of missense mutations in the alpha-synuclein (alpha-Syn) gene SNCA in families with inherited Parkinson disease (PD) has reinforced the central role of alpha-Syn in PD pathogenesis. Recently, a new missense mutation (H50Q) in alpha-Syn was described in patients with a familial form of PD and dementia. Here we investigated the effects of this novel mutation on the biophysical properties of alpha-Syn and the consequences for its cellular function. We found that the H50Q mutation affected neither the structure of free or membrane-bound alpha-Syn monomer, its interaction with metals, nor its capacity to be phosphorylated in vitro. However, compared with the wild-type (WT) protein, the H50Q mutation accelerated alpha-Syn fibrillization in vitro. In cell-based models, H50Q mutation did not affect alpha-Syn subcellular localization or its ability to be phosphorylated by PLK2 and GRK6. Interestingly, H50Q increased alpha-Syn secretion from SHSY5Y cells into culture medium and induced more mitochondrial fragmentation in hippocampal neurons. Although the transient overexpression of WT or H50Q did not induce toxicity, both species induced significant cell death when added to the culture medium of hippocampal neurons. Strikingly, H50Q exhibited more toxicity, suggesting that the H50Q-related enhancement of alpha-Syn aggregation and secretion may play a role in the extracellular toxicity of this mutant. Together, our results provide novel insight into the mechanism by which this newly described PD-associated mutation may contribute to the pathogenesis of PD and related disorders.	[Khalaf, Ossama; Fauvet, Bruno; Oueslati, Abid; Mahul-Mellier, Anne-Laure; Mbefo, Martial K.; Vercruysse, Filip; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Ruggeri, Francesco Simone; Dietler, Giovanni] Ecole Polytech Fed Lausanne, Lab Phys Living Matter, CH-1015 Lausanne, Switzerland; [Eliezer, David] Weill Cornell Med Coll, Dept Biochem, Program Struct Biol, New York, NY 10065 USA; [Lee, Seung-Jae] Konkuk Univ, Dept Biomed Sci & Technol, Seoul 143701, South Korea	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; Konkuk University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Oueslati, Abid/ABG-8116-2020; Khalaf, Ossama/AAE-9775-2021; Dikiy, Igor/M-1031-2019; Ruggeri, Francesco Simone/C-8004-2012	Dikiy, Igor/0000-0002-8155-7788; Ruggeri, Francesco Simone/0000-0002-1232-1907; Oueslati, Abid/0000-0003-1122-7086; Khalaf, Ossama/0000-0002-8576-2260; Lee, Seung-Jae/0000-0002-5155-5335	National Institutes of Health [P41GM066354]; Keck Foundation; New York State Assembly; U.S. Department of Defense; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG019391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); New York State Assembly; U.S. Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Nathalie Jordan and Trudy Ramlall for their excellent technical support. The 900 MHz NMR spectrometers were purchased with funds from National Institutes of Health Grant P41GM066354, the Keck Foundation, the New York State Assembly, and the U.S. Department of Defense.	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Baba M, 1998, AM J PATHOL, V152, P879; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dudzik CG, 2011, BIOCHEMISTRY-US, V50, P1771, DOI 10.1021/bi101912q; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Gui YX, 2012, NEUROBIOL AGING, V33, P2841, DOI 10.1016/j.neurobiolaging.2012.02.001; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hejjaoui M, 2012, J AM CHEM SOC, V134, P5196, DOI 10.1021/ja210866j; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kara E, 2013, NEUROSCI LETT, V546, P67, DOI 10.1016/j.neulet.2013.04.058; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; Kim YS, 2006, J MOL BIOL, V360, P386, DOI 10.1016/j.jmb.2006.05.004; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Ko LW, 2008, J NEUROPATH EXP NEUR, V67, P1084, DOI 10.1097/NEN.0b013e31818c3618; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kowalik-Jankowska T, 2006, DALTON T, P5068, DOI 10.1039/b610619f; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2011, EXP MOL MED, V43, P216, DOI 10.3858/emm.2011.43.4.026; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Oueslati A, 2012, J NEUROSCI, V32, P1536, DOI 10.1523/JNEUROSCI.3784-11.2012; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pandey N, 2006, EXP NEUROL, V197, P515, DOI 10.1016/j.expneurol.2005.10.019; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Proukakis C, 2013, MOVEMENT DISORD, V28, P705, DOI 10.1002/mds.25502; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Sung YH, 2006, BBA-PROTEINS PROTEOM, V1764, P5, DOI 10.1016/j.bbapap.2005.11.003; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Sweers KKM, 2012, SOFT MATTER, V8, P7215, DOI 10.1039/c2sm25426c; Tabrizi SJ, 2000, HUM MOL GENET, V9, P2683, DOI 10.1093/hmg/9.18.2683; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wislet-Gendebien S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-92; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang HY, 2013, BIOPHYS J, V104, P2706, DOI 10.1016/j.bpj.2013.04.050	62	125	129	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21856	21876		10.1074/jbc.M114.553297	http://dx.doi.org/10.1074/jbc.M114.553297			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24936070	Green Published, hybrid			2022-12-28	WOS:000340593500005
J	Sanchez, HA; Bienkowski, R; Slavi, N; Srinivas, M; Verselis, VK				Sanchez, Helmuth A.; Bienkowski, Rick; Slavi, Nefeli; Srinivas, Miduturu; Verselis, Vytas K.			Altered Inhibition of Cx26 Hemichannels by pH and Zn2+ in the A40V Mutation Associated with Keratitis-Ichthyosis-Deafness Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNEL; HORIZONTAL CELLS; XENOPUS-OOCYTES; SKIN-DISEASE; CONNEXIN26-CONTAINING CHANNELS; CONNEXIN HEMICHANNELS; FUNCTIONAL EXPRESSION; ZINC MODULATION; CA2+ REGULATION; ATP RELEASE	Excessive opening of undocked Cx26 hemichannels in the plasma membrane is associated with disease pathogenesis in keratitis-ichthyosis-deafness (KID) syndrome. Thus far, excessive opening of KID mutant hemichannels has been attributed, almost solely, to aberrant inhibition by extracellular Ca2+. This study presents two new possible contributing factors, pH and Zn2+. Plasma pH levels and micromolar concentrations of Zn2+ inhibit WT Cx26 hemichannels. However, A40V KID mutant hemichannels show substantially reduced inhibition by these factors. Using excised patches, acidification was shown to be effective from either side of the membrane, suggesting a protonation site accessible to H+ flux through the pore. Sensitivity to pH was not dependent on extracellular aminosulfonate pH buffers. Single channel recordings showed that acidification did not affect unitary conductance or block the hemichannel but rather promoted gating to the closed state with transitions characteristic of the intrinsic loop gating mechanism. Examination of two nearby KID mutants in the E1 domain, G45E and D50N, showed no changes in modulation by pH or Zn2+. N-bromo-succinimide, but not thiol-specific reagents, attenuated both pH and Zn2+ responses. Individually mutating each of the five His residues in WT Cx26 did not reveal a key His residue that conferred sensitivity to pH or Zn2+. From these data and the crystal structure of Cx26 that suggests that Ala-40 contributes to an intrasubunit hydrophobic core, the principal effect of the A40V mutation is probably a perturbation in structure that affects loop gating, thereby affecting multiple factors that act to close Cx26 hemichannels via this gating mechanism.	[Sanchez, Helmuth A.; Verselis, Vytas K.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Bienkowski, Rick] Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA 30322 USA; [Slavi, Nefeli; Srinivas, Miduturu] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	Yeshiva University; Albert Einstein College of Medicine; Emory University; State University of New York (SUNY) System; SUNY Optometry	Verselis, VK (corresponding author), Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	vytas.verselis@einstein.yu.edu		SANCHEZ RIQUELME, HELMUTH/0000-0003-0770-9082	National Institutes of Health [GM054179, EY013869, T32 NS007439]; NATIONAL EYE INSTITUTE [R01EY013869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM054179 (to V. K. V.), EY013869 (to M. S.), and T32 NS007439 (to H. A. S).	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Beahm DL, 2002, BIOPHYS J, V82, P2016, DOI 10.1016/S0006-3495(02)75550-1; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Chappell RL, 2004, BIOL BULL-US, V207, P188, DOI 10.2307/1543206; Dermietzel R, 2000, J NEUROSCI, V20, P8331, DOI 10.1523/JNEUROSCI.20-22-08331.2000; Di WL, 2001, J INVEST DERMATOL, V117, P958, DOI 10.1046/j.0022-202x.2001.01468.x; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Gossman DG, 2008, CELL COMMUN ADHES, V15, P305, DOI 10.1080/15419060802357217; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; Hombach S, 2004, EUR J NEUROSCI, V19, P2633, DOI 10.1111/j.0953-816X.2004.03360.x; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Klaassen LJ, 2012, BRAIN RES, V1487, P25, DOI 10.1016/j.brainres.2012.04.059; Kumar Piyush, 2012, Dermatol Online J, V18, P1; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Lee JR, 2009, J INVEST DERMATOL, V129, P870, DOI 10.1038/jid.2008.335; Lee SH, 2006, YONSEI MED J, V47, P293, DOI 10.3349/ymj.2006.47.3.293; Levit NA, 2012, BBA-BIOMEMBRANES, V1818, P2014, DOI 10.1016/j.bbamem.2011.09.003; Locke D, 2011, J GEN PHYSIOL, V138, P321, DOI 10.1085/jgp.201110634; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lopez W, 2013, J GEN PHYSIOL, V142, P23, DOI 10.1085/jgp.201210893; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Mese G, 2011, MOL BIOL CELL, V22, P4776, DOI 10.1091/mbc.E11-09-0778; Mhaske PV, 2013, AM J PHYSIOL-CELL PH, V304, pC1150, DOI 10.1152/ajpcell.00374.2012; Miles E W, 1977, Methods Enzymol, V47, P431; Nakagawa S, 2010, CURR OPIN STRUC BIOL, V20, P423, DOI 10.1016/j.sbi.2010.05.003; Ripps H, 2004, CELL MOL NEUROBIOL, V24, P647, DOI 10.1023/B:CEMN.0000036403.43484.3d; Rubinos C, 2012, J GEN PHYSIOL, V139, P69, DOI 10.1085/jgp.201110678; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Scott CA, 2012, BBA-BIOMEMBRANES, V1818, P1952, DOI 10.1016/j.bbamem.2011.09.004; Spande T F, 1970, Adv Protein Chem, V24, P97, DOI 10.1016/S0065-3233(08)60242-9; SPRAY DC, 1981, J GEN PHYSIOL, V77, P77, DOI 10.1085/jgp.77.1.77; Stefaniak AB, 2013, SKIN RES TECHNOL, V19, P59, DOI 10.1111/srt.12016; Stong BC, 2006, LARYNGOSCOPE, V116, P2205, DOI 10.1097/01.mlg.0000241944.77192.d2; Sun Z, 2009, J NEUROPHYSIOL, V101, P1774, DOI 10.1152/jn.90581.2008; Tao L, 2004, J BIOL CHEM, V279, P38544, DOI 10.1074/jbc.M405654200; Terrinoni A, 2010, BIOCHEM BIOPH RES CO, V394, P909, DOI 10.1016/j.bbrc.2010.03.073; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Xu J, 2013, BBA-BIOMEMBRANES, V1828, P167, DOI 10.1016/j.bbamem.2012.06.024; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102; Zoidl G, 2004, J BIOL CHEM, V279, P2913, DOI 10.1074/jbc.M304850200	47	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21519	21532		10.1074/jbc.M114.578757	http://dx.doi.org/10.1074/jbc.M114.578757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939841	hybrid, Green Published			2022-12-28	WOS:000340558300028
J	Brozzi, F; Gerlo, S; Grieco, FA; Nardelli, TR; Lievens, S; Gysemans, C; Marselli, L; Marchetti, P; Mathieu, C; Tavernier, J; Eizirik, DL				Brozzi, Flora; Gerlo, Sarah; Grieco, Fabio Arturo; Nardelli, Tarlliza Romanna; Lievens, Sam; Gysemans, Conny; Marselli, Lorella; Marchetti, Piero; Mathieu, Chantal; Tavernier, Jan; Eizirik, Decio L.			A Combined "Omics" Approach Identifies N-Myc Interactor as a Novel Cytokine-induced Regulator of IRE1 alpha Protein and c-Jun N-terminal Kinase in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; CANDIDATE GENE; MESSENGER-RNAS; ISLET INFLAMMATION; ER STRESS; NOD MICE; TYPE-1; DEATH	Type 1 diabetes is an autoimmune disease with a strong inflammatory component. The cytokines interleukin-1 beta and interferon-gamma contribute to beta cell apoptosis in type 1 diabetes. These cytokines induce endoplasmic reticulum stress and the unfolded protein response (UPR), contributing to the loss of beta cells. IRE1 alpha, one of the UPR mediators, triggers insulin degradation and inflammation in beta cells and is critical for the transition from "physiological" to "pathological" UPR. The mechanisms regulating inositol-requiring protein 1 alpha (IRE1 alpha) activation and its signaling for beta cell "adaptation," "stress response," or "apoptosis" remain to be clarified. To address these questions, we combined mammalian protein-protein interaction trap-based IRE1 alpha interactome and functional genomic analysis of human and rodent beta cells exposed to pro-inflammatory cytokines to identify novel cytokine-induced regulators of IRE1 alpha. Based on this approach, we identified N-Myc interactor (NMI) as an IRE1 alpha-interacting/modulator protein in rodent and human pancreatic beta cells. An increased expression of NMI was detected in islets from nonobese diabetic mice with insulitis and in rodent or human beta cells exposed in vitro to the pro-inflammatory cytokines interleukin-1 beta and interferon-gamma. Detailed mechanistic studies demonstrated that NMI negatively modulates IRE1 alpha-dependent activation of JNK and apoptosis in rodent and human pancreatic beta cells. In conclusion, by using a combined omics approach, we identified NMI induction as a novel negative feedback mechanism that decreases IRE1 alpha-dependent activation of JNK and apoptosis in cytokine-exposed beta cells.	[Brozzi, Flora; Grieco, Fabio Arturo; Nardelli, Tarlliza Romanna; Eizirik, Decio L.] Univ Libre Bruxelles, Lab Expt Med, B-1070 Brussels, Belgium; [Brozzi, Flora; Grieco, Fabio Arturo; Nardelli, Tarlliza Romanna; Eizirik, Decio L.] Univ Libre Bruxelles, Ctr Diabet Res, B-1070 Brussels, Belgium; [Gerlo, Sarah; Lievens, Sam; Tavernier, Jan] Flanders Interuniv Inst Biotechnol VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Gerlo, Sarah; Lievens, Sam; Tavernier, Jan] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Nardelli, Tarlliza Romanna] Univ Estadual Campinas, Lab Endocrine Pancreas & Metab, BR-13083970 Sao Paulo, Brazil; [Gysemans, Conny; Mathieu, Chantal] KULeuven, Lab Clin & Expt Endocrinol, B-3000 Leuven, Belgium; [Marselli, Lorella; Marchetti, Piero] Univ Pisa, Dept Clin & Expt Med, Islet Cell Lab, I-56126 Pisa, Italy	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University; Universidade Estadual de Campinas; KU Leuven; University of Pisa	Eizirik, DL (corresponding author), Univ Libre Bruxelles, Lab Expt Med, Route Lennik 808,CP618, B-1070 Brussels, Belgium.	deizirik@ulb.ac.be	Tavernier, Jan/AAG-3636-2019; Marchetti, Piero/J-7439-2013; mathieu, chantal/ABD-5505-2021	Marchetti, Piero/0000-0003-4907-0635; mathieu, chantal/0000-0002-4055-5233; gysemans, conny/0000-0003-3559-6089; Marselli, Lorella/0000-0002-6698-2962	Juvenile Diabetes Research Foundation [17-2013-515]; European Union Projects NAMIT and BetaBat, in the Framework Programme 7 of the European Community; Actions de Recherche Concertee de la Communaute Francaise; Fonds National de la Recherche Scientifique, Belgium; Ghent University GROUP-ID Multidisciplinary Research Platform; Katholieke Universiteit Leuven and the seventh Framework Program of the European Union	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union Projects NAMIT and BetaBat, in the Framework Programme 7 of the European Community; Actions de Recherche Concertee de la Communaute Francaise; Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); Ghent University GROUP-ID Multidisciplinary Research Platform; Katholieke Universiteit Leuven and the seventh Framework Program of the European Union	This work was supported in part by Juvenile Diabetes Research Foundation International Grant 17-2013-515, European Union Projects NAMIT and BetaBat, in the Framework Programme 7 of the European Community, Actions de Recherche Concertee de la Communaute Francaise, and the Fonds National de la Recherche Scientifique, Belgium.; Postdoctoral fellow of the Research Foundation-Flanders and supported by the Ghent University GROUP-ID Multidisciplinary Research Platform.; Supported by the Katholieke Universiteit Leuven and the seventh Framework Program of the European Union with Natural Immunomodulators as Novel Immunotherapies for Type 1 Diabetes.	Allagnat F, 2012, CELL DEATH DIFFER, V19, P1836, DOI 10.1038/cdd.2012.67; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; Bonny C, 2000, J BIOL CHEM, V275, P16466, DOI 10.1074/jbc.M908297199; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe7; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Grieco FA, 2014, DIABETOLOGIA, V57, P502, DOI 10.1007/s00125-013-3135-2; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109; Koga S, 2012, BRAIN RES, V1436, P137, DOI 10.1016/j.brainres.2011.12.004; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lee S, 2010, BRIT J CANCER, V103, P265, DOI 10.1038/sj.bjc.6605711; Lee SI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3750; Lievens S, 2012, METHODS MOL BIOL, V812, P283, DOI 10.1007/978-1-61779-455-1_17; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Marroqui L, 2014, DIABETES, V63, P2516, DOI 10.2337/db13-1443; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Miani M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.236; Miani M, 2012, ENDOCRINOLOGY, V153, P3017, DOI 10.1210/en.2011-2090; Moore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031062; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Pirot P, 2007, DIABETOLOGIA, V50, P1006, DOI 10.1007/s00125-007-0609-0; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rodriguez DA, 2012, EMBO J, V31, P2322, DOI 10.1038/emboj.2012.84; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santin I, 2013, DIABETES OBES METAB, V15, P71, DOI 10.1111/dom.12162; Santin I, 2011, DIABETES, V60, P3279, DOI 10.2337/db11-0758; Schulz K, 1999, NITRIC OXIDE-BIOL CH, V3, P225, DOI 10.1006/niox.1999.0226; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	69	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20677	20693		10.1074/jbc.M114.568808	http://dx.doi.org/10.1074/jbc.M114.568808			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936061	Green Published, hybrid			2022-12-28	WOS:000339396600026
J	Neueder, A; Achilli, F; Moussaoui, S; Bates, GP				Neueder, Andreas; Achilli, Francesca; Moussaoui, Saliha; Bates, Gillian P.			Novel Isoforms of Heat Shock Transcription Factor 1, HSF1 gamma alpha and HSF1 gamma beta, Regulate Chaperone Protein Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; FACTOR FAMILY; NUCLEAR-LOCALIZATION; FACTOR ACTIVATION; STRESS-RESPONSE; RAINBOW-TROUT; DANIO-RERIO; EXPRESSION; MOUSE; DISTINCT	The heat shock response, resulting in the production of heat shock proteins or molecular chaperones, is triggered by elevated temperature and a variety of other stressors. Its master regulator is heat shock transcription factor 1 (HSF1). Heat shock factors generally exist in multiple isoforms. The two known isoforms of HSF1 differ in the inclusion (HSF1 alpha) or exclusion (HSF1 beta) of exon 11. Although there are some data concerning the differential expression patterns and transcriptional activities of HSF2 isoforms during development, little is known about the distinct properties of the HSF1 isoforms. Here we present evidence for two novel HSF1 isoforms termed HSF1 gamma alpha and HSF1 gamma beta, and we show that the HSF1 isoform ratio differentially regulates heat shock protein gene transcription. Hsf1 gamma isoforms are expressed in various mouse tissues and are translated into protein. Furthermore, after heat shock, HSF1 gamma isoforms are exported from the nucleus more rapidly or degraded more quickly than HSF1 alpha or HSF1 beta. We also show that each individual HSF1 isoform is sufficient to induce the heat shock response and that expression of combinations of HSF1 isoforms, in particular HSF1 alpha and HSF1 beta, results in a synergistic enhancement of the transcriptional response. In addition, HSF1 gamma isoforms potentially suppress the synergistic effect of HSF1 alpha and HSF1 beta co-expression. Collectively, our observations suggest that the expression of HSF1 isoforms in a specific ratio provides an additional layer in the regulation of heat shock protein gene transcription.	[Neueder, Andreas; Achilli, Francesca; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Moussaoui, Saliha] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	University of London; King's College London; Novartis	Bates, GP (corresponding author), Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England.	gillian.bates@kcl.ac.uk	Neueder, Andreas/K-4319-2015; Bates, Gillian/E-1146-2012	Neueder, Andreas/0000-0002-2389-5236; Bates, Gillian/0000-0002-4041-6305	Medical Research Council [G0801314]; MRC [G0801314] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (Grant G0801314).	Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; Airaksinen S, 2003, COMP BIOCHEM PHYS A, V134, P839, DOI 10.1016/S1095-6433(03)00033-3; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alastalo TP, 2003, J CELL SCI, V116, P3557, DOI 10.1242/jcs.00671; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Buckley BA, 2002, J EXP BIOL, V205, P3231; Carnemolla A, 2014, HUM MOL GENET, V23, P3641, DOI 10.1093/hmg/ddu073; de Thonel A, 2012, INT J BIOCHEM CELL B, V44, P1593, DOI 10.1016/j.biocel.2012.06.012; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; FIORENZA MT, 1995, NUCLEIC ACIDS RES, V23, P467, DOI 10.1093/nar/23.3.467; Fritah S, 2009, MOL BIOL CELL, V20, P4976, DOI 10.1091/mbc.E09-04-0295; Fu S, 2006, PLANTA, V224, P42, DOI 10.1007/s00425-005-0191-y; Fujikake N, 2005, FEBS LETT, V579, P3842, DOI 10.1016/j.febslet.2005.05.074; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475; GOODSON ML, 1995, BIOCHEM BIOPH RES CO, V211, P943, DOI 10.1006/bbrc.1995.1903; GOODSON ML, 1995, MOL CELL BIOL, V15, P5288; Gothard LQ, 2003, J BIOL CHEM, V278, P9322, DOI 10.1074/jbc.M209412200; Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749; He HY, 2003, J BIOL CHEM, V278, P35465, DOI 10.1074/jbc.M304663200; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Kawabe S, 2011, J EXP ZOOL PART A, V315A, P394, DOI 10.1002/jez.685; Kayani AC, 2008, REJUV RES, V11, P1021, DOI 10.1089/rej.2008.0795; Kregel KC, 1996, J APPL PHYSIOL, V80, P547, DOI 10.1152/jappl.1996.80.2.547; Le Goff P, 1999, BIOCHEM BIOPH RES CO, V259, P15, DOI 10.1006/bbrc.1999.0729; Lecomte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056085; Locke M, 1996, CELL STRESS CHAPERON, V1, P251, DOI 10.1379/1466-1268(1996)001<0251:DHSRIT>2.3.CO;2; Locke M, 2000, CELL STRESS CHAPERON, V5, P45, DOI 10.1379/1466-1268(2000)005<0045:HSTFAA>2.0.CO;2; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Menezes DL, 2012, MOL CANCER THER, V11, P730, DOI 10.1158/1535-7163.MCT-11-0667; MEZGER V, 1994, DEV BIOL, V166, P819, DOI 10.1006/dbio.1994.1361; MURPHY SP, 1994, MOL CELL BIOL, V14, P5309, DOI 10.1128/MCB.14.8.5309; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Ojima N, 2004, EUR J BIOCHEM, V271, P703, DOI 10.1111/j.1432-1033.2003.03972.x; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Rabergh CMI, 2000, J EXP BIOL, V203, P1817; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; Rallu M, 1997, P NATL ACAD SCI USA, V94, P2392, DOI 10.1073/pnas.94.6.2392; Raychaudhuri S, 2014, CELL, V156, P975, DOI 10.1016/j.cell.2014.01.055; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1995, NATURE, V374, P126, DOI 10.1038/374126a0; SARGE KD, 1994, BIOL REPROD, V50, P1334, DOI 10.1095/biolreprod50.6.1334; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; Sasi BK, 2014, J MOL BIOL, V426, P116, DOI 10.1016/j.jmb.2013.09.008; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Xu YM, 2012, J PROTEOME RES, V11, P2625, DOI 10.1021/pr201151a; Zhang Y, 2001, J CELL BIOCHEM, V82, P692, DOI 10.1002/jcb.1191; ZIMARINO V, 1990, MOL CELL BIOL, V10, P752, DOI 10.1128/MCB.10.2.752	59	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19894	19906		10.1074/jbc.M114.570739	http://dx.doi.org/10.1074/jbc.M114.570739			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24855652	hybrid, Green Published			2022-12-28	WOS:000339395200008
J	Wang, LH; Cao, HL; Liu, LP; Wang, BM; Walker, WA; Acra, SA; Yan, F				Wang, Lihong; Cao, Hailong; Liu, Liping; Wang, Bangmao; Walker, W. Allan; Acra, Sari A.; Yan, Fang			Activation of Epidermal Growth Factor Receptor Mediates Mucin Production Stimulated by p40, a Lactobacillus rhamnosus GG-derived Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; GENE-EXPRESSION; IN-VITRO; DEPENDENT MECHANISM; SOLUBLE-PROTEIN; DRUG-DELIVERY; MOUSE STOMACH; MUCUS LAYERS; SECRETION; COLON	The mucus layer coating the gastrointestinal tract serves as the first line of intestinal defense against infection and injury. Probiotics promote mucin production by goblet cells in the intestine. p40, a Lactobacillus rhamnosus GG-derived soluble protein, has been shown to transactivate the EGF receptor (EGFR) in intestinal epithelial cells, which is required for inhibition of apoptosis and preservation of barrier function in the colon, thereby ameliorating intestinal injury and colitis. Because activation of EGFR has been shown to up-regulate mucin production in goblet cells, the purpose of this study was to investigate the effects and mechanisms of p40 regulation of mucin production. p40 activated EGFR and its downstream target, Akt, in a concentration-dependent manner in LS174T cells. p40 stimulated Muc2 gene expression and mucin production in LS174T cells, which were abolished by inhibition of EGFR kinase activity, down-regulation of EGFR expression by EGFR siRNA transfection, or suppression of Akt activation. Treatment with p40 increased mucin production in the colonic epithelium, thus thickening the mucus layer in the colon of wild type, but not of Egfr(wa5) mice, which have a dominant negative mutation in the EGFR kinase domain. Furthermore, inhibition of mucin-type O-linked glycosylation suppressed the effect of p40 on increasing mucin production and protecting intestinal epithelial cells from TNF-induced apoptosis in colon organ culture. Thus, these results suggest that p40-stimulated activation of EGFR mediates up-regulation of mucin production, which may contribute to the mechanisms by which p40 protects the intestinal epithelium from injury.	[Wang, Lihong; Liu, Liping; Acra, Sari A.; Yan, Fang] Vanderbilt Univ, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Med Ctr, Nashville, TN 37232 USA; [Cao, Hailong; Wang, Bangmao] Tianjin Med Univ, Dept Gastroenterol, Gen Hosp, Tianjin 300052, Peoples R China; [Walker, W. Allan] Harvard Univ, Mucosal Immunol & Biol Res Ctr, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA	Vanderbilt University; Tianjin Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yan, F (corresponding author), Vanderbilt Univ, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Med Ctr, 2215 Garland Ave,MRB 4,Rm 1035, Nashville, TN 37232 USA.	fang.yan@vanderbilt.edu	liu, li/HGC-0900-2022		National Institutes of Health [R01 DK081134, P01 DK033506, R01 HD059126, P30 DK058404]; Research Fund for the Doctoral Program of Higher Education of China [20121202110018]; National Natural Science Foundation of China [81300272]; Tianjin Research Program of Application Foundation and Advanced Technology of China [13JCQNJC10600]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, P30DK040561, R01DK081134, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology of China; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK081134 (to F. Y.), and P01 DK033506 and R01 HD059126 (to W. A. W.), and P30 DK058404 (to Vanderbilt University Medical Center's Digestive Disease Research Center). This work was also supported by Research Fund for the Doctoral Program of Higher Education of China Grant 20121202110018 (to B. M. W.), and National Natural Science Foundation of China Grant 81300272 (to H. L. C.) and Tianjin Research Program of Application Foundation and Advanced Technology of China Grant 13JCQNJC10600 (to H. L. C.).	Basu S, 2009, J CLIN GASTROENTEROL, V43, P208, DOI 10.1097/MCG.0b013e31815a5780; Bucci M, 2000, BRIT J PHARMACOL, V131, P13, DOI 10.1038/sj.bjp.0703549; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Dartt DA, 2000, EXP EYE RES, V71, P619, DOI 10.1006/exer.2000.0915; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Doron S, 2005, GASTROENTEROL CLIN N, V34, P483, DOI 10.1016/j.gtc.2005.05.011; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Gorbach SL, 1996, NUTR TODAY, V31, P25, DOI DOI 10.1097/00017285-199611001-00002; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Hodges RR, 2012, EXP EYE RES, V103, P99, DOI 10.1016/j.exer.2012.08.010; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kim YD, 2002, J KOREAN MED SCI, V17, P765, DOI 10.3346/jkms.2002.17.6.765; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Lee D, 2004, MAMM GENOME, V15, P525, DOI 10.1007/s00335-004-2384-2; Liu LS, 2006, DRUG DELIV, V13, P417, DOI 10.1080/10717540500394935; Liu LS, 2003, BIOMATERIALS, V24, P3333, DOI 10.1016/S0142-9612(03)00213-8; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mattar AF, 2002, PEDIATR SURG INT, V18, P586, DOI 10.1007/s00383-002-0855-7; McElroy SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG656, DOI 10.1152/ajpgi.00550.2010; Nadel JA, 2001, RESP RES, V2, P85, DOI 10.1186/rr43; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Perrais M, 2002, J BIOL CHEM, V277, P32258, DOI 10.1074/jbc.M204862200; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; Rubin Bruce K, 2002, Respir Care, V47, P761; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Truant S, 2003, INT J CANCER, V104, P683, DOI 10.1002/ijc.11011; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2013, J BIOL CHEM, V288, P30742, DOI 10.1074/jbc.M113.492397; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	51	88	93	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20234	20244		10.1074/jbc.M114.553800	http://dx.doi.org/10.1074/jbc.M114.553800			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895124	hybrid, Green Published			2022-12-28	WOS:000339395200036
J	Wei, SP; Roessler, BC; Chauvet, S; Guo, JY; Hartman, JL; Kirk, KL				Wei, Shipeng; Roessler, Bryan C.; Chauvet, Sylvain; Guo, Jingyu; Hartman, John L.; Kirk, Kevin L.			Conserved Allosteric Hot Spots in the Transmembrane Domains of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels and Multidrug Resistance Protein (MRP) Pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; ATP-BINDING; CHLORIDE CHANNEL; ABC TRANSPORTERS; A-LOOP; MODEL; HYDROLYSIS; MECHANISM; CASSETTE; PEPTIDE	ATP-binding cassette (ABC) transporters are an ancient family of transmembrane proteins that utilize ATPase activity to move substrates across cell membranes. The ABCC subfamily of the ABC transporters includes active drug exporters (the multidrug resistance proteins (MRPs)) and a unique ATP-gated ion channel (cystic fibrosis transmembrane conductance regulator (CFTR)). The CFTR channel shares gating principles with conventional ligand-gated ion channels, but the allosteric network that couples ATP binding at its nucleotide binding domains (NBDs) with conformational changes in its transmembrane helices (TMs) is poorly defined. It is also unclear whether the mechanisms that govern CFTR gating are conserved with the thermodynamically distinct MRPs. Here we report a new class of gain of function (GOF) mutation of a conserved proline at the base of the pore-lining TM6. Multiple substitutions of this proline promoted ATP-free CFTR activity and activation by the weak agonist, 5' -adenylyl-beta,gamma-imidodiphosphate (AMP-PNP). TM6 proline mutations exhibited additive GOF effects when combined with a previously reported GOF mutation located in an outer collar of TMs that surrounds the pore-lining TMs. Each TM substitution allosterically rescued the ATP sensitivity of CFTR gating when introduced into an NBD mutant with defective ATP binding. Both classes of GOF mutations also rescued defective drug export by a yeast MRP (Yor1p) with ATP binding defects in its NBDs. We conclude that the conserved TM6 proline helps set the energy barrier to both CFTR channel opening and MRP-mediated drug efflux and that CFTR channels and MRP pumps utilize similar allosteric mechanisms for coupling conformational changes in their translocation pathways to ATP binding at their NBDs.	[Wei, Shipeng; Roessler, Bryan C.; Chauvet, Sylvain; Kirk, Kevin L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Guo, Jingyu; Hartman, John L.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Kirk, Kevin L.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kirk, KL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 982B MCLM,1720 2nd Ave S, Birmingham, AL 35294 USA.	klkirk@uab.edu	Guo, Jingyu/M-9024-2017	Guo, Jingyu/0000-0001-6498-9848; Chauvet, Sylvain/0000-0002-7440-613X; Hartman, John/0000-0003-1176-6469	National Institutes of Health [RO1 DK056796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK056796 (to K. L. K.).	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Che Y, 2006, BIOPOLYMERS, V81, P392, DOI 10.1002/bip.20431; Chen J, 2012, J PHYS CHEM B, V116, P9346, DOI 10.1021/jp3042846; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Demchuk E, 1997, FOLD DES, V2, P35, DOI 10.1016/S1359-0278(97)00004-7; El-Sheikh AAK, 2008, MOL PHARMACOL, V74, P964, DOI 10.1124/mol.107.043661; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Gaudet R, 2001, TECHNOL REV, V104, P20; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kim IW, 2006, BIOCHEMISTRY-US, V45, P7605, DOI 10.1021/bi060308o; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; Meng HY, 2006, BIOPOLYMERS, V84, P192, DOI 10.1002/bip.20382; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okeyo G, 2013, J BIOL CHEM, V288, P17122, DOI 10.1074/jbc.M112.442582; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Shah NA, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-3; Singh I, 2009, GENETICS, V181, P289, DOI 10.1534/genetics.108.092981; Szentpetery Z, 2004, ANTICANCER RES, V24, P449; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	66	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19942	19957		10.1074/jbc.M114.562116	http://dx.doi.org/10.1074/jbc.M114.562116			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24876383	Green Published, hybrid			2022-12-28	WOS:000339395200012
J	Shieh, BH; Kristaponyte, I; Hong, Y				Shieh, Bih-Hwa; Kristaponyte, Inga; Hong, Yuan			Distinct Roles of Arrestin 1 Protein in Photoreceptors during Drosophila Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-INDUCED PHOSPHORYLATION; RETINAL-DEGENERATION; RHODOPSIN-KINASE; PHOSRESTIN-I; RECEPTOR; ENDOCYTOSIS; SYSTEM; GENE; BETA-ARRESTIN-2; MELANOGASTER	Arrestin regulates many facets of G-protein coupled receptor signaling. In Drosophila, Arrestin 1 (Arr1) is expressed at a lower level than Arrestin 2 (Arr2), and the role of Arr1 in visual physiology is less understood. Here we generated transgenic flies expressing enhanced green fluorescent protein tagged Arr1 (Arr1-eGFP) and explored its trafficking in live photoreceptors. We show that Arr1-eGFP is localized in the cytoplasm and displays light-dependent translocation to the rhabdomere possibly by interacting with photoactivated rhodopsin 1 (Rh1*). In the adult, translocation of Arr1-eGFP occurs with slower kinetics when compared with that of Arr2-eGFP. This slower kinetic activity may be attributable to a reduced level of phosphorylated Rh1*. Indeed, a reduced level of phosphorylated Rh1* recruits a lower level of Arr1-eGFP to rhabdomeres. To investigate whether Arr1 is required for the deactivation of phosphorylated Rh1*, we show that in flies with reduced Arr1 prolonged depolarizing afterpotential can be triggered with fewer light pulses, indicating that inactivation of phosphorylated Rh1* is compromised when the Arr1 level is reduced. Consistently, Arr1 is no longer required for deactivation of Rh1 in flies expressing phosphorylation- deficient Rh1. Previously it was reported that Arr1 displays light-dependent internalization. Unexpectedly, in adult photoreceptors we failed to observe endocytosis of Arr1-eGFP. In contrast, we show that in pupal photoreceptors Arr1-eGFP becomes internalized and sequestered in vesicles within the cytoplasm. Taken together, we propose that Arr1 plays distinct roles during development and adulthood. Arr1 orchestrates the recycling of phosphorylated Rh1* in pupae whereas it regulates the deactivation in adult.	Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Vis Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Shieh, BH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 402 Robinson Res Bldg, Nashville, TN 37232 USA.	bih-hwa.shieh@vanderbilt.edu			National Institutes of Health [R01 EY019519, P30 EY08126]; NATIONAL EYE INSTITUTE [R01EY019519, P30EY008126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY019519 (to B.-H. S.) and P30 EY08126 (to Vanderbilt University).	BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; HYDE DR, 1990, P NATL ACAD SCI USA, V87, P1008, DOI 10.1073/pnas.87.3.1008; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kristaponyte I, 2012, J NEUROSCI, V32, P10758, DOI 10.1523/JNEUROSCI.0565-12.2012; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; Lee SJ, 2004, P NATL ACAD SCI USA, V101, P11874, DOI 10.1073/pnas.0402205101; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; MATSUMOTO H, 1991, BIOCHEM BIOPH RES CO, V177, P1306, DOI 10.1016/0006-291X(91)90683-X; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; MISMER D, 1987, GENETICS, V116, P565; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; SMITH DP, 1990, P NATL ACAD SCI USA, V87, P1003, DOI 10.1073/pnas.87.3.1003; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; WILDEN U, 1986, FEBS LETT, V207, P292, DOI 10.1016/0014-5793(86)81507-1; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671	29	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18526	18534		10.1074/jbc.M114.571224	http://dx.doi.org/10.1074/jbc.M114.571224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24838243	Green Published, hybrid			2022-12-28	WOS:000338042000049
J	Kang, Q; Srividhya, J; Ipe, J; Pomerening, JR				Kang, Qing; Srividhya, Jeyaraman; Ipe, Joseph; Pomerening, Joseph R.			Evidence toward a Dual Phosphatase Mechanism That Restricts Aurora A (Thr-295) Phosphorylation during the Early Embryonic Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASES; KINASE AURORA; CENTROSOMAL PROTEIN; A OVEREXPRESSION; MITOTIC EXIT; PHASE ENTRY; IN-VITRO; ACTIVATION; TPX2; PLK1	The mitotic kinase Aurora A(AurA) is regulated by a complex network of factors that includes co-activator binding, autophosphorylation, and dephosphorylation. Dephosphorylation of AurA by PP2A (human, Ser-51; Xenopus, Ser-53) destabilizes the protein, whereas mitotic dephosphorylation of its T-loop (human, Thr-288; Xenopus, Thr-295) by PP6 represses AurA activity. However, AurA(Thr-295) phosphorylation is restricted throughout the early embryonic cell cycle, not just during M-phase, and how Thr-295 is kept dephosphorylated during interphase and whether or not this mechanism impacts the cell cycle oscillator were unknown. Titration of okadaic acid (OA) or fostriecin into Xenopus early embryonic extract revealed that phosphatase activity other than PP1 continuously suppresses AurA(Thr-295) phosphorylation during the early embryonic cell cycle. Unexpectedly, we observed that inhibiting a phosphatase activity highly sensitive to OA caused an abnormal increase in AurA(Thr-295) phosphorylation late during interphase that corresponded with delayed cyclin-dependent kinase 1 (CDK1) activation. AurA(Thr-295) phosphorylation indeed influenced this timing, because AurA isoforms retaining an intact Thr-295 residue further delayed M-phase entry. Using mathematical modeling, we determined that one phosphatase would be insufficient to restrict AurA phosphorylation and regulate CDK1 activation, whereas a dual phosphatase topology best recapitulated our experimental observations. We propose that two phosphatases target Thr-295 of AurA to prevent premature AurA activation during interphase and that phosphorylated AurA(Thr-295) acts as a competitor substrate with a CDK1-activating phosphatase in late interphase. These results suggest a novel relationship between AurA and protein phosphatases during progression throughout the early embryonic cell cycle and shed new light on potential defects caused by AurA overexpression.	[Kang, Qing; Srividhya, Jeyaraman; Ipe, Joseph; Pomerening, Joseph R.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Pomerening, JR (corresponding author), Indiana Univ, Dept Biol, 212 S Hawthorne Dr,Rm 043F, Bloomington, IN 47405 USA.	jpomeren@indiana.edu		Pomerening, Joseph/0000-0003-4120-9081; Ipe, Joseph/0000-0002-8362-4403	National Institutes of Health [R01GM086526]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM086526.	Abe Y, 2010, J CELL SCI, V123, P3978, DOI 10.1242/jcs.076315; Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Buck SB, 2003, J AM CHEM SOC, V125, P15694, DOI 10.1021/ja038672n; Cahu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003936; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; De Luca M, 2006, CELL CYCLE, V5, P296; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; FELIX MA, 1990, EMBO J, V9, P675, DOI 10.1002/j.1460-2075.1990.tb08159.x; Hammond D, 2013, J CELL SCI, V126, P3429, DOI 10.1242/jcs.128397; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hastie CJ, 1998, FEBS LETT, V431, P357, DOI 10.1016/S0014-5793(98)00775-3; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Jantscher F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-28; Joukov V, 2010, P NATL ACAD SCI USA, V107, P21022, DOI 10.1073/pnas.1014664107; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kitajima S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000944; Krasinska L, 2011, MOL CELL, V44, P437, DOI 10.1016/j.molcel.2011.10.007; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Li CC, 2009, MOL CANCER RES, V7, P678, DOI 10.1158/1541-7786.MCR-08-0483; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Maton G, 2005, J CELL SCI, V118, P2485, DOI 10.1242/jcs.02370; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mochida S, 2012, EMBO REP, V13, P197, DOI 10.1038/embor.2011.263; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Molli PR, 2010, J CELL BIOL, V190, P101, DOI 10.1083/jcb.200908050; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Reboutier D, 2012, J CELL BIOL, V197, P19, DOI 10.1083/jcb.201107134; Roghi C, 1998, J CELL SCI, V111, P557; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Swingle Mark, 2007, V365, P23; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	57	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17480	17496		10.1074/jbc.M113.527622	http://dx.doi.org/10.1074/jbc.M113.527622			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24825897	Green Published, hybrid			2022-12-28	WOS:000338018100016
J	Schulz, D; Pirkl, N; Lehmann, E; Cramer, P				Schulz, Daniel; Pirkl, Nicole; Lehmann, Elisabeth; Cramer, Patrick			Rpb4 Subunit Functions Mainly in mRNA Synthesis by RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; DECAY; TRANSCRIPTION; REVEALS; STRESS; DEGRADATION; RECRUITMENT; SUBCOMPLEX; DELETION	RNA polymerase II (Pol II) is the central enzyme that carries out eukaryotic mRNA transcription and consists of a 10-subunit catalytic core and a subcomplex of subunits Rpb4 and Rpb7 (Rpb4/7). Rpb4/7 has been proposed to dissociate from Pol II, enter the cytoplasm, and function there in mRNA translation and degradation. Here we provide evidence that Rpb4 mainly functions in nuclear mRNA synthesis by Pol II, as well as evidence arguing against an important cytoplasmic role in mRNA degradation. We used metabolic RNA labeling and comparative Dynamic Transcriptome Analysis to show that Rpb4 deletion in Saccharomyces cerevisiae causes a drastic defect in mRNA synthesis that is compensated by down-regulation of mRNA degradation, resulting in mRNA level buffering. Deletion of Rpb4 can be rescued by covalent fusion of Rpb4 to the Pol II core subunit Rpb2, which largely restores mRNA synthesis and degradation defects caused by Rpb4 deletion. Thus, Rpb4 is a bona fide Pol II core subunit that functions mainly in mRNA synthesis.	[Schulz, Daniel; Pirkl, Nicole; Lehmann, Elisabeth; Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Schulz, Daniel; Pirkl, Nicole; Lehmann, Elisabeth; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany; [Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany	University of Munich; University of Munich; Max Planck Society	Cramer, P (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	pcramer@mpibpc.mpg.de		Schulz, Daniel/0000-0002-0913-1678				Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; CHODER M, 1993, MOL CELL BIOL, V13, P6984, DOI 10.1128/MCB.13.11.6984; Choder Mordechai, 2011, Cell Logist, V1, P37, DOI 10.4161/cl.1.1.14465; Dahan N, 2013, BBA-GENE REGUL MECH, V1829, P169, DOI 10.1016/j.bbagrm.2012.08.004; Duan RX, 2013, BIOCHEM BIOPH RES CO, V441, P266, DOI 10.1016/j.bbrc.2013.10.079; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Farago M, 2003, MOL BIOL CELL, V14, P2744, DOI 10.1091/mbc.E02-11-0740; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Haimovich G, 2013, BBA-GENE REGUL MECH, V1829, P643, DOI 10.1016/j.bbagrm.2013.01.004; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Jasiak AJ, 2008, J BIOL CHEM, V283, P26423, DOI 10.1074/jbc.M803237200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Maillet I, 1999, J BIOL CHEM, V274, P22586, DOI 10.1074/jbc.274.32.22586; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Miyao T, 2001, J BIOL CHEM, V276, P46408, DOI 10.1074/jbc.M107012200; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Pillai B, 2003, J BIOL CHEM, V278, P3339, DOI 10.1074/jbc.M112180200; Rosenheck S, 1998, J BACTERIOL, V180, P6187; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Schwalb B, 2012, BIOINFORMATICS, V28, P884, DOI 10.1093/bioinformatics/bts052; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Verma-Gaur J, 2008, EUKARYOT CELL, V7, P1009, DOI 10.1128/EC.00057-08; Walmacq C, 2009, J BIOL CHEM, V284, P19601, DOI 10.1074/jbc.M109.006908	34	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17446	17452		10.1074/jbc.M114.568014	http://dx.doi.org/10.1074/jbc.M114.568014			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24802753	hybrid, Green Published			2022-12-28	WOS:000338018100013
J	Liu, HW; Hou, PP; Guo, XY; Zhao, ZW; Hu, B; Li, X; Wang, LY; Ding, JP; Wang, S				Liu, Hao-Wen; Hou, Pan-Pan; Guo, Xi-Ying; Zhao, Zhi-Wen; Hu, Bin; Li, Xia; Wang, Lu-Yang; Ding, Jiu-Ping; Wang, Sheng			Structural Basis for Calcium and Magnesium Regulation of a Large Conductance Calcium-activated Potassium Channel with beta 1 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; BK CHANNELS; CHROMAFFIN CELLS; MOLECULAR-BASIS; VOLTAGE SENSOR; INACTIVATION; CA2+; CLONING; HKCNMB3; DOMAINS	Large conductance Ca2+- and voltage-activated potassium (BK) channels, composed of pore-forming alpha subunits and auxiliary beta subunits, play important roles in diverse physiological activities. The beta 1 is predominately expressed in smooth muscle cells, where it greatly enhances the Ca2+ sensitivity of BK channels for proper regulation of smooth muscle tone. However, the structural basis underlying dynamic interaction between BK mSlo1 alpha and beta 1 remains elusive. Using macroscopic ionic current recordings in various Ca2+ and Mg2+ concentrations, we identified two binding sites on the cytosolic N terminus of beta 1, namely the electrostatic enhancing site (mSlo1(K392,R393)-beta 1(E13,T14)), increasing the calcium sensitivity of BK channels, and the hydrophobic site (mSlo1(L906,L908)-beta 1(L5,V6,M7)), passing the physical force from the Ca2+ bowl onto the enhancing site and S6 C-linker. Dynamic binding of these sites affects the interaction between the cytosolic domain and voltage-sensing domain, leading to the reduction of Mg2+ sensitivity. A comprehensive structural model of the BK(mSlo1 alpha-beta 1) complex was reconstructed based on these functional studies, which provides structural and mechanistic insights for understanding BK gating.	[Liu, Hao-Wen; Hou, Pan-Pan; Guo, Xi-Ying; Zhao, Zhi-Wen; Hu, Bin; Li, Xia; Ding, Jiu-Ping; Wang, Sheng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Wang, Lu-Yang] Univ Toronto, SickKids Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Wang, Lu-Yang] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada	Huazhong University of Science & Technology; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Ding, JP (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Hubei, Peoples R China.	jpding@mail.hust.edu.cn; shengwang@mail.hust.edu.cn	Hu, Bin/AAF-5908-2019; Hou, Panpan/Q-2941-2019	Hu, Bin/0000-0003-0646-0182; Hou, Panpan/0000-0001-7694-2262	National Basic Research Program of China [2010CB529804]; Fundamental Research Funds for the Central Universities [2014TS087]; National Science Foundation of China [30971179, 31170814, 31028006]; Canadian Institutes of Health Research; China-Canada Joint Health Research Initiative grant; Canada Research Chair	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); China-Canada Joint Health Research Initiative grant; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by National Basic Research Program of China Grant 2010CB529804 (to J. P. D.); Fundamental Research Funds for the Central Universities Grant 2014TS087 (to S. W.); National Science Foundation of China Grants 30971179, 31170814, and 31028006 (to J. P. D.); and individual Operating Grants from the Canadian Institutes of Health Research, a China-Canada Joint Health Research Initiative grant, and the Canada Research Chair (to L. Y. W.).	Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Case DA, 2012, AMBER; Chen MR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002114; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; FUCHS PA, 1992, J NEUROSCI, V12, P800; Hou PP, 2013, SCI REP-UK, V3, DOI 10.1038/srep01666; Hu L, 2003, P NATL ACAD SCI USA, V100, P10488, DOI 10.1073/pnas.1834300100; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Qian X, 2003, P NATL ACAD SCI USA, V100, P10061, DOI 10.1073/pnas.1731650100; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Sun XH, 2013, J NEUROSCI, V33, P11253, DOI 10.1523/JNEUROSCI.0620-13.2013; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932	40	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16914	16923		10.1074/jbc.M114.557991	http://dx.doi.org/10.1074/jbc.M114.557991			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764303	hybrid, Green Published			2022-12-28	WOS:000338016200027
J	Moroishi, T; Yamauchi, T; Nishiyama, M; Nakayama, KI				Moroishi, Toshiro; Yamauchi, Takayoshi; Nishiyama, Masaaki; Nakayama, Keiichi I.			HERC2 Targets the Iron Regulator FBXL5 for Degradation and Modulates Iron Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMERYTHRIN-LIKE DOMAIN; CELL-CYCLE CONTROL; PROTEIN 5 FBXL5; F-BOX PROTEINS; UBIQUITIN LIGASES; BETA-CATENIN; E3 LIGASE; HOMEOSTASIS; MECHANISMS; RECRUITMENT	FBXL5 (F-box and leucine-rich repeat protein 5) is the F-box protein subunit of, and therefore responsible for substrate recognition by, the SCFFBXL5 ubiquitin-ligase complex, which targets iron regulatory protein 2 (IRP2) for proteasomal degradation. IRP2 plays a central role in the maintenance of cellular iron homeostasis in mammals through posttranscriptional regulation of proteins that contribute to control of the intracellular iron concentration. The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo, given that mice lacking FBXL5 die during early embryogenesis as a result of unrestrained IRP2 activity and oxidative stress attributable to excessive iron accumulation. Despite its pivotal role in the control of iron homeostasis, however, little is known of the upstream regulation of FBXL5 activity. We now show that FBXL5 undergoes constitutive ubiquitin-dependent degradation at the steady state. With the use of a proteomics approach to the discovery of proteins that regulate the stability of FBXL5, we identified the large HECT-type ubiquitin ligase HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2) as an FBXL5-associated protein. Inhibition of the HERC2-FBXL5 interaction or depletion of endogenous HERC2 by RNA interference resulted in the stabilization of FBXL5 and a consequent increase in its abundance. Such accumulation of FBXL5 in turn led to a decrease in the intracellular content of ferrous iron. Our results thus suggest that HERC2 regulates the basal turnover of FBXL5, and that this ubiquitin-dependent degradation pathway contributes to the control of mammalian iron metabolism.	[Moroishi, Toshiro; Yamauchi, Takayoshi; Nishiyama, Masaaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Nishiyama, Masaaki/GWU-5575-2022	Moroishi, Toshiro/0000-0001-6419-3882				Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Berthelet S, 2010, GENETICS, V185, P1111, DOI 10.1534/genetics.110.117531; Chollangi S, 2012, J BIOL CHEM, V287, P23710, DOI 10.1074/jbc.M112.360404; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hochrainer K, 2005, GENOMICS, V85, P153, DOI 10.1016/j.ygeno.2004.10.006; Ji YG, 2000, GENOME RES, V10, P319, DOI 10.1101/gr.10.3.319; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; MAHLER HR, 1954, J BIOL CHEM, V210, P165; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Prohaska R, 2012, NEUROBIOL DIS, V46, P607, DOI 10.1016/j.nbd.2012.03.006; Puffenberger EG, 2012, HUM MUTAT, V33, P1639, DOI 10.1002/humu.22237; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tahara-Hanaoka S, 2002, EXP HEMATOL, V30, P11, DOI 10.1016/S0301-472X(01)00761-5; Thompson JW, 2012, BBA-MOL CELL RES, V1823, P1484, DOI 10.1016/j.bbamcr.2012.02.003; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Yumimoto K, 2012, J PROTEOME RES, V11, P3175, DOI 10.1021/pr201216u	34	32	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16430	16441		10.1074/jbc.M113.541490	http://dx.doi.org/10.1074/jbc.M113.541490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778179	Green Published, hybrid			2022-12-28	WOS:000337965700045
J	Sunryd, JC; Cheon, B; Graham, JB; Giorda, KM; Fissore, RA; Hebert, DN				Sunryd, Johan C.; Cheon, Banyoon; Graham, Jill B.; Giorda, Kristina M.; Fissore, Rafael A.; Hebert, Daniel N.			TMTC1 and TMTC2 Are Novel Endoplasmic Reticulum Tetratricopeptide Repeat-containing Adapter Proteins Involved in Calcium Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; ER; OSCILLATIONS; DEGRADATION; CALNEXIN; COMPLEX; PREDICTION; PATHWAYS	The endoplasmic reticulum (ER) is organized in part by adapter proteins that nucleate the formation of large protein complexes. Tetratricopeptide repeats (TPR) are well studied protein structural motifs that support intermolecular protein-protein interactions. TMTC1 and TMTC2 were identified by an in silico search as TPR-containing proteins possessing N-terminal ER targeting signal sequences and multiple hydrophobic segments, suggestive of polytopic membrane proteins that are targeted to the secretory pathway. A variety of cell biological and biochemical assays was employed to demonstrate that TMTC1 and TMTC2 are both ER resident integral membrane proteins with multiple clusters of TPR domains oriented within the ER lumen. Proteomic analysis followed by co-immunoprecipitation verification found that both proteins associated with the ER calcium uptake pump SERCA2B, and TMTC2 also bound to the carbohydrate-binding chaperone calnexin. Live cell calcium measurements revealed that overexpression of either TMTC1 or TMTC2 caused a reduction of calcium released from the ER following stimulation, whereas the knockdown of TMTC1 or TMTC2 increased the stimulated calcium released. Together, these results implicate TMTC1 and TMTC2 as ER proteins involved in ER calcium homeostasis.	[Sunryd, Johan C.; Graham, Jill B.; Giorda, Kristina M.; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Cheon, Banyoon; Fissore, Rafael A.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Sunryd, Johan C.; Cheon, Banyoon; Graham, Jill B.; Giorda, Kristina M.; Fissore, Rafael A.; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hebert, DN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 240 Thatcher Rd, Amherst, MA 01003 USA.	dhebert@biochem.umass.edu			National Institutes of Health from USPHS [GM086874, HD051872]; National Institutes of Health [GM008515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086874, T32GM008515] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086874 (to D. N. H.) and HD051872 (to R. A. F.) from USPHS.; Supported in part by National Institutes of Health Training Grant GM008515.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Giorda KM, 2012, J VIROL, V86, P3180, DOI 10.1128/JVI.07047-11; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Luo D, 2001, J BIOL CHEM, V276, P5613, DOI 10.1074/jbc.M007524200; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Magliery TJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-240; MOSTOV KE, 1981, NATURE, V292, P87, DOI 10.1038/292087a0; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; Svedine S, 2004, J CELL SCI, V117, P2937, DOI 10.1242/jcs.01154; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Tamura T, 2011, J BIOL CHEM, V286, P24906, DOI 10.1074/jbc.M111.243998; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu XY, 2002, J BIOL CHEM, V277, P13597, DOI 10.1074/jbc.M110881200; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	44	44	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16085	16099		10.1074/jbc.M114.554071	http://dx.doi.org/10.1074/jbc.M114.554071			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764305	Green Published, hybrid			2022-12-28	WOS:000337965700017
J	Crapeau, M; Merhi, A; Andre, B				Crapeau, Myriam; Merhi, Ahmad; Andre, Bruno			Stress Conditions Promote Yeast Gap1 Permease Ubiquitylation and Down-regulation via the Arrestin-like Bul and Aly Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY PATHWAY; AMINO ACID PERMEASES; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; INDUCED DEGRADATION; URACIL PERMEASE; UBIQUITIN; ENDOCYTOSIS; LIGASE; TRAFFICKING	Gap1, the yeast general amino acid permease, is a convenient model for studying how the intracellular traffic of membrane transporters is regulated. Present at the plasma membrane under poor nitrogen supply conditions, it undergoes ubiquitylation, endocytosis, and degradation upon activation of the TORC1 kinase complex in response to an increase in internal amino acids. This down-regulation is stimulated by TORC1-dependent phosphoinhibition of the Npr1 kinase, resulting in activation by dephosphorylation of the arrestin-like Bul1 and Bul2 adaptors recruiting the Rsp5 ubiquitin ligase to Gap1. We report here that Gap1 is also down-regulated when cells are treated with the TORC1 inhibitor rapamycin or subjected to various stresses and that a lack of the Tco89 subunit of TORC1 causes constitutive Gap1 down-regulation. Both the Bul1 and Bul2 and the Aly1 and Aly2 arrestin-like adaptors of Rsp5 promote this down-regulation without undergoing dephosphorylation. Furthermore, they act via the C-terminal regions of Gap1 not involved in ubiquitylation in response to internal amino acids, whereas a Gap1 mutant altered in the N-terminal tail and resistant to ubiquitylation by internal amino acids is efficiently down-regulated under stress via the Bul and Aly adaptors. Although the Bul proteins mediate Gap1 ubiquitylation of two possible lysines, Lys-9 and Lys-16, the Aly proteins promote ubiquitylation of the Lys-16 residue only. This stress-induced pathway of Gap1 down-regulation targets other permeases as well, and it likely allows cells facing adverse conditions to retrieve amino acids from permease degradation.	[Crapeau, Myriam; Merhi, Ahmad; Andre, Bruno] Univ Libre Brussels, Inst Biol & Med Mol, B-6041 Gosselies, Belgium		Andre, B (corresponding author), Inst Biol & Med Mol, Lab Physiol Mol Cellule, CP300,11 Rue Pr Jeener & Brachet, B-6041 Gosselies, Belgium.	bran@ulb.ac.be		Merhi, Ahmad/0000-0001-7046-2508	Fonds National de la Recherche Scientifique [3.4.592.08.F]; Actions de Recherche Concertees Grant AUWB of the Federation Wallonie-Bruxelles [2010- 15-2]	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees Grant AUWB of the Federation Wallonie-Bruxelles	This work was supported by Fonds National de la Recherche Scientifique Grant 3.4.592.08.F and Actions de Recherche Concertees Grant AUWB 2010- 15-2 of the Federation Wallonie-Bruxelles.	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Babst M, 2014, J CELL BIOL, V205, P11, DOI 10.1083/jcb.201310113; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Becuwe M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/242764; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Brohee S, 2010, BBA-BIOMEMBRANES, V1798, P1908, DOI 10.1016/j.bbamem.2010.06.008; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Ghaddar K, 2014, J BIOL CHEM, V289, P7232, DOI 10.1074/jbc.M113.525915; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Halova L, 2013, J CELL BIOL, V203, P595, DOI 10.1083/jcb.201305103; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Holst B, 2000, MOL MICROBIOL, V37, P108, DOI 10.1046/j.1365-2958.2000.01968.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Jones CB, 2012, TRAFFIC, V13, P468, DOI 10.1111/j.1600-0854.2011.01314.x; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Krampe S, 2002, FEBS LETT, V513, P193, DOI 10.1016/S0014-5793(02)02297-4; Lauwers E, 2007, MOL BIOL CELL, V18, P3068, DOI 10.1091/mbc.E07-03-0196; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mayordomo I, 2003, FEBS LETT, V544, P160, DOI 10.1016/S0014-5793(03)00498-8; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Merhi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018457; Nikko E, 2003, J BIOL CHEM, V278, P50732, DOI 10.1074/jbc.M306953200; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Snowdon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050458; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Springael JY, 1999, J CELL SCI, V112, P1375; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459	49	63	64	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22103	22116		10.1074/jbc.M114.582320	http://dx.doi.org/10.1074/jbc.M114.582320			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942738	Green Published, hybrid			2022-12-28	WOS:000340593500026
J	Baeza, J; Dowell, JA; Smallegan, MJ; Fan, J; Amador-Noguez, D; Khan, Z; Denu, JM				Baeza, Josue; Dowell, James A.; Smallegan, Michael J.; Fan, Jing; Amador-Noguez, Daniel; Khan, Zia; Denu, John M.			Stoichiometry of Site-specific Lysine Acetylation in an Entire Proteome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL REPOSITORY; POSTTRANSLATIONAL MODIFICATIONS; METABOLIC ENZYMES; QUANTIFICATION; WIDESPREAD; ACTIVATION; SIRT3	Acetylation of lysine epsilon-amino groups influences many cellular processes and has been mapped to thousands of sites across many organisms. Stoichiometric information of acetylation is essential to accurately interpret biological significance. Here, we developed and employed a novel method for directly quantifying stoichiometry of site-specific acetylation in the entire proteome of Escherichia coli. By coupling isotopic labeling and a novel pairing algorithm, our approach performs an in silico enrichment of acetyl peptides, circumventing the need for immunoenrichment. We investigated the function of the sole NAD(+)-dependent protein deacetylase, CobB, on both site-specific and global acetylation. We quantified 2206 peptides from 899 proteins and observed a wide distribution of acetyl stoichiometry, ranging from less than 1% up to 98%. Bioinformatic analysis revealed that metabolic enzymes, which either utilize or generate acetyl-CoA, and proteins involved in transcriptional and translational processes displayed the highest degree of acetylation. Loss of CobB led to increased global acetylation at low stoichiometry sites and induced site-specific changes at high stoichiometry sites, and biochemical analysis revealed altered acetyl-CoA metabolism. Thus, this study demonstrates that sirtuin deacetylase deficiency leads to both site-specific and global changes in protein acetylation stoichiometry, affecting central metabolism.	[Baeza, Josue; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; [Baeza, Josue; Dowell, James A.; Smallegan, Michael J.; Fan, Jing; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Amador-Noguez, Daniel] Univ Wisconsin, Dept Bacteriol, Madison, WI 53715 USA; [Khan, Zia] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Khan, Zia] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Denu, JM (corresponding author), Univ Wisconsin, 330 N Orchard St, Madison, WI 53715 USA.	jmdenu@wisc.edu		Baeza, Josue/0000-0003-4960-3905; Khan, Zia/0000-0002-7859-3489; Fan, Jing/0000-0002-5326-5358; Smallegan, Michael/0000-0002-5919-6736	National Institutes of Health [GM065386]; National Science Foundation [GRF DGE-1256259]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM065386, R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065386 (to J. M. D.). This work was also supported by National Science Foundation Grant GRF DGE-1256259 (to J. B.).	Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DANCHIN A, 1984, MOL GEN GENET, V193, P473, DOI 10.1007/BF00382086; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Khan Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r122; Khan Z, 2009, P NATL ACAD SCI USA, V106, P15544, DOI 10.1073/pnas.0904100106; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Riordan J F, 1972, Methods Enzymol, V25, P494, DOI 10.1016/S0076-6879(72)25045-5; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Starai VJ, 2003, GENETICS, V163, P545; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Vos S, 1998, J MOL BIOL, V282, P875, DOI 10.1006/jmbi.1998.2051; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wu RH, 2011, NAT METHODS, V8, P677, DOI [10.1038/nmeth.1636, 10.1038/NMETH.1636]; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	40	115	115	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21326	21338		10.1074/jbc.M114.581843	http://dx.doi.org/10.1074/jbc.M114.581843			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24917678	Green Published, hybrid			2022-12-28	WOS:000340558300013
J	Nakatsukasa, K; Kanada, A; Matsuzaki, M; Byrne, SD; Okumura, F; Kamura, T				Nakatsukasa, Kunio; Kanada, Akira; Matsuzaki, Mariko; Byrne, Stuart D.; Okumura, Fumihiko; Kamura, Takumi			The Nutrient Stress-induced Small GTPase Rab5 Contributes to the Activation of Vesicle Trafficking and Vacuolar Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; YEAST; AUTOPHAGY; PROTEINS; REVEALS; PATHWAY; FUSION; VPS21; LOCALIZATION	Rab family small GTPases regulate membrane trafficking by spatiotemporal recruitment of various effectors. However, it remains largely unclear how the expression and functions of Rab proteins are regulated in response to extracellular or intracellular stimuli. Here we show that Ypt53, one isoform of Rab5 in Saccharomyces cerevisiae, is up-regulated significantly under nutrient stress. Under non-stress conditions, Vps21, a constitutively expressed Rab5 isoform, is crucial to Golgi-vacuole trafficking and to vacuolar hydrolase activity. However, when cells are exposed to nutrient stress for an extended period of time, the up-regulated Ypt53 and the constitutive Vps21 function redundantly to maintain these activities, which, in turn, prevent the accumulation of reactive oxygen species and maintain mitochondrial respiration. Together, our results clarify the relative roles of these constitutive and nutrient stress-inducible Rab5 proteins that ensure adaptable vesicle trafficking and vacuolar hydrolase activity, thereby allowing cells to adapt to environmental changes.	[Nakatsukasa, Kunio; Kanada, Akira; Matsuzaki, Mariko; Byrne, Stuart D.; Okumura, Fumihiko; Kamura, Takumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University	Nakatsukasa, K (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	z47875a@cc.nagoya-u.ac.jp; z47617a@nucc.cc.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25870312, 25291023]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [24112006]; Grants-in-Aid for Scientific Research [24112006] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 25870312 (to K. N.) and 25291023 (to T. K.) and by Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant 24112006 (to T. K.).	Amberg DC., 2005, METHODS YEAST GENETI; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Barbieri MA, 1998, J BIOL CHEM, V273, P25850, DOI 10.1074/jbc.273.40.25850; Bridges D, 2012, J BIOL CHEM, V287, P20913, DOI 10.1074/jbc.M111.334060; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Frei SB, 2006, MOL CELL BIOL, V26, P7299, DOI 10.1128/MCB.02405-05; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jie LZ, 1999, EMBO J, V18, P58, DOI 10.1093/emboj/18.1.58; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Liu Y, 2011, MOL BIOL CELL, V22, P1575, DOI 10.1091/mbc.E10-08-0716; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakamura A, 1996, J BIOCHEM, V119, P768; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nakatsukasa K, 2013, MOL BIOL CELL, V24, P1765, DOI 10.1091/mbc.E12-12-0907; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Pei G, 2012, J LEUKOCYTE BIOL, V92, P41, DOI 10.1189/jlb.0212076; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; PITTMAN D, 1960, GENETICS, V45, P1023; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; STEVENS TH, 1986, J CELL BIOL, V102, P1551, DOI 10.1083/jcb.102.5.1551; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	47	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20970	20978		10.1074/jbc.M114.548297	http://dx.doi.org/10.1074/jbc.M114.548297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923442	Green Published, hybrid			2022-12-28	WOS:000339396600050
J	Schunder, E; Gillmaier, N; Kutzner, E; Herrmann, V; Lautner, M; Heuner, K; Eisenreich, W				Schunder, Eva; Gillmaier, Nadine; Kutzner, Erika; Herrmann, Vroni; Lautner, Monika; Heuner, Klaus; Eisenreich, Wolfgang			Amino Acid Uptake and Metabolism of Legionella pneumophila Hosted by Acanthamoeba castellanii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR MULTIPLICATION; MOLECULAR ECOLOGY; SHIKIMATE PATHWAY; LIQUID-MEDIUM; EXPRESSION; VIRULENCE; GROWTH; MACROPHAGES; ADAPTATION; INFECTION	Legionella pneumophila survives and replicates within a Legionella-containing vacuole (LCV) of amoebae and macrophages. Less is known about the carbon metabolism of the bacteria within the LCV. We have now analyzed the transfer and usage of amino acids from the natural host organism Acanthamoeba castellanii to Legionella pneumophila under in vivo (LCV) conditions. For this purpose, A. castellanii was C-13-labeled by incubation in buffer containing [U-C-13(6)] glucose. Subsequently, these C-13-prelabeled amoebae were infected with L. pneumophila wild type or some mutants defective in putative key enzymes or regulators of carbon metabolism. C-13-Isotopologue compositions of amino acids from bacterial and amoebal proteins were then determined by mass spectrometry. In a comparative approach, the profiles documented the efficient uptake of Acanthamoeba amino acids into the LCV and further into L. pneumophila where they served as precursors for bacterial protein biosynthesis. More specifically, A. castellanii synthesized from exogenous [U-C-13(6)] glucose unique isotopologue mixtures of several amino acids including Phe and Tyr, which were also observed in the same amino acids from LCV-grown L. pneumophila. Minor but significant differences were only detected in the isotopologue profiles of Ala, Asp, and Glu from the amoebal or bacterial protein fractions, respectively, indicating partial de novo synthesis of these amino acids by L. pneumophila. The similar isotopologue patterns in amino acids from L. pneumophila wild type and the mutants under study reflected the robustness of amino acid usage in the LCV of A. castellannii.	[Schunder, Eva; Herrmann, Vroni; Lautner, Monika; Heuner, Klaus] Robert Koch Inst, D-13353 Berlin, Germany; [Gillmaier, Nadine; Kutzner, Erika; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany	Robert Koch Institute; Technical University of Munich	Heuner, K (corresponding author), Robert Koch Inst, Working Grp Cellular Interact Bacterial Pathogens, ZBS 2, Nordufer 20, D-13353 Berlin, Germany.	heunerk@rki.de; wolfgang.eisenreich@ch.tum.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279	Deutsche Forschungsgemeinschaft [EI 384/4-1]; Robert Koch Institute [HE 2845/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert Koch Institute	This work was supported by Deutsche Forschungsgemeinschaft Grant EI 384/4-1 (to W. E.) and Robert Koch Institute Grant HE 2845/6-1 (to K. H.).	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Albert-Weissenberger C, 2008, THESIS U WURZBURG WU; Albert-Weissenberger C, 2010, J BACTERIOL, V192, P446, DOI 10.1128/JB.00610-09; ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Anderson IJ, 2005, PROTIST, V156, P203, DOI 10.1016/j.protis.2005.04.001; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Ausubel FM, 1988, MOL REPROD DEV; Berg J.M., 2002, BIOCHEMISTRY-US, P433; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Brown MJ, 2014, MICROBES INFECT, V16, P300, DOI 10.1016/j.micinf.2013.12.003; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; CATRENICH CE, 1989, INFECT IMMUN, V57, P1862, DOI 10.1128/IAI.57.6.1862-1864.1989; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Clarke M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r11; DOLPHIN WD, 1976, J PROTOZOOL, V23, P445; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; Elandalloussi LM, 2005, MOL BIOCHEM PARASIT, V142, P106, DOI 10.1016/j.molbiopara.2005.03.014; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Faucher SP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00060; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Fonseca MV, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00012; Fonseca Maris V., 2008, P213; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; Garduno RA, 2002, INFECT IMMUN, V70, P6273, DOI 10.1128/IAI.70.11.6273-6283.2002; Ge JN, 2011, CELL MICROBIOL, V13, P1870, DOI 10.1111/j.1462-5822.2011.01710.x; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Gesbert G, 2014, CELL MICROBIOL, V16, P434, DOI 10.1111/cmi.12227; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harada E, 2010, J BACTERIOL, V192, P2892, DOI 10.1128/JB.01535-09; Herrmann V, 2011, INT J MED MICROBIOL, V301, P133, DOI 10.1016/j.ijmm.2010.08.016; Heuner K, 1999, FEMS MICROBIOL LETT, V175, P69, DOI 10.1016/S0378-1097(99)00160-3; Heuner K, 2002, INFECT IMMUN, V70, P1604, DOI 10.1128/IAI.70.3.1604-1608.2002; Heuner Klaus, 2013, Methods Mol Biol, V954, P163, DOI 10.1007/978-1-62703-161-5_8; Hoffman PS, 2008, INFEC AGENT, P113; Jacobi S, 2004, J BACTERIOL, V186, P2540, DOI 10.1128/JB.186.9.2540-2547.2004; James BW, 1999, APPL ENVIRON MICROB, V65, P822; KEEN MG, 1984, CURR MICROBIOL, V11, P81, DOI 10.1007/BF01567708; KHAN NA, 2009, AC BIOL PATH, P1; Kiderlen AF, 2009, PARASITOL RES, V104, P663, DOI 10.1007/s00436-008-1243-6; KORZEKWA K, 1990, BIOMED ENVIRON MASS, V19, P211, DOI 10.1002/bms.1200190402; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; MAUCHLINE WS, 1992, J GEN MICROBIOL, V138, P2371, DOI 10.1099/00221287-138-11-2371; Molmeret M, 2010, ENVIRON MICROBIOL, V12, P704, DOI 10.1111/j.1462-2920.2009.02114.x; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; O'Shaughnessy JB, 2003, BIOTECHNIQUES, V35, P112; PINE L, 1979, J CLIN MICROBIOL, V9, P615; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Price CTD, 2014, ENVIRON MICROBIOL, V16, P350, DOI 10.1111/1462-2920.12290; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; REEVES MW, 1981, J CLIN MICROBIOL, V13, P688, DOI 10.1128/JCM.13.4.688-695.1981; Richards AM, 2013, VIRULENCE, V4, P307, DOI 10.4161/viru.24290; RISTROPH JD, 1981, J CLIN MICROBIOL, V13, P115, DOI 10.1128/JCM.13.1.115-119.1981; RISTROPH JD, 1980, J CLIN MICROBIOL, V11, P19, DOI 10.1128/JCM.11.1.19-21.1980; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; Rupp J, 2007, CELL MICROBIOL, V9, P2181, DOI 10.1111/j.1462-5822.2007.00948.x; Sambrook J., 1989, MOL CLONING LABORATO, P31; Sauer JD, 2005, P NATL ACAD SCI USA, V102, P9924, DOI 10.1073/pnas.0502767102; Schulz T, 2012, ARCH MICROBIOL, V194, P977, DOI 10.1007/s00203-012-0833-y; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; TESH MJ, 1983, J BACTERIOL, V154, P1104, DOI 10.1128/JB.154.3.1104-1109.1983; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEISS E, 1984, APPL ENVIRON MICROB, V48, P380, DOI 10.1128/AEM.48.2.380-385.1984; WEISS E, 1980, CURR MICROBIOL, V4, P1, DOI 10.1007/BF02602882; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x	80	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21040	21054		10.1074/jbc.M114.570085	http://dx.doi.org/10.1074/jbc.M114.570085			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24904060	Green Published, hybrid			2022-12-28	WOS:000339396600056
J	Cannan, WJ; Tsang, BP; Wallace, SS; Pederson, DS				Cannan, Wendy J.; Tsang, Betty P.; Wallace, Susan S.; Pederson, David S.			Nucleosomes Suppress the Formation of Double-strand DNA Breaks during Attempted Base Excision Repair of Clustered Oxidative Damages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLASE ACTIVITY; AP-ENDONUCLEASE; CORE PARTICLE; URACIL; STIMULATION; RECOGNITION; HOGG1; INITIATION; HISTONES; BINDING	Exposure to ionizing radiation can produce multiple, clustered oxidative lesions in DNA. The near simultaneous excision of nearby lesions in opposing DNA strands by the base excision repair (BER) enzymes can produce double-strand DNA breaks (DSBs). This attempted BER accounts for many of the potentially lethal or mutagenic DSBs that occur in vivo. To assess the impact of nucleosomes on the frequency and pattern of BER-dependent DSB formation, we incubated nucleosomes containing oxidative damages in opposing DNA strands with selected DNA glycosylases and human apurinic/apyrimidinic endonuclease 1. Overall, nucleosomes substantially suppressed DSB formation. However, the degree of suppression varied as a function of (i) the lesion type and DNA glycosylase tested, (ii) local sequence context and the stagger between opposing strand lesions, (iii) the helical orientation of oxidative lesions relative to the underlying histone octamer, and (iv) the distance between the lesion cluster and the nucleosome edge. In some instances the binding of a BER factor to one nucleosomal lesion appeared to facilitate binding to the opposing strand lesion. DSB formation did not invariably lead to nucleosome dissolution, and in some cases, free DNA ends resulting from DSB formation remained associated with the histone octamer. These observations explain how specific structural and dynamic properties of nucleosomes contribute to the suppression of BER-generated DSBs. These studies also suggest that most BER-generated DSBs will occur in linker DNA and in genomic regions associated with elevated rates of nucleosome turnover or remodeling.	[Cannan, Wendy J.; Tsang, Betty P.; Wallace, Susan S.; Pederson, David S.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Pederson, DS (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Stafford Bldg,Rm 220,95 Carrigan Dr, Burlington, VT 05405 USA.	david.pederson@uvm.edu	Cannan, Wendy J/L-6359-2016	Cannan, Wendy J/0000-0002-7629-8611; Wallace, Susan S./0000-0002-3906-0321	National Institutes of Health [P01-CA098993]; National Science Foundation [MCB-0821941]; NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-CA098993 (NCI; to D. S. P.). This work was also supported by National Science Foundation Grant MCB-0821941 (to D. S. P.).	Bailey SM, 2006, DNA REPAIR, V5, P1171, DOI 10.1016/j.dnarep.2006.05.033; Bergonzo C, 2011, J AM CHEM SOC, V133, P14504, DOI 10.1021/ja205142d; Blaisdell JO, 2001, RADIAT PROT DOSIM, V97, P25, DOI 10.1093/oxfordjournals.rpd.a006634; Blaisdell JO, 2001, P NATL ACAD SCI USA, V98, P7426, DOI 10.1073/pnas.131077798; Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Cole H. A., 2012, BIOCHIM BIOPHYS ACTA, V1819, P643; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; Duclos S, 2012, ISSUES TOXICOL, V13, P115, DOI 10.1039/9781849732925-00115; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eccles LJ, 2011, MUTAT RES-FUND MOL M, V711, P134, DOI 10.1016/j.mrfmmm.2010.11.003; Einstein A, 1905, ANN PHYS-BERLIN, V17, P132; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; Friedberg E C, 2006, DNA REPAIR MUTAGENES, P9; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Halliwell B, 2001, FREE RADICALS OTHER; Harrison L, 1999, J MOL BIOL, V290, P667, DOI 10.1006/jmbi.1999.2892; Harrison L, 1998, NUCLEIC ACIDS RES, V26, P932, DOI 10.1093/nar/26.4.932; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; KANE CM, 1981, J BIOL CHEM, V256, P3405; Leipold MD, 2003, BIOCHEMISTRY-US, V42, P11373, DOI 10.1021/bi034951b; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Liu X, 2002, J MOL BIOL, V321, P265, DOI 10.1016/S0022-2836(02)00623-X; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maher RL, 2013, DNA REPAIR, V12, P964, DOI 10.1016/j.dnarep.2013.08.010; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; Meira LB, 2005, ADV EXP MED BIOL, V570, P125, DOI 10.1007/1-4020-3764-3_5; Odell ID, 2013, J CELL PHYSIOL, V228, P258, DOI 10.1002/jcp.24134; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Odell ID, 2010, DNA REPAIR, V9, P134, DOI 10.1016/j.dnarep.2009.11.005; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; PEDERSON DS, 1986, P NATL ACAD SCI USA, V83, P7206, DOI 10.1073/pnas.83.19.7206; Pope MA, 2005, DNA REPAIR, V4, P315, DOI 10.1016/j.dnarep.2004.10.003; Pope MA, 2002, J BIOL CHEM, V277, P22605, DOI 10.1074/jbc.M203037200; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sung JS, 2000, BIOCHEMISTRY-US, V39, P10224, DOI 10.1021/bi0007066; Takata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075622; TCHOU J, 1993, J BIOL CHEM, V268, P26738; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Yang HJ, 2001, NUCLEIC ACIDS RES, V29, P743, DOI 10.1093/nar/29.3.743; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014; Ye Y, 2012, BIOCHEMISTRY-US, V51, P6028, DOI 10.1021/bi3006412	62	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19881	19893		10.1074/jbc.M114.571588	http://dx.doi.org/10.1074/jbc.M114.571588			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24891506	hybrid, Green Published			2022-12-28	WOS:000339395200007
J	Cho, YD; Yoon, WJ; Kim, WJ; Woo, KM; Baek, JH; Lee, G; Ku, Y; van Wijnen, AJ; Ryoo, HM				Cho, Young-Dan; Yoon, Won-Joon; Kim, Woo-Jin; Woo, Kyung-Mi; Baek, Jeong-Hwa; Lee, Gene; Ku, Young; van Wijnen, Andre J.; Ryoo, Hyun-Mo			Epigenetic Modifications and Canonical Wingless/int-1 Class (WNT) Signaling Enable Trans-differentiation of Nonosteogenic Cells into Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; ALKALINE-PHOSPHATASE EXPRESSION; DNA METHYLATION; BETA-CATENIN; CPG ISLANDS; PATHWAY; DEDIFFERENTIATION; MUTATIONS; DISEASE	Mesenchymal cells alter and retain their phenotype during skeletal development through activation or suppression of signaling pathways. For example, we have shown that Wnt3a only stimulates osteoblast differentiation in cells with intrinsic osteogenic potential (e.g. MC3T3-E1 pre-osteoblasts) and not in fat cell precursors or fibroblasts (3T3-L1 pre-adipocytes or NIH3T3 fibroblasts, respectively). Wnt3a promotes osteogenesis in part by stimulating autocrine production of the osteoinductive ligand Bmp2. Here, we show that the promoter regions of the genes for Bmp2 and the osteoblast marker Alp are epigenetically locked to prevent their expression in nonosteogenic cells. Both genes have conserved CpG islands that exhibit increased CpG methylation, as well as decreased acetylation and increased methylation of histone H3 lysine 9 (H3-K9) specifically in nonosteogenic cells. Treatment of pre-adipocytes or fibroblasts with the CpG-demethylating agent 5' -aza-2' -deoxycytidine or the histone deacetylase inhibitor trichostatin-A renders Bmp2 and Alp responsive to Wnt3a. Hence, drug-induced epigenetic activation of Bmp2 gene expression contributes to Wnt3a-mediated direct trans-differentiation of pre-adipocytes or fibroblasts into osteoblasts. We propose that direct conversion of nonosteogenic cells into osteoblastic cell types without inducing pluripotency may improve prospects for novel epigenetic therapies to treat skeletal afflictions.	[Cho, Young-Dan; Yoon, Won-Joon; Kim, Woo-Jin; Woo, Kyung-Mi; Baek, Jeong-Hwa; Lee, Gene; Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea; [Ku, Young] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul 110749, South Korea; Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 110749, South Korea; [van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg & Biochem, Rochester, MN 55902 USA; [van Wijnen, Andre J.] Mayo Clin, Dept Mol Biol, Rochester, MN 55902 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Mayo Clinic; Mayo Clinic	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg & Biochem, 200 First St SW, Rochester, MN 55902 USA.	vanWijnen.Andre@mayo.edu; hmryoo@snu.ac.kr	van Wijnen, Andre J./AAG-3578-2019; Ryoo, Hyun-Mo/D-5839-2012; Woo, Kyung Mi/A-2793-2009; Cho, Young-Dan/AAR-4573-2021	van Wijnen, Andre J./0000-0002-4458-0946; Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189; 	National Institutes of Health [R01 AR049069]; National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2013R1A1A3011102]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR049069. This work was also supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning Grant 2013R1A1A3011102.	Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cho Y. - D., 2011, J BONE MINER RES  S1, V26, P161; Cho YD, 2012, J CELL PHYSIOL, V227, P2287, DOI 10.1002/jcp.24038; Cho YD, 2009, J BIOL CHEM, V284, P25230, DOI 10.1074/jbc.M109.008391; DiNardo DNM, 2001, ONCOGENE, V20, P5331, DOI 10.1038/sj.onc.1204697; Fujita N, 1999, MOL CELL BIOL, V19, P6415; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Khavinson V Kh, 2012, Adv Gerontol, V25, P11; Kim JS, 2002, CANCER RES, V62, P2744; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kuroda K, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-5; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Li GH, 2005, J BONE MINER RES, V20, P1611, DOI 10.1359/JBMR.050513; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Meivar-Levy I, 2007, HEPATOLOGY, V46, P898, DOI 10.1002/hep.21766; Moon C, 2009, TRANSPL P, V41, P1848, DOI 10.1016/j.transproceed.2009.02.101; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Ohgane J, 2008, PLACENTA, V29, pS29, DOI 10.1016/j.placenta.2007.09.011; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279; Zhang M, 2009, J CELL BIOCHEM, V108, P896, DOI 10.1002/jcb.22319; Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029	43	44	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20120	20128		10.1074/jbc.M114.558064	http://dx.doi.org/10.1074/jbc.M114.558064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24867947	Green Published, hybrid			2022-12-28	WOS:000339395200025
J	Kaur, H; Singh, S; Rathore, YS; Sharma, A; Furukawa, K; Hohmann, S; Ashish; Mondal, AK				Kaur, Harsimran; Singh, Shikha; Rathore, Yogendra S.; Sharma, Anupam; Furukawa, Kentaro; Hohmann, Stefan; Ashish; Mondal, Alok K.			Differential Role of HAMP-like Linkers in Regulating the Functionality of the Group III Histidine Kinase DhNik1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SYSTEM; SIGNAL-TRANSDUCTION; NITRATE SENSOR; DOMAIN; FLUDIOXONIL; SENSITIVITY; RESISTANCE; MECHANISM; YEAST; GENE	Nik1 orthologs are sensor kinases that function upstream of the high osmolarity glycerol/p38 MAPK pathway in fungi. They contain a poly-HAMP module at their N terminus, which plays a pivotal role in osmosensing as well as fungal death upon exposure to fludioxonil. DhNik1p is a typical member of this class that contains five HAMP domains and four HAMP-like linkers. We investigated the contribution of each of the HAMP-like linker regions to the functionality of DhNik1p and found that the HAMP4b linker was essential as its deletion resulted in the complete loss of activity. Replacement of this linker with flexible peptide sequences did not restore DhNik1p activity. Thus, the HAMP-like sequence and possibly structural features of this linker region are indispensable for the kinase activity of DhNik1p. To gain insight into the global shape of the poly-HAMP module in DhNik1p (HAMP1-5), multi-angle laser light and small angle x-ray scattering studies were carried out. Those data demonstrate that the maltose-binding protein-tagged HAMP1-5 protein exist as a dimer in solution with an elongated shape of maximum linear dimension similar to 365 angstrom. Placement of a sequence similarity based model of the HAMP1-5 protein inside experimental data-based models showed how two chains of HAMP1-5 are entwined on each other and the overall structure retained a periodicity. Normal mode analysis of the structural model is consistent with the H4b linker being a key to native-like collective motion in the protein. Overall, our shape-function studies reveal how different elements in the HAMP1-5 structure mediate its function.	[Kaur, Harsimran; Singh, Shikha; Rathore, Yogendra S.; Sharma, Anupam; Ashish; Mondal, Alok K.] CSIR Inst Microbial Technol, Chandigarh 160036, India; [Furukawa, Kentaro; Hohmann, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Gothenburg	Ashish (corresponding author), CSIR Inst Microbial Technol, Sec 39-A, Chandigarh 160036, India.	ashgang@imtech.res.in; alok@imtech.res.in	MAHTO, ANUPAM SHARMA/CAG-1514-2022; Hohmann, Stefan/K-9895-2013	MAHTO, ANUPAM SHARMA/0000-0002-9974-3001; Hohmann, Stefan/0000-0002-0809-1985; Singh, Shikha/0000-0003-0266-4241; Furukawa, Kentaro/0000-0002-1551-1538	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DEAC02-98CH10886]	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We acknowledge the use of National Synchrotron Light Source, Brookhaven National Laboratory, which was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract number DEAC02-98CH10886. We acknowledge the technical help provided by R. Sharma and D. Bhatt.	Airola MV, 2013, J MOL BIOL, V425, P886, DOI 10.1016/j.jmb.2012.12.011; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Cui W, 2002, FUNGAL GENET BIOL, V36, P187, DOI 10.1016/S1087-1845(02)00009-9; Dunin-Horkawicz S, 2010, J MOL BIOL, V397, P1156, DOI 10.1016/j.jmb.2010.02.031; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Furukawa K, 2012, FEBS LETT, V586, P2417, DOI 10.1016/j.febslet.2012.05.057; Gould AD, 2010, J BIOL CHEM, V285, P11290, DOI 10.1074/jbc.M109.089078; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P844, DOI 10.1271/bbb.70051; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Meena N, 2010, J BIOL CHEM, V285, P12121, DOI 10.1074/jbc.M109.075721; Miller TK, 2002, FUNGAL GENET BIOL, V35, P147, DOI 10.1006/fgbi.2001.1306; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; Ochiai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2209, DOI 10.1271/bbb.66.2209; Ochiai N, 2001, PEST MANAG SCI, V57, P437, DOI 10.1002/ps.302; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Randhawa A, 2013, BIOCHEM BIOPH RES CO, V438, P140, DOI 10.1016/j.bbrc.2013.07.041; Sanchez R, 2000, METH MOL B, V143, P97; Sharma P, 2005, CURR GENET, V48, P162, DOI 10.1007/s00294-005-0010-9; Stewart V, 2010, J BACTERIOL, V192, P734, DOI 10.1128/JB.00172-09; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watts KJ, 2008, J BACTERIOL, V190, P2118, DOI 10.1128/JB.01858-07; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yoshimi A, 2005, EUKARYOT CELL, V4, P1820, DOI 10.1128/EC.4.11.1820-1828.2005; Yoshimi A, 2004, MOL GENET GENOMICS, V271, P228, DOI 10.1007/s00438-003-0974-4; Zhou Q, 2011, MOL MICROBIOL, V80, P596, DOI 10.1111/j.1365-2958.2011.07577.x; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x	41	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20245	20258		10.1074/jbc.M114.554303	http://dx.doi.org/10.1074/jbc.M114.554303			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895133	Green Published, hybrid			2022-12-28	WOS:000339395200037
J	Premkumar, L; Kurth, F; Duprez, W; Groftehauge, MK; King, GJ; Halili, MA; Heras, B; Martin, JL				Premkumar, Lakshmanane; Kurth, Fabian; Duprez, Wilko; Groftehauge, Morten K.; King, Gordon J.; Halili, Maria A.; Heras, Begona; Martin, Jennifer L.			Structure of the Acinetobacter baumannii Dithiol Oxidase DsbA Bound to Elongation Factor EF-Tu Reveals a Novel Protein Interaction Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; BIOFILM FORMATION; IDENTIFICATION; VIRULENCE; PATHOGEN; OUTBREAK	The multidrug resistant bacterium Acinetobacter baumannii is a significant cause of nosocomial infection. Biofilm formation, that requires both disulfide bond forming and chaperone-usher pathways, is a major virulence trait in this bacterium. Our biochemical characterizations show that the periplasmic A. baumannii DsbA (AbDsbA) enzyme has an oxidizing redox potential and dithiol oxidase activity. We found an unexpected non-covalent interaction between AbDsbA and the highly conserved prokaryotic elongation factor, EF-Tu. EF-Tu is a cytoplasmic protein but has been localized extracellularly in many bacterial pathogens. The crystal structure of this complex revealed that the EF-Tu switch I region binds to the non-catalytic surface of AbDsbA. Although the physiological and pathological significance of a DsbA/EF-Tu association is unknown, peptides derived from the EF-Tu switch I region bound to AbDsbA with submicromolar affinity. We also identified a seven-residue DsbB-derived peptide that bound to AbDsbA with low micromolar affinity. Further characterization confirmed that the EF-Tu- and DsbB-derived peptides bind at two distinct sites. These data point to the possibility that the non-catalytic surface of DsbA is a potential substrate or regulatory protein interaction site. The two peptides identified in this work together with the newly characterized interaction site provide a novel starting point for inhibitor design targeting AbDsbA.	[Premkumar, Lakshmanane; Kurth, Fabian; Duprez, Wilko; Groftehauge, Morten K.; King, Gordon J.; Halili, Maria A.; Heras, Begona; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4067, Australia	University of Queensland	Premkumar, L (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4067, Australia.	p.lakshmanane@uq.edu.au; j.martin@imb.uq.edu.au	Heras, Begona/H-8686-2014; Halili, Maria A/J-8362-2014; King, Gordon/J-8718-2014; Martin, Jennifer L./A-6039-2010	Heras, Begona/0000-0003-3469-7988; Halili, Maria A/0000-0003-4407-5269; Martin, Jennifer L./0000-0002-9225-8863; Groftehauge, Morten/0000-0002-1823-3713	Australian Research Council	Australian Research Council(Australian Research Council)	These authors were supported by an Australian Research Council Laureate award to J. L. M.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Barbolla RE, 2003, DIAGN MICR INFEC DIS, V45, P261, DOI 10.1016/S0732-8893(02)00538-2; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bessette PH, 2001, J BACTERIOL, V183, P980, DOI 10.1128/JB.183.3.980-988.2001; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Burall LS, 2004, INFECT IMMUN, V72, P2922, DOI 10.1128/IAI.72.5.2922-2938.2004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chow JY, 2014, ANTIMICROB AGENTS CH, V58, P1802, DOI 10.1128/AAC.02410-13; Cisneros JM, 2002, CLIN MICROBIOL INFEC, V8, P687, DOI 10.1046/j.1469-0691.2002.00487.x; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Crespo MD, 2012, NAT CHEM BIOL, V8, P707, DOI [10.1038/NCHEMBIO.1019, 10.1038/nchembio.1019]; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Dallo SF, 2012, SCI WORLD J, DOI 10.1100/2012/128705; de Vries SPW, 2014, MOL MICROBIOL, V91, P522, DOI 10.1111/mmi.12475; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Doidge M, 2010, INFECT CONT HOSP EP, V31, P418, DOI 10.1086/651312; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fu J, 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/835836; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Garcia-Quintanilla M, 2013, CURR PHARM BIOTECHNO, V14, P897; Garnett JA, 2012, P NATL ACAD SCI USA, V109, P3950, DOI 10.1073/pnas.1106733109; Genevaux P, 1999, FEMS MICROBIOL LETT, V173, P403, DOI 10.1016/S0378-1097(99)00110-X; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gootz TD, 2008, EXPERT REV ANTI-INFE, V6, P309, DOI 10.1586/14787210.6.3.309; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heras B, 2015, BRIT J CLIN PHARMACO, V79, P208, DOI 10.1111/bcp.12356; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kidmose RT, 2010, P NATL ACAD SCI USA, V107, P10884, DOI 10.1073/pnas.1003015107; King GJ, 2008, ANAL CHEM, V80, P5036, DOI 10.1021/ac702277q; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kurth F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080210; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Landman D, 2002, ARCH INTERN MED, V162, P1515, DOI 10.1001/archinte.162.13.1515; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Montefour K, 2008, CRIT CARE NURSE, V28, P15; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Onarheim H, 2000, Tidsskr Nor Laegeforen, V120, P1028; Otto J, 2001, J BACTERIOL, V183, P2445, DOI 10.1128/JB.183.8.2445-2453.2001; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Porcella SF, 1996, MICROBIOL-SGM, V142, P2481, DOI 10.1099/00221287-142-9-2481; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rinaldi FC, 2009, BIOCHEMISTRY-US, V48, P3508, DOI 10.1021/bi801899x; Rosadini CV, 2008, INFECT IMMUN, V76, P1498, DOI 10.1128/IAI.01378-07; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott RD, 2009, DIRECT MED COSTS HEA; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Shouldice SR, 2010, ANTIOXID REDOX SIGN, V12, P921, DOI 10.1089/ars.2009.2736; Snyder L, 2003, J MOL BIOL, V334, P349, DOI 10.1016/j.jmb.2003.09.063; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright MS, 2014, MBIO, V5, DOI 10.1128/mBio.00963-13; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998	85	10	10	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19869	19880		10.1074/jbc.M114.571737	http://dx.doi.org/10.1074/jbc.M114.571737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24860094	hybrid, Green Published			2022-12-28	WOS:000339395200006
J	Choi, WI; Yoon, JH; Kim, MY; Koh, DI; Licht, JD; Kim, K; Hur, MW				Choi, Won-Il; Yoon, Jae-Hyeon; Kim, Min-Young; Koh, Dong-In; Licht, Jonathan D.; Kim, Kunhong; Hur, Man-Wook			Promyelocytic Leukemia Zinc Finger-Retinoic Acid Receptor alpha (PLZF-RAR alpha), an Oncogenic Transcriptional Repressor of Cyclin-dependent Kinase Inhibitor 1A (p21WAF/CDKN1A) and Tumor Protein p53 (TP53) Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; P21(WAF1/CIP1) GENE; FUSION PROTEINS; BINDING; INTERACTS; COMPLEX; TRANSLOCATION; SUPPRESSION; ACTIVATION; PROMOTER	Promyelocytic leukemia zinc finger-retinoic acid receptor alpha (PLZF-RAR alpha) is an oncogene transcriptional repressor that is generated by a chromosomal translocation between the PLZF and RAR alpha genes in acute promyelocytic leukemia (APL-type) patients. The molecular interaction between PLZF-RAR alpha and the histone deacetylase corepressor was proposed to be important in leukemogenesis. Wefound that PLZF-RAR alpha can repress transcription of the p21WAF/CDKN1A gene, which encodes the negative cell cycle regulator p21 by binding to its proximal promoter Sp1-binding GC-boxes 3, 4, 5/6, a retinoic acid response element (RARE), and distal p53-responsive elements (p53REs). PLZF-RAR alpha also acts as a competitive transcriptional repressor of p53, RAR alpha, and Sp1. PLZF-RAR alpha interacts with co-repressors such as mSin3A, NCoR, and SMRT, thereby deacetylating histones Ac-H3 and Ac-H4 at the CDKN1A promoter. PLZF-RAR alpha also interacts with the MBD3-NuRD complex, leading to epigenetic silencing of CDKN1A through DNA methylation. Furthermore, PLZF-RAR alpha represses TP53 and increases p53 protein degradation by ubiquitination, further repressing p21 expression. Resultantly, PLZF-RAR alpha promotes cell proliferation and significantly increases the number of cells in S-phase.	[Choi, Won-Il; Yoon, Jae-Hyeon; Kim, Min-Young; Koh, Dong-In; Kim, Kunhong; Hur, Man-Wook] Yonsei Univ, Sch Med, Severance Biomed Sci Inst, Dept Biochem & Mol Biol,Brain Korea Plus Project, Seoul 120752, South Korea; [Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA	Yonsei University; Northwestern University; Feinberg School of Medicine	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Severance Biomed Sci Inst, Dept Biochem & Mol Biol,Brain Korea Plus Project, 50 Yonsei Ro, Seoul 120752, South Korea.	mwhur2@yuhs.ac	Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369; Kim, Kunhong/0000-0001-5639-6372; Hur, Man-Wook/0000-0002-3416-1334	National R & D Program for Cancer Control, Korean Ministry for Health, Welfare and Family affairs [00001561]; DOYAK Research Grant from the Korea Research Foundation of the Korea Ministry of Education, Science and Technology [2011-0028817]	National R & D Program for Cancer Control, Korean Ministry for Health, Welfare and Family affairs; DOYAK Research Grant from the Korea Research Foundation of the Korea Ministry of Education, Science and Technology	This work was supported by Grant 00001561 (to M.-W. H.) from the National R & D Program for Cancer Control, Korean Ministry for Health, Welfare and Family affairs and DOYAK Research Grant 2011-0028817 (to M.-W. H.) from the Korea Research Foundation of the Korea Ministry of Education, Science and Technology.	CHEN Z, 1994, P NATL ACAD SCI USA, V91, P1178, DOI 10.1073/pnas.91.3.1178; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Choi WI, 2013, NUCLEIC ACIDS RES, V41, P6403, DOI 10.1093/nar/gkt359; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Choi WI, 2009, CELL PHYSIOL BIOCHEM, V23, P359, DOI 10.1159/000218182; Crook JM, 2006, NAT CELL BIOL, V8, P212, DOI 10.1038/ncb0306-212; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; HARPER JW, 1993, CELL, V75, P805; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Licht JD, 1996, ONCOGENE, V12, P323; Lin RJ, 2001, ONCOGENE, V20, P7204, DOI 10.1038/sj.onc.1204853; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Noh EJ, 2005, CANCER RES, V65, P11400, DOI 10.1158/0008-5472.CAN-05-1092; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Reese KJ, 2007, PLOS GENET, V3, P1407, DOI 10.1371/journal.pgen.0030137; Rice KL, 2009, BLOOD, V114, P5499, DOI 10.1182/blood-2009-03-206524; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Spicuglia S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024176; Villa R, 2006, P NATL ACAD SCI USA, V103, P1400, DOI 10.1073/pnas.0509343103; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Warrell RP, 1998, JNCI-J NATL CANCER I, V90, P1621, DOI 10.1093/jnci/90.21.1621; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307	36	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18641	18656		10.1074/jbc.M113.538777	http://dx.doi.org/10.1074/jbc.M113.538777			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24821728	Green Published, hybrid			2022-12-28	WOS:000339062900003
J	Hachani, A; Allsopp, LP; Oduko, Y; Filloux, A				Hachani, Abderrahman; Allsopp, Luke P.; Oduko, Yewande; Filloux, Alain			The VgrG Proteins Are "a la Carte" Delivery Systems for Bacterial Type VI Effectors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETION-SYSTEM; CRYSTAL-STRUCTURE; TAIL; TOXIN; GENES; IDENTIFICATION; IMMUNITY; STRAIN; RHS; WIDESPREAD	The bacterial type VI secretion system (T6SS) is a supra-molecular complex akin to bacteriophage tails, with VgrG proteins acting as a puncturing device. The Pseudomonas aeruginosa H1-T6SS has been extensively characterized. It is involved in bacterial killing and in the delivery of three toxins, Tse1-3. Here, we demonstrate the independent contribution of the three H1-T6SS co-regulated vgrG genes, vgrG1abc, to bacterial killing. A putative toxin is encoded in the vicinity of each vgrG gene, supporting the concept of specific VgrG/toxin couples. In this respect, VgrG1c is involved in the delivery of an Rhs protein, RhsP1. The RhsP1 C terminus carries a toxic activity, from which the producing bacterium is protected by a cognate immunity. Similarly, VgrG1a-dependent toxicity is associated with the PA0093 gene encoding a two-domain protein with a putative toxin domain (Toxin_61) at the C terminus. Finally, VgrG1b-dependent killing is detectable upon complementation of a triple vgrG1abc mutant. The VgrG1b-dependent killing is mediated by PA0099, which presents the characteristics of the superfamily nuclease 2 toxin members. Overall, these data develop the concept that VgrGs are indispensable components for the specific delivery of effectors. Several additional vgrG genes are encoded on the P. aeruginosa genome and are not linked genetically to other T6SS genes. A closer inspection of these clusters reveals that they also encode putative toxins. Overall, these associations further support the notion of an original form of secretion system, in which VgrG acts as the carrier.	[Hachani, Abderrahman; Allsopp, Luke P.; Oduko, Yewande; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England	Imperial College London	Filloux, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	a.filloux@imperial.ac.uk	Hachani, Abderrahman/AAV-3320-2020; Allsopp, Luke/AAG-2488-2020; Hachani, Abderrahman/H-1801-2013	Hachani, Abderrahman/0000-0001-8032-2154; Allsopp, Luke/0000-0002-0313-9265; Filloux, Alain/0000-0003-1307-0289	Medical Research Council [MR/K001930/1]; BBSRC Biotechnology and Biological Sciences Research Council [BB/I019871/1]; Wellcome Trust [WT091939]; Marie Curie Fellowship [PIIF-GA-2012-328261 T6SS-PSEUDO-EFFECTOR]; Biotechnology and Biological Sciences Research Council [BB/I019871/1] Funding Source: researchfish; BBSRC [BB/I019871/1] Funding Source: UKRI; MRC [MR/J006874/1, MR/K001930/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Marie Curie Fellowship(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Program Grant MR/K001930/1 and the BBSRC Biotechnology and Biological Sciences Research Council Grant BB/I019871/1.; Supported by Wellcome Trust Grant WT091939.; Supported by Marie Curie Fellowship PIIF-GA-2012-328261 T6SS-PSEUDO-EFFECTOR.	Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Brooks TM, 2013, J BIOL CHEM, V288, P7618, DOI 10.1074/jbc.M112.436725; Casabona MG, 2013, ENVIRON MICROBIOL, V15, P471, DOI 10.1111/j.1462-2920.2012.02816.x; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Durand E, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.390153; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2013, NATURE, V500, P284, DOI 10.1038/nature12545; Filloux A, 2009, EMBO J, V28, P309, DOI 10.1038/emboj.2008.301; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hachani A, 2013, JOVE-J VIS EXP, DOI 10.3791/50103; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Jones C, 2014, J BACTERIOL, V196, P800, DOI 10.1128/JB.00863-13; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lossi NS, 2012, MOL MICROBIOL, V86, P437, DOI 10.1111/j.1365-2958.2012.08204.x; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Viarre V, 2009, J BIOL CHEM, V284, P33815, DOI 10.1074/jbc.M109.065938; Whitney JC, 2013, J BIOL CHEM, V288, P26616, DOI 10.1074/jbc.M113.488320; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081074	66	118	126	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17872	17884		10.1074/jbc.M114.563429	http://dx.doi.org/10.1074/jbc.M114.563429			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24794869	hybrid, Green Published			2022-12-28	WOS:000338018100048
J	Jacob, AG; Singh, RK; Mohammad, F; Bebee, TW; Chandler, DS				Jacob, Aishwarya G.; Singh, Ravi K.; Mohammad, Fuad; Bebee, Thomas W.; Chandler, Dawn S.			The Splicing Factor FUBP1 Is Required for the Efficient Splicing of Oncogene MDM2 Pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAR UPSTREAM ELEMENT; FUSE-BINDING PROTEIN-1; RIBOSOMAL ENTRY SITE; PEDIATRIC RHABDOMYOSARCOMA; GENE AMPLIFICATION; PROTEOMIC ANALYSIS; ONCOPROTEIN MDM2; CANCER GENOMICS; BREAST-CANCER; CELL-GROWTH	Alternative splicing of the oncogene MDM2 is a phenomenon that occurs in cells in response to genotoxic stress and is also a hallmark of several cancer types with important implications in carcinogenesis. However, the mechanisms regulating this splicing event remain unclear. Previously, we uncovered the importance of intron 11 in MDM2 that affects the splicing of a damage-responsive MDM2 minigene. Here, we have identified discrete cis regulatory elements within intron 11 and report the binding of FUBP1 (Far Upstream element-Binding Protein 1) to these elements and the role it plays in MDM2 splicing. Best known for its oncogenic role as a transcription factor in the context of c-MYC, FUBP1 was recently described as a splicing regulator with splicing repressive functions. In the case of MDM2, we describe FUBP1 as a positive splicing regulatory factor. We observed that blocking the function of FUBP1 in in vitro splicing reactions caused a decrease in splicing efficiency of the introns of the MDM2 minigene. Moreover, knockdown of FUBP1 in cells induced the formation of MDM2-ALT1, a stress-induced splice variant of MDM2, even under normal conditions. These results indicate that FUBP1 is also a strong positive splicing regulator that facilitates efficient splicing of the MDM2 pre-mRNA by binding its introns. These findings are the first report describing the regulation of alternative splicing of MDM2 mediated by the oncogenic factor FUBP1.	[Jacob, Aishwarya G.; Singh, Ravi K.; Mohammad, Fuad; Bebee, Thomas W.; Chandler, Dawn S.] Nationwide Childrens Hosp, Ctr Childhood Canc, Res Inst, Columbus, OH 43205 USA; [Jacob, Aishwarya G.; Singh, Ravi K.; Bebee, Thomas W.; Chandler, Dawn S.] Ohio State Univ, Dept Pediat, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Jacob, Aishwarya G.; Mohammad, Fuad; Chandler, Dawn S.] Ohio State Univ, Ctr RNA Biol, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chandler, DS (corresponding author), Nationwide Childrens Hosp, Ctr Childhood Canc, Res Inst, Rm WA5023,700 Childrens Dr, Columbus, OH 43205 USA.	Dawn.Chandler@nationwidechildrens.org		Singh, Ravi/0000-0002-2524-6109; Mohammad, Fuad/0000-0002-0589-5216	National Institutes of Health [1R01CA133571]; NATIONAL CANCER INSTITUTE [R01CA133571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA133571 (to D. S. C.).	Atanassov BS, 2011, EMBO REP, V12, P924, DOI 10.1038/embor.2011.140; Back SH, 2002, J BIOL CHEM, V277, P27200, DOI 10.1074/jbc.M203887200; Bartel F, 2001, ONCOL RES, V12, P451, DOI 10.3727/096504001108747459; Baumgarten P, 2014, NEUROPATH APPL NEURO, V40, P205, DOI 10.1111/nan.12088; Benjamin LR, 2008, P NATL ACAD SCI USA, V105, P18296, DOI 10.1073/pnas.0803279105; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Dias CS, 2006, CANCER RES, V66, P9467, DOI 10.1158/0008-5472.CAN-05-3013; Ding ZM, 2015, MOL CARCINOGEN, V54, P405, DOI 10.1002/mc.22114; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Evdokiou A, 2001, INT J ONCOL, V19, P625; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fridman JS, 2003, CANCER RES, V63, P5703; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hori M, 2000, PATHOL INT, V50, P786, DOI 10.1046/j.1440-1827.2000.01119.x; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Izquierdo JM, 2008, MOL BIOL CELL, V19, P3299, DOI 10.1091/mbc.E07-11-1125; Jacob AG, 2013, NEOPLASIA, V15, P1049, DOI 10.1593/neo.13286; Kraus A, 1999, INT J CANCER, V80, P930, DOI 10.1002/(SICI)1097-0215(19990315)80:6<930::AID-IJC20>3.3.CO;2-D; Li H, 2013, P NATL ACAD SCI USA, V110, pE2687, DOI 10.1073/pnas.1310607110; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Lukas J, 2001, CANCER RES, V61, P3212; Ma J, 2013, INT J ONCOL, V42, P1093, DOI 10.3892/ijo.2013.1782; Malz M, 2009, HEPATOLOGY, V50, P1130, DOI 10.1002/hep.23051; Matsumoto R, 1998, CANCER RES, V58, P609; Mayeda A, 1999, METH MOL B, V118, P309; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Page-McCaw PS, 1999, RNA, V5, P1548, DOI 10.1017/S1355838299991938; Rabenhorst U, 2009, HEPATOLOGY, V50, P1121, DOI 10.1002/hep.23098; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Sahm F, 2012, ACTA NEUROPATHOL, V123, P853, DOI 10.1007/s00401-012-0993-5; Sanchez-Aguilera A, 2006, ONCOGENE, V25, P2565, DOI 10.1038/sj.onc.1209282; Sigalas I, 1996, NAT MED, V2, P912, DOI 10.1038/nm0896-912; Singer S, 2009, CANCER RES, V69, P2234, DOI 10.1158/0008-5472.CAN-08-3338; Singh RK, 2009, EXP CELL RES, V315, P3419, DOI 10.1016/j.yexcr.2009.07.017; Steinman HA, 2004, J BIOL CHEM, V279, P4877, DOI 10.1074/jbc.M305966200; Tamborini E, 2001, INT J CANCER, V92, P790, DOI 10.1002/ijc.1271; Vindigni A, 2001, NUCLEIC ACIDS RES, V29, P1061, DOI 10.1093/nar/29.5.1061; Volk EL, 2009, MOL CANCER RES, V7, P863, DOI 10.1158/1541-7786.MCR-08-0418; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Weber A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-369; Xiao JY, 2009, CELL CYCLE, V8, P889, DOI 10.4161/cc.8.6.7898; Zhang FC, 2013, ONKOLOGIE, V36, P650, DOI 10.1159/000355659; Zheng TS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3996; Zheng YH, 2011, INT J BIOCHEM CELL B, V43, P1641, DOI 10.1016/j.biocel.2011.08.001; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu H, 2003, MOL CELL BIOL, V23, P5959, DOI 10.1128/MCB.23.17.5959-5971.2003	58	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17350	17364		10.1074/jbc.M114.554717	http://dx.doi.org/10.1074/jbc.M114.554717			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24798327	Green Published, hybrid			2022-12-28	WOS:000338018100006
J	Peruchetti, DB; Cheng, J; Caruso-Neves, C; Guggino, WB				Peruchetti, Diogo B.; Cheng, Jie; Caruso-Neves, Celso; Guggino, William B.			Mis-regulation of Mammalian Target of Rapamycin (mTOR) Complexes Induced by Albuminuria in Proximal Tubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; ANGIOTENSIN-II; PHOSPHORYLATION; AKT; ENDOCYTOSIS; PATHWAY; CANCER; RAPTOR; CELLS; TSC2	High albumin concentrations in the proximal tubule of the kidney causes tubulointerstitial injury, but how this process occurs is not completely known. To address the signal transduction pathways mis-regulated in renal injury, we studied the modulation of mammalian target of rapamycin (mTOR) complexes by physiologic and pathophysiologic albumin concentrations in proximal tubule cells. Physiologic albumin concentrations activated the PI3K/mTORC2/PKB/mTORC1/S6 kinase (S6K) pathway, but pathophysiologically high albumin concentrations overactivated mTORC1 and inhibited mTORC2 activity. This control process involved the activation of ERK1/2, which promoted the inhibition of TSC2 and activation of S6K. Furthermore, S6K was crucial to promoting the over activation of mTORC1 and inhibition of mTORC2. Megalin expression at the luminal membrane is reduced by high concentrations of albumin. In addition, knockdown of megalin mimicked all the effects of pathophysiologic albumin concentrations, which disrupt normal signal transduction pathways and lead to an over-activation of mTORC1 and inhibition of mTORC2. These data provide new perspectives for understanding the molecular mechanisms behind the effects of albumin on the progression of renal disease.	[Peruchetti, Diogo B.; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil; [Peruchetti, Diogo B.; Cheng, Jie; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Universidade Federal do Rio de Janeiro; Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St,WBSB202, Baltimore, MD 21205 USA.	wguggino@jhmi.edu	Caruso-Neves, Celso/C-4014-2013; Peruchetti, Diogo B/L-3706-2017	Caruso-Neves, Celso/0000-0002-2415-7753; Peruchetti, Diogo B/0000-0002-7572-9731	National Institutes of Health [DK032753]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, R01DK032753, R37DK032753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK032753.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Brunskill NJ, 1998, J CLIN INVEST, V101, P2140, DOI 10.1172/JCI1923; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Diekmann F, 2007, J AM SOC NEPHROL, V18, P2653, DOI 10.1681/ASN.2007010087; Dixon R, 2000, CLIN SCI, V98, P295, DOI 10.1042/CS19990214; EDDY AA, 1989, AM J PATHOL, V135, P719; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lee JY, 2011, AM J PHYSIOL-RENAL, V300, pF1214, DOI 10.1152/ajprenal.00710.2010; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; Nakagawa S, 2010, BIOCHEM PHARMACOL, V79, P67, DOI 10.1016/j.bcp.2009.07.015; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Peruchetti DB, 2011, J BIOL CHEM, V286, P45041, DOI 10.1074/jbc.M111.260737; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Stylianou K, 2012, NEPHROL DIAL TRANSPL, V27, P3141, DOI 10.1093/ndt/gfr791; Takaya K, 2003, AM J PHYSIOL-RENAL, V284, pF1037, DOI 10.1152/ajprenal.00230.2002; Thomas ME, 1999, KIDNEY INT, V55, P890, DOI 10.1046/j.1523-1755.1999.055003890.x; Tojo A, 2003, HYPERTENS RES, V26, P413, DOI 10.1291/hypres.26.413; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	31	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16790	16801		10.1074/jbc.M114.549717	http://dx.doi.org/10.1074/jbc.M114.549717			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24790108	hybrid, Green Published			2022-12-28	WOS:000338016200017
J	Guo, H; Xiong, Y; Witkowski, P; Cui, JQ; Wang, LJ; Sun, JH; Lara-Lemus, R; Haataja, L; Hutchison, K; Shan, SO; Arvan, P; Liu, M				Guo, Huan; Xiong, Yi; Witkowski, Piotr; Cui, Jingqing; Wang, Ling-jia; Sun, Jinhong; Lara-Lemus, Roberto; Haataja, Leena; Hutchison, Kathryn; Shan, Shu-ou; Arvan, Peter; Liu, Ming			Inefficient Translocation of Preproinsulin Contributes to Pancreatic beta Cell Failure and Late-onset Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; PRION PROTEIN; ESCHERICHIA-COLI; INS GENE; POSTTRANSLATIONAL TRANSLOCATION; CYTOPLASMIC MEMBRANE; INSULIN-BIOSYNTHESIS; HYDROPHOBIC SEGMENT; SECRETORY PROTEINS	Among the defects in the early events of insulin biosynthesis, proinsulin misfolding and endoplasmic reticulum (ER) stress have drawn increasing attention as causes of beta cell failure. However, no studies have yet addressed potential defects at the cytosolic entry point of preproinsulin into the secretory pathway. Here, we provide the first evidence that inefficient translocation of preproinsulin (caused by loss of a positive charge in the n region of its signal sequence) contributes to beta cell failure and diabetes. Specifically, we find that, after targeting to the ER membrane, preproinsulin signal peptide (SP) mutants associated with autosomal dominant late-onset diabetes fail to be fully translocated across the ER membrane. The newly synthesized, untranslocated preproinsulin remains strongly associated with the ER membrane, exposing its proinsulin moiety to the cytosol. Rather than accumulating in the ER and inducing ER stress, untranslocated preproinsulin accumulates in a juxtanuclear compartment distinct from the Golgi complex, induces the expression of heat shock protein 70 (HSP70), and promotes beta cell death. Restoring an N-terminal positive charge to the mutant preproinsulin SP significantly improves the translocation defect. These findings not only reveal a novel molecular pathogenesis of beta cell failure and diabetes but also provide the first evidence of the physiological and pathological significance of the SP n region positive charge of secretory proteins.	[Guo, Huan; Xiong, Yi; Cui, Jingqing; Sun, Jinhong; Lara-Lemus, Roberto; Haataja, Leena; Hutchison, Kathryn; Arvan, Peter; Liu, Ming] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Witkowski, Piotr; Wang, Ling-jia] Univ Chicago, Div Organ Transplantat, Chicago, IL 60637 USA; [Cui, Jingqing; Liu, Ming] Tianjin Med Univ, Gen Hosp, Div Metab, Tianjin 300052, Peoples R China; [Lara-Lemus, Roberto] Natl Inst Resp Dis Ismael Cosio Villegas, Dept Res Biochem, Mexico City 14080, DF, Mexico; [Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	University of Michigan System; University of Michigan; University of Chicago; Tianjin Medical University; California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu; parvan@umich.edu; mingli@umich.edu	Lara-Lemus, Roberto/J-4531-2013	Lara-Lemus, Roberto/0000-0001-5419-4283; Liu, Ming/0000-0003-2665-4072; Witkowski, Andrzej/0000-0002-0442-4586	National Institutes of Health [RO1-DK088856, RO1-DK-48280, RO1 GM078024, P60-DK-20572]; National Natural Science Foundation of China [81070629]; March of Dimes Foundation; Protein Folding Disease Initiatives of the University of Michigan; University of Chicago DRTC Grant [P30-DK020595]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, P30DK020572, R01DK088856, P30DK020595, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); March of Dimes Foundation(March of Dimes); Protein Folding Disease Initiatives of the University of Michigan; University of Chicago DRTC Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK088856 (to M.L.), RO1-DK-48280 (to P.A.), RO1 GM078024 (to S.S.), and P60-DK-20572 (to the Molecular Biology and DNA Sequencing Core of the Diabetes Research and Training Center). This work was also supported by National Natural Science Foundation of China Research Grant 81070629 (to M.L.), by a research grant from the March of Dimes Foundation (to M.L.), and by the Protein Folding Disease Initiatives of the University of Michigan. Human pancreatic islet processing was supported by Illinois Department of Public Health Grant "Pancreatic Islets Transplantation."; Supported by University of Chicago DRTC Grant P30-DK020595.	ALARCON C, 1995, J CLIN INVEST, V95, P1032, DOI 10.1172/JCI117748; ANDERSSON H, 1994, EMBO J, V13, P2267, DOI 10.1002/j.1460-2075.1994.tb06508.x; Bionda T, 2010, J MOL BIOL, V402, P510, DOI 10.1016/j.jmb.2010.07.052; Boesgaard TW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-42; Debure L, 2003, J CELL SCI, V116, P3109, DOI 10.1242/jcs.00619; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fujita H, 2010, MOL BIOL CELL, V21, P2045, DOI 10.1091/mbc.E09-12-1060; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; IINO T, 1987, J BIOL CHEM, V262, P7412; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaufman RJ, 2011, NEW ENGL J MED, V365, P1931, DOI 10.1056/NEJMcibr1109442; Kocik L, 2012, J MOL BIOL, V424, P368, DOI 10.1016/j.jmb.2012.10.010; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2012, DIABETES, V61, P828, DOI 10.2337/db11-0878; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Miesbauer M, 2010, CURR ISSUES MOL BIOL, V12, P109; OKUN MM, 1992, J BIOL CHEM, V267, P11476; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U; PATZELT C, 1978, P NATL ACAD SCI USA, V75, P1260, DOI 10.1073/pnas.75.3.1260; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rane NS, 2010, J CELL BIOL, V188, P515, DOI 10.1083/jcb.200911115; Reiner T, 2011, P NATL ACAD SCI USA, V108, P12815, DOI 10.1073/pnas.1109859108; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; SASAKI S, 1990, J BIOL CHEM, V265, P4358; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Strom A, 2007, LAB INVEST, V87, P139, DOI 10.1038/labinvest.3700500; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Viswanathan J, 2011, TRAFFIC, V12, P330, DOI 10.1111/j.1600-0854.2010.01149.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; WOLIN SL, 1993, J CELL BIOL, V121, P1211, DOI 10.1083/jcb.121.6.1211; Zhang BY, 2003, J BIOL CHEM, V278, P3687, DOI 10.1074/jbc.M209474200	62	39	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16290	16302		10.1074/jbc.M114.562355	http://dx.doi.org/10.1074/jbc.M114.562355			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24770419	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000337965700033
J	Muench, SP; Rawson, S; Eyraud, V; Delmas, AF; Da Silva, P; Phillips, C; Trinick, J; Harrison, MA; Gressent, F; Huss, M				Muench, Stephen P.; Rawson, Shaun; Eyraud, Vanessa; Delmas, Agnes F.; Da Silva, Pedro; Phillips, Clair; Trinick, John; Harrison, Michael A.; Gressent, Frederic; Huss, Markus			PA1b Inhibitor Binding to Subunits c and e of the Vacuolar ATPase Reveals Its Insecticidal Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							16-KDA PROTEOLIPID SUBUNIT; H+-ATPASE; V-ATPASES; MALARIA PARASITE; PROTON PUMPS; MEMBRANE; GENE; RING; SITE; BIOINSECTICIDE	The vacuolar ATPase (V-ATPase) is a 1MDa transmembrane proton pump that operates via a rotary mechanism fuelled by ATP. Essential for eukaryotic cell homeostasis, it plays central roles in bone remodeling and tumor invasiveness, making it a key therapeutic target. Its importance in arthropod physiology also makes it a promising pesticide target. The major challenge in designing lead compounds against the V-ATPase is its ubiquitous nature, such that any therapeutic must be capable of targeting particular isoforms. Here, we have characterized the binding site on the V-ATPase of pea albumin 1b (PA1b), a small cystine knot protein that shows exquisitely selective inhibition of insect V-ATPases. Electron microscopy shows that PA1b binding occurs across a range of equivalent sites on the c ring of the membrane domain. In the presence of Mg.ATP, PA1b localizes to a single site, distant from subunit a, which is predicted to be the interface for other inhibitors. Photoaffinity labeling studies show radiolabeling of subunits c and e. In addition, weevil resistance to PA1b is correlated with bafilomycin resistance, caused by mutation of subunit c. The data indicate a binding site to which both subunits c and e contribute and inhibition that involves locking the c ring rotor to a static subunit e and not subunit a. This has implications for understanding the V-ATPase mechanism and that of inhibitors with therapeutic or pesticidal potential. It also provides the first evidence for the position of subunit e within the complex.	[Muench, Stephen P.; Rawson, Shaun; Phillips, Clair; Harrison, Michael A.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Eyraud, Vanessa; Da Silva, Pedro; Gressent, Frederic] Univ Lyon, Inst Natl Rech Agron, Inst Natl Sci Appl Lyon, IFR 41,UMR203,BF2I, F-69621 Villeurbanne, France; [Delmas, Agnes F.] CNRS, Ctr Biophys Mol, Unite Propre Rech 4301, F-45071 Orleans 2, France; [Trinick, John] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Huss, Markus] Univ Osnabruck, Abt Tierphysiol, Fachbereich Biol Chem, D-49069 Osnabruck, Germany	University of Leeds; INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); University of Leeds; University Osnabruck	Muench, SP (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England.	s.p.muench@leeds.ac.uk	Muench, Stephen/AAI-9529-2020	Muench, Stephen/0000-0001-6869-4414; GRESSENT, Frederic/0000-0002-7029-8709; Rawson, Shaun/0000-0002-2973-2630	Medical Research Council [G1000567]; British Biotechnology Research Council (BBSRC) Grant [BB/D016142/1]; Deutsche Forschungsgemeinschaft [SFB 431, SFB 944]; Wellcome Trust [099752/Z/12/Z]; Biotechnology and Biological Sciences Research Council [BB/D016142/1] Funding Source: researchfish; BBSRC [BB/D016142/1] Funding Source: UKRI; MRC [G1000567] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Biotechnology Research Council (BBSRC) Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G1000567 (to S. P. M.) and British Biotechnology Research Council (BBSRC) Grant BB/D016142/1 (to M.A.H. and J.T.) and by Deutsche Forschungsgemeinschaft Grants SFB 431 and SFB 944 (to M. H.).; Supported by Wellcome Trust Studentship 099752/Z/12/Z.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bockelmann S, 2010, J BIOL CHEM, V285, P38304, DOI 10.1074/jbc.M110.137539; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; Capparelli R, 2009, GENES IMMUN, V10, P641, DOI 10.1038/gene.2009.48; Chouabe C, 2011, J BIOL CHEM, V286, P36291, DOI 10.1074/jbc.M111.281055; Cociancich SO, 1999, J BIOL CHEM, V274, P12650, DOI 10.1074/jbc.274.18.12650; Da Silva P, 2010, J BIOL CHEM, V285, P32689, DOI 10.1074/jbc.M110.147199; Da Silva P, 2009, BIOPOLYMERS, V92, P436, DOI 10.1002/bip.21217; Delobel B., 1998, French Patent, Patent No. [9805877, 98 05877]; Farina C, 1999, DRUG DISCOV TODAY, V4, P163, DOI 10.1016/S1359-6446(99)01321-5; FINBOW ME, 1994, J CELL SCI, V107, P1817; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Grenier AM, 1997, HEREDITY, V79, P15, DOI 10.1038/hdy.1997.118; Gressent F, 2003, EUR J BIOCHEM, V270, P2429, DOI 10.1046/j.1432-1033.2003.03611.x; Gressent F, 2007, J INSECT SCI, V7; Gressent F, 2011, TOXINS, V3, P1502, DOI 10.3390/toxins3121502; Harrison MA, 1999, J BIOL CHEM, V274, P25461, DOI 10.1074/jbc.274.36.25461; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Jouvensal L, 2003, BIOCHEMISTRY-US, V42, P11915, DOI 10.1021/bi034803l; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Louis S, 2007, PHYTOCHEMISTRY, V68, P521, DOI 10.1016/j.phytochem.2006.11.032; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Merzendorfer H, 1999, J BIOL CHEM, V274, P17372, DOI 10.1074/jbc.274.24.17372; Mizutani K, 2011, P NATL ACAD SCI USA, V108, P13474, DOI 10.1073/pnas.1103287108; Moriyama Y, 2003, J BIOENERG BIOMEMBR, V35, P367, DOI 10.1023/A:1025785000544; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Osteresch C, 2012, J BIOL CHEM, V287, P31866, DOI 10.1074/jbc.M112.372169; Pali T, 2004, BBA-BIOMEMBRANES, V1663, P14, DOI 10.1016/j.bbamem.2004.03.003; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Qin A, 2012, INT J BIOCHEM CELL B, V44, P1422, DOI 10.1016/j.biocel.2012.05.014; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Supino R, 2008, J PHARMACOL EXP THER, V324, P15, DOI 10.1124/jpet.107.128587; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; WALKER M, 1985, J MOL BIOL, V184, P535, DOI 10.1016/0022-2836(85)90300-6; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200	53	25	27	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16399	16408		10.1074/jbc.M113.541250	http://dx.doi.org/10.1074/jbc.M113.541250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24795045	Green Published, hybrid			2022-12-28	WOS:000337965700042
J	Jaworski, E; Narayanan, A; Van Duyne, R; Shabbeer-Meyering, S; Iordanskiy, S; Saifuddin, M; Das, R; Afonso, PV; Sampey, GC; Chung, M; Popratiloff, A; Shrestha, B; Sehgal, M; Jain, P; Vertes, A; Mahieux, R; Kashanchi, F				Jaworski, Elizabeth; Narayanan, Aarthi; Van Duyne, Rachel; Shabbeer-Meyering, Shabana; Iordanskiy, Sergey; Saifuddin, Mohammed; Das, Ravi; Afonso, Philippe V.; Sampey, Gavin C.; Chung, Myung; Popratiloff, Anastas; Shrestha, Bindesh; Sehgal, Mohit; Jain, Pooja; Vertes, Akos; Mahieux, Renaud; Kashanchi, Fatah			Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTLV-I TAX; DNA-DAMAGE RESPONSE; MOLECULAR-MECHANISMS; CEREBROSPINAL-FLUID; PROTEOMICS ANALYSIS; MEDIATED TRANSFER; MESSENGER-RNAS; INFECTED-CELLS; LEUKEMIA-CELLS; HUMAN SALIVA	Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis. The HTLV-1 transactivator protein Tax controls many critical cellular pathways, including host cell DNA damage response mechanisms, cell cycle progression, and apoptosis. Extracellular vesicles called exosomes play critical roles during pathogenic viral infections as delivery vehicles for host and viral components, including proteins, mRNA, and microRNA. We hypothesized that exosomes derived from HTLV-1-infected cells contain unique host and viral proteins that may contribute to HTLV-1-induced pathogenesis. We found exosomes derived from infected cells to contain Tax protein and proinflammatory mediators as well as viral mRNA transcripts, including Tax, HBZ, and Env. Furthermore, we observed that exosomes released from HTLV-1-infected Tax-expressing cells contributed to enhanced survival of exosome-recipient cells when treated with Fas antibody. This survival was cFLIP-dependent, with Tax showing induction of NF-kappa B in exosome-recipient cells. Finally, IL-2-dependent CTLL-2 cells that received Tax-containing exosomes were protected from apoptosis through activation of AKT. Similar experiments with primary cultures showed protection and survival of peripheral blood mononuclear cells even in the absence of phytohemagglutinin/IL-2. Surviving cells contained more phosphorylated Rb, consistent with the role of Tax in regulation of the cell cycle. Collectively, these results suggest that exosomes may play an important role in extracellular delivery of functional HTLV-1 proteins and mRNA to recipient cells.	[Jaworski, Elizabeth; Narayanan, Aarthi; Van Duyne, Rachel; Shabbeer-Meyering, Shabana; Iordanskiy, Sergey; Saifuddin, Mohammed; Das, Ravi; Sampey, Gavin C.; Chung, Myung; Kashanchi, Fatah] George Mason Univ, Sch Syst Biol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Van Duyne, Rachel; Iordanskiy, Sergey] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Shrestha, Bindesh; Vertes, Akos] George Washington Univ, Med Ctr, Ctr Microscopy & Image Anal, Washington, DC 20037 USA; [Popratiloff, Anastas] George Washington Univ, Dept Chem, Washington, DC 20037 USA; [Mahieux, Renaud] Univ Lyon 1, Ecole Normale Super Lyon, Equipe Labelisee Ligue Natl Canc,Equipe Oncogenes, Int Ctr Res Infectiol,CNRS,INSERM,U1111,UMR5308, F-69364 Lyon 07, France; [Afonso, Philippe V.] Inst Pasteur, Dept Virol, Unite Epidemiol & Physiopathol Virus Oncogenes, F-75015 Paris, France; [Afonso, Philippe V.] CNRS, UMR3569, F-75015 Paris, France; [Sehgal, Mohit; Jain, Pooja] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Drexel Inst Biotechnol & Virol Res, Doylestown, PA 18902 USA	George Mason University; George Washington University; George Washington University; George Washington University; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Drexel University	Kashanchi, F (corresponding author), George Mason Univ, Discovery Hall,Rm 182,10900 Univ Blvd MS 1H8, Manassas, VA 20110 USA.	fkashanc@gmu.edu	Vertes, Akos/B-7159-2008; Afonso, Philippe V/ABB-5692-2021; Afonso, Philippe/D-2234-2014; Van Duyne, Rachel/ABI-2429-2020; Van Duyne, Rachel/I-7365-2019; Shrestha, Bindesh/B-8821-2008	Vertes, Akos/0000-0001-5186-5352; Afonso, Philippe V/0000-0002-4828-3797; Afonso, Philippe/0000-0002-4828-3797; Van Duyne, Rachel/0000-0003-2914-6874; Das, Ravi/0000-0002-4301-0642; Sehgal, Mohit/0000-0001-5544-3675; Shrestha, Bindesh/0000-0002-7595-3506; mahieux, renaud/0000-0002-5129-6804	National Institutes of Health (NIH), NCI [R01 CA054559]; NIH, NIAID [R01 AI077414]; NIH [AI078859, AI074410, AI043894]; United States Department of Energy [DE-SC0001599, DE-FG02-01ER15129]; George Mason University; equipe labelisee Ligue Contre le Cancer; NATIONAL CANCER INSTITUTE [R01CA054559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078859, R01AI077414, R21AI074410, R01AI043894] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); George Mason University; equipe labelisee Ligue Contre le Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grant R01 CA054559 and NIH, NIAID, Grant R01 AI077414 (supporting P. J. and M. S.) and NIH Grants AI078859, AI074410, and AI043894 (to F. K.). This work was also supported by United States Department of Energy Grant DE-SC0001599 (to F. K.), an indirect account at George Mason University, and equipe labelisee Ligue Contre le Cancer (to R. M.). This work was also supported by the United States Department of Energy through Grant DE-FG02-01ER15129 (to A. V.) for conducting the LAESI-MS measurements.	Ahuja J, 2006, J NEUROVIROL, V12, P47, DOI 10.1080/13550280600614981; Ahuja J, 2007, BIOMED PHARMACOTHER, V61, P201, DOI 10.1016/j.biopha.2007.02.006; Alefantis T, 2005, J BIOMED SCI, V12, P961, DOI 10.1007/s11373-005-9026-x; Araya N, 2011, VIRUSES-BASEL, V3, P1532, DOI 10.3390/v3091532; Arenz C, 2001, CHEMBIOCHEM, V2, P141, DOI 10.1002/1439-7633(20010202)2:2<141::AID-CBIC141>3.0.CO;2-P; Banerjee P, 2007, J VIROL, V81, P1690, DOI 10.1128/JVI.01513-06; Belgnaoui SM, 2010, J BIOL CHEM, V285, P32897, DOI 10.1074/jbc.M110.146373; Bellon M, 2008, BLOOD, V112, P2946, DOI 10.1182/blood-2008-01-134692; BHAT NK, 1993, VIROLOGY, V196, P15, DOI 10.1006/viro.1993.1450; Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Starling ALB, 2013, ACTA TROP, V125, P75, DOI 10.1016/j.actatropica.2012.09.012; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Cabezas SC, 2013, CELL MICROBIOL, V15, P412, DOI 10.1111/cmi.12046; Callahan MK, 2003, J IMMUNOL, V170, P4840, DOI 10.4049/jimmunol.170.9.4840; Cartier L, 2005, ARCH VIROL, V150, P743, DOI 10.1007/s00705-004-0443-3; Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1, DOI 10.1097/00126334-200105010-00001; Ceccarelli S, 2007, INT J CANCER, V121, P1494, DOI 10.1002/ijc.22844; Chandhasin C, 2008, J VIROL, V82, P6952, DOI 10.1128/JVI.02331-07; Chen CL, 2012, J PROTEOME RES, V11, P5611, DOI 10.1021/pr3008732; Cheng H, 2012, PROTEIN CELL, V3, P581, DOI 10.1007/s13238-012-2047-0; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Chlichlia K, 2010, CHEM-BIOL INTERACT, V188, P359, DOI 10.1016/j.cbi.2010.06.005; Cook LB, 2013, VIROLOGY, V435, P131, DOI 10.1016/j.virol.2012.09.028; Cowan EP, 1997, J VIROL, V71, P6982, DOI 10.1128/JVI.71.9.6982-6989.1997; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; de la Fuente C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-43; Dear JW, 2013, PROTEOMICS, V13, P1572, DOI 10.1002/pmic.201200285; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074/jbc.M804931200; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Giri PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002461; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GRASSMANN R, 1989, P NATL ACAD SCI USA, V86, P3351, DOI 10.1073/pnas.86.9.3351; Grossman WJ, 1997, BLOOD, V90, P783, DOI 10.1182/blood.V90.2.783.783_783_794; Guerreiro JB, 2006, CLIN EXP IMMUNOL, V145, P296, DOI 10.1111/j.1365-2249.2006.03150.x; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Haller K, 2002, MOL CELL BIOL, V22, P3327, DOI 10.1128/MCB.22.10.3327-3338.2002; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Honegger A, 2013, INT J CANCER, V133, P1631, DOI 10.1002/ijc.28164; Hu G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.114; IJICHI S, 1993, MED HYPOTHESES, V41, P542, DOI 10.1016/0306-9877(93)90111-3; Ijichi S, 1997, Nihon Rinsho, V55, P926; Inlora J, 2011, J VIROL, V85, P3802, DOI 10.1128/JVI.02383-10; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Iwanaga R, 2001, ONCOGENE, V20, P2055, DOI 10.1038/sj.onc.1204304; Iwanaga Y, 1999, J VIROL, V73, P1271, DOI 10.1128/JVI.73.2.1271-1277.1999; Jain P, 2007, J BIOL CHEM, V282, P34581, DOI 10.1074/jbc.M707317200; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Jeong SJ, 2008, VIROLOGY, V370, P264, DOI 10.1016/j.virol.2007.09.003; Jin DY, 1997, NUCLEIC ACIDS RES, V25, P379, DOI 10.1093/nar/25.2.379; Kamoi K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00270; KASHANCHI F, 1992, NUCLEIC ACIDS RES, V20, P4673, DOI 10.1093/nar/20.17.4673; Kawakami A, 1999, BLOOD, V94, P3847, DOI 10.1182/blood.V94.11.3847.423a24_3847_3854; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08; Kim YM, 2010, ONCOGENE, V29, P2142, DOI 10.1038/onc.2009.498; KIMATA JT, 1994, VIROLOGY, V204, P656, DOI 10.1006/viro.1994.1581; Kinjo T, 2010, J VIROL, V84, P5431, DOI 10.1128/JVI.02460-09; Kooij G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00074; Kooij G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008212; Krueger A, 2006, BLOOD, V107, P3933, DOI 10.1182/blood-2005-06-2567; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; LINDHOLM P F, 1990, New Biologist, V2, P1034; LINDHOLM PF, 1992, J VIROL, V66, P1294, DOI 10.1128/JVI.66.3.1294-1302.1992; Liu MH, 2008, J VIROL, V82, P8442, DOI 10.1128/JVI.00091-08; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Macaire H, 2012, J BIOL CHEM, V287, P21357, DOI 10.1074/jbc.M112.340992; Macovei A, 2006, BIOCHEM BIOPH RES CO, V346, P1083, DOI 10.1016/j.bbrc.2006.06.023; Maeda Y, 2011, LEUKEMIA LYMPHOMA, V52, P150, DOI 10.3109/10428194.2010.527406; Majone F, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-15; Manuel SL, 2009, J LEUKOCYTE BIOL, V86, P1205, DOI 10.1189/jlb.0309172; MARRIOTT SJ, 1991, NEW BIOL, V3, P678; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montanheiro P, 2007, J NEUROIMMUNOL, V188, P138, DOI 10.1016/j.jneuroim.2007.05.015; Mori N, 2004, INT J CANCER, V111, P548, DOI 10.1002/ijc.20266; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; NIMER SD, 1989, ONCOGENE, V4, P671; NISHIMOTO N, 1990, J NEUROL SCI, V97, P183, DOI 10.1016/0022-510X(90)90217-B; Norris PJ, 2010, VIRULENCE, V1, P19, DOI 10.4161/viru.1.1.9868; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; PAL R, 1991, AIDS RES HUM RETROV, V7, P707, DOI 10.1089/aid.1991.7.707; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; POPOVIC M, 1983, P NATL ACAD SCI-BIOL, V80, P5402, DOI 10.1073/pnas.80.17.5402; Principe S, 2013, PROTEOMICS, V13, P1667, DOI 10.1002/pmic.201200561; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Rahman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034490; Rood IM, 2010, KIDNEY INT, V78, P810, DOI 10.1038/ki.2010.262; SAIFUDDIN M, 1995, J EXP MED, V182, P501, DOI 10.1084/jem.182.2.501; Saito K, 2010, VIROLOGY, V403, P173, DOI 10.1016/j.virol.2010.04.018; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Santiago F, 1999, J VIROL, V73, P9917, DOI 10.1128/JVI.73.12.9917-9927.1999; Schmitt I, 1998, J VIROL, V72, P633, DOI 10.1128/JVI.72.1.633-640.1998; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Shrestha B, 2012, CHEM COMMUN, V48, P3700, DOI 10.1039/c2cc17225a; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; SPEAR GT, 1995, J IMMUNOL, V155, P4376; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Takashima H, 1996, ANN RHEUM DIS, V55, P632, DOI 10.1136/ard.55.9.632; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Testa JS, 2010, J IMMUNOL, V185, P6608, DOI 10.4049/jimmunol.1001768; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vajente N, 2009, APOPTOSIS, V14, P153, DOI 10.1007/s10495-008-0289-3; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wahlgren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049723; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Watanabe T, 2011, INT J HEMATOL, V94, P430, DOI 10.1007/s12185-011-0934-4; Welton JL, 2010, MOL CELL PROTEOMICS, V9, P1324, DOI 10.1074/mcp.M000063-MCP201; Wurdinger T, 2012, ADV VIROL, V2012, DOI 10.1155/2012/767694; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yamano Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00389; Yang LP, 2011, J VIROL, V85, P3001, DOI 10.1128/JVI.00086-10; Yasunaga J, 2011, INT J HEMATOL, V94, P435, DOI 10.1007/s12185-011-0937-1	134	106	112	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22284	22305		10.1074/jbc.M114.549659	http://dx.doi.org/10.1074/jbc.M114.549659			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24939845	hybrid, Green Published			2022-12-28	WOS:000340593500041
J	McKown, RL; Frazier, EVC; Zadrozny, KK; Deleault, AM; Raab, RW; Ryan, DS; Sia, RK; Lee, JK; Laurie, GW				McKown, Robert L.; Frazier, Erin V. Coleman; Zadrozny, Kaneil K.; Deleault, Andrea M.; Raab, Ronald W.; Ryan, Denise S.; Sia, Rose K.; Lee, Jae K.; Laurie, Gordon W.			A Cleavage-potentiated Fragment of Tear Lacritin Is Bactericidal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI-CELLS; ANTIMICROBIAL PEPTIDE; STAPHYLOCOCCUS-AUREUS; ANTIBACTERIAL FACTOR; STRESS; DERMCIDIN; SECRETION; SWEAT; SUSCEPTIBILITY; POLYAMINES	Antimicrobial peptides are important as the first line of innate defense, through their tendency to disrupt bacterial membranes or intracellular pathways and potentially as the next generation of antibiotics. How they protect wet epithelia is not entirely clear, with most individually inactive under physiological conditions and many preferentially targeting Gram-positive bacteria. Tears covering the surface of the eye are bactericidal for Gram-positive and -negative bacteria. Here we narrow much of the bactericidal activity to a latent C-terminal fragment in the prosecretory mitogen lacritin and report that the mechanism combines membrane permeabilization with rapid metabolic changes, including reduced levels of dephosphocoenzyme A, spermidine, putrescine, and phosphatidylethanolamines and elevated alanine, leucine, phenylalanine, tryptophan, proline, glycine, lysine, serine, glutamate, cadaverine, and pyrophosphate. Thus, death by metabolic stress parallels cellular attempts to survive. Cleavage-dependent appearance of the C-terminal cationic amphipathic alpha-helix is inducible within hours by Staphylococcus epidermidis and slowly by another mechanism, in a chymotrypsin-or leupeptin protease-inhibitable manner. Although bactericidal at low micromolar levels, within a biphasic 1-10 nM dose optimum, the same domain is mitogenic and cytoprotective for epithelia via a syndecan-1 targeting mechanism dependent on heparanase. Thus, the C terminus of lacritin is multifunctional by dose and proteolytic processing and appears to play a key role in the innate protection of the eye, with wider potential benefit elsewhere as lacritin flows from exocrine secretory cells.	[McKown, Robert L.; Frazier, Erin V. Coleman; Zadrozny, Kaneil K.; Deleault, Andrea M.; Raab, Ronald W.] James Madison Univ, Dept Integrated Sci & Technol, Harrisonburg, VA 22807 USA; [Ryan, Denise S.; Sia, Rose K.] Warfighter Refract Eye Surg Program & Res Ctr Ft, Ft Belvoir, VA 22060 USA; [Lee, Jae K.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Lee, Jae K.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	James Madison University; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Laurie, GW (corresponding author), Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	glaurie@virginia.edu	Laurie, Gordon W/A-5244-2008	Laurie, Gordon W/0000-0002-5311-2650	National Institutes of Health [RO1 EY013143, EY018222]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018222, R01EY013143, R01EY024327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY013143 and EY018222 (to G. W. L.). G. W. L. is co-founder of TearSolutions, LLC, which seeks to take a lacritin C-terminal peptide through phase II human trials for treating dry eye.	Baechle D, 2006, J BIOL CHEM, V281, P5406, DOI 10.1074/jbc.M504670200; Bashir A, 2014, APPL ENVIRON MICROB, V80, P2773, DOI 10.1128/AEM.00078-14; BENJAMIN WJ, 1983, INVEST OPHTH VIS SCI, V24, P1624; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bernheim J., 1893, BEITR AUGENHEILK VON; Biville F, 1996, RES MICROBIOL, V147, P597, DOI 10.1016/0923-2508(96)84015-0; Brown-Elliott BA, 2012, CORNEA, V31, P900, DOI 10.1097/ICO.0b013e31823f8bb9; Butovich IA, 2013, EXP EYE RES, V117, P4, DOI 10.1016/j.exer.2013.05.010; Cerovsky V, 2008, CHEMBIOCHEM, V9, P2815, DOI 10.1002/cbic.200800476; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Chen LY, 2011, J PROTEOME RES, V10, P4876, DOI 10.1021/pr2004874; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; Farris R L, 1986, Trans Am Ophthalmol Soc, V84, P250; Fleiszig SMJ, 2003, INFECT IMMUN, V71, P3866, DOI 10.1128/IAI.71.7.3866-3874.2003; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FORD LC, 1976, AM J OPHTHALMOL, V81, P30, DOI 10.1016/0002-9394(76)90188-4; FRIEDLAND BR, 1972, AM J OPHTHALMOL, V74, P52, DOI 10.1016/0002-9394(72)91125-7; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; GILBARD JP, 1978, ARCH OPHTHALMOL-CHIC, V96, P677; Graham Joanna E, 2007, Invest Ophthalmol Vis Sci, V48, P5616; Haneburger I, 2012, J MOL BIOL, V424, P15, DOI 10.1016/j.jmb.2012.08.023; Imura Y, 2008, BIOPHYS J, V95, P5757, DOI 10.1529/biophysj.108.133488; Iwalokun BA, 2011, J OPHTHALMIC INFLAMM, V1, P95, DOI 10.1007/s12348-011-0024-z; JANSSEN PT, 1984, INVEST OPHTH VIS SCI, V25, P1156; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Karimian F, 2011, CORNEA, V30, P620, DOI 10.1097/ICO.0b013e3181e16f7c; Karnati R, 2013, EXP EYE RES, V117, P39, DOI 10.1016/j.exer.2013.05.020; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Malhotra S, 2005, Indian J Pathol Microbiol, V48, P538; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; Melanowski WH, 1937, AM J OPHTHALMOL; Morimoto-Tochigi A, 2010, INVEST OPHTH VIS SCI, V51, P4395, DOI 10.1167/iovs.09-4573; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nagaoka I, 2000, INFLAMM RES, V49, P73, DOI 10.1007/s000110050561; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; O'Toole N, 2003, PROTEIN SCI, V12, P327, DOI 10.1110/ps.0227803; Paulmann M, 2012, J BIOL CHEM, V287, P8434, DOI 10.1074/jbc.M111.332270; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; Rieg S, 2006, J INVEST DERMATOL, V126, P354, DOI 10.1038/sj.jid.5700041; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Samudre S, 2011, INVEST OPHTH VIS SCI, V52, P6265, DOI 10.1167/iovs.10-6220; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schroll C, 2014, VET MICROBIOL, V170, P144, DOI 10.1016/j.vetmic.2014.01.034; Seifert K, 2012, INVEST OPHTH VIS SCI, V53, P6610, DOI 10.1167/iovs.11-8729; Sitaramamma T, 1998, Indian Journal of Ophthalmology, V46, P239; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; Stromstedt A. A., BIOCH BIOPHYS ACTA, V1788, P1916; Tam C, 2012, J CLIN INVEST, V122, P3665, DOI 10.1172/JCI64416; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Tossi A, 2000, BIOPOLYMERS, V55, P4; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Velez VF, 2013, INVEST OPHTH VIS SCI, V54, P2123, DOI 10.1167/iovs.12-11488; Wang JH, 2006, J CELL BIOL, V174, P689, DOI 10.1083/jcb.200605140; Wang N, 2013, J BIOL CHEM, V288, P18146, DOI 10.1074/jbc.M112.436584; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zaidi TS, 2006, INFECT IMMUN, V74, P975, DOI 10.1128/IAI.74.2.975-983.2006; Zhang YH, 2013, J BIOL CHEM, V288, P12090, DOI 10.1074/jbc.M112.422717; Zhou L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001291; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	70	25	26	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22172	22182		10.1074/jbc.M114.570143	http://dx.doi.org/10.1074/jbc.M114.570143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942736	Green Published, hybrid			2022-12-28	WOS:000340593500032
J	Sakurai, Y; Anzai, I; Furukawa, Y				Sakurai, Yasuyuki; Anzai, Itsuki; Furukawa, Yoshiaki			A Primary Role for Disulfide Formation in the Productive Folding of Prokaryotic Cu,Zn-superoxide Dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; COPPER CHAPERONE; POSTTRANSLATIONAL MODIFICATIONS; STRUCTURAL DYNAMICS; ZINC; SALMONELLA; OXYGEN; BOND; MUTATIONS	Enzymatic activation of Cu,Zn-superoxide dismutase (SOD1) requires not only binding of a catalytic copper ion but also formation of an intramolecular disulfide bond. Indeed, the disulfide bond is completely conserved among all species possessing SOD1; however, it remains obscure how disulfide formation controls the enzymatic activity of SOD1. Here, we show that disulfide formation is a primary event in the folding process of prokaryotic SOD1 (SodC) localized to the periplasmic space. Escherichia coli SodC was found to attain beta-sheet structure upon formation of the disulfide bond, whereas disulfide-reduced SodC assumed little secondary structure even in the presence of copper and zinc ions. Moreover, reduction of the disulfide bond made SodC highly susceptible to proteolytic degradation. We thus propose that the thiol-disulfide status in SodC controls the intracellular stability of this antioxidant enzyme and that the oxidizing environment of the periplasm is required for the enzymatic activation of SodC.	[Sakurai, Yasuyuki; Anzai, Itsuki; Furukawa, Yoshiaki] Keio Univ, Dept Chem, Lab Mech Chem Biomol, Yokohama, Kanagawa 2238522, Japan	Keio University	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp	Furukawa, Yoshiaki/F-2871-2014	Furukawa, Yoshiaki/0000-0002-1918-372X; Anzai, Itsuki/0000-0001-9307-943X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25291028, 24657093]; Cooperative Research in Joint Studies at Institute for Molecular Science, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cooperative Research in Joint Studies at Institute for Molecular Science, Japan	This work was supported by Grants-in-aid 25291028 for Scientific Research (B) and 24657093 for Challenging Exploratory Research (to Y. F.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Cooperative Research in Joint Studies at Institute for Molecular Science, Japan.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Banci L, 2005, P NATL ACAD SCI USA, V102, P7541, DOI 10.1073/pnas.0502450102; Battistoni A, 1996, BIOCHEM J, V320, P713, DOI 10.1042/bj3200713; Battistoni A, 1998, J BIOL CHEM, V273, P5655, DOI 10.1074/jbc.273.10.5655; Battistoni A, 1999, FEBS LETT, V443, P313, DOI 10.1016/S0014-5793(98)01725-6; BENOV LT, 1994, J BIOL CHEM, V269, P25310; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Cupane A, 1995, BIOCHEMISTRY-US, V34, P16313, DOI 10.1021/bi00050a011; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DONG AC, 1995, ARCH BIOCHEM BIOPHYS, V320, P59, DOI 10.1006/abbi.1995.1342; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Imlay KRC, 1996, J BACTERIOL, V178, P2564, DOI 10.1128/jb.178.9.2564-2571.1996; Ishikawa H, 2007, P NATL ACAD SCI USA, V104, P19309, DOI 10.1073/pnas.0709760104; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Krishnakumar R, 2007, J BACTERIOL, V189, P4343, DOI 10.1128/JB.00010-07; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Lyons TJ, 2000, J BIOL INORG CHEM, V5, P189, DOI 10.1007/s007750050363; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mealman TD, 2011, BIOCHEMISTRY-US, V50, P2559, DOI 10.1021/bi102012j; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Pesce A, 1997, J MOL BIOL, V274, P408, DOI 10.1006/jmbi.1997.1400; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SALVATO B, 1989, BIOCHIM BIOPHYS ACTA, V998, P14, DOI 10.1016/0167-4838(89)90112-X; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; Sroga GE, 2002, BIOTECHNOL BIOENG, V78, P761, DOI 10.1002/bit.10269; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; WEBER MJ, 1966, P NATL ACAD SCI USA, V55, P1224, DOI 10.1073/pnas.55.5.1224	43	15	15	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20139	20149		10.1074/jbc.M114.567677	http://dx.doi.org/10.1074/jbc.M114.567677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24917671	hybrid, Green Published			2022-12-28	WOS:000339395200027
J	Volkova, NA; Fomina, EG; Smolnikova, VV; Zinovieva, NA; Fomin, IK				Volkova, Natalia A.; Fomina, Elena G.; Smolnikova, Viktoryia V.; Zinovieva, Natalia A.; Fomin, Igor K.			The U3 Region of Moloney Murine Leukemia Virus Contains Position-independent Cis-acting Sequences Involved in the Nuclear Export of Full-length Viral Transcripts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; 5' RNA TERMINUS; RETROVIRAL VECTORS; R-REGION; SECONDARY STRUCTURE; LENTIVIRUS VECTOR; GENE-TRANSFER; EXPRESSION; GAG; SIGNAL	The distinguishing feature of self-inactivating (SIN) retroviral vectors is the deletion of the enhancer/promoter sequences in the U3 region of the 3' long terminal repeat. This design is used to overcome transcriptional interference and prevent downstream transcription from the 3' long terminal repeat. SIN vectors were derived from a number of different retroviruses. Studies of SIN vectors show that extensive U3 deletions in HIV-based vectors do not alter viral titers or the in vitro and in vivo properties of the vectors. However, deletion of the U3 sequences in gamma- and alpha-retroviruses correlates with defects in 3' RNA processing and reduces viral titers by >10-fold. Here, we studied the steps in the retroviral life cycle that are affected by the deletion of sequences in the 3' U3 region of Moloney murine leukemia virus-derived retroviral vectors. The results show that the amounts of both full-length and internal RNA transcripts of U3-minus vectors are reduced in the nuclei of transfected cells, an effect that is probably due to a general defect in 3' RNA processing. Furthermore, full-length RNA transcripts were also defective in terms of nuclear export. This defect was complemented by transferring the U3 region to another position within the retroviral vector, indicating that the U3 region contains position-independent cis-acting sequences that are required for the transport of full-length viral transcripts. The results also suggest that the leader region of Moloney murine leukemia virus contains inhibitory/regulatory sequences, which prevent export and mediate nuclear retention of full-length viral RNA.	[Fomina, Elena G.] Republ Res & Pract Ctr Epidemiol & Microbiol, Lab Biotechnol & Immunodiagnosis, Minsk 220114, BELARUS; [Smolnikova, Viktoryia V.] Republ Ctr Hematol & Bone Marrow Transplantat, Minsk 220116, BELARUS			n_zinovieva@mail.ru; ikfomin@mail.ru	Volkova, Natalia/AAE-3311-2019	Volkova, Natalia/0000-0001-7191-3550				Basyuk E, 2005, J MOL BIOL, V354, P330, DOI 10.1016/j.jmb.2005.09.071; Blissenbach M, 2010, J VIROL, V84, P6598, DOI 10.1128/JVI.02264-09; Butsch M, 1999, J VIROL, V73, P4847, DOI 10.1128/JVI.73.6.4847-4855.1999; Cupelli L, 1998, J VIROL, V72, P7807, DOI 10.1128/JVI.72.10.7807-7814.1998; CUPELLI LA, 1991, J VIROL, V65, P6961, DOI 10.1128/JVI.65.12.6961-6968.1991; Dangel AW, 2002, J VIROL, V76, P3292, DOI 10.1128/JVI.76.7.3292-3300.2002; DOUGHERTY JP, 1987, P NATL ACAD SCI USA, V84, P1197, DOI 10.1073/pnas.84.5.1197; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; FLAMANT F, 1993, J GEN VIROL, V74, P39, DOI 10.1099/0022-1317-74-1-39; Hlavaty J, 2004, J VIROL, V78, P1384, DOI 10.1128/JVI.78.3.1384-1392.2004; Hull S, 2002, J VIROL, V76, P10211, DOI 10.1128/JVI.76.20.10211-10218.2002; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; Kharytonchyk SA, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-3; Klein D, 2000, GENE THER, V7, P458, DOI 10.1038/sj.gt.3301112; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; OLSON P, 1992, J VIROL, V66, P1336, DOI 10.1128/JVI.66.3.1336-1343.1992; OLSON P, 1994, J VIROL, V68, P7060, DOI 10.1128/JVI.68.11.7060-7066.1994; Roberts TM, 2000, J VIROL, V74, P8111, DOI 10.1128/JVI.74.17.8111-8118.2000; Roberts TM, 2003, J VIROL, V77, P11973, DOI 10.1128/JVI.77.22.11973-11984.2003; Russell RA, 2001, J VIROL, V75, P6817, DOI 10.1128/JVI.75.15.6817-6824.2001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Schambach A, 2007, MOL THER, V15, P1167, DOI 10.1038/sj.mt.6300152; Schomber T, 2004, BLOOD, V103, P4511, DOI 10.1182/blood-2003-07-2397; SHINNICK TM, 1981, NATURE, V293, P543, DOI 10.1038/293543a0; Sinn PL, 2005, GENE THER, V12, P1089, DOI 10.1038/sj.gt.3302570; Smagulova F, 2005, J MOL BIOL, V354, P1118, DOI 10.1016/j.jmb.2005.10.021; Trubetskoy AM, 1999, J VIROL, V73, P3477, DOI 10.1128/JVI.73.4.3477-3483.1999; YEE JK, 1987, P NATL ACAD SCI USA, V84, P5197, DOI 10.1073/pnas.84.15.5197; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	33	6	6	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20158	20169		10.1074/jbc.M113.545855	http://dx.doi.org/10.1074/jbc.M113.545855			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24878957	hybrid, Green Published			2022-12-28	WOS:000339395200029
J	Yamamoto-Tanaka, M; Motoyama, A; Miyai, M; Matsunaga, Y; Matsuda, J; Tsuboi, R; Hibino, T				Yamamoto-Tanaka, Mami; Motoyama, Akira; Miyai, Masashi; Matsunaga, Yukiko; Matsuda, Junko; Tsuboi, Ryoji; Hibino, Toshihiko			Mesotrypsin and Caspase-14 Participate in Prosaposin Processing POTENTIAL RELEVANCE TO EPIDERMAL PERMEABILITY BARRIER FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DIFFERENTIATION; SAPOSINS; LEUKODYSTROPHY; IDENTIFICATION; MUTATIONS; PROTEINS; DISEASE; STORAGE; GENE; SKIN	A proteomics-based search for molecules interacting with caspase-14 identified prosaposin and epidermal mesotrypsin as candidates. Prosaposin is a precursor of four sphingolipid activator proteins (saposins A-D) that are essential for lysosomal hydrolysis of sphingolipids. Thus, we hypothesized that caspase-14 and mesotrypsin participate in processing of prosaposin. Because we identified a saposin A sequence as an interactor with these proteases, we prepared a specific antibody to saposin A and focused on saposin A-related physiological reactions. We found that mesotrypsin generated saposins A-D from prosaposin, and mature caspase-14 contributed to this process by activating mesotrypsinogen to mesotrypsin. Knockdown of these proteases markedly down-regulated saposin A synthesis in skin equivalent models. Saposin A was localized in granular cells, whereas prosaposin was present in the upper layer of human epidermis. The proximity ligation assay confirmed interaction between prosaposin, caspase-14, and mesotrypsin in the granular layer. Oil Red staining showed that the lipid envelope was significantly reduced in the cornified layer of skin from saposin A-deficient mice. Ultrastructural studies revealed severely disorganized cornified layer structure in both prosaposin- and saposin A-deficient mice. Overall, our results indicate that epidermal mesotrypsin and caspase-14 work cooperatively in prosaposin processing. We propose that they thereby contribute to permeability barrier formation in vivo.	[Hibino, Toshihiko] Shiseido Innovat Sci Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan; [Yamamoto-Tanaka, Mami; Tsuboi, Ryoji] Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, Tokyo 1600023, Japan; [Matsuda, Junko] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 2591292, Japan	Shiseido Company, Limited; Tokyo Medical University; Tokai University	Hibino, T (corresponding author), Shiseido Innovat Sci Res Ctr, Tsuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	toshihiko.hibino1@to.shiseido.co.jp						Alibardi L, 2004, J HISTOCHEM CYTOCHEM, V52, P1561, DOI 10.1369/jhc.4A6300.2004; ANDERSON RGW, 1977, J CELL BIOL, V72, P482, DOI 10.1083/jcb.72.2.482; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Dale B A, 1980, Curr Probl Dermatol, V10, P311; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; Eckhart L, 2000, J INVEST DERMATOL, V115, P1148, DOI 10.1046/j.1523-1747.2000.00205.x; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Hibino T, 2010, J CELL BIOCHEM, V109, P487, DOI 10.1002/jcb.22425; Hiraiwa M, 1997, ARCH BIOCHEM BIOPHYS, V341, P17, DOI 10.1006/abbi.1997.9958; HOROWITZ M, 1994, HUM MUTAT, V3, P1, DOI 10.1002/humu.1380030102; Ishida-Yamamoto A, 1998, EXP DERMATOL, V7, P1, DOI 10.1111/j.1600-0625.1998.tb00295.x; Jensen JM, 2009, GIORN ITAL DERMAT V, V144, P689; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; LIGHT A, 1989, TRENDS BIOCHEM SCI, V14, P110, DOI 10.1016/0968-0004(89)90133-3; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; Matsuda J, 2007, J NEUROCHEM, V103, P32, DOI 10.1111/j.1471-4159.2007.04709.x; Miyai M, 2014, J INVEST DERMATOL, V134, P1665, DOI 10.1038/jid.2014.3; Motoyama A, 2007, ANAL CHEM, V79, P3623, DOI 10.1021/ac062292d; Motoyama A, 2006, ANAL CHEM, V78, P5109, DOI 10.1021/ac060354u; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; PROKSCH E, 1993, BRIT J DERMATOL, V128, P473, DOI 10.1111/j.1365-2133.1993.tb00222.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Sahin-Toth M, 2005, PROTEIN PEPTIDE LETT, V12, P457, DOI 10.2174/0929866054395356; Scharschmidt TC, 2009, J INVEST DERMATOL, V129, P2435, DOI 10.1038/jid.2009.104; Vaccaro AM, 1999, NEUROCHEM RES, V24, P307, DOI 10.1023/A:1022530508763; Vaccaro AM, 2010, HUM MOL GENET, V19, P2987, DOI 10.1093/hmg/ddq204; Van de Craen M, 1998, CELL DEATH DIFFER, V5, P838, DOI 10.1038/sj.cdd.4400444; Yamamoto M, 2012, J BIOL CHEM, V287, P32825, DOI 10.1074/jbc.M112.357467	34	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20026	20038		10.1074/jbc.M113.543421	http://dx.doi.org/10.1074/jbc.M113.543421			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24872419	Green Published, hybrid			2022-12-28	WOS:000339395200018
J	Kudo-Sakamoto, Y; Akazawa, H; Ito, K; Takano, J; Yano, M; Yabumoto, C; Naito, AT; Oka, T; Lee, JK; Sakata, Y; Suzuki, J; Saido, TC; Komuro, I				Kudo-Sakamoto, Yoko; Akazawa, Hiroshi; Ito, Kaoru; Takano, Jiro; Yano, Masamichi; Yabumoto, Chizuru; Naito, Atsuhiko T.; Oka, Toru; Lee, Jong-Kook; Sakata, Yasushi; Suzuki, Jun-ichi; Saido, Takaomi C.; Komuro, Issei			Calpain-dependent Cleavage of N-cadherin Is Involved in the Progression of Post-myocardial Infarction Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; TYPE-1 RECEPTOR; PLASMA-MEMBRANE; CELL-DEATH; RAT-HEART; IN-VITRO; ACTIVATION; INHIBITION	Enzymatic proteolysis by calpains, Ca2+-dependent intracellular cysteine proteases, has been implicated in pathological processes such as cellular degeneration or death. Here, we investigated the role of calpain activation in the hearts subjected to myocardial infarction. We produced myocardial infarction in Cast(-/-) mice deficient for calpastatin, the specific endogenous inhibitory protein for calpains, and Cast(+/+) mice. The activity of cardiac calpains in Cast(+/+) mice was not elevated within 1 day but showed a gradual elevation after 7 days following myocardial infarction, which was further pronounced in Cast(-/-) mice. Although the prevalence of cardiomyocyte death was indistinguishable between Cast(-/-) and Cast(+/+) mice, Cast(-/-) mice exhibited profound contractile dysfunction and chamber dilatation and showed a significant reduction in survival rate after myocardial infarction as compared with Cast(+/+) mice. Notably, immunofluorescence revealed that at 28 days after myocardial infarction, calpains were activated in cardiomyocytes exclusively at the border zone and that Cast(-/-) mice showed higher intensity and a broader extent of calpain activation at the border zone than Cast(+/+) mice. In the border zone of Cast(-/-) mice, pronounced activation of calpains was associated with a decrease in N-cadherin expression and up-regulation of molecular markers for cardiac hypertrophy and fibrosis. In cultured rat neonatal cardiomyocytes, calpain activation by treatment with ionomycin induced cleavage of N-cadherin and decreased expression levels of beta-catenin and connexin 43, which was attenuated by calpain inhibitor. These results thus demonstrate that activation of calpains disassembles cell-cell adhesion at intercalated discs by degrading N-cadherin and thereby promotes left ventricular remodeling after myocardial infarction.	[Kudo-Sakamoto, Yoko; Yano, Masamichi; Yabumoto, Chizuru; Oka, Toru; Sakata, Yasushi] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akazawa, Hiroshi; Suzuki, Jun-ichi] Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, Tokyo 1138655, Japan; [Ito, Kaoru] Chiba Univ, Dept Cardiovasc Sci & Med, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; [Takano, Jiro; Saido, Takaomi C.] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Naito, Atsuhiko T.; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Lee, Jong-Kook] Osaka Univ, Dept Cardiovasc Regenerat Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akazawa, Hiroshi; Naito, Atsuhiko T.; Oka, Toru; Komuro, Issei] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; University of Tokyo; Chiba University; RIKEN; University of Tokyo; Osaka University; Japan Science & Technology Agency (JST)	Akazawa, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	akazawah-tky@umin.ac.jp; komuro-tky@umin.ac.jp	Saido, Takaomi C/N-5472-2015; Ito, Kaoru/AAZ-3440-2021; Sado, Takaomi/AAN-2759-2021	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903; Akazawa, Hiroshi/0000-0002-3574-9607; Sakata, Yasushi/0000-0002-5618-4721	Japan Society for the Promotion of Science (KAKENHI) [21229010, 23390213, 24659390, 25-40014]; Health and Labor Sciences Research Grants; Japan Foundation for Applied Enzymology	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Japan Foundation for Applied Enzymology	This work was supported in part by grants from Japan Society for the Promotion of Science (KAKENHI 21229010, 23390213, 24659390, and 25-40014) and Health and Labor Sciences Research Grants (to I. K. and H. A.) and Japan Foundation for Applied Enzymology (to H. A.).	Artal-Sanz M, 2005, FEBS LETT, V579, P3287, DOI 10.1016/j.febslet.2005.03.052; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chen Q, 2011, BIOCHEM BIOPH RES CO, V415, P533, DOI 10.1016/j.bbrc.2011.10.037; Dorn GW, 2009, NAT REV CARDIOL, V6, P283, DOI 10.1038/nrcardio.2009.12; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hernando V, 2010, J MOL CELL CARDIOL, V49, P271, DOI 10.1016/j.yjmcc.2010.02.024; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Inserte J, 2005, CIRC RES, V97, P465, DOI 10.1161/01.RES.0000181170.87738.f3; Jackson BM, 2002, J AM COLL CARDIOL, V40, P1160, DOI 10.1016/S0735-1097(02)02121-6; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Kang MY, 2010, CIRC RES, V107, P903, DOI 10.1161/CIRCRESAHA.110.220772; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Khalil PN, 2005, EUR J PHARMACOL, V528, P124, DOI 10.1016/j.ejphar.2005.10.032; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Ma J, 2012, J BIOL CHEM, V287, P27480, DOI 10.1074/jbc.M112.358929; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; Matsumura Y, 1996, CIRC RES, V79, P447, DOI 10.1161/01.RES.79.3.447; Matsushita T, 1999, CIRC RES, V85, P1046; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Neuhof C, 2004, BIOL CHEM, V385, P1077, DOI 10.1515/BC.2004.139; Papp Z, 2000, CARDIOVASC RES, V45, P981, DOI 10.1016/S0008-6363(99)00374-0; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Saitoh T, 2006, CARDIOVASC PATHOL, V15, P130, DOI 10.1016/j.carpath.2006.01.003; Sandmann S, 2002, BRIT J PHARMACOL, V135, P1951, DOI 10.1038/sj.bjp.0704661; Sandmann S, 2001, BRIT J PHARMACOL, V132, P767, DOI 10.1038/sj.bjp.0703860; Sato N, 1995, BIOCHEM BIOPH RES CO, V217, P649, DOI 10.1006/bbrc.1995.2823; Scalia R, 2011, CIRC RES, V108, P1102, DOI 10.1161/CIRCRESAHA.110.229393; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; STEENBERGEN C, 1987, CIRC RES, V60, P700, DOI 10.1161/01.RES.60.5.700; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Takahashi M, 2006, J CARDIOVASC PHARM, V47, P413; Takahashi M, 2005, CARDIOVASC RES, V65, P356, DOI 10.1016/j.cardiores.2004.09.022; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Taneike M, 2011, J BIOL CHEM, V286, P32170, DOI 10.1074/jbc.M111.248088; Tsuji T, 2001, AM J PHYSIOL-HEART C, V281, pH1286, DOI 10.1152/ajpheart.2001.281.3.H1286; Wang XJ, 1999, J MOL CELL CARDIOL, V31, P333, DOI 10.1006/jmcc.1998.0886; Yoshida H, 2003, CARDIOVASC RES, V59, P419, DOI 10.1016/S0008-6363(03)00385-7; Yoshikawa Y, 2005, AM J PHYSIOL-HEART C, V288, pH1690, DOI 10.1152/ajpheart.00666.2004; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	54	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19408	19419		10.1074/jbc.M114.567206	http://dx.doi.org/10.1074/jbc.M114.567206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891510	hybrid, Green Published			2022-12-28	WOS:000339326800017
J	Pandey, KK; Bera, S; Korolev, S; Campbell, M; Yin, ZQ; Aihara, H; Grandgenett, DP				Pandey, Krishan K.; Bera, Sibes; Korolev, Sergey; Campbell, Mary; Yin, Zhiqi; Aihara, Hideki; Grandgenett, Duane P.			Rous Sarcoma Virus Synaptic Complex Capable of Concerted Integration Is Kinetically Trapped by Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOTYPE FOAMY VIRUS; HIV-1 INTEGRASE; VIRAL-DNA; DISSOCIATION; BINDING; CONFORMATIONS; ORGANIZATION; RALTEGRAVIR; RESISTANCE; MECHANISM	We determined conditions to produce milligram quantities of the soluble Rous sarcoma virus (RSV) synaptic complex that is kinetically trapped by HIV strand transfer inhibitors (STIs). Concerted integration catalyzed by RSV integrase (IN) is effectively inhibited by HIV STIs. Optimized assembly of the RSV synaptic complex required IN, a gain-of-function 3'-OH-recessed U3 oligonucleotide, and an STI under specific conditions to maintain solubility of the trapped synaptic complex at 4 C. A C-terminal truncated IN (1-269 residues) produced a homogeneous population of trapped synaptic complex that eluted at similar to 151,000 Da upon Superdex 200 size-exclusion chromatography (SEC). Approximately 90% of input IN and DNA are incorporated into the trapped synaptic complex using either the C-terminally truncated IN or wild type IN (1-286 residues). No STI is present in the SEC running buffer suggesting the STI-trapped synaptic complex is kinetically stabilized. The yield of the trapped synaptic complex correlates with the dissociative half-life of the STI observed with HIV IN-DNA complexes. Dolutegravir, MK-2048, and MK-0536 are equally effective, whereas raltegravir is similar to 70% as effective. Without an STI present in the assembly mixture, no trapped synaptic complex was observed. Fluorescence and mass spectroscopy analyses demonstrated that the STI remains associated with the trapped complex. SEC-multiangle light scattering analyses demonstrated that wild type IN and the C-terminal IN truncation are dimers that acted as precursors to the tetramer. The purified STI-trapped synaptic complex contained a tetramer as shown by cross-linking studies. Structural studies of this three-domain RSV IN in complex with viral DNA may be feasible.	[Pandey, Krishan K.; Bera, Sibes; Grandgenett, Duane P.] St Louis Univ, Hlth Sci Ctr, Inst Mol Virol, St Louis, MO 63104 USA; [Korolev, Sergey] St Louis Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Campbell, Mary] St Louis Univ, Hlth Sci Ctr, Ctr World Hlth & Med, St Louis, MO 63104 USA; [Yin, Zhiqi; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Saint Louis University; Saint Louis University; Saint Louis University; University of Minnesota System; University of Minnesota Twin Cities	Grandgenett, DP (corresponding author), St Louis Univ, Sch Med, Inst Mol Virol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	grandgdp@slu.edu	Korolev, Sergey/ABA-7517-2020	Korolev, Sergey/0000-0001-9313-7126; Pandey, Krishan/0000-0002-3973-9844	National Institutes of Health [AI100682]; Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI100682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI100682 (to D. G.). This work was also supported by Saint Louis University.	Bera S, 2005, BIOCHEMISTRY-US, V44, P15106, DOI 10.1021/bi0508340; Bera S, 2011, J MOL BIOL, V410, P831, DOI 10.1016/j.jmb.2011.01.043; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; DeAnda F, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0077448; Di Santo R, 2014, J MED CHEM, V57, P539, DOI 10.1021/jm400674a; Garvey EP, 2009, BIOCHEMISTRY-US, V48, P1644, DOI 10.1021/bi802141y; GRANDGENETT DP, 1978, VIROLOGY, V89, P119, DOI 10.1016/0042-6822(78)90046-6; Grobler JA, 2009, ANTIVIR THER, V14, pA27; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hightower KE, 2011, ANTIMICROB AGENTS CH, V55, P4552, DOI 10.1128/AAC.00157-11; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Koh Y, 2011, J VIROL, V85, P3677, DOI 10.1128/JVI.02541-10; Kotova S, 2010, J MOL BIOL, V399, P491, DOI 10.1016/j.jmb.2010.04.026; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Langley DR, 2008, BIOCHEMISTRY-US, V47, P13481, DOI 10.1021/bi801372d; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; McCord M, 1998, PROTEIN EXPRES PURIF, V14, P167, DOI 10.1006/prep.1998.0954; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Pandey KK, 2007, J VIROL, V81, P12189, DOI 10.1128/JVI.02863-06; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; Pandey KK, 2010, BIOCHEMISTRY-US, V49, P8376, DOI 10.1021/bi100514s; Peletskaya E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027751; Pereira HD, 2005, J MOL BIOL, V353, P584, DOI 10.1016/j.jmb.2005.08.045; Poirier JM, 2008, J CHROMATOGR B, V867, P277, DOI 10.1016/j.jchromb.2008.03.026; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Quashie PK, 2013, ANTIMICROB AGENTS CH, V57, P6223, DOI 10.1128/AAC.01835-13; Shi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056892; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Xiang L, 2008, J MAGN RESON, V194, P147, DOI 10.1016/j.jmr.2008.06.006; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463	43	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19648	19658		10.1074/jbc.M114.573311	http://dx.doi.org/10.1074/jbc.M114.573311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872410	hybrid, Green Published			2022-12-28	WOS:000339326800037
J	Rountree, AM; Neal, AS; Lisowski, M; Rizzo, N; Radtke, J; White, S; Luciani, DS; Kim, F; Hampe, CS; Sweet, IR				Rountree, Austin M.; Neal, Adam S.; Lisowski, Mark; Rizzo, Norma; Radtke, Jared; White, Sarah; Luciani, Dan S.; Kim, Francis; Hampe, Christiane S.; Sweet, Ian R.			Control of Insulin Secretion by Cytochrome c and Calcium Signaling in Islets with Impaired Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; AMPLIFYING PATHWAYS; OXYGEN-CONSUMPTION; ENERGY-PRODUCTION; CA2+ SENSOR; GLUCOSE; GLUCOKINASE; RELEASE; RESPIRATION; APOPTOSIS	The aim of the study was to assess the relative control of insulin secretion rate (ISR) by calcium influx and signaling from cytochrome c in islets where, as in diabetes, the metabolic pathways are impaired. This was achieved either by culturing isolated islets at low (3 mM) glucose or by fasting rats prior to the isolation of the islets. Culture in low glucose greatly reduced the glucose response of cytochrome c reduction and translocation and ISR, but did not affect the response to the mitochondrial fuel alpha-ketoisocaproate. Unexpectedly, glucose-stimulated calcium influx was only slightly reduced in low glucose-cultured islets and was not responsible for the impairment in glucose-stimulated ISR. A glucokinase activator acutely restored cytochrome c reduction and translocation and ISR, independent of effects on calcium influx. Islets from fasted rats had reduced ISR and cytochrome c reduction in response to both glucose and alpha-ketoisocaproate despite normal responses of calcium. Our data are consistent with the scenario where cytochrome c reduction and translocation are essential signals in the stimulation of ISR, the loss of which can result in impaired ISR even when calcium response is normal.	[Rountree, Austin M.; Neal, Adam S.; Lisowski, Mark; Rizzo, Norma; Radtke, Jared; Kim, Francis; Hampe, Christiane S.; Sweet, Ian R.] Univ Washington, Diabet & Obes Ctr, Dept Med, Seattle, WA 98195 USA; [White, Sarah; Luciani, Dan S.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z4, Canada	University of Washington; University of Washington Seattle; University of British Columbia	Sweet, IR (corresponding author), Univ Washington, Diabet & Obes Ctr, Box 358055,850 Republican St, Seattle, WA 98195 USA.	isweet@u.washington.edu	Hampe, Christiane Susanne/GSD-7679-2022	Luciani, Dan/0000-0002-4318-4159; Hampe, Christiane/0000-0001-9111-6671	National Institutes of Health [DK17047]; University of Washington Diabetes and Obesity Center; Washington State Life Sciences Discovery Fund, National Science Foundation [IIP-0750508]; American Diabetes Association/Gail Patrick Estate [1-13-IN-53]; Canadian Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026190, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Diabetes and Obesity Center; Washington State Life Sciences Discovery Fund, National Science Foundation(National Science Foundation (NSF)); American Diabetes Association/Gail Patrick Estate; Canadian Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK17047 (the Diabetes Research Center (DRC) Islet Core and the Immunology and Inflammation Core, and an R24 seed grant supplement), funding from the University of Washington Diabetes and Obesity Center and the Washington State Life Sciences Discovery Fund, National Science Foundation Grant IIP-0750508, and a grant from the American Diabetes Association/Gail Patrick Estate (Grant 1-13-IN-53).; Supported by an operating grant from the Canadian Diabetes Association.	Barg S, 2004, J GEN PHYSIOL, V124, P623, DOI 10.1085/jgp.200409206; BARNES WS, 1993, MED SCI SPORT EXER, V25, P473; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; BURCH PT, 1981, DIABETES, V30, P923, DOI 10.2337/diabetes.30.11.923; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Doliba NM, 2012, DIABETES OBES METAB, V14, P109, DOI 10.1111/j.1463-1326.2012.01652.x; ERECINSKA M, 1991, P NATL ACAD SCI USA, V88, P7600, DOI 10.1073/pnas.88.17.7600; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guzman-Perez A, 2011, 242 ACS NAT M DENV C; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HENQUIN JC, 1994, DIABETES METAB, V20, P132; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Jung SR, 2011, J BIOL CHEM, V286, P17422, DOI 10.1074/jbc.M110.202820; Jung SR, 2009, AM J PHYSIOL-ENDOC M, V297, pE717, DOI 10.1152/ajpendo.00282.2009; Luciani DS, 2013, DIABETES, V62, P170, DOI 10.2337/db11-1464; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Matschinsky F. M., 2010, F1000 MED REP, V2, P43, DOI DOI 10.3410/M2-43; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matsumoto S, 1999, TRANSPLANTATION, V67, pS220, DOI 10.1097/00007890-199904150-00880; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Philipson LH, 2008, CELL METAB, V7, P280, DOI 10.1016/j.cmet.2008.03.009; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; Prentki M, 1997, DIABETOLOGIA, V40, pS32, DOI 10.1007/s001250051395; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Remedi MS, 2005, DIABETES, V54, P2925, DOI 10.2337/diabetes.54.10.2925; Rountree AM, 2013, DIABETOLOGIA, V56, P803, DOI 10.1007/s00125-012-2808-6; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Sweet IR, 2004, BIOCHEM BIOPH RES CO, V314, P976, DOI 10.1016/j.bbrc.2003.12.182; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; SWEET IR, 1995, AM J PHYSIOL-ENDOC M, V268, pE775, DOI 10.1152/ajpendo.1995.268.4.E775; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wilson D F, 1977, Adv Exp Med Biol, V94, P279; WOLF BA, 1985, BIOCHEM J, V227, P965, DOI 10.1042/bj2270965; YIN L, 1992, DIABETES, V41, P792; Zawalich WS, 2000, J ENDOCRINOL, V166, P111, DOI 10.1677/joe.0.1660111	50	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19110	19119		10.1074/jbc.M114.556050	http://dx.doi.org/10.1074/jbc.M114.556050			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841202	Green Published, hybrid			2022-12-28	WOS:000339062900041
J	Shioda, N; Yabuki, Y; Kobayashi, Y; Onozato, M; Owada, Y; Fukunaga, K				Shioda, Norifumi; Yabuki, Yasushi; Kobayashi, Yuka; Onozato, Misaki; Owada, Yuji; Fukunaga, Kohji			FABP3 Protein Promotes alpha-Synuclein Oligomerization Associated with 1-Methyl-1,2,3,6-tetrahydropiridine-induced Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING PROTEIN; PARKINSONS-DISEASE; FATTY-ACIDS; LEWY BODIES; BRAIN; MUTATION; DEMENTIA; NEURONS; CELLS; MECHANISMS	alpha-Synuclein (alpha Syn) accumulation in dopaminergic (DA) neurons is partly regulated by long-chain polyunsaturated fatty acids. We found that fatty acid-binding protein 3 (FABP3, H-FABP), a factor critical for arachidonic acid (AA) transport and metabolism in brain, is highly expressed in DA neurons. Fabp3 knock-out (Fabp3(-/-)) mice were resistant to 1-methyl1,2,3,6-tetrahydropiridine- induced DA neurodegeneration in the substantia nigra pars compacta and showed improved motor function. Interestingly, FABP3 interacted with alpha Syn in the substantia nigra pars compacta, and alpha Syn accumulation following 1-methyl-1,2,3,6-tetrahydropiridine treatment was attenuated in Fabp3(-/-) compared with wild-type mice. We confirmed that FABP3 overexpression aggravates AA-induced alpha Syn oligomerization and promotes cell death in PC12 cells, whereas overexpression of a mutant form of FABP3 lacking fatty-acid binding capacity did not. Taken together, alpha Syn oligomerization in DA neurons is likely aggravated by AA through FABP3 in Parkinson disease pathology.	[Shioda, Norifumi; Yabuki, Yasushi; Kobayashi, Yuka; Onozato, Misaki; Fukunaga, Kohji] Tohoku Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Owada, Yuji] Yamaguchi Univ, Grad Sch Med, Dept Organ Anat, Ube, Yamaguchi 7558505, Japan	Tohoku University; Yamaguchi University	Fukunaga, K (corresponding author), Tohoku Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 9808578, Japan.	kfukunaga@m.tohoku.ac.jp	Yabuki, Yasushi/AAF-7931-2021; Fukunaga, Kohji/AAI-8811-2021	Fukunaga, Kohji/0000-0001-8526-2824; Owada, Yuji/0000-0002-5109-0531	"Foundation of Synapse and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science and Technology, Japan [25110705, 25460090, 24102505, 25293124]	"Foundation of Synapse and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by Grants-in-aid for Scientific Research on Innovative Area "Foundation of Synapse and Neurocircuit Pathology" 25110705 and 25460090 (to N. S.) and 24102505 and 25293124 (to K. F.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Binas B, 1999, FASEB J, V13, P805, DOI 10.1096/fasebj.13.8.805; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen H, 2003, AM J EPIDEMIOL, V157, P1007, DOI 10.1093/aje/kwg073; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Ferguson MC, 2010, NEUROPHARMACOLOGY, V59, P31, DOI 10.1016/j.neuropharm.2010.03.013; Fornai F, 2003, J NEUROSCI, V23, P8955; Golovko MY, 2006, BIOCHEMISTRY-US, V45, P6956, DOI 10.1021/bi0600289; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Julien C, 2006, NEUROCHEM INT, V48, P404, DOI 10.1016/j.neuint.2005.12.002; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Mollenhauer B, 2007, NEURODEGENER DIS, V4, P366, DOI 10.1159/000105157; Murphy EJ, 2005, BIOCHEMISTRY-US, V44, P6350, DOI 10.1021/bi047292r; Nguyen SM, 2007, J NEUROSCI METH, V161, P281, DOI 10.1016/j.jneumeth.2006.10.026; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Owada Y., 2003, FATTY ACID BINDING P, P253; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song GX, 2012, J CELL BIOCHEM, V113, P3701, DOI 10.1002/jcb.24243; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Wada-Isoe K, 2008, J NEUROL SCI, V266, P20, DOI 10.1016/j.jns.2007.08.018; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zimmerman AW, 1999, BIOCHEM J, V344, P495, DOI 10.1042/0264-6021:3440495	44	54	55	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18957	18965		10.1074/jbc.M113.527341	http://dx.doi.org/10.1074/jbc.M113.527341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855640	Green Published, hybrid			2022-12-28	WOS:000339062900028
J	Mizoguchi, Y; Kato, TA; Seki, Y; Ohgidani, M; Sagata, N; Horikawa, H; Yamauchi, Y; Sato-Kasai, M; Hayakawa, K; Inoue, R; Kanba, S; Monji, A				Mizoguchi, Yoshito; Kato, Takahiro A.; Seki, Yoshihiro; Ohgidani, Masahiro; Sagata, Noriaki; Horikawa, Hideki; Yamauchi, Yusuke; Sato-Kasai, Mina; Hayakawa, Kohei; Inoue, Ryuji; Kanba, Shigenobu; Monji, Akira			Brain-derived Neurotrophic Factor (BDNF) Induces Sustained Intracellular Ca2+ Elevation through the Up-regulation of Surface Transient Receptor Potential 3 (TRPC3) Channels in Rodent Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; IN-VITRO; ACTIVATION; SCHIZOPHRENIA; ARIPIPRAZOLE; INHIBITION; DEPRESSION; RELEASE; CALCIUM; NEURONS	Microglia are immune cells that release factors, including proinflammatory cytokines, nitric oxide (NO), and neurotrophins, following activation after disturbance in the brain. Elevation of intracellular Ca2+ concentration ([Ca2+](i)) is important for microglial functions such as the release of cytokines and NO from activated microglia. There is increasing evidence suggesting that pathophysiology of neuropsychiatric disorders is related to the inflammatory responses mediated by microglia. Brain-derived neurotrophic factor (BDNF) is a neurotrophin well known for its roles in the activation of microglia as well as in pathophysiology and/or treatment of neuropsychiatric disorders. In this study, we sought to examine the underlying mechanism of BDNF-induced sustained increase in [Ca2+](i) in rodent microglial cells. We observed that canonical transient receptor potential 3 (TRPC3) channels contribute to the maintenance of BDNF-induced sustained intracellular Ca2+ elevation. Immunocytochemical technique and flow cytometry also revealed that BDNF rapidly up-regulated the surface expression of TRPC3 channels in rodent microglial cells. In addition, pretreatment with BDNF suppressed the production of NO induced by tumor necrosis factor alpha (TNF alpha), which was prevented by co-adiministration of a selective TRPC3 inhibitor. These suggest that BDNF induces sustained intracellular Ca2+ elevation through the up-regulation of surface TRPC3 channels and TRPC3 channels could be important for the BDNF-induced suppression of the NO production in activated microglia. We show that TRPC3 channels could also play important roles in microglial functions, which might be important for the regulation of inflammatory responses and may also be involved in the pathophysiology and/or the treatment of neuropsychiatric disorders.	[Mizoguchi, Yoshito; Monji, Akira] Saga Univ, Fac Med, Dept Psychiat, Saga 8498501, Japan; [Kato, Takahiro A.; Seki, Yoshihiro; Ohgidani, Masahiro; Sagata, Noriaki; Horikawa, Hideki; Yamauchi, Yusuke; Sato-Kasai, Mina; Hayakawa, Kohei; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Higashi Ku, Fukuoka 8128582, Japan; [Kato, Takahiro A.; Ohgidani, Masahiro; Sagata, Noriaki] Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 8128582, Japan; [Inoue, Ryuji] Fukuoka Univ, Sch Med, Dept Physiol, Jyonan Ku, Fukuoka 8120180, Japan	Saga University; Kyushu University; Kyushu University; Fukuoka University	Mizoguchi, Y (corresponding author), Saga Univ, Fac Med, Dept Neuropsychiat, 5-1-1 Nabeshima, Saga 8498501, Japan.	ymizo@pk2.so-net.ne.jp	Yamauchi, Yusuke/D-2780-2015; Kato, Takahiro/R-7665-2019	Yamauchi, Yusuke/0000-0001-7854-927X; Kato, Takahiro/0000-0001-5169-2930	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y. M., T. A. K., S. K., and A. M.).	Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Cheepsunthorn P, 2001, GLIA, V35, P53, DOI 10.1002/glia.1070; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Horikawa H, 2010, PROG NEURO-PSYCHOPH, V34, P1306, DOI 10.1016/j.pnpbp.2010.07.015; Kalinchuk AV, 2010, J NEUROSCI, V30, P13254, DOI 10.1523/JNEUROSCI.0014-10.2010; Kato TA, 2013, CURR MED CHEM, V20, P331; Kato TA, 2011, MINI-REV MED CHEM, V11, P565; Kato T, 2008, J NEUROCHEM, V106, P815, DOI 10.1111/j.1471-4159.2008.05435.x; Kato TA, 2011, SCHIZOPHR RES, V129, P172, DOI 10.1016/j.schres.2011.03.019; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim MS, 2011, GASTROENTEROLOGY, V140, P2107, DOI 10.1053/j.gastro.2011.02.052; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Koller H, 1996, BRAIN, V119, P2021, DOI 10.1093/brain/119.6.2021; Mizoguchi Y, 2011, MINI-REV MED CHEM, V11, P575, DOI 10.2174/138955711795906932; Mizoguchi Y, 2003, J BIOL CHEM, V278, P44097, DOI 10.1074/jbc.M305872200; Mizoguchi Y, 2003, J PHYSIOL-LONDON, V548, P703, DOI 10.1113/jphysiol.2003.038935; Mizoguchi Y, 2009, J IMMUNOL, V183, P7778, DOI 10.4049/jimmunol.0901326; Monji A, 2013, PROG NEURO-PSYCHOPH, V42, P115, DOI 10.1016/j.pnpbp.2011.12.002; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Naziroglu M, 2011, NEUROCHEM RES, V36, P355, DOI 10.1007/s11064-010-0347-4; Patel VH, 2008, PFLUG ARCH EUR J PHY, V456, P635, DOI 10.1007/s00424-007-0440-y; Seki Y, 2011, NEUROPATHOLOGY, V31, P215, DOI 10.1111/j.1440-1789.2010.01163.x; Simen BB, 2006, BIOL PSYCHIAT, V59, P775, DOI 10.1016/j.biopsych.2005.10.013	26	62	63	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18549	18555		10.1074/jbc.M114.555334	http://dx.doi.org/10.1074/jbc.M114.555334			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24811179	hybrid, Green Published			2022-12-28	WOS:000338042000051
J	Ponce-Coria, J; Markadieu, N; Austin, TM; Flammang, L; Rios, K; Welling, PA; Delpire, E				Ponce-Coria, Jose; Markadieu, Nicolas; Austin, Thomas M.; Flammang, Lindsey; Rios, Kerri; Welling, Paul A.; Delpire, Eric			A Novel Ste20-related Proline/Alanine-rich Kinase (SPAK)-independent Pathway Involving Calcium-binding Protein 39 (Cab39) and Serine Threonine Kinase with No Lysine Member 4 (WNK4) in the Activation of Na-K-Cl Cotransporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-CAUSING MUTATIONS; NA+-K+-2CL(-) COTRANSPORTER; CRYSTAL-STRUCTURE; OSR1 KINASE; SPAK; HYPERTENSION; SPAK/OSR1; COMPLEX; TRANSPORTERS; SENSITIVITY	Na+-dependent chloride cotransporters (NKCC1, NKCC2, and NCC) are activated by phosphorylation to play critical roles in diverse physiological responses, including renal salt balance, hearing, epithelial fluid secretion, and volume regulation. Serine threonine kinase WNK4 (With No K = lysine member 4) and members of the Ste20 kinase family, namely SPAK and OSR1 (Ste20-related proline/alanine-rich kinase, Oxidative stress-responsive kinase) govern phosphorylation. According to present understanding, WNK4 phosphorylates key residues within SPAK/OSR1 leading to kinase activation, allowing SPAK/OSR1 to bind to and phosphorylate NKCC1, NKCC2, and NCC. Recently, the calcium-binding protein 39 (Cab39) has emerged as a binding partner and enhancer of SPAK/OSR1 activity, facilitating kinase autoactivation and promoting phosphorylation of the cotransporters. In the present study, we provide evidence showing that Cab39 differentially interacts with WNK4 and SPAK/OSR1 to switch the classic two kinase cascade into a signal kinase transduction mechanism. We found that WNK4 in association with Cab39 activates NKCC1 in a SPAK/OSR1-independent manner. We discovered that WNK4 possesses a domain that bears close resemblance to the SPAK/OSR1 C-terminal CCT/PF2 domain, which is required for physical interaction between the Ste20 kinases and the Na+-driven chloride cotransporters. Modeling, yeast two-hybrid, and functional data reveal that this PF2-like domain located downstream of the catalytic domain in WNK4 promotes the direct interaction between the kinase and NKCC1. We conclude that in addition to SPAK and OSR1, WNK4 is able to anchor itself to the N-terminal domain of NKCC1 and to promote cotransporter activation.	[Ponce-Coria, Jose; Markadieu, Nicolas; Austin, Thomas M.; Flammang, Lindsey; Rios, Kerri; Delpire, Eric] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; [Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Vanderbilt University; University System of Maryland; University of Maryland Baltimore	Delpire, E (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, T-4202 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.	eric.delpire@vanderbilt.edu	Ponce-Coria, Jose/D-4866-2016	Ponce-Coria, Jose/0000-0002-3345-0206	National Institutes of Health from the NIDDK [DK093501]; Foundation for Anesthesia Education and Research grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, R01DK093501] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; Foundation for Anesthesia Education and Research grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK093501 from the NIDDK (to E. D. and P. A. W.).; Supported by a Foundation for Anesthesia Education and Research grant.	Ahlstrom R, 2009, AM J PHYSIOL-RENAL, V297, pF685, DOI 10.1152/ajprenal.00358.2009; Alexander Nathan, 2011, IEEE Int Conf Comput Adv Bio Med Sci, V2011, P13, DOI 10.1109/ICCABS.2011.5729867; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Delpire E, 2007, PHYSIOL GENOMICS, V28, P223, DOI 10.1152/physiolgenomics.00173.2006; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; Gagnon KB, 2011, CELL PHYSIOL BIOCHEM, V28, P1219, DOI 10.1159/000335854; Gagnon KB, 2010, J PHYSIOL-LONDON, V588, P3385, DOI 10.1113/jphysiol.2010.191932; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Gagnon KBE, 2007, AM J PHYSIOL-CELL PH, V292, pC1809, DOI 10.1152/ajpcell.00580.2006; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; James P, 1996, GENETICS, V144, P1425; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; MIYAMOTO H, 1993, MOL REPROD DEV, V34, P1, DOI 10.1002/mrd.1080340102; Na T, 2012, BIOCHEM BIOPH RES CO, V419, P293, DOI 10.1016/j.bbrc.2012.02.013; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2012, AM J PHYSIOL-CELL PH, V303, pC1198, DOI 10.1152/ajpcell.00284.2012; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Shin JH, 2004, J BIOL CHEM, V279, P18567, DOI 10.1074/jbc.M400639200; Villa F, 2007, EMBO REP, V8, P839, DOI 10.1038/sj.embor.7401048; Villa F, 2008, PROTEINS, V73, P1082, DOI 10.1002/prot.22238; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377	43	32	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17680	17688		10.1074/jbc.M113.540518	http://dx.doi.org/10.1074/jbc.M113.540518			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24811174	Green Published, hybrid			2022-12-28	WOS:000338018100032
J	Sayyah, J; Bartakova, A; Nogal, N; Quilliam, LA; Stupack, DG; Brown, JH				Sayyah, Jacqueline; Bartakova, Alena; Nogal, Nekeisha; Quilliam, Lawrence A.; Stupack, Dwayne G.; Brown, Joan Heller			The Ras-related Protein, Rap1A, Mediates Thrombin-stimulated, Integrin-dependent Glioblastoma Cell Proliferation and Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; FOCAL ADHESION KINASE; DNA-SYNTHESIS; LYSOPHOSPHATIDIC ACID; SIGNALING PATHWAYS; GENE-EXPRESSION; FACTOR RECEPTOR; RHO GTPASES; CALDAG-GEFI; MAP KINASE	Rap1 is a Ras family GTPase with a well documented role in ERK/MAP kinase signaling and integrin activation. Stimulation of the G-protein-coupled receptor PAR-1 with thrombin in human 1321N1 glioblastoma cells led to a robust increase in Rap1 activation. This response was sustained for up to 6 h and mediated through RhoA and phospholipase D (PLD). Thrombin treatment also induced a 5-fold increase in cell adhesion to fibronectin, which was blocked by down-regulating PLD or Rap1A or by treatment with a beta(1) integrin neutralizing antibody. In addition, thrombin treatment led to increases in phospho-focal adhesion kinase (tyrosine 397), ERK1/2 phosphorylation and cell proliferation, which were significantly inhibited in cells treated with beta(1) integrin antibody or Rap1A siRNA. To assess the role of Rap1A in tumor formation in vivo, we compared growth of 1321N1 cells stably expressing control, Rap1A or Rap1B shRNA in a mouse xenograft model. Deletion of Rap1A, but not of Rap1B, reduced tumor mass by >70% relative to control. Similar observations were made with U373MG glioblastoma cells in which Rap1A was down-regulated. Collectively, these findings implicate a Rap1A/beta(1) integrin pathway, activated downstream of G-protein-coupled receptor stimulation and RhoA, in glioblastoma cell proliferation. Moreover, our data demonstrate a critical role for Rap1A in glioblastoma tumor growth in vivo.	[Sayyah, Jacqueline; Nogal, Nekeisha; Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Bartakova, Alena; Stupack, Dwayne G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Quilliam, Lawrence A.] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Indiana University System; Indiana University-Purdue University Indianapolis	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr,Mail Code 0636, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu	Quilliam, Lawrence/B-6447-2015; Quilliam, Lawrence/Q-4987-2019	Bartakova, Alena/0000-0002-1344-6103	NCI, National Institutes of Health [T32CA121938]; National Institutes of Health [T32CA121938, GM 36927, HL28143, R01 CA107263, R37HLO28143]; U.S. Department of Defense [W81XWH1110355]; NATIONAL CANCER INSTITUTE [R01CA107263, P30CA023100, T32CA121938] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028143, R37HL028143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036927, R56GM036927] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NCI, National Institutes of Health Award T32CA121938 and National Institutes of Health Grants GM 36927 and HL28143.; Supported by National Institutes of Health Grant T32CA121938.; Supported by National Institutes of Health Grant R01 CA107263.; Supported by National Institutes of Health Grants GM 36927 and R37HLO28143.; Supported by U.S. Department of Defense Award W81XWH1110355.	Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; An DS, 1999, J VIROL, V73, P7671, DOI 10.1128/JVI.73.9.7671-7677.1999; ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; Banerjee Rajat, 2012, Small GTPases, V3, P192, DOI 10.4161/sgtp.20413; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Castro AF, 2005, METHODS, V37, P190, DOI 10.1016/j.ymeth.2005.05.015; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Collins LR, 1997, ONCOGENE, V15, P595, DOI 10.1038/sj.onc.1201220; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Dupuy AJ, 2001, J BIOL CHEM, V276, P11804, DOI 10.1074/jbc.M008970200; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gayral S, 2006, CIRC RES, V99, P132, DOI 10.1161/01.RES.0000232323.86227.8b; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Holinstat M, 2007, MOL PHARMACOL, V71, P686, DOI 10.1124/mol.106.029371; Hua Y, 2005, J THROMB HAEMOST, V3, P1917, DOI 10.1111/j.1538-7836.2005.01446.x; Hua Y, 2003, ACT NEUR S, V86, P503; Huang M, 2012, ONCOGENE, V31, P2783, DOI 10.1038/onc.2011.450; Ishida D, 2003, CANCER CELL, V4, P55, DOI 10.1016/S1535-6108(03)00163-6; Kato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046576; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Liberto M, 2002, ONCOGENE, V21, P1590, DOI 10.1038/sj.onc.1205242; Lim J., J CELL BIOCH, V111, P999; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Ogiichi T, 2000, J NEURO-ONCOL, V46, P1, DOI 10.1023/A:1006323200001; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Post GR, 1996, MOL BIOL CELL, V7, P1679, DOI 10.1091/mbc.7.11.1679; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Riemenschneider MJ, 2005, AM J PATHOL, V167, P1379, DOI 10.1016/S0002-9440(10)61225-4; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Russo MA, 2013, INT J ONCOL, V42, P83, DOI 10.3892/ijo.2012.1708; Schonherr C, 2010, ONCOGENE, V29, P2817, DOI 10.1038/onc.2010.27; Seasholtz TM, 2001, CIRC RES, V89, P488, DOI 10.1161/hh1801.096337; Seasholtz TM, 1999, MOL PHARMACOL, V55, P949, DOI 10.1124/mol.55.6.949; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; Siehler S, 2001, J BIOL CHEM, V276, P48733, DOI 10.1074/jbc.M011072200; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Walker SJ, 2002, J BIOL CHEM, V277, P26260, DOI 10.1074/jbc.M201811200; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Whitehead IP, 2001, ONCOGENE, V20, P1547, DOI 10.1038/sj.onc.1204188; Wittchen Erika S, 2011, Small GTPases, V2, P65; WOJTUKIEWICZ MZ, 1995, CANCER RES, V55, P698; Yan JL, 2008, MOL CELL BIOL, V28, P5803, DOI 10.1128/MCB.00393-08; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang ZC, 2006, AM J PATHOL, V168, P585, DOI 10.2353/ajpath.2006.050132; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	70	40	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17689	17698		10.1074/jbc.M113.536227	http://dx.doi.org/10.1074/jbc.M113.536227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24790104	Green Published, hybrid			2022-12-28	WOS:000338018100033
J	Swanson, CJ; Ritt, M; Wang, W; Lang, MJ; Narayan, A; Tesmer, JJ; Westfall, M; Sivaramakrishnan, S				Swanson, Carter J.; Ritt, Michael; Wang, William; Lang, Michael J.; Narayan, Arvind; Tesmer, John J.; Westfall, Margaret; Sivaramakrishnan, Sivaraj			Conserved Modular Domains Team up to Latch-open Active Protein Kinase C alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; CATALYTIC DOMAIN; SINGLE-MOLECULE; ACTIVATION; MECHANISM; PKC; PHOSPHORYLATION; CALCIUM; PSEUDOSUBSTRATE; IDENTIFICATION	Signaling proteins comprised of modular domains have evolved along with multicellularity as a method to facilitate increasing intracellular bandwidth. The effects of intramolecular interactions between modular domains within the context of native proteins have been largely unexplored. Here we examine intra-and intermolecular interactions in the multidomain signaling protein, protein kinase C alpha (PKC alpha). We identify three interactions between two activated PKC molecules that synergistically stabilize a nanomolar affinity homodimer. Disruption of the homodimer results in a loss of PKC-mediated ERK1/2 phosphorylation, whereas disruption of the auto-inhibited state promotes the homodimer and prolongs PKC membrane localization. These observations support a novel regulatory mechanism wherein homodimerization dictates the equilibrium between the auto-inhibited and active states of PKC by sequestering auto-inhibitory interactions. Our findings underscore the physiological importance of context-dependent modular domain interactions in cell signaling.	[Swanson, Carter J.; Tesmer, John J.; Sivaramakrishnan, Sivaraj] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Ritt, Michael; Wang, William; Lang, Michael J.; Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Wang, William; Westfall, Margaret] Univ Michigan, Dept Cardiac Surg, Ann Arbor, MI 48109 USA; [Narayan, Arvind; Westfall, Margaret; Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Biomed Engn, Inst Life Sci, Ann Arbor, MI 48109 USA; [Tesmer, John J.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Tesmer, John J.] Univ Michigan, Dept Biol Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Dept Cell & Dev Biol, 3045 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	sivaraj@umich.edu		Westfall, Margaret/0000-0001-9491-0125; lang, michael/0000-0003-3544-5221; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [1DP2 CA186752-01]; American Heart Association [13SDG14270009]; MCubed program at the University of Michigan; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL086865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); MCubed program at the University of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1DP2 CA186752-01 (to S. S.). This work was also supported by American Heart Association Scientist Development Grant 13SDG14270009 (to S. S.).; Supported in part by the MCubed program at the University of Michigan.	Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Bauer AF, 2012, J BIOL CHEM, V287, P20590, DOI 10.1074/jbc.M111.327437; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Braun DC, 2005, J BIOL CHEM, V280, P8164, DOI 10.1074/jbc.M413896200; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Copley RR, 1999, CURR OPIN STRUC BIOL, V9, P408, DOI 10.1016/S0959-440X(99)80055-4; Doran JD, 2004, BIOCHEM J, V384, P255, DOI 10.1042/BJ20040344; Dubin AE, 2010, J NEUROSCI, V30, P7300, DOI 10.1523/JNEUROSCI.6151-09.2010; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; FLINT AJ, 1990, SCIENCE, V249, P408, DOI 10.1126/science.2377895; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Giorgione Jennifer, 2003, Methods Mol Biol, V233, P105; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Guo BQ, 2006, J MOL BIOL, V357, P820, DOI 10.1016/j.jmb.2005.12.056; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Heikkila T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024825; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG KP, 1989, TRENDS NEUROSCI, V12, P425, DOI 10.1016/0166-2236(89)90091-X; Huang SM, 1999, BIOCHEMISTRY-US, V38, P12020, DOI 10.1021/bi990594m; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Keshwani MM, 2008, J BIOL CHEM, V283, P11972, DOI 10.1074/jbc.M800114200; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Kirwan AF, 2003, BIOCHEM J, V373, P571, DOI 10.1042/BJ20030011; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Masters TA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000738; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; Ni DQ, 2000, PROTEIN SCI, V9, P1818, DOI 10.1110/ps.9.9.1818; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Raghunath A, 2003, BIOCHEM J, V370, P901, DOI 10.1042/BJ20021420; Ritt M, 2013, J BIOL CHEM, V288, P8875, DOI 10.1074/jbc.M112.421164; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sando JJ, 1998, J BIOL CHEM, V273, P34022, DOI 10.1074/jbc.273.51.34022; Schmalz D, 1998, J CELL SCI, V111, P1823; Sivaramakrishnan S, 2009, BIOPHYS J, V97, P2993, DOI 10.1016/j.bpj.2009.09.009; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stensman H, 2004, J BIOL CHEM, V279, P40576, DOI 10.1074/jbc.M405560200; Stensman H, 2007, J BIOL CHEM, V282, P28627, DOI 10.1074/jbc.M702248200; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; VANDUUREN BL, 1976, CHEM-BIOL INTERACT, V15, P233, DOI 10.1016/0009-2797(76)90149-6; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; WALKER JM, 1988, J BIOL CHEM, V263, P4537; Yamaguchi H, 2006, STRUCTURE, V14, P589, DOI 10.1016/j.str.2005.11.024; Yang L, 1996, BIOCHEMISTRY-US, V35, P13966, DOI 10.1021/bi9610008; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yeong SS, 2006, J BIOL CHEM, V281, P30768, DOI 10.1074/jbc.M511278200; Ziemba BP, 2014, BIOCHEMISTRY-US, V53, P1697, DOI 10.1021/bi4016082	64	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17812	17829		10.1074/jbc.M113.534750	http://dx.doi.org/10.1074/jbc.M113.534750			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24790081	Green Published, hybrid			2022-12-28	WOS:000338018100044
J	Hirai, T; Tanaka, K; Togari, A				Hirai, Takao; Tanaka, Kenjiro; Togari, Akifumi			alpha 1-Adrenergic Receptor Signaling in Osteoblasts Regulates Clock Genes and Bone Morphogenetic Protein 4 Expression through Up-regulation of the Transcriptional Factor Nuclear Factor IL-3 (Nfil3)/E4 Promoter-binding Protein 4 (E4BP4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; IA RECEPTOR; COUPLED RECEPTORS; VRILLE; PROLIFERATION; STIMULATION; NEURONS; SYSTEM; BMPRIA; MICE	Several studies have demonstrated that the alpha 1-adrenergic receptor (AR) plays an important role in regulating cell growth and function in osteoblasts. However, the physiological role of alpha 1-AR signaling in bone metabolism is largely unknown. In this study, the stimulation of phenylephrine (PHE), a nonspecific alpha 1-AR agonist, increased the transcriptional factor Nfil3/E4BP4 and led to the rhythmic expression of bone morphogenetic protein 4 (Bmp4) in MC3T3-E1 osteoblastic cells. We also showed that Bmp4 mRNA expression peaked in bone near zeitgeber time 8 in a 24-h rhythm. Furthermore, the expression of Nfil3 and Bmp4 displayed a circadian pattern with opposing phases, which suggested that Nfil3 repressed the expression of the Bmp4 gene during a circadian cycle. On a molecular level, both loss-of-function and gain-of-function experiments demonstrated that Nfil3/E4BP4 negatively regulated Bmp4 expression in osteoblasts. Furthermore, the systemic administration of PHE increased the expression of Nfil3 mRNA in bone, whereas it decreased that of Bmp4 mRNA. The expression of Bmp4 mRNA was decreased significantly by exposure to PHE, and this was concomitant with the increase in Nfil3 binding to the D-box-containing Bmp4 promoter region in MC3T3-E1 cells, which indicates that the expression of Nfil3 by alpha 1-AR signaling can bind directly to the Bmp4 promoter and inhibit Bmp4 expression in osteoblasts. Our results suggest that alpha 1-AR signaling regulates clock genes and Bmp4 expression in osteoblasts. Moreover, alpha 1-AR signaling negatively regulated Bmp4 expression by up-regulating the transcriptional factor Nfil3/E4BP4 in osteoblasts.	[Hirai, Takao; Tanaka, Kenjiro; Togari, Akifumi] Aichi Gakuin Univ, Sch Dent, Dept Pharmacol, Nagoya, Aichi 4648650, Japan	Aichi Gakuin University	Togari, A (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Pharmacol, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	togariaf@dpc.agu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24790291]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research 24790291 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. H.).	Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Fujihara Y, 2014, BONE, V61, P1, DOI 10.1016/j.bone.2013.12.026; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Hatta T, 2000, BIOPOLYMERS, V55, P399, DOI 10.1002/1097-0282(2000)55:5<399::AID-BIP1014>3.0.CO;2-9; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Hirai T, 2006, J NEUROCHEM, V96, P1519, DOI 10.1111/j.1471-4159.2006.03655.x; Huang H, 2009, DYNAMICS OF SURFACE WAVES IN COASTAL WATERS: WAVE-CURRENT-BOTTOM INTERACTIONS, P1; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Kamiya N, 2008, J BONE MINER RES, V23, P2007, DOI 10.1359/JBMR.080809; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kodama D, 2013, BRIT J PHARMACOL, V168, P1230, DOI 10.1111/bph.12000; Komoto S, 2012, CHRONOBIOL INT, V29, P66, DOI 10.3109/07420528.2011.636496; Kondo H, 2011, CALCIFIED TISSUE INT, V88, P23, DOI 10.1007/s00223-010-9421-9; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Mengatto CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015848; Nishiura T, 2007, ARCH ORAL BIOL, V52, P778, DOI 10.1016/j.archoralbio.2007.01.005; Okubo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078306; Philipp M, 2004, PHARMACOL THERAPEUT, V101, P65, DOI 10.1016/j.pharmthera.2003.10.004; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Suzuki A, 1999, ENDOCRINOLOGY, V140, P3177, DOI 10.1210/en.140.7.3177; Suzuki A, 1998, BONE, V23, P197, DOI 10.1016/S8756-3282(98)00099-4; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Takeuchi T, 2001, BIOCHEM PHARMACOL, V61, P579, DOI 10.1016/S0006-2952(00)00591-8; Togari A, 1997, NEUROSCI LETT, V233, P125, DOI 10.1016/S0304-3940(97)00649-6; Togari A, 2005, EXPERT OPIN THER TAR, V9, P931, DOI 10.1517/14728222.9.5.931; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhang HB, 1996, DEVELOPMENT, V122, P2977	41	25	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17174	17183		10.1074/jbc.M113.546135	http://dx.doi.org/10.1074/jbc.M113.546135			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24794868	Green Published, hybrid			2022-12-28	WOS:000338016200050
J	Moynihan, PJ; Clarke, AJ				Moynihan, Patrick J.; Clarke, Anthony J.			Substrate Specificity and Kinetic Characterization of Peptidoglycan O-Acetyltransferase B from Neisseria gonorrhoeae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; EGG-WHITE LYSOZYME; ACETYLPEPTIDOGLYCAN ESTERASE; CROSS-LINKING; CELL-WALL; STAPHYLOCOCCUS-AUREUS; PENICILLIN RESISTANCE; ANTIBACTERIAL TARGET; MUREIN BIOSYNTHESIS; PROTEUS-MIRABILIS	The O-acetylation of the essential cell wall polymer peptidoglycan is a major virulence factor identified in many bacteria, both Gram-positive and Gram-negative, including Staphylococcus aureus, Bacillus anthracis, Neisseria gonorrhoeae, and Neisseria meningitidis. With Gram-negative bacteria, the translocation of acetyl groups from the cytoplasm is performed by an integral membrane protein, PatA, for its transfer to peptidoglycan by O-acetyltransferase PatB, whereas a single bimodal membrane protein, OatA, appears to catalyze both reactions of the process in Gram-positive bacteria. Only phenotypic evidence existed in support of these pathways because no in vitro biochemical assay was available for their analysis, which reflected the complexities of investigating integral membrane proteins that act on a totally insoluble and heterogeneous substrate, such as peptidoglycan. In this study, we present the first biochemical and kinetic analysis of a peptidoglycan O-acetyltransferase using PatB from N. gonorrhoeae as the model system. The enzyme has specificity for muropeptides that possess tri- and tetrapeptide stems on muramyl residues. With chitooligosac charides as substrates, rates of reaction increase with increasing degrees of polymerization to 5/6. This information will be valuable for the identification and development of peptidoglycan O-acetyltransferase inhibitors that could represent potential leads to novel classes of antibiotics.	[Moynihan, Patrick J.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	a.clarke@exec.uoguelph.ca	Moynihan, Patrick J/I-3393-2013	Moynihan, Patrick J/0000-0003-4182-6223	Canadian Institutes of Health Research [TGC114045]; Ontario Graduate Scholarship from the Province of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship from the Province of Ontario	This work was supported by Canadian Institutes of Health Research Team Grant TGC114045 (to A. J. C.) and an Ontario Graduate Scholarship from the Province of Ontario (to P. J. M.).	ABRAMS A, 1958, J BIOL CHEM, V230, P949; Antignac A, 2003, J BIOL CHEM, V278, P31521, DOI 10.1074/jbc.M304749200; Aubry C, 2011, J INFECT DIS, V204, P731, DOI 10.1093/infdis/jir396; BANERJEE SK, 1975, J BIOL CHEM, V250, P4355; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2006, INFECT IMMUN, V74, P4598, DOI 10.1128/IAI.00301-06; BERGER LR, 1957, BIOCHIM BIOPHYS ACTA, V26, P517, DOI 10.1016/0006-3002(57)90098-7; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; BRUMFITT W, 1958, NATURE, V181, P1783, DOI 10.1038/1811783a0; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Clarke AJ, 2000, GLYCOMICROBIOLOGY, P187; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; Fujimoto Y, 2012, NAT PROD REP, V29, P568, DOI 10.1039/c2np00091a; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GMEINER J, 1987, EUR J BIOCHEM, V163, P389, DOI 10.1111/j.1432-1033.1987.tb10811.x; GMEINER J, 1981, EUR J BIOCHEM, V117, P171; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; KIEFER LL, 1989, PHYTOCHEMISTRY, V28, P2105, DOI 10.1016/S0031-9422(00)97928-7; Laaberki MH, 2011, J BIOL CHEM, V286, P5278, DOI 10.1074/jbc.M110.183236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAR AL, 1983, J GEN MICROBIOL, V129, P885; LEAR AL, 1987, J GEN MICROBIOL, V133, P1743; LEAR AL, 1986, J GEN MICROBIOL, V132, P2413; Moynihan PJ, 2013, ANAL BIOCHEM, V439, P73, DOI 10.1016/j.ab.2013.04.022; Moynihan PJ, 2011, INT J BIOCHEM CELL B, V43, P1655, DOI 10.1016/j.biocel.2011.08.007; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Pagotto FJ, 2000, GENE, V244, P13, DOI 10.1016/S0378-1119(99)00557-0; Peroutka RJ, 2011, METHODS MOL BIOL, V705, P15, DOI 10.1007/978-1-61737-967-3_2; Pfeffer JM, 2012, CHEMBIOCHEM, V13, P722, DOI 10.1002/cbic.201100744; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; SNOWDEN MA, 1991, J GEN MICROBIOL, V137, P1661, DOI 10.1099/00221287-137-7-1661; Strating H, 2001, ANAL BIOCHEM, V291, P149, DOI 10.1006/abio.2001.5007; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Veyrier FJ, 2013, MOL MICROBIOL, V87, P1100, DOI 10.1111/mmi.12153; Weadge JT, 2007, BIOCHEMISTRY-US, V46, P4932, DOI 10.1021/bi700254m; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s; Zarantonelli ML, 2013, CELL HOST MICROBE, V13, P735, DOI 10.1016/j.chom.2013.04.016	43	23	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16748	16760		10.1074/jbc.M114.567388	http://dx.doi.org/10.1074/jbc.M114.567388			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24795044	Green Published, hybrid			2022-12-28	WOS:000338016200014
